PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Borgonovi, F; Pokropek, A				Borgonovi, Francesca; Pokropek, Artur			Education and Self-Reported Health: Evidence from 23 Countries on the Role of Years of Schooling, Cognitive Skills and Social Capital	PLOS ONE			English	Article							RATED HEALTH; INCOME INEQUALITY; CIVIC ENGAGEMENT; ADULT MORTALITY; ASSOCIATION; TRUST; ATTAINMENT; NETWORK; SPREAD; SIZE	We examine the contribution of human capital to health in 23 countries worldwide using the OECD Survey of Adult Skills, a unique large-scale international assessment of 16-65 year olds that contains information about self-reported health, schooling, cognitive skills and indicators of interpersonal trust, which represents the cognitive dimension of social capital. We identify cross-national differences in education, skill and social capital gradients in selfreported health and explore the interaction between human capital and social capital to examine if and where social capital is a mediator or a moderator of years of schooling and cognitive abilities. We find large education gaps in self-reported health across all countries in our sample and a strong positive relationship between self-reported health and both literacy and trust in the majority of countries. Education and skill gradients in self-reported health appear to be largest in the United States and smallest in Italy, France, Sweden and Finland. On average around 5.5% of both the schooling gap in self-reported health and the literacy gap in self-reported health can be explained by the higher levels of interpersonal trust that better educated/more skilled individuals have, although the mediating role of trust varies considerably across countries. We find no evidence of a moderation effect: the relationships between health and years of schooling and health and cognitive skills are similar among individuals with different levels of trust.	[Borgonovi, Francesca] Org Econ Cooperat & Dev, Dept Educ & Skills, Paris, France; [Pokropek, Artur] Polish Acad Sci, Inst Philosophy & Sociol, Warsaw, Poland	Organisation for Economic Co-operation & Development (OECD); Polish Academy of Sciences; Institute of Philosophy & Sociology of the Polish Academy of Sciences	Borgonovi, F (corresponding author), Org Econ Cooperat & Dev, Dept Educ & Skills, Paris, France.	francesca.borgonovi@oecd.org	Pokropek, Artur/H-5509-2013	Pokropek, Artur/0000-0002-5899-2917				Adams S.J., 2002, EDUC ECON, V10, P97, DOI DOI 10.1080/09645290110110227; Albouy V, 2009, J HEALTH ECON, V28, P155, DOI 10.1016/j.jhealeco.2008.09.003; Almedom AM, 2005, SOC SCI MED, V61, P943, DOI 10.1016/j.socscimed.2004.12.025; Arendt JN, 2005, ECON EDUC REV, V24, P149, DOI 10.1016/j.econedurev.2004.04.008; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Berkman L. F., 2000, SOCIAL EPIDEMIOLOGY, V1, P137, DOI DOI 10.4135/9781412952576.N192]; Bloom DE, 2011, GLOBAL EC BURDEN NON; Borgonovi F, 2008, SOC SCI MED, V66, P2321, DOI 10.1016/j.socscimed.2008.01.011; Brunello G, 2015, HLTH EC; Case A, 2005, J HEALTH ECON, V24, P365, DOI 10.1016/j.jhealeco.2004.09.008; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Clark D, AM EC REV IN PRESS; Clark D, 2013, AM ECON REV, V103, P2087, DOI 10.1257/aer.103.6.2087; Cutler David, 2014, ENCY HLTH EC, V1, P232; Cutler DM, 2015, SOC SCI MED, V127, P63, DOI 10.1016/j.socscimed.2014.07.056; Cutler DM, 2010, J HEALTH ECON, V29, P1, DOI 10.1016/j.jhealeco.2009.10.003; Cutler DM., 2008, ED HLTH EVALUATING T; De Silva MJ, 2005, J EPIDEMIOL COMMUN H, V59, P619, DOI 10.1136/jech.2004.029678; Dee TS, 2004, J PUBLIC ECON, V88, P1697, DOI 10.1016/j.jpubeco.2003.11.002; Delhey J, 2011, AM SOCIOL REV, V76, P786, DOI 10.1177/0003122411420817; Ding W, 2009, J HEALTH ECON, V28, P578, DOI 10.1016/j.jhealeco.2008.11.006; Farmer MM, 1997, J HEALTH SOC BEHAV, V38, P298, DOI 10.2307/2955372; Franks P, 2003, SOC SCI MED, V56, P2505, DOI 10.1016/S0277-9536(02)00281-2; Freedman VA, 2008, SOC SCI MED, V66, P1588, DOI 10.1016/j.socscimed.2007.11.037; Fukuyama F., 1996, TRUST SOCIAL VIRTUES; Fukuyama F., 2002, SAIS REV, V22, P23, DOI [10.1353/sais.2002.0009, DOI 10.1353/SAIS.2002.0009]; Glaeser EL, 2000, Q J ECON, V115, P811, DOI 10.1162/003355300554926; Glied S, 2008, DEMOGRAPHY, V45, P741; Goldman D, 2005, AM ECON REV, V95, P234, DOI 10.1257/000282805774669907; Grossman M, 2000, HDB HLTH EC; Grossman M., 2005, HDB EC ED; Grossman M, 1997, SOCIAL BENEFITS ED, P69, DOI DOI 10.3998/MPUB.15129; Grossman M., 1972, DEMAND HLTH THEORETI; Helliwell J., 2011, INT J WELL BEING, V1, P42, DOI DOI 10.5502/IJW.V1I1.9; Helliwell JF, 2004, PHILOS T R SOC B, V359, P1435, DOI 10.1098/rstb.2004.1522; Henderson S, 2003, LANCET, V362, P505, DOI 10.1016/S0140-6736(03)14150-5; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Imai K, 2010, PSYCHOL METHODS, V15, P309, DOI 10.1037/a0020761; Inglehart R., 1997, MODERNIZATION POSTMO; Islam M Kamrul, 2006, Int J Equity Health, V5, P3, DOI 10.1186/1475-9276-5-3; Jones KS, 2006, NONPROF VOLUNT SEC Q, V35, P249, DOI 10.1177/0899764006287464; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Kawachi I., 2008, SOCIAL CAPITAL HLTH, P1, DOI DOI 10.1007/978-0-387-71311-3_1; Knack S, 1997, Q J ECON, V112, P1251, DOI 10.1162/003355300555475; KUNST AE, 1994, AM J PUBLIC HEALTH, V84, P932, DOI 10.2105/AJPH.84.6.932; Lleras-Muney A, 2005, REV ECON STUD, V72, P189, DOI 10.1111/0034-6527.00329; Long J. Scott, 2009, GROUP COMP LOG UNPUB; Lundborg P., 2008, 3399 IZA; Lynch JW, 2000, BMJ-BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200; Mazumder B, 2006, N200623 FED RES BANK; McKenzie K, 2002, BRIT J PSYCHIAT, V181, P280, DOI 10.1192/bjp.181.4.280; MCKINLAY JB, 1993, SOC SCI MED, V36, P109, DOI 10.1016/0277-9536(93)90202-F; McPherson JM, 1996, AM SOCIOL REV, V61, P179, DOI 10.2307/2096330; Meara ER, 2008, HEALTH AFFAIR, V27, P350, DOI 10.1377/hlthaff.27.2.350; Milligan K, 2004, J PUBLIC ECON, V88, P1667, DOI 10.1016/j.jpubeco.2003.10.005; Montez JK, 2015, SOC SCI MED, V127, P1, DOI 10.1016/j.socscimed.2014.12.029; Mood C, 2010, EUR SOCIOL REV, V26, P67, DOI 10.1093/esr/jcp006; Murcia M, 2012, SANTE PUBLIQUE, V23, P59; Nannestad P, 2008, ANNU REV POLIT SCI, V11, P413, DOI 10.1146/annurev.polisci.11.060606.135412; OECD, 2013, PIAAC TECHN REP; OECD, 2014, NAT ACC GALNC 2014; OECD, 2007, UND SOC OUTC LEARN; Oreopoulos P, 2006, AM ECON REV, V96, P152, DOI 10.1257/000282806776157641; Ostrom E., 1990, GOVERNING COMMONS EV; Prins E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130257; Putnam R., 1993, AM PROSPECT, V13; Putnam R., 2001, CANADIAN J POLICY RE, V2, P41; Putnam RD., 2000, BOWLING ALONE COLLAP; Reeskens T, 2008, SOC INDIC RES, V85, P515, DOI 10.1007/s11205-007-9100-z; Rosenberg M, 1957, OCCUPATIONS VALUES; ROSENZWEIG MR, 1983, J POLIT ECON, V91, P723, DOI 10.1086/261179; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Schutte S, 2013, SCAND J PUBLIC HEALT, V41, P51, DOI 10.1177/1403494812469854; Seeman TE, 1996, ANN EPIDEMIOL, V6, P442, DOI 10.1016/S1047-2797(96)00095-6; Silles MA, 2009, ECON EDUC REV, V28, P122, DOI 10.1016/j.econedurev.2008.02.003; SMITH DH, 1994, NONPROF VOLUNT SEC Q, V23, P243, DOI 10.1177/089976409402300305; Stephens KK, 2004, J HEALTH COMMUN, V9, P97, DOI 10.1080/10810730490271557; Subramanian SV, 2002, J URBAN HEALTH, V79, pS21, DOI 10.1093/jurban/79.suppl_1.S21; Subramanian SV, 2001, SOC SCI MED, V53, P9, DOI 10.1016/S0277-9536(00)00309-9; Suhrcke M, 2011, IMPACT HLTH HLTH BEH; Szreter S, 2004, INT J EPIDEMIOL, V33, P650, DOI 10.1093/ije/dyh013; Tavits M, 2006, POLIT RES QUART, V59, P211, DOI 10.1177/106591290605900204; Uslaner EM, 2012, HANDBOOK OF RESEARCH METHODS ON TRUST, P72; van der Kooi ALF, 2013, AM J PUBLIC HEALTH, V103, pE49, DOI 10.2105/AJPH.2013.301593; van Doorslaer E, 2003, SOC SCI MED, V57, P1621, DOI 10.1016/S0277-9536(02)00559-2; Viswanath K, 2006, AM J PUBLIC HEALTH, V96, P1456, DOI 10.2105/AJPH.2003.029793; Wilkinson RG, 2006, SOC SCI MED, V62, P1768, DOI 10.1016/j.socscimed.2005.08.036; Wilson J, 2000, ANNU REV SOCIOL, V26, P215, DOI 10.1146/annurev.soc.26.1.215; Wolfinger R.E., 1980, WHO VOTES; World Health Organization, 2003, SOCIAL DETERMINANTS	91	21	24	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149716	10.1371/journal.pone.0149716	http://dx.doi.org/10.1371/journal.pone.0149716			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26901130	Green Submitted, Green Published, gold			2022-12-27	WOS:000371276100132
J	Cassiano, GC; Furini, AAC; Capobianco, MP; Storti-Melo, LM; Cunha, MG; Kano, FS; Carvalho, LH; Soares, IS; Santos, SE; Povoa, MM; Machado, RLD				Cassiano, Gustavo C.; Furini, Adriana A. C.; Capobianco, Marcela P.; Storti-Melo, Luciane M.; Cunha, Maristela G.; Kano, Flora S.; Carvalho, Luzia H.; Soares, Irene S.; Santos, Sidney E.; Povoa, Marinete M.; Machado, Ricardo L. D.			Polymorphisms in B Cell Co-Stimulatory Genes Are Associated with IgG Antibody Responses against Blood-Stage Proteins of Plasmodium vivax	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; SINGLE-NUCLEOTIDE POLYMORPHISM; APICAL MEMBRANE ANTIGEN-1; DUFFY BINDING-PROTEIN; C-TERMINAL FRAGMENT; GROWTH IN-VITRO; FALCIPARUM ANTIGENS; ERYTHROCYTE INVASION; ACQUIRED-IMMUNITY; MALARIA PARASITES	The development of an effective immune response can help decrease mortality from malaria and its clinical symptoms. However, this mechanism is complex and has significant inter-individual variation, most likely owing to the genetic contribution of the human host. Therefore, this study aimed to investigate the influence of polymorphisms in genes involved in the costimulation of B-lymphocytes in the naturally acquired humoral immune response against proteins of the asexual stage of Plasmodium vivax. A total of 319 individuals living in an area of malaria transmission in the Brazilian Amazon were genotyped for four SNPs in the genes CD40, CD40L, BLYS and CD86. In addition, IgG antibodies against P. vivax apical membrane antigen 1 (PvAMA-1), Duffy binding protein (PvDBP) and merozoite surface protein 1 (PvMSP-1(19)) were detected by ELISA. The SNP BLYS -871C>T was associated with the frequency of IgG responders to PvAMA-1 and PvMSP-1(19). The SNP CD40 -1C>T was associated with the IgG response against PvDBP, whereas IgG antibody titers against PvMSP-1(19) were influenced by the polymorphism CD86 + 1057G>A. These data may help to elucidate the immunological aspects of vivax malaria and consequently assist in the design of malaria vaccines.	[Cassiano, Gustavo C.; Capobianco, Marcela P.; Machado, Ricardo L. D.] Univ Estadual Paulista, Sao Paulo State Univ, UNESP, Dept Biol, Sao Jose Do Rio Preto, SP, Brazil; [Furini, Adriana A. C.] Coll Med Sao Jose do Rio Preto, Dept Dermatol Infect & Parasit Dis, Sao Jose Do Rio Preto, SP, Brazil; [Storti-Melo, Luciane M.] Univ Fed Sergipe, Dept Biol, Aracaju, Sergipe, Brazil; [Cunha, Maristela G.] Fed Univ Para, UFPA, Inst Biol Sci, Lab Microbiol & Immunol, BR-66059 Belem, Para, Brazil; [Kano, Flora S.; Carvalho, Luzia H.] Fundacao Oswaldo Cruz, Rene Rachou Res Ctr, Lab Malaria, Belo Horizonte, MG, Brazil; [Soares, Irene S.] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, SP, Brazil; [Santos, Sidney E.] Fed Univ Para, Lab Human & Med Genet, BR-66059 Belem, Para, Brazil; [Povoa, Marinete M.; Machado, Ricardo L. D.] Evandro Chagas Inst, Sect Parasitol, Lab Basic Res Malaria, Belem, Para, Brazil	Universidade Estadual Paulista; Universidade Federal de Sergipe; Universidade Federal do Para; Fundacao Oswaldo Cruz; Universidade de Sao Paulo; Universidade Federal do Para; Instituto Evandro Chagas	Cassiano, GC (corresponding author), Univ Estadual Paulista, Sao Paulo State Univ, UNESP, Dept Biol, Sao Jose Do Rio Preto, SP, Brazil.	gcapatti@hotmail.com	Povoa, Marinete Marins/C-7039-2017; Carvalho, Luzia H/AAW-3461-2021; Kano, Flora/N-7749-2017; Soares, Irene Silva/C-5974-2012; Machado, Ricardo Luiz Dantas Dantas/P-1288-2014; Cassiano, Gustavo C/G-5728-2013; Soares, Irene/GQF-1984-2022; Machado, Ricardo/GXM-8198-2022; Kano, Flora S./AAS-3215-2020	Povoa, Marinete Marins/0000-0003-3517-2227; Kano, Flora/0000-0002-2364-9772; Soares, Irene Silva/0000-0002-3336-6856; Machado, Ricardo Luiz Dantas Dantas/0000-0002-8955-3204; Cassiano, Gustavo C/0000-0002-6971-5974; Storti-Melo, Luciane Moreno/0000-0002-2305-7996	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [471605/2011-5]; Fundacao Amazonia de Amparo a Estudos e Pesquisas do Para [ICAAF-005/2011]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Amazonia de Amparo a Estudos e Pesquisas do Para(Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA))	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, No 471605/2011-5, http://www.cnpq.br/, RLDM, and Fundacao Amazonia de Amparo a Estudos e Pesquisas do Para, No ICAAF-005/2011, http://www.fapespa.pa.gov.br/, MMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu B, 2014, J INFECT DIS, V209, P285, DOI 10.1093/infdis/jit422; Afridi S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-308; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barbedo MB, 2007, MEM I OSWALDO CRUZ, V102, P335, DOI 10.1590/S0074-02762007005000040; Capobianco MP, 2013, T ROY SOC TROP MED H, V107, P377, DOI 10.1093/trstmh/trt031; Carpenter D, 2007, HUM IMMUNOL, V68, P165, DOI 10.1016/j.humimm.2006.12.002; Cassiano GC, 2015, HUM IMMUNOL, V76, P836, DOI 10.1016/j.humimm.2015.09.045; Chatzigeorgiou A, 2009, BIOFACTORS, V35, P474, DOI 10.1002/biof.62; Clark EA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00472; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Cunha MG, 2001, VACCINE, V20, P385, DOI 10.1016/S0264-410X(01)00359-0; Delneste Y, 2000, IMMUNOGENETICS, V51, P762, DOI 10.1007/s002510000203; Dewasurendra RL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-281; Dias S, 2011, INFECT GENET EVOL, V11, P145, DOI 10.1016/j.meegid.2010.09.007; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Duah NO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007381; Egan AF, 1999, PARASITE IMMUNOL, V21, P133, DOI 10.1046/j.1365-3024.1999.00209.x; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Garraud O, 2002, INFECT IMMUN, V70, P2820, DOI 10.1128/IAI.70.6.2820-2827.2002; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Jacobson EM, 2005, ENDOCRINOLOGY, V146, P2684, DOI 10.1210/en.2004-1617; Kajeguka D, 2012, SCAND J IMMUNOL, V75, P355, DOI 10.1111/j.1365-3083.2011.02661.x; Kawasaki A, 2002, GENES IMMUN, V3, P424, DOI 10.1038/sj.gene.6363923; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; Li XR, 2004, J BIOL CHEM, V279, P5765, DOI 10.1074/jbc.M308716200; Lima JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036419; Liu XQ, 2012, EUR J IMMUNOL, V42, P3291, DOI 10.1002/eji.201242689; Lokossou AG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-215; Maiga B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075675; Malheiros D, 2009, GENES IMMUN, V10, P547, DOI 10.1038/gene.2009.36; Moss DK, 2012, INFECT IMMUN, V80, P1280, DOI 10.1128/IAI.05887-11; Nduati E, 2011, J INFECT DIS, V204, P962, DOI 10.1093/infdis/jir438; NOELLE RJ, 1992, IMMUNOL TODAY, V13, P431, DOI 10.1016/0167-5699(92)90068-I; Novak AJ, 2006, J CLIN ONCOL, V24, P983, DOI 10.1200/JCO.2005.02.7938; Ntumngia FB, 2012, INFECT IMMUN, V80, P1203, DOI 10.1128/IAI.05924-11; Pandey JP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-229; Rau FC, 2009, J IMMUNOL, V183, P7661, DOI 10.4049/jimmunol.0803783; de Almeida ERA, 2013, INT J IMMUNOGENET, V40, P178, DOI 10.1111/j.1744-313X.2012.01152.x; Rummel T, 2004, INFECT IMMUN, V72, P5768, DOI 10.1128/IAI.72.10.5768-5774.2004; Sabbagh A, 2013, TISSUE ANTIGENS, V82, P53, DOI 10.1111/tan.12140; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Santos NPC, 2010, HUM MUTAT, V31, P184, DOI 10.1002/humu.21159; Singh SK, 2006, NATURE, V439, P741, DOI 10.1038/nature04443; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Soares IS, 1997, INFECT IMMUN, V65, P1606, DOI 10.1128/IAI.65.5.1606-1614.1997; Souza-Silva FA, 2010, AM J TROP MED HYG, V82, P185, DOI 10.4269/ajtmh.2010.08-0580; Stadanlick JE, 2008, CURR OPIN IMMUNOL, V20, P158, DOI 10.1016/j.coi.2008.03.015; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; Storti-Melo LM, 2012, ACTA TROP, V121, P152, DOI 10.1016/j.actatropica.2011.10.009; Tangteerawatana P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-286; Taylor-Robinson AW, 1999, IMMUNOLOGY, V96, P498, DOI 10.1046/j.1365-2567.1999.00718.x; Tomer Y, 2002, THYROID, V12, P1129, DOI 10.1089/105072502321085234; Vicentin EC, 2014, INFECT IMMUN, V82, P1296, DOI 10.1128/IAI.01169-13; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864	56	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149581	10.1371/journal.pone.0149581	http://dx.doi.org/10.1371/journal.pone.0149581			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901523	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100103
J	Jayaratne, YSN; Zwahlen, RA				Jayaratne, Yasas Shri Nalaka; Zwahlen, Roger Arthur			The Oropharyngeal Airway in Young Adults with Skeletal Class II and Class III Deformities: A 3-D Morphometric Analysis	PLOS ONE			English	Article							VOLUME	Objectives 1) To determine the accuracy and reliability of an automated anthropometric measurement software for the oropharyngeal airway and 2) To compare the anthropometric dimensions of the oropharyngeal airway in skeletal class II and III deformity patients. Methods Cone-beam CT (CBCT) scans of 62 patients with skeletal class II or III deformities were used for this study. Volumetric, linear and surface area measurements retroglossal (RG) and retropalatal (RP) compartments of the oropharyngeal airway was measured with the 3dMDVultus software. Accuracy of automated anthropometric pharyngeal airway measurements was assessed using an airway phantom. Results The software was found to be reasonably accurate for measuring dimensions of air passages. The total oropharyngeal volume was significantly greater in the skeletal class III deformity group (16.7 +/- 9.04 mm(3)) compared with class II subjects (11.87 +/- 4.01 mm(3)). The average surface area of both the RG and RP compartments were significantly larger in the class III deformity group. The most constricted area in the RG and RP airway was significantly larger in individuals with skeletal class III deformity. The anterior-posterior (AP) length of this constriction was significantly greater in skeletal class III individuals in both compartments, whereas the width of the constriction was not significantly different between the two groups in both compartments. The RP compartment was larger but less uniform than the RG compartment in both skeletal deformities. Conclusion Significant differences were observed in morphological characteristics of the oropharyngeal airway in individuals with skeletal class II and III deformities. This information may be valuable for surgeons in orthognathic treatment planning, especially for mandibular setback surgery that might compromise the oropharyngeal patency.	[Jayaratne, Yasas Shri Nalaka] Univ Connecticut, Sch Dent Med, Dept Craniofacial Sci, Div Orthodont, Farmington, CT 06032 USA; [Jayaratne, Yasas Shri Nalaka; Zwahlen, Roger Arthur] Univ Hong Kong, Fac Dent, Discipline Oral & Maxillofacial Surg, Sai Ying Pun, Hong Kong, Peoples R China	University of Connecticut; University of Hong Kong	Zwahlen, RA (corresponding author), Univ Hong Kong, Fac Dent, Discipline Oral & Maxillofacial Surg, Sai Ying Pun, Hong Kong, Peoples R China.	zwahlen@hku.hk		Jayaratne, Yasas/0000-0002-4813-648X				Abramson ZR, 2010, J ORAL MAXIL SURG, V68, P363, DOI 10.1016/j.joms.2009.09.086; Athanasiou AE., 1995, ORTHODONTIC CEPHALOM; Caufield P.W., 2006, RADIOGRAPHIC CEPHALO; Demetriades N, 2010, J ORAL MAXIL SURG, V68, P2431, DOI 10.1016/j.joms.2010.02.033; El H, 2011, AM J ORTHOD DENTOFAC, V139, pE511, DOI 10.1016/j.ajodo.2011.02.015; Enacar A, 1994, Int J Adult Orthodon Orthognath Surg, V9, P285; Foltan R, 2009, INT J ORAL MAX SURG, V38, P1036, DOI 10.1016/j.ijom.2009.06.001; Foltan R, 2011, ORAL SURG ORAL MED O, V111, P3, DOI 10.1016/j.tripleo.2010.09.077; Foltan R, 2011, INT J ORAL MAX SURG, V40, P146, DOI 10.1016/j.ijom.2010.10.006; Grauer D, 2009, AM J ORTHOD DENTOFAC, V136, P805, DOI 10.1016/j.ajodo.2008.01.020; Guijarro-Martinez R, 2011, INT J ORAL MAXILLOFA; Harris EF, 2009, ARCH ORAL BIOL, V54; Hasebe D, 2011, INT J ORAL MAX SURG, V40, P584, DOI 10.1016/j.ijom.2011.01.011; Hong JS, 2011, AM J ORTHOD DENTOFAC, V140, pE161, DOI 10.1016/j.ajodo.2011.04.020; Iwasaki T, 2009, AM J ORTHOD DENTOFAC, V136, DOI 10.1016/j.ajodo.2009.04.010; Kim YJ, 2010, AM J ORTHOD DENTOFAC, V137, DOI 10.1016/j.ajodo.2009.10.025; Lye KW, 2008, ANN ACAD MED SINGAP, V37, P677; Ma CM, 1999, PHYS MED BIOL, V44, P131, DOI 10.1088/0031-9155/44/1/011; Schwab RJ, 1998, OTOLARYNG CLIN N AM, V31, P931, DOI 10.1016/S0030-6665(05)70100-6; Sittitavornwong S, 2009, ORAL MAXIL SURG CLIN, V21, P389, DOI 10.1016/j.coms.2009.08.004; Swennen GRJ, 2005, 3 DIMENSIONAL CEPHAL; Tso HH, 2009, ORAL SURG ORAL MED O, V108, P768, DOI 10.1016/j.tripleo.2009.05.026; Yi B, 1999, Chin J Dent Res, V2, P59; Zhao Y, 2010, AM J ORTHOD DENTOFAC, V137, pS71, DOI 10.1016/j.ajodo.2008.08.026	24	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148086	10.1371/journal.pone.0148086	http://dx.doi.org/10.1371/journal.pone.0148086			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901313	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100013
J	Cota, GF; de Sousa, MR; Fereguetti, TO; Saleme, PS; Alvarisa, TK; Rabello, A				Cota, Glaucia Fernandes; de Sousa, Marcos Roberto; Fereguetti, Tatiani Oliveira; Saleme, Priscila Said; Alvarisa, Thais Kawagoe; Rabello, Ana			The Cure Rate after Placebo or No Therapy in American Cutaneous Leishmaniasis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CONTROLLED CLINICAL-TRIAL; SODIUM STIBOGLUCONATE; KETOCONAZOLE; ALLOPURINOL; EFFICACY; RISK	Introduction There are few drugs with proven efficacy in cutaneous leishmaniasis (CL), and pentavalent antimonial derivatives are still the main first-line therapeutic agents worldwide, despite their recognized high toxicities. Randomized controlled clinical trials assessing the efficacy and safety of new therapeutic modalities are of high priority, and the definition of the design of such trials raises debate about the use of placebo as a comparator. To support the use of placebo as a comparator, two main points need to be addressed: 1- the cure rate without any therapeutic intervention and 2- the damage caused by CL and its impact on patients. Objective The aim of this study was to systematically assess the spontaneous cure rate for American CL and to broaden the discussion about placebo use in CL trials. Methods The PRISMA guidelines for systematic reviews and the Cochrane manual were followed. The sources used were the PubMed and LILACS databases. Studies were included if they reported cure rates using placebo or no treatment in American CL. Results Thirteen studies of a total of 352 patients were ultimately included in this review. The summarized global cure rates for all Leishmania species according to the intention-to-treat analyses performed at approximately three ("initial cure") and nine ("definitive cure") months after "no treatment" or placebo use were 26% (CI95%: 16 to 40%) and 26% (CI95%: 16 to 38%), respectively. Notably, a significantly lower cure rate was observed for L. braziliensis infection (6.4%, CI95%: 0.2 to 20%) than for L. mexicana infection (44%, CI95%: 19 to 72%), p = 0.002. Of note, relapse occurred in 20% of patients with initial healing (CI95%: 9.2 to 38.9%). Conclusion These results clearly demonstrate a low spontaneous cure rate following no-treatment or placebo use, confirming that this strategy for the control group in CL studies expose patients to greater morbidity, especially for CL caused by L. braziliensis. Therefore, from this point, the crucial questionto consider regarding placebo use isthe seriousness of the suffering caused by this disease.	[Cota, Glaucia Fernandes; Rabello, Ana] Fiocruz MS, Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Clin Res & Publ Policy Infect & Parasit Dis, Belo Horizonte, MG, Brazil; [de Sousa, Marcos Roberto] Univ Fed Minas Gerais, Postgrad Program Adult Hlth Sci, Belo Horizonte, MG, Brazil; [Fereguetti, Tatiani Oliveira; Saleme, Priscila Said; Alvarisa, Thais Kawagoe] Fundacao Hosp Estado Minas Gerais FHEMIG, Hosp Eduardo de Menezes, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais	Cota, GF (corresponding author), Fiocruz MS, Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Clin Res & Publ Policy Infect & Parasit Dis, Belo Horizonte, MG, Brazil.	cota@cpqrr.fiocruz.br	Cota, Glaucia/ABC-5378-2020	Cota, Glaucia/0000-0003-0538-7403	CNPq (National Counsel of Technological and Scientific Development) [311641/2009-1]	CNPq (National Counsel of Technological and Scientific Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Ana Rabello is currently receiving a grant [311641/2009-1] from CNPq (National Counsel of Technological and Scientific Development). The authors received no specific funding for this work.	64th World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [10.1001/jama.2013.281053, DOI 10.1001/JAMA.2013.281053]; [Anonymous], 1997, Cardiovasc Res, V35, P2; [Anonymous], 2013, LEISHM AM REC TRAT C; Arana BA, 2001, AM J TROP MED HYG, V65, P466, DOI 10.4269/ajtmh.2001.65.466; Bailey MS, 2007, CLIN DERMATOL, V25, P203, DOI 10.1016/j.clindermatol.2006.05.008; Blum J, 2012, INT HEALTH, V4, P153, DOI 10.1016/j.inhe.2012.06.004; Chico M., 1995, Biomedica, V15, P116; Emanuel EJ, 2001, NEW ENGL J MED, V345, P915, DOI 10.1056/NEJM200109203451211; Gonzalez U, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004834.pub2; Gonzalez U, 2010, CLIN INFECT DIS, V51, P409, DOI 10.1086/655134; Goto H, 2010, EXPERT REV ANTI-INFE, V8, P419, DOI [10.1586/eri.10.19, 10.1586/ERI.10.19]; GUDERIAN RH, 1991, AM J TROP MED HYG, V45, P92, DOI 10.4269/ajtmh.1991.45.92; Hendrickx EP, 1998, AM J TROP MED HYG, V59, P889, DOI 10.4269/ajtmh.1998.59.889; HERWALDT BL, 1992, J INFECT DIS, V165, P518, DOI 10.1093/infdis/165.3.518; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lopez-Jaramillo P, 1998, LANCET, V351, P1176, DOI 10.1016/S0140-6736(05)79119-4; Machado-Coelho GLL, 2005, T ROY SOC TROP MED H, V99, P55, DOI 10.1016/j.trstmh.2003.08.001; MARTINEZ S, 1992, NEW ENGL J MED, V326, P741, DOI 10.1056/NEJM199203123261105; NAVIN TR, 1992, J INFECT DIS, V165, P528, DOI 10.1093/infdis/165.3.528; NAVIN TR, 1990, AM J TROP MED HYG, V42, P43, DOI 10.4269/ajtmh.1990.42.43; Neva FA, 1997, T ROY SOC TROP MED H, V91, P473, DOI 10.1016/S0035-9203(97)90290-X; Olliaro P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002130; Reveiz L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061843; ROTHMAN KJ, 1994, NEW ENGL J MED, V331, P394, DOI 10.1056/NEJM199408113310611; SAENZ RE, 1990, AM J MED, V89, P147, DOI 10.1016/0002-9343(90)90292-L; Soto J, 2006, T ROY SOC TROP MED H, V100, pS34, DOI 10.1016/j.trstmh.2006.02.022; Soto J, 2004, CLIN INFECT DIS, V38, P1266, DOI 10.1086/383321; Soto J, 2013, CLIN INFECT DIS, V56, P1255, DOI 10.1093/cid/cit049; Soto JM, 2002, AM J TROP MED HYG, V66, P147, DOI 10.4269/ajtmh.2002.66.147; SOTOMANCIPE J, 1993, CLIN INFECT DIS, V16, P417, DOI 10.1093/clind/16.3.417; Temple R, 2000, ANN INTERN MED, V133, P455, DOI 10.7326/0003-4819-133-6-200009190-00014; Tuon FF, 2008, INT J DERMATOL, V47, P109, DOI 10.1111/j.1365-4632.2008.03417.x; Velez I, 1997, ANN INTERN MED, V126, P232, DOI 10.7326/0003-4819-126-3-199702010-00010; Wise ES, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001688; World Health Organization (WHO), 2007, 5 CONS M HIVLEISHMAN; Yamey G, 2002, BMJ-BRIT MED J, V325, P352; Yepez Y., 1995, Boletin de la Direccion de Malariologia y Saneamiento Ambiental, V35, P71	38	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149697	10.1371/journal.pone.0149697	http://dx.doi.org/10.1371/journal.pone.0149697			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894430	gold, Green Submitted, Green Published			2022-12-27	WOS:000371223400076
J	Hall, SS; Wright, HF; Mills, DS				Hall, Sophie Susannah; Wright, Hannah F.; Mills, Daniel Simon			What Factors Are Associated with Positive Effects of Dog Ownership in Families with Children with Autism Spectrum Disorder? The Development of the Lincoln Autism Pet Dog Impact Scale	PLOS ONE			English	Article							COMPANION ANIMALS; SOCIAL-SKILLS; ADOLESCENTS; INTERVENTIONS; THERAPY; LINKAGES; PARENTS	Scientific literature exploring the value of assistance dogs to children with autism spectrum disorder (ASD) is rapidly emerging. However, there is comparably less literature reporting the effects of pet (as opposed to assistance) dogs to these children. In particular, there are no known validated scales which assess how children may alter their behaviours in the presence of the dog, to evaluate the efficacy of pet dogs to these families. Additionally, given the highly individualised nature of ASD it is likely that some children and families gain more benefits from dog ownership than others, yet no research has reported the effect of individual differences. This pilot study reports the development of a 28-item scale based on the perceived impact of a pet dog on a child with autism by parents (Lincoln Autism Pet Dog Impact Scale-LAPDIS). The scale is comprised of three mathematically derived factors: Adaptability, Social Skills and Conflict Management. We assessed how individual differences (aspects) may be associated with scores on these three factors. Family Aspects and Dog Aspects were not significantly associated with ratings on the three factors, but Child Aspects (including: contact with horses, child age, disability level and language abilities) were related to impact of the dog on all factors. Training Aspects were related to scores on Social Skills (formal training with children with ASD and dogs and attendance at PAWS workshops run by Dogs for Good). These results suggest that individual differences associated with the child and the training approach may be important considerations for a positive impact from dog ownership on families with children with ASD. Differences in family features and the dog may not be so important, but may be worthy of further investigations given the early stage of development in this field.	[Hall, Sophie Susannah; Wright, Hannah F.; Mills, Daniel Simon] Lincoln Univ, Sch Life Sci, Lincoln, Lincs, England	University of Lincoln	Hall, SS (corresponding author), Lincoln Univ, Sch Life Sci, Lincoln, Lincs, England.	shall@lincoln.ac.uk		Hall, Sophie/0000-0002-9847-8269	Morris Animal Foundation [D14HA-008]; Big Lottery Fund [RGT/1/010334400]; Big Lottery [RGT/1/010334400]	Morris Animal Foundation; Big Lottery Fund; Big Lottery	The study was partly supported by the Morris Animal Foundation, http://www.morrisanimalfoundation.org/, Grant ID/Title: D14HA-008 / Long Term Effects of Pet Dogs on Families with Children with Autism. Funding was awarded to DSM. The study was also partly supported by the Big Lottery Fund, https://www.biglotteryfund.org.uk/, Grant ID: RGT/1/010334400. This was awarded to Peter Gorbing, Dogs for the Disabled CEO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The survey was part of a larger project funded by the Big Lottery (Grant Name: Pet dogs for children with Autism research project, Grant ID: RGT/1/010334400) awarded to Dogs for Good (previously known as Dogs for the Disabled). A follow-up project funded by the Morris Animal Foundation (ID: D14HA-008, awarded to D. Mills) allowed for the analysis and write up of the survey. The project was a collaboration between the University of Lincoln (UK), National Autistic Society (London, UK) and Dogs for Good (previously Dogs for the Disabled), Banbury, UK. Dogs for Good contributors: Peter Gorbing, Helen McCain, Dr Corri Waitt, PAWS project team (Katie Bristow-Wade, Amy Davies, Kate Thomas). The study was guided by a formal advisory group: Dr Lorna Wing, Jo Stevens. Dr Lorna Wing, Dr Bob Michell, Denis Lane, Dr Jane Fossey, Professor Shaun Lawson, Peter Gorbing, Helen McCain, Susan Aston and Sarah Milne. We also thank the parents who gave up their time to participate in this study. We also thank Jessica Hardiman (previously University of Lincoln, now Dogs for Good), Annette Hames (University of Lincoln) and Richard Mills (National Autistic Society) for their support.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; ATTWOOD T, 1998, ASPERGERS SYNDROME G; Autism Speaks, 2010, IS AUT TREAT; Baker JK, 2011, J FAM PSYCHOL, V25, P601, DOI 10.1037/a0024409; Bass M, 2009, J AUTISM DEV DISORD, V39, P1261, DOI 10.1007/s10803-009-0734-3; Beetz A, 2012, FRONT PSYCHOL, V3, DOI [10.3389/fpsyg.2012.00234, 10.3389/fpsyg.2012.00352]; Bellini S., 2006, FOCUS AUTISM DEV DIS, V21, P138, DOI [DOI 10.1177/10883576060210030201, 10.1177/10883576060210030201]; Bellini S, 2007, REM SPEC EDUC, V28, P153, DOI 10.1177/07419325070280030401; Berry A, 2013, J ALTERN COMPLEM MED, V19, P73, DOI 10.1089/acm.2011.0835; Burgoyne L, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004786; Burrows KE, 2008, QUAL HEALTH RES, V18, P1642, DOI 10.1177/1049732308327088; Bystrom KM, 2015, ANTHROZOOS, V28, P263, DOI 10.2752/089279315X14219211661813; Carlisle GK, 2015, J AUTISM DEV DISORD, V45, P1137, DOI 10.1007/s10803-014-2267-7; Carlisle GK, 2014, J PEDIATR NURS, V29, P114, DOI 10.1016/j.pedn.2013.09.005; Cattell R.B., 1978, SCI USE FACTOR ANAL, DOI [DOI 10.1007/978-1-4684-2262-7_5, 10.1007/978-1-4684-2262-7_5]; Comrey A, 1992, 1 COURSE FACTOR ANAL, V2nd, P2; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; FRIEDMANN E, 1983, J NERV MENT DIS, V171, P461, DOI 10.1097/00005053-198308000-00002; Gabriels RL, 2012, RES AUTISM SPECT DIS, V6, P578, DOI 10.1016/j.rasd.2011.09.007; Gee NR, 2014, ANTHROZOOS, V27, P513, DOI 10.2752/089279314X14072268687763; Gorsuch R.L., 1983, FACTOR ANAL, V2nd ed.; Grandgeorge M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041739; Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304; Howlin P, 2005, J NEURAL TRANSM-SUPP, P101; Hume K, 2005, TOP EARLY CHILD SPEC, V25, P195, DOI 10.1177/02711214050250040101; Hurley RSE, 2007, J AUTISM DEV DISORD, V37, P1679, DOI 10.1007/s10803-006-0299-3; Kelly AB, 2008, J ABNORM CHILD PSYCH, V36, P1069, DOI 10.1007/s10802-008-9234-8; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; Kohane IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033224; Konst MJ, 2013, RES AUTISM SPECT DIS, V7, P1068, DOI 10.1016/j.rasd.2013.05.006; La Greca AM, 1998, J ABNORM CHILD PSYCH, V26, P83, DOI 10.1023/A:1022684520514; Lanning BA, 2014, J AUTISM DEV DISORD, V44, P1897, DOI 10.1007/s10803-014-2062-5; Mills D, 2014, VET REC, V174, P269, DOI 10.1136/vr.g1929; Mukaddes NM, 2010, WORLD J BIOL PSYCHIA, V11, P486, DOI [10.1080/15622970902789130, 10.3109/15622970902789130]; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; O'Haire M, 2010, J VET BEHAV, V5, P226, DOI 10.1016/j.jveb.2010.02.002; O'Haire ME, 2013, J AUTISM DEV DISORD, V43, P1606, DOI 10.1007/s10803-012-1707-5; O'Haire ME, 2015, DEV PSYCHOBIOL; Prothmann A, 2009, ANTHROZOOS, V22, P161, DOI 10.2752/175303709X434185; REDEFER LA, 1989, J AUTISM DEV DISORD, V19, P461, DOI 10.1007/BF02212943; Reichow Brian, 2013, Evid Based Child Health, V8, P266, DOI 10.1002/ebch.1903; Silva K, 2011, J ALTERN COMPLEM MED, V17, P655, DOI 10.1089/acm.2010.0436; Simpson Richard L., 2004, AUTISM SPECTRUM DISO; Smith, 2005, LIFE JOURNEY AUTISM; Solomon O, 2010, ETHOS, V38, P143, DOI 10.1111/j.1548-1352.2010.01085.x; Somervill J.W., 2009, N AM J PSYCHOL, V11, P111; Tabachnick B.G., 2007, EXPT DESIGNS USING A; Tantam D, 2000, AUTISM, V4, P47, DOI DOI 10.1177/1362361300004001004; Viau R, 2010, PSYCHONEUROENDOCRINO, V35, P1187, DOI 10.1016/j.psyneuen.2010.02.004; Volkmar F. R., 1997, HDB AUTISM PERVASIVE, P173, DOI DOI 10.1002/9780470939345.CH11; Ward SC, 2013, J AUTISM DEV DISORD, V43, P2190, DOI 10.1007/s10803-013-1773-3; Welsh M, 2001, J SCHOOL PSYCHOL, V39, P463, DOI 10.1016/S0022-4405(01)00084-X; Wright H, 2015, PET DOGS IM IN PRESS; Wright H, HUM ANIM IN IN PRESS; Wright H, 2015, J AUTISM DEV DISORD, P1	55	14	14	5	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149736	10.1371/journal.pone.0149736	http://dx.doi.org/10.1371/journal.pone.0149736			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3DG	26894820	gold, Green Published, Green Accepted			2022-12-27	WOS:000371223400079
J	Magnano, C; Belov, P; Krawiecki, J; Hagemeier, J; Beggs, C; Zivadinov, R				Magnano, Christopher; Belov, Pavel; Krawiecki, Jacqueline; Hagemeier, Jesper; Beggs, Clive; Zivadinov, Robert			Internal Jugular Vein Cross-Sectional Area Enlargement Is Associated with Aging in Healthy Individuals	PLOS ONE			English	Article							CEREBROSPINAL VENOUS INSUFFICIENCY; ENDOTHELIAL PROGENITOR CELLS; MULTIPLE-SCLEROSIS; INTRAVASCULAR ULTRASOUND; CATHETER VENOGRAPHY; ALZHEIMERS-DISEASE; COLOR-DOPPLER; ABNORMALITIES; FLOW; HEMODYNAMICS	Background Internal jugular vein (IJV) narrowing has been implicated in central nervous system pathologies, however normal physiological age-and gender-related IJV variance in healthy individuals (HIs) has not been adequately assessed. Objectives We assessed the relationship between IJV cross-sectional area (CSA) and aging. Materials and Methods This study involved 193 HIs (63 males and 130 females) who received 2-dimensional magnetic resonance venography at 3T. The minimum CSA of the IJVs at cervical levels C2/C3, C4, C5/C6, and C7/T1 was obtained using a semi-automated contouring-thresholding technique. Subjects were grouped by decade. Pearson and partial correlation (controlled for cardiovascular risk factors, including hypertension, heart disease, smoking and body mass index) and analysis of variance analyses were used, with paired t-tests comparing side differences. Results Mean right IJV CSA ranges were: in males, 41.6 mm(2) (C2/C3) to 82.0 mm(2) (C7/T1); in females, 38.0 mm(2) (C2/C3) to 62.3 mm(2) (C7/T1), while the equivalent left side ranges were: in males, 28.0 mm(2) (C2/C3) to 52.2 mm(2) (C7/T1); in females, 27.2 mm(2) (C2/C3) to 47.8 mm(2) (C7/T1). The CSA of the right IJVs was significantly larger (p<0.001) than the left at all cervical levels. Controlling for cardiovascular risk factors, the correlation between age and IJV CSA was more robust in males than in the females for all cervical levels. Conclusions In HIs age, gender, hand side and cervical location all affect IJV CSA. These findings suggest that any definition of IJV stenosis needs to account for these factors.	[Magnano, Christopher; Belov, Pavel; Krawiecki, Jacqueline; Hagemeier, Jesper; Beggs, Clive; Zivadinov, Robert] SUNY Buffalo, Sch Med & Biomed Sci, Dept Neurol, Buffalo Neuroimaging Anal Ctr, Buffalo, NY 14260 USA; [Magnano, Christopher; Zivadinov, Robert] SUNY Buffalo, Sch Med & Biomed Sci, MRI Clin & Translat Res Ctr, Buffalo, NY 14260 USA; [Beggs, Clive] Univ Bradford, Ctr Infect Control & Biophys, Richmond Rd, Bradford BD7 1DP, W Yorkshire, England; [Beggs, Clive] Leeds Beckett Univ, Inst Sport Phys Act & Leisure, Leeds LS1 3HE, W Yorkshire, England	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Bradford; Leeds Beckett University	Zivadinov, R (corresponding author), SUNY Buffalo, Sch Med & Biomed Sci, Dept Neurol, Buffalo Neuroimaging Anal Ctr, Buffalo, NY 14260 USA.; Zivadinov, R (corresponding author), SUNY Buffalo, Sch Med & Biomed Sci, MRI Clin & Translat Res Ctr, Buffalo, NY 14260 USA.	rzivadinov@bnac.net	Zivadinov, Robert/Q-2054-2019; Belov, Pavel/AAN-7857-2020	Zivadinov, Robert/0000-0002-7799-1485; Belov, Pavel/0000-0002-5107-2763; Hagemeier, Jesper/0000-0002-3286-5207	Jacquemin Family Foundation	Jacquemin Family Foundation	This study was supported by the Jacquemin Family Foundation.	Beggs C, 2014, PHLEBOLOGY, V29, P191, DOI 10.1258/phleb.2012.012039; Beggs C, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-157; Beggs CB, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-142; Blinkenberg M, 2012, ACTA NEUROL SCAND, V126, P421, DOI 10.1111/j.1600-0404.2012.01671.x; Bloomfield GL, 1997, CRIT CARE MED, V25, P496, DOI 10.1097/00003246-199703000-00020; Chung CP, 2014, J ALZHEIMERS DIS, V39, P601, DOI 10.3233/JAD-131112; Chung CP, 2011, ANN NEUROL, V69, P553, DOI 10.1002/ana.22276; Chung CP, 2010, ULTRASOUND MED BIOL, V36, P1776, DOI 10.1016/j.ultrasmedbio.2010.07.006; Ciuti G, 2013, AM J NEURORADIOL, V34, P2000, DOI 10.3174/ajnr.A3557; Di Berardino F, 2015, PHLEBOLOGY, V30, P274, DOI 10.1177/0268355514526871; Doepp F, 2010, ANN NEUROL, V68, P173, DOI 10.1002/ana.22085; Feng W, 2012, NEUROL RES, V34, P802, DOI 10.1179/1743132812Y.0000000079; Filipo R, 2015, EUR ARCH OTO-RHINO-L, V272, P77, DOI 10.1007/s00405-013-2841-1; FISHER J, 1982, CIRCULATION, V65, P188, DOI 10.1161/01.CIR.65.1.188; Frezza EE, 2004, DIGEST DIS SCI, V49, P1062, DOI 10.1023/B:DDAS.0000034572.76687.2d; Frezza EE, 2007, DIGEST DIS SCI, V52, P1038, DOI 10.1007/s10620-006-9203-4; Haacke EM, 2012, J VASC INTERV RADIOL, V23, P60, DOI 10.1016/j.jvir.2011.09.027; Hutter R, 2012, MED CLIN N AM, V96, P93, DOI 10.1016/j.mcna.2012.01.008; Kappus N, 2016, J NEUROL NEUROSUR PS, V87, P181, DOI 10.1136/jnnp-2014-310051; Karmon Y, 2013, J VASC INTERV RADIOL, V24, P1487, DOI 10.1016/j.jvir.2013.06.012; Liu MJ, 2015, J VASC SURG, V61, P1511, DOI 10.1016/j.jvs.2014.02.021; Magnano C., 2014, VEINS LYMPHAT, V3, DOI [10.4081/vl.2014.4632, DOI 10.4081/VL.2014.4632]; McAuliffe W, 2013, AM J NEURORADIOL, V34, P1370, DOI 10.3174/ajnr.A3390; PATEL S, 1981, J COMPUT ASSIST TOMO, V5, P197, DOI 10.1097/00004728-198104000-00010; Rahman MS, 2013, ANAL BIOCHEM, V433, P79, DOI 10.1016/j.ab.2012.10.018; Robb AO, 2007, REPRODUCTION, V133, P1, DOI 10.1530/REP-06-0219; Scalise F, 2013, PHLEBOLOGY, V28, P409, DOI 10.1258/phleb.2012.012079; Schaller B, 2004, BRAIN RES REV, V46, P243, DOI 10.1016/j.brainresrev.2004.04.005; Sethi SK, 2015, J NEUROIMAGING, V25, P600, DOI 10.1111/jon.12183; Sieveking DP, 2010, CURR OPIN ENDOCRINOL, V17, P277, DOI 10.1097/MED.0b013e3283394e20; Traboulsee AL, 2014, LANCET, V383, P138, DOI 10.1016/S0140-6736(13)61747-X; Zamboni P, 2009, J NEUROL NEUROSUR PS, V80, P392, DOI 10.1136/jnnp.2008.157164; Zamboni P, 2012, J APPL PHYSIOL, V112, P904, DOI 10.1152/japplphysiol.00712.2011; Zamboni P, 2009, J NEUROL SCI, V282, P21, DOI 10.1016/j.jns.2008.11.027; Zivadinov R, 2011, NEUROLOGY, V77, P138, DOI 10.1212/WNL.0b013e318212a901; Zivadinov R, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-260; Zivadinov R, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-151	37	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149532	10.1371/journal.pone.0149532	http://dx.doi.org/10.1371/journal.pone.0149532			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895434	Green Published, Green Accepted, gold			2022-12-27	WOS:000371223400062
J	Xie, B; Zhang, PH; Liu, MG; Zeng, W; Yang, JT; Liu, HM				Xie, Bin; Zhang, Penghui; Liu, Menggang; Zeng, Wei; Yang, Juntao; Liu, Hongming			Deltex1 Polymorphisms Are Associated with Hepatitis B Vaccination Non-Response in Southwest China	PLOS ONE			English	Article							VIRUS INFECTION; GENE POLYMORPHISMS; IMMUNE-RESPONSE; NOTCH; VARIANTS; ANTIGEN; POPULATION; MECHANISMS; INTRONS; PROTEIN	Background Hepatitis B vaccination is the most important tool available for preventing hepatitis B virus (HBV) infection and reducing the prevalence of infection. However, epidemiological studies have demonstrated that morethan 5% of patients exhibit a non-or hypo-response to the HBV vaccine. Genetic variations associated with T cell immunity contribute to the immune response to HBV vaccination. The deltex 1 (DTX1) gene is involved in T cell anergy, which may also be associated with the immune response to the HBV vaccination. Methods We detected 10 single nucleotide polymorphisms (SNPs) in or around the DTX1 gene in 601 infants out of a population from Southwest China, including 299 high responders(HRs; HBsAb > 100 mIU/mL) and 302 non-responders (NRs; HBsAb < 10 mIU/mL). An additional validation study was performed, comprising 230 adult patients(135 HRs and 95 NRs) from Southwest China. Results This study found that the minor allele 'G' of rs2384077 (adjusted p = 2.63E(-04),) and the minor allele 'C' of rs10744794 (adjusted p = 3.69E(-04)) in the first intron of the DTX1 gene were remarkably associated with the immune response to HBV vaccination in both infant and adult populations. Moreover, a subsequent analysis indicated that haplotypes (A-T, G-C) of the two SNPs were significantly associated with the immune response to HBV vaccination. Conclusions Two SNPs (rs2384077 and rs10744794) in an intron of DTX1 and the linkage disequilibrium (LD) block are significantly associated with the immune response to HBV vaccination. The functional element annotation of the LD block between the two SNPs contains four transcriptional regulatory elements. The results suggest that these two SNPs may be involved in the immune response to HBV vaccination.	[Xie, Bin; Liu, Menggang; Zeng, Wei; Yang, Juntao; Liu, Hongming] Third Mil Med Univ, Daping Hosp, Dept Hepatobiliary Surg, Chongqing, Peoples R China; [Xie, Bin; Liu, Menggang; Zeng, Wei; Yang, Juntao; Liu, Hongming] Third Mil Med Univ, Inst Surg Res, Chongqing, Peoples R China; [Zhang, Penghui] Chongqing Med Univ, Childrens Hosp, Dept Clin Lab Med, Chongqing, Peoples R China	Army Medical University; Army Medical University; Chongqing Medical University	Liu, HM (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Hepatobiliary Surg, Chongqing, Peoples R China.; Liu, HM (corresponding author), Third Mil Med Univ, Inst Surg Res, Chongqing, Peoples R China.	lhming56@163.com			Nature Science Foundation of China [81172739]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	Hongming Liu recieved funding from the Nature Science Foundation of China, grant number: 81172739 (http://www.nsfc.gov.cn).	Bayard F, 2010, VACCINE, V28, P3818, DOI 10.1016/j.vaccine.2010.03.026; Bhathena A, 2008, CURR OPIN PHARMACOL, V8, P639, DOI 10.1016/j.coph.2008.07.013; Chen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013574; Chorev Michal, 2012, Frontiers in Genetics, V3, P55, DOI 10.3389/fgene.2012.00055; Desombere I, 1998, TISSUE ANTIGENS, V51, P593, DOI 10.1111/j.1399-0039.1998.tb03001.x; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Grzegorzewska AE, 2013, MOL BIOL REP, V40, P6899, DOI 10.1007/s11033-013-2809-7; Hori K, 2004, DEVELOPMENT, V131, P5527, DOI 10.1242/dev.01448; Hou SH, 2015, MICROBIOL IMMUNOL, V59, P209, DOI 10.1111/1348-0421.12239; Hsiao HW, 2009, IMMUNITY, V31, P72, DOI 10.1016/j.immuni.2009.04.017; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Hui CK, 2005, J CLIN VIROL, V34, pS44, DOI 10.1016/S1386-6532(05)80009-5; Izon DJ, 2002, IMMUNITY, V16, P231, DOI 10.1016/S1074-7613(02)00271-6; Johnson S, 2015, J IMMUNOL, V194, P1755, DOI 10.4049/jimmunol.1401771; Kimkong I, 2015, TISSUE ANTIGENS, V85, P177, DOI 10.1111/tan.12517; Krawczyk A, 2014, VACCINE, V32, P5077, DOI 10.1016/j.vaccine.2014.06.076; Li XF, 2014, MICROB PATHOGENESIS, V74, P59, DOI 10.1016/j.micpath.2014.07.010; Lobaina Y, 2015, MOL IMMUNOL, V63, P320, DOI 10.1016/j.molimm.2014.08.003; Mert G, 2014, J MICROBIOL IMMUNOL, V47, P9, DOI 10.1016/j.jmii.2013.01.004; Almeida APMM, 2014, VACCINE, V32, P2181, DOI 10.1016/j.vaccine.2014.02.053; Pan LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035303; Ramain P, 2001, CURR BIOL, V11, P1729, DOI 10.1016/S0960-9822(01)00562-0; Rogozin IB, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-11; Romano Maurizio, 2013, Int J Cell Biol, V2013, P810572, DOI 10.1155/2013/810572; Ryckman KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012273; Saffar H, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.22223; Tan PL, 2001, VACCINE, V19, P2434, DOI 10.1016/S0264-410X(00)00468-0; Van LH, 2001, ENV HLTH PERSPECT, V109, P757; Vermehren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032605; Wang CB, 2004, HEPATOLOGY, V39, P978, DOI 10.1002/hep.20142; Wang HC, 2009, MOL CELL BIOL, V29, P4640, DOI 10.1128/MCB.00119-09; Yao JY, 2015, WORLD J GASTROENTERO, V21, P4232, DOI 10.3748/wjg.v21.i14.4232; Ye B, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.42; Yenerall P, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-29; Yucesoy B, 2002, VACCINE, V20, P3193, DOI 10.1016/S0264-410X(02)00267-0; Yucesoy B, 2013, VACCINE, V31, P5381, DOI 10.1016/j.vaccine.2013.09.026; Yun TJ, 2003, J IMMUNOL, V170, P5834, DOI 10.4049/jimmunol.170.12.5834; Zhang X, 2014, INT J IMMUNOGENET, V41, P298, DOI 10.1111/iji.12120; Zuckerman JN, 2000, J INFECTION, V41, P130, DOI 10.1053/jinf.2000.0720; Zweifel ME, 2005, STRUCTURE, V13, P1599, DOI 10.1016/j.str.2005.07.015	40	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149199	10.1371/journal.pone.0149199	http://dx.doi.org/10.1371/journal.pone.0149199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894927	Green Published, Green Submitted, gold			2022-12-27	WOS:000371223400036
J	Jansen, PA; Grontvedt, RN; Tarpai, A; Helgesen, KO; Horsberg, TE				Jansen, Peder A.; Grontvedt, Randi N.; Tarpai, Attila; Helgesen, Kari O.; Horsberg, Tor Einar			Surveillance of the Sensitivity towards Antiparasitic Bath-Treatments in the Salmon Louse (Lepeophtheirus salmonis)	PLOS ONE			English	Article							SEA LICE; EMAMECTIN BENZOATE; REDUCED SENSITIVITY; DRUG-RESISTANCE; ATLANTIC; SALAR; AQUACULTURE; BIOASSAY; COPEPODA; FARMS	The evolution of drug resistant parasitic sea lice is of major concern to the salmon farming industry worldwide and challenges sustainable growth of this enterprise. To assess current status and development of L. salmonis sensitivity towards different pesticides used for parasite control in Norwegian salmon farming, a national surveillance programme was implemented in 2013. The programme aims to summarize data on the use of different pesticides applied to control L. salmonis and to test L. salmonis sensitivity to different pesticides in farms along the Norwegian coast. Here we analyse two years of test-data from biological assays designed to detect sensitivity-levels towards the pesticides azamethiphos and deltamethrin, both among the most common pesticides used in bath-treatments of farmed salmon in Norway in later years. The focus of the analysis is on how different variables predict the binomial outcome of the bioassay tests, being whether L. salmonis are immobilized/die or survive pesticide exposure. We found that local kernel densities of bath treatments, along with a spatial geographic index of test-farm locations, were significant predictors of the binomial outcome of the tests. Furthermore, the probability of L. salmonis being immobilized/dead after test-exposure was reduced by odds-ratios of 0.60 (95% CI: 0.42-0.86) for 2014 compared to 2013 and 0.39 (95% CI: 0.36-0.42) for low concentration compared to high concentration exposure. There were also significant but more marginal effects of parasite gender and developmental stage, and a relatively large random effect of test-farm. We conclude that the present data support an association between local intensities of bath treatments along the coast and the outcome of bioassay tests where salmon lice are exposed to azamethiphos or deltamethrin. Furthermore, there is a predictable structure of L. salmonis phenotypes along the coast in the data, characterized by high susceptibility to pesticides in the far north and far south, but low susceptibility in mid Norway. The study emphasizes the need to address local susceptibility to pesticides and the need for restrictive use of pesticides to preserve treatment efficacy.	[Jansen, Peder A.; Grontvedt, Randi N.; Tarpai, Attila] Norwegian Vet Inst, Oslo, Norway; [Helgesen, Kari O.; Horsberg, Tor Einar] Sea Lice Res Ctr, NMBU Sch Vet Sci, Oslo, Norway; [Jansen, Peder A.] Univ Bergen, Dept Biol, Sea Lice Res Ctr, Bergen, Norway	Norwegian Veterinary Institute; Norwegian University of Life Sciences; University of Bergen	Jansen, PA (corresponding author), Norwegian Vet Inst, Oslo, Norway.	Peder.jansen@vetinst.no			Norwegian Food safety Authority	Norwegian Food safety Authority	The Norwegian Food safety Authority, http://www.mattilsynet.no/, is responsible for management of fish health. Thereby, they fund the Surveillance program for salmon louse resistance to antiparasitics. The paper reports data from this activity.	Aaen SM, 2015, TRENDS PARASITOL, V31, P72, DOI 10.1016/j.pt.2014.12.006; Aldrin M, 2011, J R SOC INTERFACE, V8, P1346, DOI 10.1098/rsif.2010.0737; Aldrin M, 2010, PREV VET MED, V93, P51, DOI 10.1016/j.prevetmed.2009.09.010; [Anonymous], 2015, FORUTSIGBAR MILJOMES; Besnier F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-937; Cleveland W. S., 1992, LOCAL REGRESSION MOD, DOI 10.1201/9780203738535; Denholm I, 2002, PEST MANAG SCI, V58, P528, DOI 10.1002/ps.482; Dohoo I., 2003, VET EPIDEMIOLOGY RES; Fallang A, 2005, DIS AQUAT ORGAN, V65, P129, DOI 10.3354/dao065129; Glover KA, 2011, MAR ECOL PROG SER, V427, P161, DOI 10.3354/meps09045; Grontvedt R. J., 2015, SURVEILLANCE PROGRAM; Helgesen KO, 2014, J FISH DIS, V37, P877, DOI 10.1111/jfd.12223; Helgesen KO, 2013, J FISH DIS, V36, P261, DOI 10.1111/jfd.12053; Jansen PA, 2012, P ROY SOC B-BIOL SCI, V279, P2330, DOI 10.1098/rspb.2012.0084; JONES MW, 1992, J FISH DIS, V15, P197, DOI 10.1111/j.1365-2761.1992.tb00654.x; Jones PG, 2012, DIS AQUAT ORGAN, V102, P53, DOI 10.3354/dao02517; Kaur K, 2015, PLOS ONE UNPUB; Kaur K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124220; Kristoffersen AB, 2013, PREV VET MED, V111, P165, DOI 10.1016/j.prevetmed.2013.03.015; Kristoffersen AB, 2014, EPIDEMICS-NETH, V9, P31, DOI 10.1016/j.epidem.2014.09.007; Kristoffersen AB, 2013, PREV VET MED, V109, P136, DOI 10.1016/j.prevetmed.2012.08.012; Leclercq E, 2014, PEST MANAG SCI, V70, P1274, DOI 10.1002/ps.3692; Lees F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001549; Ljungfeldt LER, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-108; Marin SL, 2015, PREV VET MED, V122, P33, DOI 10.1016/j.prevetmed.2015.09.017; McEwan GF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139128; R Development Coar Team, 2014, R LANG ENV STAT COMP; Read AF, 2011, P NATL ACAD SCI USA, V108, P10871, DOI 10.1073/pnas.1100299108; Roth M, 1996, AQUACULTURE, V140, P217, DOI 10.1016/0044-8486(95)01181-1; Sevatdal S, 2005, AQUACULTURE, V244, P19, DOI 10.1016/j.aquaculture.2004.11.009; Sevatdal S, 2003, AQUACULTURE, V218, P21, DOI 10.1016/S0044-8486(02)00339-3; Skiftesvik AB, 2014, MAR BIOL RES, V10, P289, DOI 10.1080/17451000.2013.810760; Tjensvoll K, 2006, DIS AQUAT ORGAN, V68, P251, DOI 10.3354/dao068251; Todd CD, 2004, CAN J FISH AQUAT SCI, V61, P1176, DOI 10.1139/F04-069; Torrissen O, 2013, J FISH DIS, V36, P171, DOI 10.1111/jfd.12061; Viljugrein H, 2009, DIS AQUAT ORGAN, V88, P35, DOI 10.3354/dao02151	36	18	18	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149006	10.1371/journal.pone.0149006	http://dx.doi.org/10.1371/journal.pone.0149006			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26889677	Green Published, gold, Green Submitted			2022-12-27	WOS:000371221500019
J	Yasuga, H; Kawano, R; Takinoue, M; Tsuji, Y; Osaki, T; Kamiya, K; Miki, N; Takeuchi, S				Yasuga, Hiroki; Kawano, Ryuji; Takinoue, Masahiro; Tsuji, Yutaro; Osaki, Toshihisa; Kamiya, Koki; Miki, Norihisa; Takeuchi, Shoji			Logic Gate Operation by DNA Translocation through Biological Nanopores	PLOS ONE			English	Article							ALPHA-HEMOLYSIN; COMPUTATION; CHANNELS; SENSORS; SYSTEM; ROBOTS	Logical operations using biological molecules, such as DNA computing or programmable diagnosis using DNA, have recently received attention. Challenges remain with respect to the development of such systems, including label-free output detection and the rapidity of operation. Here, we propose integration of biological nanopores with DNA molecules for development of a logical operating system. We configured outputs "1" and "0" as single-stranded DNA (ssDNA) that is or is not translocated through a nanopore; unlabeled DNA was detected electrically. A negative-AND (NAND) operation was successfully conducted within approximately 10 min, which is rapid compared with previous studies using unlabeled DNA. In addition, this operation was executed in a four-droplet network. DNA molecules and associated information were transferred among droplets via biological nanopores. This system would facilitate linking of molecules and electronic interfaces. Thus, it could be applied to molecular robotics, genetic engineering, and even medical diagnosis and treatment.	[Yasuga, Hiroki; Kawano, Ryuji; Tsuji, Yutaro; Osaki, Toshihisa; Kamiya, Koki; Miki, Norihisa; Takeuchi, Shoji] Kanagawa Acad Sci & Technol, Artificial Cell Membrane Syst Grp, Kawasaki, Kanagawa, Japan; [Yasuga, Hiroki; Tsuji, Yutaro; Miki, Norihisa] Keio Univ, Dept Mech Engn, Yokohama, Kanagawa 223, Japan; [Takinoue, Masahiro] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Yokohama, Kanagawa 227, Japan; [Osaki, Toshihisa; Takeuchi, Shoji] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Kawano, Ryuji] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Tokyo, Japan	Kanagawa Academy Science & Technology; Keio University; Tokyo Institute of Technology; University of Tokyo; Tokyo University of Agriculture & Technology	Takeuchi, S (corresponding author), Kanagawa Acad Sci & Technol, Artificial Cell Membrane Syst Grp, Kawasaki, Kanagawa, Japan.; Takeuchi, S (corresponding author), Univ Tokyo, Inst Ind Sci, Tokyo, Japan.	takeuchi@iis.u-tokyo.ac.jp	Takinoue, Masahiro/AAI-6179-2020; Takinoue, Masahiro/A-1490-2014; Kamiya, Koki/F-9889-2018; Yasuga, Hiroki/AGZ-6419-2022; OSAKI, Toshihisa/F-3815-2012; Miki, Norihisa/F-7659-2014; Takeuchi, Shoji/J-5349-2019; Kamiya, Koki/AAL-6950-2020; Kawano, Ryuji/A-3177-2011	Takinoue, Masahiro/0000-0002-3874-2670; Takinoue, Masahiro/0000-0002-3874-2670; OSAKI, Toshihisa/0000-0003-1659-2541; Kamiya, Koki/0000-0001-9143-9841; Kawano, Ryuji/0000-0001-6523-0649; Takeuchi, Shoji/0000-0001-6946-0409; Yasuga, Hiroki/0000-0003-2040-9017	Regional Innovation Strategy Support Program; Ministry of Education, Culture, Sports, Science, and Technology, Japan [25246017];  [24104002];  [26540160];  [25708024]; Grants-in-Aid for Scientific Research [15H00803, 26540160] Funding Source: KAKEN	Regional Innovation Strategy Support Program; Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "Molecular Robotics" (No. 24104002) to RK and MT; a Grant-in-Aid for Challenging Exploratory Research (No. 26540160) to RK; a Grant-in-Aid for Young Scientists (A) (No. 25708024) to RK; the Regional Innovation Strategy Support Program to ST; a Grant-in-Aid for Scientific Research (A) (No. 25246017) to ST of The Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir Y, 2014, NAT NANOTECHNOL, V9, P353, DOI [10.1038/NNANO.2014.58, 10.1038/nnano.2014.58]; Ayukawa S, 2011, ACCOUNTS CHEM RES, V44, P1369, DOI 10.1021/ar200128b; Bayley H, 2008, MOL BIOSYST, V4, P1191, DOI 10.1039/b808893d; Benenson Y, 2001, NATURE, V414, P430, DOI 10.1038/35106533; Benenson Y, 2004, NATURE, V429, P423, DOI 10.1038/nature02551; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Deamer D, 2010, ANNU REV BIOPHYS, V39, P79, DOI 10.1146/annurev.biophys.093008.131250; Dirks RM, 2007, SIAM REV, V49, P65, DOI 10.1137/060651100; Faulhammer D, 2000, P NATL ACAD SCI USA, V97, P1385, DOI 10.1073/pnas.97.4.1385; Gouaux E, 1998, J STRUCT BIOL, V121, P110, DOI 10.1006/jsbi.1998.3959; GOUAUX JE, 1994, P NATL ACAD SCI USA, V91, P12828, DOI 10.1073/pnas.91.26.12828; Hagiya M, 2014, ACCOUNTS CHEM RES, V47, P1681, DOI 10.1021/ar400318d; Howorka S, 2009, CHEM SOC REV, V38, P2360, DOI 10.1039/b813796j; Kawano R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102427; Kawano R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01995; Kawano R, 2011, J AM CHEM SOC, V133, P8474, DOI 10.1021/ja2026085; Miyamoto T, 2013, ACS SYNTH BIOL, V2, P72, DOI 10.1021/sb3001112; Qian L, 2011, NATURE, V475, P368, DOI 10.1038/nature10262; Reiner JE, 2012, CHEM REV, V112, P6431, DOI 10.1021/cr300381m; Sauer-Budge AF, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.238101; Sekiya K, 2007, MICROBES INFECT, V9, P1341, DOI 10.1016/j.micinf.2007.06.010; Stojanovic MN, 2002, J AM CHEM SOC, V124, P3555, DOI 10.1021/ja016756v; Tsuji Y, 2013, ANAL CHEM, V85, P10913, DOI 10.1021/ac402299z; Tsuji Y, 2013, LAB CHIP, V13, P1476, DOI 10.1039/c3lc41359d; Yoshida W, 2007, CHEM COMMUN, P195, DOI 10.1039/b613201d; You MX, 2015, J AM CHEM SOC, V137, P667, DOI 10.1021/ja509263k; Zhang DY, 2011, NAT CHEM, V3, P103, DOI [10.1038/nchem.957, 10.1038/NCHEM.957]	27	26	27	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149667	10.1371/journal.pone.0149667	http://dx.doi.org/10.1371/journal.pone.0149667			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890568	Green Submitted, Green Published, gold			2022-12-27	WOS:000371221500070
J	Jagannadham, J; Jaiswal, HK; Agrawal, S; Rawal, K				Jagannadham, Jaisri; Jaiswal, Hitesh Kumar; Agrawal, Stuti; Rawal, Kamal			Comprehensive Map of Molecules Implicated in Obesity	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; SIGNALING PATHWAYS; BIOLOGICAL NETWORKS; INSULIN-RESISTANCE; ANTIOBESITY DRUGS; GHRELIN; MICROARRAY; MODULARITY; ADIPOGENESIS; EXPRESSION	Obesity is a global epidemic affecting over 1.5 billion people and is one of the risk factors for several diseases such as type 2 diabetes mellitus and hypertension. We have constructed a comprehensive map of the molecules reported to be implicated in obesity. A deep curation strategy was complemented by a novel semi-automated text mining system in order to screen 1,000 full-length research articles and over 90,000 abstracts that are relevant to obesity. We obtain a scale free network of 804 nodes and 971 edges, composed of 510 proteins, 115 genes, 62 complexes, 23 RNA molecules, 83 simple molecules, 3 phenotype and 3 drugs in "bow-tie" architecture. We classify this network into 5 modules and identify new links between the recently discovered fat mass and obesity associated FTO gene with well studied examples such as insulin and leptin. We further built an automated docking pipeline to dock orlistat as well as other drugs against the 24,000 proteins in the human structural proteome to explain the therapeutics and side effects at a network level. Based upon our experiments, we propose that therapeutic effect comes through the binding of one drug with several molecules in target network, and the binding propensity is both statistically significant and different in comparison with any other part of human structural proteome.	[Jagannadham, Jaisri; Jaiswal, Hitesh Kumar; Agrawal, Stuti; Rawal, Kamal] Jaypee Inst Informat Technol, Dept Biotechnol, Noida 201307, UP, India; [Jagannadham, Jaisri] Jaipur Natl Univ, Jaipur, Rajasthan, India; [Agrawal, Stuti] Univ Chicago, Ctr Data Intens Sci, Chicago, IL 60637 USA	Jaypee Institute of Information Technology (JIIT); Jaipur National University; University of Chicago	Rawal, K (corresponding author), Jaypee Inst Informat Technol, Dept Biotechnol, Noida 201307, UP, India.	kamal.rawal@gmail.com						Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Aronne LJ, 2002, OBES RES, V10, p105S, DOI 10.1038/oby.2002.203; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066149; Bourguignon PY, 2006, LECT NOTES COMPUT SC, V4220, P1; Brandes U, 2007, LECT NOTES COMPUT SC, V4769, P121; Bravard A, 2011, DIABETES, V60, P258, DOI 10.2337/db10-0281; Brohee S, 2008, NUCLEIC ACIDS RES, V36, pW444, DOI 10.1093/nar/gkn336; Brown CD, 2000, OBES RES, V8, P605, DOI 10.1038/oby.2000.79; Calzone L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.7; Chung F, 2007, P NATL ACAD SCI USA, V104, P19735, DOI 10.1073/pnas.0708838104; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; de Silva E, 2005, J R SOC INTERFACE, V2, P419, DOI 10.1098/rsif.2005.0067; Dhillon IS, 2007, IEEE T PATTERN ANAL, V29, P1944, DOI 10.1109/TP'AMI.2007.1115; Ebert MH, 1997, J NEUROPSYCH CLIN N, V9, P75; Eisenberg E, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.138701; Elangbam CS, 2009, VET PATHOL, V46, P10, DOI 10.1354/vp.46-1-10; ERDOS P, 1960, B INT STATIST INST, V38, P343; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Funahashi Akira, 2003, Biosilico, V1, P159, DOI 10.1016/S1478-5382(03)02370-9; Gallagher EJ, 2010, CURR DIABETES REP, V10, P93, DOI 10.1007/s11892-010-0101-y; Gao ZT, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-104; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Haw R, 2011, DATABASE, V2011, P1; Hearn T, 2005, DIABETES, V54, P1581, DOI 10.2337/diabetes.54.5.1581; Higham DJ, 2007, J COMPUT APPL MATH, V204, P25, DOI 10.1016/j.cam.2006.04.026; Hogart A, 2007, HUM MOL GENET, V16, P691, DOI 10.1093/hmg/ddm014; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Itariu BK, 2012, AM J CLIN NUTR, V96, P1137, DOI 10.3945/ajcn.112.037432; Janjic V, 2012, MOL BIOSYST, V8, P2614, DOI 10.1039/c2mb25230a; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jordan IK, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-1; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kapushesky M, 2012, NUCLEIC ACIDS RES, V40, pD1077, DOI 10.1093/nar/gkr913; Karger DR, 1996, J ACM, V43, P601, DOI 10.1145/234533.234534; Kitano H, 2004, DIABETES, V53, pS6, DOI 10.2337/diabetes.53.suppl_3.S6; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kohn KW, 1999, MOL BIOL CELL, V10, P2703, DOI 10.1091/mbc.10.8.2703; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Lee H, 2011, J ETHNOPHARMACOL, V133, P788, DOI 10.1016/j.jep.2010.11.009; Lee M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S17-S6; Li S, 2006, BIOINFORMATICS, V22, P2143, DOI 10.1093/bioinformatics/btl363; Liu HF, 2010, J MOL GRAPH MODEL, V29, P326, DOI 10.1016/j.jmgm.2010.09.004; Logsdon BA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-53; Lusis AJ, 2010, CIRCULATION, V121, P157, DOI 10.1161/CIRCULATIONAHA.108.847699; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Meyer M, 2009, JASSS-J ARTIF SOC S, V12, pA224; Miller WC, 1997, INT J OBESITY, V21, P941, DOI 10.1038/sj.ijo.0800499; Mitka M, 2003, JAMA-J AM MED ASSOC, V289, P1761, DOI 10.1001/jama.289.14.1761; Mizuno S, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-52; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P176; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Nishikawa T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.014101; Niswender KD, 2011, NEUROPSYCHOPHARMACOL, V36, P359, DOI 10.1038/npp.2010.167; Nogueiras R, 2008, ANN NY ACAD SCI, V1126, P14, DOI 10.1196/annals.1433.054; Oda K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100057; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Orchard S, 2012, NAT METHODS, V9, P345, DOI [10.1038/NMETH.1931, 10.1038/nmeth.1931]; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Pontzer H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040503; Prestwich TC, 2007, CURR OPIN CELL BIOL, V19, P612, DOI 10.1016/j.ceb.2007.09.014; PRICE RA, 1989, HUM HERED, V39, P121; PRICE RA, 1990, HUM BIOL, V62, P747; Purnell JQ, 2013, CIRCULATION, V127, P180, DOI 10.1161/CIRCULATIONAHA.111.077487; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Saeed R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-128; Scardoni G., 2011, INT J COMPLEX SYST S, V1, P164; Scerif M, 2011, MOL CELL ENDOCRINOL, V340, P15, DOI 10.1016/j.mce.2011.02.011; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Smith SC, 2011, NEOPLASIA, V13, P72, DOI 10.1593/neo.101214; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Tam CS, 2011, EXPERT OPIN BIOL TH, V11, P1677, DOI 10.1517/14712598.2011.619974; Tieri P, 2011, METHODS MOL BIOL, V719, P415, DOI 10.1007/978-1-61779-027-0_19; Toh SA, 2011, METABOLIC BASIS OF OBESITY, P293, DOI 10.1007/978-1-4419-1607-5_15; Toshinai K, 2003, ENDOCRINOLOGY, V144, P1506, DOI 10.1210/en.2002-220788; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Ucar D, 2006, LECT NOTES ARTIF INT, V4213, P371; Uruno A, 2011, J MOL ENDOCRINOL, V46, P37, DOI 10.1677/JME-10-0088; Verma A, 2008, SAUDI MED J, V29, P1135; Viner RM, 2010, OBES REV, V11, P593, DOI 10.1111/j.1467-789X.2009.00651.x; Wang JG, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr251; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010137; Yamada N, 2011, ENDOCRINOLOGY, V152, P2634, DOI 10.1210/en.2011-0004; Yoon J, 2006, BIOINFORMATICS, V22, P3106, DOI 10.1093/bioinformatics/btl533; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhang N, 2011, AM J MED SCI, V341, P48, DOI 10.1097/MAJ.0b013e3181ec41ed	99	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0146759	10.1371/journal.pone.0146759	http://dx.doi.org/10.1371/journal.pone.0146759			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886906	Green Published, Green Submitted, gold			2022-12-27	WOS:000371218400003
J	Prachantasena, S; Charununtakorn, P; Muangnoicharoen, S; Hankla, L; Techawal, N; Chaveerach, P; Tuitemwong, P; Chokesajjawatee, N; Williams, N; Humphrey, T; Luangtongkum, T				Prachantasena, Sakaoporn; Charununtakorn, Petcharatt; Muangnoicharoen, Suthida; Hankla, Luck; Techawal, Natthaporn; Chaveerach, Prapansak; Tuitemwong, Pravate; Chokesajjawatee, Nipa; Williams, Nicola; Humphrey, Tom; Luangtongkum, Taradon			Distribution and Genetic Profiles of Campylobacter in Commercial Broiler Production from Breeder to Slaughter in Thailand	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; ANTIMICROBIAL RESISTANCE; JEJUNI STRAINS; POULTRY; SPP.; FLOCKS; CONTAMINATION; PREVALENCE; CHICKEN; MEAT	Poultry and poultry products are commonly considered as the major vehicle of Campylobacter infection in humans worldwide. To reduce the number of human cases, the epidemiology of Campylobacter in poultry must be better understood. Therefore, the objective of the present study was to determine the distribution and genetic relatedness of Campylobacter in the Thai chicken production industry. During June to October 2012, entire broiler production processes (i.e., breeder flock, hatchery, broiler farm and slaughterhouse) of five broiler production chains were investigated chronologically. Representative isolates of C. jejuni from each production stage were characterized by flaA SVR sequencing and multilocus sequence typing (MLST). Amongst 311 selected isolates, 29 flaA SVR alleles and 17 sequence types (STs) were identified. The common clonal complexes (CCs) found in this study were CC-45, CC-353, CC-354 and CC-574. C. jejuni isolated from breeders were distantly related to those isolated from broilers and chicken carcasses, while C. jejuni isolates from the slaughterhouse environment and meat products were similar to those isolated from broiler flocks. Genotypic identification of C. jejuni in slaughterhouses indicated that broilers were the main source of Campylobacter contamination of chicken meat during processing. To effectively reduce Campylobacter in poultry meat products, control and prevention strategies should be aimed at both farm and slaughterhouse levels.	[Prachantasena, Sakaoporn; Charununtakorn, Petcharatt; Muangnoicharoen, Suthida; Hankla, Luck; Techawal, Natthaporn; Luangtongkum, Taradon] Chulalongkorn Univ, Fac Vet Sci, Dept Vet Publ Hlth, Bangkok, Thailand; [Luangtongkum, Taradon] Chulalongkorn Univ, Fac Vet Sci, Res Unit Microbial Food Safety & Antimicrobial Re, Bangkok, Thailand; [Chaveerach, Prapansak] Khon Kaen Univ, Fac Vet Med, Dept Vet Publ Hlth, Khon Kaen, Thailand; [Tuitemwong, Pravate] King Mongkuts Univ Technol Thonburi, Fac Sci, Dept Microbiol, Bangkok, Thailand; [Chokesajjawatee, Nipa] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Pathum Thani, Thailand; [Williams, Nicola] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Humphrey, Tom] Swansea Univ, Coll Med, Singleton Pk, Swansea, W Glam, Wales	Chulalongkorn University; Chulalongkorn University; Khon Kaen University; King Mongkuts University of Technology Thonburi; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); University of Liverpool; Swansea University	Luangtongkum, T (corresponding author), Chulalongkorn Univ, Fac Vet Sci, Dept Vet Publ Hlth, Bangkok, Thailand.; Luangtongkum, T (corresponding author), Chulalongkorn Univ, Fac Vet Sci, Res Unit Microbial Food Safety & Antimicrobial Re, Bangkok, Thailand.	taradon.L@chula.ac.th		Humphrey, Tom/0000-0001-7965-8988; Luangtongkum, Taradon/0000-0001-6150-3259; Williams, Nicola/0000-0003-4709-4190	National Science and Technology Development Agency (NSTDA) [P-11-00757]; H. M. the King Bhumibol Adulyadej's 72nd Anniversary Scholarship; Royal Golden Jubilee Ph.D. Program [PHD/0006/2554]; TRF [RTA5780006]; Biotechnology and Biological Sciences Research Council [BB/J019771/1] Funding Source: researchfish	National Science and Technology Development Agency (NSTDA); H. M. the King Bhumibol Adulyadej's 72nd Anniversary Scholarship; Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF)); TRF(Thailand Research Fund (TRF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the National Science and Technology Development Agency (NSTDA) grant P-11-00757. Ms. Sakaoporn Prachantasena is a recipient of H. M. the King Bhumibol Adulyadej's 72nd Anniversary Scholarship and the Royal Golden Jubilee Ph.D. Program (PHD/0006/2554). Financial support to Ms. Prachantasena from the TRF Senior Scholar to Alongkorn Amonsin (RTA5780006) is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agunos A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104905; Altekruse SF, 2003, J AM VET MED ASSOC, V223, P445, DOI 10.2460/javma.2003.223.445; Andreoletti O, 2011, EFSA J, V9, DOI [10.2903/j.efsa.2011.2105, 10.2903/j.efsa.2011.2490]; Arsenault J, 2007, PREV VET MED, V81, P250, DOI 10.1016/j.prevetmed.2007.04.016; Bull SA, 2006, APPL ENVIRON MICROB, V72, P645, DOI 10.1128/AEM.72.1.645-652.2006; Colles FM, 2012, MICROBIOL-SGM, V158, P2695, DOI 10.1099/mic.0.062000-0; Colles FM, 2015, ENVIRON MICROBIOL, V17, P938, DOI 10.1111/1462-2920.12415; Colles FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022825; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Dingle KE, 2005, J CLIN MICROBIOL, V43, P340, DOI 10.1128/JCM.43.1.340-347.2005; Gerchman I, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-90; Gibreel A, 2006, J ANTIMICROB CHEMOTH, V58, P243, DOI 10.1093/jac/dkl210; Griekspoor P, 2010, VET MICROBIOL, V140, P180, DOI 10.1016/j.vetmic.2009.07.022; Habib I, 2009, APPL ENVIRON MICROB, V75, P4264, DOI 10.1128/AEM.00168-09; Hansson I, 2007, J APPL MICROBIOL, V103, P640, DOI 10.1111/j.1365-2672.2007.03291.x; Hansson I, 2005, J APPL MICROBIOL, V99, P1149, DOI 10.1111/j.1365-2672.2005.02689.x; Hermans D, 2012, VECTOR-BORNE ZOONOT, V12, P89, DOI 10.1089/vbz.2011.0676; Hermans D, 2011, VET MICROBIOL, V152, P219, DOI 10.1016/j.vetmic.2011.03.010; Hofshagen M, 2005, J FOOD PROTECT, V68, P2220, DOI 10.4315/0362-028X-68.10.2220; Hook H, 2005, VET MICROBIOL, V106, P109, DOI 10.1016/j.vetmic.2004.12.017; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kaakoush NO, 2015, CLIN MICROBIOL REV, V28, P687, DOI 10.1128/CMR.00006-15; Kalupahana RS, 2013, APPL ENVIRON MICROB, V79, P393, DOI 10.1128/AEM.02269-12; Levin RE, 2007, FOOD BIOTECHNOL, V21, P271, DOI 10.1080/08905430701536565; Linton D, 1996, RES MICROBIOL, V147, P707, DOI 10.1016/S0923-2508(97)85118-2; Meinersmann RJ, 1997, J CLIN MICROBIOL, V35, P2810, DOI 10.1128/JCM.35.11.2810-2814.1997; Melero B, 2012, FOOD MICROBIOL, V32, P124, DOI 10.1016/j.fm.2012.04.020; Messens W, 2009, VET MICROBIOL, V138, P120, DOI 10.1016/j.vetmic.2009.02.012; Newell DG, 2011, APPL ENVIRON MICROB, V77, P8605, DOI 10.1128/AEM.01090-10; O'Mahony E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028490; PACHA RE, 1987, APPL ENVIRON MICROB, V53, P1574, DOI 10.1128/AEM.53.7.1574-1579.1987; Patriarchi A, 2011, FOODBORNE PATHOG DIS, V8, P99, DOI 10.1089/fpd.2010.0637; Peyrat MB, 2008, INT J FOOD MICROBIOL, V124, P188, DOI 10.1016/j.ijfoodmicro.2008.03.030; Ragimbeau C, 2008, APPL ENVIRON MICROB, V74, P7715, DOI 10.1128/AEM.00865-08; Reich F, 2008, INT J FOOD MICROBIOL, V127, P116, DOI 10.1016/j.ijfoodmicro.2008.06.018; Rosenquist H, 2009, EPIDEMIOL INFECT, V137, P1742, DOI 10.1017/S0950268809002684; Sasaki Y, 2013, ZOONOSES PUBLIC HLTH, V60, P134, DOI 10.1111/j.1863-2378.2012.01509.x; Schonberg-Norio D, 2010, EPIDEMIOL INFECT, V138, P1004, DOI 10.1017/S0950268809991099; Sheppard SK, 2007, ZOONOSES PUBLIC HLTH, V54, P36; Sheppard SK, 2009, INT J FOOD MICROBIOL, V134, P96, DOI 10.1016/j.ijfoodmicro.2009.02.010; Slader J, 2002, APPL ENVIRON MICROB, V68, P713, DOI 10.1128/AEM.68.2.713-719.2002; Sopwith W, 2008, EMERG INFECT DIS, V14, P1769, DOI 10.3201/eid1411.071678; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wales AD, 2015, ANTIBIOTICS-BASEL, V4, P567, DOI 10.3390/antibiotics4040567; Williams NJ, 2010, APPL ENVIRON MICROB, V76, P7318, DOI 10.1128/AEM.00511-10; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718; Zweifel C, 2008, INT J FOOD MICROBIOL, V125, P182, DOI 10.1016/j.ijfoodmicro.2008.03.038	47	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149585	10.1371/journal.pone.0149585	http://dx.doi.org/10.1371/journal.pone.0149585			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886590	Green Published, gold, Green Submitted			2022-12-27	WOS:000371218400099
J	Senger, DR; Li, D; Jaminet, SC; Cao, SG				Senger, Donald R.; Li, Dan; Jaminet, Shou-Ching; Cao, Shugeng			Activation of the Nrf2 Cell Defense Pathway by Ancient Foods: Disease Prevention by Important Molecules and Microbes Lost from the Modern Western Diet	PLOS ONE			English	Article							TRADITIONAL FERMENTED FOODS; TRANSCRIPTION FACTOR NRF2; CAFFEIC ACID METABOLISM; OXIDATIVE STRESS; PHENOLIC-COMPOUNDS; LACTOBACILLUS-PLANTARUM; KNOCKOUT MICE; CHEMOPREVENTIVE AGENTS; PROTECTIVE ENZYMES; ALZHEIMERS-DISEASE	The Nrf2 (NFE2L2) cell defense pathway protects against oxidative stress and disorders including cancer and neurodegeneration. Although activated modestly by oxidative stress alone, robust activation of the Nrf2 defense mechanism requires the additional presence of co-factors that facilitate electron exchange. Various molecules exhibit this co-factor function, including sulforaphane from cruciferous vegetables. However, natural co-factors that are potent and widely available from dietary sources have not been identified previously. The objectives of this study were to investigate support of the Nrf2 cell defense pathway by the alkyl catechols: 4-methylcatechol, 4-vinylcatechol, and 4-ethylcatechol. These small electrochemicals are naturally available from numerous sources but have not received attention. Findings reported here illustrate that these compounds are indeed potent co-factors for activation of the Nrf2 pathway both in vitro and in vivo. Each strongly supports expression of Nrf2 target genes in a variety of human cell types; and, in addition, 4-ethylcatechol is orally active in mice. Furthermore, findings reported here identify important and previously unrecognized sources of these compounds, arising from biotransformation of common plant compounds by lactobacilli that express phenolic acid decarboxylase. Thus, for example, Lactobacillus plantarum, Lactobacillus brevis, and Lactobacillus collinoides, which are consumed from a diet rich in traditionally fermented foods and beverages, convert common phenolic acids found in fruits and vegetables to 4-vinylcatechol and/or 4-ethylcatechol. In addition, all of the alkyl catechols are found in wood smoke that was used widely for food preservation. Thus, the potentially numerous sources of alkyl catechols in traditional foods suggest that these co-factors were common in ancient diets. However, with radical changes in food preservation, alkyl catechols have been lost from modern foods. The absence of alkyl catechols from the modern Western diet suggests serious negative consequences for Nrf2 cell defense, resulting in reduced protection against multiple chronic diseases associated with oxidative stress.	[Senger, Donald R.; Li, Dan; Jaminet, Shou-Ching] Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA; [Senger, Donald R.; Li, Dan; Jaminet, Shou-Ching] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Senger, Donald R.; Jaminet, Shou-Ching] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Cao, Shugeng] Univ Hawaii, Dept Pharmaceut Sci, Daniel K Inouye Coll Pharm, Hilo, HI 96720 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Hawaii System; University Hawaii Hilo	Senger, DR (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.; Senger, DR (corresponding author), Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA.; Senger, DR (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	dsenger@bidmc.harvard.edu			National Center for Complementary and Integrative Health of the National Institutes of Health [R01AT007022]; National Center for Complementary & Integrative Health [R01AT007022] Funding Source: NIH RePORTER	National Center for Complementary and Integrative Health of the National Institutes of Health; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research reported in this publication was supported by the National Center for Complementary and Integrative Health of the National Institutes of Health under Award Number R01AT007022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aerts JL, 2004, BIOTECHNIQUES, V36, P84, DOI 10.2144/04361ST04; Almenier Hazem A, 2012, Front Biosci (Elite Ed), V4, P1335; Curiel JA, 2010, FOOD CHEM, V120, P225, DOI 10.1016/j.foodchem.2009.10.012; BAKKE OM, 1969, J NUTR, V98, P209, DOI 10.1093/jn/98.2.209; Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Basu S, 2001, BIOCHEM BIOPH RES CO, V288, P275, DOI 10.1006/bbrc.2001.5747; Becks L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-540; Bel-Rhlid R, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-28; Bensasson RV, 2008, CHEM RES TOXICOL, V21, P805, DOI 10.1021/tx7002883; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Beyer TA, 2008, EMBO J, V27, P212, DOI 10.1038/sj.emboj.7601950; Borgstrom G., 2012, FISH FOOD V3 PROCE 1, P72; Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x; Buron N, 2012, INT J FOOD MICROBIOL, V153, P159, DOI 10.1016/j.ijfoodmicro.2011.11.002; Buron N, 2011, FOOD MICROBIOL, V28, P1243, DOI 10.1016/j.fm.2011.05.001; Buron N, 2011, FOOD CHEM, V125, P542, DOI 10.1016/j.foodchem.2010.09.046; Cabrita MJ, 2012, CIENCIA TECNOL ALIME, V32, P106, DOI 10.1590/S0101-20612012005000024; Calkins MJ, 2009, ANTIOXID REDOX SIGN, V11, P497, DOI [10.1089/ars.2008.2242, 10.1089/ARS.2008.2242]; Carmody RN, 2011, P NATL ACAD SCI USA, V108, P19199, DOI 10.1073/pnas.1112128108; Carroll RE, 2011, CANCER PREV RES, V4, P354, DOI 10.1158/1940-6207.CAPR-10-0098; Cavin JF, 1997, APPL ENVIRON MICROB, V63, P1939, DOI 10.1128/AEM.63.5.1939-1944.1997; Chatonnet P, 1995, AM J ENOL VITICULT, V46, P463; Chian S, 2014, BIOCHEM BIOPH RES CO, V447, P602, DOI 10.1016/j.bbrc.2014.04.039; Cornblatt BS, 2007, CARCINOGENESIS, V28, P1485, DOI 10.1093/carcin/bgm049; Dalleau S, 2013, CELL DEATH DIFFER, V20, P1615, DOI 10.1038/cdd.2013.138; de Ferrars RM, 2014, BRIT J PHARMACOL, V171, P3268, DOI 10.1111/bph.12676; de Ferrars RM, 2014, MOL NUTR FOOD RES, V58, P490, DOI 10.1002/mnfr.201300322; Dinkova-Kostova AT, 2006, CANCER LETT, V240, P243, DOI 10.1016/j.canlet.2005.09.012; Dinkova-Kostova AT, 2015, FREE RADICAL BIO MED, V88, P179, DOI 10.1016/j.freeradbiomed.2015.04.036; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Doe P., 1998, FISH DRYING SMOKING, P44; EDLIN DAN, 1995, FEMS MICROBIOL LETT, V125, P311, DOI [10.1111/j.1574-6968.1995.tb07374.x, 10.1016/0378-1097(94)00516-T]; Egner PA, 2011, CANCER PREV RES, V4, P384, DOI 10.1158/1940-6207.CAPR-10-0296; EPA, HLTH EFF BREATH WOOD; Fernandes R, 2011, AM J PHYSIOL-CELL PH, V300, pC927, DOI 10.1152/ajpcell.00140.2010; Filannino P, 2015, FOOD MICROBIOL, V46, P272, DOI 10.1016/j.fm.2014.08.018; Fonseca-Azevedo K, 2012, P NATL ACAD SCI USA, V109, P18571, DOI 10.1073/pnas.1206390109; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Frank O, 2007, J AGR FOOD CHEM, V55, P1945, DOI 10.1021/jf0632280; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gadaga TH, 1999, INT J FOOD MICROBIOL, V53, P1, DOI 10.1016/S0168-1605(99)00154-3; Ganzle MG, 2014, FOOD MICROBIOL, V37, P2, DOI 10.1016/j.fm.2013.04.007; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gilgun-Sherki Y, 2004, J NEUROL, V251, P261, DOI 10.1007/s00415-004-0348-9; Gills JJ, 2006, CANCER LETT, V236, P72, DOI 10.1016/j.canlet.2005.05.007; Godoy L, 2014, FOOD CONTROL, V45, P81, DOI 10.1016/j.foodcont.2014.03.041; Guglielmetti S, 2008, APPL ENVIRON MICROB, V74, P1284, DOI 10.1128/AEM.02093-07; Halliwell B, 2007, BIOCHEM J, V401, P1, DOI 10.1042/BJ20061131; Hallowell B., 2007, FREE RADICALS BIOL M; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Hirota A, 2011, EXP DERMATOL, V20, P664, DOI 10.1111/j.1600-0625.2011.01292.x; Holland R, 2010, ANTIOXID REDOX SIGN, V13, P1749, DOI 10.1089/ars.2010.3273; Holmstrom KM, 2013, BIOL OPEN, V2, P761, DOI 10.1242/bio.20134853; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Huys G, 2008, J FOOD PROTECT, V71, P339, DOI 10.4315/0362-028X-71.2.339; Inano H, 1999, CARCINOGENESIS, V20, P1011, DOI 10.1093/carcin/20.6.1011; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Itoh K, 2010, ANTIOXID REDOX SIGN, V13, P1665, DOI 10.1089/ars.2010.3222; Jain M, 2004, CIRCULATION, V109, P898, DOI 10.1161/01.CIR.0000112605.43318.CA; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Ji LL, 2015, FREE RADICAL BIO MED, V85, P12, DOI 10.1016/j.freeradbiomed.2015.03.035; Johnson JA, 2008, ANN NY ACAD SCI, V1147, P61, DOI 10.1196/annals.1427.036; Kabak B, 2011, CRIT REV FOOD SCI, V51, P248, DOI 10.1080/10408390903569640; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Keller UAD, 2006, MOL CELL BIOL, V26, P3773, DOI 10.1128/MCB.26.10.3773-3784.2006; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kensler TW, 2013, TOP CURR CHEM, V329, P163, DOI 10.1007/128_2012_339; Khor TO, 2008, CANCER PREV RES, V1, P187, DOI 10.1158/1940-6207.CAPR-08-0028; Kim J, 2010, PHYSIOL GENOMICS, V40, P100, DOI 10.1152/physiolgenomics.00105.2009; Knockaert D, 2012, J SCI FOOD AGR, V92, P2291, DOI 10.1002/jsfa.5623; Kumar RS, 2013, INT J FOOD SCI NUTR, V64, P415, DOI 10.3109/09637486.2012.746288; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Larcher R, 2008, ANAL CHIM ACTA, V609, P235, DOI 10.1016/j.aca.2007.12.038; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lippross S, 2014, CALCIFIED TISSUE INT, V95, P349, DOI 10.1007/s00223-014-9900-5; Liu M, 2009, KIDNEY INT, V76, P277, DOI 10.1038/ki.2009.157; Long DJ, 2000, CANCER RES, V60, P5913; Lucas PW, 2011, P NATL ACAD SCI USA, V108, P19101, DOI 10.1073/pnas.1116813108; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Miller CJ, 2012, BBA-MOL BASIS DIS, V1822, P1038, DOI 10.1016/j.bbadis.2012.02.007; Montazeri N, 2013, FOOD SCI NUTR, V1, P102, DOI 10.1002/fsn3.9; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Mtshali PS, 2010, J APPL MICROBIOL, V108, P1389, DOI 10.1111/j.1365-2672.2009.04535.x; Nakamura Y, 2003, BIOCHEMISTRY-US, V42, P4300, DOI 10.1021/bi0340090; Oelofse A, 2008, S AFR J ENOL VITIC, V29, P128; Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66; Paupe V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004253; PEPPERCO.MA, 1972, P NATL ACAD SCI USA, V69, P1413, DOI 10.1073/pnas.69.6.1413; PEPPERCORN MA, 1971, J BACTERIOL, V108, P996, DOI 10.1128/JB.108.3.996-1000.1971; Pohanka M, 2014, CURR MED CHEM, V21, P356; Prasad S, 2014, CANCER RES TREAT, V46, P2, DOI 10.4143/crt.2014.46.1.2; Pratico D, 2008, TRENDS PHARMACOL SCI, V29, P609, DOI 10.1016/j.tips.2008.09.001; PROCHASKA HJ, 1985, P NATL ACAD SCI USA, V82, P8232, DOI 10.1073/pnas.82.23.8232; Radjendirane V, 1998, J BIOL CHEM, V273, P7382, DOI 10.1074/jbc.273.13.7382; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; RAO CV, 1995, CANCER RES, V55, P259; Reuter G, 2001, Curr Issues Intest Microbiol, V2, P43; Rhee SJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S5; Roberts RA, 2009, TOXICOL SCI, V112, P4, DOI 10.1093/toxsci/kfp179; Rodriguez H, 2008, FOOD CHEM, V107, P1393, DOI 10.1016/j.foodchem.2007.09.067; Rodriguez H, 2009, INT J FOOD MICROBIOL, V132, P79, DOI 10.1016/j.ijfoodmicro.2009.03.025; Sanchez-Maldonado AF, 2011, J APPL MICROBIOL, V111, P1176, DOI 10.1111/j.1365-2672.2011.05141.x; Satoh T, 2009, BIOCHEM BIOPH RES CO, V379, P537, DOI 10.1016/j.bbrc.2008.12.106; Saw CL, 2011, MOL CARCINOGEN, V50, P479, DOI 10.1002/mc.20725; Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096; Schwanke S. K., 1995, J FOOD LIPIDS, V2, P239, DOI DOI 10.1111/J.1745-4522.1995.TB00046.X; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; SHARPE ME, 1973, J GEN MICROBIOL, V77, P37, DOI 10.1099/00221287-77-1-37; Shih SC, 2005, EXP MOL PATHOL, V79, P14, DOI 10.1016/j.yexmp.2005.03.004; Shureiqi I, 2011, CANCER PREV RES, V4, P296, DOI 10.1158/1940-6207.CAPR-11-0060; Silva I, 2011, J APPL MICROBIOL, V111, P360, DOI 10.1111/j.1365-2672.2011.05052.x; Slocum SL, 2011, ARCH TOXICOL, V85, P273, DOI 10.1007/s00204-011-0675-4; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Stahl B, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00376-13; Svensson L, 2010, J AGR FOOD CHEM, V58, P9214, DOI 10.1021/jf101504v; Swain Manas Ranjan, 2014, Biotechnol Res Int, V2014, P250424, DOI 10.1155/2014/250424; Takagi H, 1998, DIABETES, V47, P1480, DOI 10.2337/diabetes.47.9.1480; Tang XW, 2011, FREE RADICAL BIO MED, V50, P1599, DOI 10.1016/j.freeradbiomed.2011.03.008; Tanigawa S, 2007, FREE RADICAL BIO MED, V42, P1690, DOI 10.1016/j.freeradbiomed.2007.02.017; van Beek S, 2000, APPL ENVIRON MICROB, V66, P5322, DOI 10.1128/AEM.66.12.5322-5328.2000; Wada Y, 2011, CYTOTECHNOLOGY, V63, P25, DOI 10.1007/s10616-010-9315-8; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Walker WA, 1998, J NUTR BIOCHEM, V9, P668, DOI 10.1016/S0955-2863(98)00058-8; Walter J, 2008, APPL ENVIRON MICROB, V74, P4985, DOI 10.1128/AEM.00753-08; WATTENBERG LW, 1980, CANCER RES, V40, P2820; Wells PG, 2009, TOXICOL SCI, V108, P4, DOI 10.1093/toxsci/kfn263; WHITING GC, 1959, NATURE, V184, P1427, DOI 10.1038/1841427a0; WHITING GC, 1957, NATURE, V180, P1479, DOI 10.1038/1801479a0; Wilson Carol, 2014, Nat Rev Endocrinol, V10, P3, DOI 10.1038/nrendo.2013.225; Wittkowski R RJ, 1992, ACS SYM SER, P232; Wrangham RW, 2009, CATCHING FIRE COOKIN; Wruck CJ, 2011, ANN RHEUM DIS, V70, P844, DOI 10.1136/ard.2010.132720; Wu RP, 2010, P NATL ACAD SCI USA, V107, P7479, DOI 10.1073/pnas.1002890107; Xu CJ, 2006, CANCER RES, V66, P8293, DOI 10.1158/0008-5472.CAN-06-0300; Xu YZ, 2010, FASEB J, V24, P609, DOI 10.1096/fj.09-135731; Yakobson C., CROOKED STAVE ARTISA; Yet SF, 2003, FASEB J, V17, P1759, DOI 10.1096/fj.03-0187fje; Yet SF, 1999, J CLIN INVEST, V103, pR23, DOI 10.1172/JCI6163; Yoh K, 2001, KIDNEY INT, V60, P1343, DOI 10.1046/j.1523-1755.2001.00939.x; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang TS, 2014, ARCH BIOCHEM BIOPHYS, V557, P36, DOI 10.1016/j.abb.2014.05.023; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; ZHANG YS, 1994, P NATL ACAD SCI USA, V91, P3147, DOI 10.1073/pnas.91.8.3147; Zhao ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019456	148	69	70	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148042	10.1371/journal.pone.0148042	http://dx.doi.org/10.1371/journal.pone.0148042			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885667	Green Published, gold			2022-12-27	WOS:000371218400015
J	de Groot, MH; van Campen, JPCM; Kosse, NM; de Vries, OJ; Beijnen, JH; Lamoth, CJC				de Groot, Maartje H.; van Campen, Jos P. C. M.; Kosse, Nienke M.; de Vries, Oscar J.; Beijnen, Jos H.; Lamoth, Claudine J. C.			The Association of Medication-Use and Frailty-Related Factors with Gait Performance in Older Patients	PLOS ONE			English	Article							RISK-INCREASING DRUGS; MINI-MENTAL-STATE; POSTURAL CONTROL; ELDERLY-PATIENTS; WALKING SPEED; FALLS; VARIABILITY; PEOPLE; METAANALYSIS; POPULATION	The increased fall risk associated with the use of psychotropic drugs might be caused by underlying problems in postural control that are induced by sedative side-effects of these drugs. The current literature on the effects of psychotropics on postural control only examined acute single-drug effects, and included relatively healthy young elderly. Consequently, it is unclear what the impact of the long-term use of these drugs is on gait in frail older persons with polypharmacy. Therefore, it was aimed in the present study to explore the association between the use of psychotropics, multiple other medications, frailty-related parameters and gait performance in older patients. Eighty older persons (79 +/- 5.6 years) were recruited. Comorbid diseases, frailty-related parameters, and medication-use were registered. Trunk accelerations during a 3-minute-walking-task were recorded, whereof walking speed, mean stride times, coefficient of variation (CV) of stride times, and step consistency were determined. Multivariate Partial Least Squares (PLS) regression analysis was used to examine the association between population characteristics and medication-use, versus gait parameters. A PLS-model existing of four latent variables was built, explaining 45% of the variance in four gait parameters. Frailty-related factors, being female, and laxative-use were most strongly associated with lower walking speed, higher mean stride times, higher CV of stride times, and less consistent steps. In conclusion, frailty-related parameters were stronger associated with impaired gait performance than the use of psychotropic drugs. Possibly, at a certain frailty-level, the effect of the deterioration in physical functioning in frailty is so large, that the instability-provoking side-effects of psychotropic drugs have less impact on gait.	[de Groot, Maartje H.; van Campen, Jos P. C. M.] MC Slotervaart, Dept Geriatr Med, Amsterdam, Netherlands; [de Groot, Maartje H.] The Hague Univ Appl Sci, Fac Hlth Nutr & Sport, The Hague, Netherlands; [Kosse, Nienke M.; Lamoth, Claudine J. C.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Kosse, Nienke M.] Univ Grenoble Alpes, CNRS UJF UPMF EPHE, FRE AGIM Lab 3405, La Tronche, France; [de Vries, Oscar J.] OLVG, Dept Internal Med, Amsterdam, Netherlands; [Beijnen, Jos H.] MC Slotervaart, Dept Pharm & Pharmacol, Amsterdam, Netherlands; [Beijnen, Jos H.] Univ Utrecht, Dept Pharmaceut Sci, Fac Sci, Utrecht, Netherlands	Slotervaart Hospital; University of Groningen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Slotervaart Hospital; Utrecht University	Lamoth, CJC (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	C.J.C.Lamoth@umcg.nl	Lamoth, Claudine JC/N-4325-2013	Lamoth, Claudine JC/0000-0002-6495-2823				Abdi H, 2010, WIRES COMPUT STAT, V2, P97, DOI 10.1002/wics.51; Allali G, 2015, ARCH GERONTOL GERIAT, V60, P389, DOI 10.1016/j.archger.2015.02.009; Askari M, 2013, DRUG AGING, V30, P845, DOI 10.1007/s40266-013-0110-z; Beauchet O, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-32; Bloch F, 2011, J AGING HEALTH, V23, P329, DOI 10.1177/0898264310381277; Boulesteix AL, 2007, BRIEF BIOINFORM, V8, P32, DOI 10.1093/bib/bb1016; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; de Groot MH, 2014, GAIT POSTURE, V39, P767, DOI 10.1016/j.gaitpost.2013.10.015; de Groot MH, 2013, DRUG AGING, V30, P901, DOI 10.1007/s40266-013-0113-9; de Vries OJ, 2013, OSTEOPOROSIS INT, V24, P2397, DOI 10.1007/s00198-013-2303-z; Ellis G, 2004, BRIT MED BULL, V71, P45, DOI 10.1093/bmb/ldh033; Eriksson L., 2006, MULTI AND MEGAVARIAT; Eriksson S, 2008, ARCH GERONTOL GERIAT, V46, P293, DOI 10.1016/j.archger.2007.05.002; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Ganz DA, 2007, JAMA-J AM MED ASSOC, V297, P77, DOI 10.1001/jama.297.1.77; Haenlein M., 2004, UNDERSTANDING STAT, V3, P283, DOI [10.1207/s15328031us0304_4, DOI 10.1207/S15328031US0304_4]; Ham AC, 2014, DRUG AGING, V31, P917, DOI 10.1007/s40266-014-0225-x; Hamacher D, 2011, J R SOC INTERFACE, V8, P1682, DOI 10.1098/rsif.2011.0416; Hartikainen S, 2007, J GERONTOL A-BIOL, V62, P1172, DOI 10.1093/gerona/62.10.1172; Ijmker T, 2012, GAIT POSTURE, V35, P126, DOI 10.1016/j.gaitpost.2011.08.022; Kang HG, 2008, GAIT POSTURE, V27, P572, DOI 10.1016/j.gaitpost.2007.07.009; Kosse NM, 2015, INT PSYCHOGERIATR, V27, P803, DOI 10.1017/S104161021400249X; Kwok CS, 2011, BONE, V48, P768, DOI 10.1016/j.bone.2010.12.015; Lader M, 2009, CNS DRUGS, V23, P19, DOI 10.2165/0023210-200923010-00002; Lamoth CJ, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-2; Lewis JR, 2014, J BONE MINER RES, V29, P2489, DOI 10.1002/jbmr.2279; Lundebjerg N, 2001, J AM GERIATR SOC, V49, P664, DOI 10.1046/j.1532-5415.2001.49115.x; Marzetti E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032829; Menant JC, 2014, AGEING RES REV, V16, P83, DOI 10.1016/j.arr.2014.06.001; Montero-Odasso M, 2011, J GERONTOL A-BIOL, V66, P568, DOI 10.1093/gerona/glr007; Mouli V Pratap, 2011, Trop Gastroenterol, V32, P175; Papegaaij S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00028; Plotnik M, 2007, EXP BRAIN RES, V181, P561, DOI 10.1007/s00221-007-0955-7; Pluijm SMF, 2006, OSTEOPOROSIS INT, V17, P417, DOI 10.1007/s00198-005-0002-0; Roerdink M, 2007, PHYS THER, V87, P1009, DOI 10.2522/ptj.20050394; Schwenk M, 2014, GERONTOLOGY, V60, P79, DOI 10.1159/000354211; Sturnieks DL, 2008, NEUROPHYSIOL CLIN, V38, P467, DOI 10.1016/j.neucli.2008.09.001; Teramura-Gronblad M, 2010, SCAND J PRIM HEALTH, V28, P154, DOI 10.3109/02813432.2010.493315; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881; WALD A, 1993, DRUG AGING, V3, P220, DOI 10.2165/00002512-199303030-00003; WHO Collaborating Centre for Drug Statistics Methodology, 2013, GUID ATC CLASS DDD A; WOLD H., 1966, MULTIVARIATE ANAL, P391, DOI DOI 10.1007/S00423-022-02505-9; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Woolcott JC, 2009, ARCH INTERN MED, V169, P1952, DOI 10.1001/archinternmed.2009.357	46	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149888	10.1371/journal.pone.0149888	http://dx.doi.org/10.1371/journal.pone.0149888			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26901048	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100176
J	Klistorner, A; Wang, CY; Yiannikas, C; Graham, SL; Parratt, J; Barnett, MH				Klistorner, Alexander; Wang, Chenyu; Yiannikas, Con; Graham, Stuart L.; Parratt, John; Barnett, Michael H.			Progressive Injury in Chronic Multiple Sclerosis Lesions Is Gender-Specific: A DTI Study	PLOS ONE			English	Article							RADIAL DIFFUSIVITY; CORPUS-CALLOSUM; IN-VIVO; DAMAGE; SEX; DEMYELINATION; DEGENERATION; ESTROGEN	Objective To evaluate the longitudinal integrity of white matter tracts in patients with relapsing remitting multiple sclerosis (RRMS) as determined by changes in diffusivity indices of lesional and non-lesional white matter in the optic radiation over 12 months. Methods The optic radiation (OR) was identified in sixty RRMS patients using probabilistic tractography. MS lesions were segmented on FLAIR T2 images and a lesion mask was intersected with the co-registered OR. Lesions within the OR were identified in 39 patients. Voxel-based analysis of axial diffusivity (AD) and radial diffusivity (RD) within OR lesions and non-lesional normal appearing white matter (NAWM) was performed at baseline and 12 months in 34 patients (five patients excluded due to new OR lesions). Results Both RD and AD demonstrated much higher values within the lesions compared with non-lesional NAWM. There was a significant (p<0.001) increase of lesional AD and RD during the follow-up period. This increase, however, was driven almost entirely by the male cohort, in which a significantly greater change in both AD (M-2.7%, F-0.9%) and RD (M-4.6%, F-0.7%) was observed during the follow-up period. Non-lesional NAWM also demonstrated an increase in both AD and RD, albeit on a much lesser scale (1.0% and 0.6% respectively). In contradistinction to lesions, the diffusivity change in non-lesional NAWM was similar between sexes. Conclusions The evolution of AD and RD in chronic MS lesions over 12 months suggests ongoing inflammatory demyelinating activity accompanied by axonal loss. In addition, our findings are consistent with the recently observed trend of more rapid clinical progression in males and establish a potential in vivo biomarker of gender dichotomy by demonstrating a significantly faster rate of microstructural change in the chronic lesions of male patients with MS.	[Klistorner, Alexander] Univ Sydney, Dept Ophthalmol, Save Sight Inst, Sydney, NSW 2006, Australia; [Klistorner, Alexander; Graham, Stuart L.] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia; [Klistorner, Alexander; Wang, Chenyu; Barnett, Michael H.] Sydney Neuroimaging Anal Ctr, Sydney, NSW, Australia; [Wang, Chenyu; Barnett, Michael H.] Univ Sydney, Brain & Mind Ctr, Sydney, NSW 2006, Australia; [Yiannikas, Con; Parratt, John] North Shore Hosp, Sydney, NSW, Australia	University of Sydney; Macquarie University; University of Sydney; Royal North Shore Hospital	Klistorner, A (corresponding author), Univ Sydney, Dept Ophthalmol, Save Sight Inst, Sydney, NSW 2006, Australia.; Klistorner, A (corresponding author), Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia.; Klistorner, A (corresponding author), Sydney Neuroimaging Anal Ctr, Sydney, NSW, Australia.	sasha@eye.usyd.edu.au		Klistorner, Alexander/0000-0003-0361-6399; Graham, Stuart/0000-0001-7519-969X	Save Neuron grant (Novartis); National MS Society (US); Sydney Eye Hospital; Novartis Farma	Save Neuron grant (Novartis); National MS Society (US)(National Multiple Sclerosis Society); Sydney Eye Hospital; Novartis Farma	The work was supported by Save Neuron grant (Novartis), grants from National MS Society (US) and Sydney Eye Hospital. MRI acquisition for this study was partially funded by Novartis Farma. However, this does not alter the authors adherence to PLOS ONE policies on sharing data and materials. None of the authors employed by or receive consultancy from or involved in product development or holding patents with Novartis Farma. AK takes full responsibility for the data, the analysis, the interpretation and the conduct of the research. AK has full access to all of the data and has right to publish any data and all data separate and apart from any sponsor. All authors report no conflicts of interest. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2007, BRAIN, V130, P2211, DOI 10.1093/brain/awm110; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bramow S, 2010, BRAIN, V133, P2983, DOI 10.1093/brain/awq250; Budde MD, 2011, CONTRIBUTION GLIOSIS, P2248; Caruso A, 2004, J NEUROCHEM, V88, P1179, DOI 10.1046/j.1471-4159.2004.02284.x; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Confavreux C, 2006, MCALPINES MULTIPLE S, P183; Eikelenboom MJ, 2009, J NEUROL SCI, V286, P40, DOI 10.1016/j.jns.2009.06.025; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Fu L, 1998, BRAIN, V121, P103, DOI 10.1093/brain/121.1.103; Gold SM, 2009, PROG BRAIN RES, V175, P239, DOI 10.1016/S0079-6123(09)17516-7; Greer JM, 2011, J NEUROIMMUNOL, V234, P7, DOI 10.1016/j.jneuroim.2011.03.003; Harbo HF, 2013, THER ADV NEUROL DISO, V6, P237, DOI 10.1177/1756285613488434; Kalincik T, 2013, BRAIN, V136, P3609, DOI 10.1093/brain/awt281; Klistorner A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122114; Klistorner A, 2014, NEUROLOGY, V82, P2165, DOI 10.1212/WNL.0000000000000522; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Kumar R, 2013, BRAIN RES, V1512, P22, DOI 10.1016/j.brainres.2013.03.028; Lassmann H, 2007, CURR NEUROL NEUROSCI, V7, P239, DOI 10.1007/s11910-007-0036-0; Luchetti S, 2014, J NEUROPATH EXP NEUR, V73, P123, DOI 10.1097/NEN.0000000000000037; Miller DH, 2014, MULT SCLER J, V20, P527, DOI 10.1177/1352458513519840; Prineas JW, 2001, ANN NEUROL, V50, P646, DOI 10.1002/ana.1255; Reich DS, 2009, DAMAGE OPTIC RAD MUL, P998, DOI [10.1001/archneurol.2009.107, DOI 10.1001/ARCHNEUROL.2009.107]; Ribbons KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122686; Rocca MA, 2013, MULT SCLER J, V19, P1610, DOI 10.1177/1352458513485146; Rovaris M, 2005, NEUROIMAGE, V24, P1139, DOI 10.1016/j.neuroimage.2004.10.006; Sbardella E, 2013, MULT SCLER INT, P671; Schmierer K, 2007, NEUROIMAGE, V35, P467, DOI 10.1016/j.neuroimage.2006.12.010; Sherbondy AJ, 2008, J VISION, V8, DOI 10.1167/8.10.12; Shirani A, 2012, MULT SCLER J, V18, P442, DOI 10.1177/1352458511422097; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Tomassini V, 2006, J NEUROL, V253, P287, DOI 10.1007/s00415-005-0979-5; Tomassini V, 2009, J NEUROL SCI, V286, P35, DOI 10.1016/j.jns.2009.04.014; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Westerhausen R, 2003, NEUROSCI LETT, V351, P99, DOI 10.1016/j.neulet.2003.07.011; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965	37	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149245	10.1371/journal.pone.0149245	http://dx.doi.org/10.1371/journal.pone.0149245			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901540	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100048
J	Li, J; Gu, CZ; Su, JB; Zhu, LH; Zhou, Y; Huang, HY; Liu, CF				Li, Jia; Gu, Cheng-zhi; Su, Jian-bin; Zhu, Lian-hai; Zhou, Yong; Huang, Huai-yu; Liu, Chun-feng			Changes in Olfactory Bulb Volume in Parkinson's Disease: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							EARLY-STAGE; DYSFUNCTION; DURATION; QUALITY; HUMANS; SCORES; SCALE; BIAS	Objective The changes in olfactory bulb (OB) volume in Parkinson's disease (PD) patients have not yet been comprehensively evaluated. The purpose of this meta-analysis was to explore whether the OB volume was significantly different between PD patients and healthy controls. Methods PubMed and Embase were searched up to March 6, 2015 with no language restrictions. Two independent reviewers screened eligible studies and extracted data on study characteristics and OB volume. Additionally, a systematic review and meta-analysis using a random-effects model were conducted. Publication bias was determined by using funnel plots and Begg's and Egger's tests. Subgroup analyses were performed to assess possible sources of heterogeneity. Results Six original case-control studies of 216 PD patients and 175 healthy controls were analyzed. The pooled weighted mean difference (WMD) in the OB volume between the PD patients and the healthy participants was -8.071 for the right OB and -10.124 for the left OB; these values indicated a significant difference among PD patients compared with healthy controls. In addition, a significant difference in the lateralized OB volume was observed in PD patients, with a pooled MD of 1.618; these results indicated a larger right OB volume than left OB volume in PD patients. In contrast, no difference in the lateralized OB volume was found in healthy controls. No statistical evidence of publication bias among studies was found based on Egger's or Begg's tests. Sensitivity analyses revealed that the results were consistent and robust. Conclusions Overall, both the left and the right OB volume were significantly smaller in PD patients than in healthy controls. However, significant heterogeneity and an insufficient number of studies underscore the need for further observational research.	[Li, Jia; Liu, Chun-feng] Soochow Univ, Affiliated Hosp 2, Dept Neurol, Suzhou 215004, Peoples R China; [Li, Jia; Liu, Chun-feng] Soochow Univ, Inst Neurosci, Suzhou 215123, Peoples R China; [Li, Jia; Gu, Cheng-zhi; Zhu, Lian-hai; Zhou, Yong; Huang, Huai-yu] Nantong Univ, Affiliated Hosp 2, Dept Neurol, Nantong 226001, Peoples R China; [Su, Jian-bin] Nantong Univ, Affiliated Hosp 2, Dept Endocrinol, Nantong 226001, Peoples R China	Soochow University - China; Soochow University - China; Nantong University; Nantong University	Liu, CF (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Neurol, Suzhou 215004, Peoples R China.; Liu, CF (corresponding author), Soochow Univ, Inst Neurosci, Suzhou 215123, Peoples R China.; Huang, HY (corresponding author), Nantong Univ, Affiliated Hosp 2, Dept Neurol, Nantong 226001, Peoples R China.	jshuanghuaiyu@163.com; liucf@suda.edu.cn						Altinayar S, 2014, EUR REV MED PHARMACO, V18, P3659; Alves G, 2008, J NEUROL, V255, P18, DOI 10.1007/s00415-008-5004-3; Berardelli A, 2013, EUR J NEUROL, V20, P16, DOI 10.1111/ene.12022; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Braak H, 2003, J NEURAL TRANSM, V110, P517, DOI 10.1007/s00702-002-0808-2; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brodoehl S, 2012, MOVEMENT DISORD, V27, P1019, DOI 10.1002/mds.25087; Chen S, 2014, EUR J RADIOL, V83, P564, DOI 10.1016/j.ejrad.2013.11.024; Copeland B, 2012, MOVEMENT DISORD, V27, pS112; Copeland B, 2012, NEUROLOGY, V78; Davie CA, 2008, BRIT MED BULL, V86, P109, DOI 10.1093/bmb/ldn013; Doty RL, 2007, PARKINSONISM RELAT D, V13, pS225, DOI 10.1016/S1353-8020(08)70006-3; Doty RL, 2012, NEUROBIOL DIS, V46, P527, DOI 10.1016/j.nbd.2011.10.026; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ellmore T, 2012, MOVEMENT DISORD, V27, pS233; Haehner A, 2008, ARCH OTOLARYNGOL, V134, P621, DOI 10.1001/archotol.134.6.621; Hakyemez HA, 2010, EUR J NEUROL, V17, P392; Hakyemez HA, 2013, J CLIN NEUROSCI, V20, P1469, DOI 10.1016/j.jocn.2012.11.017; Hang Wei, 2015, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V50, P20; Hawkes CH, 2007, NEUROPATH APPL NEURO, V33, P599, DOI 10.1111/j.1365-2990.2007.00874.x; Held P, 2000, J NEURORADIOLOGY, V27, P112; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoogland PV, 2003, NEUROPATH APPL NEURO, V29, P303, DOI 10.1046/j.1365-2990.2003.00459.x; Hummel T, 2013, NEUROSCIENCE, V237, P51, DOI [10.1016/J.neuroscience.2013.01.044, 10.1016/j.neuroscience.2013.01.044]; HUMMEL T, 1995, EPILEPSIA, V36, P79, DOI 10.1111/j.1528-1157.1995.tb01670.x; Hummel T, 2010, J NEUROL SCI, V289, P119, DOI 10.1016/j.jns.2009.08.026; JONESGOTMAN M, 1993, BRAIN COGNITION, V22, P182, DOI 10.1006/brcg.1993.1033; Kim JY, 2007, MOVEMENT DISORD, V22, P1563, DOI 10.1002/mds.21490; Lemer A, 2008, MOVEMENT DISORD, V23, P1076, DOI 10.1002/mds.22066; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mueller A, 2005, J NEURAL TRANSM, V112, P1363, DOI 10.1007/s00702-005-0280-x; Rombaux P, 2009, RHINOLOGY, V47, P3; Ross GW, 2008, ANN NEUROL, V63, P167, DOI 10.1002/ana.21291; Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8; Sengoku R, 2013, MOVEMENT DISORD, V28, pS229; Sengoku R, 2012, MOVEMENT DISORD, V27, pS256; Shao M, 2012, PARKINSONISM RELAT D, V18, pS92; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stuck AE, 1998, BRIT MED J, V316, P469, DOI 10.1136/bmj.316.7129.469; Wang J, 2011, AM J NEURORADIOL, V32, P677, DOI 10.3174/ajnr.A2350; ZATORRE RJ, 1992, NATURE, V360, P339, DOI 10.1038/360339a0; Zesiewicz TA, 2010, NEUROLOGY, V74, P924, DOI 10.1212/WNL.0b013e3181d55f24	43	28	29	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149286	10.1371/journal.pone.0149286	http://dx.doi.org/10.1371/journal.pone.0149286			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900958	Green Submitted, gold, Green Published			2022-12-27	WOS:000371276100054
J	Li, KQ; Xu, XY; Huang, XS				Li, Kong-Qing; Xu, Xiao-Yong; Huang, Xiao-San			Identification of Differentially Expressed Genes Related to Dehydration Resistance in a Highly Drought-Tolerant Pear, Pyrus betulaefolia, as through RNA-Seq	PLOS ONE			English	Article							HIGH-SALINITY STRESSES; TRANSCRIPTION FACTOR; ABSCISIC-ACID; PONCIRUS-TRIFOLIATA; ARABIDOPSIS; PLANT; RESPONSES; PROFILES; ABA; GENOME	Drought is a major abiotic stress that affects plant growth, development and productivity. Pear is one of the most important deciduous fruit trees in the world, but the mechanisms of drought tolerance in this plant are still unclear. To better understand the molecular basis regarding drought stress response, RNA-seq was performed on samples collected before and after dehydration in Pyrus betulaefolia. In total, 19,532 differentially expressed genes (DEGs) were identified. These genes were annotated into 144 Gene Ontology (GO) terms and 18 clusters of orthologous groups (COG) involved in 129 Kyoto Encyclopedia of Genes and Genomes (KEGG) defined pathways. These DEGs comprised 49 (26 up-regulated, 23 down-regulated), 248 (166 up-regulated, 82 down-regulated), 3483 (1295 up-regulated, 2188 down-regulated), 1455 (1065 up-regulated, 390 down-regulated) genes from the 1 h, 3 h and 6 h dehydration-treated samples and a 24 h recovery samples, respectively. RNA-seq was validated by analyzing the expresson patterns of randomly selected 16 DEGs by quantitative real-time PCR. Photosynthesis, signal transduction, innate immune response, protein phosphorylation, response to water, response to biotic stimulus, and plant hormone signal transduction were the most significantly enriched GO categories amongst the DEGs. A total of 637 transcription factors were shown to be dehydration responsive. In addition, a number of genes involved in the metabolism and signaling of hormones were significantly affected by the dehydration stress. This dataset provides valuable information regarding the Pyrus betulaefolia transcriptome changes in response to dehydration and may promote identification and functional analysis of potential genes that could be used for improving drought tolerance via genetic engineering of non-model, but economically-important, perennial species.	[Li, Kong-Qing] Nanjing Agr Univ, Coll Rural Dev, Nanjing 210095, Jiangsu, Peoples R China; [Huang, Xiao-San] Nanjing Agr Univ, Coll Hort, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China; [Xu, Xiao-Yong] Yangzhou Univ, Sch Hort & Plant Protect, Yangzhou 225009, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University; Yangzhou University	Huang, XS (corresponding author), Nanjing Agr Univ, Coll Hort, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China.	huangxs@njau.edu.cn			National Natural Science Foundation of China [31301758]; Fundamental Research Funds for the Central Universities [KYTZ201401, SK2014007]; Ministry of Education of Humanities and Social Science project [14YJC630058]; Research Fund for the Doctoral Program of Higher Education [130600661]; Jiangsu Provincial Natural Science Foundation [BK20130689, BK20150681]; National Postdoctoral Fund [2013T60545, 2012M521092, 2014M551615]; Jiangsu Provincial Postdoctoral Fund [1201019B, 1401125C]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Ministry of Education of Humanities and Social Science project; Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); Jiangsu Provincial Natural Science Foundation(Natural Science Foundation of Jiangsu Province); National Postdoctoral Fund(China Postdoctoral Science Foundation); Jiangsu Provincial Postdoctoral Fund	This work was supported by the National Natural Science Foundation of China (31301758), the Fundamental Research Funds for the Central Universities (KYTZ201401, SK2014007), the Ministry of Education of Humanities and Social Science project (14YJC630058), the Research Fund for the Doctoral Program of Higher Education (130600661), the Jiangsu Provincial Natural Science Foundation (BK20130689, BK20150681), the National Postdoctoral Fund (2013T60545, 2012M521092, 2014M551615), and the Jiangsu Provincial Postdoctoral Fund (1201019B, 1401125C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Aswath CR, 2005, PLANT GROWTH REGUL, V47, P129, DOI 10.1007/s10725-005-3380-6; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bailly C, 2001, J EXP BOT, V52, P701, DOI 10.1093/jexbot/52.357.701; Boudsocq M, 2007, PLANT MOL BIOL, V63, P491, DOI 10.1007/s11103-006-9103-1; Bray EA, 2004, J EXP BOT, V55, P2331, DOI 10.1093/jxb/erh270; Breton G, 2003, PLANT PHYSIOL, V132, P64, DOI 10.1104/pp.102.015255; Chaves M, 2007, PHOTOSYNTH RES, V91, P300; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Colebrook EH, 2014, J EXP BIOL, V217, P67, DOI 10.1242/jeb.089938; Cominelli E, 2005, CURR BIOL, V15, P1196, DOI 10.1016/j.cub.2005.05.048; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Eulgem T, 2005, TRENDS PLANT SCI, V10, P71, DOI 10.1016/j.tplants.2004.12.006; Fernandez-Calvo P, 2011, PLANT CELL, V23, P701, DOI 10.1105/tpc.110.080788; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Fujii H, 2011, P NATL ACAD SCI USA, V108, P1717, DOI 10.1073/pnas.1018367108; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Gong PJ, 2010, J EXP BOT, V61, P3563, DOI 10.1093/jxb/erq167; GORTON HL, 1987, PLANT PHYSIOL, V83, P945, DOI 10.1104/pp.83.4.945; Guo PG, 2009, J EXP BOT, V60, P3531, DOI 10.1093/jxb/erp194; Hanin M, 2011, PLANT SIGNAL BEHAV, V6, P1503, DOI 10.4161/psb.6.10.17088; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hayano-Kanashiro C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007531; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Huang DQ, 2008, J EXP BOT, V59, P2991, DOI 10.1093/jxb/ern155; Huang XS, 2013, PLANT PHYSIOL, V162, P1178, DOI 10.1104/pp.112.210740; Huang XS, 2011, J EXP BOT, V62, P5191, DOI 10.1093/jxb/err229; Huang XS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-230; Huang XS, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2233-6; Huang XS, 2015, SCI REP-UK, V5, DOI 10.1038/srep17620; Huang Y, 2015, MOL BIOL REP, V42, P893, DOI 10.1007/s11033-014-3826-x; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Lenka SK, 2011, PLANT BIOTECHNOL J, V9, P315, DOI 10.1111/j.1467-7652.2010.00560.x; Li HM, 2007, PLANT MOL BIOL, V65, P655, DOI 10.1007/s11103-007-9230-3; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu JH, 2014, PLANT MOL BIOL REP, V32, P303, DOI 10.1007/s11105-013-0667-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mare C, 2004, PLANT MOL BIOL, V55, P399, DOI 10.1007/s11103-004-0906-7; Miao WG, 2010, J EXP BOT, V61, P4263, DOI 10.1093/jxb/erq227; Morano KA, 2007, ANN NY ACAD SCI, V1113, P1, DOI 10.1196/annals.1391.018; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Ning J, 2010, PLANT PHYSIOL, V152, P876, DOI 10.1104/pp.109.149856; Okubo M, 2000, SCI HORTIC-AMSTERDAM, V85, P85, DOI 10.1016/S0304-4238(99)00141-7; Pratt LH, 2005, PLANT PHYSIOL, V139, P869, DOI 10.1104/pp.105.066134; Qi XX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-727; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Rong W, 2014, PLANT BIOTECHNOL J, V12, P468, DOI 10.1111/pbi.12153; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Sharp RE, 2002, J EXP BOT, V53, P33, DOI 10.1093/jexbot/53.366.33; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Song CP, 2005, PLANT CELL, V17, P2384, DOI 10.1105/tpc.105.033043; Storozhenko S, 1998, PLANT PHYSIOL, V118, P1005, DOI 10.1104/pp.118.3.1005; Talame V, 2007, J EXP BOT, V58, P229, DOI 10.1093/jxb/erl163; Tena G, 2001, CURR OPIN PLANT BIOL, V4, P392, DOI 10.1016/S1369-5266(00)00191-6; Umezawa T, 2006, PLANT J, V46, P171, DOI 10.1111/j.1365-313X.2006.02683.X; Urano K, 2009, PLANT J, V57, P1065, DOI 10.1111/j.1365-313X.2008.03748.x; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wang YC, 2006, PLANT SCI, V171, P655, DOI 10.1016/j.plantsci.2006.06.011; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei W, 2008, PLANT CELL REP, V27, P795, DOI 10.1007/s00299-007-0499-0; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Xu YJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-662; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zheng XN, 2009, BIOCHEM BIOPH RES CO, V379, P985, DOI 10.1016/j.bbrc.2008.12.163; Zong Y, 2014, TREE GENET GENOMES, V10, P739, DOI 10.1007/s11295-014-0718-0; Zou XL, 2007, PLANT SCI, V172, P997, DOI 10.1016/j.plantsci.2007.02.003	72	52	56	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149352	10.1371/journal.pone.0149352	http://dx.doi.org/10.1371/journal.pone.0149352			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900681	gold, Green Published, Green Submitted			2022-12-27	WOS:000371276100063
J	Lo Gullo, A; Koster, MJ; Crowson, CS; Makol, A; Ytterberg, SR; Saitta, A; Salvarani, C; Matteson, EL; Warrington, KJ				Lo Gullo, Alberto; Koster, Matthew J.; Crowson, Cynthia S.; Makol, Ashima; Ytterberg, Steven R.; Saitta, Antonino; Salvarani, Carlo; Matteson, Eric L.; Warrington, Kenneth J.			Venous Thromboembolism and Cerebrovascular Events in Patients with Giant Cell Arteritis: A Population-Based Retrospective Cohort Study	PLOS ONE			English	Article							CRANIAL ISCHEMIC COMPLICATIONS; CARDIOVASCULAR-DISEASE; RHEUMATOID-ARTHRITIS; ANGIOGENIC ACTIVITY; PULMONARY-EMBOLISM; RISK-FACTORS; STROKE; THROMBOSIS; DIAGNOSIS; SERIES	Objective To investigate the incidence of venous thromboembolism (VTE) and cerebrovascular events in a community-based incidence cohort of patients with giant cell arteritis (GCA) compared to the general population. Methods A population-based inception cohort of patients with incident GCA between January 1, 1950 and December 31, 2009 in Olmsted County, Minnesota and a cohort of non-GCA subjects from the same population were assembled and followed until December 31, 2013. Confirmed VTE and cerebrovascular events were identified through direct medical record review. Results The study population included 244 patients with GCA with a mean +/- SD age at diagnosis of 76.2 +/- 8.2 years (79% women) and an average length of follow-up of 10.2 +/- 6.8 years. Compared to non-GCA subjects of similar age and sex, patients diagnosed with GCA had a higher incidence (%) of amaurosis fugax (cumulative incidence +/- SE: 2.1 +/- 0.9 versus 0, respectively; p = 0.014) but similar rates of stroke, transient ischemic attack (TIA), and VTE. Among patients with GCA, neither baseline characteristics nor laboratory parameters at diagnosis reliably predicted risk of VTE or cerebrovascular events. Conclusion In this population-based study, the incidence of VTE, stroke and TIA was similar in patients with GCA compared to non-GCA subjects.	[Lo Gullo, Alberto; Saitta, Antonino] Univ Messina, Dept Clin & Expt Med, Messina, ME, Italy; [Koster, Matthew J.; Crowson, Cynthia S.; Makol, Ashima; Ytterberg, Steven R.; Matteson, Eric L.; Warrington, Kenneth J.] Mayo Clin, Coll Med, Div Rheumatol, Dept Med, Rochester, MN USA; [Crowson, Cynthia S.] Mayo Clin, Coll Med, Div Biomed Stat, Dept Hlth Sci Res, Rochester, MN USA; [Matteson, Eric L.] Mayo Clin, Coll Med, Div Epidemiol, Dept Hlth Sci Res, Rochester, MN USA; [Salvarani, Carlo] Azienda Osped ASMN, Rheumatol Unit, Dept Internal Med, Reggio Emilia, Italy	University of Messina; Mayo Clinic; Mayo Clinic; Mayo Clinic; IRCCS Arcispedale S. Maria Nuova	Koster, MJ (corresponding author), Mayo Clin, Coll Med, Div Rheumatol, Dept Med, Rochester, MN USA.	koster.matthew@mayo.edu	Warrington, Kenneth/CAG-1626-2022; Gullo, Alberto Lo/AAC-2766-2019; Salvarani, Carlo/K-2431-2018	Warrington, Kenneth/0000-0001-7708-2487; Makol, Ashima/0000-0002-8748-898X; Lo Gullo, Alberto/0000-0003-4383-0314; Salvarani, Carlo/0000-0001-5426-5133	US National Institute on Aging of the National Institutes of Health (NIH) [R01AG034676]; National Center for Advancing Translational Sciences (NCATS) [UL1 TR000135]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034676] Funding Source: NIH RePORTER	US National Institute on Aging of the National Institutes of Health (NIH); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the resources of the Rochester Epidemiology Project, which is supported by the US National Institute on Aging of the National Institutes of Health (NIH) under Award Number R01AG034676 and by Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS). The content is solely the responsibility of the listed authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allenbach Y, 2009, ANN RHEUM DIS, V68, P564, DOI 10.1136/ard.2008.099051; Ames PRJ, 2001, RHEUMATOLOGY, V40, P652, DOI 10.1093/rheumatology/40.6.652; Amiri N, 2016, RHEUMATOLOGY, V55, P33, DOI 10.1093/rheumatology/kev262; Avina-Zubieta JA, 2016, ANN RHEUM DIS, V75, P148, DOI 10.1136/annrheumdis-2014-205665; Bacani AK, 2012, ARTHRITIS RHEUM-US, V64, P53, DOI 10.1002/art.33322; Berger CT, 2009, RHEUMATOLOGY, V48, P258, DOI 10.1093/rheumatology/ken480; Bhavsar SV, 2014, ARTHRITIS RHEUMATOL, V66, pS351; CASELLI RJ, 1988, NEUROLOGY, V38, P352, DOI 10.1212/WNL.38.3.352; Chung WS, 2014, J THROMB HAEMOST, V12, P452, DOI 10.1111/jth.12518; Cid MC, 2002, CIRCULATION, V106, P1664, DOI 10.1161/01.CIR.0000030185.67510.C0; Cid MC, 1998, ARTHRITIS RHEUM-US, V41, P26, DOI 10.1002/1529-0131(199801)41:1<26::AID-ART4>3.0.CO;2-0; Cohen R, 2010, OPTOMETRY, V81, P359, DOI 10.1016/j.optm.2009.10.013; Faurschou M, 2014, ARTHRIT CARE RES, V66, P1910, DOI 10.1002/acr.22423; FUTRELL N, 1989, STROKE, V20, P583, DOI 10.1161/01.STR.20.5.583; Gonzalez-Gay MA, 2000, MEDICINE, V79, P283, DOI 10.1097/00005792-200009000-00001; Gonzalez-Gay MA, 2004, MEDICINE, V83, P342, DOI 10.1097/01.md.0000145369.25558.b5; Gonzalez-Gay MA, 2009, MEDICINE, V88, P227, DOI 10.1097/MD.0b013e3181af4518; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hernandez-Rodriguez J, 2003, CIRCULATION, V107, P2428, DOI 10.1161/01.CIR.0000066907.83923.32; Hernandez-Rodriguez J, 2007, MEDICINE, V86, P233, DOI 10.1097/MD.0b013e318145275c; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1122; Isene R, 2014, SCAND J GASTROENTERO, V49, P820, DOI 10.3109/00365521.2014.910545; Lopez-Diaz MJ, 2008, SEMIN ARTHRITIS RHEU, V38, P116, DOI 10.1016/j.semarthrit.2007.10.014; Nadareishvili Z, 2008, ARTHRIT RHEUM-ARTHR, V59, P1090, DOI 10.1002/art.23935; Nesher G, 2004, ARTHRITIS RHEUM, V50, P1332, DOI 10.1002/art.20171; Pego-Reigosa R, 2004, CLIN EXP RHEUMATOL, V22, pS13; Ray JG, 2005, HEART, V91, P324, DOI 10.1136/hrt.2004.037481; Salvarani C, 2009, RHEUMATOLOGY, V48, P250, DOI 10.1093/rheumatology/ken465; Samson M, 2015, J NEUROL NEUROSUR PS, V86, P216, DOI 10.1136/jnnp-2014-307614; Sarica-Kucukoglu R, 2006, INT J DERMATOL, V45, P919, DOI 10.1111/j.1365-4632.2006.02832.x; Solem CA, 2004, AM J GASTROENTEROL, V99, P97, DOI 10.1046/j.1572-0241.2003.04026.x; St Sauver JL, 2011, AM J EPIDEMIOL, V173, P1059, DOI 10.1093/aje/kwq482; Stassen PM, 2008, RHEUMATOLOGY, V47, P530, DOI 10.1093/rheumatology/ken035; Timlin H, 2013, LUPUS, V22, P1251, DOI 10.1177/0961203313497416; Tomasson G, 2014, ANN INTERN MED, V160, P73, DOI 10.7326/M12-3046; Udayakumar PD, 2015, ARTHRIT CARE RES, V67, P396, DOI 10.1002/acr.22416; Unizony S, 2015, RHEUMATOLOGY, V54, P1360, DOI 10.1093/rheumatology/keu483; WILKINSON IM, 1972, ARCH NEUROL-CHICAGO, V27, P378, DOI 10.1001/archneur.1972.00490170010003; Wiszniewska M, 2007, CEREBROVASC DIS, V24, P226, DOI 10.1159/000104482; Zenone T, 2013, RHEUMATOL INT, V33, P3017, DOI 10.1007/s00296-013-2814-0	41	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149579	10.1371/journal.pone.0149579	http://dx.doi.org/10.1371/journal.pone.0149579			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901431	Green Submitted, gold, Green Published			2022-12-27	WOS:000371276100102
J	Ghavami, A; van der Giessen, E; Onck, PR				Ghavami, Ali; van der Giessen, Erik; Onck, Patrick R.			Energetics of Transport through the Nuclear Pore Complex	PLOS ONE			English	Article							FG-REPEAT DOMAINS; FREE-ENERGY; FACILITATED TRANSPORT; PERMEABILITY BARRIER; STRUCTURAL BASIS; NUCLEOPORINS; TRANSLOCATION; ARCHITECTURE; DYNAMICS; MODEL	Molecular transport across the nuclear envelope in eukaryotic cells is solely controlled by the nuclear pore complex (NPC). The NPC provides two types of nucleocytoplasmic transport: passive diffusion of small molecules and active chaperon-mediated translocation of large molecules. It has been shown that the interaction between intrinsically disordered proteins that line the central channel of the NPC and the transporting cargoes is the determining factor, but the exact mechanism of transport is yet unknown. Here, we use coarse-grained molecular dynamics simulations to quantify the energy barrier that has to be overcome for molecules to pass through the NPC. We focus on two aspects of transport. First, the passive transport of model cargo molecules with different sizes is studied and the size selectivity feature of the NPC is investigated. Our results show that the transport probability of cargoes is significantly reduced when they are larger than similar to 5 nm in diameter. Secondly, we show that incorporating hydrophobic binding spots on the surface of the cargo effectively decreases the energy barrier of the pore. Finally, a simple transport model is proposed which characterizes the energy barrier of the NPC as a function of diameter and hydrophobicity of the transporting particles.	[Ghavami, Ali; van der Giessen, Erik; Onck, Patrick R.] Univ Groningen, Zernike Inst Adv Mat, Groningen, Netherlands	University of Groningen	Onck, PR (corresponding author), Univ Groningen, Zernike Inst Adv Mat, Groningen, Netherlands.	p.r.onck@rug.nl	Institute, Zernike/W-7033-2019	Ghavami, Ali/0000-0002-8523-1515; Van der Giessen, Erik/0000-0002-8369-2254; Onck, Patrick/0000-0001-5632-9727	Zernike Institute for Advanced Materials at the University of Groningen	Zernike Institute for Advanced Materials at the University of Groningen	This research was funded by the Zernike Institute for Advanced Materials at the University of Groningen. The authors thank SURFsara (www.surfsara.nl) for the support in using the Lisa Compute Cluster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Ando D, 2014, BIOPHYS J, V106, P1997, DOI 10.1016/j.bpj.2014.03.021; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Egorov SA, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4757017; Ermilov V, 2010, MACROMOLECULES, V43, P3511, DOI 10.1021/ma9027273; Feldherr CM, 1997, J CELL SCI, V110, P3065; Fiserova J, 2010, J CELL SCI, V123, P2773, DOI 10.1242/jcs.070730; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Fribourg S, 2001, MOL CELL, V8, P645, DOI 10.1016/S1097-2765(01)00348-3; Ghavami A, 2014, BIOPHYS J, V107, P1393, DOI [10.1016/j.bpj.2014.07.060, 10.1016/j.bpj.20014.07.060]; Ghavami A, 2013, J CHEM THEORY COMPUT, V9, P432, DOI 10.1021/ct300684j; Goryaynov A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088792; Halperin A, 2011, MACROMOLECULES, V44, P3622, DOI 10.1021/ma200068d; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007; Isgro TA, 2007, STRUCTURE, V15, P977, DOI 10.1016/j.str.2007.06.011; Isgro TA, 2007, J MOL BIOL, V366, P330, DOI 10.1016/j.jmb.2006.11.048; Izaguirre JA, 2001, J CHEM PHYS, V114, P2090, DOI 10.1063/1.1332996; Keminer O, 1999, BIOPHYS J, V77, P217, DOI 10.1016/S0006-3495(99)76883-9; Krishnan VV, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000145; Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980; Ma J, 2012, P NATL ACAD SCI USA, V109, P7326, DOI 10.1073/pnas.1201724109; Ma J, 2010, P NATL ACAD SCI USA, V107, P7305, DOI 10.1073/pnas.0908269107; Merlitz H, 2012, MACROMOLECULES, V45, P8494, DOI 10.1021/ma301781b; Miao L, 2010, BIOPHYS J, V98, P1658, DOI 10.1016/j.bpj.2009.12.4305; Miao LL, 2009, STRUCTURE, V17, P449, DOI 10.1016/j.str.2008.12.021; Milchev A, 2008, POLYMER, V49, P3611, DOI 10.1016/j.polymer.2008.04.032; Mincer JS, 2011, P NATL ACAD SCI USA, V108, pE351, DOI 10.1073/pnas.1104521108; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Morrison J, 2003, J MOL BIOL, V333, P587, DOI 10.1016/j.jmb.2003.08.050; Moussavi-Baygi R, 2011, BIOPHYS J, V100, P1410, DOI 10.1016/j.bpj.2011.01.061; Moussavi-Baygi R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002049; Naim B, 2007, J BIOL CHEM, V282, P3881, DOI 10.1074/jbc.M608329200; Naim B, 2009, EMBO J, V28, P2697, DOI 10.1038/emboj.2009.225; Osmanovic D, 2013, BIOPHYS J, V105, P2781, DOI 10.1016/j.bpj.2013.11.013; PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0; PETERS R, 1984, EMBO J, V3, P1831, DOI 10.1002/j.1460-2075.1984.tb02055.x; Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x; Peters R, 2009, BIOESSAYS, V31, P466, DOI 10.1002/bies.200800159; Rangl M, 2013, ANGEW CHEM, V125, P10546, DOI DOI 10.1002/ANGE.201305359; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Tagliazucchi M, 2013, P NATL ACAD SCI USA, V110, P3363, DOI 10.1073/pnas.1212909110; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Walde S, 2010, TRENDS CELL BIOL, V20, P461, DOI 10.1016/j.tcb.2010.05.001; Yamada J, 2010, MOL CELL PROTEOMICS, V9, P2205, DOI 10.1074/mcp.M000035-MCP201; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4	53	35	35	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148876	10.1371/journal.pone.0148876	http://dx.doi.org/10.1371/journal.pone.0148876			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894898	Green Published, Green Submitted, gold			2022-12-27	WOS:000371223400025
J	Valdes-Donoso, P; Jarvis, LS; Wright, D; Alvarez, J; Perez, AM				Valdes-Donoso, Pablo; Jarvis, Lovell S.; Wright, Dave; Alvarez, Julio; Perez, Andres M.			Measuring Progress on the Control of Porcine Reproductive and Respiratory Syndrome (PRRS) at a Regional Level: The Minnesota N212 Regional Control Project (Rcp) as a Working Example	PLOS ONE			English	Article							EPIDEMIC-DIARRHEA-VIRUS; CLASSICAL SWINE-FEVER; RISK-FACTORS; 2ND-ORDER ANALYSIS; ECONOMIC-IMPACT; TRANSMISSION; INFECTION; HERDS; TRANSPORT; VEHICLES	Due to the highly transmissible nature of porcine reproductive and respiratory syndrome (PRRS), implementation of regional programs to control the disease may be critical. Because PRRS is not reported in the US, numerous voluntary regional control projects (RCPs) have been established. However, the effect of RCPs on PRRS control has not been assessed yet. This study aims to quantify the extent to which RCPs contribute to PRRS control by proposing a methodological framework to evaluate the progress of RCPs. Information collected between July 2012 and June 2015 from the Minnesota Voluntary Regional PRRS Elimination Project (RCP-N212) was used. Demography of premises (e.g. composition of farms with sows = SS and without sows = NSS) was assessed by a repeated analysis of variance. By using general linear mixed-effects models, active participation of farms enrolled in the RCP-N212, defined as the decision to share (or not to share) PRRS status, was evaluated and used as a predictor, along with other variables, to assess the PRRS trend over time. Additionally, spatial and temporal patterns of farmers' participation and the disease dynamics were investigated. The number of farms enrolled in RCP-N212 and its geographical coverage increased, but the proportion of SS and NSS did not vary significantly over time. A significant increasing (p<0.001) trend in farmers' decision to share PRRS status was observed, but with NSS producers less willing to report and a large variability between counties. The incidence of PRRS significantly (p<0.001) decreased, showing a negative correlation between degree of participation and occurrence of PRRS (p<0.001) and a positive correlation with farm density at the county level (p = 0.02). Despite a noted decrease in PRRS, significant spatio-temporal patterns of incidence of the disease over 3-weeks and 3-kms during the entire study period were identified. This study established a systematic approach to quantify the effect of RCPs on PRRS control. Despite an increase in number of farms enrolled in the RCP-N212, active participation is not ensured. By evaluating the effect of participation on the occurrence of PRRS, the value of sharing information among producers may be demonstrated, in turn justifying the existence of RCPs.	[Valdes-Donoso, Pablo; Wright, Dave; Alvarez, Julio; Perez, Andres M.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [Valdes-Donoso, Pablo; Jarvis, Lovell S.] Univ Calif Davis, Dept Agr & Resource Econ, Davis, CA 95616 USA	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Davis	Valdes-Donoso, P (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA.; Valdes-Donoso, P (corresponding author), Univ Calif Davis, Dept Agr & Resource Econ, Davis, CA 95616 USA.	pablovd@umn.edu	donoso, pablo valdes/U-3208-2017; Alvarez, Julio/H-8292-2013; Perez, Andres/HGD-8377-2022	Alvarez, Julio/0000-0002-8999-9417; 	government of Chile through the Becas Chile program; University of Minnesota MnDrive program; Boehringer Ingelheim Vet Medica Inc.; Becas-Chile program of the National Commission for Scientific and Technological Research (CONICYT); Boehringer Ingelheim(R)	government of Chile through the Becas Chile program; University of Minnesota MnDrive program; Boehringer Ingelheim Vet Medica Inc.(Boehringer Ingelheim); Becas-Chile program of the National Commission for Scientific and Technological Research (CONICYT); Boehringer Ingelheim(R)(Boehringer Ingelheim)	This study was supported in part by grants provided by the government of Chile through the Becas Chile program, the University of Minnesota MnDrive program, and Boehringer Ingelheim Vet Medica Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Becas-Chile program of the National Commission for Scientific and Technological Research (CONICYT) has supported Pablo Valdes-Donoso to develop his Master and PhD in the US. Additional support for his Master and PhD project has been partially provided by the University of Minnesota MnDrive program and Boehringer Ingelheim(R). Also, we thank swine producers from the RCP-N212, who shared data, as well as the Swine Disease Eradication Center (SDEC) of University of Minnesota that provided the server in which data were stored and protected. No other conflicts of interest exist.	Albina E, 1997, VET MICROBIOL, V55, P309, DOI 10.1016/S0378-1135(96)01322-3; Alvarez J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120532; Bates D, 2011, LINEAR MIXED MODEL I; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Becker RA, 2014, MAPS DRAW GEOGRAPHIC; Connor J, 2014, 2014 N AM PRRS S; Corzo CA, 2010, VIRUS RES, V154, P185, DOI 10.1016/j.virusres.2010.08.016; Dee S, 2003, CAN J VET RES, V67, P12; Dee SA, 2004, CAN J VET RES, V68, P128; DIGGLE PJ, 1991, BIOMETRICS, V47, P1155, DOI 10.2307/2532668; Diggle PJ, 2005, SPATIO TEMPORAL POIN, P78; Edwards S, 2000, VET MICROBIOL, V73, P103, DOI 10.1016/S0378-1135(00)00138-3; EPA, 2012, PORK GLOSS 2012; Gabriel E, 2014, INVENTORSSTPP SPACE; Gabriel E, 2013, J STAT SOFTW, V53, P1; Gabriel E, 2009, STAT NEERL, V63, P43, DOI 10.1111/j.1467-9574.2008.00407.x; GOYAL SM, 1993, J VET DIAGN INVEST, V5, P656, DOI 10.1177/104063879300500435; Hennessy DA, 1996, AM J AGR ECON, V78, P1034, DOI 10.2307/1243859; Holtkamp DJ, 2013, J SWINE HEALTH PROD, V21, P72; Holtkamp DJ, 2011, J SWINE HEALTH PROD, V19, P44; Hurt C, 1994, CHOICES, V9; Kulldorff M, SATSCANTM V9 4 SOFTW; Kulldorff M, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-58; Kwong GPS, 2013, PREV VET MED, V110, P405, DOI 10.1016/j.prevetmed.2013.01.004; Lowe J, 2014, EMERG INFECT DIS, V20, P872, DOI 10.3201/eid2005.131628; Moennig V, 2000, VET MICROBIOL, V73, P93, DOI 10.1016/S0378-1135(00)00137-1; Morrison R, 2011, AD LEM SWIN C 2011; Mortensen S, 2002, PREV VET MED, V53, P83, DOI 10.1016/S0167-5877(01)00260-4; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; OIE, 2015, LIST DIS INF INF FOR; Otake S, 2002, J SWINE HEALTH PROD, V10, P59; Perez AM, 2015, JAVMA-J AM VET MED A, V246, P1304, DOI 10.2460/javma.246.12.1304; Pitkin A, 2009, CAN J VET RES, V73, P298; R C inventor, 2014, R LANG ENV STAT COMP; Rasmusen E, 2006, GAMES INFORM INTRO G; Schroeder J, 2014, ARC PROGRAMS CONTROL; Service NAS, CENS AGR 2012, P1; Service NAS, 2014, LIV SLAUGHT 2013 SUM; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; Taft A. C., 2000, Veterinary Research (Paris), V31, P157, DOI 10.1051/vetres:2000052; Tousignant SJ, CANADIAN J IN PRESS; USCB, 2010, QUICKFACTS; Velasova M, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-184; Wright D, 2012, PRRS VIRUS OVERVIEW; Wright D., 2015, DECADE PROGR VOLUNTA	45	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149498	10.1371/journal.pone.0149498	http://dx.doi.org/10.1371/journal.pone.0149498			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895148	Green Published, Green Submitted, gold			2022-12-27	WOS:000371223400059
J	Acqualagna, L; Botrel, L; Vidaurre, C; Kubler, A; Blankertz, B				Acqualagna, Laura; Botrel, Loic; Vidaurre, Carmen; Kuebler, Andrea; Blankertz, Benjamin			Large-Scale Assessment of a Fully Automatic Co-Adaptive Motor Imagery-Based Brain Computer Interface	PLOS ONE			English	Article							SINGLE-TRIAL ANALYSIS; CLASSIFICATION PERFORMANCE; SENSORIMOTOR RHYTHMS; EEG; BCI; COMMUNICATION; MOVEMENT; OPERATE; PATIENT; PEOPLE	In the last years Brain Computer Interface (BCI) technology has benefited from the development of sophisticated machine leaning methods that let the user operate the BCI after a few trials of calibration. One remarkable example is the recent development of co-adaptive techniques that proved to extend the use of BCIs also to people not able to achieve successful control with the standard BCI procedure. Especially for BCIs based on the modulation of the Sensorimotor Rhythm (SMR) these improvements are essential, since a not negligible percentage of users is unable to operate SMR-BCIs efficiently. In this study we evaluated for the first time a fully automatic co-adaptive BCI system on a large scale. A pool of 168 participants naive to BCIs operated the co-adaptive SMR-BCI in one single session. Different psychological interventions were performed prior the BCI session in order to investigate how motor coordination training and relaxation could influence BCI performance. A neurophysiological indicator based on the Power Spectral Density (PSD) was extracted by the recording of few minutes of resting state brain activity and tested as predictor of BCI performances. Results show that high accuracies in operating the BCI could be reached by the majority of the participants before the end of the session. BCI performances could be significantly predicted by the neurophysiological indicator, consolidating the validity of the model previously developed. Anyway, we still found about 22% of users with performance significantly lower than the threshold of efficient BCI control at the end of the session. Being the inter-subject variability still the major problem of BCI technology, we pointed out crucial issues for those who did not achieve sufficient control. Finally, we propose valid developments to move a step forward to the applicability of the promising co-adaptive methods.	[Acqualagna, Laura] Tech Univ Berlin, Neurotechnol Grp, Berlin, Germany; [Botrel, Loic; Kuebler, Andrea; Blankertz, Benjamin] Univ Wurzburg, Inst Psychol, Wurzburg, Germany; [Blankertz, Benjamin] Bernstein Focus Neurotechnol, Berlin, Germany; [Vidaurre, Carmen] Tech Univ Berlin, Machine Learning Grp, Berlin, Germany	Technical University of Berlin; University of Wurzburg; Technical University of Berlin	Acqualagna, L (corresponding author), Tech Univ Berlin, Neurotechnol Grp, Berlin, Germany.	laura.acqualagna@tu-berlin.de		Kubler, Andrea/0000-0003-4876-0415; Blankertz, Benjamin/0000-0002-2437-4846; Vidaurre, Carmen/0000-0003-3740-049X	Deutsche Forschungsgemeinschaft (DFG) [KU 1453/3-2, MU 987/3-2]; BMBF [01GQ0850]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) under contracts KU 1453/3-2 and MU 987/3-2 and by grant of the BMBF under contract #01GQ0850.	Acqualagna L, 2013, CLIN NEUROPHYSIOL, V124, P901, DOI 10.1016/j.clinph.2012.12.050; Bamdadian A, 2014, J NEUROSCI METH, V235, P138, DOI 10.1016/j.jneumeth.2014.06.011; Bamdadian A, 2012, IEEE ENG MED BIO, P2732, DOI 10.1109/EMBC.2012.6346529; Barbero A, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-34; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Birbaumer N, 2006, PSYCHOPHYSIOLOGY, V43, P517, DOI 10.1111/j.1469-8986.2006.00456.x; Blankertz B, 2008, IEEE T BIO-MED ENG, V55, P2452, DOI 10.1109/TBME.2008.923152; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Blankertz B, 2007, NEUROIMAGE, V37, P539, DOI 10.1016/j.neuroimage.2007.01.051; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Blankertz B, 2010, NEUROIMAGE, V51, P1303, DOI 10.1016/j.neuroimage.2010.03.022; Brunner Clemens, 2008, INT J BIOELEKTROMAGN, V10, P52, DOI DOI 10.1.1.330.3349; Burde W, 2006, P 3 INT BRAIN COMP I, P76; Dornhege G., 2007, BRAIN COMPUTER INTER; Faller J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101168; Fazli S, 2012, IEEE ENG MED BIO, P4911, DOI 10.1109/EMBC.2012.6347095; Gallegos-Ayala G, 2014, NEUROLOGY, V82, P1930, DOI 10.1212/WNL.0000000000000449; Grosse-Wentrup M, 2011, NEUROIMAGE, V56, P837, DOI 10.1016/j.neuroimage.2010.04.265; Guger C, 2003, IEEE T NEUR SYS REH, V11, P145, DOI 10.1109/TNSRE.2003.814481; Hammer EM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00574; Hammer EM, 2012, BIOL PSYCHOL, V89, P80, DOI 10.1016/j.biopsycho.2011.09.006; Huber P, 1975, ROBUST STAT, VSecond, P239; Kleih SC, 2010, CLIN NEUROPHYSIOL, V121, P1023, DOI 10.1016/j.clinph.2010.01.034; Kubler A, 2005, NEUROLOGY, V64, P1775, DOI 10.1212/01.WNL.0000158616.43002.6D; Kubler A, 2001, ARCH PHYS MED REHAB, V82, P1533, DOI 10.1053/apmr.2001.26621; Kubler A, 2013, BRAIN-COMPUTER INTERFACE SYSTEMS - RECENT PROGRESS AND FUTURE PROSPECTS, P1, DOI 10.5772/55802; Maeder CL, 2012, IEEE T NEUR SYS REH, V20, P653, DOI 10.1109/TNSRE.2012.2205707; McFarland DJ, 1997, ELECTROEN CLIN NEURO, V103, P386, DOI 10.1016/S0013-4694(97)00022-2; Neuper C, 2003, CLIN NEUROPHYSIOL, V114, P399, DOI 10.1016/S1388-2457(02)00387-5; Neuper C, 2006, PROG BRAIN RES, V159, P393, DOI 10.1016/S0079-6123(06)59025-9; Neuper C, 2009, CLIN NEUROPHYSIOL, V120, P239, DOI 10.1016/j.clinph.2008.11.015; Nijboer F, 2008, CLIN NEUROPHYSIOL, V119, P1909, DOI 10.1016/j.clinph.2008.03.034; Nijboer F, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00055; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pfurtscheller G, 1996, ELECTROEN CLIN NEURO, V98, P281, DOI 10.1016/0013-4694(95)00258-8; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Rui Z, 2015, BRAIN TOPOGRAPHY, V28, P1; SALMELIN R, 1994, NEUROSCIENCE, V60, P537, DOI 10.1016/0306-4522(94)90263-1; Samek W, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026013; Sannelli C, 2010, IEEE ENG MED BIO, P4351, DOI 10.1109/IEMBS.2010.5626227; Sellers EW, 2010, AMYOTROPH LATERAL SC, V11, P449, DOI 10.3109/17482961003777470; Shenoy P, 2006, J NEURAL ENG, V3, pR13, DOI 10.1088/1741-2560/3/1/R02; Sugiyama M, 2007, J MACH LEARN RES, V8, P1027; Suk HI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087056; Vidaurre C, 2011, IEEE T BIO-MED ENG, V58, P587, DOI 10.1109/TBME.2010.2093133; Vidaurre C, 2008, P 4 INT BRAIN COMP I, V2008, P122; Vidaurre C, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025009; Vidaurre C, 2011, NEURAL COMPUT, V23, P791, DOI 10.1162/NECO_a_00089; Vidaurre C, 2010, BRAIN TOPOGR, V23, P194, DOI 10.1007/s10548-009-0121-6; Wolpaw J.R., 2012, BRAIN COMPUTER INTER, DOI [10.1093/acprof:oso/9780195388855.001.0001, DOI 10.1093/ACPROF:OSO/9780195388855.001.0001]; Zhang R, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/6/066024	51	41	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0148886	10.1371/journal.pone.0148886	http://dx.doi.org/10.1371/journal.pone.0148886			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891350	Green Published, Green Submitted, gold			2022-12-27	WOS:000371221500017
J	Andrews, AM; Rizzo, V				Andrews, Allison M.; Rizzo, Victor			Microparticle-Induced Activation of the Vascular Endothelium Requires Caveolin-1/Caveolae	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; NF-KAPPA-B; MONOCYTE-DERIVED MICROPARTICLES; ANGIOTENSIN-II; POLY(ADP-RIBOSE) POLYMERASE; CIRCULATING MICROPARTICLES; NUCLEAR TRANSLOCATION; CELL MICROPARTICLES; LUNG INFLAMMATION; PLASMA-MEMBRANE	Microparticles (MPs) are small membrane fragments shed from normal as well as activated, apoptotic or injured cells. Emerging evidence implicates MPs as a causal and/or contributing factor in altering normal vascular cell phenotype through initiation of proinflammatory signal transduction events and paracrine delivery of proteins, mRNA and miRNA. However, little is known regarding the mechanism by which MPs influence these events. Caveolae are important membrane microdomains that function as centers of signal transduction and endocytosis. Here, we tested the concept that the MP-induced pro-inflammatory phenotype shift in endothelial cells (ECs) depends on caveolae. Consistent with previous reports, MP challenge activated ECs as evidenced by upregulation of intracellular adhesion molecule-1 (ICAM-1) expression. ICAM-1 upregulation was mediated by activation of NF-kappa B, Poly [ ADP-ribose] polymerase 1 (PARP-1) and the epidermal growth factor receptor (EGFR). This response was absent in ECs lacking caveolin-1/caveolae. To test whether caveolae-mediated endocytosis, a dynamin-2 dependent process, is a feature of the proinflammatory response, EC's were pretreated with the dynamin-2 inhibitor dynasore. Similar to observations in cells lacking caveolin-1, inhibition of endocytosis significantly attenuated MPs effects including, EGFR phosphorylation, activation of NF-kappa B and upregulation of ICAM-1 expression. Thus, our results indicate that caveolae play a role in mediating the pro-inflammatory signaling pathways which lead to EC activation in response to MPs.	[Andrews, Allison M.; Rizzo, Victor] Temple Univ, Lewis Katz Sch Med, Independence Blue Cross Cardiovasc Res Ctr, Philadelphia, PA 19140 USA; [Rizzo, Victor] Temple Univ, Lewis Katz Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Rizzo, V (corresponding author), Temple Univ, Lewis Katz Sch Med, 3500 North Broad St, Philadelphia, PA 19140 USA.	rizzov@temple.edu			NIH [HL086551]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086551] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this work was provided by NIH HL086551.	Abulrob A, 2010, J BIOL CHEM, V285, P3145, DOI 10.1074/jbc.M109.073338; Agelaki S, 2009, CANCER BIOL THER, V8, P1470, DOI 10.4161/cbt.8.15.8939; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Bardelli C, 2012, BRIT J PHARMACOL, V165, P716, DOI 10.1111/j.1476-5381.2011.01593.x; Boulanger CM, 2006, HYPERTENSION, V48, P180, DOI 10.1161/01.HYP.0000231507.00962.b5; Boulares AH, 2003, AM J RESP CELL MOL, V28, P322, DOI 10.1165/rcmb.2001-0015OC; Burger D, 2011, ARTERIOSCL THROM VAS, V31, P1898, DOI 10.1161/ATVBAHA.110.222703; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; Chen XW, 2010, MOL CELL BIOL, V30, P3048, DOI 10.1128/MCB.00892-09; Chironi GN, 2009, CELL TISSUE RES, V335, P143, DOI 10.1007/s00441-008-0710-9; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Dey-Hazra E, 2010, VASC HEALTH RISK MAN, V6, P1125, DOI 10.2147/VHRM.S13236; Distler JHW, 2005, P NATL ACAD SCI USA, V102, P2892, DOI 10.1073/pnas.0409781102; Engel D, 2011, FASEB J, V25, P3838, DOI 10.1096/fj.11-183350; Ferreira AC, 2004, CIRCULATION, V110, P3599, DOI 10.1161/01.CIR.0000148820.55611.6B; Fleming I, 1996, MOL CELL BIOCHEM, V157, P137; Henriksen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058148; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hussein MNA, 2008, THROMB RES, V121, P865, DOI 10.1016/j.thromres.2007.08.005; Jansen F, 2013, CARDIOVASC RES, V98, P94, DOI 10.1093/cvr/cvt013; Jansen F, 2012, ARTERIOSCL THROM VAS, V32, P1925, DOI 10.1161/ATVBAHA.112.253229; Jimenez JJ, 2003, THROMB RES, V109, P175, DOI 10.1016/S0049-3848(03)00064-1; Kauppinen TM, 2013, BBA-MOL CELL RES, V1833, P1985, DOI 10.1016/j.bbamcr.2013.04.005; Liu ML, 2012, ARTERIOSCL THROM VAS, V32, P2113, DOI 10.1161/ATVBAHA.112.255471; Makki N, 2013, INT J MOL SCI, V14, P20597, DOI 10.3390/ijms141020597; Marino M, 2008, STEROIDS, V73, P853, DOI 10.1016/j.steroids.2007.12.003; Martin S, 2004, CIRCULATION, V109, P1653, DOI 10.1161/01.CIR.0000124065.31211.6E; Massey Kerri A, 2009, Proc Am Thorac Soc, V6, P419, DOI 10.1513/pats.200903-011AW; Mastronardi ML, 2011, CRIT CARE MED, V39, P1739, DOI 10.1097/CCM.0b013e3182190b4b; Masuelli L, 2012, J CELL PHYSIOL, V227, P3344, DOI 10.1002/jcp.24034; Mause SF, 2010, CIRC RES, V107, P1047, DOI 10.1161/CIRCRESAHA.110.226456; Minshall RD, 2003, AM J PHYSIOL-LUNG C, V285, pL1179, DOI 10.1152/ajplung.00242.2003; Mirza MK, 2010, AM J PATHOL, V176, P2344, DOI 10.2353/ajpath.2010.091088; Moreno-Caceres J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.294; Mostefai HA, 2008, J IMMUNOL, V180, P5028, DOI 10.4049/jimmunol.180.7.5028; Neri T, 2011, EUR RESPIR J, V37, P1494, DOI 10.1183/09031936.00023310; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; Oh P, 2012, J BIOL CHEM, V287, P17353, DOI 10.1074/jbc.M111.338897; Oumouna-Benachour K, 2007, CIRCULATION, V115, P2442, DOI 10.1161/CIRCULATIONAHA.106.668756; Park SS, 2005, HISTOPATHOLOGY, V47, P625, DOI 10.1111/j.1365-2559.2005.02303.x; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rom S, 2015, J CEREBR BLOOD F MET, V35, P28, DOI 10.1038/jcbfm.2014.167; Sabatier F, 2002, BLOOD, V99, P3962, DOI 10.1182/blood.V99.11.3962; Schock SC, 2014, BIOCHEM BIOPH RES CO, V450, P912, DOI 10.1016/j.bbrc.2014.06.096; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Takaguri A, 2011, J MOL CELL CARDIOL, V50, P545, DOI 10.1016/j.yjmcc.2010.12.009; Takayanagi T, 2014, CLIN SCI, V126, P785, DOI 10.1042/CS20130660; Terrisse AD, 2010, J THROMB HAEMOST, V8, P2810, DOI 10.1111/j.1538-7836.2010.04088.x; Tesse A, 2005, ARTERIOSCL THROM VAS, V25, P2522, DOI 10.1161/01.ATV.0000189298.62240.5d; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Tiruppathi C, 2008, J BIOL CHEM, V283, P4210, DOI 10.1074/jbc.M703153200; van Ierssel SH, 2010, THROMB RES, V125, P332, DOI 10.1016/j.thromres.2009.12.019; Wang JG, 2011, BLOOD, V118, P2366, DOI 10.1182/blood-2011-01-330878; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P112, DOI 10.1161/01.ATV.0000191634.13057.15; Xu L, 2014, ONCOL REP, V32, P318, DOI 10.3892/or.2014.3183; Xu XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028216; Yoshida J, 2010, LIFE SCI, V86, P124, DOI 10.1016/j.lfs.2009.11.014; Zerfaoui M, 2008, CELL SIGNAL, V20, P186, DOI 10.1016/j.cellsig.2007.10.007; Zhang BF, 2007, CELL SIGNAL, V19, P1690, DOI 10.1016/j.cellsig.2007.03.005; Zhang Y, 2010, ANTIOXID REDOX SIGN, V13, P959, DOI 10.1089/ars.2009.2908	65	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149272	10.1371/journal.pone.0149272	http://dx.doi.org/10.1371/journal.pone.0149272			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891050	Green Published, Green Submitted, gold			2022-12-27	WOS:000371221500030
J	Bruns, SB; Ioannidis, JPA				Bruns, Stephan B.; Ioannidis, John P. A.			p-Curve and p-Hacking in Observational Research	PLOS ONE			English	Article							SCIENCE-WISE FALSE; DISCOVERY RATE; VALUES; TRUTH	The p-curve, the distribution of statistically significant p-values of published studies, has been used to make inferences on the proportion of true effects and on the presence of p-hacking in the published literature. We analyze the p-curve for observational research in the presence of p-hacking. We show by means of simulations that even with minimal omitted-variable bias (e.g., unaccounted confounding) p-curves based on true effects and p-curves based on null-effects with p-hacking cannot be reliably distinguished. We also demonstrate this problem using as practical example the evaluation of the effect of malaria prevalence on economic growth between 1960 and 1996. These findings call recent studies into question that use the p-curve to infer that most published research findings are based on true effects in the medical literature and in a wide range of disciplines. p-values in observational research may need to be empirically calibrated to be interpretable with respect to the commonly used significance threshold of 0.05. Violations of randomization in experimental studies may also result in situations where the use of p-curves is similarly unreliable.	[Bruns, Stephan B.] Univ Kassel, Meta Res Econ Grp, D-34125 Kassel, Germany; [Ioannidis, John P. A.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Meta Res Innovat Ctr Stanford, Stanford, CA 94305 USA	Universitat Kassel; Stanford University; Stanford University; Stanford University; Stanford University	Ioannidis, JPA (corresponding author), Stanford Univ, Dept Med, Stanford, CA 94305 USA.; Ioannidis, JPA (corresponding author), Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA.; Ioannidis, JPA (corresponding author), Stanford Univ, Dept Stat, Stanford, CA 94305 USA.; Ioannidis, JPA (corresponding author), Stanford Univ, Meta Res Innovat Ctr Stanford, Stanford, CA 94305 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011					Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Bishop DV, 2015, PEERJ PREPRINTS, V3, pe1550, DOI DOI 10.7287/PEERJ.PREPRINTS.1266V1; Boccia S, 2015, J CLIN EPID IN PRESS; Bruns SB, 2016, MAGKS JOINT DISCUSSI, V03; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dal-Re R, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007513; de Winter JCF, 2015, PEERJ, V3, DOI 10.7717/peerj.733; Durlauf SN, 2005, HANDB ECON, V22, P555; Fanelli Daniele, 2009, PLoS One, V4, pe5738, DOI 10.1371/journal.pone.0005738; Gelman A, 2014, BIOSTATISTICS, V15, P18, DOI 10.1093/biostatistics/kxt034; Greene W. H., 2012, ECONOMETRIC ANAL, V7th; Head ML, 2015, PLOS BIOL, V13, DOI [10.1371/journal.pbio.1002106, DOI 10.1371/JOURNAL.PBIO.1002106]; HENDRY DF, 1980, ECONOMICA, V47, P387, DOI 10.2307/2553385; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Ioannidis JPA, 2014, BIOSTATISTICS, V15, P28, DOI 10.1093/biostatistics/kxt036; Ioannidis JPA, 2011, ARCH GEN PSYCHIAT, V68, P773, DOI 10.1001/archgenpsychiatry.2011.28; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jager LR, 2014, BIOSTATISTICS, V15, P1, DOI 10.1093/biostatistics/kxt007; John LK, 2012, PSYCHOL SCI, V23, P524, DOI 10.1177/0956797611430953; Khoury MJ, 2014, SCIENCE, V346, P1054, DOI 10.1126/science.aaa2709; Klein RA, 2014, SOC PSYCHOL-GERMANY, V45, P142, DOI 10.1027/1864-9335/a000178; Lakens D, 2015, PEERJ, V3, DOI 10.7717/peerj.1142; Lakens D, 2015, Q J EXP PSYCHOL, V68, P829, DOI 10.1080/17470218.2014.982664; LEAMER EE, 1983, AM ECON REV, V73, P31; LOVELL MC, 1983, REV ECON STAT, V65, P1, DOI 10.2307/1924403; Patel CJ, 2015, J CLIN EPID IN PRESS; Rockey J, 2015, EUR EC REV IN PRESS; Sala-I-Martin X, 2004, AM ECON REV, V94, P813, DOI 10.1257/0002828042002570; Saquib N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4313; Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537; Schuemie MJ, 2014, BIOSTATISTICS, V15, P36, DOI 10.1093/biostatistics/kxt037; Schuemie MJ, 2014, STAT MED, V33, P209, DOI 10.1002/sim.5925; Serghiou S, 2015, J CLIN EPID IN PRESS; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Simonsohn U, 2014, J EXP PSYCHOL GEN, V143, P534, DOI 10.1037/a0033242; Tsilidis KK, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001609; Ulrich R, 2015, J EXP PSYCHOL GEN, V144, P1137, DOI 10.1037/xge0000086; White H, 2000, ECONOMETRICA, V68, P1097, DOI 10.1111/1468-0262.00152; Young SS, 2011, SIGNIFICANCE, V8, P116, DOI DOI 10.1111/J.1740-9713.2011.00506.X	40	98	98	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149144	10.1371/journal.pone.0149144	http://dx.doi.org/10.1371/journal.pone.0149144			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3BJ	26886098	Green Submitted, Green Published, gold			2022-12-27	WOS:000371218400062
J	Liu, HB; Qin, YY; Kong, ZZ; Shao, QX; Su, ZL; Wang, SJ; Chen, JG				Liu, Haibing; Qin, Yanyan; Kong, Zhenzhen; Shao, Qixiang; Su, Zhaoliang; Wang, Shengjun; Chen, Jianguo			siRNA Targeting the 2A(pro) Genomic Region Prevents Enterovirus 71 Replication In Vitro	PLOS ONE			English	Article							SMALL INTERFERING RNA; MOUTH-DISEASE; EPIDEMIOLOGY; INHIBITION; EXPRESSION; INFECTION; INDUCTION; CHILDREN; FOOT; HAND	Enterovirus 71 (EV71) is the most important etiological agent of hand, foot, and mouth disease (HFMD) in young children, which is associated with severe neurological complications and has caused significant mortalities in recent HFMD outbreaks in Asia. However, there is no effective antiviral therapy against EV71. In this study, RNA interference (RNAi) was used as an antiviral strategy to inhibit EV71 replication. Three small interfering RNAs (siRNAs) targeting the 2A(pro) region of the EV71 genome were designed and synthesized. All the siRNAs were transfected individually into rhabdomyosarcoma (RD) cells, which were then infected with strain EV71-2006-52-9. The cytopathic effects (CPEs) in the infected RD cells, cell viability, viral titer, and viral RNA and protein expression were examined to evaluate the specific viral inhibition by the siRNAs. The results of cytopathogenicity and MTT tests indicated that the RD cells transfected with the three siRNAs showed slight CPEs and significantly high viability. The 50% tissue culture infective dose (TCID50) values demonstrated that the viral titer of the groups treated with three siRNAs were lower than those of the control groups. qRT-PCR and western blotting revealed that the levels of viral RNA and protein in the RD cells treated with the three siRNAs were lower than those in the controls. When RD cells transfected with siRNAs were also infected with strain EV71-2008-43-16, the expression of the VP1 protein was significantly inhibited. The levels of interferon alpha (IFN-alpha) and IFN-beta did not differ significantly in any group. These results suggest that siRNAs targeting the 2A(pro) region of the EV71 genome exerted antiviral effects in vitro.	[Liu, Haibing; Wang, Shengjun; Chen, Jianguo] Jiangsu Univ, Affiliated Peoples Hosp, Dept Clin Lab, Zhenjiang, Peoples R China; [Qin, Yanyan; Kong, Zhenzhen; Shao, Qixiang; Su, Zhaoliang] Jiangsu Univ, Inst Lab Med, Dept Immunol, Zhenjiang, Peoples R China	Jiangsu University; Jiangsu University	Chen, JG (corresponding author), Jiangsu Univ, Affiliated Peoples Hosp, Dept Clin Lab, Zhenjiang, Peoples R China.	cjg02@126.com	, 雷克思/ABG-3956-2020	, 雷克思/0000-0003-4102-8934; Shao, Qixiang/0000-0002-8332-1605				Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Cai QX, 2013, J VIROL, V87, P7348, DOI 10.1128/JVI.03541-12; Chan YF, 2010, INFECT GENET EVOL, V10, P404, DOI 10.1016/j.meegid.2009.05.010; Deng J-X, 2012, J BIOMEDICAL SCI, V19, P1; Feng XB, 2015, SCI REP-UK, V5, DOI 10.1038/srep11700; Guo PX, 2010, ADV DRUG DELIVER REV, V62, P650, DOI 10.1016/j.addr.2010.03.008; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Juliano R, 2008, NUCLEIC ACIDS RES, V36, P4158, DOI 10.1093/nar/gkn342; Kuo RL, 2002, J GEN VIROL, V83, P1367, DOI 10.1099/0022-1317-83-6-1367; Lu WW, 2004, BIOCHEM BIOPH RES CO, V325, P494, DOI 10.1016/j.bbrc.2004.10.062; Luan Y, 2012, VIRUS RES, V163, P183, DOI 10.1016/j.virusres.2011.09.016; Ramachandran PV, 2013, APPL BIOCHEM BIOTECH, V169, P1774, DOI 10.1007/s12010-013-0098-1; Reynolds A, 2006, RNA, V12, P988, DOI 10.1261/rna.2340906; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Shih SR, 2011, J VIROL, V85, P9658, DOI 10.1128/JVI.05063-11; Sim ACN, 2005, VIROLOGY, V341, P72, DOI 10.1016/j.virol.2005.06.047; Tu YF, 2015, INT J INFECT DIS, V34, P105, DOI 10.1016/j.ijid.2015.03.017; Vlachakis D, 2013, EVOL BIOINFORM, V9, P203, DOI 10.4137/EBO.S11412; Wang SM, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/876241; Wang Y, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0308-2; Wen WH, 2007, HEPATOLOGY, V46, P84, DOI 10.1002/hep.21663; Wu ZQ, 2009, J VIROL METHODS, V159, P233, DOI 10.1016/j.jviromet.2009.04.002; Yip Cyril C Y, 2013, Emerg Health Threats J, V6, P19780, DOI 10.3402/ehtj.v6i0.19780; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94	25	8	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149470	10.1371/journal.pone.0149470	http://dx.doi.org/10.1371/journal.pone.0149470			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886455	Green Published, gold, Green Submitted			2022-12-27	WOS:000371218400087
J	Albers, C; Westkott, M; Pawelzik, K				Albers, Christian; Westkott, Maren; Pawelzik, Klaus			Learning of Precise Spike Times with Homeostatic Membrane Potential Dependent Synaptic Plasticity	PLOS ONE			English	Article							LONG-TERM POTENTIATION; VISUAL-CORTEX; NEURAL-NETWORKS; PYRAMIDAL CELLS; NEURONS; SYNAPSES; INHIBITION; DEPRESSION; EXCITATION; DENDRITES	Precise spatio-temporal patterns of neuronal action potentials underly e.g. sensory representations and control of muscle activities. However, it is not known how the synaptic efficacies in the neuronal networks of the brain adapt such that they can reliably generate spikes at specific points in time. Existing activity-dependent plasticity rules like Spike-Timing-Dependent Plasticity are agnostic to the goal of learning spike times. On the other hand, the existing formal and supervised learning algorithms perform a temporally precise comparison of projected activity with the target, but there is no known biologically plausible implementation of this comparison. Here, we propose a simple and local unsupervised synaptic plasticity mechanism that is derived from the requirement of a balanced membrane potential. Since the relevant signal for synaptic change is the postsynaptic voltage rather than spike times, we call the plasticity rule Membrane Potential Dependent Plasticity (MPDP). Combining our plasticity mechanism with spike after-hyperpolarization causes a sensitivity of synaptic change to pre- and postsynaptic spike times which can reproduce Hebbian spike timing dependent plasticity for inhibitory synapses as was found in experiments. In addition, the sensitivity of MPDP to the time course of the voltage when generating a spike allows MPDP to distinguish between weak (spurious) and strong (teacher) spikes, which therefore provides a neuronal basis for the comparison of actual and target activity. For spatio-temporal input spike patterns our conceptually simple plasticity rule achieves a surprisingly high storage capacity for spike associations. The sensitivity of the MPDP to the subthreshold membrane potential during training allows robust memory retrieval after learning even in the presence of activity corrupted by noise. We propose that MPDP represents a biophysically plausible mechanism to learn temporal target activity patterns.	[Albers, Christian; Westkott, Maren; Pawelzik, Klaus] Univ Bremen, Inst Theoret Phys, D-28359 Bremen, Germany	University of Bremen	Albers, C (corresponding author), Univ Bremen, Inst Theoret Phys, D-28359 Bremen, Germany.	calbers@neuro.uni-bremen.de			German Bundesministerium fur Bildung und Forschung (BMBF) [01GQ0964]	German Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	CA and MW were supported by the German Bundesministerium fur Bildung und Forschung (BMBF), grant number 01GQ0964. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Brea J, 2013, J NEUROSCI, V33, P9565, DOI 10.1523/JNEUROSCI.4098-12.2013; BRESSLOFF PC, 1992, J PHYS A-MATH GEN, V25, P833, DOI 10.1088/0305-4470/25/4/020; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; D'Haene M, 2009, NEURAL COMPUT, V21, P1068, DOI 10.1162/neco.2008.02-08-707; D'Souza P, 2010, P NATL ACAD SCI USA, V107, P4722, DOI 10.1073/pnas.0909394107; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Fino E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006557; Florian RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040233; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Froemke RC, 2015, ANNU REV NEUROSCI, V38, P195, DOI 10.1146/annurev-neuro-071714-034002; Gerstner W, 2002, SPIKING NEURON MODEL; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; Gutig R, 2006, NAT NEUROSCI, V9, P420, DOI 10.1038/nn1643; Haas JS, 2006, J NEUROPHYSIOL, V96, P3305, DOI 10.1152/jn.00551.2006; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hertz J., 1991, SANTA FE I SERIES, V1; Holthoff K, 2010, J PHYSIOL-LONDON, V588, P1085, DOI 10.1113/jphysiol.2009.184960; Lamsa KP, 2007, SCIENCE, V315, P1262, DOI 10.1126/science.1137450; Legenstein R, 2005, NEURAL COMPUT, V17, P2337, DOI 10.1162/0899766054796888; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Masquelier T, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00007; Memmesheimer RM, 2014, NEURON, V82, P925, DOI 10.1016/j.neuron.2014.03.026; Palmer LM, 2009, J NEUROSCI, V29, P6897, DOI 10.1523/JNEUROSCI.5847-08.2009; Pfister JP, 2006, NEURAL COMPUT, V18, P1318, DOI 10.1162/neco.2006.18.6.1318; Ponulak F, 2010, NEURAL COMPUT, V22, P467, DOI 10.1162/neco.2009.11-08-901; Popovic MA, 2014, CEREB CORTEX, V24, P385, DOI 10.1093/cercor/bhs320; Porr B, 2003, NEURAL COMPUT, V15, P831, DOI 10.1162/08997660360581921; Shouval HZ, 2002, P NATL ACAD SCI USA, V99, P10831, DOI 10.1073/pnas.152343099; Sjostrom PJ, 2004, J NEUROPHYSIOL, V92, P3338, DOI 10.1152/jn.00376.2004; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; STORM JF, 1987, J PHYSIOL-LONDON, V385, P733, DOI 10.1113/jphysiol.1987.sp016517; Urbanczik R, 2014, NEURON, V81, P521, DOI 10.1016/j.neuron.2013.11.030; Van Rullen R, 2001, NEURAL COMPUT, V13, P1255, DOI 10.1162/08997660152002852; Verhoog MB, 2013, J NEUROSCI, V 33, P17197, DOI 10.1523/JNEUROSCI.3158-13.2013; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310; Vogels TP, 2011, SCIENCE, V334, P1569, DOI 10.1126/science.1211095; Wang HX, 2005, NAT NEUROSCI, V8, P187, DOI 10.1038/nn1387; Woodin MA, 2003, NEURON, V39, P807, DOI 10.1016/S0896-6273(03)00507-5; Xie XH, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.041909; Xu SJ, 2012, NAT NEUROSCI, V15, P449, DOI 10.1038/nn.3036; Xu Y, 2013, NEURAL COMPUT, V25, P1472, DOI 10.1162/NECO_a_00450; Xue MS, 2014, NATURE, V511, P596, DOI 10.1038/nature13321; Yger P, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003272	46	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148948	10.1371/journal.pone.0148948	http://dx.doi.org/10.1371/journal.pone.0148948			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900845	Green Submitted, gold, Green Published			2022-12-27	WOS:000371276100031
J	Korolev, IO; Symonds, LL; Bozoki, AC				Korolev, Igor O.; Symonds, Laura L.; Bozoki, Andrea C.		Alzheimer's Dis Neuroimaging Initi	Predicting Progression from Mild Cognitive Impairment to Alzheimer's Dementia Using Clinical, MRI, and Plasma Biomarkers via Probabilistic Pattern Classification	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; DISEASE; CONVERSION; DIAGNOSIS; MODEL; RISK; SELECTION; BRAIN; SEGMENTATION; METAANALYSIS	Background Individuals with mild cognitive impairment (MCI) have a substantially increased risk of developing dementia due to Alzheimer's disease (AD). In this study, we developed a multi-variate prognostic model for predicting MCI-to-dementia progression at the individual patient level. Methods Using baseline data from 259 MCI patients and a probabilistic, kernel-based pattern classification approach, we trained a classifier to distinguish between patients who progressed to AD-type dementia (n = 139) and those who did not (n = 120) during a three-year follow-up period. More than 750 variables across four data sources were considered as potential predictors of progression. These data sources included risk factors, cognitive and functional assessments, structural magnetic resonance imaging (MRI) data, and plasma proteomic data. Predictive utility was assessed using a rigorous cross-validation framework. Results Cognitive and functional markers were most predictive of progression, while plasma proteomic markers had limited predictive utility. The best performing model incorporated a combination of cognitive/functional markers and morphometric MRI measures and predicted progression with 80% accuracy (83% sensitivity, 76% specificity, AUC = 0.87). Predictors of progression included scores on the Alzheimer's Disease Assessment Scale, Rey Auditory Verbal Learning Test, and Functional Activities Questionnaire, as well as volume/cortical thickness of three brain regions (left hippocampus, middle temporal gyrus, and inferior parietal cortex). Calibration analysis revealed that the model is capable of generating probabilistic predictions that reliably reflect the actual risk of progression. Finally, we found that the predictive accuracy of the model varied with patient demographic, genetic, and clinical characteristics and could be further improved by taking into account the confidence of the predictions. Conclusions We developed an accurate prognostic model for predicting MCI-to-dementia progression over a three-year period. The model utilizes widely available, cost-effective, non-invasive markers and can be used to improve patient selection in clinical trials and identify high-risk MCI patients for early treatment.	[Korolev, Igor O.; Symonds, Laura L.; Bozoki, Andrea C.] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; [Korolev, Igor O.] Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA; [Bozoki, Andrea C.] Michigan State Univ, Dept Neurol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University College of Osteopathic Medicine; Michigan State University	Korolev, IO (corresponding author), Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA.; Korolev, IO (corresponding author), Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA.	korolevi@msu.edu			DO/PhD Program; Department of Neurology at Michigan State University; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; Michigan State University High Performance Computing Center; Institute for Cyber-Enabled Research; NATIONAL INSTITUTE ON AGING [U01AG024904] Funding Source: NIH RePORTER	DO/PhD Program; Department of Neurology at Michigan State University; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DOD ADNI (Department of Defense); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michigan State University High Performance Computing Center; Institute for Cyber-Enabled Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Stipend support was provided to IOK by the DO/PhD Program, the Graduate School, and the Department of Neurology at Michigan State University. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. Data used in preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (http://adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf.; Data used in preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (http://adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf. We would like to thank Dr. Rong Jin, Dr. David Zhu, Dr. Justin McCormick, Dr. Kevin Berger, Bethany Heinlen, and Suzanne Kohler for helpful discussions and feedback; and Monica Gentchev for help with data coding. We wish to acknowledge the support of the Michigan State University High Performance Computing Center and the Institute for Cyber-Enabled Research. We are grateful to the patients and their families who participated in the ADNI.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; ALTMAN DG, 1994, BRIT MED J, V309, P188, DOI 10.1136/bmj.309.6948.188; Backman L, 2005, NEUROPSYCHOLOGY, V19, P520, DOI 10.1037/0894-4105.19.4.520; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Beach TG, 2012, J NEUROPATH EXP NEUR, V71, P266, DOI 10.1097/NEN.0b013e31824b211b; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; Bouckaert R. R., 2003, P 20 INT C MACH LEAR, P51, DOI DOI 10.5555/3041838.3041845; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Bozoki A, 2001, ARCH NEUROL-CHICAGO, V58, P411, DOI 10.1001/archneur.58.3.411; Bozoki AC, 2012, HUM BRAIN MAPP, V33, P1792, DOI 10.1002/hbm.21320; Brown G, 2012, J MACH LEARN RES, V13, P27; Cawley GC, 2010, J MACH LEARN RES, V11, P2079; Chen R, 2010, NEUROIMAGE, V52, P234, DOI 10.1016/j.neuroimage.2010.03.084; Cui Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021896; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Damoulas T, 2008, BIOINFORMATICS, V24, P1264, DOI 10.1093/bioinformatics/btn112; Damoulas T, 2009, PATTERN RECOGN LETT, V30, P46, DOI 10.1016/j.patrec.2008.08.016; Damoulas T, 2009, PATTERN RECOGN, V42, P2671, DOI 10.1016/j.patcog.2009.04.002; DAVATZIKOS C, 2011, NEUROBIOL AGING, V32, P2322, DOI [DOI 10.1016/J.NEUR0BI0LAGING.2010.05.023, DOI 10.1016/J.NEUROBIOLAGING.2010.05.023]; DELEON MJ, 1989, LANCET, V2, P672; DELEON MJ, 1993, AM J NEURORADIOL, V14, P897; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Desikan RS, 2009, BRAIN, V132, P2048, DOI 10.1093/brain/awp123; Devanand D P, 2012, Int J Alzheimers Dis, V2012, P483469, DOI 10.1155/2012/483469; Devanand DP, 2008, BIOL PSYCHIAT, V64, P871, DOI 10.1016/j.biopsych.2008.06.020; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; FLICKER C, 1991, NEUROLOGY, V41, P1006, DOI 10.1212/WNL.41.7.1006; Gomar J.J., 2014, ALZHEIMERS DEMENTIA; Gomar JJ, 2011, ARCH GEN PSYCHIAT, V68, P961, DOI 10.1001/archgenpsychiatry.2011.96; Gonen M, 2011, J MACH LEARN RES, V12, P2211; Graff-Radford NR, 2007, ARCH NEUROL-CHICAGO, V64, P354, DOI 10.1001/archneur.64.3.354; Haller S, 2011, J ALZHEIMERS DIS, V26, P389, DOI 10.3233/JAD-2011-0014; Hansson O, 2010, NEUROBIOL AGING, V31, P357, DOI 10.1016/j.neurobiolaging.2008.03.027; Herbei R, 2006, CAN J STAT, V34, P709, DOI 10.1002/cjs.5550340410; Hinrichs C, 2011, NEUROIMAGE, V55, P574, DOI 10.1016/j.neuroimage.2010.10.081; Hofmann T, 2008, ANN STAT, V36, P1171, DOI 10.1214/009053607000000677; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jack CR, 1999, NEUROLOGY, V52, P1397, DOI 10.1212/WNL.52.7.1397; Johnstone D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034341; Karow DS, 2010, RADIOLOGY, V256, P932, DOI 10.1148/radiol.10091402; Kim KI, 2011, BIOSTATISTICS, V12, P399, DOI 10.1093/biostatistics/kxq069; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Kloppel S, 2012, NEUROIMAGE, V61, P457, DOI 10.1016/j.neuroimage.2011.11.002; Kluger A, 1999, J GERIATR PSYCH NEUR, V12, P168, DOI 10.1177/089198879901200402; Koikkalainen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031112; KOROLEV IO, 2014, MED STUDENT RES J, V4, P24, DOI DOI 10.3402/MSRJ.V3I0.201333; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Manly JJ, 2008, ANN NEUROL, V63, P494, DOI 10.1002/ana.21326; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mitchell AJ, 2008, J NEUROL NEUROSUR PS, V79, P1386, DOI 10.1136/jnnp.2007.142679; Mitchell AJ, 2009, ACTA PSYCHIAT SCAND, V119, P252, DOI 10.1111/j.1600-0447.2008.01326.x; Nordberg A, 2013, EUR J NUCL MED MOL I, V40, P104, DOI 10.1007/s00259-012-2237-2; Palmqvist S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038639; Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Petersen RC, 2009, ARCH NEUROL-CHICAGO, V66, P1447, DOI 10.1001/archneurol.2009.266; Raji CA, 2009, NEUROLOGY, V73, P1899, DOI 10.1212/WNL.0b013e3181c3f293; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Salat DH, 2009, NEUROIMAGE, V44, P1247, DOI 10.1016/j.neuroimage.2008.10.030; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Schneider LS, 2011, ARCH NEUROL-CHICAGO, V68, P58, DOI 10.1001/archneurol.2010.343; Shen L, 2010, BRAIN IMAGING BEHAV, V4, P86, DOI 10.1007/s11682-010-9088-x; Smialowski P, 2010, BIOINFORMATICS, V26, P440, DOI 10.1093/bioinformatics/btp621; Soares HD, 2012, ARCH NEUROL-CHICAGO, V69, P1310, DOI 10.1001/archneurol.2012.1070; Sperling RA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007941; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Stricker NH, 2011, NEUROLOGY, V77, P713, DOI 10.1212/WNL.0b013e31822b0004; Thompson PM, 2003, J NEUROSCI, V23, P994; Tierney MC, 1996, NEUROLOGY, V46, P661, DOI 10.1212/WNL.46.3.661; Varma S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-91; Wee CY, 2013, HUM BRAIN MAPP, V34, P3411, DOI 10.1002/hbm.22156; Weiner Michael W, 2012, Alzheimers Dement, V8, pS1, DOI [10.1016/j.jalz.2013.05.1769, 10.1016/j.jalz.2011.09.172]; Westman E, 2012, NEUROIMAGE, V62, P229, DOI 10.1016/j.neuroimage.2012.04.056; Westover MB, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-20; Wishart HA, 2006, NEUROLOGY, V67, P1221, DOI 10.1212/01.wnl.0000238079.00472.3a; Yang H., 1999, P INT ICSC S ADV INT, P22; Ye JP, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-46; Young J, 2013, NEUROIMAGE-CLIN, V2, P735, DOI 10.1016/j.nicl.2013.05.004; Zhang DQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033182; Zhang DQ, 2012, NEUROIMAGE, V59, P895, DOI 10.1016/j.neuroimage.2011.09.069; Zhu DC, 2013, J ALZHEIMERS DIS, V34, P969, DOI 10.3233/JAD-121879	88	113	114	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0138866	10.1371/journal.pone.0138866	http://dx.doi.org/10.1371/journal.pone.0138866			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901338	Green Submitted, gold, Green Published			2022-12-27	WOS:000371276100002
J	Lim, SM; Jang, HY; Lee, JE; Shin, JS; Park, SH; Yoon, BH; Kim, GJ				Lim, Seung Mook; Jang, Hee Yeon; Lee, Ji Eun; Shin, Joong Sik; Park, Sun-Hwa; Yoon, Bo Hyun; Kim, Gi Jin			Alteration of Pituitary Tumor Transforming Gene-1 Regulates Trophoblast Invasion via the Integrin/Rho-Family Signaling Pathway	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; CANCER-CELLS; LUNG ADENOCARCINOMA; RHO GTPASES; IGF-II; EXPRESSION; MIGRATION; MICRORNA; MIR-186; TARGETS	Trophoblast invasion ability is an important factor in early implantation and placental development. Recently, pituitary tumor transforming gene 1 (PTTG1) was shown to be involved in invasion and proliferation of cancer. However, the role of PTTG1 in trophoblast invasion remains unknown. Thus, in this study we analyzed PTTG1 expression in trophoblasts and its effect on trophoblast invasion activity and determined the mechanism through which PTTG1 regulates trophoblast invasion. Trophoblast proliferation and invasion abilities, regardless of PTTG1 expression, were analyzed by quantitative real-time polymerase chain reaction, fluorescence-activated cell sorting analysis, invasion assay, western blot, and zymography after treatment with small interfering RNA against PTTG1 (siPTTG1). Additionally, integrin/Rho-family signaling in trophoblasts by PTTG1 alteration was analyzed. Furthermore, the effect of PTTG1 on trophoblast invasion was evaluated by microRNA (miRNA) mimic and inhibitor treatment. Trophoblast invasion was significantly reduced through decreased matrix metalloproteinase (MMP)-2 and MMP-9 expression when PTTG1 expression was inhibited by siPTTG1 (p < 0.05). Furthermore, knockdown of PTTG1 increased expression of integrin alpha 4 (ITGA4), ITGA5, and integrin beta 1 (ITGB1); otherwise, RhoA expression was significantly decreased (p < 0.05). Treatment of miRNA-186-5p mimic and inhibitor controlled trophoblast invasion ability by altering PTTG1 and MMP expression. PTTG1 can control trophoblast invasion ability via regulation of MMP expression through integrin/Rho-family signaling. In addition, PTTG1 expression and its function were regulated by miRNA-186-5p. These results help in understanding the mechanism through which PTTG1 regulates trophoblast invasion and thereby implantation and placental development.	[Lim, Seung Mook; Jang, Hee Yeon; Kim, Gi Jin] CHA Univ, Dept Biomed Sci, Songnam 463400, South Korea; [Lee, Ji Eun; Shin, Joong Sik] CHA Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Park, Sun-Hwa] Korea Univ, Coll Med, Dept Anat, Inst Human Genet, Seoul 136705, South Korea; [Yoon, Bo Hyun] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea	Pochon Cha University; Pochon Cha University; Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU)	Kim, GJ (corresponding author), CHA Univ, Dept Biomed Sci, Songnam 463400, South Korea.	gjkim@cha.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology, Republic of Korea [2012R1A13009776]; Korea health Technology R & D project, Ministry of Health & Welfare, Republic of Korea [A120855]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology, Republic of Korea; Korea health Technology R & D project, Ministry of Health & Welfare, Republic of Korea	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology, Republic of Korea (2012R1A13009776) and a grant of Korea health Technology R & D project, Ministry of Health & Welfare, Republic of Korea (A120855).	Anin Sheba Anin, 2004, Hum Fertil (Camb), V7, P169, DOI 10.1080/14647270400006911; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bilban M, 2010, PLACENTA, V31, P989, DOI 10.1016/j.placenta.2010.08.011; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bourguignon LYW, 2010, J BIOL CHEM, V285, P36721, DOI 10.1074/jbc.M110.162305; Caccavari F, 2010, CELL ADHES MIGR, V4, P124, DOI 10.4161/cam.4.1.10976; Cai JC, 2013, CANCER RES, V73, P756, DOI 10.1158/0008-5472.CAN-12-2651; Cross JC, 1998, ANN NY ACAD SCI, V857, P23, DOI 10.1111/j.1749-6632.1998.tb10104.x; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; Genbacev O, 1996, J CLIN INVEST, V97, P540, DOI 10.1172/JCI118447; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Halasz M, 2013, J REPROD IMMUNOL, V97, P43, DOI 10.1016/j.jri.2012.10.011; Hamid T, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-3; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Holtan SG, 2009, MAYO CLIN PROC, V84, P985, DOI 10.1016/S0025-6196(11)60669-1; Hsu YH, 2010, J BIOL CHEM, V285, P22630, DOI 10.1074/jbc.M109.096255; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; IRVING JA, 1995, EXP CELL RES, V217, P419, DOI 10.1006/excr.1995.1105; Iyer V, 2005, J CELL SCI, V118, P1185, DOI 10.1242/jcs.01708; Janneau JL, 2002, J CLIN ENDOCR METAB, V87, P5336, DOI 10.1210/jc.2002-021093; Ji L, 2013, MOL ASPECTS MED, V34, P981, DOI 10.1016/j.mam.2012.12.008; Jovanovic M, 2010, REPRODUCTION, V139, P789, DOI 10.1530/REP-09-0341; Kim SY, 2012, BIOCHEM BIOPH RES CO, V429, P173, DOI 10.1016/j.bbrc.2012.10.117; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li ZR, 2012, CANCER LETT, V323, P41, DOI 10.1016/j.canlet.2012.03.029; Liu Z, 2008, INT J MOL SCI, V9, P978, DOI 10.3390/ijms9060978; Luo LL, 2012, J CELL SCI, V125, P3124, DOI 10.1242/jcs.096412; Malik MT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-61; Na KH, 2012, J CELL BIOCHEM, V113, P685, DOI 10.1002/jcb.23398; Norwitz Errol R, 2007, Reprod Biomed Online, V14 Spec No 1, P101, DOI 10.1016/S1472-6483(10)61464-2; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Peleg D, 1998, AM FAM PHYSICIAN, V58, P453; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Roberts DJ, 2008, J CLIN PATHOL, V61, P1254, DOI 10.1136/jcp.2008.055236; Roomi MW, 2009, ONCOL REP, V21, P821, DOI 10.3892/or_00000290; Saso J, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094698; Schwartz MA, 2000, TRENDS BIOCHEM SCI, V25, P388, DOI 10.1016/S0968-0004(00)01605-4; Shah PP, 2012, ONCOGENE, V31, P3124, DOI 10.1038/onc.2011.488; Shields SK, 2007, ENDOCRINOLOGY, V148, P4906, DOI 10.1210/en.2007-0476; Spessotto P, 2006, J CELL SCI, V119, P4574, DOI 10.1242/jcs.03232; Staun-Ram Elsebeth, 2004, Reprod Biol Endocrinol, V2, P59, DOI 10.1186/1477-7827-2-59; Takao T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021990; Tong YG, 2009, J MOL ENDOCRINOL, V43, P179, DOI 10.1677/JME-08-0176; Vogelsgesang M, 2007, N-S ARCH PHARMACOL, V374, P347, DOI 10.1007/s00210-006-0113-y; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Wondergem B, 2012, CANCER RES, V72, P4361, DOI 10.1158/0008-5472.CAN-11-2330; Zhang J, 2002, MOL HUM REPROD, V8, P659, DOI 10.1093/molehr/8.7.659; Zhang J, 2010, ONCOL REP, V24, P1217, DOI 10.3892/or_00000975; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	50	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149371	10.1371/journal.pone.0149371	http://dx.doi.org/10.1371/journal.pone.0149371			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900962	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100065
J	Rantasalo, A; Czeizler, E; Virtanenl, R; Rousu, J; Landesmaki, H; Penttila, M; Jantti, J; Mojzita, D				Rantasalo, Anssi; Czeizler, Elena; Virtanenl, Riitta; Rousu, Juho; Landesmaki, Harri; Penttila, Merja; Jantti, Jussi; Mojzita, Dominik			Synthetic Transcription Amplifier System for Orthogonal Control of Gene Expression in Saccharomyces cerevisiae	PLOS ONE			English	Article							LEXA REPRESSOR; DNA-BINDING; CIRCUIT-DESIGN; IN-VIVO; YEAST; PROMOTER; BIOLOGY; SEQUENCE; PROTEIN; SPECIFICITY	This work describes the development and characterization of a modular synthetic expression system that provides a broad range of adjustable and predictable expression levels in S. cerevisiae. The system works as a fixed-gain transcription amplifier, where the input signal is transferred via a synthetic transcription factor (sTF) onto a synthetic promoter, containing a defined core promoter, generating a transcription output signal. The system activation is based on the bacterial LexA-DNA-binding domain, a set of modified, modular LexA-binding sites and a selection of transcription activation domains. We show both experimentally and computationally that the tuning of the system is achieved through the selection of three separate modules, each of which enables an adjustable output signal: 1) the transcription-activation domain of the sTF, 2) the binding-site modules in the output promoter, and 3) the core promoter modules which define the transcription initiation site in the output promoter. The system has a novel bidirectional architecture that enables generation of compact, yet versatile expression modules for multiple genes with highly diversified expression levels ranging from negligible to very strong using one synthetic transcription factor. In contrast to most existing modular gene expression regulation systems, the present system is independent from externally added compounds. Furthermore, the established system was minimally affected by the several tested growth conditions. These features suggest that it can be highly useful in large scale biotechnology applications.	[Rantasalo, Anssi; Virtanenl, Riitta; Penttila, Merja; Jantti, Jussi; Mojzita, Dominik] VTT Tech Res Ctr Finland, POB 1000, FI-02044 Espoo, Finland; [Landesmaki, Harri] Aalto Univ, Dept Comp Sci, POB 15400, FI-00076 Espoo, Finland; [Czeizler, Elena; Rousu, Juho] Aalto Univ, Dept Comp Sci, HIIT, POB 15400, FI-00076 Espoo, Finland	VTT Technical Research Center Finland; Aalto University; Aalto University	Mojzita, D (corresponding author), VTT Tech Res Ctr Finland, POB 1000, FI-02044 Espoo, Finland.	dominik.mojzita@vtt.fi	Penttilä, Merja E/A-4710-2013; Rousu, Juho/E-8195-2012	Rousu, Juho/0000-0002-0705-4314; Mojzita, Dominik/0000-0001-6078-4503; Penttila, Merja/0000-0002-6929-1032; Czeizler, Elena/0000-0003-4250-3979	Academy of Finland [SA-Modubio - 260957]; TEKES [40128/14]	Academy of Finland(Academy of Finland); TEKES(Finnish Funding Agency for Technology & Innovation (TEKES))	Funding provided by Academy of Finland (www.aka.fi) grant SA-Modubio - 260957 and TEKES (www.tekes.fi) grant Living Factories/LiF - 40128/14.	Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; [Anonymous], 2011, BIO PROTOCOL BIO, V101, pe24; Babiskin AH, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.4; Belli G, 1998, NUCLEIC ACIDS RES, V26, P942, DOI 10.1093/nar/26.4.942; BITTER GA, 1991, MOL GEN GENET, V231, P22, DOI 10.1007/BF00293817; Blount BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033279; Brophy JAN, 2014, NAT METHODS, V11, P508, DOI [10.1038/NMETH.2926, 10.1038/nmeth.2926]; Cardinale S, 2012, BIOTECHNOL J, V7, P856, DOI 10.1002/biot.201200085; Chelliah V, 2015, NUCLEIC ACIDS RES, V43, pD542, DOI 10.1093/nar/gku1181; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; Curran KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5002; Curran KA, 2013, METAB ENG, V19, P88, DOI 10.1016/j.ymben.2013.07.001; Da Silva NA, 2011, FEMS YEAST RES; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5820; Frolova E, 1999, NUCLEIC ACIDS RES, V27, P1350, DOI 10.1093/nar/27.5.1350; GILBERT DM, 1993, MOL CELL BIOL, V13, P462, DOI 10.1128/MCB.13.1.462; GINIGER E, 1985, CELL, V40, P767, DOI 10.1016/0092-8674(85)90336-8; Guldberg CM, 1879, ERDMANNS J PRAKTISCH, V19, P69; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; HUIE MA, 1992, MOL CELL BIOL, V12, P2690, DOI 10.1128/MCB.12.6.2690; Ito Y, 2015, ACS SYNTH BIOL, V4, P12, DOI 10.1021/sb500096y; Jensen MK, 2014, FEMS YEAST RES; Khalil AS, 2012, CELL, V150, P647, DOI 10.1016/j.cell.2012.05.045; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Liang J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1293; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Little MP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008915; Mazumder M, 2014, NUCLEIC ACIDS RES, V42, P9514, DOI 10.1093/nar/gku651; McIsaac RS, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1402; McIsaac RS, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1313; Mojzita D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-763; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nevoigt E, 2006, APPL ENVIRON MICROB, V72, P5266, DOI 10.1128/AEM.00530-06; Nielsen AAK, 2013, CURR OPIN CHEM BIOL, V17, P878, DOI 10.1016/j.cbpa.2013.10.003; Ottoz DSM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku616; Partow S, 2010, YEAST, V27, P955, DOI 10.1002/yea.1806; Relan NK, 1997, BIOCHEMISTRY-US, V36, P1077, DOI 10.1021/bi9618427; RUDEN DM, 1988, P NATL ACAD SCI USA, V85, P4262, DOI 10.1073/pnas.85.12.4262; SCHNARR M, 1991, BIOCHIMIE, V73, P423, DOI 10.1016/0300-9084(91)90109-E; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Valkonen M, 2013, APPL ENV MICROBIOL; Waage P., 1864, STUDIES CONCERNING A, P35; Wang BJ, 2014, NUCLEIC ACIDS RES, V42, P9484, DOI 10.1093/nar/gku593; Wang BJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1516; WERTMAN KF, 1985, J BACTERIOL, V163, P376, DOI 10.1128/JB.163.1.376-384.1985	47	22	23	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148320	10.1371/journal.pone.0148320	http://dx.doi.org/10.1371/journal.pone.0148320			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901642	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100016
J	Sharma, G; Narwani, T; Subramanian, S				Sharma, Gaurav; Narwani, Tarun; Subramanian, Srikrishna			Complete Genome Sequence and Comparative Genomics of a Novel Myxobacterium Myxococcus hansupus	PLOS ONE			English	Article							GLIDING MOTILITY; GENE DUPLICATION; ANNOTATION; EVOLUTION; DATABASE; TREE	Myxobacteria, a group of Gram-negative aerobes, belong to the class delta-proteobacteria and order Myxococcales. Unlike anaerobic delta-proteobacteria, they exhibit several unusual physiogenomic properties like gliding motility, desiccation-resistant myxospores and large genomes with high coding density. Here we report a 9.5 Mbp complete genome of Myxococcus hansupus that encodes 7,753 proteins. Phylogenomic and genome-genome distance based analysis suggest that Myxococcus hansupus is a novel member of the genus Myxococcus. Comparative genome analysis with other members of the genus Myxococcus was performed to explore their genome diversity. The variation in number of unique proteins observed across different species is suggestive of diversity at the genus level while the overrepresentation of several Pfam families indicates the extent and mode of genome expansion as compared to non-Myxococcales delta-proteobacteria.	[Sharma, Gaurav; Narwani, Tarun; Subramanian, Srikrishna] CSIR Inst Microbial Technol, Sect 39A, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Subramanian, S (corresponding author), CSIR Inst Microbial Technol, Sect 39A, Chandigarh, India.	krishna@imtech.res.in	Sharma, Gaurav/H-8483-2019; subramanian, srikrishna/N-3018-2019; Narwani, Tarun Jairaj/U-7818-2019	Sharma, Gaurav/0000-0002-2861-7446; subramanian, srikrishna/0000-0002-3263-1048; Narwani, Tarun Jairaj/0000-0002-8560-9880	project "Expansion and modernization of Microbial Type Culture Collection and Gene Bank (MTCC)"; Council of Scientific and Industrial Research (CSIR) [BSC0402]; Department of Biotechnology (DBT) Govt. of India [BT/PR7368/INF/22/177/2012]; CSIR [GENESIS-CSIR-BSC-0121]; CSIR network program [GENESIS-CSIR-BSC-0121]	project "Expansion and modernization of Microbial Type Culture Collection and Gene Bank (MTCC)"; Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT) Govt. of India(Department of Biotechnology (DBT) India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); CSIR network program	This work is supported by a project "Expansion and modernization of Microbial Type Culture Collection and Gene Bank (MTCC) jointly supported by Council of Scientific and Industrial Research (CSIR) Grant No. BSC0402 and Department of Biotechnology (DBT) Govt. of India Grant No. BT/PR7368/INF/22/177/2012". GS acknowledges CSIR for research fellowship. TN is supported by the CSIR network program GENESIS-CSIR-BSC-0121.; This work is supported by a project "Expansion and modernization of Microbial Type Culture Collection and Gene Bank (MTCC) jointly supported by Council of Scientific and Industrial Research (CSIR) Grant No. BSC0402 and Department of Biotechnology (DBT) Govt. of India Grant No. BT/PR7368/INF/22/177/2012". GS acknowledges CSIR for research fellowship. TN is supported by the CSIR network program GENESIS-CSIR-BSC-0121. We also thank Dr. Ramya TNC for providing us workspace and guidance in myxobacterial culturing. We thank the Genome Quebec Innovation Center, McGill University, Canada for help in obtaining Pac-Bio sequencing data. We also thank CSIR-IMTECH Electron Microscopy facility for SEM data.	Aggarwal G, 2002, J BIOSCIENCES, V27, P7, DOI 10.1007/BF02703679; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Auch AF, 2010, DIGITAL DNA DNA HYBR; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berleman JE, 2009, FEMS MICROBIOL REV, V33, P942, DOI 10.1111/j.1574-6976.2009.00185.x; Bratlie MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-588; Brenner DJ KN, 2005, BERGEYS MANUAL SYSTE; Chaudhuri RR, 2006, NUCLEIC ACIDS RES, V34, pD335, DOI 10.1093/nar/gkj140; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Gao F, 2007, BIOINFORMATICS, V23, P1866, DOI 10.1093/bioinformatics/btm255; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; Goldman B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001329; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02101; Huntley S, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00100-13; Huntley S, 2011, MOL BIOL EVOL, V28, P1083, DOI 10.1093/molbev/msq292; Kaiser D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000380; Kondrashov FA, 2012, P ROY SOC B-BIOL SCI, V279, P5048, DOI 10.1098/rspb.2012.1108; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lang E, 2009, INT J SYST EVOL MICR, V59, P2122, DOI 10.1099/ijs.0.003566-0; Lang E, 2008, INT J SYST EVOL MICR, V58, P2607, DOI 10.1099/ijs.0.2008/001859-0; Lapierrel P, 2009, TRENDS GENET, V25, P107, DOI 10.1016/j.tig.2008.12.004; Lechner M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-124; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li ZF, 2011, J BACTERIOL, V193, P5015, DOI 10.1128/JB.05516-11; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mauriello EMF, 2010, MICROBIOL MOL BIOL R, V74, P229, DOI 10.1128/MMBR.00043-09; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Miyashita M, 2008, FEMS MICROBIOL LETT, V282, P241, DOI 10.1111/j.1574-6968.2008.01127.x; Muller S, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00217-13; Muller S, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00392-13; Nan B, 2011, ANNU REV GENET, V45, P21, DOI 10.1146/annurev-genet-110410-132547; Richardson EJ, 2013, BRIEF BIOINFORM, V14, P1, DOI 10.1093/bib/bbs007; Roberts RJ, 2015, NUCLEIC ACIDS RES, V43, pD298, DOI 10.1093/nar/gku1046; Sanford RA, 2002, APPL ENVIRON MICROB, V68, P893, DOI 10.1128/AEM.68.2.893-900.2002; Schneiker S, 2007, NAT BIOTECHNOL, V25, P1281, DOI 10.1038/nbt1354; Serres MH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-46; SHIMKETS LJ, 1990, MICROBIOL REV, V54, P473, DOI 10.1128/MMBR.54.4.473-501.1990; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thaxter R, 1904, BOT GAZ, V37, P0405, DOI 10.1086/328505; Velicer GJ, 2009, ANNU REV MICROBIOL, V63, P599, DOI 10.1146/annurev.micro.091208.073158; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029149; Whitworth DE, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P1; Wolgemuth C, 2002, CURR BIOL, V12, P369, DOI 10.1016/S0960-9822(02)00716-9; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151; Wu YL, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/5/055003; Zusman DR, 2007, NAT REV MICROBIOL, V5, P862, DOI 10.1038/nrmicro1770	53	18	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148593	10.1371/journal.pone.0148593	http://dx.doi.org/10.1371/journal.pone.0148593			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900859	Green Submitted, Green Published, gold			2022-12-27	WOS:000371276100020
J	Ucchesu, M; Orru, M; Grillo, O; Venora, G; Paglietti, G; Ardu, A; Bacchetta, G				Ucchesu, Mariano; Orru, Martino; Grillo, Oscar; Venora, Gianfranco; Paglietti, Giacomo; Ardu, Andrea; Bacchetta, Gianluigi			Predictive Method for Correct Identification of Archaeological Charred Grape Seeds: Support for Advances in Knowledge of Grape Domestication Process	PLOS ONE			English	Article							IMAGE-ANALYSIS; VITIS-VINIFERA; ANOXIC CONDITIONS; COMPUTER VISION; PLANT REMAINS; WILD; L.; LANDRACES; SHAPES; EXPLOITATION	The identification of archaeological charred grape seeds is a difficult task due to the alteration of the morphological seeds shape. In archaeobotanical studies, for the correct discrimination between Vitis vinifera subsp. sylvestris and Vitis vinifera subsp. vinifera grape seeds it is very important to understand the history and origin of the domesticated grapevine. In this work, different carbonisation experiments were carried out using a hearth to reproduce the same burning conditions that occurred in archaeological contexts. In addition, several carbonisation trials on modern wild and cultivated grape seeds were performed using a muffle furnace. For comparison with archaeological materials, modern grape seed samples were obtained using seven different temperatures of carbonisation ranging between 180 and 340 degrees C for 120 min. Analysing the grape seed size and shape by computer vision techniques, and applying the stepwise linear discriminant analysis (LDA) method, discrimination of the wild from the cultivated charred grape seeds was possible. An overall correct classification of 93.3% was achieved. Applying the same statistical procedure to compare modern charred with archaeological grape seeds, found in Sardinia and dating back to the Early Bronze Age (2017-1751 2s cal. BC), allowed 75.0% of the cases to be identified as wild grape. The proposed method proved to be a useful and effective procedure in identifying, with high accuracy, the charred grape seeds found in archaeological sites. Moreover, it may be considered valid support for advances in the knowledge and comprehension of viticulture adoption and the grape domestication process. The same methodology may also be successful when applied to other plant remains, and provide important information about the history of domesticated plants.	[Ucchesu, Mariano; Orru, Martino; Grillo, Oscar; Bacchetta, Gianluigi] Univ Cagliari, CCB, Dipartimento Sci Vita & Ambiente DISVA, Vle S Ignazio da Laconi 11-13, I-09123 Cagliari, Italy; [Grillo, Oscar; Paglietti, Giacomo] Univ Cagliari, Dipartimento Storia Beni Culturali & Terr, Sez Archeol, Piazza Arsenale 1, I-09124 Cagliari, Italy; [Grillo, Oscar; Venora, Gianfranco] Stn Consorziale Sperimentale Granicoltura Sicilia, Via Sirio 1, I-95041 Borgo San Pietro Caltagi, CT, Italy; [Ardu, Andrea] Univ Cagliari, Dipartimento Sci Chim & Geol, Cittadella Univ,SP Monserrato Sestu Km 0-7, Monserrato, Italy	University of Cagliari; University of Cagliari; University of Cagliari	Ucchesu, M (corresponding author), Univ Cagliari, CCB, Dipartimento Sci Vita & Ambiente DISVA, Vle S Ignazio da Laconi 11-13, I-09123 Cagliari, Italy.	marianoucchesu_@gmail.com	Bacchetta, Gianluigi/AAD-5329-2020	Orru, Martino/0000-0002-5149-5491; BACCHETTA, GIANLUIGI/0000-0002-1714-3978; UCCHESU, Mariano/0000-0002-1587-9842	Regione Autonoma Sardegna [CRP-78809, CUPF2I1500067002]	Regione Autonoma Sardegna(Regione Sardegna)	This research has been supported by the Regione Autonoma Sardegna, project (Analisi morfocolorimetrica, ecofisiologica e omica di Vitis vinifera e Vitis sylvestris in Sardegna) funds on the basis of the Legge Regionale 7 agosto 2007, (L.7 Grant Agreement no. CRP-78809, CUPF2I1500067002).	Bacchetta G., 2008, CONSERVACION EX SITU; Bacchetta G., 2006, GUINEANA, V12, P1; Bouby L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063195; Braadbaart F, 2005, VEG HIST ARCHAEOBOT, V14, P67, DOI 10.1007/s00334-004-0050-y; Braadbaart F, 2005, ARCHAEOMETRY, V47, P103, DOI 10.1111/j.1475-4754.2005.00190.x; Braadbaart F, 2004, J THERM ANAL CALORIM, V77, P957, DOI 10.1023/B:JTAN.0000041672.45140.e9; Braadbaart F, 2004, CARBONISATION PEAS W; Braadbaart F, 2007, ECON BOT, V61, P137, DOI 10.1663/0013-0001(2007)61[137:CIMADO]2.0.CO;2; Braadbaart F, 2008, VEG HIST ARCHAEOBOT, V17, P155, DOI 10.1007/s00334-007-0134-6; Buosi C, 2015, ARCHAEOMETRY, V57, P212, DOI 10.1111/arcm.12132; Castelletti L, 1996, 13 INT C PREH PROT S, P11; Duda RO, 2001, PATTERN CLASSIFICATI, V2nd, P20; Fukunaga K., 2013, INTRO STAT PATTERN R; Grillo O, 2011, SEED SCI TECHNOL, V39, P490, DOI 10.15258/sst.2011.39.2.20; Haruta O, 2011, ANN FOR RES, V54, P99; Hastie T, 2013, ELEMENTS STAT LEARNI; Hastorf C. A., 1988, CURRENT PALEOETHNOBO; HILLMAN G, 1993, WORLD ARCHAEOL, V25, P94, DOI 10.1080/00438243.1993.9980230; Hillman G.C., 1996, J ASS ENV ARCHAEOL, V12, P195; Hillman GC., 1981, FARMING PRACTICE BRI, P123; Holden JE, 2011, EDUC PSYCHOL MEAS, V71, P870, DOI 10.1177/0013164411398357; HOPF M., 1955, BER DEUTSCH BOT GES, V68, P191; Iwata H, 2002, J HERED, V93, P384, DOI 10.1093/jhered/93.5.384; Iwata H, 2010, MOL BREEDING, V25, P203, DOI 10.1007/s11032-009-9319-2; Jacomet S., 1999, ARCHAOBOTANIK AUFGAB; Jacquat C, 1999, VEG HIST ARCHAEOBOT, V8, P25, DOI 10.1007/BF02042839; Jones GEM., 1996, CIRCAEA, V12, P177; Jones Glynis, 1984, PLANTS ANCIENT MAN S, P43; Kawabata S, 2009, SCI HORTIC-AMSTERDAM, V121, P206, DOI 10.1016/j.scienta.2009.01.024; Kilic K, 2007, J FOOD ENG, V78, P897, DOI 10.1016/j.jfoodeng.2005.11.030; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; Kuhn M., 2013, APPL PREDICTIVE MODE, P275, DOI DOI 10.1007/978-1-4614-6849-3_12; Landini Gabriel, 2006, Head Face Med, V2, P4, DOI 10.1186/1746-160X-2-4; Logothetis B, 1974, CONTRIBUTION VINE WI, V17, P5; Logothetis B, 1970, DEV VINE VITICULTURE, V13, P167; Lootens P, 2007, COMPUT ELECTRON AGR, V58, P164, DOI 10.1016/j.compag.2007.03.014; Mangafa M, 1996, J ARCHAEOL SCI, V23, P409, DOI 10.1006/jasc.1996.0036; McGovern PE, 1995, ORIGINS ANCIENT HIST; MCGOVERN PE, 1997, EXPEDITION, V39, P3; NUNEZ DR, 1989, REV PALAEOBOT PALYNO, V61, P205, DOI 10.1016/0034-6667(89)90033-X; Olmo HP, 1995, ORIGINS ANCIENT HIST, P31; Orru M, 2013, VEG HIST ARCHAEOBOT, V22, P231, DOI 10.1007/s00334-012-0362-2; Orru M, 2012, CR BIOL, V335, P602, DOI 10.1016/j.crvi.2012.08.002; Pagnoux C, 2014, VEG HIST ARCHAEOBOT, V24, P1; Pearsall D, 2016, PALEOETHNOBOTANY HDB; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; Rencher A.C., 2012, METHODS MULTIVARIATE, DOI DOI 10.1002/9781118391686; Renfrew A.C., 1972, EMERGENCE CIVILISATI; SMITH H, 1990, J ARCHAEOL SCI, V17, P317, DOI 10.1016/0305-4403(90)90026-2; SPSS, 2006, APPL GUID; Stummer A, 1911, MITTEILUNGEN ANTHR G, V61, P283; Sugiyama M, 2007, J MACH LEARN RES, V8, P1027; Tanda G, 2012, ATT 44 RIUN SCI PREI, P635; Terral JF, 2010, ANN BOT-LONDON, V105, P443, DOI 10.1093/aob/mcp298; Ucchesu M, 2015, VEG HIST ARCHAEOBOT, V24, P587, DOI 10.1007/s00334-014-0512-9; Ucchesu M, 2015, VEG HIST ARCHAEOBOT, V24, P343, DOI 10.1007/s00334-014-0470-2; Valamoti SM, 2007, ANTIQUITY, V81, P54, DOI 10.1017/S0003598X00094837; Valamoti SM, 2015, VEG HIST ARCHAEOBOT, V24, P35, DOI 10.1007/s00334-014-0487-6; van der Veen M, 2007, J ARCHAEOL SCI, V34, P968, DOI 10.1016/j.jas.2006.09.007; Venora G, 2007, AGROCHIMICA, V51, P254; Venora G, 2007, FOOD RES INT, V40, P161, DOI 10.1016/j.foodres.2006.09.001; Venora G, 2009, J CEREAL SCI, V49, P429, DOI 10.1016/j.jcs.2008.12.006; Venora G, 2009, SCI HORTIC-AMSTERDAM, V121, P410, DOI 10.1016/j.scienta.2009.03.014; Willcox G, 2005, VEG HIST ARCHAEOBOT, V14, P534, DOI 10.1007/s00334-005-0075-x; Willcox G., 2007, ORIGINS SPREAD DOMES, P21; Wright P, 2003, J ARCHAEOL SCI, V30, P577, DOI 10.1016/S0305-4403(02)00203-0; YOSHIOKA Y, 2004, ANN BOT, V94, P1, DOI 10.1093/aoblmch190.; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001; ZOHARY D, 1975, SCIENCE, V187, P319, DOI 10.1126/science.187.4174.319; ZOHARY D, 1995, ORIGINS ANCIENT HIST, P23	71	37	38	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149814	10.1371/journal.pone.0149814	http://dx.doi.org/10.1371/journal.pone.0149814			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901361	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100156
J	Yan, L; Qu, S; Liu, G; Liu, L; Yu, Y; Ding, GH; Zhao, YF; Li, YX; Xie, YH; Zhang, JQ; Qu, D				Yan, Liang; Qu, Su; Liu, Gang; Liu, Lei; Yu, Yao; Ding, Guohui; Zhao, Yanfeng; Li, Yixue; Xie, Youhua; Zhang, Junqi; Qu, Di			Comparative Transcriptomic Analysis of Primary Duck Hepatocytes Provides Insight into Differential Susceptibility to DHBV Infection	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; ENTRY; DIMETHYLSULFOXIDE; REPLICATION	Primary duck hepatocytes (PDH) displays differential susceptibility to duck hepatitis B virus when maintained in the media supplemented with fetal bovine serum or dimethyl sulfoxide (DMSO) which has been widely used for the maintenance of hepatocytes, and prolonging susceptibility to hepadnavirus. However the mechanism underlying maintenance of susceptibility to hepadnavirus by DMSO treatment remains unclear. In this study, a global transcriptome analysis of PDHs under different culture conditions was conducted for investigating the effects of DMSO on maintenance of susceptibility of PDH to DHBV in vitro. The 384 differential expressed genes (DEGs) were identified by comparisons between each library pair (PDHs cultured with or without DMSO or fresh isolated PDH). We analyzed canonical pathways in which the DEGs were enriched in Hepatic Fibrosis / Hepatic Stellate Cell Activation, Bile Acid Biosynthesis and Tight Junction signaling. After re-annotation against human genome data, the 384 DEGs were pooled together with proteins belonging to hepatitis B pathway to construct a protein-protein interaction network. The combination of decreased expression of liver-specific genes (CYP3A4, CYP1E1, CFI, RELN and GSTA1 et al) with increased expression of hepatocyte-dedifferentiation-associated genes (PLA2G4A and PLCG1) suggested that in vitro culture conditions results in the fading of hepatocyte phenotype in PDHs. The expression of seven DEGs associated with tight junction formation (JAM3, PPP2R2B, PRKAR1B, PPP2R2C, MAGI2, ACTA2 and ACTG2) was up-regulated after short-term culture in vitro, which was attenuated in the presence of DMSO. Those results could shed light on DHBV infection associated molecular events affected by DMSO.	[Yan, Liang; Qu, Su; Xie, Youhua; Zhang, Junqi; Qu, Di] Fudan Univ, Key Lab Med Mol Virol, Minist Educ & Hlth, Sch Basic Med Sci, Shanghai 200433, Peoples R China; [Qu, Su] Fudan Univ, Dept Biochem & Mol Biol, Sch Basic Med Sci, Shanghai 200433, Peoples R China; [Liu, Gang; Liu, Lei; Yu, Yao; Ding, Guohui; Li, Yixue] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Zhao, Yanfeng] Nanjing Med Univ, Affiliated Hosp 2, Dept Lab Med, Nanjing, Jiangsu, Peoples R China	Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nanjing Medical University	Xie, YH; Zhang, JQ; Qu, D (corresponding author), Fudan Univ, Key Lab Med Mol Virol, Minist Educ & Hlth, Sch Basic Med Sci, Shanghai 200433, Peoples R China.	yhxie@fudan.edu.cn; junqizhang@fudan.edu.cn; dqu@shmu.edu.cn	Qu, Di/AAO-4590-2020; Yan, Liang/AAF-6382-2022; Yan, Liang/AFE-8595-2022	Yan, Liang/0000-0002-3002-5431; Yan, Liang/0000-0002-3002-5431	National Key Project for Infectious Diseases [2012ZX10002002, 2012ZX10003008-010, 2012ZX10002-006, 2012ZX10002012-003]; National Basic Research Program [2012CB519002]; Key Project Supported by Medical Science and Technology Development Foundation, Nanjing Department of Health [YKK12198]	National Key Project for Infectious Diseases; National Basic Research Program(National Basic Research Program of China); Key Project Supported by Medical Science and Technology Development Foundation, Nanjing Department of Health	This work was supported by grants from the National Key Project for Infectious Diseases (2012ZX10002002; 2012ZX10003008-010, 2012ZX10002-006, 2012ZX10002012-003, http://www.nmp.gov.cn), National Basic Research Program (2012CB519002) and Key Project Supported by Medical Science and Technology Development Foundation, Nanjing Department of Health (YKK12198).	CONDREAY LD, 1990, J VIROL, V64, P3249, DOI 10.1128/JVI.64.7.3249-3258.1990; EZZELL RM, 1993, EXP CELL RES, V208, P442, DOI 10.1006/excr.1993.1266; Funk A, 2004, J VIROL, V78, P8289, DOI 10.1128/jvi.78.15.8289-8300.2004; Funk A, 2006, HEPATOLOGY, V44, P685, DOI 10.1002/hep.21297; GRIPON P, 1988, J VIROL, V62, P4136, DOI 10.1128/JVI.62.11.4136-4143.1988; KOST DP, 1991, J CELL PHYSIOL, V147, P274, DOI 10.1002/jcp.1041470212; Lavanchy D, 2005, J CLIN VIROL, V34, pS1, DOI 10.1016/S1386-6532(05)00384-7; Li J, 2004, J VIROL, V78, P1873, DOI 10.1128/JVI.78.4.1873-1881.2004; Li JS, 1999, J BIOL CHEM, V274, P27658, DOI 10.1074/jbc.274.39.27658; Locarnini S, 2013, HEPATOLOGY; LUSTBADER ED, 1983, SCIENCE, V220, P423, DOI 10.1126/science.6301008; PUGH JC, 1995, J VIROL, V69, P4814, DOI 10.1128/JVI.69.8.4814-4822.1995; PUGH JC, 1989, VIROLOGY, V172, P564, DOI 10.1016/0042-6822(89)90199-2; Qiao M, 1999, J GEN VIROL, V80, P2127, DOI 10.1099/0022-1317-80-8-2127; Schulze A, 2012, HEPATOLOGY, V55, P373, DOI 10.1002/hep.24707; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; Tohidi-Esfahani R, 2010, J GEN VIROL, V91, P509, DOI 10.1099/vir.0.015529-0; Tong YP, 2010, J VIROL, V84, P4569, DOI 10.1128/JVI.02281-09; TUTTLEMAN JS, 1986, J VIROL, V58, P17, DOI 10.1128/JVI.58.1.17-25.1986; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Zhao YF, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-28	21	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149702	10.1371/journal.pone.0149702	http://dx.doi.org/10.1371/journal.pone.0149702			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900848	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100130
J	Al-Tobasei, R; Paneru, B; Salem, M				Al-Tobasei, Rafet; Paneru, Bam; Salem, Mohamed			Genome-Wide Discovery of Long Non-Coding RNAs in Rainbow Trout	PLOS ONE			English	Article							INTEGRATIVE ANNOTATION; GENE-REGULATION; EXPRESSION; EVOLUTION; DATABASE; TRANSCRIPTION; REVEALS; POPULATIONS; REPRESSION; INSIGHTS	The ENCODE project revealed that similar to 70% of the human genome is transcribed. While only 1-2% of the RNAs encode for proteins, the rest are non-coding RNAs. Long non-coding RNAs (lncRNAs) form a diverse class of non-coding RNAs that are longer than 200nt. Emerging evidence indicates that lncRNAs play critical roles in various cellular processes including regulation of gene expression. LncRNAs show low levels of gene expression and sequence conservation, which make their computational identification in genomes difficult. In this study, more than two billion Illumina sequence reads were mapped to the genome reference using the TopHat and Cufflinks software. Transcripts shorter than 200nt, with more than 83-100 amino acids ORF, or with significant homologies to the NCBI nr-protein database were removed. In addition, a computational pipeline was used to filter the remaining transcripts based on a protein-coding-score test. Depending on the filtering stringency conditions, between 31,195 and 54,503 lncRNAs were identified, with only 421 matching known lncRNAs in other species. A digital gene expression atlas revealed 2,935 tissue-specific and 3,269 ubiquitously-expressed lncRNAs. This study annotates the lncRNA rainbow trout genome and provides a valuable resource for functional genomics research in salmonids.	[Al-Tobasei, Rafet; Salem, Mohamed] Middle Tennessee State Univ, Computat Sci Program, Murfreesboro, TN 37132 USA; [Paneru, Bam; Salem, Mohamed] Middle Tennessee State Univ, Dept Biol, Murfreesboro, TN 37132 USA; [Paneru, Bam; Salem, Mohamed] Middle Tennessee State Univ, Mol Biosci Program, Murfreesboro, TN 37132 USA	Middle Tennessee State University; Middle Tennessee State University; Middle Tennessee State University	Salem, M (corresponding author), Middle Tennessee State Univ, Computat Sci Program, Murfreesboro, TN 37132 USA.; Salem, M (corresponding author), Middle Tennessee State Univ, Dept Biol, Murfreesboro, TN 37132 USA.; Salem, M (corresponding author), Middle Tennessee State Univ, Mol Biosci Program, Murfreesboro, TN 37132 USA.	Mohamed.salem@mtsu.edu	Salem, Mohamed/AGB-2739-2022	Salem, Mohamed/0000-0003-2142-6716; Paneru, Bam/0000-0001-6589-8446; Al-Tobasei, Rafet/0000-0002-0578-0734	United States Department of Agriculture, National Institute of Food and Agriculture [2014-67015-21602]	United States Department of Agriculture, National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This study was supported by a competitive grant No. 2014-67015-21602 from the United States Department of Agriculture, National Institute of Food and Agriculture (MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Beaulieu YB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003078; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Bu DC, 2012, NUCLEIC ACIDS RES, V40, pD210, DOI 10.1093/nar/gkr1175; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Clark MB, 2013, ESSAYS BIOCHEM, V54, P1, DOI [10.1042/bse0540001, 10.1042/BSE0540001]; Davidson WS, 2012, MOL ECOL, V21, P219, DOI 10.1111/j.1365-294X.2011.05387.x; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dougan SK, 2011, MOL CELL BIOL, V31, P1145, DOI 10.1128/MCB.00967-10; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fox SE, 2014, MAR GENOM, V15, P13, DOI 10.1016/j.margen.2013.12.001; Giaquinto PC, 2008, BIOL RES, V41, P33, DOI [10.4067/S0716-97602008000100005, /S0716-97602008000100005]; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Ginger MR, 2006, P NATL ACAD SCI USA, V103, P5781, DOI 10.1073/pnas.0600745103; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Howe EA, 2011, BIOINFORMATICS, V27, P3209, DOI 10.1093/bioinformatics/btr490; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Kambara H, 2014, NUCLEIC ACIDS RES, V42, P10668, DOI 10.1093/nar/gku713; Kaushik K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083616; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li L, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r40; Louro R, 2009, GENOMICS, V93, P291, DOI 10.1016/j.ygeno.2008.11.009; Luo M, 2013, CANCER LETT, V333, P213, DOI 10.1016/j.canlet.2013.01.033; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; MCLAREN BA, 1947, FED PROC, V6, P413; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Narum SR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1246-5; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Papanastasiou AD, 2007, MOL IMMUNOL, V44, P1300, DOI 10.1016/j.molimm.2006.05.014; Patel M, 2006, AQUAT TOXICOL, V80, P362, DOI 10.1016/j.aquatox.2006.09.012; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Petrov AI, 2015, NUCLEIC ACIDS RES, V43, pD123, DOI 10.1093/nar/gku991; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quek XC, 2015, NUCLEIC ACIDS RES, V43, pD168, DOI 10.1093/nar/gku988; Ravasi T, 2006, GENOME RES, V16, P11, DOI 10.1101/gr.4200206; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Salem M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121778; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Schmitz KM, 2010, GENE DEV, V24, P2264, DOI 10.1101/gad.590910; Speare DJ, 1998, CONTEMP TOP LAB ANIM, V37, P55; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tripathi V, 2012, MOL BIOL CELL, V23, P3694, DOI 10.1091/mbc.E12-03-0206; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Van Peer G, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau080; Villegas VE, 2015, INT J MOL SCI, V16, P3251, DOI 10.3390/ijms16023251; Welsh PG, 2008, ECOTOX ENVIRON SAFE, V69, P199, DOI 10.1016/j.ecoenv.2007.04.003; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Williams DE, 2012, COMP BIOCHEM PHYS C, V155, P121, DOI 10.1016/j.cbpc.2011.05.013; Wuyts J, 2002, NUCLEIC ACIDS RES, V30, P183, DOI 10.1093/nar/30.1.183; Xie CY, 2014, NUCLEIC ACIDS RES, V42, pD98, DOI 10.1093/nar/gkt1222; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yin QF, 2012, MOL CELL, V48, P219, DOI 10.1016/j.molcel.2012.07.033; Yoon JH, 2013, J MOL BIOL, V425, P3723, DOI 10.1016/j.jmb.2012.11.024; Zhang KS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-845; Zhu QH, 2012, GENES-BASEL, V3, P176, DOI 10.3390/genes3010176; Zong XY, 2011, RNA BIOL, V8, P968, DOI 10.4161/rna.8.6.17606	76	62	63	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148940	10.1371/journal.pone.0148940	http://dx.doi.org/10.1371/journal.pone.0148940			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895175	Green Published, gold			2022-12-27	WOS:000371223400027
J	Ayuob, N; ElBeshbeishy, R				Ayuob, Nasra; ElBeshbeishy, Rana			Impact of an Energy Drink on the Structure of Stomach and Pancreas of Albino Rat: Can Omega-3 Provide a Protection?	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; BETA-CELL FUNCTION; INSULIN-RESISTANCE; CAFFEINE; GLUCOSE; FISH	Background and Objectives A controversy developed between the benefits of energy drinks (EDs) versus the possible health threats since its revolution. Lack of information was a call to assess the effect of chronic consumption of Power Horse (PH) as one of the EDs, on the structure of pancreas and fundic mucosa of stomach in rats, and possible protective role of Omega-3. Materials and Methods Thirty two adult male albino rats were divided equally into 4 groups; control received group which only received a standard diet, Omega-3 group, PH group which given PH and PH plus Omega-3 group received both PH plus Omega-3 for 4 weeks. Biochemical assessment of blood glucose, serum insulin, gastrin, tumor necrosis factor alpha (TNF-alpha) and inducible nitric oxide synthetase (iNOS) was performed. The antioxidant activity and histopathological examination of both pancreatic tissue and fundic mucosa of stomach were assessed. Results Administration of PH significantly increased serum insulin and glucose levels while it significantly reduced serum gastrin level compared to control. PH also caused oxidants/antioxidants imbalance in both pancreas and fundic mucosa. The latter revealed degenerative changes and increased apoptosis which was evident by increased caspase-3 immunoexpression. Pancreas exhibited signs of beta-cells overstimulation. Fundic mucosa showed reduced number of parietal cells, gastrin hormone expression compared to control group. Omega-3 administration could alleviate, to some extent, these changes. It significantly decreased TNF-alpha, iNOS and reduced glutathione (GSH) as well as significantly increasing superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities compared to the group which received PH alone. Conclusion Power Horse intake significantly injures islet cells, pancreatic acini as well as the glandular cells of the fundic mucosa. Omega-3 decreases these detrimental effects mostly through its antioxidant and anti-inflammatory action.	[Ayuob, Nasra; ElBeshbeishy, Rana] King Abdulaziz Univ, Fac Med, Dept Anat, Jeddah 21413, Saudi Arabia; [Ayuob, Nasra] Mansoura Univ, Fac Med, Dept Histol, Mansoura, Egypt; [ElBeshbeishy, Rana] Ain Shams Univ, Fac Med, Dept Anat, Cairo, Egypt	King Abdulaziz University; Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian Knowledge Bank (EKB); Ain Shams University	Ayuob, N (corresponding author), King Abdulaziz Univ, Fac Med, Dept Anat, Jeddah 21413, Saudi Arabia.; Ayuob, N (corresponding author), Mansoura Univ, Fac Med, Dept Histol, Mansoura, Egypt.	nasraayuob@gmail.com	Ayuob, Nasra/D-2504-2012	Ayuob, Nasra/0000-0002-3369-2897	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [140-006-D1434]; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	This work was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant No. (140-006-D1434). The authors, therefore, acknowledge with thanks DSR technical and financial support.	Abd El-Haleem MR, 2013, EGYPTIAN J HISTOLOGY, V36, P60; Afifi N.M., 2012, EGYPT J HISTOL, V35, P458, DOI [10.1097/01.ehx.0000418062.59636.5b, DOI 10.1097/01.EHX.0000418062.59636.5B]; Akande I. S., 2011, Annual Review & Research in Biology, V1, P45; Amer MG., 2013, EGYPT J HISTOL, V36, P13, DOI [10.1097/01.EHX.0000425554.35720.27, DOI 10.1097/01.EHX.0000425554.35720.27]; Angerer P, 2000, CURR OPIN LIPIDOL, V11, P57, DOI 10.1097/00041433-200002000-00009; [Anonymous], 2001, 13 WEEK OR GAV UNPUB; Attila S, 2011, NUTRITION, V27, P316, DOI 10.1016/j.nut.2010.02.008; Bancroft JD, 2002, J NEUROPATH EXP NEUR, V5th; Belluzzi A, 2002, P NUTR SOC, V61, P391, DOI 10.1079/PNS2002171; Boekema PJ, 1999, SCAND J GASTROENTERO, V34, P35, DOI 10.1080/003655299750025525; Bouckenooghe T, 2006, CURR OPIN CLIN NUTR, V9, P728, DOI 10.1097/01.mco.0000247469.26414.55; Bronstein AC, 2008, CLIN TOXICOL, V46, P927, DOI 10.1080/15563650802559632; Calder PC, 2009, BIOCHIMIE, V91, P791, DOI 10.1016/j.biochi.2009.01.008; Chang AM, 2006, J CLIN ENDOCR METAB, V91, P3303, DOI 10.1210/jc.2006-0913; Chepkova AN, 2002, EUR J NEUROSCI, V16, P1523, DOI 10.1046/j.1460-9568.2002.02223.x; Clauson KA, 2008, J AM PHARM ASSOC, V48, pE55, DOI 10.1331/JAPhA.2008.07055; CRISAN M, 2013, ANN OF RSCB, V18, P118; Delarue J, 2004, REPROD NUTR DEV, V44, P289, DOI 10.1051/rnd:2004033; Dias TR, 2015, TOXICOLOGY, V328, P12, DOI 10.1016/j.tox.2014.12.003; Dworzanski Wojciech, 2009, Pol Merkur Lekarski, V27, P357; Ebuehi O A T, 2011, Nig Q J Hosp Med, V21, P29; Fetterman JW, 2009, AM J HEALTH-SYST PH, V66, P1169, DOI 10.2146/ajhp080411; Fredholm BB, 1999, PHARMACOL REV, V51, P83; Hamada E, 1997, BBA-MOL CELL RES, V1356, P198, DOI 10.1016/S0167-4889(96)00177-2; Heneman K, ANR PUBLICATION, V8265; HOLLANDER D, 1991, J CLIN GASTROENTEROL, V13, pS72, DOI 10.1097/00004836-199112001-00012; Kangwan N, 2014, CURR OPIN PHARMACOL, V19, P17, DOI 10.1016/j.coph.2014.06.003; Khayyat L., 2012, The Journal of American Science, V8, P688; Khayyat LI, 2014, J ENVIRON BIOL, V35, P883; Knip M, 2005, DIABETES, V54, pS125, DOI 10.2337/diabetes.54.suppl_2.S125; KOITER TR, 1995, PHYSIOL BEHAV, V57, P717, DOI 10.1016/0031-9384(94)00290-8; Kolnes AJ, 2010, ACTA PHYSIOL, V200, P65, DOI 10.1111/j.1748-1716.2010.02103.x; LINN T, 1989, DIABETES, V38, P1402, DOI 10.2337/diabetes.38.11.1402; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Milon H., 1988, COFFEE, V3, P81; Miyazaki R., 2010, AGING MED, V35, P26, DOI [10.3793/jaam.7.26, DOI 10.3793/JAAM.7.26]; Mubarak R., 2012, The Journal of American Science, V8, P366; Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Paget GE., 1964, EVALUATION DRUG ACT, P161; Ramos-Vara JA, 2008, J VET DIAGN INVEST, V20, P393, DOI 10.1177/104063870802000401; Sadowska J, 2012, ACTA SCI POLON-TECHN, V11, P311; SAYED SS, 2013, EGYPTIAN J HISTOLOGY, V36, P253, DOI DOI 10.1097/01.EHX.0000426051.01947.cb; Schubert ML, 2009, CURR OPIN GASTROEN, V25, P529, DOI 10.1097/MOG.0b013e328331b62a; Soliman NBE., 2010, EGYPT J HISTOL, V33, P620; Spite M, 2013, P NUTR SOC, V72, P441, DOI 10.1017/S0029665113003030; Starling S., 2008, ENERGY DRINKS SAFETY; Suresh Y, 2003, NUTRITION, V19, P213, DOI 10.1016/S0899-9007(02)00855-9; Thomson B, 2010, RISK PROFILE CAFFEIN; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x; Ward OP, 2005, PROCESS BIOCHEM, V40, P3627, DOI 10.1016/j.procbio.2005.02.020; Yu JH, 2009, ANN NY ACAD SCI, V1171, P359, DOI 10.1111/j.1749-6632.2009.04703.x; Zhou SS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-746	53	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149191	10.1371/journal.pone.0149191	http://dx.doi.org/10.1371/journal.pone.0149191			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894845	Green Published, Green Submitted, gold			2022-12-27	WOS:000371223400035
J	Delwig, A; Larsen, DD; Yasumura, D; Yang, CF; Shah, NM; Copenhagen, DR				Delwig, Anton; Larsen, DeLaine D.; Yasumura, Douglas; Yang, Cindy F.; Shah, Nirao M.; Copenhagen, David R.			Retinofugal Projections from Melanopsin-Expressing Retinal Ganglion Cells Revealed by Intraocular Injections of Cre-Dependent Virus	PLOS ONE			English	Article							NEURONS; LIGHT	To understand visual functions mediated by intrinsically photosensitive melanopsin-expressing retinal ganglion cells (mRGCs), it is important to elucidate axonal projections from these cells into the brain. Initial studies reported that melanopsin is expressed only in retinal ganglion cells within the eye. However, recent studies in Opn4-Cre mice revealed Cre-mediated marker expression in multiple brain areas. These discoveries complicate the use of melanopsin-driven genetic labeling techniques to identify retinofugal projections specifically from mRGCs. To restrict labeling to mRGCs, we developed a recombinant adenoassociated virus (AAV) carrying a Cre-dependent reporter (human placental alkaline phosphatase) that was injected into the vitreous of Opn4-Cre mouse eyes. The labeling observed in the brain of these mice was necessarily restricted specifically to retinofugal projections from mRGCs in the injected eye. We found that mRGCs innervate multiple nuclei in the basal forebrain, hypothalamus, amygdala, thalamus and midbrain. Midline structures tended to be bilaterally innervated, whereas the lateral structures received mostly contralateral innervation. As validation of our approach, we found projection patterns largely corresponded with previously published results; however, we have also identified a few novel targets. Our discovery of projections to the central amygdala suggests a possible direct neural pathway for aversive responses to light in neonates. In addition, projections to the accessory optic system suggest that mRGCs play a direct role in visual tracking, responses that were previously attributed to other classes of retinal ganglion cells. Moreover, projections to the zona incerta raise the possibility that mRGCs could regulate visceral and sensory functions. However, additional studies are needed to investigate the actual photosensitivity of mRGCs that project to the different brain areas. Also, there is a concern of "overlabeling" with very sensitive reporters that uncover low levels of expression. Light-evoked signaling from these cells must be shown to be of sufficient sensitivity to elicit physiologically relevant responses.	[Delwig, Anton; Larsen, DeLaine D.; Yasumura, Douglas; Copenhagen, David R.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA USA; [Yang, Cindy F.; Shah, Nirao M.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Copenhagen, David R.] Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Copenhagen, DR (corresponding author), Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA USA.; Copenhagen, DR (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA USA.	cope@phy.ucsf.edu		Larsen, DeLaine/0000-0002-9689-8454; Yang, Cindy/0000-0001-6144-4658	National Institute of Neurological Disease and Stroke [R01NS049488]; NIH National Institute of Neurological Disease and Stroke [R01NS083872]; NIH National Eye Institute [R01EY02317, R01EY01869, T32EY007120]; NIH [P30EY002162]; National Eye Institute, NIH; Benign Essential Blepharospasm Research Foundation; That Man May See, UCSF; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY002317, R01EY023179, R01EY001869, T32EY007120, P30EY002162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049488, R01NS083872] Funding Source: NIH RePORTER	National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Benign Essential Blepharospasm Research Foundation; That Man May See, UCSF; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by R01NS049488 (NMS) National Institute of Neurological Disease and Stroke, NIH R01NS083872 (NMS) National Institute of Neurological Disease and Stroke, NIH R01EY02317 (DRC) National Eye Institute, NIH R01EY01869 (DRC) National Eye Institute, NIH T32EY007120 (AD) National Eye Institute, NIH P30EY002162 (Matthew LaVail, PI), Core Grant, National Eye Institute, NIH, Benign Essential Blepharospasm Research Foundation (DRC), www.blepharospasm.org/, That Man May See, UCSF (DRC), thatmanmaysee.org/, and Research to Prevent Blindness (DRC and Dept. of Ophthalmology, UCSF), www.rpbusa.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown TM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000558; Delwig A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043787; Dhande OS, 2013, J NEUROSCI, V33, P17797, DOI 10.1523/JNEUROSCI.2778-13.2013; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Franklin K.B.J., 2013, PAXINOS FRANKLINS MO; Giolli RA, 2006, PROG BRAIN RES, V151, P407, DOI 10.1016/S0079-6123(05)51013-6; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Hannibal J, 2004, CELL TISSUE RES, V316, P99, DOI 10.1007/s00441-004-0858-x; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Hellstrom M, 2009, GENE THER, V16, P521, DOI 10.1038/gt.2008.178; Lasky RE, 2009, PEDIATRICS, V123, P540, DOI 10.1542/peds.2007-3418; Ma TP, 1996, NEUROREPORT, V7, P2713, DOI 10.1097/00001756-199611040-00061; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Masri R, 2009, J NEUROPHYSIOL, V102, P181, DOI 10.1152/jn.00152.2009; Mitrofanis J, 2005, NEUROSCIENCE, V130, P1, DOI 10.1016/j.neuroscience.2004.08.017; Noseda R, 2011, J NEUROSCI, V13, P239, DOI [10.1038/nn.2475, DOI 10.1038/NN.2475]; Noseda R, 2010, NAT NEUROSCI, V13, P239, DOI 10.1038/nn.2475; Schmidt TM, 2014, NEURON, V82, P781, DOI 10.1016/j.neuron.2014.03.022; Shah NM, 2004, NEURON, V43, P313, DOI 10.1016/j.neuron.2004.07.008; Shogan M G, 1993, Neonatal Netw, V12, P7; WONGRILEY MTT, 1984, J COMP NEUROL, V222, P18, DOI 10.1002/cne.902220103; Xue T, 2011, NATURE, V479, P67, DOI 10.1038/nature10567; Yang CF, 2013, CELL, V153, P896, DOI 10.1016/j.cell.2013.04.017	24	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149501	10.1371/journal.pone.0149501	http://dx.doi.org/10.1371/journal.pone.0149501			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895233	gold, Green Published			2022-12-27	WOS:000371223400060
J	Engel, AC; Herbst, F; Kerres, A; Galle, JN; Hegemann, JH				Engel, Astrid C.; Herbst, Frauke; Kerres, Anne; Galle, Jan N.; Hegemann, Johannes H.			The Type III Secretion System-Related CPn0809 from Chlamydia pneumoniae	PLOS ONE			English	Article							PROTEIN; MEMBRANE; IDENTIFICATION; TRANSLOCATORS; LOCALIZATION; PREDICTION; INFECTION; REGION; CELLS; MODEL	Chlamydia pneumoniae is an intracellular Gram-negative bacterium that possesses a type III secretion system (T3SS), which enables the pathogen to deliver, in a single step, effector proteins for modulation of host-cell functions into the human host cell cytosol to establish a unique intracellular niche for replication. The translocon proteins located at the top of the T3SS needle filament are essential for its function, as they form pores in the host-cell membrane. Interestingly, unlike other Gram-negative bacteria, C. pneumoniae has two putative translocon operons, named LcrH_1 and LcrH_2. However, little is known about chlamydial translocon proteins. In this study, we analyzed CPn0809, one of the putative hydrophobic translocators encoded by the LcrH_1 operon, and identified an 'SseC-like family' domain characteristic of T3S translocators. Using bright-field and confocal microscopy, we found that CPn0809 is associated with EBs during early and very late phases of a C. pneumoniae infection. Furthermore, CPn0809 forms oligomers, and interacts with the T3SS chaperone LcrH_1, via its N-terminal segment. Moreover, expression of full-length CPn0809 in the heterologous host Escherichia coli causes a grave cytotoxic effect that leads to cell death. Taken together, our data indicate that CPn0809 likely represents one of the translocon proteins of the C. pneumoniae T3SS, and possibly plays a role in the translocation of effector proteins in the early stages of infection.	[Engel, Astrid C.; Herbst, Frauke; Kerres, Anne; Galle, Jan N.; Hegemann, Johannes H.] Univ Dusseldorf, Lehrstuhl Funkt Genomforsch Mikroorganismen, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Hegemann, JH (corresponding author), Univ Dusseldorf, Lehrstuhl Funkt Genomforsch Mikroorganismen, Dusseldorf, Germany.	Johannes.Hegemann@hhu.de		Galle, Jan Niklas/0000-0002-4433-0779	ERA-NET PathoGenoMics [0313935D, 0315442B]	ERA-NET PathoGenoMics	This work was supported by grants ERA-NET PathoGenoMics (ECIBUG; grant Nr. 0313935D; Pathomics, 362 grant Nr. 0315442B) to JHH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Aistleitner K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055010; Allmond LR, 2003, INFECT IMMUN, V71, P2230, DOI 10.1128/IAI.71.4.2230-2233.2003; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beeckman DSA, 2010, CURR ISSUES MOL BIOL, V12, P17; Betts-Hampikian HJ, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00114; Birket SE, 2007, BIOCHEMISTRY-US, V46, P8128, DOI 10.1021/bi700099c; Blasi F, 2009, CLIN MICROBIOL INFEC, V15, P29, DOI 10.1111/j.1469-0691.2008.02130.x; Bulir DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099315; Burillo A, 2010, INFECT DIS CLIN N AM, V24, P61, DOI 10.1016/j.idc.2009.10.002; Burkinshaw BJ, 2014, BBA-MOL CELL RES, V1843, P1649, DOI 10.1016/j.bbamcr.2014.01.035; Chaturvedi AK, 2010, CANCER EPIDEM BIOMAR, V19, P1498, DOI 10.1158/1055-9965.EPI-09-1261; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Dasanayake D, 2011, MOL MICROBIOL, V81, P734, DOI 10.1111/j.1365-2958.2011.07727.x; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Dersch P, 1999, EMBO J, V18, P1199, DOI 10.1093/emboj/18.5.1199; Entian KD, 1999, MOL GEN GENET, V262, P683, DOI 10.1007/PL00013817; Fechtner T, 2013, J BACTERIOL, V195, P5323, DOI 10.1128/JB.00780-13; Fields KA, 2005, J BACTERIOL, V187, P6466, DOI 10.1128/JB.187.18.6466-6478.2005; Hammerschlag MR, 2000, EUR RESPIR J, V16, P1001, DOI 10.1183/09031936.00.16510010; Harlow E, 1999, USING ANTIBODIES POR; Herrmann M, 2006, RES MICROBIOL, V157, P513, DOI 10.1016/j.resmic.2005.12.005; Hume PJ, 2003, MOL MICROBIOL, V49, P425, DOI 10.1046/j.1365-2958.2003.03559.x; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Jantos CA, 1997, J CLIN MICROBIOL, V35, P620, DOI 10.1128/JCM.35.3.620-623.1997; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; KOEHLER JE, 1992, MOL MICROBIOL, V6, P1087; Lugert R, 2004, MED MICROBIOL IMMUN, V193, P163, DOI 10.1007/s00430-003-0206-x; LUNDEMOSE AG, 1990, INFECT IMMUN, V58, P2478, DOI 10.1128/IAI.58.8.2478-2486.1990; Luo JH, 2007, MICROB PATHOGENESIS, V42, P111, DOI 10.1016/j.micpath.2006.11.006; Maurer AP, 2007, PLOS PATHOG, V3, P752, DOI 10.1371/journal.ppat.0030083; Markkula E, 2013, MICROB PATHOGENESIS, V54, P46, DOI 10.1016/j.micpath.2012.09.004; Mattei PJ, 2011, FEBS J, V278, P414, DOI 10.1111/j.1742-4658.2010.07974.x; MENARD R, 1994, CELL, V79, P515, DOI 10.1016/0092-8674(94)90260-7; Molleken K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003325; Molleken K, 2010, MOL MICROBIOL, V78, P1004, DOI 10.1111/j.1365-2958.2010.07386.x; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Mueller CA, 2008, MOL MICROBIOL, V68, P1085, DOI 10.1111/j.1365-2958.2008.06237.x; Nans A, 2014, CELL MICROBIOL; Neyt C, 1999, MOL MICROBIOL, V31, P143, DOI 10.1046/j.1365-2958.1999.01154.x; Ouellette SP, 2005, J BACTERIOL, V187, P7853, DOI 10.1128/JB.187.22.7853-7856.2005; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; ROBLIN PM, 1992, J CLIN MICROBIOL, V30, P1968, DOI 10.1128/JCM.30.8.1968-1971.1992; Romano FB, 2011, BIOCHEMISTRY-US, V50, P7117, DOI 10.1021/bi200905x; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Scidmore MA, 2011, MICROBES INFECT, V13, P527, DOI 10.1016/j.micinf.2011.02.001; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Subtil A, 2000, MICROBES INFECT, V2, P367, DOI 10.1016/S1286-4579(00)00335-X; Wilkat M, 2014, HISTOCHEM CELL BIOL, V142, P171, DOI 10.1007/s00418-014-1189-y; Wolf K, 2000, INFECT IMMUN, V68, P2379, DOI 10.1128/IAI.68.4.2379-2385.2000; Wuppermann FN, 2001, J INFECT DIS, V184, P181, DOI 10.1086/322009; Wuppermann FN, 2008, J BACTERIOL, V190, P3757, DOI 10.1128/JB.01638-07	53	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148509	10.1371/journal.pone.0148509	http://dx.doi.org/10.1371/journal.pone.0148509			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895250	Green Published, gold			2022-12-27	WOS:000371223400017
J	Buemo, CP; Gambini, A; Moro, LN; Hiriart, MI; Fernandez-Martin, R; Collas, P; Salamone, DF				Paola Buemo, Carla; Gambini, Andres; Natalia Moro, Lucia; Ines Hiriart, Maria; Fernandez-Martin, Rafael; Collas, Philippe; Felipe Salamone, Daniel			Embryo Aggregation in Pig Improves Cloning Efficiency and Embryo Quality	PLOS ONE			English	Article							IN-VITRO DEVELOPMENT; NUCLEAR TRANSFER EMBRYOS; GENE-EXPRESSION; CLONED EMBRYOS; EPIGENETIC REGULATION; CELL NUMBER; STAGE; APOPTOSIS; TROPHECTODERM; BODIES	In this study, we analyzed the effects of the cloned embryo aggregation on in vitro embryo development and embryo quality by measuring blastocyst diameter and cell number, DNA fragmentation levels and the expression of genes associated with pluripotency, apoptosis, trophoblast and DNA methylation in the porcine. Zona-free reconstructed cloned embryos were cultured in the well of the well system, placing one (1x non aggregated group) or three (3x group) embryos per microwell. Our results showed that aggregation of three embryos increased blastocyst formation rate and blastocyst diameter of cloned pig embryos. DNA fragmentation levels in 3x aggregated cloned blastocysts were significantly decreased compared to 1x blastocysts. Levels of Oct4, Klf4, Igf2, Bax and Dnmt 1 transcripts were significantly higher in aggregated embryos, whereas Nanog levels were not affected. Transcripts of Cdx2 and Bcl-xl were essentially non-detectable. Our study suggests that embryo aggregation in the porcine may be beneficial for cloned embryo development and embryo quality, through a reduction in apoptotic levels and an improvement in cell reprogramming.	[Paola Buemo, Carla; Gambini, Andres; Natalia Moro, Lucia; Ines Hiriart, Maria; Fernandez-Martin, Rafael; Felipe Salamone, Daniel] Univ Buenos Aires, Fac Agr, Lab Anim Biotechnol, Buenos Aires, DF, Argentina; [Paola Buemo, Carla; Gambini, Andres; Natalia Moro, Lucia; Ines Hiriart, Maria; Fernandez-Martin, Rafael; Felipe Salamone, Daniel] Natl Inst Sci & Technol Res, Buenos Aires, DF, Argentina; [Collas, Philippe] Univ Oslo, Inst Basic Med Sci, Fac Med, Dept Mol Med, Oslo, Norway; [Collas, Philippe] Norwegian Ctr Stem Cell Res, Oslo, Norway	University of Buenos Aires; University of Oslo	Salamone, DF (corresponding author), Univ Buenos Aires, Fac Agr, Lab Anim Biotechnol, Buenos Aires, DF, Argentina.; Salamone, DF (corresponding author), Natl Inst Sci & Technol Res, Buenos Aires, DF, Argentina.	salamone@agro.uba.ar	Salamone, Daniel F/G-1096-2019; Gambini, Andres/H-9119-2019	Salamone, Daniel F/0000-0003-0858-0313; Gambini, Andres/0000-0002-3652-2068; Fernandez-Martin, Rafael/0000-0002-4838-407X				Akagi S, 2011, J REPROD DEVELOP, V57, P500, DOI 10.1262/jrd.10-140A; Aston KI, 2010, CELL REPROGRAM, V12, P23, DOI 10.1089/cell.2009.0042; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Balbach ST, 2010, DEV BIOL, V343, P71, DOI 10.1016/j.ydbio.2010.04.012; Bang JI, 2015, THERIOGENOLOGY, V84, P509, DOI 10.1016/j.theriogenology.2015.04.008; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Betts DH, 2001, THERIOGENOLOGY, V55, P171, DOI 10.1016/S0093-691X(00)00453-2; Beyhan Z, 2007, MOL REPROD DEV, V74, P18, DOI 10.1002/mrd.20618; Boiani M, 2003, EMBO J, V22, P5304, DOI 10.1093/emboj/cdg507; Bordignon V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064613; Brison DR, 1997, BIOL REPROD, V56, P1088, DOI 10.1095/biolreprod56.5.1088; Burgstaller JP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-141; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Eckardt S, 2004, ANIM REPROD SCI, V82-3, P97, DOI 10.1016/j.anireprosci.2004.04.017; Fabian D, 2005, THERIOGENOLOGY, V64, P221, DOI 10.1016/j.theriogenology.2004.11.022; Gambini A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110998; Gambini A, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.098855; Gao Y, 2011, EPIGENETICS-US, V6, P1149, DOI 10.4161/epi.6.9.16954; Golding MC, 2011, MOL REPROD DEV, V78, P306, DOI 10.1002/mrd.21306; Haimovich G, 2013, CELL, V153, P1000, DOI 10.1016/j.cell.2013.05.012; Hao YH, 2003, BIOL REPROD, V69, P501, DOI 10.1095/biolreprod.103.016170; Hardy K, 1997, MOL HUM REPROD, V3, P919, DOI 10.1093/molehr/3.10.919; Hardy K, 2002, J ENDOCRINOL, V172, P221, DOI 10.1677/joe.0.1720221; Huan YJ, 2013, J REPROD DEVELOP, V59, P442, DOI 10.1262/jrd.2013-026; Hyun S, 2003, BIOL REPROD, V69, P1060, DOI 10.1095/biolreprod.102.014886; Jeong YI, 2013, ASIAN AUSTRAL J ANIM, V26, P1680, DOI 10.5713/ajas.2013.13029; Jones PL, 1999, SEMIN CANCER BIOL, V9, P339, DOI 10.1006/scbi.1999.0134; Ju SQ, 2010, J ASSIST REPROD GEN, V27, P49, DOI 10.1007/s10815-009-9378-7; Kamjoo M, 2002, MOL REPROD DEV, V61, P67, DOI 10.1002/mrd.1132; Kurosaka S, 2007, CLONING STEM CELLS, V9, P630, DOI 10.1089/clo.2007.0015; Lee SG, 2007, MOL REPROD DEV, V74, P1436, DOI 10.1002/mrd.20728; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Meyer S, 2004, CRIT REV BIOCHEM MOL, V39, P197, DOI 10.1080/10409230490513991; Misica-Turner PA, 2007, BIOL REPROD, V76, P268, DOI 10.1095/biolreprod.106.050922; Moro LN, 2015, REPRODUCTION, V150, P1, DOI 10.1530/REP-15-0048; Nagashima H, 2003, THERIOGENOLOGY, V59, P95, DOI 10.1016/S0093-691X(02)01261-X; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Park SK, 2014, J VET SCI, V15, P73, DOI 10.4142/jvs.2014.15.1.73; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pauley KM, 2006, EMBO REP, V7, P904, DOI 10.1038/sj.embor.7400783; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Prather RS, 2007, ADV EXP MED BIOL, V591, P1; Ribeiro ED, 2009, CLONING STEM CELLS, V11, P377, DOI 10.1089/clo.2009.0022; Siriboon C, 2014, REPROD FERT DEVELOP, V26, P395, DOI 10.1071/RD12243; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Tamada H, 2004, CYTOGENET GENOME RES, V105, P285, DOI 10.1159/000078200; Tang PC, 2000, ZYGOTE, V8, P235, DOI 10.1017/S0967199400001039; Terashita Y, 2011, REPROD DOMEST ANIM, V46, P189, DOI 10.1111/j.1439-0531.2010.01614.x; Vajta G, 2005, REPROD FERT DEVELOP, V17, P97, DOI 10.1071/RD04116; Vajta G, 2000, MOL REPROD DEV, V55, P256, DOI 10.1002/(SICI)1098-2795(200003)55:3&lt;256::AID-MRD3&gt;3.0.CO;2-7; Yoon SW, 2009, REPROD FERT DEVELOP, V21, P210, DOI 10.1071/RDv21n1Ab225; Zhao JG, 2010, CELL TISSUE RES, V341, P13, DOI 10.1007/s00441-010-1000-x; Zhou WL, 2008, MOL REPROD DEV, V75, P1281, DOI 10.1002/mrd.20875	54	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0146390	10.1371/journal.pone.0146390	http://dx.doi.org/10.1371/journal.pone.0146390			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894831	Green Published, gold, Green Submitted			2022-12-27	WOS:000371223400002
J	Gao, HH; Zhai, YF; Wang, WB; Chen, H; Zhou, XH; Zhuang, QY; Yu, Y; Li, RM				Gao, Huanhuan; Zhai, Yifan; Wang, Wenbo; Chen, Hao; Zhou, Xianhong; Zhuang, Qianying; Yu, Yi; Li, Rumei			Transcriptome Analysis and Discovery of Genes Relevant to Development in Bradysia odoriphaga at Three Developmental Stages	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; DIPTERA; EXPRESSION; INSECT; GENOME; FLY; SILKWORM; PLATFORM; BEETLE; LARVAE	Bradysia odoriphaga (Diptera: Sciaridae) is the most important pest of Chinese chive (Allium tuberosum) in Asia; however, the molecular genetics are poorly understood. To explore the molecular biological mechanism of development, Illumina sequencing and de novo assembly were performed in the third-instar, fourth-instar, and pupal B. odoriphaga. The study resulted in 16.2 Gb of clean data and 47,578 unigenes (>= 125bp) contained in 7,632,430contigs, 46.21% of which were annotated from non-redundant protein (NR), Gene Ontology (GO), Clusters of Orthologous Groups (COG), Eukaryotic Orthologous Groups (KOG), and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases. It was found that 19.67% of unigenes matched the homologous species mainly, including Aedes aegypti, Culex quinquefasciatus, Ceratitis capitata, and Anopheles gambiae. According to differentially expressed gene (DEG) analysis, 143, 490, and 309 DEGs were annotated as involved in the developmental process in the GO database respectively, in the comparisons of third-instar and fourth-instar larvae, third-instar larvae and pupae, and fourth-instar larvae and pupae. Twenty-five genes were closely related to these processes, including developmental process, reproduction process, and reproductive organs development and programmed cell death (PCD). The information of unigenes assembled in B. odoriphaga through transcriptome and DEG analyses could provide a detailed genetic basis and regulated information for elaborating the developmental mechanism from the larval, pre-pupal to pupal stages of B. odoriphaga.	[Gao, Huanhuan; Zhai, Yifan; Chen, Hao; Zhou, Xianhong; Zhuang, Qianying; Yu, Yi; Li, Rumei] Shandong Acad Agr Sci, Inst Plant Protect, Jinan, Peoples R China; [Wang, Wenbo] Shandong Acad Agr Sci, Inst Qual Stand & Testing Technol Agri Prod, Jinan, Peoples R China	Shandong Academy of Agricultural Sciences; Shandong Academy of Agricultural Sciences	Yu, Y (corresponding author), Shandong Acad Agr Sci, Inst Plant Protect, Jinan, Peoples R China.	robertyuyi@163.com			Special Fund for Agro-scientific Research in the Public Interest from the Ministry of Agriculture of China [201303027]	Special Fund for Agro-scientific Research in the Public Interest from the Ministry of Agriculture of China	Funding for this study was provided by grants from the Special Fund for Agro-scientific Research in the Public Interest from the Ministry of Agriculture of China (201303027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Biomarker Technologies Co. Ltd for transcriptome analysis related experiments. This work was financially supported through a grant from the Special Fund for Agro-scientific Research in the Public Interest from the Ministry of Agriculture of China (201303027).	Anholt RRH, 2003, NAT GENET, V35, P180, DOI 10.1038/ng1240; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Chen HL, 2015, COMP BIOCHEM PHYS D, V16, P20, DOI 10.1016/j.cbd.2015.07.001; Choi JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-703; Daines B, 2011, GENOME RES, V21, P315, DOI 10.1101/gr.107854.110; Fender JE, 2012, APPL ENVIRON MICROB, V78, P6225, DOI 10.1128/AEM.01778-12; Feng H.Q., 1987, J AGRI UNIVK SHANDON, V18, P71; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Hahn DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-234; He Hua-Liang, 2012, Acta Entomologica Sinica, V55, P1; Huang JH, 2005, GENOMICS, V86, P233, DOI 10.1016/j.ygeno.2005.04.011; Ianella P, 2008, GENET MOL RES, V7, P476, DOI 10.4238/vol7-2gmr412; Imahori Y, 2004, POSTHARVEST BIOL TEC, V31, P295, DOI 10.1016/j.postharvbio.2003.09.004; JOANISSE DR, 1994, CAN J ZOOL, V72, P1079, DOI 10.1139/z94-145; Keeling CI, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r27; Kovtunovych G, 1999, PLANT SOIL, V215, P1, DOI 10.1023/A:1004790122353; Lemke S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-278; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li Hong, 2007, Chinese Bulletin of Entomology, V44, P834; Li YP, 2000, INSECT SCI, V7, P135; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; [卢巧英 LU Qiaoying], 2006, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V15, P75; Manji GA, 2001, J BIOL CHEM, V276, P16704, DOI 10.1074/jbc.M010179200; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Margam VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021388; Mei Zeng-Xia, 2003, Entomological Knowledge, V40, P396; Misawa T, 2013, J GEN PLANT PATHOL, V79, P280, DOI 10.1007/s10327-013-0455-5; Mizrachi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-681; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Munoz-Torres MC, 2011, NUCLEIC ACIDS RES, V39, pD658, DOI 10.1093/nar/gkq1145; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Nirmala X, 2013, GENE, V517, P212, DOI 10.1016/j.gene.2012.12.012; Papanicolaou A, 2008, NUCLEIC ACIDS RES, V36, pD582, DOI 10.1093/nar/gkm853; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Pascual L, 2012, INSECT BIOCHEM MOLEC, V42, P557, DOI 10.1016/j.ibmb.2012.04.003; Schulze SK, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-524; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Shi K., 2013, TAXONOMY 8 GENERA PH; Simon CR, 2004, GENESIS, V40, P22, DOI 10.1002/gene.20059; Sze SH, 2012, INSECT MOL BIOL, V21, P205, DOI 10.1111/j.1365-2583.2011.01127.x; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Yang J. K., 1985, ACTA AGRU PERKINENSI, V11, P153; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang P, 2014, PESTIC BIOCHEM PHYS, V111, P31, DOI 10.1016/j.pestbp.2014.04.003; Zhen JQ., 2004, HDB CONT VEGETABLE P; Zou CS, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu122	49	13	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0146812	10.1371/journal.pone.0146812	http://dx.doi.org/10.1371/journal.pone.0146812			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891450	Green Submitted, gold, Green Published			2022-12-27	WOS:000371221500003
J	Zhou, J; Lee, CL; Li, KA; Tien, YH; Yeh, SL				Zhou, Jifan; Lee, Chia-Lin; Li, Kuei-An; Tien, Yung-Hsuan; Yeh, Su-Ling			Does Temporal Integration Occur for Unrecognizable Words in Visual Crowding?	PLOS ONE			English	Article							POTENTIAL INDEXES; WORKING-MEMORY; N400; CONSCIOUSNESS; ADAPTATION; REFLECT; MOTION; LOCUS	Visual crowding-the inability to see an object when it is surrounded by flankers in the periphery-does not block semantic activation: unrecognizable words due to visual crowding still generated robust semantic priming in subsequent lexical decision tasks. Based on the previous finding, the current study further explored whether unrecognizable crowded words can be temporally integrated into a phrase. By showing one word at a time, we presented Chinese four-word idioms with either a congruent or incongruent ending word in order to examine whether the three preceding crowded words can be temporally integrated to form a semantic context so as to affect the processing of the ending word. Results from both behavioral (Experiment 1) and Event-Related Potential (Experiment 2 and 3) measures showed congruency effect in only the non-crowded condition, which does not support the existence of unconscious multi-word integration. Aside from four-word idioms, we also found that two-word (modifier + adjective combination) integration-the simplest kind of temporal semantic integration-did not occur in visual crowding (Experiment 4). Our findings suggest that integration of temporally separated words might require conscious awareness, at least under the timing conditions tested in the current study.	[Zhou, Jifan; Lee, Chia-Lin; Li, Kuei-An; Tien, Yung-Hsuan; Yeh, Su-Ling] Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan; [Zhou, Jifan] Zhejiang Univ, Dept Psychol & Behav Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Lee, Chia-Lin; Yeh, Su-Ling] Natl Taiwan Univ, Grad Inst Brain & Mind Sci, Taipei 10764, Taiwan; [Lee, Chia-Lin; Yeh, Su-Ling] Natl Taiwan Univ, Neurobiol & Cognit Neurosci Ctr, Taipei 10764, Taiwan; [Lee, Chia-Lin] Natl Taiwan Univ, Grad Inst Linguist, Taipei 10764, Taiwan	National Taiwan University; Zhejiang University; National Taiwan University; National Taiwan University; National Taiwan University	Yeh, SL (corresponding author), Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan.; Yeh, SL (corresponding author), Natl Taiwan Univ, Grad Inst Brain & Mind Sci, Taipei 10764, Taiwan.; Yeh, SL (corresponding author), Natl Taiwan Univ, Neurobiol & Cognit Neurosci Ctr, Taipei 10764, Taiwan.	suling@ntu.edu.tw	Lee, Chia-Lin/AAE-1536-2019; Yeh, Su-Ling/D-6089-2016	Lee, Chia-lin/0000-0003-2679-9001; Yeh, Su-Ling/0000-0003-4597-8697	Taiwan Ministry of Science and Technology [MOST 104-2420-H-002-003-MY2, MOST 102-2811-H-002-021]	Taiwan Ministry of Science and Technology	This research was supported by Taiwan Ministry of Science and Technology grants (MOST 104-2420-H-002-003-MY2 to Su-Ling Yeh, and MOST 102-2811-H-002-021 to Ji-Fan Zhou), www.most.gov.tw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Taiwan Ministry of Science and Technology grants (MOST 104-2420-H-002-003-MY2 to Su-Ling Yeh, and MOST 102-2811-H-002-021 to Ji-Fan Zhou). We thank Shao-Yang Lee and Jen-Tse Dong for help conducting the behavioral experiment and Yu-Ting Lin for help conducting the ERP experiment.	Aghdaee SM, 2005, PERCEPTION, V34, P155, DOI 10.1068/p5298; Atas A, 2014, PSYCHOL SCI, V25, P113, DOI 10.1177/0956797613499591; Baars B. J., 1988, COGNITIVE THEORY CON; Baars BJ, 2005, PROG BRAIN RES, V150, P45, DOI 10.1016/S0079-6123(05)50004-9; Baars BJ, 2003, TRENDS COGN SCI, V7, P166, DOI 10.1016/S1364-6613(03)00056-1; Baars BJ, 2002, TRENDS COGN SCI, V6, P47, DOI 10.1016/S1364-6613(00)01819-2; Bi TY, 2009, J VISION, V9, DOI 10.1167/9.11.13; Carrol G, 2015, CROSS LANGUAGE LEXIC; Carrol G, 2014, BILING-LANG COGN, V17, P784, DOI 10.1017/S1366728913000795; Deacon D, 2000, COGNITIVE BRAIN RES, V9, P137, DOI 10.1016/S0926-6410(99)00050-6; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; Du X, 2012, J NEUROLOGY NEUROREH, V9, P7; Faivre N, 2014, COGNITION, V131, P404, DOI 10.1016/j.cognition.2014.02.008; Faivre N, 2014, FRONTIERS PSYCHOL, P5; Farzin F, 2009, J VISION, V9, DOI 10.1167/9.6.18; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Jeffreys H., 1998, THEORY PROBABILITY; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; Libben MR, 2008, MEM COGNITION, V36, P1103, DOI 10.3758/MC.36.6.1103; Livne T, 2007, J VISION, V7, DOI 10.1167/7.2.4; Lou L-g, 1989, ACTA PSYCHOL SINICA, V3, P321; Louie EG, 2007, J VISION, V7, DOI 10.1167/7.2.24; Misra M, 2003, PSYCHOPHYSIOLOGY, V40, P115, DOI 10.1111/1469-8986.00012; Morey RD, 2011, PSYCHOL METHODS, V16, P406, DOI 10.1037/a0024377; Mudrik L, 2014, TRENDS COGN SCI, V18, P488, DOI 10.1016/j.tics.2014.04.009; Pelli DG, 2008, CURR OPIN NEUROBIOL, V18, P445, DOI 10.1016/j.conb.2008.09.008; Pelli DG, 2004, J VISION, V4, P1136, DOI 10.1167/4.12.12; Peng CH, 2013, INT J PSYCHOPHYSIOL, V88, P91, DOI 10.1016/j.ijpsycho.2013.03.002; Rajimehr R, 2004, VISION RES, V44, P925, DOI 10.1016/j.visres.2003.11.020; Rolke B, 2001, PSYCHOPHYSIOLOGY, V38, P165, DOI 10.1017/S0048577201991504; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Seth AK, 2006, P NATL ACAD SCI USA, V103, P10799, DOI 10.1073/pnas.0604347103; Sklar AY, 2012, P NATL ACAD SCI USA, V109, P19614, DOI 10.1073/pnas.1211645109; Soto D, 2011, CURR BIOL, V21, pR912, DOI 10.1016/j.cub.2011.09.049; STRASBURGER H, 1991, PERCEPT PSYCHOPHYS, V49, P495, DOI 10.3758/BF03212183; van Gaal S, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0212; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Yeh SL, 2012, PSYCHOL SCI, V23, P608, DOI 10.1177/0956797611434746	40	4	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149355	10.1371/journal.pone.0149355	http://dx.doi.org/10.1371/journal.pone.0149355			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3CO	26890366	gold, Green Published			2022-12-27	WOS:000371221500039
J	Botella, C; Perez-Ara, MA; Breton-Lopez, J; Quero, S; Garcia-Palacios, A; Banos, RM				Botella, Cristina; Angeles Perez-Ara, M.; Breton-Lopez, Juana; Quero, Soledad; Garcia-Palacios, Azucena; Maria Banos, Rosa			In Vivo versus Augmented Reality Exposure in the Treatment of Small Animal Phobia: A Randomized Controlled Trial	PLOS ONE			English	Article							ONE-SESSION TREATMENT; THERAPIST-DIRECTED EXPOSURE; IV SPECIFIC PHOBIA; VIRTUAL-REALITY; ANXIETY DISORDERS; SPIDER PHOBIA; PANIC DISORDER; CLINICAL-TRIAL; SELF-EXPOSURE; FEAR	Although in vivo exposure is the treatment of choice for specific phobias, some acceptability problems have been associated with it. Virtual Reality exposure has been shown to be as effective as in vivo exposure, and it is widely accepted for the treatment of specific phobias, but only preliminary data are available in the literature about the efficacy of Augmented Reality. The purpose of the present study was to examine the efficacy and acceptance of two treatment conditions for specific phobias in which the exposure component was applied in different ways: In vivo exposure (N = 31) versus an Augmented Reality system (N = 32) in a randomized controlled trial. "One-session treatment" guidelines were followed. Participants in the Augmented Reality condition significantly improved on all the outcome measures at post-treatment and follow-ups. When the two treatment conditions were compared, some differences were found at post-treatment, favoring the participants who received in vivo exposure. However, these differences disappeared at the 3- and 6-month follow-ups. Regarding participants' expectations and satisfaction with the treatment, very positive ratings were reported in both conditions. In addition, participants from in vivo exposure condition considered the treatment more useful for their problem whereas participants from Augmented Reality exposure considered the treatment less aversive. Results obtained in this study indicate that Augmented Reality exposure is an effective treatment for specific phobias and well accepted by the participants.	[Botella, Cristina; Angeles Perez-Ara, M.; Breton-Lopez, Juana; Quero, Soledad; Garcia-Palacios, Azucena] Univ Jaume 1, Dept Basic Psychol Clin & Psychobiol, Castellon de La Plana, Spain; [Maria Banos, Rosa] Univ Valencia, Dept Personal Evaluat & Psychol Treatment, Valencia, Spain; [Botella, Cristina; Breton-Lopez, Juana; Quero, Soledad; Garcia-Palacios, Azucena; Maria Banos, Rosa] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERObn, Madrid, Spain	Universitat Jaume I; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Botella, C (corresponding author), Univ Jaume 1, Dept Basic Psychol Clin & Psychobiol, Castellon de La Plana, Spain.; Botella, C (corresponding author), Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERObn, Madrid, Spain.	botella@uji.es	BAÑOS, ROSA MARIA/C-6077-2011; Botella, Cristina/F-9230-2010	BAÑOS, ROSA MARIA/0000-0003-0626-7665; Botella, Cristina/0000-0001-8783-6959	Ministry of Economy and Competitiveness (Spain) [PSI2010-17563]; Institute of Health Carlos III (ISCiii)	Ministry of Economy and Competitiveness (Spain)(Spanish Government); Institute of Health Carlos III (ISCiii)	This study was funded by the Ministry of Economy and Competitiveness (Spain), (Plan Nacional I+D+I. PSI2010-17563), and the Institute of Health Carlos III (ISCiii). CIBERobn is an initiative of ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate Andrea F., 2011, Virtual and Mixed Reality - New Trends. Proceedings International Conference, Virtual and Mixed Reality 2011. Held as Part of HCI International 2011, P3, DOI 10.1007/978-3-642-22021-0_1; Abramowitz JS, 2013, BEHAV THER, V44, P548, DOI 10.1016/j.beth.2013.03.003; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P21; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Antony MA, 2002, ANXIETY ITS DISORDER, P380; ARNTZ A, 1993, ADV BEHAV RES THER, V15, P257, DOI 10.1016/0146-6402(93)90012-Q; Azuma RT, 1997, PRESENCE-VIRTUAL AUG, V6, P355, DOI 10.1162/pres.1997.6.4.355; Banos RM, 2009, BRIT J GUID COUNS, V37, P347, DOI 10.1080/03069880902957064; Becker CB, 2004, BEHAV RES THER, V42, P277, DOI 10.1016/S0005-7967(03)00138-4; BORKOVEC TD, 1972, J BEHAV THER EXP PSY, V3, P257, DOI 10.1016/0005-7916(72)90045-6; Botella C, 2007, CLIN PSYCHOL PSYCHOT, V14, P164, DOI 10.1002/cpp.524; Botella C, 2011, COMPUT HUM BEHAV, V27, P217, DOI 10.1016/j.chb.2010.07.043; Botella C., 2012, SEAS2012 9 INT C SOC; Botella CM, 2005, CYBERPSYCHOL BEHAV, V8, P162, DOI 10.1089/cpb.2005.8.162; Botella C, 2010, BEHAV THER, V41, P401, DOI 10.1016/j.beth.2009.07.002; Botella C, 2008, CYBERPSYCHOL BEHAV, V11, P659, DOI 10.1089/cpb.2008.0012; Bouchard S, 2003, J THERAPIE COMPORTEM, V17, P101; Bouchard Stephane, 2006, Technol Health Care, V14, P19; Breton-Lopez J, 2010, CYBERPSYCH BEH SOC N, V13, P705, DOI 10.1089/cyber.2009.0170; Choy Y, 2007, CLIN PSYCHOL REV, V27, P266, DOI 10.1016/j.cpr.2006.10.002; Cohen J.E., 1988, STAT POWER ANAL BEHA; Corbett-Davies S, 2012, INT SYM MIX AUGMENT; Craske MG, 2014, BEHAV RES THER, V58, P10, DOI 10.1016/j.brat.2014.04.006; Curtis GC, 1998, BRIT J PSYCHIAT, V173, P212, DOI 10.1192/bjp.173.3.212; Depla MFIA, 2008, SOC PSYCH PSYCH EPID, V43, P200, DOI 10.1007/s00127-007-0291-z; DiNardo P.A., 1994, ANXIETY DISORDER INT; DINARDO PA, 1993, ARCH GEN PSYCHIAT, V50, P251; Dunleavy M., 2014, HDB RES ED COMMUNICA, P735, DOI DOI 10.1007/978-1-4614-3185-5_59; Dunsmoor JE, 2014, NEUROBIOL LEARN MEM, V113, P157, DOI 10.1016/j.nlm.2014.02.010; Eysenbach G, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1923; Garcia-Palacios A, 2007, CYBERPSYCHOL BEHAV, V10, P722, DOI 10.1089/cpb.2007.9962; Garcia-Palacios A, 2002, BEHAV RES THER, V40, P983, DOI 10.1016/S0005-7967(01)00068-7; Garcia-Palacios A, 2001, CYBERPSYCHOL BEHAV, V4, P341, DOI 10.1089/109493101300210231; Gotestam K. Gunnar, 2002, Cognitive Behaviour Therapy, V31, P18, DOI 10.1080/16506070252823625; HELLSTROM K, 1995, BEHAV RES THER, V33, P959, DOI 10.1016/0005-7967(95)00028-V; Hembree EA, 2003, J TRAUMA STRESS, V16, P555, DOI 10.1023/B:JOTS.0000004078.93012.7d; Hoffman HG, 2003, INT J HUM-COMPUT INT, V16, P283, DOI 10.1207/S15327590IJHC1602_08; Iraurgi I, 2010, NORTE SALUD MENTAL, V8; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kazdin AE, 2014, S AFR J PSYCHOL; Kazdin AE, 2013, CLIN PSYCHOL SCI, V1, P170, DOI 10.1177/2167702612463566; Kazdin AE, 2011, PERSPECT PSYCHOL SCI, V6, P21, DOI 10.1177/1745691610393527; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Koch EI, 2004, BEHAV RES THER, V42, P1483, DOI 10.1016/j.brat.2003.10.005; Konnopka A, 2009, J AFFECT DISORDERS, V114, P14, DOI 10.1016/j.jad.2008.07.014; KUPFER DJ, 1991, J CLIN PSYCHIAT, V52, P28; LeBeau RT, 2010, DEPRESS ANXIETY, V27, P148, DOI 10.1002/da.20655; Leutgeb V, 2009, BIOL PSYCHOL, V82, P293, DOI 10.1016/j.biopsycho.2009.09.003; Mackenzie CS, 2012, DEPRESS ANXIETY, V29, P234, DOI 10.1002/da.20911; MARKS IM, 1979, BEHAV RES THER, V17, P263, DOI 10.1016/0005-7967(79)90041-X; McCann RA, 2014, J ANXIETY DISORD, V28, P625, DOI 10.1016/j.janxdis.2014.05.010; Meyerbroker K, 2010, DEPRESS ANXIETY, V27, P933, DOI 10.1002/da.20734; Michaliszyn D, 2010, CYBERPSYCH BEH SOC N, V13, P689, DOI 10.1089/cyber.2009.0277; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Moritz K, 2013, 47 ANN CONV COGN BEH; Muris P, 1996, J BEHAV THER EXP PSY, V27, P241, DOI 10.1016/S0005-7916(96)00022-5; Nathan P.E, 2007, GUIDE TREATMENTS WOR, V3rd; Nebot S, 2013, SEAS2013 20 AN M SOC; Olatunji BO, 2009, COGN BEHAV PRACT, V16, P172, DOI 10.1016/j.cbpra.2008.07.003; Opris D, 2012, DEPRESS ANXIETY, V29, P85, DOI 10.1002/da.20910; Ost L. G., 1997, PHOBIAS HDB THEORY R, P227; Ost LG, 2012, AUT CHILD PSYCHO, P59, DOI 10.1007/978-1-4614-3253-1_4; OST LG, 1991, BEHAV THER, V22, P407, DOI 10.1016/S0005-7894(05)80374-0; OST LG, 1989, BEHAV RES THER, V27, P1, DOI 10.1016/0005-7967(89)90113-7; Ost LG, 1998, BEHAV RES THER, V36, P17, DOI 10.1016/S0005-7967(97)10018-3; Powers MB, 2008, J ANXIETY DISORD, V22, P561, DOI 10.1016/j.janxdis.2007.04.006; Quero S, 2014, INTED PROC, P1568; Quero S, 2014, BEHAV PSYCHOL, V22; Quero S, 2014, BRIT J GUID COUNS, V42, P123, DOI 10.1080/03069885.2013.852159; Richard D.C.S., 2007, COMPREHENSIVE HDB EX, P409; Roemer L., 2001, PRACTITIONERS GUIDE; Rothbaum BO, 2006, BEHAV THER, V37, P80, DOI 10.1016/j.beth.2005.04.004; Sarver NW, 2014, J CLIN CHILD ADOLESC, V43, P63, DOI 10.1080/15374416.2013.843461; Schienle A, 2007, EUR ARCH PSY CLIN N, V257, P486, DOI 10.1007/s00406-007-0754-y; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.1186/1741-7015-8-18, 10.1016/j.ijsu.2011.09.004, 10.4103/0976-500X.72352]; SCHWARTZ D, 1967, J CHRON DIS, V20, P637, DOI 10.1016/0021-9681(67)90041-0; Shiban Y, 2015, BEHAV RES THER, V71, P45, DOI 10.1016/j.brat.2015.05.014; Shiban Y, 2013, BEHAV RES THER, V51, P68, DOI 10.1016/j.brat.2012.10.007; Stinson FS, 2007, PSYCHOL MED, V37, P1047, DOI 10.1017/S0033291707000086; SZYMANSKI J, 1995, J BEHAV THER EXP PSY, V26, P31, DOI 10.1016/0005-7916(94)00072-T; Tortella-Feliu M, 2011, BEHAV MODIF, V35, P3, DOI 10.1177/0145445510390801; Turner WA, 2014, CLIN PSYCHOL REV, V34, P634, DOI 10.1016/j.cpr.2014.10.003; Wittchen H.-U., 2003, ANXIETY DISORDERS, P25; Wolitzky-Taylor KB, 2008, CLIN PSYCHOL REV, V28, P1021, DOI 10.1016/j.cpr.2008.02.007; Wolitzky-Taylor KB, 2012, AUT CHILD PSYCHO, P195, DOI 10.1007/978-1-4614-3253-1_10; Wrzesien M, 2013, IEEE COMPUT GRAPH, V33, P80, DOI 10.1109/MCG.2013.12; Zhu E, 2014, PEERJ PREPRINTS; Zlomke K, 2008, BEHAV THER, V39, P207, DOI 10.1016/j.beth.2007.07.003	89	49	51	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148237	10.1371/journal.pone.0148237	http://dx.doi.org/10.1371/journal.pone.0148237			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3BJ	26886423	Green Published, gold, Green Submitted			2022-12-27	WOS:000371218400021
J	Novakova, L; Kovacovicova, K; Dang-Nguyen, TQ; Sodek, M; Skultety, M; Anger, M				Novakova, Lucia; Kovacovicova, Kristina; Thanh Quang Dang-Nguyen; Sodek, Martin; Skultety, Michel; Anger, Martin			A Balance between Nuclear and Cytoplasmic Volumes Controls Spindle Length	PLOS ONE			English	Article							MITOTIC SPINDLE; SIZE; CELLS; TPX2; ATTACHMENTS; VERTEBRATE; MECHANISMS; TRANSITION; OOCYTES; NUMBER	Proper assembly of the spindle apparatus is crucially important for faithful chromosome segregation during anaphase. Thanks to the effort over the last decades, we have very detailed information about many events leading to spindle assembly and chromosome segregation, however we still do not understand certain aspects, including, for example, spindle length control. When tight regulation of spindle size is lost, chromosome segregation errors emerge. Currently, there are several hypotheses trying to explain the molecular mechanism of spindle length control. The number of kinetochores, activity of molecular rulers, intracellular gradients, cell size, limiting spindle components, and the balance of the spindle forces seem to contribute to spindle size regulation, however some of these mechanisms are likely specific to a particular cell type. In search for a general regulatory mechanism, in our study we focused on the role of cell size and nuclear to cytoplasmic ratio in this process. To this end, we used relatively large cells isolated from 2-cell mouse embryos. Our results showed that the spindle size upper limit is not reached in these cells and suggest that accurate control of spindle length requires balanced ratio between nuclear and cytoplasmic volumes.	[Novakova, Lucia; Kovacovicova, Kristina; Thanh Quang Dang-Nguyen; Sodek, Martin; Skultety, Michel; Anger, Martin] Vet Res Inst, Cent European Inst Technol, Hudcova 70, Brno 62100, Czech Republic; [Novakova, Lucia; Kovacovicova, Kristina; Sodek, Martin; Anger, Martin] Inst Anim Physiol & Genet AS CR, Rumburska 89, Libechov 27721, Czech Republic; [Thanh Quang Dang-Nguyen] Natl Inst Agrobiol Sci, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058062, Japan	Czech Veterinary Research Institute; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; National Institute of Agrobiological Sciences - Japan	Anger, M (corresponding author), Vet Res Inst, Cent European Inst Technol, Hudcova 70, Brno 62100, Czech Republic.; Anger, M (corresponding author), Inst Anim Physiol & Genet AS CR, Rumburska 89, Libechov 27721, Czech Republic.	anger@vri.cz	Anger, Martin/R-9917-2019; Anger, Martin/A-3152-2015; Kovacovicova, Kristina/C-4964-2019	Anger, Martin/0000-0003-0128-1054; Anger, Martin/0000-0003-0128-1054; Dang Nguyen, Thanh Quang/0000-0001-8176-4827	Czech science foundation [P502/12/2201]; Ministry of Education, Youth and Sports (MEYS) [ED1.1.00/02.0068, LH 13072]	Czech science foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports (MEYS)(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by Czech science foundation project P502/12/2201 and by Ministry of Education, Youth and Sports (MEYS) projects ED1.1.00/02.0068 - Central European Institute of Technology (CEITEC) and LH 13072 - Kontakt II.	Bastiaens P, 2006, TRENDS CELL BIOL, V16, P125, DOI 10.1016/j.tcb.2006.01.005; Bird AW, 2008, J CELL BIOL, V182, P289, DOI 10.1083/jcb.200802005; Chan YHM, 2012, SCIENCE, V337, P1186, DOI 10.1126/science.1223539; Choi SH, 2012, CURR BIOL, V22, P225, DOI 10.1016/j.cub.2011.12.022; Ciemerych MA, 1999, ZYGOTE, V7, P293, DOI 10.1017/S0967199499000696; Courtois A, 2012, J CELL BIOL, V198, P357, DOI 10.1083/jcb.201202135; Dumont J, 2007, J CELL BIOL, V176, P295, DOI 10.1083/jcb.200605199; Dumont S, 2009, CURR BIOL, V19, pR749, DOI 10.1016/j.cub.2009.07.028; Edens LJ, 2013, TRENDS CELL BIOL, V23, P151, DOI 10.1016/j.tcb.2012.11.004; Fragouli E, 2013, HUM GENET, V132, P1001, DOI 10.1007/s00439-013-1309-0; Fu JY, 2015, J CELL BIOL, V210, P373, DOI 10.1083/jcb.201412109; Goehring NW, 2012, CURR BIOL, V22, pR330, DOI 10.1016/j.cub.2012.03.046; Good MC, 2013, SCIENCE, V342, P856, DOI 10.1126/science.1243147; Goshima G, 2010, ANNU REV CELL DEV BI, V26, P21, DOI 10.1146/annurev-cellbio-100109-104006; Greenan G, 2010, CURR BIOL, V20, P353, DOI 10.1016/j.cub.2009.12.050; Hazel J, 2013, SCIENCE, V342, P853, DOI 10.1126/science.1243110; Helmke KJ, 2014, J CELL BIOL, V206, P385, DOI 10.1083/jcb.201401014; Howe K, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.112151; Jevtic P, 2015, CURR BIOL, V25, P45, DOI 10.1016/j.cub.2014.10.051; Jevtic P, 2014, CURR OPIN CELL BIOL, V28, P16, DOI 10.1016/j.ceb.2014.01.003; Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; Nannas NJ, 2014, MOL BIOL CELL, V25, P4034, DOI 10.1091/mbc.E14-01-0016; NICKLAS RB, 1985, J CELL BIOL, V100, P1, DOI 10.1083/jcb.100.1.1; Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832; Wuhr M, 2008, CURR BIOL, V18, P1256, DOI 10.1016/j.cub.2008.07.092; Wuhr M, 2015, CURR BIOL, V25, P2663, DOI 10.1016/j.cub.2015.08.047; Yamagata K, 2013, CELL CYCLE, V12, P157, DOI 10.4161/cc.23052	28	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149535	10.1371/journal.pone.0149535	http://dx.doi.org/10.1371/journal.pone.0149535			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886125	gold, Green Published, Green Submitted			2022-12-27	WOS:000371218400095
J	Stindt, S; Cebula, P; Albrecht, U; Keitel, V; Esch, JSA; Knoefel, WT; Bartenschlager, R; Haussinger, D; Bode, JG				Stindt, Sabine; Cebula, Patricia; Albrecht, Ute; Keitel, Verena; Esch, Jan Schulte Am; Knoefel, Wolfram T.; Bartenschlager, Ralf; Haeussinger, Dieter; Bode, Johannes G.			Hepatitis C Virus Activates a Neuregulin-Driven Circuit to Modify Surface Expression of Growth Factor Receptors of the ErbB Family	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; NONSTRUCTURAL 3/4A PROTEASE; SIGNAL-TRANSDUCTION; CELL-LINES; ENTRY; TRANSCRIPTION; REPLICATION; MITHRAMYCIN; STABILITY; CLEAVAGE	Recently, the epidermal growth factor (EGF) receptor (EGFR), a member of the ErbB receptor family, and its down-stream signalling have been identified as co-factors for HCV entry and replication. Since EGFR also functions as a heterodimer with other ErbB receptor family members, the subject of the present study was to investigate a possible viral interference with these cellular components. By using genotype 1b replicon cells as well as an infection-based system we found that while transcript and protein levels of EGFR and ErbB2 were up-regulated or unaffected, respectively, HCV induced a substantial reduction of ErbB3 and ErbB4 expression. Down-regulation of ErbB3 expression by HCV involves specificity protein (Sp) 1-mediated induction of Neuregulin (NRG) 1 expression as well as activation of Akt. Consistently, at transcript level disruption of ErbB3 expression by HCV can be prevented by knockdown of NRG1 or Sp1 expression, whereas reconstitution of ErbB3 protein levels requires inhibition of HCV-induced NRG1 expression and of Akt activity. Interestingly, the NRG1-mediated suppression of ErbB3 expression by HCV results in an enhanced expression of EGFR and ErbB2 on the cell surface, which can be mimicked by siRNA-mediated knockdown of ErbB3 expression. These data delineate a novel mechanism enabling HCV to sway the composition of the ErbB family members on the surface of its host cell by an NRG1-driven circuit and unravels a yet unknown cross-regulation between ErbB3 and the two other family members ErbB2 and EGFR. The shift of the receptor surface expression of the ErbB family towards enhanced expression of ErbB2 and EGFR triggered by HCV was found to promote viral RNA replication and infectivity. This suggests that HCV rearranges expression of ErbB family members to adapt the cellular environment to its requirements.	[Stindt, Sabine; Cebula, Patricia; Albrecht, Ute; Keitel, Verena; Haeussinger, Dieter; Bode, Johannes G.] Univ Dusseldorf, Univ Hosp, Fac Med, Dept Gastroenterol Hepatol & Infect Dis, Moorenstr 5, D-40225 Dusseldorf, Germany; [Esch, Jan Schulte Am; Knoefel, Wolfram T.] Univ Dusseldorf, Univ Hosp, Fac Med, Dept Gen Visceral & Pediat Surg, Moorenstr 5, D-40225 Dusseldorf, Germany; [Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, Mol Virol, Heidelberg, Germany; [Bartenschlager, Ralf] German Canc Res Ctr, Div Virus Associated Carcinogenesis, Heidelberg, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Bode, JG (corresponding author), Univ Dusseldorf, Univ Hosp, Fac Med, Dept Gastroenterol Hepatol & Infect Dis, Moorenstr 5, D-40225 Dusseldorf, Germany.	johannes.bode@med.uni-duesseldorf.de	Esch, Jan Schulte am/AAL-9904-2021; Keitel, Verena/AAH-9016-2021; Keitel, Verena/AAF-3471-2019; Bartenschlager, Ralf/L-2582-2015	Esch, Jan Schulte am/0000-0002-2101-5012; Keitel, Verena/0000-0003-1383-7662; Bartenschlager, Ralf/0000-0001-5601-9307	Deutsche Forschungsgemeinschaft [SFB 974]; Virtual Liver Network by the German Federal Ministry of Education and Research (Forderkennzeichen) [0315713]; medical faculty, Heinrich-Heine-University of Dusseldorf; graduate school molecule of infections - Jurgen Manchot foundation;  [FOR 729];  [FOR 1202]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Virtual Liver Network by the German Federal Ministry of Education and Research (Forderkennzeichen); medical faculty, Heinrich-Heine-University of Dusseldorf; graduate school molecule of infections - Jurgen Manchot foundation; ; 	This work was supported by grants from the Deutsche Forschungsgemeinschaft in particular through the collaborative research centre SFB 974 (JGB, DH) and the research units FOR 729 (SSt, JGB, DH) and FOR 1202 (RB). Further funding came from projects of the Virtual Liver Network (UA, JGB) funded by the German Federal Ministry of Education and Research (Forderkennzeichen 0315713) and from intramural research funds of the medical faculty, Heinrich-Heine-University of Dusseldorf (SSt and JGB) as well as from the graduate school molecule of infections funded by the Jurgen Manchot (JGB) foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasthi S, 2014, J CELL PHYSIOL, V229, P1831, DOI 10.1002/jcp.24637; Bauhofer O, 2012, GASTROENTEROLOGY, V143, P429, DOI 10.1053/j.gastro.2012.04.018; Bertelsen V, 2014, MEMBRANES, V4, P424, DOI 10.3390/membranes4030424; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bode JG, 2008, BIOL CHEM, V389, P1283, DOI 10.1515/BC.2008.147; Bode JG, 2009, BIOL CHEM, V390, P1013, DOI 10.1515/BC.2009.118; Brenndorfer ED, 2014, J IMMUNOL, V192, P1671, DOI 10.4049/jimmunol.1301077; Brenndorfer ED, 2009, HEPATOLOGY, V49, P1810, DOI 10.1002/hep.22857; Cao ZW, 2007, MOL CELL BIOL, V27, P2180, DOI 10.1128/MCB.01245-06; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Diao JY, 2012, J VIROL, V86, P10935, DOI 10.1128/JVI.00750-12; Ehlting C, 2015, CELL SIGNAL, V27, P555, DOI 10.1016/j.cellsig.2014.12.016; Eierhoff T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001099; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Frensing T, 2008, BBA-GENE REGUL MECH, V1779, P139, DOI 10.1016/j.bbagrm.2007.11.007; Horiuchi K, 2005, DEV BIOL, V283, P459, DOI 10.1016/j.ydbio.2005.05.004; Kaul A, 2007, J VIROL, V81, P13168, DOI 10.1128/JVI.01362-07; Kim S, 2013, J VIROL, V87, P4214, DOI 10.1128/JVI.00954-12; Liu Z, 2012, J BIOL CHEM, V287, P41922, DOI 10.1074/jbc.M112.414789; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Mattila E, 2005, NAT CELL BIOL, V7, P78, DOI 10.1038/ncb1209; Molleken K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003325; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Osada N, 2013, J PHARMACOL SCI, V122, P251, DOI 10.1254/jphs.13R02CP; Pei RJ, 2011, J GEN VIROL, V92, P2237, DOI 10.1099/vir.0.032581-0; Pietschmann T, 2002, J VIROL, V76, P4008, DOI 10.1128/JVI.76.8.4008-4021.2002; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Presser LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056367; Rahbin N, 2013, BIOCHEM BIOPH RES CO, V433, P31, DOI 10.1016/j.bbrc.2013.02.075; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Tiganis T, 1998, MOL CELL BIOL, V18, P1622, DOI 10.1128/MCB.18.3.1622; VANDYKE MW, 1983, BIOCHEMISTRY-US, V22, P2373, DOI 10.1021/bi00279a011; Waris G, 2005, J VIROL, V79, P9725, DOI 10.1128/JVI.79.15.9725-9734.2005; Zhang HT, 2007, J CLIN INVEST, V117, P2051, DOI 10.1172/JCI32278; Zona L, 2013, CELL HOST MICROBE, V13, P302, DOI 10.1016/j.chom.2013.02.006	37	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148711	10.1371/journal.pone.0148711	http://dx.doi.org/10.1371/journal.pone.0148711			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886748	gold, Green Submitted, Green Published			2022-12-27	WOS:000371218400045
J	Sugden, K; Moffitt, TE; Pinto, L; Poulton, R; Williams, BS; Caspi, A				Sugden, Karen; Moffitt, Terrie E.; Pinto, Lauriane; Poulton, Richie; Williams, Benjamin S.; Caspi, Avshalom			Is Toxoplasma Gondii Infection Related to Brain and Behavior Impairments in Humans? Evidence from a Population-Representative Birth Cohort	PLOS ONE			English	Article							SCHIZOPHRENIA; HEALTH; RISK; SEROPREVALENCE; SEROPOSITIVITY; ASSOCIATION; PERSONALITY; DEPRESSION; DISORDERS; DOPAMINE	Background Toxoplasma gondii (T. gondii) is a protozoan parasite present in around a third of the human population. Infected individuals are commonly asymptomatic, though recent reports have suggested that infection might influence aspects of the host's behavior. In particular, Toxoplasma infection has been linked to schizophrenia, suicide attempt, differences in aspects of personality and poorer neurocognitive performance. However, these studies are often conducted in clinical samples or convenience samples. Methods/Results In a population-representative birth-cohort of individuals tested for presence of antibodies to T. gondii (N = 837) we investigated the association between infection and four facets of human behavior: neuropsychiatric disorder (schizophrenia and major depression), poor impulse control (suicidal behavior and criminality), personality, and neurocognitive performance. Suicide attempt was marginally more frequent among individuals with T. gondii seropositivity (p = .06). Seropositive individuals also performed worse on one out of 14 measures of neuropsychological function. Conclusion On the whole, there was little evidence that T. gondii was related to increased risk of psychiatric disorder, poor impulse control, personality aberrations or neurocognitive impairment.	[Sugden, Karen; Moffitt, Terrie E.; Williams, Benjamin S.; Caspi, Avshalom] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA; [Sugden, Karen; Moffitt, Terrie E.; Pinto, Lauriane; Williams, Benjamin S.; Caspi, Avshalom] Duke Univ, Duke Ctr Genom & Computat Biol, Durham, NC USA; [Moffitt, Terrie E.; Caspi, Avshalom] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC USA; [Moffitt, Terrie E.; Caspi, Avshalom] Kings Coll London, Social Genet & Dev Psychiat Ctr, Inst Psychiat, London WC2R 2LS, England; [Poulton, Richie] Univ Otago, Dept Psychol, Dunedin, New Zealand	Duke University; Duke University; Duke University; University of London; King's College London; University of Otago	Sugden, K (corresponding author), Duke Univ, Dept Psychol & Neurosci, Durham, NC USA.; Sugden, K (corresponding author), Duke Univ, Duke Ctr Genom & Computat Biol, Durham, NC USA.	karen.sugden@duke.edu	caspi, avshalom/AAJ-5874-2020; Sugden, Karen/O-6046-2019; Moffitt, Terrie E/D-5295-2011	caspi, avshalom/0000-0003-0082-4600; Sugden, Karen/0000-0002-4076-5927; Moffitt, Terrie E/0000-0002-8589-6760; Pinto, Lauriane/0000-0003-4160-1710	New Zealand Health Research Council; US National Institute on Aging (NIA) [AG032282, AG048895]; UK Medical Research Council [MR/K00381X]; Jacobs Foundation; NATIONAL INSTITUTE ON AGING [R01AG048895, P30AG034424, R01AG032282] Funding Source: NIH RePORTER; Medical Research Council [MR/K00381X/1] Funding Source: researchfish; MRC [MR/K00381X/1] Funding Source: UKRI	New Zealand Health Research Council(Health Research Council of New Zealand); US National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Jacobs Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Dunedin Multidisciplinary Health and Development Research Unit is supported by the New Zealand Health Research Council (http://www.hrc.govt.nz/; RP). This research received support from US National Institute on Aging (NIA: https://www.nia.nih.gov/) grants AG032282, AG048895 (AC and TEM), and UK Medical Research Council (http://www.mrc.ac.uk/) grant MR/K00381X (AC and TEM). Additional support was provided by the Jacobs Foundation (http://jacobsfoundation.org/) Jacobs Prize 2010 (AC and TEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado-Esquivel C, 2014, EUR J MICROBIOL IMMU, V4, P76, DOI 10.1556/EuJMI.4.2014.1.7; [Anonymous], 1944, ARM IND BATT MAN DIR; Arling TA, 2009, J NERV MENT DIS, V197, P905, DOI 10.1097/NMD.0b013e3181c29a23; Beste C, 2014, NEUROBIOL AGING, V35, P1037, DOI 10.1016/j.neurobiolaging.2013.11.012; Bondy B, 2011, WORLD J BIOL PSYCHIA, V12, P81, DOI 10.3109/15622975.2010.546428; Borsini A, 2015, TRENDS NEUROSCI, V38, P145, DOI 10.1016/j.tins.2014.12.006; Carruthers VB, 2007, SCHIZOPHRENIA BULL, V33, P745, DOI 10.1093/schbul/sbm008; Cook TB, 2015, J PSYCHIATR RES, V60, P87, DOI 10.1016/j.jpsychires.2014.09.019; Flegr J, 2003, BIOL PSYCHOL, V63, P253, DOI 10.1016/S0301-0511(03)00075-9; Flegr J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090203; Flegr J, 2013, J EXP BIOL, V216, P127, DOI 10.1242/jeb.073635; Furtado JM, 2011, J GLOB INFECT DIS, V3, P281, DOI 10.4103/0974-777X.83536; Gale SD, 2014, FOLIA PARASIT, V61, P285, DOI 10.14411/fp.2014.038; Goldman-Mellor SJ, 2014, JAMA PSYCHIAT, V71, P119, DOI 10.1001/jamapsychiatry.2013.2803; Hanauer DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070585; Havlicek J, 2001, PARASITOLOGY, V122, P515, DOI 10.1017/S0031182001007624; Ingram WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075246; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Israel S, 2014, J PERS SOC PSYCHOL, V106, P484, DOI 10.1037/a0035687; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; Jones JL, 2001, AM J EPIDEMIOL, V154, P357, DOI 10.1093/aje/154.4.357; Kannan G, 2010, FOLIA PARASIT, V57, P151, DOI 10.14411/fp.2010.019; Kar N, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-1; Khandaker GM, 2015, LANCET PSYCHIAT, V2, P258, DOI 10.1016/S2215-0366(14)00122-9; Kocazeybek B, 2009, FORENSIC SCI INT, V187, P103, DOI 10.1016/j.forsciint.2009.03.007; Lester D, 2012, PSYCHOL REP, V111, P196, DOI 10.2466/12.15.16.PR0.111.4.196-197; Lester D, 2010, PSYCHOL REP, V107, P424, DOI 10.2466/12.13.PR0.107.5.424; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Ling VJ, 2011, J NERV MENT DIS, V199, P440, DOI 10.1097/NMD.0b013e318221416e; Mcauliffe K, 2012, ATLANTIC; McLeod R, 2009, MEM I OSWALDO CRUZ, V104, P320, DOI 10.1590/S0074-02762009000200029; Meier MH, 2014, AM J PSYCHIAT, V171, P91, DOI 10.1176/appi.ajp.2013.12111438; Meier MH, 2012, P NATL ACAD SCI USA, V109, pE2657, DOI 10.1073/pnas.1206820109; Najjar S, 2015, SCHIZOPHR RES, V161, P102, DOI 10.1016/j.schres.2014.04.041; Parlog A, 2015, PARASITE IMMUNOL, V37, P159, DOI 10.1111/pim.12157; Pearce BD, 2012, BIOL PSYCHIAT, V72, P290, DOI 10.1016/j.biopsych.2012.01.003; Poulton R, 2006, NZ MED J, V119, P1235; Poulton R, 2015, SOC PSYCH PSYCH EPID, V50, P679, DOI 10.1007/s00127-015-1048-8; Prandovszky E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023866; Priplatova L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112771; SAHAKIAN BJ, 1992, J ROY SOC MED, V85, P399; Torrey EF, 2012, SCHIZOPHRENIA BULL, V38, P642, DOI 10.1093/schbul/sbs043; Torrey EF, 2003, EMERG INFECT DIS, V9, P1375, DOI 10.3201/eid0911.030143; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wechsler D., 2012, WAIS 4 KASIKIRJA; Xiao J, 2014, NEUROSCIENCE, V268, P128, DOI 10.1016/j.neuroscience.2014.03.015; Yagmur F, 2010, FORENSIC SCI INT, V199, P15, DOI 10.1016/j.forsciint.2010.02.020; Yereli K, 2006, FORENSIC SCI INT, V163, P34, DOI 10.1016/j.forsciint.2005.11.002; Zhu XL, 2014, NAT NEUROSCI, V17, P773, DOI 10.1038/nn.3713	49	83	83	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148435	10.1371/journal.pone.0148435	http://dx.doi.org/10.1371/journal.pone.0148435			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3BJ	26886853	Green Submitted, Green Published, gold			2022-12-27	WOS:000371218400035
J	Itz, ML; Schweinberger, SR; Kaufmann, JM				Itz, Marlena L.; Schweinberger, Stefan R.; Kaufmann, Juergen M.			Effects of Caricaturing in Shape or Color on Familiarity Decisions for Familiar and Unfamiliar Faces	PLOS ONE			English	Article							OWN-RACE BIAS; SURFACE REFLECTANCE; PROCESSING STAGES; RECOGNITION; BRAIN; PERCEPTION; REPRESENTATIONS; DISTINCTIVENESS; ATTRACTIVENESS; DISCRIMINATION	Recent evidence suggests that while reflectance information (including color) may be more diagnostic for familiar face recognition, shape may be more diagnostic for unfamiliar face identity processing. Moreover, event-related potential (ERP) findings suggest an earlier onset for neural processing of facial shape compared to reflectance. In the current study, we aimed to explore specifically the roles of facial shape and color in a familiarity decision task using pre-experimentally familiar (famous) and unfamiliar faces that were caricatured either in shape-only, color-only, or both (full; shape + color) by 15%, 30%, or 45%. We recorded accuracies, mean reaction times, and face-sensitive ERPs. Performance data revealed that shape caricaturing facilitated identity processing for unfamiliar faces only. In the ERP data, such effects of shape caricaturing emerged earlier than those of color caricaturing. Unsurprisingly, ERP effects were accentuated for larger levels of caricaturing. Overall, our findings corroborate the importance of shape for identity processing of unfamiliar faces and demonstrate an earlier onset of neural processing for facial shape compared to color.	[Itz, Marlena L.; Schweinberger, Stefan R.; Kaufmann, Juergen M.] Univ Jena, Dept Gen Psychol & Cognit Neurosci, Jena, Germany; [Schweinberger, Stefan R.] Univ Jena, DFG Res Unit Person Percept, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Itz, ML (corresponding author), Univ Jena, Dept Gen Psychol & Cognit Neurosci, Jena, Germany.	marlena.itz@uni-jena.de	Schweinberger, Stefan/A-1860-2009; Itz, Marlena/GOP-0516-2022	Schweinberger, Stefan/0000-0001-5762-0188; 	Deutsche Forschungsgemeinschaft (DFG) [KA 2997/2-1, KA 2997/3-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG; http://www.dfg.de/) Grant KA 2997/2-1 to JMK, and Grant KA 2997/3-2 to JMK and SRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2007, ENCYCLOPEDIA OF MEAS; Allen H, 2009, PERCEPTION, V38, P1821, DOI 10.1068/p6424; Bach M, 1997, VISION RES, V37, P1845, DOI 10.1016/S0042-6989(96)00317-3; Barragan-Jason G, 2015, NEUROPSYCHOLOGIA, V75, P390, DOI 10.1016/j.neuropsychologia.2015.06.017; BEALE JM, 1995, COGNITION, V57, P217, DOI 10.1016/0010-0277(95)00669-X; BENSON PJ, 1994, PERCEPTION, V23, P75, DOI 10.1068/p230075; Bentin S, 2000, COGN NEUROPSYCHOL, V17, P35, DOI 10.1080/026432900380472; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bruce V, 1999, J EXP PSYCHOL-APPL, V5, P339, DOI 10.1037/1076-898X.5.4.339; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Burton AM, 2015, PERSPECT PSYCHOL SCI, V10, P482, DOI 10.1177/1745691615583129; Burton AM, 2013, Q J EXP PSYCHOL, V66, P1467, DOI 10.1080/17470218.2013.800125; Burton AM, 2010, BEHAV RES METHODS, V42, P286, DOI 10.3758/BRM.42.1.286; Caharel S, 2009, NEUROIMAGE, V47, P1809, DOI 10.1016/j.neuroimage.2009.05.065; Chen J, 2010, INT J ROBOT AUTOM, V25, P162, DOI 10.2316/Journal.206.2010.2.206-3386; Dzhelyova M, 2014, J VISION, V14, DOI 10.1167/14.14.15; Eimer M, 2000, CLIN NEUROPHYSIOL, V111, P694, DOI 10.1016/S1388-2457(99)00285-0; Eimer M., 2012, OXFORD HDB FACE PERC, DOI [10.1093/oxfordhb/9780199559053.013.0017, DOI 10.1093/OXFORDHB/9780199559053.013.0017]; Gosling A, 2011, NEUROPSYCHOLOGIA, V49, P2736, DOI 10.1016/j.neuropsychologia.2011.05.025; Hancock PJB, 2000, TRENDS COGN SCI, V4, P330, DOI 10.1016/S1364-6613(00)01519-9; Henke K, 1998, CORTEX, V34, P289, DOI 10.1016/S0010-9452(08)70756-1; Huynh H, 1976, J EDUC STATIST, V1, P69, DOI DOI 10.3102/10769986001001069; Irons J, 2014, J VISION, V14, DOI 10.1167/14.2.12; Itz ML, 2014, NEUROIMAGE, V102, P736, DOI 10.1016/j.neuroimage.2014.08.042; Johnston RA, 2009, MEMORY, V17, P577, DOI 10.1080/09658210902976969; Kaufmann JM, 2008, BRAIN RES, V1228, P177, DOI 10.1016/j.brainres.2008.06.092; Kaufmann JM, 2013, NEUROPSYCHOLOGIA, V51, P1310, DOI 10.1016/j.neuropsychologia.2013.03.015; Kaufmann JM, 2012, BIOL PSYCHOL, V89, P21, DOI 10.1016/j.biopsycho.2011.08.011; Kaufmann JM, 2009, J COGNITIVE NEUROSCI, V21, P625, DOI 10.1162/jocn.2009.21080; Keil A, 2014, PSYCHOPHYSIOLOGY, V51, P1, DOI 10.1111/psyp.12147; Kemp R, 1997, APPL COGNITIVE PSYCH, V11, P211; Latinus M, 2006, BRAIN RES, V1123, P179, DOI 10.1016/j.brainres.2006.09.031; Lee KJ, 1997, PERCEPTION, V26, P733, DOI 10.1068/p260733; Lee KJ, 2000, PERCEPTION, V29, P1291, DOI 10.1068/p2792; Lix LM, 1996, REV EDUC RES, V66, P579, DOI 10.3102/00346543066004579; McIntyre AH, 2013, APPL COGNITIVE PSYCH, V27, P725, DOI 10.1002/acp.2966; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Perkins D., 1975, STUD VIS COMMUN, V2, P1, DOI [10.1525/var.1975.2.1.1, DOI 10.1525/VAR.1975.2.1.1]; Perrett DI, 2002, P ROY SOC B-BIOL SCI, V269, P873, DOI 10.1098/rspb.2002.1971; Phillips PJ, 2000, IEEE T PATTERN ANAL, V22, P1090, DOI 10.1109/34.879790; Phillips PJ, 1998, IMAGE VISION COMPUT, V16, P295, DOI 10.1016/S0262-8856(97)00070-X; RHODES G, 1987, COGNITIVE PSYCHOL, V19, P473, DOI 10.1016/0010-0285(87)90016-8; Rhodes G, 1996, SUPERPORTRAITS CARIC; Richler JJ, 2009, VISION RES, V49, P2856, DOI 10.1016/j.visres.2009.08.025; Russell R, 2007, VISION RES, V47, P157, DOI 10.1016/j.visres.2006.11.002; Schulz C, 2012, NEUROIMAGE, V63, P491, DOI 10.1016/j.neuroimage.2012.06.080; Schulz C, 2012, NEUROPSYCHOLOGIA, V50, P2426, DOI 10.1016/j.neuropsychologia.2012.06.013; Schweinberger S. R, 2011, OXFORD HDB FACE PERC, P345, DOI DOI 10.1093/OXFORDHB/9780199559053.013.0018; Schweinberger SR, 1996, J EXP PSYCHOL LEARN, V22, P1383, DOI 10.1037/0278-7393.22.6.1383; Schweinberger SR, 2003, CORTEX, V39, P9, DOI 10.1016/S0010-9452(08)70071-6; Schweinberger SR, CORTEX IN PRESS; Stahl J, 2008, NEUROREPORT, V19, P583, DOI 10.1097/WNR.0b013e3282f97b4d; STEVENAGE SV, 1995, BRIT J PSYCHOL, V86, P127, DOI 10.1111/j.2044-8295.1995.tb02550.x; Sutherland C, 2015, A BASIC GUIDE TO PSY; Tanaka JW, 2006, J COGNITIVE NEUROSCI, V18, P1488, DOI 10.1162/jocn.2006.18.9.1488; Vakli P, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00426; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Van den Stock J, 2013, J NEUROPSYCH CLIN N, V25, pE52, DOI 10.1176/appi.neuropsych.12120390; Van den Stock J, 2012, CORTEX, V48, P1088, DOI 10.1016/j.cortex.2012.03.003; White D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103510; Wiese H, 2014, NEUROPSYCHOLOGIA, V56, P26, DOI 10.1016/j.neuropsychologia.2013.12.023; Wiese H, 2014, CEREB CORTEX, V24, P826, DOI 10.1093/cercor/bhs369; Zimmermann FGS, 2013, NEUROPSYCHOLOGIA, V51, P1320, DOI 10.1016/j.neuropsychologia.2013.03.028	63	14	16	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149796	10.1371/journal.pone.0149796	http://dx.doi.org/10.1371/journal.pone.0149796			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26900690	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100151
J	Khan, MU; Hassali, MAA; Ahmad, A; Elkalmi, RM; Zaidi, STR; Dhingra, S				Khan, Muhammad Umair; Hassali, Mohamed Azmi Ahmad; Ahmad, Akram; Elkalmi, Ramadan Mohamed; Zaidi, Syed Tabish Razi; Dhingra, Sameer			Perceptions and Practices of Community Pharmacists towards Antimicrobial Stewardship in the State of Selangor, Malaysia	PLOS ONE			English	Article							ANTIBIOTIC USE; INFECTIOUS-DISEASES; PRACTITIONERS; RESISTANCE; PENICILLIN; SETTINGS; EPIDEMIC	Background Increasing antimicrobial resistance is one of the pressing concerns globally. Injudicious use of antibiotics is one of the modifiable factors responsible for antimicrobial resistance. Given the widespread use of antimicrobials in community settings, pharmacists have an important role in ensuring appropriate use of antibiotics. The objective of this study was to assess the perception and self-reported practices of community pharmacists towards antimicrobial stewardship. Methods A cross-sectional study was conducted among community pharmacists between March-April, 2015, using a self-administered, pre-tested questionnaire in the State of Selangor, Malaysia. A simple random sampling approach was used to select pharmacy sites. Descriptive and inferential statistical methods were used to analyse the data. Results A total of 188 pharmacists responded to the survey, giving a response rate of 83.5%. The majority of participants (n = 182, 96.8%) believed that antimicrobial stewardship program helps healthcare professionals to improve the quality of patient care. However, more than half of pharmacists were neutral in their opinion about the incorporation of antimicrobial stewardship programs in community pharmacies (n = 102, 54.2%). Though collaboration was often done by pharmacists with other health professionals over the use of antibiotics (n = 104, 55.3%), a significant proportion of participants (n = 102, 54.2%) rarely/occasionally participate in antimicrobial awareness campaigns. Pharmacists having postgraduate qualification were more likely to held positive perceptions of, and were engaged in, antimicrobial stewardship than their non-postgraduate counterpart (p<0.05). Similarly, more experienced pharmacists (> 10 years) held positive perceptions towards antimicrobial stewardship (p<0.05). Conclusion The study highlighted some gaps in the perception and practices of community pharmacist towards antimicrobial stewardship. Development of customized interventions would be critical to bridging these gaps and improve their perception and practices towards antimicrobial stewardship.	[Khan, Muhammad Umair; Ahmad, Akram] UCSI Univ, Fac Pharmaceut Sci, Dept Clin Pharm, Kuala Lumpur, Malaysia; [Hassali, Mohamed Azmi Ahmad] Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Social & Adm Pharm, Student Affairs & Networking, George Town, Malaysia; [Elkalmi, Ramadan Mohamed] Int Islamic Univ Malaysia, Kulliyyah Pharm, Dept Pharm Practice, Kuantan Campus, Pahang, Malaysia; [Zaidi, Syed Tabish Razi] Univ Tasmania, Fac Hlth, Sch Med, Pharm, Hobart, Tas, Australia; [Dhingra, Sameer] Univ W Indies, Fac Med Sci, Sch Pharm, Eric Williams Med Sci Complex, Uriah Butler Highway, Champ Fleurs, Trinidad Tobago	UCSI University; Universiti Sains Malaysia; International Islamic University Malaysia; University of Tasmania; University West Indies Mona Jamaica; University West Indies Saint Augustine	Dhingra, S (corresponding author), Univ W Indies, Fac Med Sci, Sch Pharm, Eric Williams Med Sci Complex, Uriah Butler Highway, Champ Fleurs, Trinidad Tobago.	sameer.dhingra@sta.uwi.edu	Hassali, Mohamed Azmi/A-6895-2011; Dhingra, Sameer/AFS-2976-2022; Dhingra, Sameer/AAT-1873-2021; ELKALMI, RAMADAN M./ABG-1872-2021; Ahmad, Akram/P-7368-2015	Hassali, Mohamed Azmi/0000-0001-9575-403X; Dhingra, Sameer/0000-0003-2537-8889; ELKALMI, RAMADAN M./0000-0002-6659-5049; Ahmad, Akram/0000-0002-9998-5860				Abbo L, 2012, JNP-J NURSE PRACT, V8, P370, DOI 10.1016/j.nurpra.2012.01.023; Adriaenssens N, 2011, J ANTIMICROB CHEMOTH, V66, P3, DOI 10.1093/jac/dkr453; Alabdi A, 2010, J PHARM PRACT RES, V40, P164; Alabid AHMA, 2014, J CLIN DIAGN RES, V8, P119, DOI 10.7860/JCDR/2014/6199.3923; Babar ZUD, 2007, PLOS MED, V4, P466, DOI 10.1371/journal.pmed.0040082; Broom A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008326; Centers for Disease Control and Prevention, 2013, ANT RES THREATS US; Cotta M. O., 2014, Healthcare Infection, V19, P89, DOI 10.1071/HI14008; de Kraker MEA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001104; Nga DTT, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-6; Drekonja DM, 2015, INFECT CONT HOSP EP, V36, P142, DOI 10.1017/ice.2014.41; Goldstein EJC, 2011, CURR OPIN INFECT DIS, V24, pS21, DOI 10.1097/01.qco.0000393485.17894.4c; Gottlieb Thomas, 2011, Med J Aust, V194, P281; Guillemot D, 2005, CLIN INFECT DIS, V41, P930, DOI 10.1086/432721; Hand K, 2007, J ANTIMICROB CHEMOTH, V60, pI73, DOI 10.1093/jac/dkm163; Howard P, 2014, ORGAN, V18; Kardas P, 2005, INT J ANTIMICROB AG, V26, P106, DOI 10.1016/j.ijantimicag.2005.04.017; Lee GC, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-96; Leung E, 2011, B WORLD HEALTH ORGAN, V89, P390, DOI 10.2471/BLT.11.088435; Lim Ka Keat, 2012, South Med Rev, V5, P26; Lim V, 2012, INT J SCI MED ED, V6, pS75; MacDougall C, 2005, CLIN MICROBIOL REV, V18, P638, DOI 10.1128/CMR.18.4.638-656.2005; Nasrin D, 2002, BRIT MED J, V324, P28, DOI 10.1136/bmj.324.7328.28; Pawluk Shane, 2015, Int J Pharm Pract, V23, P77, DOI 10.1111/ijpp.12108; Raosoft, 2008, ONL SAMPL SIZ CALC; Rosenthal VD, 2012, AM J INFECT CONTROL, V40, P396, DOI 10.1016/j.ajic.2011.05.020; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Struelens MJ, 2003, CURR OPIN INFECT DIS, V16, P305, DOI 10.1097/00001432-200308000-00001; Teng CL, 2006, J PAEDIATR CHILD H, V42, P612, DOI 10.1111/j.1440-1754.2006.00937.x; Viale P, 2015, INFECT DIS THER, V4, P65, DOI 10.1007/s40121-015-0081-y; Zaidi AKM, 2004, BMJ-BRIT MED J, V328, P811, DOI 10.1136/bmj.328.7443.811	32	15	15	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149623	10.1371/journal.pone.0149623	http://dx.doi.org/10.1371/journal.pone.0149623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901404	gold, Green Published, Green Submitted			2022-12-27	WOS:000371276100112
J	Ma, JH; Thabane, L; Beyene, J; Raina, P				Ma, Jinhui; Thabane, Lehana; Beyene, Joseph; Raina, Parminder			Power Analysis for Population-Based Longitudinal Studies Investigating Gene-Environment Interactions in Chronic Diseases: A Simulation Study	PLOS ONE			English	Article							HAZARDS REGRESSION-MODEL; SAMPLE-SIZE; MISCLASSIFICATION; ASSOCIATIONS; EPIGENETICS; SURVIVAL; AGE	Conventional methods for sample size calculation for population-based longitudinal studies tend to overestimate the statistical power by overlooking important determinants of the required sample size, such as the measurement errors and unmeasured etiological determinants, etc. In contrast, a simulation-based sample size calculation, if designed properly, allows these determinants to be taken into account and offers flexibility in accommodating complex study design features. The Canadian Longitudinal Study on Aging (CLSA) is a Canada-wide, 20-year follow-up study of 30,000 people between the ages of 45 and 85 years, with in-depth information collected every 3 years. A simulation study, based on an illness-death model, was conducted to: (1) investigate the statistical power profile of the CLSA to detect the effect of environmental and genetic risk factors, and their interaction on age-related chronic diseases; and (2) explore the design alternatives and implementation strategies for increasing the statistical power of population-based longitudinal studies in general. The results showed that the statistical power to identify the effect of environmental and genetic risk exposures, and their interaction on a disease was boosted when: (1) the prevalence of the risk exposures increased; (2) the disease of interest is relatively common in the population; and (3) risk exposures were measured accurately. In addition, the frequency of data collection every three years in the CLSA led to a slightly lower statistical power compared to the design assuming that participants underwent health monitoring continuously. The CLSA had sufficient power to detect a small (1< hazard ratio (HR) <= 1.5) or moderate effect (1.5< HR <= 2.0) of the environmental risk exposure, as long as the risk exposure and the disease of interest were not rare. It had enough power to detect a moderate or large (2.0< HR <= 3.0) effect of the genetic risk exposure when the prevalence of the risk exposure was not very low (>= 0.1) and the disease of interest was not rare (such as diabetes and dementia). The CLSA had enough power to detect a large effect of the gene-environment interaction only when both risk exposures had relatively high prevalence (0.2) and the disease of interest was very common (such as diabetes). The minimum detectable hazard ratios (MDHR) of the CLSA for the environmental and genetic risk exposures obtained from this simulation study were larger than those calculated according to the conventional sample size calculation method. For example, the MDHR for the environmental risk exposure was 1.15 according to the conventional method if the prevalence of the risk exposure was 0.1 and the disease of interest was dementia. In contrast, the MDHR was 1.61 if the same exposure was measured every 3 years with a misclassification rate of 0.1 according to this simulation study. With a given sample size, higher statistical power could be achieved by increasing the measuring frequency in participants with high risk of declining health status or changing risk exposures, and by increasing measurement accuracy of diseases and risk exposures. A properly designed simulation-based sample size calculation is superior to conventional methods when rigorous sample size calculation is necessary.	[Ma, Jinhui; Thabane, Lehana; Beyene, Joseph; Raina, Parminder] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Ma, Jinhui; Raina, Parminder] McMaster Univ, Evidence Based Practice Ctr, Hamilton, ON, Canada; [Ma, Jinhui; Thabane, Lehana] St Josephs Healthcare Hamilton, Biostat Unit, Hamilton, ON, Canada; [Thabane, Lehana] St Josephs Healthcare Hamilton, Ctr Evaluat Med, Hamilton, ON, Canada; [Thabane, Lehana] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Ma, Jinhui] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada; [Ma, Jinhui] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; Population Health Research Institute; University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario	Raina, P (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.; Raina, P (corresponding author), McMaster Univ, Evidence Based Practice Ctr, Hamilton, ON, Canada.	praina@mcmaster.ca			Canadian Longitudinal Study on Aging - Canadian Institutes of Health Research (CIHR); Canadian Network and Centre for Trials Internationally (CANNeCTIN) program; Drug Safety and Effectiveness Cross-Disciplinary Training (DSECT) Program	Canadian Longitudinal Study on Aging - Canadian Institutes of Health Research (CIHR); Canadian Network and Centre for Trials Internationally (CANNeCTIN) program; Drug Safety and Effectiveness Cross-Disciplinary Training (DSECT) Program	This study was supported in part by funds from the Canadian Longitudinal Study on Aging (which is funded in part by the Canadian Institutes of Health Research (CIHR)), Canadian Network and Centre for Trials Internationally (CANNeCTIN) program, and the Drug Safety and Effectiveness Cross-Disciplinary Training (DSECT) Program in the form of studentship and training awards for the first author.	Barsh GS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002812; Blair A, 2007, AM J IND MED, V50, P199, DOI 10.1002/ajim.20281; Calvanese V, 2009, AGEING RES REV, V8, P268, DOI 10.1016/j.arr.2009.03.004; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Collins FS, 2004, NATURE, V429, P475, DOI 10.1038/nature02628; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Garcia-Closas M, 1999, CANCER EPIDEM BIOMAR, V8, P1043; Grigorenko EL, 2005, J GERONTOL B-PSYCHOL, V60, P53, DOI 10.1093/geronb/60.Special_Issue_1.53; Hsieh FY, 2000, CONTROL CLIN TRIALS, V21, P552, DOI 10.1016/S0197-2456(00)00104-5; Khoury MJ, 2007, INT J EPIDEMIOL, V36, P439, DOI 10.1093/ije/dyl253; LACHIN JM, 1986, BIOMETRICS, V42, P507, DOI 10.2307/2531201; Lamarca R, 1998, J GERONTOL A-BIOL, V53, pM337, DOI 10.1093/gerona/53A.5.M337; Meira-Machado L, 2009, STAT METHODS MED RES, V18, P195, DOI 10.1177/0962280208092301; Raina PS, 2009, CAN J AGING, V28, P221, DOI 10.1017/S0714980809990055; SCHOENFELD DA, 1983, BIOMETRICS, V39, P499, DOI 10.2307/2531021; Thompson EA, 2002, BIOSTATISTICAL GENET, P386; van den Hout A, 2009, STAT METHODS MED RES, V18, P145, DOI 10.1177/0962280208089090	17	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149940	10.1371/journal.pone.0149940	http://dx.doi.org/10.1371/journal.pone.0149940			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901422	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100190
J	Nematollahi, M; Razeghi, M; Mehdizadeh, S; Tabatabaee, H; Piroozi, S; Shirazi, ZR; Rafiee, A				Nematollahi, Mohammadreza; Razeghi, Mohsen; Mehdizadeh, Sina; Tabatabaee, Hamidreza; Piroozi, Soraya; Shirazi, Zahra Rojhani; Rafiee, Ali			Inter-Segmental Coordination Pattern in Patients with Anterior Cruciate Ligament Deficiency during a Single-Step Descent	PLOS ONE			English	Article							GAIT ADAPTATIONS; INTRALIMB COORDINATION; JOINT COORDINATION; MOVEMENT PATTERNS; VARIABILITY; RECONSTRUCTION; WALKING; KNEE; STABILITY; MECHANICS	Anterior cruciate ligament injury is a debilitating pathology which may alter lower limb coordination pattern in both intact and affected lower extremities during activities of daily living. Emerging evidence supports the notion that kinematic variables may not be a good indicator to differentiate patients with anterior cruciate ligament deficiency during step descent task. The aim of the present study was to examine alterations in kinematics as well as coordination patterns and coordination variability of both limbs of these patients during a single step descent task. Continuous relative phase technique was used to measure coordination pattern and coordination variability between a group of anterior cruciate ligament deficient (n = 23) and a healthy control group (n = 23). A third order polynomial Curve fitting was utilized to provide a curve that best fitted to the data points of coordination pattern and coordination variability of the healthy control group. This was considered as a reference to compare to that of patient group using nonlinear regression analysis. The results of the present study demonstrated an altered coordination pattern of the supporting shank-thigh and the stepping foot-shank couplings in anterior cruciate ligament deficient subjects. It was further noticed that there was an increased coordination variability in foot-shank and shank-thigh couplings of both supporting and stepping legs. There was no significant difference in the hip, knee and ankle joints kinematics in either side of these patients. Anterior cruciate ligament deficient individuals showed altered strategies in both intact and affected legs, with increased coordination variability. Kinematic data did not indicate any significant difference between the two groups. It could be concluded that more sophisticated dynamic approach such as continuous relative phase would uncover discrepancies between the healthy and anterior cruciate ligament deficient individuals.	[Nematollahi, Mohammadreza; Razeghi, Mohsen; Piroozi, Soraya; Shirazi, Zahra Rojhani] Shiraz Univ Med Sci, Sch Rehabil Sci, Dept Physiotherapy, Shiraz, Iran; [Mehdizadeh, Sina] Amirkabir Univ Technol, Fac Biomed Engn, Biomech & Sports Engn Grp, Tehran, Iran; [Tabatabaee, Hamidreza] Shiraz Univ Med Sci, Sch Hlth, Dept Epidemiol, Shiraz, Iran; [Rafiee, Ali] Azad Univ, Kazeroon Branch, Dept Elect, Kazeroon, Iran	Shiraz University of Medical Science; Amirkabir University of Technology; Shiraz University of Medical Science	Razeghi, M (corresponding author), Shiraz Univ Med Sci, Sch Rehabil Sci, Dept Physiotherapy, Shiraz, Iran.	razeghm@sums.ac.ir	Razeghi, Mohsen/F-4344-2012; Razeghi, Mohsen/L-6634-2016; Rojhani-Shirazi, Zahra/H-2397-2016; Mehdizadeh, Sina/AAR-8923-2020; Pirouzi, Soraya/H-6255-2016	Razeghi, Mohsen/0000-0003-2179-851X; Razeghi, Mohsen/0000-0003-2179-851X; Rojhani-Shirazi, Zahra/0000-0003-2878-9560; Mehdizadeh, Sina/0000-0002-8598-6176; Pirouzi, Soraya/0000-0002-2236-6551				ANDRIACCHI TP, 1980, J BONE JOINT SURG AM, V62, P749, DOI 10.2106/00004623-198062050-00008; Barela JA, 2000, HUM MOVEMENT SCI, V19, P251, DOI 10.1016/S0167-9457(00)00014-2; BERCHUCK M, 1990, J BONE JOINT SURG AM, V72A, P871, DOI 10.2106/00004623-199072060-00012; Briggs KK, 2006, J BONE JOINT SURG AM, V88A, P698, DOI 10.2106/JBJS.E.00339; Button K, 2008, PHYS THER SPORT, V9, P97, DOI 10.1016/j.ptsp.2008.03.001; Chiu SL, 2010, GAIT POSTURE, V32, P656, DOI 10.1016/j.gaitpost.2010.09.015; Chmielewski TL, 2004, J ORTHOP RES, V22, P925, DOI 10.1016/j.orthres.2004.01.007; Crowther RG, 2008, CLIN BIOMECH, V23, P357, DOI 10.1016/j.clinbiomech.2007.10.009; DeVita P, 1997, MED SCI SPORT EXER, V29, P853, DOI 10.1097/00005768-199707000-00003; Ferber R, 2004, CLIN BIOMECH, V19, P136, DOI 10.1016/j.clinbiomech.2003.10.008; Ferber R, 2002, CLIN BIOMECH, V17, P274, DOI 10.1016/S0268-0033(02)00016-5; Gao B, 2012, HUM MOVEMENT SCI, V31, P222, DOI 10.1016/j.humov.2011.04.009; Hamill J, 1999, CLIN BIOMECH, V14, P297, DOI 10.1016/S0268-0033(98)90092-4; Hamill J, 2000, J APPL BIOMECH, V16, P407, DOI 10.1123/jab.16.4.407; Hart JM, 2010, CLIN BIOMECH, V25, P277, DOI 10.1016/j.clinbiomech.2009.12.004; Heiderscheit BC, 2002, J APPL BIOMECH, V18, P110, DOI 10.1123/jab.18.2.110; Hsu WL, 2012, HUM MOVEMENT SCI, V31, P844, DOI 10.1016/j.humov.2011.07.017; Hurd WI, 2007, J ORTHOP RES, V25, P1369, DOI 10.1002/jor.20440; Ingersoll CD, 2008, CLIN SPORT MED, V27, P383, DOI 10.1016/j.csm.2008.03.004; Kiefer AW, 2013, GAIT POSTURE, V37, P149, DOI 10.1016/j.gaitpost.2012.05.005; Knoll Z, 2004, KNEE SURG SPORT TR A, V12, P7, DOI 10.1007/s00167-003-0440-1; Kurz MJ, 2005, KNEE SURG SPORT TR A, V13, P107, DOI 10.1007/s00167-004-0554-0; Kuster M, 1995, KNEE, V2, P105; Lark SD, 2004, EUR J APPL PHYSIOL, V91, P287, DOI 10.1007/s00421-003-0981-5; Lysholm M, 1998, SCAND J MED SCI SPOR, V8, P432; Pollard CD, 2005, J APPL BIOMECH, V21, P143, DOI 10.1123/jab.21.2.143; Richards J, 2008, BIOMECHANICS CLIN RE, P181; Rudolph KS, 2004, J ELECTROMYOGR KINES, V14, P565, DOI 10.1016/j.jelekin.2004.03.002; Rudolph KS, 1998, J ELECTROMYOGR KINES, V8, P349, DOI 10.1016/S1050-6411(97)00042-4; Seay JF, 2011, CLIN BIOMECH, V26, P572, DOI 10.1016/j.clinbiomech.2010.11.012; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; van Uden CJT, 2003, CLIN BIOMECH, V18, P84, DOI 10.1016/S0268-0033(02)00170-5; Wexler G, 1998, CLIN ORTHOP RELAT R, P166; Wilson C, 2008, SPORT BIOMECH, V7, P2, DOI 10.1080/14763140701682983; ZACHAZEWSKI JE, 1993, J REHABIL RES DEV, V30, P412	35	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149837	10.1371/journal.pone.0149837	http://dx.doi.org/10.1371/journal.pone.0149837			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900698	Green Submitted, Green Published, gold			2022-12-27	WOS:000371276100162
J	Chen, YM; Lai, CH; Chang, HC; Chao, TY; Tseng, CC; Fang, WF; Wang, CC; Chung, YH; Wang, YH; Su, MC; Liu, SF; Huang, KT; Chen, HC; Chang, YC; Lin, MC				Chen, Yu-Mu; Lai, Chien-Hao; Chang, Huang-Chih; Chao, Tung-Ying; Tseng, Chia-Cheng; Fang, Wen-Feng; Wang, Chin-Chou; Chung, Yu-Hsiu; Wang, Yi-Hsi; Su, Mao-Chang; Liu, Shih-Feng; Huang, Kuo-Tung; Chen, Hung-Chen; Chang, Ya-Chun; Lin, Meng-Chih			Antacid Use and De Novo Brain Metastases in Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Who Were Treated Using First-Line First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors	PLOS ONE			English	Article							NERVOUS-SYSTEM METASTASES; PHASE-III; ERLOTINIB; GEFITINIB; MUTATIONS; CHEMOTHERAPY; THERAPY; TAIWAN; TUMORS; NSCLC	Background Antacid treatments decrease the serum concentrations of first-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs), although it is unknown whether antacids affect clinical outcomes. As cerebrospinal fluid concentrations of TKIs are much lower than serum concentrations, we hypothesized that this drug-drug interaction might affect the prognosis of patients with de novo brain metastases. Materials and Methods This retrospective study evaluated 269 patients with EGFR-mutant non-small cell lung cancer (NSCLC) who had been diagnosed between December 2010 and December 2013, and had been treated using first-line first-generation EGFR-TKIs. Among these patients, we identified patients who concurrently used H2 receptor antagonists (H2RAs) and proton pump inhibitors (PPIs) as antacids. Patients who exhibited >30% overlap between the use of TKIs and antacids were considered antacid users. Results Fifty-seven patients (57/269, 21.2%) were antacid users, and antacid use did not significantly affect progression-free survival (PFS; no antacids: 11.2 months, H2RAs: 9.4 months, PPIs: 6.7 months; p = 0.234). However, antacid use significantly reduced overall survival (OS; no antacids: 25.0 months, H2RAs: 15.5 months, PPIs: 11.3 months; p = 0.002). Antacid use did not affect PFS for various metastasis sites, although antacid users with de novo brain metastases exhibited significantly shorter OS, compared to non-users (11.8 vs. 16.3 months, respectively; p = 0.041). Antacid use did not significantly affect OS in patients with bone, liver, or pleural metastases. Conclusion Antacid use reduced OS among patients with EGFR-mutant NSCLC who were treated using first-line first-generation EGFR-TKIs, and especially among patients with de novo brain metastases.	[Chen, Yu-Mu; Lai, Chien-Hao; Chang, Huang-Chih; Chao, Tung-Ying; Tseng, Chia-Cheng; Fang, Wen-Feng; Wang, Chin-Chou; Chung, Yu-Hsiu; Wang, Yi-Hsi; Su, Mao-Chang; Liu, Shih-Feng; Huang, Kuo-Tung; Chen, Hung-Chen; Chang, Ya-Chun; Lin, Meng-Chih] Chang Gung Univ, Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Dept Internal Med,Kaohsiung Med Ctr,Coll Med, Kaohsiung, Taiwan; [Fang, Wen-Feng] Chang Gung Inst Technol, Dept Resp Care, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology	Lin, MC (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Dept Internal Med,Kaohsiung Med Ctr,Coll Med, Kaohsiung, Taiwan.	mengchih@adm.cgmh.org.tw	Fang, Wen-Feng/AAT-6296-2021	Fang, Wen-Feng/0000-0003-0350-9059; chen, hong cheng/0000-0001-9713-3835; Liu, Shih-Feng/0000-0003-1394-5401				Budha NR, 2012, CLIN PHARMACOL THER, V92, P203, DOI 10.1038/clpt.2012.73; Chen G, 2013, ANN ONCOL, V24, P1615, DOI 10.1093/annonc/mdt012; Chen YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136252; Chu MP, 2015, CLIN LUNG CANCER, V16, P33, DOI 10.1016/j.cllc.2014.07.005; Deng YM, 2014, MOL CLIN ONCOL, V2, P116, DOI 10.3892/mco.2013.190; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fukudo M, 2013, CLIN PHARMACOKINET, V52, P593, DOI 10.1007/s40262-013-0058-5; Gurpide A, 2005, CLIN LUNG CANCER, V7, P138, DOI 10.3816/CLC.2005.n.030; Henley SJ, 2014, MMWR-MORBID MORTAL W, V63, P1; Heon S, 2010, CLIN CANCER RES, V16, P5873, DOI 10.1158/1078-0432.CCR-10-1588; Hilton JF, 2013, LUNG CANCER, V82, P136, DOI 10.1016/j.lungcan.2013.06.008; Horiike A, 2007, CHEST, V131, P1628, DOI 10.1378/chest.06-1673; Kogure Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135393; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Lie CH, 2011, CLIN LUNG CANCER, V12, P116, DOI 10.1016/j.cllc.2011.03.006; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Thongprasert S, 2011, J THORAC ONCOL, V6, P1872, DOI 10.1097/JTO.0b013e31822adaf7; Togashi Y, 2012, CANCER CHEMOTH PHARM, V70, P399, DOI 10.1007/s00280-012-1929-4; Togashi Y, 2010, J THORAC ONCOL, V5, P950, DOI 10.1097/JTO.0b013e3181e2138b; Tokumo M, 2005, CLIN CANCER RES, V11, P1167; Wang BY, 2013, J THORAC ONCOL, V8, P1128, DOI 10.1097/JTO.0b013e31829ceba4; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8	22	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149722	10.1371/journal.pone.0149722	http://dx.doi.org/10.1371/journal.pone.0149722			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894507	Green Published, gold, Green Submitted			2022-12-27	WOS:000371223400077
J	Franca, VF; Barbosa, AR; D'Orsi, E				Franca, Vivian Francielle; Barbosa, Aline Rodrigues; D'Orsi, Eleonora			Cognition and Indicators of Dietary Habits in Older Adults from Southern Brazil	PLOS ONE			English	Article							MENTAL-STATE-EXAMINATION; ALZHEIMERS-DISEASE; MEDITERRANEAN DIET; PHYSICAL-ACTIVITY; FISH CONSUMPTION; POPULATION; IMPAIRMENT; AGE; ASSOCIATIONS; DECLINE	Objective To assess the association between unhealthy dietary habits and cognition in older adults from Southern Brazil. Methods This cross-sectional study analyzed data from the second wave of a population-and house-hold-based epidemiological survey (2013-2014) conducted in the city of Florianopolis. A total of 1,197 older adults (778 women) over 60 years old participated in the study. Cognition, the dependent variable, was measured by the Mini-Mental State Examination (MMSE). The independent variables were the following indicators of unhealthy dietary habits: low intake of fruits and vegetables (<= 4 servings/day); fish (< 1 serving/week); and habitual fatty meat intake (yes/no). Adjustments were made for age, education level, income, smoking status, alcohol intake, leisure-time physical activity, depression symptoms, chronic diseases, and body mass index. Simple and multiple linear regression analyses were performed, considering sampling weights and stratification by gender. Results The mean MMSE scores for men and women were 25.15 +/- 5.56 and 24.26 +/- 5.68, respectively (p = 0.009). After adjustments, in women low fruit and vegetable intake (<= 4 servings/day) was independently associated with the lowest MMSE scores. No associations were found in men. Additionally, women's mean MMSE scores increased as their daily frequency of fruit and vegetable intake increased (p = 0.001). Conclusion Women with low fruit and vegetable intake according to the World Health Organization (WHO) have lower cognition scores. Regular intake of fruits, vegetables, and fish in exchange of fatty meats may be a viable public policy strategy to preserve cognition in aging.	[Franca, Vivian Francielle] Univ Fed Santa Catarina, Programa Pos Grad Nutr, Florianopolis, SC, Brazil; [Barbosa, Aline Rodrigues] Univ Fed Santa Catarina, Programa Pos Grad Nutr, Ctr Desportos, Dept Nutr, Florianopolis, SC, Brazil; [D'Orsi, Eleonora] Univ Fed Santa Catarina, Programa Pos Grad Saude Colet, Dept Saude Publ, Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC)	Franca, VF (corresponding author), Univ Fed Santa Catarina, Programa Pos Grad Nutr, Florianopolis, SC, Brazil.	vivianfranca@unipar.br	d'Orsi, Eleonora/D-1905-2015		Brazilian National Council for Scientific and Technological Development (CNPq) [569834/2008-2]	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This paper is based on the EPIFLORIPA2009 - Florianopolis Ageing Health Survey. Funding institution: Brazilian National Council for Scientific and Technological Development (CNPq), grant number 569834/2008-2. URL: http://www.cnpq.br/. Author who received the funding: ED. This research was developed in the Graduate Program in Public Health, Federal University of Santa Catarina, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida OP, 1999, ARQ NEURO-PSIQUIAT, V57, P421, DOI 10.1590/S0004-282X1999000300013; Almeida OP, 1998, ARQ NEURO-PSIQUIAT, V56, P605, DOI 10.1590/S0004-282X1998000400014; Andrade FCD, 2014, ARCH GERONTOL GERIAT, V58, P219, DOI 10.1016/j.archger.2013.10.007; Babor TF., 2001, AUDIT ALCOHOL USE DI; Bernstein M, 2012, J ACAD NUTR DIET, V112, P1255, DOI 10.1016/j.jand.2012.06.015; BERTOLUCCI PHF, 1994, ARQ NEURO-PSIQUIAT, V52, P1, DOI 10.1590/S0004-282X1994000100001; Brasil. Ministerio da Saude, 2012, VIG FAT RISC PROT DO; Brasil. Ministerio da Saude, 2012, ATENCAO A SAUDE DO I; Brasil. Ministerio da Saude, 2004, VIG AL NUTR SISV OR; Brasil. Ministerio da Saude, 2010, AL SAUD PESS ID MAN; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia de Doencas e Agravos nao Transmissiveis e Promocao da Saude, 2013, VIG FAT RISC PROT DO; Campolina AG, 2013, CAD SAUDE PUBLICA, V29, P1217, DOI [10.1590/S0102-311X2013000600018, 10.1590/S0102-311X2013001000018]; Cardoso BR, 2013, CLIN INTERV AGING, V8, P531, DOI 10.2147/CIA.S27983; Chan R, 2013, J NUTR HEALTH AGING, V17, P757, DOI 10.1007/s12603-013-0348-5; Chang SL, 2015, PREV MED, V77, P68, DOI 10.1016/j.ypmed.2015.05.001; Chen X, 2012, J NUTR HEALTH AGING, V16, P549, DOI 10.1007/s12603-012-0023-2; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068; Eshkoor SA, 2015, CLIN INTERV AGING, V10, P687, DOI 10.2147/CIA.S73922; Feart C, 2013, P NUTR SOC, V72, P140, DOI 10.1017/S0029665112002959; FRISANCHO AR, 1984, AM J CLIN NUTR, V40, P808, DOI 10.1093/ajcn/40.4.808; Gao Ming-yue, 2015, Beijing Da Xue Xue Bao Yi Xue Ban, V47, P443; Han C, 2008, ARCH GERONTOL GERIAT, V47, P302, DOI 10.1016/j.archger.2007.08.012; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2011, PESQ ORC FAM POF 200; Kesse-Guyot E, 2011, J NUTR HEALTH AGING, V15, P115, DOI 10.1007/s12603-011-0023-7; Kiefer I., 2005, J MENS HLTH GENDER, V2, P194, DOI 10.1016/j.jmhg.2005.04.010; Li RN, 2014, FRONT NEUROENDOCRIN, V35, P385, DOI 10.1016/j.yfrne.2014.01.002; Loef M, 2012, J NUTR HEALTH AGING, V16, P626, DOI 10.1007/s12603-012-0097-x; Lourenco RA, 2006, REV SAUDE PUBL, V40, P712, DOI 10.1590/S0034-89102006000500023; Monteiro CA, 2008, REV SAUDE PUBL, V42, P582, DOI 10.1590/S0034-89102008000400002; Morris MC, 2006, NEUROLOGY, V67, P1370, DOI 10.1212/01.wnl.0000240224.38978.d8; Morris MC, 2005, ARCH NEUROL-CHICAGO, V62, P1849, DOI 10.1001/archneur.62.12.noc50161; Nitrini R., 1999, ARQ NEURO-PSIQUIAT, V57, P7; Parrott MD, 2013, J NUTR, V143, P1767, DOI 10.3945/jn.113.181115; Pastor-Valero M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104139; Programa das Nacoes Unidas para o desenvolvimento (PNUD), 2013, ATL DES HUM BRAS; Raji CA, 2014, AM J PREV MED, V47, P444, DOI 10.1016/j.amepre.2014.05.037; Scazufca M, 2009, EUR ARCH PSY CLIN N, V259, P8, DOI 10.1007/s00406-008-0827-6; Soares LM, 2012, ARCH GERONTOL GERIAT, V54, pE187, DOI 10.1016/j.archger.2011.11.014; Titova OE, 2013, EXP GERONTOL, V48, P1443, DOI 10.1016/j.exger.2013.10.002; Titova OE, 2013, AGE, V35, P1495, DOI 10.1007/s11357-012-9453-3; Torres SJ, 2012, NUTRIENTS, V4, P1542, DOI 10.3390/nu4111542; Tur JA, 2012, BRIT J NUTR, V107, pS23, DOI 10.1017/S0007114512001456; Valle EA, 2009, CAD SAUDE PUBLICA, V25, P918, DOI 10.1590/S0102-311X2009000400023; Veras Renato, 2009, Rev. Saúde Pública, V43, P548, DOI 10.1590/S0034-89102009005000025; Warnberg J, 2009, ANN NY ACAD SCI, V1153, P164, DOI 10.1111/j.1749-6632.2008.03985.x; Wang Y, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0116359, 10.1371/journal.pone.0124566]; Wang ZQ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-595; WHO, 2003, DIET NUTR PREVENTION, V916; WHO, 2005, ENV AT POL SAUD; Holz Adriana Winter, 2013, Rev. bras. epidemiol., V16, P880, DOI 10.1590/S1415-790X2013000400008; Ye XW, 2013, BRIT J NUTR, V109, P503, DOI 10.1017/S0007114512001183; Zattar LC, 2013, CAD SAUDE PUBLICA, V29, P507, DOI 10.1590/S0102-311X2013000300009	53	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0147820	10.1371/journal.pone.0147820	http://dx.doi.org/10.1371/journal.pone.0147820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3DG	26894259	Green Published, gold			2022-12-27	WOS:000371223400009
J	Jain, S; Aresu, L; Comazzi, S; Shi, JG; Worrall, E; Clayton, J; Humphries, W; Hemmington, S; Davis, P; Murray, E; Limeneh, AA; Ball, K; Ruckova, E; Muller, P; Vojtesek, B; Fahraeus, R; Argyle, D; Hupp, TR				Jain, Saurabh; Aresu, Luca; Comazzi, Stefano; Shi, Jianguo; Worrall, Erin; Clayton, John; Humphries, William; Hemmington, Sandra; Davis, Paul; Murray, Euan; Limeneh, Asmare A.; Ball, Kathryn; Ruckova, Eva; Muller, Petr; Vojtesek, Borek; Fahraeus, Robin; Argyle, David; Hupp, Ted R.			The Development of a Recombinant scFv Monoclonal Antibody Targeting Canine CD20 for Use in Comparative Medicine	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; ONE WORLD; AUTOIMMUNE-DISEASES; ONE HEALTH; PHAGE-DISPLAY; MOUSE MODELS; B-CELLS; CANCER; RITUXIMAB; THERAPY	Monoclonal antibodies are leading agents for therapeutic treatment of human diseases, but are limited in use by the paucity of clinically relevant models for validation. Sporadic canine tumours mimic the features of some human equivalents. Developing canine immunotherapeutics can be an approach for modeling human disease responses. Rituximab is a pioneering agent used to treat human hematological malignancies. Biologic mimics that target canine CD20 are just being developed by the biotechnology industry. Towards a comparative canine-human model system, we have developed a novel anti-CD20 monoclonal antibody (NCD1.2) that binds both human and canine CD20. NCD1.2 has a sub-nanomolar K-d as defined by an octet red binding assay. Using FACS, NCD1.2 binds to clinically derived canine cells including B-cells in peripheral blood and in different histotypes of B-cell lymphoma. Immunohistochemical staining of canine tissues indicates that the NCD1.2 binds to membrane localized cells in Diffuse Large B-cell lymphoma, Marginal Zone Lymphoma, and other canine B-cell lymphomas. We cloned the heavy and light chains of NCD1.2 from hybridomas to determine whether active scaffolds can be acquired as future biologics tools. The V-H and V-L genes from the hybridomas were cloned using degenerate primers and packaged as single chains (scFv) into a phage-display library. Surprisingly, we identified two scFv (scFv-3 and scFv-7) isolated from the hybridoma with bioactivity towards CD20. The two scFv had identical VH genes but different V-L genes and identical CDR3s, indicating that at least two light chain mRNAs are encoded by NCD1.2 hybridoma cells. Both scFv-3 and scFv-7 were cloned into mammalian vectors for secretion in CHO cells and the antibodies were bioactive towards recombinant CD20 protein or peptide. The scFv-3 and scFv-7 were cloned into an ADEPT-CPG2 bioconjugate vector where bioactivity was retained when expressed in bacterial systems. These data identify a recombinant anti-CD20 scFv that might form a useful tool for evaluation in bioconjugate-directed anti-CD20 immunotherapies in comparative medicine.	[Jain, Saurabh; Shi, Jianguo; Worrall, Erin; Murray, Euan; Ball, Kathryn; Argyle, David; Hupp, Ted R.] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh EH4 2XR, Midlothian, Scotland; [Jain, Saurabh; Shi, Jianguo; Worrall, Erin; Murray, Euan; Ball, Kathryn; Argyle, David; Hupp, Ted R.] Sch Vet Med, Edinburgh EH4 2XR, Midlothian, Scotland; [Aresu, Luca] Univ Padua, Dept Comparat Biomed & Food Sci, Dipartimento Biomed Comparata & Alimentaz BCA, I-35020 Legnaro, PD, Italy; [Comazzi, Stefano] Univ Milan, Dipartimento Sci Vet & Sanita Pubbl, Via Celoria 10, I-20133 Milan, Italy; [Clayton, John; Humphries, William; Hemmington, Sandra; Davis, Paul] Mologic Ltd, Bedford Technol Pk, Bedford MK44 2YP, England; [Limeneh, Asmare A.] Bahit Dar Univ, Coll Med & Hlth Sci, Dept Med Biochem & Mol Biol, Bahir Dar, Ethiopia; [Ruckova, Eva; Muller, Petr; Vojtesek, Borek] Masaryk Mem Canc Inst, Reg Ctr Appl Mol Oncol, Brno 65653, Czech Republic; [Murray, Euan; Fahraeus, Robin] Univ Paris 07, Hop St Louis, Inst Genet Mol, INSERM U940, 27 Rue Juliette Dodu, Paris, France	University of Edinburgh; University of Padua; University of Milan; Masaryk Memorial Cancer Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Hupp, TR (corresponding author), Univ Edinburgh, Inst Genet & Mol Med, Edinburgh EH4 2XR, Midlothian, Scotland.; Hupp, TR (corresponding author), Sch Vet Med, Edinburgh EH4 2XR, Midlothian, Scotland.	Ted.Hupp@ed.ac.uk	Muller, Petr/AAK-5014-2021; Muller, Petr/F-7762-2015; fahraeus, robin/K-8726-2014; Aresu, Luca/J-9788-2018	Muller, Petr/0000-0002-8404-4494; Muller, Petr/0000-0002-8404-4494; Humphries, William/0000-0002-6869-6601; , robin/0000-0003-0402-8492; Hupp, Ted/0000-0003-0391-0352; Aresu, Luca/0000-0002-7893-1740	BBSRC [BB/J00751X/1]; INSERM (Inserm Plan Cancer) [A12112HS]; Petplan; project Ministry of Education Youth and Sports (MEYS) [NPS-I - LO1413]; Czech Science Foundation (GACR) [P206/12/G151]; Regional Center for Applied Molecular Oncology (RECAMO) [ED2.1.00/03.0101]; Biotechnology and Biological Sciences Research Council [BB/J00751X/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); INSERM (Inserm Plan Cancer); Petplan; project Ministry of Education Youth and Sports (MEYS); Czech Science Foundation (GACR)(Grant Agency of the Czech Republic); Regional Center for Applied Molecular Oncology (RECAMO); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the BBSRC (BB/J00751X/1), INSERM (Inserm Plan Cancer A12112HS; EM), partially supported by Petplan, and was partially supported by the project Ministry of Education Youth and Sports (MEYS) - NPS-I - LO1413. BV and PM were supported with Czech Science Foundation (GACR) P206/12/G151. BV, ER, and PM were supported by ED2.1.00/03.0101 - Regional Center for Applied Molecular Oncology (RECAMO) (2011-2014, MSM / ED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagshawe KD, 2009, CURR DRUG TARGETS, V10, P152, DOI 10.2174/138945009787354520; Bhatia J, 2000, INT J CANCER, V85, P571; BLAKEY DC, 1995, BRIT J CANCER, V72, P1083, DOI 10.1038/bjc.1995.469; Calistri P, 2013, TRANSBOUND EMERG DIS, V60, P4, DOI 10.1111/tbed.12145; Castillo-Trivino T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066308; Chambers SA, 2005, LUPUS, V14, P210, DOI 10.1191/0961203305lu2138oa; Comazzi S, 2011, VET J, V188, P149, DOI 10.1016/j.tvjl.2010.03.011; Das Thakur M, 2014, J PATHOL, V232, P103, DOI 10.1002/path.4285; Doerner A, 2014, FEBS LETT, V588, P278, DOI 10.1016/j.febslet.2013.11.025; Du JM, 2007, J BIOL CHEM, V282, P15073, DOI 10.1074/jbc.M701654200; Eisenhardt SU, 2007, NAT PROTOC, V2, P3063, DOI 10.1038/nprot.2007.455; Ernst JA, 2005, BIOCHEMISTRY-US, V44, P15150, DOI 10.1021/bi0511078; Ferraresso S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092707; Griffin MM, 2013, EXPERT OPIN BIOL TH, V13, P803, DOI 10.1517/14712598.2013.786698; Grillo-Lopez Antonio J, 2002, Expert Rev Anticancer Ther, V2, P485, DOI 10.1586/14737140.2.5.485; Henry Carolyn J, 2013, Mo Med, V110, P216; Ito D, 2014, VET IMMUNOLOGY IMMUN; Ito D, 2014, LEUKEMIA LYMPHOMA; Jubala CM, 2005, VET PATHOL, V42, P468, DOI 10.1354/vp.42-4-468; Khanna C, 2006, NAT BIOTECHNOL, V24, P1065, DOI 10.1038/nbt0906-1065b; Klopfleisch R, 2011, VET J, V190, P236, DOI 10.1016/j.tvjl.2011.04.010; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; LANE DP, 1981, J IMMUNOL METHODS, V47, P303, DOI 10.1016/0022-1759(81)90286-6; Lee S, 2010, J ALLERGY CLIN IMMUN, V125, P814, DOI 10.1016/j.jaci.2010.02.025; Luengo-Fernandez R, 2013, LANCET ONCOL, V14, P1165, DOI 10.1016/S1470-2045(13)70442-X; Malaney P, 2014, CANCER LETT, V344, P1, DOI 10.1016/j.canlet.2013.10.010; Maloney DG, 1997, BLOOD, V90, P2188; Milenic DE, 2002, CURR PHARM DESIGN, V8, P1749, DOI 10.2174/1381612023393963; Mittra J, 2012, NEW BIOTECHNOL, V29, P709, DOI 10.1016/j.nbt.2012.03.003; Mudaliar MAV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072591; Nathan Sheila, 2002, J Biochem Mol Biol Biophys, V6, P45, DOI 10.1080/10258140290010232; Nixon AE, 2014, MABS-AUSTIN, V6, P73, DOI 10.4161/mabs.27240; Osburn B, 2009, REV SCI TECH OIE, V28, P481, DOI 10.20506/rst.28.2.1884; Parker HG, 2010, ANNU REV GENET, V44, P309, DOI 10.1146/annurev-genet-102808-115200; Peldschus K, 2014, METHODS MOL BIOL, V1070, P213, DOI 10.1007/978-1-4614-8244-4_16; Perosa F, 2005, AUTOIMMUN REV, V4, P526, DOI 10.1016/j.autrev.2005.04.004; Perosa F, 2009, J IMMUNOL, V182, P416, DOI 10.4049/jimmunol.182.1.416; Pinho SS, 2012, TRANSL RES, V159, P165, DOI 10.1016/j.trsl.2011.11.005; Poggi A, 2013, VET COMP ONCOLOGY; Porrello A, 2006, J EXP CLIN CANC RES, V25, P97; Pouget JP, 2011, NAT REV CLIN ONCOL, V8, P720, DOI 10.1038/nrclinonc.2011.160; Powers Glenn A, 2012, Methods Mol Biol, V907, P699, DOI 10.1007/978-1-61779-974-7_39; Ranieri G, 2013, CRIT REV ONCOL HEMAT, V88, P187, DOI 10.1016/j.critrevonc.2013.03.005; Ricart AD, 2007, NAT CLIN PRACT ONCOL, V4, P245, DOI 10.1038/ncponc0774; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Shearin AL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000310; Siller E, 2010, J MOL BIOL, V396, P1310, DOI 10.1016/j.jmb.2009.12.042; Sinha A, 2013, NAT REV NEPHROL, V9, P154, DOI 10.1038/nrneph.2012.289; Sinha G, 2014, NAT BIOTECHNOL, V32, P12, DOI 10.1038/nbt.2793; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; Tobinai K, 2003, CANCER CHEMOTH PHARM, V52, pS90, DOI 10.1007/s00280-003-0595-y; Torgerson PR, 2013, VET PARASITOL, V195, P223, DOI 10.1016/j.vetpar.2013.04.004; van Helden PD, 2013, EMBO REP, V14, P497, DOI 10.1038/embor.2013.61; Vital EM, 2013, EXPERT OPIN BIOL TH, V13, P1049, DOI 10.1517/14712598.2013.787064; Vo AA, 2014, TRANSPLANTATION; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Wiseman GA, 2002, BLOOD, V99, P4336, DOI 10.1182/blood.V99.12.4336; Yang J, 2013, BIOTECHNOL APPL BIOC, V60, P289, DOI 10.1002/bab.1080	58	25	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148366	10.1371/journal.pone.0148366	http://dx.doi.org/10.1371/journal.pone.0148366			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894679	Green Submitted, Green Published, gold			2022-12-27	WOS:000371223400012
J	Aron-Wisnewsky, J; Verger, EO; Bounaix, C; Dao, MC; Oppert, JM; Bouillot, JL; Chevallier, JM; Clement, K				Aron-Wisnewsky, Judith; Verger, Eric O.; Bounaix, Carine; Dao, Maria Carlota; Oppert, Jean-Michel; Bouillot, Jean-Luc; Chevallier, Jean-Marc; Clement, Karine			Nutritional and Protein Deficiencies in the Short Term following Both Gastric Bypass and Gastric Banding	PLOS ONE			English	Article							VERTICAL BANDED GASTROPLASTY; LIFE-STYLE INTERVENTION; MORBIDLY OBESE-PATIENTS; BARIATRIC SURGERY; BODY-COMPOSITION; WEIGHT-LOSS; NATIONAL NUTRITION; DIETARY-INTAKE; MANAGEMENT; VITAMIN	Background The number of morbidly obese patients undergoing bariatric surgery (BS) has increased dramatically in recent years. Therefore, monitoring food intake and its consequences in terms of nutritional status is necessary to prevent nutritional deficiencies. The aim of this study was to analyze the effect of food restriction on nutritional parameters in the short-term (<= 3 months) period after BS in morbid obesity. Method In a prospective study, we followed 22 obese women who underwent Roux-en-Y gastric bypass (GBP) or adjustable gastric banding (AGB) at baseline (T0) and 1 (T1) and 3 (T3) months after surgery. We evaluated food intake, nutrient adequacy and serum concentrations of vitamins and minerals known to be at risk for deficiency following BS. Results Before surgery, we observed suboptimal food intakes, leading to a risk of micronutrient deficiencies. Serum analysis confirmed nutritional deficiencies for iron and thiamine for 27 and 23% of the patients, respectively. The drastic energy and food reduction seen in the short term led to very low probabilities of adequacy for nutrients equivalent across both surgeries. Serum analysis demonstrated a continuous decrease in prealbumin during the follow-up, indicating mild protein depletion in 21 and 57% of GBP patients and 50 and 63% of AGB patients, respectively, at T1 and T3. Regarding vitamins and minerals, systematic supplementation after GBP prevented most nutritional deficiencies. By contrast, AGB patients, for whom there is no systematic supplementation, developed such deficiencies. Conclusions Our results suggest that cautious monitoring of protein intake after BS is mandatory. Furthermore, AGB patients might also benefit from systematic multivitamin and mineral supplementation at least in the short term.	[Aron-Wisnewsky, Judith; Verger, Eric O.; Dao, Maria Carlota; Oppert, Jean-Michel; Clement, Karine] Hop La Pitie Salpetriere, AP HP, ICAN, Inst Cardiometab & Nutr,Dept Nutr, F-75013 Paris, France; [Aron-Wisnewsky, Judith; Bounaix, Carine; Clement, Karine] UPMC Univ Paris 06, Univ Sorbonne, UMR S 1166 I, ICAN,Nutri Team, F-75005 Paris, France; [Aron-Wisnewsky, Judith; Verger, Eric O.; Bounaix, Carine; Dao, Maria Carlota; Clement, Karine] INSERM, UMR S U1166, Nutri Team, F-75013 Paris, France; [Bouillot, Jean-Luc] Ambroise Pare Hosp, AP HP, Visceral Surg Dept, F-92100 Boulogne, France; [Chevallier, Jean-Marc] Hop Europeen Georges Pompidou, AP HP, Visceral Surg Dept, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Aron-Wisnewsky, J; Clement, K (corresponding author), Hop La Pitie Salpetriere, AP HP, ICAN, Inst Cardiometab & Nutr,Dept Nutr, F-75013 Paris, France.; Aron-Wisnewsky, J; Clement, K (corresponding author), UPMC Univ Paris 06, Univ Sorbonne, UMR S 1166 I, ICAN,Nutri Team, F-75005 Paris, France.; Aron-Wisnewsky, J; Clement, K (corresponding author), INSERM, UMR S U1166, Nutri Team, F-75013 Paris, France.	judith.aron-wisnewsky@psl.aphp.fr; karine.clement@psl.aphp.fr	Clément, karine/R-1120-2017; Oppert, Jean-Michel/F-2810-2017; ARON-WISNEWSKY, judith/AAH-7608-2020; Verger, Eric/J-9163-2016	Verger, Eric/0000-0002-8689-8290	European Union [HEALTH-F4-2012-305312]; "Programme Hospitalier de Recherche Clinique" from Health ministry [PHRC Microbaria AOM10285/ P100111]; Institut Appert; Nestle research	European Union(European Commission); "Programme Hospitalier de Recherche Clinique" from Health ministry; Institut Appert(Centre National de la Recherche Scientifique (CNRS)); Nestle research(Nestle SA)	This project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement HEALTH-F4-2012-305312 (Metacardis). It is also supported by the "Programme Hospitalier de Recherche Clinique" from Health ministry (PHRC Microbaria AOM10285/ P100111). JAW received a grant from Institut Appert and from Nestle research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement HEALTH-F4-2012-305312 (Metacardis). It is also supported by the "Programme Hospitalier de Recherche Clinique" from Health ministry (PHRC Microbaria AOM10285/ P100111). JAW received a grant from Institut Appert and from Nestle research.	Aasheim ET, 2008, AM J CLIN NUTR, V87, P362, DOI 10.1093/ajcn/87.2.362; Aasheim ET, 2009, AM J CLIN NUTR, V90, P15, DOI 10.3945/ajcn.2009.27583; Aasheim ET, 2008, ANN SURG, V248, P714, DOI 10.1097/SLA.0b013e3181884308; Aasheim ET, 2012, SURG OBES RELAT DIS, V8, P169, DOI 10.1016/j.soard.2011.01.038; Andreu A, 2010, OBES SURG, V20, P1509, DOI 10.1007/s11695-010-0268-y; Angrisani L, 2015, OBES SURG, V25, P1822, DOI 10.1007/s11695-015-1657-z; Aron-Wisnewsky J, 2012, J HEPATOL, V56, P225, DOI 10.1016/j.jhep.2011.04.022; Bavaresco M, 2010, OBES SURG, V20, P716, DOI 10.1007/s11695-008-9721-6; Bernert CP, 2007, DIABETES METAB, V33, P13, DOI 10.1016/j.diabet.2006.11.004; Black JA, 2013, OBES REV, V14, P634, DOI 10.1111/obr.12037; Bozbora A, 2000, OBES SURG, V10, P274, DOI 10.1381/096089200321643610; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Carrodeguas L, 2005, SURG OBES RELAT DIS, V1, P522, DOI DOI 10.1016/j.soard.2005.08.003; Castetbon K, 2009, BRIT J NUTR, V102, P733, DOI 10.1017/S0007114509274745; Chapman AE, 2004, SURGERY, V135, P326, DOI 10.1016/S0039-6060(03)00392-1; Ciangura C, 2010, OBESITY, V18, P760, DOI 10.1038/oby.2009.348; Coupaye M, 2014, OBES SURG, V24, P276, DOI 10.1007/s11695-013-1089-6; Coupaye M, 2009, OBES SURG, V19, P56, DOI 10.1007/s11695-008-9571-2; Cui YF, 2011, J GASTROINTEST SURG, V15, P1879, DOI 10.1007/s11605-011-1585-8; Rocha VCA, 2012, NUTR HOSP, V27, P1134, DOI 10.3305/nh.2012.27.4.5812; Dalmas E, 2011, AM J CLIN NUTR, V94, P450, DOI 10.3945/ajcn.111.013771; Davis CJ, 2012, JPEN-PARENTER ENTER, V36, P197, DOI 10.1177/0148607111413896; Dias Maria Carolina G., 2006, Clinics, V61, P93, DOI 10.1590/S1807-59322006000200002; Dixon JB, 2011, NAT REV GASTRO HEPAT, V8, P429, DOI 10.1038/nrgastro.2011.112; Dyson PA, 2010, DIABETES OBES METAB, V12, P941, DOI 10.1111/j.1463-1326.2010.01256.x; Ells LJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011740; Ernst B, 2009, OBES SURG, V19, P274, DOI 10.1007/s11695-008-9769-3; Estaquio C, 2009, J AM DIET ASSOC, V109, P1031, DOI 10.1016/j.jada.2009.03.012; Favretti F, 2002, AM J SURG, V184, p38S, DOI 10.1016/S0002-9610(02)01178-9; Foster-Schubert KE, 2011, CURR OPIN ENDOCRINOL, V18, P129, DOI 10.1097/MED.0b013e32834449b9; Freeman RA, 2014, OBES RES CLIN PRACT, V8, pE183, DOI 10.1016/j.orcp.2013.02.002; Fried M, 2013, OBESITY FACTS, V6, P449, DOI [10.1159/000355480, 10.1007/s11695-013-1079-8]; Gesquiere I, 2014, OBES SURG, V24, P1896, DOI 10.1007/s11695-014-1325-8; Godlewski AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022324; Heber D, 2010, J CLIN ENDOCR METAB, V95, P4823, DOI 10.1210/jc.2009-2128; Hercberg S, 2008, INT J PUBLIC HEALTH, V53, P68, DOI 10.1007/s00038-008-7016-2; Johnson LK, 2013, BRIT J NUTR, V110, P127, DOI 10.1017/S0007114512004631; KENLER HA, 1990, AM J CLIN NUTR, V52, P87, DOI 10.1093/ajcn/52.1.87; Le Moullec N, CAH NUTR DIETETIQUE, V31, P158; Ledoux S, 2006, OBES SURG, V16, P1041, DOI 10.1381/096089206778026415; Lefebvre P, 2014, SURG OBES RELAT DIS, V10, P540, DOI 10.1016/j.soard.2013.10.003; Lissner L, 1998, EUR J CLIN NUTR, V52, P316, DOI 10.1038/sj.ejcn.1600567; Livingstone MBE, 2003, J NUTR, V133, p895S, DOI 10.1093/jn/133.3.895S; Lo Menzo E, 2014, BARIATR SURG PRACT P, V9, P9, DOI 10.1089/bari.2014.9969; Mechanick JI, 2009, OBESITY, V17, pS1, DOI 10.1038/oby.2009.28; Moize V, 2003, OBES SURG, V13, P23, DOI 10.1381/096089203321136548; Moize V, 2013, CLIN NUTR, V32, P550, DOI 10.1016/j.clnu.2012.11.007; Nielsen BM, 2009, J NUTR, V139, P2337, DOI 10.3945/jn.109.112599; O'Brien PE, 2010, JAMA-J AM MED ASSOC, V303, P519, DOI 10.1001/jama.2010.81; Olbers T, 2006, ANN SURG, V244, P715, DOI 10.1097/01.sla.0000218085.25902.f8; Peterson LA, 2015, MALNUTRITION BARIATR; Quesada KR, 2014, J AM COLL NUTR, V33, P155, DOI 10.1080/07315724.2013.874893; Raftopoulos I, 2011, SURG OBES RELAT DIS, V7, P733, DOI 10.1016/j.soard.2011.07.008; Sanchez A, 2015, OBES SURG; Schweiger C, 2010, OBES SURG, V20, P193, DOI 10.1007/s11695-009-0008-3; Shah M, 2006, J CLIN ENDOCR METAB, V91, P4223, DOI 10.1210/jc.2006-0557; TALLAKSEN CME, 1991, J CHROMATOGR-BIOMED, V564, P127, DOI 10.1016/0378-4347(91)80075-N; Touvier M, 2011, BRIT J NUTR, V105, P1055, DOI 10.1017/S0007114510004617; TROSTLER N, 1995, OBES SURG, V5, P39, DOI 10.1381/096089295765558141; Verger EO, 2015, OBES SURG; Verger EO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042155; Veugelers PJ, 2015, NUTRIENTS, V7, P10189, DOI 10.3390/nu7125527; Vuillemin A, 2000, MED SCI SPORT EXER, V32, P1119, DOI 10.1097/00005768-200006000-00013; Wing RR, 2005, AM J CLIN NUTR, V82, p222S, DOI 10.1093/ajcn/82.1.222S; Zitsman JL, 2015, SURG OBES RELAT DIS, V11, P101, DOI 10.1016/j.soard.2014.06.001	65	56	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149588	10.1371/journal.pone.0149588	http://dx.doi.org/10.1371/journal.pone.0149588			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891123	Green Published, Green Submitted, gold			2022-12-27	WOS:000371221500061
J	Borne, Y; Smith, JG; Nilsson, PM; Melander, O; Hedblad, B; Engstrom, G				Borne, Yan; Smith, J. Gustav; Nilsson, Peter M.; Melander, Olle; Hedblad, Bo; Engstroem, Gunnar			Total and Differential Leukocyte Counts in Relation to Incidence of Diabetes Mellitus: A Prospective Population-Based Cohort Study	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; NECROSIS-FACTOR-ALPHA; BLOOD-CELL COUNT; GENETIC-VARIANTS; MALMO DIET; INSULIN SENSITIVITY; ADAPTER PROTEIN; INTERLEUKIN-6; RISK; ATHEROSCLEROSIS	Objective High concentrations of leukocytes in blood have been associated with diabetes mellitus. This prospective study aimed to explore whether total and differential leukocyte counts are associated with incidence of diabetes. A missense variant R262W in the SH2B3 (SH2B adaptor protein 3) gene, coding for a protein that negatively regulates hematopoietic cell proliferation, was also studied in relation to incidence of diabetes. Methods and Results Leukocyte count and its subtypes (neutrophils, lymphocytes and mixed cells) were analyzed in 26,667 men and women, 45-73 years old, from the population-based Malmo Diet and Cancer study. Information about the R262W polymorphism (rs3184504) in SH2B3 was genotyped in 24,489 subjects. Incidence of diabetes was studied during a mean follow-up of 14 years. Cox proportional hazards regression was used to examine incidence of diabetes by total and differential leukocyte counts. Mendelian randomization analysis using R262W as an instrumental variable was performed with two-stage least squares regression. A total of 2,946 subjects developed diabetes during the follow-up period. After taking several possible confounders into account, concentrations of total leukocyte count, neutrophils and lymphocytes were all significantly associated with incidence of diabetes. The adjusted hazard ratios (95% confidence interval; quartile 4 vs quartile 1) were 1.37 (1.22-1.53) for total leukocytes, 1.33 (1.19-1.49) for neutrophils and 1.29 (1.15-1.44) for lymphocytes. The R262W polymorphism was strongly associated with leukocytes (0.11x10(9) cells/l per T allele, p = 1.14 x10(-12)), lymphocytes (p = 4.3 x10(-16)), neutrophils (p = 8.0 x10(-6)) and mixed cells (p = 3.0 x10(-6)). However, there was no significant association between R262W and fasting glucose, HbA1c or incidence of diabetes. Conclusions Concentrations of total leukocytes, neutrophils and lymphocytes are associated with incidence of diabetes. However, the lack of association with the R262W polymorphism suggests that the associations may not be causal, although limitations in statistical power and balancing pleiotropic effects cannot be excluded.	[Borne, Yan; Nilsson, Peter M.; Melander, Olle; Hedblad, Bo; Engstroem, Gunnar] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Smith, J. Gustav] Lund Univ, Dept Cardiol, Clin Sci, Lund, Sweden; [Smith, J. Gustav] Skane Univ Hosp, Lund, Sweden; [Smith, J. Gustav] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Smith, J. Gustav] Harvard Univ, Sch Med, Boston, MA USA; [Smith, J. Gustav] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Smith, J. Gustav] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Nilsson, Peter M.; Melander, Olle] Skane Univ Hosp, Dept Internal Med, Malmo, Sweden	Lund University; Lund University; Lund University; Skane University Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Lund University; Skane University Hospital	Borne, Y (corresponding author), Lund Univ, Dept Clin Sci, Malmo, Sweden.	Yan.Borne@med.lu.se	b, y/AAG-3349-2019	Melander, Olle/0000-0002-2581-484X	Swedish Research Council [2011-3891, 2014-2265]; Swedish Heart and Lung Foundation [20100244, 20130249]; Lundstrom Foundation; Skane University Hospital; Novo Nordisk Fonden [NNF13OC0005339] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Lundstrom Foundation; Skane University Hospital; Novo Nordisk Fonden(Novo Nordisk Foundation)	The study was supported by grants from the Swedish Research Council (Dnr 2011-3891; 2014-2265), the Swedish Heart and Lung Foundation (Grant Nos. 20100244; 20130249), the Lundstrom Foundation and by funds from the Skane University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Swedish National Diabetes Register (NDR), the Malmo HbA<INF>1c</INF> register (MHR), the Diabetes 2000 registers and the National Board of Health and Welfare are acknowledged for valuable assistance in retrieval of diabetes end-points. The study was supported by grants from the Swedish Heart and Lung foundation and the Swedish Research council.	Alcina A, 2010, GENES IMMUN, V11, P439, DOI 10.1038/gene.2010.30; Barzilay JI, 2001, DIABETES, V50, P2384, DOI 10.2337/diabetes.50.10.2384; Baum C., IVREG2 STATA MODULE; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Crosslin DR, 2012, HUM GENET, V131, P639, DOI 10.1007/s00439-011-1103-9; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Ebrahim S, 2008, HUM GENET, V123, P15, DOI 10.1007/s00439-007-0448-6; Enhorning S, 2010, CIRCULATION, V121, P2102, DOI 10.1161/CIRCULATIONAHA.109.909663; Fernandez-Real JM, 2000, DIABETES, V49, P517, DOI 10.2337/diabetes.49.3.517; Fitau J, 2006, J BIOL CHEM, V281, P20148, DOI 10.1074/jbc.M510997200; Ford ES, 2002, AM J EPIDEMIOL, V155, P57, DOI 10.1093/aje/155.1.57; Gkrania-Klotsas E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013405; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hedblad B, 2000, DIABETIC MED, V17, P299, DOI 10.1046/j.1464-5491.2000.00280.x; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Li C, 2009, EUR J CLIN NUTR, V63, P1448, DOI 10.1038/ejcn.2009.69; Li YJ, 2000, J IMMUNOL, V164, P5199, DOI 10.4049/jimmunol.164.10.5199; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Maahs DM, 2010, ENDOCRIN METAB CLIN, V39, P481, DOI 10.1016/j.ecl.2010.05.011; Manjer J, 2001, EUR J CANCER PREV, V10, P489, DOI 10.1097/00008469-200112000-00003; Melander O, 2012, JAMA-J AM MED ASSOC, V308, P1469, DOI 10.1001/jama.2012.12998; Muller-Steinhardt M, 2007, CLIN EXP IMMUNOL, V147, P339, DOI 10.1111/j.1365-2249.2006.03273.x; Nalls MA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002113; Nilsson J, 1998, ARTERIOSCL THROM VAS, V18, P1199, DOI 10.1161/01.ATV.18.8.1199; Orru V, 2013, CELL, V155, P242, DOI 10.1016/j.cell.2013.08.041; Perez-Garcia A, 2013, BLOOD, V122, P2425, DOI 10.1182/blood-2013-05-500850; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Reddy MVPL, 2011, GENES IMMUN, V12, P208, DOI 10.1038/gene.2010.70; Rosvall M, 2015, ATHEROSCLEROSIS, V239, P615, DOI 10.1016/j.atherosclerosis.2015.01.030; Rosvall M, 2000, AM J EPIDEMIOL, V152, P334, DOI 10.1093/aje/152.4.334; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; Smedman C, 2009, J IMMUNOL METHODS, V346, P1, DOI 10.1016/j.jim.2009.04.001; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Takaki S, 2002, J EXP MED, V195, P151, DOI 10.1084/jem.20011170; Vozarova B, 2002, DIABETES, V51, P455, DOI 10.2337/diabetes.51.2.455; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Zheng JS, 2013, J NUTR, V143, P354, DOI 10.3945/jn.112.168401; Zia E, 2012, J INTERN MED, V272, P298, DOI 10.1111/j.1365-2796.2012.02526.x; Zia E, 2007, STROKE, V38, P2681, DOI 10.1161/STROKEAHA.106.479725	41	7	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0148963	10.1371/journal.pone.0148963	http://dx.doi.org/10.1371/journal.pone.0148963			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891449	Green Published, gold			2022-12-27	WOS:000371221500018
J	Devakumar, D; Hallal, PC; Horta, BL; Barros, FC; Wells, JCK				Devakumar, D.; Hallal, P. C.; Horta, B. L.; Barros, F. C.; Wells, J. C. K.			Association between Birth Interval and Cardiovascular Outcomes at 30 Years of Age: A Prospective Cohort Study from Brazil	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; NUTRITIONAL-STATUS; BODY-COMPOSITION; CHILD HEALTH; PREGNANCY; INFANT; FETAL; DISEASE; GROWTH; UNDERNUTRITION	Background Birth interval is an important and potentially modifiable factor that is associated with child health. Whether an association exists with longer-term outcomes in adults is less well known. Methods Using the 1982 Pelotas (Brazil) Birth Cohort Study, the association of birth interval with markers of cardiovascular health at 30 years of age was examined. Multivariable linear regression was used with birth interval as a continuous variable and categorical variable, and effect modification by gender was explored. Results Birth interval and cardiovascular data were present for 2,239 individuals. With birth interval as a continuous variable, no association was found but stratification by gender tended to show stronger associations for girls. When compared to birth intervals of <18 months, as binary variable, longer intervals were associated with increases in height (1.6 cm; 95% CI: 0.5, 2.8) and lean mass (1.7 kg; 95% CI: 0.2, 3.2). No difference was seen with other cardiovascular outcomes. Conclusions An association was generally not found between birth interval and cardiovascular outcomes at 30 years of age, though some evidence existed for differences between males and females and for an association with height and lean mass for birth intervals of 18 months and longer.	[Devakumar, D.] UCL, Inst Global Hlth, London, England; [Hallal, P. C.; Horta, B. L.; Barros, F. C.] Univ Fed Pelotas, Postgrad Programme Epidemiol, Pelotas, Brazil; [Wells, J. C. K.] UCL, Inst Child Hlth, London, England	University of London; University College London; Universidade Federal de Pelotas; University of London; University College London	Devakumar, D (corresponding author), UCL, Inst Global Hlth, London, England.	d.devakumar@ucl.ac.uk	Wells, Jonathan/A-4604-2009; Horta, Bernardo/A-7604-2008	Wells, Jonathan/0000-0003-0411-8025; Horta, Bernardo/0000-0001-9843-412X; Barros, Fernando/0000-0001-5973-1746	Wellcome Trust; International Development Research Center (Canada); Brazilian National Research Council (CNPq); Rio Grande do Sul State Research Support Foundation (FAPERGS); Brazilian Ministry of Health; International Development Research Center; World Health Organization; Overseas Development Administration; European Union; National Support Program for Centers of Excellence (PRONEX); CNPq; FAPERGS; National Institute for Health Research; Wellcome Trust through a New Investigator Award; National Institute for Health Research [ACF-2007-18-008, CL-2015-18-004] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); International Development Research Center (Canada)(CGIAR); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio Grande do Sul State Research Support Foundation (FAPERGS); Brazilian Ministry of Health; International Development Research Center; World Health Organization(World Health Organization); Overseas Development Administration; European Union(European Commission); National Support Program for Centers of Excellence (PRONEX); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERGS(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust through a New Investigator Award(Wellcome Trust); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors received no specific funding for this work. The cohort study was funded by the Wellcome Trust; the International Development Research Center (Canada); the Brazilian National Research Council (CNPq); Rio Grande do Sul State Research Support Foundation (FAPERGS); and the Brazilian Ministry of Health. The study is based on data from the study "Pelotas Birth Cohort, 1982" done by the Postgraduate Program in Epidemiology at Universidade Federal de Pelotas, with the collaboration of the Brazilian Public Health Association (ABRASCO). From 2004 to 2013, the Wellcome Trust supported the 1982 birth cohort study. The International Development Research Center, World Health Organization, Overseas Development Administration, European Union, National Support Program for Centers of Excellence (PRONEX), CNPq, FAPERGS, and the Brazilian Ministry of Health supported previous phases of the study. PCH is funded by the Wellcome Trust through a New Investigator Award. DD receives salary support from the National Institute for Health Research.	BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Barros FC, 2008, REV SAUDE PUBL, V42, P7, DOI 10.1590/S0034-89102008000900003; Conde-Agudelo A, 2005, INT J GYNECOL OBSTET, V89, pS34, DOI 10.1016/j.ijgo.2004.08.003; Conde-Agudelo A, 2012, STUD FAMILY PLANN, V43, P93, DOI 10.1111/j.1728-4465.2012.00308.x; Dewey KG, 2007, MATERN CHILD NUTR, V3, P151, DOI 10.1111/j.1740-8709.2007.00092.x; Gernand AD, 2012, J NUTR, V142, P2010, DOI 10.3945/jn.112.163634; Gribble JN, 2009, MATERN CHILD NUTR, V5, P49, DOI 10.1111/j.1740-8709.2008.00158.x; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Horta BL, 2015, INT J EPIDEMIOL, V44, P441, DOI 10.1093/ije/dyv017; HUTTLY SRA, 1992, PEDIATRICS, V89, P1049; Jansen WH, 2005, INT J GYNECOL OBSTET, V89, pS50, DOI 10.1016/j.ijgo.2004.11.013; Kirkwood BR, 2003, ESSENTIAL MED STAT; Kozuki N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S6; Kozuki N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S5; Mason JB, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.23623; Mathews F, 2004, AM J CLIN NUTR, V79, P103; Mathews F, 1999, BRIT MED J, V319, P339, DOI 10.1136/bmj.319.7206.339; Norton M, 2005, INT J GYNECOL OBSTET, V89, pS1, DOI 10.1016/j.ijgo.2004.12.012; O' Connor C, 2014, PRENATAL DIAG, V34, P605, DOI 10.1002/pd.4336; Painter RC, 2006, AM J CLIN NUTR, V84, P322; Razzaque A, 2005, INT J GYNECOL OBSTET, V89, pS41, DOI 10.1016/j.ijgo.2005.01.003; RichEdwards JW, 1997, BRIT MED J, V315, P396, DOI 10.1136/bmj.315.7105.396; Rutstein SO, 2005, INT J GYNECOL OBSTET, V89, pS7, DOI 10.1016/j.ijgo.2004.11.012; Siervo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013907; Thame M, 2004, EUR J CLIN NUTR, V58, P894, DOI 10.1038/sj.ejcn.1601909; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Wells JCK, 2011, AM J EPIDEMIOL, V174, P1028, DOI 10.1093/aje/kwr232; Wells JCK, 2010, AM J HUM BIOL, V22, P1, DOI 10.1002/ajhb.20994; Wendt A, 2012, PAEDIATR PERINAT EP, V26, P239, DOI 10.1111/j.1365-3016.2012.01285.x; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233; World Health Organization, 2006, REP WHO TECHN CONS B	32	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149054	10.1371/journal.pone.0149054	http://dx.doi.org/10.1371/journal.pone.0149054			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890250	gold, Green Published, Green Submitted			2022-12-27	WOS:000371221500023
J	Mittra, ES; Koglin, N; Mosci, C; Kumar, M; Hoehne, A; Keu, KV; Iagaru, AH; Mueller, A; Berndt, M; Bullich, S; Friebe, M; Schmitt-Willich, H; Gekeler, V; Fels, LM; Bacher-Stier, C; Moon, DH; Chin, FT; Stephens, AW; Dinkelborg, LM; Gambhir, SS				Mittra, Erik S.; Koglin, Norman; Mosci, Camila; Kumar, Meena; Hoehne, Aileen; Keu, Khun Visith; Iagaru, Andrei H.; Mueller, Andre; Berndt, Mathias; Bullich, Santiago; Friebe, Matthias; Schmitt-Willich, Heribert; Gekeler, Volker; Fels, Lueder M.; Bacher-Stier, Claudia; Moon, Dae Hyuk; Chin, Frederick T.; Stephens, Andrew W.; Dinkelborg, Ludger M.; Gambhir, Sanjiv S.			Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[F-18]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies	PLOS ONE			English	Article							X(C)(-) TRANSPORTER ACTIVITY; CYSTINE/GLUTAMATE ANTIPORTER; GLUTAMATE TRANSPORTERS; TUMOR; ACID; DIAGNOSIS; GLIOMAS; PATHWAY	Purpose (S)-4-(3-[F-18] Fluoropropyl)-L-glutamic acid (18F-FSPG) is a novel radiopharmaceutical for Positron Emission Tomography (PET) imaging. It is a glutamate analogue that can be used to measure x(C)(-) transporter activity. This study was performed to assess the feasibility of 18F-FSPG for imaging orthotopic brain tumors in small animals and the translation of this approach in human subjects with intracranial malignancies. Experimental Design For the small animal study, GS9L glioblastoma cells were implanted into brains of Fischer rats and studied with 18F-FSPG, the 18F-labeled glucose derivative 18F-FDG and with the 18F-labeled amino acid derivative 18F-FET. For the human study, five subjects with either primary or metastatic brain cancer were recruited (mean age 50.4 years). After injection of 300 MBq of 18F-FSPG, 3 whole-body PET/Computed Tomography (CT) scans were obtained and safety parameters were measured. The three subjects with brain metastases also had an 18F-FDG PET/CT scan. Quantitative and qualitative comparison of the scans was performed to assess kinetics, biodistribution, and relative efficacy of the tracers. Results In the small animals, the orthotopic brain tumors were visualized well with 18F-FSPG. The high tumor uptake of 18F-FSPG in the GS9L model and the absence of background signal led to good tumor visualization with high contrast (tumor/brain ratio: 32.7). 18F-FDG and 18F-FET showed T/B ratios of 1.7 and 2.8, respectively. In the human pilot study, 18F-FSPG was well tolerated and there was similar distribution in all patients. All malignant lesions were positive with 18F-FSPG except for one low-grade primary brain tumor. In the 18F-FSPG-PET-positive tumors a similar T/B ratio was observed as in the animal model. Conclusions 18F-FSPG is a novel PET radiopharmaceutical that demonstrates good uptake in both small animal and human studies of intracranial malignancies. Future studies on larger numbers of subjects and a wider array of brain tumors are planned.	[Mittra, Erik S.; Mosci, Camila; Kumar, Meena; Hoehne, Aileen; Keu, Khun Visith; Iagaru, Andrei H.; Chin, Frederick T.; Gambhir, Sanjiv S.] Stanford Hosp & Clin, Dept Radiol, Mol Imaging Program, Stanford, CA USA; [Koglin, Norman; Mueller, Andre; Berndt, Mathias; Friebe, Matthias; Schmitt-Willich, Heribert; Gekeler, Volker; Fels, Lueder M.; Bacher-Stier, Claudia; Stephens, Andrew W.; Dinkelborg, Ludger M.] Bayer Pharma AG, Berlin, Germany; [Koglin, Norman; Mueller, Andre; Berndt, Mathias; Bullich, Santiago; Friebe, Matthias; Schmitt-Willich, Heribert; Stephens, Andrew W.; Dinkelborg, Ludger M.] Piramal Imaging GmbH, Berlin, Germany; [Moon, Dae Hyuk] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Nucl Med, Seoul, South Korea; [Gambhir, Sanjiv S.] Stanford Univ, Dept Mat Sci & Engn, Dept Bioengn, Bio X Program, Stanford, CA 94305 USA	Stanford University; Bayer AG; Bayer Healthcare Pharmaceuticals; University of Ulsan; Asan Medical Center; Stanford University	Gambhir, SS (corresponding author), Stanford Hosp & Clin, Dept Radiol, Mol Imaging Program, Stanford, CA USA.; Gambhir, SS (corresponding author), Stanford Univ, Dept Mat Sci & Engn, Dept Bioengn, Bio X Program, Stanford, CA 94305 USA.	sgambhir@stanford.edu	Moon, Dae Hyuk/ACK-5262-2022	Koglin, Norman/0000-0001-7583-8201; Mueller, Andre/0000-0001-7271-9303	Bayer Healthcare; Ben and Catherine Ivy Foundation; NCI In Vivo Cellular & Molecular Imaging Center [ICMIC P50]; Bayer HealthCare, Inc. / Piramal Imaging	Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Ben and Catherine Ivy Foundation; NCI In Vivo Cellular & Molecular Imaging Center; Bayer HealthCare, Inc. / Piramal Imaging	The study was sponsored by Bayer Healthcare. Bayer Healthcare provided support in the form of salaries for authors [NK, AM, MB, HSW, VG, MF, LMD, AWS, LMF, and CBS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding was also provided by the Ben and Catherine Ivy Foundation (SSG), and the NCI In Vivo Cellular & Molecular Imaging Center (ICMIC P50) (SSG).; The clinical work was supported by funding from Bayer HealthCare, Inc. / Piramal Imaging as part of a sponsored clinical research trial. We would like to thank the research study participants and families, our referring physicians, our clinical research coordinators, the Radiochemistry Facility and staff, in particular Dr. Bin Shen, Amit Hetstron, and So-Hee Kim, all our PET/CT technologists, and the research staff at Bayer HealthCare / Piramal Imaging Berlin for their assistance in this project. We would also like to thank the Ben and Catherine Ivy Foundation (SSG), and the NCI In Vivo Cellular & Molecular Imaging Center (ICMIC P50) (SSG) for funding support.	Alexiou GA, 2009, J NEURO-ONCOL, V95, P1, DOI 10.1007/s11060-009-9897-1; Baek S, 2013, J NUCL MED, V54, P117, DOI 10.2967/jnumed.112.108704; Baek S, 2012, CLIN CANCER RES, V18, P5427, DOI 10.1158/1078-0432.CCR-12-0214; Bridges RJ, 2012, BRIT J PHARMACOL, V165, P20, DOI 10.1111/j.1476-5381.2011.01480.x; Cha S, 2009, NEUROTHERAPEUTICS, V6, P465, DOI 10.1016/j.nurt.2009.05.002; Fahlbusch Rudolf, 2007, Clin Neurosurg, V54, P100; Ferguson SD, 2011, DM-DIS MON, V57, P558, DOI 10.1016/j.disamonth.2011.08.020; Gao HL, 2013, CANCER IMAGING, V13, P466, DOI 10.1102/1470-7330.2013.0039; Heiss P, 1999, J NUCL MED, V40, P1367; Heiss WD, 2014, J NUCL MED, V55, P1219, DOI 10.2967/jnumed.114.142661; Heiss WD, 2011, J NUCL MED, V52, P1585, DOI 10.2967/jnumed.110.084210; Howlader N NA, 2008, SEER CANCER STATISTI; Iagaru A, 2009, HELL J NUCL MED, V12, P26; Iagaru AH, 2008, NUCL MED COMMUN, V29, P1046, DOI 10.1097/MNM.0b013e32831089cb; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Koglin N, 2011, CLIN CANCER RES, V17, P6000, DOI 10.1158/1078-0432.CCR-11-0687; la Fougere C, 2011, NEURO-ONCOLOGY, V13, P806, DOI 10.1093/neuonc/nor054; Lapa C, 2014, J NUCL MED, V55, P1611, DOI 10.2967/jnumed.114.140608; Lewerenz J, 2006, J NEUROCHEM, V98, P916, DOI 10.1111/j.1471-4159.2006.03921.x; Lyons SA, 2007, CANCER RES, V67, P9463, DOI 10.1158/0008-5472.CAN-07-2034; Marshall D, 2012, HAND CLINIC, V104, P309, DOI 10.1016/B978-0-444-52138-5.00020-7; Nedergaard MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100009; Parney IF, 2012, HAND CLINIC, V104, P187, DOI 10.1016/B978-0-444-52138-5.00015-3; Penas-Prado M, 2012, HAND CLINIC, V105, P485, DOI 10.1016/B978-0-444-53502-3.00004-5; Prabhu A, 2014, CANCER RES, V74, P787, DOI 10.1158/0008-5472.CAN-13-1423; Robert SM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8103; Robert SM, 2014, CELL MOL LIFE SCI, V71, P1839, DOI 10.1007/s00018-013-1521-z; Smolarz K, 2013, J NUCL MED, V54, P861, DOI 10.2967/jnumed.112.112581; Takeuchi S, 2013, NEUROSURGERY, V72, P33, DOI 10.1227/NEU.0b013e318276b2de; Venneti S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1009; Watkins S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5196; Webster JM, 2014, J NUCL MED, V55, P657, DOI 10.2967/jnumed.113.126664	32	36	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0148628	10.1371/journal.pone.0148628	http://dx.doi.org/10.1371/journal.pone.0148628			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890637	Green Published, gold, Green Submitted			2022-12-27	WOS:000371221500011
J	Sunnadeniya, R; Bean, A; Brown, M; Akhavan, N; Hatlestad, G; Gonzalez, A; Symonds, VV; Lloyd, A				Sunnadeniya, Rasika; Bean, Alexander; Brown, Matthew; Akhavan, Neda; Hatlestad, Gregory; Gonzalez, Antonio; Symonds, V. Vaughan; Lloyd, Alan			Tyrosine Hydroxylation in Betalain Pigment Biosynthesis Is Performed by Cytochrome P450 Enzymes in Beets (Beta vulgaris)	PLOS ONE			English	Article							POLYPHENOL OXIDASE; LOCUS ENCODES; PURIFICATION; EXPRESSION; IDENTIFICATION; DIOXYGENASE; EVOLUTION; VECTORS; PROTEIN; CLONING	Yellow and red-violet betalain plant pigments are restricted to several families in the order Caryophyllales, where betacyanins play analogous biological roles to anthocyanins. The initial step in betalain biosynthesis is the hydroxylation of tyrosine to form L-DOPA. Using gene expression experiments in beets, yeast, and Arabidopsis, along with HPLC/MS analysis, the present study shows that two novel cytochrome P450 (CYP450) enzymes, CYP76AD6 and CYP76AD5, and the previously described CYP76AD1 can perform this initial step. Co-expressing these CYP450s with DOPA 4,5-dioxygenase in yeast, and overexpression of these CYP450s in yellow beets show that CYP76AD1 efficiently uses L-DOPA leading to red betacyanins while CYP76AD6 and CYP76AD5 lack this activity. Furthermore, CYP76AD1 can complement yellow beetroots to red while CYP76AD6 and CYP76AD5 cannot. Therefore CYP76AD1 uniquely performs the beet R locus function and beets appear to be genetically redundant for tyrosine hydroxylation. These new functional data and ancestral character state reconstructions indicate that tyrosine hydroxylation alone was the most likely ancestral function of the CYP76AD alpha and beta groups and the ability to convert L-DOPA to cyclo-DOPA evolved later in the alpha group.	[Sunnadeniya, Rasika; Bean, Alexander; Brown, Matthew; Akhavan, Neda; Hatlestad, Gregory; Gonzalez, Antonio; Lloyd, Alan] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Symonds, V. Vaughan] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand	University of Texas System; University of Texas Austin; Massey University	Lloyd, A (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.	amlloyd@utexas.edu		Symonds, Vaughan/0000-0003-2533-6830	US National Science Foundation [MCB-1122179]; Direct For Biological Sciences [1556348] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funded by US National Science Foundation MCB-1122179. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by funds from the US National Science Foundation.	BILYK A, 1981, J FOOD SCI, V46, P298, DOI 10.1111/j.1365-2621.1981.tb14588.x; Brockington SF, 2015, NEW PHYTOL, V207, P1170, DOI 10.1111/nph.13441; Brockington SF, 2011, NEW PHYTOL, V190, P854, DOI 10.1111/j.1469-8137.2011.03687.x; Christinet L, 2004, PLANT PHYSIOL, V134, P265, DOI 10.1104/pp.103.031914; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DeLoache WC, 2015, NAT CHEM BIOL, V11, P465, DOI 10.1038/nchembio.1816; Dohm JC, 2014, NATURE, V505, P546, DOI 10.1038/nature12817; Gandia-Herrero F, 2005, NATURE, V437, P334, DOI 10.1038/437334a; Gandia-Herrero F, 2004, J AGR FOOD CHEM, V52, P609, DOI 10.1021/jf034381m; Gandia-Herrero F, 2013, J AGR FOOD CHEM, V61, P4294, DOI 10.1021/jf400337g; Gandia-Herrero F, 2012, PLANTA, V236, P91, DOI 10.1007/s00425-012-1593-2; Gao ZJ, 2009, FOOD CHEM, V117, P342, DOI 10.1016/j.foodchem.2009.04.013; Harris NN, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-34; Hatlestad GJ, 2015, NAT GENET, V47, P92, DOI 10.1038/ng.3163; Hatlestad GJ, 2012, NAT GENET, V44, P816, DOI 10.1038/ng.2297; JOY RW, 1995, PLANT PHYSIOL, V107, P1083, DOI 10.1104/pp.107.4.1083; Kapadia GJ, 2003, PHARMACOL RES, V47, P141, DOI 10.1016/S1043-6618(02)00285-2; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keller W, 1936, J AGRIC RES, V52, P0027; Khan MI, 2012, LWT-FOOD SCI TECHNOL, V47, P315, DOI 10.1016/j.lwt.2012.01.025; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Mayer AM, 2006, PHYTOCHEMISTRY, V67, P2318, DOI 10.1016/j.phytochem.2006.08.006; Nakatsuka T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01970; Polturak G, 2016, NEW PHYTOL, V210, P269, DOI 10.1111/nph.13796; QUANDT HJ, 1993, MOL PLANT MICROBE IN, V6, P699, DOI 10.1094/MPMI-6-699; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sasaki N, 2009, PLANT CELL PHYSIOL, V50, P1012, DOI 10.1093/pcp/pcp053; Schliemann W, 1999, PLANT PHYSIOL, V119, P1217, DOI 10.1104/pp.119.4.1217; Steiner U, 1999, PLANTA, V208, P114, DOI 10.1007/s004250050541; Stintzing FC, 2004, TRENDS FOOD SCI TECH, V15, P19, DOI 10.1016/j.tifs.2003.07.004; Strack D, 2001, ANGEW CHEM INT EDIT, V40, P3791, DOI 10.1002/1521-3773(20011015)40:20<3791::AID-ANIE3791>3.0.CO;2-T; Sullivan ML, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00783; Urban P, 1997, J BIOL CHEM, V272, P19176, DOI 10.1074/jbc.272.31.19176; Van Mullem V, 2003, YEAST, V20, P739, DOI 10.1002/yea.999; Xu B, 2013, MOL BIOL EVOL, V30, P2723, DOI 10.1093/molbev/mst179; Yamamoto K, 2001, PLANT CELL PHYSIOL, V42, P969, DOI 10.1093/pcp/pce125; Zhao M, 2008, DEVELOPMENT, V135, P1991, DOI 10.1242/dev.016873	38	61	69	3	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149417	10.1371/journal.pone.0149417	http://dx.doi.org/10.1371/journal.pone.0149417			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890886	gold, Green Published, Green Submitted			2022-12-27	WOS:000371221500043
J	Olson, ZH; Beasley, JC; Rhodes, OE				Olson, Zachary H.; Beasley, James C.; Rhodes, Olin E., Jr.			Carcass Type Affects Local Scavenger Guilds More than Habitat Connectivity	PLOS ONE			English	Article							PATCH OCCUPANCY; CARRION; SELECTION; SANITARY; VULTURES; DECOMPOSITION; VERTEBRATES; COMPETITION; PARAMETERS; PATHOGENS	Scavengers and decomposers provide an important ecosystem service by removing carrion from the environment. Scavenging and decomposition are known to be temperature-dependent, but less is known about other factors that might affect carrion removal. We conducted an experiment in which we manipulated combinations of patch connectivity and carcass type, and measured responses by local scavenger guilds along with aspects of carcass depletion. We conducted twelve, 1-month trials in which five raccoon (Procyon lotor), Virginia opossum (Didelphis virginiana), and domestic rabbit (Oryctolagus spp.) carcasses (180 trials total) were monitored using remote cameras in 21 forest patches in north-central Indiana, USA. Of 143 trials with complete data, we identified fifteen species of vertebrate scavengers divided evenly among mammalian (N = 8) and avian species (N = 7). Fourteen carcasses (9.8%) were completely consumed by invertebrates, vertebrates exhibited scavenging behavior at 125 carcasses (87.4%), and four carcasses (2.8%) remained unexploited. Among vertebrates, mammals scavenged 106 carcasses, birds scavenged 88 carcasses, and mammals and birds scavenged 69 carcasses. Contrary to our expectations, carcass type affected the assemblage of local scavenger guilds more than patch connectivity. However, neither carcass type nor connectivity explained variation in temporal measures of carcass removal. Interestingly, increasing richness of local vertebrate scavenger guilds contributed moderately to rates of carrion removal (approximate to 6% per species increase in richness). We conclude that scavenger-specific differences in carrion utilization exist among carcass types and that reliable delivery of carrion removal as an ecosystem service may depend on robust vertebrate and invertebrate communities acting synergistically.	[Olson, Zachary H.] Univ New England, Dept Psychol, 11 Hills Beach Rd, Biddeford, ME USA; [Beasley, James C.; Rhodes, Olin E., Jr.] Univ Georgia, Savannah River Ecol Lab, Aiken, SC USA; [Beasley, James C.] Univ Georgia, DB Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Rhodes, Olin E., Jr.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA	University of New England - Maine; United States Department of Energy (DOE); Savannah River Ecology Laboratory; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Olson, ZH (corresponding author), Univ New England, Dept Psychol, 11 Hills Beach Rd, Biddeford, ME USA.	zolson@une.edu			Indiana Academy of Science; Purdue University, Department of Forestry & Natural Resouces; Department of Forestry and Natural Resources at Purdue University	Indiana Academy of Science; Purdue University, Department of Forestry & Natural Resouces; Department of Forestry and Natural Resources at Purdue University	This study was funded in part by a research grant from the Indiana Academy of Science (Fall 2008) to ZHO and OER. < http://www.indianaacademyofscience.org/Research-Grants.aspx >. Purdue University, Department of Forestry & Natural Resouces also provided support for this work. < https://ag.purdue.edu/fnr/Pages/default.aspx >. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the landowners of the Upper Wabash River Basin for allowing us access to their land. This study was supported by the Department of Forestry and Natural Resources at Purdue University.	Allen ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102257; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beasley JC, 2010, CAN J ZOOL, V88, P161, DOI 10.1139/Z09-137; Beasley JC, 2007, J WILDLIFE MANAGE, V71, P1125, DOI 10.2193/2006-228; Beasley JC, 2012, OIKOS, V121, P1021, DOI 10.1111/j.1600-0706.2012.20353.x; Beatty WS, 2014, CAN J ZOOL, V92, P41, DOI 10.1139/cjz-2013-0225; Blazquez M, 2009, ACTA OECOL, V35, P645, DOI 10.1016/j.actao.2009.06.002; Bormann F. H., 1979, PATTERN PROCESS FORE, DOI [10.1007/978-1-4612-6232-9, DOI 10.1007/978-1-4612-6232-9]; Bump JK, 2009, ECOLOGY, V90, P3159, DOI 10.1890/09-0292.1; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Byrd JH, 2001, FORENSIC SCI INT, V120, P79, DOI 10.1016/S0379-0738(01)00431-5; Carter DO, 2007, NATURWISSENSCHAFTEN, V94, P12, DOI 10.1007/s00114-006-0159-1; Castner J.L., 2010, FORENSIC ENTOMOLOGY, V2nd, P493; Castrale JS, 1998, ATLAS BREEDING BIRDS; DeVault TL, 2004, CAN J ZOOL, V82, P502, DOI 10.1139/Z04-022; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; DeVault TL, 2011, BASIC APPL ECOL, V12, P268, DOI 10.1016/j.baae.2011.02.008; Donazar JA, 2009, SCIENCE, V326, P664, DOI 10.1126/science.326_664a; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fauth JE, 1996, AM NAT, V147, P282, DOI 10.1086/285850; Fenwick SG, 2004, J WILDLIFE DIS, V40, P566, DOI 10.7589/0090-3558-40.3.566; Gibbs JP, 2001, ECOL APPL, V11, P79, DOI 10.1890/1051-0761(2001)011[0079:HFAACC]2.0.CO;2; Green GI, 1997, J WILDLIFE MANAGE, V61, P1040, DOI 10.2307/3802101; Green RE, 2004, J APPL ECOL, V41, P793, DOI 10.1111/j.0021-8901.2004.00954.x; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hart BL, 2011, PHILOS T R SOC B, V366, P3406, DOI 10.1098/rstb.2011.0092; HART BL, 1990, NEUROSCI BIOBEHAV R, V14, P273, DOI 10.1016/S0149-7634(05)80038-7; Henning J, 2005, EPIDEMIOL INFECT, V133, P719, DOI 10.1017/S0950268805003766; JANZEN DH, 1977, AM NAT, V111, P691, DOI 10.1086/283200; Killengreen ST, 2012, DIVERS DISTRIB, V18, P563, DOI 10.1111/j.1472-4642.2011.00861.x; Kjorlien YP, 2009, FORENSIC SCI INT, V188, P103, DOI 10.1016/j.forsciint.2009.03.022; Krofel M, 2012, BEHAV ECOL SOCIOBIOL, V66, P1297, DOI 10.1007/s00265-012-1384-6; KRUUK H, 1967, ARDEA, V55, P171; Kuznetsova A, 2013, IMERTEST TESTS RANDO, P0; Maichak EJ, 2009, J WILDLIFE DIS, V45, P398, DOI 10.7589/0090-3558-45.2.398; Margalida A, 2014, ECOL APPL, V24, P436, DOI 10.1890/13-0414.1; Margalida A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00753; Margalida A, 2010, J APPL ECOL, V47, P931, DOI 10.1111/j.1365-2664.2010.01835.x; Matuszewski S, 2010, FORENSIC SCI INT, V194, P85, DOI 10.1016/j.forsciint.2009.10.016; McGarigal K., 2002, FRAGSTATS SPATIAL PA, DOI DOI 10.1016/S0022-3913(12)00047-9; Moleon M, 2015, OIKOS, V124, P1391, DOI 10.1111/oik.02222; Moore JE, 2005, J WILDLIFE MANAGE, V69, P933, DOI 10.2193/0022-541X(2005)069[0933:MPOBFR]2.0.CO;2; Moreno-Opo R, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00009.1; Moreno-Opo R, 2015, BIOL CONSERV, V181, P27, DOI 10.1016/j.biocon.2014.10.022; Mumford RE., 2010, MAMMALS OF INDIANA; NICHOLSON AJ, 1954, AUST J ZOOL, V2, P9, DOI 10.1071/ZO9540009; Ogada DL, 2012, CONSERV BIOL, V26, P453, DOI 10.1111/j.1523-1739.2012.01827.x; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Olson ZH, 2012, OIKOS, V121, P77, DOI 10.1111/j.1600-0706.2011.19771.x; Parmenter RR, 2009, ECOL MONOGR, V79, P637, DOI 10.1890/08-0972.1; Pereira LM, 2014, MAMMAL REV, V44, P44, DOI 10.1111/mam.12005; R Core Team, 2021, R LANGUAGE ENV STAT; Rouquet P, 2005, EMERG INFECT DIS, V11, P283, DOI 10.3201/eid1102.040533; Sebastian-Gonzalez E, 2013, IBIS, V155, P881, DOI 10.1111/ibi.12079; Selva N, 2005, CAN J ZOOL, V83, P1590, DOI 10.1139/Z05-158; Shivik JA, 2006, BIOSCIENCE, V56, P819, DOI 10.1641/0006-3568(2006)56[819:AVBADS]2.0.CO;2; Simmons T, 2010, J FORENSIC SCI, V55, P8, DOI 10.1111/j.1556-4029.2009.01206.x; Sugiura S, 2013, BIOL CONSERV, V159, P206, DOI 10.1016/j.biocon.2012.11.003; Swihart RK, 2003, J BIOGEOGR, V30, P1259, DOI 10.1046/j.1365-2699.2003.00925.x; Tomberlin JK, 2011, ANNU REV ENTOMOL, V56, P401, DOI 10.1146/annurev-ento-051710-103143; Turnbull PCB, 2008, ONDERSTEPOORT J VET, V75, P95; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Wikenros C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077373; Wilson EE, 2011, TRENDS ECOL EVOL, V26, P129, DOI 10.1016/j.tree.2010.12.011	67	44	47	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0147798	10.1371/journal.pone.0147798	http://dx.doi.org/10.1371/journal.pone.0147798			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886299	Green Published, Green Submitted, gold			2022-12-27	WOS:000371218400009
J	Sainju, UM				Sainju, Upendra M.			Can Novel Management Practice Improve Soil and Environmental Quality and Sustain Crop Yield Simultaneously?	PLOS ONE			English	Article							LONG-TERM TILLAGE; NITROUS-OXIDE; CARBON-DIOXIDE; GREENHOUSE GASES; NO-TILL; IRRIGATION; INTENSITY; EMISSIONS; SYSTEMS; AGRICULTURE	Little is known about management practices that can simultaneously improve soil and environmental quality and sustain crop yields. The effects of novel and traditional management practices that included a combination of tillage, crop rotation, and N fertilization on soil C and N, global warming potential (GWP), greenhouse gas intensity (GHGI), and malt barley (Hordeum vulgarie L.) yield and quality were examined under non-irrigated and irrigated cropping systems from 2008 to 2011 in eastern Montana and western North Dakota, USA. In loamy soil under non-irrigated condition in eastern Montana, novel and traditional management practices were no-till malt barley-pea (Pisum sativum L.) with 80 kg N ha(-1) and conventional till malt barley-fallow with 80 kg N ha(-1), respectively. In sandy loam soil under irrigated and non-irrigated conditions in western North Dakota, novel and traditional management practices included no-till malt barley-pea with 67 (non-irrigated) to 134 kg N ha(-1) (irrigated) and conventional till malt barley with 67 (non-irrigated) to 134 kg N ha(-1) (irrigated), respectively. Compared with the traditional management practice, soil organic C (SOC) and total N (STN) at 0-120 cm were 5% greater with the novel management practice under non-irrigated condition in eastern Montana and under irrigated condition in western North Dakota, but were not different under non-irrigated condition in western North Dakota. In both places under irrigated and non-irrigated conditions, total applied N rate, residual soil NO3-N content at 0-120 cm, global warming potential (GWP), and greenhouse gas intensity (GHGI) were 15 to 70% lower with the novel than the traditional management practice. Malt barley yield and quality were not different between the two practices in both places. Novel management practices, such as no-till malt barley-pea with reduced N rate, can simultaneously enhance soil and environmental quality, reduce N input, and sustain crop yield compared with traditional practices in the northern Great Plains, USA.	[Sainju, Upendra M.] ARS, USDA, Northern Plains Agr Res Lab, Sidney, MT 59270 USA	United States Department of Agriculture (USDA)	Sainju, UM (corresponding author), ARS, USDA, Northern Plains Agr Res Lab, Sidney, MT 59270 USA.	upendra.sainju@ars.usda.gov	ONE, PLOS/H-3321-2019	ONE, PLOS/0000-0001-6943-733X	USDA-ARS-GRACEnet project; USDA-ARS, Sidney, MT; ARS [ARS-0425353] Funding Source: Federal RePORTER	USDA-ARS-GRACEnet project; USDA-ARS, Sidney, MT; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funded in part by USDA-ARS-GRACEnet project. Other funding was contributed by USDA-ARS, Sidney, MT. No proposal was submitted and therefore no grant number.	AASE JK, 1995, AGRON J, V87, P652, DOI 10.2134/agronj1995.00021962008700040008x; Al-Kaisi MM, 2008, J ENVIRON QUAL, V37, P325, DOI 10.2134/jeq2007.0240; American Malting Barley Association, 2005, MALT BARL BREED GUID; Amos B, 2005, SOIL SCI SOC AM J, V69, P387, DOI 10.2136/sssaj2005.0387; Barsotti JL, 2013, SOIL SCI SOC AM J, V77, P1012, DOI 10.2136/sssaj2012.0386; Bergstrom L, 2004, J ENVIRON QUAL, V33, P1786, DOI 10.2134/jeq2004.1786; BRONSON KF, 1994, BIOL FERT SOILS, V17, P263, DOI 10.1007/BF00383979; DEIBERT EJ, 1986, J SOIL WATER CONSERV, V41, P53; Denef K, 2008, GEODERMA, V145, P121, DOI 10.1016/j.geoderma.2008.03.002; Drury CF, 2006, SOIL SCI SOC AM J, V70, P570, DOI 10.2136/sssaj2005.0042; Dusenbury MP, 2008, J ENVIRON QUAL, V37, P542, DOI 10.2134/jeq2006.0395; ECK HV, 1992, AGRON J, V84, P660, DOI 10.2134/agronj1992.00021962008400040025x; Farahani HJ, 1998, ADV AGRON, V64, P197, DOI 10.1016/S0065-2113(08)60505-2; Follett RF, 2001, SOIL TILL RES, V61, P77, DOI 10.1016/S0167-1987(01)00180-5; Follett RF, 2013, SOIL SCI SOC AM J, V77, P951, DOI 10.2136/sssaj2012.0413; Gregory PJ, 2002, AGR ECOSYST ENVIRON, V88, P279, DOI 10.1016/S0167-8809(01)00263-8; Hallberg G. R., 1989, Nitrogen management and ground water protection., P35; Halvorson AD, 2002, SOIL SCI SOC AM J, V66, P906, DOI 10.2136/sssaj2002.0906; HUTCHINSON GL, 1981, SOIL SCI SOC AM J, V45, P311, DOI 10.2136/sssaj1981.03615995004500020017x; Kuo S, 1997, SOIL SCI SOC AM J, V61, P1392, DOI 10.2136/sssaj1997.03615995006100050016x; Lal R, 2004, ENVIRON INT, V30, P981, DOI 10.1016/j.envint.2004.03.005; Lal R., 1995, Subsoil management techniques., P1; Lemke RL, 1999, CAN J SOIL SCI, V79, P15, DOI 10.4141/S98-013; Lenssen AW, 2007, SOIL TILL RES, V94, P362, DOI 10.1016/j.still.2006.08.012; Liebig MA, 2010, SOIL SCI SOC AM J, V74, P358, DOI 10.2136/sssaj2008.0368; Littell RC, 1991, SAS SYSTEM FOR LINEA; Miller PR, 2002, AGRON J, V94, P261, DOI 10.2134/agronj2002.0261; Mosier AR, 2005, NUTR CYCL AGROECOSYS, V72, P67, DOI 10.1007/s10705-004-7356-0; Mosier AR, 2006, J ENVIRON QUAL, V35, P1584, DOI 10.2134/jeq2005.0232; Paustian K., 1995, ADV SOIL SCI, P69; Peterson GA, 1998, SOIL TILL RES, V47, P207, DOI 10.1016/S0167-1987(98)00107-X; Robertson G. Philip, 2004, Environment Development and Sustainability, V6, P51, DOI 10.1023/B:ENVI.0000003629.32997.9e; Robertson GP, 2009, ANNU REV ENV RESOUR, V34, P97, DOI 10.1146/annurev.environ.032108.105046; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; SAINJU UM, 2010, J ENVIRON QUAL, V37, P98, DOI DOI 10.2134/JEQ2006.0392; Sainju UM, 2012, SOIL TILL RES, V118, P123, DOI 10.1016/j.still.2011.10.020; Sainju UM, 2011, SOIL SCI SOC AM J, V75, P669, DOI 10.2136/sssaj2010.0221; Sainju UM, 2009, AGRON J, V101, P243, DOI 10.2134/agronj2008.0080x; Schipper LA, 2013, SOIL SCI SOC AM J, V77, P246, DOI 10.2136/sssaj2012.0126; Stevens WB, 2010, AGRON J, V102, P1745, DOI 10.2134/agronj2010.0122; Vigil MF, 1997, CROP SCI, V37, P844, DOI 10.2135/cropsci1997.0011183X003700030025x; WOOD CW, 1990, AGRON J, V82, P1115, DOI 10.2134/agronj1990.00021962008200060018x	42	3	3	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149005	10.1371/journal.pone.0149005	http://dx.doi.org/10.1371/journal.pone.0149005			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886932	gold, Green Submitted, Green Published			2022-12-27	WOS:000371218400058
J	Chen, Y; Zheng, JF; Huang, QN; Deng, FY; Huang, RL; Zhao, WJ; Yin, JP; Song, LN; Chen, J; Gao, X; Liu, ZG; Petersen, F; Yu, XH				Chen, Yan; Zheng, Junfeng; Huang, Qiaoniang; Deng, Fengyuan; Huang, Renliang; Zhao, Wenjie; Yin, Junping; Song, Lina; Chen, Juan; Gao, Xing; Liu, Zuguo; Petersen, Frank; Yu, Xinhua			Autoantibodies against the Second Extracellular Loop of M3R Do neither Induce nor Indicate Primary Sjogren's Syndrome	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR; T-CELLS; ANTIBODIES; PEPTIDES; SERUM; IGG	Objectives Anti-muscarinic acetylcholine type-3 receptor (anti-M3R) autoantibodies have been suggested to be pathogenic for primary Sjogren's syndrome (pSS), and the second extracellular loop of M3R is suspected to carry a disease-promoting epitope. In this study, we aimed to evaluate the pathogenicity of autoantibodies against peptides derived from the second extracellular loop of M3R in mice and to determine whether those autoantibodies could be used as biomarker for pSS. Methods BALB/c mice were immunized with modified linear or cyclic peptides of the second extracellular loop of M3R. The function of exocrine glands was evaluated by measuring the secretion of saliva and tears. The histological evaluations were performed by using H&E staining or direct immunofluorescence staining. Autoantibodies against linear or cyclic peptides of the second extracellular loop of M3R in human and mice were determined using ELISA. Results Immunization induced mice to produce autoantibodies against the linear or cyclic peptides of the second extracellular loop of M3R, and those autoantibodies could bind onto salivary glands. However, those mice showed neither impairment in the secretion of tears or saliva nor histological abnormality in the exocrine glands. Furthermore, passive transfer of the IgG isolated from the immunized mice into healthy mice did not induced the dysfunction of the exocrine glands. The prevalence of autoantibodies against the peptides of the second extracellular loop of M3R was low in pSS patients, and it did not differ significantly from that in healthy controls. Conclusions Our results suggest that the autoantibodies against peptides of the second extracellular loop of M3R are not pathogenic in vivo and they are not suitable as biomarkers for pSS diagnosis.	[Chen, Yan; Zheng, Junfeng; Huang, Qiaoniang; Deng, Fengyuan; Huang, Renliang; Zhao, Wenjie; Yin, Junping; Yu, Xinhua] Xiamen Univ, Coll Med, Lab Autoimmun, Xiamen, Peoples R China; [Chen, Yan] Xinxiang Med Univ, Affiliated Hosp 1, Dept Pharm, Xinxiang, Henan, Peoples R China; [Song, Lina; Chen, Juan] Xiamen Univ, Afflict Hosp 1, Dept Rheumatol, Xiamen, Peoples R China; [Gao, Xing] Xiamen Univ, Xiamen Univ Hosp, Dept Clin Lab, Xiamen, Peoples R China; [Liu, Zuguo] Xiamen Univ, Inst Eye, Xiamen, Peoples R China; [Liu, Zuguo] Xiamen Univ, Affiliated Xiamen Eye Ctr, Xiamen, Peoples R China; [Petersen, Frank; Yu, Xinhua] ARCN, Res Ctr Borstel, Prior Area Asthma & Allergy, Borstel, Germany	Xiamen University; Xinxiang Medical University; Xiamen University; Xiamen University; Xiamen University; Xiamen University; Forschungszentrum Borstel	Yu, XH (corresponding author), Xiamen Univ, Coll Med, Lab Autoimmun, Xiamen, Peoples R China.; Yu, XH (corresponding author), ARCN, Res Ctr Borstel, Prior Area Asthma & Allergy, Borstel, Germany.	xinhuayu@fz-borstel.de			National Natural Science Foundation of China [81371325]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81371325).	Cavill D, 2004, SCAND J IMMUNOL, V59, P261, DOI 10.1111/j.0300-9475.2004.01395.x; Cavill D, 2002, J RHEUMATOL, V29, P1342; Dawson LJ, 2006, ARTHRITIS RHEUM, V54, P1165, DOI 10.1002/art.21764; Dawson LJ, 2004, RHEUMATOLOGY, V43, P1488, DOI 10.1093/rheumatology/keh389; Gao JH, 2004, ARTHRITIS RHEUM-US, V50, P2615, DOI 10.1002/art.20371; He J, 2012, CLIN EXP RHEUMATOL, V30, P322; He J, 2011, RHEUMATOLOGY, V50, P879, DOI 10.1093/rheumatology/keq420; HULME EC, 1990, ANNU REV PHARMACOL, V30, P633, DOI 10.1146/annurev.pa.30.040190.003221; Iizuka M, 2010, J AUTOIMMUN, V35, P383, DOI 10.1016/j.jaut.2010.08.004; Koo NY, 2008, RHEUMATOLOGY, V47, P828, DOI 10.1093/rheumatology/ken064; Kovacs L, 2005, RHEUMATOLOGY, V44, P1021, DOI 10.1093/rheumatology/keh672; Kyriakidis NC, 2014, J AUTOIMMUN, V51, P67, DOI 10.1016/j.jaut.2013.11.001; Li HM, 2004, IMMUNITY, V21, P551, DOI 10.1016/j.immuni.2004.08.013; Mavragani CP, 2010, AUTOIMMUN REV, V9, pA305, DOI 10.1016/j.autrev.2009.11.004; MITCHISON N A, 1971, European Journal of Immunology, V1, P18, DOI 10.1002/eji.1830010104; Moutsopoulos HM, 2014, J AUTOIMMUN, V51, P1, DOI 10.1016/j.jaut.2014.01.001; Nakamura Y, 2008, ANN RHEUM DIS, V67, P136, DOI 10.1136/ard.2007.072421; Nguyen KHT, 2000, ARTHRITIS RHEUM-US, V43, P2297, DOI 10.1002/1529-0131(200010)43:10<2297::AID-ANR18>3.0.CO;2-X; Patel R, 2014, CLIN EPIDEMIOL, V6, P247, DOI 10.2147/CLEP.S47399; Pringle S, 2011, JOVE-J VIS EXP, DOI 10.3791/2484; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; Robinson CP, 1998, P NATL ACAD SCI USA, V95, P7538, DOI 10.1073/pnas.95.13.7538; Roescher N, 2011, ANN RHEUM DIS, V70, P235, DOI 10.1136/ard.2010.129049; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; Sumida T, 2014, J AUTOIMMUN, V51, P44, DOI 10.1016/j.jaut.2013.12.012; Tsuboi H, 2010, CLIN EXP IMMUNOL, V162, P53, DOI 10.1111/j.1365-2249.2010.04188.x; Tsuboi H, 2012, MOD RHEUMATOL, V22, P264, DOI 10.1007/s10165-011-0514-8; Uchida T, 1998, DEV BIOL STAND, V92, P353; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Yu XH, 2015, CURR PHARM DESIGN, V21, P2308, DOI 10.2174/1381612821666150316115412	30	8	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149485	10.1371/journal.pone.0149485	http://dx.doi.org/10.1371/journal.pone.0149485			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901532	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100081
J	Gosmann, J; Eliasmith, C				Gosmann, Jan; Eliasmith, Chris			Optimizing Semantic Pointer Representations for Symbol-Like Processing in Spiking Neural Networks	PLOS ONE			English	Article							MODEL	The Semantic Pointer Architecture (SPA) is a proposal of specifying the computations and architectural elements needed to account for cognitive functions. By means of the Neural Engineering Framework (NEF) this proposal can be realized in a spiking neural network. However, in any such network each SPA transformation will accumulate noise. By increasing the accuracy of common SPA operations, the overall network performance can be increased considerably. As well, the representations in such networks present a trade-off between being able to represent all possible values and being only able to represent the most likely values, but with high accuracy. We derive a heuristic to find the near-optimal point in this trade-off. This allows us to improve the accuracy of common SPA operations by up to 25 times. Ultimately, it allows for a reduction of neuron number and a more efficient use of both traditional and neuromorphic hardware, which we demonstrate here.	[Gosmann, Jan; Eliasmith, Chris] Univ Waterloo, Ctr Theoret Neurosci, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Gosmann, J (corresponding author), Univ Waterloo, Ctr Theoret Neurosci, Waterloo, ON N2L 3G1, Canada.	jgosmann@uwaterloo.ca			Canada Research Chairs program; Natural Sciences and Engineering Research Council of Canada [261453]; Air Force Office of Scientific Research [FA8655-13-1-3084]; Canada Foundation for Innovation; Ontario Innovation Trust	Canada Research Chairs program(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Innovation Trust	This work was supported by the Canada Research Chairs program (http://www.chairs-chaires.gc.ca/), the Natural Sciences and Engineering Research Council of Canada Discovery grant 261453 (http://www.nserc-crsng.gc.ca/), Air Force Office of Scientific Research grant FA8655-13-1-3084 (http://www.afosr.af.mil/), Canada Foundation for Innovation (http://www.innovation.ca/), and Ontario Innovation Trust. All funding was received by CE. This work made also use of SHARCNET (https://www.sharcnet.ca) and Compute Canada (https://www.computecanada.ca/) computer resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, NEURAL ENG COMPUTATI; Bekolay T, 2014, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00048; Bekolay T, 2014, J NEUROSCI, V34, P1892, DOI 10.1523/JNEUROSCI.2421-13.2014; Benjamin B, 2014, P IEEE, V102, P699, DOI 10.1109/JPROC.2014.2313565; Choudhary Swadesh, 2012, Artificial Neural Networks and Machine Learning - ICANN 2012. Proceedings of the 22nd International Conference on Artificial Neural Networks, P121, DOI 10.1007/978-3-642-33269-2_16; Conklin J, 2005, J COMPUT NEUROSCI, V18, P183, DOI 10.1007/s10827-005-6558-z; Eliasmith C, 2005, 27 ANN M COGN SCI SO; Eliasmith C, 2012, SCIENCE, V338, P1202, DOI 10.1126/science.1225266; Fischer BJ, 2005, MODEL COMPUTATIONS L; Fischer BJ, 2007, J NEUROPHYSIOL, V98, P1181, DOI 10.1152/jn.00370.2007; Furber SB, 2014, P IEEE, V102, P652, DOI 10.1109/JPROC.2014.2304638; Gayler RW, 2003, INT C COGN SCI; Gosmann J., 2015, P 37 ANN M COGN SCI, P812; Gosmann Jan, 2015, PRECISE MULTIPLICATI; Kuo PD, 2005, BIOL CYBERN, V93, P178, DOI 10.1007/s00422-005-0576-9; Litt A, 2008, COGN SYST RES, V9, P252, DOI 10.1016/j.cogsys.2007.11.001; Merolla PA, 2014, SCIENCE, V345, P668, DOI 10.1126/science.1254642; Mundy A, 2015, IEEE IJCNN; PLATE TA, 1995, IEEE T NEURAL NETWOR, V6, P623, DOI 10.1109/72.377968; Rasmussen D, 2014, INTELLIGENCE, V42, P53, DOI 10.1016/j.intell.2013.10.003; Serrano-Gotarredona R, 2009, IEEE T NEURAL NETWOR, V20, P1417, DOI 10.1109/TNN.2009.2023653; Singh R, 2006, J NEUROSCI, V26, P3667, DOI 10.1523/JNEUROSCI.4864-05.2006; Stewart T. C., 2014, PROC ANN M COGN SCI, P1533; Wang R, 2015, NEUROMORPHIC HARDWAR	25	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149928	10.1371/journal.pone.0149928	http://dx.doi.org/10.1371/journal.pone.0149928			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900931	gold, Green Published, Green Submitted			2022-12-27	WOS:000371276100186
J	Hoffmann, M; Hernandez, MG; Berger, E; Marzi, A; Pohlmann, S				Hoffmann, Markus; Hernandez, Mariana Gonzalez; Berger, Elisabeth; Marzi, Andrea; Poehlmann, Stefan			The Glycoproteins of All Filovirus Species Use the Same Host Factors for Entry into Bat and Human Cells but Entry Efficiency Is Species Dependent	PLOS ONE			English	Article							EBOLA-VIRUS GLYCOPROTEIN; VESICULAR STOMATITIS-VIRUS; ACUTE RESPIRATORY SYNDROME; LECTINS DC-SIGN; MARBURG VIRUS; FRUIT BATS; PROTEOLYTIC ACTIVATION; ENVELOPE GLYCOPROTEIN; PROTEASE INHIBITORS; SPIKE PROTEIN	Ebola and marburgviruses, members of the family Filoviridae, can cause severe hemorrhagic fever in humans. The ongoing Ebola virus (EBOV) disease epidemic in Western Africa claimed more than 11,300 lives and was associated with secondary cases outside Africa, demonstrating that filoviruses pose a global health threat. Bats constitute an important natural reservoir of filoviruses, including viruses of the recently identified Cuevavirus genus within the Filoviridae family. However, the interactions of filoviruses with bat cells are incompletely understood. Here, we investigated whether filoviruses employ different strategies to enter human and bat cells. For this, we examined host cell entry driven by glycoproteins (GP) from all filovirus species into cell lines of human and fruit bat origin. We show that all GPs were able to mediate entry into human and most fruit bat cell lines with roughly comparable efficiency. In contrast, the efficiency of entry into the cell line EidNi/41 derived from a straw-colored fruit bat varied markedly between the GPs of different filovirus species. Furthermore, inhibition studies demonstrated that filoviruses employ the same host cell factors for entry into human, non-human primate and fruit bat cell lines, including cysteine proteases, two pore channels and NPC1 (Niemann-Pick C1 molecule). Finally, processing of GP by furin and the presence of the mucin-like domain in GP were dispensable for entry into both human and bat cell lines. Collectively, these results show that filoviruses rely on the same host cell factors for entry into human and fruit bat cells, although the efficiency of the usage of these factors might differ between filovirus species.	[Hoffmann, Markus; Hernandez, Mariana Gonzalez; Berger, Elisabeth; Poehlmann, Stefan] German Primate Ctr, Infect Biol Unit, Gottingen, Germany; [Marzi, Andrea] NIAID, Lab Virol Div Intramural Res, NIH, Hamilton, MT USA	Deutsches Primatenzentrum (DPZ); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hoffmann, M; Pohlmann, S (corresponding author), German Primate Ctr, Infect Biol Unit, Gottingen, Germany.	mhoffmann@dpz.eu; spoehlmann@dpz.eu	Marzi, Andrea/AAF-4617-2020; Hoffmann, Markus/J-7836-2018; Pöhlmann, Stefan/H-2395-2011	Marzi, Andrea/0000-0003-0186-9587; Hoffmann, Markus/0000-0003-4603-7696; Pöhlmann, Stefan/0000-0001-6086-9136; Gonzalez Hernandez, Mariana/0000-0001-7019-2165	BMBF (EBOKON Verbund); Leibniz foundation (Graduate School for Emerging Infectious Diseases); Division of Intramural Research, NIAID, NIH; DAAD (Deutscher Akademischer Austauschdienst); CONACYT (Consejo Nacional de Ciencia y Tecnologia) by the National Council for Science and Technology in Mexico	BMBF (EBOKON Verbund)(Federal Ministry of Education & Research (BMBF)); Leibniz foundation (Graduate School for Emerging Infectious Diseases); Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DAAD (Deutscher Akademischer Austauschdienst)(Deutscher Akademischer Austausch Dienst (DAAD)); CONACYT (Consejo Nacional de Ciencia y Tecnologia) by the National Council for Science and Technology in Mexico	This study was funded by BMBF (EBOKON Verbund) (https://www.bmbf.de/presse/bmbf-staerkt-forschung-zu-ebola-721.html), the Leibniz foundation (Graduate School for Emerging Infectious Diseases) (http://www.dpz.eu/en/career/graduate-training/emerging-infectious-diseases/leibniz-graduate-school-for-emerging-infectious-diseases-eidis.html) and partly by the Division of Intramural Research, NIAID, NIH. MGH is supported within a German-Mexican cooperation program of the DAAD (Deutscher Akademischer Austauschdienst) and CONACYT (Consejo Nacional de Ciencia y Tecnologia) by the National Council for Science and Technology in Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Amman BR, 2015, J WILDLIFE DIS, V51, P113, DOI 10.7589/2014-08-198; Amman BR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002877; Barrette RW, 2009, SCIENCE, V325, P204, DOI 10.1126/science.1172705; Biek R, 2006, PLOS PATHOG, V2, P885, DOI 10.1371/journal.ppat.0020090; Biesold SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028131; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Brudner M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060838; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Chaipan C, 2009, J VIROL, V83, P3200, DOI 10.1128/JVI.02205-08; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Chazal N, 2001, J VIROL, V75, P4014, DOI 10.1128/JVI.75.8.4014-4018.2001; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Dahlmann F, 2015, J INFECT DIS, V212, pS247, DOI 10.1093/infdis/jiv140; Diederich S, 2008, VIROLOGY, V375, P391, DOI 10.1016/j.virol.2008.02.019; Gierer S, 2013, J VIROL, V87, P5502, DOI 10.1128/JVI.00128-13; Gnirss K, 2012, VIROLOGY, V424, P3, DOI 10.1016/j.virol.2011.11.031; Groseth A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002847; Hanika A, 2005, J GEN VIROL, V86, P1455, DOI 10.1099/vir.0.80788-0; He B, 2015, EMERG INFECT DIS, V21, P1675, DOI 10.3201/eid2109.150260; Hoffmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072942; Hofmann-Winkler H, 2015, J INFECT DIS, V212, pS172, DOI 10.1093/infdis/jiv101; Hofmann-Winkler H, 2012, VIRUSES-BASEL, V4, P3336, DOI 10.3390/v4123336; HOSOYA M, 1992, ANTIMICROB AGENTS CH, V36, P1432, DOI 10.1128/AAC.36.7.1432; Hunt CL, 2011, J VIROL, V85, P334, DOI 10.1128/JVI.01278-09; Jayme SI, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0331-3; Jeffers SA, 2002, J VIROL, V76, P12463, DOI 10.1128/JVI.76.24.12463-12472.2002; Jones MEB, 2015, VIRUSES-BASEL, V7, P3420, DOI 10.3390/v7072779; Kondratowicz AS, 2011, P NATL ACAD SCI USA, V108, P8426, DOI 10.1073/pnas.1019030108; Kruger N, 2014, J VIROL, V88, P11973, DOI 10.1128/JVI.01561-14; Kuhl A, 2011, J INFECT DIS, V204, pS840, DOI 10.1093/infdis/jir306; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Leroy EM, 2004, J INFECT DIS, V190, P1895, DOI 10.1086/425421; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Lu FR, 2015, ELIFE, V4, DOI 10.7554/eLife.12177; Maruyama J, 2014, J VIROL, V88, P99, DOI 10.1128/JVI.02265-13; Marzi A, 2004, J VIROL, V78, P12090, DOI 10.1128/JVI.78.21.12090-12095.2004; Marzi A, 2007, J INFECT DIS, V196, pS237, DOI 10.1086/520607; Marzi A, 2006, J VIROL, V80, P6305, DOI 10.1128/JVI.02545-05; Marzi A, 2015, EMERG INFECT DIS, V21, P1777, DOI 10.3201/eid2110.150259; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; Medina MF, 2003, MOL THER, V8, P777, DOI 10.1016/S1525-0016(03)00266-1; Moratelli R, 2015, MEM I OSWALDO CRUZ, V110, P1, DOI 10.1590/0074-02760150048; Muller MA, 2012, MBIO, V3, DOI 10.1128/mBio.00515-12; Negredo A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002304; Neumann G, 2002, J VIROL, V76, P406, DOI 10.1128/JVI.76.1.406-410.2002; Neumann G, 2007, J VIROL, V81, P2995, DOI 10.1128/JVI.02486-06; Ng M, 2015, ELIFE, V4, DOI 10.7554/eLife.11785; Ng M, 2014, VIROLOGY, V468, P637, DOI 10.1016/j.virol.2014.08.019; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nkoghe D, 2005, B SOC PATHOL EXOT, V98, P224; Paweska JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045479; Redlist I, IUCN RED LIST THREAT; Rentsch MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025858; Sakurai Y, 2015, SCIENCE, V347, P995, DOI 10.1126/science.1258758; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Schornberg KL, 2009, P NATL ACAD SCI USA, V106, P8003, DOI 10.1073/pnas.0807578106; Shah PP, 2010, MOL PHARMACOL, V78, P319, DOI 10.1124/mol.110.064261; Shimojima M, 2006, J VIROL, V80, P10109, DOI 10.1128/JVI.01157-06; Shirato K, 2013, J VIROL, V87, P12552, DOI 10.1128/JVI.01890-13; Shoemaker CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056265; Simmons G, 2003, VIROLOGY, V305, P115, DOI 10.1006/viro.2002.1730; Simmons G, 2002, J VIROL, V76, P2518, DOI 10.1128/JVI.76.5.2518-2528.2002; Smith I, 2013, CURR OPIN VIROL, V3, P84, DOI 10.1016/j.coviro.2012.11.006; Swanepoel R, 2007, EMERG INFECT DIS, V13, P1847, DOI 10.3201/eid1312.071115; Takada A, 2004, J VIROL, V78, P2943, DOI 10.1128/JVI.78.6.2943-2947.2004; Takada A, 2001, TRENDS MICROBIOL, V9, P506, DOI 10.1016/S0966-842X(01)02201-6; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taniguchi S, 2011, EMERG INFECT DIS, V17, P1559, DOI 10.3201/eid1708.101693; Towner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000764; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; Wool-Lewis RJ, 1999, J VIROL, V73, P1419, DOI 10.1128/JVI.73.2.1419-1426.1999; Wool-Lewis RJ, 1998, J VIROL, V72, P3155, DOI 10.1128/JVI.72.4.3155-3160.1998; Wrensch F, 2015, J INFECT DIS, V212, pS210, DOI 10.1093/infdis/jiv255; Yao Y, 2003, VIROLOGY, V310, P319, DOI 10.1016/S0042-6822(03)00146-6; Yuan JF, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-236; Zhou Y, 2015, ANTIVIR RES, V116, P76, DOI 10.1016/j.antiviral.2015.01.011; Zimmer G, 2014, J GEN VIROL, V95, P1634, DOI 10.1099/vir.0.065201-0	79	24	24	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149651	10.1371/journal.pone.0149651	http://dx.doi.org/10.1371/journal.pone.0149651			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901159	Green Published, gold			2022-12-27	WOS:000371276100122
J	Park, JW; Chu, MK; Kim, JM; Park, SG; Cho, SJ				Park, Jeong-Wook; Chu, Min Kyung; Kim, Jae-Moon; Park, Sang-Gue; Cho, Soo-Jin			Analysis of Trigger Factors in Episodic Migraineurs Using a Smartphone Headache Diary Applications	PLOS ONE			English	Article							TENSION-TYPE HEADACHE; PREMONITORY FEATURES; ATTACKS; SYMPTOMS; STRESS; SLEEP; AURA; PAIN	Background Various stimuli can trigger migraines in susceptible individuals. We examined migraine trigger factors by using a smartphone headache diary application. Method Episodic migraineurs who agreed to participate in our study downloaded smartphone headache diary application, which was designed to capture the details regarding headache trigger factors and characteristics for 3 months. The participants were asked to access the smartphone headache diary application daily and to confirm the presence of a headache and input the types of trigger factors. Results Sixty-two participants kept diary entries until the end of the study. The diary data for 4,579 days were analyzed. In this data set, 1,099 headache days (336 migraines, 763 non-migraine headaches) were recorded; of these, 772 headache events had with trigger factors, and 327 events did not have trigger factors. The common trigger factors that were present on headache days included stress, fatigue, sleep deprivation, hormonal changes, and weather changes. The likelihood of a headache trigger was 57.7% for stress, 55.1% for sleep deprivation, 48.5% for fatigue, and 46.5% for any trigger. The headaches with trigger factors were associated with greater pain intensity (p<0.001), headache-related disability (p<0.001), abortive medication use (p = 0.02), and the proportion of migraine (p < 0.001), relative to those without trigger factors. Traveling (odd ratios [OR]: 6.4), hormonal changes (OR: 3.5), noise (OR: 2.8), alcohol (OR: 2.5), overeating (OR: 2.4), and stress (OR:1.8) were significantly associated with migraines compared to non-migraine headaches. The headaches that were associated with hormonal changes or noise were more often migraines, regardless of the preventive medication. The headaches due to stress, overeating, alcohol, and traveling were more often migraines without preventive medication, but it was not evident with preventive medication. Conclusion Smartphone headache diary application is an effective tool to assess migraine trigger factors. The headaches with trigger factors had greater severity or migraine features. The type of triggers and the presence of preventive medication influenced the headache characteristics; hence, an investigation of trigger factors would be helpful in understanding migraine occurrences.	[Park, Jeong-Wook] Catholic Univ Korea, Coll Med, Dept Neurol, Seoul, South Korea; [Chu, Min Kyung] Hallym Univ, Coll Med, Sacred Heart Hosp, Dept Neurol, Anyang, South Korea; [Kim, Jae-Moon] Chungnam Natl Univ, Coll Med, Dept Neurol, Daejeon, South Korea; [Park, Sang-Gue] Chung Ang Univ, Dept Appl Stat, Seoul 156756, South Korea; [Cho, Soo-Jin] Hallym Univ, Coll Med, Dept Neurol, Dongtan Sacred Heart Hosp, Hwaseong, South Korea	Catholic University of Korea; Hallym University; Chungnam National University; Chung Ang University; Hallym University	Cho, SJ (corresponding author), Hallym Univ, Coll Med, Dept Neurol, Dongtan Sacred Heart Hosp, Hwaseong, South Korea.	dowonc@naver.com	PARK, Sang-Gue/V-7768-2019		Korean Headache Society; Hallym University Research Fund [HURF-2014-51]	Korean Headache Society; Hallym University Research Fund	This study was supported by a grant from Korean Headache Society (http://www.headache.or.kr/) and by Hallym University Research Fund (HURF-2014-51).	Baldacci F, 2013, HEADACHE, V53, P834, DOI 10.1111/head.12083; Baldacci F, 2013, HEADACHE, V53, P152, DOI 10.1111/head.12012; Brennan KC, 2009, SEMIN NEUROL, V29, P406, DOI 10.1055/s-0029-1237113; Chu Min Kyung, 2009, [Journal of the Korean Neurological Association, 대한신경과학회지], V27, P1; Goldberg J, 2007, HEADACHE, V47, P384, DOI 10.1111/j.1526-4610.2006.00441.x; Granella F, 2004, CEPHALALGIA, V24, P707, DOI 10.1111/j.1468-2982.2004.00741.x; Haque B, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-82; Hashizume M, 2008, BIOPSYCHOSOC MED, V2, DOI 10.1186/1751-0759-2-14; Hoffmann J, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0370-7; Hougaard A, 2013, NEUROLOGY, V80, P428, DOI 10.1212/WNL.0b013e31827f0f10; Houle TT, 2013, HEADACHE, V53, P636, DOI 10.1111/head.12075; Houle TT, 2012, PAIN, V153, P2432, DOI 10.1016/j.pain.2012.08.014; Hundert AS, 2014, JMIR MHEALTH UHEALTH, V19, P36; Jacob E, 2012, J PEDIAT HEMATOL ONC, V34, P326, DOI 10.1097/MPH.0b013e318257a13c; Koppen H, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-99; Krogh AB, 2015, CEPHALALGIA IN PRESS; Lee HS., 2000, J KOREAN NEUROL ASS, V18, P287; Lieba-Samal D, 2011, EUR J PAIN, V15, P205, DOI 10.1016/j.ejpain.2010.06.013; Lipton RB, 2000, HEADACHE, V40, P783, DOI 10.1046/j.1526-4610.2000.00143.x; Lipton RB, 2014, HEADACHE, V54, P1661, DOI 10.1111/head.12464; Lipton RB, 2014, NEUROLOGY, V82, P1395, DOI 10.1212/WNL.0000000000000332; MacGregor EA, 2012, CURR PAIN HEADACHE R, V16, P452, DOI 10.1007/s11916-012-0282-y; Maniyar FH, 2015, HEADACHE, V55, P609, DOI 10.1111/head.12572; Moloney MF, 2009, HEADACHE, V49, P673, DOI 10.1111/j.1526-4610.2009.01399.x; Noseda R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103929; Odegard SS, 2010, J HEADACHE PAIN, V11, P197, DOI 10.1007/s10194-010-0201-8; Parashar R, 2014, INT J WOMENS HEALTH, V6, P921, DOI 10.2147/IJWH.S62922; Pavlovic JM, 2014, HEADACHE, V54, P1670, DOI 10.1111/head.12468; Peroutka SJ, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-014-0454-z; Rosser BA, 2011, J TELEMED TELECARE, V17, P308, DOI 10.1258/jtt.2011.101102; Salhofer-Polanyi S, 2012, HEADACHE, V52, P1236, DOI 10.1111/j.1526-4610.2012.02166.x; Scheidt J, 2013, INT J BIOMETEOROL, V57, P649, DOI 10.1007/s00484-012-0582-2; Schurks M, 2011, CEPHALALGIA, V31, P861, DOI 10.1177/0333102411401635; Schwedt TJ, 2013, CURR OPIN NEUROL, V26, P248, DOI 10.1097/WCO.0b013e328360edb1; Silberstein S, 2014, EXPERT OPIN PHARMACO, V15, P2063, DOI 10.1517/14656566.2014.947959; Silva-Neto RP, 2014, CEPHALALGIA, V34, P14, DOI 10.1177/0333102413495969; Sorbi MJ, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.5.e38; Tekatas A, 2013, EUR NEUROL, V70, P263, DOI 10.1159/000354165; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Turner DP, 2013, HEADACHE, V53, P628, DOI 10.1111/head.12076; Ulrich V, 1996, PAIN, V67, P501, DOI 10.1016/0304-3959(96)03164-8; Unalp A, 2008, J CHILD NEUROL, V23, P1377, DOI 10.1177/0883073808318547; Wang J, 2013, EUR J NEUROL, V20, P689, DOI 10.1111/ene.12039; Wober C, 2007, CEPHALALGIA, V27, P304, DOI 10.1111/j.1468-2982.2007.01279.x; Yang AC, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0533-5; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	46	57	60	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149577	10.1371/journal.pone.0149577	http://dx.doi.org/10.1371/journal.pone.0149577			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901341	Green Submitted, Green Published, gold			2022-12-27	WOS:000371276100101
J	Zhao, YX; Zhang, X; Li, JN; Bian, Y; Sheng, MM; Liu, B; Fu, ZD; Zhang, Y; Yang, BF				Zhao, Yixiu; Zhang, Xin; Li, Jiannan; Bian, Yu; Sheng, Miaomiao; Liu, Bin; Fu, Zidong; Zhang, Yan; Yang, Baofeng			Jujuboside B Reduces Vascular Tension by Increasing Ca2+ Influx and Activating Endothelial Nitric Oxide Synthase	PLOS ONE			English	Article							POTASSIUM CHANNEL; DEPENDENT VASORELAXATION; MYOCARDIAL-ISCHEMIA; CELLS; RATS; NO; PHOSPHORYLATION; CALCIUM; MICE; HYPERTENSION	Jujuboside B has been reported to have protective effect on many cardiovascular diseases. However, the effects of Jujuboside B on vascular tension and endothelial function are unknown. The present study investigated the effects of Jujuboside B on reducing vascular tension, protecting endothelial function and the potential mechanisms. The tension of isolated rat thoracic aorta ring was measured by Wire myograph system. The concentration of nitric oxide (NO) and the activity of endothelial nitric oxide synthase (eNOS) in human aortic endothelial cells (HAECs) were determined by Griess reagent method and enzyme-linked immune sorbent assay. The protein levels of eNOS and p-eNOS at Serine-1177 were determined by western blot analysis. Intracellular Ca2+ concentration in HAECs was measured by laser confocal imaging microscopy. Results showed that Jujuboside B reduced the tension of rat thoracic aorta rings with intact endothelium in a dose-dependent manner. L-AME, KN93, EGTA, SKF96365, iberiotoxin and glibenclamide significantly attenuated Jujuboside B-induced vasodilation in endothelium-intact tissues. In contrast, indometacin and 4-DAMP had no such effects. Jujuboside B also promoted NO generation and increased eNOS activity, which were attenuated by L-NAME, EGTA and SKF96365. Moreover, Jujuboside B increased intracellular Ca2+ concentration dose-dependently, which was inhibited by EGTA and SKF96365. Besides, Jujuboside B induced a rapid Ca2+ influx instantaneously after depleting intracellular Ca2+ store, which was significantly inhibited by SKF96365. In conclusion, this study preliminarily confirmed that Jujuboside B reduced vascular tension endothelium-dependently. The underlying mechanisms involved that Jujuboside B increased extracellular Ca2+ influx through endothelial transient receptor potential cation (TRPC) channels, phosphorylated eNOS and promoted NO generation in vascular endothelial cells. In addition, Jujuboside B-induced vasodilation involved endothelium-dependent hyperpolarizaiton through endothelial potassium channels. Jujuboside B is a natural compound with new pharmacological effects on improving endothelial dysfunction and treating vascular diseases.	[Zhao, Yixiu; Zhang, Xin; Li, Jiannan; Bian, Yu; Sheng, Miaomiao; Liu, Bin; Fu, Zidong; Zhang, Yan; Yang, Baofeng] Harbin Med Univ, Dept Pharmacol, Harbin, Heilongjiang, Peoples R China; [Zhao, Yixiu; Zhang, Xin; Li, Jiannan; Bian, Yu; Sheng, Miaomiao; Liu, Bin; Fu, Zidong; Zhang, Yan; Yang, Baofeng] Harbin Med Univ, Minist Educ, Key Lab Cardiovasc Med Res, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University	Zhang, Y; Yang, BF (corresponding author), Harbin Med Univ, Dept Pharmacol, Harbin, Heilongjiang, Peoples R China.; Zhang, Y; Yang, BF (corresponding author), Harbin Med Univ, Minist Educ, Key Lab Cardiovasc Med Res, Harbin, Heilongjiang, Peoples R China.	zhangyan@ems.hrbmu.edu.cn; yangbf@ems.hrbmu.edu.cn	Fu, Zidong/A-2703-2017	bian, yu/0000-0002-6741-1192				Bi CWC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051670; Busse R, 2002, TRENDS PHARMACOL SCI, V23, P374, DOI 10.1016/S0165-6147(02)02050-3; Cai H, 2008, CARDIOVASC RES, V77, P30, DOI 10.1093/cvr/cvm010; Carrier GO, 1997, AM J PHYSIOL-HEART C, V273, pH76, DOI 10.1152/ajpheart.1997.273.1.H76; CHANG J, 1987, BIOCHEM PHARMACOL, V36, P2429, DOI 10.1016/0006-2952(87)90512-0; CHEN XJ, 1990, ACTA PHARM SINIC, V11, P153; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Cheng J, 2010, J PHARMACOL EXP THER, V332, P57, DOI 10.1124/jpet.109.159863; Cordellini S, 1998, GEN PHARMACOL-VASC S, V30, P79, DOI 10.1016/S0306-3623(97)00074-8; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dudzinski DM, 2006, ANNU REV PHARMACOL, V46, P235, DOI 10.1146/annurev.pharmtox.44.101802.121844; Emerson GG, 2000, CIRC RES, V87, P474; Fleming I, 1999, CARDIOVASC RES, V43, P532, DOI 10.1016/S0008-6363(99)00094-2; Ford RJ, 2011, AM J PHYSIOL-HEART C, V300, pH64, DOI 10.1152/ajpheart.00597.2010; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; Garcia-Morales V, 2014, VASC PHARMACOL, V60, P95, DOI 10.1016/j.vph.2014.01.004; Goeckeler ZM, 2005, J BIOL CHEM, V280, P33083, DOI 10.1074/jbc.M503173200; Govers R, 2001, AM J PHYSIOL-RENAL, V280, pF193, DOI 10.1152/ajprenal.2001.280.2.F193; Gu WX, 1987, DI YI JUN YI DA XUE, V7, P8; Gutterman DD, 2005, ARTERIOSCL THROM VAS, V25, P671, DOI 10.1161/01.ATV.0000158497.09626.3b; Halcox JPJ, 2001, CORONARY ARTERY DIS, V12, P475, DOI 10.1097/00019501-200109000-00006; Hottinger Daniel G, 2014, J Anaesthesiol Clin Pharmacol, V30, P462, DOI 10.4103/0970-9185.142799; Huang KC, 1999, PHARM CHINESE HERBS; Huang Y, 1999, BBA-GEN SUBJECTS, V1427, P322, DOI 10.1016/S0304-4165(99)00034-3; Isenovic ER, 2003, METABOLISM, V52, P482, DOI 10.1053/meta.2003.50079; Jackson WF, 2005, MICROCIRCULATION, V12, P113, DOI 10.1080/10739680590896072; Kang KT, 2014, TOX RESEARCH, V30, P141, DOI 10.5487/TR.2014.30.3.141; Khurana S, 2004, EUR J PHARMACOL, V493, P127, DOI 10.1016/j.ejphar.2004.04.012; KUKOVETZ WR, 1979, J CYCLIC NUCL PROT, V5, P469; Kwan HY, 2007, TRP CHANNELS ENDOTHE, V17772, P907; Leeya Y, 2010, EUR J PHARMACOL, V649, P301, DOI 10.1016/j.ejphar.2010.09.038; Li LM, 2005, J INTEGR PLANT BIOL, V47, P494, DOI 10.1111/j.1744-7909.2005.00060.x; Luscher TF, 1997, CLIN CARDIOL, V20, P3; Munzel T, 1997, J MOL MED-JMM, V75, P891, DOI 10.1007/s001090050181; Orii R, 2010, BIOSCI TRENDS, V4, P260; Qian J., 2013, FRONT PHYSIOL, V4, P1; ROZANSKI A, 1988, NEW ENGL J MED, V318, P1005, DOI 10.1056/NEJM198804213181601; Sandow SL, 2012, ADV EXP MED BIOL, V740, P811, DOI 10.1007/978-94-007-2888-2_36; Sarti P, 2012, BBA-BIOENERGETICS, V1817, P610, DOI 10.1016/j.bbabio.2011.09.002; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Sorensen CM, 2012, AM J PHYSIOL-RENAL, V302, pF505, DOI 10.1152/ajprenal.00052.2011; Stankevicius Edgaras, 2003, Medicina (Kaunas), V39, P333; Steinkamp-Fenske K, 2007, J PHARMACOL EXP THER, V322, P836, DOI 10.1124/jpet.107.123356; Sullivan MN, 2013, AM J PHYSIOL-CELL PH, V305, pC999, DOI 10.1152/ajpcell.00273.2013; Taddei S, 1998, CIRCULATION, V97, P2222, DOI 10.1161/01.CIR.97.22.2222; Tang EHC, 2010, PFLUG ARCH EUR J PHY, V459, P995, DOI 10.1007/s00424-010-0786-4; Tiruppathi C, 2002, VASC PHARMACOL, V39, P173, DOI 10.1016/S1537-1891(03)00007-7; Tran QK, 2000, CARDIOVASC RES, V48, P13, DOI 10.1016/S0008-6363(00)00172-3; Vanhoutte PM, 2009, ACTA PHYSIOL, V196, P193, DOI 10.1111/j.1748-1716.2009.01964.x; Wang GG, 2015, CROAT MED J, V56, P4, DOI 10.3325/cmj.2015.56.4; Wang H, 2007, CARDIOVASC RES, V73, P497, DOI 10.1016/j.cardiores.2006.10.007; Wang Xiao-liang, 2005, Zhongguo Zhongyao Zazhi, V30, P753; Yu Y, 2012, FREE RADICAL RES, V46, P1346, DOI 10.3109/10715762.2012.715369; Zhao J, 2006, J CHROMATOGR A, V1108, P188, DOI 10.1016/j.chroma.2005.12.104	55	20	23	7	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149386	10.1371/journal.pone.0149386	http://dx.doi.org/10.1371/journal.pone.0149386			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901291	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100066
J	Azuma, J; Wong, RJ; Morisawa, T; Hsu, M; Maegdefessel, L; Zhao, H; Kalish, F; Kayama, Y; Wallenstein, MB; Deng, AC; Spin, JM; Stevenson, DK; Dalman, RL; Tsao, PS				Azuma, Junya; Wong, Ronald J.; Morisawa, Takeshi; Hsu, Mark; Maegdefessel, Lars; Zhao, Hui; Kalish, Flora; Kayama, Yosuke; Wallenstein, Matthew B.; Deng, Alicia C.; Spin, Joshua M.; Stevenson, David K.; Dalman, Ronald L.; Tsao, Philip S.			Heme Oxygenase-1 Expression Affects Murine Abdominal Aortic Aneurysm Progression	PLOS ONE			English	Article							GENE-EXPRESSION; CARBON-MONOXIDE; SIMVASTATIN SUPPRESSES; STATINS; ANTIOXIDANT; BILIRUBIN; MECHANISM; MICE; POLYMORPHISM; INHIBITOR	Heme oxygenase-1 (HO-1), the rate-limiting enzyme in heme degradation, is a cytoprotective enzyme upregulated in the vasculature by increased flow and inflammatory stimuli. Human genetic data suggest that a diminished HO-1 expression may predispose one to abdominal aortic aneurysm (AAA) development. In addition, heme is known to strongly induce HO-1 expression. Utilizing the porcine pancreatic elastase (PPE) model of AAA induction in HO-1 heterozygous (HO-1(+/-), HO-1 Het) mice, we found that a deficiency in HO-1 leads to augmented AAA development. Peritoneal macrophages from HO-1(+/-) mice showed increased gene expression of pro-inflammatory cytokines, including MCP-1, TNF-alpha, IL-1-beta, and IL-6, but decreased expression of anti-inflammatory cytokines IL-10 and TGF-beta. Furthermore, treatment with heme returned AAA progression in HO-1 Het mice to a wild-type profile. Using a secondmurine AAA model (Ang II-ApoE(-/-)), we showed that low doses of the HMG-CoA reductase inhibitor rosuvastatin can induce HO-1 expression in aortic tissue and suppress AAA progression in the absence of lipid lowering. Our results support those studies that suggest that pleiotropic statin effects might be beneficial in AAA, possibly through the upregulation of HO-1. Specific targeted therapies designed to induce HO-1 could become an adjunctive therapeutic strategy for the prevention of AAA disease.	[Azuma, Junya; Hsu, Mark; Maegdefessel, Lars; Kayama, Yosuke; Deng, Alicia C.; Spin, Joshua M.; Tsao, Philip S.] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Wong, Ronald J.; Morisawa, Takeshi; Zhao, Hui; Kalish, Flora; Wallenstein, Matthew B.; Stevenson, David K.] Stanford Univ, Dept Pediat, Sch Med, Div Neonatal & Dev Med, Stanford, CA 94305 USA; [Dalman, Ronald L.] Stanford Univ, Sch Med, Div Vasc Surg, Stanford, CA 94305 USA; [Kayama, Yosuke; Deng, Alicia C.; Spin, Joshua M.; Tsao, Philip S.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Wong, RJ (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Div Neonatal & Dev Med, Stanford, CA 94305 USA.	rjwong@stanford.edu	Maegdefessel, Lars/AAW-8243-2020; Maegdefessel, Lars/C-2955-2015	Spin, Joshua/0000-0002-4256-9161; Maegdefessel, Lars/0000-0001-5228-2634	National Institutes of Health [1R01HL122939]; Department of Veterans Affairs [101BX002641]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122939] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by research grants from the National Institutes of Health (1R01HL122939 [PST]) and the Department of Veterans Affairs (101BX002641 [PST]).	Ailawadi G, 2003, J VASC SURG, V38, P584, DOI 10.1016/S0741-5214(03)00324-0; ANIDJAR S, 1992, J VASC SURG, V16, P139, DOI 10.1016/0741-5214(92)90101-D; Bigatel DA, 1999, J VASC SURG, V29, P130, DOI 10.1016/S0741-5214(99)70354-X; Carsten CG, 2001, J VASC SURG, V33, P1255, DOI 10.1067/mva.2001.112706; Chen YH, 2002, HUM GENET, V111, P1, DOI 10.1007/s00439-002-0769-4; Dalman RL, 2006, ANN NY ACAD SCI, V1085, P92, DOI 10.1196/annals.1383.008; Datta PK, 1999, KIDNEY INT, V55, P1734, DOI 10.1046/j.1523-1755.1999.00429.x; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.0000118013.72016.ea; Duckers HJ, 2001, NAT MED, V7, P693, DOI 10.1038/89068; Dulak J, 2005, ENDOTHELIUM-J ENDOTH, V12, P233, DOI 10.1080/10623320500476559; Durante W, 1997, CIRC RES, V80, P557, DOI 10.1161/01.RES.80.4.557; Eto M, 2002, CIRCULATION, V105, P1756, DOI 10.1161/01.CIR.0000015465.73933.3B; Evans J, 2007, EUR J VASC ENDOVASC, V34, P302, DOI 10.1016/j.ejvs.2007.04.011; Ferguson CD, 2010, AM HEART J, V159, DOI 10.1016/j.ahj.2009.11.016; Foresti R, 2001, AM J PHYSIOL-HEART C, V281, pH1976, DOI 10.1152/ajpheart.2001.281.5.H1976; Grosser N, 2004, FREE RADICAL BIO MED, V37, P2064, DOI 10.1016/j.freeradbiomed.2004.09.009; Grosser N, 2004, BIOCHEM BIOPH RES CO, V325, P871, DOI 10.1016/j.bbrc.2004.10.123; Hance KA, 2002, J VASC SURG, V35, P254, DOI 10.1067/mva.2002.120382; He CX, 2011, PEDIATR RES, V70, P467, DOI 10.1203/PDR.0b013e31822e1675; Hoekstra KA, 2004, BIOCHEM CELL BIOL, V82, P351, DOI 10.1139/O04-006; Hsu M, 2006, BIOCHEM BIOPH RES CO, V343, P738, DOI 10.1016/j.bbrc.2006.03.036; Johanning JM, 2001, J VASC SURG, V33, P579, DOI 10.1067/mva.2001.111805; Kalyanasundaram A, 2006, J VASC SURG, V43, P117, DOI 10.1016/j.jvs.2005.08.007; Koh KK, 2000, CARDIOVASC RES, V47, P648, DOI 10.1016/S0008-6363(00)00146-2; Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266; Lawrence DM, 2004, J VASC SURG, V40, P334, DOI 10.1016/j.jvs.2004.05.020; Lee TS, 2004, CIRCULATION, V110, P1296, DOI 10.1161/01.CIR.0000140694.67251.9C; Maegdefessel L, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003441; Maron DJ, 2000, CIRCULATION, V101, P207, DOI 10.1161/01.CIR.101.2.207; Muchova L, 2007, CAN J PHYSIOL PHARM, V85, P800, DOI 10.1139/Y07-077; Nagashima H, 2002, J VASC SURG, V36, P158, DOI 10.1067/mva.2002.123680; Nakahashi TK, 2002, ARTERIOSCL THROM VAS, V22, P2017, DOI 10.1161/01.ATV.0000042082.38014.EA; Nydegger UE, 2002, TRANSPL IMMUNOL, V9, P215, DOI 10.1016/S0966-3274(02)00049-7; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Schillinger M, 2002, THROMB RES, V106, P131, DOI 10.1016/S0049-3848(02)00100-7; Schouten O, 2006, EUR J VASC ENDOVASC, V32, P21, DOI 10.1016/j.ejvs.2005.12.024; Schulz S, 2015, PEDIATR RES, V77, P640, DOI 10.1038/pr.2015.22; Son JW, 2003, INT J CARDIOL, V88, P77, DOI 10.1016/S0167-5273(02)00368-6; Steinmetz EF, 2005, ANN SURG, V241, P92, DOI 10.1097/01.sla.0000150258.36236.e0; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; STOCKER R, 1989, FREE RADICAL RES COM, V6, P57, DOI 10.3109/10715768909073428; Suttner DM, 1999, FASEB J, V13, P1800, DOI 10.1096/fasebj.13.13.1800; Takagi H, 2010, J VASC SURG, V52, P1675, DOI 10.1016/j.jvs.2010.04.082; Takemoto M, 2001, ARTERIOSCL THROM VAS, V21, P1712, DOI 10.1161/hq1101.098486; Tedesco MM, 2009, ARTERIOSCL THROM VAS, V29, P1452, DOI 10.1161/ATVBAHA.109.187757; Thompson RW, 2006, ANN NY ACAD SCI, V1085, P59, DOI 10.1196/annals.1383.029; Vitek L., 2006, CURR ENZYM INHIB, V2, P261, DOI DOI 10.2174/157340806777934775; VREMAN HJ, 1988, ANAL BIOCHEM, V168, P31, DOI 10.1016/0003-2697(88)90006-1; Wagner CT, 1997, J CLIN INVEST, V100, P589, DOI 10.1172/JCI119569; Wierzbicki AS, 2003, PHARMACOL THERAPEUT, V99, P95, DOI 10.1016/S0163-7258(03)00055-X; Wilson WRW, 2005, EUR J VASC ENDOVASC, V30, P259, DOI 10.1016/j.ejvs.2005.02.044; Yajima N, 2002, J VASC SURG, V36, P379, DOI 10.1067/mva.2002.124366; Yet SF, 2003, FASEB J, V17, P1759, DOI 10.1096/fj.03-0187fje	53	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149288	10.1371/journal.pone.0149288	http://dx.doi.org/10.1371/journal.pone.0149288			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894432	Green Submitted, gold, Green Published			2022-12-27	WOS:000371223400043
J	Bodnar, AL; Schroder, MN; Scott, MP				Bodnar, Anastasia L.; Schroder, Megan N.; Scott, M. Paul			Recurrent Selection for Transgene Activity Levels in Maize Results in Proxy Selection for a Native Gene with the Same Promoter	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; ZEIN; MARKER	High activity levels of a transgene can be very useful, making a transgene easier to evaluate for safety and efficacy. High activity levels can also increase the economic benefit of the production of high value proteins in transgenic plants. The goal of this research is to determine if recurrent selection for activity of a transgene will result in higher activity, and if selection for activity of a transgene controlled by a native promoter will also increase protein levels of the native gene with the same promoter. To accomplish this goal we used transgenic maize containing a construct encoding green fluorescent protein controlled by the promoter for the maize endosperm-specific 27kDa gamma zein seed storage protein. We carried out recurrent selection for fluorescence intensity in two breeding populations. After three generations of selection, both selected populations were significantly more fluorescent and had significantly higher levels of 27kDa gamma zein than the unselected control populations. These higher levels of the 27kDa gamma zein occurred independently of the presence of the transgene. The results show that recurrent selection can be used to increase activity of a transgene and that selection for a transgene controlled by a native promoter can increase protein levels of the native gene with the same promoter via proxy selection. Moreover, the increase in native gene protein level is maintained in the absence of the transgene, demonstrating that proxy selection can be used to produce non-transgenic plants with desired changes in gene expression.	[Bodnar, Anastasia L.; Schroder, Megan N.] Iowa State Univ, Interdept Genet Program, Ames, IA USA; [Scott, M. Paul] ARS, USDA, Corn Insects & Crop Genet Res Unit, Ames, IA USA; [Bodnar, Anastasia L.] Anim & Plant Hlth Inspect Serv, USDA, Plant Protect & Quarantine, Riverdale, MD USA; [Schroder, Megan N.] DuPont Pioneer, Johnston, IA USA	Iowa State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); DuPont; Pioneer Hi-Bred International, Inc.	Scott, MP (corresponding author), ARS, USDA, Corn Insects & Crop Genet Res Unit, Ames, IA USA.	paul.scott@ars.usda.gov		Bodnar, Anastasia/0000-0002-3320-825X	United States Department of Agriculture Agricultural Research Service [3625-21000-055D]; United States Department of Agriculture Cooperative State Ressearch, Education and Extension Service; ARS [ARS-0425213] Funding Source: Federal RePORTER	United States Department of Agriculture Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); United States Department of Agriculture Cooperative State Ressearch, Education and Extension Service; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was funded by the United States Department of Agriculture Agricultural Research Service (http://www.ars.usda.gov/main/main.htm) CRIS project number 3625-21000-055D, MPS and the United States Department of Agriculture Cooperative State Ressearch, Education and Extension Service (no URL available) special appropriation Biotechnology Test Production, IA: Recovery and Purification of Recombinant Proteins from Plants for Therapeutics and Industrial Enzymes, ALB, MNS.	BIANCHI MW, 1988, PLANT MOL BIOL, V11, P203, DOI 10.1007/BF00015672; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Cho MJ, 2000, PLANT CELL REP, V19, P1084, DOI 10.1007/s002990000238; Coleman CE, 1996, PLANT CELL, V8, P2335, DOI 10.1105/tpc.8.12.2335; de Leon N, 2002, CROP SCI, V42, P325, DOI 10.2135/cropsci2002.0325; Dudley J. W., 2004, Plant Breeding Reviews, V24, P79; Flint-Garcia SA, 2009, THEOR APPL GENET, V119, P1129, DOI 10.1007/s00122-009-1115-1; Hallauer A. R., 2004, Plant Breeding Reviews, V24, P153; HALLAUER.AR, 1967, CROP SCI, V7, P192, DOI 10.2135/cropsci1967.0011183X000700030007x; Hood EE, 2003, PLANT BIOTECHNOL J, V1, P129, DOI 10.1046/j.1467-7652.2003.00014.x; HORNER ES, 1990, CROP SCI, V30, P964, DOI 10.2135/cropsci1990.0011183X003000040057x; Kawakatsu T, 2010, PLANT BIOTECHNOLOGY, V8, P1; LOPES MA, 1991, CROP SCI, V31, P1655, DOI 10.2135/cropsci1991.0011183X003100060055x; PAULIS JW, 1977, J AGR FOOD CHEM, V25, P265, DOI 10.1021/jf60210a022; SAS INSTITUTE INC, 2008, JMP VERS 8; Scott MP, 2008, CROP SCI, V48, P1705, DOI 10.2135/cropsci2008.01.0010; Shepherd CT, 2008, CEREAL CHEM, V85, P188, DOI 10.1094/CCHEM-85-2-0188; THOMPSON GA, 1989, BIOESSAYS, V10, P108, DOI 10.1002/bies.950100404; Tracy WF, 2007, MAYDICA, V52, P71; Wang ZD, 1998, GENE, V223, P321, DOI 10.1016/S0378-1119(98)00244-3; WILSON CM, 1991, PLANT PHYSIOL, V95, P777, DOI 10.1104/pp.95.3.777	22	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148587	10.1371/journal.pone.0148587	http://dx.doi.org/10.1371/journal.pone.0148587			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895451	gold, Green Published, Green Submitted			2022-12-27	WOS:000371223400019
J	He, SS; Liu, FH; Xu, L; Yin, P; Li, DY; Mei, C; Jiang, LS; Ma, YF; Xu, JQ				He, Shasha; Liu, Fenghua; Xu, Lei; Yin, Peng; Li, Deyin; Mei, Chen; Jiang, Linshu; Ma, Yunfei; Xu, Jianqin			Protective Effects of Ferulic Acid against Heat Stress-Induced Intestinal Epithelial Barrier Dysfunction In Vitro and In Vivo	PLOS ONE			English	Article							TIGHT JUNCTIONS; E-CADHERIN; PROTEIN EXPRESSION; INDUCED INJURY; OCCLUDIN; PERMEABILITY; PATHOGENESIS; HOMEOSTASIS; MECHANISMS; CLAUDIN-1	Heat stress is important in the pathogenesis of intestinal epithelial barrier dysfunction. Ferulic acid (FA), a phenolic acid widely found in fruits and vegetables, can scavenge free radicals and activate cell stress responses. This study is aimed at investigating protective effects of FA on heat stress-induced dysfunction of the intestinal epithelial barrier in vitro and in vivo. Intestinal epithelial (IEC-6) cells were pretreated with FA for 4 h and then exposed to heat stress. Heat stress caused decreased transepithelial electrical resistance (TER) and increased permeability to 4-kDa fluorescein isothiocyanate (FITC)-dextran (FD4). Both effects were inhibited by FA in a dose-dependent manner. FA significantly attenuated the decrease in occludin, ZO-1 and E-cadherin expression observed with heat stress. The distortion and redistribution of occludin, ZO-1 and E-cadherin proteins were also effectively prevented by FA pretreatment. Moreover, heat stress diminished electron-dense material detected in tight junctions (TJs), an effect also alleviated by FA in a dose-dependent manner. In an in vivo heat stress model, FA (50 mg/kg) was administered to male Sprague- Dawley rats for 7 consecutive days prior to exposure to heat stress. FA pretreatment significantly attenuated the effects of heat stress on the small intestine, including the increased FD4 permeability, disrupted tight junctions and microvilli structure, and reduced occludin, ZO-1 and E-cadherin expression. Taken together, our results demonstrate that FA pretreatment is potentially protective against heat stress-induced intestinal epithelial barrier dysfunction.	[He, Shasha; Yin, Peng; Ma, Yunfei; Xu, Jianqin] CAU, Coll Vet Med, CAU BUA TCVM Teaching & Researching Team, Beijing, Peoples R China; [Liu, Fenghua; Xu, Lei; Li, Deyin; Mei, Chen; Jiang, Linshu] BUA, Coll Anim Sci & Technol, Beijing Key Lab Dairy Cow Nutr, Beijing, Peoples R China	Beijing University of Agriculture; China Agricultural University	Ma, YF; Xu, JQ (corresponding author), CAU, Coll Vet Med, CAU BUA TCVM Teaching & Researching Team, Beijing, Peoples R China.; Jiang, LS (corresponding author), BUA, Coll Anim Sci & Technol, Beijing Key Lab Dairy Cow Nutr, Beijing, Peoples R China.	kjxnb@vip.sina.com; yunfeima@cau.edu.cn; xujianqincau@126.com		Jiang, Linshu/0000-0002-9076-5749	National Twelve-Five Technological Supported Plan of China [2013BAD10B04]; Ministry of Agriculture, Public Service Sectors Agriculture Research Projects [201403051-07]; Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions [CITTCD20130324]	National Twelve-Five Technological Supported Plan of China; Ministry of Agriculture, Public Service Sectors Agriculture Research Projects; Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions	This work was supported by grants from National Twelve-Five Technological Supported Plan of China (No. 2013BAD10B04), Ministry of Agriculture, Public Service Sectors Agriculture Research Projects (No. 201403051-07), Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions (CIT&TCD20130324).	Aijaz S, 2006, INT REV CYTOL, V248, P261, DOI 10.1016/S0074-7696(06)48005-0; Al-Sadi R, 2011, AM J PHYSIOL-GASTR L, V300, pG1054, DOI 10.1152/ajpgi.00055.2011; Costantini TW, 2009, LIFE SCI, V84, P18, DOI 10.1016/j.lfs.2008.10.007; Dorfel MJ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/807356; Dokladny K, 2008, AM J PATHOL, V172, P659, DOI 10.2353/ajpath.2008.070522; Fasano A, 2005, NAT CLIN PRACT GASTR, V2, P416, DOI 10.1038/ncpgasthep0259; Fink Mitchell P, 2003, Curr Opin Crit Care, V9, P143, DOI 10.1097/00075198-200304000-00011; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; He SS, 2015, MOL BIOSYST, V11, P826, DOI 10.1039/c4mb00495g; Kim HJ, 2013, PHYTOTHER RES, V27, P362, DOI 10.1002/ptr.4717; Krack A, 2005, EUR HEART J, V26, P2368, DOI 10.1093/eurheartj/ehi389; Lambert G. Patrick, 2008, V53, P61, DOI 10.1159/000151550; Laukoetter MG, 2008, WORLD J GASTROENTERO, V14, P401, DOI 10.3748/wjg.14.401; Mancuso C, 2014, FOOD CHEM TOXICOL, V65, P185, DOI 10.1016/j.fct.2013.12.024; McCall IC, 2009, TOXICOL APPL PHARM, V241, P61, DOI 10.1016/j.taap.2009.08.002; Nita-Lazar M, 2010, EXP CELL RES, V316, P1871, DOI 10.1016/j.yexcr.2010.02.008; Pearce SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070215; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Quiros M, 2014, SEMIN CELL DEV BIOL, V36, P194, DOI 10.1016/j.semcdb.2014.09.003; Rodgers LS, 2013, J CELL SCI, V126, P1565, DOI 10.1242/jcs.113399; Sander GR, 2005, FEBS LETT, V579, P4851, DOI 10.1016/j.febslet.2005.07.066; Schneider MR, 2015, BIOESSAYS, V37, P294, DOI 10.1002/bies.201400141; Schneider MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014325; Schnoor M, 2015, DIGEST DIS SCI, V60, P816, DOI 10.1007/s10620-015-3622-z; Severson EA, 2010, BIOCHEM BIOPH RES CO, V397, P592, DOI 10.1016/j.bbrc.2010.05.164; Shanthakumar J, 2012, EUR J PHARMACOL, V691, P268, DOI 10.1016/j.ejphar.2012.06.027; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Srinivasan M, 2007, J CLIN BIOCHEM NUTR, V40, P92, DOI 10.3164/jcbn.40.92; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Varasteh S, 2015, J FUNCT FOODS, V16, P265, DOI 10.1016/j.jff.2015.04.045; Wang H, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/787393; WHEELOCK MJ, 1992, J CELL BIOL, V117, P415, DOI 10.1083/jcb.117.2.415; Xiao GZ, 2015, SHOCK, V44, P348, DOI 10.1097/SHK.0000000000000417; Xiao GZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073571; Xu QL, 2015, CELL BIOL INT, V39, P411, DOI 10.1002/cbin.10408; Yang PC, 2007, J GASTROEN HEPATOL, V22, P1823, DOI 10.1111/j.1440-1746.2006.04710.x; Yu J, 2013, STRESS, V16, P99, DOI 10.3109/10253890.2012.680526; Zhao ZH, 2008, FOOD CHEM, V109, P691, DOI 10.1016/j.foodchem.2008.02.039	41	31	36	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0145236	10.1371/journal.pone.0145236	http://dx.doi.org/10.1371/journal.pone.0145236			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894689	Green Published, gold, Green Submitted			2022-12-27	WOS:000371223400001
J	Hu, R; Wang, ZS; Peng, QH; Zou, HW; Wang, HZ; Yu, XQ; Jing, XP; Wang, YX; Cao, BH; Bao, SK; Zhang, WH; Zhao, SN; Ji, HZ; Kong, XY; Niu, QX				Hu, Rui; Wang, Zhisheng; Peng, Quanhui; Zou, Huawei; Wang, Hongze; Yu, Xiaoqiang; Jing, Xiaoping; Wang, Yixin; Cao, Binghai; Bao, Shanke; Zhang, Wenhua; Zhao, Suonan; Ji, Hanzhong; Kong, Xiangying; Niu, Quanxi			Effects of GHRP-2 and Cysteamine Administration on Growth Performance, Somatotropic Axis Hormone and Muscle Protein Deposition in Yaks (Bos grunniens) with Growth Retardation	PLOS ONE			English	Article							FACTOR-I CONCENTRATION; SKELETAL-MUSCLE; PEPTIDE-2 GHRP-2; GENE-EXPRESSION; BODY-WEIGHT; SYNTHETIC HEXAPEPTIDE; CARCASS COMPOSITION; UBIQUITIN LIGASES; BINDING-PROTEINS; HOLSTEIN STEERS	The objective of this study was to investigate the effects of growth hormone-releasing peptide-2 (GHRP-2) and cysteamine (CS) administration on growth performance in yaks with growth retardation and try to elucidate its regulatory mechanisms. Trial 1, thirty-six 1-year-old Qinghai high plateau yaks (body weight 38-83.2 kg) were randomly chosen for body weight and jugular blood samples collection. The relationship between body weight and serum GHRH (P < 0.05, R = 0.45), GH (P < 0.05, R = 0.47), IGF-1 (P < 0.05, R = 0.62) was significantly correlated in yaks colonies with lighter body weights. Trial 2, fifteen 1-year-old Qinghai high plateau yaks with growth retardation (average body weight 54.8 +/- 8.24 kg) were randomly selected and assigned to negative control group (NG), GHRP-2 injection group (GG) and cysteamine feeding group (CG), with 5 yaks per group. Another five 1-year-old Qinghai high plateau yaks with normal growth performance (average body weight 75.3 +/- 2.43 kg) were selected as positive control group (PG). The average daily gain (ADG) of the GG and CG were significantly higher than those in the PG and NG (P < 0.05). Both GHRP-2 and CS administration significantly enhanced the myofiber diameter and area of skeletal muscle (P<0.05). GHRP-2 significantly enhanced the serum GH and IGF-1 levels (P < 0.05), and up-regulated GHR, IGF-1 and IGF-1R mRNA expression in the liver and skeletal muscle (P < 0.05), enhanced the mRNA expression of PI3K, AKt and mTOR in the skeletal muscle (P<0.05). CS significantly reduced the serum SS levels and the hypothalamus SS mRNA expression (P < 0.05), and enhanced GHR and IGF-1 mRNA expression in the liver (P < 0.05), decreased the mRNA expression of muscle atrophy F-box (Atrogin-1) and muscle ring finger 1 (MuRF1) mRNA (P < 0.05). Conclusions: Growth retardation in yaks was primarily due to somatotropic axis hormones secretion deficiency. Both GHRP-2 and CS administration can accelerate growth performance and GH, IGF-1 secretion in yaks with growth retardation. GHRP-2 enhanced muscle protein deposition mainly by up-regulated the protein synthesis pathways, whereas CS worked mainly by down-regulated the ubiquitin-proteasome pathway.	[Hu, Rui; Wang, Zhisheng; Peng, Quanhui; Zou, Huawei; Wang, Hongze; Yu, Xiaoqiang; Jing, Xiaoping] Sichuan Agr Univ, Inst Anim Nutr, Key Lab Low Carbon Culture & Safety Prod Cattle S, Chengdu, Sichuan, Peoples R China; [Cao, Binghai] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100094, Peoples R China; [Bao, Shanke; Zhao, Suonan; Ji, Hanzhong; Kong, Xiangying] Anim Husb & Vet Inst, Haibei, Qinghai, Peoples R China; [Zhang, Wenhua] Ningxia Xiahua Muslim Food Co Ltd, Zhongwei, Ningxia, Peoples R China; [Wang, Yixin] Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; China Agricultural University; Sichuan Agricultural University	Wang, ZS (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Key Lab Low Carbon Culture & Safety Prod Cattle S, Chengdu, Sichuan, Peoples R China.	zswangsicau@126.com	Jing, Xiaoping/GQA-3866-2022	Jing, Xiaoping/0000-0003-1759-9366	China Agriculuture (Beef Cattle/Yak) Research System [CARS-38]; Efficiently Special Key Technologies of Converting Grass to Livestock in Qinghai-Tibet Plateau Community [201203008]	China Agriculuture (Beef Cattle/Yak) Research System; Efficiently Special Key Technologies of Converting Grass to Livestock in Qinghai-Tibet Plateau Community	This study was supported by China Agriculuture (Beef Cattle/Yak) Research System (CARS-38) (http://www.beefsys.com/) and Efficiently Special Key Technologies of Converting Grass to Livestock in Qinghai-Tibet Plateau Community (201203008). ZW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett PA, 1997, ENDOCRINOLOGY, V138, P4552, DOI 10.1210/en.138.11.4552; Bock H-D, 1989, PROTEIN METABOLISM F; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; BOWERS CY, 1992, J CLIN ENDOCR METAB, V74, P292, DOI 10.1210/jc.74.2.292; BOWERS CY, 1984, ENDOCRINOLOGY, V114, P1537, DOI 10.1210/endo-114-5-1537; Brickell JS, 2009, DOMEST ANIM ENDOCRIN, V36, P67, DOI 10.1016/j.domaniend.2008.10.005; Chaze T, 2008, PROTEOMICS, V8, P4236, DOI 10.1002/pmic.200701101; Confortim HD, 2015, MICRON; Davis ME, 2006, J ANIM SCI, V84, P2299, DOI 10.2527/jas.2005-567; Du G, 2012, DOMEST ANIM ENDOCRIN, V42, P203, DOI 10.1016/j.domaniend.2011.12.003; Eley HL, 2007, AM J PHYSIOL-ENDOC M, V293, pE923, DOI 10.1152/ajpendo.00314.2007; Fawzi WW, 1997, AM J CLIN NUTR, V65, P1062, DOI 10.1093/ajcn/65.4.1062; Fiorotto M, 2003, FASEB J, V17, pA700, DOI 10.1096/fj.02-0289fje; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Graham TW, 2010, J ANIM SCI, V88, P2585, DOI 10.2527/jas.2009-2610; Granado M, 2005, AM J PHYSIOL-ENDOC M, V289, pE1007, DOI 10.1152/ajpendo.00109.2005; Hashizume T, 1999, DOMEST ANIM ENDOCRIN, V16, P31, DOI 10.1016/S0739-7240(98)00048-4; Hoffman PC, 1997, J ANIM SCI, V75, P836; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Jagoe RT, 2001, CURR OPIN CLIN NUTR, V4, P183, DOI 10.1097/00075197-200105000-00003; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Kimball SR, 2007, BIOCHEM SOC T, V35, P1298, DOI 10.1042/BST0351298; Lancaster PA, 2008, J ANIM SCI, V86, P2862, DOI 10.2527/jas.2008-1083; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; Lee CY, 2005, LIVEST PROD SCI, V95, P163, DOI 10.1016/j.livprodsci.2005.01.002; Lee HG, 2005, DOMEST ANIM ENDOCRIN, V28, P134, DOI 10.1016/j.domaniend.2004.07.001; Lee HG, 2000, DOMEST ANIM ENDOCRIN, V18, P293, DOI 10.1016/S0739-7240(00)00051-5; Liu GM, 2009, LIVEST SCI, V122, P86, DOI 10.1016/j.livsci.2008.07.027; Lupu F, 2001, DEV BIOL, V229, P141, DOI 10.1006/dbio.2000.9975; MACHLIN LJ, 1972, J ANIM SCI, V35, P794; MCLEOD KR, 1995, J ANIM SCI, V73, P77; Millard W, 1985, FEDERATION P; Mourits MCM, 1997, J DAIRY SCI, V80, P1406, DOI 10.3168/jds.S0022-0302(97)76070-3; Nakagawa T, 1996, LIFE SCI, V59, P705, DOI 10.1016/0024-3205(96)00356-6; Owens PC, 1999, J ANIM SCI, V77, P2098; PAPACHRISTOU DN, 1994, REGUL PEPTIDES, V49, P237, DOI 10.1016/0167-0115(94)90146-5; Peroni CN, 2012, CLINICS, V67, P265, DOI 10.6061/clinics/2012(03)11; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phung LT, 2000, DOMEST ANIM ENDOCRIN, V18, P279, DOI 10.1016/S0739-7240(00)00050-3; Phung LT, 2001, DOMEST ANIM ENDOCRIN, V20, P9, DOI 10.1016/S0739-7240(00)00085-0; Pihoker C, 1997, J ENDOCRINOL, V155, P79, DOI 10.1677/joe.0.1550079; Renaville R, 2002, DOMEST ANIM ENDOCRIN, V23, P351, DOI 10.1016/S0739-7240(02)00170-4; Roh SG, 1997, J ANIM SCI, V75, P2744; Roh SG, 1996, ENDOCR J, V43, P291, DOI 10.1507/endocrj.43.291; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Sarkar M, 2008, LIVEST SCI, V115, P313, DOI 10.1016/j.livsci.2007.08.007; Sheriff S, 2009, PEPTIDES, V30, P1909, DOI 10.1016/j.peptides.2009.06.029; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Sugiyama M, 2012, REGUL PEPTIDES, V178, P21, DOI 10.1016/j.regpep.2012.06.003; Tse MCL, 2006, BRIT J NUTR, V96, P650, DOI 10.1079/BJN20061870; TUILPAKOV AN, 1995, METABOLISM, V44, P1199, DOI 10.1016/0026-0495(95)90016-0; XU RJ, 1994, J PEDIATR GASTR NUTR, V18, P231, DOI 10.1097/00005176-199402000-00018; Yamamoto D, 2008, LIFE SCI, V82, P460, DOI 10.1016/j.lfs.2007.11.019; Yang CB, 2005, J SCI FOOD AGR, V85, P1947, DOI 10.1002/jsfa.2123; Yokote R, 1998, PEPTIDES, V19, P15, DOI 10.1016/S0196-9781(97)00263-5	56	16	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149461	10.1371/journal.pone.0149461	http://dx.doi.org/10.1371/journal.pone.0149461			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894743	Green Published, gold, Green Submitted			2022-12-27	WOS:000371223400056
J	Mizokami, SS; Hohmann, MSN; Staurengo-Ferrari, L; Carvalho, TT; Zarpelon, AC; Possebon, MI; de Souza, AR; Veneziani, RCS; Arakawa, NS; Casagrande, R; Verri, WA				Mizokami, Sandra S.; Hohmann, Miriam S. N.; Staurengo-Ferrari, Larissa; Carvalho, Thacyana T.; Zarpelon, Ana C.; Possebon, Maria I.; de Souza, Anderson R.; Veneziani, Rodrigo C. S.; Arakawa, Nilton S.; Casagrande, Rubia; Verri, Waldiceu A., Jr.			Pimaradienoic Acid Inhibits Carrageenan-Induced Inflammatory Leukocyte Recruitment and Edema in Mice: Inhibition of Oxidative Stress, Nitric Oxide and Cytokine Production	PLOS ONE			English	Article							VIGUIERA-ARENARIA ASTERACEAE; CHANNEL SIGNALING PATHWAY; PIMARANE-TYPE DITERPENES; ACUTE CORONARY SYNDROMES; KAPPA-B ACTIVATION; ANTIMICROBIAL ACTIVITY; NEUTROPHIL MIGRATION; KAURENOIC ACID; PERITONEAL-MACROPHAGES; RHEUMATOID-ARTHRITIS	Pimaradienoic acid (PA; ent-pimara-8(14), 15-dien-19-oic acid) is a pimarane diterpene found in plants such as Vigueira arenaria Baker (Asteraceae) in the Brazilian savannas. Although there is evidence on the analgesic and in vitro inhibition of inflammatory signaling pathways, and paw edema by PA, its anti-inflammatory effect deserves further investigation. Thus, the objective of present study was to investigate the anti-inflammatory effect of PA in carrageenan-induced peritoneal and paw inflammation in mice. Firstly, we assessed the effect of PA in carrageenan-induced leukocyte recruitment in the peritoneal cavity and paw edema and myeloperoxidase activity. Next, we investigated the mechanisms involved in the anti-inflammatory effect of PA. The effect of PA on carrageenan-induced oxidative stress in the paw skin and peritoneal cavity was assessed. We also tested the effect of PA on nitric oxide, superoxide anion, and inflammatory cytokine production in the peritoneal cavity. PA inhibited carrageenan-induced recruitment of total leukocytes and neutrophils to the peritoneal cavity in a dose-dependent manner. PA also inhibited carrageenan-induced paw edema and myeloperoxidase activity in the paw skin. The anti-inflammatory mechanism of PA depended on maintaining paw skin antioxidant activity as observed by the levels of reduced glutathione, ability to scavenge the ABTS cation and reduce iron as well as by the inhibition of superoxide anion and nitric oxide production in the peritoneal cavity. Furthermore, PA inhibited carrageenan-induced peritoneal production of inflammatory cytokines TNF-alpha and IL-1 beta. PA presents prominent anti-inflammatory effect in carrageenan-induced inflammation by reducing oxidative stress, nitric oxide, and cytokine production. Therefore, it seems to be a promising anti-inflammatory molecule that merits further investigation.	[Mizokami, Sandra S.; Hohmann, Miriam S. N.; Staurengo-Ferrari, Larissa; Carvalho, Thacyana T.; Zarpelon, Ana C.; Verri, Waldiceu A., Jr.] Univ Estadual Londrina, Ctr Ciencias Biol, Dept Ciencias Patol, Londrina, Parana, Brazil; [Possebon, Maria I.; Arakawa, Nilton S.; Casagrande, Rubia] Univ Estadual Londrina, Ctr Ciencias Saude, Dept Ciencias Farmaceut, Londrina, Parana, Brazil; [de Souza, Anderson R.; Veneziani, Rodrigo C. S.] Univ Franca, Nucleo Pesquisa Ciencias Exatas & Tecnol, Sao Paulo, Brazil	Universidade Estadual de Londrina; Universidade Estadual de Londrina; Universidad de Franca	Verri, WA (corresponding author), Univ Estadual Londrina, Ctr Ciencias Biol, Dept Ciencias Patol, Londrina, Parana, Brazil.; Casagrande, R (corresponding author), Univ Estadual Londrina, Ctr Ciencias Saude, Dept Ciencias Farmaceut, Londrina, Parana, Brazil.	rubiacasa@uel.br; waverri@uel.br	Veneziani, Rodrigo Cassio Sola/C-2360-2012; de Carvalho, Thacyana Teixeira/AAJ-7187-2020; Casagrande, Rubia/I-1377-2013; Casagrande, Rubia/U-6019-2019; WA, Verri/I-1330-2013; Arakawa, Nilton/I-6240-2012	Veneziani, Rodrigo Cassio Sola/0000-0001-7057-9706; de Carvalho, Thacyana Teixeira/0000-0002-8580-6200; Casagrande, Rubia/0000-0002-2296-1668; WA, Verri/0000-0003-2756-9283; Arakawa, Nilton/0000-0002-0325-1660; Hohmann, Miriam Sayuri Nagashima/0000-0003-2667-3919	Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil); Ministerio da Ciencia, Tecnologia e Inovacao (MCTI)/Secretaria da Ciencia, Tecnologia e Ensino Superior (SETI)/Fundacao Araucaria; Parana State Government (Brazil); CAPES/Fundacao Araucaria; CNPq; Ministerio da Ciencia, Tecnologia e Inovacao (MCTI); Secretaria da Ciencia, Tecnologia e Ensino Superior (SETI)/Fundacao Araucaria; Governo do Estado do Parana (Brazil)	Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministerio da Ciencia, Tecnologia e Inovacao (MCTI)/Secretaria da Ciencia, Tecnologia e Ensino Superior (SETI)/Fundacao Araucaria; Parana State Government (Brazil); CAPES/Fundacao Araucaria; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministerio da Ciencia, Tecnologia e Inovacao (MCTI); Secretaria da Ciencia, Tecnologia e Ensino Superior (SETI)/Fundacao Araucaria; Governo do Estado do Parana (Brazil)	This work was supported by Brazilian grants from Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil-SSM MSNH TTC ACZ ARS RC WAV), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil-LSF RCSV RC WAV), Ministerio da Ciencia, Tecnologia e Inovacao (MCTI)/Secretaria da Ciencia, Tecnologia e Ensino Superior (SETI)/Fundacao Araucaria, and Parana State Government (Brazil-MSNH ACZ RC WAV). ACZ received a post-doc fellowship from CAPES/Fundacao Araucaria. LSF received a post-doc fellowship of CNPq. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil), Ministerio da Ciencia, Tecnologia e Inovacao (MCTI), Secretaria da Ciencia, Tecnologia e Ensino Superior (SETI)/Fundacao Araucaria and Governo do Estado do Parana (Brazil). The authors thank F. B. Costa for providing the plant material. ACZ received a post-doc fellowship from CAPES/Fundacao Araucaria. LSF received a post-doc fellowship of CNPq.	Ambrosio SR, 2008, Z NATURFORSCH C, V63, P326; Ambrosio SR, 2006, LIFE SCI, V79, P925, DOI 10.1016/j.lfs.2006.05.015; Ambrosio SR, 2004, BIOCHEM SYST ECOL, V32, P221, DOI 10.1016/S0305-1978(03)00139-X; Ambrosio SR, 2002, FITOTERAPIA, V73, P484, DOI 10.1016/S0367-326X(02)00170-3; Ashley NT, 2012, ANNU REV ECOL EVOL S, V43, P385, DOI 10.1146/annurev-ecolsys-040212-092530; Biswas SK, 2001, NITRIC OXIDE-BIOL CH, V5, P566, DOI 10.1006/niox.2001.0370; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Campanini MZ, 2013, J PHOTOCH PHOTOBIO B, V127, P153, DOI 10.1016/j.jphotobiol.2013.08.007; Carvalho TC, 2011, MOLECULES, V16, P543, DOI 10.3390/molecules160100543; Casagrande R, 2006, J PHOTOCH PHOTOBIO B, V84, P21, DOI 10.1016/j.jphotobiol.2006.01.006; Dal Secco D, 2003, NITRIC OXIDE-BIOL CH, V9, P153, DOI 10.1016/j.niox.2003.11.001; de Miguel LS, 2002, J AM COLL CARDIOL, V39, P818, DOI 10.1016/S0735-1097(01)01828-9; DRAPIER JC, 1988, J IMMUNOL, V140, P2829; Joosten LAB, 2006, P NATL ACAD SCI USA, V103, P3298, DOI 10.1073/pnas.0511233103; Kang HS, 1996, CELL IMMUNOL, V170, P212, DOI 10.1006/cimm.1996.0154; Kang OH, 2008, EUR J PHARMACOL, V601, P179, DOI 10.1016/j.ejphar.2008.10.012; Kato FH, 2012, MUTAT RES-GEN TOX EN, V749, P87, DOI 10.1016/j.mrgentox.2012.09.001; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Komala I, 2010, J NAT MED-TOKYO, V64, P417, DOI 10.1007/s11418-010-0423-8; Li JM, 2005, MOL CELL BIOL, V25, P2320, DOI 10.1128/MCB.25.6.2320-2330.2005; Lim H, 2009, ARCH PHARM RES, V32, P1237, DOI 10.1007/s12272-009-1909-3; Lu JM, 2010, J CELL MOL MED, V14, P840, DOI 10.1111/j.1582-4934.2009.00897.x; Maioli NA, 2015, BRAZ J MED BIOL RES, V48, P321, DOI [10.1590/1414-431X20144187, 10.1590/1414-431x20144187]; Martin KR, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14056; Martinez RM, 2012, REV BRAS FARMACOGN, V22, P587, DOI 10.1590/S0102-695X2012005000006; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Michlewska S, 2009, FASEB J, V23, P844, DOI 10.1096/fj.08-121228; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Mizokami SS, 2012, J NAT PROD, V75, P896, DOI 10.1021/np200989t; Navarro SA, 2013, PHARMACOL BIOCHEM BE, V105, P183, DOI 10.1016/j.pbb.2013.02.018; OKUYAMA E, 1991, CHEM PHARM BULL, V39, P405, DOI 10.1248/cpb.39.405; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Peterson K, 2010, DRUG CLASS REVIEW NO; Porto TS, 2009, MOLECULES, V14, P191, DOI 10.3390/molecules14010191; Porto TS, 2009, FITOTERAPIA, V80, P432, DOI 10.1016/j.fitote.2009.06.003; Possebon MI, 2014, J NAT PROD, V77, P2488, DOI 10.1021/np500563b; Prado WA, 2002, EUR J PHARMACOL, V441, P57, DOI 10.1016/S0014-2999(02)01413-9; Pulli B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067976; Rubio J, 2005, Z NATURFORSCH C, V60, P711; Saito S, 1996, J LEUKOCYTE BIOL, V59, P908, DOI 10.1002/jlb.59.6.908; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Schilling E. E., 2000, Edinburgh Journal of Botany, V57, P323, DOI 10.1017/S0960428600000330; Sugiyama S, 2001, AM J PATHOL, V158, P879, DOI 10.1016/S0002-9440(10)64036-9; SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2; Tirapelli CR, 2005, J PHARM PHARMACOL, V57, P997, DOI 10.1211/0022357056578; Tirapelli CR, 2004, EUR J PHARMACOL, V492, P233, DOI 10.1016/j.ejphar.2004.04.003; Tirapelli CR, 2004, PHARMACOLOGY, V70, P31, DOI 10.1159/000074240; Valerio DAR, 2007, EUR J PHARMACOL, V562, P155, DOI 10.1016/j.ejphar.2007.01.029; Verri WA, 2007, EUR J IMMUNOL, V37, P3373, DOI 10.1002/eji.200737488; Verri WA, 2006, PHARMACOL THERAPEUT, V112, P116, DOI 10.1016/j.pharmthera.2006.04.001; Verri WA, 2010, ANN RHEUM DIS, V69, P1697, DOI 10.1136/ard.2009.122655; Wu CH, 2002, MOL CELL ENDOCRINOL, V194, P9, DOI 10.1016/S0303-7207(02)00212-5; Zarpelon AC, 2013, BRIT J PHARMACOL, V169, P90, DOI 10.1111/bph.12110	53	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149656	10.1371/journal.pone.0149656	http://dx.doi.org/10.1371/journal.pone.0149656			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895409	Green Published, gold			2022-12-27	WOS:000371223400073
J	Trebicky, V; Fialova, J; Kleisner, K; Havlicek, J				Trebicky, Vit; Fialova, Jitka; Kleisner, Karel; Havlicek, Jan			Focal Length Affects Depicted Shape and Perception of Facial Images	PLOS ONE			English	Article							TO-HEIGHT RATIO; PERCEIVED DOMINANCE; ATTRACTIVENESS; WIDTH; FACE; INCREASES; PICTURES; PREDICTS; COLOR; FRUIT	Static photographs are currently the most often employed stimuli in research on social perception. The method of photograph acquisition might affect the depicted subject's facial appearance and thus also the impression of such stimuli. An important factor influencing the resulting photograph is focal length, as different focal lengths produce various levels of image distortion. Here we tested whether different focal lengths (50, 85, 105 mm) affect depicted shape and perception of female and male faces. We collected three portrait photographs of 45 (22 females, 23 males) participants under standardized conditions and camera setting varying only in the focal length. Subsequently, the three photographs from each individual were shown on screen in a randomized order using a 3-alternative forced-choice paradigm. The images were judged for attractiveness, dominance, and femininity/masculinity by 369 raters (193 females, 176 males). Facial width-to-height ratio (fWHR) was measured from each photograph and overall facial shape was analysed employing geometric morphometric methods (GMM). Our results showed that photographs taken with 50 mm focal length were rated as significantly less feminine/masculine, attractive, and dominant compared to the images taken with longer focal lengths. Further, shorter focal lengths produced faces with smaller fWHR. Subsequent GMM revealed focal length significantly affected overall facial shape of the photographed subjects. Thus methodology of photograph acquisition, focal length in this case, can significantly affect results of studies using photographic stimuli perhaps due to different levels of perspective distortion that influence shapes and proportions of morphological traits.	[Trebicky, Vit; Fialova, Jitka; Kleisner, Karel; Havlicek, Jan] Charles Univ Prague, Fac Sci, Prague, Czech Republic; [Trebicky, Vit; Fialova, Jitka; Havlicek, Jan] Natl Inst Mental Hlth, Klecany, Czech Republic	Charles University Prague; National Institute of Mental Health - Czech Republic	Trebicky, V (corresponding author), Charles Univ Prague, Fac Sci, Prague, Czech Republic.; Trebicky, V (corresponding author), Natl Inst Mental Hlth, Klecany, Czech Republic.	vit.trebicky@natur.cuni.cz	Trebicky, Vit/P-3115-2016; Havlíček, Jan/F-8985-2011; Fialová, Jitka/E-3125-2018; Kleisner, Karel/M-2718-2017	Trebicky, Vit/0000-0003-1440-1772; Havlíček, Jan/0000-0003-2374-7337; Fialová, Jitka/0000-0003-2419-7461; Kleisner, Karel/0000-0002-3277-8365	Charles University Grant Agency [GAUK 918214]; Czech Science Foundation [GACR P407/15-05048S]; project "National Institute of Mental Health (NIMH-CZ)" [ED2.1.00/03.0078]; project "National Institute of Mental Health (NIMH-CZ)" (European Regional Development Fund)	Charles University Grant Agency; Czech Science Foundation(Grant Agency of the Czech Republic); project "National Institute of Mental Health (NIMH-CZ)"; project "National Institute of Mental Health (NIMH-CZ)" (European Regional Development Fund)	JF was supported by Charles University Grant Agency GAUK 918214 (http://www.cuni.cz/ukeng-33.html), VT and KK by Czech Science Foundation GACR P407/15-05048S (http://gacr.cz/en/) and VT, JF, and JH by the project "National Institute of Mental Health (NIMH-CZ)", grant number ED2.1.00/03.0078 (and the European Regional Development Fund, http://ec.europa.eu/regional_policy/en/funding/erdf/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, 1 IMPRESSIONS; Banks MS, 2014, ECOL PSYCHOL, V26, P30, DOI 10.1080/10407413.2014.877284; Bohrnstedt GW, 1970, ATTITUDE MEASUREMENT, P81; Borenstein M, 2009, CONVERTING EFFECT SI; Bryan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045301; Burke D, 2010, EVOL PSYCHOL-US, V8, P573, DOI 10.1177/147470491000800404; Burriss RP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130093; Calder A., 2011, OXFORD HDB FACE PERC; Carre JM, 2008, P ROY SOC B-BIOL SCI, V275, P2651, DOI 10.1098/rspb.2008.0873; Cooper EA, 2012, J VISION, V12, DOI 10.1167/12.5.8; Deutschmann R, 2011, MULTIPLE FLASH PHOTO; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Geniole SN, 2015, EVOL HUM BEHAV, V36, P279, DOI 10.1016/j.evolhumbehav.2014.12.005; Haselhuhn MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122637; HAYDUK LA, 1983, PSYCHOL BULL, V94, P293, DOI 10.1037/0033-2909.94.2.293; Hehman E, 2013, J EXP SOC PSYCHOL, V49, P747, DOI 10.1016/j.jesp.2013.02.015; Hong GW, 2001, COLOR RES APPL, V26, P76, DOI 10.1002/1520-6378(200102)26:1<76::AID-COL8>3.0.CO;2-3; Jenkins F.A., 2001, FUNDAMENTALS OPTICS, Vfourth; Kelby S, 2010, DIGITAL PHOTOGRAPHY, V3; Kingslake R, 1992, OPTICS PHOTOGRAPHY; Kleisner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081237; Kleisner K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053285; Kleisner K, 2010, PERS INDIV DIFFER, V49, P59, DOI 10.1016/j.paid.2010.03.011; Lefevre CE, 2015, Q J EXP PSYCHOL, V68, P284, DOI 10.1080/17470218.2014.944194; Little AC, 2014, WIRES COGN SCI, V5, P621, DOI 10.1002/wcs.1316; Loehr J, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0049; Mileva VR, 2014, PERS INDIV DIFFER, V69, P115, DOI 10.1016/j.paid.2014.05.019; Oksanen AJ, 2015, PACKAGE VEGAN, P280; Park JH, 2007, PERS INDIV DIFFER, V43, P1960, DOI 10.1016/j.paid.2007.05.020; Peron Ana Paula Lazzari Marques, 2012, Dental Press J. Orthod., V17, P124; Perona P., 2010, J VIS, V7, P992; Pezdirc K, 2015, NUTRIENTS, V7, P5800, DOI 10.3390/nu7075251; Postma E, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0966; RCore Team, 2020, R LANG ENV STAT COMP; Roberts SC, 2004, P ROY SOC B-BIOL SCI, V271, pS270, DOI 10.1098/rsbl.2004.0174; Rohlf F, 2004, TPSSUPER VERSION 1 1; Rohlf FJ., 2008, TPSRELW VERSION 146; Rubesova A., 2011, SOCIAL PSYCHOL DYNAM, P113; Schneider TM, 2012, PERCEPTION, V41, P121, DOI 10.1068/p7140; Stephen ID, 2009, INT J PRIMATOL, V30, P845, DOI 10.1007/s10764-009-9380-z; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; Sulikowski D, 2015, ETHOLOGY, V121, P1002, DOI 10.1111/eth.12412; Todorov A, 2015, ANNU REV PSYCHOL, V66, P519, DOI 10.1146/annurev-psych-113011-143831; Trebicky V, 2015, AGGRESSIVE BEHAV, V41, P331, DOI 10.1002/ab.21559; Trebicky V, 2013, PSYCHOL SCI, V24, P1664, DOI 10.1177/0956797613477117; Valentine KA, 2014, PSYCHOL SCI, V25, P806, DOI 10.1177/0956797613511823; Verhoff MA, 2008, FORENSIC SCI INT, V178, P153, DOI 10.1016/j.forsciint.2008.03.011; Whitehead RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032988; Windhager S, 2011, AM J HUM BIOL, V23, P805, DOI 10.1002/ajhb.21219	49	33	33	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149313	10.1371/journal.pone.0149313	http://dx.doi.org/10.1371/journal.pone.0149313			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3DG	26894832	gold, Green Published, Green Submitted			2022-12-27	WOS:000371223400046
J	Dominguez-Vicent, A; Birkeldh, U; Carl-Gustaf, L; Nilson, M; Brautaset, R				Dominguez-Vicent, Alberto; Birkeldh, Ulrika; Carl-Gustaf, Laurell; Nilson, Maria; Brautaset, Rune			Objective Assessment of Nuclear and Cortical Cataracts through Scheimpflug Images: Agreement with the LOCS III Scale	PLOS ONE			English	Article							CLASSIFICATION-SYSTEM-III; HUMAN LENS; LIGHT; AGE; PARAMETERS; SEGMENT; INDEX	Purpose To assess nuclear and cortical opacities through the objective analysis of Scheimpflug images, and to check the correlation with the Lens Opacity Classification System III (LOCS III). Methods Nuclear and cortical opacities were graded according to the LOCS III rules after pupil dilation. The maximum and average pixel intensity values along an elliptical mask within the lens nucleus were taken to analyse nuclear cataracts. A new metric based on the percentage of opaque pixels within a region of interest was used to analyse cortical cataracts. The percentage of opaque pixels was also calculated for half, third and quarter areas from the region of interest's periphery. Results The maximum and average intensity values along the nucleus were directly proportional to the LOCS III grade: The larger the LOCS III value, the larger maximum and average intensity ones. These metrics showed a positive and significant correlation with the LOCS grade: The larger the LOCS grade, the higher was percentage of opaque pixels along the cortex within the same mask's size. This metric showed a significant correlation to the LOCS grade. Conclusion The metrics used to assess nuclear opacities showed good correlation with the LOCS III. The percentage of opaque pixels showed to be a useful metric to measure objectively the severity of the cortical opacity. These metrics could be implemented in an algorithm to detect and grade lens opacities automatically and objectively.	[Dominguez-Vicent, Alberto] Univ Valencia, Dept Opt & Optometry & Vis Sci, Optometry Res Grp, Burjassot, Comunidad Valen, Spain; [Birkeldh, Ulrika; Carl-Gustaf, Laurell; Nilson, Maria; Brautaset, Rune] Karolinska Inst, Dept Clin Neurosci, Unit Optometry, Stockholm, Sweden; [Birkeldh, Ulrika; Carl-Gustaf, Laurell] St Erik Eye Hosp, Stockholm, Sweden	University of Valencia; Karolinska Institutet	Dominguez-Vicent, A (corresponding author), Univ Valencia, Dept Opt & Optometry & Vis Sci, Optometry Res Grp, Burjassot, Comunidad Valen, Spain.	alberto.vicent@uv.es	Brautaset, Rune/GQZ-1681-2022; Dominguez-Vicent, Alberto/GPT-0905-2022	Nilsson, Maria/0000-0001-8416-4819	"Atraccio de talent" research scholarship (Universidad de Valencia) [UV-INV-PREDOC13-110412]	"Atraccio de talent" research scholarship (Universidad de Valencia)	This research was founded by an "Atraccio de talent" research scholarship (Universidad de Valencia) awarded to Alberto Dominguez-Vicent (UV-INV-PREDOC13-110412), and the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; DATILES MB, 1995, BRIT J OPHTHALMOL, V79, P527, DOI 10.1136/bjo.79.6.527; Eckerskorn U, 1987, Dev Ophthalmol, V15, P82; Fan S H, 2003, AUTOMATIC SYSTEM CLA, P592; Foo KPY, 1996, OPHTHALMIC RES, V28, P32, DOI 10.1159/000267954; FUJISAWA K, 1995, OPHTHALMIC RES, V27, P89, DOI 10.1159/000267604; Grewal DS, 2009, OPHTHALMOLOGY, V116, P1436, DOI 10.1016/j.ophtha.2009.03.002; Gupta M, 2013, J CATARACT REFR SURG, V39, P1818, DOI 10.1016/j.jcrs.2013.05.052; KARBASSI M, 1993, OPTOMETRY VISION SCI, V70, P923, DOI 10.1097/00006324-199311000-00009; Kirwan JF, 2003, OPHTHALMIC EPIDEMIOL, V10, P259, DOI 10.1076/opep.10.4.259.15908; Lee DA, 1999, CLIN GUIDE COMPREHEN; Li HQ, 2010, IEEE T BIO-MED ENG, V57, P1690, DOI 10.1109/TBME.2010.2041454; MAGNO BV, 1994, CURR EYE RES, V13, P825, DOI 10.3109/02713689409025138; Michael R, 2011, PHILOS T R SOC B, V366, P1278, DOI 10.1098/rstb.2010.0300; Pan AP, 2015, AM J OPHTHALMOL, V159, P241, DOI 10.1016/j.ajo.2014.10.025; Pei X, 2008, BRIT J OPHTHALMOL, V92, P1471, DOI 10.1136/bjo.2007.136978; Qian W, 2000, EYE, V14, P56, DOI 10.1038/eye.2000.12; Sasaki H, 1999, OPHTHALMIC RES, V31, P93, DOI 10.1159/000055519; Savini G, 2013, J REFRACT SURG, V29, P121, DOI 10.3928/1081597X-20130117-07; Shetty R, 2014, INVEST OPHTH VIS SCI, V55, P5263, DOI 10.1167/iovs.14-15055; Tan AC, 2008, J CATARACT REFR SURG, V34, P1948, DOI 10.1016/j.jcrs.2008.06.037; Tkachov SI, 2006, GRAEF ARCH CLIN EXP, V244, P596, DOI 10.1007/s00417-005-0091-7; Ullrich K, 2012, J CATARACT REFR SURG, V38, P2100, DOI 10.1016/j.jcrs.2012.07.033; Wegener A, 2009, CLIN EXP OPHTHALMOL, V37, P144, DOI 10.1111/j.1442-9071.2009.02018.x	24	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149249	10.1371/journal.pone.0149249	http://dx.doi.org/10.1371/journal.pone.0149249			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890694	Green Published, gold, Green Submitted			2022-12-27	WOS:000371221500027
J	Le, HH; El-Khatib, C; Mombled, M; Guitarian, F; Al-Gobari, M; Fall, M; Janiaud, P; Marchant, I; Cucherat, M; Bejan-Angoulvant, T; Gueyffier, F				Le, Hai-Ha; El-Khatib, Chadia; Mombled, Margaux; Guitarian, Frederic; Al-Gobari, Muaamar; Fall, Mor; Janiaud, Perrine; Marchant, Ivanny; Cucherat, Michel; Bejan-Angoulvant, Theodora; Gueyffier, Francois			Impact of Aldosterone Antagonists on Sudden Cardiac Death Prevention in Heart Failure and Post-Myocardial Infarction Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							MINERALOCORTICOID RECEPTOR ANTAGONISTS; LEFT-VENTRICULAR DYSFUNCTION; PRESERVED EJECTION FRACTION; ACUTE MYOCARDIAL-INFARCTION; WORSENING RENAL-FUNCTION; LONG-TERM; DOUBLE-BLIND; SPIRONOLACTONE; EPLERENONE; MILD	Background and Objectives Sudden cardiac death (SCD) is a severe burden of modern medicine. Aldosterone antagonist is publicized as effective in reducing mortality in patients with heart failure (HF) or post myocardial infarction (MI). Our study aimed to assess the efficacy of AAs on mortality including SCD, hospitalization admission and several common adverse effects. Methods We searched Embase, PubMed, Web of Science, Cochrane library and clinicaltrial.gov for randomized controlled trials (RCTs) assigning AAs in patients with HF or post MI through May 2015. The comparator included standard medication or placebo, or both. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed. Event rates were compared using a random effects model. Prospective RCTs of AAs with durations of at least 8 weeks were selected if they included at least one of the following outcomes: SCD, all-cause/cardiovascular mortality, all-cause/ cardiovascular hospitalization and common side effects (hyperkalemia, renal function degradation and gynecomastia). Results Data from 19,333 patients enrolled in 25 trials were included. In patients with HF, this treatment significantly reduced the risk of SCD by 19% (RR 0.81; 95% CI, 0.67-0.98; p = 0.03); all-cause mortality by 19% (RR 0.81; 95% CI, 0.74-0.88, p<0.00001) and cardiovascular death by 21% (RR 0.79; 95% CI, 0.70-0.89, p<0.00001). In patients with post-MI, the matching reduced risks were 20%(RR 0.80; 95% CI, 0.66-0.98; p = 0.03), 15%(RR 0.85; 95% CI, 0.76-0.95, p = 0.003) and 17% (RR 0.83; 95% CI, 0.74-0.94, p = 0.003), respectively. Concerning both subgroups, the relative risks respectively decreased by 19% (RR 0.81; 95% CI, 0.71-0.92; p = 0.002) for SCD, 18%(RR 0.82; 95% CI, 0.77-0.88, p < 0.0001) for all-cause mortality and 20%(RR 0.80; 95% CI, 0.74-0.87, p < 0.0001) for cardiovascular mortality in patients treated with AAs. As well, hospitalizations were significantly reduced, while common adverse effects were significantly increased. Conclusion Aldosterone antagonists appear to be effective in reducing SCD and other mortality events, compared with placebo or standard medication in patients with HF and/or after a MI.	[Le, Hai-Ha; El-Khatib, Chadia; Mombled, Margaux; Guitarian, Frederic; Fall, Mor; Janiaud, Perrine; Cucherat, Michel; Gueyffier, Francois] Univ Lyon 1, Equipe Modelisat Effets Therapeut, Lab Biol & Biometrie Evolut, UMR 5558, F-69365 Lyon, France; [Al-Gobari, Muaamar] Lausanne Univ Hosp CHUV, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Marchant, Ivanny] Univ Valparaiso, Dept Preclin, Escuela Med, Valparaiso, Chile; [Bejan-Angoulvant, Theodora] Hop Bretonneau, Serv Pharmacol Clin, CHRU Tours, Tours, France; [Bejan-Angoulvant, Theodora] CNRS, UMR 7292, Tours, France; [Bejan-Angoulvant, Theodora] Univ Tours, GICC, Tours, France; [Gueyffier, Francois] Hosp Civils Lyon, Serv Pharmacol Clin & Essais Therapeut, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Universidad de Valparaiso; CHU Tours; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Tours; CHU Lyon	Gueyffier, F (corresponding author), Univ Lyon 1, Equipe Modelisat Effets Therapeut, Lab Biol & Biometrie Evolut, UMR 5558, F-69365 Lyon, France.; Gueyffier, F (corresponding author), Hosp Civils Lyon, Serv Pharmacol Clin & Essais Therapeut, Lyon, France.	francois.gueyffier@univ-lyon1.fr	Al-Gobari, Muaamar/D-7382-2016; Cucherat, Michel/B-2343-2008	Al-Gobari, Muaamar/0000-0003-1522-9812; Cucherat, Michel/0000-0003-2150-5932; Bejan-Angoulvant, Theodora/0000-0002-0018-9996; Janiaud, Perrine/0000-0001-7684-8014	Claude Bernard Lyon 1 University (French Ministry of Higher Education Research)	Claude Bernard Lyon 1 University (French Ministry of Higher Education Research)	The work has been done as a part of master internships of the three co-authors (HHL, CEK and MM). HHL is currently receiving a salary from Claude Bernard Lyon 1 University (scholarship of French Ministry of Higher Education & Research) for her three-year PhD at the UMR 5558 CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton C, 2003, J CLIN PHARM THER, V28, P285, DOI 10.1046/j.1365-2710.2003.00491.x; Atlas SA, 2007, J MANAGE CARE PHARM, V13, pS9, DOI 10.18553/jmcp.2007.13.s8-b.9; Bangalore Sripal, 2013, Congest Heart Fail, V19, P107, DOI 10.1111/chf.12011; Bapoje SR, 2013, CIRC-HEART FAIL, V6, P166, DOI 10.1161/CIRCHEARTFAILURE.112.000003; Boccanelli A, 2009, EUR J HEART FAIL, V11, P68, DOI 10.1093/eurjhf/hfn015; Caccamo Marco A, 2011, Congest Heart Fail, V17, P213, DOI 10.1111/j.1751-7133.2011.00235.x; Catena C, 2012, HORM METAB RES, V44, P181, DOI 10.1055/s-0031-1291318; Chan AKY, 2007, J AM COLL CARDIOL, V50, P591, DOI 10.1016/j.jacc.2007.03.062; Chatterjee S, 2012, AM J MED, V125, P817, DOI 10.1016/j.amjmed.2011.12.018; Chen YM, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0261-8; Cicoira M, 2002, J AM COLL CARDIOL, V40, P304, DOI 10.1016/S0735-1097(02)01965-4; Clark H, 2014, EUR J HEART FAIL, V16, P41, DOI 10.1002/ejhf.13; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Deswal A, 2011, J CARD FAIL, V17, P634, DOI 10.1016/j.cardfail.2011.04.007; Di Pasquale P, 2005, AM HEART J, V150, DOI 10.1016/j.ahj.2005.03.032; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Edelmann F, 2013, JAMA-J AM MED ASSOC, V309, P781, DOI 10.1001/jama.2013.905; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Englestein E, 1998, HEART ARTERIES VEINS; Ezekowitz JA, 2009, EUR HEART J, V30, P469, DOI 10.1093/eurheartj/ehn543; Gao XR, 2007, J CARD FAIL, V13, P170, DOI 10.1016/j.cardfail.2006.11.015; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hu LJ, 2013, BRIT J CLIN PHARMACO, V75, P1202, DOI 10.1111/bcp.12012; Kayrak M, 2010, CORONARY ARTERY DIS, V21, P477, DOI 10.1097/MCA.0b013e32833fd243; Li XB, 2013, CIRC-HEART FAIL, V6, P156, DOI 10.1161/CIRCHEARTFAILURE.112.000074; Mak GJ, 2009, J AM COLL CARDIOL, V54, P1674, DOI 10.1016/j.jacc.2009.08.021; MANTEL N, 1959, J NATL CANCER I, V22, P719; McMurray J, 2006, EUR HEART J, V27, P1773, DOI 10.1093/eurheartj/ehl123; Mehta D, 1997, CIRCULATION, V96, P3215, DOI 10.1161/01.CIR.96.9.3215; Modena MG, 2001, AM HEART J, V141, P41, DOI 10.1067/mhj.2001.111258; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Montalescot G, 2014, EUR HEART J, V35, P2295, DOI 10.1093/eurheartj/ehu164; Munger Mark A, 2011, P T, V36, P22; Myerburg R, 1997, HEART DIS TXB CARDIO; Nappi JM, 2011, VASC HEALTH RISK MAN, V7, P353, DOI 10.2147/VHRM.S13779; O'Meara E, 2012, CIRC-HEART FAIL, V5, P586, DOI 10.1161/CIRCHEARTFAILURE.111.965160; Phelan D, 2012, HEART, V98, P1693, DOI 10.1136/heartjnl-2012-302178; Pitt B, 1996, AM J CARDIOL, V78, P902; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Pitt B, 2014, NEW ENGL J MED, V370, P1383, DOI 10.1056/NEJMoa1313731; Rossi R, 2015, J RENIN-ANGIO-ALDO S, V16, P119, DOI 10.1177/1470320313482603; Rossignol P, 2014, CIRC-HEART FAIL, V7, P51, DOI 10.1161/CIRCHEARTFAILURE.113.000792; Sica Domenic A, 2003, Congest Heart Fail, V9, P224, DOI 10.1111/j.1527-5299.2003.02397.x; Sterne JAC, 2011, COCHRANE HDB SYSTEMA; Taheri S, 2012, SAUDI J KIDNEY DIS T, V23, P507; Taheri S, 2009, SAUDI J KIDNEY DIS T, V20, P392; Tang WHW, 2005, MAYO CLIN PROC, V80, P1623, DOI 10.4065/80.12.1623; Udelson JE, 2010, CIRC-HEART FAIL, V3, P347, DOI 10.1161/CIRCHEARTFAILURE.109.906909; Uzunhasan I, 2009, SCAND J CLIN LAB INV, V69, P545, DOI 10.1080/00365510902802278; Vatankulu MA, 2013, CARDIOVASC THER, V31, P224, DOI 10.1111/1755-5922.12006; Vizzardi E, 2014, AM J MED SCI, V347, P271, DOI 10.1097/MAJ.0b013e31829dd6b1; Vizzardi E, 2010, AM J CARDIOL, V106, P1292, DOI 10.1016/j.amjcard.2010.06.052; Weir RAP, 2009, AM HEART J, V157, P1088, DOI 10.1016/j.ahj.2009.04.001; Wu CT, 2013, WORLD J EMERG MED, V4, P48, DOI [10.5847/wjem.j.issn.1920-8642.2013.01.009, 10.5847/wjem.j.1920-8642.2013.01.009]; Yancy CW, 2013, CIRCULATION, V128, pE240, DOI 10.1161/CIR.0b013e31829e8776; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492	57	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0145958	10.1371/journal.pone.0145958	http://dx.doi.org/10.1371/journal.pone.0145958			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891235	Green Published, gold, Green Submitted			2022-12-27	WOS:000371221500001
J	Li, J; Tran, M; Siwabessy, J				Li, Jin; Tran, Maggie; Siwabessy, Justy			Selecting Optimal Random Forest Predictive Models: A Case Study on Predicting the Spatial Distribution of Seabed Hardness	PLOS ONE			English	Article							BACKSCATTER INTENSITY; GRAIN-SIZE; CLASSIFICATION; INTERPOLATION; PERFORMANCE; SURROGATES; SEDIMENTS; CHANNEL; SCALE	Spatially continuous predictions of seabed hardness are important baseline environmental information for sustainable management of Australia's marine jurisdiction. Seabed hardness is often inferred from multibeam backscatter data with unknown accuracy and can be inferred from underwater video footage at limited locations. In this study, we classified the seabed into four classes based on two new seabed hardness classification schemes (i.e., hard90 and hard70). We developed optimal predictive models to predict seabed hardness using random forest (RF) based on the point data of hardness classes and spatially continuous multibeam data. Five feature selection (FS) methods that are variable importance (VI), averaged variable importance (AVI), knowledge informed AVI (KIAVI), Boruta and regularized RF (RRF) were tested based on predictive accuracy. Effects of highly correlated, important and unimportant predictors on the accuracy of RF predictive models were examined. Finally, spatial predictions generated using the most accurate models were visually examined and analysed. This study confirmed that: 1) hard90 and hard70 are effective seabed hardness classification schemes; 2) seabed hardness of four classes can be predicted with a high degree of accuracy; 3) the typical approach used to pre-select predictive variables by excluding highly correlated variables needs to be re-examined; 4) the identification of the important and unimportant predictors provides useful guidelines for further improving predictive models; 5) FS methods select the most accurate predictive model(s) instead of the most parsimonious ones, and AVI and Boruta are recommended for future studies; and 6) RF is an effective modelling method with high predictive accuracy for multi-level categorical data and can be applied to 'small p and large n' problems in environmental sciences. Additionally, automated computational programs for AVI need to be developed to increase its computational efficiency and caution should be taken when applying filter FS methods in selecting predictive models.	[Li, Jin; Tran, Maggie; Siwabessy, Justy] Geosci Australia, GPO Box 378, Canberra, ACT 2601, Australia	Geoscience Australia	Li, J (corresponding author), Geosci Australia, GPO Box 378, Canberra, ACT 2601, Australia.	Jin.Li@ga.gov.au	Siwabessy, Paulus Justy W./I-1818-2019	Siwabessy, Paulus Justy W./0000-0002-8399-5909	Geoscience Australia	Geoscience Australia	This study was internally funded by Geoscience Australia.	Anderson JT, 2008, ICES J MAR SCI, V65, P1004, DOI 10.1093/icesjms/fsn061; Anderson T.J., 2008, MAPPING SEAFLOOR HAB, P71; Anderson TJ, 2011, NO AUSTR GA0325SOL51; Austin MP, 2006, ECOL MODEL, V199, P197, DOI 10.1016/j.ecolmodel.2006.05.023; Biau G, 2012, J MACH LEARN RES, V13, P1063; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Buhl-Mortensen L, 2012, HYDROBIOLOGIA, V685, P191, DOI 10.1007/s10750-011-0988-6; Buhl-Mortensen P, 2009, ICES J MAR SCI, V66, P2026, DOI 10.1093/icesjms/fsp200; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; De Falco G, 2010, CONT SHELF RES, V30, P1941, DOI 10.1016/j.csr.2010.09.006; Deng H., 2013, ARXIV13060237, V1306.0237, P1; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Dougherty ER, 2009, CURR GENOMICS, V10, P365, DOI 10.2174/138920209789177629; ESRI Inc, 2002, ARCGIS 10 0; Ferrini VL, 2006, MAR GEOL, V228, P153, DOI 10.1016/j.margeo.2005.11.010; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Goff JA, 2000, GEO-MAR LETT, V20, P43, DOI 10.1007/s003670000032; Gray J.S., 2009, ECOLOGY MARINE SEDIM, Vsecond; Guyon I, 2009, JMLR WORKSHOP C P; Hamilton LJ, 2011, CONT SHELF RES, V31, P138, DOI 10.1016/j.csr.2010.12.002; Hapfelmeier A, 2013, COMPUT STAT DATA AN, V60, P50, DOI 10.1016/j.csda.2012.09.020; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Heap AD, 2010, SEABED ENV E J BONAP; Ho TK, 1998, IEEE T PATTERN ANAL, V20, P832, DOI 10.1109/34.709601; Janecek AG, 2008, RELATIONSHIP FEATURE; Kloser RJ, 2010, CONT SHELF RES, V30, P1772, DOI 10.1016/j.csr.2010.08.004; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; Li J, 2013, 20TH INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION (MODSIM2013), P394; Li J, 2012, AUSTR STAT C 2012 9; Li J., 2012, PREDICTING SEABED SA; Li J, 2013, METHODOLOGIES MULTIB; Li J, 2011, PREDICTING SEABED MU; Li J, 2013, DATA MINING APPL R, P299; Li J, 2013, GEOSC AUSTR WEDN SEM, P47; Li J, 2013, P 11 AUSTR DAT MIN C, V146; Li J, 2010, PREDICTING SEABED MU; Li J, 2011, ENVIRON MODELL SOFTW, V26, P1647, DOI 10.1016/j.envsoft.2011.07.004; Li J, 2011, CONT SHELF RES, V31, P1365, DOI 10.1016/j.csr.2011.05.015; Marmion M, 2009, ECOL MODEL, V220, P3512, DOI 10.1016/j.ecolmodel.2008.10.019; McArthur MA, 2010, ESTUAR COAST SHELF S, V88, P21, DOI 10.1016/j.ecss.2010.03.003; Mortensen PB, 2004, MAR BIOL, V144, P1223, DOI 10.1007/s00227-003-1280-8; Newell RC, 2001, J MAR BIOL ASSOC UK, V81, P1, DOI 10.1017/S0025315401003344; Okun O., 2007, LECT NOTES COMPUTER, V4478; Post AL, 2006, MAR FRESHWATER RES, V57, P469, DOI 10.1071/MF05182; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Przeslawski R., 2011, SEABED HABITATS HAZA; R Core Team, 2021, R LANGUAGE ENV STAT; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Saxena NK., 1999, MAR GEOD, V22, P249, DOI [10.1080/014904199273380, DOI 10.1080/014904199273380]; Siwabessy J, 2013, METHODOLOGIES MULTIB; Siwabessy PJW, 2013, METHODOLOGIES SEABED; SMITH SJ, 2011, CONDITIONAL VARIABLE; STEIN DL, 1992, FISH B-NOAA, V90, P540; Stephens D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093950; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Thrush SF, 2001, MAR ECOL PROG SER, V221, P255, DOI 10.3354/meps221255; Tin Kam Ho, 1995, Proceedings of the Third International Conference on Document Analysis and Recognition, P278, DOI 10.1109/ICDAR.1995.598994; WARWICK RM, 1977, ESTUAR COAST MAR SCI, V5, P267, DOI 10.1016/0302-3524(77)90022-6; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910; Williams IM, 1999, OCEANOL ACTA, V22, P651, DOI 10.1016/S0399-1784(00)88956-2; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893	64	39	41	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149089	10.1371/journal.pone.0149089	http://dx.doi.org/10.1371/journal.pone.0149089			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890307	Green Published, gold, Green Submitted			2022-12-27	WOS:000371221500024
J	Zhang, DL; Dubey, J; Koushika, SP; Rongo, C				Zhang, Donglei; Dubey, Jyoti; Koushika, Sandhya P.; Rongo, Christopher			RAB-6.1 and RAB-6.2 Promote Retrograde Transport in C-elegans	PLOS ONE			English	Article							GLR-1 GLUTAMATE RECEPTORS; J-DOMAIN PROTEIN; ENDOPLASMIC-RETICULUM; MOLECULAR-CLONING; RAB GENES; RETROMER; ENDOSOMES; ASSOCIATION; SECRETION; FAMILY	Retrograde transport is a critical mechanism for recycling certain membrane cargo. Following endocytosis from the plasma membrane, retrograde cargo is moved from early endosomes to Golgi followed by transport (recycling) back to the plasma membrane. The complete molecular and cellular mechanisms of retrograde transport remain unclear. The small GTPase RAB-6.2 mediates the retrograde recycling of the AMPA-type glutamate receptor (AMPAR) subunit GLR-1 in C. elegans neurons. Here we show that RAB-6.2 and a close paralog, RAB-6.1, together regulate retrograde transport in both neurons and non-neuronal tissue. Mutants for rab-6.1 or rab-6.2 fail to recycle GLR-1 receptors, resulting in GLR-1 turnover and behavioral defects indicative of diminished GLR-1 function. Loss of both rab-6.1 and rab-6.2 results in an additive effect on GLR-1 retrograde recycling, indicating that these two C. elegans Rab6 isoforms have overlapping functions. MIG-14 (Wntless) protein, which undergoes retrograde recycling, undergoes a similar degradation in intestinal epithelia in both rab-6.1 and rab-6.2 mutants, suggesting a broader role for these proteins in retrograde transport. Surprisingly, MIG-14 is localized to separate, spatially segregated endosomal compartments in rab-6.1 mutants compared to rab-6.2 mutants. Our results indicate that RAB-6.1 and RAB-6.2 have partially redundant functions in overall retrograde transport, but also have their own unique cellular-and subcellular functions.	[Zhang, Donglei; Rongo, Christopher] Rutgers State Univ, Waksman Inst, Dept Genet, Piscataway, NJ USA; [Dubey, Jyoti; Koushika, Sandhya P.] Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India; [Dubey, Jyoti] Inst Stem Cell Biol & Regenerat Med InStem, Bangalore, Karnataka, India; [Dubey, Jyoti] Manipal Univ, Manipal, Karnataka, India; [Zhang, Donglei] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Rutgers State University New Brunswick; Tata Institute of Fundamental Research (TIFR); Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Manipal Academy of Higher Education (MAHE); University of Chicago	Rongo, C (corresponding author), Rutgers State Univ, Waksman Inst, Dept Genet, Piscataway, NJ USA.	rongo@waksman.rutgers.edu		Zhang, Donglei/0000-0002-2720-1414; Koushika, Sandhya/0000-0002-1742-7356	National Institutes of Health [R01 NS42023, R01 GM101972]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by (CR) National Institutes of Health R01 NS42023, https://www.nihms.nih.gov/db/sub.cgi?; (CR) National Institutes of Health R01 GM101972, https://www.nihms.nih.gov/db/sub.cgi?. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the C. elegans Genetics Center, Barth Grant, Villu Maricq, Joshua Kaplan, and Shohei Mitani for reagents and strains. In addition, we thank Barth Grant and Eunchan Park for suggestions and feedback on the experimental approach and the manuscript. This work was supported by National Institutes of Health (NIH) R01 NS42023 and R01 GM101972.	Armstrong J, 1996, J CELL SCI, V109, P1265; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; BALDINI G, 1995, P NATL ACAD SCI USA, V92, P4284, DOI 10.1073/pnas.92.10.4284; Belenkaya TY, 2008, DEV CELL, V14, P120, DOI 10.1016/j.devcel.2007.12.003; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Chang HCH, 2005, J CELL SCI, V118, P1945, DOI 10.1242/jcs.02320; Chen D, 1996, GENE, V174, P129, DOI 10.1016/0378-1119(96)00509-4; Chen D, 1997, BIOCHEM MOL MED, V60, P27, DOI 10.1006/bmme.1996.2559; Chun DK, 2008, MOL BIOL CELL, V19, P2682, DOI 10.1091/mbc.E07-11-1120; DARCHEN F, 1990, P NATL ACAD SCI USA, V87, P5692, DOI 10.1073/pnas.87.15.5692; Del Nery E, 2006, TRAFFIC, V7, P394, DOI 10.1111/j.1600-0854.2006.00395.x; Echard A, 2000, MOL BIOL CELL, V11, P3819, DOI 10.1091/mbc.11.11.3819; Franch-Marro X, 2008, NAT CELL BIOL, V10, P170, DOI 10.1038/ncb1678; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Glodowski DR, 2007, MOL BIOL CELL, V18, P4387, DOI 10.1091/mbc.E07-05-0486; Glodowski DR, 2005, MOL BIOL CELL, V16, P1417, DOI 10.1091/mbc.E04-10-0885; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Henley JM, 2011, TRENDS NEUROSCI; Hoerndli FJ, 2015, NEURON, V86, P457, DOI 10.1016/j.neuron.2015.03.011; Hoerndli FJ, 2013, NEURON, V80, P1421, DOI 10.1016/j.neuron.2013.10.050; Iezzi M, 1999, MOL ENDOCRINOL, V13, P202, DOI 10.1210/me.13.2.202; Januschke J, 2007, DEVELOPMENT, V134, P3419, DOI 10.1242/dev.008078; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Lundquist Erik A, 2006, WormBook, P1; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; Martinez O, 1997, P NATL ACAD SCI USA, V94, P1828, DOI 10.1073/pnas.94.5.1828; Mellem JE, 2002, NEURON, V36, P933, DOI 10.1016/S0896-6273(02)01088-7; Monteiro MI, 2012, MOL BIOL CELL, V23, P3647, DOI 10.1091/mbc.E12-04-0334; Nonet ML, 1998, J NEUROSCI, V18, P70; NUOFFER C, 1994, J CELL BIOL, V125, P225, DOI 10.1083/jcb.125.2.225; Opdam FJM, 2000, J CELL SCI, V113, P2725; Pan CL, 2008, DEV CELL, V14, P132, DOI 10.1016/j.devcel.2007.12.001; Park EC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004284; Port F, 2008, NAT CELL BIOL, V10, P178, DOI 10.1038/ncb1687; Rojas R, 2007, MOL CELL BIOL, V27, P1112, DOI 10.1128/MCB.00156-06; Rolls MM, 2002, MOL BIOL CELL, V13, P1778, DOI 10.1091/mbc.01-10-0514; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Sato Ken, 2014, WormBook, P1, DOI 10.1895/wormbook.1.77.2; Shafaq-Zadah M, 2016, NAT CELL BIOL, V18, P54, DOI 10.1038/ncb3287; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shi AB, 2009, EMBO J, V28, P3290, DOI 10.1038/emboj.2009.272; Shim J, 2004, MOL BIOL CELL, V15, P4818, DOI 10.1091/mbc.E04-02-0108; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Valente C, 2010, NAT CELL BIOL, V12, P635, DOI 10.1038/ncb0710-635; VONMOLLARD GF, 1990, P NATL ACAD SCI USA, V87, P1988, DOI 10.1073/pnas.87.5.1988; Wandinger-Ness A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a022616; Yang PT, 2008, DEV CELL, V14, P140, DOI 10.1016/j.devcel.2007.12.004; Yeo SCL, 2003, J CELL SCI, V116, P3957, DOI 10.1242/jcs.00751; Young J, 2010, J MOL BIOL, V397, P69, DOI 10.1016/j.jmb.2010.01.009; Zhang D, 2012, J CELL BIOL, V196, P85, DOI 10.1083/jcb.201104141; Zhang YH, 2001, MOL BIOL CELL, V12, P2011, DOI 10.1091/mbc.12.7.2011; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	59	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149314	10.1371/journal.pone.0149314	http://dx.doi.org/10.1371/journal.pone.0149314			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891225	Green Published, Green Submitted, gold			2022-12-27	WOS:000371221500032
J	Changrob, S; Wang, B; Han, JH; Lee, SK; Nyunt, MH; Lim, CS; Tsuboi, T; Chootong, P; Han, ET				Changrob, Siriruk; Wang, Bo; Han, Jin-Hee; Lee, Seong-Kyun; Nyunt, Myat Htut; Lim, Chae Seung; Tsuboi, Takafumi; Chootong, Patchanee; Han, Eun-Taek			Naturally-Acquired Immune Response against Plasmodium vivax Rhoptry-Associated Membrane Antigen	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; C-TERMINAL REGION; FALCIPARUM-MALARIA; VACCINE CANDIDATE; ANTIBODY-RESPONSES; IGG SUBCLASSES; INDIVIDUALS; INFECTION; IDENTIFICATION; IMMUNIZATION	Rhoptry-associated membrane antigen (RAMA) is an abundant glycophosphatidylinositol (GPI)-anchored protein that is embedded within the lipid bilayer and is implicated in parasite invasion. Antibody responses against rhoptry proteins are produced by individuals living in a malaria-endemic area, suggesting the immunogenicity of Plasmodium vivax RAMA (PvRAMA) for induction of immune responses during P. vivax infection. To determine whether PvRAMA contributes to the acquisition of immunity to malaria and could be a rational candidate for a vaccine, the presence of memory T cells and the stability of the antibody response against PvRAMA were evaluated in P. vivax-exposed individuals. The immunogenicity of PvRAMA for the induction of T cell responses was evaluated by in vitro stimulation of peripheral blood mononuclear cells (PBMCs). High levels of interferon (IFN)-gamma and interleukin (IL)-10 cytokines were detected in the culture supernatant of PBMCs, and the CD4(+) T cells predominantly produced IL-10 cytokine. The levels of total anti-PvRAMA immunoglobulin G (IgG) antibody were significantly elevated, and these antibodies persisted over the 12 months of the study. Interestingly, IgG1, IgG2 and IgG3 were the major antibody subtypes in the response to PvRAMA. The frequency of IgG3 in specific to PvRAMA antigen maintained over 12 months. These data could explain the immunogenicity of PvRAMA antigen in induction of both cell-mediated and antibody-mediated immunity in natural P. vivax infection, in which IFN-gamma helps antibody class switching toward the IgG1, IgG2 and IgG3 isotypes and IL-10 supports PvRAMA-specific antibody production.	[Changrob, Siriruk; Chootong, Patchanee] Mahidol Univ, Fac Med Technol, Dept Clin Microbiol & Appl Technol, Bangkok 10700, Thailand; [Wang, Bo; Han, Jin-Hee; Lee, Seong-Kyun; Nyunt, Myat Htut] Kangwon Natl Univ, Dept Med Environm Biol & Trop Med, Sch Med, Chunchon, Gangwon Do, South Korea; [Wang, Bo; Han, Eun-Taek] Anhui Med Univ, Affiliated Hosp 1, Dept Clin Lab, Hefei, Anhui, Peoples R China; [Nyunt, Myat Htut] Dept Med Res, Yangon, Myanmar; [Lim, Chae Seung] Korea Univ, Guro Hosp, Coll Med, Dept Lab Med, Seoul, South Korea; [Tsuboi, Takafumi] Ehime Univ, Div Malaria Res, Proteosci Ctr, Matsuyama, Ehime, Japan	Mahidol University; Kangwon National University; Anhui Medical University; Korea University; Korea University Medicine (KU Medicine); Ehime University	Chootong, P (corresponding author), Mahidol Univ, Fac Med Technol, Dept Clin Microbiol & Appl Technol, Bangkok 10700, Thailand.; Han, ET (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Clin Lab, Hefei, Anhui, Peoples R China.	pchooton@gmail.com; ethan@kangwon.ac.kr	Nyunt, Myat Htut/R-2424-2017; Tsuboi, Takafumi/AAK-6145-2021; Changrob, Siriruk/AAZ-6282-2021	Nyunt, Myat Htut/0000-0002-2026-8026; Changrob, Siriruk/0000-0002-1826-4333; Tsuboi, Takafumi/0000-0002-7415-1325; Han, Jin-Hee/0000-0003-0836-6675	National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2014R1A2A1A11052079]; Korea Health Technology R&D Project, the Ministry of Health & Welfare, Republic of Korea [A121180]	National Research Foundation of Korea (NRF) - Korea government (MSIP); Korea Health Technology R&D Project, the Ministry of Health & Welfare, Republic of Korea	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. NRF-2014R1A2A1A11052079) and a grant from the Korea Health Technology R&D Project, the Ministry of Health & Welfare, Republic of Korea (A121180). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MT, 2008, PARASITE IMMUNOL, V30, P379, DOI 10.1111/j.1365-3024.2008.01033.x; Arevalo-Herrera M, 2010, HUM VACCINES, V6, P124, DOI 10.4161/hv.6.1.9931; Artavanis-Tsakonas K, 2003, CLIN EXP IMMUNOL, V133, P145, DOI 10.1046/j.1365-2249.2003.02174.x; Aucan C, 2000, INFECT IMMUN, V68, P1252, DOI 10.1128/IAI.68.3.1252-1258.2000; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Changrob S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0681-8; Chen JH, 2010, J PROTEOME RES, V9, P6479, DOI 10.1021/pr100705g; CLYDE DF, 1990, B WORLD HEALTH ORGAN, V68, P9; CLYDE DF, 1975, AM J TROP MED HYG, V24, P397, DOI 10.4269/ajtmh.1975.24.397; Counihan NA, 2013, TRENDS PARASITOL, V29, P228, DOI 10.1016/j.pt.2013.03.003; Fonjungo PN, 1998, INFECT IMMUN, V66, P1037, DOI 10.1128/IAI.66.3.1037-1044.1998; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Holdsworth SR, 1999, KIDNEY INT, V55, P1198, DOI 10.1046/j.1523-1755.1999.00369.x; Ismail HA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-425; Kraaij MD, 2014, CYTOKINE, V67, P7, DOI 10.1016/j.cyto.2014.02.001; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lu F, 2014, J PROTEOMICS, V102, P66, DOI 10.1016/j.jprot.2014.02.029; Bouillet LEM, 2011, INFECT IMMUN, V79, P3642, DOI 10.1128/IAI.05048-11; MCGREGOR IA, 1964, AM J TROP MED HYG, V13, P237, DOI 10.4269/ajtmh.1964.13.237; Mehrizi AA, 2009, ACTA TROP, V112, P1, DOI 10.1016/j.actatropica.2009.05.016; Menard R, 2013, NAT REV MICROBIOL, V11, P701, DOI 10.1038/nrmicro3111; Mongui A, 2007, BIOCHEM BIOPH RES CO, V358, P861, DOI 10.1016/j.bbrc.2007.05.015; Pandey JP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-229; Patarroyo MA, 2005, BIOCHEM BIOPH RES CO, V337, P853, DOI 10.1016/j.bbrc.2005.09.120; Perez-Leal O, 2006, BIOCHEM BIOPH RES CO, V341, P1053, DOI 10.1016/j.bbrc.2006.01.061; Pitabut Nada, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P1; Riccio EKP, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-326; Richards JS, 2009, IMMUNOL CELL BIOL, V87, P377, DOI 10.1038/icb.2009.27; RIDLEY RG, 1990, PARASITOLOGY, V101, P187, DOI 10.1017/S0031182000063228; Rojas-Caraballo J, 2009, VACCINE, V27, P2870, DOI 10.1016/j.vaccine.2009.02.083; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Sauerwein RW, 2011, NAT REV IMMUNOL, V11, P57, DOI 10.1038/nri2902; Targett GAT, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-362; Teirlinck AC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002389; Tongren JE, 2006, INFECT IMMUN, V74, P257, DOI 10.1128/IAI.74.1.257-264.2006; Topolska AE, 2004, INFECT IMMUN, V72, P3325, DOI 10.1128/IAI.72.6.3325-3330.2004; Tran TM, 2005, AM J TROP MED HYG, V73, P244, DOI 10.4269/ajtmh.2005.73.244; Tsuboi T, 2008, INFECT IMMUN, V76, P1702, DOI 10.1128/IAI.01539-07; Wang B, 2015, INFECT IMMUN, V83, P3083, DOI 10.1128/IAI.03067-14; Wang B, 2013, PARASITOL RES, V112, P585, DOI 10.1007/s00436-012-3170-9; Wipasa J, 2002, IMMUNOL CELL BIOL, V80, P401, DOI 10.1046/j.1440-1711.2002.01107.x; Wipasa J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001281; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770; Woodberry T, 2008, J INFECT DIS, V198, P134, DOI 10.1086/588711; Zakeri S, 2011, AM J TROP MED HYG, V84, P944, DOI 10.4269/ajtmh.2011.11-0001; Zeeshan M, 2013, J INFECT DIS, V207, P175, DOI 10.1093/infdis/jis650	46	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148723	10.1371/journal.pone.0148723	http://dx.doi.org/10.1371/journal.pone.0148723			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886867	gold, Green Published, Green Submitted			2022-12-27	WOS:000371218400046
J	Guida, L; Walker, TI; Reina, RD				Guida, Leonardo; Walker, Terence I.; Reina, Richard D.			Temperature Insensitivity and Behavioural Reduction of the Physiological Stress Response to Longline Capture by the Gummy Shark, Mustelus antarcticus	PLOS ONE			English	Article							GILL-NET CAPTURE; POSTRELEASE SURVIVORSHIP; ELASMOBRANCH; SURVIVAL; CAUGHT; INDICATORS; MORTALITY; TRANSPORT	Many factors influence the physiological stress response to fisheries capture in elasmobranchs. However, the influence of sea surface temperatures (SST) and behaviour are unknown and crucial considering global fishing pressures. We investigated the effect of SST and behaviour on the physiological stress response to capture of the gummy shark, Mustelus antarcticus, and compared our results to a laboratory study using similar conditions to test whether stress responses of in situ capture are consistent with those from laboratory simulations. Capture time for 23 M. antarcticus ranged 32-241 min as measured by hook timers or time depth recorders (TDR) in SSTs ranging 12-20 degrees C. TDR data from 13 M. antarcticus were analysed to quantify capture behaviour as the percentage of time spent moving during capture. Several physiological variables measured from blood samples obtained immediately upon the animals' landing indicated that although warmer SSTs increased metabolic rate, the stress response to capture was not exacerbated by capture duration. During capture movement occurred for an average of 10% of the time and since M. antarcticus can respire whilst stationary, restricted movement probably mitigated potential influences of increased SSTs and capture duration on the stress response. Previous laboratory findings were also shown to be indicative of in situ conditions and we thus advise that studies control for water temperature given the influence it has on variables (e.g. lactate) used to measure capture stress in elasmobranchs. We highlight the importance of seasonal water temperatures and capture behaviour when assessing the resilience to fisheries capture and the implementation of appropriate fisheries management strategies.	[Guida, Leonardo; Walker, Terence I.; Reina, Richard D.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia	Monash University	Guida, L (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia.	leoguida85@gmail.com	Reina, Richard/AAC-7017-2019; Walker, Terence I/AAD-8458-2019	Walker, Terence I/0000-0001-6552-9042	Australian Research Council Linkage [LP110200572]	Australian Research Council Linkage(Australian Research Council)	This work was supported by Australian Research Council Linkage grant LP110200572 to RDR and TIW which included the Department of Economic Development, Jobs, Transport and Resources Victoria; Australian Fisheries Management Authority; Melbourne Aquarium and Monash University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks EJ, 2012, COMP BIOCHEM PHYS A, V162, P94, DOI 10.1016/j.cbpa.2011.04.012; Camhi M. D., 2008, SHARKS OPEN OCEAN BI, P166; Cicia AM, 2012, COMP BIOCH PHYSL A; Dapp DR, 2016, FISH FISH, V17, P507, DOI 10.1111/faf.12124; Davis MW, 2002, CAN J FISH AQUAT SCI, V59, P1834, DOI 10.1139/F02-139; Ditmer MA, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00199.1; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Ellison AM, 1996, ECOL APPL, V6, P1036, DOI 10.2307/2269588; Frick LH, 2012, COMP BIOCHEM PHYS A, V162, P88, DOI 10.1016/j.cbpa.2011.02.023; Frick LH, 2010, J EXP MAR BIOL ECOL, V385, P29, DOI 10.1016/j.jembe.2010.01.013; Frick LH, 2009, N AM J FISH MANAGE, V29, P127, DOI 10.1577/M08-031.1; Gallagher AJ, 2014, GLOB ECOL CONSERV, V1, P50, DOI 10.1016/j.gecco.2014.06.003; Gallagher AJ, 2014, MAR ECOL PROG SER, V496, P207, DOI 10.3354/meps10490; Gallagher AJ, 2010, J AQUAT ANIM HEALTH, V22, P229, DOI 10.1577/H10-012.1; Gilman E, 2008, MAR POLICY, V32, P1, DOI 10.1016/j.marpol.2007.05.001; Grace MA, 2010, SOUTHEAST NAT, V9, P191, DOI 10.1656/058.009.0201; Harter TS, 2015, CONSERV PHYSL, V3, DOI [10.1093/conphys/cov002, DOI 10.1093/CONPHYS/C0V002]; Hight BV, 2007, MAR FRESHWATER RES, V58, P145, DOI 10.1071/MF05260; Hoffmayer ER, 2012, COMP BIOCHEM PHYS A, V162, P81, DOI 10.1016/j.cbpa.2011.05.002; HOPKINS TE, 1994, COPEIA, P529, DOI 10.2307/1447005; Hyatt MW, 2012, COMP BIOCHEM PHYS A, V162, P113, DOI 10.1016/j.cbpa.2011.05.004; Jones S, 2014, J APPL ANIM WELF SCI, V17, P18, DOI 10.1080/10888705.2014.856241; Kneebone J, 2013, FISH RES, V147, P103, DOI 10.1016/j.fishres.2013.04.009; Mandelman JW, 2007, ICES J MAR SCI, V64, P122, DOI 10.1093/icesjms/fsl003; Mandelman JW, 2009, J COMP PHYSIOL B, V179, P267, DOI 10.1007/s00360-008-0306-4; Manire C, 2001, T AM FISH SOC, V130, P1038, DOI 10.1577/1548-8659(2001)130&lt;1038:SCAWGN&gt;2.0.CO;2; Morgan Alexia, 2007, Gulf and Caribbean Research, V19, P123; Morgan A, 2010, FISH RES, V101, P32, DOI 10.1016/j.fishres.2009.09.004; Moyes CD, 2006, T AM FISH SOC, V135, P1389, DOI 10.1577/T05-224.1; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Renshaw GMC, 2012, COMP BIOCHEM PHYS A, V162, P101, DOI 10.1016/j.cbpa.2011.08.001; Santurtun E, 2015, J ANIM SCI, V93, P1250, DOI 10.2527/jas.2014-8037; Skomal G, 2010, CRC MAR BIOL SER, P459; Skomal GB, 2012, COMP BIOCHEM PHYS A, V162, P146, DOI 10.1016/j.cbpa.2011.10.002; Van Rijn JA, 2010, FISH SHELLFISH IMMUN, V29, P534, DOI 10.1016/j.fsi.2010.04.016; Walker TI, 1998, MAR FRESHWATER RES, V49, P553, DOI 10.1071/MF98017; Water Melbourne, 2011, W PORT ENV SCI REV	37	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148829	10.1371/journal.pone.0148829	http://dx.doi.org/10.1371/journal.pone.0148829			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886126	gold, Green Published, Green Submitted			2022-12-27	WOS:000371218400051
J	Hall, KW; Eisthen, HL; Williams, BL				Hall, Kevin W.; Eisthen, Heather L.; Williams, Barry L.			Proteinaceous Pheromone Homologs Identified from the Cloacal Gland Transcriptome of a Male Axolotl, Ambystoma mexicanum	PLOS ONE			English	Article							NEWT CYNOPS-PYRRHOGASTER; VENOM ALPHA-NEUROTOXINS; RNA-SEQ DATA; TERRESTRIAL SALAMANDER; COURTSHIP PHEROMONE; FEMALE RECEPTIVITY; ABDOMINAL GLAND; GENES; SIGNALS; GENOME	Pheromones play an important role in modifying vertebrate behavior, especially during courtship and mating. Courtship behavior in urodele amphibians often includes female exposure to secretions from the cloacal gland, as well as other scent glands. The first vertebrate proteinaceous pheromone discovered, the decapeptide sodefrin, is a female attracting pheromone secreted by the cloacal gland of male Cynops pyrrhogaster. Other proteinaceous pheromones in salamanders have been shown to elicit responses from females towards conspecific males. The presence and levels of expression of proteinaceous pheromones have not been identified in the family Ambystomatidae, which includes several important research models. The objective of this research was therefore to identify putative proteinaceous pheromones from male axolotls, Ambystoma mexicanum, as well as their relative expression levels. The results indicate that axolotls possess two different forms of sodefrin precursor-like factor (alpha and beta), as well as a putative ortholog of plethodontid modulating factor. The beta form of sodefrin precursor-like factor was amongst the most highly expressed transcripts within the cloacal gland. The ortholog of plethodontid modulating factor was expressed at a level equivalent to the beta sodefrin precursor-like factor. The results are from a single male axolotl; therefore, we are unable to assess how representative our results may be. Nevertheless, the presence of these highly expressed proteinaceous pheromones suggests that male axolotls use multiple chemical cues to attract female conspecifics. Behavioral assays would indicate whether the putative protein pheromones elicit courtship activity from female axolotls.	[Williams, Barry L.] Michigan State Univ, Dept Integrat Biol, E Lansing, MI 48824 USA; Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Williams, BL (corresponding author), Michigan State Univ, Dept Integrat Biol, E Lansing, MI 48824 USA.	BarryW@msu.edu			U. S. National Science Foundation [IOS-1354089, DBI-0951484]; Michigan State University; Division Of Integrative Organismal Systems [1354089] Funding Source: National Science Foundation	U. S. National Science Foundation(National Science Foundation (NSF)); Michigan State University; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the U. S. National Science Foundation (Grant Number: IOS-1354089) (HLE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Ambystoma Genetic Stock Center (supported by the U. S. National Science Foundation, DBI-0951484) for supplying the axolotl used in this experiment. We thank Cory B. Kohn for his assistance with understanding how to code scripts to more efficiently process and analyze data and Dr. Matthew Scholz for his assistance in understanding of the various modules utilized in the assembly and analysis of the transcriptome discussed in this thesis. This work was supported by the U. S. National Science Foundation (IOS-1354089) as well as by Michigan State University through computational resources provided by the Institute for Cyber-Enabled Research.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amaldi F, 1995, BIOCHEM CELL BIOL, V73, P969, DOI 10.1139/o95-104; Armstrong J, 1989, RAISING AXOLOTL CAPT; Arnold S.J., 1977, P141; Bolger AM, 2014, BIOINFORMATICS; Brown C.T., 2012, ARXIV12034802; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crusoe M, 2014, KHMER SOFTWARE PACKA; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Eisthen HL, 2005, CHEM SIGNAL, V10, P216, DOI 10.1007/0-387-25160-X_26; Gadow H, 1903, NATURE, V67, P330, DOI 10.1038/067330b0; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Houck LD, 2008, CHEM SENSES, V33, P623, DOI 10.1093/chemse/bjn027; Houck LD, 2008, CHEM SIGNAL, V11, P213, DOI 10.1007/978-0-387-73945-8_20; Huggins P, 2012, COMP BIOCHEM PHYS C, V155, P128, DOI 10.1016/j.cbpc.2011.03.006; Iwata T, 2004, PEPTIDES, V25, P1537, DOI 10.1016/j.peptides.2003.10.027; JAEGER RG, 1981, AM NAT, V117, P962, DOI 10.1086/283780; Janssenswillen S, 2015, MOL BIOL EVOL, V32, P472, DOI 10.1093/molbev/msu316; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; KIEFFER B, 1994, BIOCHEMISTRY-US, V33, P4471, DOI 10.1021/bi00181a006; Kikuyama S, 2002, COMP BIOCHEM PHYS B, V132, P69, DOI 10.1016/S1096-4959(01)00534-6; KIKUYAMA S, 1995, SCIENCE, V267, P1643, DOI 10.1126/science.7886452; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0553-5; Li FG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123730; Lo CC, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0366-2; MASON RT, 1989, SCIENCE, V245, P290, DOI 10.1126/science.2749261; MATHIS A, 1990, BEHAVIOUR, V112, P162, DOI 10.1163/156853990X00176; Meredith M, 1998, ANN NY ACAD SCI, V855, P349, DOI 10.1111/j.1749-6632.1998.tb10593.x; Nakada T, 2007, PEPTIDES, V28, P774, DOI 10.1016/j.peptides.2006.12.006; Osikowski A, 2008, ZOOL SCI, V25, P587, DOI 10.2108/zsj.25.587; Palmer CA, 2007, FEBS J, V274, P2300, DOI 10.1111/j.1742-4658.2007.05766.x; Palmer CA, 2007, EVOLUTION, V61, P202, DOI 10.1111/j.1558-5646.2007.00017.x; Park D, 2004, J COMP PHYSIOL A, V190, P415, DOI 10.1007/s00359-004-0510-y; PLOUG M, 1994, FEBS LETT, V349, P163, DOI 10.1016/0014-5793(94)00674-1; Rajchard J, 2005, VET MED-CZECH, V50, P385, DOI 10.17221/5637-VETMED; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Rollmann SM, 1999, SCIENCE, V285, P1907, DOI 10.1126/science.285.5435.1907; SALTHE SN, 1967, COPEIA, P100; SMITH HM, 1969, BIOSCIENCE, V19, P593, DOI 10.2307/1294932; Smith JJ, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-181; Stacey N, 2003, CAN J PHYSIOL PHARM, V81, P329, DOI [10.1139/y03-024, 10.1139/Y03-024]; Stebbins R. C., 2021, NATURAL HIST AMPHIBI; Stewart R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002936; Tsetlin V, 1999, EUR J BIOCHEM, V264, P281, DOI 10.1046/j.1432-1327.1999.00623.x; Van Bocxlaer I, 2014, PEERJ PREPRINTS, P2; Wheat CW, 2011, METHODS MOL BIOL, V772, P129, DOI 10.1007/978-1-61779-228-1_7; Yamamoto K, 2000, FEBS LETT, V472, P267, DOI 10.1016/S0014-5793(00)01455-1; Zhang P, 2008, MOL PHYLOGENET EVOL, V49, P586, DOI 10.1016/j.ympev.2008.08.020; Zhang SY, 2013, ZOOL SCI, V30, P658, DOI 10.2108/zsj.30.658	54	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0146851	10.1371/journal.pone.0146851	http://dx.doi.org/10.1371/journal.pone.0146851			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885665	Green Published, gold, Green Submitted			2022-12-27	WOS:000371218400004
J	Kimura, K; Huang, RCC				Kimura, Kotohiko; Huang, Ru Chih C.			Tetra-O-Methyl Nordihydroguaiaretic Acid Broadly Suppresses Cancer Metabolism and Synergistically Induces Strong Anticancer Activity in Combination with Etoposide, Rapamycin and UCN-01	PLOS ONE			English	Article							MITOCHONDRIAL ELECTRON-TRANSPORT; INHIBITOR TERAMEPROCOL; OXIDATIVE STRESS; CELL-DEATH; PHASE-I; AUTOPHAGY; APOPTOSIS; TARGETS; BNIP3; CLEAVAGE	The ability of Tetra-O-methyl nordihydroguaiaretic acid (M4N) to induce rapid cell death in combination with Etoposide, Rapamycin, or UCN-01 was examined in LNCaP cells, both in cell culture and animal experiments. Mice treated with M4N drug combinations with either Etoposide or Rapamycin showed no evidence of tumor and had a 100% survival rate 100 days after tumor implantation. By comparison all other vehicles or single drug treated mice failed to survive longer than 30 days after implantation. This synergistic improvement of anticancer effect was also confirmed in more than 20 cancer cell lines. In LNCaP cells, M4N was found to reduce cellular ATP content, and suppress NDUFS1 expression while inducing hyperpolarization of mitochondrial membrane potential. M4N-treated cells lacked autophagy with reduced expression of BNIP3 and ATG5. To understand the mechanisms of this anticancer activity of M4N, the effect of this drug on three cancer cell lines (LNCaP, AsPC-1, and L428 cells) was further examined via transcriptome and metabolomics analyses. Metabolomic results showed that there were reductions of 26 metabolites essential for energy generation and/or production of cellular components in common with these three cell lines following 8 hours of M4N treatment. Deep RNA sequencing analysis demonstrated that there were sixteen genes whose expressions were found to be modulated following 6 hours of M4N treatment similarly in these three cell lines. Six out of these 16 genes were functionally related to the 26 metabolites described above. One of these up-regulated genes encodes for CHAC1, a key enzyme affecting the stress pathways through its degradation of glutathione. In fact M4N was found to suppress glutathione content and induce reactive oxygen species production. The data overall indicate that M4N has profound specific negative impacts on a wide range of cancer metabolisms supporting the use of M4N combination for cancer treatments.	[Kimura, Kotohiko; Huang, Ru Chih C.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Johns Hopkins University	Huang, RCC (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	rhuang@jhu.edu			National Institutes of Health [R01DE12165]; Biocuremedical, LLC; Dorothy Yen Trust [P690-C25-2407]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biocuremedical, LLC; Dorothy Yen Trust; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by grants from the National Institutes of Health (R01DE12165), Biocuremedical, LLC, and the Dorothy Yen Trust (P690-C25-2407) to RCH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinaga S, 2000, ANTI-CANCER DRUG DES, V15, P43; Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Arlt A, 2013, CANCER LETT, V332, P346, DOI 10.1016/j.canlet.2010.10.015; Balasubramanian MN, 2013, AM J PHYSIOL-ENDOC M, V304, pE789, DOI 10.1152/ajpendo.00015.2013; Beale EG, 2007, CELL BIOCHEM BIOPHYS, V48, P89, DOI 10.1007/s12013-007-0025-6; Beishline K, 2015, FEBS J, V282, P224, DOI 10.1111/febs.13148; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Ben-Sahra I, 2013, CELL DEATH DIFFER, V20, P611, DOI 10.1038/cdd.2012.157; Bonnefont Jean-Paul, 2004, Molecular Aspects of Medicine, V25, P495, DOI 10.1016/j.mam.2004.06.004; Boohaker RJ, 2011, AM J PHYSIOL-CELL PH, V300, pC1466, DOI 10.1152/ajpcell.00325.2010; Boucher D, 2012, P NATL ACAD SCI USA, V109, P5669, DOI 10.1073/pnas.1200934109; Cain DW, 2013, J IMMUNOL, V191, P4665, DOI 10.4049/jimmunol.1300581; Chang CC, 2004, P NATL ACAD SCI USA, V101, P13239, DOI 10.1073/pnas.0405407101; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Cheong H, 2012, NAT BIOTECHNOL, V30, P671, DOI 10.1038/nbt.2285; Chinnadurai G, 2008, ONCOGENE, V27, pS114, DOI 10.1038/onc.2009.49; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chua BT, 2000, J BIOL CHEM, V275, P5131, DOI 10.1074/jbc.275.7.5131; Dent P, 2011, MOL INTERV, V11, P133, DOI 10.1124/mi.11.2.11; Di Lisa F, 2009, J MOL CELL CARDIOL, V46, P775, DOI 10.1016/j.yjmcc.2009.03.006; Flaveny CA, 2015, CANCER CELL, V28, P42, DOI 10.1016/j.ccell.2015.05.007; Fruehauf JP, 2008, EXPERT REV ANTICANC, V8, P1751, DOI 10.1586/14737140.8.11.1751; Gafni J, 2009, J BIOL CHEM, V284, P25441, DOI 10.1074/jbc.M109.038174; Gergely P, 2002, J IMMUNOL, V169, P1092, DOI 10.4049/jimmunol.169.2.1092; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Glick D, 2012, MOL CELL BIOL, V32, P2570, DOI 10.1128/MCB.00167-12; Grossman SA, 2012, NEURO-ONCOLOGY, V14, P511, DOI 10.1093/neuonc/nor230; Gustafsson AB, 2011, PEDIATR CARDIOL, V32, P267, DOI 10.1007/s00246-010-9876-5; Hardie DG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-36; Heller JD, 2001, CANCER RES, V61, P5499; Huang RC, 2011, US Patent, Patent No. [0014192 A1, 0014192]; Huang RC, 2013, PCT/US13/24595, Patent No. 1324595; Huang SL, 2003, CANCER BIOL THER, V2, P222, DOI 10.4161/cbt.2.3.360; Hwu JR, 1998, J MED CHEM, V41, P2994, DOI 10.1021/jm970819w; Iuso A, 2006, J BIOL CHEM, V281, P10374, DOI 10.1074/jbc.M513387200; Joo NE, 2012, CANCER MED-US, V1, P295, DOI 10.1002/cam4.35; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kumar A, 2012, EMBO REP, V13, P1095, DOI 10.1038/embor.2012.156; Lambert JD, 2001, J CHROMATOGR B, V754, P85, DOI 10.1016/S0378-4347(00)00592-2; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Lopez RA, 2007, ANTI-CANCER DRUG, V18, P933; Lu JM, 2010, MED SCI MONITOR, V16, pRA93; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Manda G., 2009, CURR CHEM BIOL, V3, P22, DOI [10.2174/187231309787158271, DOI 10.2174/187231309787158271, DOI 10.2174/22127968109030]; Morales JC, 2014, CRIT REV EUKAR GENE, V24, P15, DOI 10.1615/CritRevEukaryotGeneExpr.2013006875; Mungrue IN, 2009, J IMMUNOL, V182, P466, DOI 10.4049/jimmunol.182.1.466; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; PARDINI RS, 1970, BIOCHEM PHARMACOL, V19, P2695, DOI 10.1016/0006-2952(70)90095-X; PARDINI RS, 1973, BIOCHEM PHARMACOL, V22, P1921, DOI 10.1016/0006-2952(73)90052-X; Park R, 2005, CLIN CANCER RES, V11, P4601, DOI 10.1158/1078-0432.CCR-04-2188; Pavlides S, 2010, CELL CYCLE, V9, P3485, DOI 10.4161/cc.9.17.12721; Porporato PE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00049; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Rutter J, 2010, MITOCHONDRION, V10, P393, DOI 10.1016/j.mito.2010.03.001; Ruzza P, 2009, ANTI-CANCER AGENT ME, V9, P763, DOI 10.2174/187152009789056895; Salani R, 2006, INT J GYNECOLOGIC S3, V16, P682; Schlaepfer IR, 2014, MOL CANCER THER, V13, P2361, DOI 10.1158/1535-7163.MCT-14-0183; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Spans L, 2012, PROSTATE, V72, P1317, DOI 10.1002/pros.22480; Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x; Tibes R, 2015, INVEST NEW DRUG, V33, P389, DOI 10.1007/s10637-014-0198-y; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Vanella A, 2000, CELL BIOL TOXICOL, V16, P99, DOI 10.1023/A:1007638025856; Wang LW, 2003, CLIN CANCER RES, V9, P6371; Wang XO, 1999, PROSTATE, V39, P182, DOI 10.1002/(SICI)1097-0045(19990515)39:3<182::AID-PROS6>3.0.CO;2-B; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Wlodkowic D, 2011, METHOD CELL BIOL, V103, P55, DOI 10.1016/B978-0-12-385493-3.00004-8; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16	76	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148685	10.1371/journal.pone.0148685	http://dx.doi.org/10.1371/journal.pone.0148685			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886430	gold, Green Published, Green Submitted			2022-12-27	WOS:000371218400043
J	Lee, IC; Chen, EE; Tsai, CH; Yen, NS; Chen, ALP; Lin, WC				Lee, I-Ching; Chen, Eva E.; Tsai, Chia-Hung; Yen, Nai-Shing; Chen, Arbee L. P.; Lin, Wei-Chieh			Voting Intention and Choices: Are Voters Always Rational and Deliberative?	PLOS ONE			English	Article							PARTY IDENTIFICATION; BOUNDED RATIONALITY; NETWORKS; ELECTION; MEDIA; PERSPECTIVE; INFORMATION; DYNAMICS; IDENTITY; IMPLICIT	Human rationality-the ability to behave in order to maximize the achievement of their presumed goals (i.e., their optimal choices)-is the foundation for democracy. Research evidence has suggested that voters may not make decisions after exhaustively processing relevant information; instead, our decision-making capacity may be restricted by our own biases and the environment. In this paper, we investigate the extent to which humans in a democratic society can be rational when making decisions in a serious, complex situation-voting in a local political election. We believe examining human rationality in a political election is important, because a well-functioning democracy rests largely upon the rational choices of individual voters. Previous research has shown that explicit political attitudes predict voting intention and choices (i.e., actual votes) in democratic societies, indicating that people are able to reason comprehensively when making voting decisions. Other work, though, has demonstrated that the attitudes of which we may not be aware, such as our implicit (e.g., subconscious) preferences, can predict voting choices, which may question the well-functioning democracy. In this study, we systematically examined predictors on voting intention and choices in the 2014 mayoral election in Taipei, Taiwan. Results indicate that explicit political party preferences had the largest impact on voting intention and choices. Moreover, implicit political party preferences interacted with explicit political party preferences in accounting for voting intention, and in turn predicted voting choices. Ethnic identity and perceived voting intention of significant others were found to predict voting choices, but not voting intention. In sum, to the comfort of democracy, voters appeared to engage mainly explicit, controlled processes in making their decisions; but findings on ethnic identity and perceived voting intention of significant others may suggest otherwise.	[Lee, I-Ching; Yen, Nai-Shing] Natl Chengchi Univ, Dept Psychol, 64 Chihnan Rd,Sec 2 Wenshan, Taipei 11623, Taiwan; [Lee, I-Ching; Yen, Nai-Shing] Natl Chengchi Univ, Res Ctr Mind Brain & Learning, 64 Chihnan Rd,Sec 2 Wenshan, Taipei 11623, Taiwan; [Chen, Eva E.] Hong Kong Univ Sci & Technol, Div Social Sci, Hong Kong, Hong Kong, Peoples R China; [Tsai, Chia-Hung] Natl Chengchi Univ, Elect Study Ctr, 64 Chihnan Rd,Sec 2 Wenshan, Taipei 11623, Taiwan; [Chen, Arbee L. P.] Asia Univ, Dept Comp Sci & Informat Engn, Taichung, Taiwan; [Lin, Wei-Chieh] Natl Chengchi Univ, Dept Comp Sci, 64 Chihnan Rd,Sec 2 Wenshan, Taipei 11623, Taiwan	National Chengchi University; National Chengchi University; Hong Kong University of Science & Technology; National Chengchi University; Asia University Taiwan; National Chengchi University	Lee, IC (corresponding author), Natl Chengchi Univ, Dept Psychol, 64 Chihnan Rd,Sec 2 Wenshan, Taipei 11623, Taiwan.; Lee, IC (corresponding author), Natl Chengchi Univ, Res Ctr Mind Brain & Learning, 64 Chihnan Rd,Sec 2 Wenshan, Taipei 11623, Taiwan.	iclee@nccu.edu.tw		Tsai, Chia-hung/0000-0002-0672-7783; Lee, I-Ching Lee/0000-0003-0520-4435	MOST [103-2221-E-004 -007 -MY3, 102-2420-H-004 -014 -MY3]; PLOS ONE; Research Center for Mind, Brain, and Learning at National Chengchi University	MOST(Ministry of Science & Technology (MOST), Republic of Korea); PLOS ONE; Research Center for Mind, Brain, and Learning at National Chengchi University	This work was supported by MOST 103-2221-E-004 -007 -MY3 to Dr. Arbee C. P. Chen in hiring WCL to assist with the project. It was also supported by MOST 102-2420-H-004 -014 -MY3 to Dr. Lee in hiring research assistants to do literature search and for the PLOS ONE publication fee. Financial assistance (no grant numbers were given) from the the Research Center for Mind, Brain, and Learning at National Chengchi University covered expanses for IRB approval and participants' incentives.	Achen CH, TAIWAN VOTE IN PRESS; ALDRICH JH, 1993, AM J POLIT SCI, V37, P246, DOI 10.2307/2111531; [Anonymous], 1997, ADM BEHAV; Bartels L.M., 2010, OXFORD HDB AM ELECTI, P1; Beck PA, 2002, AM POLIT SCI REV, V96, P57, DOI 10.1017/S0003055402004239; Campbell Angus., 1960, AM VOTER; Fischer-Neumann M, 2014, J ETHN MIGR STUD, V40, P339, DOI 10.1080/1369183X.2013.847362; Friese M, 2007, EXP PSYCHOL, V54, P247, DOI 10.1027/1618-3169.54.4.247; Galdi S, 2008, SCIENCE, V321, P1100, DOI 10.1126/science.1160769; Glasford DE, 2008, J APPL SOC PSYCHOL, V38, P2648, DOI 10.1111/j.1559-1816.2008.00408.x; Graves S, 2000, SOC SCI QUART, V81, P226; Hofstede G., 1998, MASCULINITY FEMININI; Hofstede G, GEERT HOFSTEDE TM CU; Hsieh JFS, 1996, INT POLIT SCI REV, V17, P13, DOI 10.1177/019251296017001002; HUCKFELDT R, 1987, AM POLIT SCI REV, V81, P1197, DOI 10.2307/1962585; Ikeda K, 2005, POLIT PSYCHOL, V26, P517, DOI 10.1111/j.1467-9221.2005.00429.x; Jackson MS, 2011, POLIT PSYCHOL, V32, P691, DOI 10.1111/j.1467-9221.2011.00823.x; Jang SJ, 2009, AM POLIT RES, V37, P879, DOI 10.1177/1532673X09332790; Jones BD, 1999, ANNU REV POLIT SCI, V2, P297, DOI 10.1146/annurev.polisci.2.1.297; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; KENNY C, 1993, AM POLIT QUART, V21, P223, DOI 10.1177/1532673X9302100204; KNOKE D, 1990, SOC FORCES, V68, P1041, DOI 10.2307/2579133; Li L, 2014, CHINA POST      0320; Lindenberg S, 1992, RATIONAL CHOICE THEO, P3; MILLER WE, 1991, AM POLIT SCI REV, V85, P557, DOI 10.2307/1963175; QUATTRONE GA, 1988, AM POLIT SCI REV, V82, P719, DOI 10.2307/1962487; Roccato M, 2010, POLIT PSYCHOL, V31, P249, DOI 10.1111/j.1467-9221.2009.00751.x; Schmitt-Beck R, 2003, BRIT J POLIT SCI, V33, P233, DOI 10.1017/S0007123403000103; Schmitt-Beck R, 2010, ELECT STUD, V29, P392, DOI 10.1016/j.electstud.2010.03.011; Simon B, 2001, AM PSYCHOL, V56, P319, DOI 10.1037//0003-066X.56.4.319; The Election Study Center of National Chengchi University, 2014, CHANG PART ID TAIW T; Tsai CH, 2008, J ASIAN AFR STUD, V43, P615, DOI [10.1177/0021909608096657, DOI 10.1177/0021909608096657]; Tsai CH, 2003, THESIS OHIO STATE U; Tsai CH, 2012, REV SOC SCI, V6, P35; Tsebelis G., 1990, NESTED GAMES RATIONA; Wang C, 2014, TAIPEI TIMES; Wu CL, 2010, TAIWAN DEMOCRACY Q, V7, P137; Zafirovski M, 1999, CURR SOCIOL, V47, P47, DOI [DOI 10.1177/0011392199047001005, 10.1177/0011392199047001005]	38	6	6	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148643	10.1371/journal.pone.0148643	http://dx.doi.org/10.1371/journal.pone.0148643			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3BJ	26886266	Green Published, Green Submitted, gold			2022-12-27	WOS:000371218400042
J	Long, LC; Fox, MP; Sauls, C; Evans, D; Sanne, I; Rosen, SB				Long, Lawrence C.; Fox, Matthew P.; Sauls, Celeste; Evans, Denise; Sanne, Ian; Rosen, Sydney B.			The High Cost of HIV-Positive Inpatient Care at an Urban Hospital in Johannesburg, South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; ADULTS; INFECTION; MORBIDITY; HIV/AIDS; DISEASE; IMPACT; SOWETO	Background While most HIV care is provided on an outpatient basis, hospitals continue to treat serious HIV-related admissions, which is relatively resource-intensive and expensive. This study reports the primary reasons for HIV-related admission at a regional, urban hospital in Johannesburg, South Africa and estimates the associated lengths of stay and costs. Methods and Findings A retrospective cohort study of adult, medical admissions was conducted. Each admission was assigned a reason for admission and an outcome. The length of stay was calculated for all patients (N = 1,041) and for HIV-positive patients (n = 469), actual utilization and associated costs were also estimated. Just under half were known to be HIV-positive admissions. Deaths and transfers were proportionately higher amongst HIV-positive admissions compared to HIV-negative and unknown. The three most common reasons for admission were tuberculosis and other mycobacterial infections (18%, n = 187), cardiovascular disorders (12%, n = 127) and bacterial infections (12%, n = 121). The study sample utilized a total of 7,733 bed days of those, 55% (4,259/7,733) were for HIV-positive patients. The average cost per admission amongst confirmed HIV-positive patients, which was an average of 9.3 days in length, was $1,783 (United States Dollars). Conclusions Even in the era of large-scale antiretroviral treatment, inpatient facilities in South Africa shoulder a significant HIV burden. The majority of this burden is related to patients not on ART (298/469, 64%), and accounts for more than half of all inpatient resources. Reducing the costs of inpatient care is thus another important benefit of expanding access to ART, promoting earlier ART initiation, and achieving rates of ART retention and adherence.	[Long, Lawrence C.; Fox, Matthew P.; Sauls, Celeste; Evans, Denise; Sanne, Ian; Rosen, Sydney B.] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Dept Internal Med, Johannesburg, South Africa; [Long, Lawrence C.; Fox, Matthew P.; Evans, Denise; Sanne, Ian] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Long, Lawrence C.; Fox, Matthew P.; Sauls, Celeste; Evans, Denise; Sanne, Ian; Rosen, Sydney B.] Wits Hlth Consortium, Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa; [Fox, Matthew P.; Sanne, Ian] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Fox, Matthew P.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; Boston University; Harvard University; Harvard T.H. Chan School of Public Health	Long, LC (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Dept Internal Med, Johannesburg, South Africa.; Long, LC (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa.; Long, LC (corresponding author), Wits Hlth Consortium, Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa.	llong@heroza.org	Fox, Matthew/K-2004-2019; Sanne, Ian/ABH-2231-2020	Rosen, Sydney/0000-0002-6560-2964; Long, Lawrence/0000-0003-4986-4988	United States Agency for International Development (USAID) [674-A-00-09-00018-00, 674-A-12-00029]; USAID [674-A-12-00029]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); USAID(United States Agency for International Development (USAID))	LCL, MPF, CS, DE, and SBR were funded for this work by United States Agency for International Development (USAID) through the following agreements: 674-A-00-09-00018-00 & 674-A-12-00029. IS was funded for this work by USAID through the following agreement: 674-A-12-00029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The author's views expressed in this publication do not necessarily reflect the views of the United States Agency for International Development or the United States Government.	Badri M, 2006, PLOS MED, V3, P48, DOI 10.1371/journal.pmed.0030004; Cleary SM, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000327621.24232.71; Cleary Susan M, 2006, Cost Eff Resour Alloc, V4, P20, DOI 10.1186/1478-7547-4-20; Colvin M, 2001, INT J STD AIDS, V12, P386, DOI 10.1258/0956462011923336; Corbett EL, 2002, CLIN INFECT DIS, V34, P1251, DOI 10.1086/339540; de Cherif TKS, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-205; Department of Public Service and Administration, 2013, SCAL TRANS KEYS EMPL; Floyd K, 1999, JAMA-J AM MED ASSOC, V282, P1087, DOI 10.1001/jama.282.11.1087; Gilks CF, 1998, J ACQ IMMUN DEF SYND, V18, P234, DOI 10.1097/00042560-199807010-00006; GOVENDER V, 2000, COSTS PERCEIVED QUAL; Harling G, 2007, JAIDS-J ACQ IMM DEF, V45, P348; HASSIG SE, 1990, AIDS, V4, P883, DOI 10.1097/00002030-199009000-00009; Kevany S, 2009, SAMJ S AFR MED J, V99, P320; Leisegang R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000189; Long L, 2010, AIDS, V24, P915, DOI 10.1097/QAD.0b013e3283360976; Martinson N, 2009, JAIDS-J ACQ IMM DEF, V50, P327, DOI 10.1097/QAI.0b013e3181958546; Massyn N, 2013, DISTRICT HLTH BAROME; Meyer-Rath G, NATL ART COST MODEL; Meyer-Rath G, 2013, JAIDS-J ACQ IMM DEF, V62, P322, DOI 10.1097/QAI.0b013e31827e8785; Meyer-Rath G, 2013, AIDS, V27, P243, DOI 10.1097/QAD.0b013e32835a5b92; Meyer-Rath G, 2012, JAIDS-J ACQ IMM DEF, V61, pE25, DOI 10.1097/QAI.0b013e31826cc575; Pfuntner A., 2013, MOST FREQUENT CONDIT; Rosen S, 2008, TROP MED INT HEALTH, V13, P1005, DOI 10.1111/j.1365-3156.2008.02114.x; Shisana O, 2014, S AFRICAN NATL HIV P; TEMBO G, 1994, AIDS, V8, P1169, DOI 10.1097/00002030-199408000-00021; Thomas LS, 2007, JAIDS-J ACQ IMM DEF, V46, P410, DOI 10.1097/QAI.0b013e318156ec90; UNAIDS, 2014, GAP REP; Walensky RP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000382; Wilkinson D, 1999, INT J STD AIDS, V10, P735, DOI 10.1258/0956462991913439; Winter J, 2015, ADMITTED PATIENT CAR	30	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148546	10.1371/journal.pone.0148546	http://dx.doi.org/10.1371/journal.pone.0148546			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885977	Green Published, Green Submitted, gold			2022-12-27	WOS:000371218400039
J	Szabo-Rogers, H; Yakob, W; Liu, KJ				Szabo-Rogers, Heather; Yakob, Wardati; Liu, Karen J.			Frontal Bone Insufficiency in Gsk3 beta Mutant Mice	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; EPITHELIAL-MESENCHYMAL TRANSITION; CUBITUS INTERRUPTUS; BETA-CATENIN; CANCER CELLS; NEURAL-TUBE; SKULL VAULT; DIFFERENTIATION; TWIST; MORPHOGENESIS	The development of the mammalian skull is a complex process that requires multiple tissue interactions and a balance of growth and differentiation. Disrupting this balance can lead to changes in the shape and size of skull bones, which can have serious clinical implications. For example, insufficient ossification of the bony elements leads to enlarged anterior fontanelles and reduced mechanical protection of the brain. In this report, we find that loss of Gsk3 beta leads to a fully penetrant reduction of frontal bone size and subsequent enlarged frontal fontanelle. In the absence of Gsk3 beta the frontal bone primordium undergoes increased cell death and reduced proliferation with a concomitant increase in Fgfr2-IIIc and Twist1 expression. This leads to a smaller condensation and premature differentiation. This phenotype appears to be Wnt-independent and is not rescued by decreasing the genetic dose of beta-catenin/Ctnnb1. Taken together, our work defines a novel role for Gsk3 beta in skull development.	[Szabo-Rogers, Heather; Yakob, Wardati; Liu, Karen J.] Kings Coll London, Craniofacial Dev & Stem Cell Biol, Floor 27,Tower Wing,Guys Campus, London SE1 9RT, England; [Szabo-Rogers, Heather] Univ Pittsburgh, Dept Dev Biol, Dept Oral Biol, Ctr Craniofacial Regenerat, Pittsburgh, PA 15261 USA; [Yakob, Wardati] Minist Hlth, Dept Dent Serv, Negara, Brunei	University of London; King's College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Liu, KJ (corresponding author), Kings Coll London, Craniofacial Dev & Stem Cell Biol, Floor 27,Tower Wing,Guys Campus, London SE1 9RT, England.	karen.liu@kcl.ac.uk	Liu, Karen/F-2870-2010	Liu, Karen/0000-0002-2483-2165; Szabo-Rogers, Heather/0000-0002-7921-8031	Wellcome Trust [081880/Z/06/Z]; Biotechnology and Biological Sciences Research Council [BB/I021922/1, BB/E013872/1]; BBSRC [BB/I021922/1, BB/E013872/1]; MRC [MR/L017237/1]; Medical Research Council [MR/L017237/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding for this project was provided to KJL by the Wellcome Trust (081880/Z/06/Z, http://www.wellcome.ac.uk/) and the Biotechnology and Biological Sciences Research Council (BB/I021922/1 and BB/E013872/1, http://www.bbsrc.ac.uk/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Jacqui Tabler for critical reading of the manuscript. We would also like to thank members of the Liu lab and the Department of Craniofacial Development and Stem Cell Biology for helpful discussions, with particular thanks to Triona Bolger and Jacqui Tabler for their enthusiasm. Funding for this project was provided by the Wellcome Trust (081880/Z/06/Z), the BBSRC (BB/I021922/1 and BB/E013872/1) and the MRC (MR/L017237/1).	Alliman S, 2010, CLIN GENET, V78, P162, DOI 10.1111/j.1399-0004.2010.01373.x; Ashique AM, 2002, INT J DEV BIOL, V46, P243; Barrell WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050422; Behr B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070240; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Bildsoe H, 2009, DEV BIOL, V331, P176, DOI 10.1016/j.ydbio.2009.04.034; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Connerney J, 2008, DEV BIOL, V318, P323, DOI 10.1016/j.ydbio.2008.03.037; Connerney J, 2006, DEV DYNAM, V235, P1345, DOI 10.1002/dvdy.20717; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; FUCHTBAUER EM, 1995, DEV DYNAM, V204, P316; Gillespie JR, 2013, ENDOCRINOLOGY, V154, P3702, DOI 10.1210/en.2013-1155; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Goodnough LH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004152; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ishii M, 2003, DEVELOPMENT, V130, P6131, DOI 10.1242/dev.00793; Jia JH, 2002, NATURE, V416, P548, DOI 10.1038/nature733; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; Johnson D, 2011, EUR J HUM GENET, V19, P369, DOI 10.1038/ejhg.2010.235; Kerkela R, 2008, J CLIN INVEST, V118, P3609, DOI 10.1172/JCI36245; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Kress W, 2006, EUR J HUM GENET, V14, P39, DOI 10.1038/sj.ejhg.5201507; Kugimiya F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000837; Lander R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2543; Lewandoski M, 1997, NAT GENET, V17, P223, DOI 10.1038/ng1097-223; Liberman Z, 2005, J BIOL CHEM, V280, P4422, DOI 10.1074/jbc.M410610200; Liu B, 2007, DEV BIOL, V301, P298, DOI 10.1016/j.ydbio.2006.10.018; Liu KJ, 2007, NATURE, V446, P79, DOI 10.1038/nature05557; MacAulay K, 2007, CELL METAB, V6, P329, DOI 10.1016/j.cmet.2007.08.013; Murray SA, 2006, CELL CYCLE, V5, P2566, DOI 10.4161/cc.5.22.3502; Murray SA, 2006, P NATL ACAD SCI USA, V103, P10300, DOI 10.1073/pnas.0602234103; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Reimao R, 2003, PEDIATR NEUROL, V29, P341, DOI 10.1016/S0887-8994(03)00279-0; Richtsmeier JT, 2013, ACTA NEUROPATHOL, V125, P469, DOI 10.1007/s00401-013-1104-y; Saito H, 2012, DIS MODEL MECH, V5, P948, DOI 10.1242/dmm.009274; Soo K, 2002, DEV BIOL, V247, P251, DOI 10.1006/dbio.2002.0699; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stankunas K, 2003, MOL CELL, V12, P1615, DOI 10.1016/S1097-2765(03)00491-X; SUN JK, 1995, RADIOLOGY, V197, P497, DOI 10.1148/radiology.197.2.7480701; Surjit M, 2007, CELL CYCLE, V6, P580, DOI 10.4161/cc.6.5.3899; Szabo-Rogers HL, 2008, DEV BIOL, V318, P289, DOI 10.1016/j.ydbio.2008.03.027; Tabler JM, 2013, DEV CELL, V25, P623, DOI 10.1016/j.devcel.2013.05.021; Thomas BL, 1998, EUR J ORAL SCI, V106, P48, DOI 10.1111/j.1600-0722.1998.tb02153.x; Ting MC, 2009, DEVELOPMENT, V136, P855, DOI 10.1242/dev.028605; Wang Q, 2008, CELL DEATH DIFFER, V15, P908, DOI 10.1038/cdd.2008.2; Winslow MM, 2006, DEV CELL, V10, P771, DOI 10.1016/j.devcel.2006.04.006; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Wuyts W, 2000, HUM MOL GENET, V9, P1251, DOI 10.1093/hmg/9.8.1251; Yaguchi Y, 2009, DEV DYNAM, V238, P2058, DOI 10.1002/dvdy.22013; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Yoshida Toshiyuki, 2005, Kokubyo Gakkai Zasshi, V72, P19; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007; Yu HMI, 2005, DEVELOPMENT, V132, P1995, DOI 10.1242/dev.01786; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Zhou XP, 2001, AM J HUM GENET, V69, P704, DOI 10.1086/323703	60	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149604	10.1371/journal.pone.0149604	http://dx.doi.org/10.1371/journal.pone.0149604			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886780	Green Published, gold, Green Submitted			2022-12-27	WOS:000371218400100
J	Virlogeux, V; Yang, J; Fang, VJ; Feng, LZ; Tsang, TK; Jiang, H; Wu, P; Zheng, JD; Lau, EHY; Qin, Y; Peng, ZB; Peiris, JSM; Yu, HJ; Cowling, BJ				Virlogeux, Victor; Yang, Juan; Fang, Vicky J.; Feng, Luzhao; Tsang, Tim K.; Jiang, Hui; Wu, Peng; Zheng, Jiandong; Lau, Eric H. Y.; Qin, Ying; Peng, Zhibin; Peiris, J. S. Malik; Yu, Hongjie; Cowling, Benjamin J.			Association between the Severity of Influenza A(H7N9) Virus Infections and Length of the Incubation Period	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; A H7N9; CORONAVIRUS	Background In early 2013, a novel avian-origin influenza A(H7N9) virus emerged in China, and has caused sporadic human infections. The incubation period is the delay from infection until onset of symptoms, and varies from person to person. Few previous studies have examined whether the duration of the incubation period correlates with subsequent disease severity. Methods and Findings We analyzed data of period of exposure on 395 human cases of laboratory-confirmed influenza A(H7N9) virus infection in China in a Bayesian framework using a Weibull distribution. We found a longer incubation period for the 173 fatal cases with a mean of 3.7 days (95% credibility interval, CrI: 3.4-4.1), compared to a mean of 3.3 days (95% CrI: 2.9-3.6) for the 222 non-fatal cases, and the difference in means was marginally significant at 0.47 days (95% CrI: -0.04, 0.99). There was a statistically significant correlation between a longer incubation period and an increased risk of death after adjustment for age, sex, geographical location and underlying medical conditions (adjusted odds ratio 1.70 per day increase in incubation period; 95% credibility interval 1.47-1.97). Conclusions We found a significant association between a longer incubation period and a greater risk of death among human H7N9 cases. The underlying biological mechanisms leading to this association deserve further exploration.	[Virlogeux, Victor] Ecole Normale Super Lyon, Dept Biol, 15 Parvis Rene Descartes, F-69007 Lyon, France; [Virlogeux, Victor; Fang, Vicky J.; Tsang, Tim K.; Wu, Peng; Lau, Eric H. Y.; Peiris, J. S. Malik; Cowling, Benjamin J.] Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, 21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China; [Yang, Juan; Feng, Luzhao; Jiang, Hui; Zheng, Jiandong; Qin, Ying; Peng, Zhibin; Yu, Hongjie] Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, 155 Changbai Rd, Beijing 102206, Peoples R China	Ecole Normale Superieure de Lyon (ENS de LYON); University of Hong Kong; World Health Organization; Chinese Center for Disease Control & Prevention	Yu, HJ (corresponding author), Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, 155 Changbai Rd, Beijing 102206, Peoples R China.	yuhj@chinacdc.cn	Cowling, Benjamin John/C-4263-2009; Yu, Hongjie/GZK-5351-2022; Lau, Eric/AAJ-6588-2021; Peiris, Joseph Sriyal Malik/C-4380-2009	Cowling, Benjamin John/0000-0002-6297-7154; Lau, Eric/0000-0002-6688-9637; Tsang, Tim Kam Lun/0000-0001-5037-6776; Wu, Peng/0000-0003-1157-9401; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Yang, Juan/0000-0001-5028-2227	Ministry of Science and Technology of China [2014BAI13B05]; US National Institutes of Health [U19 AI51915]; Program for Changjiang Scholars, Ministry of Education of the People's Republic of China; Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences [U54 GM088558]; Health and Medical Research Fund of the Health, Welfare and Food Bureau of the Hong Kong SAR Government; Research Grants Council of the Hong Kong Special Administrative Region, China [T11-705/14N];  [81525023]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Program for Changjiang Scholars, Ministry of Education of the People's Republic of China; Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences; Health and Medical Research Fund of the Health, Welfare and Food Bureau of the Hong Kong SAR Government; Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by grants from the Ministry of Science and Technology of China (2014BAI13B05)(http://www.most.gov.cn/eng/) (HJY), the US National Institutes of Health (Comprehensive International Program for Research on AIDS grant U19 AI51915) (http://nih.gov/)(HJY), Distinguished Young Scholars (81525023)(http://www.nsfc.gov.cn/publish/portal1/) (HJY), Program for Changjiang Scholars, Ministry of Education of the People's Republic of China (http://en.moe.gov.cn/)(HJY), the Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences (grant no. U54 GM088558)(http://www.nigms.nih.gov/Pages/default.aspx)(BJC), a commissioned grant from the Health and Medical Research Fund of the Health, Welfare and Food Bureau of the Hong Kong SAR Government (http://rfs1.fhb.gov.hk/), and the Research Grants Council of the Hong Kong Special Administrative Region (http://www.ugc.edu.hk/eng/rgc/index.htm), China (Project No. T11-705/14N) (BJC). The funding bodies had no role in study design, data collection and analysis, preparation of the manuscript, or the decision to publish.	Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cowling BJ, 2007, EPIDEMIOLOGY, V18, P253, DOI 10.1097/01.ede.0000254660.07942.fb; Cowling BJ, 2013, LANCET, V382, P129, DOI 10.1016/S0140-6736(13)61171-X; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; de Wilde AH, 2013, J GEN VIROL, V94, P1749, DOI 10.1099/vir.0.052910-0; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Ho MS, 2005, EMERG INFECT DIS, V11, P1730, DOI 10.3201/eid1111.040659; Hui DS, 2014, CURR OPIN PULM MED, V20, P233, DOI 10.1097/MCP.0000000000000046; Josset L, 2013, MBIO, V4, DOI 10.1128/mBio.00165-13; Kindler E, 2013, MBIO, V4, DOI 10.1128/mBio.00611-12; Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Meliopoulos VA, 2014, J VIROL, V88, P12982, DOI 10.1128/JVI.01571-14; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; Peiris M, 2006, NOVART FDN SYMP, V279, P60; Peiris M, 2006, NOVART FDN SYMP, V279, P216; Peiris Malik, 2006, Novartis Found Symp, V279, P56; van den Brand JMA, 2015, J PATHOL, V235, P175, DOI 10.1002/path.4458; Virlogeux V, 2016, EMERG INFECT DIS, V22, P526, DOI 10.3201/eid2203.151437; Virlogeux V, 2015, AM J EPIDEMIOL, V182, P723, DOI 10.1093/aje/kwv115; Virlogeux V, 2015, EPIDEMIOLOGY, V26, P666, DOI 10.1097/EDE.0000000000000339; Zielecki F, 2013, J VIROL, V87, P5300, DOI 10.1128/JVI.03496-12	22	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148506	10.1371/journal.pone.0148506	http://dx.doi.org/10.1371/journal.pone.0148506			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885816	Green Published, gold			2022-12-27	WOS:000371218400038
J	Kaur, K; Jansen, PA; Aspehaug, VT; Horsberg, TE				Kaur, Kiranpreet; Jansen, Peder Andreas; Aspehaug, Vidar Teis; Horsberg, Tor Einar			Phe362Tyr in AChE: A Major Factor Responsible for Azamethiphos Resistance in Lepeophtheirus salmonis in Norway	PLOS ONE			English	Article							INSECTICIDE RESISTANCE; SEA LICE; MUTATIONS; BIOASSAY	Organophosphates (OP) are one of the major treatments used against the salmon louse (Lepeophtherius salmonis) in Norwegian salmonid aquaculture. The use of OP since the late 1970s has resulted in widespread resistant parasites. Recently, we reported a single mutation (Phe362Tyr) in acetylcholinesterase (AChE) as the major mechanism behind resistance in salmon louse towards OP. The present study was carried out to validate this mechanism at the field level. A total of 6658 salmon louse samples were enrolled from 56 different fish farms across the Norwegian coast, from Vest Agder in the south to Finnmark in the north. All the samples were genotyped using a TaqMan probe assay for the Phe362Tyr mutation. A strong association was observed between areas with frequent use of the OP (azamethiphos) and the Phe362Tyr mutation. This was confirmed at 15 sites where results from independently conducted bioassays and genotyping of parasites correlated well. Furthermore, genotyping of surviving and moribund parasites from six bioassay experiments demonstrated a highly significant negative correlation between the frequency of resistance alleles and the probability of dying when exposed to azamethiphos in a bioassay. Based on these observations, we could strongly conclude that the Phe362Tyr mutation is a major factor responsible for OP resistance in salmon louse on Norwegian fish farms.	[Kaur, Kiranpreet; Horsberg, Tor Einar] NMBU Sch Vet Sci, Sea Lice Res Ctr, POB 8146 Dept, NO-0033 Oslo, Norway; [Jansen, Peder Andreas] Norwegian Vet Inst, Pb 750, N-0106 Oslo, Norway; [Aspehaug, Vidar Teis] PatoGen Anal AS, Postboks 1527, N-6025 Alesund, Norway	Norwegian University of Life Sciences; Norwegian Veterinary Institute	Kaur, K (corresponding author), NMBU Sch Vet Sci, Sea Lice Res Ctr, POB 8146 Dept, NO-0033 Oslo, Norway.	kiran.kaur@nmbu.no	Kaur, Kiran/R-3535-2018	Kaur, Kiran/0000-0002-7285-5513	Norwegian Research Council through the centre for Innovation Sea Lice Research Centre [NFR 203513/O30]	Norwegian Research Council through the centre for Innovation Sea Lice Research Centre	The study was financially supported by the Norwegian Research Council through the centre for Innovation Sea Lice Research Centre, grant number NFR 203513/O30. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This funding organisation did not play any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript and provided only financial support in the form of salaries to Kiranpreet Kaur and Tor Einar Horsberg. The specific roles of all the authors are articulated in the 'author contributions' section. One of the authors of the study is from a commercial company called PatoGen Analyse AS, who contributed in sample collection, running of TaqMan Probe assay and compilation of data for analysis. Moreover, this author did not play any role in the study design, statistical data analysis or the decision to publish.	Aaen SM, 2015, TRENDS PARASITOL, V31, P72, DOI 10.1016/j.pt.2014.12.006; Bass C, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-51; Cleveland W. S., 1992, LOCAL REGRESSION MOD, DOI 10.1201/9780203738535; Denholm I, 2002, PEST MANAG SCI, V58, P528, DOI 10.1002/ps.482; Dohoo I., 2003, VET EPIDEMIOLOGY RES; Grave K, 2004, DIS AQUAT ORGAN, V60, P123, DOI 10.3354/dao060123; GRAVE K, 1991, ACTA VET SCAND, V32, P1; Grontvedt RN, 2015, ANN REPORT 2014 NORW; Helgesen KO, 2014, J FISH DIS, V37, P877, DOI 10.1111/jfd.12223; Helgesen KO, 2013, J FISH DIS, V36, P261, DOI 10.1111/jfd.12053; Hotelier T, 2010, J PESTIC SCI, V35, P315, DOI 10.1584/jpestics.R10-10; Jansen PA, 2015, PLOS ONE UNPUB; Kaur K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125362; Kaur K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124220; Kristoffersen AB, 2013, PREV VET MED, V109, P136, DOI 10.1016/j.prevetmed.2012.08.012; Naerings og fiskeridepartementet, FORSKR BEKJ LAKS AKV; R Core Team, 2020, R LANG ENV STAT COMP; Shi MA, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-5; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b	19	21	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149264	10.1371/journal.pone.0149264	http://dx.doi.org/10.1371/journal.pone.0149264			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882536	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000371219000064
J	Li, F; Shen, KX; Long, XL; Wen, JS; Xie, XJ; Zeng, XY; Liang, YY; Wei, YS; Lin, ZF; Huang, WR; Zhong, RD				Li, Feng; Shen, Kaixuan; Long, Xiaolin; Wen, Jiasheng; Xie, Xiaojie; Zeng, Xiangyun; Liang, Yanyan; Wei, Yansha; Lin, Zefeng; Huang, Wenrou; Zhong, Ruida			Preparation and Characterization of Biochars from Eichornia crassipes for Cadmium Removal in Aqueous Solutions	PLOS ONE			English	Article							POTENTIAL USE; IMPACT; MECHANISMS; IMMOBILIZATION; ADSORPTION; PERTINENT; CU(II); CD(II); WATER	The study investigated the preparation and characterization of biochars from water hyacinth at 300 degrees C to 700 degrees C for cadmium (Cd) removal from aqueous solutions. The adsorption process was dominated by oxygen-containing functional groups with irregular surfaces via esterification reactions. Furthermore, the mineral components in the biochars also contributed to Cd absorption through precipitation. Parameters such as the effects of solution pH, contact time, and initial concentration were studied. The optimum pH value was observed at 5.0, in which nearly 90% of Cd was removed. The maximum Cd adsorption capacities based on the Langmuir isotherm were calculated at 49.837, 36.899, and 25.826 mg g(-1). The adsorption processes of the biochars followed the pseudo-second-order kinetics, with the equilibrium achieved around 5 h. The biochar from E. crassipes is a promising adsorbent for the treatment of wastewater, which can in turn convert one environmental problem to a new cleaning Technology.	[Li, Feng; Shen, Kaixuan; Long, Xiaolin; Wen, Jiasheng; Xie, Xiaojie; Zeng, Xiangyun; Liang, Yanyan; Wei, Yansha; Lin, Zefeng; Huang, Wenrou; Zhong, Ruida] S China Univ Technol, Sch Civil Engn, Guangzhou 510640, Guangdong, Peoples R China; [Li, Feng] S China Univ Technol, State Key Lab Subtrop Bldg Sci, Guangzhou 510640, Guangdong, Peoples R China	South China University of Technology; South China University of Technology	Li, F (corresponding author), S China Univ Technol, Sch Civil Engn, Guangzhou 510640, Guangdong, Peoples R China.; Li, F (corresponding author), S China Univ Technol, State Key Lab Subtrop Bldg Sci, Guangzhou 510640, Guangdong, Peoples R China.	hjlifeng@scut.edu.cn			China Geological Survey [1212010914020]; National Natural Science Foundation of China [41001341]; Fundamental Research Funds for the Central Universities [2014ZZ0012]; National Natural Science Foundation of China (NSFC); Fundamental Research Funds for the Central Universities (FRFC); Ministry of Education; South China University of Technology; Guangdong Province [2012B091100143, 2013B090500022]; China Ministry of education [2012B091100143, 2013B090500022]; Science and Technology Planning Project of Dongguan City [2014108101042]; Baibuti Project of SCUT [DA20315001]; Student Research Project of SCUT [105612015S586]	China Geological Survey(China Geological Survey); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities (FRFC); Ministry of Education; South China University of Technology; Guangdong Province; China Ministry of education(Ministry of Education, China); Science and Technology Planning Project of Dongguan City; Baibuti Project of SCUT; Student Research Project of SCUT	This study was founded by the projects of China Geological Survey (Grant No. 1212010914020), National Natural Science Foundation of China (Grant No. 41001341), and the Fundamental Research Funds for the Central Universities (Grant No. 2014ZZ0012). National Natural Science Foundation of China (NSFC) is the most important funding agency of creative basic research. The URL of NSFC's web site is (http://www.nsfc.gov.cn/Portal0/default152.htm). The Fundamental Research Funds for the Central Universities (FRFC) has established by state educational ministry of china, and the main goal is to support the basic research. Research funds of FRFC are allocated by central universities (That is, the universities directly under the Ministry of Education, including South China University of Technology). The URL of web sites related to FRFC: The department of science & technology, Ministry of Education of the People's Republic of China (http://www.dost.moe.edu.cn/dostmoe) (http://www.dost.moe.edu.cn/dostmoe/tzgg/zxtz/20120416112009). The department of science & technology, South China University of Technology (http://www2.scut.edu.cn/science) (http://www2.scut.edu.cn/s/41/t/18/51/71/info86385.htm). The projects of China Geological Survey (http://www.cgs.gov.cn/gzdt/gzdongtai/19910.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was funded by the projects of National Natural Science Foundation of China (Grant No.41001341), the Fundamental Research Funds for the Central Universities (Grant No. 2014ZZ0012), the joint funding research project by Guangdong Province and China Ministry of education (Grant No. 2012B091100143, 2013B090500022), Science and Technology Planning Project of Dongguan City (2014108101042), Baibuti Project of SCUT (DA20315001), and Student Research Project of SCUT (105612015S586)	Atkinson CJ, 2010, PLANT SOIL, V337, P1, DOI 10.1007/s11104-010-0464-5; Beesley L, 2011, ENVIRON POLLUT, V159, P474, DOI 10.1016/j.envpol.2010.10.016; Cantrell KB, 2012, BIORESOURCE TECHNOL, V107, P419, DOI 10.1016/j.biortech.2011.11.084; Cao XD, 2010, BIORESOURCE TECHNOL, V101, P5222, DOI 10.1016/j.biortech.2010.02.052; Chen T, 2015, CHEMOSPHERE, V134, P286, DOI 10.1016/j.chemosphere.2015.04.052; Dong XL, 2011, J HAZARD MATER, V190, P909, DOI 10.1016/j.jhazmat.2011.04.008; Gai XP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0113888, 10.1371/journal.pone.0097730]; Gilbert UA, 2011, BIOMASS BIOENERG, V35, P2517, DOI 10.1016/j.biombioe.2011.02.024; Gurwick NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075932; Ho YS, 2006, BIOCHEM ENG J, V30, P117, DOI 10.1016/j.bej.2006.02.012; Lehmann J, 2009, EARTHSCAN, DOI [10.4324/9780203762264, DOI 10.4324/9780203762264]; Liu ZG, 2009, J HAZARD MATER, V167, P933, DOI 10.1016/j.jhazmat.2009.01.085; Masto RE, 2013, CATENA, V111, P64, DOI 10.1016/j.catena.2013.06.025; Meng J, 2014, ENVIRON SCI POLLUT R, V21, P7035, DOI 10.1007/s11356-014-2627-z; Mohan D, 2014, BIORESOURCE TECHNOL, V160, P191, DOI 10.1016/j.biortech.2014.01.120; Mohan D, 2014, CHEM ENG J, V236, P513, DOI 10.1016/j.cej.2013.09.057; Patel S, 2012, REV ENVIRON SCI BIO, V11, P249, DOI 10.1007/s11157-012-9289-4; Roh H, 2015, J IND ENG CHEM, V26, P226, DOI 10.1016/j.jiec.2014.11.034; Ruiz Tellez T., 2008, Aquatic Invasions, V3, P42, DOI 10.3391/ai.2008.3.1.8; Su Q, 2010, J COLLOID INTERF SCI, V349, P607, DOI 10.1016/j.jcis.2010.05.052; Sun K, 2013, ENVIRON SCI TECHNOL, V47, P11473, DOI 10.1021/es4026744; Tan XF, 2015, ENVIRON SCI POLLUT R, V22, P12597, DOI 10.1007/s11356-015-4523-6; Tsai WT, 2012, CHEMOSPHERE, V89, P198, DOI 10.1016/j.chemosphere.2012.05.085; Uchimiya M, 2010, J AGR FOOD CHEM, V58, P5538, DOI 10.1021/jf9044217; Wang HY, 2015, BIORESOURCE TECHNOL, V197, P356, DOI 10.1016/j.biortech.2015.08.132; Xu XY, 2013, ENVIRON SCI POLLUT R, V20, P358, DOI 10.1007/s11356-012-0873-5	26	46	49	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148132	10.1371/journal.pone.0148132	http://dx.doi.org/10.1371/journal.pone.0148132			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882239	Green Published, Green Submitted, gold			2022-12-27	WOS:000371219000012
J	Prazuck, T; Karon, S; Gubavu, C; Andre, J; Legall, JM; Bouvet, E; Kreplak, G; Teglas, JP; Pialoux, G				Prazuck, Thierry; Karon, Stephen; Gubavu, Camelia; Andre, Jerome; Legall, Jean Marie; Bouvet, Elisabeth; Kreplak, Georges; Teglas, Jean Paul; Pialoux, Gilles			A Finger-Stick Whole-Blood HIV Self-Test as an HIV Screening Tool Adapted to the General Public	PLOS ONE			English	Article							COLLECTION; INFECTION; POLICY; RISK	Background In 2013, the French Health Authority approved the use of HIV self-tests in pharmacies for the general public. This screening tool will allow an increase in the number of screenings and a reduction in the delay between infection and diagnosis, thus reducing the risk of further infections. We previously compared 5 HIV-self test candidates (4 oral fluid and one whole blood) and demonstrated that the whole blood HIV test exhibited the optimal level of performance (sensitivity/specificity). We studied the practicability of an easy-to-use finger-stick whole blood HIV self-test "autotest VIH (R)", when used in the general public. Methods and Materials This multicenter cross-sectional study involved 411 participants from the Parisian region (AIDES and HF association) between April and July 2014 and was divided into 2 separate studies: one evaluating the capability of participants to obtain an interpretable result using only the information notice, and a second evaluating the interpretation of test results, using a provided chart. Results A total of 411 consenting participants, 264 in the first study and 147 in the second, were included. All participants were over 18 years of age. In the first study, 99.2% of the 264 participants correctly administered the auto-test, and 21.2% needed, upon their request, telephone assistance. Ninety-two percent of participants responded that the test was easy/very easy to perform, and 93.5% did not find any difficulty obtaining a sufficient good quantity of blood. In the second study, 98.1% of the 147 participants correctly interpreted the results. The reading/interpretation errors concerned the negative (2.1%) or the indeterminate (3.3%) auto-tests. Conclusions The success rate of handling and interpretation of this self-test is very satisfactory, demonstrating its potential for use by the general public and its utility to increase the number of opportunities to detect HIV patients.	[Prazuck, Thierry; Karon, Stephen; Gubavu, Camelia] Ctr Hosp Reg, Dept Infect Dis, Orleans, France; [Andre, Jerome] HF Prevent, Trappes, France; [Legall, Jean Marie] Aides, Paris, France; [Bouvet, Elisabeth] Hop Univ Bichat Claude Bernard, Dept Infect Dis, Paris, France; [Kreplak, Georges] CBCV, Paris, France; [Teglas, Jean Paul] Hop Kremlin Bicetre, INSERM, INED, U822, Le Kremlin Bicetre, France; [Pialoux, Gilles] Hop Tenon, Dept Infect Dis, F-75970 Paris, France	Centre Hospitalier Annecy Genevois; Centre Hospitalier Regional d'Orleans; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Prazuck, T (corresponding author), Ctr Hosp Reg, Dept Infect Dis, Orleans, France.	thierry.prazuck@chr-orleans.fr			CHR Orleans	CHR Orleans	The study was sponsored by the public hospital (CHR Orleans) without a grant from pharmaceutical companies. No grant was received from the HIV test manufacturer.	[Anonymous], CMAJ, V162, P1545; [Anonymous], INF REG HOM ACC HIV; [Anonymous], CMAJ, V162, P1547; Cazein F, 2014, B EPIDEMIOLOGIQUE HE, V9-10, P154; Colfax GN, 2002, AIDS CARE, V14, P675, DOI 10.1080/0954012021000005533a; Conseil national du sida, 2012, AV AUT DEP INF VIH; Delpierre C, 2006, AIDS PATIENT CARE ST, V20, P838, DOI 10.1089/apc.2006.20.838; Figueroa C, 2015, AIDS BEHAV; Frith L, 2007, LANCET, V369, P243, DOI 10.1016/S0140-6736(07)60113-5; Jaspard M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101148; Katz D, 2012, C RETR OPP INF CROI; Krause J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-735; Mayer K., 2014, AIDS 2014; Ochako R, 2014, INSIGHTS POTENTIAL U; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Pai NP, 2012, LANCET INFECT DIS, V12, P373, DOI 10.1016/S1473-3099(11)70368-1; Peck RB, 2014, AIDS BEHAV, V18, pS422, DOI 10.1007/s10461-014-0818-8; Richter ML, 2012, S AFR J HIV MED, P186, DOI 10.7196/SAJHIVMED.858; Spielberg F, 2004, LANCET INFECT DIS, V4, P640, DOI 10.1016/S1473-3099(04)01150-8; Spielberg F, 2001, SEX TRANSM DIS, V28, P51, DOI 10.1097/00007435-200101000-00012	20	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0146755	10.1371/journal.pone.0146755	http://dx.doi.org/10.1371/journal.pone.0146755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882229	Green Submitted, Green Published, gold			2022-12-27	WOS:000371219000002
J	Alves, KA; Alves, BG; Gastal, GDA; de Tarso, SGS; Gastal, MO; Figueiredo, JR; Gambarini, ML; Gastal, EL				Alves, Kele A.; Alves, Benner G.; Gastal, Gustavo D. A.; de Tarso, Saulo G. S.; Gastal, Melba O.; Figueiredo, Jose R.; Gambarini, Maria L.; Gastal, Eduardo L.			The Mare Model to Study the Effects of Ovarian Dynamics on Preantral Follicle Features	PLOS ONE			English	Article							PRIMORDIAL FOLLICLES; IN-VITRO; DOMINANT FOLLICLE; CELL-INTERACTIONS; BIOPSY; GROWTH; BOVINE; DENSITY; MORPHOLOGY; ENDOCRINE	Ovarian tissue collected by biopsy procedures allows the performance ofmany studies with clinical applications in the field of female fertility preservation. The aim of the present study was to investigate the influence of reproductive phase (anestrous vs. diestrous) and ovarian structures (antral follicles and corpus luteum) on the quality, class distribution, number, and density of preantral follicles, and stromal cell density. Ovarian fragments were harvested by biopsy pick-up procedures from mares and submitted to histological analysis. Themean preantral follicle and ovarian stromal cell densities were greater in the diestrous phase and a positive correlation of stromal cell density with the number and density of preantral follicles was observed. Themean area (mm2) of ovarian structures increased in the diestrous phase and had positive correlations with number of preantral follicles, follicle density, and stromal cell density. Biopsy fragments collected from ovaries containing an active corpus luteum had a higher follicle density, stromal cell density, and proportion of normal preantral follicles. In conclusion, our results showed: (1) the diestrous phase influenced positively the preantral follicle quality, class distribution, and follicle and stromal cell densities; (2) the area of ovarian structures was positively correlated with the follicle and stromal cell densities; and (3) the presence of an active corpus luteum had a positive effect on the quality of preantral follicles, and follicle and stromal densities. Therefore, herein we demonstrate that the presence of key ovarian structures favors the harvest of ovarian fragments containing an appropriate number of healthy preantral follicles.	[Alves, Kele A.; Alves, Benner G.; Gastal, Gustavo D. A.; de Tarso, Saulo G. S.; Gastal, Melba O.; Gastal, Eduardo L.] So Illinois Univ, Dept Anim Sci Food & Nutr, Carbondale, IL 62901 USA; [Alves, Kele A.; Gambarini, Maria L.] Univ Fed Goias, Coll Vet & Anim Sci, Ctr Studies & Res Anim Reprod Biol, Goiania, Go, Brazil; [Figueiredo, Jose R.] Univ Estadual Ceara, Fac Vet Med, Lab Manipulat Oocytes & Preantral Follicles LAMOF, Fortaleza, Ceara, Brazil	Southern Illinois University System; Southern Illinois University; Universidade Federal de Goias; Universidade Estadual do Ceara	Gastal, EL (corresponding author), So Illinois Univ, Dept Anim Sci Food & Nutr, Carbondale, IL 62901 USA.	egastal@siu.edu	Gastal, Eduardo Leite/O-8359-2019; Alves, Benner/D-3599-2014; Gastal, Gustavo Desire Antunes/K-7424-2013; Alves, Kele Amaral A/P-8422-2015; Gastal, Eduardo Leite/Q-9854-2017	Gastal, Eduardo Leite/0000-0002-8855-6980; Alves, Benner/0000-0001-9465-8054; Gastal, Gustavo Desire Antunes/0000-0002-5317-2207; Alves, Kele Amaral A/0000-0001-7359-3570; Gastal, Eduardo Leite/0000-0002-8855-6980; Figueiredo, Jose Ricardo/0000-0002-5139-0964; Gambarini, Maria Lucia/0000-0003-0517-7270	Southern Illinois University (SIU), USA; Foundation for Research Support of the State of Goias (FAPEG), Brazil [201210267001032]; National Council for Scientific and Technological Development (CNPq), Brazil [203563/2013-1]	Southern Illinois University (SIU), USA; Foundation for Research Support of the State of Goias (FAPEG), Brazil; National Council for Scientific and Technological Development (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Research was supported by Southern Illinois University (SIU), USA, and Foundation for Research Support of the State of Goias (FAPEG; 201210267001032), Brazil. KAA was the recipient of a PhD sandwich scholarship from The National Council for Scientific and Technological Development (CNPq; 203563/2013-1), Brazil.	Aerts JMJ, 2005, THERIOGENOLOGY, V64, P947, DOI 10.1016/j.theriogenology.2005.01.011; Al-zi'abil MO, 2003, REPRODUCTION, V125, P259, DOI 10.1530/rep.0.1250259; ALGUBORY KH, 1987, ANIM REPROD SCI, V13, P269, DOI 10.1016/0378-4320(87)90064-9; Alves KA, 2015, THERIOGENOLOGY, V83, P1048, DOI 10.1016/j.theriogenology.2014.12.004; Araujo VR, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-78; AULETTA FJ, 1987, AM J OBSTET GYNECOL, V157, P1010, DOI 10.1016/S0002-9378(87)80107-2; Baerwald A. R., 2009, Animal Reproduction, V6, P20; Baerwald AR, 2009, FERTIL STERIL, V91, P440, DOI 10.1016/j.fertnstert.2007.11.054; Carnevale EM, 2008, THERIOGENOLOGY, V69, P23, DOI 10.1016/j.theriogenology.2007.09.011; Commin L, 2012, REPROD FERT DEVELOP, V24, P461, DOI 10.1071/RD11166; Dath C, 2011, HUM REPROD, V26, P1431, DOI 10.1093/humrep/der073; Donadeu FX, 2007, ANIM REPROD SCI, V100, P225, DOI 10.1016/j.anireprosci.2006.12.001; Faustino LR, 2010, ANIM REPROD SCI, V122, P90, DOI 10.1016/j.anireprosci.2010.08.001; Forabosco A, 2007, FERTIL STERIL, V88, P675, DOI 10.1016/j.fertnstert.2006.11.191; Fortune JE, 2003, ANIM REPROD SCI, V78, P135, DOI 10.1016/S0378-4320(03)00088-5; Fransolet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091073; Gao JianMing, 2001, Chinese Journal of Veterinary Science, V21, P181; Gastal E. L., 2009, Animal Reproduction, V6, P144; Gastal EL, 1997, BIOL REPROD, V57, P1320, DOI 10.1095/biolreprod57.6.1320; Gastal EL., 2011, ACTA SCI VET, V39, ps57; Gerritse R, 2011, REPROD BIOMED ONLINE, V23, P755, DOI 10.1016/j.rbmo.2011.08.008; Gilchrist RB, 2004, ANIM REPROD SCI, V82-3, P431, DOI 10.1016/j.anireprosci.2004.05.017; Ginther OJ, 2012, THERIOGENOLOGY, V77, P818, DOI 10.1016/j.theriogenology.2011.09.025; Ginther OJ, 2005, REPRODUCTION, V130, P379, DOI 10.1530/rep.1.00757; Ginther OJ, 2004, BIOL REPROD, V71, P1195, DOI 10.1095/biolreprod.104.031054; Gupta PSP, 2007, ANIM REPROD SCI, V101, P145, DOI 10.1016/j.anireprosci.2006.11.011; Haag KT, 2013, THERIOGENOLOGY, V79, P911, DOI 10.1016/j.theriogenology.2013.01.001; Haag KT, 2013, THERIOGENOLOGY, V79, P735, DOI 10.1016/j.theriogenology.2012.10.023; Haag KT, 2013, THERIOGENOLOGY, V79, P599, DOI 10.1016/j.theriogenology.2012.11.012; Jorssen EPA, 2014, THERIOGENOLOGY, V82, P387, DOI 10.1016/j.theriogenology.2014.04.019; Kezele P, 2003, ENDOCRINOLOGY, V144, P3329, DOI 10.1210/en.2002-0131; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Kwok R, 2012, REPROD BIOMED ONLINE, V24, P492, DOI 10.1016/j.rbmo.2012.01.020; Lass A, 1997, HUM REPROD, V12, P1028; Lass A, 2001, HUM REPROD, V16, P1055, DOI 10.1093/humrep/16.6.1055; Martelli A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-72; Mihm M, 2008, REPROD DOMEST ANIM, V43, P48, DOI 10.1111/j.1439-0531.2008.01142.x; Niswender GD, 2000, PHYSIOL REV, V80, P1, DOI 10.1152/physrev.2000.80.1.1; Orisaka M, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-9; Palermo R, 2007, REPROD BIOMED ONLINE, V15, P326, DOI 10.1016/S1472-6483(10)60347-1; Qiu MN, 2013, J STEROID BIOCHEM, V138, P325, DOI 10.1016/j.jsbmb.2013.06.005; Robinson RS, 2009, REPRODUCTION, V138, P869, DOI 10.1530/REP-09-0283; Schmidt KLT, 2003, HUM REPROD, V18, P1158, DOI 10.1093/humrep/deg246; Silva JRV, 2000, THERIOGENOLOGY, V54, P809, DOI 10.1016/S0093-691X(00)00392-7; Skinner MK, 2005, HUM REPROD UPDATE, V11, P461, DOI 10.1093/humupd/dmi020; Telfer EE, 2013, FERTIL STERIL, V99, P1523, DOI 10.1016/j.fertnstert.2013.03.043; Thomas FH, 2003, HUM REPROD UPDATE, V9, P541, DOI 10.1093/humupd/dmg042; Thorne JT, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.121368; Tingen CM, 2011, REPRODUCTION, V141, P809, DOI 10.1530/REP-10-0483; Vanacker J, 2013, FERTIL STERIL, V99, P1363, DOI 10.1016/j.fertnstert.2012.12.016; Yang MY, 2007, MOL REPROD DEV, V74, P1095, DOI 10.1002/mrd.20633; Young JM, 2010, REPRODUCTION, V140, P489, DOI 10.1530/REP-10-0094	52	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149693	10.1371/journal.pone.0149693	http://dx.doi.org/10.1371/journal.pone.0149693			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900687	Green Published, gold			2022-12-27	WOS:000371276100129
J	Bageshwar, UK; VerPlank, L; Baker, D; Dong, W; Hamsanathan, S; Whitaker, N; Sacchettini, JC; Musser, SM				Bageshwar, Umesh K.; VerPlank, Lynn; Baker, Dwight; Dong, Wen; Hamsanathan, Shruthi; Whitaker, Neal; Sacchettini, James C.; Musser, Siegfried M.			High Throughput Screen for Escherichia coli Twin Arginine Translocation (Tat) Inhibitors	PLOS ONE			English	Article							SEC-INDEPENDENT PROTEIN; SIGNAL PEPTIDE; TRANSPORT SYSTEM; EXPORT PATHWAY; COMPLEX-I; TRICLOSAN; MEMBRANE; VIRULENCE; EXPRESSION; EVOLUTION	The twin arginine translocation (Tat) pathway transports fully-folded and assembled proteins in bacteria, archaea and plant thylakoids. The Tat pathway contributes to the virulence of numerous bacterial pathogens that cause disease in humans, cattle and poultry. Thus, the Tat pathway has the potential to be a novel therapeutic target. Deciphering the Tat protein transport mechanism has been challenging since the active translocon only assembles transiently in the presence of substrate and a proton motive force. To identify inhibitors of Tat transport that could be used as biochemical tools and possibly as drug development leads, we developed a high throughput screen (HTS) to assay the effects of compounds in chemical libraries against protein export by the Escherichia coli Tat pathway. The primary screen is a live cell assay based on a fluorescent Tat substrate that becomes degraded in the cytoplasm when Tat transport is inhibited. Consequently, low fluorescence in the presence of a putative Tat inhibitor was scored as a hit. Two diverse chemical libraries were screened, yielding average Z'-factors of 0.74 and 0.44, and hit rates of similar to 0.5% and 0.04%, respectively. Hits were evaluated by a series of secondary screens. Electric field gradient (Delta psi) measurements were particularly important since the bacterial Tat transport requires a Delta psi. Seven low IC50 hits were eliminated by Delta psi assays, suggesting ionophore activity. As Delta psi collapse is generally toxic to animal cells and efficient membrane permeability is generally favored during the selection of library compounds, these results suggest that secondary screening of hits against electrochemical effects should be done early during hit validation. Though none of the short-listed compounds inhibited Tat transport directly, the screening and follow-up assays developed provide a roadmap to pursue Tat transport inhibitors.	[Bageshwar, Umesh K.; Hamsanathan, Shruthi; Whitaker, Neal; Musser, Siegfried M.] Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX USA; [VerPlank, Lynn] Broad Inst, Cambridge, MA USA; [Baker, Dwight; Dong, Wen; Sacchettini, James C.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Texas A&M University System; Texas A&M University College Station	Musser, SM (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX USA.	smusser@tamhsc.edu		Musser, Siegfried/0000-0002-7793-2557	National Institutes of Health [GM065534, NS063904, U54 HG005032, R21 NS063904-01]; Welch Foundation grant [A-0015]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG005032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS063904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation grant(The Welch Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the National Institutes of Health (GM065534 & NS063904 to SMM; U54 HG005032 & R21 NS063904-01 to Molecular Libraries Probe Development Network) and the Welch Foundation grant (A-0015 to JCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Aldridge C, 2014, J CELL BIOL, V205, P51, DOI 10.1083/jcb.201311057; Bageshwar UK, 2007, J CELL BIOL, V179, P87, DOI 10.1083/jcb.200702082; Bageshwar UK, 2009, MOL MICROBIOL, V74, P209, DOI 10.1111/j.1365-2958.2009.06862.x; Behrendt J, 2004, FEMS MICROBIOL LETT, V234, P303, DOI 10.1016/j.femsle.2004.03.048; Berks BC, 2005, CURR OPIN MICROBIOL, V8, P174, DOI 10.1016/j.mib.2005.02.010; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; CASADABAN MJ, 1979, P NATL ACAD SCI USA, V76, P4530, DOI 10.1073/pnas.76.9.4530; Chen GZ, 2003, ANTIMICROB AGENTS CH, V47, P3485, DOI 10.1128/AAC.47.11.3485-3493.2003; CLINE K, 1992, J BIOL CHEM, V267, P2688; De Buck E, 2008, TRENDS MICROBIOL, V16, P442, DOI 10.1016/j.tim.2008.06.004; de Keyzer J, 2003, CELL MOL LIFE SCI, V60, P2034, DOI 10.1007/s00018-003-3006-y; De Leeuw E, 2001, FEBS LETT, V506, P143, DOI 10.1016/S0014-5793(01)02904-0; DeLisa MP, 2002, J BIOL CHEM, V277, P29825, DOI 10.1074/jbc.M201956200; Dhillon GS, 2015, INT J ENV RES PUB HE, V12, P5657, DOI 10.3390/ijerph120505657; Durant JL, 2002, J CHEM INF COMP SCI, V42, P1273, DOI 10.1021/ci010132r; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Forman SA, 2015, NEUROPHARMACOLOGY, V96, P169, DOI 10.1016/j.neuropharm.2014.10.002; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; HORWITZ AH, 1984, J BACTERIOL, V158, P141, DOI 10.1128/JB.158.1.141-147.1984; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Jeong KJ, 2004, J MOL BIOL, V341, P901, DOI 10.1016/j.jmb.2004.05.078; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; KIN E, 1974, J BIOCHEM-TOKYO, V76, P667, DOI 10.1093/oxfordjournals.jbchem.a130612; Koch S, 2012, J BIOL CHEM, V287, P14420, DOI 10.1074/jbc.M112.354555; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Liang FC, 2009, MOL BIOL CELL, V20, P4256, DOI 10.1091/mbc.E09-01-0075; Lindenstrauss U, 2010, FEBS LETT, V584, P3644, DOI 10.1016/j.febslet.2010.07.039; Ma XY, 2013, PLANT CELL, V25, P999, DOI 10.1105/tpc.112.107409; McDonough JA, 2005, J BACTERIOL, V187, P7667, DOI 10.1128/JB.187.22.7667-7679.2005; Moody AJ, 1997, BIOCHEM J, V324, P743; MOULD RM, 1991, J BIOL CHEM, V266, P12189; Ochsner UA, 2002, P NATL ACAD SCI USA, V99, P8312, DOI 10.1073/pnas.082238299; Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002; Pereira DA, 2007, BRIT J PHARMACOL, V152, P53, DOI 10.1038/sj.bjp.0707373; Pett W, 2013, INTEGR COMP BIOL, V53, P495, DOI 10.1093/icb/ict079; Pradel N, 2003, INFECT IMMUN, V71, P4908, DOI 10.1128/IAI.71.9.4908-4916.2003; Price CE, 2010, BBA-MOL CELL RES, V1803, P748, DOI 10.1016/j.bbamcr.2010.01.019; Proudfoot AEI, 2015, CYTOKINE, V74, P259, DOI 10.1016/j.cyto.2015.02.011; Ramasamy S, 2013, STRUCTURE, V21, P777, DOI 10.1016/j.str.2013.03.004; Rollauer SE, 2012, NATURE, V492, P210, DOI 10.1038/nature11683; Russell AD, 2004, J ANTIMICROB CHEMOTH, V53, P693, DOI 10.1093/jac/dkh171; Saint-Joanis B, 2006, J BACTERIOL, V188, P6669, DOI 10.1128/JB.00631-06; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Sebaugh JL, 2011, PHARM STAT, V10, P128, DOI 10.1002/pst.426; Settles AM, 1997, SCIENCE, V278, P1467, DOI 10.1126/science.278.5342.1467; Stanley NR, 2001, J BACTERIOL, V183, P139, DOI 10.1128/JB.183.1.139-144.2001; Thomas JD, 2001, MOL MICROBIOL, V39, P47, DOI 10.1046/j.1365-2958.2001.02253.x; Tu LC, 2013, EMBO J, V32, P3220, DOI 10.1038/emboj.2013.239; Vasil ML, 2012, ANTIMICROB AGENTS CH, V56, P6223, DOI 10.1128/AAC.01575-12; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Wang XH, 2013, CHEM SOC REV, V42, P4859, DOI 10.1039/c3cs60039d; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Whitaker N, 2012, J BIOL CHEM, V287, P11252, DOI 10.1074/jbc.M111.324525; Wu LF, 2000, J MOL MICROB BIOTECH, V2, P179; Yahr TL, 2001, EMBO J, V20, P2472, DOI 10.1093/emboj/20.10.2472; Yazdankhah SP, 2006, MICROB DRUG RESIST, V12, P83, DOI 10.1089/mdr.2006.12.83; Yen MR, 2002, ARCH MICROBIOL, V177, P441, DOI 10.1007/s00203-002-0408-4; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; Yueh MF, 2014, P NATL ACAD SCI USA, V111, P17200, DOI 10.1073/pnas.1419119111; ZAFAR AB, 1995, AM J INFECT CONTROL, V23, P200, DOI 10.1016/0196-6553(95)90042-X; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	64	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149659	10.1371/journal.pone.0149659	http://dx.doi.org/10.1371/journal.pone.0149659			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901445	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100124
J	Becker, AS; Nagel, HW; Wolfrum, C; Burger, IA				Becker, Anton S.; Nagel, Hannes W.; Wolfrum, Christian; Burger, Irene A.			Anatomical Grading for Metabolic Activity of Brown Adipose Tissue	PLOS ONE			English	Article							OBESITY; FAT	Background Recent advances in obesity research suggest that BAT activity, or absence thereof, may be an important factor in the growing epidemic of obesity and its manifold complications. It is thus important to assess larger populations for BAT-activating and deactivating factors. (18)FDG-PET/CT is the standard method to detect and quantify metabolic BAT activity, however, the manual measurement is not suitable for large studies due to its time-consuming nature and poor reproducibility across different software and devices. Methodology/Main Findings In a retrospective study, 1060 consecutive scans of 1031 patients receiving a diagnostic 18FDG-PET/CT were examined for the presence of active BAT. Patients were classified according to a 3-tier system (supraclavicular, mediastinal, infradiaphragmatic) depending on the anatomical location of their active BAT depots, with the most caudal location being the decisive factor. The metabolic parameters (maximum activity, total volume and total glycolysis) were measured on a standard PET/CT workstation. Mean age of the population was 60 +/- 14.6y. 41.61% of patients were female. Metabolically active BAT was found in 53 patients (5.1%). Female, younger and leaner patients tended to have more active BAT, higher metabolic activity and more caudally active BAT. In total, 15 patients showed only supraclavicular, 27 additional mediastinal, and 11 infradiaphragmal activity. Interestingly, the activation of BAT always followed a cranio-caudal gradient. This anatomical pattern correlated with age and BMI as well as with all metabolic parameters, including maximum and total glycolysis (p<0.001). Conclusion Based on our data we propose a simple method to grade or quantify the degree of BAT amount/activity in patients based on the most caudally activated depot. As new modalities for BAT visualization may arise in the future, this system would allow direct comparability with other modalities, in contrary to the PET-metrics, which are restricted to (18)FDG-PET/CT.	[Becker, Anton S.; Nagel, Hannes W.; Burger, Irene A.] Univ Zurich Hosp, Dept Nucl Med, CH-8091 Zurich, Switzerland; [Becker, Anton S.] Univ Zurich Hosp, Dept Diagnost & Intervent Radiol, CH-8091 Zurich, Switzerland; [Wolfrum, Christian] ETH, Dept Hlth Sci & Technol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich	Becker, AS (corresponding author), Univ Zurich Hosp, Dept Nucl Med, CH-8091 Zurich, Switzerland.; Becker, AS (corresponding author), Univ Zurich Hosp, Dept Diagnost & Intervent Radiol, CH-8091 Zurich, Switzerland.	anton.becker@usz.ch	Becker, Anton S./H-5416-2019; Burger, Irene/AAG-1077-2020	Becker, Anton S./0000-0001-8372-6496; Wolfrum, Christian/0000-0002-3862-6805				Admiraal WM, 2013, DIABETOLOGIA, V56, P2231, DOI 10.1007/s00125-013-2938-5; Au-Yong ITH, 2009, DIABETES, V58, P2583, DOI 10.2337/db09-0833; Boellaard R, 2010, EUR J NUCL MED MOL I, V37, P181, DOI 10.1007/s00259-009-1297-4; Bray GA, 2006, J MED CHEM, V49, P4001, DOI 10.1021/jm0680124; Broeders EPM, 2015, CELL METAB, V22, P418, DOI 10.1016/j.cmet.2015.07.002; Cohade C, 2003, J NUCL MED, V44, P170; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Doak CM, 2012, OBES REV, V13, P174, DOI 10.1111/j.1467-789X.2011.00943.x; Hany TF, 2002, EUR J NUCL MED MOL I, V29, P1393, DOI 10.1007/s00259-002-0902-6; HEATON JM, 1972, J ANAT, V112, P35; Kanoun S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140830; Kaukua J, 2003, INT J OBESITY, V27, P1072, DOI 10.1038/sj.ijo.0802366; KONTTINEN A, 1964, AM J PHYSIOL, V207, P845, DOI 10.1152/ajplegacy.1964.207.4.845; LEAN MEJ, 1989, P NUTR SOC, V48, P243, DOI 10.1079/PNS19890036; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; Niedergaard J, 2007, UNEXPECTED EVIDENCE, DOI [10.1152/ajpendo.00691.2006, DOI 10.1152/AJPENDO.00691.2006]; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Powell AG, 2011, CLIN PHARMACOL THER, V90, P40, DOI 10.1038/clpt.2011.82; Quak E, 2015, EUR J NUCL MED MOL I, V42, P2072, DOI 10.1007/s00259-015-3128-0; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Rosenwald M, 2014, ADIPOCYTE, V3, P4, DOI 10.4161/adip.26232; Sacks H, 2013, DIABETES, V62, P1783, DOI 10.2337/db12-1430; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Soderlund V, 2007, EUR J NUCL MED MOL I, V34, P1018, DOI 10.1007/s00259-006-0318-9; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; van Marken Lichtenbelt WD, 2009, COLD ACTIVATED BROWN, DOI [10.1056/NEJMoa0808718, DOI 10.1056/NEJMOA0808718]; Vijgen GH, 2011, BROWN ADIPOSE TISSUE, DOI [10.1371/journal.pone.0017247, DOI 10.1371/JOURNAL.PONE.0017247]; Virtanen KA, 2009, FUNCTIONAL BROWN ADI, DOI [10.1056/NEJMoa0808949, DOI 10.1056/NEJMOA0808949]; Visscher TLS, 2012, EUR HEART J, V33, P157, DOI 10.1093/eurheartj/ehr217; Wang QD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123795; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	32	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149458	10.1371/journal.pone.0149458	http://dx.doi.org/10.1371/journal.pone.0149458			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901352	Green Published, gold, Green Accepted			2022-12-27	WOS:000371276100079
J	Biggs, BT; Tang, T; Krimm, RF				Biggs, Bradley T.; Tang, Tao; Krimm, Robin F.			Insulin-Like Growth Factors Are Expressed in the Taste System, but Do Not Maintain Adult Taste Buds	PLOS ONE			English	Article							PAPILLA DEVELOPMENT; NEUROTROPHIC FACTOR; RECEPTOR-CELLS; FUNGIFORM PAPILLA; SOFT PALATE; TONGUE; MOUSE; RAT; BDNF; INNERVATION	Growth factors regulate cell growth and differentiation in many tissues. In the taste system, as yet unknown growth factors are produced by neurons to maintain taste buds. A number of growth factor receptors are expressed at greater levels in taste buds than in the surrounding epithelium and may be receptors for candidate factors involved in taste bud maintenance. We determined that the ligands of eight of these receptors were expressed in the E14.5 geniculate ganglion and that four of these ligands were expressed in the adult geniculate ganglion. Of these, the insulin-like growth factors (IGF1, IGF2) were expressed in the ganglion and their receptor, insulin-like growth factor receptor 1 (IGF1R), were expressed at the highest levels in taste buds. To determine whether IGF1R regulates taste bud number or structure, we conditionally eliminated IGF1R from the lingual epithelium of mice using the keratin 14 (K14) promoter (K14-Cre::Igf1r(lox/lox)). While K14-Cre:: Igf1r(lox/lox) mice had significantly fewer taste buds at P30 compared with control mice (Igf1r(lox/lox)), this difference was not observed by P80. IGF1R removal did not affect taste bud size or cell number, and the number of phospholipase C beta 2-(PLC beta 2)and carbonic anhydrase 4-(Car4) positive taste receptor cells did not differ between genotypes. Taste buds at the back of the tongue fungiform taste field were larger and contained more cells than those at the tongue tip, and these differences were diminished in K14-Cre:: Igf1r(lox/lox) mice. The epithelium was thicker at the back versus the tip of the tongue, and this difference was also attenuated in K14-Cre:: Igf1r(lox/lox) mice. We conclude that, although IGFs are expressed at high levels in the taste system, they likely play little or no role in maintaining adult taste bud structure. IGFs have a potential role in establishing the initial number of taste buds, and there may be limits on epithelial thickness in the absence of IGF1R signaling.	[Biggs, Bradley T.; Tang, Tao; Krimm, Robin F.] Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40202 USA	University of Louisville	Krimm, RF (corresponding author), Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40202 USA.	rfkrim01@louisville.edu	Krimm, Robin/AAK-3014-2020; Tang, Tao/T-4998-2017		National Institutes of Health [DC007176, 8P30GM103507]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health grant DC007176 (R.F.K.). The statistical core facility, used for data analysis, is supported by National Institutes of Health grant 8P30GM103507.	Annenkov A, 2009, MOL NEUROBIOL, V40, P195, DOI 10.1007/s12035-009-8081-0; BARLOW LA, 1995, DEV BIOL, V169, P273, DOI 10.1006/dbio.1995.1143; BEIDLER LM, 1965, J CELL BIOL, V27, P263, DOI 10.1083/jcb.27.2.263; Chandrashekar J, 2009, SCIENCE, V326, P443, DOI 10.1126/science.1174601; Chao W, 2008, CYTOKINE GROWTH F R, V19, P111, DOI 10.1016/j.cytogfr.2008.01.005; Clapp TR, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-7; Clapp TR, 2004, J COMP NEUROL, V468, P311, DOI 10.1002/cne.10963; COLLINGS VB, 1974, PERCEPT PSYCHOPHYS, V16, P169, DOI 10.3758/BF03203270; DELAY RJ, 1986, J COMP NEUROL, V253, P242, DOI 10.1002/cne.902530210; Finger TE, 2005, CHEM SENSES, V30, pI54, DOI 10.1093/chemse/bjh110; Gaillard D, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005208; GUTH L, 1957, ANAT REC, V128, P715, DOI 10.1002/ar.1091280406; Harlow DE, 2011, DEV DYNAM, V240, P309, DOI 10.1002/dvdy.22527; Huang T, 2014, DEV BIOL, V386, P308, DOI 10.1016/j.ydbio.2013.12.031; Huang T, 2010, DEV DYNAM, V239, P2637, DOI 10.1002/dvdy.22412; Ito A, 2009, CELL TISSUE RES, V337, P349, DOI 10.1007/s00441-009-0833-7; Iwatsuki K, 2007, P NATL ACAD SCI USA, V104, P2253, DOI 10.1073/pnas.0607399104; Kapsimali M, 2013, SEMIN CELL DEV BIOL, V24, P200, DOI 10.1016/j.semcdb.2012.11.002; Kataoka S, 2008, CHEM SENSES, V33, P243, DOI 10.1093/chemse/bjm083; Liebl DJ, 1999, DEV BIOL, V213, P378, DOI 10.1006/dbio.1999.9385; Liu F, 2007, NAT GENET, V39, P106, DOI 10.1038/ng1932; Liu HX, 2013, DEV BIOL, V382, P82, DOI 10.1016/j.ydbio.2013.07.022; Liu HX, 2008, DEV DYNAM, V237, P2378, DOI 10.1002/dvdy.21657; Liu HX, 2012, DEV BIOL, V361, P39, DOI 10.1016/j.ydbio.2011.10.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez GF, 2006, J NEUROBIOL, V66, P1033, DOI 10.1002/neu.20289; Ma LQ, 2009, J NEUROSCI, V29, P3354, DOI 10.1523/JNEUROSCI.3970-08.2009; McLaughlin SK, 2000, J NEUROSCI, V20, P5679, DOI 10.1523/JNEUROSCI.20-15-05679.2000; MISTRETTA CM, 1988, J NEUROSCI, V8, P73; Mistretta CM, 1998, ANN NY ACAD SCI, V855, P1, DOI 10.1111/j.1749-6632.1998.tb10542.x; Miura H, 2014, DEV DYNAM, V243, P1286, DOI [10.1002/DVDY.24121, 10.1002/dvdy.24121]; MURRAY R G, 1969, Journal of Ultrastructure Research, V27, P444, DOI 10.1016/S0022-5320(69)80043-2; MURRAY RG, 1967, J ULTRA MOL STRUCT R, V19, P327, DOI 10.1016/S0022-5320(67)80224-7; Nosrat CA, 1996, J COMP NEUROL, V376, P587, DOI 10.1002/(SICI)1096-9861(19961223)376:4<587::AID-CNE7>3.0.CO;2-Y; Nosrat IV, 2004, J NEUROCYTOL, V33, P607, DOI 10.1007/s11068-005-3330-2; OAKLEY B, 1990, NEUROSCIENCE, V36, P831, DOI 10.1016/0306-4522(90)90026-Z; Oakley B, 2004, J NEUROCYTOL, V33, P631, DOI 10.1007/s11068-005-3332-0; Okubo T, 2009, STEM CELLS, V27, P442, DOI 10.1634/stemcells.2008-0611; Patel AV, 2012, DEV BIOL, V365, P50, DOI 10.1016/j.ydbio.2012.02.008; Patel AV, 2010, J COMP NEUROL, V518, P3290, DOI 10.1002/cne.22400; Patel AV, 2010, DEV BIOL, V340, P419, DOI 10.1016/j.ydbio.2010.01.024; Perea-Martinez I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053399; Petersen CI, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002098; Stachelscheid H, 2008, EMBO J, V27, P2091, DOI 10.1038/emboj.2008.141; Sullivan JM, 2010, EUR J NEUROSCI, V31, P1549, DOI 10.1111/j.1460-9568.2010.07184.x; Sun H, 2002, DEV BIOL, V242, P31, DOI 10.1006/dbio.2001.0526; Suzuki Y, 2005, J COMP NEUROL, V482, P74, DOI 10.1002/cne.20379; Yang RB, 2000, J COMP NEUROL, V425, P139, DOI 10.1002/1096-9861(20000911)425:1<139::AID-CNE12>3.0.CO;2-#; Yang RB, 2000, J COMP NEUROL, V424, P205, DOI 10.1002/1096-9861(20000821)424:2<205::AID-CNE2>3.0.CO;2-F; Yee CL, 2001, J COMP NEUROL, V440, P97, DOI 10.1002/cne.1372; Yee KK, 2013, STEM CELLS, V31, P992, DOI 10.1002/stem.1338; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	52	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148315	10.1371/journal.pone.0148315	http://dx.doi.org/10.1371/journal.pone.0148315			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901525	Green Submitted, Green Published, gold			2022-12-27	WOS:000371276100015
J	El Ayadi, AM; Nathan, HL; Seed, PT; Butrick, EA; Hezelgrave, NL; Shennan, AH; Miller, S				El Ayadi, Alison M.; Nathan, Hannah L.; Seed, Paul T.; Butrick, Elizabeth A.; Hezelgrave, Natasha L.; Shennan, Andrew H.; Miller, Suellen			Vital Sign Prediction of Adverse Maternal Outcomes in Women with Hypovolemic Shock: The Role of Shock Index	PLOS ONE			English	Article							BLOOD-PRESSURE DEVICE; POSTPARTUM HEMORRHAGE; EMERGENCY-DEPARTMENT; OBSTETRIC HEMORRHAGE; MANAGEMENT; PREGNANCY; GARMENT; DEATH	Objective To determine the optimal vital sign predictor of adverse maternal outcomes in women with hypovolemic shock secondary to obstetric hemorrhage and to develop thresholds for referral/intensive monitoring and need for urgent intervention to inform a vital sign alert device for low-resource settings. Study Design We conducted secondary analyses of a dataset of pregnant/postpartum women with hypovolemic shock in low-resource settings (n = 958). Using receiver-operating curve analysis, we evaluated the predictive ability of pulse, systolic blood pressure, diastolic blood pressure, shock index, mean arterial pressure, and pulse pressure for three adverse maternal outcomes: (1) death, (2) severe maternal outcome (death or severe end organ dysfunction morbidity); and (3) a combined severe maternal and critical interventions outcome comprising death, severe end organ dysfunction morbidity, intensive care admission, blood transfusion >= 5 units, or emergency hysterectomy. Two threshold parameters with optimal rule-in and rule-out characteristics were selected based on sensitivities, specificities, and positive and negative predictive values. Results Shock index was consistently among the top two predictors across adverse maternal outcomes. Its discriminatory ability was significantly better than pulse and pulse pressure for maternal death (p<0.05 and p<0.01, respectively), diastolic blood pressure and pulse pressure for severe maternal outcome (p<0.01), and systolic and diastolic blood pressure, mean arterial pressure and pulse pressure for severe maternal outcome and critical interventions (p<0.01). A shock index threshold of >= 0.9 maintained high sensitivity (100.0) with clinical practicality, >= 1.4 balanced specificity (range 70.0-74.8) with negative predictive value (range 93.2-99.2), and >= 1.7 further improved specificity (range 80.7-90.8) without compromising negative predictive value (range 88.8-98.5). Conclusions For women with hypovolemic shock from obstetric hemorrhage, shock index was consistently a strong predictor of all adverse outcomes. In lower-level facilities in low resource settings, we recommend a shock index threshold of >= 0.9 indicating need for referral, >= 1.4 indicating urgent need for intervention in tertiary facilities and >= 1.7 indicating high chance of adverse outcome. The vital sign alert device incorporated values 0.9 and 1.7; however, all thresholds will be prospectively validated and clinical pathways for action appropriate to setting established prior to clinical implementation.	[El Ayadi, Alison M.; Butrick, Elizabeth A.; Miller, Suellen] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Bixby Ctr Global Reprod Hlth, San Francisco, CA USA; [Nathan, Hannah L.; Seed, Paul T.; Hezelgrave, Natasha L.; Shennan, Andrew H.] Kings Coll London, Womens Hlth Acad Ctr, London, England	University of California System; University of California San Francisco; University of London; King's College London	El Ayadi, AM (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Bixby Ctr Global Reprod Hlth, San Francisco, CA USA.	alison.elayadi@ucsf.edu	Seed, Paul T/C-4435-2008	Seed, Paul T/0000-0001-7904-7933; Shennan, Andrew/0000-0001-5273-3132	Bill & Melinda Gates Foundation [OPP1086183, 48541]; MacArthur Foundation [05-84956-000-GSS]; National Institutes of Health [R01HD053129]; MRC [MR/N006240/1] Funding Source: UKRI; Medical Research Council [MR/N006240/1] Funding Source: researchfish; National Institute for Health Research [ACF-2015-17-014, ACF-2009-17-019, DRF-2013-06-171] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD053129] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); MacArthur Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The current work was supported by the Bill & Melinda Gates Foundation (AS; OPP1086183; www.gatesfoundation.org). The original data collection was supported by grants from the MacArthur Foundation (SM; 05-84956-000-GSS; www.macfound.org), National Institutes of Health (SM; R01HD053129; www.nih.gov), and the Bill & Melinda Gates Foundation (SM; 48541; www.gatesfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2010, ENCY MEASUREMENT STA; AbouZahr C, 2003, BRIT MED BULL, V67, P1, DOI 10.1093/bmb/ldg015; Al-Foudri H, 2010, BJA EDUC, V10, P81, DOI 10.1093/bjaceaccp/mkq009; [Anonymous], 2014, Obstet Gynecol, V123, P722, DOI 10.1097/01.AOG.0000444442.04111.c6; Birkhahn RH, 2005, AM J EMERG MED, V23, P323, DOI 10.1016/j.ajem.2005.02.029; Birkhahn RH, 2003, AM J OBSTET GYNECOL, V189, P1293, DOI 10.1067/S0002-9378(03)00663-X; Bonanno Fabrizio Giuseppe, 2012, J Emerg Trauma Shock, V5, P285, DOI 10.4103/0974-2700.102357; Carroli G, 2008, BEST PRACT RES CL OB, V22, P999, DOI 10.1016/j.bpobgyn.2008.08.004; Cecconi M, 2014, INTENS CARE MED, V40, P1795, DOI 10.1007/s00134-014-3525-z; de Greeff A, 2008, BLOOD PRESS MONIT, V13, P342, DOI 10.1097/MBP.0b013e32830fd07c; Gregory Kim, 2009, EARLY RECOGNITION RA; Le Bas A, 2014, INT J GYNECOL OBSTET, V124, P253, DOI 10.1016/j.ijgo.2013.08.020; Linden A, 2006, J EVAL CLIN PRACT, V12, P132, DOI 10.1111/j.1365-2753.2005.00598.x; McAuley DF, 2005, CLIN ULTIMATE REFERE; Mcnab A, 2012, SURGERY, V152, P473, DOI 10.1016/j.surg.2012.07.010; Miller S, 2006, BJOG-INT J OBSTET GY, V113, P424, DOI 10.1111/j.1471-0528.2006.00873.x; Miller S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076477; Miller S, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-64; Nathan HL, 2015, BJOG-INT J OBSTET GY, V122, P268, DOI 10.1111/1471-0528.13206; Nathan HL, 2015, BLOOD PRESS MONIT, V20, P52, DOI 10.1097/MBP.0000000000000086; Nathan HL, BLOOD PRESS IN PRESS; Nathan HL, 2015, PREGNANCY HYPERTENSI, V5, P104; Oates M, 2011, BJOG-INT J OBSTET GY, V118, P132, DOI 10.1111/j.1471-0528.2010.02847.x; Onah H E, 2006, J Obstet Gynaecol, V26, P445, DOI 10.1080/01443610600747314; Pacagnella RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057594; Pepe MS, 2004, STAT EVALUATION MED; RADY MY, 1992, RESUSCITATION, V23, P227, DOI 10.1016/0300-9572(92)90006-X; RADY MY, 1994, ANN EMERG MED, V24, P685, DOI 10.1016/S0196-0644(94)70279-9; RADY MY, 1992, AM J EMERG MED, V10, P538, DOI 10.1016/0735-6757(92)90178-Z; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Schorn MN, 2010, J MIDWIFERY WOM HEAL, V55, P20, DOI 10.1016/j.jmwh.2009.02.014; Sloan EP, 2014, WEST J EMERG MED, V15, P795, DOI 10.5811/westjem.2014.7.21304; Sohn CH, 2013, SHOCK, V40, P101, DOI 10.1097/SHK.0b013e31829b1778; Varpula M, 2005, INTENS CARE MED, V31, P1066, DOI 10.1007/s00134-005-2688-z; WHO, 2003, MAN COMPL PREGN CILD; World Health Organization (WHO), 2011, EV QUAL CAR SEV PREG	36	57	58	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148729	10.1371/journal.pone.0148729	http://dx.doi.org/10.1371/journal.pone.0148729			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901161	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100023
J	Guo, H; Liu, JM; Zhang, JY; Ma, RL; Ding, YS; Zhang, M; He, J; Xu, SZ; Li, SG; Yan, YZ; Mu, LT; Rui, DS; Niu, Q; Guo, SX				Guo, Heng; Liu, Jiaming; Zhang, Jingyu; Ma, Rulin; Ding, Yusong; Zhang, Mei; He, Jia; Xu, Shangzhi; Li, Shugang; Yan, Yizhong; Mu, Lati; Rui, Dongsheng; Niu, Qiang; Guo, Shuxia			The Prevalence of Metabolic Syndrome Using Three Different Diagnostic Criteria among Low Earning Nomadic Kazakhs in the Far Northwest of China: New Cut-Off Points of Waist Circumference to Diagnose MetS and Its Implications	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; ABDOMINAL OBESITY; XINJIANG PROVINCE; BODY-COMPOSITION; RISK-FACTORS; ADULTS; POPULATIONS; OVERWEIGHT; HAN	Background Although the epidemic of metabolic syndrome (MetS) has aroused wide public concern, most studies on MetS tend to examine urban and high income settings, and few studies cover nomadic areas and low earning populations. This research aims to investigate the prevalence of MetS and explore the cut-off point of waist circumference in a nomadic minority typical of low income populations in the remote northwest region of China. Methods A cross-sectional study was performed in a representative sample of 3900 Kazakh adults aged 18-84 years from 2009-2010. Three widely used criteria (ATP III\IDF\JIS)were employed to estimate the prevalence of MetS in Kazakhs to compare them with other populations. Receiver operator characteristic (ROC) curve analysis was used to explore the optimal cut-off values of waist circumference. Results The age-adjusted prevalence of MetS was 13.8%, 20.9%, and 24.8% based on the ATP III, IDF, and JIS criteria, respectively. The prevalence of MetS was higher in women and increased with age. Except for reduced HDL-cholesterol, the risk of other components of MetS increased with waist circumference enlargement. The cut-off point of waist circumference in screening at least two other components of MetS was 88 cm in men (Sensitivity = 61.1%, Specificity = 62.1%, ROC Curve Distance = 0.54) and 83 cm in women (Sensitivity = 60.0%, Specificity = 59.6%, ROC Curve Distance = 0.57). Conclusion The prevalence of MetS in Kazakhs is higher than the national level of China and falls in between the Euro-American and Asia levels, as their cut-off points of waist circumference differ from that recommended for Chinese. We suggest a cost-effective strategy to screen for MetS and prevent cardiovascular disease using new cut-off points of waist circumference in low earning nomadic Kazakhs.	[Guo, Heng; Liu, Jiaming; Zhang, Jingyu; Ma, Rulin; Ding, Yusong; Zhang, Mei; He, Jia; Xu, Shangzhi; Li, Shugang; Yan, Yizhong; Mu, Lati; Rui, Dongsheng; Niu, Qiang; Guo, Shuxia] Shihezi Univ, Sch Med, Dept Prevent Med, Shihezi 832000, Xinjiang, Peoples R China	Shihezi University	Guo, SX (corresponding author), Shihezi Univ, Sch Med, Dept Prevent Med, Shihezi 832000, Xinjiang, Peoples R China.	pge88@sina.com		zhong, yan/0000-0003-1957-5421	National Key Technology R&D Program of China [2009BAI82B04]; National Natural Science Foundation of China [81560551]	National Key Technology R&D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Key Technology R&D Program of China (Grant No. 2009BAI82B04) and National Natural Science Foundation of China (GrantNo.81560551), http://isisn.nsfc.gov.cn/egrantweb/. The funders contributed to study design, data collection, preparation of the manuscript, decision to publish.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Arai H, 2006, J ATHEROSCLER THROMB, V13, P202, DOI 10.5551/jat.13.202; Banerji MA, 1999, J CLIN ENDOCR METAB, V84, P137, DOI 10.1210/jc.84.1.137; Black ML, 2006, HUM BIOL, V78, P277, DOI 10.1353/hub.2006.0041; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Du H, 2013, AM J CLIN NUTR, V97, P487, DOI DOI 10.3945/AJCN.112.046854; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Ford ES, 2010, J DIABETES, V2, P180, DOI 10.1111/j.1753-0407.2010.00078.x; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Further Study Of Risk Factors For Stroke And Coronary Heart Disease group, 2002, Zhonghua Yu Fang Yi Xue Za Zhi, V36, P298; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Hara K, 2006, DIABETES CARE, V29, P1123, DOI 10.2337/dc05-2540; Jiang JM, 2015, INT J CARDIOL, V179, P558, DOI 10.1016/j.ijcard.2014.10.077; Kaya E, 2015, J SEX MED, V12, P856, DOI 10.1111/jsm.12828; Kim HK, 2009, DIABETES RES CLIN PR, V85, P35, DOI 10.1016/j.diabres.2009.04.009; Liu F, 2014, BLOOD PRESSURE, V23, P154, DOI 10.3109/08037051.2013.838827; Lu Qingli, 2009, J Cardiometab Syndr, V4, P120, DOI 10.1111/j.1559-4572.2008.00045.x; Lu ZS, 2009, HYPERTENS RES, V32, P1097, DOI 10.1038/hr.2009.159; Ma X, 2014, ETHNIC DIS, V24, P316; Marcuello C, 2013, ACTA DIABETOL, V50, P615, DOI 10.1007/s00592-013-0468-8; Misra A, 2005, NUTRITION, V21, P969, DOI 10.1016/j.nut.2005.01.007; Misra A, 2004, NUTRITION, V20, P482, DOI 10.1016/j.nut.2004.01.020; Molarius A, 1999, J CLIN EPIDEMIOL, V52, P1213, DOI 10.1016/S0895-4356(99)00114-6; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; National Bureau of Statistics of China, TAB 2000 POP CENS PO; Ntandou G, 2009, NUTR RES, V29, P180, DOI 10.1016/j.nutres.2009.02.001; Saito I, 2012, CIRC J, V76, P1066, DOI 10.1253/circj.CJ-11-1519; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Song MY, 2002, J APPL PHYSIOL, V92, P2285, DOI 10.1152/japplphysiol.01066.2001; Song QB, 2015, DIABETES VASC DIS RE, V12, P189, DOI 10.1177/1479164114562410; Statistic Bureau of Xinjiang Uyghur Autonomous Region, XINJ STAT YB 2014; Wagner DR, 2000, AM J CLIN NUTR, V71, P1392; Wang F, 2009, NUTR METAB CARDIOVAS, V19, P542, DOI 10.1016/j.numecd.2008.11.006; Wang W, 2003, HUM GENET, V113, P244, DOI 10.1007/s00439-003-0948-y; Xi B, 2013, PREV MED, V57, P867, DOI 10.1016/j.ypmed.2013.09.023; Yan WL, 2015, ETHNIC HEALTH, V20, P365, DOI 10.1080/13557858.2014.921894; Zhai Fengying, 2007, Wei Sheng Yan Jiu, V36, P539; Zhou Bei-fan, 2005, Zhonghua Xinxueguanbing Zazhi, V33, P81; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	41	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148976	10.1371/journal.pone.0148976	http://dx.doi.org/10.1371/journal.pone.0148976			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901035	gold, Green Published, Green Submitted			2022-12-27	WOS:000371276100033
J	Nabokina, SM; Ramos, MB; Said, HM				Nabokina, Svetlana M.; Ramos, Mel Brendan; Said, Hamid M.			Mechanism(S) Involved in the Colon-Specific Expression of the Thiamine Pyrophosphate (Tpp) Transporter	PLOS ONE			English	Article							WATER-SOLUBLE VITAMINS; INTESTINAL EPITHELIAL-CELLS; CPG ISLANDS; DNA METHYLATION; TRANSCRIPTION FACTOR; GENE; MICRORNAS; CHROMATIN; DIFFERENTIATION; PROMOTERS	Microbiota of the large intestine synthesizes considerable amount of vitamin B1 (thiamine) in the form of thiamine pyrophosphate (TPP). We have recently demonstrated the existence of an efficient and specific carrier-mediated uptake process for TPP in human colonocytes, identified the TPP transporter (TPPT) involved (product of the SLC44A4 gene), and shown that expression of TPPT along the gastrointestinal (GI) tract is restricted to the colon. Our aim in this study was to determine the molecular basis of the colon-specific expression of TPPT focusing on a possible epigenetic mechanism. Our results showed that the CpG island predicted in the SLC44A4 promoter is non-methylated in the human colonic epithelial NCM460 cells, but is hyper-methylated in the human duodenal epithelial HuTu80 cells (as well as in the human retinal pigment epithelial ARPE19 cells). In the mouse (where TPPT expression in the GI tract is also restricted to the colon), the CpG island predicted in the Slc44a4 promoter is non-methylated in both the jejunum and colon, thus arguing against possible contribution of DNA methylation in the colon-specific expression of TPPT. A role for histone modifications in the tissue-specific pattern of Slc44a4 expression, however, was suggested by the findings that in mouse colon, histone H3 in the 5'-regulatory region of Slc44a4 is tri-methylated at lysine 4 and acetylated at lysine 9, whereas the tri-methylation at lysine 27 modification was negligible. In contrast, in the mouse jejunum, histone H3 is hyper-trimethylated at lysine 27 (repressor mark). Similarly, possible involvement of miRNA (s) in the tissue-specific expression of TPPT was also suggested by the findings that the 3'-UTR of SLC44A4 is targeted by specific miRNAs/RNA binding proteins in non-colonic, but not in colonic, epithelial cells. These studies show, for the first time, epigenetic mechanisms (histone modifications) play a role in determining the tissue-specific pattern of expression of TPPT in the GI tract.	[Nabokina, Svetlana M.; Ramos, Mel Brendan; Said, Hamid M.] Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA; [Nabokina, Svetlana M.; Ramos, Mel Brendan; Said, Hamid M.] Univ Calif Irvine, Dept Physiol Biophys, Irvine, CA 92697 USA; [Said, Hamid M.] Dept Vet Affairs Med Ctr, Long Beach, CA 90822 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System	Said, HM (corresponding author), Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA.; Said, HM (corresponding author), Univ Calif Irvine, Dept Physiol Biophys, Irvine, CA 92697 USA.; Said, HM (corresponding author), Dept Vet Affairs Med Ctr, Long Beach, CA 90822 USA.	hmsaid@uci.edu			DVA; NIH [DK56061, DK58057]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK056061, R01DK058057, R01DK056061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018071] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001142] Funding Source: NIH RePORTER	DVA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	Supported by grants from the DVA and the NIH (DK56061 and DK58057).	Anbazhagan AN, 2014, AM J PHYSIOL-GASTR L, V306, pG123, DOI 10.1152/ajpgi.00222.2013; ANTEQUERA F, 1990, CELL, V62, P503, DOI 10.1016/0092-8674(90)90015-7; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Ayyadurai S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087614; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berdanier C.D., 1998, ADV NUTR MICRONUTRIE, P183; Bettendorff L, 2009, FEBS J, V276, P2917, DOI 10.1111/j.1742-4658.2009.07019.x; Blackledge NP, 2011, EPIGENETICS-US, V6, P147, DOI 10.4161/epi.6.2.13640; Calingasan NY, 1999, J NEUROPATH EXP NEUR, V58, P946, DOI 10.1097/00005072-199909000-00005; Dalmasso G, 2010, DIFFERENTIATION, V80, P147, DOI 10.1016/j.diff.2010.06.005; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gillen AE, 2011, BIOCHEM J, V438, P25, DOI 10.1042/BJ20110672; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Imai S, 2009, MOL PHARMACOL, V75, P568, DOI 10.1124/mol.108.052589; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kikuchi R, 2007, MOL PHARMACOL, V72, P1619, DOI 10.1124/mol.107.039701; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Malhotra P, 2014, J BIOL CHEM, V289, P23132, DOI 10.1074/jbc.M113.546283; Maruyama R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001369; McKenna LB, 2010, GASTROENTEROLOGY, V139, P1654, DOI 10.1053/j.gastro.2010.07.040; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nabokina SM, 2015, AM J PHYSIOL-CELL PH, V308, pC750, DOI 10.1152/ajpcell.00381.2014; Nabokina SM, 2014, J BIOL CHEM, V289, P4405, DOI 10.1074/jbc.M113.528257; Nabokina SM, 2012, AM J PHYSIOL-GASTR L, V303, pG389, DOI 10.1152/ajpgi.00151.2012; Ng AYN, 2002, GASTROENTEROLOGY, V122, P1455, DOI 10.1053/gast.2002.32990; Oettgen P, 1997, MOL CELL BIOL, V17, P4419, DOI 10.1128/MCB.17.8.4419; Pekow JR, 2012, INFLAMM BOWEL DIS, V18, P187, DOI 10.1002/ibd.21691; Portari GV, 2008, BASIC CLIN PHARMACOL, V103, P482, DOI 10.1111/j.1742-7843.2008.00311.x; Qiao H, 2011, BIOCHEM J, V440, P73, DOI 10.1042/BJ20110392; Reidling JC, 2007, AM J PHYSIOL-GASTR L, V292, pG275, DOI 10.1152/ajpgi.00327.2006; Rindi G, 2000, P SOC EXP BIOL MED, V224, P246, DOI 10.1046/j.1525-1373.2000.22428.x; Said HM, 2015, WORLD REV NUTR DIET, V111, P30, DOI 10.1159/000362294; Said HM, 2013, AM J PHYSIOL-GASTR L, V305, pG601, DOI 10.1152/ajpgi.00231.2013; Said HM, 2011, BIOCHEM J, V437, P357, DOI 10.1042/BJ20110326; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shen L, 2007, PLOS GENET, V3, P2023, DOI 10.1371/journal.pgen.0030181; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Singleton Charles K., 2001, Current Molecular Medicine (Hilversum), V1, P197, DOI 10.2174/1566524013363870; Tanphaichitr V., 1994, MODERN NUTR HLTH DIS, P359; Tumer E, 2013, J BIOL CHEM, V288, P33813, DOI 10.1074/jbc.M113.482760; Victor M., 1989, WERNICKE KORSAKOFF S, V2nd	47	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149255	10.1371/journal.pone.0149255	http://dx.doi.org/10.1371/journal.pone.0149255			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901654	Green Published, gold			2022-12-27	WOS:000371276100049
J	Querques, G; Merle, BMJ; Pumariega, NM; Benlian, P; Delcourt, C; Zourdani, A; Leisy, HB; Lee, MD; Smith, RT; Souied, EH				Querques, Giuseppe; Merle, Benedicte M. J.; Pumariega, Nicole M.; Benlian, Pascale; Delcourt, Cecile; Zourdani, Alain; Leisy, Heather B.; Lee, Michele D.; Smith, R. Theodore; Souied, Eric H.			Dynamic Drusen Remodelling in Participants of the Nutritional AMD Treatment-2 (NAT-2) Randomized Trial	PLOS ONE			English	Article							AGE-RELATED MACULOPATHY; POLYUNSATURATED FATTY-ACIDS; MACULAR DEGENERATION; DIETARY-FAT; FISH INTAKE; DOCOSAHEXAENOIC ACID; GEOGRAPHIC ATROPHY; 5-YEAR INCIDENCE; RISK; AUTOFLUORESCENCE	Purpose To evaluate the dynamic remodeling of drusen in subjects with unilateral neovascular age-related macular degeneration (AMD) receiving a three-year course of oral docosahexaenoic acid (DHA) or placebo. Setting Institutional setting. Methods Three hundred subjects with age-related maculopathy and neovascular AMD in the fellow eye were randomly assigned to receive either 840 mg/day DHA or placebo for 3 years. Main outcome measures of this post-hoc sub-group analysis were progression of drusen number, total diameter, and total area on fundus photography, and their association with DHA supplementation, socio-demographic and genetic characteristics. Results Drusen progression was analyzed in 167 subjects that did not develop CNV (87 that received DHA and 80 that received placebo). None of the drusen remodeling outcomes were significantly associated with DHA supplementation. Total drusen diameter reduction in the inner subfield was significantly associated with age (older patients: r = -0.17; p = 0.003). Women showed a tendency to decreased total drusen diameter in the inner subfield with CFH polymorphism (p = 0.03), where women with TT genotype tended to have a greater reduction in drusen diameter than other genotypes (CC and CT). Drusen area in the inner subfield was more reduced in older patients (r = -0.17) and in women (p = 0.01). Drusen number showed no significant trends. Conclusions Dynamic drusen remodeling with net reduction in drusen load over three years was found in patients with exudative AMD in one eye and drusen in the other eye (study-eye). This reduction was correlated with increased age and female gender, and showed a tendency to be influenced by CFH genotype, but did not appear to be affected by DHA supplementation.	[Querques, Giuseppe; Merle, Benedicte M. J.; Zourdani, Alain; Souied, Eric H.] Univ Paris Est Creteil, Hop Intercommunal Creteil, Dept Ophthalmol, Creteil, France; [Pumariega, Nicole M.; Leisy, Heather B.; Lee, Michele D.; Smith, R. Theodore] NYU, Dept Ophthalmol, 550 1St Ave, New York, NY 10016 USA; [Benlian, Pascale] Hop St Antoine, APHP, Biochem & Mol Biol Dept, F-75012 Paris, France; [Benlian, Pascale] Univ Lille 2, INSERM, UMRS 1011, Lille, France; [Delcourt, Cecile] INSERM, Ctr INSERM, Epidemiol Biostat U897, Bordeaux, France; [Delcourt, Cecile] Univ Bordeaux, ISPED, Bordeaux, France	Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; New York University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Querques, G (corresponding author), Univ Paris Est Creteil, Hop Intercommunal Creteil, Dept Ophthalmol, Creteil, France.	giuseppe.querques@hotmail.it	Delcourt, Cecile/I-2627-2013; Merle, Benedicte MJ/AAQ-5021-2021; Merle, Benedicte MJ/F-1247-2015; Benlian, Pascale/I-7964-2016	Delcourt, Cecile/0000-0002-2099-0481; Merle, Benedicte MJ/0000-0003-1332-0954; Merle, Benedicte MJ/0000-0003-1332-0954; Querques, Giuseppe/0000-0002-3292-9581; Lee, Michele/0000-0003-4772-1908; Benlian, Pascale/0000-0002-3423-8979	Laboratoire Bausch & Lomb - Chauvin, Clinical Research, Montpellier, Cedex 2, France	Laboratoire Bausch & Lomb - Chauvin, Clinical Research, Montpellier, Cedex 2, France	This study was supported by a grant from Laboratoire Bausch & Lomb - Chauvin, Clinical Research, 416, rue Samuel Morse, CS 99535, 34961 Montpellier, Cedex 2, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Age-Related Eye Disease Study 2 Research G, 2003, JAMA-J AM MED ASSOC, V309, P2005; Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S, DOI 10.1093/ajcn/83.6.1467S; Augood C, 2008, AM J CLIN NUTR, V88, P398, DOI 10.1093/ajcn/88.2.398; Bazan NG, 2009, PROSTAG LEUKOTR ESS, V81, P205, DOI 10.1016/j.plefa.2009.05.024; BRESSLER NM, 1995, ARCH OPHTHALMOL-CHIC, V113, P301, DOI 10.1001/archopht.1995.01100030055022; Cangemi Francis E, 2007, BMC Ophthalmol, V7, P3, DOI 10.1186/1471-2415-7-3; Cho E, 2001, AM J CLIN NUTR, V73, P209; Chong EWT, 2008, ARCH OPHTHALMOL-CHIC, V126, P826, DOI 10.1001/archopht.126.6.826; Christen WG, 2011, ARCH OPHTHALMOL-CHIC, V129, P921, DOI 10.1001/archophthalmol.2011.34; Chua B, 2006, ARCH OPHTHALMOL-CHIC, V124, P981, DOI 10.1001/archopht.124.7.981; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; Feher J, 2005, OPHTHALMOLOGICA, V219, P154, DOI 10.1159/000085248; Ferris FL, 2005, ARCH OPHTHALMOL-CHIC, V123, P1570; GASS JDM, 1973, ARCH OPHTHALMOL-CHIC, V90, P206; Hwang JC, 2006, INVEST OPHTH VIS SCI, V47, P2655, DOI 10.1167/iovs.05-1027; Hyman Leslie, 2002, Curr Opin Ophthalmol, V13, P171; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Klein R, 2007, OPHTHALMOLOGY, V114, P253, DOI 10.1016/j.ophtha.2006.10.040; Leveziel N, 2007, MOL VIS, V13, P2153; Lukiw WJ, 2008, J NUTR, V138, P2510, DOI 10.3945/jn.108.096016; Marik PE, 2009, CLIN CARDIOL, V32, P365, DOI 10.1002/clc.20604; Merle B, 2001, INVEST OPHTH VIS SCI, V52, P6004; Merle BMJ, 2014, INVEST OPHTH VIS SCI, V55, P2010, DOI 10.1167/iovs.14-13916; Merle BMJ, 2013, J NUTR, V143, P505, DOI 10.3945/jn.112.171033; OMS, 2018, TOP 10 CAUS DEATH; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Park DW, 2006, OPHTHALMOLOGY, V113, P1974, DOI 10.1016/j.ophtha.2006.08.015; PAULEIKHOFF D, 1990, AM J OPHTHALMOL, V109, P38, DOI 10.1016/S0002-9394(14)75576-X; Pepe S, 2005, EXP GERONTOL, V40, P369, DOI 10.1016/j.exger.2005.03.005; Resnikoff S, 2002, B WORLD HEALTH ORGAN, V82, P844; Sallo FB, 2009, BRIT J OPHTHALMOL, V93, P1345, DOI 10.1136/bjo.2008.150334; SanGiovanni JP, 2009, AM J CLIN NUTR, V90, P1601, DOI 10.3945/ajcn.2009.27594; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; SARKS JP, 1988, EYE, V2, P552, DOI 10.1038/eye.1988.106; Seddon JM, 2006, OPHTHALMOLOGY, V113, P260, DOI 10.1016/j.ophtha.2005.11.001; Seddon JM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1728, DOI 10.1001/archopht.121.12.1728; Seddon JM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1191, DOI 10.1001/archopht.119.8.1191; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Smith RT, 2010, BRIT J OPHTHALMOL, V94, P1618, DOI 10.1136/bjo.2009.166843; Smith RT, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-10; Smith RT, 2005, INVEST OPHTH VIS SCI, V46, P2940, DOI 10.1167/iovs.04-0778; Smith RT, 2005, ARCH OPHTHALMOL-CHIC, V123, P200, DOI 10.1001/archopht.123.2.200; Smith RT, 2004, J BIOMED OPT, V9, P162, DOI 10.1117/1.1630604; Smith W, 2000, ARCH OPHTHALMOL-CHIC, V118, P401, DOI 10.1001/archopht.118.3.401; Souied EH, 2013, OPHTHALMOLOGY, V120, P1619, DOI 10.1016/j.ophtha.2013.01.005; Sparrow JM, 1997, EYE, V11, P315, DOI 10.1038/eye.1997.67	47	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149219	10.1371/journal.pone.0149219	http://dx.doi.org/10.1371/journal.pone.0149219			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901353	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100046
J	Tagawa, M; Maekawa, N; Konnai, S; Takagi, S				Tagawa, Michihito; Maekawa, Naoya; Konnai, Satoru; Takagi, Satoshi			Evaluation of Costimulatory Molecules in Peripheral Blood Lymphocytes of Canine Patients with Histiocytic Sarcoma	PLOS ONE			English	Article							T-CELLS; CTLA-4; EXPRESSION; DOGS; CD152; FAMILY; PD-1; CD28; CCNU	Histiocytic sarcoma is a rapidly progressive and fatal neoplastic disease in dogs. It is unclear whether costimulatory molecules, including CD28, cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4), and programmed death-1 (PD-1), are expressed on peripheral blood lymphocytes (PBLs) of canine patients with histiocytic sarcoma. The objective of this study was to evaluate the expression of CD28, CTLA-4, and PD-1 molecules on PBLs of patients with histiocytic sarcoma, patients with other tumors, and healthy controls. Twenty-six dogs were included in the study, with eight, ten, and eight dogs in the histiocytic sarcoma, other tumor, and healthy control groups, respectively. PBLs and serum were prospectively obtained from patients diagnosed histopathologically with histiocytic sarcoma, other tumors and healthy controls. The surface expression of CTLA-4, CD28, and PD-1 on T lymphocytes was examined using flow cytometric analysis. Serum samples were frozen at -30 degrees C until serum interferon-gamma (IFN-gamma) was measured by enzyme-linked immunosorbent assay. The expression level of CTLA-4 on CD4+ lymphocytes was significantly higher in the histiocytic sarcoma group than in the control group. The expression of CTLA-4 on CD8+ lymphocytes was significantly higher in the histiocytic sarcoma group than in the other two groups. In addition, the expression of PD-1 on CD8+ lymphocytes was significantly higher in the histiocytic sarcoma group than in the control group. However, no significant differences in CD28 expressions and serum IFN-gamma levels were observed. The present results provided evidence showing that the expression levels of CTLA-4 on both CD4+ and CD8+ lymphocytes and PD-1 on CD8+ lymphocytes in peripheral blood obtained from dogs with histiocytic sarcoma were upregulated. The overexpressions of CTLA 4 and PD-1 suggested that antitumor immunity may be suppressed in dogs with histiocytic sarcoma.	[Tagawa, Michihito] Obihiro Univ Agr & Vet Med, Ctr Vet Med, Dept Vet Clin Sci, Obihiro, Hokkaido 080, Japan; [Maekawa, Naoya; Konnai, Satoru] Hokkaido Univ, Dept Dis Control, Grad Sch Vet Med, Sappro, Hokkaido, Japan; [Takagi, Satoshi] Hokkaido Univ, Dept Vet Clin Sci, Grad Sch Vet Med, Vet Teaching Hosp, Sappro, Hokkaido, Japan	Obihiro University of Agriculture & Veterinary Medicine; Hokkaido University; Hokkaido University	Takagi, S (corresponding author), Hokkaido Univ, Dept Vet Clin Sci, Grad Sch Vet Med, Vet Teaching Hosp, Sappro, Hokkaido, Japan.	stake@vetmed.hokudai.ac.jp		TAKAGI, Satoshi/0000-0001-6653-5890; Satoru, Konnai/0000-0002-3230-7109	JSPS [26450420]; Grants-in-Aid for Scientific Research [26450420, 25257415] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (https://www.jsps.go.jp/j-grantsinaid/index.html) Grant Numbers 26450420. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayukawa H, 2004, CLIN EXP IMMUNOL, V137, P151, DOI 10.1111/j.1365-2249.2004.02502.x; Brzezinska A, 2004, EXP GERONTOL, V39, P539, DOI 10.1016/j.exger.2003.09.026; Callahan MK, 2013, J LEUKOCYTE BIOL, V94, P41, DOI 10.1189/jlb.1212631; Capece D, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/926321; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Choi SY, 2005, PEDIAT ALLERG IMM-UK, V16, P422, DOI 10.1111/j.1399-3038.2005.00274.x; Craig LE, 2002, VET PATHOL, V39, P66, DOI 10.1354/vp.39-1-66; Erfani N, 2012, LUNG CANCER, V77, P306, DOI 10.1016/j.lungcan.2012.04.011; Esch KJ, 2013, J IMMUNOL, V191, P5542, DOI 10.4049/jimmunol.1301810; Folk A, 2010, VET IMMUNOL IMMUNOP, V134, P33, DOI 10.1016/j.vetimm.2009.10.006; Friedrichs KR, 2010, J VET INTERN MED, V24, P904, DOI 10.1111/j.1939-1676.2010.0543.x; Fulmer AK, 2007, CAN VET J, V48, P1041; Gardner D, 2014, AM J TRANSPLANT, V14, P1985, DOI 10.1111/ajt.12834; Graves SS, 2011, TRANSPLANTATION, V91, P833, DOI 10.1097/TP.0b013e31820f07ff; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Jaberipour M, 2010, PATHOL ONCOL RES, V16, P547, DOI 10.1007/s12253-010-9256-8; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; KOL R, 1983, RADIAT RES, V95, P108, DOI 10.2307/3576075; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Li J, 2014, ONCOL LETT, V8, P1682, DOI 10.3892/ol.2014.2391; Moore PF, 2006, VET PATHOL, V43, P632, DOI 10.1354/vp.43-5-632; Moore PF, 2014, VET PATHOL, V51, P167, DOI 10.1177/0300985813510413; Motta M, 2005, LEUKEMIA, V19, P1788, DOI 10.1038/sj.leu.2403907; Nielsen LN, 2012, VET COMP ONCOL, V10, P124, DOI 10.1111/j.1476-5829.2011.00285.x; Nielsen LN, 2013, VET J, V198, P424, DOI 10.1016/j.tvjl.2013.07.030; Ott PA, 2013, CLIN CANCER RES, V19, P5300, DOI 10.1158/1078-0432.CCR-13-0143; Rassnick KM, 2010, J VET INTERN MED, V24, P1528, DOI 10.1111/j.1939-1676.2010.0588.x; Saito H, 2013, J SURG ONCOL, V107, P517, DOI 10.1002/jso.23281; Sakai M, 2006, J VET MED SCI, V68, P1219, DOI 10.1292/jvms.68.1219; Salazar-Fontana LI, 2001, CLIN IMMUNOL, V99, P253, DOI 10.1006/clim.2001.5003; Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x; Skorupski KA, 2007, J VET INTERN MED, V21, P121, DOI 10.1892/0891-6640(2007)21[121:CFTTOD]2.0.CO;2; Takahashi M, 2014, J VET MED SCI, V76, P661, DOI 10.1292/jvms.13-0414; Tosti G, 2013, CLIN COSMET INVESTI, V6, P245, DOI 10.2147/CCID.S24246; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Wulfing C, 2014, NAT IMMUNOL, V15, P408, DOI 10.1038/ni.2870; Yamazaki H, 2014, J VET INTERN MED, V28, P204, DOI 10.1111/jvim.12244	38	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0150030	10.1371/journal.pone.0150030	http://dx.doi.org/10.1371/journal.pone.0150030			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901565	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100202
J	Wen, SW; Guo, YF; Rodger, M; White, RR; Yang, QY; Smith, GN; Perkins, SL; Walker, MC				Wen, Shi Wu; Guo, Yanfang; Rodger, Marc; White, Ruth Rennicks; Yang, Qiuying; Smith, Graeme N.; Perkins, Sherry L.; Walker, Mark C.			Folic Acid Supplementation in Pregnancy and the Risk of Pre-Eclampsia-A Cohort Study	PLOS ONE			English	Article							PERICONCEPTIONAL MULTIVITAMIN USE; HYPERTENSIVE DISORDERS; PREECLAMPSIA; WOMEN; FOLATE; COMPLICATIONS; MORTALITY; MOTHERS	This prospective cohort study designed to assess the effect of folic acid supplementation in pregnancy on the risk of preeclampsia (PE) took place in Ottawa, ON and Kingston, ON, Canada, from September 1, 2002 to August 31, 2008. Pregnant women, less than 20 weeks gestational age were recruited and delivered in the Ottawa region and the Kingston General Hospital. Demographic characteristics of the study participants and the patterns of supplementation of folic acid were described and occurrence of PE between women with folic acid supplementation during pregnancy and women without were compared. Multiple logistic regression was used in the estimation of the independent effect of supplementation of folic acid. Additional analyses assessing the effect of low RBC and serum folate and dose-response relationship were performed. Analyses were performed in all study participants, and then in high risk and low risk sub-groups, respectively. A total of 7,669 participants were included in the final analysis. Ninety five percent of the study participants were taking folic acid supplementation in early second trimester. The rate of PE was lower in the supplementation group than in the no supplementation group, and the difference was statistically significant in high risk women. Similar patterns of associations were observed in analysis by RBC and serum folate levels and in dose-response analysis. Folic acid supplementation in pregnancy may reduce PE risk in pregnant women, especially in those women with increased risk of developing PE.	[Wen, Shi Wu; Guo, Yanfang; White, Ruth Rennicks; Walker, Mark C.] Univ Ottawa, Fac Med, Dept Obstet & Gynecol, OMNI Res Grp, Ottawa, ON, Canada; [Wen, Shi Wu; Guo, Yanfang; Rodger, Marc; White, Ruth Rennicks; Walker, Mark C.] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Wen, Shi Wu; Rodger, Marc; Walker, Mark C.] Univ Ottawa, Fac Med, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada; [Rodger, Marc] Univ Ottawa, Fac Med, Div Hematol, Dept Med, Ottawa, ON, Canada; [Yang, Qiuying] Publ Hlth Agcy Canada, Ottawa, ON, Canada; [Smith, Graeme N.] Kingston Gen Hosp, Queens Perinatal Res Unit, Kingston, ON K7L 2V7, Canada; [Smith, Graeme N.] Queens Univ, Dept Obstet & Gynecol, Sch Med, Kingston, ON, Canada; [Perkins, Sherry L.] Ottawa Hosp, Div Biochem, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Public Health Agency of Canada; Queens University - Canada; Queens University - Canada; University of Ottawa; Ottawa Hospital Research Institute	Wen, SW (corresponding author), Univ Ottawa, Fac Med, Dept Obstet & Gynecol, OMNI Res Grp, Ottawa, ON, Canada.; Wen, SW (corresponding author), Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.; Wen, SW (corresponding author), Univ Ottawa, Fac Med, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada.	swwen@ohri.ca	Smith, Graeme Neil/ABB-6863-2021	Smith, Graeme Neil/0000-0002-3128-4523; Rodger, Marc/0000-0001-8166-3487	Canadian Institute for Health Research [MOP 82802]	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by a grant from the Canadian Institute for Health Research (grant #MOP 82802).	ACOG Task Force on Hypertension in Pregnancy, 2013, OBSTET GYNECOLOGY, V122, DOI [10.1097/01.AOG.0000437382.03963.88, DOI 10.1097/01.AOG.0000437382.03963.88]; ALES KL, 1988, J CLIN EPIDEMIOL, V41, P1095, DOI 10.1016/0895-4356(88)90079-0; BARKER DJP, 1989, LANCET, V2, P577; Bodnar LM, 2006, AM J EPIDEMIOL, V164, P470, DOI 10.1093/aje/kwj218; Branum AM, 2013, J NUTR, V143, P486, DOI 10.3945/jn.112.169987; Catov JM, 2009, AM J EPIDEMIOL, V169, P1304, DOI 10.1093/aje/kwp052; de la Calle M, 2003, EUROPEAN J OBSTET GY, V107, P125; Dekker GA, 1998, AM J OBSTET GYNECOL, V179, P1359, DOI 10.1016/S0002-9378(98)70160-7; GOLDENBERG RL, 1992, OBSTET GYNECOL, V79, P719; Hernandez-Diaz S, 2002, AM J EPIDEMIOL, V156, P806, DOI 10.1093/aje/kwf129; Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213; Keating E, 2009, REPROD TOXICOL, V28, P511, DOI 10.1016/j.reprotox.2009.07.001; Kupferminc MJ, 1999, NEW ENGL J MED, V340, P9, DOI 10.1056/NEJM199901073400102; Liu AZ, 2009, HYPERTENS PREGNANCY, V28, P76, DOI 10.1080/10641950802366252; Magee LA, 2008, J OBSTET GYNAECOL CA, V30, pS1, DOI 10.1016/S1701-2163(16)32776-1; Nilsen RM, 2008, AM J EPIDEMIOL, V167, P867, DOI 10.1093/aje/kwm373; Paul DA, 2009, AM J PERINAT, V26, P467, DOI 10.1055/s-0029-1214246; Peek MJ, 1995, MED J AUSTR, V162; Ray JG, 1999, PLACENTA, V20, P519, DOI 10.1053/plac.1999.0417; Roberts JM, 2002, PLACENTA, V23, P359, DOI 10.1053/plac.2002.0819; Sen S, 2014, J PERINATOL, V34, P105, DOI 10.1038/jp.2013.153; Smith GN, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.06.035; Timmermans S, 2011, NUTR METAB CARDIOVAS, V21, P54, DOI 10.1016/j.numecd.2009.07.002; Vogel JP1, 2014, BMC PREGNANCY CHILDB, V14; Vollset SE, 2000, AM J CLIN NUTR, V71, P962; Wen SW, 2008, CAN MED ASSOC J, V179, P1263, DOI 10.1503/cmaj.080859; Wen SW, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.067; Whitfield MF, 1997, ADC FETAL NEONATAL E, V77; World Health Organization, 2015, OPT SER RED BLOOD CE; Yaremco E, 2013, BIRTH DEFECTS RES A, V97, P416, DOI 10.1002/bdra.23144; Zhang J, 2003, HYPERTENS PREGNANCY, V22, P203, DOI 10.1081/PRG-120021066	31	29	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149818	10.1371/journal.pone.0149818	http://dx.doi.org/10.1371/journal.pone.0149818			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901463	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100157
J	Wind, DK; Sapiezynski, P; Furman, MA; Lehmann, S				Wind, David Kofoed; Sapiezynski, Piotr; Furman, Magdalena Anna; Lehmann, Sune			Inferring Stop-Locations from WiFi	PLOS ONE			English	Article								Human mobility patterns are inherently complex. In terms of understanding these patterns, the process of converting raw data into series of stop-locations and transitions is an important first step which greatly reduces the volume of data, thus simplifying the subsequent analyses. Previous research into the mobility of individuals has focused on inferring 'stop locations' (places of stationarity) from GPS or CDR data, or on detection of state (static/active). In this paper we bridge the gap between the two approaches: we introduce methods for detecting both mobility state and stop-locations. In addition, our methods are based exclusively on WiFi data. We study two months of WiFi data collected every two minutes by a smartphone, and infer stop-locations in the form of labelled time-intervals. For this purpose, we investigate two algorithms, both of which scale to large datasets: a greedy approach to select the most important routers and one which uses a density-based clustering algorithm to detect router fingerprints. We validate our results using participants' GPS data as well as ground truth data collected during a two month period.	[Wind, David Kofoed; Sapiezynski, Piotr; Furman, Magdalena Anna; Lehmann, Sune] Tech Univ Denmark, DTU Compute, Copenhagen, Denmark	Technical University of Denmark	Wind, DK (corresponding author), Tech Univ Denmark, DTU Compute, Copenhagen, Denmark.	dawi@dtu.dk		Lehmann, Sune/0000-0001-6099-2345	Villum Foundation; University of Copenhagen [UCPH2016]; Villum Fonden [00007192] Funding Source: researchfish	Villum Foundation(Villum Fonden); University of Copenhagen; Villum Fonden(Villum Fonden)	This work was supported by Villum Foundation, http://villumfoundation.dk/C12576AB0041F11B/0/4F7615B6F43A8EA5C1257AEF003D9930?OpenDocument, Young Investigator programme 2012, High Resolution Networks (SL) and University of Copenhagen, http://dsin.ku.dk/news/ucph_funds/, through the UCPH2016 Social Fabric grant (SL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharony N, 2011, PERVASIVE MOB COMPUT, V7, P643, DOI 10.1016/j.pmcj.2011.09.004; [Anonymous], 2007, BIOECOLOGICAL MODEL; Crandall DJ, 2010, P NATL ACAD SCI USA, V107, P22436, DOI 10.1073/pnas.1006155107; Cuttone A, 2014, PROCEEDINGS OF THE 2014 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING (UBICOMP'14 ADJUNCT), P995, DOI 10.1145/2638728.2641283; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Krumm J, 2004, PROCEEDINGS OF MOBIQUITOUS 2004, P4; Marston SA, 2005, T I BRIT GEOGR, V30, P416, DOI 10.1111/j.1475-5661.2005.00180.x; Montoliu R, 2010, P 9 INT C MOB UB MUL, P12, DOI DOI 10.1145/1899475.1899487; Mun M, 2008, P 5 WORKSH EMB NETW; Muthukrishnan K, 2007, LECT NOTES COMPUT SC, V4793, P62; Paek J, 2010, P 8 INT C MOBILE SYS, P299, DOI 10.1145/1814433.1814463; Ranjan G, 2012, MOB COMPUT COMMUN RE, V16, P33, DOI 10.1145/2412096.2412101; Sapiezynski P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130824; Staiano J, 2014, UBICOMP'14: PROCEEDINGS OF THE 2014 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING, P583, DOI 10.1145/2632048.2632074; Wang D., 2011, P 17 ACM SIGKDD INT, P1100, DOI DOI 10.1145/2020408.2020581; Wang XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084954; Winkel G, 2009, J ENVIRON PSYCHOL, V29, P318, DOI 10.1016/j.jenvp.2009.02.005; Yan XY, 2013, SCI REP-UK, V3, DOI 10.1038/srep02678	24	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149105	10.1371/journal.pone.0149105	http://dx.doi.org/10.1371/journal.pone.0149105			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901663	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100038
J	Giles, DA; Moreno-Fernandez, ME; Stankiewicz, TE; Cappelletti, M; Huppert, SS; Iwakura, Y; Dong, C; Shanmukhappa, SK; Divanovic, S				Giles, Daniel A.; Moreno-Fernandez, Maria E.; Stankiewicz, Traci E.; Cappelletti, Monica; Huppert, Stacey S.; Iwakura, Yoichiro; Dong, Chen; Shanmukhappa, Shiva K.; Divanovic, Senad			Regulation of Inflammation by IL-17A and IL-17F Modulates Non-Alcoholic Fatty Liver Disease Pathogenesis	PLOS ONE			English	Article							CHOLINE-DEFICIENT DIET; HEPATIC STEATOSIS; IL-17-PRODUCING CELLS; KUPFFER CELLS; FIBROSIS; STEATOHEPATITIS; PROGRESSION; NASH; ADIPOGENESIS; RECRUITMENT	Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease worldwide. While it is well-accepted that inflammation is central to NAFLD pathogenesis, the immune pathway(s) orchestrating disease progression are poorly defined. Notably, IL-17RA signaling, via IL-17A, plays an important role in obesity-driven NAFLD pathogenesis. However, the role of the IL-17F, another IL-17RA ligand, in NAFLD pathogenesis has not been examined. Further, the cell types expressing IL-17RA and producing IL-17RA ligands in the pathogenesis of NAFLD have not been defined. Here, IL-17RA(-/-), IL-17A(-/-), IL-17F(-/-) and wild-type (WT) mice were fed either standard chow diet or methionine and choline deficient diet (MCDD)-a diet known to induce steatosis and hepatic inflammation through beta-oxidation dysfunction-and hepatic inflammation and NAFLD progression were subsequently quantified. MCDD feeding augmented hepatic IL-17RA expression and significantly increased hepatic infiltration of macrophages and IL-17A and IL-17F producing CD4(+) and CD8(+) T cells in WT mice. In contrast, IL-17RA(-/-), IL-17A(-/-), and IL-17F(-/-) mice, despite increased steatosis, exhibited significant protection from hepatocellular damage compared to WT controls. Protection from hepatocellular damage correlated with decreased levels of hepatic T-cell and macrophage infiltration and decreased expression of inflammatory mediators associated with NAFLD. In sum, our results indicate that the IL-17 axis also plays a role in a MCDD-induced model of NAFLD pathogenesis. Further, we show for the first time that IL-17F, and not only IL-17A, plays an important role in NAFLD driven inflammation.	[Giles, Daniel A.; Moreno-Fernandez, Maria E.; Stankiewicz, Traci E.; Cappelletti, Monica; Divanovic, Senad] Cincinnati Childrens Hosp Res Fdn, Div Immunobiol, Cincinnati, OH USA; [Giles, Daniel A.; Moreno-Fernandez, Maria E.; Stankiewicz, Traci E.; Cappelletti, Monica; Huppert, Stacey S.; Shanmukhappa, Shiva K.; Divanovic, Senad] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Huppert, Stacey S.] Cincinnati Childrens Hosp Res Fdn, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH USA; [Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Noda, Chiba 278, Japan; [Dong, Chen] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Shanmukhappa, Shiva K.] Cincinnati Childrens Hosp Res Fdn, Div Pathol & Lab Med, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Tokyo University of Science; University of Texas System; UTMD Anderson Cancer Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Divanovic, S (corresponding author), Cincinnati Childrens Hosp Res Fdn, Div Immunobiol, Cincinnati, OH USA.; Divanovic, S (corresponding author), Univ Cincinnati, Coll Med, Cincinnati, OH USA.	senad.divanovic@cchmc.org	dong, chen/B-3181-2009; Huppert, Stacey S/A-4103-2010; Iwakura, Yoichiro/E-5457-2011	dong, chen/0000-0002-0084-9130; Huppert, Stacey S/0000-0003-3977-8728; Iwakura, Yoichiro/0000-0002-9934-5775	NIH [R01DK099222, R01DK099222-S1]; PHS [P30 DK078392]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099222, P30DK078392] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by NIH R01DK099222 and R01DK099222-S1 (to S.D.) and by PHS Grant P30 DK078392 Pathology of the Digestive Disease Research Core Center at CCHMC. There was no additional external funding received for this study.	Ahmed M, 2013, CYTOKINE, V61, P898, DOI 10.1016/j.cyto.2012.12.007; Alam S, 2014, INDIAN J GASTROENTER, V33, P452, DOI 10.1007/s12664-014-0488-5; Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Balanescu P, 2012, Rom J Intern Med, V50, P13; Chae MK, 2012, EXP DIABETES RES, DOI 10.1155/2012/762565; Chang SH, 2007, CELL RES, V17, P435, DOI 10.1038/cr.2007.35; Ciric B, 2009, J IMMUNOL, V182, P5296, DOI 10.4049/jimmunol.0900036; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Divanovic S, 2012, J INFECT DIS, V205, P152, DOI 10.1093/infdis/jir621; Divanovic S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001316; Du WJ, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-40; Fabrega E, 2009, LIVER TRANSPLANT, V15, P629, DOI 10.1002/lt.21724; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Giles DA, 2015, CURR DRUG TARGETS; Harley ITW, 2014, HEPATOLOGY, V59, P1830, DOI 10.1002/hep.26746; Huang TT, 2006, HUM MOL GENET, V15, P1187, DOI 10.1093/hmg/ddl034; Itagaki H, 2013, INT J CLIN EXP PATHO, V6, P2683; Jie ZL, 2014, J IMMUNOL, V192, P3289, DOI 10.4049/jimmunol.1303281; Jin W, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.58; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Kohli R, 2010, HEPATOLOGY, V52, P934, DOI 10.1002/hep.23797; Lan RYZ, 2009, J AUTOIMMUN, V32, P43, DOI 10.1016/j.jaut.2008.11.001; Lemmers A, 2009, HEPATOLOGY, V49, P646, DOI 10.1002/hep.22680; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Liu Y, 2014, INT IMMUNOPHARMACOL, V23, P489, DOI 10.1016/j.intimp.2014.09.024; Lu L, 2013, J IMMUNOTHER, V36, P451, DOI 10.1097/CJI.0b013e3182a802cf; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Meng FL, 2012, GASTROENTEROLOGY, V143, P765, DOI 10.1053/j.gastro.2012.05.049; Park HS, 2011, MOL CELLS, V32, P571, DOI 10.1007/s10059-011-0184-6; Peverill W, 2014, INT J MOL SCI, V15, P8591, DOI 10.3390/ijms15058591; Provenzano A, 2014, LIVER INT, V34, P918, DOI 10.1111/liv.12500; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Rinella ME, 2011, HEPATOLOGY, V54, P1118, DOI 10.1002/hep.24634; Sundrud MS, 2013, SEMIN IMMUNOL, V25, P263, DOI 10.1016/j.smim.2013.10.021; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Trujillo G, 2008, AM J PATHOL, V172, P1209, DOI 10.2353/ajpath.2008.070832; Vizzutti F, 2010, LAB INVEST, V90, P104, DOI 10.1038/labinvest.2009.112; Wang AJ, 2015, J IMMUNOL, V195, P4771, DOI 10.4049/jimmunol.1500337; Xu RF, 2013, ACTA BIOCH BIOPH SIN, V45, P726, DOI 10.1093/abbs/gmt065; Yamaguchi K, 2010, LAB INVEST, V90, P1169, DOI 10.1038/labinvest.2010.75; Yan S, 2012, IMMUNOL CELL BIOL, V90, P421, DOI 10.1038/icb.2011.59; Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033; Zhang X, 2014, J HEPATOL, V61, P1365, DOI 10.1016/j.jhep.2014.07.006; Zigmond E, 2014, J IMMUNOL, V193, P344, DOI 10.4049/jimmunol.1400574; Zuniga LA, 2010, J IMMUNOL, V185, P6947, DOI 10.4049/jimmunol.1001269	48	67	70	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149783	10.1371/journal.pone.0149783	http://dx.doi.org/10.1371/journal.pone.0149783			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895034	gold, Green Published, Green Submitted			2022-12-27	WOS:000371223400081
J	Hehre, EJ; Meeuwig, JJ				Hehre, E. James; Meeuwig, Jessica J.			A Global Analysis of the Relationship between Farmed Seaweed Production and Herbivorous Fish Catch	PLOS ONE			English	Article							CORAL-REEFS; FISHERIES; PHILIPPINES; SIGANIDAE; RECOVERY; IMPACTS; FUTURE; DEGRADATION; BIOMASS; SHIFTS	Globally, farmed seaweed production is expanding rapidly in shallow marine habitats. While seaweed farming provides vital income to millions of artisanal farmers, it can negatively impact shallow coral reef and seagrass habitats. However, seaweed farming may also potentially provide food subsidies for herbivorous reef fish such as the Siganidae, a valuable target family, resulting in increased catch. Comparisons of reef fish landings across the central Philippines revealed that the catch of siganids was positively correlated to farmed seaweed production whilst negatively correlated to total reef fish catch over the same period of time. We tested the generality of this pattern by analysing seaweed production, siganid catch, and reef fish catch for six major seaweed-producing countries in the tropics. We hypothesized that increased seaweed production would correspond with increased catch of siganids but not other reef fish species. Analysis of the global data showed a positive correlation between farmed seaweeds and siganids in Southeast Asia (Indonesia, Malaysia, and the Philippines) but not Africa (Tanzania and Zanzibar), or the Western Pacific (Fiji). In Southeast Asia, siganid catch increased disproportionately faster with seaweed production than did reef fish catch. Low continuity, sporadic production and smaller volumes of seaweed farming may explain the differences.	[Hehre, E. James] Univ British Columbia, Sea Us Project, Inst Oceans & Fisheries, Vancouver, BC V5Z 1M9, Canada; [Meeuwig, Jessica J.] Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia; [Meeuwig, Jessica J.] Univ Western Australia, Ctr Marine Futures, Crawley, WA, Australia	University of British Columbia; University of Western Australia; University of Western Australia	Hehre, EJ (corresponding author), Univ British Columbia, Sea Us Project, Inst Oceans & Fisheries, Vancouver, BC V5Z 1M9, Canada.	jhehre@gmail.com		Meeuwig, Jessica/0000-0003-1169-8785	Jerry and Jan Barto Foundation; Craig and Gigi Barto Foundation; Endeavour Fellowship; UBC Four Year Fellowship	Jerry and Jan Barto Foundation; Craig and Gigi Barto Foundation; Endeavour Fellowship; UBC Four Year Fellowship	This study was funded in part by The Jerry and Jan Barto Foundation, Craig and Gigi Barto Foundation, The Endeavour Fellowship, and the UBC Four Year Fellowship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DC, 2012, ECOLOGY, V93, P2165, DOI 10.1890/11-1541.1; Allen KR, 1971, RELATION PRODUCTION; Allison EH, 2001, MAR POLICY, V25, P377, DOI 10.1016/S0308-597X(01)00023-9; Anticamara JA, 2011, FISH RES, V107, P131, DOI 10.1016/j.fishres.2010.10.016; Armada N, 2009, COAST MANAGE, V37, P308, DOI 10.1080/08920750902851609; Badjeck MC, 2010, MAR POLICY, V34, P375, DOI 10.1016/j.marpol.2009.08.007; Beddington J.R., 1983, 242 FAO; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bergman KC, 2001, MAR POLLUT BULL, V42, P1379, DOI 10.1016/S0025-326X(01)00168-0; BLANKENHORN SU, 2007, THESIS; Borsa P, 2007, MOL PHYLOGENET EVOL, V44, P427, DOI 10.1016/j.ympev.2007.01.015; Brandl SJ, 2014, CORAL REEFS, V33, P421, DOI 10.1007/s00338-013-1110-5; Brandl SJ, 2013, CORAL REEFS, V32, P835, DOI 10.1007/s00338-013-1042-0; Bryceson I, 2002, WEST INDIAN OCEAN J, V1, P1; Burke Lauretta, 2011, REEFS AT RISK; Chopin T, 2001, J PHYCOL, V37, P975, DOI 10.1046/j.1529-8817.2001.01137.x; Christensen V, 1995, NAGA ICLARM Q, P34; Christie P., 2006, COASTAL ENV FISHERIE, P1; de la Torre-Castro M, 2010, MAR POLICY, V34, P77, DOI 10.1016/j.marpol.2009.04.012; Eklof JS, 2006, MAR ECOL PROG SER, V325, P73, DOI 10.3354/meps325073; FAO (Food and Agriculture Organization of the United Nations) Fisheries and Aquaculture Department, 2012, THE STATE OF THE WOR; Fox RJ, 2008, CORAL REEFS, V27, P605, DOI 10.1007/s00338-008-0359-6; Fox RJ, 2009, MAR ECOL PROG SER, V385, P261, DOI 10.3354/meps08059; Frocklin S, 2011, WORLD AQUACULTURE, V356, P30; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2015, NATURE, V518, P94, DOI 10.1038/nature14140; Graham NAJ, 2014, CURR BIOL, V24, pR359, DOI 10.1016/j.cub.2014.03.069; Green S, 2004, FLUID VORTICES, P1; Harper S, 2011, FISHERIES CATCH RE 2, P19; Hehre EJ, 2015, PLOS ONE, P1; Hill NAO, 2012, CONSERV BIOL, V26, P324, DOI 10.1111/j.1523-1739.2011.01796.x; Hoey AS, 2013, CORAL REEFS, V32, P973, DOI 10.1007/s00338-013-1043-z; Hoey AS, 2011, ECOL LETT, V14, P267, DOI 10.1111/j.1461-0248.2010.01581.x; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings S, 1996, AMBIO, V25, P44; Juanich GL, 1988, MANUAL SEAWEED FARMI; Kite-Powell H, 2005, INTEGRATED SEAWEED S, P12; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Lal A., 2010, SPC WOMEN FISHERIES, V21, P11; LAM TJ, 1974, AQUACULTURE, V3, P325, DOI 10.1016/0044-8486(74)90001-5; MacNeil MA, 2015, NATURE, V520, P341, DOI 10.1038/nature14358; Mantyka CS, 2007, CORAL REEFS, V26, P435, DOI 10.1007/s00338-007-0214-1; Marcus JE, 2007, MAR POLLUT BULL, V54, P1483, DOI 10.1016/j.marpolbul.2007.04.011; Maunder MN, 2006, ICES J MAR SCI, V63, P1373, DOI 10.1016/j.icesjms.2006.05.008; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McCook LJ, 1997, MAR BIOL, V129, P713, DOI 10.1007/s002270050214; McManus JW, 1997, CORAL REEFS, V16, pS121, DOI 10.1007/s003380050248; Msuya F.E., 2007, COMP EC ANAL 2 SEAWE, P27; Munro J, 1996, CHAPMAN HALL FISH FI, DOI [10.1007/978-94-015-8779-2_1, DOI 10.1007/978-94-015-8779-2_1]; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; NORBERG RA, 1977, J ANIM ECOL, V46, P511, DOI 10.2307/3827; OGDEN J C, 1978, Environmental Biology of Fishes, V3, P49, DOI 10.1007/BF00006308; ORTH RJ, 1984, ESTUARIES, V7, P339, DOI 10.2307/1351618; Pauly D., 1994, TRADITIONAL MARINE R, V3, P7; Pettersson-Lofquist P., 1995, SOCIAL EC CHANGE ZAN; Polunin NVC, 1996, TROPHODYNAMICS REEF; Rasher DB, 2013, ECOLOGY, V94, P1347, DOI 10.1890/12-0389.1; Robinson J, 2007, INVESTIGATION IMPORT; Rogers A, 2014, CURR BIOL, V24, P1000, DOI 10.1016/j.cub.2014.03.026; Samoilys M. A., 2013, WIOMSA BOOK SERIES, V13, P33; Sievanen L, 2005, OCEAN COAST MANAGE, V48, P297, DOI 10.1016/j.ocecoaman.2005.04.015; SOLIMAN VS, 2008, KUROSHIO SCI, V2, P67; Spalding M. D., 2001, WORLD ATLAS CORAL RE; Swartz W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015143; Vincent I. V., 2011, Western Indian Ocean Journal of Marine Science, V10, P83; Williamson DH, 2014, ECOL EVOL, V4, P337, DOI 10.1002/ece3.934; Wilson SK, 2010, ECOL APPL, V20, P442, DOI 10.1890/08-2205.1; Woodland DJ, 1990, INDOPACIIFIC FISH; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Worm B, 2012, TRENDS ECOL EVOL, V27, P594, DOI 10.1016/j.tree.2012.07.005; Zar JH., 2010, BIOSTAT ANAL, V5th	73	23	25	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148250	10.1371/journal.pone.0148250	http://dx.doi.org/10.1371/journal.pone.0148250			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894553	Green Published, Green Submitted, gold			2022-12-27	WOS:000371223400011
J	Shashkova, T; Popenko, A; Tyakht, A; Peskov, K; Kosinsky, Y; Bogolubsky, L; Raigorodskii, A; Ischenko, D; Alexeev, D; Govorun, V				Shashkova, Tatiana; Popenko, Anna; Tyakht, Alexander; Peskov, Kirill; Kosinsky, Yuri; Bogolubsky, Lev; Raigorodskii, Andrei; Ischenko, Dmitry; Alexeev, Dmitry; Govorun, Vadim			Agent Based Modeling of Human Gut Microbiome Interactions and Perturbations	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; ANTIBIOTIC PERTURBATION; GASTROINTESTINAL-TRACT; INTESTINAL MICROBIOTA; BACTERIAL BIOFILMS; METABOLISM; DYNAMICS; COLON; SUSCEPTIBILITY; INFLAMMATION	Background Intestinal microbiota plays an important role in the human health. It is involved in the digestion and protects the host against external pathogens. Examination of the intestinal microbiome interactions is required for understanding of the community influence on host health. Studies of the microbiome can provide insight on methods of improving health, including specific clinical procedures for individual microbial community composition modification and microbiota correction by colonizing with new bacterial species or dietary changes. Methodology/Principal Findings In this work we report an agent-based model of interactions between two bacterial species and between species and the gut. The model is based on reactions describing bacterial fermentation of polysaccharides to acetate and propionate and fermentation of acetate to butyrate. Antibiotic treatment was chosen as disturbance factor and used to investigate stability of the system. System recovery after antibiotic treatment was analyzed as dependence on quantity of feedback interactions inside the community, therapy duration and amount of antibiotics. Bacterial species are known to mutate and acquire resistance to the antibiotics. The ability to mutate was considered to be a stochastic process, under this suggestion ratio of sensitive to resistant bacteria was calculated during antibiotic therapy and recovery. Conclusion/Significance The model confirms a hypothesis of feedbacks mechanisms necessity for providing functionality and stability of the system after disturbance. High fraction of bacterial community was shown to mutate during antibiotic treatment, though sensitive strains could become dominating after recovery. The recovery of sensitive strains is explained by fitness cost of the resistance. The model demonstrates not only quantitative dynamics of bacterial species, but also gives an ability to observe the emergent spatial structure and its alteration, depending on various feedback mechanisms. Visual version of the model shows that spatial structure is a key factor, which helps bacteria to survive and to adapt to changed environmental conditions.	[Shashkova, Tatiana; Popenko, Anna; Tyakht, Alexander; Ischenko, Dmitry; Alexeev, Dmitry; Govorun, Vadim] Res Inst Phys Chem Med, Malaya Pirogovskaya 1a, Moscow 119435, Russia; [Shashkova, Tatiana; Alexeev, Dmitry] Moscow Inst Phys & Technol, Inst Skiy Pereulok 9, Dolgoprudnyi 141700, Russia; [Peskov, Kirill; Kosinsky, Yuri] M&S Decis LLC, Narishkinskaya Alleya 5, Moscow 125167, Russia; [Bogolubsky, Lev; Raigorodskii, Andrei] Yandex LLC, 16 Leo Tolstoy St, Moscow 119021, Russia	Lopukhin Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency; Moscow Institute of Physics & Technology	Alexeev, D (corresponding author), Res Inst Phys Chem Med, Malaya Pirogovskaya 1a, Moscow 119435, Russia.; Alexeev, D (corresponding author), Moscow Inst Phys & Technol, Inst Skiy Pereulok 9, Dolgoprudnyi 141700, Russia.	alexeev@niifhm.ru	Govorun, Vadim M/A-9043-2018; Tyakht, Alexander/O-1327-2015; Shashkova, Tatiana/AAO-3579-2020; Alexeev, Dmitry/A-6167-2013; Raigorodskii, Andrei M/L-5095-2017	Shashkova, Tatiana/0000-0002-8754-8727; Alexeev, Dmitry/0000-0003-0783-1176; Raigorodskii, Andrei/0000-0001-8614-9612; Bogolubsky, Lev/0000-0001-6178-7239; Tyakht, Alexander/0000-0002-7358-2537; Peskov, Kirill/0000-0003-0678-5729	Russian ministry of education and science [14.604.21.0119]; Rusiina scientific foundation [15-14-00066]; Russian Science Foundation [15-14-00066] Funding Source: Russian Science Foundation	Russian ministry of education and science(Ministry of Education and Science, Russian Federation); Rusiina scientific foundation; Russian Science Foundation(Russian Science Foundation (RSF))	Russian ministry of education and science-grant number 14.604.21.0119-supported the data collection and Rusiina scientific foundation-grant 15-14-00066-supported the model development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock J, 2014, BIOESSAYS, V36, P940, DOI 10.1002/bies.201400071; An G., 2013, WILEY INTERDISCIP RE, V1, P156; An G, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-11; Ananthasubramaniam B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104761; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Bucci V, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002497; Bucci V, 2011, AM NAT, V178, pE162, DOI 10.1086/662668; Carey HV, 2013, AM J PHYSIOL-REG I, V304, pR33, DOI 10.1152/ajpregu.00387.2012; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Cinquin O, 2002, J THEOR BIOL, V216, P229, DOI 10.1006/jtbi.2002.2544; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Cockrell C, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003507; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; Dodd D, 2010, J BIOL CHEM, V285, P30261, DOI 10.1074/jbc.M110.141788; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Fernandes J, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.23; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Frey E, 2010, PHYSICA A, V389, P4265, DOI 10.1016/j.physa.2010.02.047; Gore J, 2009, NATURE, V459, P253, DOI 10.1038/nature07921; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; HARIG JM, 1991, AM J PHYSIOL, V260, pG776, DOI 10.1152/ajpgi.1991.260.5.G776; Heinken A, 2015, WIRES SYST BIOL MED, V7, P195, DOI 10.1002/wsbm.1301; Heinken A, 2015, APPL ENVIRON MICROB, V81, P4049, DOI 10.1128/AEM.00101-15; Hu YF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3151; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Inglis R. F., 2013, BIOL LETT, V9, P8; Johnson S, 2014, P NATL ACAD SCI USA, V111, P17923, DOI 10.1073/pnas.1409077111; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Levy R, 2013, P NATL ACAD SCI USA, V110, P12804, DOI 10.1073/pnas.1300926110; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026542; Li YH, 2012, SENSORS-BASEL, V12, P2519, DOI 10.3390/s120302519; Lidicker WZ, 1979, CLARIFICATION INTERA, V29, P475; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Lupton JR, 2004, J NUTR, V134, P479, DOI 10.1093/jn/134.2.479; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Marino S, 2014, P NATL ACAD SCI USA, V111, P439, DOI 10.1073/pnas.1311322111; MAY RM, 1975, SIAM J APPL MATH, V29, P243, DOI 10.1137/0129022; Moreira CG, 2010, INFECT IMMUN, V78, P914, DOI 10.1128/IAI.01038-09; Morohashi M, 2002, J THEOR BIOL, V216, P19, DOI 10.1006/jtbi.2002.2537; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; Panda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095476; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rendulic S, 2004, SCIENCE, V303, P689, DOI 10.1126/science.1093027; Rhee Sang H, 2013, PRINCIPLES AND CLINI, P6; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Sahoo S, 2015, FEBS J, V282, P297, DOI 10.1111/febs.13128; Scheuring I, 2012, ECOL LETT, V15, P1300, DOI 10.1111/j.1461-0248.2012.01853.x; Schluter J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001424; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Seth EC, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00350; Shulzhenko N, 2011, NAT MED, V17, P1585, DOI 10.1038/nm.2505; Sommer MOA, 2011, CURR OPIN MICROBIOL, V14, P556, DOI 10.1016/j.mib.2011.07.005; Stein RR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003388; Theriot CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4114; Tosh PK, 2012, CLIN INFECT DIS, V54, P707, DOI 10.1093/cid/cir899; Tyakht AV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3469; VONENGELHARDT W, 1994, J PHYSIOL-LONDON, V477, P365, DOI 10.1113/jphysiol.1994.sp020198; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Wagener S, 2004, J PEDIATR SURG, V39, P166, DOI 10.1016/j.jpedsurg.2003.10.002; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Wintermute EH, 2010, GENE DEV, V24, P2603, DOI 10.1101/gad.1985210; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	75	35	37	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148386	10.1371/journal.pone.0148386	http://dx.doi.org/10.1371/journal.pone.0148386			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894828	gold, Green Published			2022-12-27	WOS:000371223400013
J	Kolawole, KA; Folayan, MO; Agbaje, HO; Oyedele, TA; Oziegbe, EO; Onyejaka, NK; Chukwumah, NM; Oshomoji, OV				Kolawole, Kikelomo Adebanke; Folayan, Morenike Oluwatoyin; Agbaje, Hakeem Olatunde; Oyedele, Titus Ayodeji; Oziegbe, Elizabeth Obhioneh; Onyejaka, Nneka Kate; Chukwumah, Nneka Maureen; Oshomoji, Olusegun Victor			Digit Sucking Habit and Association with Dental Caries and Oral Hygiene Status of Children Aged 6 Months to 12 Years Resident in Semi-Urban Nigeria	PLOS ONE			English	Article							THUMB-SUCKING; HEALTH; EXPERIENCE; DENTITION; GENDER	Objectives Non-nutritive sucking (NNS) is a common behavior in childhood. The association between digit sucking, dental caries and oral health has been studied with inconclusive results. The objectives of this study were to determine the prevalence of, and the association between digit sucking, caries and oral hygiene status of children age six months to 12 years, resident in Ile-Ife, Osun State, Nigeria. Methods A cross-sectional study was conducted in Ife Central Local Government Area of Osun State. Data were collected through a household survey using a multi-stage sampling procedure from children between six months and 12 years. Details of each child's socio-demographic characteristics, digit sucking habits, caries status and oral health status were collected. The association between digit sucking, caries status and oral hygiene status was determined using Chi square and Logistic regression. Results The mean age of the 992 study participants was 5.8 +/- (3.2) years. The prevalence of digit sucking, caries and poor oral hygiene were 7.2%, 10.5% and 2.4% respectively. The mean dmft score was 0.22 +/- (0.80), mean DMFT score was 0.04 +/- (0.30) while mean Oral Hygiene Index score was 1.27 +/- (0.73). Digit sucking increased the odds of having caries (OR: 1.28; CI: 0.58-2.81) but decreased the odds of having poor oral hygiene (OR: 0.58; CI: 0.341.01) insignificantly. Conclusions Digit sucking was not a significant predictor of caries and oral hygiene status, although the odds of having caries increased while the odds of having poor oral hygiene decreased with digit sucking.	[Kolawole, Kikelomo Adebanke; Folayan, Morenike Oluwatoyin; Oziegbe, Elizabeth Obhioneh] Obafemi Awolowo Univ, Fac Dent, Dept Child Dent Hlth, Ife, Osun State, Nigeria; [Agbaje, Hakeem Olatunde; Oyedele, Titus Ayodeji; Onyejaka, Nneka Kate; Chukwumah, Nneka Maureen; Oshomoji, Olusegun Victor] Obafemi Awolowo Univ, Teaching Hosp Complex, Dept Child Dent Hlth, Ife, Osun State, Nigeria	Obafemi Awolowo University; Obafemi Awolowo University	Kolawole, KA (corresponding author), Obafemi Awolowo Univ, Fac Dent, Dept Child Dent Hlth, Ife, Osun State, Nigeria.	kikelomokolawole@gmail.com	Kate, Onyejaka Nneka/W-3283-2019; Folayan, Morenike/A-8632-2018	Folayan, Morenike/0000-0002-9008-7730; Agbaje, Hakeem/0000-0002-8257-5283				Adair Steven M, 2003, Pediatr Dent, V25, P449; Akpata ES, 2009, AFR HEALTH SCI, V9, P227; Al-Jobair A, 2004, Int J Paediatr Dent, V14, P347, DOI 10.1111/j.1365-263X.2004.00567.x; [Anonymous], 2003, RES METHODOLOGY STAT; [Anonymous], 1934, WEBST NEW INT DICT; Boing Antonio Fernando, 2014, Rev. bras. epidemiol., V17, P102, DOI 10.1590/1809-4503201400060009; Cinar Dede Nursan, 2004, Contemp Nurse, V17, P109; Du MQ, 2007, QUINTESSENCE INT, V38, P143; Dye BA, 2015, SERVICES USDOHAH; Ferri M, 2010, INT J BIOMED IMAGING, V2010, DOI [10.1155/2010/621357, 10.1155/2010/649643]; Folayan M O, 2004, Eur J Paediatr Dent, V5, P19; Folayan M O, 2003, Int J Paediatr Dent, V13, P20, DOI 10.1046/j.1365-263X.2003.00411.x; Folayan M, 2007, AM J PHYS ANTHROPOL, V134, P443, DOI 10.1002/ajpa.20635; Folayan Morenike, 2008, J Clin Pediatr Dent, V32, P171; Folayan MO, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-156; FRIMAN PC, 1993, PEDIATRICS, V91, P784; Gopinath Vellore Kannan, 2015, Eur J Dent, V9, P36, DOI 10.4103/1305-7456.149636; GREENE JC, 1964, J AM DENT ASSOC, V68, P7, DOI 10.14219/jada.archive.1964.0034; Ha DH, 2014, AUST J RURAL HEALTH, V22, P316, DOI 10.1111/ajr.12107; Jyoti S, 2014, DENTISTRY, V4, P1; Khanal S, 2014, Nepal Med Coll J, V16, P84; Kharbanda O P, 2003, J Indian Soc Pedod Prev Dent, V21, P120; Kolawole KA, 2011, INT J DENT HYG, V9, P143, DOI 10.1111/j.1601-5037.2010.00466.x; Misbah M.M., 2005, J BAGHDAD COLL DENT, V17, P109; Natto Z S, 2014, Niger Postgrad Med J, V21, P241; Nicklisch N, 2015, ANN ANAT; Olusanya O., 1985, W AFR J MED, V4, P205; Oredugba F., 2012, ORAL HLTH CARE PEDIA, P69, DOI [10.5772/21727, DOI 10.5772/21727]; Oziegbe EO, 2013, EUR ARCH PAEDIATR DE, V14, P227, DOI 10.1007/s40368-013-0052-5; Peres KG, 2007, REV SAUDE PUBL, V41, P343, DOI 10.1590/S0034-89102007000300004; Petersen PE, 2004, INT DENT J, V54, P329; Proffit W, 2007, ORTODONCJA WSPOLCZES, V4th; Quashie-Williams R, 2010, Niger Postgrad Med J, V17, P113; Rowe N H, 1976, Pediatrics, V57, P457; Salah Afraa, 2007, Int J Orofacial Myology, V33, P37; Sgan-Cohen HD, 2014, COMMUNITY DENT HLTH, V31, P163, DOI 10.1922/CDH_3362Cohen04; Singh G, 2017, TXB ORTHODONTICS; Sowole A, 2007, Eur Arch Paediatr Dent, V8, P206; TurgeonOBrien H, 1996, J DENT CHILD, V63, P321; Vallejos-Sanchez AA, 2006, J DENT, V34, P709, DOI 10.1016/j.jdent.2006.01.003; Warren JJ, 2002, AM J ORTHOD DENTOFAC, V121, P347, DOI 10.1067/mod.2002.121445; WATSON TS, 1993, J AM ACAD CHILD PSY, V32, P830, DOI 10.1097/00004583-199307000-00019; WHO, 1997, WHO ORAL HLTH SURV B; Yonezu Takuro, 2008, Bull Tokyo Dent Coll, V49, P59, DOI 10.2209/tdcpublication.49.59; Zeng XJ, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-138	45	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0148322	10.1371/journal.pone.0148322	http://dx.doi.org/10.1371/journal.pone.0148322			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890262	Green Published, Green Submitted, gold			2022-12-27	WOS:000371221500008
J	Liu, XY; Winterton, SL				Liu, Xingyue; Winterton, Shaun L.			A New Fishfly Species (Megaloptera: Corydalidae: Neohermes Banks) Discovered from North America by a Systematic Revision, with Phylogenetic and Biogeographic Implications	PLOS ONE			English	Article							UNITED-STATES; GENUS; VICARIANCE; DISPERSAL; SIALIDAE	The taxonomy of Megaloptera from the Nearctic region is fairly well known and their faunal diversity has been largely surveyed, even in relatively remote regions. However, the evolutionary history of Nearctic Megaloptera is still poorly known with phylogenetic and biogeographic studies lacking. In this paper, we report a new fishfly species of the endemic North American genus Neohermes Banks, 1908, increasing the total number known of species to six. This new species (Neohermes inexpectatus sp. nov.) is currently known to occur only in California (USA) and is apparently confined to the Northern Coastal Range. The new species resembles the three Neohermes species from eastern North America based on the relatively small body size and the presence of female gonostyli 9. However, our phylogenetic analysis using adult morphological data recovered the new species as the sister species to the remaining Neohermes, which includes two species from western North America and three from eastern North America. According to the present interspecific phylogeny of Neohermes, with reconstructed ancestral areas, the initial divergence within the genus was found to take place in western North America, with a subsequent eastward dispersal. This likely lead to the modern distribution of Neohermes in eastern North America with the closure of the Mid-Continental Seaway, which separated western and eastern North America in the Mid-Late Cretaceous (100-80 MYA) and finally disappeared at the end of the Cretaceous (70 MYA). The uplift of the Cordilleran System probably accounted for the divergence between the eastern and two western Neohermes species.	[Liu, Xingyue] China Agr Univ, Dept Entomol, Beijing 100193, Peoples R China; [Winterton, Shaun L.] Calif Dept Food & Agr, Calif State Collect Arthropods, Sacramento, CA 95814 USA	China Agricultural University; California Department of Food & Agriculture	Liu, XY (corresponding author), China Agr Univ, Dept Entomol, Beijing 100193, Peoples R China.	xingyue_liu@yahoo.com	Liu, Xingyue/A-3019-2013	Liu, Xingyue/0000-0002-9168-0659	National Natural Science Foundation of China [31322501, 41271063]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [201178]; United States National Science Foundation [DEB-1144119]; Division Of Environmental Biology [1144119] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); United States National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the National Natural Science Foundation of China (Nos. 31322501 and 41271063), the Foundation for the Author of National Excellent Doctoral Dissertation of PR China (No. 201178) and the United States National Science Foundation (DEB-1144119).	Aspock H, 1980, NEUROPTEREN EUROPAS, V1; Avise John C., 1996, P431; Banks N., 1903, Proceedings of the Entomological Society of Washington, Vv, P237; Banks Nathan, 1908, Proceedings of the Entomological Society of Washington DC, V10; Bowles David E., 1992, Insecta Mundi, V6, P145; Contreras-Ramos A., 1998, MARYLAND T SAY MONOG; Contreras-Ramos A., 2007, ANN MUSEO CIVICO STO, V8, P67; Contreras-Ramos A, 2008, ANN ENTOMOL SOC AM, V101, P808, DOI 10.1603/0013-8746(2008)101[808:NOSNAS]2.0.CO;2; Contreras-Ramos A, 2011, ZOOTAXA, P1; Dedering U., 2010, WIKIMEDIA COMMONS FR; Evans E.D., 1972, THESIS OREGON STATE; EVANS ED, 1984, PAN-PAC ENTOMOL, V60, P1; FLINT O S JR, 1973, Revista Chilena de Entomologia, V7, P31; FLINT OLIVER S., 1965, PSYCHE J ENTOMOL [CAMBRIDGE MASSACHUSETTS], V72, P255; GLORIOSO MJ, 1981, SYST ENTOMOL, V6, P253, DOI 10.1111/j.1365-3113.1981.tb00440.x; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Johnson KP, 2011, J BIOGEOGR, V38, P1069, DOI 10.1111/j.1365-2699.2011.02501.x; Liu X.Y., 2010, FAUNA SINICA INSECTA, V51; Liu XY, 2016, SYST ENTOMOL, V41, P256, DOI 10.1111/syen.12154; Liu XY, 2015, ARTHROPOD SYST PHYLO, V73, P41; Liu XY, 2015, CLADISTICS, V31, P18, DOI 10.1111/cla.12071; Liu XY, 2011, ZOOTAXA, P1; Liu XY, 2014, ZOOTAXA, V3796, P320, DOI 10.11646/zootaxa.3796.2.5; Liu XY, 2013, SYST ENTOMOL, V38, P543, DOI 10.1111/syen.12009; Liu XY, 2012, SYST ENTOMOL, V37, P657, DOI 10.1111/j.1365-3113.2012.00635.x; Liu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040345; Liu XY, 2009, ZOOTAXA, P22, DOI 10.11646/zootaxa.2146.1.2; Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570; New Timothy R., 1993, Handbuch der Zoologie (Berlin), V4, P1; Nixon K.C., 2002, WINCLADA VER 1 00 08; Oswald J.D., 2015, NEUROPTERIDA SPECIES; Pauly GB, 2007, MOL ECOL, V16, P415, DOI 10.1111/j.1365-294X.2006.03149.x; PENNY ND, 1993, ENTOMOL NEWS, V104, P17; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Ross H. H., 1937, ILLINOIS NATURAL HIS, V21, P57; Sanmartin I, 2001, BIOL J LINN SOC, V73, P345, DOI 10.1006/bijl.2001.0542; TARTER DC, 1979, ENTOMOL NEWS, V90, P29; THEISCHINGER G, 1983, AQUAT INSECT, V5, P77, DOI 10.1080/01650428309361130; VSHIVKOVA T S, 1985, Entomologicheskoe Obozrenie, V64, P146; WHITING MF, 1991, GREAT BASIN NAT, V51, P411; Yu Y., 2011, RASP RECONSTRUCT ANC	42	1	1	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148319	10.1371/journal.pone.0148319	http://dx.doi.org/10.1371/journal.pone.0148319			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886194	Green Published, gold, Green Submitted			2022-12-27	WOS:000371218400030
J	Ding, GL; Chen, JL; Chopp, M; Li, L; Yan, T; Li, QJ; Cui, CC; Davarani, SPN; Jiang, Q				Ding, Guangliang; Chen, Jieli; Chopp, Michael; Li, Lian; Yan, Tao; Li, Qingjiang; Cui, Chengcheng; Davarani, Siamak P. N.; Jiang, Quan			Cell Treatment for Stroke in Type Two Diabetic Rats Improves Vascular Permeability Measured by MRI	PLOS ONE			English	Article							MARROW STROMAL CELLS; CONTRAST-ENHANCED MRI; ANGIOGENESIS; INJURY; MODEL; TRANSPLANTATION; STREPTOZOTOCIN; PATHOGENESIS; MELLITUS; DAMAGE	Treatment of stroke with bone marrow stromal cells (BMSC) significantly enhances brain remodeling and improves neurological function in non-diabetic stroke rats. Diabetes is a major risk factor for stroke and induces neurovascular changes which may impact stroke therapy. Thus, it is necessary to test our hypothesis that the treatment of stroke with BMSC has therapeutic efficacy in the most common form of diabetes, type 2 diabetes mellitus (T2DM). T2DM was induced in adult male Wistar rats by administration of a high fat diet in combination with a single intraperitoneal injection (35mg/kg) of streptozotocin. These rats were then subjected to 2h of middle cerebral artery occlusion (MCAo). T2DM rats received BMSC (5x10(6), n = 8) or an equal volume of phosphate-buffered saline (PBS) (n = 8) via tail-vein injection at 3 days after MCAo. MRI was performed one day and then weekly for 5 weeks post MCAo for all rats. Compared with vehicle treated control T2DM rats, BMSC treatment of stroke in T2DM rats significantly (p<0.05) decreased blood-brain barrier disruption starting at 1 week post stroke measured using contrast enhanced T-1-weighted imaging with gadopentetate, and reduced cerebral hemorrhagic spots starting at 3 weeks post stroke measured using susceptibility weighted imaging, although BMSC treatment did not reduce the ischemic lesion volumes as demarcated by T-2 maps. These MRI measurements were consistent with histological data. Thus, BMSC treatment of stroke in T2DM rats initiated at 3 days after stroke significantly reduced ischemic vascular damage, although BMSC treatment did not change infarction volume in T2DM rats, measured by MRI.	[Ding, Guangliang; Chen, Jieli; Chopp, Michael; Li, Lian; Yan, Tao; Li, Qingjiang; Cui, Chengcheng; Davarani, Siamak P. N.; Jiang, Quan] Henry Ford Hosp, Dept Neurol, 2799 West Grand Blvd, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI 48309 USA; [Yan, Tao] Tianjin Med Univ, Gen Hosp, Dept Neurol, Tianjin 300052, Peoples R China	Henry Ford Health System; Henry Ford Hospital; Oakland University; Tianjin Medical University	Jiang, Q (corresponding author), Henry Ford Hosp, Dept Neurol, 2799 West Grand Blvd, Detroit, MI 48202 USA.	qjiang1@hfhs.org	Nejad-Davarani, Siamak/AAH-8399-2021; Yan, Tao/B-2930-2012	Yan, Tao/0000-0003-3138-4468; Ding, Guangliang/0000-0003-1286-5901; Nejad-Davarani, Siamak/0000-0002-2415-6689; Li, Lian/0000-0003-0097-1184	NIH [RO1 NS083078, NS064134, AG037506, R41 S080329]; American Heart Association (AHA) [14GRNT20460026]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R41NS080329, R01NS083078, R01NS064134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037506] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was financially supported by NIH RO1 NS083078 (JC), NS064134 (QJ), AG037506 (MC), R41 S080329 (JC), and American Heart Association (AHA) 14GRNT20460026 (JC). The content is solely the responsibility of the authors and does not necessarily represent the official view of the National Institutes of Health.	Aryal MP, 2014, NMR BIOMED, V27, P1230, DOI 10.1002/nbm.3178; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cameron N, 2003, DIABETES RES CLIN PR, V61, pS35, DOI 10.1016/S0168-8227(03)00123-2; Chen JL, 2011, STROKE, V42, P3551, DOI 10.1161/STROKEAHA.111.627174; Chen JL, 2011, STROKE, V42, P445, DOI 10.1161/STROKEAHA.110.596486; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Ding G, 2014, NEUROSCIENCE, V271, P1, DOI 10.1016/j.neuroscience.2014.04.025; Ding GL, 2008, STROKE, V39, P1563, DOI 10.1161/STROKEAHA.107.502146; Ding GL, 2017, J CEREBR BLOOD F MET, V37, P241, DOI 10.1177/0271678X15622464; Ding GL, 2015, STROKE, V46, P507, DOI 10.1161/STROKEAHA.114.007538; Ergul A, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-33; Ergul A, 2009, VASC PHARMACOL, V51, P44, DOI 10.1016/j.vph.2009.02.004; Ewing JR, 2013, NMR BIOMED, V26, P1028, DOI 10.1002/nbm.2996; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Idris I, 2006, INT J CLIN PRACT, V60, P48, DOI 10.1111/j.1368-5031.2006.00682.x; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Liberman G, T1 MAPPING USING VAR; Martini SR, 2007, J CEREBR BLOOD F MET, V27, P435, DOI 10.1038/sj.jcbfm.9600355; Piotrowski P, 2003, FOLIA NEUROPATHOL, V41, P167; Reed MJ, 2000, METABOLISM, V49, P1390, DOI 10.1053/meta.2000.17721; Shen LH, 2006, NEUROSCIENCE, V137, P393, DOI 10.1016/j.neuroscience.2005.08.092; Skovso S, 2014, J DIABETES INVEST, V5, P349, DOI 10.1111/jdi.12235; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Wei N, 2013, CNS NEUROSCI THER, V19, P753, DOI 10.1111/cns.12123; Yan T, 2015, STROKE, V46, P2599, DOI 10.1161/STROKEAHA.115.009870; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Yu DY, 2001, CLIN EXP OPHTHALMOL, V29, P164; Zacharek A, 2007, J CEREBR BLOOD F MET, V27, P1684, DOI 10.1038/sj.jcbfm.9600475; Zhang C, 2006, NEUROSCIENCE, V141, P687, DOI 10.1016/j.neuroscience.2006.04.054	31	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149147	10.1371/journal.pone.0149147	http://dx.doi.org/10.1371/journal.pone.0149147			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900843	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100042
J	Ebou, MH; Singh-Estivalet, A; Launay, JM; Callebert, J; Tronche, F; Ferre, P; Gautier, JF; Guillemain, G; Breant, B; Blondeau, B; Riveline, JP				Ebou, Moina Hasni; Singh-Estivalet, Amrit; Launay, Jean-Marie; Callebert, Jacques; Tronche, Francois; Ferre, Pascal; Gautier, Jean-Francois; Guillemain, Ghislaine; Breant, Bernadette; Blondeau, Bertrand; Riveline, Jean-Pierre			Glucocorticoids Inhibit Basal and Hormone-Induced Serotonin Synthesis in Pancreatic Beta Cells	PLOS ONE			English	Article							INSULIN-SECRETION; GENE-EXPRESSION; FRONTAL-CORTEX; ISLET FUNCTION; TRYPTOPHAN; COUNTERACTS; EXPANSION; INSIGHTS; MASS	Diabetes is a major complication of chronic Glucocorticoids (GCs) treatment. GCs induce insulin resistance and also inhibit insulin secretion from pancreatic beta cells. Yet, a full understanding of this negative regulation remains to be deciphered. In the present study, we investigated whether GCs could inhibit serotonin synthesis in beta cell since this neurotransmitter has been shown to be involved in the regulation of insulin secretion. To this aim, serotonin synthesis was evaluated in vitro after treatment with GCs of either islets from CD1 mice or MIN6 cells, a beta-cell line. We also explored the effect of GCs on the stimulation of serotonin synthesis by several hormones such as prolactin and GLP 1. We finally studied this regulation in islet in two in vivo models: mice treated with GCs and with liraglutide, a GLP1 analog, and mice deleted for the glucocorticoid receptor in the pancreas. We showed in isolated islets and MIN6 cells that GCs decreased expression and activity of the two key enzymes of serotonin synthesis, Tryptophan Hydroxylase 1 (Tph1) and 2 (Tph2), leading to reduced serotonin contents. GCs also blocked the induction of serotonin synthesis by prolactin or by a previously unknown serotonin activator, the GLP-1 analog exendin-4. In vivo, activation of the Glucagon-like-Peptide-1 receptor with liraglutide during 4 weeks increased islet serotonin contents and GCs treatment prevented this increase. Finally, islets from mice deleted for the GR in the pancreas displayed an increased expression of Tph1 and Tph2 and a strong increased serotonin content per islet. In conclusion, our results demonstrate an original inhibition of serotonin synthesis by GCs, both in basal condition and after stimulation by prolactin or activators of the GLP-1 receptor. This regulation may contribute to the deleterious effects of GCs on beta cells.	[Ebou, Moina Hasni; Singh-Estivalet, Amrit; Ferre, Pascal; Gautier, Jean-Francois; Guillemain, Ghislaine; Breant, Bernadette; Blondeau, Bertrand; Riveline, Jean-Pierre] Ctr Rech Cordeliers, INSERM, UMR S 1138, F-75006 Paris, France; [Ebou, Moina Hasni; Singh-Estivalet, Amrit; Tronche, Francois; Ferre, Pascal; Gautier, Jean-Francois; Guillemain, Ghislaine; Breant, Bernadette; Blondeau, Bertrand; Riveline, Jean-Pierre] Univ Paris 06, Sorbonne Univ, Ctr Rech Cordeliers, UMR S 1138, F-75006 Paris, France; [Ebou, Moina Hasni; Singh-Estivalet, Amrit; Ferre, Pascal; Gautier, Jean-Francois; Guillemain, Ghislaine; Breant, Bernadette; Blondeau, Bertrand; Riveline, Jean-Pierre] Univ Paris 05, Sorbonne Paris Cite, Ctr Rech Cordeliers, UMR S 1138, F-75006 Paris, France; [Launay, Jean-Marie; Callebert, Jacques] Hop Lariboisiere, AP HP, Serv Biochim, INSERM,U942, F-75475 Paris, France; [Tronche, Francois] CNRS, INSERM, UMR 952, CNRS 7224, Paris, France; [Gautier, Jean-Francois; Riveline, Jean-Pierre] Hop Lariboisiere, AP HP, Dept Endocrinol & Diabet, F-75475 Paris, France; [Gautier, Jean-Francois] Univ Paris Diderot, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Blondeau, B (corresponding author), Ctr Rech Cordeliers, INSERM, UMR S 1138, F-75006 Paris, France.; Blondeau, B (corresponding author), Univ Paris 06, Sorbonne Univ, Ctr Rech Cordeliers, UMR S 1138, F-75006 Paris, France.; Blondeau, B (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Ctr Rech Cordeliers, UMR S 1138, F-75006 Paris, France.	bertrand.blondeau@crc.jussieu.fr	Ferré, Pascal/K-1250-2013; callebert, jacques/L-4569-2017; TRONCHE, François/F-3895-2011; Guillemain, Ghislaine/P-7740-2017	Ferré, Pascal/0000-0003-0115-7045; Guillemain, Ghislaine/0000-0002-8256-9545; Blondeau, Bertrand/0000-0002-1106-1509	Inserm (Institut National de la Sante et de la Recherche Medicale); CNRS (Centre National de la Recherche Scientifique); Fondation pour la Recherche Medicale (Equipe FRM) [DEQ20140329504]; European Union [QLK1-CT-2000-00083, Food-CT-2005-007036]; Agence Nationale de la Recherche [A05245DS]; Societe Francophone du Diabete (SFD); Lilly; European Association for the Study on Diabetes (EASD); Institut Benjamin Delessert	Inserm (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale (Equipe FRM)(Fondation pour la Recherche Medicale); European Union(European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Societe Francophone du Diabete (SFD); Lilly(Eli Lilly); European Association for the Study on Diabetes (EASD); Institut Benjamin Delessert	Supports for these studies were provided by Inserm (Institut National de la Sante et de la Recherche Medicale), CNRS (Centre National de la Recherche Scientifique), Fondation pour la Recherche Medicale (Equipe FRM DEQ20140329504), the European Union (FP5 Nutrix QLK1-CT-2000-00083 and FP6 Earnest Food-CT-2005-007036 programs), the Agence Nationale de la Recherche (Grant Gramsy No A05245DS), Societe Francophone du Diabete (SFD) and Lilly to JP Riveline, European Association for the Study on Diabetes (EASD) to B Breant, and Institut Benjamin Delessert to B Blondeau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2006, CURR DRUG TARGETS, V7, P649, DOI 10.2174/138945006777435344; Borboni P, 1996, MOL CELL ENDOCRINOL, V117, P175, DOI 10.1016/0303-7207(95)03745-4; Brouwers B, 2014, CELL METAB, V20, P979, DOI 10.1016/j.cmet.2014.11.004; Brunetti L, 2008, PEPTIDES, V29, P1377, DOI 10.1016/j.peptides.2008.04.007; Butler AE, 2013, DIABETES, V62, P2595, DOI 10.2337/db12-1686; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Clark JA, 2008, MOL PSYCHIATR, V13, P498, DOI 10.1038/sj.mp.4002041; Di Dalmazi G, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/525093; DRUCKER DJ, 1987, P NATL ACAD SCI USA, V84, P3434, DOI 10.1073/pnas.84.10.3434; El-Merahbi R, 2015, FEBS LETT, V589, P1728, DOI 10.1016/j.febslet.2015.05.054; Fransson L, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-3; Garcia-Osta A, 2004, MOL BRAIN RES, V126, P181, DOI 10.1016/j.molbrainres.2004.04.006; Gesina E, 2004, DIABETES, V53, P2322, DOI 10.2337/diabetes.53.9.2322; Gremlich S, 1997, J BIOL CHEM, V272, P3216, DOI 10.1074/jbc.272.6.3216; HAMAMDZIC D, 1995, AM J PHYSIOL-ENDOC M, V269, pE162, DOI 10.1152/ajpendo.1995.269.1.E162; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Hirschfeld RMA, 2000, J CLIN PSYCHIAT, V61, P4; JAIMETCH.G, 1968, ENDOCRINOLOGY, V83, P917, DOI 10.1210/endo-83-5-917; KEMA IP, 1993, CLIN CHIM ACTA, V221, P143, DOI 10.1016/0009-8981(93)90029-4; Khan IA, 2001, BIOL REPROD, V64, P955, DOI 10.1095/biolreprod64.3.955; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Lambillotte C, 1997, J CLIN INVEST, V99, P414, DOI 10.1172/JCI119175; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nesan D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080726; OHNEDA M, 1993, J CLIN INVEST, V92, P1950, DOI 10.1172/JCI116788; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Paulmann N, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000229; Pivonello R, 2010, NEUROENDOCRINOLOGY, V92, P77, DOI 10.1159/000314319; Protzek AOP, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/983453; Resmini E, 2009, ACTA DIABETOL, V46, P85, DOI 10.1007/s00592-009-0112-9; Schraenen A, 2010, DIABETOLOGIA, V53, P2589, DOI 10.1007/s00125-010-1913-7; Tronche F, 1998, CURR OPIN GENET DEV, V8, P532, DOI 10.1016/S0959-437X(98)80007-5; Ullrich S, 2005, DIABETES, V54, P1090, DOI 10.2337/diabetes.54.4.1090; Valtat B, 2011, DIABETOLOGIA, V54, P350, DOI 10.1007/s00125-010-1898-2; Valtat B, 2013, DIABETES, V62, P1206, DOI 10.2337/db12-0314; van Raalte DH, 2009, EUR J CLIN INVEST, V39, P81, DOI 10.1111/j.1365-2362.2008.02067.x; van Raalte DH, 2011, DIABETES CARE, V34, P412, DOI 10.2337/dc10-1677; Weinhaus AJ, 2000, ENDOCRINOLOGY, V141, P1384, DOI 10.1210/en.141.4.1384; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Zawalich WS, 2006, METABOLISM, V55, P35, DOI 10.1016/j.metabol.2005.06.023	40	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149343	10.1371/journal.pone.0149343	http://dx.doi.org/10.1371/journal.pone.0149343			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901633	gold, Green Published, Green Submitted			2022-12-27	WOS:000371276100060
J	Lapointe-Shaw, L; Tran, KL; Coyte, PC; Hancock-Howard, RL; Powis, J; Poutanen, SM; Hota, S				Lapointe-Shaw, Lauren; Tran, Kim L.; Coyte, Peter C.; Hancock-Howard, Rebecca L.; Powis, Jeff; Poutanen, Susan M.; Hota, Susy			Cost-Effectiveness Analysis of Six Strategies to Treat Recurrent Clostridium difficile Infection	PLOS ONE			English	Article							FECAL MICROBIOTA TRANSPLANTATION; ORAL VANCOMYCIN; 1ST RECURRENCE; DISEASE; FIDAXOMICIN; THERAPY; EPIDEMIOLOGY; COLONOSCOPY; METRONIDAZOLE; DIARRHEA	Objective To assess the cost-effectiveness of six treatment strategies for patients diagnosed with recurrent Clostridium difficile infection (CDI) in Canada: 1. oral metronidazole; 2. oral vancomycin; 3. oral fidaxomicin; 4. fecal transplantation by enema; 5. fecal transplantation by nasogastric tube; and 6. fecal transplantation by colonoscopy. Perspective Public insurer for all hospital and physician services. Setting Ontario, Canada. Methods A decision analytic model was used to model costs and lifetime health effects of each strategy for a typical patient experiencing up to three recurrences, over 18 weeks. Recurrence data and utilities were obtained from published sources. Cost data was obtained from published sources and hospitals in Toronto, Canada. The willingness-to-pay threshold was $50,000/QALY gained. Results Fecal transplantation by colonoscopy dominated all other strategies in the base case, as it was less costly and more effective than all alternatives. After accounting for uncertainty in all model parameters, there was an 87% probability that fecal transplantation by colonoscopy was the most beneficial strategy. If colonoscopy was not available, fecal transplantation by enema was cost-effective at $1,708 per QALY gained, compared to metronidazole. In addition, fecal transplantation by enema was the preferred strategy if the probability of recurrence following this strategy was below 8.7%. If fecal transplantation by any means was unavailable, fidaxomicin was cost-effective at an additional cost of $25,968 per QALY gained, compared to metronidazole. Conclusion Fecal transplantation by colonoscopy (or enema, if colonoscopy is unavailable) is cost-effective for treating recurrent CDI in Canada. Where fecal transplantation is not available, fidaxomicin is also cost-effective.	[Lapointe-Shaw, Lauren; Powis, Jeff; Poutanen, Susan M.; Hota, Susy] Univ Toronto, Dept Med, Toronto, ON, Canada; [Lapointe-Shaw, Lauren; Tran, Kim L.; Poutanen, Susan M.; Hota, Susy] Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Coyte, Peter C.; Hancock-Howard, Rebecca L.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Powis, Jeff] Toronto East Gen Hosp, Dept Med, Toronto, ON, Canada; [Poutanen, Susan M.] Mt Sinai Hosp, Dept Med & Med Microbiol, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Toronto East General Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Lapointe-Shaw, L (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.; Lapointe-Shaw, L (corresponding author), Univ Hlth Network, Dept Med, Toronto, ON, Canada.	lauren.lapointe.shaw@mail.utoronto.ca	Hota, Susy/L-1903-2019; Poutanen, Susan M/F-9640-2012; Poutanen, Susan M./N-8066-2019; Hancock-Howard, Rebecca Laura/AIE-8302-2022; Lapointe-Shaw, Lauren/ABG-2601-2021	Poutanen, Susan M/0000-0003-4747-2550; Poutanen, Susan M./0000-0003-4747-2550; Hancock-Howard, Rebecca Laura/0000-0002-0997-988X; Lapointe-Shaw, Lauren/0000-0003-4485-6719; Powis, Jeff/0000-0003-2053-6083	University of Toronto; Cubist Pharmaceuticals	University of Toronto(University of Toronto); Cubist Pharmaceuticals	This project did not utilize any specific project-related financial support. Dr. Lauren Lapointe-Shaw is supported by the Clinician Scientist Training Program at the University of Toronto. Dr. Susy Hota has received clinic funding and advisory honoraria from Cubist Pharmaceuticals, the makers of fidaxomicin. Dr. Susan Poutanen has received advisory board and/or speaker honoraria from Optimer, Merck, Cubist, Sunovian, Hoffman-LaRoche, Paladin Labs, Pathogenica, and Accelerate Diagnostics.	Aas J, 2003, CLIN INFECT DIS, V36, P580, DOI 10.1086/367657; Ahmad A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-133; Allen-Vercoe E, 2012, CAN J GASTROENTEROL, V26, P457, DOI 10.1155/2012/213828; [Anonymous], 2013, MONTHLY AVERAGE EXCH; BARTLETT JG, 1980, GASTROENTEROLOGY, V78, P431; Bartsch SM, 2013, CLIN INFECT DIS, V57, P555, DOI 10.1093/cid/cit346; Belmares J, 2007, J INFECTION, V55, P495, DOI 10.1016/j.jinf.2007.09.015; Brandt LJ, 2012, AM J GASTROENTEROL, V107, P1079, DOI 10.1038/ajg.2012.60; Canadian Agency for Drugs and Technologies in Health (CADTH), 2017, GUID EC EV HLTH TECH; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Collins CE, 2014, J AM COLL SURGEONS, V218, P1141, DOI 10.1016/j.jamcollsurg.2014.01.053; Comely OA, 2012, CLIN INFECT DIS, V55, pS154, DOI 10.1093/cid/cis462; Cornely OA, 2012, LANCET INFECT DIS, V12, P281, DOI 10.1016/S1473-3099(11)70374-7; Crook DW, 2012, CLIN INFECT DIS, V55, pS93, DOI 10.1093/cid/cis499; Debast SB, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12418; Eyre DW, 2012, CLIN INFECT DIS, V55, pS77, DOI 10.1093/cid/cis356; Garborg K, 2010, SCAND J INFECT DIS, V42, P857, DOI 10.3109/00365548.2010.499541; Gold MR, 1998, MED CARE, V36, P778, DOI 10.1097/00005650-199806000-00002; Government of Canada, 2013, EXPL CAR WAG REP; Gravel D, 2004, CLOSTRIDIUM DIFFICIL; Gravel D, 2009, CLIN INFECT DIS, V48, P568, DOI 10.1086/596703; Halabi WJ, 2013, J AM COLL SURGEONS, V217, P802, DOI 10.1016/j.jamcollsurg.2013.05.028; Health Canada, 2015, FEC MICR THER US TRE; Kassam Z, 2013, AM J GASTROENTEROL, V108, P500, DOI 10.1038/ajg.2013.59; Kassam Z, 2012, ARCH INTERN MED, V172, P191, DOI 10.1001/archinte.172.2.191; Kelly CR, 2012, J CLIN GASTROENTEROL, V46, P145, DOI 10.1097/MCG.0b013e318234570b; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; Konijeti GG, 2014, CLIN INFECT DIS, V58, P1507, DOI 10.1093/cid/ciu128; Law Michael R, 2013, Healthc Policy, V8, P17; Levin TR, 2006, ANN INTERN MED, V145, P880, DOI 10.7326/0003-4819-145-12-200612190-00004; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; Lund-Tonnesen Stein, 1998, Tidsskrift for den Norske Laegeforening, V118, P1027; Lynne V., 1999, INFECT CONT HOSP EP, V20, P43, DOI [10.1086/501553, DOI 10.1086/501553]; Macconnachie AA, 2009, QJM-INT J MED, V102, P781, DOI 10.1093/qjmed/hcp118; Mattila E, 2012, GASTROENTEROLOGY, V142, P490, DOI 10.1053/j.gastro.2011.11.037; McFarland LV, 1999, INFECT CONT HOSP EP, V20, P43, DOI 10.1086/501553; McFarland LV, 2002, AM J GASTROENTEROL, V97, P1769, DOI 10.1111/j.1572-0241.2002.05839.x; MCFARLAND LV, 1995, AM J INFECT CONTROL, V23, P295, DOI 10.1016/0196-6553(95)90060-8; MCFARLAND LV, 1994, JAMA-J AM MED ASSOC, V271, P1913, DOI 10.1001/jama.271.24.1913; Mellow Mark H, 2011, J Okla State Med Assoc, V104, P89; Ministry of Health and Long Term Care, 2013, SCHED OF BEN; Ministry of Health and Long-term Care, EXEPTIONAL ACCES PRO; Mittmann N, 1999, PHARMACOECONOMICS, V15, P369, DOI 10.2165/00019053-199915040-00004; Mohseninejad L, 2013, EUR J HEALTH ECON, V14, P947, DOI 10.1007/s10198-012-0441-4; Naimark DMJ, 2013, MED DECIS MAKING, V33, P961, DOI 10.1177/0272989X13501558; O'Brien JA, 2007, INFECT CONT HOSP EP, V28, P1219, DOI 10.1086/522676; Patel NC, 2013, MAYO CLIN PROC, V88, P799, DOI 10.1016/j.mayocp.2013.04.022; Pepin J, 2006, CLIN INFECT DIS, V42, P758, DOI 10.1086/501126; Poutanen SM, 2004, CAN MED ASSOC J, V171, P51, DOI 10.1503/cmaj.1031189; Rassias, 1998, Crit Care, V2, P25, DOI 10.1186/cc120; Roberts M, 2012, VALUE HEALTH, V15, P804, DOI 10.1016/j.jval.2012.06.016; Rohlke F, 2010, J CLIN GASTROENTEROL, V44, P567, DOI 10.1097/MCG.0b013e3181dadb10; Sharara N, 2008, CAN J GASTROENTEROL, V22, P565, DOI 10.1155/2008/854984; Statistics Canada, 2015, CONS PRIC IND HLTH P; Statistics Canada, 2015, TABL 7A COMPL LIF TA; Stranges PM, 2013, VALUE HEALTH, V16, P297, DOI 10.1016/j.jval.2012.11.004; U.S. National Institutes of Health, 2013, OR VANC FOLL FEC TRA; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Vardakas KZ, 2012, INT J ANTIMICROB AG, V40, P1, DOI 10.1016/j.ijantimicag.2012.01.004; Wagner M, 2014, CAN J INFECT DIS MED, V25, P87, DOI 10.1155/2014/793532; Walker AS, 2013, CLIN INFECT DIS, V56, P1589, DOI 10.1093/cid/cit127; Wenisch C, 1996, CLIN INFECT DIS, V22, P813, DOI 10.1093/clinids/22.5.813; Yoon SS, 2010, J CLIN GASTROENTEROL, V44, P562, DOI 10.1097/MCG.0b013e3181dac035; Zipursky JS, 2014, CAN J GASTROENTEROL, V28, P319, DOI 10.1155/2014/403828	64	41	41	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149521	10.1371/journal.pone.0149521	http://dx.doi.org/10.1371/journal.pone.0149521			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901316	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100090
J	Shin, SY; Lee, SG				Shin, Sung Yae; Lee, Sang Gyu			Effects of Hospital Workers' Friendship Networks on Job Stress	PLOS ONE			English	Article							SOCIAL SUPPORT; MENTAL-HEALTH; WORKPLACE; CARE; PERFORMANCE; BURNOUT; INTERVENTION; DETERMINANTS; SATISFACTION; PROFESSIONS	Background This study attempted to identify the sources of job stress according to job position and investigate how friendship networks affect job stress. Methods Questionnaires based on The Health Professions Stress Inventory (HPSI) developed by Wolfgang experienced by healthcare providers were collected from 420 nurses, doctors and radiological technologists in two general hospitals in Korea by a multistage cluster sampling method. Multiple regression analysis was used to examine the effects of friendship networks on job stress after controlling for other factors. Results The severity of job stress differed according to level of job demands (p = .006); radiologic technologists experienced the least stress (45.4), nurses experienced moderate stress (52.4), and doctors experienced the most stress (53.6). Those with long-term friendships characterized by strong connections reported lower levels of stress than did those with weak ties to friends among nurses (1.3, p <. 05) and radiological technologists (11.4, p <. 01). The degree of cohesion among friends had a positive impact on the level of job stress experienced by nurses (8.2, p <. 001) and radiological technologists (14.6, p <. 1). Doctors who participated in workplace alumni meetings scored higher than those who did not. However, those who participated in alumni meetings outside the workplace showed the opposite tendency, scoring 9.4 (p <. 05) lower than those who did not. The resources from their friendship network include both information and instrumental support. As most radiological technologists were male, their instrumental support positively affected their job stress (9.2, p <. 05). Life information support was the primary positive contributor to control of nurses' (4.1, p <. 05), radiological technologists' (8.0, p <. 05) job stress. Conclusion The strength and density of such friendship networks were related to job stress. Life information support from their friendship network was the primary positive contributor to control of job stress.	[Shin, Sung Yae] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Qual Improvement & Patient Safety, Seoul, South Korea; [Lee, Sang Gyu] Yonsei Univ, Grad Sch Publ Hlth, Dept Hosp Management, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, SG (corresponding author), Yonsei Univ, Grad Sch Publ Hlth, Dept Hosp Management, Seoul 120749, South Korea.	leevan@yuhs.ac		Lee, Sang Gyu/0000-0003-4847-2421				AbuAlRub RF, 2004, J NURS SCHOLARSHIP, V36, P73, DOI 10.1111/j.1547-5069.2004.04016.x; Allen T D, 2000, J Occup Health Psychol, V5, P278, DOI 10.1037/1076-8998.5.2.278; [Anonymous], 1999, DHHS PUBLICATION; [Anonymous], 2008, DHHS PUBLICATION; Babbie E, 2013, PRACTICE SOCIAL RES, P215; Baek S.H., 2012, KOREAN ACAD MANAGEME, V20, P77; Bandiera O, 2010, REV ECON STUD, V77, P417, DOI 10.1111/j.1467-937X.2009.00574.x; BARNETT RC, 1993, J PERS SOC PSYCHOL, V64, P794, DOI 10.1037/0022-3514.64.5.794; Bennett J, 2010, PROP MANAG, V28, P138, DOI 10.1108/02637471011051282; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Bourbonnais R, 2006, OCCUP ENVIRON MED, V63, P326, DOI 10.1136/oem.2004.018069; Bovier PA, 2003, EUR J PUBLIC HEALTH, V13, P299, DOI 10.1093/eurpub/13.4.299; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Brough P., 2004, INT J ORGAN BEHAV, V8, P472; Burt D.J., 1992, STRUCTURAL HOLES SOC; CASSEL J, 1976, AM J EPIDEMIOL, V104, P107, DOI 10.1093/oxfordjournals.aje.a112281; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Cohen S, 2000, SOCIAL SUPPORT MEASU; Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685; Cohen S, 2007, HEALTH PSYCHOL, V26, P410, DOI 10.1037/0278-6133.26.4.410; Cross R, 2004, ACAD MANAGE J, V47, P928, DOI 10.2307/20159632; Felton JS, 1998, OCCUP MED-OXFORD, V48, P237, DOI 10.1093/occmed/48.4.237; GOURASH N, 1978, AM J COMMUN PSYCHOL, V6, P413, DOI 10.1007/BF00941418; Grunfeld E, 2000, CAN MED ASSOC J, V163, P166; House JS, 1981, WORK STRESS SOCIAL S; Hutt MD, 2000, SLOAN MANAGE REV, V41, P51; IBARRA H, 1993, ACAD MANAGE J, V36, P471, DOI 10.2307/256589; Innstrand ST, 2004, J APPL RES INTELLECT, V17, P119, DOI 10.1111/j.1360-2322.2004.00189.x; Israel B A, 2001, Educ Health (Abingdon), V14, P182; Jick T.D., 1985, SEX DIFFERENCES WORK; JONES JW, 1988, J APPL PSYCHOL, V73, P727, DOI 10.1037/0021-9010.73.4.727; Kamau C, 2015, ARCH ENVIRON OCCUP H, V70, P305, DOI 10.1080/19338244.2014.891967; Karadzinska-Bislimovska J, 2014, BRIT J HEALTH PSYCH, V19, P425, DOI 10.1111/bjhp.12040; Kim JH, 2005, KOREAN J OCCUPATIONA, V14, P108; Koo J.S., 2004, KOREAN ACAD ORG MANA, V28, P1; Kossek EE, 2011, PERS PSYCHOL, V64, P289, DOI 10.1111/j.1744-6570.2011.01211.x; Kroenke CH, 2006, J CLIN ONCOL, V24, P1105, DOI 10.1200/JCO.2005.04.2846; Laere K.V., 2003, J WORKPLACE LEARNING, V15, P248, DOI DOI 10.1108/13665620310488548; Lee D.S., 2001, J KOREAN NEUROPSYCHI, V40, P217; Lua PL., 2011, MALAYSIAN J PSYCHIAT, V24; Mamming M.R., 1986, J APPLOED PSYCOLOGY, V71, P618; Marin MF, 2011, NEUROBIOL LEARN MEM, V96, P583, DOI 10.1016/j.nlm.2011.02.016; McGrath A, 2003, INT J NURS STUD, V40, P555, DOI 10.1016/S0020-7489(03)00058-0; Mehra A, 2001, ADMIN SCI QUART, V46, P121, DOI 10.2307/2667127; Michie S, 2003, OCCUP ENVIRON MED, V60, P3, DOI 10.1136/oem.60.1.3; MITCHELL RE, 1980, COMMUNITY MENT HLT J, V16, P27, DOI 10.1007/BF00780665; Nishitani N, 2010, IND HEALTH, V48, P178, DOI 10.2486/indhealth.48.178; Olatunji S.O., 2014, INT MULTIDISCIPLINAR, V8, P126, DOI [10.4314/afrrev.v8i1.10, DOI 10.4314/AFRREV.V8I1.10]; Park，Dong-Kun, 2004, [Korean Journal of Health Psychology, 한국심리학회지: 건강], V9, P831; Podolny JM, 1997, AM SOCIOL REV, V62, P673, DOI 10.2307/2657354; Pressman SD, 2005, HEALTH PSYCHOL, V24, P297, DOI 10.1037/0278-6133.24.3.297; Reagans R, 2003, ADMIN SCI QUART, V48, P240, DOI 10.2307/3556658; RIORDAN CM, 1995, J BUS PSYCHOL, V10, P141, DOI 10.1007/BF02249575; Rivera-Torres P, 2013, INT J ENV RES PUB HE, V10, P375, DOI 10.3390/ijerph10010375; Roberts R, 2012, MEDSCAPE; Salam A, 2014, EUROPEAN SCI J, V10, P156; Shultz KS, 2010, J APPL GERONTOL, V29, P21, DOI 10.1177/0733464809334286; Snow DL, 2003, WORK STRESS, V17, P241, DOI 10.1080/02678370310001625630; Taylor C, 2005, LANCET, V366, P742, DOI 10.1016/S0140-6736(05)67178-4; Taylor C, 2007, BRIT J PSYCHIAT, V190, P268, DOI 10.1192/bjp.bp.106.023234; THOITS PA, 1995, J HEALTH SOC BEHAV, V35, P53, DOI 10.2307/2626957; Uzzi B, 1996, AM SOCIOL REV, V61, P674, DOI 10.2307/2096399; Vermeulen M, 2000, J Occup Health Psychol, V5, P428, DOI 10.1037/1076-8998.5.4.428; Viswesvaran C, 1999, J VOCAT BEHAV, V54, P314, DOI 10.1006/jvbe.1998.1661; Wilkins Kathryn, 2007, Health Rep, V18, P33; WOLFGANG AP, 1988, BEHAV MED, V14, P43, DOI 10.1080/08964289.1988.9935123; WOLFGANG AP, 1988, PSYCHOL REP, V62, P220, DOI 10.2466/pr0.1988.62.1.220; Yadav R.K., 2014, INT LETT SOCIAL HUMA, V26, P63; Youm Y, 2002, SEX TRANSM DIS, V29, P689, DOI 10.1097/00007435-200211000-00012; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; 염유식, 2011, [Korean Journal of Sociology, 한국사회학], V45, P91	71	4	4	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149428	10.1371/journal.pone.0149428	http://dx.doi.org/10.1371/journal.pone.0149428			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26900945	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100076
J	Yang, J; Zhu, FM; Wang, XH; Yao, WQ; Wang, M; Pei, GC; Hu, ZZ; Guo, YJ; Zhao, Z; Wang, P; Mou, JY; Sun, J; Zeng, R; Xu, G; Liao, WH; Yao, Y				Yang, Juan; Zhu, Fengming; Wang, Xiaohui; Yao, Weiqi; Wang, Meng; Pei, Guangchang; Hu, Zhizhi; Guo, Yujiao; Zhao, Zhi; Wang, Pengge; Mou, Jingyi; Sun, Jie; Zeng, Rui; Xu, Gang; Liao, Wenhui; Yao, Ying			Continuous AMD3100 Treatment Worsens Renal Fibrosis through Regulation of Bone Marrow Derived Pro-Angiogenic Cells Homing and T-Cell-Related Inflammation	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; ISCHEMIA-REPERFUSION INJURY; CHRONIC KIDNEY-DISEASE; MOUSE MODEL; ANTAGONIST AMD3100; CXCR4 ANTAGONIST; STEM-CELLS; TRANSPLANTATION; MOBILIZATION; SURVIVAL	AMD3100 is a small molecule inhibitor of chemokine receptor type 4 (CXCR4), which is located in the cell membranes of CD34+ cells and a variety of inflammatory cells and has been reported to reduce organ fibrosis in the lung, liver and myocardium. However, the effect of AMD3100 on renal fibrosis is unknown. This study investigated the impact of AMD3100 on renal fibrosis. C57bl/6 mice were subjected to unilateral ureteral obstruction (UUO) surgery with or without AMD3100 administration. Tubular injury, collagen deposition and fibrosis were detected and analyzed by histological staining, immunocytochemistry and Western Blot. Bone marrow derived pro-angiogenic cells (CD45+, CD34+ and CD309+ cells) and capillary density (CD31+) were measured by flow cytometry (FACS) and immunofluorescence (IF). Inflammatory cells, chemotactic factors and T cell proliferation were characterized. We found that AMD3100 treatment did not alleviate renal fibrosis but, rather, increased tissue damage and renal fibrosis. Continuous AMD3100 administration did not improve bone marrow derived pro-angiogenic cells mobilization but, rather, inhibited the migration of bone marrow derived pro-angiogenic cells into the fibrotic kidney. Additionally, T cell infiltration was significantly increased in AMD3100-treated kidneys compared to untreated kidneys. Thus, treatment of UUO mice with AMD3100 led to an increase in T cell infiltration, suggesting that AMD3100 aggravated renal fibrosis.	[Yang, Juan; Zhu, Fengming; Wang, Meng; Pei, Guangchang; Hu, Zhizhi; Guo, Yujiao; Zhao, Zhi; Wang, Pengge; Mou, Jingyi; Sun, Jie; Zeng, Rui; Xu, Gang; Yao, Ying] Huazhong Univ Sci & Technol, Tongji Hosp, Div Nephrol, Tongji Med Coll, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China; [Wang, Xiaohui] Fifth Hosp Wuhan, Dept Nephrol, 122 Xianzheng St, Wuhan 430050, Hubei, Peoples R China; [Yao, Weiqi] Wuhan Hamilton Biotechnol Co LTD, Wuhan Inst Biotechnol, B6-4,666 Gaoxin Rd, Wuhan 430073, Hubei, Peoples R China; [Liao, Wenhui] Huazhong Univ Sci & Technol, Dept Geriatr, Tongji Hosp, Tongji Med Coll, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Yao, Y (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Div Nephrol, Tongji Med Coll, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China.; Liao, WH (corresponding author), Huazhong Univ Sci & Technol, Dept Geriatr, Tongji Hosp, Tongji Med Coll, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China.	liaowh126@126.com; yaoyingkk@126.com	Yang, Juan/ABF-4433-2021; Zeng, Rui/GRY-0646-2022; Zeng, RUI/AAF-7238-2019	Zeng, Rui/0000-0003-1188-3198; 	National Natural Sciences Foundation of China [81270770, 81270771, 81170686]; Health and Family Planning Commission of Hubei Province [WJ2015MB011]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Health and Family Planning Commission of Hubei Province	This work was funded by National Natural Sciences Foundation of China, URL: http://www.nsfc.gov.cn/, (Grants 81270770 received by G.X., 81270771 received by R.Z. and 81170686 received by Y.Y.) with additional funding from Health and Family Planning Commission of Hubei Province project, URL: http://www.hbwsjs.gov.cn/ (Grant WJ2015MB011 received by Y.Y.).	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Ballermann BJ, 2014, KIDNEY INT SUPPL, V4, P45, DOI 10.1038/kisup.2014.9; Basile DP, 2014, J CELL PHYSIOL, V229, P10, DOI 10.1002/jcp.24423; Broxmeyer HE, 2008, CURR OPIN HEMATOL, V15, P49, DOI 10.1097/MOH.0b013e3282f29012; Bussolati B, 2005, AM J PATHOL, V166, P545, DOI 10.1016/S0002-9440(10)62276-6; Cantaluppi V, 2015, NEPHROL DIAL TRANSPL, V30, P410, DOI 10.1093/ndt/gfu364; Cantaluppi V, 2012, KIDNEY INT, V82, P412, DOI 10.1038/ki.2012.105; Chade AR, 2009, CIRCULATION, V119, P547, DOI 10.1161/CIRCULATIONAHA.108.788653; Chang FC, 2012, J FORMOS MED ASSOC, V111, P589, DOI 10.1016/j.jfma.2012.09.008; Chen B, 2013, TRANSPL P, V45, P2034, DOI 10.1016/j.transproceed.2013.01.096; Chen YC, 2015, HEPATOLOGY, V61, P1591, DOI 10.1002/hep.27665; Chou YH, 2014, J FORMOS MED ASSOC, V113, P201, DOI 10.1016/j.jfma.2013.12.001; Cui X. Y., 2014, CHINESE GEN PRACTICE, V21, P1929, DOI [10.3969/j.issn.1674-4748.2014.21.005, DOI 10.3969/J.ISSN.1674-4748.2014.21.005, DOI 10.1002/HEP.27665]; Decleves AE, 2014, NAT REV NEPHROL, V10, P257, DOI 10.1038/nrneph.2014.31; Fan YF, 2010, ANN NEUROL, V67, P488, DOI 10.1002/ana.21919; Fine LG, 2008, KIDNEY INT, V74, P867, DOI 10.1038/ki.2008.350; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Guo Y, 2005, STEM CELLS, V23, P1324, DOI 10.1634/stemcells.2005-0085; Huang TH, 2015, AM J TRANSL RES, V7, P804; Jujo K, 2010, P NATL ACAD SCI USA, V107, P11008, DOI 10.1073/pnas.0914248107; Kean LS, 2011, BLOOD, V118, P6580, DOI 10.1182/blood-2011-06-359331; Kim BJ, 2013, CELL TISSUE RES, V354, P395, DOI 10.1007/s00441-013-1689-4; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Krishnamurthy P, 2011, CIRC RES, V109, P1280, DOI 10.1161/CIRCRESAHA.111.248369; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Kuksin CA, 2015, BLOOD, V125, P2087, DOI 10.1182/blood-2014-08-594796; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Li HQ, 2013, INT J CARDIOL, V162, P100, DOI 10.1016/j.ijcard.2011.05.074; Liu LL, 2012, AM J NEPHROL, V36, P386, DOI 10.1159/000343283; Liu Q, 2015, EUR J IMMUNOL, V45, P1855, DOI 10.1002/eji.201445245; Ma YY, 2010, LIFE SCI, V86, P798, DOI 10.1016/j.lfs.2010.03.013; MacDonald KPA, 2014, J IMMUNOL, V192, P3180, DOI 10.4049/jimmunol.1302315; Nishimura Y, 2012, J INVEST DERMATOL, V132, P711, DOI 10.1038/jid.2011.356; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Pleniceanu O, 2010, STEM CELLS, V28, P1649, DOI 10.1002/stem.486; Righi E, 2011, CANCER RES, V71, P5522, DOI 10.1158/0008-5472.CAN-10-3143; Roncalli J, 2011, J AM COLL CARDIOL, V57, P2444, DOI 10.1016/j.jacc.2010.11.069; Shen L, 2011, MED HYPOTHESES, V76, P256, DOI 10.1016/j.mehy.2010.10.014; Shepherd RM, 2006, BLOOD, V108, P3662, DOI 10.1182/blood-2006-06-030577; Shu HKG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079768; Snelgrove SL, 2012, AM J PATHOL, V180, P91, DOI 10.1016/j.ajpath.2011.09.039; Song JS, 2010, EXP MOL MED, V42, P465, DOI 10.3858/emm.2010.42.6.048; Sradnick J, 2016, J AM SOC NEPHROL, V27, P1714, DOI 10.1681/ASN.2015030321; Watanabe M, 2007, J IMMUNOL, V178, P5888, DOI 10.4049/jimmunol.178.9.5888	45	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149926	10.1371/journal.pone.0149926	http://dx.doi.org/10.1371/journal.pone.0149926			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900858	Green Submitted, Green Published, gold			2022-12-27	WOS:000371276100185
J	Jin, YP; Bai, YY; Li, Q; Bhugul, PA; Huang, XC; Liu, LW; Pan, LL; Ni, HZ; Chen, BC; Sun, HW; Zhang, QY; Hehir, M; Zhou, MT				Jin, Yuepeng; Bai, Yongyu; Li, Qiang; Bhugul, Pravin Avinash; Huang, Xince; Liu, Lewei; Pan, Liangliang; Ni, Haizhen; Chen, Bicheng; Sun, Hongwei; Zhang, Qiyu; Hehir, Michael; Zhou, Mengtao			Reduced Pancreatic Exocrine Function and Organellar Disarray in a Canine Model of Acute Pancreatitis	PLOS ONE			English	Article							MITOCHONDRIAL INJURY; IMPAIRED AUTOPHAGY; ACINAR-CELL; RATS; PATHOGENESIS; SECRETION; DYSFUNCTION; ACTIVATION	The aim of the present study was to investigate the pancreatic exocrine function in a canine model and to analyze the changes in organelles of pancreatic acinar cells during the early stage of acute pancreatitis (AP). AP was induced by retrograde injection of 5% sodium taurocholate (0.5 ml/kg) into the main pancreatic duct of dogs. The induction of AP resulted in serum hyperamylasemia and a marked reduction of amylase activity in the pancreatic fluid (PF). The pancreatic exocrine function was markedly decreased in subjects with AP compared with the control group. After the induction of AP, histological examination showed acinar cell edema, cytoplasmic vacuolization, fibroblasts infiltration, and inflammatory cell infiltration in the interstitium. Electron micrographs after the induction of AP revealed that most of the rough endoplasmic reticulum (RER) were dilated and that some of the ribosomes were no longer located on the RER. The mitochondria were swollen, with shortened and broken cristae. The present study demonstrated, in a canine model, a reduced volume of PF secretion with decreased enzyme secretion during the early stage of AP. Injury of mitochondria and dilatation and degranulation of RER may be responsible for the reduced exocrine function in AP. Furthermore, the present model and results may be useful for researching novel therapeutic measures in AP.	[Jin, Yuepeng; Ni, Haizhen; Sun, Hongwei; Zhang, Qiyu; Zhou, Mengtao] Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg, Wenzhou, Zhejiang, Peoples R China; [Bai, Yongyu; Li, Qiang; Bhugul, Pravin Avinash; Huang, Xince; Pan, Liangliang] Wenzhou Med Univ, Wenzhou, Zhejiang, Peoples R China; [Liu, Lewei] Wenzhou Med Univ, YueQing Peoples Hosp, YueQing Affiliated Hosp, Yueqing, Zhejiang, Peoples R China; [Chen, Bicheng] Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg, Zhejiang Prov Top Key Discipline Surg,Wenzhou Key, Wenzhou, Zhejiang, Peoples R China; [Hehir, Michael] Ningbo Univ, Sch Med, Ningbo 315211, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Ningbo University	Zhou, MT (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg, Wenzhou, Zhejiang, Peoples R China.	zmt0417@hotmail.com			Zhejiang Provincial Natural Science Foundation of China [LY12H03007]; China National Natural Science Foundation [81370563]; Ministry of Health of China [WKJ2012-2-033]; Science Technology Department of Zhejiang province [2012C23108]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Health of China; Science Technology Department of Zhejiang province	This work was funded by the Zhejiang Provincial Natural Science Foundation of China (No. LY12H03007), China National Natural Science Foundation (No. 81370563), Ministry of Health of China (No. WKJ2012-2-033), and Public Welfare Technology application research project supported by Science Technology Department of Zhejiang province (No. 2012C23108).	Babic T, 2013, AM J PHYSIOL-GASTR L, V304, pG437, DOI 10.1152/ajpgi.00402.2012; bdulla A, 2011, J LEUKOCYTE BIOL, V90, P975, DOI [10.1189/jlb.0411195, DOI 10.1189/JLB.0411195]; Biczo G, 2011, ANTIOXID REDOX SIGN, V15, P2669, DOI 10.1089/ars.2011.4065; Bumbasirevic V, 2009, PANCREAS, V38, P122, DOI 10.1097/MPA.0b013e31818a392f; Cao YN, 2013, PANCREAS, V42, P301, DOI 10.1097/MPA.0b013e31825b9f2c; Czako L, 1997, PANCREAS, V15, P83, DOI 10.1097/00006676-199707000-00012; Czako L, 1997, DIGEST DIS SCI, V42, P265, DOI 10.1023/A:1018893230319; Dawra R, 2011, GASTROENTEROLOGY, V141, P2210, DOI 10.1053/j.gastro.2011.08.033; Gerasimenko OV, 2012, PFLUG ARCH EUR J PHY, V464, P89, DOI 10.1007/s00424-012-1117-8; Gukovsky I, 2012, J GASTROEN HEPATOL, V27, P27, DOI 10.1111/j.1440-1746.2011.07004.x; Gukovsky I, 2011, ANTIOXID REDOX SIGN, V15, P2699, DOI 10.1089/ars.2011.4068; Hegyi P, 2011, GUT, V60, P544, DOI 10.1136/gut.2010.218461; Leung PS, 2006, INT J BIOCHEM CELL B, V38, P1024, DOI 10.1016/j.biocel.2005.12.001; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Maleth J, 2013, ACTA PHYSIOL, V207, P226, DOI 10.1111/apha.12037; Mooren FC, 2003, J BIOL CHEM, V278, P9361, DOI 10.1074/jbc.M207454200; MURAYAMA KM, 1990, SURGERY, V107, P302; NIEDERAU C, 1990, GASTROENTEROLOGY, V99, P1120, DOI 10.1016/0016-5085(90)90633-C; Noble MD, 2005, CURR OPIN GASTROEN, V21, P531, DOI 10.1097/01.mog.0000174220.85085.95; Ogasawara T, 1999, INT J PANCREATOL, V26, P59, DOI 10.1007/BF02781732; Pandol SJ, 2007, GASTROENTEROLOGY, V132, P1127, DOI 10.1053/j.gastro.2007.01.055; Sailai Y, 2010, J INVEST MED, V58, P38, DOI 10.2310/JIM.0b013e3181b91bd6; Samuel I, 2006, J GASTROINTEST SURG, V10, P1376, DOI 10.1016/j.gassur.2006.09.003; Sata N, 1996, J GASTROENTEROL, V31, P94, DOI 10.1007/BF01211193; Sun ZZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055124, 10.1371/journal.pone.0055249, 10.1371/journal.pone.0074672]; Xu P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081767	26	3	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148458	10.1371/journal.pone.0148458	http://dx.doi.org/10.1371/journal.pone.0148458			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895040	Green Submitted, Green Published, gold			2022-12-27	WOS:000371223400015
J	Lawlor, C; O'Connor, G; O'Leary, S; Gallagher, PJ; Cryan, SA; Keane, J; O'Sullivan, MP				Lawlor, Ciaran; O'Connor, Gemma; O'Leary, Seonadh; Gallagher, Paul J.; Cryan, Sally-Ann; Keane, Joseph; O'Sullivan, Mary P.			Treatment of Mycobacterium tuberculosis-Infected Macrophages with Poly(Lactic-Co-Glycolic Acid) Microparticles Drives NF kappa B and Autophagy Dependent Bacillary Killing	PLOS ONE			English	Article							DENDRITIC CELLS; INHALABLE MICROPARTICLES; ALVEOLAR MACROPHAGES; IN-VITRO; PLGA-MICROSPHERES; DEFENSE-MECHANISM; PHAGOCYTOSIS; APOPTOSIS; IMMUNOTHERAPY; INHIBITION	The emergence of multiple-drug-resistant tuberculosis (MDR-TB) has pushed our available repertoire of anti-TB therapies to the limit of effectiveness. This has increased the urgency to develop novel treatment modalities, and inhalable microparticle (MP) formulations are a promising option to target the site of infection. We have engineered poly(lactic-co-glycolic acid) (PLGA) MPs which can carry a payload of anti-TB agents, and are successfully taken up by human alveolar macrophages. Even without a drug cargo, MPs can be potent immunogens; yet little is known about how they influence macrophage function in the setting of Mycobacterium tuberculosis (Mtb) infection. To address this issue we infected THP-1 macrophages with Mtb H37Ra or H37Rv and treated with MPs. In controlled experiments we saw a reproducible reduction in bacillary viability when THP-1 macrophages were treated with drug-free MPs. NF kappa B activity was increased in MP-treated macrophages, although cytokine secretion was unaltered. Confocal microscopy of immortalized murine bone marrow-derived macrophages expressing GFP-tagged LC3 demonstrated induction of autophagy. Inhibition of caspases did not influence the MP-induced restriction of bacillary growth, however, blockade of NF kappa B or autophagy with pharmacological inhibitors reversed this MP effect on macrophage function. These data support harnessing inhaled PLGA MP-drug delivery systems as an immunotherapeutic in addition to serving as a vehicle for targeted drug delivery. Such "added value" could be exploited in the generation of inhaled vaccines as well as inhaled MDR-TB therapeutics when used as an adjunct to existing treatments.	[Lawlor, Ciaran; O'Connor, Gemma; Gallagher, Paul J.; Cryan, Sally-Ann] Royal Coll Surgeons Ireland, Sch Pharm, Dublin 2, Ireland; [Cryan, Sally-Ann] Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin 2, Ireland; [Lawlor, Ciaran; O'Connor, Gemma; O'Leary, Seonadh; Keane, Joseph; O'Sullivan, Mary P.] Trinity Coll Dublin, Inst Mol Med, Dept Clin Med, Dublin 2, Ireland; [Lawlor, Ciaran; O'Connor, Gemma; O'Leary, Seonadh; Keane, Joseph; O'Sullivan, Mary P.] St James Hosp, Dublin 8, Ireland; [Lawlor, Ciaran] Moderna Therapeut, Cambridge, MA USA	Royal College of Surgeons - Ireland; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	O'Sullivan, MP (corresponding author), Trinity Coll Dublin, Inst Mol Med, Dept Clin Med, Dublin 2, Ireland.	mary.osullivan@tcd.ie	Keane, Joseph/AAX-6658-2021; O'Sullivan, Mary P/C-9413-2012	Keane, Joseph/0000-0001-5313-385X; O'Sullivan, Mary P/0000-0002-6104-8943; O'Leary, Seonadh/0000-0002-7903-2325; Cryan, Sally-Ann/0000-0002-3941-496X	Irish Health Research Board [RP/2006/152, HRB HRAPOR/2012/43, HRB CSA/2012/16]; Royal City of Dublin Hospital Trust; Science Foundation Ireland [08/RFP/BMT1689]	Irish Health Research Board; Royal City of Dublin Hospital Trust; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by the Irish Health Research Board (http://www.hrb.ie/home/) under grant RP/2006/152 and HRB HRAPOR/2012/43 (SAC), HRB CSA/2012/16 and the Royal City of Dublin Hospital Trust, (JK) and Science Foundation Ireland (http://www.sfi.ie/) 08/RFP/BMT1689 (MOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcila ML, CELLULAR IMMUNOLOGY, V249, P80; Bonilla DL, 2013, IMMUNITY, V39, P537, DOI 10.1016/j.immuni.2013.08.026; Briken V, 2008, FUTURE MICROBIOL, V3, P415, DOI 10.2217/17460913.3.4.415; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Edwards DA, 2002, ANNU REV BIOMED ENG, V4, P93, DOI 10.1146/annurev.bioeng.4.100101.132311; Evora C, 1998, J CONTROL RELEASE, V51, P143, DOI 10.1016/S0168-3659(97)00149-1; Getts DR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007563; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911; Hartman ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027972; Hirota K, 2010, J CONTROL RELEASE, V142, P339, DOI 10.1016/j.jconrel.2009.11.020; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Lawlor C, 2012, J MATER SCI-MATER M, V23, P89, DOI 10.1007/s10856-011-4511-4; Lawlor C, 2011, TUBERCULOSIS, V91, P93, DOI 10.1016/j.tube.2010.12.001; Lawlor C, 2011, MOL PHARMACEUT, V8, P1100, DOI 10.1021/mp1004178; Lewis JS, 2012, BIOMATERIALS, V33, P7221, DOI 10.1016/j.biomaterials.2012.06.049; Lu DM, 2007, PHARM RES-DORDR, V24, P1834, DOI 10.1007/s11095-007-9302-8; Malyala P, 2008, J PHARM SCI-US, V97, P1155, DOI 10.1002/jps.21065; Marques AP, 2004, J BIOMED MATER RES A, V71A, P419, DOI 10.1002/jbm.a.30155; Mueller M, 2012, J CONTROL RELEASE, V162, P159, DOI 10.1016/j.jconrel.2012.06.015; Muttil P, 2007, EUR J PHARM SCI, V32, P140, DOI 10.1016/j.ejps.2007.06.006; Muttil P, 2009, PHARM RES-DORDR, V26, P2401, DOI 10.1007/s11095-009-9957-4; Nicolete R, 2011, INT IMMUNOPHARMACOL, V11, P1557, DOI 10.1016/j.intimp.2011.05.014; O'Hara P, 2000, PHARMACEUT RES, V17, P955, DOI 10.1023/A:1007527204887; O'Leary S, 2011, AM J RESP CELL MOL, V45, P172, DOI 10.1165/rcmb.2010-0319OC; O'Sullivan MP, 2007, INFECT IMMUN, V75, P1984, DOI 10.1128/IAI.01107-06; Pham NLL, 2010, P NATL ACAD SCI USA, V107, P12198, DOI 10.1073/pnas.1004661107; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Roberts RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062115; Ryan RCM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-237; Salminen Antero, 2012, Int J Cell Biol, V2012, P849541, DOI 10.1155/2012/849541; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Schlosser E, 2008, VACCINE, V26, P1626, DOI 10.1016/j.vaccine.2008.01.030; Sharma R, 2007, J ANTIMICROB CHEMOTH, V59, P499, DOI 10.1093/jac/dkl533; Sharma R, 2011, TUBERCULOSIS, V91, P107, DOI 10.1016/j.tube.2010.11.003; Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106; Shui WQ, 2008, P NATL ACAD SCI USA, V105, P16952, DOI 10.1073/pnas.0809218105; Stern ST, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-20; Thi EP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002551; van der Vaart M, 2014, CELL HOST MICROBE, V15, P753, DOI 10.1016/j.chom.2014.05.005; Waeckerle-Men Y, 2004, J IMMUNOL METHODS, V287, P109, DOI 10.1016/j.jim.2004.01.010; Wang CC, 2009, AAPS J, V11, P139, DOI 10.1208/s12248-009-9089-0; Yadav AB, 2010, TUBERCULOSIS, V90, P188, DOI 10.1016/j.tube.2010.03.001; Yadav AB, 2009, INDIAN J EXP BIOL, V47, P469	45	40	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149167	10.1371/journal.pone.0149167	http://dx.doi.org/10.1371/journal.pone.0149167			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894562	Green Published, gold, Green Submitted			2022-12-27	WOS:000371223400033
J	Yang, HJ; Zhang, JY; Wei, C; Yang, LY; Zuo, QF; Zhuang, Y; Feng, YJ; Srinivas, S; Zeng, H; Zou, QM				Yang, Hui-Jie; Zhang, Jin-Yong; Wei, Chao; Yang, Liu-Yang; Zuo, Qian-Fei; Zhuang, Yuan; Feng, You-Jun; Srinivas, Swaminath; Zeng, Hao; Zou, Quan-Ming			Immunisation With Immunodominant Linear B Cell Epitopes Vaccine of Manganese Transport Protein C Confers Protection against Staphylococcus aureus Infection	PLOS ONE			English	Article							COMMUNITY-ASSOCIATED MRSA; UNITED-STATES; COLONIZATION; ANTIBODIES; RESISTANCE; VIRULENCE; EFFICACY	Vaccination strategies for Staphylococcus aureus, particularly methicillin-resistant S. aureus (MRSA) infections have attracted much research attention. Recent efforts have been made to select manganese transport protein C, or manganese binding surface lipoprotein C (MntC), which is a metal ion associated with pathogen nutrition uptake, as potential candidates for an S. aureus vaccine. Although protective humoral immune responses to MntC are well-characterised, much less is known about detailed MntC-specific B cell epitope mapping and particularly epitope vaccines, which are less-time consuming and more convenient. In this study, we generated a recombinant protein rMntC which induced strong antibody response when used for immunisation with CFA/IFA adjuvant. On the basis of the results, linear B cell epitopes within MntC were finely mapped using a series of overlapping synthetic peptides. Further studies indicate that MntC113-136, MntC209-232, and MntC263-286 might be the original linear B-cell immune dominant epitope of MntC, furthermore, three-dimensional (3-d) crystal structure results indicate that the three immunodominant epitopes were displayed on the surface of the MntC antigen. On the basis of immunodominant MntC113-136, MntC209-232, and MntC263-286 peptides, the epitope vaccine for S. aureus induces a high antibody level which is biased to TH2 and provides effective immune protection and strong opsonophagocytic killing activity in vitro against MRSA infection. In summary, the study provides strong proof of the optimisation of MRSA B cell epitope vaccine designs and their use, which was based on the MntC antigen in the development of an MRSA vaccine.	[Yang, Hui-Jie; Zhang, Jin-Yong; Wei, Chao; Yang, Liu-Yang; Zuo, Qian-Fei; Zhuang, Yuan; Zeng, Hao; Zou, Quan-Ming] Third Mil Med Univ, Dept Microbiol & Biochem Pharm, Coll Pharm, Natl Engn Res Ctr Immunol Prod, Chongqing 400038, Peoples R China; [Feng, You-Jun] Zhejiang Univ, Sch Basic Med Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Srinivas, Swaminath] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	Army Medical University; Zhejiang University; University of Illinois System; University of Illinois Urbana-Champaign	Zeng, H; Zou, QM (corresponding author), Third Mil Med Univ, Dept Microbiol & Biochem Pharm, Coll Pharm, Natl Engn Res Ctr Immunol Prod, Chongqing 400038, Peoples R China.	zeng1109@163.com; qmzou2007@163.com	liu, yang/HHY-8583-2022; yang, liu/GVU-8760-2022; Srinivas, Swaminath/AAK-7213-2021	Zhang, Jinyong/0000-0001-9622-5834; Srinivas, Swaminath/0000-0002-7210-5122	National Key Technology R & D Programme of China [2012EP001003/2014BAI15B00]; Chinese National Natural Science Foundation [31370932, 31400792]; "Young 1000 Talents" Award	National Key Technology R & D Programme of China(National Key Technology R&D Program); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); "Young 1000 Talents" Award	This work was supported by The National Key Technology R & D Programme of China (2012EP001003/2014BAI15B00), Chinese National Natural Science Foundation Project (Nos 31370932 and 31400792). YF is a recipient of the "Young 1000 Talents" Award. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja S, 2015, STRUCTURE, V23, P713, DOI 10.1016/j.str.2015.01.020; Anderson AS, 2012, J INFECT DIS, V205, P1688, DOI 10.1093/infdis/jis272; Barg N, 1998, J ANTIMICROB CHEMOTH, V42, P257, DOI 10.1093/jac/42.2.257; Barroso L, 2014, VACCINE, V32, P1218, DOI 10.1016/j.vaccine.2013.06.056; Bassetti M, 2009, INT J ANTIMICROB AG, V34, pS15, DOI 10.1016/S0924-8579(09)70544-8; Blot S, 1998, NEW ENGL J MED, V339, P2025; Burton RL, 2012, CLIN VACCINE IMMUNOL, V19, P835, DOI 10.1128/CVI.00086-12; Chambers HF, 2005, NEW ENGL J MED, V352, P1485, DOI 10.1056/NEJMe058023; Chen L, 2013, GASTROENTEROLOGY, V144, P591, DOI 10.1053/j.gastro.2012.12.002; Coady A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138350; Cosseron-Zerbib M, 1998, J HOSP INFECT, V40, P225, DOI 10.1016/S0195-6701(98)90140-2; Daum RS, 1998, PEDIATR INFECT DIS J, V17, P745, DOI 10.1097/00006454-199808000-00015; Diep BA, 2014, J INFECT DIS, V209, P1533, DOI 10.1093/infdis/jit662; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gong R, 2010, CLIN VACCINE IMMUNOL, V17, P1746, DOI 10.1128/CVI.00162-10; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Gribenko A, 2013, J MOL BIOL, V425, P3429, DOI 10.1016/j.jmb.2013.06.033; Gupta SK, 2010, VACCINE, V28, P7092, DOI 10.1016/j.vaccine.2010.08.005; Harenska K, 1998, Przegl Epidemiol, V52, P199; Hu DL, 2003, J INFECT DIS, V188, P743, DOI 10.1086/377308; Ibarra JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-126; Jin X, 2009, VACCINE, V27, P7080, DOI 10.1016/j.vaccine.2009.09.060; Karauzum H, 2012, J BIOL CHEM, V287, P25203, DOI 10.1074/jbc.M112.364075; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Lin MS, 2011, IMMUNOL RES, V50, P213, DOI 10.1007/s12026-011-8215-0; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Manhold C, 1998, INTENS CARE MED, V24, P1327, DOI 10.1007/s001340050770; McKenna M, 2012, NATURE, V482, P23, DOI 10.1038/482023a; McNamara LA, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-18; Mohammadi M, 1997, GASTROENTEROLOGY, V113, P1848, DOI 10.1016/S0016-5085(97)70004-0; Oliveira D., 1998, Clin Microbiol Infect, V4, P373, DOI 10.1111/j.1469-0691.1998.tb00081.x; Olmos A, 1998, J CLIN MICROBIOL, V36, P1128, DOI 10.1128/JCM.36.4.1128-1134.1998; Paul S, 2010, EXPERT REV VACCINES, V9, P1027, DOI 10.1586/ERV.10.77; PLOS ONE Staff, 2015, PLoS One, V10, pe0121192, DOI 10.1371/journal.pone.0121192; Rozemeijer W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116945; Uruse M, 2014, J BIOCHEM, V155, P265, DOI 10.1093/jb/mvu005; Varshney AK, 2011, J BIOL CHEM, V286, P9737, DOI 10.1074/jbc.M110.212407; Vaudaux P, 1998, DRUG RESIST UPDATE, V1, P352, DOI 10.1016/S1368-7646(98)80011-3; Wang J, 1998, J HOSP INFECT, V39, P221, DOI 10.1016/S0195-6701(98)90261-4; Yi L, 2016, VIRUS RES, V213, P1, DOI 10.1016/j.virusres.2015.10.022; Yzerman EPF, 1998, J ANTIMICROB CHEMOTH, V42, P233, DOI 10.1093/jac/42.2.233; Zhao Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep12371	42	19	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149638	10.1371/journal.pone.0149638	http://dx.doi.org/10.1371/journal.pone.0149638			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895191	gold, Green Published, Green Submitted			2022-12-27	WOS:000371223400071
J	Husain, I; Sharma, A; Kumar, S; Malik, F				Husain, Islam; Sharma, Anjana; Kumar, Suresh; Malik, Fayaz			Purification and Characterization of Glutaminase Free Asparaginase from Enterobacter cloacae: In-Vitro Evaluation of Cytotoxic Potential against Human Myeloid Leukemia HL-60 Cells	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; EXTRACELLULAR L-ASPARAGINASE; ESCHERICHIA-COLI; CANCER; ELECTROPHORESIS; APOPTOSIS; CLEAVAGE; SERUM; YEAST; VIVO	Asparaginase is an important antileukemic agent extensively used worldwide but the intrinsic glutaminase activity of this enzymatic drug is responsible for serious life threatening side effects. Hence, glutaminase free asparaginase is much needed for upgradation of therapeutic index of asparaginase therapy. In the present study, glutaminase free asparaginase produced from Enterobacter cloacae was purified to apparent homogeneity. The purified enzyme was found to be homodimer of approximately 106 kDa with monomeric size of approximately 52 kDa and p/ 4.5. Purified enzyme showed optimum activity between pH 7-8 and temperature 35-40 degrees C, which is close to the internal environment of human body. Monovalent cations such as Na+ and K+ enhanced asparaginase activity whereas divalent and trivalent cations, Ca2+, Mg2+, Zn2+, Mn2+, and Fe3+ inhibited the enzyme activity. Kinetic parameters K-m, V-max and K-cat of purified enzyme were found to be 1.58x10(-3) M, 2.22 IU mu g(-1) and 5.3 x 10(4) S-1, respectively. Purified enzyme showed prolonged in vitro serum (T-1/2 = similar to 39 h) and trypsin (T-1/2 = similar to 32min) half life, which is therapeutically remarkable feature. The cytotoxic activity of enzyme was examined against a panel of human cancer cell lines, HL-60, MOLT-4, MDA-MB-231 and T47D, and highest cytotoxicity observed against HL-60 cells (IC50 similar to 3.1 IU ml(-1)), which was comparable to commercial asparaginase. Cell and nuclear morphological studies of HL-60 cells showed that on treatment with purified asparaginase symptoms of apoptosis were increased in dose dependent manner. Cell cycle progression analysis indicates that enzyme induces apoptosis by cell cycle arrest in G0/G1 phase. Mitochondrial membrane potential loss showed that enzyme also triggers the mitochondrial pathway of apoptosis. Furthermore, the enzyme was found to be nontoxic for human noncancerous cells FR-2 and non-hemolytic for human erythrocytes.	[Husain, Islam; Sharma, Anjana] Rani Durgavati Univ, Dept PG Studies & Res Biol Sci, Bacteriol Lab, Jabalpur, Madhya Pradesh, India; [Kumar, Suresh; Malik, Fayaz] Indian Inst Integrat Med, Canc Pharmacol Div, Jammu, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM)	Sharma, A (corresponding author), Rani Durgavati Univ, Dept PG Studies & Res Biol Sci, Bacteriol Lab, Jabalpur, Madhya Pradesh, India.	anjoo1999@gmail.com	Husain, Islam/S-4237-2019	Husain, Islam/0000-0002-6150-5788; Malik, Fayaz/0000-0001-5475-6610	Madhya Pradesh Biotechnology Council (MPBC), Bhopal, India [56]	Madhya Pradesh Biotechnology Council (MPBC), Bhopal, India	Madhya Pradesh Biotechnology Council (MPBC), Bhopal, India, provided funds for this research work by issuing letter no. 56, dated 26-01-2012 (http://www.mpbiotech.nic.in). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], INT J PHARM BIO SC B; [Anonymous], 2015, INT J CURR MICROBIOL; ASSELIN BL, 1989, CANCER RES, V49, P4363; Avramis VI, 2002, BLOOD, V99, P1986, DOI 10.1182/blood.V99.6.1986; Bansal S, 2010, BIOCHEMISTRY-MOSCOW+, V75, P375, DOI 10.1134/S0006297910030144; BROOME JD, 1965, J NATL CANCER I, V35, P967; BROOME JD, 1961, NATURE, V191, P1114, DOI 10.1038/1911114a0; Bulmus V, 2003, J CONTROL RELEASE, V93, P105, DOI 10.1016/j.jconrel.2003.06.001; Chan WK, 2014, BLOOD, V123, P3596, DOI 10.1182/blood-2013-10-535112; Denicourt C, 2004, SCIENCE, V305, P1411, DOI 10.1126/science.1102974; Dey SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058055; El-Bessoumy AA, 2004, J BIOCHEM MOL BIOL, V37, P387, DOI 10.5483/BMBRep.2004.37.4.387; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GONG SS, 1990, NUCLEIC ACIDS RES, V18, P3509, DOI 10.1093/nar/18.12.3509; GORG A, 1988, ELECTROPHORESIS, V9, P531, DOI 10.1002/elps.1150090913; HASKELL CM, 1969, CANCER RES, V29, P974; Huang SH, 2013, INT J BIOL MACROMOL, V62, P124, DOI 10.1016/j.ijbiomac.2013.08.048; IMADA A, 1973, J GEN MICROBIOL, V76, P85, DOI 10.1099/00221287-76-1-85; Kavitha CV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069103; Kumar NSM, 2013, WORLD J MICROB BIOT, V29, P577, DOI 10.1007/s11274-012-1213-0; Kumar S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.399; Kumar S, 2011, BIORESOURCE TECHNOL, V102, P2077, DOI 10.1016/j.biortech.2010.07.114; Kurtzberg J, 2003, CANC MED, VIV, P699; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambu MR, 2013, J MED CHEM, V56, P6122, DOI 10.1021/jm400515c; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lubkowski J, 1996, EUR J BIOCHEM, V241, P201, DOI 10.1111/j.1432-1033.1996.0201t.x; Mahajan RV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099037; Malik F, 2007, APOPTOSIS, V12, P2115, DOI 10.1007/s10495-007-0129-x; MANNA S, 1995, CURR MICROBIOL, V30, P291, DOI 10.1007/BF00295504; MESAS JM, 1990, J GEN MICROBIOL, V136, P515, DOI 10.1099/00221287-136-3-515; Mukherjee J, 1999, FOLIA MICROBIOL, V44, P15, DOI 10.1007/BF02816214; Muller HJ, 1998, CRIT REV ONCOL HEMAT, V28, P97, DOI 10.1016/S1040-8428(98)00015-8; Narta UK, 2007, CRIT REV ONCOL HEMAT, V61, P208, DOI 10.1016/j.critrevonc.2006.07.009; OHNUMA T, 1967, BIOCHEM J, V103, P238, DOI 10.1042/bj1030238; Onishi Y, 2011, ANN MICROBIOL, V61, P517, DOI 10.1007/s13213-010-0167-4; Pal HC, 2010, TOXICOL IN VITRO, V24, P1599, DOI 10.1016/j.tiv.2010.06.007; PETERSON RE, 1969, APPL MICROBIOL, V18, P64, DOI 10.1128/AEM.18.1.64-67.1969; Piatkowska-Jakubas Beata, 2008, Pol Arch Med Wewn, V118, P664; Pieters R, 2011, CANCER-AM CANCER SOC, V117, P238, DOI 10.1002/cncr.25489; Prakasham RS, 2010, APPL BIOCHEM BIOTECH, V160, P72, DOI 10.1007/s12010-009-8679-8; Prista A. A., 2001, MOL CELL BIOCHEM, V216, P93; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Ramya LN, 2012, APPL BIOCHEM BIOTECH, V167, P2144, DOI 10.1007/s12010-012-9755-z; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; Shahabuddin MS, 2011, INVEST NEW DRUG, V29, P523, DOI 10.1007/s10637-009-9379-5; Shimizu T, 1998, EUR J PEDIATR, V157, P561, DOI 10.1007/s004310050878; Singh Y, 2013, APPL BIOCHEM BIOTECH, V171, P1759, DOI 10.1007/s12010-013-0455-0; STORY MD, 1993, CANCER CHEMOTH PHARM, V32, P129, DOI 10.1007/BF00685615; Tabandeh MR, 2009, J BIOTECHNOL, V141, P189, DOI 10.1016/j.jbiotec.2009.03.020; TRIANTAFILLOU DJ, 1988, MOL CELL BIOCHEM, V81, P43; Trung LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055183; Tsuchiya E, 2010, BIOSCI BIOTECH BIOCH, V74, P411, DOI 10.1271/bbb.90633; Wei YJ, 2008, J CHROMATOGR SCI, V46, P556, DOI 10.1093/chromsci/46.6.556; Wikman LEK, 2005, ACTA CRYSTALLOGR F, V61, P407, DOI 10.1107/S1744309105008249; WILLIS RC, 1974, J BACTERIOL, V118, P231, DOI 10.1128/JB.118.1.231-241.1974; WRISTON JC, 1985, METHOD ENZYMOL, V113, P608; Zhang YQ, 2005, J BIOTECHNOL, V120, P315, DOI 10.1016/j.jbiotec.2005.06.027	58	52	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0148877	10.1371/journal.pone.0148877	http://dx.doi.org/10.1371/journal.pone.0148877			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891220	Green Published, Green Submitted, gold			2022-12-27	WOS:000371221500016
J	Brennan, GI; Abbott, Y; Burns, A; Leonard, F; McManus, BA; O'Connell, B; Coleman, DC; Shore, AC				Brennan, Grainne I.; Abbott, Yvonne; Burns, Aisling; Leonard, Finola; McManus, Brenda A.; O'Connell, Brian; Coleman, David C.; Shore, Anna C.			The Emergence and Spread of Multiple Livestock-Associated Clonal Complex 398 Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Strains among Animals and Humans in the Republic of Ireland, 2010-2014	PLOS ONE			English	Article							GENE; MRSA; DNA; ST398; PIGS; PCR	Clonal complex (CC) 398 methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) are associated with carriage and infection among animals and humans but only a single case of CC398 MRSA has been reported in the Republic of Ireland (ROI). The present study investigated the molecular epidemiology of CC398 MRSA (n = 22) and MSSA (n = 10) from animals and humans in the ROI from 2010-2014. Isolates underwent antimicrobial susceptibility testing, spa typing, DNA microarray profiling and PCR for CC398-associated resistance genes. All MRSA underwent SCCmec IV or V subtyping. Four distinct CC398-MRSA incidents were identified from (i) a man in a nursing home (spa type t011-SCCmec IVa, immune evasion complex (IEC) negative), (ii) a horse and veterinarian who had recently travelled to Belgium (t011-IVa, IEC positive), (iii) pigs (n = 9) and farm workers (n = 9) on two farms, one which had been restocked with German gilts and the other which was a finisher farm (t034-VT, IEC negative, 3/9 pigs; t011-VT, IEC negative, 6/9 pigs & 9/9 farm workers), and (iv) a child who had worked on a pig farm in the UK (t034-VT, IEC negative). Isolates also carried different combinations of multiple resistance genes including erm(A), erm(B), tet(K), tet(M) & tet(L), fexA, spc, dfrG, dfrK aacAaphD and aadD further highlighting the presence of multiple CC398-MRSA strains. CC398 MSSA were recovered from pigs (n = 8) and humans (n = 2). CC398 MSSA transmission was identified among pigs but zoonotic transmission was not detected with animal and human isolates exhibiting clade-specific traits. This study highlights the importation and zoonotic spread of CC398 MRSA in the ROI and the spread of CC398 MSSA among pigs. Increased surveillance is warranted to prevent further CC398 MRSA importation and spread in a country that was considered CC398 MRSA free.	[Brennan, Grainne I.; McManus, Brenda A.; O'Connell, Brian] St James Hosp, Natl MRSA Reference Lab, Jamess St, Dublin 8, Ireland; [Brennan, Grainne I.; Coleman, David C.; Shore, Anna C.] Univ Dublin Trinity Coll, Dublin Dent Univ Hosp, Div Oral Biosci, Microbiol Res Unit, Dublin 2, Ireland; [Abbott, Yvonne; Burns, Aisling; Leonard, Finola] Natl Univ Ireland Univ Coll Dublin, Sch Vet Med, Pathobiol, Dublin 4, Ireland; [O'Connell, Brian; Shore, Anna C.] Univ Dublin, Trinity Coll, St Jamess Hosp, Dept Clin Microbiol, Jamess St, Dublin 8, Ireland	Trinity College Dublin; Trinity College Dublin; University College Dublin; Trinity College Dublin	Shore, AC (corresponding author), Univ Dublin Trinity Coll, Dublin Dent Univ Hosp, Div Oral Biosci, Microbiol Res Unit, Dublin 2, Ireland.; Shore, AC (corresponding author), Univ Dublin, Trinity Coll, St Jamess Hosp, Dept Clin Microbiol, Jamess St, Dublin 8, Ireland.	anna.shore@dental.tcd.ie	Coleman, David C./C-2008-2009; McManus, Brenda/H-8600-2019	Coleman, David C./0000-0003-1797-2888; McManus, Brenda/0000-0003-3969-054X	Microbiology Research Unit, Dublin Dental University Hospital; Food Institute Research Measure from The Department of Agriculture, Food and the Marine [08 RDD 680]	Microbiology Research Unit, Dublin Dental University Hospital; Food Institute Research Measure from The Department of Agriculture, Food and the Marine	This work was supported by the Microbiology Research Unit, Dublin Dental University Hospital and, in part, by the Food Institute Research Measure grant 08 RDD 680 from The Department of Agriculture, Food and the Marine (FL). The grant body had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argudin MA, 2011, APPL ENVIRON MICROB, V77, P3052, DOI 10.1128/AEM.02260-10; Brennan GI, 2012, EPI INSIGHT, V13; CARROLL D, 1995, MOL MICROBIOL, V16, P877, DOI 10.1111/j.1365-2958.1995.tb02315.x; Chroboczek T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068462; Clinical and Laboratory Standards Institute, 2013, M100S23 CLSI; COLEMAN DC, 1989, J GEN MICROBIOL, V135, P1679; Cuny C, 2015, VET MICROBIOL, V177, P219, DOI 10.1016/j.vetmic.2015.02.031; Cuny C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083165; Dahms C, 2014, ACTA VET SCAND, V56, DOI 10.1186/s13028-014-0053-3; EUCAST, 2014, BREAKP TABL INT MICS; EUCAST (European Committee on Antimicrobial Susceptibility Testing), 2015, ANT SUSC TEST EUCAST; Fessler A, 2010, J ANTIMICROB CHEMOTH, V65, P619, DOI 10.1093/jac/dkq021; GOV. UK, 2013, LIV ASS MRSA FOUND F; Hadjirin NF, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.24.21156; Hall S, 2015, VET REC, V176, DOI 10.1136/vr.h627; Hartley H, 2014, VET REC, V175, DOI 10.1136/vr.g4620; Higuchi W, 2008, BIOCHEM BIOPH RES CO, V377, P752, DOI 10.1016/j.bbrc.2008.10.009; Horgan M, 2011, VET J, V190, P255, DOI 10.1016/j.tvjl.2010.10.025; Kadlec K, 2012, CLIN MICROBIOL INFEC, V18, P745, DOI 10.1111/j.1469-0691.2012.03842.x; Kadlec K, 2009, ANTIMICROB AGENTS CH, V53, P776, DOI 10.1128/AAC.01128-08; Kock R, 2014, BERL MUNCH TIERARZTL, V127, P384, DOI 10.2376/0005-9366-127-384; Krupa P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/141475; Loeffler A, 2009, J HOSP INFECT, V72, P269, DOI 10.1016/j.jhin.2009.04.002; Malachowa N, 2010, CELL MOL LIFE SCI, V67, P3057, DOI 10.1007/s00018-010-0389-4; McManus BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138079; Mellmann A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-98; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Ng LK, 2001, MOL CELL PROBE, V15, P209, DOI 10.1006/mcpr.2001.0363; Pantosti A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00127; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Rossney AS, 2007, J CLIN MICROBIOL, V45, P2554, DOI 10.1128/JCM.00245-07; ROSSNEY AS, 1990, J CLIN PATHOL, V43, P246, DOI 10.1136/jcp.43.3.246; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Stegger M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079645; Uhlemann AC, 2013, CLIN INFECT DIS, V57, P700, DOI 10.1093/cid/cit375; Valentin-Domelier AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028369; Van den Eede A, 2009, VET MICROBIOL, V133, P138, DOI 10.1016/j.vetmic.2008.06.021; Vandendriessche S, 2014, J ANTIMICROB CHEMOTH, V69, P355, DOI 10.1093/jac/dkt366; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428	41	18	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149396	10.1371/journal.pone.0149396	http://dx.doi.org/10.1371/journal.pone.0149396			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886749	Green Published, gold, Green Submitted			2022-12-27	WOS:000371218400078
J	Cui, FR; Wang, JJ; Opal, SM; Tripathi, A				Cui, Francis R.; Wang, Jingjing; Opal, Steven M.; Tripathi, Anubhav			Isolating Influenza RNA from Clinical Samples Using Microfluidic Oil-Water Interfaces	PLOS ONE			English	Article							EXTRACTION METHODS; DNA EXTRACTION; PURIFICATION; VIRUS; SYSTEMS	The effective and robust separation of biomolecules of interest from patient samples is an essential step in diagnostic applications. We present a platform for the fast extraction of nucleic acids from clinical specimens utilizing paramagnetic PMPs, an oil-water interface, a small permanent magnet and a microfluidic channel to separate and purify captured nucleic acids from lysate in less than one minute, circumventing the need for multiple washing steps and greatly simplifying and expediting the purification procedure. Our device was able to isolate influenza RNA from clinical nasopharyngeal swab samples with high efficiency when compared to the Ambion (R) MagMAX (TM) Viral RNA Isolation Kit, sufficiently separating nucleic acid analytes from PCR-inhibiting contaminants within the lysate while also critically maintaining high integrity of the viral genome. We find that this design has great potential for rapid, efficient and sensitive nucleic acid separation from patient sample.	[Cui, Francis R.; Wang, Jingjing; Tripathi, Anubhav] Brown Univ, Sch Engn, Ctr Biomed Engn, Providence, RI 02912 USA; [Opal, Steven M.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Opal, Steven M.] Brown Univ, Mem Hosp Rhode Isl, Pawtucket, RI 02860 USA	Brown University; Brown University; Brown University	Tripathi, A (corresponding author), Brown Univ, Sch Engn, Ctr Biomed Engn, Providence, RI 02912 USA.	anubhav_tripathi@brown.edu	WANG, JINGYI/GSJ-1241-2022; wang, jing/GRS-7509-2022		Brown University; National Aeronautics Space Administration -Rhode Island grant	Brown University; National Aeronautics Space Administration -Rhode Island grant	The work was supported by Brown University seed funds. No number assigned to it. F.R.C. was partially supported through National Aeronautics Space Administration -Rhode Island grant. No number was assigned to it. F.R.C was also supported by Graduate Student Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendall SC, 2012, NAT BIOTECHNOL, V30, P639, DOI 10.1038/nbt.2283; Berry SM, 2014, J MOL DIAGN, V16, P297, DOI 10.1016/j.jmoldx.2014.01.004; Berry SM, 2011, BIOMED MICRODEVICES, V13, P1033, DOI 10.1007/s10544-011-9573-z; Berry SM, 2011, LAB CHIP, V11, P1747, DOI 10.1039/c1lc00004g; Bordelon H, 2011, ACS APPL MATER INTER, V3, P2161, DOI 10.1021/am2004009; Breadmore MC, 2003, ANAL CHEM, V75, P1880, DOI 10.1021/ac0204855; Cady NC, 2003, BIOSENS BIOELECTRON, V19, P59, DOI 10.1016/S0956-5663(03)00123-4; Cui F, 2014, ANNU REV BIOMED ENG, DOI [10.1146/annurev-bioeng-071114-040538, DOI 10.1146/ANNUREV-BI0ENG-071114-040538]; den Dulk RC, 2013, LAB CHIP, V13, P106, DOI 10.1039/c2lc40929a; Deng MY, 2005, J VET DIAGN INVEST, V17, P574, DOI 10.1177/104063870501700609; Holland CA, 2005, CURR OPIN MICROBIOL, V8, P504, DOI 10.1016/j.mib.2005.08.001; Kim J, 2009, INTEGR BIOL-UK, V1, P574, DOI 10.1039/b905844c; MCGEOCH D, 1976, P NATL ACAD SCI USA, V73, P3045, DOI 10.1073/pnas.73.9.3045; Monleau M, 2009, J CLIN MICROBIOL, V47, P1107, DOI 10.1128/JCM.02255-08; Rahman MM, 2012, DRUG DISCOV TODAY, V17, P1199, DOI 10.1016/j.drudis.2012.07.001; Ribaudo Randall, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1011s04; Stals A, 2012, FOOD ENVIRON VIROL, V4, P153, DOI 10.1007/s12560-012-9092-y; Strotman LN, 2012, ANALYST, V137, P4023, DOI 10.1039/c2an35506j; Sur K, 2010, J MOL DIAGN, V12, P620, DOI 10.2353/jmoldx.2010.090190; Tan SC, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/574398; van Reenen A, 2014, LAB CHIP, V14, P1966, DOI 10.1039/c3lc51454d; Wen J, 2006, ANAL CHEM, V78, P1673, DOI 10.1021/ac051796t; World Health Organization, 2009, CDC PROT REALT RTPCR	23	12	12	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149522	10.1371/journal.pone.0149522	http://dx.doi.org/10.1371/journal.pone.0149522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886007	Green Submitted, Green Published, gold			2022-12-27	WOS:000371218400094
J	Kent, ST; Bromfield, SG; Burkholder, GA; Falzon, L; Oparil, S; Overton, ET; Mugavero, MJ; Schwartz, JE; Shimbo, D; Muntner, P				Kent, Shia T.; Bromfield, Samantha G.; Burkholder, Greer A.; Falzon, Louise; Oparil, Suzanne; Overton, Edgar T.; Mugavero, Michael J.; Schwartz, Joseph E.; Shimbo, Daichi; Muntner, Paul			Ambulatory Blood Pressure Monitoring in Individuals with HIV: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CARDIOVASCULAR-DISEASE; INFECTED INDIVIDUALS; OLDER PATIENTS; SLEEP QUALITY; HYPERTENSION; RISK; VARIABILITY; INFLAMMATION; WOMEN	Introduction Abnormal diurnal blood pressure (BP) rhythms may contribute to the high cardiovascular disease risk in HIV-positive (HIV+) individuals. To synthesize the current literature on ambulatory BP monitoring (ABPM) in HIV+ individuals, a systematic literature review and meta-analysis were performed. Methods Medical databases were searched through November 11, 2015 for studies that reported ABPM results in HIV+ individuals. Data were extracted by 2 reviewers and pooled differences between HIV+ and HIV-negative (HIV-) individuals in clinic BP and ABPM measures were calculated using random-effects inverse variance weighted models. Results Of 597 abstracts reviewed, 8 studies with HIV+ cohorts met the inclusion criteria. The 420 HIV+ and 714 HIV- individuals in 7 studies with HIV- comparison groups were pooled for analyses. The pooled absolute nocturnal systolic and diastolic BP declines were 3.16% (95% confidence interval [CI]: 1.13%, 5.20%) and 2.92% (95% CI: 1.64%, 4.19%) less, respectively, in HIV+ versus HIV- individuals. The pooled odds ratio for non-dipping systolic BP (nocturnal systolic BP decline < 10%) in HIV+ versus HIV-individuals was 2.72 (95% CI: 1.92, 3.85). Differences in mean clinic, 24-hour, daytime, or nighttime BP were not statistically significant. I-2 and heterogeneity chi-squared statistics indicated the presence of high heterogeneity for all outcomes except percent DBP dipping and non-dipping SBP pattern. Conclusions An abnormal diurnal BP pattern may be more common among HIV+ versus HIV- individuals. However, results were heterogeneous for most BP measures, suggesting more research in this area is needed.	[Kent, Shia T.; Bromfield, Samantha G.; Muntner, Paul] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; [Burkholder, Greer A.; Overton, Edgar T.; Mugavero, Michael J.] Univ Alabama Birmingham, Dept Med, Div Infect Dis, Birmingham, AL 35294 USA; [Falzon, Louise; Schwartz, Joseph E.; Shimbo, Daichi] Columbia Univ, Dept Med, Med Ctr, Ctr Behav Cardiovasc Hlth, New York, NY USA; [Oparil, Suzanne] Univ Alabama Birmingham, Dept Med, Vasc Biol & Hypertens Program, Birmingham, AL 35294 USA; [Schwartz, Joseph E.] SUNY Stony Brook, Sch Med, Dept Psychiat, Appl Behav Med Res Inst, Stony Brook, NY 11794 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Columbia University; University of Alabama System; University of Alabama Birmingham; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kent, ST (corresponding author), Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA.	shia@uab.edu	Falzon, Louise/AAG-2404-2019; Falzon, Louise/HCI-2175-2022	Falzon, Louise/0000-0002-9449-6056; Overton, Edgar/0000-0002-4013-536X; Schwartz, Joseph/0000-0002-8944-3566	University of Alabama at Birmingham (UAB) Center for AIDS Research CFAR, a National Institutes of Health [P30AI027767]; National Heart, Lung, and Blood Institute [T32HL00745733]; National Institutes of Health [P30AI027767, P01HL088117, P01HL047540, K24HL084034]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088117, K24HL125704, P01HL047540, K24HL084034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER	University of Alabama at Birmingham (UAB) Center for AIDS Research CFAR, a National Institutes of Health; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the University of Alabama at Birmingham (UAB) Center for AIDS Research CFAR, a National Institutes of Health funded program (P30AI027767) that was made possible by the following institutes: NIAID, NCI, NICHD, NHLBI, NIDA, NIA, NIDDK, NIGMS, and OAR. This work was supported by the National Heart, Lung, and Blood Institute [T32HL00745733 to S.T.K.] and National Institutes of Health [P01HL088117, P01HL047540, and K24HL084034 to L.F., P30AI027767 to T.O.].	Aouizerat BE, 2010, J ASSOC NURSE AIDS C, V21, P125, DOI 10.1016/j.jana.2009.10.003; Armah KA, 2014, CLIN INFECT DIS, V58, P121, DOI 10.1093/cid/cit652; Baekken M, 2009, HIV MED, V10, P44, DOI 10.1111/j.1468-1293.2008.00655.x; Baguet JP, 2015, J HYPERTENS, V33, pE112, DOI 10.1097/01.hjh.0000467653.00544.5f; Boggia J, 2007, LANCET, V370, P1219, DOI 10.1016/S0140-6736(07)61538-4; Borkum M, 2014, CARDIOVASC J AFR, V25, P153, DOI 10.5830/CVJA-2014-029; Breet E, 2014, AIDS CARE, V26, P947, DOI 10.1080/09540121.2014.901486; Chen W-T, 2013, J AIDS CLIN RES, V4, P1, DOI [DOI 10.4172/2155-6113.1000214, 10.4172/2155-6113.1000214.]; Chow DC, 2011, HIV CLIN TRIALS, V12, P141, DOI 10.1310/hct1203-141; Das A, 2013, SOC SCI MED, V77, P75, DOI 10.1016/j.socscimed.2012.11.007; Dauphinot V, 2013, INT J CARDIOL, V168, P4010, DOI 10.1016/j.ijcard.2013.06.080; Dauphinot V, 2010, HYPERTENS RES, V33, P1032, DOI 10.1038/hr.2010.130; De Socio GVL, 2010, JAIDS-J ACQ IMM DEF, V55, P356, DOI 10.1097/QAI.0b013e3181e46456; Denning Paul H., 2011, Morbidity and Mortality Weekly Report, V60, P1045; Duncan MJ, 2008, AM J PHYSIOL-REG I, V295, pR1680, DOI 10.1152/ajpregu.90496.2008; Erdogan D, 2013, CHRONOBIOL INT, V30, P973, DOI 10.3109/07420528.2013.790045; Gamaldo CE, 2013, AIDS BEHAV, V17, P2808, DOI 10.1007/s10461-012-0401-0; Grandi AM, 2012, J HUM HYPERTENS, V26, P570, DOI 10.1038/jhh.2011.81; Guasti L, 2005, ACTA CARDIOL, V60, P319, DOI 10.2143/AC.60.3.2005011; Hansen TW, 2010, HYPERTENSION, V55, P1049, DOI [10.1161/HYPERTENSIONAHA.109.140798, 10.1161/HYP.0b013e3181dfc0ad]; Hemkens LG, 2014, EUR HEART J, V35, P1373, DOI 10.1093/eurheartj/eht528; Hermida RC, 2010, CHRONOBIOL INT, V27, P1629, DOI 10.3109/07420528.2010.510230; Hillebrand S, 2013, EUROPACE, V15, P742, DOI 10.1093/europace/eus341; Bernardino JI, 2011, JAIDS-J ACQ IMM DEF, V58, P54, DOI 10.1097/QAI.0b013e3182267406; Ingelsson E, 2006, JAMA-J AM MED ASSOC, V295, P2859, DOI 10.1001/jama.295.24.2859; Ipp H, 2013, CLIN CHIM ACTA, V416, P96, DOI 10.1016/j.cca.2012.11.025; Islam FM, 2012, HIV MED, V13, P453, DOI 10.1111/j.1468-1293.2012.00996.x; Jean-Louis G, 2012, SLEEP, V35, P131, DOI 10.5665/sleep.1602; Kent ST, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0598-1; Lopes M, 2012, J CLIN PSYCHIAT, V73, P384, DOI 10.4088/JCP.10m06304; Maggi P, 2013, J AIDS CLIN RES, V4; Mahabala C, 2013, VASC HEALTH RISK MAN, V9, P125, DOI 10.2147/VHRM.S33515; Manner IW, 2010, BLOOD PRESSURE, V19, P188, DOI 10.3109/08037051.2010.483055; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; Muntner P, 2015, AM J HYPERTENS, V28, P640, DOI 10.1093/ajh/hpu193; Nuernberg M, 2015, J HYPERTENS, V33, pE7, DOI 10.1097/01.hjh.0000467370.50452.31; O'Brien E, 2013, J HYPERTENS, V31, P1731, DOI 10.1097/HJH.0b013e328363e964; Ohkubo T, 2002, J HYPERTENS, V20, P2183, DOI 10.1097/00004872-200211000-00017; Onen SH, 2012, J AM MED DIR ASSOC, V13, P752, DOI 10.1016/j.jamda.2012.07.003; Patil SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099258; Paxton KC, 2004, AIDS BEHAV, V8, P405, DOI 10.1007/s10461-004-7325-2; Peacock J, 2014, J HUM HYPERTENS, V28, P521, DOI 10.1038/jhh.2014.9; Pereira EJ, 2013, J CLIN SLEEP MED, V9, P1259, DOI 10.5664/jcsm.3264; Piper MA, 2015, ANN INTERN MED, V162, P192, DOI 10.7326/M14-1539; Pozdisek Z, 2008, Vnitr Lek, V54, P615; Rahman M, 2013, HYPERTENSION, V61, P82, DOI 10.1161/HYPERTENSIONAHA.112.200477; Sandoval R., 2014, Journal of the International Association of Providers of AIDS Care, V13, P328, DOI 10.1177/2325957413494237; Schillaci G, 2015, CURR PHARM DESIGN, V21, P756; Schillaci G, 2013, J HYPERTENS, V31, P560, DOI 10.1097/HJH.0b013e32835ca949; Seay JS, 2013, PSYCHONEUROENDOCRINO, V38, P2647, DOI 10.1016/j.psyneuen.2013.06.022; Sherr L, 2011, PSYCHOL HEALTH MED, V16, P612, DOI 10.1080/13548506.2011.579991; Shimbo D, 2015, ANN INTERN MED, V163, P691, DOI 10.7326/M15-1270; Staessen JA, 1999, JAMA-J AM MED ASSOC, V282, P539, DOI 10.1001/jama.282.6.539; Sterne JAC., 2014, COCHRANE RISK BIAS A; Tedaldi EM, 2008, JAIDS-J ACQ IMM DEF, V47, P441, DOI 10.1097/QAI.0b013e3181609da8; Ulmer CS, 2013, BEHAV MED, V39, P111, DOI 10.1080/08964289.2013.813434; Yesavage JA, 2014, NAT SCI SLEEP, V6, P123, DOI 10.2147/NSS.S65034; Yilmaz MB, 2007, BLOOD PRESSURE, V16, P101, DOI 10.1080/08037050701343225	58	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148920	10.1371/journal.pone.0148920	http://dx.doi.org/10.1371/journal.pone.0148920			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882469	Green Published, Green Submitted, gold			2022-12-27	WOS:000371219000034
J	Baan, F; Liebregts, J; Xi, T; Schreurs, R; de Koning, M; Berge, S; Maal, T				Baan, Frank; Liebregts, Jeroen; Xi, Tong; Schreurs, Ruud; de Koning, Martien; Berge, Stefaan; Maal, Thomas			A New 3D Tool for Assessing the Accuracy of Bimaxillary Surgery: The OrthoGnathicAnalyser	PLOS ONE			English	Article							GUIDED NAVIGATION; MODEL SURGERY; SIMULATION; SPLINT; REPRODUCIBILITY; PREDICTABILITY; PROTOCOL; MAXILLA	Aim The purpose of this study was to present and validate an innovative semi-automatic approach to quantify the accuracy of the surgical outcome in relation to 3D virtual orthognathic planning among patients who underwent bimaxillary surgery. Material and Method For the validation of this new semi-automatic approach, CBCT scans of ten patients who underwent bimaxillary surgery were acquired pre-operatively. Individualized 3D virtual operation plans were made for all patients prior to surgery. During surgery, the maxillary and mandibular segments were positioned as planned by using 3D milled interocclusal wafers. Consequently, post-operative CBCT scan were acquired. The 3D rendered pre- and post-operative virtual head models were aligned by voxel-based registration upon the anterior cranial base. To calculate the discrepancies between the 3D planning and the actual surgical outcome, the 3D planned maxillary and mandibular segments were segmented and superimposed upon the postoperative maxillary and mandibular segments. The translation matrices obtained from this registration process were translated into translational and rotational discrepancies between the 3D planning and the surgical outcome, by using the newly developed tool, the OrthoGnathicAnalyser. To evaluate the reproducibility of this method, the process was performed by two independent observers multiple times. Results Low intra-observer and inter-observer variations in measurement error (mean error < 0.25 mm) and high intraclass correlation coefficients (> 0.97) were found, supportive of the observer independent character of the OrthoGnathicAnalyser. The pitch of the maxilla and mandible showed the highest discrepancy between the 3D planning and the postoperative results, 2.72 degrees and 2.75 degrees respectively. Conclusion This novel method provides a reproducible tool for the evaluation of bimaxillary surgery, making it possible to compare larger patient groups in an objective and time-efficient manner in order to optimize the current workflow in orthognathic surgery.	[Baan, Frank; Liebregts, Jeroen; Xi, Tong; Schreurs, Ruud; de Koning, Martien; Berge, Stefaan; Maal, Thomas] Radboud Univ Nijmegen, Med Ctr, Dept Oral & Maxillofacial Surg, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Xi, T (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Oral & Maxillofacial Surg, NL-6525 ED Nijmegen, Netherlands.	Tong.Xi@radboudumc.nl	Baan, Frank/P-6767-2015; Liebregts, Jeroen/P-7016-2015; Xi, Tong/P-6268-2015; Maal, Thomas JJ/L-4497-2015; Berge, Stefaan/AAP-3708-2020; Bergé, S.J./H-8011-2014; Schreurs, Ruud/P-6769-2015	Baan, Frank/0000-0002-3626-656X; Xi, Tong/0000-0002-9142-9253; Maal, Thomas JJ/0000-0002-1702-4733; Schreurs, Ruud/0000-0003-2429-2071				Centenero SAH, 2012, J CRANIO MAXILL SURG, V40, P162, DOI 10.1016/j.jcms.2011.03.014; Almukhtar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093402; Bouchard C, 2013, INT J ORAL MAX SURG, V42, P592, DOI 10.1016/j.ijom.2012.10.034; De Riu G, 2014, BRIT J ORAL MAX SURG, V52, P251, DOI 10.1016/j.bjoms.2013.12.010; ELLIS E, 1990, J ORAL MAXIL SURG, V48, P1161, DOI 10.1016/0278-2391(90)90532-7; FERGUSON JW, 1992, J CRANIO MAXILL SURG, V20, P333, DOI 10.1016/S1010-5182(05)80360-9; Gower JC, 2004, PROCRUSTES PROBLEMS, Vxi; Gupta A, 2015, INT J COMPUT ASS RAD, V10, P1737, DOI 10.1007/s11548-015-1173-6; Haas OL, 2015, INT J ORAL MAX SURG, V44, P329, DOI 10.1016/j.ijom.2014.10.025; Hernandez-Alfaro F, 2013, INT J ORAL MAX SURG, V42, P1547, DOI 10.1016/j.ijom.2013.03.025; Hsu SSP, 2013, J ORAL MAXIL SURG, V71, P128, DOI 10.1016/j.joms.2012.03.027; Katkar RA, 2013, DENTOMAXILLOFAC RAD, V42, DOI 10.1259/dmfr.20130059; Kim BC, 2011, ORAL SURG ORAL MED O, V111, P278, DOI 10.1016/j.tripleo.2010.04.038; Kretschmer WB, 2009, BRIT J ORAL MAX SURG, V47, P446, DOI 10.1016/j.bjoms.2009.06.004; Lee CY, 2013, KOREAN J ORTHOD, V43, P74, DOI 10.4041/kjod.2013.43.2.74; Li B, 2013, BRIT J ORAL MAX SURG, V51, pE239, DOI 10.1016/j.bjoms.2013.03.007; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Marchetti C, 2006, J CRANIOFAC SURG, V17, P661, DOI 10.1097/00001665-200607000-00009; Mazzoni S, 2010, J CRANIOFAC SURG, V21, P1698, DOI 10.1097/SCS.0b013e3181f3c6a8; Mestiri Makram H.K., 2014, INT J IMAGE PROCESS, V8, P17; Nada RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016520; Ong TK, 2001, BRIT J ORAL MAX SURG, V39, P96, DOI 10.1054/bjom.2000.0577; Plooij JM, 2009, INT J ORAL MAX SURG, V38, P267, DOI 10.1016/j.ijom.2008.12.009; POLIDO WD, 1991, INT J ORAL MAX SURG, V20, P349, DOI 10.1016/S0901-5027(05)80263-2; Schendel SA, 2009, J ORAL MAXIL SURG, V67, P2107, DOI 10.1016/j.joms.2009.04.111; Schneider M, 2005, J CRANIO MAXILL SURG, V33, P8, DOI 10.1016/j.jcms.2004.05.010; Shahidi S, 2014, BMC MED IMAGING, V14, DOI 10.1186/1471-2342-14-32; Shehab MF, 2013, OR SURG OR MED OR PA, V115, pE16, DOI 10.1016/j.oooo.2011.09.035; Stokbro K, 2014, INT J ORAL MAX SURG, V43, P957, DOI 10.1016/j.ijom.2014.03.011; Sun Y, 2014, J CRANIOFAC SURG, V25, P1095, DOI 10.1097/SCS.0000000000000633; Sun Y, 2013, J CRANIOFAC SURG, V24, P1871, DOI 10.1097/SCS.0b013e31829a80d9; Swennen GRJ, 2006, J CRANIOFAC SURG, V17, P314, DOI 10.1097/00001665-200603000-00019; Swennen GRJ, 2009, J ORAL MAXIL SURG, V67, P2080, DOI 10.1016/j.joms.2009.06.007; Swennen GRJ, 2009, J CRANIOFAC SURG, V20, P297, DOI 10.1097/SCS.0b013e3181996803; Titiz I, 2012, EUR J ORTHODONT, V34, P276, DOI 10.1093/ejo/cjq190; Tucker S, 2010, J ORAL MAXIL SURG, V68, P2412, DOI 10.1016/j.joms.2009.09.058; TURVEY TA, 1982, J ORAL MAXIL SURG, V40, P96; van Loon B, 2015, INT J ORAL MAX SURG, V44, P83, DOI 10.1016/j.ijom.2014.08.001; VANSICKELS JE, 1986, ORAL SURG ORAL MED O, V61, P542, DOI 10.1016/0030-4220(86)90089-7; Xi T, 2013, INT J ORAL MAX SURG, V42, P1023, DOI 10.1016/j.ijom.2013.01.016; Xia JJ, 2007, J ORAL MAXIL SURG, V65, P248, DOI 10.1016/j.joms.2006.10.005; Zinser MJ, 2012, OR SURG OR MED OR PA, V113, P673, DOI 10.1016/j.oooo.2011.11.009	42	63	64	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149625	10.1371/journal.pone.0149625	http://dx.doi.org/10.1371/journal.pone.0149625			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901524	gold, Green Published, Green Submitted			2022-12-27	WOS:000371276100113
J	Jiang, Y; Li, JQ; Wang, J; Xiao, H; Li, TT; Liu, H; Liu, WY				Jiang, Yi; Li, Jiaqi; Wang, Jing; Xiao, Hu; Li, Tingting; Liu, Hui; Liu, Wenya			Assessment of Vascularity in Hepatic Alveolar Echinococcosis: Comparison of Quantified Dual-Energy CT with Histopathologic Parameters	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; COMPUTED-TOMOGRAPHY; FOLLOW-UP; RESPONSE ASSESSMENT; TUMOR-RESPONSE; PERFUSION CT; LIVER; CANCER; MULTILOCULARIS; THERAPY	Purpose To investigate whether dual-energy computer tomography(DECT) could determine the angiographic vascularity of alveolar echinococcosis lesions by comparing the quantitative iodine concentration (IC) with the microvascular density (MVD). Material and Methods Twenty-five patients (16 men, 9 women; mean age, 40.9 +/- 13.8 years) with confirmed hepatic alveolar echinococcosis (HAE) underwent DECT of the abdomen, consisting of arterial phase (AP), portal venous phase (PVP), and delayed phase (DP) scanning, in dualsource mode (100 kV/140 kV). Image data were processed with a DECT software algorithm that was designed for the evaluation of iodine distribution in the different layers (marginal zone, solid and cystic) of the lesions. The CT patterns of HAE lesions were classified into three types: solid type, pseudocystic type and 'geographic map' (mixed) type. The IC measurements in different layers and different types of lesions were statistically compared. MVD was examined using CD34 immunohistochemical staining of the resected HAE tissue and scored based on the percentage of positively stained cells and their intensity. Pearson's correlation analysis was used to evaluate the potential correlation between DECT parameters and MVD. Results A total of 27 HAE lesions were evaluated, of which 9 were solid type, 3 were pseudocystic type and 15 were mixed type. The mean lesion size was 100.7 +/- 47.3 mm. There was a significant difference in the IC measurements between different layers of HAE lesions during each scan phase (p < 0.001). The IC in the marginal zone was significantly higher than in the solid and cystic components in AP (2.15 mg/mL vs. 0.17 or 0.01 mg/mL), PVP (3.08 mg/mL vs. 0.1 or 0.02 mg/mL), and DP (2.93 mg/mL vs. 0.04 or 0.02 mg/mL). No significant difference was found among the different CT patterns of HAE lesions. Positive expression of CD34 in the marginal zones surrounding HAE lesions was found in 92.5% (25/27) of lesions, of which 18.5% (5/27) were strongly positive, 62.7%(17/27) were moderately positive, and 11.1% (3/27) were weakly positive. In contrast, 7.4% (2/27) of the lesions were negative for CD34. There was a positive correlation between IC measurements and MVD in the marginal zone of HAE lesions (r = 0.73, p < 0.05). Conclusions The DECT quantitative iodine concentration was significantly correlated with MVD in the marginal zones surrounding HAE lesions. Dual-energy CT using a quantitative analytic methodology can be used to evaluate the vascularity of AE.	[Jiang, Yi; Li, Jiaqi; Wang, Jing; Xiao, Hu; Li, Tingting; Liu, Hui; Liu, Wenya] Xinjiang Med Univ, Affiliated Hosp 1, Imaging Ctr, Urumqi, Xinjiang, Peoples R China	Xinjiang Medical University	Liu, WY (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Imaging Ctr, Urumqi, Xinjiang, Peoples R China.	wenyaliu2002@163.com			Key laboratory of echinococcosis foundation medicine of Xinjiang province [XJDX0202-2013-8]	Key laboratory of echinococcosis foundation medicine of Xinjiang province	This work was supported by the Key laboratory of echinococcosis foundation medicine of Xinjiang province, grant number: XJDX0202-2013-8 (YJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, INVENTORS HEPATIC AL; Apfaltrer P, 2012, INVEST RADIOL, V47, P65, DOI 10.1097/RLI.0b013e31823003d2; Ascenti G, 2013, EUR RADIOL, V23, P2288, DOI 10.1007/s00330-013-2811-4; Azizi A, 2015, ABDOM IMAGING, V40, P56, DOI 10.1007/s00261-014-0183-0; Bali MA, 2011, RADIOLOGY, V261, P456, DOI 10.1148/radiol.11103515; Bresson-Hadni S, 2006, PARASITOL INT, V55, pS267, DOI 10.1016/j.parint.2005.11.053; Bresson-Hadni S, 2008, B ACAD NAT MED PARIS, V192, P1131, DOI 10.1016/S0001-4079(19)32712-8; Brunetti E, 2010, ACTA TROP, V114, P1, DOI 10.1016/j.actatropica.2009.11.001; Caoduro C, 2013, J NUCL MED, V54, P358, DOI 10.2967/jnumed.112.109942; Coskun A, 2004, ACTA RADIOL, V45, P492, DOI 10.1080/02841850410005912; Craig P, 2003, CURR OPIN INFECT DIS, V16, P437, DOI 10.1097/00001432-200310000-00010; Dai X, 2013, EUR J RADIOL, V82, P327, DOI 10.1016/j.ejrad.2012.11.013; Ehrhardt AR, 2007, ABDOM IMAGING, V32, P730, DOI [10.1007/s00261-006-9173-1, 10.1007/s00261-007-9177-5]; Folkman J, 1992, Semin Cancer Biol, V3, P65; Fornaro J, 2011, INSIGHTS IMAGING, V2, P149, DOI 10.1007/s13244-010-0057-0; Gottstein B, 2014, PARASITE, V21, DOI 10.1051/parasite/2014063; Guerret S, 1998, PARASITOL RES, V84, P657, DOI 10.1007/s004360050466; Kantarci M, 2012, RADIOGRAPHICS, V32, P2053, DOI 10.1148/rg.327125708; Kim JW, 2012, KOREAN J RADIOL, V13, pS89, DOI 10.3348/kjr.2012.13.S1.S89; Kodama Y, 2003, RADIOLOGY, V228, P172, DOI 10.1148/radiol.2281020323; Kratzer W, 2005, ABDOM IMAGING, V30, P286, DOI 10.1007/s00261-004-0263-7; Lee SH, 2011, INVEST RADIOL, V46, P77, DOI 10.1097/RLI.0b013e3181f23fcd; Liu YH, 2009, T ROY SOC TROP MED H, V103, P768, DOI 10.1016/j.trstmh.2009.04.006; McManus DP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3866; Merkle E, 1995, Aktuelle Radiol, V5, P101; Meyer M, 2013, EUR J RADIOL, V82, P923, DOI 10.1016/j.ejrad.2013.01.006; Piarroux M, 2011, J HEPATOL, V55, P1025, DOI 10.1016/j.jhep.2011.02.018; Porot C, 2014, IEEE ENG MED BIO, P5587, DOI 10.1109/EMBC.2014.6944893; Reiner CS, 2013, INVEST RADIOL, V48, P183, DOI 10.1097/RLI.0b013e31827c63a3; Reuter S, 2001, INFECTION, V29, P119, DOI 10.1007/s15010-001-1081-2; SINICROPE FA, 1995, CANCER RES, V55, P237; Spira D, 2013, J COMPUT ASSIST TOMO, V37, P15, DOI 10.1097/RCT.0b013e318277c84f; Stumpe KDM, 2007, INFECTION, V35, P11, DOI 10.1007/s15010-007-6133-9; van Niekerk CG, 2014, EUR RADIOL, V24, P2597, DOI 10.1007/s00330-014-3301-z; Vuitton DA, 2003, ACTA TROP, V85, P119, DOI 10.1016/S0001-706X(02)00230-9; VUITTON DA, 1986, Z PARASITENKD, V72, P97, DOI 10.1007/BF00927740; Vuitton DA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/923193; [王静 Wang Jing], 2011, [中华放射学杂志, Chinese Journal of Radiology], V45, P1036	38	7	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149440	10.1371/journal.pone.0149440	http://dx.doi.org/10.1371/journal.pone.0149440			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901164	Green Published, gold			2022-12-27	WOS:000371276100078
J	Jones, BA; Rich, KM; Mariner, JC; Anderson, J; Jeggo, M; Thevasagayam, S; Cai, Y; Peters, AR; Roeder, P				Jones, Bryony A.; Rich, Karl M.; Mariner, Jeffrey C.; Anderson, John; Jeggo, Martyn; Thevasagayam, Sam; Cai, Yi; Peters, Andrew R.; Roeder, Peter			The Economic Impact of Eradicating Peste des Petits Ruminants: A Benefit-Cost Analysis	PLOS ONE			English	Article							RINDERPEST CONTROL; SOCIOECONOMIC IMPACTS; VIRUS; OUTBREAK; STRATEGIES; ANTIBODIES; INFECTION; DIAGNOSIS; DISEASES; LOSSES	Peste des petits ruminants (PPR) is an important cause of mortality and production loss among sheep and goats in the developing world. Despite control efforts in a number of countries, it has continued to spread across Africa and Asia, placing an increasing burden on the livelihoods of livestock keepers and on veterinary resources in affected countries. Given the similarities between PPR and rinderpest, and the lessons learned from the successful global eradication of rinderpest, the eradication of PPR seems appealing, both eliminating an important disease and improving the livelihoods of the poor in developing countries. We conducted a benefit-cost analysis to examine the economic returns from a proposed programme for the global eradication of PPR. Based on our knowledge and experience, we developed the eradication strategy and estimated its costs. The benefits of the programme were determined from (i) the averted mortality costs, based on an analysis of the literature, (ii) the downstream impact of reduced mortality using a social accounting matrix, and (iii) the avoided control costs based on current levels of vaccination. The results of the benefit-cost analysis suggest strong economic returns from PPR eradication. Based on a 15-year programme with total discounted costs of US$2.26 billion, we estimate discounted benefits of US$76.5 billion, yielding a net benefit of US$74.2 billion. This suggests a benefit cost ratio of 33.8, and an internal rate of return (IRR) of 199%. As PPR mortality rates are highly variable in different populations, we conducted a sensitivity analysis based on lower and higher mortality scenarios. All the scenarios examined indicate that investment in PPR eradication would be highly beneficial economically. Furthermore, removing one of the major constraints to small ruminant production would be of considerable benefit to many of the most vulnerable communities in Africa and Asia.	[Jones, Bryony A.] Univ London, Royal Vet Coll, Prod & Populat Hlth Dept, Hatfield, Herts, England; [Rich, Karl M.] Lab 863 Ltd, Edgware, Middx, England; [Rich, Karl M.] Norwegian Inst Int Affairs, Oslo, Norway; [Mariner, Jeffrey C.] Tufts Cummings Sch Vet Med, North Grafton, MA USA; [Anderson, John] Nelson Mandela African Inst Sci & Technol, Arusha, Tanzania; [Jeggo, Martyn] Deakin Univ, Fac Med, Geelong Ctr Emerging Infect Dis, Geelong, Vic 3217, Australia; [Thevasagayam, Sam; Cai, Yi] Bill & Melinda Gates Fdn, Seattle, WA USA; [Peters, Andrew R.] Scotlands Rural Coll, Edinburgh, Midlothian, Scotland; [Roeder, Peter] Taurus Anim Hlth, Headley Down, Hants, England; [Rich, Karl M.] Lincoln Univ, Fac Agribusiness & Commerce, Christchurch, New Zealand	University of London; University of London Royal Veterinary College; Nelson Mandela African Institution of Science & Technology; Deakin University; Bill & Melinda Gates Foundation; Scotland's Rural College; Lincoln University - New Zealand	Jones, BA (corresponding author), Univ London, Royal Vet Coll, Prod & Populat Hlth Dept, Hatfield, Herts, England.	bajones@rvc.ac.uk		Jones, Bryony/0000-0003-4383-2504	Bill & Melinda Gates Foundation; Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Gates Foundation(Bill & Melinda Gates Foundation)	This paper is based on research funded by the Bill & Melinda Gates Foundation (http://www.gatesfoundation.org/). The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation. ST and YC are employees of The Bill and Melinda Gates Foundation. BAJ, KMR, JCM, JA, MJ, ARP and PR were funded by the Gates Foundation to carry out the study. There was no additional external funding received for this study. The funder provided support in the form of salaries (ST, YC) or honoraria (BAJ, KMR, JCM, JA, MJ, ARP and PR) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abu Elzein EME, 2004, J VET MED B, V51, P68, DOI 10.1111/j.1439-0450.2004.00731.x; Abubakar M, 2014, TRANSBOUND EMERG DIS, V61, P7, DOI 10.1111/tbed.12192; AKEREJOLA O O, 1979, Bulletin of Animal Health and Production in Africa, V27, P65; ANDERSON J, 1994, EPIDEMIOL INFECT, V112, P225, DOI 10.1017/S0950268800057599; Anderson J, 2011, VET REC, V169, P10, DOI 10.1136/vr.d4011; [Anonymous], 1999, RECOGNIZING PESTE PE; Awa DN, 2000, TROP ANIM HEALTH PRO, V32, P391, DOI 10.1023/A:1005233703331; Banyard AC, 2010, J GEN VIROL, V91, P2885, DOI 10.1099/vir.0.025841-0; Bao JY, 2011, RES VET SCI, V90, P238, DOI 10.1016/j.rvsc.2010.05.031; Baron J, 2014, TRANSBOUND EMERG DIS, V61, P390, DOI 10.1111/tbed.12266; Baron MD, 2011, VET REC, V169, P16, DOI 10.1136/vr.d3947; Battena CA, 2011, J VIROL METHODS, V171, P401, DOI 10.1016/j.jviromet.2010.11.022; Ekboir J. M., 1999, POTENTIAL IMPACT FOO; Elsawalhy A. A., 2010, Bulletin of Animal Health and Production in Africa, V58, P193; FAO, 2008, PEST PET RUM PPR MOR; FAO, 2008, THE IMPACT OF PESTE, P59; Felton M.R., 1978, STUDIES CONTROL RIND; FURLEY CW, 1987, VET REC, V121, P443, DOI 10.1136/vr.121.19.443; GARNER MG, 1995, PREV VET MED, V23, P9, DOI 10.1016/0167-5877(94)00433-J; Govindarajan R, 1997, VET REC, V141, P573, DOI 10.1136/vr.141.22.573; Hoffmann B, 2012, TRANSBOUND EMERG DIS, V59, P173, DOI 10.1111/j.1865-1682.2011.01270.x; Khalafalla AI, 2010, ACTA TROP, V116, P161, DOI 10.1016/j.actatropica.2010.08.002; Kinne J, 2010, EPIDEMIOL INFECT, V138, P1211, DOI 10.1017/S0950268809991592; Kiringai J, 2006, 2003 SOCIAL AC UNPUB; LEWIS BD, 1992, WORLD DEV, V20, P881, DOI 10.1016/0305-750X(92)90058-4; LIBEAU G, 1994, VET REC, V134, P300, DOI 10.1136/vr.134.12.300; LIBEAU G, 1995, RES VET SCI, V58, P50, DOI 10.1016/0034-5288(95)90088-8; Mariner JC, 2005, PREV VET MED, V69, P245, DOI 10.1016/j.prevetmed.2005.02.001; Mariner JC, 2012, SCIENCE, V337, P1309, DOI 10.1126/science.1223805; Miller M, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1163; Miller R., 2009, INPUT OUTPUT ANAL FD; Munir M, 2014, TRANSBOUND EMERG DIS, V61, P411, DOI 10.1111/tbed.12052; OIE FAO., 2015, GLOB STRAT CONTR ER; OPASINA BA, 1985, TROP ANIM HEALTH PRO, V17, P219, DOI 10.1007/BF02356980; Perry B. D, 2003, IMPACT POVERTY REDUC; Rich KM, 2014, FOOD POLICY, V44, P248, DOI 10.1016/j.foodpol.2013.09.018; Rich KM, 2010, AM J TROP MED HYG, V83, P52, DOI 10.4269/ajtmh.2010.09-0291; Rich KM, 1997, WORLD DEV, V25, P2105, DOI 10.1016/S0305-750X(97)00099-5; Roeder P, 2009, IFPRI DISCUSSION PAP; Sadoulet E., 1995, QUANTITATIVE DEV POL; Singh B, 2014, VET WORLD, V7, P194, DOI 10.14202/vetworld.2014.194-199; Singh B, 2009, INDIAN J ANIM SCI, V79, P1265; Singh B., 2008, AGR EC RES REV, V21, P297, DOI DOI 10.22004/ag.econ.47686; Singh RP, 2004, REV SCI TECH OIE, V23, P807, DOI 10.20506/rst.23.3.1522; STEM C, 1993, PREV VET MED, V16, P141, DOI 10.1016/0167-5877(93)90084-7; Tambi EN, 2004, REV SCI TECH OIE, V23, P737; Tambi EN, 1999, REV SCI TECH OIE, V18, P458, DOI 10.20506/rst.18.2.1164; Thombare N.N., 2009, AGR EC RES REV, V22, P319, DOI 10.22004/ag.econ.57469; Venkataramanan R, 2005, INDIAN J ANIM SCI, V75, P456; Wu X, 2016, TRANSBOUND EMERG DIS, V63, pE441, DOI 10.1111/tbed.12308	50	68	72	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149982	10.1371/journal.pone.0149982	http://dx.doi.org/10.1371/journal.pone.0149982			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26900944	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100197
J	Stocker, AM; O'Leary, DDM				Stocker, Adam M.; O'Leary, Dennis D. M.			Emx1 Is Required for Neocortical Area Patterning	PLOS ONE			English	Article							DEVELOPING CEREBRAL-CORTEX; THALAMOCORTICAL AXONS; MAMMALIAN NEOCORTEX; HOMEOBOX GENES; COUP-TFI; ROR-BETA; EXPRESSION; SPECIFICATION; REGIONALIZATION; DIFFERENTIATION	Establishing appropriate area patterning in the neocortex is a critical developmental event, and transcription factors whose expression is graded across the developing neural axes have been implicated in this process. While previous reports suggested that the transcription factor Emx1 does not contribute to neocortical area patterning, those studies were performed at perinatal ages prior to the emergence of primary areas. We therefore examined two different Emx1 deletion mouse lines once primary areas possess mature features. Following the deletion of Emx1, the frontal and motor areas were expanded while the primary visual area was reduced, and overall the areas shifted posterio-medially. This patterning phenotype was consistent between the two Emx1 deletion strategies. The present study demonstrates that Emx1 is an area patterning transcription factor and is required for the specification of the primary visual area.	[Stocker, Adam M.; O'Leary, Dennis D. M.] Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Stocker, Adam M.] Minnesota State Univ Moorhead, Biosci Dept, 1104 7th Ave South, Moorhead, MN 56563 USA	Salk Institute; Minnesota State Colleges & Universities; Minnesota State University Moorhead	Stocker, AM (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.; Stocker, AM (corresponding author), Minnesota State Univ Moorhead, Biosci Dept, 1104 7th Ave South, Moorhead, MN 56563 USA.	stocker@mnstate.edu	Stocker, Adam/R-6580-2016	Stocker, Adam/0000-0002-7629-5170	National Institute of Mental Health [5 R01 MH086147]; National Institute of Neurological Disorders and Stroke [5 R01 NS031558 21]; National Eye Institute [T32 EY 020503]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031558] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institute of Mental Health, grant number 5 R01 MH086147, awarded to DDMO (https://www.nimh.nih.gov/index.shtml), and National Institute of Neurological Disorders and Stroke, grant number 5 R01 NS031558 21, awarded to DDMO (http://www.ninds.nih.gov/). AMS was a trainee on the National Eye Institute training grant number T32 EY 020503 (https://nei.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6632; Alfano C, 2013, DEV NEUROBIOL, V73, P411, DOI 10.1002/dneu.22067; Armentano M, 2007, NAT NEUROSCI, V10, P1277, DOI 10.1038/nn1958; Beckmann J, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-35; Bishop KM, 2003, J COMP NEUROL, V457, P345, DOI 10.1002/cne.10550; Bishop KM, 2002, J NEUROSCI, V22, P7627; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Braisted JE, 1999, DEV BIOL, V208, P430, DOI 10.1006/dbio.1999.9216; Briata P, 1996, MECH DEVELOP, V57, P169, DOI 10.1016/0925-4773(96)00544-8; Bulchand S, 2003, DEV DYNAM, V226, P460, DOI 10.1002/dvdy.10235; Chou SJ, 2013, SCIENCE, V340, P1239, DOI 10.1126/science.1232806; Force A, 1999, GENETICS, V151, P1531; FUJIMIYA M, 1986, J COMP NEUROL, V246, P191, DOI 10.1002/cne.902460205; Gangemi RMR, 2006, EUR J NEUROSCI, V23, P325, DOI 10.1111/j.1460-9568.2005.04559.x; Gorski JA, 2002, J NEUROSCI, V22, P6309; Guido W, 2008, J PHYSIOL-LONDON, V586, P4357, DOI 10.1113/jphysiol.2008.157115; Gulisano M, 1996, EUR J NEUROSCI, V8, P1037, DOI 10.1111/j.1460-9568.1996.tb01590.x; Hamasaki T, 2004, NEURON, V43, P359, DOI 10.1016/j.neuron.2004.07.016; Hoch RV, 2009, SEMIN CELL DEV BIOL, V20, P378, DOI 10.1016/j.semcdb.2009.02.005; Hong SM, 2007, EXP NEUROL, V206, P24, DOI 10.1016/j.expneurol.2007.03.028; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Kaas JH, 2001, CURR OPIN NEUROBIOL, V11, P498, DOI 10.1016/S0959-4388(00)00240-3; Korematsu K, 1997, J COMP NEUROL, V387, P291; Leingartner A, 2007, P NATL ACAD SCI USA, V104, P4153, DOI 10.1073/pnas.0611723104; Li H, 2006, MOL CELL NEUROSCI, V33, P136, DOI 10.1016/j.mcn.2006.06.012; Lim JWC, 2015, DEVELOPMENT, V142, P3746, DOI 10.1242/dev.119909; Mallamaci A, 2000, NAT NEUROSCI, V3, P679, DOI 10.1038/76630; Miyamoto N, 1997, DEVELOPMENT, V124, P1653; Molnar Z, 2012, EUR J NEUROSCI, V35, P1573, DOI 10.1111/j.1460-9568.2012.08119.x; Muzio L, 2003, CEREB CORTEX, V13, P641, DOI 10.1093/cercor/13.6.641; Nakagawa Y, 2003, DEV NEUROSCI-BASEL, V25, P234, DOI 10.1159/000072271; Nakagawa Y, 1999, J NEUROSCI, V19, P10877, DOI 10.1523/JNEUROSCI.19-24-10877.1999; O'Leary DDM, 2013, COMPREHENSIVE DEVELOPMENTAL NEUROSCIENCE: PATTERNING AND CELL TYPE SPECIFICATION IN THE DEVELOPING CNS AND PNS, P61, DOI 10.1016/B978-0-12-397265-1.00021-6; Pellegrini M, 1997, ANAT EMBRYOL, V196, P427, DOI 10.1007/s004290050110; Pellegrini M, 1996, DEVELOPMENT, V122, P3893; Pellegrini M, 2001, DEV BIOL, V232, P149, DOI 10.1006/dbio.2001.0159; Price DJ, 2006, EUR J NEUROSCI, V23, P910, DOI 10.1111/j.1460-9568.2006.04620.x; Qiu MS, 1996, DEV BIOL, V178, P174, DOI 10.1006/dbio.1996.0207; R Core Team, 2021, R LANGUAGE ENV STAT; Rubenstein JLR, 1999, CEREB CORTEX, V9, P524, DOI 10.1093/cercor/9.6.524; Sahara S, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-10; Sansom SN, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002519; Schaeren-Wiemers N, 1997, EUR J NEUROSCI, V9, P2687, DOI 10.1111/j.1460-9568.1997.tb01698.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SIMEONE A, 1992, EMBO J, V11, P2541, DOI 10.1002/j.1460-2075.1992.tb05319.x; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; Tank EM, 2009, EVOL DEV, V11, P343, DOI 10.1111/j.1525-142X.2009.00341.x; Torre ER, 2010, MOL CELL NEUROSCI, V44, P135, DOI 10.1016/j.mcn.2010.03.003; Tropea D, 2006, NAT NEUROSCI, V9, P660, DOI 10.1038/nn1689; Vue TY, 2013, J NEUROSCI, V33, P8442, DOI 10.1523/JNEUROSCI.5786-12.2013; Wright AG, 2007, J NEUROSCI, V27, P13667, DOI 10.1523/JNEUROSCI.2888-07.2007; Yoshida M, 1997, DEVELOPMENT, V124, P101; Zembrzycki A, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-8; Zembrzycki A, 2015, ELIFE, V4, DOI 10.7554/eLife.11416; Zembrzycki A, 2015, P NATL ACAD SCI USA, V112, P6736, DOI 10.1073/pnas.1424440112; Zembrzycki A, 2013, NAT NEUROSCI, V16, P1060, DOI 10.1038/nn.3454; Zhou C, 2001, GENE DEV, V15, P2054, DOI 10.1101/gad.913601	57	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149900	10.1371/journal.pone.0149900	http://dx.doi.org/10.1371/journal.pone.0149900			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901526	Green Submitted, gold, Green Published			2022-12-27	WOS:000371276100180
J	Zhang, CY; Bruce, H; Yang, TF; Charagu, P; Kemp, RA; Boddicker, N; Miar, Y; Wang, ZQ; Plastow, G				Zhang, Chunyan; Bruce, Heather; Yang, Tianfu; Charagu, Patrick; Kemp, Robert Alan; Boddicker, Nicholas; Miar, Younes; Wang, Zhiquan; Plastow, Graham			Genome Wide Association Studies (GWAS) Identify QTL on SSC2 and SSC17 Affecting Loin Peak Shear Force in Crossbred Commercial Pigs	PLOS ONE			English	Article							MEAT QUALITY TRAITS; SINGLE-NUCLEOTIDE POLYMORPHISMS; CAST GENETIC POLYMORPHISMS; DRY-CURED HAMS; CANDIDATE GENES; PORK QUALITY; CALPASTATIN GENE; MUSCLE; TENDERNESS; LOCI	Of all the meat quality traits, tenderness is considered the most important with regard to eating quality and market value. In this study we have utilised genome wide association studies (GWAS) for peak shear force (PSF) of loin muscle as a measure of tenderness for 1,976 crossbred commercial pigs, genotyped for 42,721 informative SNPs using the Illumina Por-cineSNP60 Beadchip. Four 1 Mb genomic regions, three on SSC2 (at 4 Mb, 5 Mb and 109 Mb) and one on SSC17 (at 20 Mb), were detected which collectively explained about 15.30% and 3.07% of the total genetic and phenotypic variance for PSF respectively. Markers ASGA0008566, ASGA0008695, DRGA0003285 and ASGA0075615 in the four regions were strongly associated with the effects. Analysis of the reference genome sequence in the region with the most important SNPs for SSC2_5 identified FRMD8, SLC25A45 and LTBP3 as potential candidate genes for meat tenderness on the basis of functional annotation of these genes. The region SSC2_109 was close to a previously reported candidate gene CAST; however, the very weak LD between DRGA0003285 (the best marker representing region SSC2_109) and CAST indicated the potential for additional genes which are distinct from, or interact with, CAST to affect meat tenderness. Limited information of known genes in regions SSC2_109 and SSC17_20 restricts further analysis. Re-sequencing of these regions for informative animals may help to resolve the molecular architecture and identify new candidate genes and causative mutations affecting this trait. These findings contribute significantly to our knowledge of the genomic regions affecting pork shear force and will potentially lead to new insights into the molecular mechanisms regulating meat tenderness.	[Zhang, Chunyan; Bruce, Heather; Yang, Tianfu; Miar, Younes; Wang, Zhiquan; Plastow, Graham] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Charagu, Patrick] Hypor Inc, Regina, SK, Canada; [Kemp, Robert Alan; Boddicker, Nicholas] Genesus Inc, Oakville, MB, Canada	University of Alberta	Plastow, G (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	plastow@ualberta.ca	Bruce, Heather/GNP-7840-2022	Bruce, Heather/0000-0002-8522-813X; Miar, Younes/0000-0001-9933-5414; Plastow, Graham/0000-0002-3774-3110	Natural Sciences and Engineering Research Council of Canada (NSERC) [CRDPJ 379911]; Hypor Inc.; Genesus Inc.; CZ and GP Mitacs Elevate Program [IT03418]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Hypor Inc.; Genesus Inc.; CZ and GP Mitacs Elevate Program	GP acknowledges the financial support from Natural Sciences and Engineering Research Council of Canada (NSERC) CRDPJ 379911: www.nserc-crsng.gc.ca; Hypor Inc. www.hypor.com/; Genesus Inc. www.genesus.com/; and CZ and GP Mitacs Elevate Program IT03418: https://www.mitacs.ca/en/progra,s/elevate. The industry funders (Hypor Inc. and Genesus Inc.) provided support in the form of salaries for authors (PC, RAK, and NB), and data collection at the commercial units, but did not have any additional role in the study design and analysis, or decision to publish. The specific roles of these authors are articulated in the "author contributions" section. The other funders did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bernevic B, 2011, INT J MASS SPECTROM, V305, P217, DOI 10.1016/j.ijms.2010.11.010; Bredahl L, 1998, FOOD QUAL PREFER, V9, P273, DOI 10.1016/S0950-3293(98)00007-X; Cepica S, 2013, MEAT SCI, V95, P368, DOI 10.1016/j.meatsci.2013.05.002; Ciobanu DC, 2011, GENETICS OF THE PIG, 2ND EDITION, P355, DOI 10.1079/9781845937560.0355; Ciobanu DC, 2004, J ANIM SCI, V82, P2829; Dong Q, 2014, FRONT AGRIC SCI ENG, V1, P137, DOI 10.15302/J-FASE-2014014; Fortomaris P, 2006, MEAT SCI, V72, P688, DOI 10.1016/j.meatsci.2005.09.019; Gandolfi G, 2011, MEAT SCI, V88, P694, DOI 10.1016/j.meatsci.2011.02.031; Gilmour AR, 2009, ASREML USER GUIDE RE; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Gou P, 2012, MEAT SCI, V92, P346, DOI 10.1016/j.meatsci.2012.06.018; Grunert KG, 2004, MEAT SCI, V66, P259, DOI 10.1016/S0309-1740(03)00130-X; Haitina T, 2006, GENOMICS, V88, P779, DOI 10.1016/j.ygeno.2006.06.016; Harper GS, 1999, AUST J AGR RES, V50, P1105, DOI 10.1071/AR98191; Hu Zhi-Liang, 2011, Frontiers in Genetics, V2, P43, DOI 10.3389/fgene.2011.00043; Kapelanski Wojciech, 2004, Animal Science Papers and Reports, V22, P435; Kemp CM, 2006, J ANIM SCI, V84, P2841, DOI 10.2527/jas.2006-163; Koohmaraie M, 2002, MEAT SCI, V62, P345, DOI 10.1016/S0309-1740(02)00127-4; KOOHMARAIE M, 1991, J ANIM SCI, V69, P617; Lindholm-Perry AK, 2009, ANIM GENET, V40, P713, DOI 10.1111/j.1365-2052.2009.01903.x; Liu G, 2007, ANIM GENET, V38, P241, DOI 10.1111/j.1365-2052.2007.01592.x; Liu GS, 2008, MAMM GENOME, V19, P429, DOI 10.1007/s00335-008-9132-y; Ma JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064047; Malek M, 2001, MAMM GENOME, V12, P637, DOI 10.1007/s003350020019; Markljung E, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-22; McClure MC, 2012, ANIM GENET, V43, P662, DOI 10.1111/j.1365-2052.2012.02323.x; MCCORMICK RJ, 1994, MEAT SCI, V36, P79, DOI 10.1016/0309-1740(94)90035-3; Melody JL, 2004, J ANIM SCI, V82, P1195; Miar Y, 2014, J ANIM SCI, V92, P2869, DOI 10.2527/jas.2014-7685; Nonneman D, 2011, J ANIM SCI, V89, P2663, DOI 10.2527/jas.2010-3556; Nonneman DJ, 2013, J ANIM SCI, V91, P4043, DOI 10.2527/jas.2013-6255; Olfert ED, 1993, GUIDE CARE USE EXPT; Page BT, 2002, J ANIM SCI, V80, P3077; Paredi G, 2012, J PROTEOMICS, V75, P4275, DOI 10.1016/j.jprot.2012.04.011; Parr T, 1999, J ANIM SCI, V77, P661; Ponsuksili S, 2014, INT J BIOL SCI, V10, P327, DOI 10.7150/ijbs.8134; Promeyrat A, 2011, FOOD CHEM, V127, P1097, DOI 10.1016/j.foodchem.2011.01.108; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rohrer GA, 2012, MEAT SCI, V92, P511, DOI 10.1016/j.meatsci.2012.05.020; Rohrer GA, 2006, ANIM GENET, V37, P17, DOI 10.1111/j.1365-2052.2005.01368.x; Ropka-Molik K, 2014, MEAT SCI, V97, P143, DOI 10.1016/j.meatsci.2014.01.021; Sanchez MP, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-12; Sante-Lhoutellier V, 2012, MEAT SCI, V92, P354, DOI 10.1016/j.meatsci.2012.06.022; Sargolzaei M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-478; Sieczkowska H, 2010, MEAT SCI, V84, P137, DOI 10.1016/j.meatsci.2009.08.038; Skrlep M, 2012, MEAT SCI, V92, P360, DOI 10.1016/j.meatsci.2012.06.021; Warner RD, 2010, MEAT SCI, V86, P171, DOI 10.1016/j.meatsci.2010.04.042; Wimmers K, 2007, ANIM GENET, V38, P474, DOI 10.1111/j.1365-2052.2007.01639.x; Zhang CY, 2014, ANIM GENET, V45, P508, DOI 10.1111/age.12155	50	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0145082	10.1371/journal.pone.0145082	http://dx.doi.org/10.1371/journal.pone.0145082			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901498	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100004
J	Pech-Puch, D; Cruz-Lopez, H; Canche-Ek, C; Campos-Espinosa, G; Garcia, E; Mascaro, M; Rosas, C; Chavez-Velasco, D; Rodriguez-Morales, S				Pech-Puch, Dawrin; Cruz-Lopez, Honorio; Canche-Ek, Cindy; Campos-Espinosa, Gabriela; Garcia, Elpidio; Mascaro, Maite; Rosas, Carlos; Chavez-Velasco, Daniel; Rodriguez-Morales, Sergio			Chemical Tools of Octopus maya during Crab Predation Are Also Active on Conspecifics	PLOS ONE			English	Article							POSTERIOR SALIVARY-GLANDS; ELEDONE-CIRRHOSA MOLLUSCA; CEPHALOPODA; VULGARIS; CYANEA; PREY; PHARMACOLOGY; INJECTION; SEROTONIN; PROTEINS	Octopus maya is a major socio-economic resource from the Yucatan Peninsula in Mexico. In this study we report for the first time the chemical composition of the saliva of O. maya and its effect on natural prey, i.e. the blue crab (Callinectes sapidus), the crown conch snail (Melongena corona bispinosa), as well as conspecifics. Salivary posterior glands were collected from octopus caught by local fishers and extracted with water; this extract paralyzed and predigested crabs when it was injected into the third pereiopod. The water extract was fractionated by membrane ultrafiltration with a molecular weight cut-off of 3kDa leading to a metabolic phase (>3kDa) and a neurotoxic fraction (<3kDa). The neurotoxic fraction injected in the crabs caused paralysis and postural changes. Crabs recovered to their initial condition within two hours, which suggests that the effects of the neurotoxic fraction were reversible. The neurotoxic fraction was also active on O. maya conspecifics, partly paralyzing and sedating them; this suggests that octopus saliva might be used among conspecifics for defense and for reduction of competition. Bioguided separation of the neurotoxic fraction by chromatography led to a paralysis fraction and a relaxing fraction. The paralyzing activity of the saliva was exerted by amino acids, while the relaxing activity was due to the presence of serotonin. Prey-handling studies revealed that O. maya punctures the eye or arthrodial membrane when predating blue crabs and uses the radula to bore through crown conch shells; these differing strategies may help O. maya to reduce the time needed to handle its prey.	[Pech-Puch, Dawrin; Cruz-Lopez, Honorio; Canche-Ek, Cindy; Campos-Espinosa, Gabriela; Rodriguez-Morales, Sergio] Univ Nacl Autonoma Mexico, Fac Quim, Unidad Quim Sisal, Sisal, Yucatan, Mexico; [Garcia, Elpidio] Univ Nacl Autonoma Mexico, Fac Quim, Dept Bioquim, Mexico City 04510, DF, Mexico; [Mascaro, Maite; Rosas, Carlos] Univ Nacl Autonoma Mexico, Fac Ciencias, Unidad Multidisciplinaria Docencia & Invest, Sisal, Yucatan, Mexico; [Chavez-Velasco, Daniel] Inst Tecnol Tijuana, Ctr Grad & Invest Quim, Tijuana, Baja Calif Nort, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Rodriguez-Morales, S (corresponding author), Univ Nacl Autonoma Mexico, Fac Quim, Unidad Quim Sisal, Sisal, Yucatan, Mexico.	sergiorodriguez@unam.mx	MIQUELAJAUREGUI, MAITE MASCARO/AAD-5843-2021; Cruz-Lopez, Honorio/B-1687-2017; Rodriguez, Sergio/ABA-8038-2021; Garcia, Elpidio/L-5258-2019; Rosas, Carlos/A-7052-2009; Pech-Puch, Dawrin/GVR-8458-2022; Cruz-López, Honorio/AAA-3197-2019	MIQUELAJAUREGUI, MAITE MASCARO/0000-0003-3614-4383; Cruz-Lopez, Honorio/0000-0001-9736-0288; Cruz-López, Honorio/0000-0001-9736-0288; PECH-PUCH, DAWRIN/0000-0002-1680-4340; Rosas, Carlos/0000-0002-1301-7368	Direccion General de Asuntos del Personal Academico (DGAPA)-UNAM (PAPIIT) [TA200314]; Consejo Nacional de Ciencia y Tecnologia (CONACyT); Yucatan government (FOMIX-YUCATAN) [107350]	Direccion General de Asuntos del Personal Academico (DGAPA)-UNAM (PAPIIT); Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Yucatan government (FOMIX-YUCATAN)	This work was supported by grants from the Direccion General de Asuntos del Personal Academico (DGAPA)-UNAM (PAPIIT TA200314), from Consejo Nacional de Ciencia y Tecnologia (CONACyT) and the Yucatan government (FOMIX-YUCATAN 107350).	Agnisola C, 1996, PHYSIOL BEHAV, V59, P729, DOI 10.1016/0031-9384(95)02153-1; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson RC, 2008, MAR ECOL PROG SER, V371, P199, DOI 10.3354/meps07649; Anderson RC, 2008, VELIGER, V50, P326; ANDREWS PLR, 1981, PROC R SOC SER B-BIO, V213, P93, DOI 10.1098/rspb.1981.0056; ARNOLD JM, 1969, AM ZOOL, V9, P991; BARLOW JJ, 1974, J COMP PHYSIOL, V89, P105, DOI 10.1007/BF00694786; Boyle P, 2005, CEPHALOPODS: ECOLOGY AND FISHERIES, P222; BOYLE PR, 1981, J ZOOL, V193, P1; Brodie E, 2009, CURR BIOL, pR927; Caldwell RL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134152; CARIELLO L, 1977, COMP BIOCHEM PHYS C, V57, P169, DOI 10.1016/0306-4492(77)90066-1; Clarke K, 2006, PRIMER V6 USER MANUA, P190; Cooke I. R., 2015, EVOLUTION VENOMOUS A; Fiorito G, 2014, INVERTEBR NEUROSCI, V14, P13, DOI 10.1007/s10158-013-0165-x; FLACHSENBERGER W, 1985, TOXICON, V23, P997, DOI 10.1016/0041-0101(85)90393-9; Forsythe JW, 1997, J EXP MAR BIOL ECOL, V209, P15, DOI 10.1016/S0022-0981(96)00057-3; Fry BG, 2009, J MOL EVOL, V68, P311, DOI 10.1007/s00239-009-9223-8; George-Zamora A, 2011, AQUACULTURE, V314, P215, DOI 10.1016/j.aquaculture.2011.02.022; GERSCHENFELD HM, 1973, PHYSIOL REV, V53, P1, DOI 10.1152/physrev.1973.53.1.1; GHIRETTI F, 1960, ANN NY ACAD SCI, V90, P726, DOI 10.1111/j.1749-6632.1960.tb26417.x; Gleadall IG, 2013, J EXP MAR BIOL ECOL, V447, P23, DOI 10.1016/j.jembe.2013.02.008; Grisley MS, 1996, J EXP MAR BIOL ECOL, V202, P225, DOI 10.1016/0022-0981(96)00035-4; Hanlon RT, 2008, MAR FRESHW BEHAV PHY, V41, P19, DOI 10.1080/10236240701661123; Hanlon RT, 1999, BIOL J LINN SOC, V66, P1; HARTWICK EB, 1978, MAR BEHAV PHYSIOL, V5, P193, DOI 10.1080/10236247809378535; HOWDEN MEH, 1974, TOXICON, V12, P317, DOI 10.1016/0041-0101(74)90076-2; Huffard CL, 2015, MOLLUSCAN RES, V35, P12, DOI 10.1080/13235818.2014.909558; Ibanez CM, 2010, REV FISH BIOL FISHER, V20, P123, DOI 10.1007/s11160-009-9129-y; JUORIO AV, 1973, COMP BIOCHEM PHYSIOL, V44, P1059, DOI 10.1016/0300-9629(73)90243-0; Kanda A, 2003, PEPTIDES, V24, P35, DOI 10.1016/S0196-9781(02)00274-7; Key LN, 2002, TOXICON, V40, P677, DOI 10.1016/S0041-0101(01)00254-9; Krnjevic K, 2010, J PHYSIOL-LONDON, V588, P33, DOI 10.1113/jphysiol.2009.176990; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Legendre P, 2012, DEV ENV MODELLING, V24, P109; Leite TS, 2009, MAR BIOL, V156, P2355, DOI 10.1007/s00227-009-1264-4; LIVINGSTONE MS, 1980, SCIENCE, V208, P76, DOI 10.1126/science.208.4439.76; Mather J. A., 1994, Vie et Milieu, V44, P267; MATHER JA, 1991, B MAR SCI, V49, P256; Mather JA, 2014, CEPHALOPOD CULTURE, P17, DOI [DOI 10.1007/978-94-017-8648-5, 10.1007/978-94-017-8648-5]; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; NIXON M, 1980, J ZOOL, V191, P75; NIXON M, 1979, J ZOOL, V187, P291; NIXON M, 1984, J ZOOL, V202, P441, DOI 10.1111/j.1469-7998.1984.tb05094.x; Rosas C., 2014, CEPHALOPOD CULTURE, DOI [10.1007/978-94-017-8648-5_20, DOI 10.1007/978-94-017-8648-5_20]; Rothschild BJ, 1992, 92003036 CBL; Sanchez-Rodriguez J, 2006, ARCH TOXICOL, V80, P436, DOI 10.1007/s00204-006-0059-3; Spitzer N, 2008, J EXP BIOL, V211, P92, DOI 10.1242/jeb.012450; Steer MA, 2003, J EXP MAR BIOL ECOL, V290, P165, DOI 10.1016/S0022-0981(03)00076-5; Sykes AV, 2014, CEPHALOPOD CULTURE, P59, DOI DOI 10.1007/978-94-017-8648-5_4; Undheim EAB, 2010, TOXICON, V56, P897, DOI 10.1016/j.toxicon.2010.06.013; Uriarte I, 2011, J WORLD AQUACULT SOC, V42, P735, DOI 10.1111/j.1749-7345.2011.00524.x; WODINSKY J, 1973, MAR BIOL, V20, P154, DOI 10.1007/BF00351454; WODINSKY J, 1969, AM ZOOL, V9, P997; WOOD DE, 1995, J COMP PHYSIOL A, V177, P321	55	12	12	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148922	10.1371/journal.pone.0148922	http://dx.doi.org/10.1371/journal.pone.0148922			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895025	gold, Green Published, Green Submitted			2022-12-27	WOS:000371223400026
J	Devoe, NC; Corbett, IJ; Barker, L; Chang, R; Gudis, P; Mullen, N; Perez, K; Raposo, H; Scholz, J; May, M				Devoe, Neil C.; Corbett, Ian J.; Barker, Linsey; Chang, Robert; Gudis, Polyxeni; Mullen, Nathan; Perez, Kailey; Raposo, Hugo; Scholz, John; May, Meghan			Differential Evolutionary Selection and Natural Evolvability Observed in ALT Proteins of Human Filarial Parasites	PLOS ONE			English	Article							LYMPHATIC FILARIASIS; BRUGIA-MALAYI; WUCHERERIA-BANCROFTI; LARVAL; ANTIGEN; GENES; INFORMATION; POPULATION; PROTECTION; INFECTION	The abundant larval transcript (ALT-2) protein is present in all members of the Filarioidea, and has been reported as a potential candidate antigen for a subunit vaccine against lymphatic filariasis. To assess the potential for vaccine escape or heterologous protection, we examined the evolutionary selection acting on ALT-2. The ratios of nonsynonymous (K(a)) to synonymous (K(s)) mutation frequencies (omega) were calculated for the alt-2 genes of the lymphatic filariasis agents Brugia malayi and Wuchereria bancrofti and the agents of river blindness and African eyeworm disease Onchocerca volvulus and Loa loa. Two distinct Bayesian models of sequence evolution showed that ALT-2 ofW. bancrofti and L. loa were under significant (P< 0.05; P < 0.001) diversifying selection, while ALT-2 of B. malayi and O. volvulus were under neutral to stabilizing selection. Diversifying selection as measured by omega values was notably strongest on the region of ALT-2 encoding the signal peptide of L. loa and was elevated in the variable acidic domain of L. loa and W. bancrofti. Phylogenetic analysis indicated that the ALT-2 consensus sequences formed three clades: the first consisting of B. malayi, the second consisting ofW. bancrofti, and the third containing both O. volvulus and L. loa. ALT-2 selection was therefore not predictable by phylogeny or pathology, as the two species parasitizing the eye were selected differently, as were the two species parasitizing the lymphatic system. The most immunogenic regions of L. loa andW. bancrofti ALT-2 sequence as modeled by antigenicity prediction analysis did not correspond with elevated levels of diversifying selection, and were not selected differently than predicted antigenic epitopes in B. malayi and O. volvulus. Measurements of ALT-2 evolvability made by chi(2) analysis between alleles that were stable (O. volvulus and B. malayi) and those that were under diversifying selection (W. bancrofti and L. loa) indicated significant (P<0.01) deviations from a normal distribution for both W. bancrofti and L. loa. The relationship between evolvability and selection in L. loa followed a second order polynomial distribution (R-2 = 0.89), indicating that the two factors relate to one another in accordance with an additional unknown factor. Taken together, these findings indicate discrete evolutionary drivers acting on ALT-2 of the four organisms examined, and the described variation has implications for design of novel vaccines and diagnostic reagents. Additionally, this represents the first mathematical description of evolvability in a naturally occurring setting.	[Devoe, Neil C.; Corbett, Ian J.; Barker, Linsey; Chang, Robert; Gudis, Polyxeni; Mullen, Nathan; Perez, Kailey; Raposo, Hugo; Scholz, John; May, Meghan] Univ New England, Coll Osteopath Med, Biddeford, ME 04005 USA	University of New England - Maine	May, M (corresponding author), Univ New England, Coll Osteopath Med, Biddeford, ME 04005 USA.	mmay3@une.edu						Allen JE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000217; Aparnaa R, 2014, PARASITE IMMUNOL, V36, P475, DOI 10.1111/pim.12120; APPEL RD, 1994, TRENDS BIOCHEM SCI, V19, P258, DOI 10.1016/0968-0004(94)90153-8; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Dakshinamoorthy G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112982; Das L. K., 2003, Filaria Journal, V2; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; ECK RV, 1966, SCIENCE, V152, P363, DOI 10.1126/science.152.3720.363; FELSENSTEIN J, 1992, GENET RES, V60, P209, DOI 10.1017/S0016672300030962; Fernandez-Fuentes N, 2007, NUCLEIC ACIDS RES, V35, pW363, DOI 10.1093/nar/gkm341; Fong MY, 2008, TROP BIOMED, V25, P87; Frank GR, 1996, MOL BIOCHEM PARASIT, V75, P231, DOI 10.1016/0166-6851(95)02534-0; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Gomez-Escobar N, 2002, MOL BIOCHEM PARASIT, V125, P59, DOI 10.1016/S0166-6851(02)00219-0; Gopal Vijaya, 2010, Syst Synth Biol, V4, P293, DOI 10.1007/s11693-011-9074-7; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Graves CJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003766; Gregory WF, 2000, INFECT IMMUN, V68, P4174, DOI 10.1128/IAI.68.7.4174-4179.2000; Gregory WF, 1997, MOL BIOCHEM PARASIT, V87, P85, DOI 10.1016/S0166-6851(97)00050-9; Hodges MH, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-120; Hussain MA, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-31; Joseph GT, 1998, MOL BIOCHEM PARASIT, V96, P177, DOI 10.1016/S0166-6851(98)00094-2; Joseph SK, 2013, VACCINE, V31, P3320, DOI 10.1016/j.vaccine.2013.05.077; KAR SK, 1993, ACTA TROP, V55, P21, DOI 10.1016/0001-706X(93)90045-D; Lu YJ, 2013, ASIAN PAC J TROP MED, V6, P709, DOI 10.1016/S1995-7645(13)60123-6; Madhumathi J, 2010, PARASITE IMMUNOL, V32, P760, DOI 10.1111/j.1365-3024.2010.01239.x; Mahalakshmi N, 2013, PARASITOL RES, V112, P3203, DOI 10.1007/s00436-013-3496-y; May M, 2011, J BACTERIOL, V193, P2116, DOI 10.1128/JB.00022-11; Mugal CF, 2014, MOL BIOL EVOL, V31, P212, DOI 10.1093/molbev/mst192; Nei M, 1998, P NATL ACAD SCI USA, V95, P12390, DOI 10.1073/pnas.95.21.12390; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; OTTESEN EA, 1992, PARASITOLOGY, V104, pS71, DOI 10.1017/S0031182000075259; Pieper U, 2014, NUCLEIC ACIDS RES, V42, pD336, DOI 10.1093/nar/gkt1144; PINDER M, 1988, J IMMUNOL, V141, P2480; Ramachandran S, 2004, MICROBIOL IMMUNOL, V48, P945, DOI 10.1111/j.1348-0421.2004.tb03624.x; Ramanathan A, 2015, LYMPHAT RES BIOL, V13, P120, DOI 10.1089/lrb.2014.0034; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schwab AE, 2005, AM J TROP MED HYG, V73, P234, DOI 10.4269/ajtmh.2005.73.234; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sharmila S, 2011, EXP PARASITOL, V129, P247, DOI 10.1016/j.exppara.2011.08.005; Sniegowski PD, 2006, CURR BIOL, V16, pR831, DOI 10.1016/j.cub.2006.08.080; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Swanson WJ, 2003, CURR OPIN GENET DEV, V13, P617, DOI 10.1016/j.gde.2003.10.007; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thirugnanam S, 2007, EXP PARASITOL, V116, P483, DOI 10.1016/j.exppara.2007.02.017; WHO, 2013, WKLY EPIDEMIOL REC, V88, P389; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Zarowiecki M, 2015, PARASITOLOGY, V142, pS85, DOI 10.1017/S0031182014001449	51	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0148611	10.1371/journal.pone.0148611	http://dx.doi.org/10.1371/journal.pone.0148611			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890364	Green Published, gold			2022-12-27	WOS:000371221500009
J	Greninger, AL; Chatterjee, SS; Chan, LC; Hamilton, SM; Chambers, HF; Chiu, CY				Greninger, Alexander L.; Chatterjee, Som S.; Chan, Liana C.; Hamilton, Stephanie M.; Chambers, Henry F.; Chiu, Charles Y.			Whole-Genome Sequencing of Methicillin-Resistant Staphylococcus aureus Resistant to Fifth-Generation Cephalosporins Reveals Potential Non-mecA Mechanisms of Resistance	PLOS ONE			English	Article							PENICILLIN-BINDING PROTEINS; BETA-LACTAM RESISTANCE; CEFTAROLINE FOSAMIL; INTEGRATED ANALYSIS; COMPLICATED SKIN; SUSCEPTIBILITY; MUTATIONS; EPIDEMIOLOGY; MULTICENTER; VANCOMYCIN	Fifth-generation cephalosporins, ceftobiprole and ceftaroline, are promising drugs for treatment of bacterial infections from methicillin-resistant Staphylococcus aureus (MRSA). These antibiotics are able to bind native PBP2a, the penicillin-binding protein encoded by the mecA resistance determinant that mediates broad class resistance to nearly all other beta-lactam antibiotics, at clinically achievable concentrations. Mechanisms of resistance to ceftaroline based on mecA mutations have been previously described. Here we compare the genomes of 11 total parent-daughter strains of Staphylococcus aureus for which specific selection by serial passaging with ceftaroline or ceftobiprole was used to identify novel non-mecA mechanisms of resistance. All 5 ceftaroline-resistant strains, derived from 5 different parental strains, contained mutations directly upstream of the pbp4 gene (coding for the PBP4 protein), including four with the same thymidine insertion located 377 nucleotides upstream of the promoter site. In 4 of 5 independent ceftaroline-driven selections, we also isolated mutations to the same residue (Asn138) in PBP4. In addition, mutations in additional candidate genes such as ClpX endopeptidase, PP2C protein phosphatase and transcription terminator Rho, previously undescribed in the context of resistance to ceftaroline or ceftobiprole, were detected in multiple selections. These genomic findings suggest that non-mecA mechanisms, while yet to be encountered in the clinical setting, may also be important in mediating resistance to 5th-generation cephalosporins.	[Greninger, Alexander L.; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Greninger, Alexander L.; Chiu, Charles Y.] UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA USA; [Chatterjee, Som S.; Chan, Liana C.; Hamilton, Stephanie M.; Chambers, Henry F.] San Francisco Gen Hosp, Div Infect Dis, Dept Med, San Francisco, CA 94110 USA	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center	Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.; Chiu, CY (corresponding author), UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA USA.	charles.chiu@ucsf.edu		Greninger, Alexander/0000-0002-7443-0527	NIH (National Institutes of Health) [R01-AI100291]; NIH [R01-AI100291, R01-HL105704]; Abbott Pathogen Discovery Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100291] Funding Source: NIH RePORTER	NIH (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abbott Pathogen Discovery Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by NIH (National Institutes of Health) grant R01-AI100291 (to HFC), NIH grant R01-HL105704 (to CYC), and an Abbott Pathogen Discovery Award (to CYC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded in part by NIH grant R01-AI100291 (to HFC), NIH grant R01-HL105704 (to CYC), and an Abbott Pathogen Discovery Award (to CYC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm RA, 2014, J ANTIMICROB CHEMOTH, V69, P2065, DOI 10.1093/jac/dku114; Baek KT, 2014, ANTIMICROB AGENTS CH, V58, P4593, DOI 10.1128/AAC.02802-14; Baneriee R, 2008, ANTIMICROB AGENTS CH, V52, P2089, DOI 10.1128/AAC.01403-07; Banerjee R, 2010, ANTIMICROB AGENTS CH, V54, P4900, DOI 10.1128/AAC.00594-10; Beresford E, 2014, EXPERT REV CLIN PHAR, V7, P123, DOI 10.1586/17512433.2014.884457; Biedenbach DJ, 2016, ANTIMICROB AGENTS CH, V60, P343, DOI 10.1128/AAC.01867-15; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Chan LC, 2015, ANTIMICROB AGENTS CH, V59, P2960, DOI 10.1128/AAC.05004-14; Corey GR, 2010, CLIN INFECT DIS, V51, P641, DOI 10.1086/655827; Dantes R, 2013, JAMA INTERN MED, V173, P1970, DOI 10.1001/jamainternmed.2013.10423; Das AK, 1996, EMBO J, V15, P6798, DOI 10.1002/j.1460-2075.1996.tb01071.x; File TM, 2010, CLIN INFECT DIS, V51, P1395, DOI 10.1086/657313; Henze UU, 1996, ANTIMICROB AGENTS CH, V40, P2121, DOI 10.1128/AAC.40.9.2121; Jones RN, 2010, J ANTIMICROB CHEMOTH, V65, piv17, DOI 10.1093/jac/dkq252; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kosowska-Shick K, 2010, ANTIMICROB AGENTS CH, V54, P1670, DOI 10.1128/AAC.00019-10; Kristich CJ, 2011, MBIO, V2, DOI 10.1128/mBio.00199-11; Kumar KM, 2014, 3 BIOTECH, V4, P241, DOI 10.1007/s13205-013-0147-z; Lee YH, 2014, J BACTERIOL, V196, P3700, DOI 10.1128/JB.02022-14; Leski TA, 2005, J BACTERIOL, V187, P1815, DOI 10.1128/JB.187.5.1815-1824.2005; Long SW, 2014, ANTIMICROB AGENTS CH, V58, P6668, DOI 10.1128/AAC.03622-14; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Memmi G, 2008, ANTIMICROB AGENTS CH, V52, P3955, DOI 10.1128/AAC.00049-08; Mendes RE, 2012, J CLIN MICROBIOL, V50, P3694, DOI 10.1128/JCM.02024-12; Moisan H, 2010, J ANTIMICROB CHEMOTH, V65, P713, DOI 10.1093/jac/dkp503; Navratna V, 2010, J BACTERIOL, V192, P134, DOI 10.1128/JB.00822-09; Zapun A, 2008, FEMS MICROBIOL REV, V32, P361, DOI 10.1111/j.1574-6976.2007.00095.x	29	40	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149541	10.1371/journal.pone.0149541	http://dx.doi.org/10.1371/journal.pone.0149541			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890675	Green Published, gold, Green Submitted			2022-12-27	WOS:000371221500056
J	Richardson, M; Cormack, A; McRobert, L; Underhill, R				Richardson, Miles; Cormack, Adam; McRobert, Lucy; Underhill, Ralph			30 Days Wild: Development and Evaluation of a Large-Scale Nature Engagement Campaign to Improve Well-Being	PLOS ONE			English	Article							PUBLIC-HEALTH INTERVENTIONS; NEARBY NATURE; CONNECTEDNESS; CONNECTION; PEOPLE; SELF; CONSERVATION; DISTINCTION; ASSESSMENTS; HAPPINESS	There is a need to increase people's engagement with and connection to nature, both for human well-being and the conservation of nature itself. In order to suggest ways for people to engage with nature and create a wider social context to normalise nature engagement, The Wildlife Trusts developed a mass engagement campaign, 30 Days Wild. The campaign asked people to engage with nature every day for a month. 12,400 people signed up for 30 Days Wild via an online sign-up with an estimated 18,500 taking part overall, resulting in an estimated 300,000 engagements with nature by participants. Samples of those taking part were found to have sustained increases in happiness, health, connection to nature and pro-nature behaviours. With the improvement in health being predicted by the improvement in happiness, this relationship was mediated by the change in connection to nature.	[Richardson, Miles] Univ Derby, Coll Life & Nat Sci, Dept Life Sci, Derby DE22 1GB, England; [Cormack, Adam; McRobert, Lucy] Wildlife Trusts, Newark, England; [Underhill, Ralph] Publ Interest Res Ctr, Machynlleth, Wales	University of Derby	Richardson, M (corresponding author), Univ Derby, Coll Life & Nat Sci, Dept Life Sci, Derby DE22 1GB, England.	m.richardson@derby.ac.uk		Richardson, Miles/0000-0002-7223-7053				Abdel-Khalek AM, 2006, SOC BEHAV PERSONAL, V34, P139, DOI 10.2224/sbp.2006.34.2.139; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bonell CP, 2011, J EPIDEMIOL COMMUN H, V65, P582, DOI 10.1136/jech.2008.082602; Bruni C. M., 2015, ENVIRON EDUC RES, P1, DOI [10.1080/13504622.2015.1074659, DOI 10.1080/13504622.2015.1074659]; Capaldi CA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00976; Cervinka R, 2011, J HEALTH PSYCHOL; Chapman J, 2010, PSYCHOL HEALTH, V25, P365, DOI 10.1080/08870440802642148; Chapman J, 2009, PSYCHOL HEALTH, V24, P317, DOI 10.1080/08870440701864538; Cronon W, 1995, UNCOMMON GROUND, P69; Cugelman B, 2011, J MED INTERNET RES, V13, P84, DOI 10.2196/jmir.1367; Department for Environment Food and Rural Affairs, 2011, THE NATURAL CHOICE S, V8082; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Dunn RR, 2006, CONSERV BIOL, V20, P1814, DOI 10.1111/j.1523-1739.2006.00533.x; Ernst J, 2011, ENVIRON EDUC RES, V17, P577, DOI 10.1080/13504622.2011.565119; Frantz CM, 2014, STUD EDUC EVAL, V41, P85, DOI 10.1016/j.stueduc.2013.10.001; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; Haluza D, 2014, INT J ENV RES PUB HE, V11, P1176, DOI 10.3390/ijerph110101176; Hartig T, 2014, ANNU REV PUBL HEALTH, V35, P207, DOI 10.1146/annurev-publhealth-032013-182443; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Johnson-Pynn J.S., 2014, INT J ENV SCI ED, V9, P311, DOI DOI 10.12973/IJESE.2014.217A; Kaplan R, 1989, THE EXPERIENCE OF NA; Kellert SR., 1995, THE BIOPHILIA HYPOTH; Lin BB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087422; Maller C, 2006, HEALTH PROMOT INT, V21, P45, DOI 10.1093/heapro/dai032; Mayer FS, 2004, J ENVIRON PSYCHOL, V24, P503, DOI 10.1016/j.jenvp.2004.10.001; McCambridge J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039116; Newman L, 2013, ENVIRON VALUE, V22, P401, DOI 10.3197/096327113X13648087563827; Nisbet EK, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00813; Nisbet EK, 2011, PSYCHOL SCI, V22, P1101, DOI 10.1177/0956797611418527; Nisbet EK, 2011, J HAPPINESS STUD, V12, P303, DOI 10.1007/s10902-010-9197-7; Nisbet EK, 2009, ENVIRON BEHAV, V41, P715, DOI 10.1177/0013916508318748; ONS, 2012, SUMMARY OF RESULTS F; Ostrove JM, 2000, HEALTH PSYCHOL, V19, P613, DOI 10.1037/0278-6133.19.6.613; PIRC, 2013, COMMON CAUSE FOR NAT; Pollard CM, 2008, PUBLIC HEALTH NUTR, V11, P314, DOI 10.1017/S1368980007000523; Prevot-Julliard AC, 2011, ENVIRON MANAGE, V47, P315, DOI 10.1007/s00267-011-9615-6; Pyle RM, 2003, ORYX, V37, P206, DOI 10.1017/S0030605303000383; Richardson M., 2015, ECOPSYCHOLOGY, V7, P166; Richardson M, 2015, ENVIRON VALUE, V24, P603, DOI 10.3197/096327115X14384223590131; Russell R, 2013, ANNU REV ENV RESOUR, V38, P473, DOI 10.1146/annurev-environ-012312-110838; Rychetnik L, 2002, J EPIDEMIOL COMMUN H, V56, P119, DOI 10.1136/jech.56.2.119; Sanson-Fisher RW, 2007, AM J PREV MED, V33, P155, DOI 10.1016/j.amepre.2007.04.007; Schultz PW, 2001, J ENVIRON PSYCHOL, V21, P327; Schultz PW, 2000, J SOC ISSUES, V56, P391, DOI 10.1111/0022-4537.00174; Skandrani Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130215; Stevens P, 2010, PERSPECT PUBLIC HEAL, V130, P265, DOI 10.1177/1757913910384047; Tam KP, 2013, J ENVIRON PSYCHOL, V34, P64, DOI 10.1016/j.jenvp.2013.01.004; Taylor T, 2010, THE ARTIFICIAL APE H; Vining J, 2008, HUM ECOL REV, V15, P1; Wilhelm-Rechmann A, 2014, BIOL CONSERV, V180, P206, DOI 10.1016/j.biocon.2014.10.012; Zuo A, 2015, J ENVIRON PLAN MANAG	52	70	71	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149777	10.1371/journal.pone.0149777	http://dx.doi.org/10.1371/journal.pone.0149777			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3CO	26890891	Green Published, Green Submitted, gold			2022-12-27	WOS:000371221500073
J	Williams, M; Villarreal, A; Davis, B; Talbot, P				Williams, Monique; Villarreal, Amanda; Davis, Barbara; Talbot, Prue			Comparison of the Performance of Cartomizer Style Electronic Cigarettes from Major Tobacco and Independent Manufacturers	PLOS ONE			English	Article							IN-VITRO; NICOTINE; SMOKE	Objective This study compared the performance of 12 brands of cartomizer style electronic cigarettes (EC) using different puffing protocols and measured the concentrations of nicotine in each product. Methods Air flow rate, pressure drop, and aerosol absorbance were measured using two different protocols, first 10 puffs and a modified smoke-out protocol. Results First 10 puff protocol: The air flow rate required to produce aerosol ranged between brands from 4-21 mL/s. Pressure drop was relatively stable within a brand but ranged between brands from 14-71 mmH(2)O and was much lower than the earlier classic 3-piece models. Absorbance, a measure of aerosol density, was relatively consistent between puffs, but varied between brands. With the modified smoke-out protocol, most brands were puffed until 300 puffs. The pressure drop was relatively stable for all brands except three. Absorbance of the aerosol decreased as the number of puffs increased. Although there was some uniformity in performance within some brands, there was large variation between brands. The labeled and measured nicotine concentrations were within 10% of each other in only 1 out of 10 brands. Conclusions Over 10 puffs, the cartomizers all perform similarly within a brand but varied between brands. In smoke-out trials, most brands lasted at least 300 puffs, and performed similarly within brands with respect to pressure drop and absorbance. For five brands, products purchased at different times performed differently. These data show some improvement in performance during evolution of these products, but nevertheless indicate problems with quality control in manufacture.	[Williams, Monique; Villarreal, Amanda; Davis, Barbara; Talbot, Prue] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA	University of California System; University of California Riverside	Talbot, P (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA.	talbot@ucr.edu	Talbot, Prue/AAY-3896-2021		National Institutes of Health [R01DA036493]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Support was provided by the National Institutes of Health Grant #R01DA036493. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahl V, 2012, REPROD TOXICOL, V34, P529, DOI 10.1016/j.reprotox.2012.08.001; Behar RZ, 2014, TOXICOL IN VITRO, V28, P198, DOI 10.1016/j.tiv.2013.10.006; Behar RZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117222; Cameron JM, 2014, TOB CONTROL, V23, P77, DOI 10.1136/tobaccocontrol-2012-050604; Davis B, 2016, TOB CONTROL, V25, pE67, DOI 10.1136/tobaccocontrol-2015-052468; Davis B, 2015, NICOTINE TOB RES, V17, P134, DOI 10.1093/ntr/ntu080; Glasser AM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007688; Goniewicz ML, 2013, NICOTINE TOB RES, V15, P158, DOI 10.1093/ntr/nts103; Grana R, 2014, CIRCULATION, V129, P1972, DOI 10.1161/CIRCULATIONAHA.114.007667; Hua M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2324; Hua M, 2013, TOB CONTROL, V22, P103, DOI 10.1136/tobaccocontrol-2011-050226; Jensen RP, 2015, NEW ENGL J MED, V372, P392, DOI 10.1056/NEJMc1413069; Knoll M, 1998, REPROD TOXICOL, V12, P57, DOI 10.1016/S0890-6238(97)00100-7; KNOLL M, 1995, BIOL REPROD, V53, P29, DOI 10.1095/biolreprod53.1.29; Meikle J, 2015, GUARDIAN; Pisinger C, 2014, PREV MED, V69, P248, DOI 10.1016/j.ypmed.2014.10.009; Polosa R, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-19; Robinson R J, 2015, PLoS One, V10, pe0129296, DOI 10.1371/journal.pone.0129296; Trehy ML, 2011, J LIQ CHROMATOGR R T, V34, P1442, DOI 10.1080/10826076.2011.572213; Trtchounian A, 2011, TOB CONTROL, V20, P47, DOI 10.1136/tc.2010.037259; Trtchounian A, 2010, NICOTINE TOB RES, V12, P905, DOI 10.1093/ntr/ntq114; Williams M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138933; Williams M, 2015, NICOTINE TOB RES, V17, P201, DOI 10.1093/ntr/ntu118; Williams M, 2011, NICOTINE TOB RES, V13, P1276, DOI 10.1093/ntr/ntr164; Williams M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057987; Zhu SH, 2014, TOB CONTROL, V23, P3, DOI 10.1136/tobaccocontrol-2014-051670	26	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149251	10.1371/journal.pone.0149251	http://dx.doi.org/10.1371/journal.pone.0149251			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890864	Green Published, Green Submitted, gold			2022-12-27	WOS:000371221500028
J	Zhang, ZL; Yu, CP; Velet, L; Li, YH; Jiang, LJ; Zhou, FJ				Zhang, Zhiling; Yu, Chunping; Velet, Liliya; Li, Yonghong; Jiang, Lijuan; Zhou, Fangjian			The Difference in Prognosis between Renal Sinus Fat and Perinephric Fat Invasion for pT3a Renal Cell Carcinoma: A Meta-Analysis	PLOS ONE			English	Article							INVOLVEMENT; SURVIVAL; BIAS	Background In the current Tumour-Node-Metastasis (TNM) classification system for renal cell carcinoma (RCC), both renal sinus fat invasion (SFI) and perinephric fat invasion (PFI) are defined as T3a, suggesting that the prognosis should be similar for the two pathologic findings. Several studies, however, have reported a worse prognosis for SFI in patients with a T3a tumor. In order to compare the prognosis of these two pathologic findings (SFI versus. PFI) in a more comprehensive way, this meta-analysis was performed. Methods To identify relevant studies, Medline, Embase, Cochrane Library, and Scopus database were searched from the inception until October 2014. A meta-analysis was performed using Review Manager 5.2 and STATA 11. Pooled Odds ratio (OR) and/or hazard ratio (HR) with 95% confidence interval (CI) were calculated to examine the risk or hazard association. Results A total of 6 studies including 1031 patients qualified for analysis. T3a RCC patients with SFI were significantly associated with poor cancer specific survival(CSS) (HR: 1.47, 95% CI: 1.19-1.83; P<0.001) compared to those with PFI. In T3aNx/N0M0 subgroup, SFI patients also showed a worse prognosis than those with PFI (CSS, HR: 1.94, 95% CI: 1.21-3.12; P = 0.006). T3a RCC patients with SFI had higher Furhman grade, greater possibility of lymph node metastasis, sarcomatoid differentiation and tumour necrosis. Main limitation is the relatively small number of included studies. Conclusion The present meta-analysis suggested that SFI is associated with worse CSS in patients with pT3a RCC. However, due to the small number of included studies, future studies with a large sample size are required to further verify our findings.	[Zhang, Zhiling; Yu, Chunping; Li, Yonghong; Jiang, Lijuan; Zhou, Fangjian] Sun Yat Sen Univ, Ctr Canc, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Zhiling; Yu, Chunping; Li, Yonghong; Jiang, Lijuan; Zhou, Fangjian] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Zhang, Zhiling; Yu, Chunping; Li, Yonghong; Jiang, Lijuan; Zhou, Fangjian] Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Zhang, Zhiling] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Nephrol, Guangzhou, Guangdong, Peoples R China; [Velet, Liliya] Northeast Ohio Med Univ, Rootstown, OH USA	Sun Yat Sen University; State Key Lab Oncology South China; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Northeast Ohio Medical University (NEOMED)	Zhou, FJ (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China.; Zhou, FJ (corresponding author), State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.; Zhou, FJ (corresponding author), Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.	zhoufj@sysucc.org.cn			Natural Science Foundation of China [81272810, 81402114, 81300597]; Natural Science Foundation of Guangdong Province, China [S2013040015908]; China Scholarship Council	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); China Scholarship Council(China Scholarship Council)	This study was supported by grants from the Natural Science Foundation of China (Nos. 81272810, 81402114 and 81300597), the Natural Science Foundation of Guangdong Province, China (No. S2013040015908), and China Scholarship Council.	Bedke J, 2009, BJU INT, V103, P1349, DOI 10.1111/j.1464-410X.2008.08236.x; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bertini R, 2009, J UROLOGY, V181, P2027, DOI 10.1016/j.juro.2009.01.048; Bonsib SM, 2005, J UROLOGY, V174, P1199, DOI 10.1097/01.ju.0000173631.01329.1f; Bonsib SM, 2000, AM J SURG PATHOL, V24, P451, DOI 10.1097/00000478-200003000-00015; Portela SC, 2011, ROM J MORPHOL EMBRYO, V52, P569; Delahunt B, 2014, UROLOGY, V83, P969, DOI 10.1016/j.urology.2014.02.004; Edge SB, 2010, AJCC CANC STAGING MA; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ficarra V, 2007, EUR UROL, V51, P722, DOI 10.1016/j.eururo.2006.07.010; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Han KR, 2003, J UROLOGY, V169, P899, DOI 10.1097/01.ju.0000051480.62175.35; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Margulis V, 2007, J UROLOGY, V178, P1878, DOI 10.1016/j.juro.2007.07.011; Poon SA, 2009, BJU INT, V103, P1622, DOI 10.1111/j.1464-410X.2008.08239.x; Thompson RH, 2005, J UROLOGY, V173, P918, DOI 10.1097/01.ju.0000153419.98715.24; Thompson RH, 2007, AM J SURG PATHOL, V31, P1089; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Van Poppel H, 2011, EUR UROL, V59, P543, DOI 10.1016/j.eururo.2010.12.013; Wells GA., 2003, NEWCASTLE OTTAWA SCA	20	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149420	10.1371/journal.pone.0149420	http://dx.doi.org/10.1371/journal.pone.0149420			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891054	Green Published, gold			2022-12-27	WOS:000371221500044
J	Lerman, K; Yan, XR; Wu, XZ				Lerman, Kristina; Yan, Xiaoran; Wu, Xin-Zeng			The "Majority Illusion" in Social Networks	PLOS ONE			English	Article							DYNAMICS; BEHAVIOR; SPREAD; GRAPHS; MODEL	Individual's decisions, from what product to buy to whether to engage in risky behavior, often depend on the choices, behaviors, or states of other people. People, however, rarely have global knowledge of the states of others, but must estimate them from the local observations of their social contacts. Network structure can significantly distort individual's local observations. Under some conditions, a state that is globally rare in a network may be dramatically over-represented in the local neighborhoods of many individuals. This effect, which we call the "majority illusion," leads individuals to systematically overestimate the prevalence of that state, which may accelerate the spread of social contagions. We develop a statistical model that quantifies this effect and validate it with measurements in synthetic and real-world networks. We show that the illusion is exacerbated in networks with a heterogeneous degree distribution and disassortative structure.	[Lerman, Kristina; Yan, Xiaoran; Wu, Xin-Zeng] USC Informat Sci Inst, Marina Del Rey, CA USA; [Wu, Xin-Zeng] Univ So Calif, Dept Phys & Astron, Los Angeles, CA USA; [Yan, Xiaoran] Indiana Univ, Network Sci Inst, Bloomington, IN USA	University of Southern California; University of Southern California; Indiana University System; Indiana University Bloomington	Lerman, K (corresponding author), USC Informat Sci Inst, Marina Del Rey, CA USA.	lerman@isi.edu	Lerman, Kristina/P-5138-2019; Lerman, Kristina/F-4198-2010	Lerman, Kristina/0000-0002-5071-0575	Air Force Office of Scientific Research [FA9550-10-1-0569]; National Science Foundation [CIF-1217605]; Defense Advanced Research Projects Agency [W911NF-12-1-0034]; AFOSR [FA9550-10-1-0569]; NSF [CIF-1217605]; DARPA [W911NF-12-1-0034]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Science Foundation(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF(National Science Foundation (NSF)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was supported in part by Air Force Office of Scientific Research (contract FA9550-10-1-0569), by the National Science Foundation (grant CIF-1217605) and by Defense Advanced Research Projects Agency (contract W911NF-12-1-0034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors are grateful to Nathan Hodas and Farshad Kooti for their inputs into this work. This work was supported in part by AFOSR (contract FA9550-10-1-0569), by NSF (grant CIF-1217605) and by DARPA (contract W911NF-12-1-0034).	Achlioptas D., 2005, P 37 ACM S THEOR COM; Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; BAER JS, 1991, J STUD ALCOHOL, V52, P580, DOI 10.15288/jsa.1991.52.580; Bearak JM, 2014, SOC FORCES, V93, P091, DOI [10.1093/sf/sou091, DOI 10.1093/SF/S0U091]; BENDER EA, 1978, J COMB THEORY A, V24, P296, DOI 10.1016/0097-3165(78)90059-6; Berkowitz A. D., 2005, CHANGING CULTURE COL, P193; Bettencourt LMA, 2006, PHYSICA A, V364, P513, DOI 10.1016/j.physa.2005.08.083; Centola D, 2005, AM J SOCIOL, V110, P1009, DOI 10.1086/427321; Centola D, 2007, PHYSICA A, V374, P449, DOI 10.1016/j.physa.2006.06.018; Centola D, 2015, P NATL ACAD SCI USA, V112, P1989, DOI 10.1073/pnas.1418838112; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Christakis NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012948; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Eom YH, 2014, SCI REP-UK, V4, DOI 10.1038/srep04603; Feld S. L., 1977, RES HIGH EDUC, V6, P215, DOI [DOI 10.1007/BF00991287, 10.1007/BF00991287]; FELD SL, 1991, AM J SOCIOL, V96, P1464, DOI 10.1086/229693; Galam S., 2013, GLOBAL ECON REV, V18, P2, DOI [DOI 10.1016/S2340-1540(13)70002-1, 10.1016/S2340-1540(13)70002-1]; Garcia-Herranz M, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0092413, 10.1371/journal.pone.0086067]; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; Gupta S, 2015, 2015 IEEE C COMP VIS; Hodas NO., 2013, P 7 INT AAAI C WEBL, V13, P8; Hogg T, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds5; Jo HH, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.022809; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kempe D., 2003, P 9 ACM SIGKDD INT C, V11, P105, DOI DOI 10.1145/956750.956769; Kitts JA, 2003, SOC PSYCHOL QUART, V66, P222, DOI 10.2307/1519823; Kooti F, 2014, P 8 INT AAAI C WEBL, P266; LATANE B, 1969, AM SCI, V57, P244; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; MARKS G, 1987, PSYCHOL BULL, V102, P72, DOI 10.1037/0033-2909.102.1.72; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; MILLER DT, 1994, PERS SOC PSYCHOL B, V20, P541, DOI 10.1177/0146167294205011; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; PRENTICE DA, 1993, J PERS SOC PSYCHOL, V64, P243, DOI 10.1037/0022-3514.64.2.243; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Salganik MJ, 2011, SOC NETWORKS, V33, P70, DOI 10.1016/j.socnet.2010.10.006; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; SCHELLING TC, 1973, J CONFLICT RESOLUT, V17, P381, DOI 10.1177/002200277301700302; Smith LM, 2013, ASE IEEE INT C SOC C; TVERSKY A, 1973, COGNITIVE PSYCHOL, V5, P207, DOI 10.1016/0010-0285(73)90033-9; Valente TW, 1995, QUANTITATIVE METHODS; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Young HP, 2011, P NATL ACAD SCI USA, V108, P21285, DOI 10.1073/pnas.1100973108	47	84	84	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0147617	10.1371/journal.pone.0147617	http://dx.doi.org/10.1371/journal.pone.0147617			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3BJ	26886112	Green Published, Green Submitted, gold			2022-12-27	WOS:000371218400007
J	Winther, M; Knudsen, S; Dahlgaard, J; Jensen, T; Hansen, A; Jensen, PB; Tramm, T; Alsner, J; Nordsmark, M				Winther, Mette; Knudsen, Steen; Dahlgaard, Jesper; Jensen, Thomas; Hansen, Anker; Jensen, Peter Buhl; Tramm, Trine; Alsner, Jan; Nordsmark, Marianne			Clinical Impact of a Novel MicroRNA Chemo-Sensitivity Predictor in Gastrooesophageal Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ESOPHAGEAL; CHEMOTHERAPY; RESISTANCE; THERAPY	Background miRNAs might be potentially useful biomarkers for prediction of response to chemotherapeutic agents, radiotherapy and survival. The aim of this retrospective study was to validate miRNA response predictors in a cohort of patients with gastrooesophageal cancer in order to predict overall survival (OS) and disease-specific survival (DSS). Material and Methods The study population encompassed 53 patients treated with curative intend for loco-regional gastrooesophageal cancer. miRNA expression was quantified from pre-therapeutic and diagnostic, formalin-fixed, paraffin embedded tumour specimens using Affymetrix GeneChip miRNA 1.0 Array. Based on growth inhibition of the NCI60 panel in the presence of cisplatin, epirubicine and capecitabine, a miRNA based response predictor was developed. The Cox proportional hazards model was applied to assess the correlations of the response predictor with OS and DSS. Results A univariate analysis demonstrated a statistical significant improvement of OS for patients who had undergone surgical resection with prediction scores above the median prediction score (HR: 0.41 (95% CI: 0.17-0.96). Adjusting for surgery and stage, this predictor was identified to be independently associated with both OS (HR: 0.37 (95% CI: 0.16-0.87)) and DSS (HR: 0.32 (0.12-0.87)). Conclusion The miRNA profile predictive for sensitivity to cisplatin, epirubicine and capecitabine was shown to be independently associated with OS and DSS in patients with gastrooesophageal cancer.	[Winther, Mette; Alsner, Jan] Aarhus Univ Hosp, Dept Expt Clin Oncol, DK-8000 Aarhus, Denmark; [Knudsen, Steen; Jensen, Thomas; Hansen, Anker; Jensen, Peter Buhl] Med Prognosis Inst, Horsholm, Denmark; [Dahlgaard, Jesper] VIA Univ Coll, Ctr Hlth Promot & Rehabil, Fac Hlth Sci, Aarhus, Denmark; [Tramm, Trine] Aarhus Univ Hosp, Dept Pathol, DK-8000 Aarhus, Denmark; [Nordsmark, Marianne] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Winther, M (corresponding author), Aarhus Univ Hosp, Dept Expt Clin Oncol, DK-8000 Aarhus, Denmark.	mette@oncology.dk		Alsner, Jan/0000-0002-5395-3193; Dahlgaard, Jesper/0000-0002-1798-6799; Tramm, Trine/0000-0003-3894-4552	Danish Cancer Society; CIRRO - The Lundbeck Foundation Center for Interventional Research in Radiation Oncology; Danish Council for Strategic Research; Karen A. Tolstrups Fond; A. P. Moeller Foundation for the Advancement of Medical Science; Dansk Kraeftforsknings Fond	Danish Cancer Society(Danish Cancer Society); CIRRO - The Lundbeck Foundation Center for Interventional Research in Radiation Oncology; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Karen A. Tolstrups Fond; A. P. Moeller Foundation for the Advancement of Medical Science; Dansk Kraeftforsknings Fond	The study was financially supported by The Danish Cancer Society, CIRRO - The Lundbeck Foundation Center for Interventional Research in Radiation Oncology and The Danish Council for Strategic Research, Karen A. Tolstrups Fond, The A. P. Moeller Foundation for the Advancement of Medical Science and Dansk Kraeftforsknings Fond.	Broxterman HJ, 2009, DRUG RESIST UPDATE, V12, P114, DOI 10.1016/j.drup.2009.07.001; Chan E, 2011, TRENDS MOL MED, V17, P235, DOI 10.1016/j.molmed.2011.01.008; Chang L, 2014, PATHOL ONCOL RES, V20, P93, DOI 10.1007/s12253-013-9664-7; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Hamano R, 2011, CLIN CANCER RES, V17, P3029, DOI 10.1158/1078-0432.CCR-10-2532; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; Imanaka Y, 2011, J HUM GENET, V56, P270, DOI 10.1038/jhg.2011.1; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Knudsen S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115538; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Sarkar FH, 2010, DRUG RESIST UPDATE, V13, P57, DOI 10.1016/j.drup.2010.02.001; Skinner HD, 2014, CANCER-AM CANCER SOC, V120, P3635, DOI 10.1002/cncr.28911; Sugimura K, 2012, CLIN CANCER RES, V18, P5144, DOI 10.1158/1078-0432.CCR-12-0701; Tanaka K, 2013, ANN SURG ONCOL, V20, pS607, DOI 10.1245/s10434-013-3093-4; Tang HL, 2013, CLIN CANCER RES, V19, P5602, DOI 10.1158/1078-0432.CCR-13-1326	16	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148070	10.1371/journal.pone.0148070	http://dx.doi.org/10.1371/journal.pone.0148070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885979	Green Published, Green Submitted, gold			2022-12-27	WOS:000371218400017
J	Zindel, S; Ehret, V; Ehret, M; Hentschel, M; Witt, S; Kramer, A; Fiebig, D; Juttner, N; Frols, S; Pfeifer, F; Fuchsbauer, HL				Zindel, Stephan; Ehret, Vera; Ehret, Marina; Hentschel, Madeleine; Witt, Samantha; Kraemer, Andreas; Fiebig, David; Juettner, Norbert; Froels, Sabrina; Pfeifer, Felicitas; Fuchsbauer, Hans-Lothar			Involvement of a Novel Class C Beta-Lactamase in the Transglutaminase Mediated Cross-Linking Cascade of Streptomyces mobaraensis DSM 40847	PLOS ONE			English	Article							PENICILLIN-BINDING PROTEINS; STREPTOVERTICILLIUM-MOBARAENSE; CYSTEINE PROTEASES; KINETIC-PARAMETERS; SUBSTRATE; PURIFICATION; INHIBITOR; METALLOPROTEASE; COELICOLOR	Streptomyces mobaraensis DSM 40847 secretes transglutaminase that cross-links proteins via gamma-glutamyl-epsilon-lysine isopeptide bonds. Characterized substrates are inhibitory proteins acting against various serine, cysteine and metalloproteases. In the present study, the bacterial secretome was examined to uncover additional transglutaminase substrates. Fractional ethanol precipitation of the exported proteins at various times of culture growth, electrophoresis of the precipitated proteins, and sequencing of a 39 kDa protein by mass spectrometry revealed the novel beta-lactamase Sml-1. As indicated by biotinylated probes, Sml-1, produced in E. coli, exhibits glutamine and lysine residues accessible for transglutaminase. The chromogenic cephalosporin analogue, nitrocefin, was hydrolyzed by Sml-1 with low velocity. The obtained K-m and k(cat) values of the recombinant enzyme were 94.3 +/- 1.8 mu M and 0.39 +/- 0.03 s(-1), respectively. Penicillin G and ampicillin proved to be weak inhibitors of nitrocefin hydrolysis (K-i of 0.1 mM and 0.18 mM). Negligible influence of metals on beta-lactamase activity ruled out that Sml-1 is a Zn2+-dependent class B beta-lactamase. Rather, sequence motifs such as SITK, YSN, and HDG forming the active core in a hypothetical structure may be typical for class C beta-lactamases. Based on the results, we assume that the novel transglutaminase substrate ensures undisturbed growth of aerial hyphae in Streptomyces mobaraensis by trapping and inactivating hostile beta-lactam antibiotics.	[Zindel, Stephan; Ehret, Vera; Ehret, Marina; Hentschel, Madeleine; Witt, Samantha; Kraemer, Andreas; Fiebig, David; Juettner, Norbert; Fuchsbauer, Hans-Lothar] Univ Appl Sci Darmstadt, Dept Chem Engn & Biotechnol, Darmstadt, Germany; [Froels, Sabrina; Pfeifer, Felicitas] Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany	Hochschule Darmstadt; Technical University of Darmstadt	Fuchsbauer, HL (corresponding author), Univ Appl Sci Darmstadt, Dept Chem Engn & Biotechnol, Darmstadt, Germany.	hans-lothar.fuchsbauer@h-da.de		Kramer, Andreas/0000-0003-3294-2660; Fuchsbauer, Hans-Lothar/0000-0003-4954-5741; Pfeifer, Felicitas/0000-0003-1631-1543				ANDO H, 1989, AGR BIOL CHEM TOKYO, V53, P2613, DOI 10.1080/00021369.1989.10869735; Chater KF, 2011, STREPTOMYCES: MOLECULAR BIOLOGY AND BIOTECHNOLOGY, P43; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Claessen D, 2004, MOL MICROBIOL, V53, P433, DOI 10.1111/j.1365-2958.2004.04143.x; Claessen D, 2003, GENE DEV, V17, P1714, DOI 10.1101/gad.264303; DEMEESTER F, 1987, BIOCHEM J, V244, P427, DOI 10.1042/bj2440427; FELICI A, 1993, BIOCHEM J, V291, P151, DOI 10.1042/bj2910151; Folk J E, 1977, Adv Protein Chem, V31, P1, DOI 10.1016/S0065-3233(08)60217-X; GALLENI M, 1988, BIOCHEM J, V255, P123, DOI 10.1042/bj2550123; GERBER U, 1994, BIOCHEM J, V299, P825, DOI 10.1042/bj2990825; GHUYSEN JM, 1991, ANNU REV MICROBIOL, V45, P37, DOI 10.1146/annurev.mi.45.100191.000345; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Kashiwagi T, 2002, J BIOL CHEM, V277, P44252, DOI 10.1074/jbc.M203933200; Kodani S, 2004, P NATL ACAD SCI USA, V101, P11448, DOI 10.1073/pnas.0404220101; Lenzini M V, 1985, J Enzyme Inhib, V1, P25, DOI 10.3109/14756368509031279; Mehta K, 2005, PROGR EXPT TUMOR RES, P38; OCALLAGHAN CH, 1972, ANTIMICROB AGENTS CH, V1, P283, DOI 10.1128/AAC.1.4.283; Ogawara H, 2015, J ANTIBIOT, V68, P223, DOI 10.1038/ja.2014.148; Pasternack R, 1998, EUR J BIOCHEM, V257, P570, DOI 10.1046/j.1432-1327.1998.2570570.x; Pratt RF, 2008, CELL MOL LIFE SCI, V65, P2138, DOI 10.1007/s00018-008-7591-7; Ruzin A, 2002, J BACTERIOL, V184, P2141, DOI 10.1128/JB.184.8.2141-2147.2002; Sarafeddinov A, 2011, J MICROBIOL BIOTECHN, V21, P617, DOI 10.4014/jmb.1012.12004; Sarafeddinov A, 2009, BIOSCI BIOTECH BIOCH, V73, P993, DOI 10.1271/bbb.80769; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Schmidt S, 2008, FEBS LETT, V582, P3132, DOI 10.1016/j.febslet.2008.07.049; Wilkinson AS, 2003, BIOCHEMISTRY-US, V42, P1950, DOI 10.1021/bi0266941; Zindel S, 2013, ANTIMICROB AGENTS CH, V57, P3388, DOI 10.1128/AAC.00129-13; Zotzel J, 2003, EUR J BIOCHEM, V270, P4149, DOI 10.1046/j.1432-1033.2003.03809.x; Zotzel J, 2003, EUR J BIOCHEM, V270, P3214, DOI 10.1046/j.1432-1033.2003.03703.x	30	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149145	10.1371/journal.pone.0149145	http://dx.doi.org/10.1371/journal.pone.0149145			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886195	Green Submitted, gold, Green Published			2022-12-27	WOS:000371218400063
J	Maidenbaum, S; Buchs, G; Abboud, S; Lavi-Rotbain, O; Amedi, A				Maidenbaum, Shachar; Buchs, Galit; Abboud, Sami; Lavi-Rotbain, Ori; Amedi, Amir			Perception of Graphical Virtual Environments by Blind Users via Sensory Substitution	PLOS ONE			English	Article							DEVICE; COLOR; PEOPLE; AREA	Graphical virtual environments are currently far from accessible to blind users as their content is mostly visual. This is especially unfortunate as these environments hold great potential for this population for purposes such as safe orientation, education, and entertainment. Previous tools have increased accessibility but there is still a long way to go. Visual-toaudio Sensory-Substitution-Devices (SSDs) can increase accessibility generically by sonifying on-screen content regardless of the specific environment and offer increased accessibility without the use of expensive dedicated peripherals like electrode/vibrator arrays. Using SSDs virtually utilizes similar skills as when using them in the real world, enabling both training on the device and training on environments virtually before real-world visits. This could enable more complex, standardized and autonomous SSD training and new insights into multisensory interaction and the visually-deprived brain. However, whether congenitally blind users, who have never experienced virtual environments, will be able to use this information for successful perception and interaction within them is currently unclear. We tested this using the EyeMusic SSD, which conveys whole-scene visual information, to perform virtual tasks otherwise impossible without vision. Congenitally blind users had to navigate virtual environments and find doors, differentiate between them based on their features (Experiment1:task1) and surroundings (Experiment1:task2) and walk through them; these tasks were accomplished with a 95% and 97% success rate, respectively. We further explored the reactions of congenitally blind users during their first interaction with a more complex virtual environment than in the previous tasks-walking down a virtual street, recognizing different features of houses and trees, navigating to cross-walks, etc. Users reacted enthusiastically and reported feeling immersed within the environment. They highlighted the potential usefulness of such environments for understanding what visual scenes are supposed to look like and their potential for complex training and suggested many future environments they wished to experience.	[Maidenbaum, Shachar; Buchs, Galit; Abboud, Sami; Lavi-Rotbain, Ori; Amedi, Amir] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Res, Jerusalem, Israel; [Maidenbaum, Shachar; Abboud, Sami; Amedi, Amir] Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Med Neurobiol, Fac Med, Jerusalem, Israel; [Buchs, Galit; Amedi, Amir] Hebrew Univ Jerusalem, Dept Cognit Sci, Fac Humanities, Jerusalem, Israel; [Amedi, Amir] Univ Paris 06, Sorbonne Univ, Inst Vis Paris, Paris, France	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; UDICE-French Research Universities; Sorbonne Universite	Amedi, A (corresponding author), Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Res, Jerusalem, Israel.; Amedi, A (corresponding author), Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Med Neurobiol, Fac Med, Jerusalem, Israel.; Amedi, A (corresponding author), Hebrew Univ Jerusalem, Dept Cognit Sci, Fac Humanities, Jerusalem, Israel.; Amedi, A (corresponding author), Univ Paris 06, Sorbonne Univ, Inst Vis Paris, Paris, France.	amir.amedi@ekmd.huji.ac.il	Maidenbaum, Shachar/K-4277-2019	Maidenbaum, Shachar/0000-0002-2078-3896; Amedi, Amir/0000-0001-5042-2533	European Research Council [310809]; Charitable Gatsby Foundation; James S. McDonnell Foundation Scholar Award [220020284]; Israel Science Foundation [ISF 1684/08]; The Edmond and Lily Safra Center for Brain Sciences (ELSC) Vision center	European Research Council(European Research Council (ERC)European Commission); Charitable Gatsby Foundation; James S. McDonnell Foundation Scholar Award; Israel Science Foundation(Israel Science Foundation); The Edmond and Lily Safra Center for Brain Sciences (ELSC) Vision center	This work was supported by a European Research Council grant (grant number 310809); The Charitable Gatsby Foundation; The James S. McDonnell Foundation Scholar Award (grant number 220020284); The Israel Science Foundation (grant number ISF 1684/08); The Edmond and Lily Safra Center for Brain Sciences (ELSC) Vision center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The Authors wish to thank Michal Rabinovits for her help in running the experiment. This work was supported by a European Research Council grant (grant number 310809); The Charitable Gatsby Foundation; The James S. McDonnell Foundation Scholar Award (grant number 220020284); The Israel Science Foundation (grant number ISF 1684/08); The Edmond and Lily Safra Center for Brain Sciences (ELSC) Vision center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud S., 2014, ISSUES, V12, P14; Abboud S, 2015, NATURE COMUNICATIONS; Alsberg BK, 2012, IS SENSING SPATIALLY; Bach-y-Rita P, 1972, BRAIN MECH SENSORY S, DOI 10.1068/p010491; Chebat DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126307; Chebat DR, 2011, NEUROREPORT, V22, P342, DOI 10.1097/WNR.0b013e3283462def; Connors E., 2014, FRONTIERS HUMAN NEUR, V8; Deroy O, 2012, FRONTIERS PSYCHOL, V3; Elli GV, 2014, MULTISENS RES, V27, P271, DOI 10.1163/22134808-00002460; Feintuch U, 2006, 2006 INTERNATIONAL WORKSHOP ON VIRTUAL REHABILITATION, P78, DOI 10.1109/IWVR.2006.1707531; Giudice NA, 2010, ACM T APPL PERCEPT, V7, DOI 10.1145/1658349.1658352; Gomez JD, 2014, J ASSIST TECHNOL, V8, P77, DOI 10.1108/JAT-08-2013-0025; Haigh A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00330; Hamilton-Fletcher G, 2013, MULTISENS RES, V26, P503, DOI 10.1163/22134808-00002434; Hanneton S, 2010, APPL BIONICS BIOMECH, V7, P269, DOI 10.1080/11762322.2010.512734; Hertz U, 2014, CEREB CORTEX; Kaspar K, 2014, CONSCIOUS COGN, V28, P47, DOI 10.1016/j.concog.2014.06.006; Kupers R, 2010, P NATL ACAD SCI USA, V107, P12716, DOI 10.1073/pnas.1006199107; Lahav O, 2012, ICDVRAT 2012; Lahav O., 2011, IEEE VIRTUAL REHABIL, P1; Lazar J, 2007, INT J HUM-COMPUT INT, V22, P247, DOI 10.1080/10447310709336964; Lenay C., 2003, TOUCHING KNOWING COG, P275, DOI [10.1075/aicr.53.22len, DOI 10.1075/AICR.53.22LEN]; Levy-Tzedek S, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00358; Levy-Tzedek S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00949; Loomis JM, 2012, SENSORY SUBSTITUTION; Maidenbaum S., 2012, P 9 INT C DIS VIRT R, P471; Maidenbaum S, 2014, VISION DEPRIVED VIRT, P1231; Maidenbaum S, 2014, VISION OTHER SENSES; Maidenbaum S, 2014, RESTOR NEUROL NEUROS, V32, P813, DOI 10.3233/RNN-130351; Maidenbaum S, 2014, NEUROSCI BIOBEHAV R, V41, P3, DOI 10.1016/j.neubiorev.2013.11.007; Maidenbaum S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072555; Manduchi R, 2011, AER J RES PRACTICE V; MEIJER PBL, 1992, IEEE T BIO-MED ENG, V39, P112, DOI 10.1109/10.121642; Merabet LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044958; Palani H., 2014, P 16 INT ACM SIGACCE, P293; Poppinga B., 2011, MOBILEHCI 2011, P545, DOI [10.1145/2037373.2037458, DOI 10.1145/2037373.2037458]; Proulx MJ, 2014, NEUROSCI BIOBEHAV R, V41, P16, DOI 10.1016/j.neubiorev.2012.11.017; Reardon S, 2011, SCIENCE, V333, P1816, DOI 10.1126/science.333.6051.1816; Reynolds Z., 2009, P AP CAP OCT, P131; Reynolds Z., 2012, PHILOS STUDY, V2, P432, DOI [10.17265/2159-5313, DOI 10.17265/2159-5313]; Smith K, 2012, UNIVERSAL ACCESS INF, V11, P387, DOI 10.1007/s10209-011-0254-8; Stiles NRB, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00842; Striem-Amit E, 2014, CURR BIOL, V24, P687, DOI 10.1016/j.cub.2014.02.010; Striem-Amit E, 2012, NEURON, V76, P640, DOI 10.1016/j.neuron.2012.08.026; Su J, 2010, INT CONF COMPUT AUTO, P177, DOI 10.1109/ICCAE.2010.5452046; Ward J, 2010, CONSCIOUS COGN, V19, P492, DOI 10.1016/j.concog.2009.10.006; Westin T, 2011, LECT NOTES COMPUT SC, V6766, P400, DOI 10.1007/978-3-642-21663-3_43; White G. R., 2008, P 3 INT C DIG INT ME, P134, DOI DOI 10.1145/1413634.1413663; WHO WhO, 2014, VIS IMP BLINDN KEY F; Wright TD, 2015, EXP BRAIN RES, V233, P851, DOI 10.1007/s00221-014-4160-1; Yip AW, 2002, PERCEPTION, V31, P995, DOI 10.1068/p3376	51	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0147501	10.1371/journal.pone.0147501	http://dx.doi.org/10.1371/journal.pone.0147501			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882473	Green Published, gold, Green Submitted			2022-12-27	WOS:000371219000004
J	Chaddad, A; Desrosiers, C; Bouridane, A; Toews, M; Hassan, L; Tanougast, C				Chaddad, Ahmad; Desrosiers, Christian; Bouridane, Ahmed; Toews, Matthew; Hassan, Lama; Tanougast, Camel			Multi Texture Analysis of Colorectal Cancer Continuum Using Multispectral Imagery	PLOS ONE			English	Article							INDIVIDUAL PATIENT DATA; COLON-CANCER; CT TEXTURE; FEATURES; LIVER	Purpose This paper proposes to characterize the continuum of colorectal cancer (CRC) using multiple texture features extracted from multispectral optical microscopy images. Three types of pathological tissues (PT) are considered: benign hyperplasia, intraepithelial neoplasia and carcinoma. Materials and Methods In the proposed approach, the region of interest containing PT is first extracted from multispectral images using active contour segmentation. This region is then encoded using texture features based on the Laplacian-of-Gaussian (LoG) filter, discrete wavelets (DW) and gray level co-occurrence matrices (GLCM). To assess the significance of textural differences between PT types, a statistical analysis based on the Kruskal-Wallis test is performed. The usefulness of texture features is then evaluated quantitatively in terms of their ability to predict PT types using various classifier models. Results Preliminary results show significant texture differences between PT types, for all texture features (p-value < 0.01). Individually, GLCM texture features outperform LoG and DW features in terms of PT type prediction. However, a higher performance can be achieved by combining all texture features, resulting in a mean classification accuracy of 98.92%, sensitivity of 98.12%, and specificity of 99.67%. Conclusions These results demonstrate the efficiency and effectiveness of combining multiple texture features for characterizing the continuum of CRC and discriminating between pathological tissues in multispectral images.	[Chaddad, Ahmad; Desrosiers, Christian; Toews, Matthew] Ecole Technol Super, Lab Imagery Vis & Artificial Intelligence, Montreal, PQ, Canada; [Chaddad, Ahmad; Hassan, Lama; Tanougast, Camel] Univ Lorraine, Lab Concept Optimizat & Modelling Syst, Metz, Lorraine, France; [Bouridane, Ahmed] Northumbria Univ, Sch Comp Engn & Informat Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England	University of Quebec; Ecole de Technologie Superieure - Canada; Universite de Lorraine; Northumbria University	Chaddad, A (corresponding author), Ecole Technol Super, Lab Imagery Vis & Artificial Intelligence, Montreal, PQ, Canada.; Chaddad, A (corresponding author), Univ Lorraine, Lab Concept Optimizat & Modelling Syst, Metz, Lorraine, France.	achaddad@livia.etsmtl.ca	Chaddad, Ahmad/AAG-3730-2020; Tanougast, Camel/V-7936-2018	Chaddad, Ahmad/0000-0003-3402-9576; Tanougast, Camel/0000-0002-5399-1683; Hassan, Lama/0000-0002-2368-0366				Aggarwal CC, 2014, CH CRC DATA MIN KNOW, P457; AKAY M, 1995, ANN BIOMED ENG, V23, P529, DOI 10.1007/BF02584452; Belongie S, 2002, IEEE T PATTERN ANAL, V24, P509, DOI 10.1109/34.993558; Breiman L., 2017, CLASSIFICATION REGRE; Chaddad A, 2013, PR SOUTH BIOMED ENG, P129, DOI 10.1109/SBEC.2013.73; Chaddad A., 2011, 2011 IEEE International Conference on Computer Applications and Industrial Electronics (ICCAIE 2011), P87, DOI 10.1109/ICCAIE.2011.6162110; Chaddad Ahmad, 2011, WSEAS Transactions on Biology and Biomedicine, V8, P39; Chaddad A, 2015, HEALTH TECHNOL-GER, V5, P179, DOI 10.1007/s12553-015-0115-1; Clausi DA, 2002, CAN J REMOTE SENS, V28, P45, DOI 10.5589/m02-004; Cooper LAD, 2015, LAB INVEST, V95, P366, DOI 10.1038/labinvest.2014.153; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Dasarathy B. V., 1991, NEAREST NEIGHBOR NN; Esgiar A N, 1998, IEEE Trans Inf Technol Biomed, V2, P197, DOI 10.1109/4233.735785; Esgiar AN, 2002, IEEE T INF TECHNOL B, V6, P54, DOI 10.1109/4233.992163; Esgiar AN, 1998, ANAL QUANT CYTOL, V20, P297; Ganeshan B, 2007, ACAD RADIOL, V14, P1058, DOI 10.1016/j.acra.2007.05.023; Guo YQ, 2007, BIOSTATISTICS, V8, P86, DOI 10.1093/biostatistics/kxj035; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hilado SDF, 2014, J ADV COMPUT INTELL, V18, P792, DOI 10.20965/jaciii.2014.p0792; HIRAOKA Y, 1987, SCIENCE, V238, P36, DOI 10.1126/science.3116667; Histace A, 2013, ANN BRIT MACHINE VIS, V2013, P1; Jiao L., 2013, IFMBE P, P1283, DOI [10.1007/978-3-642-29305-4_336, DOI 10.1007/978-3-642-29305-4_336]; Kalkan H, 2012, INT C PATT RECOG, P61; Kim TY, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/536217; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Loughrey MB, 2015, VIRCHOWS ARCH, V467, P137, DOI 10.1007/s00428-015-1780-1; Low RN, 2002, ABDOM IMAGING, V27, P418, DOI 10.1007/s00261-001-0122-8; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Matuszewski B. J., 2011, 2011 18th IEEE International Conference on Image Processing (ICIP 2011), P3081, DOI 10.1109/ICIP.2011.6116316; Miller PJ, 1995, MULTISPECTRAL IMAGIN, P354, DOI [10.1117/12.198889, DOI 10.1117/12.198889]; Ng F, 2013, RADIOLOGY, V266, P177, DOI 10.1148/radiol.12120254; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Peyreti R, 2015, IEEE ENG MED BIO, P7218, DOI 10.1109/EMBC.2015.7320057; Rao SX, 2014, UNITED EUR GASTROENT, V2, P530, DOI 10.1177/2050640614552463; Rathore S, 2013, IEEEACM T COMPUT BIO; Refaeilzadeh P., 2009, ENCY DATABASE SYSTEM, VVolume 5, P532, DOI DOI 10.1007/978-0-387-39940-9_565; Rokach L, 2007, DATA MINING DECISION; Sargent DJ, 2007, J CLIN ONCOL, V25, P4569, DOI 10.1200/JCO.2006.10.4323; Sargent DJ, 2005, J CLIN ONCOL, V23, P8664, DOI 10.1200/JCO.2005.01.6071; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Witten I.H., 2005, DATA MINING PRACTICA; Yan Xu, 2014, 2014 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), P1626, DOI 10.1109/ICASSP.2014.6853873	42	28	28	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149893	10.1371/journal.pone.0149893	http://dx.doi.org/10.1371/journal.pone.0149893			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901134	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000371276100177
J	Wu, YX; Kang, XJ; Zheng, HY; Liu, HY; Huang, Q; Liu, JQ				Wu, Yixuan; Kang, Xiangjin; Zheng, Haiyan; Liu, Haiying; Huang, Qing; Liu, Jianqiao			Effect of Paternal Age on Reproductive Outcomes of Intracytoplasmic Sperm Injection	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; MALE-FERTILITY; PRETERM BIRTH; PREGNANCY; FATHERS; COUPLES	The impact of paternal age on reproduction, especially using assisted reproductive technologies, has not been well studied to date. To investigate the effect of paternal age on reproductive outcomes, here we performed a retrospective analysis of 2,627 intracytoplasmic sperm injection (ICSI) cycles performed at the Reproductive Medicine Center of the Third Affiliated Hospital of Guangzhou Medical University (China) between January 2007 and May 2015. Effect of paternal age on embryo quality [number of fertilized oocytes, 2 pronucleus zygotes (2PNs), viable embryos, and high-quality embryos] was analyzed by multiple linear regression. Relationships between paternal age and pregnancy outcomes were analyzed by binary logistic regression. After adjusting for female age, no association between paternal age and the following parameters of embryo quality was observed: number of fertilized oocytes (B = -0.032; 95% CI -0.069-0.005; P = 0.088), number of 2PNs (B = -0.005; 95% CI -0.044-0.034; P = 0.806), and number of viable embryos (B = -0.025; 95% CI -0.052-0.001; P = 0.062). However, paternal age negatively influenced the number of highquality embryos (B = -0.020; 95% CI -0.040-0.000; P = 0.045). Moreover, paternal age had no effect on pregnancy outcomes (OR for a 5-year interval), including the rates of clinical pregnancy (OR 0.919; 95% CI 0.839-1.006; P = 0.067), ongoing pregnancy (OR 0.914; 95% CI 0.833-1.003; P = 0.058), early pregnancy loss (OR 1.019; 95% CI 0.823-1.263; P = 0.861), live births (OR 0.916; 95% CI 0.833-1.007; P = 0.070), and preterm births (OR 1.061; 95% CI 0.898-1.254; P = 0.485). Therefore, increased paternal age negatively influences the number of high-quality embryos, but has no effect on pregnancy outcomes in couples undergoing ICSI cycles. However, more studies including men aged over 60 years with a longer-term follow-up are needed.	[Wu, Yixuan; Kang, Xiangjin; Zheng, Haiyan; Liu, Haiying; Huang, Qing; Liu, Jianqiao] Guangzhou Med Univ, Affiliated Hosp 3, Dept Reprod Med, Guangzhou, Guangdong, Peoples R China; [Wu, Yixuan] Key Lab Reprod Med Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Wu, Yixuan] Key Lab Major Obstet Dis Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Wu, Yixuan] Key Lab Reprod & Genet Guangdong Higher Educ Inst, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University	Liu, JQ (corresponding author), Guangzhou Med Univ, Affiliated Hosp 3, Dept Reprod Med, Guangzhou, Guangdong, Peoples R China.	ljq88gz@163.com			National Natural Science Foundation of China [81401254]; Science and Technology Plan of Guangdong Province [2013B022000022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Plan of Guangdong Province	Funding provided by a grant from the National Natural Science Foundation of China, (No. 81401254) (grant recipient: XJK), URL: http://www.nsfc.gov.cn/. Role of funder: performed the experiments; data collection, decision to publish. Funding also provided by a grant from the Science and Technology Plan of Guangdong Province (No. 2013B022000022) (grant recipient: QH), URL: http://pro.gdstc.gov.cn/egrantweb/.	Aboulghar M, 2007, REPROD BIOMED ONLINE, V14, P588, DOI 10.1016/S1472-6483(10)61050-4; Astolfi P, 2006, EPIDEMIOLOGY, V17, P218, DOI 10.1097/01.ede.0000197053.61176.f4; Begueria R, 2014, HUM REPROD, V29, P2114, DOI 10.1093/humrep/deu189; Bellver J, 2008, REPROD BIOMED ONLINE, V17, P595, DOI 10.1016/S1472-6483(10)60305-7; Cocuzza M, 2008, UROLOGY, V71, P490, DOI 10.1016/j.urology.2007.11.041; de la Rochebrochard E, 2006, FERTIL STERIL, V85, P1420, DOI 10.1016/j.fertnstert.2005.11.040; Ferreira RC, 2010, FERTIL STERIL, V93, P1870, DOI 10.1016/j.fertnstert.2008.12.043; Frattarelli JL, 2008, FERTIL STERIL, V90, P97, DOI 10.1016/j.fertnstert.2007.06.009; Jenkins TG, 2013, FERTIL STERIL, V100, P945, DOI 10.1016/j.fertnstert.2013.05.039; Kazaura M, 2004, ANN EPIDEMIOL, V14, P566, DOI 10.1016/j.annepidem.2003.10.003; Klonoff-Cohen HS, 2004, AM J OBSTET GYNECOL, V191, P507, DOI 10.1016/j.ajog.2004.01.035; Kovac JR, 2014, UROL ANNALS, V6, P41, DOI 10.4103/0974-7796.127026; Luna M, 2009, FERTIL STERIL, V92, P1772, DOI 10.1016/j.fertnstert.2009.05.036; Moskovtsev SI, 2006, FERTIL STERIL, V85, P496, DOI 10.1016/j.fertnstert.2005.05.075; Paulson RJ, 2001, AM J OBSTET GYNECOL, V184, P818, DOI 10.1067/mob.2001.113852; Plas E, 2000, EXP GERONTOL, V35, P543, DOI 10.1016/S0531-5565(00)00120-0; Sartorelli EMP, 2001, FERTIL STERIL, V76, P1119, DOI 10.1016/S0015-0282(01)02894-1; Spandorfer SD, 1998, HUM REPROD, V13, P334, DOI 10.1093/humrep/13.2.334; Tsai YR, 2013, TAIWAN J OBSTET GYNE, V52, P351, DOI 10.1016/j.tjog.2013.06.001; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Wu YX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135734; Zhu JL, 2005, EPIDEMIOLOGY, V16, P259, DOI 10.1097/01.ede.0000152526.63279.da	22	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149867	10.1371/journal.pone.0149867	http://dx.doi.org/10.1371/journal.pone.0149867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901529	gold, Green Published, Green Submitted			2022-12-27	WOS:000371276100169
J	Zhang, HM; Wang, LY; Yan, B; Li, L; Cai, AL; Hu, GE				Zhang, Hanming; Wang, Linyuan; Yan, Bin; Li, Lei; Cai, Ailong; Hu, Guoen			Constrained Total Generalized p-Variation Minimization for Few-View X-Ray Computed Tomography Image Reconstruction	PLOS ONE			English	Article							AUGMENTED LAGRANGIAN METHOD; CT RECONSTRUCTION; ALGORITHM; TV; EFFICIENT; RADIATION	Total generalized variation (TGV)-based computed tomography (CT) image reconstruction, which utilizes high-order image derivatives, is superior to total variation-based methods in terms of the preservation of edge information and the suppression of unfavorable staircase effects. However, conventional TGV regularization employs l(1)-based form, which is not the most direct method for maximizing sparsity prior. In this study, we propose a total generalized p-variation (TGpV) regularization model to improve the sparsity exploitation of TGV and offer efficient solutions to few-view CT image reconstruction problems. To solve the nonconvex optimization problem of the TGpV minimization model, we then present an efficient iterative algorithm based on the alternating minimization of augmented Lagrangian function. All of the resulting subproblems decoupled by variable splitting admit explicit solutions by applying alternating minimization method and generalized p-shrinkage mapping. In addition, approximate solutions that can be easily performed and quickly calculated through fast Fourier transform are derived using the proximal point method to reduce the cost of inner subproblems. The accuracy and efficiency of the simulated and real data are qualitatively and quantitatively evaluated to validate the efficiency and feasibility of the proposed method. Overall, the proposed method exhibits reasonable performance and outperforms the original TGV-based method when applied to few-view problems.	[Zhang, Hanming; Wang, Linyuan; Yan, Bin; Li, Lei; Cai, Ailong; Hu, Guoen] Natl Digital Switching Syst Engn & Technol Res Ct, Zhengzhou 450002, Peoples R China	PLA Information Engineering University	Yan, B (corresponding author), Natl Digital Switching Syst Engn & Technol Res Ct, Zhengzhou 450002, Peoples R China.	ybspace@hotmail.com			National High Technology Research and Development Program of China [2012AA011603]; National Natural Science Foundation of China [61372172]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National High Technology Research and Development Program of China (2012AA011603) (http://www.863.gov.cn) and the National Natural Science Foundation of China (61372172) (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage P, 2002, STAT METHODS INMEDIC; Bian JG, 2010, PHYS MED BIOL, V55, P6575, DOI 10.1088/0031-9155/55/22/001; Bredies K, 2010, SIAM J IMAGING SCI, V3, P492, DOI 10.1137/090769521; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Cai AL, 2015, COMPUT MED IMAG GRAP, V45, P1, DOI 10.1016/j.compmedimag.2015.06.004; Cai AL, 2014, J X-RAY SCI TECHNOL, V22, P335, DOI 10.3233/XST-140429; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Chang M, 2013, J X-RAY SCI TECHNOL, V21, P161, DOI 10.3233/XST-130370; Chartrand Rick, 2014, 2014 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), P1025, DOI 10.1109/ICASSP.2014.6853752; Chartrand R, 2007, IEEE SIGNAL PROC LET, V14, P707, DOI 10.1109/LSP.2007.898300; Chartrand R, 2013, CONF REC ASILOMAR C, P665, DOI 10.1109/ACSSC.2013.6810365; Chen JL, 2015, J X-RAY SCI TECHNOL, V23, P683, DOI 10.3233/XST-150521; Chen ZQ, 2013, PHYS MED BIOL, V58, P2119, DOI 10.1088/0031-9155/58/7/2119; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Duan XH, 2009, IEEE T NUCL SCI, V56, P1377, DOI 10.1109/TNS.2008.2009990; Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; Fessler JA, 1999, IEEE T IMAGE PROCESS, V8, P688, DOI 10.1109/83.760336; Goldstein T, 2009, SIAM J IMAGING SCI, V2, P323, DOI 10.1137/080725891; Han X, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/16/5245; Hu Y, 2014, IEEE T IMAGE PROCESS, V23, P2423, DOI 10.1109/TIP.2014.2315156; ICRU, 1992, 48 ICRU; Jia MX, 2012, J APPL CLIN MED PHYS, V13, P117, DOI 10.1120/jacmp.v13i5.3766; Jia X, 2010, MED PHYS, V37, P1757, DOI 10.1118/1.3371691; Li CB, 2013, COMPUT OPTIM APPL, V56, P507, DOI 10.1007/s10589-013-9576-1; Liu Y, 2014, IEEE T MED IMAGING, V33, P749, DOI 10.1109/TMI.2013.2295738; Liu Y, 2012, PHYS MED BIOL, V57, P7923, DOI 10.1088/0031-9155/57/23/7923; Mehranian A, 2013, IEEE T NUCL SCI, V60, P3318, DOI 10.1109/TNS.2013.2275919; Niu SZ, 2014, PHYS MED BIOL, V59, P2997, DOI 10.1088/0031-9155/59/12/2997; Ramani S, 2012, IEEE T MED IMAGING, V31, P677, DOI 10.1109/TMI.2011.2175233; Ritschl L, 2011, PHYS MED BIOL, V56, P1545, DOI 10.1088/0031-9155/56/6/003; Segars WP, 2004, MOL IMAGING BIOL, V6, P149, DOI 10.1016/j.mibio.2004.03.002; Sidky EY, 2008, PHYS MED BIOL, V53, P4777, DOI 10.1088/0031-9155/53/17/021; Sidky EY, 2006, J X-RAY SCI TECHNOL, V14, P119; Sidky EY, 2014, IEEE J TRANSL ENG HE, V2, DOI 10.1109/JTEHM.2014.2300862; Sidky EY, 2013, MED PHYS, V40, DOI 10.1118/1.4790698; Sidky EY, 2012, PHYS MED BIOL, V57, P3065, DOI 10.1088/0031-9155/57/10/3065; Smith DS, 2011, INT SOC MAGN RES MED, P2845; Tang J, 2009, PHYS MED BIOL, V54, P5781, DOI 10.1088/0031-9155/54/19/008; Tian Z, 2011, PHYS MED BIOL, V56, P5949, DOI 10.1088/0031-9155/56/18/011; Wang J, 2006, IEEE T MED IMAGING, V25, P1272, DOI 10.1109/TMI.2006.882141; Wang YL, 2008, SIAM J IMAGING SCI, V1, P248, DOI 10.1137/080724265; Woodworth J, 2014, CAM REP, P14; Wu CL, 2010, SIAM J IMAGING SCI, V3, P300, DOI 10.1137/090767558; Xiao YH, 2012, J MATH IMAGING VIS, V44, P114, DOI 10.1007/s10851-011-0314-y; Xiao YH, 2012, INVERSE PROBL IMAG, V6, P547, DOI 10.3934/ipi.2012.6.547; Yang JS, 2010, INVERSE PROBL, V26, DOI 10.1088/0266-5611/26/3/035013; Yu W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130793; Zhang HM, 2013, CHINESE PHYS B, V22, DOI 10.1088/1674-1056/22/7/078701; Zhang Y, 2013, INT J IMAG SYST TECH, V23, P249, DOI 10.1002/ima.22058	49	21	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149899	10.1371/journal.pone.0149899	http://dx.doi.org/10.1371/journal.pone.0149899			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901410	Green Submitted, Green Published, gold			2022-12-27	WOS:000371276100179
J	Daude, N; Lee, I; Kim, TK; Janus, C; Glaves, JP; Gapeshina, H; Yang, J; Sykes, BD; Carlson, GA; Hood, LE; Westaway, D				Daude, Nathalie; Lee, Inyoul; Kim, Taek-Kyun; Janus, Christopher; Glaves, John Paul; Gapeshina, Hristina; Yang, Jing; Sykes, Brian D.; Carlson, George A.; Hood, Leroy E.; Westaway, David			A Common Phenotype Polymorphism in Mammalian Brains Defined by Concomitant Production of Prolactin and Growth Hormone	PLOS ONE			English	Article							RAT-BRAIN; IMMUNOREACTIVE PROLACTIN; MESSENGER-RNA; CELLULAR-LOCALIZATION; GENE-EXPRESSION; TRANSGENIC MICE; RECEPTOR; STRESS; MOUSE; HYPOTHALAMUS	Pituitary Prolactin (PRL) and Growth Hormone (GH) are separately controlled and sub-serve different purposes. Surprisingly, we demonstrate that extra-pituitary expression in the adult mammalian central nervous system(CNS) is coordinated at mRNA and protein levels. However this was not a uniform effect within populations, such that wide inter-individual variation was superimposed on coordinate PRL/GH expression. Up to 44% of individuals in healthy cohorts of mice and rats showed protein levels above the norm and coordinated expression of PRL and GH transcripts above baseline occurred in the amygdala, frontal lobe and hippocampus of 10% of human subjects. High levels of PRL and GH present in post mortem tissue were often presaged by altered responses in fear conditioning and stress induced hyperthermia behavioral tests. Our data define a common phenotype polymorphism in healthy mammalian brains, and, given the pleiotropic effects known for circulating PRL and GH, further consequences of coordinated CNS over-expression may await discovery.	[Daude, Nathalie; Gapeshina, Hristina; Yang, Jing; Westaway, David] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada; [Lee, Inyoul; Kim, Taek-Kyun; Hood, Leroy E.] Inst Syst Biol, 401 Terry Ave North, Seattle, WA 98109 USA; [Janus, Christopher] Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32611 USA; [Glaves, John Paul; Sykes, Brian D.] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Carlson, George A.; Westaway, David] Mclaughlin Res Inst, 1520 23rd St South, Great Falls, MT 59405 USA	University of Alberta; Institute for Systems Biology (ISB); State University System of Florida; University of Florida; University of Alberta; McLaughlin Research Institute for Biomedical Sciences, Inc.	Westaway, D (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada.; Westaway, D (corresponding author), Mclaughlin Res Inst, 1520 23rd St South, Great Falls, MT 59405 USA.	david.westaway@ualberta.ca			Canada Foundation for Innovation; Canada Research Chair award; USA Department of Defense Research Contracts [W911NF-10-2-0001, W911SR-07-C0101]; USPHS, NIH, NINDS program [NS41997]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS041997] Funding Source: NIH RePORTER	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); USA Department of Defense Research Contracts(United States Department of Defense); USPHS, NIH, NINDS program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Work in the CPPFD was supported by the Canada Foundation for Innovation and a Canada Research Chair award to DW. The authors thank Quentin Pittman and Sui Hwang for useful discussions. Work at Institute for Systems Biology was supported by USA Department of Defense Research Contracts, W911NF-10-2-0001 and W911SR-07-C0101). Work at the McLaughlin Research Institute was supported by USPHS, NIH, NINDS program project grant number NS41997.	Addison ML, 2012, ENDOCRINOLOGY, V153, P1898, DOI 10.1210/en.2011-1982; Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; Bartke A, 2011, TRENDS ENDOCRIN MET, V22, P437, DOI 10.1016/j.tem.2011.07.004; BenJonathan N, 1996, ENDOCR REV, V17, P639, DOI 10.1210/er.17.6.639; BERWAER M, 1994, MOL ENDOCRINOL, V8, P635, DOI 10.1210/me.8.5.635; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; BLANCHARD RJ, 1969, J COMP PHYSIOL PSYCH, V67, P370, DOI 10.1037/h0026779; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; BRIDGES RS, 1985, SCIENCE, V227, P782, DOI 10.1126/science.3969568; Brown RSE, 2010, J COMP NEUROL, V518, P92, DOI 10.1002/cne.22208; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Buvat J, 2003, INT J IMPOT RES, V15, P373, DOI 10.1038/sj.ijir.3901043; CARLSON GA, 1994, P NATL ACAD SCI USA, V91, P5690, DOI 10.1073/pnas.91.12.5690; Daude N, 2012, P NATL ACAD SCI USA, V109, P9035, DOI 10.1073/pnas.1202130109; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DEVITO WJ, 1988, NEUROENDOCRINOLOGY, V47, P284, DOI 10.1159/000124926; Donahue CP, 2006, P NATL ACAD SCI USA, V103, P6031, DOI 10.1073/pnas.0507776103; DRAGO F, 1982, PHYSIOL BEHAV, V28, P1, DOI 10.1016/0031-9384(82)90092-0; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; EMANUELE NV, 1992, MOL ENDOCRINOL, V6, P35, DOI 10.1210/me.6.1.35; Freemark M, 1996, ENDOCRINOLOGY, V137, P934, DOI 10.1210/en.137.3.934; Fujikawa T, 2000, BRAIN RES, V874, P186, DOI 10.1016/S0006-8993(00)02576-2; Gehlenborg N, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap011; GELLERSEN B, 1994, MOL ENDOCRINOL, V8, P356, DOI 10.1210/me.8.3.356; Goffin V, 1996, ENDOCR REV, V17, P385, DOI 10.1210/er.17.4.385; Grattan DR, 2008, J NEUROENDOCRINOL, V20, P752, DOI 10.1111/j.1365-2826.2008.01736.x; Hanna A, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt124; HARLAN RE, 1989, NEUROENDOCRINOLOGY, V49, P7, DOI 10.1159/000125085; Harvey S, 2003, J MOL NEUROSCI, V20, P1, DOI 10.1385/JMN:20:1:1; Harvey S, 2012, ENDOCRINE, V41, P19, DOI 10.1007/s12020-011-9557-z; Harvey S, 2014, GEN COMP ENDOCR, V205, P55, DOI 10.1016/j.ygcen.2014.03.041; Hoffman AR, 2000, GROWTH HORM IGF RES, V10, pS18, DOI 10.1016/S1096-6374(00)90008-X; HOJVAT S, 1982, DEV BRAIN RES, V4, P427, DOI 10.1016/0165-3806(82)90186-9; Hsu SD, 2008, NUCLEIC ACIDS RES, V36, pD165, DOI 10.1093/nar/gkm1012; Hurst JL, 2010, NAT METHODS, V7, P825, DOI [10.1038/nmeth.1500, 10.1038/NMETH.1500]; Hwang D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.10; Janus C, 2004, LEARN MEMORY, V11, P337, DOI 10.1101/lm.70104; Janus C, 2014, BEHAV BRAIN RES, V259, P253, DOI 10.1016/j.bbr.2013.11.010; JONES BK, 1995, MOL CELL BIOL, V15, P7010; Kim JS, 2008, J NEUROSCI, V28, P6030, DOI 10.1523/JNEUROSCI.0891-08.2008; Kinney BA, 2001, PHYSIOL BEHAV, V72, P653, DOI 10.1016/S0031-9384(01)00423-1; Laron Zvi, 2011, Pediatr Endocrinol Rev, V9, P546; Larsen CM, 2010, ENDOCRINOLOGY, V151, P3805, DOI 10.1210/en.2009-1385; Leimar O, 2005, AM NAT, V165, P669, DOI 10.1086/429566; Levites Y, 2006, J NEUROSCI, V26, P11923, DOI 10.1523/JNEUROSCI.2795-06.2006; MILLER WL, 1981, PEDIATR RES, V15, P1550, DOI 10.1203/00006450-198112000-00093; Moderscheim TAE, 2007, NEUROSCIENCE, V145, P963, DOI 10.1016/j.neuroscience.2006.12.053; NIALL HD, 1971, P NATL ACAD SCI USA, V68, P866, DOI 10.1073/pnas.68.4.866; Nyberg F, 1996, HORM RES, V45, P18, DOI 10.1159/000184753; ONO M, 1990, P NATL ACAD SCI USA, V87, P4330, DOI 10.1073/pnas.87.11.4330; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; Passini MA, 2003, J VIROL, V77, P7034, DOI 10.1128/JVI.77.12.7034-7040.2003; Pathipati P, 2011, NEUROSCIENCE, V190, P409, DOI 10.1016/j.neuroscience.2011.05.029; PAUTPAGANO L, 1993, NEUROENDOCRINOLOGY, V58, P682, DOI 10.1159/000126609; Poos K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003210; Rivera JC, 2008, EXP EYE RES, V86, P314, DOI 10.1016/j.exer.2007.11.003; SCHACHTER BS, 1984, ENDOCRINOLOGY, V114, P1947, DOI 10.1210/endo-114-5-1947; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; SINHA YN, 1992, TRENDS ENDOCRIN MET, V3, P100, DOI 10.1016/1043-2760(92)90021-R; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; THOMPSON SA, 1982, CELL TISSUE RES, V225, P79, DOI 10.1007/BF00216220; Torner L, 2001, J NEUROSCI, V21, P3207, DOI 10.1523/JNEUROSCI.21-09-03207.2001; Torner L, 2002, STRESS, V5, P249, DOI 10.1080/1025389021000048638; TOUBEAU G, 1979, J ENDOCRINOL, V83, P261, DOI 10.1677/joe.0.0830261; VanderHeyden JAM, 1997, PHYSIOL BEHAV, V62, P463, DOI 10.1016/S0031-9384(97)00157-1; Voikar V, 2004, GENES BRAIN BEHAV, V3, P27, DOI 10.1046/j.1601-183X.2003.0044.x; Walker JR, 2004, GENOME RES, V14, P742, DOI 10.1101/gr.2161804; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; West-Eberhard MJ, 2005, P NATL ACAD SCI USA, V102, P6543, DOI 10.1073/pnas.0501844102; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yip SH, 2012, J NEUROENDOCRINOL, V24, P1484, DOI 10.1111/j.1365-2826.2012.02357.x; Yoshizato H, 1998, ENDOCRINOLOGY, V139, P2545, DOI 10.1210/en.139.5.2545; Yue M, 2011, NEUROBIOL AGING, V32, P590, DOI 10.1016/j.neurobiolaging.2009.04.006; Zhang ZC, 2010, J BIOL CHEM, V285, P34718, DOI 10.1074/jbc.M110.126441	76	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149410	10.1371/journal.pone.0149410	http://dx.doi.org/10.1371/journal.pone.0149410			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894278	Green Submitted, gold, Green Published			2022-12-27	WOS:000371223400053
J	Jee, D; Kang, S; Yuan, CZ; Cho, E; Arroyo, JG				Jee, Donghyun; Kang, Seungbum; Yuan, Changzheng; Cho, Eunyoung; Arroyo, Jorge G.		Epidemiologic Survey Comm Korean	Serum 25-Hydroxyvitamin D Levels and Dry Eye Syndrome: Differential Effects of Vitamin D on Ocular Diseases	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; KOREA NATIONAL-HEALTH; ASSOCIATION	Purpose To investigate associations between serum 25-hydroxyvitamin D levels and dry eye syndrome (DES), and to evaluate the differential effect of vitamin D on ocular diseases including age-related macular disease (AMD), diabetic retinopathy (DR), cataract, and DES. Methods A total of 16,396 participants aged >19 years were randomly selected from the Korean National Health and Nutrition Examination Survey. All participants participated in standardized interviews, blood 25-hydroxyvitamin D level evaluations, and comprehensive ophthalmic examinations. DES was defined by a history of clinical diagnosis of dry eyes by a physician. The association between vitamin D and DES was compared to the associations between vitamin D and AMD, DR, cataract, and DES from our previous studies. Results The odds of DES non-significantly decreased as the quintiles of serum 25-hydroxyvitamin D levels increased (quintile 5 versus 1, OR = 0.85, 95% CI: 0.55-1.30, P for trend = 0.076) after adjusting for potential confounders including age, sex, hypertension, diabetes, smoking status, and sunlight exposure times. The relative odds of DES (OR = 0.70, 95% CI: 0.30-1.64) and cataract (OR = 0.76, 95% CI: 0.59-0.99) were relatively high, while those of DR (OR = 0.37, 95% CI: 0.18-0.76) and late AMD (OR = 0.32, 95% CI: 0.12-0.81) were lower in men. Conclusions The present study does not support an association between serum 25-hydroxyvitamin D levels and DES. The preventive effect of serum 25-hydroxyvitamin D may be more effective for DR and late AMD than it is for cataract and DES.	[Jee, Donghyun] Catholic Univ Korea, Coll Med, Dept Ophthalmol & Visual Sci, Suwon, South Korea; [Jee, Donghyun] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol & Biostat, Boston, MA 02115 USA; [Kang, Seungbum] Catholic Univ Korea, Daejeon St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Daejeon, South Korea; [Yuan, Changzheng] Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr & Epidemiol, Boston, MA 02115 USA; [Cho, Eunyoung] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Cho, Eunyoung] Harvard Univ, Sch Med, Boston, MA USA; [Cho, Eunyoung] Brown Univ, Dept Dermatol, Warren Alpert Med Sch, Providence, RI 02912 USA; [Arroyo, Jorge G.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Ophthalmol, Boston, MA 02215 USA	Catholic University of Korea; Harvard University; Harvard T.H. Chan School of Public Health; Catholic University of Korea; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Brown University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kang, S (corresponding author), Catholic Univ Korea, Daejeon St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Daejeon, South Korea.	john7030@catholic.ac.kr	Cho, Eunyoung/AAV-4469-2020	Cho, Eunyoung/0000-0001-6594-2582; Arroyo, Jorge/0000-0001-9812-296X	St. Vincent's hospital, research institute of medical science [SVHR-2013-12]	St. Vincent's hospital, research institute of medical science	The authors wish to acknowledge the financial support of the St. Vincent's hospital, research institute of medical science (SVHR-2013-12). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JM, 2014, AM J OPHTHALMOL, V158, P1205, DOI 10.1016/j.ajo.2014.08.021; Alvarez JA, 2014, CLIN ENDOCRINOL, V81, P458, DOI 10.1111/cen.12449; Chailurkit LO, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-853; Choi HS, 2008, J CLIN ENDOCR METAB, V96, P643, DOI DOI 10.1210/JC.2010-2133; Choi JL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/456569; Chun YH, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-84; Dang Sen-Tao, 2004, Di Yi Jun Yi Da Xue Xue Bao, V24, P892; Galor A, 2014, CORNEA, V33, P437, DOI 10.1097/ICO.0000000000000089; Grant W B, 2003, J Cosmet Dermatol, V2, P86, DOI 10.1111/j.1473-2130.2004.00041.x; Hagenau T, 2009, OSTEOPOROSIS INT, V20, P133, DOI 10.1007/s00198-008-0626-y; Jee D, 2015, J CATARACT REFR SURG, V41, P1705, DOI 10.1016/j.jcrs.2014.12.052; Jee D, 2015, J CATARACT REFR SURG, V41, P756, DOI 10.1016/j.jcrs.2014.11.034; Jee DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115199; Jee D, 2014, INVEST OPHTH VIS SCI, V55, P5081, DOI 10.1167/iovs.14-14483; Kim EC, 2014, INVEST OPHTH VIS SCI, V55, P4823, DOI 10.1167/iovs.14-14763; Kim Yangho, 2013, J Prev Med Public Health, V46, P96, DOI 10.3961/jpmph.2013.46.2.96; Kurtul BE, 2015, EYE, V29, P1081, DOI 10.1038/eye.2015.96; Lee YA, 2014, PUBLIC HEALTH NUTR, V17, P764, DOI 10.1017/S1368980013000438; Lu L, 2009, DIABETES CARE, V32, P1278, DOI 10.2337/dc09-0209; Mangge H, 2013, CURRENT VASCULAR PHA; Millen AE, 2011, ARCH OPHTHALMOL-CHIC, V129, P481, DOI 10.1001/archophthalmol.2011.48; Muller MJ, 2015, CLIN CHEM, V61, P1033, DOI 10.1373/clinchem.2015.241430; Nimitphong H, 2013, DERM-ENDOCRINOL, V5, DOI 10.4161/derm.24054; Park HA, 2013, KOREAN J FAM MED, V34, P79, DOI 10.4082/kjfm.2013.34.2.79; Patrick PA, 2012, ARCH OPHTHALMOL-CHIC, V130, P756, DOI 10.1001/archophthalmol.2011.2749; Payne JF, 2012, ENDOCR PRACT, V18, P185, DOI 10.4158/EP11147.OR; Sempos CT, 2012, SCAND J CLIN LAB INV, V72, P32, DOI 10.3109/00365513.2012.681935; Smith M, 2010, BIOSCI HORIZ, V3, P124; Suzuki T, 2000, INVEST OPHTH VIS SCI, V41, P154; Uberti F, 2014, J CLIN ENDOCR METAB, V99, P1367, DOI 10.1210/jc.2013-2103; Uchino Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045805; Wakamatsu TH, 2008, ARQ BRAS OFTALMOL, V71, P72, DOI 10.1590/S0004-27492008000700015; Waterhouse JC, 2009, ANN NY ACAD SCI, V1173, P757, DOI 10.1111/j.1749-6632.2009.04637.x; Wei Y, 2014, EYE CONTACT LENS, V40, P248, DOI 10.1097/ICL.0000000000000042; Yildirim P, 2016, INT J RHEUM DIS, V19, P49, DOI 10.1111/1756-185X.12727; Yin ZH, 2011, INVEST OPHTH VIS SCI, V52, P7359, DOI 10.1167/iovs.11-7605	36	20	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149294	10.1371/journal.pone.0149294	http://dx.doi.org/10.1371/journal.pone.0149294			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894581	Green Published, gold, Green Submitted			2022-12-27	WOS:000371223400044
J	Yamada, K; Yokomaku, K; Haruki, R; Taguchi, K; Nagao, S; Maruyama, T; Otagiri, M; Komatsu, T				Yamada, Kana; Yokomaku, Kyoko; Haruki, Risa; Taguchi, Kazuaki; Nagao, Saori; Maruyama, Toru; Otagiri, Masaki; Komatsu, Teruyuki			Influence of Molecular Structure on O-2-Binding Properties and Blood Circulation of Hemoglobin Albumin Clusters	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; PROTEIN; BOVINE; GLYCOL	A hemoglobin wrapped covalently by three human serum albumins, a Hb-HSA(3) cluster, is an artificial O-2-carrier with the potential to function as a red blood cell substitute. This paper describes the synthesis and O-2-binding properties of new hemoglobin. albumin clusters (i) bearing four HSA units at the periphery (Hb-HSA(4), large-size variant) and (ii) containing an intramolecularly crosslinked Hb in the center (XLHb-HSA(3), high O-2-affinity variant). Dynamic light scattering measurements revealed that the Hb-HSA(4) diameter is greater than that of either Hb-HSA(3) or XLHb-HSA(3). The XLHb-HSA(3) showed moderately high O-2-affinity compared to the others because of the chemical linkage between the Cys-93(beta) residues in Hb. Furthermore, the blood circulation behavior of I-125-labeled clusters was investigated by assay of blood retention and tissue distribution after intravenous administration into anesthetized rats. The XLHb-HSA(3) was metabolized faster than Hb-HSA(3) and Hb-HSA(4). Results suggest that the molecular structure of the protein cluster is a factor that can influence in vivo circulation behavior.	[Yamada, Kana; Yokomaku, Kyoko; Haruki, Risa; Komatsu, Teruyuki] Chuo Univ, Dept Appl Chem, Fac Sci & Engn, Bunkyo Ku, 1-13-27 Kasuga, Tokyo 1128551, Japan; [Taguchi, Kazuaki; Otagiri, Masaki] Sojo Univ, Fac Pharmaceut Sci, Nishi Ku, 4-22-1 Ikeda, Kumamoto 8600082, Japan; [Nagao, Saori; Maruyama, Toru] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Chuo Ku, 5-1 Oe Honmachi, Kumamoto 8620973, Japan	Chuo University; Sojo University; Kumamoto University	Komatsu, T (corresponding author), Chuo Univ, Dept Appl Chem, Fac Sci & Engn, Bunkyo Ku, 1-13-27 Kasuga, Tokyo 1128551, Japan.	komatsu@kc.chuo-u.ac.jp			MEXT Japan [2107, 21108013]; Chuo University; Institute of Science and Engineering, Chuo University	MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Chuo University; Institute of Science and Engineering, Chuo University	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Area ("Coordination Programming" Area 2107, No. 21108013) from MEXT Japan, Chuo University Grant for Special Research, and Joint Research Grant from the Institute of Science and Engineering, Chuo University.	Antonini E., 1971, N HOLLAND RES MONOGR, V21, P13; Buehler PW, 2005, ANAL CHEM, V77, P3466, DOI 10.1021/ac050064y; Bureau of Social Welfare and Public Health, RES BLOOD TRANSF SIT; Daijima Y, 2014, CHEM COMMUN, V50, P14716, DOI 10.1039/c4cc06076h; Doherty DH, 1998, NAT BIOTECHNOL, V16, P672, DOI 10.1038/nbt0798-672; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Gould SA, 1996, WORLD J SURG, V20, P1200; GRASSETTI DR, 1967, ARCH BIOCHEM BIOPHYS, V119, P41, DOI 10.1016/0003-9861(67)90426-2; GUYTON AC, 1964, CIRC RES, V15, P60; Haruki R, 2015, SCI REP-UK, V5, DOI 10.1038/srep12778; Hosaka H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110541; Hu DX, 2008, BIOCHEMISTRY-US, V47, P12551, DOI 10.1021/bi801452b; Hu T, 2007, BIOCHEM J, V402, P143, DOI 10.1042/BJ20061434; Intaglietta M, 2004, PROG APPL MICROCIR, V25, P8; Jahr JS, 2008, EXPERT OPIN BIOL TH, V8, P1425, DOI 10.1517/14712598.8.9.1425 ; Jahr JS, 2011, CHEMISTRY AND BIOCHEMISTRY OF OXYGEN THERAPEUTICS: FROM TRANSFUSION TO ARTIFICIAL BLOOD, P301; Kimura T, 2015, J MATER CHEM B, V3, P6157, DOI 10.1039/c5tb00540j; Kluger R, 2003, J AM CHEM SOC, V125, P6070, DOI 10.1021/ja034376z; Kluger R., 2013, HEMOGLOBIN BASED OXY, P159, DOI DOI 10.1007/978-3-642-40717-8_10; Kluger R, 2010, CURR OPIN CHEM BIOL, V14, P538, DOI 10.1016/j.cbpa.2010.03.021; Komatsu T, 2004, BBA-GEN SUBJECTS, V1675, P21, DOI 10.1016/j.bbagen.2004.08.010; Li DX, 2009, BIOCONJUGATE CHEM, V20, P2062, DOI 10.1021/bc900170e; Manjula BN, 2003, BIOCONJUGATE CHEM, V14, P464, DOI 10.1021/bc0200733; Manjula BN, 2000, J BIOL CHEM, V275, P5527, DOI 10.1074/jbc.275.8.5527; Ministry of Health Labor and Welfare Japan., 2014, P BLOOD DON PROM COM; Mueser TC, 2000, BIOCHEMISTRY-US, V39, P15353, DOI 10.1021/bi0012944; Natanson C, 2008, JAMA-J AM MED ASSOC, V299, P2304, DOI 10.1001/jama.299.19.jrv80007; Pearce L.B., 2006, BLOOD SUBSTITUTES, P437; Rennen HJJM, 2001, NUCL MED BIOL, V28, P401, DOI 10.1016/S0969-8051(01)00208-6; Rohlfs RJ, 1998, J BIOL CHEM, V273, P12128, DOI 10.1074/jbc.273.20.12128; SCHULTZ SC, 1993, J LAB CLIN MED, V122, P301; Tomita D, 2013, BIOMACROMOLECULES, V14, P1816, DOI 10.1021/bm400204y; Vandegriff KD, 2003, TRANSFUSION, V43, P509, DOI 10.1046/j.1537-2995.2003.00341.x; Winslow RM, 2003, J INTERN MED, V253, P508, DOI 10.1046/j.1365-2796.2003.01150.x; Zhang N, 2010, BIOTECHNOL PROGR, V26, P1481, DOI 10.1002/btpr.467; Zhang YL, 2008, BIOCONJUGATE CHEM, V19, P2221, DOI 10.1021/bc8003205	36	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149526	10.1371/journal.pone.0149526	http://dx.doi.org/10.1371/journal.pone.0149526			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895315	Green Published, Green Submitted, gold			2022-12-27	WOS:000371223400061
J	Yu, Y; Wang, K; Deng, JH; Sun, M; Jia, J; Wang, XM				Yu, Yan; Wang, Ke; Deng, Jiahui; Sun, Min; Jia, Jun; Wang, Xiaomin			Electroacupuncture Produces the Sustained Motor Improvement in 6-Hydroxydopamine-Lesioned Mice	PLOS ONE			English	Article							MEDIAL FOREBRAIN-BUNDLE; PARKINSONS-DISEASE; MOUSE MODEL; ACUPUNCTURE; STIMULATION; NEURONS; RATS; THERAPY; LESIONS; TIME	Clinical and research evidence has shown that electroacupuncture (EA) promotes recovery of motor function in patients with Parkinson's disease (PD). However, the "efficacy span" of EA treatment, especially the long-term effect of EA that is thought to last after the cessation of EA treatment, has not been investigated. The present study thus investigated and compared the effect of EA during and after chronic EA application on motor activity and dopamine lesions in a 6-hydroxydopamine (6-OHDA)-lesioned mouse model of PD. Chronic EA treatment (30 min a day, 6 days a week for 2 or 4 weeks) significantly attenuated motor deficiency and reduced dopamine neuron degeneration. Remarkably, EA showed a long-lasting effect after the cessation of EA stimulation. At 2 and 4 weeks after the termination of EA, EA continued to improve motor function in 6-OHDA-lesioned mice. Consistent with sustained behavioral effects, EA induced an enduring increase in the dopamine turnover ratio in the striatum 2 weeks after the cessation of EA treatment. Here we demonstrated that the therapeutic effect of EA outlasted the duration of EA application. During a relatively long period of time after the completion of EA treatment, EA is able to continue to improve motor function and enhance dopamine availability in 6-OHDA-lesioned PD mice.	[Jia, Jun; Wang, Xiaomin] Capital Med Univ, Beijing Inst Brain Disorders, Beijing Key Lab Parkinsons Dis, Dept Neurobiol,Key Lab Neurodegenerat Disorders,M, Beijing 100069, Peoples R China; [Jia, Jun; Wang, Xiaomin] Capital Med Univ, Beijing Inst Brain Disorders, Beijing Key Lab Parkinsons Dis, Dept Physiol,Key Lab Neurodegenerat Disorders,Min, Beijing 100069, Peoples R China	Capital Medical University; Capital Medical University	Jia, J; Wang, XM (corresponding author), Capital Med Univ, Beijing Inst Brain Disorders, Beijing Key Lab Parkinsons Dis, Dept Neurobiol,Key Lab Neurodegenerat Disorders,M, Beijing 100069, Peoples R China.; Jia, J; Wang, XM (corresponding author), Capital Med Univ, Beijing Inst Brain Disorders, Beijing Key Lab Parkinsons Dis, Dept Physiol,Key Lab Neurodegenerat Disorders,Min, Beijing 100069, Peoples R China.	jiajun@ccmu.edu.cn; xmwang@ccmu.edu.cn			National Basic Research Program of China [2011CB504100]; National Natural Science Foundation of China [81072858, 81473770, 31401024]; Beijing Natural Science Foundation [7152021]; Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions [CITTCD201304185]; Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges under the Beijing Municipality [IDHT20140514]; Seed Grant of International Alliance of Translational Neuroscience [PXM2014_014226_000015]; Postdoctoral Science Foundation of China [2014M561007]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions; Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges under the Beijing Municipality; Seed Grant of International Alliance of Translational Neuroscience; Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	This study was supported by the National Basic Research Program of China (2011CB504100; http://www.973.gov.cn), the National Natural Science Foundation of China (81072858, 81473770, 31401024; http://www.nsfc.gov.cn), Beijing Natural Science Foundation (7152021; http://www.bjkw.gov.cn), the Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions (CIT&TCD201304185; www.bjedu.gov.cn), the Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges under the Beijing Municipality (IDHT20140514; http://www.bjedu.gov.cn), the Seed Grant of International Alliance of Translational Neuroscience (PXM2014_014226_000015; http://www.bibd.org.cn), and Postdoctoral Science Foundation of China (2014M561007; http://jj.chinapostdoctor.org.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTAR CA, 1992, P NATL ACAD SCI USA, V89, P11347, DOI 10.1073/pnas.89.23.11347; Alvarez-Fischer D, 2008, EXP NEUROL, V210, P182, DOI 10.1016/j.expneurol.2007.10.012; Asakawa T, 2012, INTRACTABLE RARE DIS, V1, P144, DOI 10.5582/irdr.2012.v1.4.144; Boix J, 2015, BEHAV BRAIN RES, V284, P196, DOI 10.1016/j.bbr.2015.01.053; Cho SY, 2012, PARKINSONISM RELAT D, V18, P948, DOI 10.1016/j.parkreldis.2012.04.030; Cohen AD, 2011, BRAIN RES, V1370, P80, DOI 10.1016/j.brainres.2010.11.006; Cristian A, 2005, MOVEMENT DISORD, V20, P1185, DOI 10.1002/mds.20503; Deng JH, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0302-z; Dewey RB, 2004, NEUROLOGY, V62, pS3, DOI 10.1212/WNL.62.6_suppl_4.S3; Grealish S, 2010, EUR J NEUROSCI, V31, P2266, DOI 10.1111/j.1460-9568.2010.07265.x; Huang C, 2000, NEUROSCI LETT, V294, P159, DOI 10.1016/S0304-3940(00)01572-X; Iancu R, 2005, BEHAV BRAIN RES, V162, P1, DOI 10.1016/j.bbr.2005.02.023; Jia J, 2010, BEHAV NEUROSCI, V124, P305, DOI 10.1037/a0018931; Jia J, 2009, BEHAV BRAIN RES, V205, P214, DOI 10.1016/j.bbr.2009.06.024; Kawagishi K, 2014, NEUROSCIENCE, V272, P29, DOI 10.1016/j.neuroscience.2014.04.050; Kim HJ, 2013, PARKINSONISM RELAT D, V19, P831, DOI 10.1016/j.parkreldis.2013.03.018; Kim HJ, 2014, J NEUROL SCI, V341, P1, DOI 10.1016/j.jns.2014.04.016; Kim SH, 2011, PLOS ONE, V6; Liang XB, 2002, MOL BRAIN RES, V108, P51, DOI 10.1016/S0169-328X(02)00513-2; Meissner W, 2002, NEUROSCI LETT, V328, P105, DOI 10.1016/S0304-3940(02)00463-9; Rabinstein AA, 2003, NEUROLOGIST, V9, P137, DOI 10.1097/00127893-200305000-00002; SAINTCYR JA, 1993, NEUROLOGY, V43, P47; Shiotsuki H, 2010, J NEUROSCI METH, V189, P180, DOI 10.1016/j.jneumeth.2010.03.026; Sun ZL, 2012, NEUROSCI LETT, V520, P32, DOI 10.1016/j.neulet.2012.05.021; Wang H. W., 2013, WORLD CHINESE MED, V8, P5, DOI DOI 10.1371/J0UNIAL.P0NE.0063225; Wang HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019790; Wang X, 2008, NEUROCHEM RES, V33, P1956, DOI 10.1007/s11064-008-9691-z; Yuan H, 2005, J NEUROSCI METH, V144, P35, DOI 10.1016/j.jneumeth.2004.10.004; Zeng BY, 2013, INT REV NEUROBIOL, V111, P141, DOI 10.1016/B978-0-12-411545-3.00007-9	29	13	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149111	10.1371/journal.pone.0149111	http://dx.doi.org/10.1371/journal.pone.0149111			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894437	Green Published, Green Submitted, gold			2022-12-27	WOS:000371223400032
J	Chi, MH; Craven, KD				Chi, Myoung-Hwan; Craven, Kelly D.			RacA-Mediated ROS Signaling Is Required for Polarized Cell Differentiation in Conidiogenesis of Aspergillus fumigatus	PLOS ONE			English	Article							CANDIDA-ALBICANS; NADPH OXIDASES; NIDULANS; GROWTH; FUNGUS; ABAA; DOWNSTREAM; EMERGENCE; HOMOLOG; KINASE	Conidiophore development of fungi belonging to the genus Aspergillus involves dynamic changes in cellular polarity and morphogenesis. Synchronized differentiation of phialides from the subtending conidiophore vesicle is a good example of the transition from isotropic to multi-directional polarized growth. Here we report a small GTPase, RacA, which is essential for reactive oxygen species (ROS) production in the vesicle as well as differentiation of phialides in Aspergillus fumigatus. We found that wild type A. fumigatus accumulates ROS in these conidiophore vesicles and that null mutants of racA did not, resulting in the termination of conidiophore development in this early vesicle stage. Further, we found that stress conditions resulting in atypical ROS accumulation coincide with partial recovery of phialide emergence but not subsequent apical dominance of the phialides in the racA null mutant, suggesting alternative means of ROS generation for the former process that are lacking in the latter. Elongation of phialides was also suppressed by inhibition of NADPH-oxidase activity. Our findings provide not only insights into role of ROS in fungal cell polarity and morphogenesis but also an improved model for the developmental regulatory pathway of conidiogenesis in A. fumigatus.	[Chi, Myoung-Hwan; Craven, Kelly D.] Samuel Roberts Noble Fdn Inc, Div Plant Biol, 2510 Sam Noble Pkwy, Oklahoma City, OK USA	Noble Research Institute	Craven, KD (corresponding author), Samuel Roberts Noble Fdn Inc, Div Plant Biol, 2510 Sam Noble Pkwy, Oklahoma City, OK USA.	kdcraven@noble.org		Craven, Kelly/0000-0002-1597-9413	Samuel Roberts Noble Foundation	Samuel Roberts Noble Foundation	This research is funded internally by the Samuel Roberts Noble Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is funded internally by the Samuel Roberts Noble Foundation.	ADAMS TH, 1988, CELL, V54, P353, DOI 10.1016/0092-8674(88)90198-5; Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; ANDRIANOPOULOS A, 1994, MOL CELL BIOL, V14, P2503, DOI 10.1128/MCB.14.4.2503; Bassilana M, 2006, EUKARYOT CELL, V5, P321, DOI 10.1128/EC.5.2.321-329.2006; Chen JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000202; Chi MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074805; Egan MJ, 2007, P NATL ACAD SCI USA, V104, P11772, DOI 10.1073/pnas.0700574104; HANSBERG W, 1993, FREE RADICAL BIO MED, V14, P287, DOI 10.1016/0891-5849(93)90025-P; Hernandez-Rodriguez Y, 2012, EUKARYOT CELL, V11, P311, DOI 10.1128/EC.05164-11; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Hurtado CAR, 2000, J BACTERIOL, V182, P2376, DOI 10.1128/JB.182.9.2376-2386.2000; Juvvadi PR, 2011, BIOCHEM BIOPH RES CO, V405, P238, DOI 10.1016/j.bbrc.2011.01.017; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Lara-Ortiz T, 2003, MOL MICROBIOL, V50, P1241, DOI 10.1046/j.1365-2958.2003.03800.x; Li HY, 2011, EUKARYOT CELL, V10, P174, DOI 10.1128/EC.00288-10; Lindsey R, 2010, EUKARYOT CELL, V9, P155, DOI 10.1128/EC.00269-09; Mah JH, 2006, EUKARYOT CELL, V5, P1585, DOI 10.1128/EC.00192-06; Morre DJ, 2002, ANTIOXID REDOX SIGN, V4, P207, DOI 10.1089/152308602753625960; Munkres KD., 1990, FUNG GENET NEWSLETT, V37, P24, DOI DOI 10.4148/1941-4765.1477; Nesher I, 2011, EUKARYOT CELL, V10, P1122, DOI 10.1128/EC.00321-10; Ni M, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P559; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Rolke Y, 2008, MOL MICROBIOL, V68, P405, DOI 10.1111/j.1365-2958.2008.06159.x; Ryder LS, 2013, P NATL ACAD SCI USA, V110, P3179, DOI 10.1073/pnas.1217470110; Semighini CP, 2008, GENETICS, V179, P1919, DOI 10.1534/genetics.108.089318; SEWALL TC, 1990, PLANT CELL, V2, P731, DOI 10.1105/tpc.2.8.731; Shimizu K, 2001, GENETICS, V157, P591; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Tanaka A, 2008, MOL MICROBIOL, V68, P1165, DOI 10.1111/j.1365-2958.2008.06217.x; Tao L, 2011, MICROBIOL-SGM, V157, P313, DOI 10.1099/mic.0.044271-0; Vallim MA, 2005, EUKARYOT CELL, V4, P1066, DOI 10.1128/EC.4.6.1066-1078.2005; Yu JH, 2006, EUKARYOT CELL, V5, P1577, DOI 10.1128/EC.00193-06	32	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149548	10.1371/journal.pone.0149548	http://dx.doi.org/10.1371/journal.pone.0149548			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890813	gold, Green Submitted, Green Published			2022-12-27	WOS:000371221500057
J	Marschner, JA; Schafer, H; Holderied, A; Anders, HJ				Marschner, Julian A.; Schaefer, Hannah; Holderied, Alexander; Anders, Hans-Joachim			Optimizing Mouse Surgery with Online Rectal Temperature Monitoring and Preoperative Heat Supply. Effects on Post-Ischemic Acute Kidney Injury	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; BODY-TEMPERATURE; RENAL-FAILURE; HYPOTHERMIA; ANESTHESIA; RECOVERY; MODEL; PROTECTION; INFUSION; RATS	Body temperature affects outcomes of tissue injury. We hypothesized that online body core temperature recording and selective interventions help to standardize peri-interventional temperature control and the reliability of outcomes in experimental renal ischemia reperfusion injury (IRI). We recorded core temperature in up to seven mice in parallel using a Thermes USB recorder and ret-3-iso rectal probes with three different protocols. Setup A: Heating pad during ischemia time; Setup B: Heating pad from incision to wound closure; Setup C: A ventilated heating chamber before surgery and during ischemia time with surgeries performed on a heating pad. Temperature profile recording displayed significant declines upon installing anesthesia. The profile of the baseline experimental setup A revealed that <1% of the temperature readings were within the target range of 36.5 to 38.5 degrees C. Setup B and C increased the target range readings to 34.6 +/- 28.0% and 99.3 +/- 1.5%, respectively. Setup C significantly increased S3 tubular necrosis, neutrophil influx, and mRNA expression of kidney injury markers. In addition, using setup C different ischemia times generated a linear correlation with acute tubular necrosis parameters at a low variability, which further correlated with the degree of kidney atrophy 5 weeks after surgery. Changing temperature control setup A to C was equivalent to 10 minutes more ischemia time. We conclude that body temperature drops quickly in mice upon initiating anesthesia. Immediate heat supply, e.g. in a ventilated heating chamber, and online core temperature monitoring can help to standardize and optimize experimental outcomes.	[Marschner, Julian A.; Schaefer, Hannah; Holderied, Alexander; Anders, Hans-Joachim] Klinikum Univ Munchen, Med Klin & Poliklin 4, Munich, Germany	University of Munich	Anders, HJ (corresponding author), Klinikum Univ Munchen, Med Klin & Poliklin 4, Munich, Germany.	hjanders@med.uni-muenchen.de	Marschner, Julian A./AAC-4421-2020; Anders, Hans-Joachim/ABD-6247-2021	Marschner, Julian Aurelio/0000-0002-5564-7085; Anders, Hans-Joachim/0000-0003-2434-2956	Deutsche Forschungsgemeinschaft [AN372/11-2, AN372/23-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/): AN372/11-2 and AN372/23-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Deutsche Forschungsgemeinschaft (AN372/11-2 and AN372/23-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CALNE RY, 1963, BMJ-BRIT MED J, P651; Caro AC, 2013, J AM ASSOC LAB ANIM, V52, P577; Delbridge MS, 2007, TRANSPL P, V39, P2983, DOI 10.1016/j.transproceed.2007.04.028; Devey L, 2008, LAB ANIM-UK, V42, P12, DOI 10.1258/la.2007.06009e; Flecknell Pa ScienceDirect (Online service), 1996, LAB ANIMAL ANAESTHES; Haq M, 1998, J AM SOC NEPHROL, V9, P614; Harkness JE, 1995, BIOL MED RABBITS ROD; HEIER T, 1991, ANESTHESIOLOGY, V74, P815, DOI 10.1097/00000542-199105000-00003; Hoyt RE, 2007, MOUSE BIOMEDICAL RES, P23, DOI DOI 10.1016/B978-012369454-6/50056-X; JUST B, 1992, ANESTHESIOLOGY, V76, P60, DOI 10.1097/00000542-199201000-00009; Kim HJ, 2014, J IMMUNOL METHODS, V407, P146, DOI 10.1016/j.jim.2014.03.014; Lech M, 2014, J AM SOC NEPHROL, V25, P292, DOI 10.1681/ASN.2013020152; Lech M, 2013, KIDNEY INT, V83, P647, DOI 10.1038/ki.2012.463; MITCHELL RM, 1957, TRANSPLAN B, V4, P15; Moler FW, 2015, NEW ENGL J MED, V372, P1898, DOI 10.1056/NEJMoa1411480; Niemann CU, 2015, NEW ENGL J MED, V373, P405, DOI 10.1056/NEJMoa1501969; OSIAS MB, 1977, ARCH SURG-CHICAGO, V112, P729; Ponticelli CE, 2015, KIDNEY INT, V87, P272, DOI 10.1038/ki.2014.359; R Core Team, 2013, R LANG ENV STAT COMP; Roehl AB, 2011, LAB ANIM-UK, V45, P45, DOI 10.1258/la.2010.010076; Sanchez-Alavez M, 2011, AGE, V33, P89, DOI 10.1007/s11357-010-9164-6; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Taylor DK, 2007, J AM ASSOC LAB ANIM, V46, P37; VALERI CR, 1987, ANN SURG, V205, P175, DOI 10.1097/00000658-198702000-00012; Vielhauer V, 2001, J AM SOC NEPHROL, V12, P1173, DOI 10.1681/ASN.V1261173; Wei QQ, 2012, AM J PHYSIOL-RENAL, V303, pF1487, DOI 10.1152/ajprenal.00352.2012; Yamada K, 2004, J IMMUNOL, V172, P3869, DOI 10.4049/jimmunol.172.6.3869; ZAGER RA, 1989, CIRC RES, V65, P1263, DOI 10.1161/01.RES.65.5.1263	28	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149489	10.1371/journal.pone.0149489	http://dx.doi.org/10.1371/journal.pone.0149489			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890071	Green Published, Green Submitted, gold			2022-12-27	WOS:000371221500052
J	Williams, PB; Mangelsdorf, HH; Kontra, C; Nusbaum, HC; Hoeckner, B				Williams, Patrick B.; Mangelsdorf, Heather H.; Kontra, Carly; Nusbaum, Howard C.; Hoeckner, Berthold			The Relationship between Mental and Somatic Practices and Wisdom	PLOS ONE			English	Article							LOVING-KINDNESS; MOTOR-SKILLS; KNOWLEDGE; CHILDREN; ANXIETY; HANDS; MIND	In this study we sought to explore how experience with specific mental and somatic practices is associated with wisdom, using self-report measures of experience and wisdom. We administered standard surveys to measure wisdom and experience among four groups of practitioners of mental and somatic practices, namely, meditators, practitioners of the Alexander Technique, practitioners of the Feldenkrais Method, and classical ballet dancers. We additionally administered surveys of trait anxiety and empathy to all participants to explore possible mediating relationships of experience and wisdom by characteristics thought to be components of wisdom. Wisdom was higher on average among meditation practitioners, and lowest among ballet dancers, and this difference held when controlling for differences in age between practices, supporting the view that meditation is linked to wisdom and that ballet is not. However, we found that increased experience with meditation and ballet were both positively associated with wisdom, and that lowered trait anxiety mediated this positive association among meditation practitioners, and, non-significantly, among ballet dancers. These results suggest that not all practices that are purported to affect mental processing are related to wisdom to the same degree and different kinds of experience appear to relate to wisdom in different ways, suggesting different mechanisms that might underlie the development of wisdom with experience.	[Williams, Patrick B.; Mangelsdorf, Heather H.; Kontra, Carly; Nusbaum, Howard C.] Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA; [Hoeckner, Berthold] Univ Chicago, Dept Mus, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Williams, PB (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.	pbwilliams@uchicago.edu		Mangelsdorf, Heather/0000-0003-3621-3326	Templeton Grant from the John Templeton Foundation [37775]	Templeton Grant from the John Templeton Foundation	This study was supported by Templeton Grant ID#: 37775 from the John Templeton Foundation (www.templeton.org). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts Hugo J E M, 2011, Mindfulness (N Y), V2, P73; Ardelt M, 2004, HUM DEV, V47, P257, DOI 10.1159/000079154; Ardelt M, 2003, RES AGING, V25, P275, DOI 10.1177/0164027503025003004; Ardelt M, 1998, J AGING STUD, V12, P291, DOI 10.1016/S0890-4065(98)90005-6; Ardelt M, 2010, J ADULT DEV, V17, P193, DOI 10.1007/s10804-009-9088-5; Bailey A., 2008, J UNCONVENTIONAL PAR, V1, P9; Baltes PB, 2000, AM PSYCHOL, V55, P122, DOI 10.1037/0003-066X.55.1.122; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Barrell G, 2013, MED PROBLEMS PERFORM, V18, P59; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Benedikovicova J, 2008, STUD PSYCHOL, V50, P179; Bergen-Cico D, 2014, MINDFULNESS, V5, P505, DOI 10.1007/s12671-013-0205-y; Bergsma A, 2012, J HAPPINESS STUD, V13, P481, DOI 10.1007/s10902-011-9275-5; Bizarro, 2015, PSYCHOL NEUROSCI, V8, P350, DOI [DOI 10.1037/PNE0000015, https://doi.org/10.1037/pne0000015]; Blasing B, 2009, PSYCHOL SPORT EXERC, V10, P350, DOI 10.1016/j.psychsport.2008.10.001; Bodhidharma, 1987, ZEN TEACHING BODHIDH; Bohmig-Krumhaar SA, 2002, Z ENTWICKL PADAGOGIS, V34, P30, DOI 10.1026//0049-8637.34.1.30; Broaders SC, 2007, J EXP PSYCHOL GEN, V136, P539, DOI 10.1037/0096-3445.136.4.539; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Carney DR, 2010, PSYCHOL SCI, V21, P1363, DOI 10.1177/0956797610383437; Casasanto D, 2009, J EXP PSYCHOL GEN, V138, P351, DOI 10.1037/a0015854; Colzato LS, 2012, PSYCHON B REV, V19, P541, DOI 10.3758/s13423-012-0241-y; Duckworth AL, 2007, J PERS SOC PSYCHOL, V92, P1087, DOI 10.1037/0022-3514.92.6.1087; Ferrari M., 2013, SCI STUDY PERSONAL W; Ferrari M, 2011, RES HUM DEV, V8, P128, DOI 10.1080/15427609.2011.568869; Glck J., 2013, SCI STUDY PERSONAL W, P75, DOI [DOI 10.1007/978-94-007-7987-7_4, 10.1007/978-94-007-7987-7_4]; Goldin-Meadow S, 2009, PSYCHOL SCI, V20, P267, DOI 10.1111/j.1467-9280.2009.02297.x; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555; Hopper C., 1999, J BODYWORK MOVEMENT, V3, P238, DOI DOI 10.1016/S1360-8592(99)80010-2; Hutcherson CA, 2008, EMOTION, V8, P720, DOI 10.1037/a0013237; James Michelle, 1998, Aust J Physiother, V44, P49; Jeste DV, 2010, JAMA-J AM MED ASSOC, V304, P1602, DOI 10.1001/jama.2010.1458; Jola C, 2011, EXP BRAIN RES, V213, P257, DOI 10.1007/s00221-011-2743-7; Jolliffe D, 2006, J ADOLESCENCE, V29, P589, DOI 10.1016/j.adolescence.2005.08.010; Jones FP, 1997, FREEDOM CHANGE DEV S; Kiken LG, 2014, J RES PERS, V53, P22, DOI 10.1016/j.jrp.2014.08.002; Kiken LG, 2011, SOC PSYCHOL PERS SCI, V2, P425, DOI 10.1177/1948550610396585; Kitchener K., 1990, WISDOM ITS NATURE OR, P212, DOI [DOI 10.1017/CBO9781139173704.011, https://doi.org/10.1017/CBO9781139173704.011]; Kleiner S, 2009, SYMB INTERACT, V32, P236, DOI 10.1525/si.2009.32.3.236; Kontra C, 2015, PSYCHOL SCI, V26, P737, DOI 10.1177/0956797615569355; Kross E, 2012, J EXP PSYCHOL GEN, V141, P43, DOI 10.1037/a0024158; Lake B, 1985, Aust Fam Physician, V14, P1175; LESTE A, 1990, AM J DANCE THER, V12, P19, DOI 10.1007/BF00844312; Leung MK, 2013, SOC COGN AFFECT NEUR, V8, P34, DOI 10.1093/scan/nss076; Novack MA, 2014, PSYCHOL SCI, V25, P903, DOI 10.1177/0956797613518351; Ping R., UNPACKING G IN PRESS; Ping RM, 2008, DEV PSYCHOL, V44, P1277, DOI 10.1037/0012-1649.44.5.1277; Reniers RLEP, 2011, J PERS ASSESS, V93, P84, DOI 10.1080/00223891.2010.528484; RISKIND J H, 1982, Motivation and Emotion, V6, P273, DOI 10.1007/BF00992249; Shapiro SL, 2007, TRAIN EDUC PROF PSYC, V1, P105, DOI 10.1037/1931-3918.1.2.105; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; Soloway E, 1996, INT FELDENKRAIS FEDE, V3, P22; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Spielberger C. D., 1989, STATE TRAIT ANXIETY; Stallibrass C, 2002, CLIN REHABIL, V16, P695, DOI 10.1191/0269215502cr544oa; Staudinger U. M., 2013, SCI STUDY PERSONAL W, DOI [10.1007/978-90-481-9231-1_1, DOI 10.1007/978-94-007-7987-7_1]; Staudinger UM, 1996, J PERS SOC PSYCHOL, V71, P746, DOI 10.1037/0022-3514.71.4.746; STAUDINGER UM, 2006, SOCIAL STRUCTURES AG, P33; STEPPER S, 1993, J PERS SOC PSYCHOL, V64, P211, DOI 10.1037/0022-3514.64.2.211; Tiberius V., 2008, REFLECTIVE LIFE LIVI; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322	62	10	11	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149369	10.1371/journal.pone.0149369	http://dx.doi.org/10.1371/journal.pone.0149369			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3CO	26890493	Green Published, Green Submitted, gold			2022-12-27	WOS:000371221500040
J	Yamada, H; Mori, S; Miyakawa, T; Morikawa, R; Katagiri, F; Hozumi, K; Kikkawa, Y; Nomizu, M; Takasu, M				Yamada, Hironao; Mori, Sakiko; Miyakawa, Takeshi; Morikawa, Ryota; Katagiri, Fumihiko; Hozumi, Kentaro; Kikkawa, Yamato; Nomizu, Motoyoshi; Takasu, Masako			Structural Study of Cell Attachment Peptide Derived from Laminin by Molecular Dynamics Simulation	PLOS ONE			English	Article							HOMOLOGOUS LOOP REGIONS; FREE-ENERGY LANDSCAPE; BINDING-SITES; BETA-HAIRPIN; BIOLOGICAL-ACTIVITIES; ALPHA-DYSTROGLYCAN; CRYSTAL-STRUCTURE; G-DOMAIN; CHAIN; IDENTIFICATION	Peptides with cell attachment activity are beneficial component of biomaterials for tissue engineering. Conformational structure is one of the important factors for the biological activities. The EF1 peptide (DYATLQLQEGRLHFMFDLG) derived from laminin promotes cell spreading and cell attachment activity mediated by alpha 2 beta 1 integrin. Although the sequence of the EF2 peptide (DFATVQLRNGFPYFSYDLG) is homologous sequence to that of EF1, EF2 does not promote cell attachment activity. To determine whether there are structural differences between EF1 and EF2, we performed replica exchange molecular dynamics (REMD) simulations and conventional molecular dynamics (MD) simulations. We found that EF1 and EF2 had beta-sheet structure as a secondary structure around the global minimum. However, EF2 had variety of structures around the global minimum compared with EF1 and has easily escaped from the bottom of free energy. The structural fluctuation of the EF1 is smaller than that of the EF2. The structural variation of EF2 is related to these differences in the structural fluctuation and the number of the hydrogen bonds (H-bonds). From the analysis of H-bonds in the beta-sheet, the number of H-bonds in EF1 is larger than that in EF2 in the time scale of the conventional MD simulation, suggesting that the formation of H-bonds is related to the differences in the structural fluctuation between EF1 and EF2. From the analysis of other non-covalent interactions in the amino acid sequences of EF1 and EF2, EF1 has three pairs of residues with hydrophobic interaction, and EF2 has two pairs. These results indicate that several non-covalent interactions are important for structural stabilization. Consequently, the structure of EF1 is stabilized by H-bonds and pairs of hydrophobic amino acids in the terminals. Hence, we propose that non-covalent interactions around N-terminal and C-terminal of the peptides are crucial for maintaining the beta-sheet structure of the peptides.	[Yamada, Hironao; Mori, Sakiko; Miyakawa, Takeshi; Morikawa, Ryota; Takasu, Masako] Tokyo Univ Pharm & Life Sci, Sch Life Sci, 1432-1 Horinouchi, Tokyo 1920392, Japan; [Katagiri, Fumihiko; Hozumi, Kentaro; Kikkawa, Yamato; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Sch Pharm, 1432-1 Horinouchi, Tokyo 1920392, Japan	Tokyo University of Pharmacy & Life Sciences; Tokyo University of Pharmacy & Life Sciences	Yamada, H (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, 1432-1 Horinouchi, Tokyo 1920392, Japan.	s077112@toyaku.ac.jp	Kikkawa, Yamato/D-1503-2010	Hozumi, Kentaro/0000-0002-6671-4386	JSPS KAKENHI [24540442]; Grants-in-Aid for Scientific Research [26430123] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 24540442.	Alberts B, 2007, MOL BIOL CELL, P1167; Altis A, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2945165; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; BURGESON RE, 1994, MATRIX BIOL, V14, P209, DOI 10.1016/0945-053X(94)90184-8; Chodera JD, 2007, J CHEM THEORY COMPUT, V3, P26, DOI 10.1021/ct0502864; Collier JH, 2011, BIOMATERIALS, V32, P4198, DOI 10.1016/j.biomaterials.2011.02.030; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Csontos J, 2008, BIOPOLYMERS, V89, P1002, DOI 10.1002/bip.21049; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; EISENHABER F, 1995, J COMPUT CHEM, V16, P273, DOI 10.1002/jcc.540160303; Garcia AE, 2001, PROTEINS, V42, P345, DOI 10.1002/1097-0134(20010215)42:3<345::AID-PROT50>3.0.CO;2-H; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Harrison D, 2007, J BIOL CHEM, V282, P11573, DOI 10.1074/jbc.M610657200; Hatfield MPD, 2010, J PHYS CHEM B, V114, P3028, DOI 10.1021/jp910465e; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hohenester E, 1999, MOL CELL, V4, P783, DOI 10.1016/S1097-2765(00)80388-3; Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6; Hozumi K, 2012, BIOMATERIALS, V33, P4241, DOI 10.1016/j.biomaterials.2012.02.055; Iivanainen A, 1999, J BIOL CHEM, V274, P14107, DOI 10.1074/jbc.274.20.14107; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Katagiri F, 2014, BIOCHEMISTRY-US, V53, P3699, DOI 10.1021/bi5003822; Kato K, 2002, BIOCHEMISTRY-US, V41, P10747, DOI 10.1021/bi020180k; Li SH, 2003, DEV CELL, V4, P613, DOI 10.1016/S1534-5807(03)00128-X; Libby RT, 2000, J NEUROSCI, V20, P6517, DOI 10.1523/JNEUROSCI.20-17-06517.2000; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Makino M, 2002, EXP CELL RES, V277, P95, DOI 10.1006/excr.2002.5540; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; Nielsen PK, 2000, J BIOL CHEM, V275, P14517, DOI 10.1074/jbc.275.19.14517; Nomizu M, 1997, J BIOL CHEM, V272, P32198, DOI 10.1074/jbc.272.51.32198; Nomizu M, 1998, J BIOL CHEM, V273, P32491, DOI 10.1074/jbc.273.49.32491; NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583; Nomizu M, 2000, ARCH BIOCHEM BIOPHYS, V378, P311, DOI 10.1006/abbi.2000.1828; Okabe T, 2001, CHEM PHYS LETT, V335, P435, DOI 10.1016/S0009-2614(01)00055-0; Okazaki I, 2002, J BIOL CHEM, V277, P37070, DOI 10.1074/jbc.M201672200; Pande VS, 1999, P NATL ACAD SCI USA, V96, P9062, DOI 10.1073/pnas.96.16.9062; Powell SK, 1997, INT J BIOCHEM CELL B, V29, P401, DOI 10.1016/S1357-2725(96)00110-0; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Ramadhani D, 2012, ACTA HISTOCHEM CYTOC, V45, P309, DOI 10.1267/ahc.12028; Sasaki T, 2004, J CELL BIOL, V164, P959, DOI 10.1083/jcb.200401058; Singh G, 2007, NIC SERIES, V36, P275; Suzuki N, 2003, J BIOL CHEM, V278, P45697, DOI 10.1074/jbc.M304667200; Tisi D, 2000, EMBO J, V19, P1432, DOI 10.1093/emboj/19.7.1432; Umezawa K, 2009, BIOPOLYMERS, V92, P124, DOI 10.1002/bip.21148; Utani A, 2001, J BIOL CHEM, V276, P28779, DOI 10.1074/jbc.M101420200; Yamada H, 2013, PEPTIDE SCI, V2012, P339; Yamada H, 2014, JPS C P, V1; Yamada H, 2012, PEPTIDE SCI, V2011, P201; YAMADA KM, 1991, J BIOL CHEM, V266, P12809; Yamada Yoshihiko, 1992, Current Opinion in Cell Biology, V4, P819, DOI 10.1016/0955-0674(92)90105-L; Yamaguchi H, 2000, J BIOL CHEM, V275, P29458, DOI 10.1074/jbc.M003103200; Zhang W, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2056540; Zhou RH, 2004, J MOL GRAPH MODEL, V22, P451, DOI 10.1016/j.jmgm.2003.12.011; Zhou RH, 2001, P NATL ACAD SCI USA, V98, P14931, DOI 10.1073/pnas.201543998; ZIMMERMANN K, 1991, J COMPUT CHEM, V12, P310, DOI 10.1002/jcc.540120305	57	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149474	10.1371/journal.pone.0149474	http://dx.doi.org/10.1371/journal.pone.0149474			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26889829	Green Submitted, Green Published, gold			2022-12-27	WOS:000371221500050
J	Ding, T; Case, KA; Omolo, MA; Reiland, HA; Metz, ZP; Diao, XY; Baumler, DJ				Ding, Tong; Case, Kyle A.; Omolo, Morrine A.; Reiland, Holly A.; Metz, Zachary P.; Diao, Xinyu; Baumler, David J.			Predicting Essential Metabolic Genome Content of Niche-Specific Enterobacterial Human Pathogens during Simulation of Host Environments	PLOS ONE			English	Article							ESCHERICHIA-COLI; RECONSTRUCTIONS	Microorganisms have evolved to occupy certain environmental niches, and the metabolic genes essential for growth in these locations are retained in the genomes. Many microorganisms inhabit niches located in the human body, sometimes causing disease, and may retain genes essential for growth in locations such as the bloodstream and urinary tract, or growth during intracellular invasion of the hosts' macrophage cells. Strains of Escherichia coli (E. coli) and Salmonella spp. are thought to have evolved over 100 million years from a common ancestor, and now cause disease in specific niches within humans. Here we have used a genome scale metabolic model representing the pangenome of E. coli which contains all metabolic reactions encoded by genes from 16 E. coli genomes, and have simulated environmental conditions found in the human bloodstream, urinary tract, and macrophage to determine essential metabolic genes needed for growth in each location. We compared the predicted essential genes for three E. coli strains and one Salmonella strain that cause disease in each host environment, and determined that essential gene retention could be accurately predicted using this approach. This project demonstrated that simulating human body environments such as the bloodstream can successfully lead to accurate computational predictions of essential/important genes.	[Ding, Tong; Case, Kyle A.; Omolo, Morrine A.; Reiland, Holly A.; Metz, Zachary P.; Diao, Xinyu; Baumler, David J.] Univ Minnesota Twin Cities, Dept Food Sci & Nutr, St Paul, MN USA; [Baumler, David J.] Univ Minnesota Twin Cities, Microbial & Plant Genom Inst, St Paul, MN USA; [Baumler, David J.] Univ Minnesota Twin Cities, Inst Biotechnol, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Baumler, DJ (corresponding author), Univ Minnesota Twin Cities, Dept Food Sci & Nutr, St Paul, MN USA.; Baumler, DJ (corresponding author), Univ Minnesota Twin Cities, Microbial & Plant Genom Inst, St Paul, MN USA.; Baumler, DJ (corresponding author), Univ Minnesota Twin Cities, Inst Biotechnol, St Paul, MN USA.	dbaumler@umn.edu			Department of Food Science and Nutrition at the University of Minnesota-Twin Cities; College of Food, Agricultural and Natural Resource Sciences at the University of Minnesota-Twin Cities; Global Food Ventures Graduate Student Fellowship from the University of Minnesota-Twin Cities; Schlumberger Faculty for the Future Graduate Student Fellowship	Department of Food Science and Nutrition at the University of Minnesota-Twin Cities; College of Food, Agricultural and Natural Resource Sciences at the University of Minnesota-Twin Cities; Global Food Ventures Graduate Student Fellowship from the University of Minnesota-Twin Cities; Schlumberger Faculty for the Future Graduate Student Fellowship(Schlumberger)	We would also like to thank Dr(s). William R. Harcombe, Guy Plunkett III, Bob Mau, and Eric Cabot for insightful discussions regarding gene essentiality within the genomes of members of the family Enterobacteriaceae. This work was partially funded by the Department of Food Science and Nutrition and the College of Food, Agricultural and Natural Resource Sciences at the University of Minnesota-Twin Cities (DJB), and partially by the Global Food Ventures Graduate Student Fellowship from the University of Minnesota-Twin Cities (ZPM), and the Schlumberger Faculty for the Future Graduate Student Fellowship (MAO).	Baumler DJ, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-46; Baumler DJ, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-182; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; Glasner JD, 2006, NUCLEIC ACIDS RES, V34, pD41, DOI 10.1093/nar/gkj164; KEITEL HG, 1955, BLOOD, V10, P370, DOI 10.1182/blood.V10.4.370.370; Monk JM, 2013, P NATL ACAD SCI USA, V110, P20338, DOI 10.1073/pnas.1307797110; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Pal C, 2006, NATURE, V440, P667, DOI 10.1038/nature04568; Putnam D.F., 1971, COMPOSITION CONCENTR; Raghunathan A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-38; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Reiland HA, 2014, ADV MICROBIOLOGY, V4, P7; Russo TA, 2003, MICROBES INFECT, V5, P449, DOI 10.1016/S1286-4579(03)00049-2	16	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149423	10.1371/journal.pone.0149423	http://dx.doi.org/10.1371/journal.pone.0149423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885654	Green Published, gold, Green Submitted			2022-12-27	WOS:000371218400081
J	Even, Y; Escande, ML; Fayet, C; Geneviere, AM				Even, Yasmine; Escande, Marie-Line; Fayet, Claire; Geneviere, Anne-Marie			CDK13, a Kinase Involved in Pre-mRNA Splicing, Is a Component of the Perinucleolar Compartment	PLOS ONE			English	Article							TRACT-BINDING PROTEIN; POLYMERASE-III TRANSCRIPTS; CYCLIN-DEPENDENT KINASES; INTRANUCLEAR DISTRIBUTION; MYOTONIC-DYSTROPHY; K/CDK12 COMPLEX; HNRNP-I; CANCER; PTB; DNA	The perinucleolar compartment (PNC) is a subnuclear stucture forming predominantly in cancer cells; its prevalence positively correlates with metastatic capacity. Although several RNA-binding proteins have been characterized in PNC, the molecular function of this compartment remains unclear. Here we demonstrate that the cyclin-dependent kinase 13 (CDK13) is a newly identified constituent of PNC. CDK13 is a kinase involved in the regulation of gene expression and whose overexpression was found to alter pre-mRNA processing. In this study we show that CDK13 is enriched in PNC and co-localizes all along the cell cycle with the PNC component PTB. In contrast, neither the cyclins K and L, known to associate with CDK13, nor the potential kinase substrates accumulate in PNC. We further show that CDK13 overexpression increases PNC prevalence suggesting that CDK13 may be determinant for PNC formation. This result linked to the finding that CDK13 gene is amplified in different types of cancer indicate that this kinase can contribute to cancer development in human.	[Even, Yasmine; Escande, Marie-Line; Fayet, Claire; Geneviere, Anne-Marie] Univ Paris 06, Sorbonne Univ, CNRS, BIOM,Observ Oceanol, F-66650 Banyuls Sur Mer, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Geneviere, AM (corresponding author), Univ Paris 06, Sorbonne Univ, CNRS, BIOM,Observ Oceanol, F-66650 Banyuls Sur Mer, France.	anne-marie.geneviere@obs-banyuls.fr			Cancer Research foundation, "Association pour la Recherche sur le Cancer" [ARC 5290]; Cancer Research foundation, "Ligue contre le cancer" Languedoc-Roussillon (LR); Fondation pour la Recherche Medicale; "Ligue contre le cancer" LR; Soroptimist	Cancer Research foundation, "Association pour la Recherche sur le Cancer"; Cancer Research foundation, "Ligue contre le cancer" Languedoc-Roussillon (LR); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); "Ligue contre le cancer" LR; Soroptimist	This work was funded by grants from Cancer Research foundations, "Association pour la Recherche sur le Cancer" (ARC 5290), and "Ligue contre le cancer" Languedoc-Roussillon (LR). Y. Even received short-term fellowships from the "Fondation pour la Recherche Medicale", "Ligue contre le cancer" LR and Soroptimist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari D, 2015, J CANCER RES CLIN, V141, P369, DOI 10.1007/s00432-014-1817-x; Ball LJ, 2005, ANGEW CHEM INT EDIT, V44, P2852, DOI 10.1002/anie.200400618; Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; Berro R, 2008, J VIROL, V82, P7155, DOI 10.1128/JVI.02543-07; BIGGIOGERA M, 1990, DEVELOPMENT, V110, P1263; Blazek D, 2012, CELL CYCLE, V11, P1049, DOI 10.4161/cc.11.6.19678; Blazek D, 2011, GENE DEV, V25, P2158, DOI 10.1101/gad.16962311; Bubulya PA, 2004, J CELL BIOL, V167, P51, DOI 10.1083/jcb.200404120; Cao LH, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-10; Chen HR, 2014, EXP NEUROL, V261, P10, DOI 10.1016/j.expneurol.2014.06.024; Chen HH, 2007, BIOCHEM BIOPH RES CO, V354, P735, DOI 10.1016/j.bbrc.2007.01.049; Chen TP, 1999, MOL BIOL CELL, V10, P3015, DOI 10.1091/mbc.10.9.3015; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; Dai Q, 2012, J BIOL CHEM, V287, P25344, DOI 10.1074/jbc.M111.321760; Duncan PI, 1998, EXP CELL RES, V241, P300, DOI 10.1006/excr.1998.4083; Even Y, 2006, J CELL BIOCHEM, V99, P890, DOI 10.1002/jcb.20986; Fernandez-Guerra A, 2006, DEV BIOL, V300, P238, DOI 10.1016/j.ydbio.2006.09.012; Galbraith MD, 2010, TRANSCR-AUSTIN, V1, P4, DOI 10.4161/trns.1.1.12373; GHETTI A, 1992, NUCLEIC ACIDS RES, V20, P3671, DOI 10.1093/nar/20.14.3671; Gromak N, 2003, EMBO J, V22, P6356, DOI 10.1093/emboj/cdg609; Guen VJ, 2013, P NATL ACAD SCI USA, V110, P19525, DOI 10.1073/pnas.1306814110; Harfmann AM, 1999, MOL BIOL CELL, V10, P3909, DOI 10.1091/mbc.10.11.3909; Hernandez-Verdun D, 2002, J CELL SCI, V115, P2265; Hu DL, 2003, J BIOL CHEM, V278, P8623, DOI 10.1074/jbc.M210057200; Huang S, 1997, J CELL BIOL, V137, P965, DOI 10.1083/jcb.137.5.965; Huang S, 2000, J STRUCT BIOL, V129, P233, DOI 10.1006/jsbi.2000.4247; Kamath RV, 2005, CANCER RES, V65, P246; Kim HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043223; Kohoutek J, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-12; Li PL, 2013, CHIN RES PERSP SOC, V1, P1; Liang K, 2015, MOL CELL BIOL, V35, P928, DOI 10.1128/MCB.01426-14; LIN CH, 1995, RNA, V1, P234; Loyer P, 2008, J BIOL CHEM, V283, P7721, DOI 10.1074/jbc.M708188200; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Mao YTS, 2011, TRENDS GENET, V27, P295, DOI 10.1016/j.tig.2011.05.006; Marques F, 2000, BIOCHEM BIOPH RES CO, V279, P832, DOI 10.1006/bbrc.2000.4042; MATERA AG, 1995, J CELL BIOL, V129, P1181, DOI 10.1083/jcb.129.5.1181; Norton JT, 2008, CANCER-AM CANCER SOC, V113, P861, DOI 10.1002/cncr.23632; Norton JT, 2009, J BIOL CHEM, V284, P4090, DOI 10.1074/jbc.M807255200; OCHS RL, 1985, BIOL CELL, V54, P123, DOI 10.1111/j.1768-322X.1985.tb00387.x; PATTON JG, 1991, GENE DEV, V5, P1237, DOI 10.1101/gad.5.7.1237; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Pollock C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000679; RASKA I, 1989, BIOL CELL, V65, P79, DOI 10.1016/0248-4900(89)90013-0; Rodgers JT, 2010, CELL METAB, V11, P23, DOI 10.1016/j.cmet.2009.11.006; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Shepard PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-242; Shin C, 2004, NAT REV MOL CELL BIO, V5, P727, DOI 10.1038/nrm1467; Sleeman JE, 1999, CURR OPIN CELL BIOL, V11, P372, DOI 10.1016/S0955-0674(99)80052-0; Soret J, 2003, Prog Mol Subcell Biol, V31, P89; Valcarcel J, 1997, CURR BIOL, V7, pR705, DOI 10.1016/S0960-9822(06)00361-7; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Wang C, 2003, MOL BIOL CELL, V14, P2425, DOI 10.1091/mbc.E02-12-0818	54	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149184	10.1371/journal.pone.0149184	http://dx.doi.org/10.1371/journal.pone.0149184			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886422	gold, Green Published			2022-12-27	WOS:000371218400065
J	Liu, ZY; Brown, A; Fisher, D; Wu, YM; Warren, J; Cui, XX				Liu, Zhenyi; Brown, Andrew; Fisher, Dan; Wu, Yumei; Warren, Joe; Cui, Xiaoxia			Tissue Specific Expression of Cre in Rat Tyrosine Hydroxylase and Dopamine Active Transporter-Positive Neurons	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; MESSENGER-RNA EXPRESSION; GENE KNOCKOUT RATS; HOMOLOGOUS RECOMBINATION; PROGRAMMABLE NUCLEASES; BRAIN; MICROINJECTION; ESTABLISHMENT; CRISPR/CAS9; BLASTOCYSTS	The rat is a preferred model system over the mouse for neurological studies, and cell type-specific Cre expression in the rat enables precise ablation of gene function in neurons of interest, which is especially valuable for neurodegenerative disease modeling and optogenetics. Yet, few such Cre rats are available. Here we report the characterization of two Cre rats, tyrosine hydroxylase (TH)-Cre and dopamine active transporter (DAT or Slc6a3)-Cre, by using a combination of immunohistochemistry (IHC) and mRNA fluorescence in situ hybridization (FISH) as well as a fluorescent reporter for Cre activity. We detected Cre expression in expected neurons in both Cre lines. Interestingly, we also found that in Th-Cre rats, but not DAT-Cre rats, Cre is expressed in female germ cells, allowing germline excision of the floxed allele and hence the generation of whole-body knockout rats. In summary, our data demonstrate that targeted integration of Cre cassette lead to faithful recapitulation of expression pattern of the endogenous promoter, and mRNA FISH, in addition to IHC, is an effective method for the analysis of the spatiotemporal gene expression patterns in the rat brain, alleviating the dependence on high quality antibodies that are often not available against rat proteins. The Th-Cre and the DAT-Cre rat lines express Cre in selective subsets of dopaminergic neurons and should be particularly useful for researches on Parkinson's disease.	[Liu, Zhenyi; Brown, Andrew; Fisher, Dan; Wu, Yumei; Warren, Joe; Cui, Xiaoxia] SAGE Labs, St Louis, MO USA		Cui, XX (corresponding author), SAGE Labs, St Louis, MO USA.	xiaoxia.cui@horizondiscovery.com						Beck IM, 2015, TRANSGENIC RES, V24, P179, DOI 10.1007/s11248-014-9856-2; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Brown AJ, 2013, NAT METHODS, V10, P638, DOI 10.1038/nmeth.2516; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; CERRUTI C, 1993, MOL BRAIN RES, V18, P181, DOI 10.1016/0169-328X(93)90187-T; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FUJITA M, 1993, MOL BRAIN RES, V19, P222, DOI 10.1016/0169-328X(93)90031-J; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; GALL CM, 1987, J COMP NEUROL, V266, P307, DOI 10.1002/cne.902660302; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Iannaccone PM, 2009, DIS MODEL MECH, V2, P206, DOI 10.1242/dmm.002733; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Liu ZY, 2015, DEVELOPMENT, V142, P1193, DOI 10.1242/dev.119529; Liu ZY, 2013, DEV CELL, V25, P585, DOI 10.1016/j.devcel.2013.05.022; Liu ZY, 2011, J CLIN INVEST, V121, P800, DOI 10.1172/JCI43114; Ma YW, 2014, FEBS J, V281, P3779, DOI 10.1111/febs.12935; Ma YW, 2014, CELL RES, V24, P122, DOI 10.1038/cr.2013.157; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Nagatsu T, 1995, ESSAYS BIOCHEM, V30, P15; Nunes I, 2003, P NATL ACAD SCI USA, V100, P4245, DOI 10.1073/pnas.0230529100; Sato Y, 2004, BIOCHEM BIOPH RES CO, V319, P1197, DOI 10.1016/j.bbrc.2004.04.204; Satoh A, 2010, J NEUROSCI, V30, P10220, DOI 10.1523/JNEUROSCI.1385-10.2010; Schonig K, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-77; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Tong C, 2011, NAT PROTOC, V6, P827, DOI 10.1038/nprot.2011.338; Tong C, 2010, NATURE, V467, P211, DOI 10.1038/nature09368; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Vooijs M, 2007, DEVELOPMENT, V134, P535, DOI 10.1242/dev.02733; Weber T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028283; Winkeler CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042005; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Zhang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082818	41	15	15	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149379	10.1371/journal.pone.0149379	http://dx.doi.org/10.1371/journal.pone.0149379			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886559	Green Submitted, gold, Green Published			2022-12-27	WOS:000371218400077
J	Tallman, M				Tallman, Melissa			Shape Ontogeny of the Distal Femur in the Hominidae with Implications for the Evolution of Bipedality	PLOS ONE			English	Article							T-BOX GENES; LOWLAND GORILLAS; KNUCKLE-WALKING; GREAT APES; HOX GENES; HINDLIMB; TBX5; PITX1; HETEROCHRONY; MORPHOLOGY	Heterochrony has been invoked to explain differences in the morphology of modern humans as compared to other great apes. The distal femur is one area where heterochrony has been hypothesized to explain morphological differentiation among Plio-Pleistocene hominins. This hypothesis is evaluated here using geometric morphometric data to describe the ontogenetic shape trajectories of extant hominine distal femora and place Plio-Pleistocene hominins within that context. Results of multivariate statistical analyses showed that in both Homo and Gorilla, the shape of the distal femur changes significantly over the course of development, whereas that of Pan changes very little. Development of the distal femur of Homo is characterized by an elongation of the condyles, and a greater degree of enlargement of the medial condyle relative to the lateral condyle, whereas Gorilla are characterized by a greater degree of enlargement of the lateral condyle, relative to the medial. Early Homo and Australopithecus africanus fossils fell on the modern human ontogenetic shape trajectory and were most similar to either adult or adolescent modern humans while specimens of Australopithecus afarensis were more similar to Gorilla/Pan. These results indicate that shape differences among the distal femora of Plio-Pleistocene hominins and humans cannot be accounted for by heterochrony alone; heterochrony could explain a transition from the distal femoral shape of early Homo/A. africanus to modern Homo, but not a transition from A. afarensis to Homo. That change could be the result of genetic or epigenetic factors.	[Tallman, Melissa] Grand Valley State Univ, Dept Biomed Sci, Allendale, MI 49401 USA	Grand Valley State University	Tallman, M (corresponding author), Grand Valley State Univ, Dept Biomed Sci, Allendale, MI 49401 USA.	tallmame@gvsu.edu	Tallman, Melissa/H-3189-2019	Tallman, Melissa/0000-0003-3747-5600	Wenner-Gren Grant [7515]; National Science Foundation Doctoral Dissertation Improvement Grant [0550901]	Wenner-Gren Grant; National Science Foundation Doctoral Dissertation Improvement Grant(National Science Foundation (NSF))	This work was supported by Wenner-Gren Grant 7515 and the National Science Foundation Doctoral Dissertation Improvement Grant 0550901. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Agarwal P, 2003, DEVELOPMENT, V130, P623, DOI 10.1242/dev.00191; Ahn DG, 2002, NATURE, V417, P754, DOI 10.1038/nature00814; ALBERCH P, 1979, PALEOBIOLOGY, V5, P296, DOI 10.1017/S0094837300006588; Bastir M, 2007, P ROY SOC B-BIOL SCI, V274, P1125, DOI 10.1098/rspb.2006.0448; Berge C, 1996, NATO ADV SCI INST SE, V284, P441; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; BROMAGE TG, 1987, J HUM EVOL, V16, P257, DOI 10.1016/0047-2484(87)90002-9; Capellini TD, 2012, AM J PHYS ANTHROPOL, V147, P111; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Dainton M, 1999, J HUM EVOL, V36, P171, DOI 10.1006/jhev.1998.0265; DeLaurier A, 2006, DEV BIOL, V299, P22, DOI 10.1016/j.ydbio.2006.06.055; Doran D, 1996, APE SOC, P213; Doran DM, 1997, J HUM EVOL, V32, P323, DOI 10.1006/jhev.1996.0095; Erlacher L, 1998, J BONE MINER RES, V13, P383, DOI 10.1359/jbmr.1998.13.3.383; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; GibsonBrown JJ, 1996, MECH DEVELOP, V56, P93, DOI 10.1016/0925-4773(96)00514-X; Godfrey LR, 1996, AM J PHYS ANTHROPOL, V99, P17, DOI 10.1002/ajpa.1330990102; Gordon AR, 2010, HUMAN ORIGINS DATABA; Gould S. J., 1977, ONTOGENY PHYLOGENY; Hasson P, 2010, DEV CELL, V18, P148, DOI 10.1016/j.devcel.2009.11.013; HEIPLE KG, 1971, AM J PHYS ANTHROPOL, V35, P75, DOI 10.1002/ajpa.1330350109; Hotten GC, 1996, GROWTH FACTORS, V13, P65, DOI 10.3109/08977199609034567; INOUYE SE, 1994, J HUM EVOL, V26, P459, DOI 10.1006/jhev.1994.1028; Johanson DC, 1978, NEW SPECIES GENUS AU, V28; KETTELKAMP DB, 1973, ARCH SURG-CHICAGO, V107, P406; Kim K, 2002, PALEOBIOLOGY, V28, P364, DOI 10.1666/0094-8373(2002)028<0364:MAOOAA>2.0.CO;2; Kivell TL, 2009, P NATL ACAD SCI USA, V106, P14241, DOI 10.1073/pnas.0901280106; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Kmita M, 2005, NATURE, V435, P1113, DOI 10.1038/nature03648; Lague MR, 2002, J HUM EVOL, V42, P609, DOI 10.1006/jhev.2002.0545; LEAKEY REF, 1973, NATURE, V242, P447, DOI 10.1038/242447a0; Logan M, 1999, SCIENCE, V283, P1736, DOI 10.1126/science.283.5408.1736; Lovejoy CO, 2007, GAIT POSTURE, V25, P325, DOI 10.1016/j.gaitpost.2006.05.001; Lovejoy CO, 1999, P NATL ACAD SCI USA, V96, P13247, DOI 10.1073/pnas.96.23.13247; LOVEJOY CO, 1988, SCI AM, V259, P118, DOI 10.1038/scientificamerican1188-118; Marcil A, 2003, DEVELOPMENT, V130, P45, DOI 10.1242/dev.00192; McDougall I, 2008, J GEOL SOC LONDON, V165, P549, DOI 10.1144/0016-76492006-170; MCNAMARA KJ, 1986, J PALEONTOL, V60, P4, DOI 10.1017/S0022336000021454; McNulty K. P., 2003, THESIS CITY U NEW YO; Merino R, 1999, DEV BIOL, V206, P33, DOI 10.1006/dbio.1998.9129; Minguillon C, 2005, DEV CELL, V8, P75, DOI 10.1016/j.devcel.2004.11.013; Mitteroecker P, 2005, EVOL DEV, V7, P244, DOI 10.1111/j.1525-142X.2005.05027.x; Mitteroecker P, 2004, J HUM EVOL, V46, P679, DOI 10.1016/j.jhevol.2004.03.006; Naiche LA, 2003, DEVELOPMENT, V130, P2681, DOI 10.1242/dev.00504; Preuschoft H, 1996, FOLIA PRIMATOL, V66, P82, DOI 10.1159/000157187; Rallis C, 2003, DEVELOPMENT, V130, P2741, DOI 10.1242/dev.00473; REMIS M, 1995, AM J PHYS ANTHROPOL, V97, P413, DOI 10.1002/ajpa.1330970408; Remis MJ, 1998, PRIMATE LOCOMOTION, P95; Robinson J.T., 1972, EARLY HOMINID POSTUR; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; Ross SR, 2006, APPL ANIM BEHAV SCI, V96, P143, DOI 10.1016/j.applanim.2005.06.005; RUFF C, 1988, J HUM EVOL, V17, P687, DOI 10.1016/0047-2484(88)90025-5; Ruvinsky I, 2000, DEV GENES EVOL, V210, P82, DOI 10.1007/s004270050014; Senut B., 1985, P193; SHEA BT, 1985, AM J PRIMATOL, V8, P183, DOI 10.1002/ajp.1350080208; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; SMITH BH, 1991, AM J PHYS ANTHROPOL, V86, P157, DOI 10.1002/ajpa.1330860206; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; Storm EE, 1999, DEV BIOL, V209, P11, DOI 10.1006/dbio.1999.9241; Susman RL, 2001, J HUM EVOL, V41, P607, DOI 10.1006/jhev.2001.0510; Szeto DP, 1999, GENE DEV, V13, P484, DOI 10.1101/gad.13.4.484; TABIN C, 1993, NATURE, V361, P692, DOI 10.1038/361692a0; Tallman M, 2010, THESIS CITY U NEW YO; Tallman M, 2013, ANAT REC, V296, P290, DOI 10.1002/ar.22624; Tardieu C, 1998, AM J PHYS ANTHROPOL, V107, P163; Tardieu C, 1999, AM J PHYS ANTHROPOL, V110, P365, DOI 10.1002/(SICI)1096-8644(199911)110:3<365::AID-AJPA8>3.0.CO;2-T; Tardieu C, 1997, CR ACAD SCI II A, V325, P899, DOI 10.1016/S1251-8050(99)80191-8; Torchia, 1998, DEV HUMAN CLIN ORIEN; Turley K, 2014, AM J PHYS ANTHROPOL, V154, P447, DOI 10.1002/ajpa.22528; Vrba ES, 1996, J ANTHROPOL RES, V52, P1; Walker Alan, 1993, P63; Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049; Zelditch ML, 2000, EVOLUTION, V54, P1363; [No title captured]	75	9	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148371	10.1371/journal.pone.0148371	http://dx.doi.org/10.1371/journal.pone.0148371			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886416	Green Published, gold			2022-12-27	WOS:000371218400032
J	Xu, WF; Li, HZ; Ji, ZG; Yan, WG; Zhang, YS; Zhang, XB; Li, Q				Xu, Weifeng; Li, Hanzhong; Ji, Zhigang; Yan, Weigang; Zhang, Yushi; Zhang, Xuebin; Li, Qian			Retroperitoneal Laparoscopic Management of Paraganglioma: A Single Institute Experience	PLOS ONE			English	Article							OPEN ADRENALECTOMY; PHEOCHROMOCYTOMA; RESECTION; OUTCOMES	Objectives To explore the feasibility and safety of retroperitoneal laparoscopic resection of paraganglioma (RLPG) in a large study population. Methods In a six-year period, 49 patients with primary retroperitoneal paragangliomas (PG) underwent retroperitoneal laparoscopic surgery in a single center. Medical records were reviewed, and collected the following data, which were clinical characteristics, perioperative data (operative time, estimated blood loss, intraoperative hemodynamic changes, intraoperative and postoperative complications, and open conversions), and follow-up data (recurrence or distant metastases). Results All PGs were removed with negative tumor margin confirmed by postoperative histopathology. The operative time of RLPG was 101.59 +/- 31.12 minutes, and the estimated blood loss was 169.78 +/- 176.70ml. Intraoperative hypertensive and hypotensive episodes occurred in 25 cases and 27 cases, respectively. Two open conversions occurred. Two intraoperative complications occurred but were successfully managed endoscopically. Postoperative complications were minor and unremarkable. No local recurrence or distant metastasis were observed during the follow-up period. Conclusions Our experience indicates the feasibility and safety of resection of PGs in a relatively large study population.	[Xu, Weifeng; Li, Hanzhong; Ji, Zhigang; Yan, Weigang; Zhang, Yushi; Zhang, Xuebin] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Urol, Beijing 100730, Peoples R China; [Li, Qian] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiol, Boston, MA USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Li, HZ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Urol, Beijing 100730, Peoples R China.	windslipper@163.com	Li, Qian/J-5883-2019	Li, Qian/0000-0001-8827-939X; Yan, Weigang/0000-0002-8995-1456				Bhandarkar D, 2012, SURG LAPARO ENDO PER, V22, pE148, DOI 10.1097/SLE.0b013e318248be1c; Chai YJ, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/918346; Conzo G, 2013, INT J SURG, V11, P152, DOI 10.1016/j.ijsu.2012.12.007; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Disick Grant I S, 2007, Curr Urol Rep, V8, P83, DOI 10.1007/s11934-007-0025-5; Goers TA, 2013, SURG ENDOSC, V27, P428, DOI 10.1007/s00464-012-2451-9; Hattori S, 2014, J ENDOUROL, V28, P686, DOI 10.1089/end.2013.0706; Hisano M, 2012, CLINICS, V67, P161, DOI 10.6061/clinics/2012(Sup01)27; Lang B, 2008, J UROLOGY, V179, P57, DOI 10.1016/j.juro.2007.08.147; Li HZ, 2011, UROLOGY, V77, P131, DOI 10.1016/j.urology.2010.03.094; Li QY, 2010, J ENDOUROL, V24, P1441, DOI 10.1089/end.2010.0065; Nozaki T, 2013, J ENDOUROL, V27, P862, DOI 10.1089/end.2012.0745; ORiordain DS, 1996, WORLD J SURG, V20, P916, DOI 10.1007/s002689900139; Solorzano CC, 2007, ANN SURG ONCOL, V14, P3004, DOI 10.1245/s10434-007-9489-2; Thapar PM, 2006, J LAPAROENDOSC ADV S, V16, P620, DOI 10.1089/lap.2006.16.620; Tiberio GAM, 2008, SURG ENDOSC, V22, P1435, DOI 10.1007/s00464-008-9904-1; Tiyadath BN, 2007, ASIAN J SURG, V30, P244, DOI 10.1016/S1015-9584(08)60033-0; Tobias-Machado Marcos, 2006, Arch Esp Urol, V59, P49; Walz MK, 2006, WORLD J SURG, V30, P899, DOI 10.1007/s00268-005-0373-6; Walz MK, 2002, WORLD J SURG, V26, P1005, DOI 10.1007/s00268-002-6632-x; Wang JJ, 2014, J ENDOUROL, V28, P1345, DOI 10.1089/end.2014.0345; Yankovic F, 2014, J PEDIATR UROL, V10, DOI 10.1016/j.jpurol.2013.10.024; Zacharias M, 2006, EUR UROL, V49, P448, DOI 10.1016/j.eururo.2006.01.014	23	20	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149433	10.1371/journal.pone.0149433	http://dx.doi.org/10.1371/journal.pone.0149433			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885838	Green Submitted, Green Published, gold			2022-12-27	WOS:000371218400082
J	Feinberg, I; Frijters, J; Johnson-Lawrence, V; Greenberg, D; Nightingale, E; Moodie, C				Feinberg, Iris; Frijters, Jan; Johnson-Lawrence, Vicki; Greenberg, Daphne; Nightingale, Elena; Moodie, Chelsea			Examining Associations between Health Information Seeking Behavior and Adult Education Status in the US: An Analysis of the 2012 PIAAC Data	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; DECISION-MAKING; LITERACY; COMMUNICATION; CHALLENGES; INTERNET; SKILLS; CARE; ATTITUDES; ABILITY	This paper presents data from the Program for the International Assessment of Adult Competencies with a focus on the interrelationships among health information seeking behavior (HISB), and health status or use of preventive health measures for U.S. adults both with and without a high school diploma. Key results of ordinal and binary logistic regression analyses indicated that, after controlling for demographic factors, (1) adults with a high school diploma use more text-based health information sources while adults without a high school diploma use more oral sources, (2) using the Internet as a source of health information is more strongly related to reporting excellent/very good health status than having a high school diploma, (3) those without a high school diploma who use the Internet report the largest increase in health status over any other health information source, and (4) for those with learning disability or vision problem, a high facility in reading English is an important predictor of whether the Internet is used as a health information source. The Internet appears to play a key role in both enhancing health status and enabling use of preventive measures for those with and without a high school diploma; although, individuals without a high school diploma who use the Internet for health information derive substantial benefit in health status.	[Feinberg, Iris] Georgia State Univ, Coll Educ & Human Dev, Adult Literacy Res Ctr, Atlanta, GA 30303 USA; [Frijters, Jan] Brock Univ, Child & Youth Studies, Toronto, ON, Canada; [Johnson-Lawrence, Vicki] Univ Michigan, Publ Hlth & Hlth Sci, Flint, MI 48503 USA; [Greenberg, Daphne] Georgia State Univ, Educ Psychol Special Educ & Commun Disorders, Atlanta, GA 30303 USA; [Nightingale, Elena; Moodie, Chelsea] Georgia State Univ, Ctr Study Adult Literacy, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University; Brock University; University of Michigan System; University of Michigan; University of Michigan Flint; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Feinberg, I (corresponding author), Georgia State Univ, Coll Educ & Human Dev, Adult Literacy Res Ctr, Atlanta, GA 30303 USA.	ifeinberg2@gsu.edu	Johnson-Lawrence, Vicki/G-8539-2014; Frijters, Jan/D-7329-2013	Johnson-Lawrence, Vicki/0000-0002-8582-3916; Frijters, Jan/0000-0001-5625-4892; Feinberg, Iris/0000-0002-2379-2501				Adler N., 2007, REACHING HLTH LIFE F; Adler NE, 1999, ANN NY ACAD SCI, V896, P3, DOI 10.1111/j.1749-6632.1999.tb08101.x; Altindag D, 2011, ECON EDUC REV, V30, P792, DOI 10.1016/j.econedurev.2010.10.003; Andrus MR, 2002, PHARMACOTHERAPY, V22, P282, DOI 10.1592/phco.22.5.282.33191; Anker AE, 2011, PATIENT EDUC COUNS, V82, P346, DOI 10.1016/j.pec.2010.12.008; Arozullah AM, 2007, MED CARE, V45, P1026, DOI 10.1097/MLR.0b013e3180616c1b; Baker D, 2007, SURG GEN WORKSH IMPR, P16; Baker DP, 2011, POPUL DEV REV, V37, P307, DOI 10.1111/j.1728-4457.2011.00412.x; Baker DW, 1997, AM J PUBLIC HEALTH, V87, P1027, DOI 10.2105/AJPH.87.6.1027; Baum S., 2013, ED PAYS; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentley T., 1998, LEARNING CLASSROOM E; Birru MS, 2004, J MED INTERNET RES, V6, P66, DOI 10.2196/jmir.6.3.e25; Bostock S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1602; Braveman P, 2011, ANNU REV PUBL HEALTH, V32, P381, DOI 10.1146/annurev-publhealth-031210-101218; Brodie M, 2000, HEALTH AFFAIR, V19, P255, DOI 10.1377/hlthaff.19.6.255; Brown SM, 2011, PATIENT EDUC COUNS, V83, P92, DOI 10.1016/j.pec.2010.04.027; Case DO., 2012, LOOKING INFORM SURVE, V3rd; Chandola T, 2006, J R STAT SOC A STAT, V169, P337, DOI 10.1111/j.1467-985X.2006.00411.x; Chervin C, 2012, HEALTH PROMOT PRACT, V13, P738, DOI 10.1177/1524839912437367; Collins JC, 2014, HLTH WELLNESS RACIAL, V142; Committee on Quality of Health Care in America, 2013, CROSSING QUALITY CHA; Coreil JM, 2009, SOCIAL BEHAV FDN PUB; Cutler David., 2006, NATL BUREAU EC RES W; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; Diehl S. J., 2011, NEW DIRECTIONS ADULT, V2011, P29, DOI [10.1002/ace.408, DOI 10.1002/ACE.408]; Duncan GJ, 2002, AM J PUBLIC HEALTH, V92, P1151, DOI 10.2105/AJPH.92.7.1151; Dutta-Bergman MJ, 2004, HEALTH COMMUN, V16, P273, DOI 10.1207/S15327027HC1603_1; Eide ER, 2011, ECON EDUC REV, V30, P778, DOI 10.1016/j.econedurev.2011.03.009; Eng TR, 1998, JAMA-J AM MED ASSOC, V280, P1371, DOI 10.1001/jama.280.15.1371; Epstein RM, 2005, SOC SCI MED, V61, P1516, DOI 10.1016/j.socscimed.2005.02.001; Fagerlin A, 2011, JNCI-J NATL CANCER I, V103, P1436, DOI 10.1093/jnci/djr318; FEINSTEIN JS, 1993, MILBANK Q, V71, P279, DOI 10.2307/3350401; Fletcher Jason M, 2009, J Hum Cap, V3, P144; Fox S, 2013, PEW RES INT PROJECT; Furuya Y, 2013, HLTH PROMOT INT; Ginde AA, 2012, ARCH INTERN MED, V172, P642, DOI 10.1001/archinternmed.2012.34; Gross M, 2012, J AM SOC INF SCI TEC, V63, P574, DOI 10.1002/asi.21681; Hayward MD, 2000, AM SOCIOL REV, V65, P910, DOI 10.2307/2657519; Hibbard JH, 2007, MED CARE RES REV, V64, P379, DOI 10.1177/1077558707301630; Hill LH, 2011, NEW DIRECTIONS ADULT, V130; House J.S, 2008, MAKING AM HLTH SOCIA; Houston TK, 2002, J MED INTERNET RES, V4, DOI 10.2196/jmir.4.2.e7; Interact for Health's Ohio Health Issues Poll (OHIP), 2014, SELF REP HLTH LINK I; Kiesler DJ, 2006, PATIENT EDUC COUNS, V61, P319, DOI 10.1016/j.pec.2005.08.002; Kontos Emily, 2014, J Med Internet Res, V16, pe172, DOI 10.2196/jmir.3117; Lambert SD, 2007, QUAL HEALTH RES, V17, P1006, DOI 10.1177/1049732307305199; Larrimore J, 2011, MILBANK Q, V89, P694, DOI 10.1111/j.1468-0009.2011.00647.x; Lee HY, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3576; Levinson W, 2005, J GEN INTERN MED, V20, P531, DOI 10.1111/j.1525-1497.2005.04101.x; Levy H, 2014, MED DECIS MAKING, V34, P107, DOI 10.1177/0272989X13493144; Manyika J., 2011, GREAT TRANSFORMER IM; Matsuyama RK, 2011, PATIENT EDUC COUNS, V85, pE229, DOI 10.1016/j.pec.2011.03.022; McCray AT, 2005, J AM MED INFORM ASSN, V12, P152, DOI 10.1197/jamia.M1687; Merriam S.B., 2011, PROFESSION PRACTICE; Miller EA, 2009, J HEALTH POLIT POLIC, V34, P261, DOI 10.1215/03616878-2008-046; National Center for Education Statistics, 2013, 2014008 NCES US DEP; Norman CD, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.2.e9; Norris P., 2001, DIGITAL DIVIDE CIVIC; North Carolina Institute of Medicine; North Carolina Division of Public Health, 2009, PREV HLTH N CAR PREV, P243; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; OECD, 2013, OECD SKILLS OUTL 201, P45, DOI 10.1787/9789264204256-5-en; Palsdottir A, 2009, INFORM RES, V14; PARKER RM, 1995, J GEN INTERN MED, V10, P537, DOI 10.1007/BF02640361; Percheski C, 2011, J AM COLL HEALTH, V59, P379, DOI 10.1080/07448481.2010.513406; PRINS E, 2014, HLTH WELLNESS RACIAL, V142, P25; Redding CA, 2000, INT ELECT J HLTH ED; Rogers RG, 2013, SOC SCI RES, V42, P465, DOI 10.1016/j.ssresearch.2012.09.003; ROSS CE, 1995, AM SOCIOL REV, V60, P719, DOI 10.2307/2096319; Roter DL, 2011, NURS OUTLOOK, V59, P79, DOI 10.1016/j.outlook.2010.11.005; Rothman RL, 2006, AM J PREV MED, V31, P391, DOI 10.1016/j.amepre.2006.07.025; Rubin D, 2014, ROUT HANDB APPL, P153; Salwen M, 2009, INTEGRATED APPROACH; Sambamoorthi U, 2003, PREV MED, V37, P475, DOI 10.1016/S0091-7435(03)00172-5; SCHILLING K, 1995, B MED LIBR ASSOC, V83, P176; Schuller T., 2004, BENEFITS LEARNING IM; Stowasser T, 2011, HLTH WEALTHY WISE RE; STRECHER VJ, 1986, HEALTH EDUC QUART, V13, P73, DOI 10.1177/109019818601300108; US Department of Commerce National Telecommunications and Information Administration, 2010, 21 CENT AM PROGR BRO; US Department of Education, PROGR AD ED GRANTS S; Voogt J, 2013, J COMPUT ASSIST LEAR, V29, P403, DOI 10.1111/jcal.12029; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4; Weiner S, 2011, ED LIB, V34; Williams DR, 2010, ANN NY ACAD SCI, V1186, P69, DOI 10.1111/j.1749-6632.2009.05339.x; Yi YJ, 2012, LIBR INFORM SCI RES, V34, P45, DOI 10.1016/j.lisr.2011.06.001; Yin HS, 2012, ACAD PEDIATR, V12, P117, DOI 10.1016/j.acap.2012.01.001	86	46	46	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148751	10.1371/journal.pone.0148751	http://dx.doi.org/10.1371/journal.pone.0148751			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3BP	26882339	gold, Green Published			2022-12-27	WOS:000371219000023
J	Ben Khalaf, N; Taha, S; Bakhiet, M; Fathallah, MD				Ben Khalaf, Noureddine; Taha, Safa; Bakhiet, Moiz; Fathallah, M. Dahmani			A Central Nervous System-Dependent Intron-Embedded Gene Encodes a Novel Murine Fyn Binding Protein	PLOS ONE			English	Article							TO-BRAIN COMMUNICATION; PREDICTION; PHOSPHORYLATION; SEQUENCE; IMMUNE	The interplay between the nervous and immune systems is gradually being unraveled. We previously reported in the mouse the novel soluble immune system factor ISRAA, whose activation in the spleen is central nervous system-dependent. We also showed that ISRAA plays a role in modulating anti-infection immunity. Herein, we report the genomic description of the israa locus, along with some insights into the structure-function relationship of the protein. Our findings revealed that israa is nested within intron 6 of the mouse zmiz1 gene. Protein sequence analysis revealed a typical SH2 binding motif (Y102TEV), with Fyn being the most likely binding partner. Docking simulation showed a favorable conformation for the ISRAA-Fyn complex, with a specific binding mode for the binding of the YTEV motif to the SH2 domain. Experimental studies showed that in vitro, recombinant ISRAA is phosphorylated by Fyn at tyrosine 102. Cell transfection and pull-down experiments revealed Fyn as a binding partner of ISRAA in the EL4 mouse T-cell line. Indeed, we demonstrated that ISRAA downregulates T-cell activation and the phosphorylation of an activation tyrosine (Y-416) of Src-family kinases in mouse splenocytes. Our observations highlight ISRAA as a novel Fyn binding protein that is likely to be involved in a signaling pathway driven by the nervous system.	[Ben Khalaf, Noureddine; Fathallah, M. Dahmani] Arabian Gulf Univ, Coll Postgrad Studies, Manama, Bahrain; [Ben Khalaf, Noureddine; Taha, Safa; Bakhiet, Moiz] HH Al Jawhara Ctr Mol Med & Inherited Dis, Manama, Bahrain	Arabian Gulf University	Fathallah, MD (corresponding author), Arabian Gulf Univ, Coll Postgrad Studies, Manama, Bahrain.	d.fathallahh@agu.edu.bh	Khalaf, Noureddine Ben/AAG-2650-2021	Khalaf, Noureddine Ben/0000-0001-7573-754X	Arabian Gulf University Research Division	Arabian Gulf University Research Division	This work was supported and funded by an internal grant from the Arabian Gulf University Research Division.	[Anonymous], PYMOL MOL GRAPH SYST; Bakhiet M, 2008, IMMUNOL CELL BIOL, V86, P688, DOI 10.1038/icb.2008.57; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; BLALOCK JE, 1989, PHYSIOL REV, V69, P1, DOI 10.1152/physrev.1989.69.1.1; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; COOKE M P, 1989, New Biologist, V1, P66; Dantzer R, 2004, BRAIN BEHAV IMMUN, V18, P1, DOI 10.1016/j.bbi.2003.09.008; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Goehler LE, 2000, AUTON NEUROSCI-BASIC, V85, P49, DOI 10.1016/S1566-0702(00)00219-8; GUTIERREZ EG, 1994, J NEUROIMMUNOL, V55, P153, DOI 10.1016/0165-5728(94)90005-1; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lenaerts T, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-43; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; MORRISON DA, 1977, J BACTERIOL, V132, P349, DOI 10.1128/JB.132.1.349-351.1977; Nachman J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011215; Neuberger G, 2003, J MOL BIOL, V328, P567, DOI 10.1016/S0022-2836(03)00318-8; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Pellicena P, 2001, J BIOL CHEM, V276, P28190, DOI 10.1074/jbc.M100055200; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Procaccini C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00143; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Saeed RW, 2005, J EXP MED, V201, P1113, DOI 10.1084/jem.20040463; Saito YD, 2010, CANCER-AM CANCER SOC, V116, P1629, DOI 10.1002/cncr.24879; Seykora JT, 2002, J BIOL CHEM, V277, P2812, DOI 10.1074/jbc.M106813200; van Gunsteren SRB W. F., 1996, BIOMOLECULAR SIMULAT; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; WATKINS LR, 1995, LIFE SCI, V57, P1011, DOI 10.1016/0024-3205(95)02047-M; Wiederstein M., 2007, NUCL ACIDS RES, V35, pW407, DOI DOI https://doi.org/10.1093/nar/gkm290	40	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149612	10.1371/journal.pone.0149612	http://dx.doi.org/10.1371/journal.pone.0149612			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901312	gold, Green Published, Green Submitted			2022-12-27	WOS:000371276100111
J	Chan, ACS; Qiu, Q; Choi, SW; Wong, SSC; Chan, ACY; Irwin, MG; Cheung, CW				Chan, Alfred Chor San; Qiu, Qiu; Choi, Siu Wai; Wong, Stanley Sau Ching; Chan, Albert Chi Yan; Irwin, Michael G.; Cheung, Chi Wai			Effects of Intra-Operative Total Intravenous Anaesthesia with Propofol versus Inhalational Anaesthesia with Sevoflurane on Post-Operative Pain in Liver Surgery: A Retrospective Case-Control Study	PLOS ONE			English	Article							PATIENT-CONTROLLED ANALGESIA; SPINAL-CORD; PHARMACOKINETICS; DESFLURANE; RECEPTORS; SELECTION; CIRRHOSIS; RESECTION; CHANNELS; MODEL	Background Patients receiving total intravenous anesthesia (TIVA) with propofol have been shown to experience less postoperative pain. We evaluated the post-operative analgesic effects of propofol compared with sevoflurane maintenance of anesthesia in liver surgery. This study was registered at ClinicalTrials.gov (NCT02179437). Methods In this retrospective study, records of patients who underwent liver surgery between 2010 and 2013 were reviewed. Ninety-five patients anesthetized with propofol TIVA were matched with 95 patients anesthetized with sevoflurane. Numeric pain rating scale (NRS) pain scores, postoperative morphine consumption, side effects and patients' satisfaction with pain relief were evaluated. Results The TIVA group reported lower NRS pain scores during coughing on postoperative days 1 and 2 but not 3 (p = 0.0127, p = 0.0472, p = 0.4556 respectively). They also consumed significantly less daily (p = 0.001 on day 1, p = 0.0231 on day 2, p = 0.0004 on day 3), accumulative (p = 0.001 on day 1, p < 0.0001 on day 2 and p = 0.0064 on day 3) and total morphine (p = 0.03) when compared with the sevoflurane group. There were no differences in total duration of intravenous patient controlled analgesia (PCA) morphine use and patient satisfaction. No difference was found in reported side effects. Conclusion Patients anesthetized with propofol TIVA reported less pain during coughing and consumed less daily, accumulative and total morphine after liver surgery.	[Chan, Alfred Chor San] Queen Mary Hosp, Dept Anaesthesiol, Hong Kong, Hong Kong, Peoples R China; [Qiu, Qiu; Choi, Siu Wai; Wong, Stanley Sau Ching; Irwin, Michael G.; Cheung, Chi Wai] Univ Hong Kong, Dept Anaesthesiol, Lab & Clin Res Inst Pain, Hong Kong, Hong Kong, Peoples R China; [Chan, Albert Chi Yan] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Cheung, CW (corresponding author), Univ Hong Kong, Dept Anaesthesiol, Lab & Clin Res Inst Pain, Hong Kong, Hong Kong, Peoples R China.	cheucw@hku.hk	Irwin, Michael Garnet/C-4286-2009; Chan, Albert/AAC-1642-2022; Irwin, Michael Garnet/GLR-9714-2022; /I-7963-2013	Irwin, Michael Garnet/0000-0001-5801-274X; Chan, Albert/0000-0002-1383-2952; Irwin, Michael Garnet/0000-0001-5801-274X; /0000-0002-8763-5687	Department of Anesthesiology at the University of Hong Kong	Department of Anesthesiology at the University of Hong Kong	This submission was funded by the Department of Anesthesiology at the University of Hong Kong. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An K, 2008, ANAESTHESIA, V63, P1187, DOI 10.1111/j.1365-2044.2008.05627.x; Antognini JF, 2000, CAN J ANAESTH, V47, P273, DOI 10.1007/BF03018926; Bandschapp O, 2010, ANESTHESIOLOGY, V113, P421, DOI 10.1097/ALN.0b013e3181e33ac8; Behne M, 1999, CLIN PHARMACOKINET, V36, P13, DOI 10.2165/00003088-199936010-00002; Breivik H, 2008, BRIT J ANAESTH, V101, P17, DOI 10.1093/bja/aen103; Chandok N, 2010, MAYO CLIN PROC, V85, P451, DOI 10.4065/mcp.2009.0534; Cheng SS, 2008, ANESTH ANALG, V106, P264, DOI 10.1213/01.ane.0000287653.77372.d9; Cheung CW, 2012, J ORAL MAXIL SURG, V70, P25, DOI 10.1016/j.joms.2011.03.056; Cheung CW, 2009, EUR J PAIN, V13, P464, DOI 10.1016/j.ejpain.2008.05.013; Cho AR, 2013, ANESTH ANALG, V116, P685, DOI 10.1213/ANE.0b013e31827ee372; Costela JL, 1996, ACTA ANAESTH SCAND, V40, P741, DOI 10.1111/j.1399-6576.1996.tb04521.x; Fang Y, 2014, J GASTROEN HEPATOL, V29, P193, DOI 10.1111/jgh.12441; Fassoulaki A, 2008, ANESTH ANALG, V107, P1715, DOI 10.1213/ane.0b013e318182d84e; Feltracco P, 2014, TRANSPL P, V46, P2300, DOI 10.1016/j.transproceed.2014.07.023; Ganapathi S, 2015, BRIT J PAIN, V9, P78, DOI 10.1177/2049463714525140; Guindon J, 2007, ANESTH ANALG, V104, P1563, DOI 10.1213/01.ane.0000263278.05423.a3; Hand R Jr, 2001, AANA J, V69, P466; Hasani A, 2013, PAIN MED, V14, P442, DOI 10.1111/pme.12031; Honda M, 2014, J CLIN ONCOL, V32, P3200, DOI 10.1200/JCO.2014.55.9682; Hotbauer RK, 2004, ANESTHESIOLOGY, V100, P386, DOI 10.1097/00000542-200402000-00031; Kingston S, 2006, ANESTHESIOLOGY, V104, P763, DOI 10.1097/00000542-200604000-00021; Ko JS, 2009, LIVER TRANSPLANT, V15, P381, DOI 10.1002/lt.21625; Kumar G, 2014, ANAESTHESIA, V69, P1138, DOI 10.1111/anae.12713; Li M, 2012, ACTA ANAESTH SCAND, V56, P368, DOI 10.1111/j.1399-6576.2011.02603.x; Lyashchenko AK, 2007, J PHYSIOL-LONDON, V583, P37, DOI 10.1113/jphysiol.2007.136465; Ma X, 2013, ARCH BIOCHEM BIOPHYS, V533, P1, DOI 10.1016/j.abb.2013.03.002; Mu XB, 2010, NEUROSCI LETT, V484, P206, DOI 10.1016/j.neulet.2010.08.055; Nadeson R, 1997, J PHARMACOL EXP THER, V282, P1181; Niven Daniel J, 2012, Clin Epidemiol, V4, P99, DOI 10.2147/CLEP.S30816; Rudin A, 2007, ANESTH ANALG, V104, P1409, DOI 10.1213/01.ane.0000261847.26044.1d; Samir A, 2015, ANTIINFLAMMATORY EFF; Schultz NA, 2013, BRIT J SURG, V100, P138, DOI 10.1002/bjs.8996; SERVIN F, 1990, BRIT J ANAESTH, V65, P177, DOI 10.1093/bja/65.2.177; SMITH I, 1994, ANESTHESIOLOGY, V81, P1005; Suttner S, 1999, ANESTH ANALG, V88, P77, DOI 10.1097/00000539-199901000-00015; Tan T, 2010, ANESTH ANALG, V111, P83, DOI 10.1213/ANE.0b013e3181c0ee9e; Taura P, 2003, ANESTH ANALG, V96, P475, DOI 10.1097/00000539-200302000-00033; Tibbs GR, 2013, J PHARMACOL EXP THER, V345, P363, DOI 10.1124/jpet.113.203620; Tsuchiya M, 2001, AM J RESP CRIT CARE, V163, P26, DOI 10.1164/ajrccm.163.1.9911120; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1019, DOI 10.1093/oxfordjournals.aje.a116396	40	11	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149753	10.1371/journal.pone.0149753	http://dx.doi.org/10.1371/journal.pone.0149753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901037	gold, Green Submitted, Green Published			2022-12-27	WOS:000371276100143
J	Gong, YF; Tao, LM; Jing, L; Liu, DS; Hu, SJ; Liu, W; Zhou, NJ; Xie, Y				Gong, Yanfeng; Tao, Liming; Jing, Lei; Liu, Dongsheng; Hu, Sijun; Liu, Wei; Zhou, Nanjin; Xie, Yong			Association of TLR4 and Treg in Helicobacter pylori Colonization and Inflammation in Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; INFECTION; RESPONSES; IMMUNITY; VACCINE; DIFFERENTIATION; ADJUVANT; CHITOSAN; CANCER	The host immune response plays an important role in the pathogenesis of Helicobacter pylori infection. The aim of this study was to clarify the immune pathogenic mechanism of Helicobacter pylori infection via TLR signaling and gastric mucosal Treg cells in mice. To discover the underlying mechanism, we selectively blocked the TLR signaling pathway and subpopulations of regulatory T cells in the gastric mucosa of mice, and examined the consequences on H. pylori infection and inflammatory response as measured by MyD88, NF-kappa B p65, and Foxp3 protein expression levels and the levels of Th1, Th17 and Th2 cytokines in the gastric mucosa. We determined that blocking TLR4 signaling in H. pylori infected mice decreased the numbers of Th1 and Th17 Treg cells compared to controls (P < 0.001-0.05), depressed the immune response as measured by inflammatory grade (P < 0.05), and enhanced H. pylori colonization (P < 0.05). In contrast, blocking CD25 had the opposite effects, wherein the Th1 and Th17 cell numbers were increased (P < 0.001-0.05), immune response was enhanced (P < 0.05), and H. pylori colonization was inhibited (P < 0.05) compared to the non-blocked group. In both blocked groups, the Th2 cytokine IL-4 remained unchanged, although IL-10 in the CD25 blocked group was significantly decreased (P < 0.05). Furthermore, MyD88, NF-kappa B p65, and Foxp3 in the non-blocked group were significantly lower than those in the TLR4 blocked group (P < 0.05), but significantly higher than those of the CD25 blocked group (P < 0.05). Together, these results suggest that there might be an interaction between TLR signaling and Treg cells that is important for limiting H. pylori colonization and suppressing the inflammatory response of infected mice.	[Gong, Yanfeng; Jing, Lei; Liu, Dongsheng; Hu, Sijun; Liu, Wei; Xie, Yong] Nanchang Univ, Affiliated Hosp 1, Dept Gastroenterol, 17 Yongwai Zheng St, Nanchang, Jiangxi, Peoples R China; [Gong, Yanfeng] Nanchang Univ, Affiliated Hosp 1, Dept Geriatr, 17 Yongwai Zheng St, Nanchang, Jiangxi, Peoples R China; [Zhou, Nanjin] Jiangxi Acad Med Sci, Dept Biochem & Mol Biol, Nanchang, Jiangxi, Peoples R China; [Tao, Liming] Nanchang Univ, Affiliated Hosp 1, Dept Obstet, 17 Yongwai Zheng St, Nanchang, Jiangxi, Peoples R China	Nanchang University; Nanchang University; Nanchang University	Xie, Y (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Gastroenterol, 17 Yongwai Zheng St, Nanchang, Jiangxi, Peoples R China.; Zhou, NJ (corresponding author), Jiangxi Acad Med Sci, Dept Biochem & Mol Biol, Nanchang, Jiangxi, Peoples R China.	jxznj@tom.com; xieyon_med@163.com	TAO, Li/HIR-4254-2022		National Natural Science Foundation of China [30660068]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (no. 30660068), and YX received the funding.	An HZ, 2010, SCI CHINA LIFE SCI, V53, P34, DOI 10.1007/s11427-010-0011-x; Banerjee A, 2014, INFECT IMMUN, V82, P356, DOI 10.1128/IAI.01344-13; Cao AT, 2014, J LEUKOCYTE BIOL, V96, P895, DOI 10.1189/jlb.3A0114-056RR; D'Elios MM, 2014, HELICOBACTER, V19, P19, DOI 10.1111/hel.12156; deFoneska A, 2010, CURR OPIN GASTROEN, V26, P604, DOI 10.1097/MOG.0b013e32833f1222; Gong YF, 2015, MOL MED REP, V12, P4123, DOI 10.3892/mmr.2015.3950; Hu SJ, 2009, INDIAN J MED RES, V130, P115; Kabisch R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104804; Kang JY, 2011, ANNU REV BIOCHEM, V80, P917, DOI 10.1146/annurev-biochem-052909-141507; Kawahara Tsukasa, 2001, Journal of Medical Investigation, V48, P190; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Knechtle SJ, 2010, TRANSPL P, V42, pS13, DOI 10.1016/j.transproceed.2010.07.039; Lacave-Lapalun JV, 2014, J LEUKOCYTE BIOL, V95, P931, DOI 10.1189/jlb.0413209; Lagunes-Servin H, 2013, HELICOBACTER, V18, P423, DOI 10.1111/hel.12067; Li P, 2014, GENET TEST MOL BIOMA, V18, P610, DOI 10.1089/gtmb.2014.0047; Lundgren A, 2005, INFECT IMMUN, V73, P523, DOI 10.1128/IAI.73.1.523-531.2005; Menon R, 2011, GASTROENTEROL CLIN N, V40, P427, DOI 10.1016/j.gtc.2011.03.002; Munari F, 2014, J IMMUNOL, V193, P5584, DOI 10.4049/jimmunol.1302865; Murphy TJ, 2005, J IMMUNOL, V174, P2957, DOI 10.4049/jimmunol.174.5.2957; Okeke EB, 2013, SHOCK, V40, P65, DOI 10.1097/SHK.0b013e318296e65b; Piccioni M, 2014, ADV EXP MED BIOL, V841, P67, DOI 10.1007/978-94-017-9487-9_4; Rad R, 2007, GASTROENTEROLOGY, V133, P150, DOI 10.1053/j.gastro.2007.04.071; Rad R, 2006, GASTROENTEROLOGY, V131, P525, DOI 10.1053/j.gastro.2006.05.001; Raghavan S, 2003, CLIN EXP IMMUNOL, V132, P393, DOI 10.1046/j.1365-2249.2003.02177.x; Smith SM, 2004, WORLD J GASTROINTEST, V5, P133; Sun X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074595; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Toka FN, 2004, J VIROL, V78, P13082, DOI 10.1128/JVI.78.23.13082-13089.2004; Triantafilou M, 2007, CELL MICROBIOL, V9, P2030, DOI 10.1111/j.1462-5822.2007.00935.x; Voo KS, 2014, J IMMUNOL, V193, P627, DOI 10.4049/jimmunol.1203334; Wang Qiang, 2013, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V21, P469, DOI 10.7534/j.issn.1009-2137.2013.02.044; Wang RF, 2006, SEMIN CANCER BIOL, V16, P106, DOI 10.1016/j.semcancer.2005.11.004; Wang TR, 2014, INT J CLIN EXP PATHO, V7, P6950; Wang XP, 2005, PANCREAS, V31, P251, DOI 10.1097/01.mpa.0000175179.62916.17; Xie Y, 2007, WORLD J GASTROENTERO, V13, P1547, DOI 10.3748/wjg.v13.i10.1547; Xie Yong, 2007, Zhonghua Nei Ke Za Zhi, V46, P220	36	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149629	10.1371/journal.pone.0149629	http://dx.doi.org/10.1371/journal.pone.0149629			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901645	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100114
J	Cai, XN; Wang, C; Chen, SD; Lu, J				Cai, Xiaonan; Wang, Chen; Chen, Shengdi; Lu, Jian			Model Development for Risk Assessment of Driving on Freeway under Rainy Weather Conditions	PLOS ONE			English	Article							YOUNG NOVICE DRIVERS; ACCIDENTS	Rainy weather conditions could result in significantly negative impacts on driving on freeways. However, due to lack of enough historical data and monitoring facilities, many regions are not able to establish reliable risk assessment models to identify such impacts. Given the situation, this paper provides an alternative solution where the procedure of risk assessment is developed based on drivers' subjective questionnaire and its performance is validated by using actual crash data. First, an ordered logit model was developed, based on questionnaire data collected from Freeway G15 in China, to estimate the relationship between drivers' perceived risk and factors, including vehicle type, rain intensity, traffic volume, and location. Then, weighted driving risk for different conditions was obtained by the model, and further divided into four levels of early warning (specified by colors) using a rank order cluster analysis. After that, a risk matrix was established to determine which warning color should be disseminated to drivers, given a specific condition. Finally, to validate the proposed procedure, actual crash data from Freeway G15 were compared with the safety prediction based on the risk matrix. The results show that the risk matrix obtained in the study is able to predict driving risk consistent with actual safety implications, under rainy weather conditions.	[Cai, Xiaonan; Lu, Jian] Shanghai Jiao Tong Univ, Sch Naval Architecture Ocean & Civil Engn, Transportat Res Ctr, Shanghai 200030, Peoples R China; [Wang, Chen; Lu, Jian] Tongji Univ, Sch Transportat Engn, Shanghai 200092, Peoples R China; [Chen, Shengdi] Shanghai Maritime Univ, Coll Transport & Commun, Shanghai, Peoples R China	Shanghai Jiao Tong University; Tongji University; Shanghai Maritime University	Wang, C (corresponding author), Tongji Univ, Sch Transportat Engn, Shanghai 200092, Peoples R China.	wkobec@hotmail.com			Shanghai Pujiang Program [15PJC093]; Fundamental Research Funds for the Central Universities [1600219254]	Shanghai Pujiang Program(Shanghai Pujiang Program); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research project was partly sponsored by "Shanghai Pujiang Program" (15PJC093) and "the Fundamental Research Funds for the Central Universities" (1600219254). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrey J, 1993, WEATHER HAZARDS DRIV; Andrey J, 2013, WEATHER INFORM ROAD, V6, P14; Berdica K., 2002, TRANSPORT POL, V9, P117, DOI [10.1016/S0967-070X(02)00011-2, DOI 10.1016/S0967-070X(02)00011-2]; China Meteorological Administration, 2010, GRAD WEATH COND FREE; Clarke DD, 2006, ACCIDENT ANAL PREV, V38, P871, DOI 10.1016/j.aap.2006.02.013; Deery HA, 1999, J SAFETY RES, V30, P225, DOI 10.1016/S0022-4375(99)00018-3; Department of Transportation of P. R. China, 2004, TECHN STAND HIGHW EN; Doherty ST., 1993, CLIMATOLOGICAL B, V27, P154; Eisenberg D, 2004, ACCIDENT ANAL PREV, V36, P637, DOI 10.1016/S0001-4575(03)00085-X; ElDessouki WM, 2004, US DEP TRANSPORTATIO; Gregersen NP, 1996, ACCIDENT ANAL PREV, V28, P229, DOI 10.1016/0001-4575(95)00063-1; Henry JJ, 1998, NCHRP SYNTHESIS HIGH, V291; Kamrin MA, 2003, REPORTING RISK JOURN; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Morris RS Mounce JM Button JW Walton NE, 1977, TRANSPORT RES REC, P19; OECD (Organization for Economic Co-operation and Development) Research Group, 1976, ADV WEATH RED VIS RO; Office of Operations, 2014, ROAD WEATHER MANAGEM, V10, P16; Palutikof J. P., 1991, JOURNAL OF HIGHWAY M, P163; Ramsey D. J, 2006, IMPACT DRIVER INATTE; ROSE JG, 1977, TRANSPORT ENG-J ASCE, V103, P491; SHERRETZ LA, 1978, J APPL METEOROL, V17, P711, DOI 10.1175/1520-0450(1978)017<0711:AAOTRB>2.0.CO;2; Traffic Management Administration of the Ministry of Public Security, 2012, ANN REP ROAD ACC PEO; Underwood G, 2007, ERGONOMICS, V50, P1235, DOI 10.1080/00140130701318707	23	3	3	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149442	10.1371/journal.pone.0149442	http://dx.doi.org/10.1371/journal.pone.0149442			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894434	Green Published, gold, Green Submitted			2022-12-27	WOS:000371223400054
J	Desingu, PA; Ray, PK; Patel, BHM; Singh, R; Singh, RK; Saikumar, G				Desingu, P. A.; Ray, Pradeep K.; Patel, B. H. M.; Singh, R.; Singh, R. K.; Saikumar, G.			Pathogenic and Genotypic Characterization of a Japanese Encephalitis Virus Isolate Associated with Reproductive Failure in an Indian Pig Herd	PLOS ONE			English	Article							CHINA; FLAVIVIRUSES; PERSPECTIVE; INFECTION; PIGLETS	Background India is endemic to Japanese encephalitis virus (JEV) and recurrent outbreaks occur mainly in rice growing areas. Pigs are considered to be the amplifying host for JEV and infection in gestating pigs results in reproductive failure. Most studies conducted on JEV infection in Indian pigs have been serological surveys and very little is known about JEV genotypes circulating in pigs. So the potential risk posed by pigs in JEV transmission and the genetic relationship between viruses circulating in pigs, mosquitoes and humans is poorly understood. Methodology/Principal Findings This study was conducted in pigs with a history of reproductive failure characterized by stillborn piglets with neuropathological lesions. Japanese encephalitis (JE) suspected brain specimens inoculated intracerebrally into mice and Vero cells resulted in successful isolation of JEV/SW/IVRI/395A/2014. Clinicopathological observations in infected mice, demonstration of JEV antigen in brain, and analysis of the envelope protein identified the swine isolate as being neurovirulent. Phylogenetic analysis based on prM and E gene sequences showed that it belonged to genotype III. This swine isolate was closely related to JEV associated with the 2005 outbreak in India and JaoArS982 from Japan. Phylogenetic analysis of JEV strains collected between 1956 and 2014 in India categorized the GIII viruses into different clades blurring their spatial distribution, which has been discernible in the previous century. Conclusions/Significance Isolation of JEV from stillborn piglets and its close genetic relationship with viruses detected at least three decades ago in humans and mosquitoes in Japan suggests that the virus may have been circulating among Indian pigs for several decades. The close similarity between the present swine isolate and those detected in humans affected in the 2005 outbreak in Uttar Pradesh, India, suggests the need for more intensive surveillance of pigs and implementation of suitable strategies to control JE in India.	[Desingu, P. A.; Ray, Pradeep K.; Saikumar, G.] Indian Vet Res Inst, Div Pathol, Swine Dis Lab, Izatnagar 243122, Uttar Pradesh, India; [Patel, B. H. M.] Indian Vet Res Inst, Div Livestock Prod & Management, Izatnagar 243122, Uttar Pradesh, India; [Singh, R.] Indian Vet Res Inst, Div Pathol, Izatnagar 243122, Uttar Pradesh, India; [Singh, R. K.] Indian Vet Res Inst, Izatnagar 243122, Uttar Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute	Saikumar, G (corresponding author), Indian Vet Res Inst, Div Pathol, Swine Dis Lab, Izatnagar 243122, Uttar Pradesh, India.	saikumarivri@gmail.com	RCER, ICAR/ABD-1024-2020; Desingu, P./AGM-5446-2022; Ray, Pradeep Kumar/AAZ-2613-2020; Desingu, Perumal/AGH-9777-2022	RCER, ICAR/0000-0002-6025-3363; Desingu, P./0000-0003-4395-4472; Ray, Pradeep Kumar/0000-0002-6145-6920; 	ICAR-IVRI, Izatnagar, India	ICAR-IVRI, Izatnagar, India	The authors are thankful to ICAR-IVRI, Izatnagar, India, for financial support to conduct this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo J, 2001, J VIROL, V75, P934, DOI 10.1128/JVI.75.2.934-942.2001; Ayers M, 2006, J VIROL METHODS, V135, P235, DOI 10.1016/j.jviromet.2006.03.009; BURNS KF, 1950, P SOC EXP BIOL MED, V75, P621, DOI 10.3181/00379727-75-18285; Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233; Cao QS, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-472; Dhillon G P S, 2008, J Indian Med Assoc, V106, P660; Fulmali PV, 2011, EMERG INFECT DIS, V17, P319, DOI 10.3201/eid1702.100815; GEEVARGHESE G, 1987, INDIAN J MED RES, V86, P273; Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437; Gresham A, 2003, IN PRACTICE, V25, P466; Han N, 2014, J VIROL, V88, P11469, DOI 10.1128/JVI.02050-14; HOSOYA H., 1950, Jikken Igaku Zasshi = Japanese Journal of Experimental Medicine, V20, P587; Huxtable C.R, 1992, PATHOLOGY DOMESTIC A, VI, P412; Joo HS, 1999, DIS SWINE, P173; KALIMUDDIN MD, 1982, INT J ZOONOSES, V9, P39; Kumari Roop, 2012, WHO South East Asia J Public Health, V1, P374, DOI 10.4103/2224-3151.207040; Liu WJ, 2013, VIRUS RES, V178, P547, DOI 10.1016/j.virusres.2013.09.002; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; MORIMOTO T, 1972, NATL I ANIM HEALTH Q, V12, P127; Namachivayam V, 1982, P NAT C JAP ENC, P30; OIE, 2010, OIE TERR MAN 2010; Parida M, 2006, EMERG INFECT DIS, V12, P1427, DOI 10.3201/eid1209.060200; Ratho R. K., 1999, Journal of Communicable Diseases, V31, P113; SALMON H, 1984, REPROD NUTR DEV, V24, P197, DOI 10.1051/rnd:19840219; Sarkar A, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-271; Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263; Tiwari S, 2012, BRAZ J INFECT DIS, V16, P564, DOI 10.1016/j.bjid.2012.10.004; Wang HY, 2007, J GEN VIROL, V88, P885, DOI 10.1099/vir.0.82185-0; Yamada M, 2004, VET PATHOL, V41, P62, DOI 10.1354/vp.41-1-62	29	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0147611	10.1371/journal.pone.0147611	http://dx.doi.org/10.1371/journal.pone.0147611			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895440	Green Published, gold, Green Submitted			2022-12-27	WOS:000371223400008
J	Hu, K; Ma, RR; Cheng, JM; Ye, X; Sun, Q; Yuan, HL; Liang, N; Fang, WH; Li, HR; Yang, XL				Hu, Kun; Ma, Rong-Rong; Cheng, Jun-Ming; Ye, Xin; Sun, Qi; Yuan, Hai-Lan; Liang, Nan; Fang, Wen-Hong; Li, Hao-Ran; Yang, Xian-Le			Analysis of Saprolegnia parasitica Transcriptome following Treatment with Copper Sulfate	PLOS ONE			English	Article							PATHOGEN; EFFICACY; SPHTP1; TOPHAT	Background Massive infection caused by oomycete fungus Saprolegnia parasitica is detrimental to freshwater fish. Recently, we showed that copper sulfate demonstrated good efficacy for controlling S. parasitica infection in grass carp. In this study, we investigated the mechanism of inhibition of S. parasitica growth by copper sulfate by analyzing the transcriptome of copper sulfate-treated S. parasitica. To examine the mechanism of copper sulfate inhibiting S. parasitica, we utilized RNA-seq technology to compare differential gene expression in S. parasitica treated with or without copper sulfate. Results The total mapped rates of the reads with the reference genome were 90.50% in the control group and 73.50% in the experimental group. In the control group, annotated splice junctions, partial novel splice junctions and complete novel splice junctions were about 83%, 3% and 14%, respectively. In the treatment group, the corresponding values were about 75%, 6% and 19%. Following copper sulfate treatment, a total 310 genes were markedly upregulated and 556 genes were markedly downregulated in S. parasitica. Material metabolism related GO terms including cofactor binding (33 genes), 1,3-beta-D-glucan synthase complex (4 genes), carboxylic acid metabolic process (40 genes) were the most significantly enriched. KEGG pathway analysis also determined that the metabolism-related biological pathways were significantly enriched, including the metabolic pathways (98 genes), biosynthesis of secondary metabolites pathways (42 genes), fatty acid metabolism (13 genes), phenylalanine metabolism (7 genes), starch and sucrose metabolism pathway (12 genes). The qRT-PCR results were largely consistent with the RNA-Seq results. Conclusion Our results indicate that copper sulfate inhibits S. parasitica growth by affecting multiple biological functions, including protein synthesis, energy biogenesis, and metabolism.	[Hu, Kun; Ma, Rong-Rong; Cheng, Jun-Ming; Ye, Xin; Sun, Qi; Yuan, Hai-Lan; Liang, Nan; Li, Hao-Ran; Yang, Xian-Le] Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, 999 Hucheng Huan Rd, Shanghai 201306, Peoples R China; [Ma, Rong-Rong; Fang, Wen-Hong] Chinese Acad Fishery Sci, East China Sea Fisheries Res Inst, Shanghai 201306, Peoples R China	Shanghai Ocean University; Chinese Academy of Fishery Sciences; East China Sea Fisheries Research Institute, CAFS	Yang, XL (corresponding author), Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, 999 Hucheng Huan Rd, Shanghai 201306, Peoples R China.	xlyang@shou.edu.cn	Li, Hao/GPS-9834-2022; Yang, Xian/GVU-9087-2022		863 Program [2011AA10A216]; Special Fund for Agro-scientific Research in the Public Interest [201203085]; National Natural Resources Platform; Shanghai University Knowledge Service Platform	863 Program(National High Technology Research and Development Program of China); Special Fund for Agro-scientific Research in the Public Interest; National Natural Resources Platform; Shanghai University Knowledge Service Platform	This study was supported by the 863 Program (Grant 2011AA10A216), the Special Fund for Agro-scientific Research in the Public Interest (Grant 201203085), the National Natural Resources Platform and the Shanghai University Knowledge Service Platform. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Jiang RHY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003272; Li CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047442; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meinelt T, 2007, AQUAT TOXICOL, V83, P93, DOI 10.1016/j.aquatox.2007.03.013; MEYER FP, 1991, J ANIM SCI, V69, P4201, DOI 10.2527/1991.69104201x; Nakagawa K, 2012, J ANTIBIOT, V65, P599, DOI 10.1038/ja.2012.86; Peng YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090636; Price DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022573; Rach JJ, 2005, N AM J AQUACULT, V67, P148, DOI 10.1577/A04-062.1; Srivastava S, 2004, AQUAT TOXICOL, V66, P319, DOI 10.1016/j.aquatox.2003.09.008; Stammati A, 2005, TOXICOL IN VITRO, V19, P853, DOI 10.1016/j.tiv.2005.06.021; Sun Q, 2014, J WORLD AQUACULT SOC, V45, P220, DOI 10.1111/jwas.12113; Torto-Alalibo T, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-46; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van West Pieter, 2006, Mycologist, V20, P99, DOI 10.1016/j.mycol.2006.06.004; van West P, 2010, FEMS MICROBIOL LETT, V310, P127, DOI 10.1111/j.1574-6968.2010.02055.x; Warrilow AGS, 2014, APPL ENVIRON MICROB, V80, P6154, DOI 10.1128/AEM.01195-14; Wawra S, 2012, P NATL ACAD SCI USA, V109, P2096, DOI 10.1073/pnas.1113775109; Yan HZ, 2006, FUNGAL GENET BIOL, V43, P430, DOI 10.1016/j.fgb.2006.01.010	21	12	12	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0147445	10.1371/journal.pone.0147445	http://dx.doi.org/10.1371/journal.pone.0147445			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895329	gold, Green Published			2022-12-27	WOS:000371223400007
J	Stiekema, APM; Liemburg, EJ; van der Meer, L; Castelein, S; Stewart, R; van Weeghel, J; Aleman, A; Bruggeman, R				Stiekema, Annemarie P. M.; Liemburg, Edith J.; van der Meer, Lisette; Castelein, Stynke; Stewart, Roy; van Weeghel, Jaap; Aleman, Andre; Bruggeman, Richard			Confirmatory Factor Analysis and Differential Relationships of the Two Subdomains of Negative Symptoms in Chronically Ill Psychotic Patients	PLOS ONE			English	Article							QUALITY-OF-LIFE; CONSENSUS STATEMENT; SCHIZOPHRENIA; DEPRESSION; PERSPECTIVE; DISORDERS; SCALE; OUTPATIENTS; AVOLITION; DEFICITS	Research suggests a two factor structure for negative symptoms in patients with psychotic disorders: social amotivation (SA) and expressive deficits (ED). Applying this two-factor structure in clinical settings may provide valuable information with regard to outcomes and to target treatments. We aimed to investigate 1) whether the factor structure is also supported in chronically ill patients with a psychotic disorder and 2) what the relationship is between these factors and functioning (overall functioning and living situation), depressive symptoms and quality of life. 1157 Patients with a psychotic disorder and a duration of illness of 5 years or more were included in the analysis (data selected from the Pharmacotherapy Monitoring Outcome Survey; PHAMOUS). A confirmatory factor analysis was performed using items of the Positive and Negative Syndrome Scale that were previously identified to reflect negative symptoms (N1-4, N6, G5, G7, G13, G16). Subsequently, regression analysis was performed on outcomes. The results confirmed the distinction between SA (N2, N4, G16) and ED (N1, N3, N6, G5, G7, G13) in chronically ill patients. Both factors were related to worse overall functioning as measured with the Health of the Nation Outcome Scales, ED was uniquely associated with residential living status. Higher scores for SA were associated with more depressive symptoms and worse quality of life. Thus, SA is most strongly related to level of social-emotional functioning, while ED are more related to living situation and thereby are indicative of level of everyday functioning. This subdivision may be useful for research purposes and be a valuable additional tool in clinical practice and treatment development.	[Stiekema, Annemarie P. M.; van der Meer, Lisette] Lentis Ctr Mental Hlth Care, Dept Rehabil, Zuidlaren, Netherlands; [Stiekema, Annemarie P. M.; Liemburg, Edith J.; van der Meer, Lisette; Castelein, Stynke; Bruggeman, Richard] Univ Groningen, Univ Med Ctr Groningen, Rob Giel Res Ctr, Groningen, Netherlands; [Liemburg, Edith J.; van der Meer, Lisette; Aleman, Andre] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands; [Liemburg, Edith J.; Castelein, Stynke] Lentis Ctr Mental Hlth Care, Res Dept, Groningen, Netherlands; [Stewart, Roy] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci Community & Occupat Med, Groningen, Netherlands; [van Weeghel, Jaap] Dijk & Duin Mental Hlth Ctr, Parnassia Grp, Castricum, Netherlands; [van Weeghel, Jaap] Tilburg Univ, Tilburg Sch Social & Behav Sci, Tranzo Sci Ctr Care & Welf, NL-5000 LE Tilburg, Netherlands; [van Weeghel, Jaap] Phrenos, Ctr Expertise Severe Mental Illness, Utrecht, Netherlands; [Bruggeman, Richard] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Psychiat, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; Parnassia Psychiatric Institute; Tilburg University; University of Groningen	Stiekema, APM (corresponding author), Lentis Ctr Mental Hlth Care, Dept Rehabil, Zuidlaren, Netherlands.; Stiekema, APM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Rob Giel Res Ctr, Groningen, Netherlands.	a.stiekema@lentis.nl		Stewart, Roy/0000-0001-9227-433X; Castelein, Stynke/0000-0002-8419-568X; Bruggeman, Richard/0000-0002-3238-8471	VICI grant from the Netherlands Organisation for Scientific Research (N.W.O.) [453-11-004]	VICI grant from the Netherlands Organisation for Scientific Research (N.W.O.)	AA was supported by a VICI grant from the Netherlands Organisation for Scientific Research (N.W.O. nr 453-11-004).	ADDINGTON D, 1990, SCHIZOPHR RES, V3, P247, DOI 10.1016/0920-9964(90)90005-R; Aleman A, 2014, ADV NEUROSCI; Alphs L, 2006, SCHIZOPHRENIA BULL, V32, P225, DOI 10.1093/schbul/sbj056; Andreasen NC, 1983, SCALE ASSESSMENT NEG; [Anonymous], 2013, INT J SOCIAL SCI STU, DOI DOI 10.11114/IJSSS.V1I1.27; Anthony W., 2002, PSYCHIAT REHABILITAT; Azorin JM, 2014, CNS NEUROSCI THER, V20, P801, DOI 10.1111/cns.12292; Bell MD, 2013, SCHIZOPHRENIA BULL, V39, P186, DOI 10.1093/schbul/sbr125; Blanchard JJ, 2006, SCHIZOPHRENIA BULL, V32, P238, DOI 10.1093/schbul/sbj013; Bobes J, 2010, J CLIN PSYCHIAT, V71, P280, DOI 10.4088/JCP.08m04250yel; de Heer-Wunderink C, 2012, COMMUNITY MENT HLT J, V48, P321, DOI 10.1007/s10597-011-9381-1; Faerden A, 2009, PSYCHIAT SERV, V60, P1495, DOI 10.1176/appi.ps.60.11.1495; Fervaha G, 2014, ACTA PSYCHIAT SCAND, P1; Fervaha G, 2014, EUR NEUROPSYCHOPHARM, V24, P1078, DOI 10.1016/j.euroneuro.2014.03.001; Fitzgerald PB, 2003, PSYCHIAT RES, V119, P55, DOI 10.1016/S0165-1781(03)00099-4; Foussias G, 2011, SCHIZOPHR RES, V132, P24, DOI 10.1016/j.schres.2011.06.026; Foussias G, 2014, J PSYCHOPHARMACOL, P1; Foussias G, 2014, EUR NEUROPSYCHOPHARM, V24, P693, DOI 10.1016/j.euroneuro.2013.10.017; Foussias G, 2010, SCHIZOPHRENIA BULL, V36, P359, DOI 10.1093/schbul/sbn094; Gard DE, 2007, SCHIZOPHR RES, V93, P253, DOI 10.1016/j.schres.2007.03.008; Gardner DM, 2010, AM J PSYCHIAT, V167, P686, DOI 10.1176/appi.ajp.2009.09060802; Gur RE, 2006, SCHIZOPHRENIA BULL, V32, P279, DOI 10.1093/schbul/sbj041; Harvey PD, 2006, SCHIZOPHRENIA BULL, V32, P250, DOI 10.1093/schbul/sbj011; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hunter R, 2012, EUR PSYCHIAT, V27, P432, DOI 10.1016/j.eurpsy.2011.02.015; Jackson DL, 2009, PSYCHOL METHODS, V14, P6, DOI 10.1037/a0014694; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; KEEFE RSE, 1992, PSYCHIAT RES, V44, P153, DOI 10.1016/0165-1781(92)90049-9; Kirkpatrick B, 2006, SCHIZOPHRENIA BULL, V32, P246, DOI 10.1093/schbul/sbj054; Kirkpatrick B, 2006, SCHIZOPHRENIA BULL, V32, P214, DOI 10.1093/schbul/sbj053; KIRKPATRICK B, 1989, PSYCHIAT RES, V30, P119, DOI 10.1016/0165-1781(89)90153-4; Kirkpatrick B, 2011, SCHIZOPHRENIA BULL, V37, P300, DOI 10.1093/schbul/sbq059; KITAMURA T, 1991, COMPR PSYCHIAT, V32, P88, DOI 10.1016/0010-440X(91)90074-M; Kring AM, 2013, AM J PSYCHIAT, V170, P165, DOI 10.1176/appi.ajp.2012.12010109; Liemburg E, 2013, J PSYCHIATR RES, V47, P718, DOI 10.1016/j.jpsychires.2013.01.024; LINDENMAYER JP, 1991, COMPR PSYCHIAT, V32, P528, DOI 10.1016/0010-440X(91)90032-8; Lyne JP, 2012, J PSYCHIATR RES, V46, P233, DOI 10.1016/j.jpsychires.2011.10.002; Malaspina D, 2014, EUR NEUROPSYCHOPHARM, V24, P710, DOI 10.1016/j.euroneuro.2013.10.018; Markou P, 1996, AUST NZ J PSYCHIAT, V30, P354, DOI 10.3109/00048679609064999; Mendella PD, 2015, SCHIZOPHR RES, V162, P108, DOI 10.1016/j.schres.2015.01.016; Messinger JW, 2011, CLIN PSYCHOL REV, V31, P161, DOI 10.1016/j.cpr.2010.09.002; Milian MJ, 2014, EUR NEUROPSYCHOPHARM, V24, P645, DOI 10.1016/j.euroneuro.2014.03.008; Muthen B.O., 2012, MPLUS USERS GUIDE, V7th; NEWCOMER JW, 1990, PSYCHIAT RES, V31, P243, DOI 10.1016/0165-1781(90)90093-K; NORMAN RMG, 1994, COMPR PSYCHIAT, V35, P34, DOI 10.1016/0010-440X(94)90167-8; Priebe S, 1999, INT J SOC PSYCHIATR, V45, P7, DOI 10.1177/002076409904500102; Rabinowitz J, 2012, SCHIZOPHR RES, V137, P147, DOI 10.1016/j.schres.2012.01.015; Robinson DG, 2004, AM J PSYCHIAT, V161, P473, DOI 10.1176/appi.ajp.161.3.473; Rocca P, 2014, PSYCHIAT RES, V218, P284, DOI 10.1016/j.psychres.2014.04.018; Sax KW, 1996, BRIT J PSYCHIAT, V168, P68, DOI 10.1192/bjp.168.1.68; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Siris SG, 2000, AM J PSYCHIAT, V157, P1379, DOI 10.1176/appi.ajp.157.9.1379; Staring ABP, 2013, J BEHAV THER EXP PSY, V44, P300, DOI 10.1016/j.jbtep.2013.01.004; Strauss GP, 2013, J PSYCHIATR RES, V47, P783, DOI 10.1016/j.jpsychires.2013.01.015; Velligan DI, 2000, AM J PSYCHIAT, V157, P1317, DOI 10.1176/appi.ajp.157.8.1317; Ventura J, 2015, SCHIZOPHR RES, V161, P407, DOI 10.1016/j.schres.2014.10.043; Ventura J, 2009, SCHIZOPHR RES, V113, P189, DOI 10.1016/j.schres.2009.03.035; Wing JK, 1998, BRIT J PSYCHIAT, V172, P11, DOI 10.1192/bjp.172.1.11	58	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149785	10.1371/journal.pone.0149785	http://dx.doi.org/10.1371/journal.pone.0149785			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3DG	26895203	gold, Green Published, Green Submitted			2022-12-27	WOS:000371223400082
J	Zaini, WH; Giuliani, F; Beaulieu, C; Kalra, S; Hanstock, C				Zaini, Wan Hazlin; Giuliani, Fabrizio; Beaulieu, Christian; Kalra, Sanjay; Hanstock, Christopher			Fatigue in Multiple Sclerosis: Assessing Pontine Involvement Using Proton MR Spectroscopic Imaging	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; WHITE-MATTER; LOCUS-COERULEUS; BASAL GANGLIA; EARLY-STAGE; METABOLISM; SYSTEM; CORTEX; GRAY; MS	Background/Objective The underlying mechanism of fatigue in multiple sclerosis (MS) remains poorly understood. Our study investigates the involvement of the ascending reticular activating system (ARAS), originating in the pontine brainstem, in MS patients with symptoms of fatigue. Methods Female relapsing-remitting MS patients (n = 17) and controls (n = 15) underwent a magnetic resonance spectroscopic imaging protocol at 1.5T. Fatigue was assessed in every subject using the Fatigue Severity Scale (FSS). Using an FSS cut-off of 36, patients were categorized into a low (n = 9, 22 +/- 10) or high (n = 10, 52 +/- 6) fatigue group. The brain metabolites N-acetylaspartate (NAA) and total creatine (tCr) were measured from sixteen 5x5x10 mm(3) spectroscopic imaging voxels in the rostral pons. Results MS patients with high fatigue had lower NAA/tCr concentration in the tegmental pons compared to control subjects. By using NAA and Cr values in the cerebellum for comparison, these NAA/tCr changes in the pons were driven by higher tCr concentration, and that these changes were focused in the WM regions. Discussion/Conclusion Since there were no changes in NAA concentration, the increase in tCr may be suggestive of gliosis, or an imbalanced equilibrium of the creatine and phosphocreatine ratio in the pons of relapsing-remitting MS patients with fatigue.	[Zaini, Wan Hazlin; Beaulieu, Christian; Hanstock, Christopher] Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada; [Giuliani, Fabrizio; Kalra, Sanjay] Univ Alberta, Dept Med, Div Neurol, Edmonton, AB, Canada	University of Alberta; University of Alberta	Hanstock, C (corresponding author), Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada.	Chris.hanstock@ualberta.ca	Beaulieu, Christian/E-9796-2011	Beaulieu, Christian/0000-0002-2342-3298; Kalra, Sanjay/0000-0003-4762-8746	University of Alberta Hospital Foundation; Multiple Sclerosis Society of Canada - EndMS Program; MS Society of Canada-EndMS Program	University of Alberta Hospital Foundation(University of Alberta); Multiple Sclerosis Society of Canada - EndMS Program; MS Society of Canada-EndMS Program	This work was supported by the University of Alberta Hospital Foundation, http://www.universityhospitalfoundation.ab.ca, and Multiple Sclerosis Society of Canada - EndMS Program, https://beta.mssociety.ca.; We acknowledge the financial support of the University of Alberta Hospital Foundation, and the MS Society of Canada-EndMS Program. We would also like to thank Dr Gregg Blevins for assistance with patient recruitment.	Aston-Jones G, 1999, BIOL PSYCHIAT, V46, P1309, DOI 10.1016/S0006-3223(99)00140-7; Beck CA, 2005, MULT SCLER J, V11, P516, DOI 10.1191/1352458505ms1192oa; BLOMSTRAND E, 1989, ACTA PHYSIOL SCAND, V136, P473, DOI 10.1111/j.1748-1716.1989.tb08689.x; BOTTOMLEY PA, 1984, SELECTIVE VOLUME MET; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Duong MVA, 2007, J NEUROL, V254, P914, DOI 10.1007/s00415-006-0474-7; Filippi M, 2010, J MAGN RESON IMAGING, V31, P770, DOI 10.1002/jmri.22102; Gadea M, 2004, BRAIN, V127, P89, DOI 10.1093/brain/awh002; Garcia-Rill E, 2015, SLEEP SCI, V8, P82, DOI 10.1016/j.slsci.2015.04.003; Hattingen E, 2011, NMR BIOMED, V24, P536, DOI 10.1002/nbm.1621; HUSTED CA, 1994, ANN NEUROL, V36, P157, DOI 10.1002/ana.410360207; Induruwa I, 2012, J NEUROL SCI, V323, P9, DOI 10.1016/j.jns.2012.08.007; Ke Y, 2002, MAGNET RESON MED, V47, P232, DOI 10.1002/mrm.10063; Kirov II, 2013, NEUROLOGY, V80, P39, DOI 10.1212/WNL.0b013e31827b1a8c; KORF J, 1973, NEUROPHARMACOLOGY, V12, P933, DOI 10.1016/0028-3908(73)90024-5; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Loder C, 2002, MED HYPOTHESES, V59, P594, DOI 10.1016/S0306-9877(02)00261-X; Moll NM, 2011, ANN NEUROL, V70, P764, DOI 10.1002/ana.22521; Narayana PA, 2005, J NEUROIMAGING, V15, p46S, DOI 10.1177/1051228405284200; NEWCOMBE J, 1980, J NEUROCHEM, V34, P700, DOI 10.1111/j.1471-4159.1980.tb11200.x; NEWCOMBE J, 1986, J NEUROCHEM, V47, P1713, DOI 10.1111/j.1471-4159.1986.tb13079.x; Ordidge R, 1983, METHODS APPARATUS OB; Pardini M, 2010, BEHAV NEUROSCI, V124, P329, DOI 10.1037/a0019585; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Poulsen MB, 2015, STROKE, V46, P3470, DOI 10.1161/STROKEAHA.115.010860; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Rocca MA, 2007, HUM BRAIN MAPP, V28, P373, DOI 10.1002/hbm.20279; Roelcke U, 1997, NEUROLOGY, V48, P1566, DOI 10.1212/WNL.48.6.1566; Sajja BR, 2009, NEUROIMAG CLIN N AM, V19, P45, DOI 10.1016/j.nic.2008.08.002; Sepulcre J, 2009, MULT SCLER J, V15, P337, DOI 10.1177/1352458508098373; Staub F, 2001, CEREBROVASC DIS, V12, P75, DOI 10.1159/000047685; Steen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010811; Tedeschi G, 2007, J NEUROL SCI, V263, P15, DOI 10.1016/j.jns.2007.07.004; Tellez N, 2008, NEURORADIOLOGY, V50, P17, DOI 10.1007/s00234-007-0304-3; Weber-Fahr W, 2002, NEUROIMAGE, V16, P49, DOI 10.1006/nimg.2002.1057; WINTERFELD M, 1977, J NEUROL, V215, P261, DOI 10.1007/BF00312497	36	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149622	10.1371/journal.pone.0149622	http://dx.doi.org/10.1371/journal.pone.0149622			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895076	gold, Green Published, Green Submitted			2022-12-27	WOS:000371223400070
J	Zhou, Q; Shaffer, J; Ying, GS				Zhou, Qiang; Shaffer, James; Ying, Gui-shuang			Pseudodrusen in the Fellow Eye of Patients with Unilateral Neovascular Age-Related Macular Degeneration: A Meta-Analysis	PLOS ONE			English	Article							SUBRETINAL DRUSENOID DEPOSITS; RETICULAR PSEUDODRUSEN; GEOGRAPHIC-ATROPHY; CLINICAL CHARACTERISTICS; RISK-FACTOR; PREVALENCE; MACULOPATHY; PROGRESSION; LESIONS	Importance The fellow eye of patients with unilateral neovascular age-related degeneration (nAMD) is at increased risk of developing late AMD. Several cohort studies have evaluated the prevalence of pseudodrusen and the association between pseudodrusen and late AMD in the fellow eye of patients with unilateral nAMD. However, these studies have limited sample sizes and their results are inconsistent. Objective To evaluate the prevalence rate of pseudodrusen, and the association between pseudodrusen and incidence of late AMD (nAMD and geographic atrophy (GA)) in the fellow eye of patients with unilateral nAMD. Data Sources The PubMed, EMBASE, Web of Science, and Cochrane Library databases were searched up to July 2015, as well as other systematic reviews. Study Selection All cohort studies for pseudodrusen with late AMD in the fellow eye of patients with unilateral nAMD. Data Extraction and Synthesis The numbers of patients with and without pseudodrusen at baseline and the numbers of incident nAMD and GA during follow up among patients with and without pseudodrusen were independently extracted by 2 authors. The results were pooled using random-effects meta-analysis. Heterogeneity was assessed using the I-2 test. Main Outcome Measures Prevalence rate of pseudodrusen, risk ratios (RRs) and their 95% confidence intervals (95% CIs) for associations between pseudodrusen and the incidence of nAMD and GA in the fellow eye. Results Five cohort studies (N = 677 patients) from 8 countries across 4 continents were included. The pooled prevalence rate of pseudodrusen in the fellow eye was 48.1% (95% CI: 36.7-59.5%, I-2 = 87%). Pseudodrusen were associated with an increased risk of nAMD (RR = 1.54, 95% CI: 1.10-2.16, I-2 = 42%), GA (RR = 4.70, 95% CI: 1.22-18.1, I-2 = 64%), and late AMD (RR = 2.03, 95% CI: 1.35-3.06, I-2 = 60%). Conclusions For patients with unilateral nAMD, pseudodrusen were present in about half of the fellow eyes. The presence of pseudodrusen was associated with a 1.5 times higher risk of developing nAMD, a 4.7 times higher risk of developing GA, and a 2 times higher risk of developing late AMD. Pseudodrusen should be considered in evaluating the risk of late AMD development; however, due to considerable heterogeneity across these studies, a larger study is needed to validate these findings.	[Zhou, Qiang] Capital Med Univ, Beijing Chaoyang Hosp, Dept Ophthalmol, Beijing, Peoples R China; [Shaffer, James; Ying, Gui-shuang] Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Perelman Sch Med, Philadelphia, PA 19104 USA	Capital Medical University; University of Pennsylvania	Zhou, Q (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Ophthalmol, Beijing, Peoples R China.	zhouqianghandan@sina.com		Zhou, Qiang/0000-0002-2351-3621	National Eye Institute, National Institutes of Health [R21EY023689, P30 EY01583-26]; Foundation Fighting Blindness; Mackall Trust Funds; NATIONAL EYE INSTITUTE [P30EY001583, R21EY023689] Funding Source: NIH RePORTER	National Eye Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Foundation Fighting Blindness(European Commission); Mackall Trust Funds; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work is supported by the National Eye Institute, National Institutes of Health grants R21EY023689, P30 EY01583-26, the Foundation Fighting Blindness, and the Mackall Trust Funds.	A Martillo Miguel, 2012, Med Hypothesis Discov Innov Ophthalmol, V1, P37; Alten F, 2015, BRIT J OPHTHALMOL, V99, P717, DOI 10.1136/bjophthalmol-2014-305339; [Anonymous], 2008, OPHTHALMOLOGY, V115, P9, DOI [10.1016/j.ophtha.2008.03.008, DOI 10.1016/J.0PHTHA.2008.03.008]; ARNOLD JJ, 1995, RETINA-J RET VIT DIS, V15, P183, DOI 10.1097/00006982-199515030-00001; Chang YS, 2016, ACTA OPHTHALMOL, V94, pE49, DOI 10.1111/aos.12748; Clemons Traci E, 2005, Ophthalmology, V112, P533; Cohen SY, 2007, BRIT J OPHTHALMOL, V91, P354, DOI 10.1136/bjo.2006.101022; Curcio CA, 2013, RETINA-J RET VIT DIS, V33, P265, DOI 10.1097/IAE.0b013e31827e25e0; De Bats F, 2016, RETINA-J RET VIT DIS, V36, P46, DOI 10.1097/IAE.0000000000000648; Finger RP, 2014, OPHTHALMOLOGY, V121, P1252, DOI 10.1016/j.ophtha.2013.12.034; Garg A, 2013, INVEST OPHTH VIS SCI, V54, P7075, DOI 10.1167/iovs.13-12474; Grewal DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092841; Haas P, 2014, INVEST OPHTH VIS SCI, V55, P2674, DOI 10.1167/iovs.13-13338; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hogg RE, 2014, OPHTHALMOLOGY, V121, P1748, DOI 10.1016/j.ophtha.2014.03.015; Hogg RE, 2014, OPTOMETRY VISION SCI, V91, P854, DOI 10.1097/OPX.0000000000000287; Joachim N, 2014, OPHTHALMOLOGY, V121, P917, DOI 10.1016/j.ophtha.2013.10.043; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Klein R, 2008, AM J OPHTHALMOL, V145, P317, DOI 10.1016/j.ajo.2007.09.008; Knudtson MD, 2004, INVEST OPHTH VIS SCI, V45, P2135, DOI 10.1167/iovs.03-1085; Lee MY, 2012, AM J OPHTHALMOL, V153, P530, DOI 10.1016/j.ajo.2011.08.012; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Marsiglia M, 2013, INVEST OPHTH VIS SCI, V54, P7362, DOI 10.1167/iovs.12-11073; MIMOUN G, 1990, J FR OPHTALMOL, V13, P511; Mrejen S, 2014, OPHTHALMOLOGY, V121, P545, DOI 10.1016/j.ophtha.2013.09.026; Oak ASW, 2014, RETINA-J RET VIT DIS, V34, P825, DOI 10.1097/IAE.0000000000000121; Pumariega NM, 2011, OPHTHALMOLOGY, V118, P1619, DOI 10.1016/j.ophtha.2011.01.029; Querques G, 2013, OPHTHALMOLOGY, V120, P872, DOI 10.1016/j.ophtha.2012.12.007; Querques G, 2012, INVEST OPHTH VIS SCI, V53, P1258, DOI 10.1167/iovs.11-8907; Rudolf M, 2008, EXP EYE RES, V87, P402, DOI 10.1016/j.exer.2008.07.010; Saade C, 2014, CLIN EXP OPHTHALMOL, V42, P865, DOI 10.1111/ceo.12353; Sarks J, 2011, BRIT J OPHTHALMOL, V95, P979, DOI 10.1136/bjo.2010.194977; SARKS SH, 1976, BRIT J OPHTHALMOL, V60, P324, DOI 10.1136/bjo.60.5.324; Sawa M, 2014, RETINA-J RET VIT DIS, V34, P761, DOI 10.1097/01.iae.0000434566.57189.37; Schmitz-Valckenberg S, 2011, INVEST OPHTH VIS SCI, V52, P5009, DOI 10.1167/iovs.11-7235; Smith RT, 2009, AM J OPHTHALMOL, V148, P733, DOI 10.1016/j.ajo.2009.06.028; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Spaide RF, 2014, RETINA-J RET VIT DIS, V34, P2336, DOI 10.1097/IAE.0000000000000377; Spaide RF, 2013, RETINA-J RET VIT DIS, V33, P1800, DOI 10.1097/IAE.0b013e31829c3765; Spaide RF, 2010, RETINA-J RET VIT DIS, V30, P1163, DOI 10.1097/IAE.0b013e3181ed8d05; Steinberg JS, 2013, INVEST OPHTH VIS SCI, V54, P4054, DOI 10.1167/iovs.12-11538; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Ueda-Arakawa N, 2013, RETINA-J RET VIT DIS, V33, P490, DOI 10.1097/IAE.0b013e318276e0ae; Wallace BC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-80; Wong T, 2008, OPHTHALMOLOGY, V115, P116, DOI 10.1016/j.ophtha.2007.03.008; Xu LN, 2013, RETINA-J RET VIT DIS, V33, P1850, DOI 10.1097/IAE.0b013e31828991b2; Yoneyama S, 2014, GRAEF ARCH CLIN EXP, V252, P1435, DOI 10.1007/s00417-014-2601-y; Zhang YH, 2014, AM J OPHTHALMOL, V158, P584, DOI 10.1016/j.ajo.2014.05.038; Zweifel SA, 2010, OPHTHALMOLOGY, V117, P1775, DOI 10.1016/j.ophtha.2010.01.027; Zweifel SA, 2010, OPHTHALMOLOGY, V117, P303, DOI 10.1016/j.ophtha.2009.07.014	50	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149030	10.1371/journal.pone.0149030	http://dx.doi.org/10.1371/journal.pone.0149030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895455	Green Published, gold, Green Submitted			2022-12-27	WOS:000371223400030
J	Scarf, V; Catling, C; Viney, R; Homer, C				Scarf, Vanessa; Catling, Christine; Viney, Rosalie; Homer, Caroline			Costing Alternative Birth Settings for Women at Low Risk of Complications: A Systematic Review	PLOS ONE			English	Article							PLANNED HOSPITAL BIRTHS; STANDARD MATERNITY CARE; HOME BIRTHS; MIDWIFERY; OUTCOMES; AUSTRALIA; CENTERS; UNIT	Background There is demand from women for alternatives to giving birth in a standard hospital setting however access to these services is limited. This systematic review examines the literature relating to the economic evaluations of birth setting for women at low risk of complications. Methods Searches of the literature to identify economic evaluations of different birth settings of the following electronic databases: MEDLINE, CINAHL, EconLit, Business Source Complete and Maternity and Infant care. Relevant English language publications were chosen using keywords and MeSH terms between 1995 and 2015. Inclusion criteria included studies focussing on the comparison of birth setting. Data were extracted with respect to study design, perspective, PICO principles, and resource use and cost data. Results Eleven studies were included from Australia, Canada, the Netherlands, Norway, the USA, and the UK. Four studies compared costs between homebirth and the hospital setting and the remaining seven focussed on the cost of birth centre care and the hospital setting. Six studies used a cost-effectiveness analysis and the remaining five studies used cost analysis and cost comparison methods. Eight of the 11 studies found a cost saving in the alternative settings. Two found no difference in the cost of the alternative settings and one found an increase in birth centre care. Conclusions There are few studies that compare the cost of birth setting. The variation in the results may be attributable to the cost data collection processes, difference in health systems and differences in which costs were included. A better understanding of the cost of birth setting is needed to inform policy makers and service providers.	[Scarf, Vanessa; Catling, Christine; Homer, Caroline] Univ Technol Sydney, Ctr Midwifery Child & Family Heath, Sydney, NSW 2007, Australia; [Viney, Rosalie] Univ Technol Sydney, Ctr Hlth Econ Res & Evaluat, Sydney, NSW 2007, Australia	University of Technology Sydney; University of Technology Sydney	Scarf, V (corresponding author), Univ Technol Sydney, Ctr Midwifery Child & Family Heath, Sydney, NSW 2007, Australia.	Vanessa.scarf@uts.edu.au	Catling, Christine J/F-8756-2015; Homer, Caroline/J-2101-2014	Catling, Christine J/0000-0001-7352-2879; Viney, Rosalie/0000-0002-0039-9635; Scarf, Vanessa/0000-0003-3503-9610; Homer, Caroline/0000-0002-7454-3011	National Health and Medical Research (NHMRC) [APP1022422]	National Health and Medical Research (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Birthplace in Australia is a National Health and Medical Research (NHMRC) funded project (APP1022422).	Alliman J, 2016, J MIDWIFERY WOMENS H; Anderson RE, 1999, J NURSE-MIDWIFERY, V44, P30, DOI 10.1016/S0091-2182(98)00072-X; Anderson R, 2010, HEALTH ECON, V19, P350, DOI 10.1002/hec.1486; [Anonymous], 2009, SYSTEMATIC REV CRDS; [Anonymous], 2009, IMPR MAT SERV AUSTR; Australian Institute of Health and Aging, 2014, AUSTR HOSP STAT 2012; Barbieri M, 2005, VALUE HEALTH, V8, P10, DOI 10.1111/j.1524-4733.2005.03070.x; Benoit C, 2005, SOCIOL HEALTH ILL, V27, P722, DOI 10.1111/j.1467-9566.2005.00471.x; Bernitz S, 2012, MIDWIFERY, V28, P591, DOI 10.1016/j.midw.2012.06.001; Blix E, 2012, SEX REPROD HEALTHC, V3, P147, DOI 10.1016/j.srhc.2012.10.001; Brocklehurst P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7400; Catling-Paull C, 2013, MED J AUSTRALIA, V198, P616, DOI 10.5694/mja12.11665; Davis Betty-Anne., 2002, BIRTH DESIGN PREGNAN, P70; Department of Health, 2011, NAT MAT SERV PLAN 20; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Economic and Social Research Institute, 2014, PER STAT REP 2013; Hatem M, 2008, MIDWIFE LED VERSUS O; Henderson J, 2008, BIRTH-ISS PERINAT C, V35, P136, DOI 10.1111/j.1523-536X.2008.00227.x; Hendrix MJC, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-211; Hilder L., 2014, AUSTR MOTHERS BABIES; Homer C S, 2001, Aust Health Rev, V24, P85; Homer CSE, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-206; Howell Embry, 2014, Medicare Medicaid Res Rev, V4, DOI 10.5600/mmrr.004.03.a06; HUNDLEY VA, 1995, MIDWIFERY, V11, P103, DOI 10.1016/0266-6138(95)90024-1; Hutton EK, 2009, BIRTH-ISS PERINAT C, V36, P180, DOI 10.1111/j.1523-536X.2009.00322.x; Janssen PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133524; Kenny C, 2015, COST COMPARISON MIDW; Khan KS, 2003, J ROY SOC MED, V96, P118, DOI 10.1258/jrsm.96.3.118; Li Z, 2013, AUSTR MOTHERS BABIES; MacDorman MF, 2014, TRENDS OUT HOSP BIRT; Monk A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006252; Mushinski M, 1998, Stat Bull Metrop Insur Co, V79, P17; Redshaw M, 2011, MAPPING MATERNITY CA; Reinharz D, 2000, CAN J PUBLIC HEALTH, V91, pI12, DOI 10.1007/BF03404261; ROOKS JP, 1989, NEW ENGL J MED, V321, P1804, DOI 10.1056/NEJM198912283212606; Sandall J, 2013, COCHRANE DATABASE SY, V8; Schroeder E, 2012, BRIT MED J, V344, P18; Schroeder L, 2011, BIRTHPLACE ENGLAND R, P5; Shemilt I, 2008, COCHRANE HDB SYSTEMA, P449, DOI DOI 10.1002/14651858.CD004741.PUB2; STONE PW, 1995, NURS ECON, V13, P299; Sutcliffe K, 2012, J ADV NURS, V68, P2376, DOI 10.1111/j.1365-2648.2012.05998.x; Toohill J, 2012, MIDWIFERY, V28, pE874, DOI 10.1016/j.midw.2011.10.012; Tracy SK, 2007, BIRTH-ISS PERINAT C, V34, P194, DOI 10.1111/j.1523-536X.2007.00171.x; Tracy SK, 2013, LANCET, V382, P1723, DOI 10.1016/S0140-6736(13)61406-3; Tracy SK, 2003, BJOG-INT J OBSTET GY, V110, P717, DOI 10.1111/j.1471-0528.2003.02045.x; Wiegers TA, 2000, MIDWIFERY, V16, P96, DOI 10.1054/midw.1999.0195	46	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149463	10.1371/journal.pone.0149463	http://dx.doi.org/10.1371/journal.pone.0149463			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3CO	26891444	Green Published, Green Submitted, gold			2022-12-27	WOS:000371221500048
J	Yu, CJ; Du, JC; Chiou, HC; Yang, SH; Liao, KW; Yang, WN; Chung, MY; Chien, LC; Hwang, BT; Chen, ML				Yu, Ching-Jung; Du, Jung-Chieh; Chiou, Hsien-Chih; Yang, Shang-Han; Liao, Kai-Wei; Yang, Winnie; Chung, Ming-Yi; Chien, Ling-Chu; Hwang, Betau; Chen, Mei-Lien			Attention Deficit/Hyperactivity Disorder and Urinary Nonylphenol Levels: A Case-Control Study in Taiwanese Children	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; BLOOD LEAD LEVELS; VERSION-IV SCALE; BISPHENOL-A; PSYCHOMETRIC PROPERTIES; ENDOCRINE DISRUPTORS; CHINESE CHILDREN; BIRTH-WEIGHT; ALCOHOL-USE; EXPOSURE	Objective Nonylphenol (NP) belongs to the family of endocrine disruptors, and it is widely used in industrial applications and is ubiquitous in daily foods. Animal studies have suggested that NP exposure might promote motor hyperactivity, likely by causing deficits in dopaminergic neurons. However, research assessing NP exposure and epidemiology studies on human populations are limited. The aim of this study was to explore the association between child NP exposure and ADHD while considering particular covariants, such as lead levels and dopamine-related gene variations. Methods A case-control study was conducted on patients with clinically diagnosed ADHD; the Swanson, Nolan and Pelham, Fourth Revision (SNAP-IV) questionnaire was used to identify normal controls aged 4-15 years. Participants were examined for urinary NP concentrations, blood lead levels, and select single-nucleotide polymorphisms of two dopamine-related genes (D4 dopamine receptor, DRD4, and dopamine transporter, DAT1). Socio-demographic variables, maternal lifestyle factors during pregnancy and family medical history were obtained using a questionnaire. Results A total of 97 children with doctor-diagnosed ADHD and 110 normal controls were enrolled. The blood lead levels in both groups were similar (1.57 +/- 0.73 vs. 1.73 +/- 0.77 mu g/dL, p = 0.15). No significant difference in urinary NP concentration was found between the children with ADHD and the control subjects (4.52 +/- 3.22 mu g/g cr. vs. 4.64 +/- 2.95 mu g/g cr., p = 0.43). ADHD was significantly more prevalent among males in this study (male to female ratio:5:1 for the ADHD group and 1.3:1 for the control group, p<0.01). The analysis was repeated after excluding the females, but this had no effect on the association between NP and ADHD. The regression model, including or excluding females, indicated no increased odds of having ADHD in the context of NP exposure after adjusting for covariants. Conclusion This study indicated that NP exposure might not promote ADHD in children, even though children in Taiwan had relatively high levels of NP compared to those reported previously and those in developed nations.	[Yu, Ching-Jung; Yang, Shang-Han; Liao, Kai-Wei; Chen, Mei-Lien] Natl Yang Ming Univ, Inst Environm & Occupat Hlth Sci, Sch Med, Taipei 112, Taiwan; [Du, Jung-Chieh; Hwang, Betau] Taipei City Hosp, Zhongxiao branch, Dept Pediat, Taipei, Taiwan; [Chiou, Hsien-Chih] Taipei City Hosp, Songde Branch, Dept Child & Adolescent Psychiat, Taipei, Taiwan; [Yang, Winnie] Taipei City Hosp, Yangming Branch, Dept Pediat, Taipei, Taiwan; [Chung, Ming-Yi] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Chung, Ming-Yi] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Chien, Ling-Chu] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei City Hospital; Taipei City Hospital; Taipei City Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Medical University	Chen, ML (corresponding author), Natl Yang Ming Univ, Inst Environm & Occupat Hlth Sci, Sch Med, Taipei 112, Taiwan.	mlchen@ym.edu.tw	Liao, Kai-Wei/AAW-5992-2020	Liao, Kai-Wei/0000-0003-3842-416X; Chien, Ling-Chu/0000-0001-5539-8974; Chung, Ming-yi/0000-0003-2198-6860	Department of Health, Taipei City Government; Aiming for the Top University Plan from the Ministry of Education of the Republic of China, Taiwan; National Science Council of Taiwan [NSC 96-2314-B-010-020-MY3]; National Core Facility Program for Biotechnology of Taiwan [MOST 103-2319-B-010-001]	Department of Health, Taipei City Government; Aiming for the Top University Plan from the Ministry of Education of the Republic of China, Taiwan; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Core Facility Program for Biotechnology of Taiwan	This study was financially supported by Department of Health, Taipei City Government, and Aiming for the Top University Plan from the Ministry of Education of the Republic of China, Taiwan. The work was also supported by the National Science Council of Taiwan, grant number NSC 96-2314-B-010-020-MY3, and by MOST 103-2319-B-010-001 from the National Core Facility Program for Biotechnology of Taiwan. The funding sources had no involvement in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.; We would like to thank the Department of Health, Taipei City Government, and Aiming for the Top University Plan from the Ministry of Education of the Republic of China, Taiwan, for financially supporting this research. The work was also supported by the National Science Council of Taiwan. The authors also acknowledge the High-throughput Genome Analysis Core Facility of National Core Facility Program for Biotechnology, Taiwan, for SNP genotyping. This manuscript has been edited by American Journal Experts.	Aguiar A, 2010, ENVIRON HEALTH PERSP, V118, P1646, DOI 10.1289/ehp.1002326; Aronson M, 1997, DEV MED CHILD NEUROL, V39, P583; Asimakopoulos AG, 2012, TOXICOL LETT, V210, P141, DOI 10.1016/j.toxlet.2011.07.032; Association A. P., 2000, DIAGN STAT MAN TEXT; Biederman J, 2005, BIOL PSYCHIAT, V57, P1215, DOI 10.1016/j.biopsych.2004.10.020; Biederman J, 2002, AM J PSYCHIAT, V159, P36, DOI 10.1176/appi.ajp.159.1.36; Biederman J, 2014, AM J PSYCHIAT; Bouchard MF, 2010, PEDIATRICS, V125, pE1270, DOI 10.1542/peds.2009-3058; Brooke L, 2005, AMBIENT AQUATIC LIFE; Brookes K, 2006, MOL PSYCHIATR, V11, P934, DOI 10.1038/sj.mp.4001869; Bussing R, 2008, ASSESSMENT, V15, P317, DOI 10.1177/1073191107313888; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; CDC, CDCS CHILDH LEAD POI; Chang CH, 2013, CHEMOSPHERE, V93, P1145, DOI 10.1016/j.chemosphere.2013.06.048; Chen HW, 2013, SCI TOTAL ENVIRON, V449, P20, DOI 10.1016/j.scitotenv.2013.01.038; Chen ML, 2008, CHEMOSPHERE, V73, pS239, DOI 10.1016/j.chemosphere.2007.04.091; Chen ML, 2009, CHEMOSPHERE, V76, P927, DOI 10.1016/j.chemosphere.2009.04.054; Chen ML, 2005, INT J ENVIRON AN CH, V85, P335, DOI 10.1080/03067310412331315575; Cheng CY, 2002, J CHROMATOGR A, V968, P143, DOI 10.1016/S0021-9673(02)00959-7; Cheuk DKL, 2006, NEUROPEDIATRICS, V37, P234, DOI 10.1055/s-2006-924577; Chiodo LM, 2004, NEUROTOXICOL TERATOL, V26, P359, DOI 10.1016/j.ntt.2004.01.010; CORYSLECHTA DA, 1995, ANNU REV PHARMACOL, V35, P391, DOI 10.1146/annurev.pharmtox.35.1.391; Das Banerjee T, 2007, ACTA PAEDIATR, V96, P1269, DOI 10.1111/j.1651-2227.2007.00430.x; de Cock M, 2012, ACTA PAEDIATR, V101, P811, DOI 10.1111/j.1651-2227.2012.02693.x; DiMaio S, 2003, J PSYCHIATR NEUROSCI, V28, P27; Ding WH, 2000, J CHROMATOGR A, V866, P79, DOI 10.1016/S0021-9673(99)01059-6; Emond V, 2009, ENCEPHALE, V35, P107, DOI 10.1016/j.encep.2008.01.005; Eubig PA, 2010, ENVIRON HEALTH PERSP, V118, P1654, DOI 10.1289/ehp.0901852; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Frumkin H. e, 2005, ENV HLTH GLOBAL LOCA, V11; Gau SSF, 2008, INT J METH PSYCH RES, V17, P35, DOI 10.1002/mpr.237; Gau SSF, 2009, J PEDIATR PSYCHOL, V34, P850, DOI 10.1093/jpepsy/jsn133; Guenther K, 2002, ENVIRON SCI TECHNOL, V36, P1676, DOI 10.1021/es010199v; Hechtman L, 1996, CAN J PSYCHIAT, V41, P350, DOI 10.1177/070674379604100605; HEINEGAR.D, 1973, CLIN CHIM ACTA, V43, P305, DOI 10.1016/0009-8981(73)90466-X; Huang HL, 2003, PSYCHIAT CLIN NEUROS, V57, P275, DOI 10.1046/j.1440-1819.2003.01117.x; Huang PC, 2012, ENVIRON INT, V40, P88, DOI 10.1016/j.envint.2011.10.011; Huang YF, 2014, ENVIRON RES, V134, P143, DOI 10.1016/j.envres.2014.07.004; Inoue K, 2001, FOOD ADDIT CONTAM, V18, P157, DOI 10.1080/02652030010018930; John DM, 1998, J BACTERIOL, V180, P4332, DOI 10.1128/JB.180.17.4332-4338.1998; Kajta M, 2013, PHARMACOL REP, V65, P1632, DOI 10.1016/S1734-1140(13)71524-X; Kim BN, 2009, BIOL PSYCHIAT, V66, P958, DOI 10.1016/j.biopsych.2009.07.034; Knopik VS, 2006, PSYCHOL MED, V36, P1461, DOI 10.1017/S0033291706007884; Kuppers E, 2001, HORM BEHAV, V40, P196, DOI 10.1006/hbeh.2001.1671; Laws SC, 2000, TOXICOL SCI, V54, P154, DOI 10.1093/toxsci/54.1.154; Li X, 2013, ENVIRON INT, V52, P81, DOI 10.1016/j.envint.2011.03.026; Linnet KM, 2006, ARCH DIS CHILD, V91, P655, DOI 10.1136/adc.2005.088872; Linnet KM, 2003, AM J PSYCHIAT, V160, P1028, DOI 10.1176/appi.ajp.160.6.1028; Lopez-Espinosa MJ, 2009, CHEMOSPHERE, V76, P847, DOI 10.1016/j.chemosphere.2009.03.063; Loyo-Rosales JE, 2004, J AGR FOOD CHEM, V52, P2016, DOI 10.1021/jf0345696; Lu J, 2008, CHEMOSPHERE, V71, P345, DOI 10.1016/j.chemosphere.2007.08.068; Lu YY, 2007, ENVIRON INT, V33, P903, DOI 10.1016/j.envint.2007.04.008; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Mao Z, 2008, NEUROSCI LETT, V439, P147, DOI 10.1016/j.neulet.2008.05.006; Markey CM, 2002, J STEROID BIOCHEM, V83, P235, DOI 10.1016/S0960-0760(02)00272-8; Masuo Y, 2004, REGUL PEPTIDES, V123, P225, DOI 10.1016/j.regpep.2004.05.010; Masuo Yoshinori, 2004, Neural Plasticity, V11, P59, DOI 10.1155/NP.2004.59; Mick E, 2002, J AM ACAD CHILD PSY, V41, P378, DOI 10.1097/00004583-200204000-00009; Millichap J.G., 2009, ATTENTION DEFICIT HY; Millichap JG, 2008, PEDIATRICS, V121, pE358, DOI 10.1542/peds.2007-1332; Muller S, 1998, ENVIRON TOXICOL PHAR, V5, P257, DOI 10.1016/S1382-6689(98)00009-X; Mundry R, 1998, ANIM BEHAV, V56, P256, DOI 10.1006/anbe.1998.0756; NEEDLEMAN HL, 1993, NEUROTOXICOLOGY, V14, P161; Nielsen E, TOXICOLOGICAL EVALUA; Pan YP, 2009, CHEMOSPHERE, V76, P381, DOI 10.1016/j.chemosphere.2009.03.034; Pirard C, 2012, ENVIRON INT, V48, P78, DOI 10.1016/j.envint.2012.07.003; Rothman K., 1998, MODERN EPIDEMIOLOGY; Sauver JLS, 2004, MAYO CLIN P; Schneider JS, 2003, NEUROTOXICOL TERATOL, V25, P555, DOI 10.1016/S0892-0362(03)00018-7; Shen Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079838; Shue MF, 2010, ENVIRON MONIT ASSESS, V168, P91, DOI 10.1007/s10661-009-1093-4; Soares A, 2008, ENVIRON INT, V34, P1033, DOI 10.1016/j.envint.2008.01.004; Swanson JM, 2001, J AM ACAD CHILD PSY, V40, P168, DOI 10.1097/00004583-200102000-00011; Swanson JM., 1995, SNAP 4 SCALE; Tan BLL, 2003, TOXICOL LETT, V143, P261, DOI 10.1016/S0378-4274(03)00172-3; Thapar A, 2013, J CHILD PSYCHOL PSYC, V54, P3, DOI 10.1111/j.1469-7610.2012.02611.x; Tsai MS, 2013, SCI TOTAL ENVIRON, V458, P367, DOI [10.1016/j.scitotenv.2013.04,039, 10.1016/j.scitotenv.2013.04.039]; Wang CL, 2002, ENVIRON RES, V89, P12, DOI 10.1006/enrs.2002.4342; Wang HL, 2008, ENVIRON HEALTH PERSP, V116, P1401, DOI 10.1289/ehp.11400; WHITE R, 1994, ENDOCRINOLOGY, V135, P175, DOI 10.1210/en.135.1.175; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8	81	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149558	10.1371/journal.pone.0149558	http://dx.doi.org/10.1371/journal.pone.0149558			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890918	Green Published, Green Submitted, gold			2022-12-27	WOS:000371221500059
J	Almoosawi, S; Jones, AR; Parkinson, KN; Pearce, MS; Collins, H; Adamson, AJ				Almoosawi, Suzana; Jones, Angela R.; Parkinson, Kathryn N.; Pearce, Mark S.; Collins, Heather; Adamson, Ashley J.			Parental Perception of Weight Status: Influence on Children's Diet in the Gateshead Millennium Study	PLOS ONE			English	Article							OVERWEIGHT; ASSOCIATION; ADOLESCENTS; PATTERNS; OBESITY; ADULTHOOD; CHILDHOOD; THINNESS; HEALTH; RISK	Objective Recognising overweight and obesity is critical to prompting action, and consequently preventing and treating obesity. The present study examined the association between parental perceptions of child weight status and child's diet. Methods Participants were members of the Gateshead Millennium Study. Parental perception of their child's weight status was assessed using a questionnaire and compared against International Obesity Task Force cut-offs for childhood overweight and obesity when the children were aged 6-8 years old. Diet was assessed at age 6-8years old using the FAST (Food Assessment in Schools Tool) food diary method. The association between parental perception and dietary patterns as defined by Principal Components Analysis, was assessed using multivariate regression after adjustment for child's gender, child's weight status, maternal body mass index (BMI), maternal education and deprivation status. Results Of the 361 parents who provided complete data on confounders and on their perception of their child's weight status, 63 (17%) parents perceived their child as being of 'normal' weight or 'overweight' when they were actually 'overweight' or 'obese', respectively. After adjustment for confounders, parents who misperceived their child's weight had children with a lower 'healthy' dietary pattern score compared to children whose parents correctly perceived their weight (beta = -0.88; 95% CI: -1.7, -0.1; P-value = 0.028). This association was found despite higher consumption of reduced sugar carbonated drinks amongst children whose parents incorrectly perceived their weight status compared to children whose parents perceived their weight correctly (52.4% vs. 33.6%; P-value = 0.005). Conclusions In conclusion, children whose parents did not correctly perceive their weight status scored lower on the 'healthy' dietary pattern. Further research is required to define parents' diets based on their perception status and to examine if a child's or parent's diet mediates the association between parental perception and child weight.	[Almoosawi, Suzana; Jones, Angela R.; Parkinson, Kathryn N.; Adamson, Ashley J.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Almoosawi, Suzana; Jones, Angela R.; Parkinson, Kathryn N.; Adamson, Ashley J.] Newcastle Univ, Human Nutr Res Ctr, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Pearce, Mark S.] Royal Victoria Infirm, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Pearce, Mark S.] Royal Victoria Infirm, Sir James Spence Inst Child Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Collins, Heather] Newcastle Univ, Fac Med Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Almoosawi, S (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Almoosawi, S (corresponding author), Newcastle Univ, Human Nutr Res Ctr, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	suzana.almoosawi@ncl.ac.uk		Adamson, Ashley/0000-0003-3735-2846; Pearce, Mark/0000-0002-0583-3779; Jones, Angela/0000-0001-8293-0858; almoosawi, suzana/0000-0003-2803-6120	National Prevention Research Initiative (British Heart Foundation); National Prevention Research Initiative (Cancer Research UK); National Prevention Research Initiative (Department of Health); National Prevention Research Initiative (Diabetes UK); National Prevention Research Initiative (Economic and Social Research Council); National Prevention Research Initiative (Food Standards Agency); National Prevention Research Initiative (Medical Research Council); National Prevention Research Initiative (Research and Development Office for the Northern Ireland Health and Social Services); National Prevention Research Initiative (Chief Scientist Office, Scottish Government Health Directorates); National Prevention Research Initiative (Welsh Assembly Government); National Prevention Research Initiative (World Cancer Research Fund); Henry Smith Charity; Sport Aiding Research in Kids (SPARKS); Gateshead NHS Trust RD; Northern and Yorkshire NHS RD; Northumberland, Tyne and Wear NHS Trust [CZH/4/484]; National Institute for Health Research (NIHR); NIHR [NIHR-RP-R2-12-001]; External Reference Group; Gateshead Education Authority; Medical Research Council [MR/K02325X/1B, G0501306, MR/K02325X/1] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-02-12-001] Funding Source: researchfish; MRC [G0501306] Funding Source: UKRI	National Prevention Research Initiative (British Heart Foundation); National Prevention Research Initiative (Cancer Research UK); National Prevention Research Initiative (Department of Health); National Prevention Research Initiative (Diabetes UK)(Diabetes UK); National Prevention Research Initiative (Economic and Social Research Council); National Prevention Research Initiative (Food Standards Agency); National Prevention Research Initiative (Medical Research Council); National Prevention Research Initiative (Research and Development Office for the Northern Ireland Health and Social Services); National Prevention Research Initiative (Chief Scientist Office, Scottish Government Health Directorates); National Prevention Research Initiative (Welsh Assembly Government); National Prevention Research Initiative (World Cancer Research Fund); Henry Smith Charity; Sport Aiding Research in Kids (SPARKS); Gateshead NHS Trust RD; Northern and Yorkshire NHS RD; Northumberland, Tyne and Wear NHS Trust; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); External Reference Group; Gateshead Education Authority; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Gateshead Millennium Study is supported by a grant from the National Prevention Research Initiative (incorporating funding from British Heart Foundation; Cancer Research UK; Department of Health; Diabetes UK; Economic and Social Research Council; Food Standards Agency; Medical Research Council; Research and Development Office for the Northern Ireland Health and Social Services; Chief Scientist Office, Scottish Government Health Directorates; Welsh Assembly Government and World Cancer Research Fund). The cohort was first established with funding from the Henry Smith Charity and Sport Aiding Research in Kids (SPARKS) and followed up with grants from Gateshead NHS Trust R&D, Northern and Yorkshire NHS R&D, and Northumberland, Tyne and Wear NHS Trust (CZH/4/484). AJA is funded by the National Institute for Health Research (NIHR) Professorship and SA is a postdoctoral fellow under the NIHR Professorship Grant (NIHR-RP-R2-12-001).; The survey was ran and field data collected by the Gateshead Millennium Study core team.We acknowledge the support of an External Reference Group in conducting the study. We appreciate the support of Gateshead Education Authority and local schools. We warmly thank the research team for their effort. Thanks are especially due to the Gateshead Millennium Study families and children for their participation in the study.	Adamson AJ, 2003, P NUTR SOC, V62, p35A; Adamson AJ, 2003, FAST FOOD ASSESSMENT, p84A; Baughcum AE, 2000, PEDIATRICS, V106, P1380, DOI 10.1542/peds.106.6.1380; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Craig LCA, 2010, BRIT J NUTR, V103, P319, DOI 10.1017/S0007114509991942; de Hoog MLA, 2012, INT J OBESITY, V36, P53, DOI 10.1038/ijo.2011.199; Doolen J, 2009, J AM ACAD NURSE PRAC, V21, P160, DOI 10.1111/j.1745-7599.2008.00382.x; Eckstein KC, 2006, PEDIATRICS, V117, P681, DOI 10.1542/peds.2005-0910; Faith MS, 2012, CIRCULATION, V125, P1186, DOI 10.1161/CIR.0b013e31824607ee; Freedman DS, 2001, PEDIATRICS, V108, P712, DOI 10.1542/peds.108.3.712; Genovesi S, 2005, ACTA PAEDIATR, V94, P747, DOI 10.1080/08035250510028894; GREGORY J, 2000, NATL DIET NUTR SURVE, V1; Gregory JR, 1995, NATL DIET NUTR SURVE; Huang JS, 2007, PEDIATRICS, V120, pE112, DOI 10.1542/peds.2006-2143; Jeffery AN, 2004, EARLYBIRD, V21; Jones AR, 2011, INT J OBESITY, V35, P953, DOI 10.1038/ijo.2011.106; Krebs J., 2002, MCCANCE WIDDOWSONS C; Lim HJ, 2013, OBESITY, V21, P2596, DOI 10.1002/oby.20361; Mikkila V, 2005, BRIT J NUTR, V93, P923, DOI 10.1079/BJN20051418; Neumark-Sztainer D, 2008, PEDIATRICS, V121, pE1495, DOI 10.1542/peds.2007-2642; Parkinson KN, 2011, INT J OBESITY, V35, P510, DOI 10.1038/ijo.2010.260; Parkinson KN, 2011, INT J EPIDEMIOL, V40, P308, DOI 10.1093/ije/dyq015; PARKINSON KN, 2007, INT J SOC RES METHOD, V10, P335; Rhee KE, 2005, PEDIATRICS, V116, pE94, DOI 10.1542/peds.2004-2479; Rietmeijer-Mentink M, 2013, MATERN CHILD NUTR, V9, P3, DOI 10.1111/j.1740-8709.2012.00462.x; Skala M, 2007, INT J RADIAT ONCOL, V68, P690, DOI 10.1016/j.ijrobp.2006.12.064; Tompkins CL, 2015, J CHILD FAM STUD, V24, P1384, DOI 10.1007/s10826-014-9945-0; WHO, 2000, OB PREV MAN GLOB EP; WHO, 2014, CHILDH OV OB	30	31	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0144931	10.1371/journal.pone.0144931	http://dx.doi.org/10.1371/journal.pone.0144931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886851	gold, Green Published, Green Submitted			2022-12-27	WOS:000371218400002
J	Andersen, TR; Schmidt, JF; Pedersen, MT; Krustrup, P; Bangsbo, J				Andersen, Thomas Rostgaard; Schmidt, Jakob Friis; Pedersen, Mogens Theisen; Krustrup, Peter; Bangsbo, Jens			The Effects of 52 Weeks of Soccer or Resistance Training on Body Composition and Muscle Function in+65-Year-Old Healthy Males - A Randomized Controlled Trial	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; CARDIOVASCULAR HEALTH; PHYSICAL-ACTIVITY; EXERCISE; FOOTBALL; PROTEIN; STRENGTH; PERFORMANCE; PREVENTION; PROFILE	The effects of 52 weeks of soccer or resistance training were investigated in untrained elderly men. The subjects aged 68.1 +/- 2.1 yrs were randomised into a soccer (SG; n = 9), a resistance (RG; n = 9) and a control group (CG; n = 8). The subjects in SG and RG, respectively, trained 1.7 +/- 0.3 and 1.8 +/- 0.3 times weekly on average during the intervention period. Muscle function and body composition were determined before and after 16 and 52 weeks of the intervention period. In SG, BMI was reduced by 1.5% and 3.0% (p<0.05) after 16 and 52 weeks, respectively, unchanged in RG and 2% higher (p<0.05) in CG after 52 weeks of the intervention period. In SG, the response to a glucose tolerance test was 16% lower (p<0.05) after 16 wks, but not after 52 wks, compared to before the intervention period, and unchanged in RG and CG. In SG, superoxide dismutase-2 expression was 59% higher (p<0.05) after 52 wks compared to before the intervention period, and unchanged in RG and CG. In RG, upper body lean mass was 3 and 2% higher (p<0.05) after 16 and 52 wks, respectively, compared to before the intervention period, and unchanged in SG and CG. In RG, Akt-2 expression increased by 28% (p<0.01) and follistatin expression decreased by 38% (p<0.05) during the 52-wk intervention period, and was unchanged in SG and CG. Thus, long-term soccer training reduces BMI and improves anti-oxidative capacity, while long-term resistance training impacts muscle protein enzyme expression and increases lean body mass in elderly men.	[Andersen, Thomas Rostgaard; Schmidt, Jakob Friis; Pedersen, Mogens Theisen; Krustrup, Peter; Bangsbo, Jens] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen Ctr Team Sport & Hlth, Copenhagen, Denmark; [Schmidt, Jakob Friis] Gentofte Univ Hosp, Dept Cardiol, Gentofte, Denmark; [Krustrup, Peter] Univ Exeter, Coll Life & Environm Sci, Sport & Hlth Sci, Exeter, Devon, England	University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Exeter	Bangsbo, J (corresponding author), Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen Ctr Team Sport & Hlth, Copenhagen, Denmark.	jbangsbo@nexs.ku.dk	Krustrup, Peter/D-2659-2019; Bangsbo, Jens/A-7192-2015; Pedersen, Mogens Theisen/C-6991-2015	Krustrup, Peter/0000-0002-1461-9838; Andersen, Thomas Rostgaard/0000-0002-0315-0202; Bangsbo, Jens/0000-0003-1305-9274; Pedersen, Mogens Theisen/0000-0002-3178-6320	FIFA - Medical Assessment and Research Centre (FMARC) (F-MARC Project) [31964]; Danish Ministry of Culture (Kulturministeriets Udvalg for Idraetsforskning) [TKIF 2010-027]; Nordea-fonden [02-2011-4360]; FIFA-Medical Assessment and Research Centre (F-MARC) [31964]	FIFA - Medical Assessment and Research Centre (FMARC) (F-MARC Project); Danish Ministry of Culture (Kulturministeriets Udvalg for Idraetsforskning); Nordea-fonden; FIFA-Medical Assessment and Research Centre (F-MARC)	The study was supported by the FIFA - Medical Assessment and Research Centre (FMARC) (F-MARC Project 31964; http://www.f-marc.com/), The Danish Ministry of Culture (Kulturministeriets Udvalg for Idraetsforskning) (TKIF 2010-027; http://kum.dk/), and Nordea-fonden (Grant code: 02-2011-4360; http://nordeafonden.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to sincerely thank the participants in the study for their efforts. Also, the technical and practical assistance of Peter Bergmann Pill, Morten Bredsgaard Randers Thomsen, Jens Jung Nielsen, Eva Wulff Helge, Martin Thomassen, Therese Hornstrup, Marie Von Hagman and Joshua Horton is greatly appreciated. The study was supported by the FIFA-Medical Assessment and Research Centre (F-MARC) (F-MARC Project 31964) The Danish Ministry of Culture (Kulturministeriets Udvalg for Idraetsforskning) (TKIF 2010-027) and Nordea-fonden (Grant code: 02-2011-4360). The authors have declared that no competing interests exist.	American College of Sports Medicine, 2009, Med Sci Sports Exerc, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; Andersen LG, 2010, SCAND J PUBLIC HEALT, V38, P707, DOI 10.1177/1403494810380099; Andersen TR, 2014, SCAND J MED SCI SPOR, V24, P76, DOI 10.1111/sms.12245; Andersen TR, 2014, SCAND J MED SCI SPOR, V24, P43, DOI 10.1111/sms.12259; Bangsbo J, 2014, SCAND J MED SCI SPOR, V24, P147, DOI 10.1111/sms.12271; Bangsbo J, 2015, BRIT J SPORT MED, V49, P568, DOI 10.1136/bjsports-2015-094781; BERGSTROM J, 1962, SCAND J CLIN LAB INV, V14, P1; BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Daugaard JR, 2001, ACTA PHYSIOL SCAND, V171, P267, DOI 10.1046/j.1365-201x.2001.00829.x; DELA F, 1994, DIABETES, V43, P862, DOI 10.2337/diabetes.43.7.862; Durstine J Larry, 2002, J Cardiopulm Rehabil, V22, P385, DOI 10.1097/00008483-200211000-00002; Duscha BD, 2012, INT J SPORTS MED, V33, P218, DOI 10.1055/s-0031-1291323; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Esmarck B, 2001, J PHYSIOL-LONDON, V535, P301, DOI 10.1111/j.1469-7793.2001.00301.x; FRONTERA WR, 1990, J APPL PHYSIOL, V68, P329, DOI 10.1152/jappl.1990.68.1.329; Fry CS, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-11; Gliemann L, 2013, J PHYSIOL-LONDON, V591, P5047, DOI 10.1113/jphysiol.2013.258061; Hamburg NM, 2007, ARTERIOSCL THROM VAS, V27, P2650, DOI 10.1161/ATVBAHA.107.153288; Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370; Helge EW, 2014, SCAND J MED SCI SPOR; Houmard JA, 1998, J APPL PHYSIOL, V85, P1337, DOI 10.1152/jappl.1998.85.4.1337; Krustrup P, 2009, BRIT J SPORT MED, V43, P825, DOI 10.1136/bjsm.2008.053124; LOWRY OH, 1972, FLEXIBLE SYSTEM ENZY, P237; McHugh ML, 2011, BIOCHEM MEDICA, V21, P203; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4; Mero AA, 2013, EUR J APPL PHYSIOL, V113, P641, DOI 10.1007/s00421-012-2466-x; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Nielsen G, 2014, SCAND J MED SCI SPOR, V24, P66, DOI 10.1111/sms.12275; Nielsen JL, 2012, J PHYSIOL-LONDON, V590, P4351, DOI 10.1113/jphysiol.2012.237008; Nordsborg N, 2008, J PHYSIOL-LONDON, V586, P1447, DOI 10.1113/jphysiol.2007.143073; Nyberg M, 2014, FREE RADIC BIOL MED; Oja P, 2015, BR J SPORTS MED; Phillips SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE99, DOI 10.1152/ajpendo.1997.273.1.E99; Randers MB, 2010, SCAND J MED SCI SPOR, V20, P14, DOI 10.1111/j.1600-0838.2010.01069.x; Schmidt JF, 2013, SCAND J MED SCI SPOR; Schmidt JF, 2014, SCAND J MED SCI SPOR; Thomassen M, 2010, J APPL PHYSL; Tipton KD, 2013, NESTLE NUTR WORKS SE, V76, P73, DOI 10.1159/000350259; Weinert BT, 2003, J APPL PHYSIOL, V95, P1706, DOI 10.1152/japplphysiol.00288.2003	41	23	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148236	10.1371/journal.pone.0148236	http://dx.doi.org/10.1371/journal.pone.0148236			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886262	gold, Green Published, Green Submitted			2022-12-27	WOS:000371218400020
J	Herzog, Q; Rabus, M; Ribeiro, BW; Laforsch, C				Herzog, Quirin; Rabus, Max; Ribeiro, Bernard Wolfschoon; Laforsch, Christian			Inducible Defenses with a "Twist": Daphnia barbata Abandons Bilateral Symmetry in Response to an Ancient Predator	PLOS ONE			English	Article							MORPHOLOGY; INDUCTION; GENOME	Predation is one of the most important drivers of natural selection. In consequence a huge variety of anti-predator defenses have evolved in prey species. Under unpredictable and temporally variable predation pressure, the evolution of phenotypically plastic defensive traits is favored. These "inducible defenses", range from changes in behavior, life history, physiology to morphology and can be found in almost all taxa from bacteria to vertebrates. An important group of model organisms in ecological, evolutionary and environmental research, water fleas of the genus Daphnia (Crustacea: Cladocera), are well known for their ability to respond to predators with an enormous variety of inducible morphological defenses. Here we report on the "twist", a body torsion, as a so far unrecognized inducible morphological defense in Daphnia, expressed by Daphnia barbata exposed to the predatory tadpole shrimp Triops cancriformis. This defense is realized by a twisted carapace with the helmet and the tail spine deviating from the body axis into opposing directions, resulting in a complete abolishment of bilateral symmetry. The twisted morphotype should considerably interfere with the feeding apparatus of the predator, contributing to the effectiveness of the array of defensive traits in D. barbata. As such this study does not only describe a completely novel inducible defense in the genus Daphnia but also presents the first report of a free living Bilateria to flexibly respond to predation risk by abandoning bilateral symmetry.	[Herzog, Quirin] Univ Munich, Dept Biol 2, Planegg Martinsried, Germany; [Rabus, Max; Ribeiro, Bernard Wolfschoon; Laforsch, Christian] Univ Bayreuth, Dept Anim Ecol 1, Bayreuth, Germany; [Laforsch, Christian] Univ Bayreuth, BayCEER, Bayreuth, Germany	University of Munich; University of Bayreuth; University of Bayreuth	Laforsch, C (corresponding author), Univ Bayreuth, Dept Anim Ecol 1, Bayreuth, Germany.; Laforsch, C (corresponding author), Univ Bayreuth, BayCEER, Bayreuth, Germany.	christian.laforsch@uni-bayreuth.de			Universitat Bayern e.V.; German Research Foundation (DFG); University of Bayreuth	Universitat Bayern e.V.; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Bayreuth	QH received a research scholarship from the Universitat Bayern e.V. (http://www.unibayern.de/). This publication was funded by the German Research Foundation (DFG) and the University of Bayreuth in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRONMARK C, 1992, SCIENCE, V258, P1348, DOI 10.1126/science.258.5086.1348; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; DODSON SI, 1974, LIMNOL OCEANOGR, V19, P721, DOI 10.4319/lo.1974.19.5.0721; Ebert D, 2011, SCIENCE, V331, P539, DOI 10.1126/science.1202092; FRYER G, 1988, PHILOS T ROY SOC B, V321, P27, DOI 10.1098/rstb.1988.0091; GILBERT JJ, 1966, SCIENCE, V151, P1234, DOI 10.1126/science.151.3715.1234; Gilbert JJ, 2011, FRESHWATER BIOL, V56, P926, DOI 10.1111/j.1365-2427.2010.02538.x; Harvell CD, 1999, THE ECOLOGY AND EVOL; Herzog Q, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-113; Lampert W., 1987, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V45, P143; Lampert W, 2011, DAPHNIA DEV MODEL OR, P45; Lively CM, 2000, ECOLOGY, V81, P1240, DOI 10.1890/0012-9658(2000)081[1240:PIDVFI]2.0.CO;2; Martindale MQ, 1998, AM ZOOL, V38, P672; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; Palmer AR, 1996, P NATL ACAD SCI USA, V93, P14279, DOI 10.1073/pnas.93.25.14279; Petrusek A, 2009, P NATL ACAD SCI USA, V106, P2248, DOI 10.1073/pnas.0808075106; Rabus M, 2011, FUNCT ECOL, V25, P1137, DOI 10.1111/j.1365-2435.2011.01840.x; TOLLRIAN R, 1994, ARCH HYDROBIOL, V130, P69; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN; Verschoor AM, 2004, ECOL LETT, V7, P1143, DOI 10.1111/j.1461-0248.2004.00675.x	20	25	25	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148556	10.1371/journal.pone.0148556	http://dx.doi.org/10.1371/journal.pone.0148556			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886196	gold, Green Published, Green Submitted			2022-12-27	WOS:000371218400041
J	Rodriguez-Poncelas, A; Mundet-Tuduri, X; Miravet-Jimenez, S; Casellas, A; Barrot-De la Puente, JF; Franch-Nadal, J; Coll-de Tuero, G				Rodriguez-Poncelas, Antonio; Mundet-Tuduri, Xavier; Miravet-Jimenez, Sonia; Casellas, Aina; Barrot-De la Puente, Joan F.; Franch-Nadal, Josep; Coll-de Tuero, Gabriel			Chronic Kidney Disease and Diabetic Retinopathy in Patients with Type 2 Diabetes	PLOS ONE			English	Article							RISK-FACTORS; RENAL-INSUFFICIENCY; PRIMARY-CARE; MICROALBUMINURIA; ASSOCIATION; PREVALENCE; ALBUMINURIA	Purpose To explore the relationship between chronic kidney disease (CKD) and diabetic retinopathy (DR) in a representative population of type 2 diabetes mellitus (DM2) patients in Catalonia (Spain). Methods This was a population-based, cross-sectional study. A total of 28,344 patients diagnosed with DM2 who had recorded ophthalmologic and renal functional examinations were evaluated. Data were obtained from a primary healthcare electronic database of medical records. CKD was defined as an estimated glomerular filtration ratio (eGFR) of <60 ml/min/1.73m(2) and/or urine albumin to creatinine ratio (UACR) >= 30 mg/g. DR was categorized as non-vision threatening diabetic retinopathy and vision threatening diabetic retinopathy. Results CKD was associated with a higher rate of DR [OR], 95% confidence interval [CI], 1.5 (1.4-1.7). When we analyzed the association between different levels of UACR and DR prevalence observed that DR prevalence rose with the increase of UACR levels, and this association was significant from UACR values >= 10 mg/g, and increased considerably with UACR values >= 300mg/g (Odds ratio [OR], 95% confidence interval [CI], 2.0 (1.6-2.5). This association was lower in patients with eGFR levels 44 to 30 mL/min/1.73m(2) [OR], 95% confidence interval [CI], 1.3 (1.1-1.6). Conclusions These results show that CKD, high UACR and/or low eGFR, appear to be associated with DR in this DM2 population.	[Rodriguez-Poncelas, Antonio; Coll-de Tuero, Gabriel] Inst Catala Salut, Gerencia Terr Girona, Primary Hlth Care Ctr Angles, Girona, Spain; [Rodriguez-Poncelas, Antonio; Casellas, Aina; Barrot-De la Puente, Joan F.; Coll-de Tuero, Gabriel] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Unitat Suport Recerca Girona, Barcelona, Spain; [Rodriguez-Poncelas, Antonio; Mundet-Tuduri, Xavier; Miravet-Jimenez, Sonia; Franch-Nadal, Josep] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Unitat Suport Recerca Barcelona Ciutat, Barcelona, Spain; [Mundet-Tuduri, Xavier] Univ Autonoma Barcelona, Bellaterra, Spain; [Miravet-Jimenez, Sonia] Inst Catala Salut, Gerencia Terr Metropolitana Sud, Primary Hlth Care Ctr Martorell, Barcelona, Spain; [Barrot-De la Puente, Joan F.] Inst Catala Salut, Gerencia Terr Girona, Primary Hlth Care Ctr Jordi Nadal Salt, Barcelona, Spain; [Franch-Nadal, Josep] Inst Catala Salut, Gerencia Ambit Atencio Primaria Barcelona Ciutat, Primary Hlth Care Ctr Raval Sud, Barcelona, Spain; [Franch-Nadal, Josep] Inst Salud Carlos III, CIBER Diabet & Associated Metab Dis CIBERDEM, Madrid, Spain	Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III	Mundet-Tuduri, X (corresponding author), Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Unitat Suport Recerca Barcelona Ciutat, Barcelona, Spain.; Mundet-Tuduri, X (corresponding author), Univ Autonoma Barcelona, Bellaterra, Spain.	xavier.mundet@uab.cat	Coll-de-Tuero, Gabriel/H-3475-2016; Franch-Nadal, Josep/AAC-1945-2019; Rodriguez Poncelas, Antonio/F-9397-2016; Casellas, Aina/Q-1247-2016	Coll-de-Tuero, Gabriel/0000-0001-7578-9569; Franch-Nadal, Josep/0000-0002-5175-1555; Rodriguez Poncelas, Antonio/0000-0003-2100-9701; Casellas, Aina/0000-0003-4939-8411; Barrot de la Puente, Joan/0000-0002-7482-7647	IDIAP J. Gol (SIDIAP from Fundacio J Gol i Gurina); Education and Research in Family Practice Chair (UAB-Novartis); IDIAP J. Gol	IDIAP J. Gol (SIDIAP from Fundacio J Gol i Gurina); Education and Research in Family Practice Chair (UAB-Novartis); IDIAP J. Gol	This study was supported by a grant from the IDIAP J. Gol (SIDIAP-2013 from Fundacio J Gol i Gurina, www.idiapjordigol.com) and the Education and Research in Family Practice Chair (UAB-Novartis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant from the IDIAP J. Gol and the Education and Research in Family Practice Chair (UAB-Novartis). We acknowledge Monica Gratacos and Amanda Prowse for providing support in the manuscript preparation and editing. CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM) is an initiative from Instituto de Salud Carlos III.	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Bolibar B, 2012, MED CLIN-BARCELONA, V138, P617, DOI 10.1016/j.medcli.2012.01.020; Chen YH, 2012, DIABETES CARE, V35, P803, DOI 10.2337/dc11-1955; Diabet Control Complications DCCT Res Grp, 1995, KIDNEY INT, V47, P1703; Estacio RO, 1998, AM J KIDNEY DIS, V31, P947, DOI 10.1053/ajkd.1998.v31.pm9631838; Kramer HJ, 2003, JAMA-J AM MED ASSOC, V289, P3273, DOI 10.1001/jama.289.24.3273; KROLEWSKI AS, 1986, DIABETES CARE, V9, P443, DOI 10.2337/diacare.9.5.443; Lee WJ, 2014, EYE, V28, P1119, DOI 10.1038/eye.2014.130; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lopez-Bastida J, 2007, DIABETIC MED, V24, P403, DOI 10.1111/j.1464-5491.2007.02074.x; Lu B, 2008, J DIABETES COMPLICAT, V22, P96, DOI 10.1016/j.jdiacomp.2007.08.001; Man REK, 2015, INVEST OPHTH VIS SCI, V56, P4810, DOI 10.1167/iovs.15-16987; Manaviat Masoud R, 2004, BMC Ophthalmol, V4, P9, DOI 10.1186/1471-2415-4-9; MATHIESEN ER, 1995, DIABETIC MED, V12, P482, DOI 10.1111/j.1464-5491.1995.tb00528.x; Nwanyanwu KH, 2013, DIABETES CARE, V36, P1562, DOI 10.2337/dc12-0790; PARVING HH, 1988, BMJ-BRIT MED J, V296, P156, DOI 10.1136/bmj.296.6616.156; Pedro RA, 2010, OPHTHAL EPIDEMIOL, V17, P251, DOI 10.3109/09286586.2010.498661; Penno G, 2012, DIABETES CARE, V35, P2317, DOI 10.2337/dc12-0628; Pugliese G, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-59; Ra H, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-29; Sabanayagam C, 2014, J DIABETES, V6, P556, DOI 10.1111/1753-0407.12148; Satchell SC, 2008, DIABETOLOGIA, V51, P714, DOI 10.1007/s00125-008-0961-8; Stratton IM, 2001, DIABETOLOGIA, V44, P156, DOI 10.1007/s001250051594; Tone A, 2005, DIABETES RES CLIN PR, V69, P237, DOI 10.1016/j.diabres.2005.02.009; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Vinagre I, 2012, DIABETES CARE, V35, P774, DOI 10.2337/dc11-1679; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Wolf G, 2007, CLIN NEPHROL, V68, P81; Wong TY, 2008, OPHTHALMOLOGY, V115, P1869, DOI 10.1016/j.ophtha.2008.05.014; Wu JY, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/326209	31	51	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149448	10.1371/journal.pone.0149448	http://dx.doi.org/10.1371/journal.pone.0149448			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886129	Green Submitted, Green Published, gold			2022-12-27	WOS:000371218400084
J	Ujiie, Y; Ishitani, Y				Ujiie, Yurika; Ishitani, Yoshiyuki			Evolution of a Planktonic Foraminifer during Environmental Changes in the Tropical Oceans	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; MAXIMUM-LIKELIHOOD; EARLY PLIOCENE; PACIFIC-OCEAN; MARINE BIODIVERSITY; MOLECULAR EVIDENCE; CRYPTIC DIVERSITY; DNA-SEQUENCES; SPECIATION; PATTERNS	Ecological adaptation to environmental changes is a strong driver of evolution, enabling speciation of pelagic plankton in the open ocean without the presence of effective physical barriers to gene flow. The tropical ocean environment, which plays an important role in shaping marine biodiversity, has drastically and frequently changed since the Pliocene. Nevertheless, the evolutionary history of tropical pelagic plankton has been poorly understood, as phylogeographic investigations are still in the developing state and paleontological approaches are insufficient to obtain a sequential record from the deep-sea sediments. The planktonic foraminifer Pulleniatina obliquiloculata is widely distributed in the tropical area throughout the world's oceans, and its phylogeography is well established. It is thus one of the best candidates to examine how past environmental changes may have shifted the spatial distribution and affected the diversification of tropical pelagic plankton. Such an examination requires the divergence history of the planktonic foraminifers, yet the gene marker (partial small subunit (SSU) rDNA) previously used for phylogeographic studies was not powerful enough to achieve a high accuracy in estimating the divergence times. The present study focuses on improving the precision of divergence time estimates for the splits between sibling species (genetic types) of planktonic foraminifers by increasing the number of genes as well as the number of nucleotide bases used for molecular clock estimates. We have amplified the entire coding regions of two ribosomal RNA genes (SSU rDNA and large subunit (LSU) rDNA) of three genetic types of P. obliquiloculata and two closely related species for the first time and applied them to the Bayesian relaxed clock method. The comparison of the credible intervals of the four datasets consisting either of sequences of the partial SSU rDNA, the complete SSU rDNA, LSU rDNA, or a combination of both genes (SSU +LSU) clearly demonstrated that the two-gene dataset improved the accuracy of divergence time estimates. The P. obliquiloculata lineage diverged twice, first at the end of the Pliocene (3.1 Ma) and again in the middle Pleistocene (1.4 Ma). Both timings coincided with the environmental changes, which indirectly involved geographic separation of populations. The habitat of P. obliquiloculata was expanded toward the higher latitudinal zones during the stable warm periods and subsequently placed on the steep environmental gradients following the global cooling. Different environmental conditions in the stable warm tropics and unstable higher latitudes may have triggered ecological divergence among the populations, leading to adaptive differentiation and eventually speciation. A comprehensive analysis of divergence time estimates combined with phylogeography enabled us to reveal the evolutionary history of the pelagic plankton and to find the potential paleoenvironmental events, which could have changed their biogeography and ecology.	[Ujiie, Yurika] Shinshu Univ, Dept Biol, Matsumoto, Nagano 390, Japan; [Ishitani, Yoshiyuki] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan	Shinshu University; University of Tokyo	Ujiie, Y (corresponding author), Shinshu Univ, Dept Biol, Matsumoto, Nagano 390, Japan.	yurikaw@shinshu-u.ac.jp		Ujiie, Yurika/0000-0001-7627-7979; Ishitani, Yoshiyuki/0000-0001-8941-6990	Japan Society for the Promotion of Science [23710012, 26400501]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science, no. 23710012 and 26400501. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurahs R, 2011, MAR MICROPALEONTOL, V79, P1, DOI 10.1016/j.marmicro.2010.12.001; Aurahs R, 2009, MOL ECOL, V18, P1692, DOI 10.1111/j.1365-294X.2009.04136.x; Aze T, 2011, BIOL REV, V86, P900, DOI 10.1111/j.1469-185X.2011.00178.x; Barton AD, 2010, SCIENCE, V327, P1509, DOI 10.1126/science.1184961; Be A.W.H., 1977, P1; BERGGREN WA, 1995, GEOL SOC AM BULL, V107, P1272, DOI 10.1130/0016-7606(1995)107<1272:LNCNPI>2.3.CO;2; Brierley CM, 2009, SCIENCE, V323, P1714, DOI 10.1126/science.1167625; Caron DA, 2009, ISME J, V3, P4, DOI 10.1038/ismej.2008.101; Casteleyn G, 2010, P NATL ACAD SCI USA, V107, P12952, DOI 10.1073/pnas.1001380107; Darling KF, 2004, P NATL ACAD SCI USA, V101, P7657, DOI 10.1073/pnas.0402401101; de Vargas C, 1998, MOL PHYLOGENET EVOL, V9, P463, DOI 10.1006/mpev.1998.0491; de Vargas C, 1999, P NATL ACAD SCI USA, V96, P2864, DOI 10.1073/pnas.96.6.2864; Douzery EJP, 2004, P NATL ACAD SCI USA, V101, P15386, DOI 10.1073/pnas.0403984101; Drummond A., 2008, TRACER; Duda TF, 2005, MOL PHYLOGENET EVOL, V34, P257, DOI 10.1016/j.ympev.2004.09.012; Fedorov AV, 2013, NATURE, V496, P43, DOI 10.1038/nature12003; Flakowski J, 2006, J MOL EVOL, V63, P30, DOI 10.1007/s00239-005-0061-z; Ford HL, 2015, GEOPHYS RES LETT, V42, P4878, DOI 10.1002/2015GL064215; Funk WC, 2016, J EVOLUTION BIOL, V29, P241, DOI 10.1111/jeb.12760; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Groussin M, 2011, MOL PHYLOGENET EVOL, V61, P157, DOI 10.1016/j.ympev.2011.06.008; GU X, 1995, MOL BIOL EVOL, V12, P546; Herbert GS, 2005, VELIGER, V47, P294; Ishitani Y, 2014, MOL PHYLOGENET EVOL, V78, P215, DOI 10.1016/j.ympev.2014.05.021; Ishitani Y, 2011, MAR MICROPALEONTOL, V81, P32, DOI 10.1016/j.marmicro.2011.06.007; Jobb G, 2008, TREEFINDER VERSION O; Kennett J.P., 1983, NEOGENE PLANKTONIC F; Kumar S, 2002, P NATL ACAD SCI USA, V99, P803, DOI 10.1073/pnas.022629899; LaRiviere JP, 2012, NATURE, V486, P97, DOI 10.1038/nature11200; Leigh EG, 2014, BIOL REV, V89, P148, DOI 10.1111/brv.12048; Locarnini RA, 2005, NOAA ATLAS NESDIS, V61, P182; Locarnini RA, 2005, WORLD OCEAN DATABASE, V1, P182; Lunt DJ, 2008, NATURE, V454, P1102, DOI 10.1038/nature07223; Meyer CP, 2003, BIOL J LINN SOC, V79, P401, DOI 10.1046/j.1095-8312.2003.00197.x; Molnar P, 2015, PALEOCEANOGRAPHY, V30, P196, DOI 10.1002/2014PA002752; Morard R, 2015, MOL ECOL RESOUR, V15, P1472, DOI 10.1111/1755-0998.12410; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Nylander J. A. A., 2004, MRMODELTEST V2; O'Brien CL, 2014, NAT GEOSCI, V7, P607, DOI 10.1038/NGEO2194; PAWLOWSKI J, 1994, MOL BIOL EVOL, V11, P929; Pawlowski J, 2010, J EUKARYOT MICROBIOL, V57, P197, DOI 10.1111/j.1550-7408.2009.00468.x; Peijnenburg KTCA, 2013, ECOL EVOL, V3, P2765, DOI 10.1002/ece3.644; Postaire B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095040; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; Ravelo AC, 2004, NATURE, V429, P263, DOI 10.1038/nature02567; Renema W, 2008, SCIENCE, V321, P654, DOI 10.1126/science.1155674; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rutherford S, 1999, NATURE, V400, P749, DOI 10.1038/23449; Schlitzer R., 2016, OCEAN DATA VIEW; Schweizer M, 2008, MAR MICROPALEONTOL, V66, P233, DOI 10.1016/j.marmicro.2007.10.003; Seears HA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-54; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Tornabene L, 2015, MOL PHYLOGENET EVOL, V82, P200, DOI 10.1016/j.ympev.2014.09.012; Ujiie Y, 2003, MAR MICROPALEONTOL, V49, P335, DOI 10.1016/S0377-8398(03)00062-8; Ujiie Y, 2012, ECOL EVOL, V2, P1725, DOI 10.1002/ece3.286; Ujiie Y, 2009, J FORAMIN RES, V39, P145, DOI 10.2113/gsjfr.39.3.145; Wara MW, 2005, SCIENCE, V309, P758, DOI 10.1126/science.1112596; Weiner AKM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092148; YANG ZB, 1994, J MOL EVOL, V39, P105; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang YG, 2014, SCIENCE, V344, P84, DOI 10.1126/science.1246172	63	9	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148847	10.1371/journal.pone.0148847	http://dx.doi.org/10.1371/journal.pone.0148847			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886349	Green Published, Green Submitted, gold			2022-12-27	WOS:000371218400053
J	Yano, Y; Greenland, P; Lloyd-Jones, DM; Daoud, EG; Koehler, JL; Ziegler, PD				Yano, Yuichiro; Greenland, Philip; Lloyd-Jones, Donald M.; Daoud, Emile G.; Koehler, Jodi L.; Ziegler, Paul D.			Simulation of Daily Snapshot Rhythm Monitoring to Identify Atrial Fibrillation in Continuously Monitored Patients with Stroke Risk Factors	PLOS ONE			English	Article							CLINICAL-SIGNIFICANCE; IMPLANTABLE DEVICES; ARRHYTHMIAS; DIAGNOSTICS; STRATEGIES	Background New technologies are diffusing into medical practice swiftly. Hand-held devices such as smartphones can record short-duration (e.g., 1-minute) ECGs, but their effectiveness in identifying patients with paroxysmal atrial fibrillation (AF) is unknown. Methods We used data from the TRENDS study, which included 370 patients (mean age 71 years, 71% men, CHADS(2) score >= 1 point: mean 2.3 points) who had no documentation of atrial tachycardia (AT)/AF or antiarrhythmic or anticoagulant drug use at baseline. All were subsequently newly diagnosed with AT/AF by a cardiac implantable electronic device (CIED) over one year of follow-up. Using a computer simulation approach (5,000 repetitions), we estimated the detection rate for paroxysmal AT/AF via daily snapshot ECG monitoring over various periods, with the probability of detection equal to the percent AT/AF burden on each day. Results The estimated AT/AF detection rates with snapshot monitoring periods of 14, 28, 56, 112, and 365 days were 10%, 15%, 21%, 28%, and 50% respectively. The detection rate over 365 days of monitoring was higher in those with CHADS(2) scores >= 2 than in those with CHADS(2) scores of 1 (53% vs. 38%), and was higher in those with AT/AF burden >= 0.044 hours/day compared to those with AT/AF burden <0.044 hours/day (91% vs. 14%; both P<0.05). Conclusions Daily snapshot ECG monitoring over 365 days detects half of patients who developed AT/AF as detected by CIED, and shorter intervals of monitoring detected fewer AT/AF patients. The detection rate was associated with individual CHADS(2) score and AT/AF burden.	[Yano, Yuichiro; Greenland, Philip; Lloyd-Jones, Donald M.] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Daoud, Emile G.] Ohio State Univ, Dept Med, Med Ctr, Div Cardiol,Richard M Ross Heart Hosp, Columbus, OH 43210 USA; [Koehler, Jodi L.; Ziegler, Paul D.] Medtronic Inc, Minneapolis, MN USA	Northwestern University; Feinberg School of Medicine; University System of Ohio; Ohio State University; Medtronic	Greenland, P (corresponding author), Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA.	p-greenland@northwestern.edu	Greenland, Philip/ABD-5528-2021	Lloyd-Jones, Donald/0000-0003-0847-6110	Medtronic, Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001422] Funding Source: NIH RePORTER	Medtronic, Inc.(Medtronic); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The original TRENDS Study was sponsored by Medtronic, Inc. The present analyses were not funded.	[Anonymous], 2001, CIRCULATION, V104, P2118; Boriani G, 2014, EUR HEART J, V35, P508, DOI 10.1093/eurheartj/eht491; Botto GL, 2009, J CARDIOVASC ELECTR, V20, P241, DOI 10.1111/j.1540-8167.2008.01320.x; Callans DJ, 2013, HEART RHYTHM, V10, P320, DOI 10.1016/j.hrthm.2012.12.021; Camm AJ, 2012, EUR HEART J, V33; Charitos EI, 2012, CIRCULATION, V126, P806, DOI 10.1161/CIRCULATIONAHA.112.098079; DeCicco AE, 2014, HEART RHYTHM, V11, P719, DOI 10.1016/j.hrthm.2014.01.001; Engdahl J, 2013, CIRCULATION, V127, P930, DOI 10.1161/CIRCULATIONAHA.112.126656; Fetsch T, 2004, EUR HEART J, V25, P1385, DOI 10.1016/j.ehj.2004.04.015; Glotzer TV, 2015, HEART RHYTHM, V12, P234, DOI 10.1016/j.hrthm.2014.09.058; Glotzer TV, 2009, CIRC-ARRHYTHMIA ELEC, V2, P474, DOI 10.1161/CIRCEP.109.849638; Glotzer TV, 2006, J INTERV CARD ELECTR, V15, P9, DOI 10.1007/s10840-006-7622-y; Glotzer TV, 2003, CIRCULATION, V107, P1614, DOI 10.1161/01.CIR.0000057981.70380.45; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575; Hendrikx T, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-41; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022, 10.1161/CIR.0000000000000142, 10.1016/j.jacc.2014.03.021]; Kamel H, 2013, STROKE, V44, P528, DOI 10.1161/STROKEAHA.112.679100; Lau JK, 2013, INT J CARDIOL, V165, P193, DOI 10.1016/j.ijcard.2013.01.220; Lowres N, 2013, THROMB HAEMOSTASIS, V110, P213, DOI 10.1160/TH13-02-0165; McManus DD, 2013, HEART RHYTHM, V10, P315, DOI 10.1016/j.hrthm.2012.12.001; Pollak WM, 2001, PACE, V24, P424, DOI 10.1046/j.1460-9592.2001.00424.x; Purerfellner H, 2004, PACE, V27, P983, DOI 10.1111/j.1540-8159.2004.00569.x; Savelieva I, 2000, J INTERV CARD ELECTR, V4, P369, DOI 10.1023/A:1009823001707; Seet RCS, 2011, CIRCULATION, V124, P477, DOI 10.1161/CIRCULATIONAHA.111.029801; Strickberger SA, 2005, HEART RHYTHM, V2, P125, DOI 10.1016/j.hrthm.2004.10.042; Vasamreddy CR, 2006, J CARDIOVASC ELECTR, V17, P134, DOI 10.1111/j.1540-8167.2006.00359.x; Walsh JA, 2014, CIRCULATION, V130, P573, DOI 10.1161/CIRCULATIONAHA.114.009024; Ziegler PD, 2012, AM J CARDIOL, V110, P1309, DOI 10.1016/j.amjcard.2012.06.034; Ziegler PD, 2010, STROKE, V41, P256, DOI 10.1161/STROKEAHA.109.571455; Ziegler PD, 2006, HEART RHYTHM, V3, P1445, DOI 10.1016/j.hrthm.2006.07.030; Zimetbaum P, 2014, CIRC-ARRHYTHMIA ELEC, V7, P1223, DOI 10.1161/CIRCEP.114.001356	32	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148914	10.1371/journal.pone.0148914	http://dx.doi.org/10.1371/journal.pone.0148914			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882334	gold, Green Submitted, Green Published			2022-12-27	WOS:000371219000033
J	Aung, NY; Ohe, R; Meng, HX; Kabasawa, T; Yang, SR; Kato, T; Yamakawa, M				Aung, Naing Ye; Ohe, Rintaro; Meng, Hongxue; Kabasawa, Takanobu; Yang, Suran; Kato, Tomoya; Yamakawa, Mitsunori			Specific Neuropilins Expression in Alveolar Macrophages among Tissue-Specific Macrophages	PLOS ONE			English	Article							MONOCYTE-DERIVED MACROPHAGES; MESSENGER-RNA; ENDOTHELIAL-CELLS; SEMAPHORIN 3A; GROWTH; CANCER; RECEPTORS; ATHEROSCLEROSIS; ANGIOGENESIS; POLARIZATION	In the immune system, neuropilins (NRPs), including NRP-1 and NRP-2, are expressed in thymocytes, dendritic cells, regulatory T cells and macrophages. Their functions on immune cells around the neoplastic cells vary into pro-angiogenesis, tumor progression and anti-angiogenesis according to their ligands. Even though NRPs expression on malignant tumors and immune system has studied, a PubMed-based literature query did not yield any articles describing NRPs expression on tissue-specific macrophages. The aims of this study were (i) to detect NRPs expression on tissue-specific macrophages in the brain, liver, spleen, lymph node and lung; (ii) to observe NRPs expression in classes of macrophages, including alveolar macrophages (AMs), bronchial macrophages (BMs), interstitial macrophages (IMs), intravascular macrophages (IVMs) and macrophage subsets (M1, M2 and Mox) in lung; and (iii) to detect the co-expression of NRPs and dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN) in AMs. Both NRPs were specifically detected in AMs among tissue-specific macrophages by immunohistochemistry (IHC). NRPs mRNA expression levels were characterized in normal lung by reverse transcriptase polymerase chain reaction (RT-PCR) and in situ-polymerase chain reaction (in situ-PCR). The expression of both NRPs was detected in AMs, BMs and IVMs by IHC. The frequency of NRPs(+) AMs in lung tissue adjacent to the cancer margin was significantly higher than the frequencies in inflamed and normal lung tissue. Double and triple IHC demonstrated that NRPs are expressed on all macrophage subsets in lung. Double IHC showed co-expression of DC-SIGN and NRPs in AMs. This study demonstrated for the first time the specific expression of both NRPs in AMs among tissue-specific macrophages and their expression on M1, M2 and Mox macrophages. Furthermore, the possible origin of AMs from blood monocytes could be suggested from a co-expression of NRPs and DC-SIGN.	[Aung, Naing Ye; Ohe, Rintaro; Meng, Hongxue; Kabasawa, Takanobu; Yang, Suran; Kato, Tomoya; Yamakawa, Mitsunori] Yamagata Univ, Fac Med, Dept Pathol Diagnost, Yamagata 990, Japan	Yamagata University	Yamakawa, M (corresponding author), Yamagata Univ, Fac Med, Dept Pathol Diagnost, Yamagata 990, Japan.	myamakaw@med.id.yamagata-u.ac.jp	Ohe, Rintaro/AAP-1604-2020	Ohe, Rintaro/0000-0002-8035-791X; Meng, Hongxue/0000-0002-1831-2737	 [25460451]		This work was supported by 25460451, https://www.jsps.go.jp/english/e-grants/ Yamagata University Faculty of Medicine, Mitsunori Yamakawa.	Aber A, 2012, INT J EXP PATHOL, V93, P243, DOI [10.1111/j.1365-2613.2012.00833.x, DOI 10.1111/J.1365-2613.2012.00833.X]; Bagasra O, 2007, NAT PROTOC, V2, P2782, DOI 10.1038/nprot.2007.395; Balhara J, 2012, MUCOSAL IMMUNOL, V5, P605, DOI 10.1038/mi.2012.74; Ball SG, 2010, BIOCHEM J, V427, P29, DOI 10.1042/BJ20091512; Baltzell K, 2012, BREAST CANCER RES TR, V132, P267, DOI 10.1007/s10549-011-1841-3; Butcher MJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00044; Cai Y, 2010, PATHOL RES PRACT, V206, P793, DOI 10.1016/j.prp.2010.08.001; Cassol E, 2009, J IMMUNOL, V182, P6237, DOI 10.4049/jimmunol.0803447; Chistiakov DA, 2015, J CELL MOL MED, V19, P1163, DOI 10.1111/jcmm.12591; Fujisawa H, 2004, J NEUROBIOL, V59, P24, DOI 10.1002/neu.10337; Fujita H, 2001, BRAIN RES, V914, P1, DOI 10.1016/S0006-8993(01)02765-2; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Hodge S, 2011, AM J RESP CELL MOL, V44, P673, DOI 10.1165/rcmb.2009-0459OC; Hsieh SH, 2008, ONCOGENE, V27, P3746, DOI 10.1038/sj.onc.1211029; Hu B, 2007, ONCOGENE, V26, P5577, DOI 10.1038/sj.onc.1210348; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Ji JD, 2009, HUM IMMUNOL, V70, P211, DOI 10.1016/j.humimm.2009.01.026; Jubb AM, 2012, HISTOPATHOLOGY, V61, P340, DOI 10.1111/j.1365-2559.2012.04224.x; Kadl A, 2010, CIRC RES, V107, P737, DOI 10.1161/CIRCRESAHA.109.215715; Kim WH, 2009, EXP CELL RES, V315, P2154, DOI 10.1016/j.yexcr.2009.04.018; Landsman L, 2007, J IMMUNOL, V179, P3488, DOI 10.4049/jimmunol.179.6.3488; Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497; Matsushita A, 2007, CANCER RES, V67, P10309, DOI 10.1158/0008-5472.CAN-07-3256; Moniuszko M, 2007, FOLIA HISTOCHEM CYTO, V45, P181; Moreira AP, 2010, J ALLERGY CLIN IMMUN, V126, P712, DOI 10.1016/j.jaci.2010.06.010; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Prud'homme GJ, 2012, ONCOTARGET, V3, P921, DOI 10.18632/oncotarget.626; Raimondi C, 2013, SEMIN CELL DEV BIOL, V24, P172, DOI 10.1016/j.semcdb.2013.01.001; Robertson D, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-13; Sierra-Filardi E, 2010, IMMUNOBIOLOGY, V215, P788, DOI 10.1016/j.imbio.2010.05.020; Staples KJ, 2011, IMMUNOBIOLOGY, V216, P832, DOI 10.1016/j.imbio.2010.12.005; Staton CA, 2007, J PATHOL, V212, P237, DOI 10.1002/path.2182; West DC, 2005, J BIOL CHEM, V280, P13457, DOI 10.1074/jbc.M410924200; Wild JRL, 2012, INT J EXP PATHOL, V93, P81, DOI 10.1111/j.1365-2613.2012.00810.x; Wolfs IMJ, 2011, THROMB HAEMOSTASIS, V106, P763, DOI 10.1160/TH11-05-0320	36	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0147358	10.1371/journal.pone.0147358	http://dx.doi.org/10.1371/journal.pone.0147358			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900851	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100009
J	Franco-Pedroso, J; Ramos, D; Gonzalez-Rodriguez, J				Franco-Pedroso, Javier; Ramos, Daniel; Gonzalez-Rodriguez, Joaquin			Gaussian Mixture Models of Between-Source Variation for Likelihood Ratio Computation from Multivariate Data	PLOS ONE			English	Article								In forensic science, trace evidence found at a crime scene and on suspect has to be evaluated from the measurements performed on them, usually in the form of multivariate data (for example, several chemical compound or physical characteristics). In order to assess the strength of that evidence, the likelihood ratio framework is being increasingly adopted. Several methods have been derived in order to obtain likelihood ratios directly from univariate or multivariate data by modelling both the variation appearing between observations (or features) coming from the same source (within-source variation) and that appearing between observations coming from different sources (between-source variation). In the widely used multivariate kernel likelihood-ratio, the within-source distribution is assumed to be normally distributed and constant among different sources and the between-source variation is modelled through a kernel density function (KDF). In order to better fit the observed distribution of the between-source variation, this paper presents a different approach in which a Gaussian mixture model (GMM) is used instead of a KDF. As it will be shown, this approach provides better-calibrated likelihood ratios as measured by the log-likelihood ratio cost (C-llr) in experiments performed on freely available forensic datasets involving different trace evidences: inks, glass fragments and car paints.	[Franco-Pedroso, Javier; Ramos, Daniel; Gonzalez-Rodriguez, Joaquin] Univ Autonoma Madrid, ATVS Biometr Recognit Grp, Madrid, Spain	Autonomous University of Madrid	Franco-Pedroso, J (corresponding author), Univ Autonoma Madrid, ATVS Biometr Recognit Grp, Madrid, Spain.	javier.franco@uam.es			Ministerio de Economia y Competitividad (ES) [TEC2012-37585-C02-01]	Ministerio de Economia y Competitividad (ES)	JFP recieved funding from "Ministerio de Economia y Competitividad (ES)" (http://www.mineco.gob.es/) through the project "CMC-V2: Caracterizacion, Modelado y Compensacion de Variabilidad en la Senal de Voz", with grant number TEC2012-37585-C02-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja RK, 2001, OPER RES, V49, P784, DOI 10.1287/opre.49.5.784.10601; Aitken C., 2004, STAT EVALUATION EVID, P26; Aitken CGG, 2004, J ROY STAT SOC C-APP, V53, P109, DOI 10.1046/j.0035-9254.2003.05271.x; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bishop C. M, 2006, PATTERN RECOGNITION; Bolck A, 2009, FORENSIC SCI INT, V191, P42, DOI 10.1016/j.forsciint.2009.06.006; Borgstrom BJ, 2013, INT CONF ACOUST SPEE, P7693, DOI 10.1109/ICASSP.2013.6639160; Brummer N, 2006, COMPUT SPEECH LANG, V20, P230, DOI 10.1016/j.csl.2005.08.001; Cook R, 1998, SCI JUSTICE, V38, P231, DOI 10.1016/S1355-0306(98)72117-3; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; EPANECHN.VA, 1969, THEOR PROBAB APPL+, V14, P153, DOI 10.1137/1114019; Gonzalez-Rodriguez J, 2007, IEEE T AUDIO SPEECH, V15, P2104, DOI 10.1109/TASL.2007.902747; Jain AK, 2006, IEEE T INF FOREN SEC, V1, P125, DOI 10.1109/TIFS.2006.873653; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Li P, 2012, IEEE T PATTERN ANAL, V34, P144, DOI 10.1109/TPAMI.2011.104; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; McLachlan Geoffrey J., 1988, APPL STAT; Ramos D, 2013, J FORENSIC SCI, V58, P1503, DOI 10.1111/1556-4029.12233; Ramos D, 2013, FORENSIC SCI INT, V230, P156, DOI 10.1016/j.forsciint.2013.04.014; Rose P, 2015, INT CONF ACOUST SPEE, P4819, DOI 10.1109/ICASSP.2015.7178886; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sizov A, 2014, LECT NOTES COMPUT SC, V8621, P464, DOI 10.1007/978-3-662-44415-3_47; Turk M. A., 1991, Proceedings 1991 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (91CH2983-5), P586, DOI 10.1109/CVPR.1991.139758; van Leeuwen David A., 2007, Speaker Classification I. Fundamentals, Features, and Methods. (Lecture Notes in Artificial Intelligence vol. 4343), P330, DOI 10.1007/978-3-540-74200-5_19; Zadora G, 2014, STATISTICAL ANALYSIS IN FORENSIC SCIENCE: EVIDENTIAL VALUE OF MULTIVARIATE PHYSICOCHEMICAL DATA, P1, DOI 10.1002/9781118763155; Zadrozny B., 2002, P 8 ACM SIGKDD INT C, P694, DOI [10.1145/775047.775151, DOI 10.1145/775047.775151]	28	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149958	10.1371/journal.pone.0149958	http://dx.doi.org/10.1371/journal.pone.0149958			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901680	Green Submitted, Green Published, gold			2022-12-27	WOS:000371276100193
J	Kapelner, T; Jiang, N; Holobar, A; Vujaklija, I; Roche, AD; Farina, D; Aszmann, OC				Kapelner, Tamas; Jiang, Ning; Holobar, Ales; Vujaklija, Ivan; Roche, Aidan D.; Farina, Dario; Aszmann, Oskar C.			Motor Unit Characteristics after Targeted Muscle Reinnervation	PLOS ONE			English	Article							SURFACE ELECTROMYOGRAM; ACTION-POTENTIALS; EMG; ELECTRODES; PATTERNS; NERVE	Targeted muscle reinnervation (TMR) is a surgical procedure used to redirect nerves originally controlling muscles of the amputated limb into remaining muscles above the amputation, to treat phantom limb pain and facilitate prosthetic control. While this procedure effectively establishes robust prosthetic control, there is little knowledge on the behavior and characteristics of the reinnervated motor units. In this study we compared the m. pectoralis of five TMR patients to nine able-bodied controls with respect to motor unit action potential (MUAP) characteristics. We recorded and decomposed high-density surface EMG signals into individual spike trains of motor unit action potentials. In the TMR patients the MUAP surface area normalized to the electrode grid surface (0.25 +/- 0.17 and 0.81 +/- 0.46, p < 0.001) and the MUAP duration (10.92 +/- 3.89 ms and 14.03 +/- 3.91 ms, p < 0.01) were smaller for the TMR group than for the controls. The mean MUAP amplitude (0.19 +/- 0.11 mV and 0.14 +/- 0.06 mV, p = 0.07) was not significantly different between the two groups. Finally, we observed that MUAP surface representation in TMR generally overlapped, and the surface occupied by motor units corresponding to only one motor task was on average smaller than 12% of the electrode surface. These results suggest that smaller MUAP surface areas in TMR patients do not necessarily facilitate prosthetic control due to a high degree of overlap between these areas, and a neural information-based control could lead to improved performance. Based on the results we also infer that the size of the motor units after reinnervation is influenced by the size of the innervating motor neuron.	[Kapelner, Tamas; Vujaklija, Ivan; Farina, Dario] Univ Gottingen, Bernstein Ctr Computat Neurosci, Univ Med Ctr Gottingen, Inst Neurorehabil Syst, D-37073 Gottingen, Germany; [Jiang, Ning] Univ Waterloo, Dept Syst Design Engn, Waterloo, ON N2L 3G1, Canada; [Holobar, Ales] Univ Maribor, Fac Elect Engn & Comp Sci, SLO-2000 Maribor, Slovenia; [Roche, Aidan D.; Aszmann, Oskar C.] Med Univ Vienna, Div Plast & Reconstruct Surg, CD Lab Restorat Extrem Funct, Vienna, Austria	University of Gottingen; University of Waterloo; University of Maribor; Medical University of Vienna	Aszmann, OC (corresponding author), Med Univ Vienna, Div Plast & Reconstruct Surg, CD Lab Restorat Extrem Funct, Vienna, Austria.	oskar.aszmann@meduniwien.ac.at	Jiang, Ning/H-1844-2011; Roche, Aidan/AAC-5695-2019; Vujaklija, Ivan/AAB-9163-2021; Farina, Dario/AAB-2648-2019	Jiang, Ning/0000-0003-1579-3114; Vujaklija, Ivan/0000-0002-7394-9474; Roche, Aidan/0000-0002-8892-5053	German Academic Exchange Service Research Grant for Doctoral Candidates and Young Academics and Scientists [57076385]; European Research Council Advanced Grant DEMOVE [267888]; Christian Doppler Research Association of the Austrian Federal Ministry of Science, Research Economy	German Academic Exchange Service Research Grant for Doctoral Candidates and Young Academics and Scientists; European Research Council Advanced Grant DEMOVE; Christian Doppler Research Association of the Austrian Federal Ministry of Science, Research Economy	This work was financially supported by the German Academic Exchange Service Research Grant for Doctoral Candidates and Young Academics and Scientists (Grant #57076385, http://www.daad.de), by the European Research Council Advanced Grant DEMOVE (contract #267888, http://erc.europa.eu/), and by the Christian Doppler Research Association of the Austrian Federal Ministry of Science, Research & Economy (https://www.cdg.ac.at/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aszmann OC, 2008, HANDCHIR MIKROCHIR P, V40, P60, DOI 10.1055/s-2007-989415; BODINEFOWLER S, 1990, MUSCLE NERVE, V13, P1133, DOI 10.1002/mus.880131208; BULLER AJ, 1960, J PHYSIOL-LONDON, V150, P417, DOI 10.1113/jphysiol.1960.sp006395; Dumanian GA, 2009, PLAST RECONSTR SURG, V124, P863, DOI 10.1097/PRS.0b013e3181b038c9; Enoka R.M., 2008, NEUROMECHANICS HUMAN; Farid D., 2013, IEEE T NEUR SYS REH, P1; Farina D, 2001, IEEE T BIO-MED ENG, V48, P637, DOI 10.1109/10.923782; Farina D, 2008, J NEUROPHYSIOL, V100, P1223, DOI 10.1152/jn.90219.2008; FOEHRING RC, 1987, J NEUROPHYSIOL, V57, P1210, DOI 10.1152/jn.1987.57.4.1210; FUGLEVAND AJ, 1992, BIOL CYBERN, V67, P143, DOI 10.1007/BF00201021; Hargrove LJ, 2013, IEEE ENG MED BIO, P1599, DOI 10.1109/EMBC.2013.6609821; Holobar A, 2007, IEEE T SIGNAL PROCES, V55, P4487, DOI 10.1109/TSP.2007.896108; Holobar A, 2009, CLIN NEUROPHYSIOL, V120, P551, DOI 10.1016/j.clinph.2008.10.160; Kapelner T, 2015, 7 INT C NEUR ENG MON, P652; KUGELBERG E, 1970, J NEUROL NEUROSUR PS, V33, P319, DOI 10.1136/jnnp.33.3.319; Kuiken TA, 2009, JAMA-J AM MED ASSOC, V301, P619, DOI 10.1001/jama.2009.116; Marasco PD, 2009, BRAIN, V132, P1441, DOI 10.1093/brain/awp082; Pette D, 2001, J APPL PHYSIOL, V90, P1119, DOI 10.1152/jappl.2001.90.3.1119; REDFERN MS, 1993, CLIN BIOMECH, V8, P44, DOI 10.1016/S0268-0033(05)80009-9; Roeleveld K, 1997, J ELECTROMYOGR KINES, V7, P221, DOI 10.1016/S1050-6411(97)00009-6; Smith LH, 2013, I IEEE EMBS C NEUR E, P1155, DOI 10.1109/NER.2013.6696143; SRETER FA, 1975, J GEN PHYSIOL, V66, P811, DOI 10.1085/jgp.66.6.811	22	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149772	10.1371/journal.pone.0149772	http://dx.doi.org/10.1371/journal.pone.0149772			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901631	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100148
J	Lengyel, S; Deri, E; Magura, T				Lengyel, Szabolcs; Deri, Eszter; Magura, Tibor			Species Richness Responses to Structural or Compositional Habitat Diversity between and within Grassland Patches: A Multi-Taxon Approach	PLOS ONE			English	Article							WESTERN-AUSTRALIAN WHEATBELT; AREA PER-SE; ISLAND AREA; PLANT PRODUCTIVITY; PREY AVAILABILITY; INSECT DIVERSITY; MANAGEMENT; BIODIVERSITY; ASSEMBLAGES; SCALE	Habitat diversity (spatial heterogeneity within and between habitat patches in a landscape, HD) is often invoked as a driver of species diversity at small spatial scales. However, the effect of HD on species richness (SR) of multiple taxa is not well understood. We quantified HD and SR in a wet-dry gradient of open grassland habitats in Hortobagy National Park (E-Hungary) and tested the effect of compositional and structural factors of HD on SR of flowering plants, orthopterans, true bugs, spiders, ground beetles and birds. Our dataset on 434 grassland species (170 plants, 264 animals) showed that the wet-dry gradient (compositional HD at the between-patch scale) was primarily related to SR in orthopterans, ground-dwelling arthropods, and all animals combined. The patchiness, or plant association richness, of the vegetation (compositional HD at the within-patch scale) was related to SR of vegetation-dwelling arthropods, whereas vegetation height (structural HD at the withinpatch scale) was related to SR of ground-dwelling arthropods and birds. Patch area was related to SR only in birds, whereas management (grazing, mowing, none) was related to SR of plants and true bugs. All relationships between HD and SR were positive, indicating increasing SR with increasing HD. However, total SR was not related to HD because different taxa showed similar positive responses to different HD variables. Our findings, therefore, show that even though HD positively influences SR in a wide range of grassland taxa, each taxon responds to different compositional or structural measures of HD, resulting in the lack of a consistent relationship between HD and SR when taxon responses are pooled. The idiosyncratic responses shown here exemplify the difficulties in detecting general HDSR relationships over multiple taxa. Our results also suggest that management and restoration aimed specifically to sustain or increase the diversity of habitats are required to conserve biodiversity in complex landscapes.	[Lengyel, Szabolcs] Hungarian Acad Sci, Danube Res Inst, Dept Tisza Res, Ctr Ecol Res, Bem Ter 18-C, H-4026 Debrecen, Hungary; [Deri, Eszter] Zool Soc London, Regents Pk, London NW1 4RY, England; [Magura, Tibor] Univ Debrecen, Dept Ecol, POB 400, H-4002 Debrecen, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Zoological Society of London; University of Debrecen	Lengyel, S (corresponding author), Hungarian Acad Sci, Danube Res Inst, Dept Tisza Res, Ctr Ecol Res, Bem Ter 18-C, H-4026 Debrecen, Hungary.	lengyel.szabolcs@okologia.mta.hu	Magura, Tibor/I-4383-2019; Lengyel, Szabolcs/A-3483-2011	Magura, Tibor/0000-0002-9130-6122; Lengyel, Szabolcs/0000-0002-7049-0100	Hungarian Scientific Research Fund (Orszagos Tudomanyos Kutatasi Alapprogramok), OTKA [K 106133]; EU LIFE-Nature programme [LIFE04NAT/HU/000119]; EU FP7 project "SCALES" [226852]	Hungarian Scientific Research Fund (Orszagos Tudomanyos Kutatasi Alapprogramok), OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); EU LIFE-Nature programme; EU FP7 project "SCALES"	This work was supported by the Hungarian Scientific Research Fund (Orszagos Tudomanyos Kutatasi Alapprogramok), OTKA K 106133, to SL; EU LIFE-Nature programme, LIFE04NAT/HU/000119, to SL; and EU FP7 project "SCALES", Contract No. 226852, to SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, MAGYARORSZAG NOVENYT; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2000, MAGYARORSZAGI EDENYE; Baldi A, 1999, ACTA OECOL, V20, P125, DOI 10.1016/S1146-609X(99)80025-3; Baldi A, 2008, J BIOGEOGR, V35, P675, DOI 10.1111/j.1365-2699.2007.01825.x; Barczi A, 2006, QUATERN INT, V156, P49, DOI 10.1016/j.quaint.2006.05.024; Beever EA, 2006, DIVERS DISTRIB, V12, P229, DOI 10.1111/j.1366-9516.2006.00260.x; BLAKE JG, 1987, ECOLOGY, V68, P1724, DOI 10.2307/1939864; BohningGaese K, 1997, J BIOGEOGR, V24, P49, DOI 10.1111/j.1365-2699.1997.tb00049.x; Boloni J, 2007, ANN BOT-COENOL PLANT, V7, P55; Brose U, 2003, OECOLOGIA, V135, P407, DOI 10.1007/s00442-003-1222-7; Burbidge AA, 1997, J BIOGEOGR, V24, P703, DOI 10.1046/j.1365-2699.1997.00145.x; BURNHAM KP, 1979, ECOLOGY, V60, P927, DOI 10.2307/1936861; Cattin MF, 2003, BIOL CONSERV, V113, P179, DOI 10.1016/S0006-3207(02)00297-5; Collinge SK, 1996, LANDSCAPE URBAN PLAN, V36, P59, DOI 10.1016/S0169-2046(96)00341-6; Davidowitz G, 1998, J BIOGEOGR, V25, P553, DOI 10.1046/j.1365-2699.1998.2530553.x; Di Giulio M, 2001, J APPL ECOL, V38, P310, DOI 10.1046/j.1365-2664.2001.00605.x; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Duelli P, 1997, AGR ECOSYST ENVIRON, V62, P81, DOI 10.1016/S0167-8809(96)01143-7; Forman R., 2014, ECOLOGICAL DESIGN PL, P217; Groom M.J., 2006, PRINCIPLES CONSERVAT; Halaj J, 2000, OIKOS, V90, P139, DOI 10.1034/j.1600-0706.2000.900114.x; Halaj J, 1998, J ARACHNOL, V26, P203; HAMILTON TH, 1963, SCIENCE, V142, P1575, DOI 10.1126/science.142.3599.1575; Hannus JJ, 2008, J BIOGEOGR, V35, P1077, DOI 10.1111/j.1365-2699.2007.01862.x; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Henle K, 2010, GAIA, V19, P187, DOI 10.14512/gaia.19.3.8; Hortal J, 2009, AM NAT, V174, pE205, DOI 10.1086/645085; Horvath R, 2005, CAN J ZOOL, V83, P324, DOI [10.1139/z05-009, 10.1139/Z05-009]; Johnson M., 1974, J BIOGEOGR, V1, P149, DOI DOI 10.2307/3037964; JOHNSON MP, 1968, AM NAT, V102, P297, DOI 10.1086/282544; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Kallimanis AS, 2010, BIODIVERS CONSERV, V19, P1225, DOI 10.1007/s10531-009-9748-6; Kallimanis AS, 2008, GLOBAL ECOL BIOGEOGR, V17, P532, DOI 10.1111/j.1466-8238.2008.00393.x; KITCHENER DJ, 1980, BIOL CONSERV, V17, P25, DOI 10.1016/0006-3207(80)90024-5; KITCHENER DJ, 1982, BIOL CONSERV, V22, P127, DOI 10.1016/0006-3207(82)90010-6; KOHN DD, 1994, J ECOL, V82, P367, DOI 10.2307/2261304; Kruess A, 2002, BIOL CONSERV, V106, P293, DOI 10.1016/S0006-3207(01)00255-5; Langellotto GA, 2004, OECOLOGIA, V139, P1, DOI 10.1007/s00442-004-1497-3; Langsrud Y, 2003, STAT COMPUT, V13, P163, DOI 10.1023/A:1023260610025; Lassau SA, 2005, DIVERS DISTRIB, V11, P73, DOI 10.1111/j.1366-9516.2005.00124.x; Lengyel S, 2012, APPL VEG SCI, V15, P264, DOI 10.1111/j.1654-109X.2011.01179.x; Lomolino MV, 2001, J BIOGEOGR, V28, P431, DOI 10.1046/j.1365-2699.2001.00550.x; LOSOS JB, 1986, OECOLOGIA, V68, P338, DOI 10.1007/BF01036735; Lovei GL, 2006, GLOBAL ECOL BIOGEOGR, V15, P283, DOI 10.1111/j.1466-8238.2005.00221.x; Magura T, 2008, ACTA OECOL, V33, P272, DOI 10.1016/j.actao.2007.11.007; Magura T, 2007, AGR ECOSYST ENVIRON, V119, P396, DOI 10.1016/j.agee.2006.08.014; MALY EJ, 1977, AM MIDL NAT, V97, P59, DOI 10.2307/2424685; Marini L, 2010, BIOL CONSERV, V143, P2164, DOI 10.1016/j.biocon.2010.05.029; Mero TO, 2015, ANIM CONSERV, V18, P442, DOI 10.1111/acv.12191; Mero TO, 2015, J ORNITHOL, V156, P579, DOI 10.1007/s10336-015-1202-9; Mester B, 2015, BIOL CONSERV, V192, P237, DOI 10.1016/j.biocon.2015.09.030; Mester B, 2015, HERPETOL CONSERV BIO, V10, P679; NILSSON SG, 1988, J ANIM ECOL, V57, P685, DOI 10.2307/4933; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; Papanikolaou AD, SCALING ECOLOGY BIOD, P156; PATTON D R, 1975, Wildlife Society Bulletin, V3, P171; Perner J, 2005, ECOGRAPHY, V28, P429, DOI 10.1111/j.0906-7590.2005.04119.x; Reid AM, 2007, AUSTRAL ECOL, V32, P708, DOI 10.1111/j.1442-9993.2007.01767.x; Ricklefs RE, 1999, J ANIM ECOL, V68, P1142, DOI 10.1046/j.1365-2656.1999.00358.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Schaffers AP, 2008, ECOLOGY, V89, P782, DOI 10.1890/07-0361.1; Shi JM, 2010, BIODIVERS CONSERV, V19, P1279, DOI 10.1007/s10531-009-9757-5; Siemann E, 1998, ECOLOGY, V79, P2057, DOI 10.1890/0012-9658(1998)079[2057:ETOEOP]2.0.CO;2; Szep Tibor, 2000, Ring, V22, P45; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Thompson WL, 2002, AUK, V119, P18, DOI 10.1642/0004-8038(2002)119[0018:TRBSAF]2.0.CO;2; Triantis KA, 2003, J BIOGEOGR, V30, P19, DOI 10.1046/j.1365-2699.2003.00805.x; Whittingham MJ, 2004, IBIS, V146, P210, DOI 10.1111/j.1474-919X.2004.00370.x; Woodcock BA, 2010, BIODIVERS CONSERV, V19, P81, DOI 10.1007/s10531-009-9703-6	70	30	34	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149662	10.1371/journal.pone.0149662	http://dx.doi.org/10.1371/journal.pone.0149662			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901569	gold, Green Accepted, Green Published			2022-12-27	WOS:000371276100125
J	Li, L; Bonneton, F; Tohme, M; Bernard, L; Chen, XY; Laudet, V				Li, Ling; Bonneton, Francois; Tohme, Marie; Bernard, Laure; Chen, Xiao Yong; Laudet, Vincent			In Vivo Screening Using Transgenic Zebrafish Embryos Reveals New Effects of HDAC Inhibitors Trichostatin A and Valproic Acid on Organogenesis	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; HORMONE-EXPRESSING CELLS; PANCREAS DEVELOPMENT; DANIO-RERIO; GENE-EXPRESSION; BISPHENOL-A; MODEL; DICLOFENAC; TOXICITY; FISH	The effects of endocrine disrupting chemicals (EDCs) on reproduction are well known, whereas their developmental effects are much less characterized. However, exposure to endocrine disruptors during organogenesis may lead to deleterious and permanent problems later in life. Zebrafish (Danio rerio) transgenic lines expressing the green fluorescent protein (GFP) in specific organs and tissues are powerful tools to uncover developmental defects elicited by EDCs. Here, we used seven transgenic lines to visualize in vivo whether a series of EDCs and other pharmaceutical compounds can alter organogenesis in zebrafish. We used transgenic lines expressing GFP in pancreas, liver, blood vessels, inner ear, nervous system, pharyngeal tooth and pectoral fins. This screen revealed that four of the tested chemicals have detectable effects on different organs, which shows that the range of effects elicited by EDCs is wider than anticipated. The endocrine disruptor tetrabromobisphenol-A (TBBPA), as well as the three drugs diclofenac, trichostatin A (TSA) and valproic acid (VPA) induced abnormalities in the embryonic vascular system of zebrafish. Moreover, TSA and VPA induced specific alterations during the development of pancreas, an observation that was confirmed by in situ hybridization with specific markers. Developmental delays were also induced by TSA and VPA in the liver and in pharyngeal teeth, resulting in smaller organ size. Our results show that EDCs can induce a large range of developmental alterations during embryogenesis of zebrafish and establish GFP transgenic lines as powerful tools to screen for EDCs effects in vivo.	[Li, Ling; Bonneton, Francois; Tohme, Marie; Bernard, Laure; Laudet, Vincent] Univ Lyon 1, Ecole Normale Super Lyon, CNRS, Inst Genom Fonct Lyon,INRA, F-69365 Lyon, France; [Li, Ling; Chen, Xiao Yong] E China Normal Univ, Sch Ecol & Environm Sci, Shanghai 200062, Peoples R China; [Laudet, Vincent] Observ Oceanol Banyuls Sur Mer, Lab Arago, Banyuls Sur Mer, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); East China Normal University; UDICE-French Research Universities; Sorbonne Universite	Laudet, V (corresponding author), Univ Lyon 1, Ecole Normale Super Lyon, CNRS, Inst Genom Fonct Lyon,INRA, F-69365 Lyon, France.; Laudet, V (corresponding author), Observ Oceanol Banyuls Sur Mer, Lab Arago, Banyuls Sur Mer, France.	vincent.laudet@obs-banyuls.fr	Chen, Xiao-Yong/B-1467-2009	Chen, Xiao-Yong/0000-0002-4795-8940; Bonneton, Francois/0000-0002-6500-1931; Laudet, Vincent/0000-0003-4022-4175; Li, Ling/0000-0003-0882-3266	Joint Research Institute for Science and Society (JORISS); French Ministry of Foreign Affairs; China Scholarship Council (CSC); ANR TOXSYN project [ANR-13-CESA-0017]	Joint Research Institute for Science and Society (JORISS); French Ministry of Foreign Affairs; China Scholarship Council (CSC)(China Scholarship Council); ANR TOXSYN project(French National Research Agency (ANR))	The Joint Research Institute for Science and Society (JORISS), the French Ministry of Foreign Affairs (Eiffel scholarships), and the China Scholarship Council (CSC) supported Li Ling. This work was funded by the ANR TOXSYN project (ANR-13-CESA-0017).	Argenton F, 1999, MECH DEVELOP, V87, P217, DOI 10.1016/S0925-4773(99)00151-3; BERGERON JM, 1994, ENVIRON HEALTH PERSP, V102, P780, DOI 10.2307/3432139; Besse JP, 2008, TOXICOL LETT, V176, P104, DOI 10.1016/j.toxlet.2007.10.012; Biemar F, 2001, DEV BIOL, V230, P189, DOI 10.1006/dbio.2000.0103; Boverhof DR, 2011, TOXICOL SCI, V121, P207, DOI 10.1093/toxsci/kfr075; Brion F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036069; Bugel Sean M, 2014, Curr Environ Health Rep, V1, P341; Carnevali O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010201; Carson Rachel, 1994, SILENT SPRING; Casals-Casas C, 2011, ANNU REV PHYSIOL, V73, P135, DOI 10.1146/annurev-physiol-012110-142200; Cha YI, 2005, DEV BIOL, V282, P274, DOI 10.1016/j.ydbio.2005.03.014; Chan LY, 2001, HUM REPROD, V16, P2390, DOI 10.1093/humrep/16.11.2390; Christen V, 2010, CHEMOSPHERE, V81, P1245, DOI 10.1016/j.chemosphere.2010.09.031; Christensen DP, 2011, MOL MED, V17, P378, DOI 10.2119/molmed.2011.00021; COLBORN T, 1995, ENVIRON HEALTH PERSP, V103, P81, DOI 10.2307/3432353; Colborn T., 1996, OUR STOLEN FUTURE; DETRICH HW, 1995, P NATL ACAD SCI USA, V92, P10713, DOI 10.1073/pnas.92.23.10713; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Epping MT, 2007, P NATL ACAD SCI USA, V104, P17777, DOI 10.1073/pnas.0702518104; Eroschenko VP, 2002, NEUROTOXICOL TERATOL, V24, P29, DOI 10.1016/S0892-0362(01)00194-5; Ertzer R, 2007, DEV BIOL, V301, P578, DOI 10.1016/j.ydbio.2006.11.004; Farooq M, 2008, DEV BIOL, V317, P336, DOI 10.1016/j.ydbio.2008.02.034; Folsvik N, 1999, CHEMOSPHERE, V38, P681, DOI 10.1016/S0045-6535(98)00202-1; Gibert Y, 2010, FASEB J, V24, P3298, DOI 10.1096/fj.09-147488; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Goldman D, 2001, TRANSGENIC RES, V10, P21, DOI 10.1023/A:1008998832552; Gore AC, 2006, ENDOCRINOLOGY, V147, pS1, DOI 10.1210/en.2005-1367; Green JD, 1997, ENVIRON RES, V72, P56, DOI 10.1006/enrs.1996.3692; Guillette LJ, 2005, INTEGR COMP BIOL, V45, P19, DOI 10.1093/icb/45.1.19; Gurvich N, 2005, FASEB J, V19, P1166, DOI 10.1096/fj.04-3425fje; Hallare AV, 2004, CHEMOSPHERE, V56, P659, DOI 10.1016/j.chemosphere.2004.04.007; Hayes TB, 2011, J STEROID BIOCHEM, V127, P64, DOI 10.1016/j.jsbmb.2011.03.015; Her GM, 2003, FEBS LETT, V538, P125, DOI 10.1016/S0014-5793(03)00157-1; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; Huang HG, 2001, MOL CELL ENDOCRINOL, V177, P117, DOI 10.1016/S0303-7207(01)00408-7; Jackman WR, 2006, P NATL ACAD SCI USA, V103, P19390, DOI 10.1073/pnas.0609575103; Khan SJ, 2002, WATER SCI TECHNOL, V46, P105, DOI 10.2166/wst.2002.0065; Kharrazian D, 2014, AUTOIMMUN DIS, V2014, DOI 10.1155/2014/743616; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kinkel MD, 2009, BIOESSAYS, V31, P139, DOI 10.1002/bies.200800123; Kudo C, 2003, BIOCHEM PHARMACOL, V66, P289, DOI 10.1016/S0006-2952(03)00235-1; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; le Maire A, 2010, NAT STRUCT MOL BIOL, V17, P801, DOI 10.1038/nsmb.1855; Lee HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090160; Lemaire G, 2006, LIFE SCI, V79, P1160, DOI 10.1016/j.lfs.2006.03.023; McCormick JM, 2010, AQUAT TOXICOL, V100, P255, DOI 10.1016/j.aquatox.2010.07.019; McGrath P, 2008, DRUG DISCOV TODAY, V13, P394, DOI 10.1016/j.drudis.2008.03.002; McLachlan JA, 2001, ENDOCR REV, V22, P319, DOI 10.1210/er.22.3.319; Miard S, 2005, INT J OBESITY, V29, pS10, DOI 10.1038/sj.ijo.0802906; Newbold RR, 2007, MOL CARCINOGEN, V46, P783, DOI 10.1002/mc.20308; Paik EJ, 2010, INT J DEV BIOL, V54, P1127, DOI 10.1387/ijdb.093042ep; Pillai R, 2004, DEV DYNAM, V231, P647, DOI 10.1002/dvdy.20168; Poupardin R, 2008, INSECT BIOCHEM MOLEC, V38, P540, DOI 10.1016/j.ibmb.2008.01.004; Riu A, 2014, TOXICOL SCI, V139, P48, DOI 10.1093/toxsci/kfu036; Santos GM, 2011, TRENDS ENDOCRIN MET, V22, P87, DOI 10.1016/j.tem.2010.11.004; Scholz S, 2008, MOL CELL ENDOCRINOL, V293, P57, DOI 10.1016/j.mce.2008.06.008; Schug TT, 2011, J STEROID BIOCHEM, V127, P204, DOI 10.1016/j.jsbmb.2011.08.007; Suzawa M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002117; Tabb MM, 2006, MOL ENDOCRINOL, V20, P475, DOI 10.1210/me.2004-0513; Tehrani Z, 2011, CELL CYCLE, V10, P3466, DOI 10.4161/cc.10.20.17764; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tiso N, 2009, MOL CELL ENDOCRINOL, V312, P24, DOI 10.1016/j.mce.2009.04.018; Toppari J, 2010, BIRTH DEFECTS RES A, V88, P910, DOI 10.1002/bdra.20707; Udvadia AJ, 2003, DEV BIOL, V256, P1, DOI 10.1016/S0012-1606(02)00083-0; van den Brandhof EJ, 2010, ECOTOX ENVIRON SAFE, V73, P1862, DOI 10.1016/j.ecoenv.2010.08.031; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Walker SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029916; Wan HY, 2006, EXP CELL RES, V312, P1526, DOI 10.1016/j.yexcr.2006.01.016; WASSERMAN DH, 1995, INT J OBESITY, V19, pS22; Wiegand C, 2001, ECOTOX ENVIRON SAFE, V49, P199, DOI 10.1006/eesa.2001.2073; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055474	73	16	17	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149497	10.1371/journal.pone.0149497	http://dx.doi.org/10.1371/journal.pone.0149497			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900852	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100086
J	Sticchi, E; Magi, A; Kamstrup, PR; Marcucci, R; Prisco, D; Martinelli, I; Mannucci, PM; Abbate, R; Giusti, B				Sticchi, Elena; Magi, Alberto; Kamstrup, Pia R.; Marcucci, Rossella; Prisco, Domenico; Martinelli, Ida; Mannucci, Pier Mannuccio; Abbate, Rosanna; Giusti, Betti			Apolipoprotein(a) Kringle-IV Type 2 Copy Number Variation Is Associated with Venous Thromboembolism	PLOS ONE			English	Article							EXTREME LIPOPROTEIN(A) LEVELS; PLASMA LIPOPROTEIN(A); RISK-FACTOR; MYOCARDIAL-INFARCTION; C/T POLYMORPHISM; LPA GENE; CORONARY; DISEASE; ATHEROSCLEROSIS; LP(A)	In addition to the established association between high lipoprotein(a) [Lp(a)] concentrations and coronary artery disease, an association between Lp(a) and venous thromboembolism (VTE) has also been described. Lp(a) is controlled by genetic variants in LPA gene, coding for apolipoprotein(a), including the kringle-IV type 2 (KIV-2) size polymorphism. Aim of the study was to investigate the role of LPA gene KIV-2 size polymorphism and single nucleotide polymorphisms (SNPs) (rs1853021, rs1800769, rs3798220, rs10455872) in modulating VTE susceptibility. Five hundred and sixteen patients with VTE without hereditary and acquired thrombophilia and 1117 healthy control subjects, comparable for age and sex, were investigated. LPA KIV-2 polymorphism, rs3798220 and rs10455872 SNPs were genotyped by TaqMan technology. Concerning rs1853021 and rs1800769 SNPs, PCR-RFLP assay was used. LPA KIV-2 repeat number was significantly lower in patients than in controls [median (interquartile range) 11(6-17) vs 15(9-25), p<0.0001]. A significantly higher prevalence of KIV-2 repeat number <= 7 was observed in patients than in controls (33.5% vs 15.5%, p<0.0001). KIV-2 repeat number was independently associated with VTE (p = 4.36 x10(-9)), as evidenced by the general linear model analysis adjusted for transient risk factors. No significant difference in allele frequency for all SNPs investigated was observed. Haplotype analysis showed that LPA haplotypes rather than individual SNPs influenced disease susceptibility. Receiver operating characteristic curves analysis showed that a combined risk prediction model, including KIV-2 size polymorphism and clinical variables, had a higher performance in identifying subjects at VTE risk than a clinical-only model, also separately in men and women.	[Sticchi, Elena; Magi, Alberto; Marcucci, Rossella; Abbate, Rosanna; Giusti, Betti] Univ Florence, Careggi Hosp, Atherothrombot Dis Ctr, Dept Expt & Clin Med, Florence, Italy; [Kamstrup, Pia R.] Copenhagen Univ Hosp, Dept Clin Biochem, Herlev, Denmark; [Prisco, Domenico] Univ Florence, Careggi Hosp, Ctr Autoimmune System Dis, Dept Expt & Clin Med,SOD Patol Med,Behcet Ctr & L, Florence, Italy; [Martinelli, Ida; Mannucci, Pier Mannuccio] Osped Maggiore Policlin, A Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy; [Mannucci, Pier Mannuccio] Fdn Ca Granda Osped Maggiore Policlin, Sci Direct, Milan, Italy	University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Copenhagen; University of Florence; Azienda Ospedaliero Universitaria Careggi; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico	Giusti, B (corresponding author), Univ Florence, Careggi Hosp, Atherothrombot Dis Ctr, Dept Expt & Clin Med, Florence, Italy.	betti.giusti@unifi.it	Magi, Alberto/M-6773-2015; Sticchi, Elena/K-8237-2016; Marcucci, Rossella/K-8471-2016; Giusti, Betti/K-6978-2016; Martinelli, ida/J-2287-2015	Magi, Alberto/0000-0001-7393-4283; Sticchi, Elena/0000-0002-0990-4618; Giusti, Betti/0000-0002-8708-9444; Martinelli, ida/0000-0001-9218-3622; Marcucci, Rossella/0000-0001-9549-7176	Italian Ministry of Health; Fiorgen Foundation, Florence, Italy	Italian Ministry of Health(Ministry of Health, Italy); Fiorgen Foundation, Florence, Italy	This work was supported by grants from Italian Ministry of Health and from Fiorgen Foundation, Florence, Italy.	BOERWINKLE E, 1989, HUM GENET, V82, P73, DOI 10.1007/BF00288277; Boonmark NW, 1997, J CLIN INVEST, V100, P558, DOI 10.1172/JCI119565; Catalano M, 2008, CLIN CHIM ACTA, V387, P109, DOI 10.1016/j.cca.2007.09.014; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Danik JS, 2013, J THROMB HAEMOST, V11, P205, DOI 10.1111/jth.12056; De Stefano V, 2012, BEST PRACT RES CL HA, V25, P253, DOI 10.1016/j.beha.2012.07.002; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063; Frezzato M, 1996, AM J EPIDEMIOL, V143, P1257; GAW A, 1994, J CLIN INVEST, V93, P2526, DOI 10.1172/JCI117263; Giusti B, 2010, THROMB HAEMOSTASIS, V104, P231, DOI 10.1160/TH09-11-0748; Greif M, 2013, EUR J INTERN MED, V24, P75, DOI 10.1016/j.ejim.2012.08.014; Gurdasani D, 2012, ARTERIOSCL THROM VAS, V32, P3058, DOI 10.1161/ATVBAHA.112.255521; Helgadottir A, 2012, J AM COLL CARDIOL, V60, P722, DOI 10.1016/j.jacc.2012.01.078; Kamstrup PR, 2008, CIRCULATION, V117, P176, DOI 10.1161/CIRCULATIONAHA.107.715698; Kamstrup PR, 2013, J AM COLL CARDIOL, V61, P1146, DOI 10.1016/j.jacc.2012.12.023; Kamstrup PR, 2012, ARTERIOSCL THROM VAS, V32, P1732, DOI 10.1161/ATVBAHA.112.248765; Kamstrup PR, 2009, JAMA-J AM MED ASSOC, V301, P2331, DOI 10.1001/jama.2009.801; Koschinsky ML, 2004, CAN J CARDIOL, V20, p37B; Kraft HG, 1996, EUR J HUM GENET, V4, P74; Kraft HG, 1998, HUM MOL GENET, V7, P257, DOI 10.1093/hmg/7.2.257; Kronenberg F, 2013, J INTERN MED, V273, P6, DOI 10.1111/j.1365-2796.2012.02592.x; Langer C, 2011, SEMIN THROMB HEMOST, V37, P810, DOI 10.1055/s-0031-1297172; Lanktree MB, 2010, CIRC-CARDIOVASC GENE, V3, P39, DOI 10.1161/CIRCGENETICS.109.907642; Lanktree MB, 2009, J LIPID RES, V50, P768, DOI 10.1194/jlr.D800050-JLR200; Lippi G, 1999, HAEMATOLOGICA, V84, P726; Marcovina Santica M, 2002, Semin Vasc Med, V2, P335, DOI 10.1055/s-2002-35404; Marcucci R, 2003, AM J MED, V115, P601, DOI 10.1016/j.amjmed.2003.06.005; MARZ W, 1990, KLIN WOCHENSCHR, V68, P111; McColl MD, 2000, BLOOD COAGUL FIBRIN, V11, P225; Momiyama Y, 2012, ATHEROSCLEROSIS, V222, P241, DOI 10.1016/j.atherosclerosis.2012.02.008; Nielsen LB, 1999, ATHEROSCLEROSIS, V143, P229, DOI 10.1016/S0021-9150(99)00064-7; Nordestgaard BG, 2010, EUR HEART J, V31, P2844, DOI 10.1093/eurheartj/ehq386; Qasim AN, 2011, INT J CARDIOL, V150, P17, DOI 10.1016/j.ijcard.2010.02.021; Sofi F, 2007, ATHEROSCLEROSIS, V195, pE147, DOI 10.1016/j.atherosclerosis.2007.05.020; Sofi F, 2007, AM J MED, V120, P728, DOI 10.1016/j.amjmed.2007.01.029; Sotiriou SN, 2006, FASEB J, V20, P559, DOI 10.1096/fj.05-4857fje; Spence JD, 2012, ARTERIOSCL THROM VAS, V32, P1550, DOI 10.1161/ATVBAHA.112.251306; Sticchi E, 2007, MOL GENET METAB, V91, P79, DOI 10.1016/j.ymgme.2006.12.011; Suzuki K, 1997, J CLIN INVEST, V99, P1361, DOI 10.1172/JCI119295; Tsai AW, 2002, ARCH INTERN MED, V162, P1182, DOI 10.1001/archinte.162.10.1182; Tsimikas S, 2012, J AM COLL CARDIOL, V60, P716, DOI 10.1016/j.jacc.2012.04.038; Undas A, 2012, THROMB RES, V130, pE184, DOI 10.1016/j.thromres.2012.06.005; von Depka M, 2000, BLOOD, V96, P3364; Vormittag R, 2007, THROMB RES, V120, P15, DOI 10.1016/j.thromres.2006.03.002; ZYSOW BR, 1995, ARTERIOSCL THROM VAS, V15, P58, DOI 10.1161/01.ATV.15.1.58	46	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149427	10.1371/journal.pone.0149427	http://dx.doi.org/10.1371/journal.pone.0149427			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900838	Green Submitted, Green Published, gold			2022-12-27	WOS:000371276100075
J	Xie, Y; Bowe, B; Xian, H; Balasubramanian, S; Al-Aly, Z				Xie, Yan; Bowe, Benjamin; Xian, Hong; Balasubramanian, Sumitra; Al-Aly, Ziyad			Renal Function Trajectories in Patients with Prior Improved eGFR Slopes and Risk of Death	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; KIDNEY-FUNCTION DECLINE; ALL-CAUSE MORTALITY; ADVERSE OUTCOMES; MIXTURE-MODELS; SAS PROCEDURE; DISEASE; TIME; CKD	Background Multiple prior studies demonstrated that patients with early Chronic Kidney Disease (CKD) and positive estimated Glomerular Filtration Rate (eGFR) slopes experience increased risk of death. We sought to characterize patients with positive eGFR slopes, examine the renal function trajectory that follows the time period where positive slope is observed, and examine the association between different trajectories and risk of death. Methods and Findings We built a cohort of 204,132 United States veterans with early CKD stage 3; eGFR slopes were defined based on Bayesian mixed-effects models using outpatient eGFR measurements between October 1999 and September 2004; to build renal function trajectories, patients were followed longitudinally thereafter (from October 2004) until September 2013. There were 41,410 (20.29%) patients with positive eGFR slope and they exhibited increased risk of death compared to patients with stable eGFR slope (HR = 1.33, CI: 1.31-1.35). There was an inverse graded association between severity of albuminuria and the odds of positive eGFR slope (OR = 0.94, CI: 0.90-0.98, and OR = 0.76, CI: 0.69-0.84 for microalbuminuria and albuminuria; respectively). Following the time period where positive eGFR slope is observed, we characterized 4 trajectory phenotypes: high eGFR intercept and positive trajectory (HIPT) (12.42%), intermediate intercept and mild negative trajectory (IIMNT) (60.04%), low intercept and fast negative trajectory (LIFNT)(23.33%), and high intercept and fast negative trajectory (HIFNT) (4.20%). Compared to IIMNT (reference group), HIPT is associated with younger age, dementia, HIV, chronic lung disease, peripheral artery disease, weight loss, and inversely associated with albuminuria; LIFNT and HIFNT were associated with diabetes, hypertension, cardiovascular disease, peripheral artery disease, and albuminuria. The risk of death at 9 years was lowest in IIMNT (HR = 1.12, CI: 1.09-1.14), highest in HIPT (HR = 1.71, CI: 1.63-1.79), and intermediate in LIFNT (HR = 1.36, CI: 1.32-1.40) and HIFNT (HR = 1.56, CI: 1.45-1.68). Conclusions Our results demonstrate that patients with positive eGFR slopes, when followed over longer period of time, follow 4 distinct trajectory phenotypes that have distinct demographic and clinical correlates and are differentially associated with risk of death.	[Xie, Yan; Bowe, Benjamin; Xian, Hong; Balasubramanian, Sumitra; Al-Aly, Ziyad] VA St Louis Hlth Care Syst, Clin Epidemiol Ctr, St Louis, MO USA; [Xian, Hong] St Louis Univ, Coll Publ Hlth & Social Justice, Dept Biostat, St Louis, MO 63103 USA; [Al-Aly, Ziyad] VA St Louis Hlth Care Syst, Dept Med, Div Nephrol, St Louis, MO USA	Saint Louis University	Al-Aly, Z (corresponding author), VA St Louis Hlth Care Syst, Clin Epidemiol Ctr, St Louis, MO USA.; Al-Aly, Z (corresponding author), VA St Louis Hlth Care Syst, Dept Med, Div Nephrol, St Louis, MO USA.	zalay@gmail.com	Al-Aly, Ziyad/S-4439-2016	Al-Aly, Ziyad/0000-0002-2600-0434; Xie, Yan/0000-0002-2457-9382	United States Department of Veterans Affairs	United States Department of Veterans Affairs(US Department of Veterans Affairs)	Funding provided by T21 Grant from the United States Department of Veterans Affairs, PI: ZAA.	Al-Aly Z, 2012, KIDNEY INT, V82, P1208, DOI 10.1038/ki.2012.276; Al-Aly Z, 2010, J AM SOC NEPHROL, V21, P1961, DOI 10.1681/ASN.2009121210; Benjamin Bowe YX, KIDNEY INT; Bhandari S, 2012, KIDNEY INT, V81, P1152, DOI 10.1038/ki.2012.49; Dodge Hiroko H, 2008, J Data Sci, V6, P247; Hemmelgarn BR, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-30; Hu B, 2012, J AM SOC NEPHROL, V23, P706, DOI 10.1681/ASN.2011050456; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Little RJA, 1996, BIOMETRICS, V52, P98, DOI 10.2307/2533148; Matsushita K, 2009, J AM SOC NEPHROL, V20, P2617, DOI 10.1681/ASN.2009010025; Murphy Patricia A, 2002, Eff Clin Pract, V5, pE4; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; O'Hare AM, 2012, AM J KIDNEY DIS, V59, P513, DOI 10.1053/j.ajkd.2011.11.044; Oddone Eugene Z, 2008, N C Med J, V69, P35; Park M, 2015, J AM SOC NEPHROL, V26, P1426, DOI 10.1681/ASN.2014010115; Perkins RM, 2011, CLIN J AM SOC NEPHRO, V6, P1879, DOI 10.2215/CJN.00470111; Tonelli M, 2011, KIDNEY INT, V80, P1306, DOI 10.1038/ki.2011.280; Turin TC, 2013, KIDNEY INT, V83, P684, DOI 10.1038/ki.2012.443; Turin TC, 2012, NEPHROL DIAL TRANSPL, V27, P3835, DOI 10.1093/ndt/gfs263; Turin TC, 2012, AM J NEPHROL, V36, P41, DOI 10.1159/000339289; Turin TC, 2012, J AM SOC NEPHROL, V23, P575, DOI 10.1681/ASN.2012020144; Turin TC, 2011, CLIN J AM SOC NEPHRO, V6, P1805, DOI 10.2215/CJN.05950611; US Department of Veterans Affairs, 2009, VIREC RES US GUID VE; US Department of Veterans Affairs VA Information Resource Center, 2007, VIREC RES US GUID VH; Xie Y, 2015, CLIN J AM SOC NEPHRO, V10, P1946, DOI 10.2215/CJN.04480415	27	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149283	10.1371/journal.pone.0149283	http://dx.doi.org/10.1371/journal.pone.0149283			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900691	gold, Green Published			2022-12-27	WOS:000371276100052
J	Morrison, MA; Churchill, NW; Cusimano, MD; Schweizer, TA; Das, S; Graham, SJ				Morrison, Melanie A.; Churchill, Nathan W.; Cusimano, Michael D.; Schweizer, Tom A.; Das, Sunit; Graham, Simon J.			Reliability of Task-Based fMRI for Preoperative Planning: A Test-Retest Study in Brain Tumor Patients and Healthy Controls	PLOS ONE			English	Article							AWAKE CRANIOTOMY; FUNCTIONAL MRI; LANGUAGE LATERALIZATION; PHYSIOLOGICAL NOISE; BOLD FMRI; REPRODUCIBILITY; ACTIVATION; LOCALIZATION; VARIABILITY; MOTION	Background Functional magnetic resonance imaging (fMRI) continues to develop as a clinical tool for patients with brain cancer, offering data that may directly influence surgical decisions. Unfortunately, routine integration of preoperative fMRI has been limited by concerns about reliability. Many pertinent studies have been undertaken involving healthy controls, but work involving brain tumor patients has been limited. To develop fMRI fully as a clinical tool, it will be critical to examine these reliability issues among patients with brain tumors. The present work is the first to extensively characterize differences in activation map quality between brain tumor patients and healthy controls, including the effects of tumor grade and the chosen behavioral testing paradigm on reliability outcomes. Method Test-retest data were collected for a group of low-grade (n = 6) and high-grade glioma (n = 6) patients, and for matched healthy controls (n = 12), who performed motor and language tasks during a single fMRI session. Reliability was characterized by the spatial overlap and displacement of brain activity clusters, BOLD signal stability, and the laterality index. Significance testing was performed to assess differences in reliability between the patients and controls, and low-grade and high-grade patients; as well as between different fMRI testing paradigms. Results There were few significant differences in fMRI reliability measures between patients and controls. Reliability was significantly lower when comparing high-grade tumor patients to controls, or to low-grade tumor patients. The motor task produced more reliable activation patterns than the language tasks, as did the rhyming task in comparison to the phonemic fluency task. Conclusion In low-grade glioma patients, fMRI data are as reliable as healthy control subjects. For high-grade glioma patients, further investigation is required to determine the underlying causes of reduced reliability. To maximize reliability outcomes, testing paradigms should be carefully selected to generate robust activation patterns.	[Morrison, Melanie A.; Graham, Simon J.] Sunnybrook Res Inst, Phys Sci Platform, Toronto, ON, Canada; [Morrison, Melanie A.; Graham, Simon J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Churchill, Nathan W.; Cusimano, Michael D.; Schweizer, Tom A.; Das, Sunit] St Michaels Hosp, Keenan Res Ctr, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Cusimano, Michael D.; Schweizer, Tom A.; Das, Sunit] St Michaels Hosp, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Cusimano, Michael D.; Schweizer, Tom A.; Das, Sunit] Univ Toronto, Dept Surg, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Morrison, MA (corresponding author), Sunnybrook Res Inst, Phys Sci Platform, Toronto, ON, Canada.; Morrison, MA (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	melanieanne.morrison@mail.utoronto.ca	VARRECCHIA, TIWANA/AAJ-8712-2021; Cusimano, Michael/GWR-1025-2022; Cusimano, Michael/X-4059-2019		Canadian Cancer Society [701770]	Canadian Cancer Society(Canadian Cancer Society (CCS))	Funded by Canadian Cancer Society Operating Grant: 701770.	Action A., 2013, GLIOMAS NEW INSIGHT; [Anonymous], 2016, J NEUROSURG, DOI [DOI 10.3171/2015.4.INS15312, 10.3171/2015.4.JNS15312, DOI 10.3171/2015.4.JNS15312]; Bennett CM, 2013, COGN AFFECT BEHAV NE, V13, P690, DOI 10.3758/s13415-013-0195-1; Bennett CM, 2010, ANN NY ACAD SCI, V1191, P133, DOI 10.1111/j.1749-6632.2010.05446.x; Benson RR, 1999, NEUROLOGY, V52, P798, DOI 10.1212/WNL.52.4.798; Brandt David J, 2013, Front Psychiatry, V4, P163, DOI 10.3389/fpsyt.2013.00163; Caceres A, 2009, NEUROIMAGE, V45, P758, DOI 10.1016/j.neuroimage.2008.12.035; Campbell KL, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00073; Carbonell F, 2011, BRAIN CONNECT, V1, P496, DOI 10.1089/brain.2011.0065; Churchill NW, 2013, NEUROIMAGE, V82, P306, DOI 10.1016/j.neuroimage.2013.05.102; Churchill NW, 2012, HUM BRAIN MAPP, V33, P609, DOI 10.1002/hbm.21238; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; De Benedictis A, 2010, NEUROSURGERY, V66, P1074, DOI 10.1227/01.NEU.0000369514.74284.78; Detre JA, 2004, EPILEPSIA, V45, P26, DOI 10.1111/j.0013-9580.2004.04006.x; Detre JA, 2006, J MAGN RESON IMAGING, V23, P808, DOI 10.1002/jmri.20585; Fesl G, 2008, EUR RADIOL, V18, P1031, DOI 10.1007/s00330-008-0850-z; Genovese CR, 2006, BIOMETRIKA, V93, P509, DOI 10.1093/biomet/93.3.509; Genovese CR, 1997, MAGNET RESON MED, V38, P497, DOI 10.1002/mrm.1910380319; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Golestanirad L, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00113; Gorgolewski KJ, 2013, NEUROIMAGE, V69, P231, DOI 10.1016/j.neuroimage.2012.10.085; Harrington GS, 2006, AM J NEURORADIOL, V27, P938; Hervey-Jumper SL, 2015, J NEUROSURG, V123, P325, DOI 10.3171/2014.10.JNS141520; Hou BL, 2006, NEUROIMAGE, V32, P489, DOI 10.1016/j.neuroimage.2006.04.188; Janecek JK, 2013, EPILEPSIA, V54, P314, DOI 10.1111/epi.12068; Jansen A, 2006, NEUROIMAGE, V33, P204, DOI 10.1016/j.neuroimage.2006.06.019; Kim SS, 2009, NEUROSURGERY, V64, P836, DOI 10.1227/01.NEU.0000342405.80881.81; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Liou M, 2006, NEUROIMAGE, V29, P383, DOI 10.1016/j.neuroimage.2005.08.015; Lurito JT, 2000, HUM BRAIN MAPP, V10, P99, DOI 10.1002/1097-0193(200007)10:3<99::AID-HBM10>3.0.CO;2-Q; Maitra R, 2010, NEUROIMAGE, V50, P124, DOI 10.1016/j.neuroimage.2009.11.070; Maldjian JA, 2002, AM J NEURORADIOL, V23, P1030; McKinsey RD, 2010, TECHNOL CANCER RES T, V9, P319, DOI 10.1177/153303461000900402; Nadkarni TN, 2015, NEUROIMAGE-CLIN, V7, P415, DOI 10.1016/j.nicl.2014.12.014; Petrella JR, 2006, RADIOLOGY, V240, P793, DOI 10.1148/radiol.2403051153; Raemaekers M, 2012, NEUROIMAGE, V60, P717, DOI 10.1016/j.neuroimage.2011.11.061; Ruddell SJS, 2007, ANIM BEHAV, V74, P1357, DOI 10.1016/j.anbehav.2007.01.024; Ruff IM, 2008, AM J NEURORADIOL, V29, P528, DOI 10.3174/ajnr.A0841; Rutten GJM, 2002, BRAIN LANG, V80, P421, DOI 10.1006/brln.2001.2600; Rutten GJM, 2002, ANN NEUROL, V51, P350, DOI 10.1002/ana.10117; Sacko O, 2011, NEUROSURGERY, V68, P1192, DOI 10.1227/NEU.0b013e31820c02a3; Seghier ML, 2004, HUM BRAIN MAPP, V23, P140, DOI 10.1002/hbm.20053; Seghier ML, 2008, MAGN RESON IMAGING, V26, P594, DOI 10.1016/j.mri.2007.10.010; Seto E, 2001, NEUROIMAGE, V14, P284, DOI 10.1006/nimg.2001.0829; Stevens MTR, 2013, J NEUROSCI METH, V219, P312, DOI 10.1016/j.jneumeth.2013.08.005; Stevens MTR, 2015, J NEUROL NEUROSUR PS, P1; Stippich C, 2007, RADIOLOGY, V243, P828, DOI 10.1148/radiol.2433060068; Stringer EA, 2011, NEUROIMAGE, V54, P1012, DOI 10.1016/j.neuroimage.2010.09.058; Strothert SC, 2002, NEUROIMAGE, V15, P747, DOI 10.1006/nimg.2001.1034; Sunaert S, 2006, J MAGN RESON IMAGING, V23, P887, DOI 10.1002/jmri.20582; Tam F, 2012, HUM BRAIN MAPP, V33, P1750, DOI 10.1002/hbm.21375; Tieleman A, 2009, EUR RADIOL, V19, P2523, DOI 10.1007/s00330-009-1429-z; Tuominen J, 2013, ACTA NEUROCHIR, V155, P1805, DOI 10.1007/s00701-013-1837-3; Wilkinson ID, 2003, BRIT J RADIOL, V76, P98, DOI 10.1259/bjr/66817309; Wurnig MC, 2013, RADIOLOGY, V268, P521, DOI 10.1148/radiol.13121357; Zec RF, 1999, ARCH CLIN NEUROPSYCH, V14, P255, DOI 10.1016/S0887-6177(98)00008-0	56	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149547	10.1371/journal.pone.0149547	http://dx.doi.org/10.1371/journal.pone.0149547			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894279	gold, Green Published, Green Submitted			2022-12-27	WOS:000371223400064
J	Adongo, PB; Tabong, PTN; Asampong, E; Ansong, J; Robalo, M; Adanu, RM				Adongo, Philip Baba; Tabong, Philip Teg-Nefaah; Asampong, Emmanuel; Ansong, Joana; Robalo, Magda; Adanu, Richard M.			Beyond Knowledge and Awareness: Addressing Misconceptions in Ghana's Preparation towards an Outbreak of Ebola Virus Disease	PLOS ONE			English	Article							STIGMA	Background Ebola Virus Disease (EVD) is not new to the world. However, the West African EVD epidemic which started in 2014 evolved into the largest, most severe and most complex outbreak in the history of the disease. The three most-affected countries faced enormous challenges in stopping the transmission and providing care for all patients. Although Ghana had not recorded any confirmed Ebola case, social factors have been reported to hinder efforts to control the outbreak in the three most affected countries. This qualitative study was designed to explore community knowledge and attitudes about Ebola and its transmission. Methods This study was carried out in five of the ten regions in Ghana. Twenty-five focus group discussions (N = 235) and 40 in-depth interviews were conducted across the five regions with community members, stakeholders and opinion leaders. The interviews were recorded digitally and transcribed verbatim. Framework analysis was adopted in the analysis of the data using Nvivo 10. Results The results showed a high level of awareness and knowledge about Ebola. The study further showed that knowledge on how to identify suspected cases of Ebola was also high among respondents. However, there was a firm belief that Ebola was a spiritual condition and could also be transmitted through air, mosquito bites and houseflies. These misconceptions resulted in perceptions of stigma and discrimination towards people who may get Ebola or work with Ebola patients. Conclusion We conclude that although knowledge and awareness about Ebola is high among Ghanaians who participated in the study, there are still misconceptions about the disease. The study recommends that health education on Ebola disease should move beyond creating awareness to targeting the identified misconceptions to improve future containment efforts.	[Adongo, Philip Baba; Tabong, Philip Teg-Nefaah; Asampong, Emmanuel] Univ Ghana, Sch Publ Hlth, Dept Social & Behav Sci, Legon, Accra, Ghana; [Ansong, Joana; Robalo, Magda] WHO, Country Off Ghana, Accra, Ghana; [Adanu, Richard M.] Univ Ghana, Dept Populat Family & Reprod Hlth, Sch Publ Hlth, Legon, Accra, Ghana	University of Ghana; World Health Organization; University of Ghana	Tabong, PTN (corresponding author), Univ Ghana, Sch Publ Hlth, Dept Social & Behav Sci, Legon, Accra, Ghana.	philgh2001@yahoo.com	Tabong, Philip Teg-Nefaah/AAG-5478-2020	Tabong, Philip/0000-0001-9445-1643; Adongo, Philip Baba/0000-0002-0614-4756	World Health Organization country office for Ghana	World Health Organization country office for Ghana	The study was funded by the World Health Organization country office for Ghana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors will like to express their unconditional gratitude to the World Health Organization Country Office for Ghana for providing funding for this study. We also acknowledge the contribution of various stakeholders who attended the dissemination seminar organized by WHO country Office for Ghana in collaboration with the School of Public Health, University of Ghana and Ghana Health Service. Participants in this dissemination seminar had demonstrated high interest in using the findings of this study to inform health education on ebola in Ghana. We are also grateful to the participants and the research assistants who collected the data.	Aboud FE, 2010, SOC SCI MED, V71, P1897, DOI 10.1016/j.socscimed.2010.09.002; Abubakar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071998; Agyepong I A, 2014, Ghana Med J, V48, P168, DOI 10.4314/gmj.v48i3.9; Aidoo H., 2014, GUARDIAN; Allen R, 1997, AUST NZ J PSYCHIAT, V31, P375, DOI 10.3109/00048679709073847; Alqahtani AS, 2015, EUROSURVEILLANCE, P1; Andrews M., 2013, DOING NARRATIVE RES; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bello IS, 2014, MALARIA J, V13, pP9, DOI [10.1186/1475-2875-13-S1-P9, DOI 10.1186/1475-2875-13-S1-P9]; Bem DJ, 1972, ADV EXPT SOCIAL PSYC, V6, P1, DOI DOI 10.1016/S0065-2601(08)60024-6; CDC, 2014, WHAT YOU NEED KNOW E; Christie A, 2015, MMWR-MORBID MORTAL W, V64, P479; CPP, 2014, STUD EB VIR DIS EVD; CRS/UNICEF/Focus 1000, 2014, STUD PUBL KNOWL ATT; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Fishbein M, 2000, AIDS CARE, V12, P273, DOI 10.1080/09540120050042918; Ghana Statistical Service (GSS), 2012, 2010 POP HOUS CENS F; Gidado S, 2015, PLOS CURR OUTBREAKS; Hewlett BS, 2003, EMERG INFECT DIS, V9, P1242; Kucharski AJ, 2014, LANCET, V384, P1260, DOI 10.1016/S0140-6736(14)61706-2; Letamo G, 2003, J HEALTH POPUL NUTR, V21, P347; Letamo G, 2007, AJAR-AFR J AIDS RES, V6, P193, DOI 10.2989/16085900709490414; Lieber E, 2006, AIDS BEHAV, V10, P463, DOI 10.1007/s10461-005-9047-5; Link BG, 2006, LANCET, V367, P528, DOI 10.1016/S0140-6736(06)68184-1; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773; PAHO/WHO, 2014, EBOL VIR DIS EVD IMP; Piot P, 2001, AIDS Policy Law, V16, P5; Qian H, 2009, AIDS CARE, V27, P417, DOI [10.1055/s-0029-1237430.Imprinting, DOI 10.1055/S-0029-1237430.IMPRINTING]; Ritchie J, 2002, ANAL QUALITATIVE DAT, P187; Rogstad KE, 2015, CURR OPIN INFECT DIS, V28, P83, DOI 10.1097/QCO.0000000000000135; Smith Joanna, 2011, Nurse Res, V18, P52; Stroebe W., 2000, SOCIAL PSYCHOL HLTH, V2nd ed; Tabong PTN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054429; Wahl O. F., 1997, MEDIA MADNESS PUBLIC; WAHL OF, 1992, J COMMUNITY PSYCHOL, V20, P343, DOI 10.1002/1520-6629(199210)20:4<343::AID-JCOP2290200408>3.0.CO;2-2; Wahl Otto E., 2002, PSYCHIAT REHABILITAT, V6, P9, DOI [DOI 10.1080/10973430208408417, 10.1080/10973430208408417]; Walsh MG, 2015, PEERJ, V3, DOI 10.7717/peerj.735; Weingartl HM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00811; Wertz FJ, 2005, J COUNS PSYCHOL, V52, P167, DOI 10.1037/0022-0167.52.2.167; WHO, 2014, EB RESP ROAD MAP SIT; WHO, 2014, EB SIT LIB NONC INT; WHO, 2014, FREQ ASK QUEST EB VI; World Health Organization, 2014, EB VIR DIS PREP STRE; Yoder P, 1997, MED ANTHROPOL Q, V11, P1997; Zierler SE Al, 2000, VIOLENCE VICTIMIZATI, V90	47	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149627	10.1371/journal.pone.0149627	http://dx.doi.org/10.1371/journal.pone.0149627			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3CO	26889683	gold, Green Submitted, Green Published			2022-12-27	WOS:000371221500064
J	Kim, JK; Ha, SB; Jeon, CH; Oh, JJ; Cho, SY; Oh, SJ; Kim, HH; Jeong, CW				Kim, Jung Kwon; Ha, Seung Beom; Jeon, Chan Hoo; Oh, Jong Jin; Cho, Sung Yong; Oh, Seung-June; Kim, Hyeon Hoe; Jeong, Chang Wook			Clinical Nomograms to Predict Stone-Free Rates after Shock-Wave Lithotripsy: Development and Internal-Validation	PLOS ONE			English	Article							RETROGRADE INTRARENAL SURGERY; PROSTATE-CANCER; PERCUTANEOUS NEPHROLITHOTOMY; COMPUTED-TOMOGRAPHY; URETERAL CALCULI; RENAL STONES; SUCCESS; FRAGMENTATION; PARAMETERS; MANAGEMENT	Purpose Shock-wave lithotripsy (SWL) is accepted as the first line treatment modality for uncomplicated upper urinary tract stones; however, validated prediction models with regards to stone-free rates (SFRs) are still needed. We aimed to develop nomograms predicting SFRs after the first and within the third session of SWL. Computed tomography (CT) information was also modeled for constructing nomograms. Materials and Methods From March 2006 to December 2013, 3028 patients were treated with SWL for ureter and renal stones at our three tertiary institutions. Four cohorts were constructed: Total-development, Total-validation, CT-development, and CT-validation cohorts. The nomograms were developed using multivariate logistic regression models with selected significant variables in a univariate logistic regression model. A C-index was used to assess the discrimination accuracy of nomograms and calibration plots were used to analyze the consistency of prediction. Results The SFR, after the first and within the third session, was 48.3% and 68.8%, respectively. Significant variables were sex, stone location, stone number, and maximal stone diameter in the Total-development cohort, and mean Hounsfield unit (HU) and grade of hydronephrosis (HN) were additional parameters in the CT-development cohort. The C-indices were 0.712 and 0.723 for after the first and within the third session of SWL in the Total-development cohort, and 0.755 and 0.756, in the CT-development cohort, respectively. The calibration plots showed good correspondences. Conclusions We constructed and validated nomograms to predict SFR after SWL. To the best of our knowledge, these are the first graphical nomograms to be modeled with CT information. These may be useful for patient counseling and treatment decision-making.	[Kim, Jung Kwon; Ha, Seung Beom; Jeon, Chan Hoo; Oh, Seung-June; Kim, Hyeon Hoe; Jeong, Chang Wook] Seoul Natl Univ Hosp, Dept Urol, Seoul 110744, South Korea; [Oh, Jong Jin] Seoul Natl Univ, Bundang Hosp, Dept Urol, Songnam, South Korea; [Cho, Sung Yong] Seoul Natl Univ, Boramae Med Ctr, Dept Urol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Jeong, CW (corresponding author), Seoul Natl Univ Hosp, Dept Urol, Seoul 110744, South Korea.	drboss@korea.com	Oh, Seung-June/D-6015-2012	Oh, Seung-June/0000-0002-0322-3539				Demirci D, 2007, J ENDOUROL, V21, P1407, DOI 10.1089/end.2006.0399; Donaldson JF, 2015, EUR UROL, V67, P612, DOI 10.1016/j.eururo.2014.09.054; El-Nahas AR, 2007, EUR UROL, V51, P1688, DOI 10.1016/j.eururo.2006.11.048; Foda K, 2013, UROLOGY, V82, P1026, DOI 10.1016/j.urology.2013.06.061; Graversen JA, 2011, J ENDOUROL, V25, P1503, DOI 10.1089/end.2010.0687; Hameed DA, 2013, UROLITHIASIS, V41, P511, DOI 10.1007/s00240-013-0596-1; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hatiboglu G, 2011, BJU INT, V108, P1192, DOI 10.1111/j.1464-410X.2010.10007.x; Ito H, 2015, BJU INT, V115, P446, DOI 10.1111/bju.12775; Jeong CW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094441; Jeong CW, 2012, INT J UROL, V19, P846, DOI 10.1111/j.1442-2042.2012.03040.x; Jung JW, 2014, UROLITHIASIS, V42, P335, DOI 10.1007/s00240-014-0650-7; Kacker R, 2008, J UROLOGY, V179, P1866, DOI 10.1016/j.juro.2008.01.038; Kanao K, 2006, J UROLOGY, V176, P1453, DOI 10.1016/j.juro.2006.06.089; Kattan MW, 2003, J UROLOGY, V170, P1792, DOI 10.1097/01.ju.0000091806.70171.41; KIRKALI Z, 1993, J ENDOUROL, V7, P277, DOI 10.1089/end.1993.7.277; Loske AM, 2010, ULTRASONICS, V50, P300, DOI 10.1016/j.ultras.2009.09.012; Onal B, 2013, BJU INT, V111, P344, DOI 10.1111/j.1464-410X.2012.11281.x; Partin AW, 2001, UROLOGY, V58, P843, DOI 10.1016/S0090-4295(01)01441-8; Perks AE, 2008, UROLOGY, V72, P765, DOI 10.1016/j.urology.2008.05.046; Preminger GM, 2007, EUR UROL, V52, P1610, DOI 10.1016/j.eururo.2007.09.039; Romero Victoriano, 2010, Rev Urol, V12, pe86; Rush Elaine, 2004, N Z Med J, V117, pU1203; Seitz C, 2006, EUR UROL, V49, P378, DOI 10.1016/j.eururo.2005.09.022; Smith A, 2013, J UROLOGY, V190, P149, DOI 10.1016/j.juro.2013.01.047; Vella M, 2007, UROL INT, V79, P47, DOI 10.1159/000104441; Wiesenthal JD, 2011, J UROLOGY, V186, P556, DOI 10.1016/j.juro.2011.03.109; Yong DZ, 2011, J ENDOUROL, V25, P1507, DOI 10.1089/end.2010.0732	28	73	82	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149333	10.1371/journal.pone.0149333	http://dx.doi.org/10.1371/journal.pone.0149333			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890006	Green Published, Green Submitted, gold			2022-12-27	WOS:000371221500036
J	Khor, SC; Razak, AM; Ngah, WZW; Yusof, YAM; Karim, NA; Makpol, S				Khor, Shy Cian; Razak, Azraul Mumtazah; Ngah, Wan Zurinah Wan; Yusof, Yasmin Anum Mohd; Karim, Norwahidah Abdul; Makpol, Suzana			The Tocotrienol-Rich Fraction Is Superior to Tocopherol in Promoting Myogenic Differentiation in the Prevention of Replicative Senescence of Myoblasts	PLOS ONE			English	Article							REGULATORY FACTORS MYOD; SKELETAL-MUSCLE; ALPHA-TOCOPHEROL; SELF-RENEWAL; STEM-CELLS; OXIDATIVE DAMAGE; SATELLITE CELLS; VITAMIN-E; REGENERATION; YOUNG	Aging results in a loss of muscle mass and strength. Myoblasts play an important role in maintaining muscle mass through regenerative processes, which are impaired during aging. Vitamin E potentially ameliorates age-related phenotypes. Hence, this study aimed to determine the effects of the tocotrienol-rich fraction (TRF) and alpha-tocopherol (ATF) in protecting myoblasts from replicative senescence and promoting myogenic differentiation. Primary human myoblasts were cultured into young and senescent stages and were then treated with TRF or ATF for 24 h, followed by an analysis of cell proliferation, senescence biomarkers, cellular morphology and differentiation. Our data showed that replicative senescence impaired the normal regenerative processes of myoblasts, resulting in changes in cellular morphology, cell proliferation, senescence-associated beta-galactosidase (SA-beta-gal) expression, myogenic differentiation and myogenic regulatory factors (MRFs) expression. Treatment with both TRF and ATF was beneficial to senescent myoblasts in reclaiming the morphology of young cells, improved cell viability and decreased SA-beta-gal expression. However, only TRF treatment increased BrdU incorporation in senescent myoblasts, as well as promoted myogenic differentiation through the modulation of MRFs at the mRNA and protein levels. MYOD1 and MYOG gene expression and myogenin protein expression were modulated in the early phases of myogenic differentiation. In conclusion, the tocotrienol-rich fraction is superior to alpha-tocopherol in ameliorating replicative senescence-related aberration and promoting differentiation via modulation of MRFs expression, indicating vitamin E potential in modulating replicative senescence of myoblasts.	[Khor, Shy Cian; Razak, Azraul Mumtazah; Ngah, Wan Zurinah Wan; Yusof, Yasmin Anum Mohd; Karim, Norwahidah Abdul; Makpol, Suzana] Univ Kebangsaan Malaysia, Med Ctr, Dept Biochem, Fac Med, Level 17,Preclin Bldg, Kuala Lumpur 56000, Malaysia	Universiti Kebangsaan Malaysia	Makpol, S (corresponding author), Univ Kebangsaan Malaysia, Med Ctr, Dept Biochem, Fac Med, Level 17,Preclin Bldg, Kuala Lumpur 56000, Malaysia.	suzanamakpol@ppukm.ukm.edu.my	MAKPOL, SUZANA/AAN-4709-2021; Khor, Shy Cian/ABA-4364-2021	Khor, Shy Cian/0000-0002-2493-1761	Universiti Kebangsaan Malaysia [AP-2012-012, UKM-FF-2013-259]	Universiti Kebangsaan Malaysia	This study was funded by the Universiti Kebangsaan Malaysia grants AP-2012-012 and UKM-FF-2013-259. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsharidah M, 2013, AGING CELL, V12, P333, DOI 10.1111/acel.12051; Alway SE, 2001, EXP PHYSIOL, V86, P509, DOI 10.1113/eph8602235; Arthur PG, 2008, CURR OPIN CLIN NUTR, V11, P408, DOI 10.1097/MCO.0b013e328302f3fe; Barberi L, 2013, BIOGERONTOLOGY, V14, P273, DOI 10.1007/s10522-013-9429-4; Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Bigot A, 2008, BIOL CELL, V100, P189, DOI 10.1042/BC20070085; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Carlson ME, 2009, EMBO MOL MED, V1, P381, DOI 10.1002/emmm.200900045; Carosio S, 2011, AGEING RES REV, V10, P35, DOI 10.1016/j.arr.2009.08.001; Cesari M, 2004, AM J CLIN NUTR, V79, P289; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chin SF, 2008, NUTRITION, V24, P1, DOI 10.1016/j.nut.2007.08.006; Cho KA, 2004, J BIOL CHEM, V279, P42270, DOI 10.1074/jbc.M402352200; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Decary S, 2000, NEUROMUSCULAR DISORD, V10, P113, DOI 10.1016/S0960-8966(99)00093-0; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Fano G, 2001, J MUSCLE RES CELL M, V22, P345, DOI 10.1023/A:1013122805060; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Howard AC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1594; Khor SC, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/914853; Kitzmann M, 1998, J CELL BIOL, V142, P1447, DOI 10.1083/jcb.142.6.1447; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lee EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092447; Lee SP, 2009, EUR J APPL PHYSIOL, V107, P587, DOI 10.1007/s00421-009-1159-6; Lim JJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/978101; Londhe P, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-14; Lorenzon P, 2004, EXP GERONTOL, V39, P1545, DOI 10.1016/j.exger.2004.07.008; Makpol S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/506171; Malatesta M, 2011, EUR J HISTOCHEM, P55; Mazlan M, 2006, J NEUROL SCI, V243, P5, DOI 10.1016/j.jns.2005.10.006; Mouly V, 2005, ACTA PHYSIOL SCAND, V184, P3, DOI 10.1111/j.1365-201X.2005.01417.x; Nehlin JO, 2011, BIOGERONTOLOGY, V12, P349, DOI 10.1007/s10522-011-9336-5; Owens J, 2013, IN VITRO CELL DEV-AN, V49, P695, DOI 10.1007/s11626-013-9655-8; Rafique R, 2004, FREE RADICAL RES, V38, P157, DOI 10.1080/10715760310001643311; Renault V, 2002, AGING CELL, V1, P132, DOI 10.1046/j.1474-9728.2002.00017.x; Saito Y, 2004, ANN NY ACAD SCI, V1031, P368, DOI 10.1196/annals.1331.047; Sen CK, 2006, LIFE SCI, V78, P2088, DOI 10.1016/j.lfs.2005.12.001; SERBINOVA E, 1991, FREE RADICAL BIO MED, V10, P263, DOI 10.1016/0891-5849(91)90033-Y; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; SUZUKI Y, 1993, BIOCHEMISTRY-US, V32, P10692, DOI 10.1021/bi00091a020; Vasilaki A, 2006, MECH AGEING DEV, V127, P830, DOI 10.1016/j.mad.2006.08.004; Yablonka-Reuveni Z, 1999, DEV BIOL, V210, P440, DOI 10.1006/dbio.1999.9284; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011	47	26	26	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149265	10.1371/journal.pone.0149265	http://dx.doi.org/10.1371/journal.pone.0149265			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885980	Green Submitted, Green Published, gold			2022-12-27	WOS:000371218400072
J	Kowalczyk, M; Siermontowski, P; Mucha, D; Ambrozy, T; Orlowski, M; Zinkiewicz, K; Kurpiewski, W; Pasnik, K; Kowalczyk, I; Pedrycz, A				Kowalczyk, Marek; Siermontowski, Piotr; Mucha, Dariusz; Ambrozy, Tadeusz; Orlowski, Marcin; Zinkiewicz, Krzysztof; Kurpiewski, Waldemar; Pasnik, Krzysztof; Kowalczyk, Iwona; Pedrycz, Agnieszka			Chromoendoscopy with a Standard-Resolution Colonoscope for Evaluation of Rectal Aberrant Crypt Foci	PLOS ONE			English	Article							COLORECTAL-CANCER; COLON; QUANTIFICATION; IDENTIFICATION; DYSPLASIA	Colorectal cancer (CRC) is the second most common cause of death worldwide. According to the theory by Vogelstein, colorectal carcinogenesis involves a series of successive changes in the normal colonic mucosa, starting with excessive proliferation and focal disorders of intestinal crypts, followed by adenoma and its subsequent malignant transformation. The first identifiable changes in CRC carcinogenesis are aberrant crypt foci (ACF). ACF are invisible during routine colonoscopy yet are well identifiable in chromoendoscopy using methylene blue or indigo carmine. High-resolution colonoscopes are used for assessment of ACF. The aim of the present study was to evaluate the usefulness of standard-resolution colonoscopy for identification of rectal ACF. The following parameters were evaluated: duration of chromoendoscopy of a given rectal segment, type of ACF, sensitivity and specificity of endoscopy combined with histopathological evaluation. The mean duration of colonoscopy and chromoendoscopy was 26.8 min. In the study population, typical ACF were found in 73 patients (p = 0.489), hyperplastic ACF in 49 (p = 0.328), and dysplastic ACF in 16 patients (p = 0.107). Mixed ACF were observed in 11 individuals (p = 0.073). The sensitivity of the method was found to be 0.96 whereas its specificity 0.99. Identification of rectal ACF using standard-resolution colonoscopy combined with rectal mucosa staining with 0.25% methylene blue is characterised by high sensitivity and specificity.	[Kowalczyk, Marek; Kurpiewski, Waldemar] Univ Hosp, Dept Oncol & Gen Surg, Olsztyn, Poland; [Siermontowski, Piotr] Mil Inst Med Gdynia, Dept Maritime, Gdynia, Poland; [Mucha, Dariusz; Ambrozy, Tadeusz] Mil Inst Med Gdynia, Hyperbar Med Dept, Gdynia, Poland; [Orlowski, Marcin] Acad Phys Educ Cracow, Dept Phys Educ & Sport, Krakow, Poland; [Zinkiewicz, Krzysztof] Ctr Diag & Treatment Gastrointestinal Dis, Gdansk, Poland; [Pasnik, Krzysztof] Med Univ Lublin, Dept Gen Gastroenterol & Gastrointestinal Oncol S, Univ Hosp 1, Lublin, Poland; [Kowalczyk, Iwona] Mil Hosp, Mil Inst Med, Dept Gen Oncol Metab & Thorac Surg, Warsaw, Poland; [Pedrycz, Agnieszka] Univ Hosp, Unit Lab Diagnost, Olsztyn, Poland; Med Univ Lublin, Dept Histol & Embryol, Unit Expt Cytol, Lublin, Poland	Medical University of Lublin; Military Institute of Aviation Medicine; Medical University of Lublin	Mucha, D (corresponding author), Mil Inst Med Gdynia, Hyperbar Med Dept, Gdynia, Poland.	nauka.autograf@gmail.com	Ambroży, Tadeusz/AAZ-4796-2021; Pedrycz, Agnieszka/AAE-2024-2019; Siermontowski, Piotr/V-7339-2018	Ambroży, Tadeusz/0000-0001-7361-9478; Siermontowski, Piotr/0000-0003-2557-3561; Kurpiewski, Waldemar/0000-0002-7363-4026; Zinkiewicz, Krzysztof/0000-0002-7048-3621; Kowalczyk, Marek/0000-0003-4202-023X				Adler DG, 2002, GASTROINTEST ENDOSC, V56, P657, DOI 10.1067/mge.2002.128540; Adler DG, 2005, COMMENTARY GASTROENT, V2, P391; BIRD RP, 1987, CANCER LETT, V37, P147, DOI 10.1016/0304-3835(87)90157-1; DiGregori C, 1997, HISTOPATHOLOGY, V30, P328, DOI 10.1046/j.1365-2559.1997.d01-626.x; Fenoglio-Preiser CM, 1999, TOXICOL PATHOL, V27, P632, DOI 10.1177/019262339902700604; Greenspan EJ, 2007, CARCINOGENESIS, V28, P769, DOI 10.1093/carcin/bgl209; Gupta AK, 2009, GASTROINTEST ENDOSC, V70, P322, DOI 10.1016/j.gie.2008.12.060; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hurlstone DP, 2005, AM J GASTROENTEROL, V100, P1283, DOI 10.1111/j.1572-0241.2005.40891.x; Kowalczyk M, 2013, POLISH HYPERBARIC RE, V3, P97; Marion JF, 2008, AM J GASTROENTEROL, V103, P2342, DOI 10.1111/j.1572-0241.2008.01934.x; Nascimbeni R, 1999, AM J SURG PATHOL, V23, P1256, DOI 10.1097/00000478-199910000-00011; Nucci MR, HUMAN PATHOLOGY, V28, P1396; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PRETLOW TP, 1991, CANCER RES, V51, P1564; Rasheed S, 2008, GASTROINTEST ENDOSC, V67, P1103, DOI 10.1016/j.gie.2007.10.038; RONCUCCI L, 1991, HUM PATHOL, V22, P287, DOI 10.1016/0046-8177(91)90163-J; Rudolph RE, 2005, CANCER EPIDEM BIOMAR, V14, P605, DOI 10.1158/1055-9965.EPI-04-0058; Samowitz WS, 2007, MOL CANCER RES, V5, P165, DOI 10.1158/1541-7786.MCR-06-0398; Shpitz B, 1998, HUM PATHOL, V29, P469, DOI 10.1016/S0046-8177(98)90062-4; Shpitz B, 2003, GUT, V52, P1598, DOI 10.1136/gut.52.11.1598; Siu IM, 1997, AM J PATHOL, V150, P1805; Stevens RG, 2007, CANCER LETT, V248, P262, DOI 10.1016/j.canlet.2006.08.003; Takayama T, 1998, NEW ENGL J MED, V339, P1277, DOI 10.1056/NEJM199810293391803; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901	25	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148286	10.1371/journal.pone.0148286	http://dx.doi.org/10.1371/journal.pone.0148286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886097	Green Published, Green Submitted, gold			2022-12-27	WOS:000371218400029
J	Willis, S; Villalobos, VM; Gevaert, O; Abramovitz, M; Williams, C; Sikic, BI; Leyland-Jones, B				Willis, Scooter; Villalobos, Victor M.; Gevaert, Olivier; Abramovitz, Mark; Williams, Casey; Sikic, Branimir I.; Leyland-Jones, Brian			Single Gene Prognostic Biomarkers in Ovarian Cancer: A Meta-Analysis	PLOS ONE			English	Article							SIGNATURE; SURVIVAL; BIOINFORMATICS; VALIDATION; GRADE	Purpose To discover novel prognostic biomarkers in ovarian serous carcinomas. Methods A meta-analysis of all single genes probes in the TCGA and HAS ovarian cohorts was performed to identify possible biomarkers using Cox regression as a continuous variable for overall survival. Genes were ranked by p-value using Stouffer's method and selected for statistical significance with a false discovery rate (FDR) <.05 using the Benjamini-Hochberg method. Results Twelve genes with high mRNA expression were prognostic of poor outcome with an FDR <.05 (AXL, APC, RAB11FIP5, C19orf2, CYBRD1, PINK1, LRRN3, AQP1, DES, XRCC4, BCHE, and ASAP3). Twenty genes with low mRNA expression were prognostic of poor outcome with an FDR <.05 (LRIG1, SLC33A1, NUCB2, POLD3, ESR2, GOLPH3, XBP1, PAXIP1, CYB561, POLA2, CDH1, GMNN, SLC37A4, FAM174B, AGR2, SDR39U1, MAGT1, GJB1, SDF2L1, and C9orf82). Conclusion A meta-analysis of all single genes identified thirty-two candidate biomarkers for their possible role in ovarian serous carcinoma. These genes can provide insight into the drivers or regulators of ovarian cancer and should be evaluated in future studies. Genes with high expression indicating poor outcome are possible therapeutic targets with known antagonists or inhibitors. Additionally, the genes could be combined into a prognostic multi-gene signature and tested in future ovarian cohorts.	[Willis, Scooter; Abramovitz, Mark; Williams, Casey; Leyland-Jones, Brian] Avera Canc Inst, Dept Mol & Expt Med, Sioux Falls, SD USA; [Villalobos, Victor M.] UC Denver, Div Med Oncol, Denver, CO USA; [Gevaert, Olivier; Sikic, Branimir I.] Stanford Univ, Stanford, CA 94305 USA	Stanford University	Willis, S (corresponding author), Avera Canc Inst, Dept Mol & Expt Med, Sioux Falls, SD USA.	willishf@gmail.com	Gevaert, Olivier/H-3413-2019	Gevaert, Olivier/0000-0002-9965-5466	NIH [R01 CA114037, NIH R01 CA 184968]; NATIONAL CANCER INSTITUTE [R01CA184968, R01CA114037] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NIH grants R01 CA114037 and NIH R01 CA 184968 (B. I. Sikic). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER TR, 1994, SEMIN SURG ONCOL, V10, P242, DOI 10.1002/ssu.2980100403; Barakat R.R., 2009, PRINCIPLES PRACTICE, V5th ed.; Bentink S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030269; Bonome T, 2005, CANCER RES, V65, P10602, DOI 10.1158/0008-5472.CAN-05-2240; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Chang SJ, 2012, ANN SURG ONCOL; Crijns A, 2009, PLOS MED; Denkert C, 2009, J PATHOL, V218, P273, DOI 10.1002/path.2547; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Hernandez L, 2010, CANCER RES, V70, P4005, DOI 10.1158/0008-5472.CAN-09-3912; Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ibeanu OA, 2010, INT J GYNECOLOGICAL; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mok SC, 2009, CANCER CELL, V16, P521, DOI 10.1016/j.ccr.2009.10.018; Nolenu BM, 2012, FUTURE ONCOL, V8, P55, DOI [10.2217/fon.11.135, 10.2217/FON.11.135]; Prlic A, 2012, BIOINFORMATICS, V28, P2693, DOI 10.1093/bioinformatics/bts494; Riester M, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju048; Sabatier R, 2011, BRIT J CANCER, V105, P304, DOI 10.1038/bjc.2011.219; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Therneau T.M., 2000, MODELING SURVIVAL DA; Therneau T. M, 2015, SURVIVAL SURVIVAL AN; Verhaak RGW, 2013, J CLIN INVEST, V123, P517, DOI 10.1172/JCI65833; Waldron L, 2014, JNCI-J NATL CANCER I, P10; Yoshihara K, 2012, CLIN CANCER RES, V18, P1374, DOI 10.1158/1078-0432.CCR-11-2725; Yoshihara K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009615	27	66	67	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149183	10.1371/journal.pone.0149183	http://dx.doi.org/10.1371/journal.pone.0149183			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886260	Green Published, Green Submitted, gold			2022-12-27	WOS:000371218400064
J	Cavaliere, G; Trinchese, G; Bergamo, P; De Filippo, C; Raso, GM; Gifuni, G; Putti, R; Moni, BH; Canani, RB; Meli, R; Mollica, MP				Cavaliere, Gina; Trinchese, Giovanna; Bergamo, Paolo; De Filippo, Chiara; Raso, Giuseppina Mattace; Gifuni, Giorgio; Putti, Rosalba; Moni, Bottu Heleena; Canani, Roberto Berni; Meli, Rosaria; Mollica, Maria Pina			Polyunsaturated Fatty Acids Attenuate Diet Induced Obesity and Insulin Resistance, Modulating Mitochondrial Respiratory Uncoupling in Rat Skeletal Muscle	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE-PHOSPHORYLATION; FISH-OIL; COACTIVATOR; ADIPONECTIN; SENSITIVITY; PGC-1-BETA; MECHANISM; RECEPTOR	Objectives Omega (omega)-3 polyunsaturated fatty acids (PUFA) are dietary compounds able to attenuate insulin resistance. Anyway, the precise actions of omega-3PUFAs in skeletal muscle are overlooked. We hypothesized that PUFAs, modulating mitochondrial function and efficiency, would ameliorate pro-inflammatory and pro-oxidant signs of nutritionally induced obesity. Study Design To this aim, rats were fed a control diet (CD) or isocaloric high fat diets containing either omega-3 PUFA (FD) or lard (LD) for 6 weeks. Results FD rats showed lower weight, lipid gain and energy efficiency compared to LD-fed animals, showing higher energy expenditure and O-2 consumption/CO2 production. Serum lipid profile and pro-inflammatory parameters in FD-fed animals were reduced compared to LD. Accordingly, FD rats exhibited a higher glucose tolerance revealed by an improved glucose and insulin tolerance tests compared to LD, accompanied by a restoration of insulin signalling in skeletal muscle. PUFAs increased lipid oxidation and reduced energy efficiency in subsarcolemmal mitochondria, and increase AMPK activation, reducing both endoplasmic reticulum and oxidative stress. Increased mitochondrial respiration was related to an increased mitochondriogenesis in FD skeletal muscle, as shown by the increase in PGC1-alpha and -beta. Conclusions our data strengthened the association of high dietary omega 3-PUFA intake with reduced mitochondrial energy efficiency in the skeletal muscle.	[Cavaliere, Gina; Trinchese, Giovanna; De Filippo, Chiara; Gifuni, Giorgio; Putti, Rosalba; Moni, Bottu Heleena; Mollica, Maria Pina] Univ Naples Federico II, Dept Biol, Naples, Italy; [Bergamo, Paolo] CNR ISA, Inst Food Sci, Avellino, Italy; [Raso, Giuseppina Mattace; Meli, Rosaria] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Canani, Roberto Berni] Univ Naples Federico II, European Lab Food Induced Dis, Dept Translat Med Sci, Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); University of Naples Federico II; University of Naples Federico II	Mollica, MP (corresponding author), Univ Naples Federico II, Dept Biol, Naples, Italy.	mariapia.mollica@unina.it	Canani, Roberto Berni/AAC-4810-2022; Bergamo, Paolo/F-7835-2013; Giovanna, Trinchese/AAC-5995-2022	Canani, Roberto Berni/0000-0002-5169-9574; Bergamo, Paolo/0000-0002-1726-7911; Giovanna, Trinchese/0000-0002-4096-6876; Heleena Moni, Bottu/0000-0003-3280-5180; Mattace Raso, Giuseppina/0000-0002-5254-139X; Meli, Rosaria/0000-0002-6246-6813; Mollica, Maria Pina/0000-0003-2726-7779	University of Naples Federico II [COAN CA0440050101]	University of Naples Federico II	This work was supported by the University of Naples Federico II, grant number COAN CA0440050101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXSON SEH, 1988, J BIOL CHEM, V263, P13564; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Barbosa MR, 2013, BBA-MOL BASIS DIS, V1832, P1591, DOI 10.1016/j.bbadis.2013.04.029; Barja G, 1998, ANN NY ACAD SCI, V854, P224, DOI 10.1111/j.1749-6632.1998.tb09905.x; BENSON AM, 1980, P NATL ACAD SCI-BIOL, V77, P5216, DOI 10.1073/pnas.77.9.5216; Bergamo P, 2007, FREE RADICAL BIO MED, V43, P71, DOI 10.1016/j.freeradbiomed.2007.03.023; Bosma M, 2012, DIABETES, V61, P2679, DOI 10.2337/db11-1402; Cacho J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1269, DOI 10.1152/ajpendo.90207.2008; Casanova E, 2014, J NUTR BIOCHEM, V25, P1003, DOI 10.1016/j.jnutbio.2014.05.003; COGSWELL AM, 1993, AM J PHYSIOL, V264, pC383, DOI 10.1152/ajpcell.1993.264.2.C383; Crescenzo R, 2006, DIABETES, V55, P2286, DOI 10.2337/db06-0312; Dominguez JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006790; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Habig W H, 1981, Methods Enzymol, V77, P398; Harper J A, 2001, Obes Rev, V2, P255, DOI 10.1046/j.1467-789X.2001.00043.x; Harper ME, 2008, ANNU REV NUTR, V28, P13, DOI 10.1146/annurev.nutr.28.061807.155357; Hausladen A, 1996, METHOD ENZYMOL, V269, P37; Holloway GP, 2008, AM J PHYSIOL-ENDOC M, V294, pE1060, DOI 10.1152/ajpendo.00726.2007; Holness MJ, 2004, DIABETES, V53, pS166, DOI 10.2337/diabetes.53.2007.S166; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Iossa S, 2002, INT J OBESITY, V26, P65, DOI 10.1038/sj.ijo.0801844; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Jelenik T, 2010, DIABETES, V59, P2737, DOI 10.2337/db09-1716; Kalupahana NS, 2010, J NUTR, V140, P1915, DOI 10.3945/jn.110.125732; Keipert S, 2014, AM J PHYSIOL-ENDOC M, V306, pE469, DOI 10.1152/ajpendo.00330.2013; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Lanza IR, 2013, AM J PHYSIOL-ENDOC M, V304, pE1391, DOI 10.1152/ajpendo.00584.2012; Lauritzen HPMM, 2013, EXERC SPORT SCI REV, V41, P77, DOI 10.1097/JES.0b013e318275574c; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Li B, 2000, NAT MED, V6, P1115, DOI 10.1038/80450; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Lionetti L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092753; Lionetti L, 2014, INT J MOL SCI, V15, P3040, DOI 10.3390/ijms15023040; Liu Y, 2014, BEST PRACT RES CL EN, V28, P33, DOI 10.1016/j.beem.2013.08.003; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Meirhaeghe A, 2003, BIOCHEM J, V373, P155, DOI 10.1042/BJ20030200; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Mollica MP, 2006, CELL MOL LIFE SCI, V63, P358, DOI 10.1007/s00018-005-5443-2; Nedergaard J, 2005, EMBO REP, V6, P917, DOI 10.1038/sj.embor.7400532; Nielsen J, 2010, AM J PHYSIOL-ENDOC M, V298, pE706, DOI 10.1152/ajpendo.00692.2009; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; RAVUSSIN E, 1988, NEW ENGL J MED, V318, P467, DOI 10.1056/NEJM198802253180802; Ruderman NB, 1999, AM J PHYSIOL-ENDOC M, V276, pE1, DOI 10.1152/ajpendo.1999.276.1.E1; Salvado L, 2013, DIABETOLOGIA, V56, P1372, DOI 10.1007/s00125-013-2867-3; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Si Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007000; SKULACHEV VP, 1991, FEBS LETT, V294, P158, DOI 10.1016/0014-5793(91)80658-P; Stannard SR, 2004, J PHYSIOL-LONDON, V554, P595, DOI 10.1113/jphysiol.2003.053926; Szendroedi J, 2012, NAT REV ENDOCRINOL, V8, P92, DOI 10.1038/nrendo.2011.138; TERADA H, 1990, ENVIRON HEALTH PERSP, V87, P213, DOI 10.2307/3431027; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; van Loon LJC, 2004, AM J PHYSIOL-ENDOC M, V287, pE558, DOI 10.1152/ajpendo.00464.2003; Wang Y, 2011, J BIOL CHEM, V286, P11119, DOI 10.1074/jbc.M110.203323; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2013, CELL METAB, V17, P185, DOI 10.1016/j.cmet.2013.01.001; Ye RS, 2013, MOL METAB, V2, P133, DOI 10.1016/j.molmet.2013.04.001; Yuzefovych LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054059; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	63	56	58	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149033	10.1371/journal.pone.0149033	http://dx.doi.org/10.1371/journal.pone.0149033			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901315	Green Submitted, gold, Green Published			2022-12-27	WOS:000371276100035
J	He, L; Pan, XH; Doug, ZH; Huang, P; Zhou, X; Peng, ZH; Zheng, JL; Zhang, JF; Yang, JZ; Xu, Y; Jiang, J; Chen, L; Jiang, JM; Wang, N				He, Lin; Pan, Xiaohong; Doug, Zhihui; Huang, Peng; Zhou, Xin; Peng, Zhihang; Zheng, Jinlei; Zhang, Jiafeng; Yang, Jiezhe; Xu, Yun; Jiang, Jun; Chen, Lin; Jiang, Jianmin; Wang, Ning			The Factors Related to CD4+T-Cell Recovery and Viral Suppression in Patients Who Have Low CD4+T Cell Counts at the Initiation of HAART: A Retrospective Study of the National HIV Treatment Sub-Database of Zhejiang Province, China, 2014	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; COTRIMOXAZOLE PROPHYLAXIS; VIROLOGICAL SUPPRESSION; IMMUNOLOGICAL RESPONSE; OBSERVATIONAL COHORT; TREATMENT OUTCOMES; TERM MORTALITY; RURAL UGANDA; INFECTION; INDIVIDUALS	Background Since China has a unique system of delivering HIV care that includes all patients' records. The factors related to CD4+ T-cell recovery and viral suppression in patients who have low CD4+ T cell counts at the initiation of HAART are understudied in the China despite subsequent virological suppression (viral load < 50 copies/mL) is unknown. Methods The authors conducted a retrospective cohort study using data from the national HIV treatment sub-database of Zhejiang province to identify records of HIV+ patients. Patient records were included if they were < 16 years of age, had an initial CD4 count < 100 cells/mu L, were on continuous HAART for at least one year by the end of December 31, 2014; and achieved and maintained continued maximum virological suppression (MVS) (< 50 copies/ml) by 9 months after starting HAART. The primary endpoint for analysis was time to first CD4+ T cell count recovery (>= 200, 350, 500 cells/mu L). Cox proportional hazard regression was used to identify the risk factors for CD4+ T cell count recovery to key thresholds (200350, 350-500, >= 00 cells/mu L) by the time of last clinical follow-up (whichever occurred first), key thresholds (follow-up date for analysis), with patients still unable to reach the end-points being censored by the end December 31, 2014 (follow-up date for analysis). Results Of the 918 patients who were included in the study, and the median CD4+ T cell count was 39 cells/mu L at the baseline. At the end of follow-up, 727 (79.2%), 363 (39.5%) and 149 (16.2%) patients had return to >= 200, 350, and 500 cells/mu L, respectively. Kaplan-Meier analysis demonstrated that the rate of patients with CD4+ count recovery to >= 200, 350, and 500 cells/mu L after 1 year on HAART was 43.6, 8.6, and 2.5%, respectively, after 3 years on treatment was 90.8, 46.3, and 17.9%, respectively, and after 5 years on HAART was 97.1, 72.2, and 36.4%, respectively. The median time to return to 200-350, 350-500, >= 500cells/mu L was 1.11, 3.33 and 6.91 years, respectively. Factors of age (aHR = 0.77, 95% CI 0.61-0.97), baseline CD4+ count (aHR = 1.60, 95% CI 1.37-1.86), initial regimens, changes in regimen (aHR = 0.58, 95% CI 0.49-0.69), and inclusion of a cotrimoxazole prophylaxis (aHR = 0.66, 95% CI 0.51-0.85) were associated with CD4+ T cell count recovery. Conclusion The proportion of patients with initially low CD4 counts after nine months of treatment and that achieved continuous virological suppression was greater than 70% for persons with CD4+ count >= 350. Conversely, only 35% of patients recovered to levels of 500 cells/mu L after 5 years of treatment, and levels continued to rise significantly with further long-term HAART. Early HAART intervention will be necessary for achieving effective CD4+ T cell responses and optimal immunological function in HIV+ patients.	[He, Lin; Pan, Xiaohong; Zhou, Xin; Zheng, Jinlei; Zhang, Jiafeng; Yang, Jiezhe; Xu, Yun; Jiang, Jun; Chen, Lin; Jiang, Jianmin] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Doug, Zhihui; Wang, Ning] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Huang, Peng; Peng, Zhihang] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Nanjing Medical University	Pan, XH (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.; Wang, N (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	xhpan@cdc.zj.cn; wangnbj@163.com			National S & T Major Project Foundation of China [2012ZX10001-001]	National S & T Major Project Foundation of China	The work was supported by National S & T Major Project Foundation of China (2012ZX10001-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff KN, 2010, AIDS, V24, P2467, DOI 10.1097/QAD.0b013e32833e6d14; Amoroso A, 2012, JAIDS-J ACQ IMM DEF, V60, P314, DOI 10.1097/QAI.0b013e31824e5256; [Anonymous], 2012, CHIN FREE ART MAN; [Anonymous], 2015, CHINESE J AIDS STD, V87; Cain L, 2012, AIDS, V26, P1691, DOI 10.1097/QAD.0b013e328354f497; Carrero-Gras A, 2014, J INT AIDS SOC, V17, P199, DOI 10.7448/IAS.17.4.19819; Chadborn TR, 2006, AIDS, V20, P2371, DOI 10.1097/QAD.0b013e32801138f7; Cheng W, 2015, B WORLD HEALTH ORGAN, V93, P152, DOI 10.2471/BLT.14.142745; Chintu C, 2004, LANCET, V364, P1865, DOI 10.1016/S0140-6736(04)17442-4; Crawford KW, 2015, HIV MED, V16, P95, DOI 10.1111/hiv.12177; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Engsig FN, 2014, CLIN INFECT DIS, V58, P1312, DOI 10.1093/cid/ciu038; Forna F, 2007, JAIDS-J ACQ IMM DEF, V44, P456, DOI 10.1097/QAI.0b013e318033ffa1; Gandhi M, 2009, JAIDS-J ACQ IMM DEF, V50, P482, DOI 10.1097/QAI.0b013e31819c3376; Haering M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/472869; Han Y, 2015, PLOS ONE, V10; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Kaufmann GR, 2003, ARCH INTERN MED, V163, P2187, DOI 10.1001/archinte.163.18.2187; Kaufmann GR, 2002, AIDS, V16, P359, DOI 10.1097/00002030-200202150-00007; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; Lee FJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097482; Ma Y, 2010, CLIN INFECT DIS, V50, P264, DOI 10.1086/649215; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Mocroft A, 2006, AIDS, V20, P1141, DOI 10.1097/01.aids.0000226954.95094.39; Moniz P, 2014, J INT AIDS SOC, V17, P185, DOI 10.7448/IAS.17.4.19797; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Mutevedzi PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021795; Nachega JB, 2008, AIDS, V22, P2117, DOI 10.1097/QAD.0b013e328310407e; O'Connor JL, 2014, AIDS, V28, P919, DOI 10.1097/QAD.0000000000000165; Patel A K, 2006, J Assoc Physicians India, V54, P915; Sarfo FS, 2014, J ANTIMICROB CHEMOTH, V69, P254, DOI 10.1093/jac/dkt336; Smit M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076071; Tang HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096098; Valdez H, 2002, AIDS, V16, P1859, DOI 10.1097/00002030-200209270-00002; van Oosterhout JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042029; Velen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064459; Viard JP, 2001, J INFECT DIS, V183, P1290, DOI 10.1086/319678; Walker AS, 2010, LANCET, V375, P1278, DOI 10.1016/S0140-6736(10)60057-8; WHO, 2010, ANT THER HIV INF AD; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4	43	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148915	10.1371/journal.pone.0148915	http://dx.doi.org/10.1371/journal.pone.0148915			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900702	gold, Green Published, Green Submitted			2022-12-27	WOS:000371276100030
J	Kleisner, KM; Fogarty, MJ; McGee, S; Barnette, A; Fratantoni, P; Greene, J; Hare, JA; Luceyl, SM; McGuire, C; Odell, J; Saba, VS; Smith, L; Weaver, KJ; Pinsky, ML				Kleisner, Kristin M.; Fogarty, Michael J.; McGee, Sally; Barnette, Analie; Fratantoni, Paula; Greene, Jennifer; Hare, Jonathan A.; Luceyl, Sean M.; McGuire, Christopher; Odell, Jay; Saba, Vincent S.; Smith, Laurel; Weaver, Katherine J.; Pinsky, Malin L.			The Effects of Sub-Regional Climate Velocity on the Distribution and Spatial Extent of Marine Species Assemblages	PLOS ONE			English	Article							RANGE SHIFTS; PHENOLOGICAL RESPONSE; CONTINENTAL-SHELF; TEMPERATURE; VALIDATION; DYNAMICS	Many studies illustrate variable patterns in individual species distribution shifts in response to changing temperature. However, an assemblage, a group of species that shares a common environmental niche, will likely exhibit similar responses to climate changes, and these community-level responses may have significant implications for ecosystem function. Therefore, we examine the relationship between observed shifts of species in assemblages and regional climate velocity (i.e., the rate and direction of change of temperature isotherms). The assemblages are defined in two sub-regions of the U.S. Northeast Shelf that have heterogeneous oceanography and bathymetry using four decades of bottom trawl survey data and we explore temporal changes in distribution, spatial range extent, thermal habitat area, and biomass, within assemblages. These sub-regional analyses allow the dissection of the relative roles of regional climate velocity and local physiography in shaping observed distribution shifts. We find that assemblages of species associated with shallower, warmer waters tend to shift west-southwest and to shallower waters over time, possibly towards cooler temperatures in the semi-enclosed Gulf of Maine, while species assemblages associated with relatively cooler and deeper waters shift deeper, but with little latitudinal change. Conversely, species assemblages associated with warmer and shallower water on the broad, shallow continental shelf from the Mid-Atlantic Bight to Georges Bank shift strongly northeast along latitudinal gradients with little change in depth. Shifts in depth among the southern species associated with deeper and cooler waters are more variable, although predominantly shifts are toward deeper waters. In addition, spatial expansion and contraction of species assemblages in each region corresponds to the area of suitable thermal habitat, but is inversely related to assemblage biomass. This suggests that assemblage distribution shifts in conjunction with expansion or contraction of thermal habitat acts to compress or stretch marine species assemblages, which may respectively amplify or dilute species interactions to an extent that is rarely considered. Overall, regional differences in climate change effects on the movement and extent of species assemblages hold important implications for management, mitigation, and adaptation on the U.S. Northeast Shelf.	[Kleisner, Kristin M.; Fogarty, Michael J.; Fratantoni, Paula; Luceyl, Sean M.; Smith, Laurel] NOAA, Northeast Fisheries Sci Ctr, Woods Hole, MA USA; [McGee, Sally; Barnette, Analie; Greene, Jennifer; McGuire, Christopher; Odell, Jay; Weaver, Katherine J.] Nature Conservancy, Boston, MA USA; [Hare, Jonathan A.] NOAA, Northeast Fisheries Sci Ctr, Narragansett, RI USA; [Saba, Vincent S.] NOAA, Northeast Fisheries Sci Ctr, Geophys Fluid Dynam Lab, Princeton Univ Forrestal Campus, Princeton, NJ USA; [Pinsky, Malin L.] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA	National Oceanic Atmospheric Admin (NOAA) - USA; Nature Conservancy; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University; Rutgers State University New Brunswick	Kleisner, KM (corresponding author), NOAA, Northeast Fisheries Sci Ctr, Woods Hole, MA USA.	kristin.kleisner@noaa.gov	Saba, Vincent/A-3799-2010; Pinsky, Malin L./K-2884-2015	Saba, Vincent/0000-0002-2974-4826; Pinsky, Malin L./0000-0002-8523-8952; McGuire, Christopher/0000-0001-7835-3728	National Oceanic and Atmospheric Administration's Northeast Fisheries Science Center; Gordon and Betty Moore Foundation; Division Of Ocean Sciences [1426891] Funding Source: National Science Foundation	National Oceanic and Atmospheric Administration's Northeast Fisheries Science Center; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding for this joint partnership project between the National Oceanic and Atmospheric Administration's Northeast Fisheries Science Center and The Nature Conservancy comes from a grant from the Gordon and Betty Moore Foundation (https://www.moore.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew NR, 2013, PEERJ, V1, DOI 10.7717/peerj.11; Aschan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062748; Bell RJ, 2015, ICES J MAR SCI, V72, P1311, DOI 10.1093/icesjms/fsu217; Brock G, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i04; Burrows MT, 2014, NATURE, V507, P492, DOI 10.1038/nature12976; Cahill AE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.1890; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cheung WWL, 2013, NATURE, V497, P365, DOI 10.1038/nature12156; Cope JM, 2012, MAR ECOL PROG SER, V451, P187, DOI 10.3354/meps09595; Dell AI, 2014, J ANIM ECOL, V83, P70, DOI 10.1111/1365-2656.12081; Drinkwater KF, 2005, ICES J MAR SCI, V62, P1327, DOI 10.1016/j.icesjms.2005.05.015; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; Dunn J. C., 1974, Journal of Cybernetics, V4, P95, DOI 10.1080/01969727408546059; Friedland K, 2014, ECOSYSTEM ADVISORY N, V1; Friedland KD, 2007, CONT SHELF RES, V27, P2313, DOI 10.1016/j.csr.2007.06.001; Garcia RA, 2014, SCIENCE, V344, P486, DOI 10.1126/science.1247579; Gaston KJ, 1996, TRENDS ECOL EVOL, V11, P197, DOI 10.1016/0169-5347(96)10027-6; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Handl J, 2005, BIOINFORMATICS, V21, P3201, DOI 10.1093/bioinformatics/bti517; Hare JA, 2010, ECOL APPL, V20, P452, DOI 10.1890/08-1863.1; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Harvey ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080955; Hijmans R. J., 2014, GEOSPHERE SPHERICAL; Hodd RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095147; Hollander M., 1973, NONPARAMETRIC STAT M; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Lucey SM, 2010, MAR ECOL PROG SER, V415, P23, DOI 10.3354/meps08743; Lyons SK, 2005, AM NAT, V165, pE168, DOI 10.1086/429699; MacCall AD., 1990, DYNAMIC GEOGRAPHY MA; Mahon R, 1998, CAN J FISH AQUAT SCI, V55, P1704, DOI 10.1139/cjfas-55-7-1704; MENGE BA, 1990, TRENDS ECOL EVOL, V5, P52, DOI 10.1016/0169-5347(90)90048-I; Millien V, 2006, ECOL LETT, V9, P853, DOI 10.1111/j.1461-0248.2006.00928.x; MOUNTAIN DG, 1987, J MAR RES, V45, P319, DOI 10.1357/002224087788401160; Northfield TD, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001685; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Ovaskainen O, 2013, P NATL ACAD SCI USA, V110, P13434, DOI 10.1073/pnas.1305533110; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Pinsky ML, 2012, CLIMATIC CHANGE, V115, P883, DOI 10.1007/s10584-012-0599-x; R Core Team, 2021, R LANGUAGE ENV STAT; Rao JS., 2001, TOPICS CIRCULAR STAT; Robinson CLK, 2013, CAN J FISH AQUAT SCI, V70, P775, DOI 10.1139/cjfas-2012-0339; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Simpson MR, 2004, J SEA RES, V51, P199, DOI 10.1016/j.seares.2003.08.007; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Taylor MH, 2009, CONT SHELF RES, V29, P433, DOI 10.1016/j.csr.2008.11.002; Walsh HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137382; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Zuur Alain F., 2009, P1	53	90	91	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149220	10.1371/journal.pone.0149220	http://dx.doi.org/10.1371/journal.pone.0149220			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901435	Green Published, gold			2022-12-27	WOS:000371276100047
J	Wallace, D; Cooper, NR; Paulmann, S; Fitzgerald, PB; Russo, R				Wallace, Denise; Cooper, Nicholas R.; Paulmann, Silke; Fitzgerald, Paul B.; Russo, Riccardo			Perceived Comfort and Blinding Efficacy in Randomised Sham-Controlled Transcranial Direct Current Stimulation (tDCS) Trials at 2 mA in Young and Older Healthy Adults	PLOS ONE			English	Article							NONINVASIVE BRAIN-STIMULATION; HUMAN MOTOR CORTEX; MINI-MENTAL-STATE; ELECTRICAL-STIMULATION; WORKING-MEMORY; DC STIMULATION; PERCEPTION; SAFETY; EXCITABILITY; ELECTRODES	Background tDCS studies typically find that: lowest levels of comfort occur at stimulation-onset; young adult participants experience less comfort than older participants; and participants' blinding seems effective at low current strengths. At 2 mA conflicting results have been reported, questioning the effectiveness of blinding in sham-controlled paradigms using higher current strengths. Investigator blinding is rarely reported. Objective Using a protocol with 30 min of 2 mA stimulation we sought to: (a) investigate the level of perceived comfort in young and older adults, ranging in age from 19 to 29 years and 63 to 76 years, respectively; (b) test investigator and participant blinding; (c) assess comfort over a longer stimulation duration; (d) add to the literature on protocols using 2 mA current strength. Methods A two-session experiment was conducted where sham and active stimulation were administered to the frontal cortex at the F8/FP1 sites in a within-subjects manner. Levels of perceived comfort were measured, using a visual analogue scale, at the start and end of stimulation in young and older adults. Post-stimulation, participants and investigators judged whether or not active stimulation was used. Results Comfort scores were lower at stimulation onset in both age groups. Older adults reported: (i) more comfort than young participants overall; (ii) comparable levels of comfort in sham and active stimulation; (iii) significantly more comfort than the young participants during active stimulation. Stimulation mode was correctly identified above chance in the second of the two sessions; 65% of all participants correctly identified the stimulation mode, resulting in a statistical trend. Similarly, the experimenter correctly identified stimulation mode significantly above chance, with 62% of all investigator judgements correct across 120 judgements. Conclusions Using 2 mA current strength over 30 minutes, tDCS stimulation comfort is lower at stimulation onset in young and older adults and, overall, lower for young participants. Investigators and participants may be able to identify active stimulation at above chance levels, although accuracy never exceeded 65% for either participants or the experimenter. Further research into blinding efficacy is recommended.	[Wallace, Denise; Cooper, Nicholas R.; Paulmann, Silke; Russo, Riccardo] Univ Essex, Dept Psychol, Colchester CO4 3SQ, Essex, England; [Wallace, Denise; Cooper, Nicholas R.; Paulmann, Silke; Russo, Riccardo] Univ Essex, Ctr Brain Sci, Colchester CO4 3SQ, Essex, England; [Fitzgerald, Paul B.] Monash Univ, Cent Clin Sch, Monash Alfred Psychiat Res Ctr, Melbourne, Vic 3004, Australia; [Fitzgerald, Paul B.] Monash Univ, Alfred, Melbourne, Vic 3004, Australia	University of Essex; University of Essex; Monash University; Monash University	Wallace, D; Russo, R (corresponding author), Univ Essex, Dept Psychol, Colchester CO4 3SQ, Essex, England.; Wallace, D; Russo, R (corresponding author), Univ Essex, Ctr Brain Sci, Colchester CO4 3SQ, Essex, England.	dwallace@essex.ac.uk; rrusso@essex.ac.uk	Fitzgerald, Paul B/A-1225-2008	Fitzgerald, Paul B/0000-0003-4217-8096; , Riccardo Russo/0000-0002-5946-8914; Paulmann, Silke/0000-0003-4148-3806	University of Essex Ageing and Assisted Living Seedcorn fund	University of Essex Ageing and Assisted Living Seedcorn fund	A grant awarded to Silke Paulmann and Riccardo Russo by the University of Essex Ageing and Assisted Living Seedcorn fund fully supported this project. There was no additional external funding received for this study.	Ambrus GG, 2012, BRAIN STIMUL, V5, P499, DOI 10.1016/j.brs.2011.12.001; Ambrus GG, 2010, CLIN NEUROPHYSIOL, V121, P1908, DOI 10.1016/j.clinph.2010.04.020; Bashir S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00111; Batsikadze G, 2013, J PHYSIOL-LONDON, V591, P1987, DOI 10.1113/jphysiol.2012.249730; Berger VW, 2012, J CLIN EPIDEMIOL, V65, P1236, DOI 10.1016/j.jclinepi.2012.04.016; Bikson M, 2009, CLIN NEUROPHYSIOL, V120, P1033, DOI 10.1016/j.clinph.2009.03.018; BINDMAN LJ, 1962, NATURE, V196, P584, DOI 10.1038/196584a0; Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002; Davis NJ, 2013, EUR J NEUROSCI, V38, P2973, DOI 10.1111/ejn.12307; Dundas JE, 2007, CLIN NEUROPHYSIOL, V118, P1166, DOI 10.1016/j.clinph.2007.01.010; Fertonani A, 2015, CLIN NEUROPHYSIOL, V126, P2181, DOI 10.1016/j.clinph.2015.03.015; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Heft MW, 2014, AGE, V36, P1, DOI 10.1007/s11357-013-9536-9; Hoy KE, 2014, SCHIZOPHR RES, V155, P96, DOI 10.1016/j.schres.2014.03.006; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; Jo JM, 2009, AM J PHYS MED REHAB, V88, P404, DOI 10.1097/PHM.0b013e3181a0e4cb; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; Kemp J, 2014, CLIN NEUROPHYSIOL, V125, P602, DOI 10.1016/j.clinph.2013.08.020; Kessler SK, 2012, BRAIN STIMUL, V5, P155, DOI 10.1016/j.brs.2011.02.007; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Liew SL, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00378; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; Meng ZQ, 2014, J PSYCHIATR RES, V54, P19, DOI 10.1016/j.jpsychires.2014.03.007; Minhas P, 2011, CLIN NEUROPHYSIOL, V122, P637, DOI 10.1016/j.clinph.2010.09.023; Monte-Silva K, 2013, BRAIN STIMUL, V6, P424, DOI 10.1016/j.brs.2012.04.011; Monti A, 2013, J NEUROL NEUROSUR PS, V84, P832, DOI 10.1136/jnnp-2012-302825; neuroConn GmbH, 2012, NEUROCONN PROGR DIR; Ngernyam N, 2015, CLIN NEUROPHYSIOL, V126, P382, DOI 10.1016/j.clinph.2014.05.034; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2011, RESTOR NEUROL NEUROS, V29, P463, DOI 10.3233/RNN-2011-0618; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; O'Connell NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047514; Ohn SH, 2008, NEUROREPORT, V19, P43, DOI 10.1097/WNR.0b013e3282f2adfd; Palm U, 2013, BRAIN STIMUL, V6, P690, DOI 10.1016/j.brs.2013.01.005; Peron J, 2011, PROG NEURO-PSYCHOPH, V35, P987, DOI 10.1016/j.pnpbp.2011.01.019; Poreisz C, 2007, BRAIN RES BULL, V72, P208, DOI 10.1016/j.brainresbull.2007.01.004; Richmond L, 2014, J COGNITIVE NEUROSCI, P1; Russo R, 2013, BRAIN STIMUL, V6, P946, DOI 10.1016/j.brs.2013.05.009; San-Juan D, 2015, BRAIN STIMUL, V8, P455, DOI 10.1016/j.brs.2015.01.001; Shiozawa P, 2014, INT J NEUROPSYCHOPH, V17, P1443, DOI 10.1017/S1461145714000418; SMITH L, 1989, CUTIS, V43, P414; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Turi Z, 2014, BRAIN STIMUL, V7, P460, DOI 10.1016/j.brs.2014.01.059; Ulam F, 2015, CLIN NEUROPHYSIOL, V126, P486, DOI 10.1016/j.clinph.2014.05.015; Zaghi S, 2010, NEUROSCIENTIST, V16, P285, DOI 10.1177/1073858409336227	47	50	50	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149703	10.1371/journal.pone.0149703	http://dx.doi.org/10.1371/journal.pone.0149703			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900961	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000371276100131
J	Laura, RP; Dong, D; Reynolds, WF; Maki, RA				Laura, Richard P.; Dong, David; Reynolds, Wanda F.; Maki, Richard A.			T47D Cells Expressing Myeloperoxidase Are Able to Process, Traffic and Store the Mature Protein in Lysosomes: Studies in T47D Cells Reveal a Role for Cys(319) in MPO Biosynthesis that Precedes Its Known Role in Inter-Molecular Disulfide Bond Formation	PLOS ONE			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; HUMAN EOSINOPHIL PEROXIDASE; RAY CRYSTAL-STRUCTURE; HYDROGEN-PEROXIDE; ANGSTROM RESOLUTION; CARBOXYPEPTIDASE E; PRECURSOR; FORMS; PROPEPTIDE; GRANULES	Among the human heme-peroxidase family, myeloperoxidase (MPO) has a unique disulfide-linked oligomeric structure resulting from multi-step processing of the pro-protein monomer (proMPO) after it exits the endoplasmic reticulum (ER). Related family members undergo some, but not all, of the processing steps involved with formation of mature MPO. Lactoperoxidase has its pro-domain proteolytically removed and is a monomer in its mature form. Eosinophil peroxidase undergoes proteolytic removal of its pro-domain followed by proteolytic separation into heavy and light chains and is a heterodimer. However, only MPO undergoes both these proteolytic modifications and then is further oligomerized into a heterotetramer by a single inter-molecular disulfide bond. The details of how and where the post-ER processing steps of MPO occur are incompletely understood. We report here that T47D breast cancer cells stably transfected with an MPO expression plasmid are able to efficiently replicate all of the processing steps that lead to formation of the mature MPO heterotetramer. MPO also traffics to the lysosome granules of T47D cells where it accumulates, allowing in-depth immunofluorescent microscopy studies of MPO trafficking and storage for the first time. Using this novel cell model we show that formation of MPO's single inter-molecular disulfide bond can occur normally in the absence of the proteolytic events that lead to separation of the MPO heavy and light chains. We further demonstrate that Cys(319), which forms MPO's unique inter-molecular disulfide bond, is important for events that precede this step. Mutation of this residue alters the glycosylation and catalytic activity of MPO and blocks its entry into the endocytic pathway where proteolytic processing and disulfide bonding occur. Finally, using the endocytic trafficking of lysosomal hydrolases as a guide, we investigate the role of candidate receptors in the endocytic trafficking of MPO.	[Laura, Richard P.; Maki, Richard A.] Torrey Pines Pharmaceut, Del Mar, CA USA; [Dong, David; Reynolds, Wanda F.; Maki, Richard A.] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA USA	Sanford Burnham Prebys Medical Discovery Institute	Maki, RA (corresponding author), Torrey Pines Pharmaceut, Del Mar, CA USA.; Maki, RA (corresponding author), Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA USA.	rmaki@sbpdiscovery.org		Dong, David/0000-0003-0192-307X	NIH [RO1 HL088428, RO1-AG017879, RO1-NS074303, RO1-AG040623, R43 HL095251, R43 AG040935]; Sanford-Burnham-Prebys Medical Discovery Institute; Torrey Pines Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088428, R43HL095251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017879, R43AG040935] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sanford-Burnham-Prebys Medical Discovery Institute; Torrey Pines Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by the NIH (RO1 HL088428, RO1-AG017879, and RO1-NS074303, RO1-AG040623 to WFR and R43 HL095251 and R43 AG040935 to RAM). Additional funds to support this study have been generously provided by Sanford-Burnham-Prebys Medical Discovery Institute. The funder (Torrey Pines Pharmaceuticals) provided support in the form of salaries for authors RPL and RAM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AKIN DT, 1986, J BIOL CHEM, V261, P8370; Andersson E, 1998, J BIOL CHEM, V273, P4747, DOI 10.1074/jbc.273.8.4747; Arnaoutova I, 2003, BIOCHEMISTRY-US, V42, P10445, DOI 10.1021/bi034277y; BAINTON DF, 1988, EXP HEMATOL, V16, P150; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Bulow E, 2002, J LEUKOCYTE BIOL, V71, P279; CULLY J, 1989, EXP CELL RES, V180, P440, DOI 10.1016/0014-4827(89)90070-0; Dahms NM, 2002, BBA-GEN SUBJECTS, V1572, P317, DOI 10.1016/S0304-4165(02)00317-3; Dell'Angelica EC, 2000, FASEB J, V14, P1265, DOI 10.1096/fj.14.10.1265; Dhanvantari S, 2000, J BIOL CHEM, V275, P29887, DOI 10.1074/jbc.M005364200; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Fomenko DE, 2003, ANTIOXID REDOX SIGN, V5, P397, DOI 10.1089/152308603768295131; Franck T, 2015, FREE RADICAL RES, V49, P790, DOI 10.3109/10715762.2015.1027197; Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017; Goedken M, 2007, J BIOL CHEM, V282, P27994, DOI 10.1074/jbc.M701984200; Hansson M, 2006, ARCH BIOCHEM BIOPHYS, V445, P214, DOI 10.1016/j.abb.2005.08.009; HASILIK A, 1984, EMBO J, V3, P2671, DOI 10.1002/j.1460-2075.1984.tb02192.x; Herskowitz JH, 2012, MOL BIOL CELL, V23, P2645, DOI 10.1091/mbc.E12-01-0014; Hope HR, 2000, PROTEIN EXPRES PURIF, V18, P269, DOI 10.1006/prep.1999.1197; HUR SJ, 1989, J BIOL CHEM, V264, P8542; Jacob KD, 2013, MECH AGEING DEV, V134, P139, DOI 10.1016/j.mad.2013.02.008; Jadot M, 1999, J BIOL CHEM, V274, P21104, DOI 10.1074/jbc.274.30.21104; Kallquist L, 2008, BLOOD, V112, P3444, DOI 10.1182/blood-2007-10-116285; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Makrypidi G, 2012, MOL CELL BIOL, V32, P774, DOI 10.1128/MCB.06195-11; McCormick S, 2012, ARCH BIOCHEM BIOPHYS, V527, P31, DOI 10.1016/j.abb.2012.07.013; McGirr R, 2013, J ENDOCRINOL, V217, P229, DOI 10.1530/JOE-12-0468; MESSNER DJ, 1993, ARCH BIOCHEM BIOPHYS, V306, P391, DOI 10.1006/abbi.1993.1528; Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107; Mullerr-Loennies S, 2010, AM J PATHOL, V177, P240, DOI 10.2353/ajpath.2010.090954; Nauseef WM, 1996, J BIOL CHEM, V271, P9546, DOI 10.1074/jbc.271.16.9546; NAUSEEF WM, 1992, BLOOD, V80, P2622; Nielsen MS, 2007, MOL CELL BIOL, V27, P6842, DOI 10.1128/MCB.00815-07; OLSEN RL, 1986, BIOCHEM J, V237, P559, DOI 10.1042/bj2370559; Oxvig C, 1999, J BIOL CHEM, V274, P16953, DOI 10.1074/jbc.274.24.16953; Pallesen LT, 2012, MOL NEUROBIOL, V45, P379, DOI 10.1007/s12035-012-8236-2; Paumann-Page M, 2013, ARCH BIOCHEM BIOPHYS, V539, P51, DOI 10.1016/j.abb.2013.09.004; PEMBER SO, 1983, ARCH BIOCHEM BIOPHYS, V221, P391, DOI 10.1016/0003-9861(83)90158-3; Probst OC, 2006, J CELL SCI, V119, P4935, DOI 10.1242/jcs.03283; Puissant E, 2014, TRAFFIC, V15, P500, DOI 10.1111/tra.12162; Purvis AR, 2007, P NATL ACAD SCI USA, V104, P15647, DOI 10.1073/pnas.0705175104; Purvis AR, 2004, J BIOL CHEM, V279, P49982, DOI 10.1074/jbc.M408727200; Qian MQ, 2008, MOL CELL PROTEOMICS, V7, P58, DOI 10.1074/mcp.M700217-MCP200; Ravnsborg T, 2010, BBA-PROTEINS PROTEOM, V1804, P2046, DOI 10.1016/j.bbapap.2010.07.001; Reinhold WC, 2012, CANCER RES, V72, P3499, DOI 10.1158/0008-5472.CAN-12-1370; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Shishehbor Mehdi H, 2004, Curr Atheroscler Rep, V6, P243, DOI 10.1007/s11883-004-0038-1; Singh AK, 2009, BIOPHYS J, V96, P646, DOI 10.1016/j.bpj.2008.09.019; SLEAT DE, 1995, CANCER RES, V55, P3424; STROMBERG K, 1986, EUR J CELL BIOL, V39, P424; Sun PL, 2008, P NATL ACAD SCI USA, V105, P16590, DOI 10.1073/pnas.0807472105; Takeuchi N, 2003, J BIOL CHEM, V278, P45318, DOI 10.1074/jbc.M307620200; Thomsen AR, 2000, ARCH BIOCHEM BIOPHYS, V379, P147, DOI 10.1006/abbi.2000.1866; VALENZANO KJ, 1995, J BIOL CHEM, V270, P16441, DOI 10.1074/jbc.270.27.16441; Van Antwerpen P, 2010, J BIOL CHEM, V285, P16351, DOI 10.1074/jbc.M109.089748; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; ZENG J, 1992, J MOL BIOL, V226, P185, DOI 10.1016/0022-2836(92)90133-5	58	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149391	10.1371/journal.pone.0149391	http://dx.doi.org/10.1371/journal.pone.0149391			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890638	Green Published, Green Submitted, gold			2022-12-27	WOS:000371221500041
J	Shimizu, H; Arimura, Y; Onodera, K; Takahashi, H; Okahara, S; Kodaira, J; Oohashi, H; Isshiki, H; Kawakami, K; Yamashita, K; Shinomura, Y; Hosokawa, M				Shimizu, Haruo; Arimura, Yoshiaki; Onodera, Kei; Takahashi, Hiroaki; Okahara, Satoshi; Kodaira, Junichi; Oohashi, Hirokazu; Isshiki, Hiroyuki; Kawakami, Kentaro; Yamashita, Kentaro; Shinomura, Yasuhisa; Hosokawa, Masao			Malignant Potential of Gastrointestinal Cancers Assessed by Structural Equation Modeling	PLOS ONE			English	Article								Background Parameters reported in pathologic reviews have been failing to assess exactly the malignant potential of gastrointestinal cancers. We hypothesized that malignant potential could be defined by common latent variables (hypothesis I), but there are substantial differences in the associations between malignant potential and pathologic parameters according to the origin of gastrointestinal cancers (hypothesis II). We shed light on these issues by structural equation modeling. Materials and Methods We conducted a cross-sectional survey of 217 esophageal, 192 gastric, and 175 colorectal cancer patients who consecutively underwent curative surgery for their pathologic stage I cancers at Keiyukai Sapporo Hospital. Latent variables identified by factor analysis and seven conventional pathologic parameters were introduced in the structural equation modeling analysis. Results Because latent variables were disparate except for their number, 'three' in the examined gastrointestinal cancers, the first hypothesis was rejected. Because configural invariance across gastrointestinal cancers was not approved, the second hypothesis was verified. We could trace the three significant paths on the causal graph from latent variables to lymph node metastasis, which were mediated through depth, lymphatic invasion, and matrilysin expression in esophageal cancer, whereas only one significant path could be traced in both gastric and colorectal cancer. Two of the three latent variables were exogenous in esophageal cancer, whereas one factor was exogenous in the other gastrointestinal cancers. Cancer stemness promoted viability in esophageal cancer, but it was suppressed in others. Conclusion These results reflect the malignant potential of esophageal cancer is higher than that of the other gastrointestinal cancers. Such information might contribute to refining clinical treatments for gastrointestinal cancers.	[Shimizu, Haruo; Arimura, Yoshiaki; Onodera, Kei; Isshiki, Hiroyuki; Kawakami, Kentaro; Yamashita, Kentaro; Shinomura, Yasuhisa] Sapporo Med Univ, Dept Gastroenterol Rheumatol & Clin Immunol, Sapporo, Hokkaido, Japan; [Takahashi, Hiroaki; Okahara, Satoshi; Kodaira, Junichi; Oohashi, Hirokazu] Keiyukai Daini Hosp, Dept Gastroenterol, Sapporo, Hokkaido, Japan; [Hosokawa, Masao] Keiyukai Hosp, Dept Surg, Sapporo, Hokkaido, Japan; [Shinomura, Yasuhisa] Ikeda Municipal Hosp, Dept Gastroenterol, Osaka, Japan	Sapporo Medical University	Arimura, Y (corresponding author), Sapporo Med Univ, Dept Gastroenterol Rheumatol & Clin Immunol, Sapporo, Hokkaido, Japan.	arimura@sapmed.ac.jp			Grants-in-Aid for Scientific Research [25460954] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Ajani J, 2015, GASTRIC CANC; Al B, 2015, RECTAL CANC; Al B, 2015, COLON CANC; Ancona E, 2008, ANN SURG ONCOL, V15, P3278, DOI 10.1245/s10434-008-0065-1; Bentler PM, 2008, EQS 6 1 WINDOWS USER, P1; Bollen K. A., 1993, TESTING STRUCTURAL E; Bollen KA, 2011, P NATL ACAD SCI USA, V108, P15639, DOI 10.1073/pnas.1010661108; Bryan A, 2007, AIDS BEHAV, V11, P365, DOI 10.1007/s10461-006-9150-2; BUSE A, 1982, AM STAT, V36, P153, DOI 10.2307/2683166; Bou JC, 2010, ORGAN RES METHODS, V13, P738, DOI 10.1177/1094428109340433; Dean J., 2009, JALT TESTING EVALUAT, V13, P20; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Japanese Society for Cancer of the Colon and Rectum, 2009, JAP CLASS COL CARC; Joreskog K. G., 1970, ETS RES B SER, V1970, P1, DOI DOI 10.1002/J.2333-8504.1970.TB00783.X; Kurokawa S, 2005, GUT, V54, P1751, DOI 10.1136/gut.2005.071035; Liefers GJ, 1998, NEW ENGL J MED, V339, P223, DOI 10.1056/NEJM199807233390403; Pennathur A, 2009, ANN THORAC SURG, V87, P1048, DOI 10.1016/j.athoracsur.2008.12.060; Preacher KJ, 2006, POWER SAMPLE SIZE US; Sobin L, 2009, TNM CLASSIFICATION M; Takubo K, 2009, ESOPHAGUS-TOKYO, V6, P1, DOI 10.1007/s10388-009-0169-0; Ueno H, 2004, GASTROENTEROLOGY, V127, P385, DOI 10.1053/j.gastro.2004.04.022; Wu, 2007, ED MEASUREMENT ISSUE, V26, P33, DOI DOI 10.1111/J.1745-3992.2007.00099.X	25	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149327	10.1371/journal.pone.0149327	http://dx.doi.org/10.1371/journal.pone.0149327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26889682	Green Submitted, Green Published, gold			2022-12-27	WOS:000371221500034
J	Caselli, E; D'Accolti, M; Vandini, A; Lanzoni, L; Camerada, MT; Coccagna, M; Branchini, A; Antonioli, P; Balboni, PG; Di Luca, D; Mazzacane, S				Caselli, Elisabetta; D'Accolti, Maria; Vandini, Alberta; Lanzoni, Luca; Camerada, Maria Teresa; Coccagna, Maddalena; Branchini, Alessio; Antonioli, Paola; Balboni, Pier Giorgio; Di Luca, Dario; Mazzacane, Sante			Impact of a Probiotic-Based Cleaning Intervention on the Microbiota Ecosystem of the Hospital Surfaces: Focus on the Resistome Remodulation	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; ENVIRONMENTAL CONTAMINATION; CLOSTRIDIUM-DIFFICILE; INFECTION PREVENTION; WASTE-WATER; TRANSMISSION; DISINFECTION; PATHOGENS; PCR; ENTEROCOCCI	Background Contamination of hospital surfaces by clinically-relevant pathogens represents a major concern in healthcare facilities, due to its impact on transmission of healthcare-associated infections (HAIs) and to the growing drug resistance of HAI-associated pathogens. Routinely used chemical disinfectants show limitations in controlling pathogen contamination, due to their inefficacy in preventing recontamination and selection of resistant strains. Recently we observed that an innovative approach, based on a cleanser added with spores of non-pathogenic probiotic Bacilli, was effective in stably counteracting the growth of several pathogens contaminating hospital surfaces. Methods Here, we wanted to study the impact of the Bacillus-based cleanser on the drug-resistance features of the healthcare pathogens population. In parallel, the ability of cleanser-derived Bacilli to infect hospitalized patients was also investigated. Results Collected data showed that Bacilli spores can germinate on dry inanimate surfaces, generating the bacterial vegetative forms which counteract the growth of pathogens and effectively substitute for them on treated surfaces. Strikingly, this procedure did not select resistant species, but conversely induced an evident decrease of antibiotic resistance genes in the contaminating microbial population. Also importantly, all the six HAI-positive patients hosted in the treated areas resulted negative for probiotic Bacilli, thus adding evidences to their safety-to-use. Conclusions These results indicate that this probiotic-based procedure is active not only in controlling surface microbial contamination but also in lowering drug-resistant species, suggesting that it may have relevant clinical and therapeutical implications for the management of HAIs.	[Caselli, Elisabetta; D'Accolti, Maria; Di Luca, Dario] Univ Ferrara, Dept Med Sci, Sect Microbiol & Med Genet, I-44100 Ferrara, Italy; [Caselli, Elisabetta; D'Accolti, Maria; Vandini, Alberta; Lanzoni, Luca; Camerada, Maria Teresa; Coccagna, Maddalena; Balboni, Pier Giorgio; Di Luca, Dario; Mazzacane, Sante] Univ Ferrara, CIAS Interdept Res Ctr Pollut Control High Steril, I-44100 Ferrara, Italy; [Branchini, Alessio] Univ Ferrara, Dept Life Sci & Biotechnol, Sect Biochem & Mol Biol, I-44100 Ferrara, Italy; [Antonioli, Paola] S Anna Univ Hosp, Dept Infect Prevent Control & Risk Management, Ferrara, Italy; [Vandini, Alberta; Camerada, Maria Teresa] Univ Ferrara, Dept Architecture, Architecture & Urban Planning Cycle 30, I-44100 Ferrara, Italy	University of Ferrara; University of Ferrara; University of Ferrara; University of Ferrara; Arcispedale Sant'Anna; University of Ferrara	Caselli, E (corresponding author), Univ Ferrara, Dept Med Sci, Sect Microbiol & Med Genet, I-44100 Ferrara, Italy.; Caselli, E (corresponding author), Univ Ferrara, CIAS Interdept Res Ctr Pollut Control High Steril, I-44100 Ferrara, Italy.	elisabetta.caselli@unife.it	Elisabetta, Caselli/H-1513-2012; Branchini, Alessio/H-8636-2019; antonioli, paola/M-8975-2016	Elisabetta, Caselli/0000-0001-6048-9141; Branchini, Alessio/0000-0002-6113-2694; antonioli, paola/0000-0002-1257-3434; Coccagna, Maddalena/0000-0003-0447-1363; D'Accolti, Maria/0000-0003-1937-5534	COPMA scrl (Ferrara, Italy)	COPMA scrl (Ferrara, Italy)	This study was financially supported by COPMA scrl (Ferrara, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; [Anonymous], 2013, POINT PREVALENCE SUR; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Boyce JM, 2007, J HOSP INFECT, V65, P50, DOI 10.1016/S0195-6701(07)60015-2; Boyce JM, 2011, INFECT CONT HOSP EP, V32, P1187, DOI 10.1086/662626; Bueche M, 2013, APPL ENVIRON MICROB, V79, P5302, DOI 10.1128/AEM.01376-13; Caini S, 2013, EURO SURVEILL, V18; Carling PC, 2008, INFECT CONT HOSP EP, V29, P1, DOI 10.1086/524329; Carling PC, 2010, AM J INFECT CONTROL, V38, pS41, DOI 10.1016/j.ajic.2010.03.004; Caselli E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002951; *CLIN LAB STAND I, 2011, M100S21 CLSI; Cookson B, 2013, J HOSP INFECT, V85, P45, DOI 10.1016/j.jhin.2013.04.019; Dancer SJ, 2011, EUR J CLIN MICROBIOL, V30, P1473, DOI 10.1007/s10096-011-1250-x; Davies A, 2011, J HOSP INFECT, V77, P199, DOI 10.1016/j.jhin.2010.08.012; Gentili V, 2012, EUR J CLIN MICROBIOL, V31, P1523, DOI 10.1007/s10096-011-1473-x; Goodman ER, 2008, INFECT CONT HOSP EP, V29, P593, DOI 10.1086/588566; Hota B, 2004, CLIN INFECT DIS, V39, P1182, DOI 10.1086/424667; Huslage K, 2013, INFECT CONT HOSP EP, V34, P211, DOI 10.1086/669092; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Kummerer K, 2001, CHEMOSPHERE, V45, P957, DOI 10.1016/S0045-6535(01)00144-8; La Fauci V, 2015, MICROBIAL BIOCH TECH, V7, P5, DOI DOI 10.4172/1948-5948.1000198; Otter JA, 2013, J HOSP INFECT, V83, P1, DOI 10.1016/j.jhin.2012.10.002; Rutala WA, 2013, AM J INFECT CONTROL, V41, pS36, DOI 10.1016/j.ajic.2012.11.006; Rutala WA, 2011, INFECT CONT HOSP EP, V32, P743, DOI 10.1086/661226; Vandini A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108598; Wattiau P, 2001, APPL MICROBIOL BIOT, V56, P816, DOI 10.1007/s002530100691; Weber DJ, 2013, AM J INFECT CONTROL, V41, pS31, DOI 10.1016/j.ajic.2012.12.005; Weber DJ, 2013, AM J INFECT CONTROL, V41, pS105, DOI 10.1016/j.ajic.2012.12.009; Weber DJ, 2010, AM J INFECT CONTROL, V38, pS25, DOI 10.1016/j.ajic.2010.04.196; Weber DJ, 1997, INFECT CONT HOSP EP, V18, P306; Wu XY, 2006, J MICROBIOL METH, V64, P107, DOI 10.1016/j.mimet.2005.04.021	32	51	54	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148857	10.1371/journal.pone.0148857	http://dx.doi.org/10.1371/journal.pone.0148857			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886448	Green Published, gold, Green Submitted			2022-12-27	WOS:000371218400054
J	Dotan, I; Roche, PJR; Paliouras, M; Mitmaker, EJ; Trifiro, MA				Dotan, Idit; Roche, Philip J. R.; Paliouras, Miltiadis; Mitmaker, Elliot J.; Trifiro, Mark A.			Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer Cells	PLOS ONE			English	Article							STIMULATING HORMONE-RECEPTOR; EXTERNAL-BEAM RADIOTHERAPY; THYROTROPIN RECEPTOR; PHOTOTHERMAL THERAPY; THERMAL ABLATION; TSH RECEPTOR; TUMOR-CELLS; IN-VITRO; DIFFERENTIAL EXPRESSION; MONOCLONAL-ANTIBODIES	Background The incidence of papillary thyroid carcinoma (PTC) has risen steadily over the past few decades as well as the recurrence rates. It has been proposed that targeted ablative physical therapy could be a therapeutic modality in thyroid cancer. Targeted bio-affinity functionalized multi-walled carbon nanotubes (BioNanofluid) act locally, to efficiently convert external light energy to heat thereby specifically killing cancer cells. This may represent a promising new cancer therapeutic modality, advancing beyond conventional laser ablation and other nanoparticle approaches. Methods Thyroid Stimulating Hormone Receptor (TSHR) was selected as a target for PTC cells, due to its wide expression. Either TSHR antibodies or Thyrogen or purified TSH (Thyrotropin) were chemically conjugated to our functionalized Bionanofluid. A diode laser system (532 nm) was used to illuminate a PTC cell line for set exposure times. Cell death was assessed using Trypan Blue staining. Results TSHR-targeted BioNanofluids were capable of selectively ablating BCPAP, a TSHR-positive PTC cell line, while not TSHR-null NSC-34 cells. We determined that a 2:1 BCPAP cell: alpha-TSHR-BioNanofluid conjugate ratio and a 30 second laser exposure killed approximately 60% of the BCPAP cells, while 65% and >70% of cells were ablated using Thyrotropin-and Thyrogen-BioNanofluid conjugates, respectively. Furthermore, minimal non-targeted killing was observed using selective controls. Conclusion A BioNanofluid platform offering a potential therapeutic path for papillary thyroid cancer has been investigated, with our in vitro results suggesting the development of a potent and rapid method of selective cancer cell killing. Therefore, BioNanofluid treatment emphasizes the need for new technology to treat patients with local recurrence and metastatic disease who are currently undergoing either re-operative neck explorations, repeated administration of radioactive iodine and as a last resort external beam radiation or chemotherapy, with fewer side effects and improved quality of life.	[Dotan, Idit; Roche, Philip J. R.; Paliouras, Miltiadis; Mitmaker, Elliot J.; Trifiro, Mark A.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Dotan, Idit; Paliouras, Miltiadis; Trifiro, Mark A.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Paliouras, Miltiadis; Mitmaker, Elliot J.] McGill Univ, Dept Surg, Montreal, PQ H3A 2T5, Canada; [Trifiro, Mark A.] McGill Univ, Jewish Gen Hosp, Div Endocrinol, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University	Paliouras, M; Mitmaker, EJ (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada.; Paliouras, M (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.; Paliouras, M; Mitmaker, EJ (corresponding author), McGill Univ, Dept Surg, Montreal, PQ H3A 2T5, Canada.	miltiadis.paliouras@mcgill.ca; elliot.mitmaker@mcgill.ce			Israel Cancer Research Fund (ICRF)	Israel Cancer Research Fund (ICRF)	I.D. received salary support from the Israel Cancer Research Fund (ICRF).	Abe E, 2003, CELL, V115, P151, DOI 10.1016/S0092-8674(03)00771-2; Al-Saif O, 2010, J CLIN ENDOCR METAB, V95, P2187, DOI 10.1210/jc.2010-0063; Avetisyan YA, 2012, APPL OPTICS, V51, pC88, DOI 10.1364/AO.51.000C88; Baffou G, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3116645; Baffou G, 2014, NANOSCALE, V6, P8984, DOI 10.1039/c4nr01644k; Boca SC, 2011, CANCER LETT, V311, P131, DOI 10.1016/j.canlet.2011.06.022; BRABANT G, 1991, MOL CELL ENDOCRINOL, V82, pR7, DOI 10.1016/0303-7207(91)90018-N; Brierley JD, 2011, J CLIN ENDOCR METAB, V96, P2289, DOI 10.1210/jc.2011-1109; Brioli A, 2014, BRIT J HAEMATOL, V165, P441, DOI 10.1111/bjh.12805; Burke A, 2009, P NATL ACAD SCI USA, V106, P12897, DOI 10.1073/pnas.0905195106; Burlaka A., 2010, Experimental Oncology, V32, P48; Busuttil BE, 2001, J CLIN ENDOCR METAB, V86, P2315, DOI 10.1210/jc.86.5.2315; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chakravarty P, 2008, P NATL ACAD SCI USA, V105, P8697, DOI 10.1073/pnas.0803557105; Chang EH, 2015, BIOCHEM BIOPH RES CO, V468, P511, DOI 10.1016/j.bbrc.2015.10.136; Chen ST, 2000, J ENDOCRINOL, V165, P379, DOI 10.1677/joe.0.1650379; Chia SY, 2007, J CLIN ENDOCR METAB, V92, P468, DOI 10.1210/jc.2006-2088; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; El-Sayed IH, 2006, CANCER LETT, V239, P129, DOI 10.1016/j.canlet.2005.07.035; Ell C, 1998, GUT, V43, P345, DOI 10.1136/gut.43.3.345; FABIEN N, 1994, CANCER, V73, P2206, DOI 10.1002/1097-0142(19940415)73:8<2206::AID-CNCR2820730828>3.0.CO;2-M; Ford D, 2003, CLIN ONCOL-UK, V15, P337, DOI 10.1016/S0936-6555(03)00162-6; Giordano D, 2012, THYROID, V22, P911, DOI 10.1089/thy.2012.0011; Hashida Y, 2014, J CONTROL RELEASE, V173, P59, DOI 10.1016/j.jconrel.2013.10.039; Huang XH, 2008, LASER MED SCI, V23, P217, DOI 10.1007/s10103-007-0470-x; Hudson DE, 2013, PHOTOMED LASER SURG, V31, P163, DOI 10.1089/pho.2012.3284; Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1; Jeffreys J, 2002, THYROID, V12, P1051, DOI 10.1089/105072502321085144; Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102; Kazaure HS, 2012, ANN SURG ONCOL, V19, P1874, DOI 10.1245/s10434-011-2129-x; Kloos Richard T, 2005, Curr Treat Options Oncol, V6, P323; Kumar S, 2011, J MOL ENDOCRINOL, V46, P155, DOI 10.1530/JME-11-0006; Lee N, 2006, ENDOCR-RELAT CANCER, V13, P971, DOI 10.1677/ERC-06-0039; Loo C, 2005, NANO LETT, V5, P709, DOI 10.1021/nl050127s; Malic E, 2006, PHYS REV B, V74, P1; Marches R, 2009, INT J CANCER, V125, P2970, DOI 10.1002/ijc.24659; Maestro LM, 2013, NANOSCALE, V5, P7882, DOI 10.1039/c3nr01398g; McLeod DSA, 2013, LANCET, V381, P1046, DOI 10.1016/S0140-6736(12)62205-3; Melisi D, 2013, CURR OPIN PHARMACOL, V13, P536, DOI 10.1016/j.coph.2013.06.012; Melong JC, 2015, J OTOLARYNGOL-HEAD N, V44, DOI 10.1186/s40463-015-0093-3; Mendoza-Nava H, 2013, PHOTOMED LASER SURG, V31, P17, DOI 10.1089/pho.2012.3320; Moodley K, 2011, J NEUROL SCI, V302, P114, DOI 10.1016/j.jns.2010.11.027; Oda Y, 1998, J MOL ENDOCRINOL, V20, P233, DOI 10.1677/jme.0.0200233; Oda Y, 2000, THYROID, V10, P1051, DOI 10.1089/thy.2000.10.1051; Pacini F, 2006, EUR J ENDOCRINOL, V154, P787, DOI 10.1530/eje.1.02158; Panchapakesan B, 2005, NANOBIOTHCHNOLOGY, V1, P7; Park A, 2013, ENDOCRINOLOGY, V154, P1373, DOI 10.1210/en.2012-2010; Pattani VP, 2012, LASER SURG MED, V44, P675, DOI 10.1002/lsm.22072; PAULIN C, 1992, CR ACAD SCI III-VIE, V315, P493; Pilli T, 2009, THYROID, V19, P1333, DOI 10.1089/thy.2009.0195; Pokrass M, 2012, OPT MATER EXPRESS, V2, P825, DOI 10.1364/OME.2.000825; RAHMAN MM, 2014, SCI WORLD J, DOI DOI 10.1155/2014/; Ritts AC, 2011, POLYMERS-BASEL, V3, P2142, DOI 10.3390/polym3042142; Schlumberger MJ, 1998, NEW ENGL J MED, V338, P297, DOI 10.1056/NEJM199801293380506; Schwartz DL, 2009, INT J RADIAT ONCOL, V74, P1083, DOI 10.1016/j.ijrobp.2008.09.023; Sellitti DF, 1997, THYROID, V7, P641, DOI 10.1089/thy.1997.7.641; Sia MA, 2010, J THROID RES, V2010, DOI 10.4061/2010/183461; Silver CE, 2011, HEAD NECK-J SCI SPEC, V33, P1052, DOI 10.1002/hed.21494; Simard EP, 2012, CA-CANCER J CLIN, V62, P118, DOI 10.3322/caac.20141; Torti SV, 2007, INT J NANOMED, V2, P707; Uchida H, 2013, SURG TODAY, V43, P848, DOI 10.1007/s00595-012-0353-z; Valyasevi RW, 1999, J CLIN ENDOCR METAB, V84, P2557, DOI 10.1210/jc.84.7.2557; VASSART G, 1992, ENDOCR REV, V13, P596, DOI 10.1210/er.13.3.596; Wang L, 2013, PHARM RES-DORDR, V30, P2757, DOI 10.1007/s11095-013-1095-3; Wang SS, 2013, ONCOL LETT, V5, P368, DOI 10.3892/ol.2012.947; Wang ZF, 2011, TUMORI, V97, P540, DOI 10.1700/950.10410; Williams GR, 2011, ANN ENDOCRINOL-PARIS, V72, P68, DOI 10.1016/j.ando.2011.03.006; Wu A, 2013, P NATL ACAD SCI USA, V110, P16103, DOI 10.1073/pnas.1314385110; Yang ST, 2012, THERANOSTICS, V2, P271, DOI 10.7150/thno.3618; Zhu LQ, 2015, GASTROENTEROLOGY RES, P1; 2007, NANOTECHNOLOGY, V18, P9	71	13	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149723	10.1371/journal.pone.0149723	http://dx.doi.org/10.1371/journal.pone.0149723			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901566	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100135
J	Lee, JY; Lim, SH; Lee, MY; Kim, HS; Ahn, JS; Im, YH; Park, YH				Lee, Ji Yun; Lim, Sung Hee; Lee, Min-Young; Kim, Hae Su; Ahn, Jin Seok; Im, Young-Hyuck; Park, Yeon Hee			The Impacts of Inclusion in Clinical Trials on Outcomes among Patients with Metastatic Breast Cancer (MBC)	PLOS ONE			English	Article							RANDOMIZED PHASE-III; DOUBLE-BLIND; POSTMENOPAUSAL WOMEN; AROMATASE INHIBITOR; PROGNOSTIC-FACTORS; MEGESTROL-ACETATE; SURVIVAL; CHEMOTHERAPY; DOCETAXEL; THERAPY	Background Metastatic breast cancer (MBC) remains a devastating and incurable disease. Over the past decade, the implementation of clinical trials both with and without molecular targeted therapeutics has impacted the daily clinical treatment of patients with MBC. In this study, we determine whether including MBC patients in clinical trials affects clinical outcomes. Methods We retrospectively reviewed data for a total of 863 patients diagnosed with initial or recurrent (after receiving adjuvant systemic treatments following surgery) metastatic disease between January 2000 and December 2013. Data were obtained from the breast cancer database of Samsung Medical Center. Results Among the 806 patients selected for inclusion, 188 (23%) had participated in clinical trials. A total of 185 clinical trials were conducted from 2000 to 2014. When compared with earlier periods (n = 10 for 2000-2004), clinical trial enrollment significantly increased over time (n = 103 for 2005-2009, P = 0.024; n = 110 for 2010-2014, P = 0.046). Multivariate analyses revealed that biologic subtype, distant recurrence free interval (DRFI), and clinical trial enrollment were independent predictors of overall survival. Patients who participated in clinical trials showed improved survival, with a hazard ratio of 0.75 (95% CI, 0.59-0.95), which was associated with a 25% reduction in the risk of death. However, subgroup analysis showed that this improved survival benefit was not maintained in patients with triple negative breast cancer (TNBC). Conclusions Although not conclusive, we could speculate that there were differences in the use of newer agents or regimens over time, and these differences appear to be associated with improved survival.	[Lee, Ji Yun; Lim, Sung Hee; Lee, Min-Young; Kim, Hae Su; Ahn, Jin Seok; Im, Young-Hyuck; Park, Yeon Hee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Park, YH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea.	yhparkhmo@skku.edu			Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of Korea [HI14C1234]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1234).	Abe O, 1998, LANCET, V352, P930; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Buzdar A, 1996, J CLIN ONCOL, V14, P2000, DOI 10.1200/JCO.1996.14.7.2000; Cameron D, 2010, ONCOLOGIST, V15, P924, DOI 10.1634/theoncologist.2009-0181; Cheng YC, 2012, BREAST CANCER-TOKYO, V19, P191, DOI 10.1007/s12282-011-0276-3; Chia SK, 2007, CANCER, V110, P973, DOI 10.1002/cncr.22867; Clarke M, 1998, LANCET, V351, P1451; Dabakuyo TS, 2008, ANN ONCOL, V19, P276, DOI 10.1093/annonc/mdm491; Dombernowsky P, 1998, J CLIN ONCOL, V16, P453, DOI 10.1200/JCO.1998.16.2.453; Giordano SH, 2004, CANCER, V100, P44, DOI 10.1002/cncr.11859; Greenberg PAC, 1996, J CLIN ONCOL, V14, P2197, DOI 10.1200/JCO.1996.14.8.2197; Hortobagyi Gabriel N, 2005, Clin Breast Cancer, V6, P391, DOI 10.3816/CBC.2005.n.043; Jassem J, 2001, J CLIN ONCOL, V19, P1707, DOI 10.1200/JCO.2001.19.6.1707; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jones SE, 2005, J CLIN ONCOL, V23, P5542, DOI 10.1200/JCO.2005.02.027; Jung KW, 2013, CANCER RES TREAT, V45, P1, DOI 10.4143/crt.2013.45.1.1; Kaufmann M, 2000, J CLIN ONCOL, V18, P1399, DOI 10.1200/JCO.2000.18.7.1399; Largillier R, 2008, ANN ONCOL, V19, P2012, DOI 10.1093/annonc/mdn424; Manglani HH, 2000, SEMIN ONCOL, V27, P299; Miller KD, 1999, HEMATOL ONCOL CLIN N, V13, P415, DOI 10.1016/S0889-8588(05)70063-0; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; O'Shaughnessy J, 2002, J CLIN ONCOL, V20, P2812, DOI 10.1200/JCO.2002.09.002; Ozer H, 2000, J CLIN ONCOL, V18, P3558, DOI 10.1200/JCO.2000.18.20.3558; Sant M, 2003, INT J CANCER, V106, P416, DOI 10.1002/ijc.11226; Santa-Maria CA, 2015, JAMA ONCOL, V1, P528, DOI 10.1001/jamaoncol.2015.1198; Schaapveld M, 2006, ANN SURG ONCOL, V13, P465, DOI 10.1245/ASO.2006.02.020; Shibuya K, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-37; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Swain SM, 2013, LANCET ONCOL, V14, P461, DOI 10.1016/S1470-2045(13)70130-X; Tevaarwerk AJ, 2013, CANCER-AM CANCER SOC, V119, P1140, DOI 10.1002/cncr.27819; vanOosterom AT, 1995, SEMIN ONCOL, V22, P22; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124	33	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149432	10.1371/journal.pone.0149432	http://dx.doi.org/10.1371/journal.pone.0149432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901062	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100077
J	Levine, SZ; Levav, I; Yoffe, R; Becher, Y; Pugachova, I				Levine, Stephen Z.; Levav, Itzhak; Yoffe, Rinat; Becher, Yifat; Pugachova, Inna			Genocide Exposure and Subsequent Suicide Risk: A Population-Based Study	PLOS ONE			English	Article							HOLOCAUST SURVIVORS; FOLLOW-UP; DISORDERS; CHILD; DEPRESSION; MODERATION; MORTALITY; DIAGNOSIS; SEQUELAE; PARENTS	The association between periods of genocide-related exposures and suicide risk remains unknown. Our study tests that association using a national population-based study design. The source population comprised of all persons born during 1922-1945 in Nazi-occupied or dominated European nations, that immigrated to Israel by 1965, were identified in the Population Register (N = 220,665), and followed up for suicide to 2014, totaling 16,953,602 person-years. The population was disaggregated to compare a trauma gradient among groups that immigrated before (indirect, n = 20,612, 9%); during (partial direct, n = 17,037, 8%); or after (full direct, n = 183,016, 83%) exposure to the Nazi era. Also, the direct exposure groups were examined regarding pre- or post-natal exposure periods. Cox regression models were used to compute Hazard Ratios (HR) of suicide risk to compare the exposure groups, adjusting for confounding by gender, residential SES and history of psychiatric hospitalization. In the total population, only the partial direct exposure subgroup was at greater risk compared to the indirect exposure group (HR = 1.73, 95% CI, 1.10, 2.73; P < .05). That effect replicated in six sensitivity analyses. In addition, sensitivity analyses showed that exposure at ages 13 plus among females, and follow-up by years since immigration were associated with a greater risk; whereas in utero exposure among persons with no psychiatric hospitalization and early postnatal exposure among males were at a reduced risk. Tentative mechanisms impute biopsychosocial vulnerability and natural selection during early critical periods among males, and feelings of guilt and entrapment or defeat among females.	[Levine, Stephen Z.; Levav, Itzhak] Univ Haifa, Fac Social Welf & Hlth Sci, Dept Community Mental Hlth, IL-31999 Haifa, Israel; [Yoffe, Rinat; Becher, Yifat; Pugachova, Inna] Minist Hlth, Dept Informat & Evaluat, Jerusalem, Israel	University of Haifa	Levine, SZ (corresponding author), Univ Haifa, Fac Social Welf & Hlth Sci, Dept Community Mental Hlth, IL-31999 Haifa, Israel.	slevine@univ.haifa.ac.il	Levine, Stephen Z/AAF-8905-2019	Levine, Stephen Z/0000-0002-5544-0420	Claims Conference [14441]; Israel Science Foundation [130/13]	Claims Conference; Israel Science Foundation(Israel Science Foundation)	This study is part of a larger project on the psychiatric aftermath of the Holocaust jointly supported by non-overlapping funds from the Claims Conference and Israel Science Foundation. The URL of the Israel Science Foundation is http://www.isf.org.il/. The URL of the Claims Conference is http://www.claimscon.org/. Through recovering the assets of the victims of the Holocaust, the Claims Conference enables organizations around the world to provide education about the Shoah and to preserve the memory of those who perished (grant no. 14441). Also, this research was supported by the Israel Science Foundation (grant no. 130/13). This work may or may not reflect the views of these funding bodies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; ANTONOVSKY A, 1971, SOC PSYCHIATR, V6, P186, DOI 10.1007/BF00578367; Aragon TJ, 2007, APPL EPIDEMIOLOGY US; Barel E, 2010, PSYCHOL BULL, V136, P677, DOI 10.1037/a0020339; BARKER DJP, 1995, BRIT MED J, V311, P1203, DOI 10.1136/bmj.311.7014.1203; Bauer J., 1992, HIST HOLOCAUST; Bedard PL, 2007, J CLIN ONCOL, V25, P3482, DOI 10.1200/JCO.2007.11.3670; Braun T, 2012, ASSESSMENT SCOPE SUI; BUCHANAN CM, 1992, PSYCHOL BULL, V111, P62, DOI 10.1037/0033-2909.111.1.62; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Central Bureau of Statistics, 1995, DEM CHAR POP LOC STA; Chakrabarti B, 2006, PROG BRAIN RES, V156, P403, DOI 10.1016/S0079-6123(06)56022-4; Collingham Lizzie, 2012, TASTE WAR WORLD WAR; Davidowitz L, 1986, WAR JEWS; DOHRENWEND BP, 1992, SCIENCE, V255, P946, DOI 10.1126/science.1546291; Fridman A, 2012, INT J BEHAV DEV, V36, P79, DOI 10.1177/0165025411406859; Geoffroy MC, 2014, PSYCHOL MED, V44, P1245, DOI 10.1017/S003329171300189X; Haklai Z, 2014, SUICIDE ISRAEL SUICI; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Henikoff S, 1997, TRENDS GENET, V13, P293, DOI 10.1016/S0168-9525(97)01219-5; Huang C, 2013, SOC SCI MED, V97, P259, DOI 10.1016/j.socscimed.2012.09.051; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Keinan-Boker L, 2009, JNCI-J NATL CANCER I, V101, P1489, DOI 10.1093/jnci/djp327; KRAL VA, 1951, AM J PSYCHIAT, V108, P185, DOI 10.1176/ajp.108.3.185; Lemkin Raphael, 1944, AXIS RULE OCCUPIED E; Lester D, 2000, POLISH PSYCHOL B, V33, P21; Lester David, 2004, Arch Suicide Res, V8, P199, DOI 10.1080/13811110490271425; Levav I., 2015, VIOLENCE MENTAL HLTH, P303, DOI [10.1007/978-94-017-8999-8, DOI 10.1007/978-94-017-8999-8]; Levine SZ, PSY MED IN PRESS; Li J, 2003, LANCET, V361, P363, DOI 10.1016/S0140-6736(03)12387-2; LIPSCOMB FM, 1945, LANCET, V249, P313; Lubin G, 2001, SOC PSYCH PSYCH EPID, V36, P123, DOI 10.1007/s001270050300; Lumey LH, 2011, ANNU REV PUBL HEALTH, V32, P237, DOI 10.1146/annurev-publhealth-031210-101230; Mirsky J, 2011, SOC PSYCH PSYCH EPID, V46, P1133, DOI 10.1007/s00127-010-0280-5; Nakash O, 2013, SUICIDE LIFE-THREAT, V43, P290, DOI 10.1111/sltb.12015; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Pat-Horenczyk R, 2013, PEACE CONFL, V19, P125, DOI 10.1037/a0032488; Qin P, 2000, BRIT J PSYCHIAT, V177, P546, DOI 10.1192/bjp.177.6.546; RABINOWITZ J, 1994, COMPR PSYCHIAT, V35, P361, DOI 10.1016/0010-440X(94)90276-3; Rostila M, 2012, J EPIDEMIOL COMMUN H, V66, P927, DOI 10.1136/jech-2011-200339; Sagi-Schwartz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069179; Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754; Tas J, 1951, PSYCHIAT QUART, V25, P679, DOI 10.1007/BF01584313; Taylor PJ, 2011, PSYCHOL BULL, V137, P391, DOI 10.1037/a0022935; Therneau T.M., 2000, MODELING SURVIVAL DA; Torrey EF, 2010, SCHIZOPHRENIA BULL, V36, P26, DOI 10.1093/schbul/sbp097; van der Hal-Van Raalte EAM, 2008, AGING MENT HEALTH, V12, P630, DOI 10.1080/13607860802343134; Van Ijzendoorn MH, 2013, J LOSS TRAUMA, V18, P64, DOI 10.1080/15325024.2012.679132; Weisera M, 2005, COMPR PSYCHIAT, V46, P38, DOI 10.1016/j.comppsych.2004.07.016; World Health Organization, 2014, PREV SUIC PREV SUIC	50	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149524	10.1371/journal.pone.0149524	http://dx.doi.org/10.1371/journal.pone.0149524			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26901411	Green Published, gold			2022-12-27	WOS:000371276100091
J	Motswaledi, MS; Kasvosve, I; Oguntibeju, OO				Motswaledi, Modisa Sekhamo; Kasvosve, Ishmael; Oguntibeju, Oluwafemi Omoniyi			Blood Group Antigens C, Lub and P1 May Have a Role in HIV Infection in Africans	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NEUTROPHIL COUNTS; PLASMODIUM-VIVAX; CHEMOKINES DARC; RECEPTOR; CELLS; SUSCEPTIBILITY; AIDS; HLA; GLYCOPROTEIN	Background Botswana is among the world's countries with the highest rates of HIV infection. It is not known whether or not this susceptibility to infection is due to genetic factors in the population. Accumulating evidence, however, points to the role of erythrocytes as potential mediators of infection. We therefore sought to establish the role, if any, of some erythrocyte antigens in HIV infection in a cross-section of the population. Methods 348 (346 HIV-negative and 2 HIV-positive) samples were obtained from the National Blood Transfusion Service as residual samples, while 194 HIV-positive samples were obtained from the Botswana-Harvard HIV Reference Laboratory. Samples were grouped for twenty three antigens. Chi-square or Fischer Exact analyses were used to compare the frequencies of the antigens in the two groups. A stepwise, binary logistic regression was used to study the interaction of the various antigens in the light of HIV-status. Results The Rh antigens C and E were associated with HIV-negative status, while blood group Jk(a), P-1 and Lu-b were associated with HIV-positive status. A stepwise binary logistic regression analysis yielded group C as the most significant protective blood group while Lu-b and P-1 were associated with significantly higher odds ratio in favor of HIV-infection. The lower-risk-associated group C was significantly lower in Africans compared to published data for Caucasians and might partially explain the difference in susceptibility to HIV-1. Conclusion The most influential antigen C, which also appears to be protective, is significantly lower in Africans than published data for Caucasians or Asians. On the other hand, there appear to be multiple antigens associated with increased risk that may override the protective role of C. A study of the distribution of these antigens in other populations may shed light on their roles in the HIV pandemic.	[Motswaledi, Modisa Sekhamo; Kasvosve, Ishmael] Univ Botswana, Dept Med Lab Sci, Fac Hlth Sci, Gaborone, Botswana; [Motswaledi, Modisa Sekhamo; Oguntibeju, Oluwafemi Omoniyi] Cape Peninsula Univ Technol, Fac Hlth & Wellness Sci, Nutr & Chron Dis Res Grp, Oxidat Stress Res Ctr,Dept Biomed Sci, Cape Town, South Africa	University of Botswana; Cape Peninsula University of Technology	Motswaledi, MS (corresponding author), Univ Botswana, Dept Med Lab Sci, Fac Hlth Sci, Gaborone, Botswana.; Motswaledi, MS (corresponding author), Cape Peninsula Univ Technol, Fac Hlth & Wellness Sci, Nutr & Chron Dis Res Grp, Oxidat Stress Res Ctr,Dept Biomed Sci, Cape Town, South Africa.	modisa.motswaledi@mopipi.ub.bw	Motswaledi, Modisa/AAY-7597-2020; Oguntibeju, Oluwafemi/AAR-2256-2020	Motswaledi, Modisa/0000-0001-8163-7166; Kasvosve, Ishmael/0000-0002-2046-545X	University of Botswana Office of Research and Development [R0649]; Cape Peninsula University of Technology; National Research Foundation (NRF) of South Africa	University of Botswana Office of Research and Development; Cape Peninsula University of Technology; National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa)	This work was funded by University of Botswana Office of Research and Development, Grant no. R0649, to MM (http://www.ub.bw/ord/), and Cape Peninsula University of Technology and National Research Foundation (NRF) of South Africa, to OO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulazeez AA, 2008, BIOMED RES-INDIA, V19, P41; Agency CSOaNAC, 2008, 2008 BOTSW AIDS IMP, P8; ANSTEE DJ, 1993, BAILLIERE CLIN HAEM, V6, P401, DOI 10.1016/S0950-3536(05)80152-0; ARENDRUP M, 1991, AIDS, V5, P441, DOI 10.1097/00002030-199104000-00014; Badjie K, 2015, MOL ANAL DETERMINING; BARNWELL JW, 1989, J EXP MED, V169, P1795, DOI 10.1084/jem.169.5.1795; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bolton MJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-523; Branch DR, 2010, CURR OPIN HEMATOL, V17, P558, DOI 10.1097/MOH.0b013e32833ece31; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; DHAWAN S, 1992, J LEUKOCYTE BIOL, V52, P62, DOI 10.1002/jlb.52.1.62; Egene J., 2004, NIGER J PHYSL SCI, V19, P7; Eyler CE, 2006, TRANSFUSION, V46, P668, DOI 10.1111/j.1537-2995.2006.00779.x; Gomez H, 2007, 2007 BOTSWANA ANC 2; Hadley TJ, 1997, BLOOD, V89, P3077, DOI 10.1182/blood.V89.9.3077; Hammache D, 1999, J VIROL, V73, P5244, DOI 10.1128/JVI.73.6.5244-5248.1999; He WJ, 2008, CELL HOST MICROBE, V4, P52, DOI 10.1016/j.chom.2008.06.002; Hellberg A, 2013, Immunohematology, V29, P25; Hellberg A, 2007, THESIS LUND; Horakova E, 2004, J IMMUNOL, V173, P4236, DOI 10.4049/jimmunol.173.6.4236; Horne KC, 2009, CELL HOST MICROBE, V5, P415, DOI 10.1016/j.chom.2009.04.013; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; *ISO, 2007, 15189 ISO; Keetile M, 2014, SAHARA J-J SOC ASP H, V11, P158, DOI 10.1080/17290376.2014.960948; Lachgar A, 1998, BIOMED PHARMACOTHER, V52, P436, DOI 10.1016/S0753-3322(99)80021-3; Lund N, 2005, AIDS, V19, P1543, DOI 10.1097/01.aids.0000183521.90878.79; Lund N, 2009, BLOOD, V113, P4980, DOI 10.1182/blood-2008-03-143396; Malhotra U, 2001, J CLIN INVEST, V107, P505, DOI 10.1172/JCI11275; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Neil SJ, 2003, A B O BLOOD GROUPS H; Nemer WE, 1998, J BIOL CHEM, V273, P16686, DOI [10.1074/jbc.273.27.16686, DOI 10.1074/JBC.273.27.16686]; Nilsson J, 2009, GLYCOCONJUGATE J, V26, P1171, DOI 10.1007/s10719-009-9237-x; Onsten Tor Gunnar Hugo, 2013, Open AIDS J, V7, P47, DOI 10.2174/1874613601307010047; PARSONS SF, 1995, P NATL ACAD SCI USA, V92, P5496, DOI 10.1073/pnas.92.12.5496; Puri A, 1998, BIOCHEM BIOPH RES CO, V242, P219, DOI 10.1006/bbrc.1997.7941; Puri A, 2004, AIDS, V18, P849, DOI 10.1097/00002030-200404090-00002; Quillent C, 1998, LANCET, V351, P14, DOI 10.1016/S0140-6736(97)09185-X; Ramsuran V, 2011, CLIN INFECT DIS, V52, P1248, DOI 10.1093/cid/cir119; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Sayal S K, 1996, Indian J Dermatol Venereol Leprol, V62, P295; Thobakgale CF, 2014, CURR OPIN HEMATOL, V21, P50, DOI 10.1097/MOH.0000000000000007; Winkler CA, 2009, CELL HOST MICROBE, V5, P411, DOI 10.1016/j.chom.2009.04.010	43	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149883	10.1371/journal.pone.0149883	http://dx.doi.org/10.1371/journal.pone.0149883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900853	Green Published, gold			2022-12-27	WOS:000371276100174
J	Rojo, C; Mesquita-Joanes, F; Monros, JS; Armengol, J; Sasa, M; Bonilla, F; Rueda, R; Benavent-Corail, J; Piculo, R; Segura, MM				Rojo, Carmen; Mesquita-Joanes, Francesc; Monros, Juan S.; Armengol, Javier; Sasa, Mahmood; Bonilla, Fabian; Rueda, Ricardo; Benavent-Corail, Jose; Piculo, Ruben; Matilde Segura, M.			Hydrology Affects Environmental and Spatial Structuring of Microalgal Metacommunities in Tropical Pacific Coast Wetlands	PLOS ONE			English	Article							COMMUNITY COMPOSITION; ECOLOGICAL DATA; DISPERSAL; PHYTOPLANKTON; FRAMEWORK; PATTERNS; RIVER; MICROORGANISMS; SIMILARITY; VARIABLES	The alternating climate between wet and dry periods has important effects on the hydrology and therefore on niche-based processes of water bodies in tropical areas. Additionally, assemblages of microorganism can show spatial patterns, in the form of a distance decay relationship due to their size or life form. We aimed to test spatial and environmental effects, modulated by a seasonal flooding climatic pattern, on the distribution of microalgae in 30 wetlands of a tropical dry forest region: the Pacific coast of Costa Rica and Nicaragua. Three surveys were conducted corresponding to the beginning, the highest peak, and the end of the hydrological year during the wet season, and species abundance and composition of planktonic and benthic microalgae was determined. Variation partitioning analysis (as explained by spatial distance or environmental factors) was applied to each seasonal dataset by means of partial redundancy analysis. Our results show that microalgal assemblages were structured by spatial and environmental factors depending on the hydrological period of the year. At the onset of hydroperiod and during flooding, neutral effects dominated community dynamics, but niche-based local effects resulted in more structured algal communities at the final periods of desiccating water bodies. Results suggest that climate-mediated effects on hydrology can influence the relative role of spatial and environmental factors on metacommunities of microalgae. Such variability needs to be accounted in order to describe accurately community dynamics in tropical coastal wetlands.	[Rojo, Carmen; Mesquita-Joanes, Francesc; Monros, Juan S.; Armengol, Javier; Benavent-Corail, Jose; Piculo, Ruben; Matilde Segura, M.] Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Paterna, Spain; [Rueda, Ricardo] Univ Nacl Autonoma Nicaragua, Fac Ciencia & Tecnol, Dept Biol, Leon, Nicaragua; [Sasa, Mahmood; Bonilla, Fabian] Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica	University of Valencia; Universidad Costa Rica	Rojo, C (corresponding author), Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Paterna, Spain.	carmen.rojo@uv.es	Mesquita-Joanes, Francesc/F-3200-2011; Monros, Juan/AAA-3726-2020; Armengol, Javier/AFX-9563-2022; Rojo, Carmen/L-5358-2014; Armengol, Javier/H-2325-2015; Monros, Juan S/L-9750-2014	Mesquita-Joanes, Francesc/0000-0001-7168-1980; Monros, Juan/0000-0002-0952-2089; Armengol, Javier/0000-0002-0312-0396; Armengol, Javier/0000-0002-0312-0396; Monros, Juan S/0000-0002-0952-2089; Rojo, Carmen/0000-0003-1034-0175; Sasa, Mahmood/0000-0003-0118-5142	Agencia espanola de coperacion y desarrollo [A1024073/09, A/031019/10, C/032994/10, A3/036594/11]; Vicerrectoria de Investigacion Universidad de Costa Rica [741-B1-517]	Agencia espanola de coperacion y desarrollo; Vicerrectoria de Investigacion Universidad de Costa Rica	The authors acknowledge financial support from the Agencia espanola de coperacion y desarrollo (http://www.aecid.es/ES), grants A1024073/09, A/031019/10, C/032994/10, A3/036594/11 received by JSM, CR, JA, FMJ, MS, FB and RR. This study was also funded by the Vicerrectoria de Investigacion Universidad de Costa Rica (http://www.vinv.ucr.ac.cr/); grant 741-B1-517 received by MS and FB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahuhta J, 2013, J BIOGEOGR, V40, P1572, DOI 10.1111/jbi.12089; Anderson MJ, 1999, J STAT COMPUT SIM, V62, P271, DOI 10.1080/00949659908811936; Angeler DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077338; Angeler DG, 2010, ECOL RES, V25, P513, DOI 10.1007/s11284-009-0681-7; [Anonymous], CLIMATE CHANGE 2007; APHA American Public Health Association, 1992, STANDARD METHODS EXA; Astorga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P365, DOI 10.1111/j.1466-8238.2011.00681.x; Beisner BE, 2006, ECOLOGY, V87, P2985, DOI 10.1890/0012-9658(2006)87[2985:TROEAS]2.0.CO;2; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Blanchet FG, 2011, OECOLOGIA, V166, P357, DOI 10.1007/s00442-010-1867-y; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bottin M, 2014, FRESHW SCI, V33, P402, DOI 10.1086/675726; Cisneros LM, 2015, J ANIM ECOL, V84, P373, DOI 10.1111/1365-2656.12299; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; de Emiliani MOG, 1997, HYDROBIOLOGIA, V357, P1; Douglas MM, 2005, MAR FRESHWATER RES, V56, P329, DOI 10.1071/MF04084; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Ellison Aaron M., 2004, Wetlands Ecology and Management, V12, P3, DOI 10.1023/B:WETL.0000016809.95746.b1; ESRI, 2006, ARCGIS 10; Fenchel T, 2004, BIOSCIENCE, V54, P777, DOI 10.1641/0006-3568(2004)054[0777:TUOSSP]2.0.CO;2; Fernandes IM, 2014, ECOGRAPHY, V37, P464, DOI 10.1111/j.1600-0587.2013.00527.x; Flinn KM, 2010, J ECOL, V98, P1292, DOI 10.1111/j.1365-2745.2010.01708.x; Garcia EA, 2015, HYDROBIOLOGIA, V760, P43, DOI 10.1007/s10750-015-2301-6; Gotelli NJ, 2013, ECOSIMR 1 00; Gothe E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072237; Gronroos M, 2013, ECOL EVOL, V3, P4473, DOI 10.1002/ece3.834; Heino J, 2012, OIKOS, V121, P537, DOI 10.1111/j.1600-0706.2011.19715.x; Heino J, 2010, OIKOS, V119, P129, DOI 10.1111/j.1600-0706.2009.17778.x; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Jeppesen E, 2005, RESTORATION AND MANAGEMENT OF TROPICAL EUTROPHIC LAKES, P341; JIMENEZ-RAMON J. A., 1999, WWF CENTROAMERICA, V2, P4; Jones D. L., 2012, FATHOM TOOLBOX MATLA; Junk WJ, 2002, ENVIRON CONSERV, V29, P414, DOI 10.1017/S0376892902000310; Kosten S, 2012, FRESHWATER BIOL, V57, P1191, DOI 10.1111/j.1365-2427.2012.02785.x; Kruk C, 2012, HYDROBIOLOGIA, V698, P191, DOI 10.1007/s10750-012-1072-6; Kruk C, 2009, FRESHWATER BIOL, V54, P2628, DOI 10.1111/j.1365-2427.2009.02274.x; Kundzewicz ZW, 2008, HYDROLOG SCI J, V53, P3, DOI 10.1623/hysj.53.1.3; Landeiro VL, 2012, FRESHWATER BIOL, V57, P1554, DOI 10.1111/j.1365-2427.2012.02816.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Liu J, 2013, J BIOGEOGR, V40, P2238, DOI 10.1111/jbi.12160; Louette G, 2008, FRESHWATER BIOL, V53, P2309, DOI 10.1111/j.1365-2427.2008.02052.x; LUND JWG, 1958, HYDROBIOLOGIA, V11, P143, DOI DOI 10.1007/BF00007865; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Meier S, 2015, HYDROBIOLOGIA, V743, P175, DOI 10.1007/s10750-014-2034-y; MELACK JM, 1979, OECOLOGIA, V44, P1, DOI 10.1007/BF00346388; Melo-Magalhaes E.M., 2011, Brazilian Journal of Aquatic Science and Technology, V15, P95; Mitra S, 2005, CURR SCI INDIA, V88, P25; MORA G., 2012, AMBIENTALES, V43, P29; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Reynolds C. S., 1984, ECOLOGY FRESHWATER P; Rojo C, 2012, BIODIVERS CONSERV, V21, P2453, DOI 10.1007/s10531-012-0307-1; Sasa M, 2015, LIMNETICA, V34, P1; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Soininen J, 2007, ECOSCIENCE, V14, P146, DOI 10.2980/1195-6860(2007)14[146:NNADOP]2.0.CO;2; Soininen J, 2014, GLOBAL ECOL BIOGEOGR, V23, P1264, DOI 10.1111/geb.12204; Soininen J, 2011, LIMNOL OCEANOGR, V56, P508, DOI 10.4319/lo.2011.56.2.0508; Soofi ES, 2000, DECISION SCI, V31, P595, DOI 10.1111/j.1540-5915.2000.tb00936.x; Thomaz SM, 2007, HYDROBIOLOGIA, V579, P1, DOI 10.1007/s10750-006-0285-y; Van der Gucht K, 2007, P NATL ACAD SCI USA, V104, P20404, DOI 10.1073/pnas.0707200104; Vanschoenwinkel B, 2010, J N AM BENTHOL SOC, V29, P1267, DOI 10.1899/09-114.1; Wang HJ, 2014, FRESHWATER BIOL, V59, P1659, DOI 10.1111/fwb.12372; Wetzel CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045071	65	18	20	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149505	10.1371/journal.pone.0149505	http://dx.doi.org/10.1371/journal.pone.0149505			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900916	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100087
J	Zhang, XY; Zhang, T; Pei, J; Liu, YY; Li, XS; Medrano-Gracia, P				Zhang, Xingyu; Zhang, Tao; Pei, Jiao; Liu, Yuanyuan; Li, Xiaosong; Medrano-Gracia, Pau			Time Series Modelling of Syphilis Incidence in China from 2005 to 2012	PLOS ONE			English	Article							NEURAL-NETWORK; EPIDEMIOLOGY; ARIMA; SEASONALITY; RISK	Background The infection rate of syphilis in China has increased dramatically in recent decades, becoming a serious public health concern. Early prediction of syphilis is therefore of great importance for heath planning and management. Methods In this paper, we analyzed surveillance time series data for primary, secondary, tertiary, congenital and latent syphilis in mainland China from 2005 to 2012. Seasonality and long-term trend were explored with decomposition methods. Autoregressive integrated moving average (ARIMA) was used to fit a univariate time series model of syphilis incidence. A separate multi-variable time series for each syphilis type was also tested using an autoregressive integrated moving average model with exogenous variables (ARIMAX). Results The syphilis incidence rates have increased three-fold from 2005 to 2012. All syphilis time series showed strong seasonality and increasing long-term trend. Both ARIMA and ARIMAX models fitted and estimated syphilis incidence well. All univariate time series showed highest goodness-of-fit results with the ARIMA(0,0,1) x(0,1,1) model. Conclusion Time series analysis was an effective tool for modelling the historical and future incidence of syphilis in China. The ARIMAX model showed superior performance than the ARIMA model for the modelling of syphilis incidence. Time series correlations existed between the models for primary, secondary, tertiary, congenital and latent syphilis.	[Zhang, Xingyu; Zhang, Tao; Liu, Yuanyuan; Li, Xiaosong] Sichuan Univ, West China Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Chengdu 610064, Sichuan, Peoples R China; [Zhang, Xingyu; Medrano-Gracia, Pau] Univ Auckland, Dept Anat Radiol, Auckland 1, New Zealand; [Pei, Jiao] Sichuan Canc Hosp & Inst, Dept Sci & Educ, Chengdu, Sichuan, Peoples R China	Sichuan University; University of Auckland	Li, XS (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Chengdu 610064, Sichuan, Peoples R China.	lixiaosong1101@126.com	liu, yuanyuan/GWZ-5838-2022	Zhang, Xingyu/0000-0001-8108-1997; Medrano-Gracia, Pau/0000-0002-6255-4864	National science and technology major special project "Data mining and analysis of the surveillance data of five syndrome pathogen" [2012ZX10004201-006]; China Scholarship Council (CSC)	National science and technology major special project "Data mining and analysis of the surveillance data of five syndrome pathogen"; China Scholarship Council (CSC)(China Scholarship Council)	The research is funded by National science and technology major special project "Data mining and analysis of the surveillance data of five syndrome pathogen (grant no. 2012ZX10004201-006)." Xingyu Zhang was financially supported by China Scholarship Council (CSC) for his doctoral studies.	Abeysinghe T, 1991, J Appl Stat, V18, P275, DOI 10.1080/02664769100000021; Bobak M, 2001, HUM REPROD, V16, P1512, DOI 10.1093/humrep/16.7.1512; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chen ZQ, 2007, LANCET, V369, P132, DOI 10.1016/S0140-6736(07)60074-9; Douglas JM, 2009, JAMA-J AM MED ASSOC, V301, P769, DOI 10.1001/jama.2009.143; Dowell D, 2012, AM J PUBLIC HEALTH, V102, P148, DOI 10.2105/AJPH.2011.300283; Faruk DO, 2010, ENG APPL ARTIF INTEL, V23, P586, DOI 10.1016/j.engappai.2009.09.015; Fong PW, 2003, COMPUT STAT DATA AN, V43, P369, DOI 10.1016/S0167-9473(02)00298-0; Galbraith JW, 1999, J ECONOMETRICS, V93, P25, DOI 10.1016/S0304-4076(98)00097-9; Garnett GP, 1997, SEX TRANSM DIS, V24, P185, DOI 10.1097/00007435-199704000-00002; Genc M, 2000, SEX TRANSM INFECT, V76, P73, DOI 10.1136/sti.76.2.73; Guo Qing, 2010, Disease Surveillance, V25, P410; Hannan E. J., 2009, MULTIPLE TIME SERIES; Ho SL, 2002, COMPUT IND ENG, V42, P371, DOI 10.1016/S0360-8352(02)00036-0; Kass-Hout T, 2010, BIOSURVEILLANCE METH; Kent ME, 2008, ANN PHARMACOTHER, V42, P226, DOI 10.1345/aph.1K086; KOEHLER AB, 1988, J R STAT SOC C-APPL, V37, P187; Lee HS, 2013, PREV VET MED, V110, P190, DOI 10.1016/j.prevetmed.2012.12.003; Li XM, 2007, AIDS EDUC PREV, V19, P396, DOI 10.1521/aeap.2007.19.5.396; Liu A-Y, 2014, GLOBAL J HLTH SCI, V7, pp249; Nobre FF, 2001, STAT MED, V20, P3051, DOI 10.1002/sim.963; Pai PF, 2005, OMEGA-INT J MANAGE S, V33, P497, DOI 10.1016/j.omega.2004.07.024; Rios M, 2000, EUR J EPIDEMIOL, V16, P483, DOI 10.1023/A:1007653329972; Schmid G, 2004, B WORLD HEALTH ORGAN, V82, P402; Stamm LV, 2010, ANTIMICROB AGENTS CH, V54, P583, DOI 10.1128/AAC.01095-09; Tan NX, 2013, J INFECT DIS; TIAO GC, 1981, J AM STAT ASSOC, V76, P802, DOI 10.2307/2287575; Tucker JD, 2011, SEX TRANSM INFECT, V87, pII16, DOI 10.1136/sti.2010.048314; Tucker JD, 2011, CURR OPIN INFECT DIS, V24, P50, DOI 10.1097/QCO.0b013e32834204bf; Tucker JD, 2010, B WORLD HEALTH ORGAN, V88, P452, DOI 10.2471/BLT.09.070326; Tucker JD, 2010, NEW ENGL J MED, V362, P1658, DOI 10.1056/NEJMp0911149; Ture M, 2006, EXPERT SYST APPL, V31, P41, DOI 10.1016/j.eswa.2005.09.002; Wangdi K, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-251; Williams K, INVESTIGATING RISK F; WRIGHT RA, 1978, BRIT J VENER DIS, V54, P433; ZAIDI AA, 1989, STAT MED, V8, P353, DOI 10.1002/sim.4780080316; Zhang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031076; Zhang XY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0088075, 10.1371/journal.pone.0101532]; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063116	39	23	36	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149401	10.1371/journal.pone.0149401	http://dx.doi.org/10.1371/journal.pone.0149401			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26901682	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100070
J	de Jong, DM; Seaver, EC				de Jong, Danielle M.; Seaver, Elaine C.			A Stable Thoracic Hox Code and Epimorphosis Characterize Posterior Regeneration in Capitella teleta	PLOS ONE			English	Article							ENCHYTRAEUS-JAPONENSIS OLIGOCHAETA; ANNELID PLATYNEREIS-DUMERILII; NERVOUS-SYSTEM; POLYCHAETE CHAETOPTERUS; ANTERIOR REGENERATION; EXPRESSION PATTERNS; CAUDAL REGENERATION; LIMB REGENERATION; STEM-CELLS; GENES	Regeneration, the ability to replace lost tissues and body parts following traumatic injury, occurs widely throughout the animal tree of life. Regeneration occurs either by remodeling of pre-existing tissues, through addition of new cells by cell division, or a combination of both. We describe a staging system for posterior regeneration in the annelid, Capitella teleta, and use the C. teleta Hox gene code as markers of regional identity for regenerating tissue along the anterior-posterior axis. Following amputation of different posterior regions of the animal, a blastema forms and by two days, proliferating cells are detected by EdU incorporation, demonstrating that epimorphosis occurs during posterior regeneration of C. teleta. Neurites rapidly extend into the blastema, and gradually become organized into discrete nerves before new ganglia appear approximately seven days after amputation. In situ hybridization shows that seven of the ten Hox genes examined are expressed in the blastema, suggesting roles in patterning the newly forming tissue, although neither spatial nor temporal colinearity was detected. We hypothesized that following amputation, Hox gene expression in pre-existing segments would be re-organized to scale, and the remaining fragment would express the complete suite of Hox genes. Surprisingly, most Hox genes display stable expression patterns in the ganglia of pre-existing tissue following amputation at multiple axial positions, indicating general stability of segmental identity. However, the three Hox genes, CapI-lox4, CapI-lox2 and CapI-Post2, each shift its anterior expression boundary by one segment, and each shift includes a subset of cells in the ganglia. This expression shift depends upon the axial position of the amputation. In C. teleta, thoracic segments exhibit stable positional identity with limited morphallaxis, in contrast with the extensive body remodeling that occurs during regeneration of some other annelids, planarians and acoel flatworms.	[de Jong, Danielle M.; Seaver, Elaine C.] Univ Florida, Whitney Lab Marine Biosci, St Augustine, FL USA	State University System of Florida; University of Florida	Seaver, EC (corresponding author), Univ Florida, Whitney Lab Marine Biosci, St Augustine, FL USA.	seaver@whitney.ufl.edu			National Science Foundation [IOS09-23754]; Hawaii Community Foundation [12ADVC-51348]; Division Of Integrative Organismal Systems [1457102] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Hawaii Community Foundation; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation IOS09-23754 to ECS (http://www.nsf.gov/); Hawaii Community Foundation 12ADVC-51348 to ECS (https://www.hawaiicommunityfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SCS, 2015, MOL BIOL EVOL, V32, P2860, DOI 10.1093/molbev/msv157; Bayascas JR, 1997, DEVELOPMENT, V124, P141; BEAUCHEMIN M, 1994, INT J DEV BIOL, V38, P641; Bely AE, 2006, INTEGR COMP BIOL, V46, P508, DOI 10.1093/icb/icj051; Bely AE, 2014, INT J DEV BIOL, V58, P623, DOI 10.1387/ijdb.140142ab; Bely AE, 2014, INTEGR COMP BIOL, V54, P688, DOI 10.1093/icb/icu109; Bely AE, 2010, TRENDS ECOL EVOL, V25, P161, DOI 10.1016/j.tree.2009.08.005; Ben Khadra Y, 2014, BIOCHEM GENET, V52, P166, DOI 10.1007/s10528-013-9637-2; BERRILL NJ, 1978, J EMBRYOL EXP MORPH, V47, P85; BERRILL NJ, 1952, BIOL REV, V27, P401, DOI 10.1111/j.1469-185X.1952.tb01512.x; BILELLO AA, 1974, ROUX ARCH DEV BIOL, V174, P234, DOI 10.1007/BF00573227; BOILLYMARER Y, 1971, CR ACAD SCI D NAT, V272, P261; Bosch TCG, 2007, DEV BIOL, V303, P421, DOI 10.1016/j.ydbio.2006.12.012; Boyle MJ, 2008, EVOL DEV, V10, P89, DOI 10.1111/j.1525-142X.2007.00216.x; Carlson MRJ, 2001, DEV BIOL, V229, P396, DOI 10.1006/dbio.2000.0104; Christen B, 2003, DEV DYNAM, V226, P349, DOI 10.1002/dvdy.10231; CORNEC JP, 1987, CAN J ZOOL, V65, P403, DOI 10.1139/z87-061; de Rosa R, 2005, EVOL DEV, V7, P574; DREWES CD, 1990, DEV BIOL, V138, P94, DOI 10.1016/0012-1606(90)90179-M; ECKELBARGER KJ, 1987, MAR BIOL, V95, P415, DOI 10.1007/BF00409572; Economides KD, 2003, DEV BIOL, V256, P317, DOI 10.1016/S0012-1606(02)00137-9; Faulkner GH, 1932, J MORPHOL, V53, P23, DOI 10.1002/jmor.1050530103; Fischer A, 2004, BIOESSAYS, V26, P314, DOI 10.1002/bies.10409; Frobius AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004004; Gardiner DM, 1996, INT J DEV BIOL, V40, P797; GARDINER DM, 1995, DEVELOPMENT, V121, P1731; Gazave E, 2013, DEV BIOL, V382, P246, DOI 10.1016/j.ydbio.2013.07.013; Gersch RP, 2005, J ORTHOP RES, V23, P882, DOI 10.1016/j.orthres.2005.02.005; Giani VC, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-10; GOLDING DW, 1967, J EMBRYOL EXP MORPH, V18, P67; GRASSLE JP, 1976, SCIENCE, V192, P567, DOI 10.1126/science.1257794; Hausen H, 2005, HYDROBIOLOGIA, V535, P37, DOI 10.1007/s10750-004-1836-8; HERLANT-MEEWIS HENRIETTE, 1964, ADVANCE MORPHOGENESIS, V4, P155; Hill SD, 2009, ANNELIDS IN MODERN BIOLOGY, P87; Hughes CL, 2004, EVOL DEV, V6, P393, DOI 10.1111/j.1525-142X.2004.04048.x; Hyman LH, 1940, AM NAT, V74, P513, DOI 10.1086/280919; Irvine SQ, 2000, DEV BIOL, V217, P333, DOI 10.1006/dbio.1999.9541; Khan PA, 1999, DEV GENES EVOL, V209, P323, DOI 10.1007/s004270050260; Kumar A, 2012, TRENDS NEUROSCI, V35, P691, DOI 10.1016/j.tins.2012.08.003; Lee JY, 2015, INT J BIOL SCI, V11, P701, DOI 10.7150/ijbs.11431; Licciano M, 2012, INVERTEBR BIOL, V131, P40, DOI 10.1111/j.1744-7410.2012.00257.x; Lybrand ZR, 2012, DEV NEUROBIOL, V72, P1256, DOI 10.1002/dneu.20993; Maloof JN, 1998, DEVELOPMENT, V125, P181; Martinez VG, 2008, J EXP ZOOL PART B, V310B, P520, DOI 10.1002/jez.b.21224; Martinez VG, 2005, MECH DEVELOP, V122, P721, DOI 10.1016/j.mod.2004.12.003; Meyer NP, 2015, FRONT ZOOL, V12, DOI 10.1186/s12983-015-0108-y; Morgan T. H., 1901, REGENERATION, P1; Morgan TH, 1902, ARCH ENTWICKLUNG ORG, V14, P562, DOI 10.1007/BF02188504; Muller MCM, 2004, DEV GROWTH DIFFER, V46, P471; Muller MCM, 2003, ZOOMORPHOLOGY, V122, P95, DOI 10.1007/s00435-003-0073-4; Myohara M, 2004, DEV DYNAM, V231, P349, DOI 10.1002/dvdy.20115; Myohara M, 1999, DEV GROWTH DIFFER, V41, P549; Nogi T, 2001, DEV GROWTH DIFFER, V43, P177; Novikova EL, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-14; Ohgo S, 2010, DEV BIOL, V338, P148, DOI 10.1016/j.ydbio.2009.11.026; Pfeifer K, 2012, DEV GENES EVOL, V222, P165, DOI 10.1007/s00427-012-0402-z; Prokop A, 1998, MECH DEVELOP, V74, P99, DOI 10.1016/S0925-4773(98)00068-9; Randolph H., 1891, Zoologischer Anzeiger, Vxiv, P154; Randolph H., 1892, Journal of Morphology, Vvii, P317; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Seaver EC, 2006, DEV BIOL, V289, P179, DOI 10.1016/j.ydbio.2005.10.025; SIMON HG, 1993, DEVELOPMENT, V117, P1397; SINGER MARCUS, 1952, QUART REV BIOL, V27, P169, DOI 10.1086/398873; Srivastava M, 2014, CURR BIOL, V24, P1107, DOI 10.1016/j.cub.2014.03.042; Stephan-Dubois F., 1954, Bull Biol, V88, P181; Sugio M, 2008, GENE EXPR PATTERNS, V8, P227, DOI 10.1016/j.gep.2007.12.008; Tadokoro R, 2006, CURR BIOL, V16, P1012, DOI 10.1016/j.cub.2006.04.036; Takeo M, 2008, DEV DYNAM, V237, P1284, DOI 10.1002/dvdy.21518; Tanaka EM, 2011, DEV CELL, V21, P172, DOI 10.1016/j.devcel.2011.06.016; Telford MJ, 1998, DEV GENES EVOL, V208, P591, DOI 10.1007/s004270050219; Thummel R, 2007, DEV GENES EVOL, V217, P413, DOI 10.1007/s00427-007-0154-3; Tornini VA, 2014, DEV CELL, V29, P139, DOI 10.1016/j.devcel.2014.04.007; Torok MA, 1998, DEV BIOL, V200, P225, DOI 10.1006/dbio.1998.8956; Varhalmi E, 2008, J MOL NEUROSCI, V36, P166, DOI 10.1007/s12031-008-9125-z; Weidhase M, 2014, J MORPHOL, V275, P1418, DOI 10.1002/jmor.20316; Yoshida-Noro C, 2000, DEV GENES EVOL, V210, P311, DOI 10.1007/s004270050318; Zattara EE, 2013, J EXP ZOOL PART B, V320, P471, DOI 10.1002/jez.b.22523; Zattara EE, 2011, EVOL DEV, V13, P80, DOI 10.1111/j.1525-142X.2010.00458.x	78	24	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149724	10.1371/journal.pone.0149724	http://dx.doi.org/10.1371/journal.pone.0149724			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894631	Green Published, gold, Green Submitted			2022-12-27	WOS:000371223400078
J	Lu, WY; Wang, WM; Wang, SJ; Feng, YH; Liu, KY				Lu, Wenyi; Wang, Weimin; Wang, Shujuan; Feng, Yonghuai; Liu, Kaiyan			Rosiglitazone Promotes Bone Marrow Adipogenesis to Impair Myelopoiesis under Stress	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; HEMATOPOIETIC STEM-CELLS; PPAR-GAMMA; IN-VITRO; PIOGLITAZONE; DIFFERENTIATION; RECOVERY; ADIPOCYTES; INHIBITION; HEMATOCRIT	Objective The therapeutic use of thiazolidinediones (TZDs) causes unwanted hematological side effects, although the underlying mechanisms of these effects are poorly understood. This study tests the hypothesis that rosiglitazone impairs the maintenance and differentiation of hematopoietic stem/progenitor cells, which ultimately leads to hematological abnormalities. Methods Mice were fed a rosiglitazone-supplemented diet or a normal diet for 6 weeks. To induce hematopoietic stress, all mice were injected once with 250 mg/kg 5-fluorouracil (5-Fu) intraperitoneally. Next, hematopoietic recovery, hematopoietic stem/progenitor cells (HSPCs) subsets, and myeloid differentiation after 5-Fu treatment were evaluated. The adipogenesis induced by rosiglitazone was assessed by histopathology and oil red O staining. The effect of adipocytes on HSPCs was studied with an in vitro co-culture system. Results Rosiglitazone significantly enhanced bone marrow adipogenesis and delayed hematopoietic recovery after 5-Fu treatment. Moreover, rosiglitazone inhibited proliferation of a granulocyte/monocyte progenitor (GMP) cell population and granulocyte/macrophage colony-stimulating factor (GM-CSF) colonies, although the proliferation andmobilization of Lin-c-kit+Sca-1+ cells (LSK) was maintained following hematopoietic stress. These effects could be partially reversed by the selective PPAR. antagonist BADGE. Finally, we demonstrated in a co-culture system that differentiated adipocytes actively suppressed the myeloid differentiation of HSPCs. Conclusion Taken together, our results demonstrate that rosiglitazone inhibits myeloid differentiation of HSPCs after stress partially by inducing bone marrow adipogenesis. Targeting the bone marrow microenvironment might be one mechanism by which rosiglitazone impairs stress-induced hematopoiesis.	[Lu, Wenyi; Wang, Weimin; Wang, Shujuan; Feng, Yonghuai; Liu, Kaiyan] Peking Univ, Peoples Hosp, Dept Hematol, Beijing 100871, Peoples R China; [Lu, Wenyi; Wang, Weimin; Wang, Shujuan; Feng, Yonghuai; Liu, Kaiyan] Peking Univ, Inst Hematol, Beijing 100871, Peoples R China; [Lu, Wenyi; Wang, Weimin; Wang, Shujuan; Feng, Yonghuai; Liu, Kaiyan] Beijing Key Lab Hematopoiet Stem Cell Transplanta, Beijing, Peoples R China; [Lu, Wenyi; Liu, Kaiyan] Peking Univ, Collaborat Innovat Ctr Hematol, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Liu, KY (corresponding author), Peking Univ, Peoples Hosp, Dept Hematol, Beijing 100871, Peoples R China.; Liu, KY (corresponding author), Peking Univ, Inst Hematol, Beijing 100871, Peoples R China.; Liu, KY (corresponding author), Beijing Key Lab Hematopoiet Stem Cell Transplanta, Beijing, Peoples R China.; Liu, KY (corresponding author), Peking Univ, Collaborat Innovat Ctr Hematol, Beijing 100871, Peoples R China.	liukaiyan@medmail.com.cn			National Natural Science Foundation of China [81270572]; National Basic Research 973 Program [2013CB733701]; Major Special Project of National Science and Technology "Creation of Major New Drugs" [2012ZX09303019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research 973 Program(National Basic Research Program of China); Major Special Project of National Science and Technology "Creation of Major New Drugs"	The authors were supported by fundings from National Natural Science Foundation of China (grant number 81270572) and National Basic Research 973 Program (grant number 2013CB733701). The authors were also supported by funding from Major Special Project of National Science and Technology "Creation of Major New Drugs" (2012ZX09303019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi P, 2015, CELL J, V17, P15; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Akbiyik F, 2004, BLOOD, V104, P1361, DOI 10.1182/blood-2004-03-0926; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Avagyan S, 2011, BLOOD, V118, P6078, DOI 10.1182/blood-2011-07-365080; Beck GR, 2013, TRANSL RES, V161, P145, DOI 10.1016/j.trsl.2012.08.006; Belaid-Choucair Z, 2008, STEM CELLS, V26, P1556, DOI 10.1634/stemcells.2008-0068; Berria R, 2006, CLIN PHARMACOL THER, V80, P105, DOI 10.1016/j.clpt.2006.03.014; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Campeau PM, 2012, J LIPID RES, V53, P1968, DOI 10.1194/jlr.P025437; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Clevidence Derek E, 2009, WMJ, V108, P462; Djazayeri K, 2005, EUR J PHARMACOL, V522, P122, DOI 10.1016/j.ejphar.2005.08.053; Frascoli M, 2012, JOVE-J VIS EXP, DOI 10.3791/3736; Geresi K, 2012, EUR J PHARMACOL, V696, P172, DOI 10.1016/j.ejphar.2012.09.018; HARRISON DE, 1991, BLOOD, V78, P1237; Karakurt F, 2010, EXP CLIN ENDOCR DIAB, V118, P96, DOI 10.1055/s-0029-1234065; Konopleva M, 2002, CURR OPIN HEMATOL, V9, P294, DOI 10.1097/00062752-200207000-00006; Lazarenko OP, 2007, ENDOCRINOLOGY, V148, P2669, DOI 10.1210/en.2006-1587; Lin KD, 2014, DIABETIC MED, V31, P1341, DOI 10.1111/dme.12481; Miyamoto T, 2013, WORLD J ORTHOP, V4, P198, DOI 10.5312/wjo.v4.i4.198; Nagasawa E, 2005, EXP HEMATOL, V33, P857, DOI 10.1016/j.exphem.2005.05.003; Nagasawa T, 2010, Patent, Patent No. [WO2011030847-A1, 2011030847]; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Patel JJ, 2014, CELL BIOCHEM FUNCT, V32, P368, DOI 10.1002/cbf.3025; Prost S, 2008, J CLIN INVEST, V118, P1765, DOI 10.1172/JCI33037; Rodriguez S, 2009, BLOOD, V114, P4064, DOI 10.1182/blood-2009-04-214916; Rotolin S, 2006, J CELL PHYSIOL, V209, P967, DOI 10.1002/jcp.20804; Sadie-Van Gijsen H, 2013, BONE, V56, P255, DOI 10.1016/j.bone.2013.06.016; Saiki M, 2006, INT J ONCOL, V29, P437; Schlezinger JJ, 2002, J IMMUNOL, V169, P6831, DOI 10.4049/jimmunol.169.12.6831; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sottile V, 2004, CALCIFIED TISSUE INT, V75, P329, DOI 10.1007/s00223-004-0224-8; Spindler TJ, 2014, STEM CELLS DEV, V23, P434, DOI 10.1089/scd.2013.0227; Tang WHW, 2003, J AM COLL CARDIOL, V41, P1394, DOI 10.1016/S0735-1097(03)00159-1; Wang WM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120629; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Zang CB, 2004, LEUKEMIA RES, V28, P387, DOI 10.1016/j.leukres.2003.07.005; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhao M, 2012, BLOOD, V120, P1831, DOI 10.1182/blood-2011-11-393991; Zhu RJ, 2013, INT J HEMATOL, V97, P58, DOI 10.1007/s12185-012-1233-4	41	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149543	10.1371/journal.pone.0149543	http://dx.doi.org/10.1371/journal.pone.0149543			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895498	Green Submitted, Green Published, gold			2022-12-27	WOS:000371223400063
J	Parikh, HA; Bussel, II; Schuman, JS; Brown, EN; Loewen, NA				Parikh, Hardik A.; Bussel, Igor I.; Schuman, Joel S.; Brown, Eric N.; Loewen, Nils A.			Coarsened Exact Matching of Phaco-Trabectome to Trabectome in Phakic Patients: Lack of Additional Pressure Reduction from Phacoemulsification	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE; CATARACT-SURGERY; GLAUCOMA; IMPLANTATION; EYES	Purpose To compare intraocular pressure (IOP) after trabectome-mediated ab interno trabeculectomy surgery in phakic patients (T) and trabectome with same session phacoemulsification (PT) using Coarsened Exact Matching. Although phacoemulsification is associated with IOP reduction when performed on its own, it is not known how much it contributes in PT. Methods Subjects were divided into phakic T and PT. Exclusion criteria were follow-up for <12 months and additional glaucoma surgery. Demographics were compared by the Mann-Whitney U test and chi-squared test for continuous and categorical variables, respectively. Multiple imputation was utilized to avoid eliminating data with missing values. Groups were then matched using Coarsened Exact Matching based on age, race, type of glaucoma, baseline IOP, and number of preoperative glaucoma medications. Univariate linear regression was used to examine IOP reduction after surgery; those variables that were statistically significant were included in the final multivariate regression model. Results A total of 753 cases were included (T: 255, PT: 498). When all variables except for age were kept constant, there was an additional IOP reduction of 0.05+/-0.01 mmHg conferred for every yearly increment in age. Every 1 mmHg increase in baseline IOP correlated to an additional IOP reduction of 0.80+/-0.02 mmHg. Phacoemulsification was not found to be a statistically significant contributor to IOP when comparing T and PT (p >= 0.05). T had a 21% IOP reduction to 15.9+/-3.5 mmHg (p<0.01) while PT had an 18% reduction to 15.5+/-3.6 mmHg (p<0.01). Number of medications decreased (p<0.01) in both groups from 2.4+/-1.2 to 1.9+/-1.3 and from 2.3+/-1.1 to 1.7+/-1.3, respectively. Conclusion Phacoemulsification does not make a significant contribution to postoperative IOP or number of medications when combined with trabectome surgery in phakic patients.	[Parikh, Hardik A.; Bussel, Igor I.; Schuman, Joel S.; Loewen, Nils A.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA; [Parikh, Hardik A.] Rutgers State Univ, Inst Ophthalmol & Visual Sci, Newark, NJ 07102 USA; [Brown, Eric N.] Vanderbilt Univ, Sch Med, Dept Ophthalmol, Nashville, TN 37212 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Rutgers State University Newark; Rutgers State University New Brunswick; Vanderbilt University	Loewen, NA (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA.	loewenna@upmc.edu	Schuman, Joel S/M-2389-2019; Loewen, Nils/E-9946-2014; Brown, Eric N/A-1018-2010; Schuman, Joel S/K-7304-2012	Schuman, Joel S/0000-0002-8885-3766; Loewen, Nils/0000-0001-7167-1213; Brown, Eric N/0000-0002-2641-1890; Schuman, Joel S/0000-0002-8885-3766	Research to Prevent Blindness Departmental Grant; Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship; NATIONAL EYE INSTITUTE [K08EY022737] Funding Source: NIH RePORTER	Research to Prevent Blindness Departmental Grant(Research to Prevent Blindness (RPB)); Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by a Research to Prevent Blindness Departmental Grant; individual grant to the Department of Ophthalmology, University of Pittsburgh; and Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship. The sponsor or funding organization had no role in the design or conduct of this research.	Bussel II, 2015, BRIT J OPHTHALMOL, V99, P914, DOI 10.1136/bjophthalmol-2014-305577; Bussel II, 2015, BRIT J OPHTHALMOL, V99, P258, DOI 10.1136/bjophthalmol-2013-304717; Chandrasekaran S, 2006, OPHTHALMOLOGY, V113, P417, DOI 10.1016/j.ophtha.2005.10.050; Fea AM, 2010, J CATARACT REFR SURG, V36, P407, DOI 10.1016/j.jcrs.2009.10.031; Honaker J, 2011, J STAT SOFTW, V45, P1; Iacus SM, 2012, POLIT ANAL, V20, P1, DOI 10.1093/pan/mpr013; Iordanous Y, 2014, J GLAUCOMA, V23, pE112, DOI 10.1097/IJG.0b013e31829d9bc7; Kaplowitz K, 2014, SURG INNOVATIONS GLA, P175, DOI DOI 10.1007/978-1-4614-8348-9_16; Kaplowitz K, 2014, BRIT J OPHTHALMOL, V98, P579, DOI 10.1136/bjophthalmol-2013-304256; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P653, DOI 10.1001/archopht.116.5.653; Malvankar-Mehta MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131770; Mansberger SL, 2012, OPHTHALMOLOGY, V119, P1826, DOI 10.1016/j.ophtha.2012.02.050; Neiweem A, TRABECTOME SUR UNPUB; Poley BJ, 2009, J CATARACT REFR SURG, V35, P1946, DOI 10.1016/j.jcrs.2009.05.061; R Core Team, 2013, R LANG ENV STAT COMP; ROSENQUIST R, 1989, CURR EYE RES, V8, P1233, DOI 10.3109/02713688909013902; Samuelson TW, 2011, OPHTHALMOLOGY, V118, P459, DOI 10.1016/j.ophtha.2010.07.007; Schuman JS, 1999, INVEST OPHTH VIS SCI, V40, P1676; Shingleton BJ, 2006, J GLAUCOMA, V15, P494, DOI 10.1097/01.ijg.0000212294.31411.92; Slabaugh MA, 2014, J CATARACT REFR SURG, V40, P538, DOI 10.1016/j.jcrs.2013.08.048; Weiner Y, 2015, J CATARACT REFR SURG, V41, P2081, DOI 10.1016/j.jcrs.2015.10.048; Yang HS, 2013, AM J OPHTHALMOL, V156, P89, DOI 10.1016/j.ajo.2013.02.003	22	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149384	10.1371/journal.pone.0149384	http://dx.doi.org/10.1371/journal.pone.0149384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895293	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000371223400050
J	Schottlaender, LV; Bettencourt, C; Kiely, AP; Chalasani, A; Neergheen, V; Holton, JL; Hargreaves, I; Houlden, H				Schottlaender, Lucia V.; Bettencourt, Conceiao; Kiely, Aoife P.; Chalasani, Annapurna; Neergheen, Viruna; Holton, Janice L.; Hargreaves, Iain; Houlden, Henry			Coenzyme Q10 Levels Are Decreased in the Cerebellum of Multiple-System Atrophy Patients	PLOS ONE			English	Article							PARKINSONS-DISEASE; INCREASED RISK; SNCA VARIANTS; Q(10) STATUS; DEFICIENCY; MUTATIONS; TRIAL; COQ2	Background The objective of this study was to evaluate whether the levels of coenzyme Q10 (CoQ10) in brain tissue of multiple system atrophy (MSA) patients differ from those in elderly controls and in patients with other neurodegenerative diseases. Methods Flash frozen brain tissue of a series of 20 pathologically confirmed MSA patients [9 olivopontocerebellar atrophy (OPCA) type, 6 striatonigral degeneration (SND) type, and 5 mixed type] was used for this study. Elderly controls (n = 37) as well as idiopathic Parkinson's disease (n = 7), dementia with Lewy bodies (n = 20), corticobasal degeneration (n = 15) and cerebellar ataxia (n = 18) patients were used as comparison groups. CoQ10 was measured in cerebellar and frontal cortex tissue by high performance liquid chromatography. Results We detected a statistically significant decrease (by 3-5%) in the level of CoQ10 in the cerebellum of MSA cases (P = 0.001), specifically in OPCA (P = 0.001) and mixed cases (P = 0.005), when compared to controls as well as to other neurodegenerative diseases [dementia with Lewy bodies (P<0.001), idiopathic Parkinson's disease (P<0.001), corticobasal degeneration (P<0.001), and cerebellar ataxia (P = 0.001)]. Conclusion Our results suggest that a perturbation in the CoQ10 biosynthetic pathway is associated with the pathogenesis of MSA but the mechanism behind this finding remains to be elucidated.	[Schottlaender, Lucia V.; Bettencourt, Conceiao; Hargreaves, Iain; Houlden, Henry] UCL Inst Neurol, Dept Mol Neurosci, Queen Sq, London, England; [Bettencourt, Conceiao] UCL Inst Neurol, Dept Clin & Expt Epilepsy, Queen Sq, London, England; [Kiely, Aoife P.; Holton, Janice L.] Reta Lila Weston Inst Neurol Studies, London, England; [Kiely, Aoife P.; Holton, Janice L.] Queen Sq Brain Bank, London, England; [Chalasani, Annapurna; Neergheen, Viruna; Hargreaves, Iain] Natl Hosp, Neurometab Unit, Queen Sq, London WC1N 3BG, England; [Houlden, Henry] Natl Hosp Neurol & Neurosurg, Neurogenet Lab, Queen Sq, London WC1N 3BG, England; [Houlden, Henry] UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London	Houlden, H (corresponding author), UCL Inst Neurol, Dept Mol Neurosci, Queen Sq, London, England.; Houlden, H (corresponding author), Natl Hosp Neurol & Neurosurg, Neurogenet Lab, Queen Sq, London WC1N 3BG, England.; Houlden, H (corresponding author), UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London, England.	h.houlden@ucl.ac.uk	Hargreaves, Iain/AAJ-6757-2020; Houlden, Henry J/C-1532-2008; Holton, Janice L/F-6831-2011	Houlden, Henry J/0000-0002-2866-7777; Holton, Janice L/0000-0002-3882-5249; Bettencourt, Conceicao/0000-0001-9090-7690	grant entitled "The role of CoQ2 in multiple system atrophy"; MSA Trust; MSA Coalition; Medical Research Council UK [MR/J004758/1]; Wellcome Trust [WT104033/Z/14/Z, WT093205MA]; National Institute for Health Research University College London Hospitals Biomedical Research Centre; Medical Research Council [G1001253, G108/638, G0802760, MR/J004758/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10082] Funding Source: researchfish; MRC [G1001253, MR/J004758/1, G0802760, G108/638] Funding Source: UKRI	grant entitled "The role of CoQ2 in multiple system atrophy"; MSA Trust; MSA Coalition; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a grant entitled "The role of CoQ2 in multiple system atrophy" - in memory of Elaine Bache, supported by the MSA Trust. The authors are also grateful to the MSA Coalition, the Medical Research Council UK (MR/J004758/1), the Wellcome Trust (WT104033/Z/14/Z and WT093205MA), and the National Institute for Health Research University College London Hospitals Biomedical Research Centre for funding this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2012, NEUROPATH APPL NEURO, V38, P4, DOI 10.1111/j.1365-2990.2011.01234.x; Al-Chalabi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007114; Beal MF, 2014, JAMA NEUROL, V71, P543, DOI 10.1001/jamaneurol.2014.131; Duncan AJ, 2005, CLIN CHEM, V51, P2380, DOI 10.1373/clinchem.2005.054643; Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018; Emmanuele V, 2012, ARCH NEUROL-CHICAGO, V69, P978, DOI 10.1001/archneurol.2012.206; Hargreaves IP, 2008, NEUROSCI LETT, V447, P17, DOI 10.1016/j.neulet.2008.09.069; Jeon BS, 2014, NEW ENGL J MED, V371, P80, DOI 10.1056/NEJMc1311763; Levavasseur F, 2001, J BIOL CHEM, V276, P46160, DOI 10.1074/jbc.M108980200; Mischley LK, 2012, J NEUROL SCI, V318, P72, DOI 10.1016/j.jns.2012.03.023; Mitsui J, 2013, NEW ENGL J MED, V369, P233, DOI 10.1056/NEJMoa1212115; Ozawa T, 2004, BRAIN, V127, P2657, DOI 10.1093/brain/awh303; Parkinson MH, 2013, J NEUROCHEM, V126, P125, DOI 10.1111/jnc.12322; Quinzii CM, 2011, BIOFACTORS, V37, P361, DOI 10.1002/biof.155; Ries V, 2011, J MOL NEUROSCI, V45, P684, DOI 10.1007/s12031-011-9606-3; Ross OA, 2010, ANN NEUROL, V67, P414, DOI 10.1002/ana.21786; Scholz SW, 2009, ANN NEUROL, V65, P610, DOI 10.1002/ana.21685; Segarane B, 2009, NEUROLOGY, V72, P1185, DOI 10.1212/01.wnl.0000345356.40399.eb; Stamelou M, 2015, PARKINSONISM RELAT D, V21, P533, DOI 10.1016/j.parkreldis.2015.03.001; Stamelou M, 2008, MOVEMENT DISORD, V23, P942, DOI 10.1002/mds.22023; Takahashi M, 2008, MECH AGEING DEV, V129, P291, DOI 10.1016/j.mad.2008.01.008; Thomas B, 2010, MOVEMENT DISORD, V25, pS155, DOI 10.1002/mds.22781	22	33	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149557	10.1371/journal.pone.0149557	http://dx.doi.org/10.1371/journal.pone.0149557			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894433	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000371223400065
J	Hanley, QS; Lewis, D; Ribeiro, HV				Hanley, Quentin S.; Lewis, Dan; Ribeiro, Haroldo V.			Rural to Urban Population Density Scaling of Crime and Property Transactions in English and Welsh Parliamentary Constituencies	PLOS ONE			English	Article							POWER-LAW DISTRIBUTIONS; DYNAMICS; GROWTH	Urban population scaling of resource use, creativity metrics, and human behaviors has been widely studied. These studies have not looked in detail at the full range of human environments which represent a continuum from the most rural to heavily urban. We examined monthly police crime reports and property transaction values across all 573 Parliamentary Constituencies in England and Wales, finding that scaling models based on population density provided a far superior framework to traditional population scaling. We found four types of scaling: i) non-urban scaling in which a single power law explained the relationship between the metrics and population density from the most rural to heavily urban environments, ii) accelerated scaling in which high population density was associated with an increase in the power-law exponent, iii) inhibited scaling where the urban environment resulted in a reduction in the power-law exponent but remained positive, and iv) collapsed scaling where transition to the high density environment resulted in a negative scaling exponent. Urban scaling transitions, when observed, took place universally between 10 and 70 people per hectare. This study significantly refines our understanding of urban scaling, making clear that some of what has been previously ascribed to urban environments may simply be the high density portion of non-urban scaling. It also makes clear that some metrics undergo specific transitions in urban environments and these transitions can include negative scaling exponents indicative of collapse. This study gives promise of far more sophisticated scale adjusted metrics and indicates that studies of urban scaling represent a high density subsection of overall scaling relationships which continue into rural environments.	[Hanley, Quentin S.] Nottingham Trent Univ, Sch Sci & Technol, Clifton Lane, Nottingham NG11 8NS, England; [Lewis, Dan] Econ Policy Ctr, UkCrimeStats, London SE1 3GA, England; [Ribeiro, Haroldo V.] Univ Estadual Maringa, Dept Fis, BR-87020900 Maringa, Parana, Brazil	Nottingham Trent University; Universidade Estadual de Maringa	Hanley, QS (corresponding author), Nottingham Trent Univ, Sch Sci & Technol, Clifton Lane, Nottingham NG11 8NS, England.	quentin.hanley@ntu.ac.uk	Hanley, Quentin/N-2253-2019; Ribeiro, Haroldo Valentin/C-8614-2012	Hanley, Quentin/0000-0002-8189-9550; Ribeiro, Haroldo Valentin/0000-0002-9532-5195	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [44650/2014-3]; CNPq [440650/2014-3]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, 44650/2014-3 (www.cnpq.br).; The authors are grateful to the Office of National Statistics and the UK Home Office for making these data publicly available. HVR thanks the financial support of CNPq (grant 440650/2014-3)	Alves LGA, 2014, PHYSICA A, V409, P175, DOI 10.1016/j.physa.2014.04.046; Alves LGA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134862; Alves LGA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069580; Alves LGA, 2013, PHYSICA A, V392, P2672, DOI 10.1016/j.physa.2013.02.002; [Anonymous], 2011, 2011 RURAL URBAN CLA; [Anonymous], 2014, 288 OFF NAT STAT; Arbesman S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016115; Arcaute E, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0745; Bettencourt L., 2013, ARXIV13015919; Bettencourt LMA, 2015, PREPRINT; Bettencourt L, 2010, NATURE, V467, P912, DOI 10.1038/467912a; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Biiby P, 2013, URBAN RURAL AREA DEF; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cabinet Office, 2010, DIAM JUB CIV HON COM; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cottineau C, 2015, ARXIV150707878; Cox W, 2015, DEMOGRAPHIA WORLD UR; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Eisler Z, 2008, ADV PHYS, V57, P89, DOI 10.1080/00018730801893043; Goedhart W, 2015, ARXIV150304795; Gomez-Lievano A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040393; Hanley QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109004; Ignazzi C.A., 2014, ESPACE GEOGRAPHIQUE, V43, P324, DOI [DOI 10.3917/EG.434.0324, 10.3917/eg.434.0324]; Keeling M, 1999, PHILOS T R SOC B, V354, P769, DOI 10.1098/rstb.1999.0429; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Lacoe J, 2015, J RES CRIME DELINQ, V52, P717, DOI 10.1177/0022427815572633; Lobo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058407; Louf R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102007; Mantovani MC, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.024802; Mantovani MC, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/48001; Masucci A.P., 2015, ARXIV150407380; Melo HPM, 2014, SCI REP-UK, V4, DOI 10.1038/srep06239; Oliveira EA, 2014, SCI REP-UK, V4, DOI 10.1038/srep04235; Pan W, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2961; Patrick R., 2012, WRITTEN EVIDENCE SUB; Pumain D, 2006, CYBERGEO, DOI 10.4000/cybergeo.2519; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Richardson A, 2003, DRINKING CRIME DISOR; Rocha LEC, 2015, J URBAN HEALTH, V92, P785, DOI 10.1007/s11524-015-9976-x; Rybski D, 2014, PREPRINT; Samaniego H., 2008, J TRANSP LAND USE, V1, P21, DOI [DOI 10.5198/JTLU.V1I1.29, 10.5198/jtlu.v1i1.29]; Schlapfer M, 2015, ARXIV151200946; United Nations, 2014, WORLD URB PROSP; Youn H, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2015.0937	47	19	19	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149546	10.1371/journal.pone.0149546	http://dx.doi.org/10.1371/journal.pone.0149546			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886219	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000371218400096
J	McAnally, K; Martin, R				McAnally, Ken; Martin, Russell			Modelling Visual Change Detection and Identification under Free Viewing Conditions	PLOS ONE			English	Article							WORKING-MEMORY; CAPACITY	We examined whether the abilities of observers to perform an analogue of a real-world monitoring task involving detection and identification of changes to items in a visual display could be explained better by models based on signal detection theory (SDT) or high threshold theory (HTT). Our study differed from most previous studies in that observers were allowed to inspect the initial display for 3s, simulating the long inspection times typical of natural viewing, and their eye movements were not constrained. For the majority of observers, combined change detection and identification performance was best modelled by a SDT-based process that assumed that memory resources were distributed across all eight items in our displays. Some observers required a parameter to allow for sometimes making random guesses at the identities of changes they had missed. However, the performance of a small proportion of observers was best explained by a HTT-based model that allowed for lapses of attention.	[McAnally, Ken; Martin, Russell] Def Sci & Technol Grp, Aerosp Div, Melbourne, Vic, Australia	Defence Science & Technology	McAnally, K (corresponding author), Def Sci & Technol Grp, Aerosp Div, Melbourne, Vic, Australia.	mcanally@unimelb.edu.au		McAnally, Ken/0000-0003-1787-0750				Anderson DE, 2011, J NEUROSCI, V31, P1128, DOI 10.1523/JNEUROSCI.4125-10.2011; Bays PM, 2008, SCIENCE, V321, P851, DOI 10.1126/science.1158023; Brady TF, 2011, J VISION, V11, DOI 10.1167/11.5.4; Carpenter RH, 1988, MOVEMENT OF THE EYES; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Department of Defence, 2014, MILSTD2525D DEP DEF; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Macmillan NA, 2005, DETECTION THEORY USE; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; NHMRC, 2018, NAT STAT ETH COND HU; PASHLER H, 1988, PERCEPT PSYCHOPHYS, V44, P369, DOI 10.3758/BF03210419; Rouder JN, 2008, P NATL ACAD SCI USA, V105, P5975, DOI 10.1073/pnas.0711295105; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; van den Berg R, 2012, P NATL ACAD SCI USA, V109, P8780, DOI 10.1073/pnas.1117465109; Wilken P, 2004, J VISION, V4, P1120, DOI 10.1167/4.12.11; YONELINAS AP, 1994, J EXP PSYCHOL LEARN, V20, P1341, DOI 10.1037/0278-7393.20.6.1341; Zhang WW, 2008, NATURE, V453, P233, DOI 10.1038/nature06860	18	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149217	10.1371/journal.pone.0149217	http://dx.doi.org/10.1371/journal.pone.0149217			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882348	Green Submitted, Green Published, gold			2022-12-27	WOS:000371219000062
J	Wolmetz, M; Elhilali, M				Wolmetz, Michael; Elhilali, Mounya			Attentional and Contextual Priors in Sound Perception	PLOS ONE			English	Article							HUMAN AUDITORY-CORTEX; INATTENTIONAL BLINDNESS; ORIENTATION PERCEPTION; SELECTIVE ATTENTION; SPATIAL ATTENTION; DYNAMIC EVENTS; FREQUENCY; NOISE; REPRESENTATION; EXPECTATIONS	Behavioral and neural studies of selective attention have consistently demonstrated that explicit attentional cues to particular perceptual features profoundly alter perception and performance. The statistics of the sensory environment can also provide cues about what perceptual features to expect, but the extent to which these more implicit contextual cues impact perception and performance, as well as their relationship to explicit attentional cues, is not well understood. In this study, the explicit cues, or attentional prior probabilities, and the implicit cues, or contextual prior probabilities, associated with different acoustic frequencies in a detection task were simultaneously manipulated. Both attentional and contextual priors had similarly large but independent impacts on sound detectability, with evidence that listeners tracked and used contextual priors for a variety of sound classes (pure tones, harmonic complexes, and vowels). Further analyses showed that listeners updated their contextual priors rapidly and optimally, given the changing acoustic frequency statistics inherent in the paradigm. A Bayesian Observer model accounted for both attentional and contextual adaptations found with listeners. These results bolster the interpretation of perception as Bayesian inference, and suggest that some effects attributed to selective attention may be a special case of contextual prior integration along a feature axis.	[Wolmetz, Michael] Johns Hopkins Univ, Appl Neurosci Sect, Appl Phys Lab, 11100 Johns Hopkins Rd, Laurel, MD 20723 USA; [Elhilali, Mounya] Johns Hopkins Univ, Dept Elect & Comp Engn, 3400 N Charles St,Barton Hall,Rm 105, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Johns Hopkins University	Elhilali, M (corresponding author), Johns Hopkins Univ, Dept Elect & Comp Engn, 3400 N Charles St,Barton Hall,Rm 105, Baltimore, MD 21218 USA.	mounya@jhu.edu	Elhilali, Mounya/A-3396-2010	Elhilali, Mounya/0000-0003-2597-738X	National Science Foundation [IIS-0846112]; National Institutes of Health [1R01AG036424, T32 DC 23-27]; Office of Naval Research [N00014-12-1-0740, N000141010278]; NATIONAL INSTITUTE ON AGING [R01AG036424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R13DC002327] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by National Science Foundation grant IIS-0846112, National Institutes of Health grants 1R01AG036424 and T32 DC 23-27, and Office of Naval Research grants N00014-12-1-0740 and N000141010278. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by National Science Foundation grant IIS-0846112, National Institutes of Health grants 1R01AG036424 and T32 DC 23-27, and Office of Naval Research grants N00014-12-1-0740 and N000141010278. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank research assistants Katherine Simeon and Nicha Apichitsopa for their valuable suggestions and contributions to data collection.	Ahveninen J, 2006, P NATL ACAD SCI USA, V103, P14608, DOI 10.1073/pnas.0510480103; Ahveninen J, 2011, P NATL ACAD SCI USA, V108, P4182, DOI 10.1073/pnas.1016134108; Andersen SK, 2009, J VISION, V9, DOI 10.1167/9.6.2; Baluchi F, 2011, TRENDS NEUROSCI, V34, P210, DOI 10.1016/j.tins.2011.02.003; Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; Bizley JK, 2009, J NEUROSCI, V29, P2064, DOI 10.1523/JNEUROSCI.4755-08.2009; BOTTE MC, 1995, J ACOUST SOC AM, V98, P2475, DOI 10.1121/1.414464; Chalk M, 2010, J VISION, V10, DOI 10.1167/10.8.2; Ciaramitaro VM, 2001, VISION RES, V41, P57, DOI 10.1016/S0042-6989(00)00203-0; Conway CM, 2005, J EXP PSYCHOL LEARN, V31, P24, DOI 10.1037/0278-7393.31.1.24; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; DAI HP, 1991, J ACOUST SOC AM, V89, P2837, DOI 10.1121/1.400721; Dalton P, 2012, COGNITION, V124, P367, DOI 10.1016/j.cognition.2012.05.012; Doherty JR, 2005, J NEUROSCI, V25, P8259, DOI 10.1523/JNEUROSCI.1821-05.2005; Feldman NH, 2009, PSYCHOL REV, V116, P752, DOI 10.1037/a0017196; Girshick AR, 2011, NAT NEUROSCI, V14, P926, DOI 10.1038/nn.2831; GLASBERG BR, 1990, HEARING RES, V47, P103, DOI 10.1016/0378-5955(90)90170-T; Green DM, 1966, SIGNAL DETECTION THE; GREENBERG GZ, 1968, J ACOUST SOC AM, V44, P1513, DOI 10.1121/1.1911290; Griffiths TL, 2006, PSYCHOL SCI, V17, P767, DOI 10.1111/j.1467-9280.2006.01780.x; Guo K, 2004, VISION RES, V44, P2349, DOI 10.1016/j.visres.2004.04.014; Hansen NC, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01052; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Kauramaki J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000909; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Kingdom F, 2009, PALAMEDES MATLAB ROU; Knill DC, 2008, PERCEPTION AS BAYESI; Kover H, 2010, CORTICAL PLASTICITY, V5; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Ma WJ, 2011, NAT NEUROSCI, V14, P783, DOI 10.1038/nn.2814; MONDOR TA, 1994, PERCEPT PSYCHOPHYS, V56, P268, DOI 10.3758/BF03209761; Norris D, 2006, PSYCHOL REV, V113, P327, DOI 10.1037/0033-295X.113.2.327; Nostl A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048569; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; Obleser J, 2004, J COGNITIVE NEUROSCI, V16, P31, DOI 10.1162/089892904322755539; Okamoto H, 2007, J NEUROSCI, V27, P10383, DOI 10.1523/JNEUROSCI.2963-07.2007; Peterson P, 2009, INTRO DECISION THEOR; Poor V., 1994, INTRO SIGNAL DETECTI; Raviv O, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002731; RECANZONE GH, 1993, J NEUROSCI, V13, P87; SCHARF B, 1987, PERCEPT PSYCHOPHYS, V42, P215, DOI 10.3758/BF03203073; Scharf B., 1970, CRITICAL BANDS, V1, P157; SCHLAUCH RS, 1991, J ACOUST SOC AM, V90, P1332, DOI 10.1121/1.401925; Signoret C, 2011, FACILITATED AUDITORY, V2; Simons DJ, 1999, PERCEPTION, V28, P1059, DOI 10.1068/p2952; Simons DJ, 2000, TRENDS COGN SCI, V4, P147, DOI 10.1016/S1364-6613(00)01455-8; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; Summerfield C, 2009, TRENDS COGN SCI, V13, P403, DOI 10.1016/j.tics.2009.06.003; Tan MN, 2008, HEARING RES, V241, P18, DOI 10.1016/j.heares.2008.04.003; TANNER WP, 1958, J ACOUST SOC AM, V30, P919, DOI 10.1121/1.1909406; Turk-Browne NB, 2005, J EXP PSYCHOL GEN, V134, P552, DOI 10.1037/0096-3445.134.4.552; Walker KMM, 2011, J NEUROSCI, V31, P14565, DOI 10.1523/JNEUROSCI.2074-11.2011; WARREN RM, 1970, SCIENCE, V167, P392, DOI 10.1126/science.167.3917.392; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601; Whiteley L, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00100; Wright BA, 2005, J ACOUST SOC AM, V117, P1299, DOI 10.1121/1.1855771; Yaron A, 2012, NEURON, V76, P603, DOI 10.1016/j.neuron.2012.08.025	57	2	2	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149635	10.1371/journal.pone.0149635	http://dx.doi.org/10.1371/journal.pone.0149635			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3BP	26882228	Green Submitted, Green Published, gold			2022-12-27	WOS:000371219000082
J	Pinto-Sarmento, TCD; Abreu, MH; Gomes, MC; Costa, EMMD; Martins, CC; Granville-Garcia, AF; Paiva, SM				de Almeida Pinto-Sarmento, Tassia Cristina; Abreu, Mauro Henrique; Gomes, Monalisa Cesarino; Melo de Brito Costa, Edja Maria; Martins, Carolina Castro; Granville-Garcia, Ana Flavia; Paiva, Saul Martins			Determinant Factors of Untreated Dental Caries and Lesion Activity in Preschool Children Using ICDAS	PLOS ONE			English	Article							ASSESSMENT SYSTEM ICDAS; EARLY-CHILDHOOD CARIES; QUALITY-OF-LIFE; SOCIOBEHAVIORAL FACTORS; FEEDING PRACTICES; PREVALENCE; RISK; COMPARABILITY; ASSOCIATION; EXPERIENCE	The aim of the present study was to investigate determinant factors associated with the presence of dental caries and lesion activity in preschool children. A population-based, cross-sectional study was carried out with 843 children of aged three to five years enrolled at public and private preschools in the city of Campina Grande, Brazil. A questionnaire addressing socio-demographic data and oral health care was self-administered by parents/caregivers. Three dentists previously calibrated examined the children for the diagnosis of dental caries and lesion activity using the International Caries Detection and Assessment System (ICDAS). Nutritional status was evaluated based on the body mass index. Logistic regression analysis for complex samples was performed (alpha = 5%). The prevalence of dental caries was 66.3%. Among the children with caries, 88.0% had active lesions. Dental caries was more prevalent in girls (OR = 1.53, 95% CI: 1.05-2.23), in children from families with a monthly household income <= US$312.50 (OR = 2.38, 95% CI: 1.65-3.43) and those whose mothers had up to eight years of schooling (OR = 1.55, 95% CI: 1.07-2.23). Lesion activity was significantly associated with mother's schooling <= 8 years (OR = 2.15, 95% CI: 1.154.00). The prevalence rates of dental caries and lesion activity were high and mainly associated with a lower socioeconomic status and mother's schooling.	[de Almeida Pinto-Sarmento, Tassia Cristina; Gomes, Monalisa Cesarino; Melo de Brito Costa, Edja Maria; Granville-Garcia, Ana Flavia] State Univ Paraiba, Dept Dent, Campina Grande, Paraiba, Brazil; [Abreu, Mauro Henrique] Univ Fed Minas Gerais, Dept Publ Hlth, Belo Horizonte, MG, Brazil; [Martins, Carolina Castro; Paiva, Saul Martins] Univ Fed Minas Gerais, Dept Paediat Dent & Orthodont, Belo Horizonte, MG, Brazil	Universidade Estadual da Paraiba; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Granville-Garcia, AF (corresponding author), State Univ Paraiba, Dept Dent, Campina Grande, Paraiba, Brazil.	anaflaviagg@hotmail.com	Granville-Garcia, Ana Flávia/Q-9297-2019; Martins, Carolina/AFD-8433-2022; Martins, Carolina Castro/O-2514-2014; Granville-Garcia, Ana F/L-6980-2013; Paiva, Saul Martins/H-5757-2012; Abreu, Mauro Henrique/G-6502-2012; Maria Melo de Brito Costa, Edja/GVT-9390-2022	Martins, Carolina/0000-0001-9072-3226; Martins, Carolina Castro/0000-0001-9072-3226; Granville-Garcia, Ana F/0000-0002-6054-8372; Paiva, Saul Martins/0000-0002-3968-1638; Abreu, Mauro Henrique/0000-0001-8794-5725; Maria Melo de Brito Costa, Edja/0000-0002-3166-709X	State University of Paraiba; Brazilian Coordination of Higher Education; Ministry of Education (CAPES); Research Foundation of the State of Minas Gerais (FAPEMIG); National Council for Scientific and Technological Development (CNPQ), Brazil [471-790.2011/7]	State University of Paraiba; Brazilian Coordination of Higher Education; Ministry of Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Research Foundation of the State of Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); National Council for Scientific and Technological Development (CNPQ), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the State University of Paraiba, the Brazilian Coordination of Higher Education, Ministry of Education (CAPES), the Research Foundation of the State of Minas Gerais (FAPEMIG) and the National Council for Scientific and Technological Development (CNPQ), Brazil)-471-790.2011/7.	Agarwal V, 2011, INT J PAEDIATR DENT, V21, P382, DOI 10.1111/j.1365-263X.2011.01141.x; Agustsdottir H, 2010, COMMUNITY DENT ORAL, V38, P299, DOI 10.1111/j.1600-0528.2010.00538.x; Altman DG, 2006, PRACTICAL STAT MED R; Borges HC, 2012, BRAZ ORAL RES, V26, P564, DOI 10.1590/S1806-83242012000600013; Braga MM, 2009, CARIES RES, V43, P245, DOI 10.1159/000217855; Braga MM, 2010, COMMUNITY DENT ORAL, V38, P549, DOI 10.1111/j.1600-0528.2010.00567.x; Browner WS, 2007, DESIGNING CLIN RES, P65; Cadavid Alexandra Saldarriaga, 2010, Braz. oral res., V24, P211, DOI 10.1590/S1806-83242010000200014; Celeste RK, 2009, SOC SCI MED, V69, P1468, DOI 10.1016/j.socscimed.2009.08.005; Chankanka O, 2015, J PUBLIC HEALTH DENT, V75, P265, DOI 10.1111/j.1752-7325.2012.00376.x; Clementino MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130602; Cohen J., 1998, STAT POWER ANAL BEHA; Cook SL, 2008, INT J PAEDIATR DENT, V18, P275, DOI 10.1111/j.1365-263X.2007.00889.x; Diniz MB, 2009, COMMUNITY DENT ORAL, V37, P399, DOI 10.1111/j.1600-0528.2009.00487.x; Feldens CA, 2012, EUR ARCH PAEDIATR DE, V13, P70, DOI 10.1007/BF03262847; Feldens CA, 2010, CARIES RES, V44, P445, DOI 10.1159/000319898; Guido JA, 2011, INT J PAEDIATR DENT, V21, P432, DOI 10.1111/j.1365-263X.2011.01146.x; Hayden C, 2013, COMMUNITY DENT ORAL, V41, P289, DOI 10.1111/cdoe.12014; Honkala E, 2011, INT J DENT, V2011, DOI 10.1155/2011/150424; Instituto Brasileiro de Geografia e Estatistic, 1 RES 2010 CENS; Ismail AI, 2007, COMMUNITY DENT ORAL, V35, P170, DOI 10.1111/j.1600-0528.2007.00347.x; Kidd E, 2011, J DENT, V39, pS3, DOI 10.1016/j.jdent.2011.11.004; Kramer PF, 2008, CAD SAUDE PUBLICA, V24, P150, DOI 10.1590/S0102-311X2008000100015; Lukacs JR, 2006, AM J HUM BIOL, V18, P540, DOI 10.1002/ajhb.20530; Mendes FM, 2010, COMMUNITY DENT ORAL, V38, P398, DOI 10.1111/j.1600-0528.2010.00557.x; Naidu R, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-30; Nishimura M, 2008, J AM DENT ASSOC, V139, P63, DOI 10.14219/jada.archive.2008.0022; Nyvad B, 2003, J DENT RES, V82, P117, DOI 10.1177/154405910308200208; Piovesan C, 2010, J PUBLIC HEALTH DENT, V70, P319, DOI 10.1111/j.1752-7325.2010.00191.x; Pitts NB, 2009, MONOGR ORAL SCI, V21, P1, DOI 10.1159/000224208; Ramos-Jorge J, 2014, COMMUNITY DENT ORAL, V42, P311, DOI 10.1111/cdoe.12086; Sarumathi T, 2013, J CLIN DIAGN RES, V7, P1789, DOI 10.7860/JCDR/2013/6201.3277; Scarpelli AC, 2013, COMMUNITY DENT ORAL, V41, P336, DOI 10.1111/cdoe.12022; Stromberg U, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-9; Thitasomakul S, 2006, COMMUNITY DENT ORAL, V34, P429, DOI 10.1111/j.1600-0528.2006.00292.x; Wagner Y, 2014, COMMUNITY DENT ORAL, V42, P160, DOI 10.1111/cdoe.12072; Wellappuli N, 2012, CARIES RES, V46, P208, DOI 10.1159/000337399; World Health Organization, 2012, ANTHROPLUS PERS COMP	39	30	34	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0150116	10.1371/journal.pone.0150116	http://dx.doi.org/10.1371/journal.pone.0150116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900846	gold, Green Published, Green Submitted			2022-12-27	WOS:000371276100207
J	Engell, A; Junghofer, M; Stein, A; Lau, P; Wunderlich, R; Wollbrink, A; Pantev, C				Engell, Alva; Junghoefer, Markus; Stein, Alwina; Lau, Pia; Wunderlich, Robert; Wollbrink, Andreas; Pantev, Christo			Modulatory Effects of Attention on Lateral Inhibition in the Human Auditory Cortex	PLOS ONE			English	Article							SELECTIVE ATTENTION; TINNITUS; NOISE; PLASTICITY; SYSTEM; FIELDS; SOUNDS; SIGNAL	Reduced neural processing of a tone is observed when it is presented after a sound whose spectral range closely frames the frequency of the tone. This observation might be explained by the mechanism of lateral inhibition (LI) due to inhibitory interneurons in the auditory system. So far, several characteristics of bottom up influences on LI have been identified, while the influence of top-down processes such as directed attention on LI has not been investigated. Hence, the study at hand aims at investigating the modulatory effects of focused attention on LI in the human auditory cortex. In the magnetoencephalograph, we present two types of masking sounds (white noise vs. withe noise passing through a notch filter centered at a specific frequency), followed by a test tone with a frequency corresponding to the center-frequency of the notch filter. Simultaneously, subjects were presented with visual input on a screen. To modulate the focus of attention, subjects were instructed to concentrate either on the auditory input or the visual stimuli. More specific, on one half of the trials, subjects were instructed to detect small deviations in loudness in the masking sounds while on the other half of the trials subjects were asked to detect target stimuli on the screen. The results revealed a reduction in neural activation due to LI, which was larger during auditory compared to visual focused attention. Attentional modulations of LI were observed in two post-N1m time intervals. These findings underline the robustness of reduced neural activation due to LI in the auditory cortex and point towards the important role of attention on the modulation of this mechanism in more evaluative processing stages.	[Engell, Alva; Junghoefer, Markus; Lau, Pia; Wollbrink, Andreas; Pantev, Christo] Univ Hosp Muenster, Inst Biomagnetism & Biosignalanal, Munster, Germany; [Stein, Alwina] Univ Munster, Inst Med Psychol & Syst Neurosci, Munster, Germany; [Wunderlich, Robert] Univ Bielefeld, Inst Physiol Psychol, D-33615 Bielefeld, Germany	University of Munster; University of Munster; University of Bielefeld	Pantev, C (corresponding author), Univ Hosp Muenster, Inst Biomagnetism & Biosignalanal, Munster, Germany.	pantev@uni-muenster.de	Junghoefer, Markus/AAA-2892-2021	Junghoefer, Markus/0000-0002-8532-2986	Deutsche Forschungsgemeinschaft [PA 392/14-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was supported by the Deutsche Forschungsgemeinschaft http://www.dfg.de (PA 392/14-1). The funding was received by CP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahveninen J, 2011, P NATL ACAD SCI USA, V108, P4182, DOI 10.1073/pnas.1016134108; ARTHUR DL, 1991, ELECTROEN CLIN NEURO, V78, P348, DOI 10.1016/0013-4694(91)90097-N; Brockelmann AK, 2011, J NEUROSCI, V31, P7801, DOI 10.1523/JNEUROSCI.6236-10.2011; BURROWS DL, 1990, J ACOUST SOC AM, V88, P180, DOI 10.1121/1.399938; Crowley KE, 2004, CLIN NEUROPHYSIOL, V115, P732, DOI 10.1016/j.clinph.2003.11.021; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Fujiki N, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-03-j0003.2002; Green D., 1966, SOCIETY, V1, P521, DOI [10.1901/jeab.1969.12-475, DOI 10.1901/JEAB.1969.12-475]; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; Jaaskelainen IP, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/216731; Junghofer M, 2000, PSYCHOPHYSIOLOGY, V37, P523, DOI 10.1111/1469-8986.3740523; Kauramaki J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000909; Kauramaki J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046872; Lagemann L, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-156; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Moore AK, 2013, J NEUROSCI, V33, P13713, DOI 10.1523/JNEUROSCI.0663-13.2013; Okamoto H, 2005, EUR J NEUROSCI, V21, P1957, DOI 10.1111/j.1460-9568.2005.04022.x; Okamoto H, 2004, HEARING RES, V196, P77, DOI 10.1016/j.heares.2004.04.017; Okamoto H, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-33; Okamoto H, 2007, J NEUROSCI, V27, P10383, DOI 10.1523/JNEUROSCI.2963-07.2007; Okamoto H, 2011, J COGNITIVE NEUROSCI, V23, P1855, DOI 10.1162/jocn.2010.21521; Okamoto H, 2010, P NATL ACAD SCI USA, V107, P1207, DOI 10.1073/pnas.0911268107; Pantev C, 2004, EUR J NEUROSCI, V19, P2337, DOI 10.1111/j.0953-816X.2004.03296.x; Pantev C, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00050; Pantev C, 2012, ANN NY ACAD SCI, V1252, P253, DOI 10.1111/j.1749-6632.2012.06452.x; Pape J, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/516163; Peyk P, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/861705; RHODE WS, 1994, J NEUROPHYSIOL, V71, P493, DOI 10.1152/jn.1994.71.2.493; Rif J., 1991, CLIN NEUROPHYSIOL, V79, P464, DOI [10.1016/0013-4694(91)90166-2, DOI 10.1016/0013-4694(91)90166-2]; Stein A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126494; Stein A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080899; Stracke H, 2009, CEREB CORTEX, V19, P1440, DOI 10.1093/cercor/bhn183; SUGA N, 1995, NEUROSCI RES, V21, P287, DOI 10.1016/0168-0102(94)00868-G; Sutter ML, 1999, J NEUROPHYSIOL, V82, P2358, DOI 10.1152/jn.1999.82.5.2358; Tong YX, 2009, BRAIN RES, V1297, P80, DOI 10.1016/j.brainres.2009.07.089; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722	37	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149933	10.1371/journal.pone.0149933	http://dx.doi.org/10.1371/journal.pone.0149933			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901149	Green Submitted, gold, Green Published			2022-12-27	WOS:000371276100188
J	Gao, J; Ji, JS; Ding, XM; Ke, S; Xin, ZH; Ning, CM; Guo, SG; Li, XL; Dong, YH; Sun, WB				Gao, Jun; Ji, Jian-Song; Ding, Xue-Mei; Ke, Shan; Xin, Zong-Hai; Ning, Chun-Min; Guo, Shi-Gang; Li, Xiao-Long; Dong, Yong-Hong; Sun, Wen-Bing			Laparoscopic Radiofrequency Ablation for Large Subcapsular Hepatic Hemangiomas: Technical and Clinical Outcomes	PLOS ONE			English	Article							COMPLICATIONS; EXPERIENCE; TUMORS; CM	Objectives The aim of this study was to evaluate the technical and clinical outcomes of using laparoscopic radiofrequency (RF) ablation for treating large subcapsular hepatic hemangiomas. Methods We retrospectively reviewed our sequential experience of treating 124 large subcapsular hepatic hemangiomas in 121 patients with laparoscopic RF ablation. Results The mean diameter of the 124 hemangiomas was 9.1 +/- 3.2 cm (5.0-16.0 cm). RF ablation was performed successfully in all patients. There were 55 complications related to the ablation in 26 patients, including 5 of 69 (7.3%) patients with hemangioma <10 cm and 21 of 52 (40.4%) patients with hemangiomas >= 10 cm (P < 0.001). No injuries to abdominal viscera occurred in all the 121 patients. According to the Dindo-Clavien classification, all the complications were minor in 26 patients (Grade I). Out of 124 hepatic hemangiomas, 118 (95.2%) were completely ablated, including 70 of 72 (97.2%) lesions <10 cm and 48 of 52 (92.3%) lesions >= 10 cm (P = 0.236). Conclusion Laparoscopic RF ablation therapy is a safe, feasible and effective procedure for large subcapsular hepatic hemangiomas, even in the hepatic hemangiomas >= 10 cm. Its use avoids thermal injury to the abdominal viscera.	[Gao, Jun; Ding, Xue-Mei; Ke, Shan; Sun, Wen-Bing] Capital Med Univ, Dept Hepatobiliary Surg, Beijing Chao Yang Hosp, 5 Jingyuan St, Beijing 100043, Peoples R China; [Ji, Jian-Song] Wenzhou Med Coll, Affiliated Hosp 5, Lishui Cent Hosp, Dept Radiol, Wenzhou 32300, Zhejiang, Peoples R China; [Xin, Zong-Hai] Zhanhua Peoples Hosp, Dept Gen Surg, Zhanhua 256800, Shandong, Peoples R China; [Ning, Chun-Min; Guo, Shi-Gang] Chaoyang Cent Hosp, Dept Gen Surg, Liaoning 122000, Peoples R China; [Li, Xiao-Long] Chifeng Univ, Dept Gen Surg, Affiliated Hosp, Neimenggu 024000, Peoples R China; [Dong, Yong-Hong] Shanxi Prov Peoples Hosp, Dept Gen Surg, Yuncheng 032200, Shanxi, Peoples R China	Capital Medical University; Wenzhou Medical University; Chifeng University; Shanxi People's Hospital	Sun, WB (corresponding author), Capital Med Univ, Dept Hepatobiliary Surg, Beijing Chao Yang Hosp, 5 Jingyuan St, Beijing 100043, Peoples R China.	cyhswb@gq.com	Ji, Jiansong/AAG-9958-2020		Dr. Jieping Wu Medical Foundation [320675007131, 32067501207]; Clinical-Basic Medicine Cooperation Fund of Capital Medical University [1300171711]; Program for Medical Key Discipline of Shijingshan District [20130001]	Dr. Jieping Wu Medical Foundation; Clinical-Basic Medicine Cooperation Fund of Capital Medical University; Program for Medical Key Discipline of Shijingshan District	This study was supported by grants 320675007131 and 32067501207 from the Dr. Jieping Wu Medical Foundation, Clinical-Basic Medicine Cooperation Fund of Capital Medical University (1300171711), and the Program for Medical Key Discipline of Shijingshan District (20130001).	Bai DS, 2015, SURG ENDOSC, V29, P3414, DOI 10.1007/s00464-014-4048-y; Beatty JS, 2013, AM SURGEON, V79, pE314; Cillo U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057249; de la Serna S, 2015, HPB, V17, P387, DOI 10.1111/hpb.12379; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Fan RF, 2006, SURG ENDOSC, V20, P281, DOI 10.1007/s00464-005-0184-8; Fonseca AZ, 2014, WORLD J HEPATOL, V6, P107, DOI 10.4254/wjh.v6.i3.107; Gadiyaram S, 2012, J MINIM ACCESS SURG, V8, P59, DOI 10.4103/0972-9941.95540; Gao J, 2015, WORLD J GASTROENTERO, V21, P5941, DOI 10.3748/wjg.v21.i19.5941; Gao J, 2015, WORLD J GASTROENTERO, V21, P5287, DOI 10.3748/wjg.v21.i17.5287; Gao J, 2014, J CLIN GASTROENTEROL, V48, P540, DOI 10.1097/MCG.0b013e31829ef037; Gao J, 2013, SURGERY, V153, P78, DOI 10.1016/j.surg.2012.06.004; Giavroglou C, 2003, CARDIOVASC INTER RAD, V26, P92, DOI 10.1007/s00270-002-2648-8; Hasan HY, 2014, JAMA SURG, V149, P1266, DOI 10.1001/jamasurg.2014.477; Herbold T, 2013, LANGENBECK ARCH SURG, V398, P47, DOI 10.1007/s00423-012-1018-5; Hocquelet A, 2015, ANN SURG; Kim In Sung, 2014, Korean J Hepatobiliary Pancreat Surg, V18, P118, DOI 10.14701/kjhbps.2014.18.4.118; Kim JE, 2013, KOREAN J RADIOL, V14, P743, DOI 10.3348/kjr.2013.14.5.743; Livraghi T, 2003, RADIOLOGY, V226, P441, DOI 10.1148/radiol.2262012198; Miura JT, 2014, HPB, V16, P924, DOI 10.1111/hpb.12291; Park SY, 2011, J HEPATOL, V54, P559, DOI 10.1016/j.jhep.2010.07.024; Schnelldorfer T, 2010, J AM COLL SURGEONS, V211, P724, DOI 10.1016/j.jamcollsurg.2010.08.006; van Tilborg AA, 2013, CLIN RADIOL, V68, pE9, DOI 10.1016/j.crad.2012.08.029; Zhang W, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001420; Zhang XW, 2016, SURG ENDOSC, V30, P756, DOI 10.1007/s00464-015-4274-y	25	20	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149755	10.1371/journal.pone.0149755	http://dx.doi.org/10.1371/journal.pone.0149755			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901132	gold, Green Published, Green Submitted			2022-12-27	WOS:000371276100144
J	La-Touche, S; Lemetre, C; Lambros, M; Stankiewicz, E; Ng, CKY; Weigelt, B; Rajab, R; Tinwell, B; Corbishley, C; Watkin, N; Berney, D; Reis-Filho, JS				La-Touche, Susannah; Lemetre, Christophe; Lambros, Maryou; Stankiewicz, Elzbieta; Ng, Charlotte K. Y.; Weigelt, Britta; Rajab, Ramzi; Tinwell, Brendan; Corbishley, Cathy; Watkin, Nick; Berney, Dan; Reis-Filho, Jorge S.			DNA Copy Number Aberrations, and Human Papillomavirus Status in Penile Carcinoma. Clinico-Pathological Correlations and Potential Driver Genes	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; COMPARATIVE GENOMIC HYBRIDIZATION; LYMPH-NODE METASTASIS; HPV INFECTION; DUCTAL CARCINOMAS; CANCER; BREAST; P53; ACTIVATION; EXPRESSION	Penile squamous cell carcinoma is a rare disease, in which somatic genetic aberrations have yet to be characterized. We hypothesized that gene copy aberrations might correlate with human papillomavirus status and clinico-pathological features. We sought to determine the spectrum of gene copy number aberrations in a large series of PSCCs and to define their correlations with human papillomavirus, histopathological subtype, and tumor grade, stage and lymph node status. Seventy formalin-fixed, paraffin embedded penile squamous cell carcinomas were centrally reviewed by expert uropathologists. DNA was extracted from micro-dissected samples, subjected to PCR-based human papillomavirus assessment and genotyping (INNO-LiPA human papillomavirus Genotyping Extra Assay) and microarray-based comparative genomic hybridization using a 32K Bacterial Artificial Chromosome array platform. Sixty-four samples yielded interpretable results. Recurrent gains were observed in chromosomes 1p13.3-q44 (88%), 3p12.3-q29 (86%), 5p15.33-p11 (67%) and 8p12-q24.3 (84%). Amplifications of 5p15.33-p11 and 11p14.1-p12 were found in seven (11%) and four (6%) cases, respectively. Losses were observed in chromosomes 2q33-q37.3 (86%), 3p26.3-q11.1 (83%) and 11q12.2-q25 (81%). Although many losses and gains were similar throughout the cohort, there were small significant differences observed at specific loci, between human papillomavirus positive and negative tumors, between tumor types, and tumor grade and nodal status. These results demonstrate that despite the diversity of genetic aberrations in penile squamous cell carcinomas, there are significant correlations between the clinico-pathological data and the genetic changes that may play a role in disease natural history and progression and highlight potential driver genes, which may feature in molecular pathways for existing therapeutic agents.	[La-Touche, Susannah; Stankiewicz, Elzbieta; Berney, Dan] Queen Mary Univ London, Ctr Mol Oncol, Barts Canc Inst, John Vane Sci Ctr, Charterhouse Sq, London, England; [Lemetre, Christophe; Ng, Charlotte K. Y.; Weigelt, Britta; Reis-Filho, Jorge S.] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Lambros, Maryou] Inst Canc Res, Mol Pathol, London SW3 6JB, England; [Rajab, Ramzi; Tinwell, Brendan; Corbishley, Cathy; Watkin, Nick] St George Hosp, London, England; [Reis-Filho, Jorge S.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA	University of London; Queen Mary University London; Memorial Sloan Kettering Cancer Center; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; St Georges University London; Memorial Sloan Kettering Cancer Center	La-Touche, S (corresponding author), Queen Mary Univ London, Ctr Mol Oncol, Barts Canc Inst, John Vane Sci Ctr, Charterhouse Sq, London, England.	latouche81@yahoo.co.uk	Ng, Charlotte K Y/AAY-3178-2021; Ng, Charlotte K Y/AAA-1670-2020	Ng, Charlotte K Y/0000-0002-6100-0026; Berney, Daniel/0000-0001-5474-8696; Stankiewicz, Elzbieta/0000-0003-0812-4086	Orchid male cancer charity; Barts Cancer Institute (London); Queen Mary University of London; St Georges Hospital (London); Memorial Sloan Kettering Cancer Center (New York); Institute of Cancer Research (London);  [ONAG1R1R]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Orchid male cancer charity; Barts Cancer Institute (London); Queen Mary University of London; St Georges Hospital (London); Memorial Sloan Kettering Cancer Center (New York); Institute of Cancer Research (London); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was financially supported by Orchid male cancer charity [http://www.orchid-cancer.org.uk], including some equipment, supplies and reimbursement for attending the 29th Annual European Association of Urology Congress. The grant code for internal use at Queen Mary, University of London was ONAG1R1R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Collaborative support was provided by Barts Cancer Institute (London), Queen Mary University of London, St Georges Hospital (London), Memorial Sloan Kettering Cancer Center (New York) and the Institute of Cancer Research (London).	Alves G, 2001, GENE CHROMOSOME CANC, V31, P48, DOI 10.1002/gcc.1117; Anic GM, 2011, PREV MED, V53, pS36, DOI 10.1016/j.ypmed.2011.08.002; Barnholtz-Sloan JS, 2007, UROL ONCOL-SEMIN ORI, V25, P361, DOI 10.1016/j.urolonc.2006.08.029; Bleeker MCG, 2009, WORLD J UROL, V27, P141, DOI 10.1007/s00345-008-0302-z; Busso-Lopes AF, 2015, CANCER PREV RES, V8, P149, DOI 10.1158/1940-6207.CAPR-14-0284; Cai CL, 2012, CELL CYCLE, V11, P1773, DOI 10.4161/cc.20121; Chaux A, 2012, HUM PATHOL, V43, P771, DOI 10.1016/j.humpath.2012.01.014; Chaux A, 2012, SEMIN DIAGN PATHOL, V29, P67, DOI 10.1053/j.semdp.2011.09.001; Coe BP, 2007, GENOMICS, V89, P647, DOI 10.1016/j.ygeno.2006.12.012; Cubilla LC, 2004, STERNBERGS DIAGNOSTI; Curado MP, 2007, CANC INCIDENCE 5 CON, P160; De Villiers EM, 2004, INT J CANCER, V109, P253, DOI 10.1002/ijc.11685; Ding XJ, 2008, ONCOL REP, V20, P1041, DOI 10.3892/or_00000107; Gstaiger M, 2001, P NATL ACAD SCI USA, V98, P5043, DOI 10.1073/pnas.081474898; Gunnarsson R, 2008, GENE CHROMOSOME CANC, V47, P697, DOI 10.1002/gcc.20575; Hernandez L, 2012, J PATHOL, V227, P42, DOI 10.1002/path.3990; Horlings HM, 2013, BREAST CANCER RES TR, V142, P257, DOI 10.1007/s10549-013-2740-6; Huang FY, 2005, CANCER GENET CYTOGEN, V157, P42, DOI 10.1016/j.cancergencyto.2004.06.002; Jung AC, 2010, INT J CANCER, V126, P1882, DOI 10.1002/ijc.24911; Klussmann JP, 2009, CLIN CANCER RES, V15, P1779, DOI 10.1158/1078-0432.CCR-08-1463; Lacroix-Triki M, 2010, J PATHOL, V222, P282, DOI 10.1002/path.2763; Liang Y, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-73; Mahajan K, 2012, J CELL PHYSIOL, V227, P3178, DOI 10.1002/jcp.24065; Matsha T, 2007, VIROLOGY, V369, P182, DOI 10.1016/j.virol.2007.07.025; Misra S, 2004, LANCET ONCOL, V5, P240, DOI 10.1016/S1470-2045(04)01427-5; Moll UM, 2003, MOL CANCER RES, V1, P1001; Natrajan R, 2009, CLIN CANCER RES, V15, P2711, DOI 10.1158/1078-0432.CCR-08-1878; Nichols Anthony C, 2012, ISRN Oncol, V2012, P809370, DOI 10.5402/2012/809370; Peschiaroli A, 2009, ONCOGENE, V28, P3157, DOI 10.1038/onc.2009.177; Policht FA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-432; Purdie KJ, 2010, BRIT J CANCER, V102, P1044, DOI 10.1038/sj.bjc.6605589; Rainsbury JW, 2013, HEAD NECK-J SCI SPEC, V35, P1048, DOI 10.1002/hed.22950; Rao PH, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-5; Sakai N, 2010, DIS ESOPHAGUS, V23, P415, DOI 10.1111/j.1442-2050.2009.01026.x; Schafer G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-185; Senba M, 2010, ONCOL LETT, V1, P599, DOI 10.3892/ol_00000106; Shi ZZ, 2011, GENE CHROMOSOME CANC, V50, P518, DOI 10.1002/gcc.20875; Singh B, 2002, GENE DEV, V16, P984, DOI 10.1101/gad.973602; Sobin LHGM., 2009, TNM CLASSIFICATION M, V7th; Stankiewicz E, 2012, J CLIN PATHOL, V65, P534, DOI 10.1136/jclinpath-2011-200638; Stankiewicz E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017517; Stankiewicz E, 2011, HISTOPATHOLOGY, V58, P433, DOI 10.1111/j.1365-2559.2011.03762.x; Stankiewicz E, 2009, MODERN PATHOL, V22, P1160, DOI 10.1038/modpathol.2009.77; Syrjanen KJ, 2002, J CLIN PATHOL, V55, P721, DOI 10.1136/jcp.55.10.721; Tan DSP, 2007, LAB INVEST, V87, P737, DOI 10.1038/labinvest.3700593; Tosco P, 2011, ORAL DIS, V17, P102, DOI 10.1111/j.1601-0825.2010.01713.x; Wang XC, 2009, MOL CANCER RES, V7, P12, DOI 10.1158/1541-7786.MCR-08-0092; Yang YL, 2008, GENE CHROMOSOME CANC, V47, P127, DOI 10.1002/gcc.20514; Yangling O, 2007, EUR J GYNAECOL ONCOL, V28, P442; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	50	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0146740	10.1371/journal.pone.0146740	http://dx.doi.org/10.1371/journal.pone.0146740			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901676	Green Submitted, Green Published, gold			2022-12-27	WOS:000371276100006
J	Vergnaud, G; Girault, G; Thierry, S; Pourcel, C; Madani, N; Blouin, Y				Vergnaud, Gilles; Girault, Guillaume; Thierry, Simon; Pourcel, Christine; Madani, Nora; Blouin, Yann			Comparison of French and Worldwide Bacillus anthracis Strains Favors a Recent, Post-Columbian Origin of the Predominant North-American Clade	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; TANDEM-REPEAT ANALYSIS; DRAFT GENOME SEQUENCE; POPULATION-STRUCTURE; EPIDEMIC ANTHRAX; DIVERSITY; EVOLUTION; DISCOVERY; OUTBREAK; FRANCE	Background Bacillus anthracis, the highly dangerous zoonotic bacterial pathogen species is currently composed of three genetic groups, called A, B and C. Group A is represented worldwide whereas group B is present essentially in Western Europe and Southern Africa. Only three strains from group C have been reported. This knowledge is derived from the genotyping of more than 2000 strains collected worldwide. Strains from both group A and group B are present in France. Previous investigations showed that the majority of sporadic French strains belong to the so-called A.Br.011/009 group A clade and define a very remarkable polytomy with six branches. Here we explore the significance of this polytomy by comparing the French B. anthracis lineages to worldwide lineages. We take advantage of whole genome sequence data previously determined for 122 French strains and 45 strains of various origins. Results A total of 6690 SNPs was identified among the available dataset and used to draw the phylogeny. The phylogeny of the French B group strains which belongs to B.Br.CNEVA indicates an expansion from the south-east part of France (the Alps) towards the south-west (Massif-Central and Pyrenees). The relatively small group A strains belonging to A.Br.001/002 results from at least two independent introductions. Strikingly, the data clearly demonstrates that the currently predominant B. anthracis lineage in North America, called WNA for Western North American, is derived from one branch of the A.Br.011/009 polytomy predominant in France. Conclusions/Significance The present work extends the range of observed substitution rate heterogeneity within B. anthracis, in agreement with its ecology and in contrast with some other pathogens. The population structure of the six branches A.Br.011/009 polytomy identified in France, diversity of branch length, and comparison with the WNA lineage, suggests that WNA is of post-Columbian and west European origin, with France as a likely source. Furthermore, it is tempting to speculate that the polytomy's most recent common ancestor -MRCA- dates back to the Hundred Years' war between France and England started in the mid-fourteenth century. These events were associated in France with deadly epidemics and major economic and social changes.	[Vergnaud, Gilles; Pourcel, Christine; Blouin, Yann] Univ Paris Saclay, Univ Paris 11, CNRS, CEA,Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France; [Girault, Guillaume; Thierry, Simon; Madani, Nora] Univ Paris Est, Anses, Hlth Anim Lab, Bacterial Zoonoses Unit, Maisons Alfort, France; [Blouin, Yann] DGA Maitrise NRBC, Dept Analyt Microbiol, Vert Le Petit, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA)	Vergnaud, G (corresponding author), Univ Paris Saclay, Univ Paris 11, CNRS, CEA,Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France.	gilles.vergnaud@u-psud.fr	Pourcel, Christine/E-4949-2017; Vergnaud, Gilles/AAC-1162-2020; Vergnaud, Gilles/P-1304-2015	Pourcel, Christine/0000-0002-8951-466X; Vergnaud, Gilles/0000-0003-0913-194X; Vergnaud, Gilles/0000-0003-0913-194X	Agence Nationale de la Recherche [ANR-11-ASTR-0007]; Anses grant; Direction Generale de l'Armement (DGA) grant; DGA	Agence Nationale de la Recherche(French National Research Agency (ANR)); Anses grant; Direction Generale de l'Armement (DGA) grant; DGA	This work is supported by the Agence Nationale de la Recherche grant number ANR-11-ASTR-0007 project Franthracis, http://www.agencenationale-recherche.fr. GG is a PhD student co-supported by Anses and Direction Generale de l'Armement (DGA) grants. Work by YB and GV on the description of dangerous pathogens is supported by DGA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Antwerpen M, 2012, J BACTERIOL, V194, P6360, DOI 10.1128/JB.01676-12; Birdsell DN, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00152-13; Birdsell DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032866; Blouin Y, 2014, EMERG INFECT DIS, V20, P21, DOI 10.3201/eid2001.130652; Blouin Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052841; Calavas D, 2009, B EPIDEMIOLOGIQUE, V32, P1; Chun JH, 2012, J BACTERIOL, V194, P4116, DOI 10.1128/JB.00159-12; Cohen-Gihon I, 2014, GENOME ANNOUNC, V2, DOI [10.1128/genorneA.00075-14e00075-14, DOI 10.1128/GENORNEA.00075-14]; Cui YJ, 2013, P NATL ACAD SCI USA, V110, P577, DOI 10.1073/pnas.1205750110; Derzelle S, 2011, J CLIN MICROBIOL, V49, P4286, DOI 10.1128/JCM.05439-11; Fouet AS, 2002, J CLIN MICROBIOL, V40, P4732, DOI 10.1128/JCM.40.12.4732-4734.2002; Girault G, 2014, GENOME ANNOUNC, V2, DOI [10.1128/genomeA.00736-14e00736-14, DOI 10.1128/GENOMEA.00736-14E00736-14]; Girault G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-288; Grissa I, 2008, BIOCHIMIE, V90, P660, DOI 10.1016/j.biochi.2007.07.014; Hang'ombe MB, 2012, TROP DOCT, V42, P136, DOI 10.1258/td.2012.110454; Harrington R, 2013, GENOME ANNOUNC, V1, DOI [10.1128/genomeA.00067-12e00067-12, DOI 10.1128/GENOMEA.00067-12E00067-12]; Hugh-Jones M, 2009, MOL ASPECTS MED, V30, P356, DOI 10.1016/j.mam.2009.08.003; Jung KH, 2012, J VET SCI, V13, P385, DOI 10.4142/jvs.2012.13.4.385; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Kenefic LJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004813; Kenefic LJ, 2010, BACTERIAL POPULATION, P169; Khmaladze E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102651; Le Fleche P, 2001, BMC Microbiol, V1, P2; Lista F, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-33; Maho A, 2006, J CLIN MICROBIOL, V44, P3422, DOI 10.1128/JCM.01269-06; Marston CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028274; Morens DM, 2003, AM J PUBLIC HEALTH, V93, P886, DOI 10.2105/AJPH.93.6.886; Morens DM, 2002, EMERG INFECT DIS, V8, P1160, DOI 10.3201/eid0810.020173; Ohnishi N, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00116-14; Okinaka RT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-477; Papazisi L, 2011, GENOMICS, V98, P26, DOI 10.1016/j.ygeno.2011.03.008; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Price EP, 2012, EMERG INFECT DIS, V18, P1307, DOI 10.3201/eid1808.111343; Price EP, 2010, ELECTROPHORESIS, V31, P3881, DOI 10.1002/elps.201000379; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Revich BA, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.8482; Rouli L, 2014, New Microbes New Infect, V2, P161, DOI 10.1002/nmi2.62; Ruckert C, 2012, J BACTERIOL, V194, P5997, DOI 10.1128/JB.01410-12; Simonson TS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-71; Thierry S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095131; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461	42	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0146216	10.1371/journal.pone.0146216	http://dx.doi.org/10.1371/journal.pone.0146216			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901621	Green Published, gold			2022-12-27	WOS:000371276100005
J	Yang, LL; Sui, WJ; Li, YQ; Qi, X; Wang, Y; Zhou, QJ; Gao, H				Yang, Lingling; Sui, Wenjie; Li, Yunqiu; Qi, Xia; Wang, Yao; Zhou, Qingjun; Gao, Hua			Substance P Inhibits Hyperosmotic Stress-Induced Apoptosis in Corneal Epithelial Cells through the Mechanism of Akt Activation and Reactive Oxygen Species Scavenging via the Neurokinin-1 Receptor	PLOS ONE			English	Article							DRY EYE; DIABETES-MELLITUS; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; HUMAN TENOCYTES; OSMOLARITY; PATHWAYS; MITOCHONDRIA; DEATH; ROS	Hyperosmolarity has been recognized as an important pathological factor in dry eye leading to ocular discomfort and damage. As one of the major neuropeptides of corneal innervation, substance P (SP) has been shown to possess anti-apoptotic effects in various cells. The aim of this study was to determine the capacity and mechanism of SP against hyperosmotic stress-induced apoptosis in cultured corneal epithelial cells. The cells were exposed to hyperosmotic stress by the addition of high glucose in the presence or absence of SP. The results showed that SP inhibited hyperosmotic stress-induced apoptosis of mouse corneal epithelial cells. Moreover, SP promoted the recovery of phosphorylated Akt level, mitochondrial membrane potential, Ca2+ contents, intracellular reactive oxygen species (ROS) and glutathione levels that impaired by hyperosmotic stress. However, the antiapoptotic capacity of SP was partially suppressed by Akt inhibitor or glutathione depleting agent, while the neurokinin-1 (NK-1) receptor antagonist impaired Akt activation and ROS scavenging that promoted by SP addition. In conclusion, SP protects corneal epithelial cells from hyperosmotic stress-induced apoptosis through the mechanism of Akt activation and ROS scavenging via the NK-1 receptor.	[Yang, Lingling; Li, Yunqiu; Qi, Xia; Wang, Yao; Zhou, Qingjun; Gao, Hua] Shandong Acad Med Sci, Shandong Eye Inst, State Key Lab Cultivat Base, Shandong Prov Key Lab Ophthalmol, Qingdao, Peoples R China; [Sui, Wenjie; Gao, Hua] Shandong Eye Hosp, Shandong Acad Med Sci, Shandong Eye Inst, Qingdao, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Zhou, QJ; Gao, H (corresponding author), Shandong Acad Med Sci, Shandong Eye Inst, State Key Lab Cultivat Base, Shandong Prov Key Lab Ophthalmol, Qingdao, Peoples R China.; Gao, H (corresponding author), Shandong Eye Hosp, Shandong Acad Med Sci, Shandong Eye Inst, Qingdao, Peoples R China.	qjzhou2000@hotmail.com; gaohua100@126.com	yang, lingling/AAP-9608-2020		Shandong Provincial Nature Science Fund for Distinguished Young Scholars [JQ201518]; National Natural Science Foundation of China [81470610, 81170816, 81200665]; Taishan Scholar Program [20150215]; Innovation Project of Shandong Academy of Medical Sciences	Shandong Provincial Nature Science Fund for Distinguished Young Scholars; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholar Program; Innovation Project of Shandong Academy of Medical Sciences	This work was partially supported by the Shandong Provincial Nature Science Fund for Distinguished Young Scholars (JQ201518) and the National Natural Science Foundation of China (81470610, 81170816, and 81200665). Qingjun Zhou and Hua Gao are partially supported by the Taishan Scholar Program (20150215) and the Innovation Project of Shandong Academy of Medical Sciences.	Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Backman LJ, 2014, BRIT J SPORT MED, V48, P1414, DOI 10.1136/bjsports-2013-092438; Backman LJ, 2013, J CELL MOL MED, V17, P723, DOI 10.1111/jcmm.12059; Bejarano I, 2008, FERTIL STERIL, V90, P1340, DOI 10.1016/j.fertnstert.2007.08.069; Bron AJ, 2002, ADV EXP MED BIOL, V506, P1087; CHANG MM, 1970, J BIOL CHEM, V245, P4784; Clouzeau C, 2012, MOL VIS, V18, P851; Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Dehlin HM, 2013, INT J CARDIOL, V168, P4643, DOI 10.1016/j.ijcard.2013.07.190; Dhanasekaran A, 2004, J BIOL CHEM, V279, P37575, DOI 10.1074/jbc.M404003200; Euler USv, 1931, J PHYSL, V72, P74; FARRIS RL, 1994, ADV EXP MED BIOL, V350, P495; Fortes MB, 2011, MED SCI SPORT EXER, V43, P1590, DOI 10.1249/MSS.0b013e31820e7cb6; Fuerst N, 2014, CLIN OPHTHALMOL, V8, P507, DOI 10.2147/OPTH.S51514; Garrett Q, 2013, EXP EYE RES, V108, P33, DOI 10.1016/j.exer.2012.12.001; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Herrera B, 2001, FASEB J, V15, P741, DOI 10.1096/fj.00-0267com; Hokfelt T, 2001, J INTERN MED, V249, P27, DOI 10.1046/j.0954-6820.2000.00773.x; Iskeleli Guzin, 2002, CLAO Journal, V28, P174; Janelsins BM, 2009, BLOOD, V113, P3017, DOI 10.1182/blood-2008-06-163121; Jiang LB, 2015, CELL CYCLE, V14, P867, DOI 10.1080/15384101.2015.1004946; Kawakita T, 2008, J CELL MOL MED, V12, P1303, DOI 10.1111/j.1582-4934.2008.00297.x; Khandekar N, 2013, MOL VIS, V19, P1945; Koon HW, 2007, P NATL ACAD SCI USA, V104, P2013, DOI 10.1073/pnas.0610664104; Lallemend F, 2003, J NEUROCHEM, V87, P508, DOI 10.1046/j.1471-4159.2003.02014.x; Lee JH, 2014, YONSEI MED J, V55, P203, DOI 10.3349/ymj.2014.55.1.203; Lim CB, 2014, ONCOTARGET; Liu HX, 2009, INVEST OPHTH VIS SCI, V50, P3671, DOI 10.1167/iovs.08-2689; Lozano GM, 2009, J REPROD DEVELOP, V55, P615, DOI 10.1262/jrd.20250; Lu L, 2001, EXP BIOL MED, V226, P653, DOI 10.1177/153537020222600711; Luo LH, 2007, CORNEA, V26, P452, DOI 10.1097/ICO.0b013e318030d259; Luo WH, 1996, CANCER RES, V56, P4983; Mayordomo C, 2012, J CELL PHYSIOL, V227, P1358, DOI 10.1002/jcp.22848; Munoz M, 2008, INVEST NEW DRUG, V26, P111, DOI 10.1007/s10637-007-9087-y; Najafi L, 2013, J DIABETES COMPLICAT, V27, P459, DOI 10.1016/j.jdiacomp.2013.04.006; Park WH, 2014, ONCOL REP, V31, P2413, DOI 10.3892/or.2014.3084; Pieri M, 2010, NEUROPHARMACOLOGY, V58, P268, DOI 10.1016/j.neuropharm.2009.06.029; Png E, 2011, J CELL PHYSIOL, V226, P693, DOI 10.1002/jcp.22389; Racz B, 2007, BONE, V40, P1536, DOI 10.1016/j.bone.2007.02.011; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Sagdik HM, 2013, OPHTHALMIC RES, V50, P1, DOI 10.1159/000345770; Severini C, 2002, PHARMACOL REV, V54, P285, DOI 10.1124/pr.54.2.285; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Wang L, 2011, INVEST OPHTH VIS SCI, V52, P3200, DOI 10.1167/iovs.10-6485; Wang WL, 2015, CANCER LETT, V358, P47, DOI 10.1016/j.canlet.2014.12.025; Yang LL, 2014, DIABETES, V63, P4262, DOI 10.2337/db14-0163; Yen CC, 2014, ONCOTARGET, V5, P716, DOI 10.18632/oncotarget.1704; Zhang YY, 2015, BIOCHEM BIOPH RES CO, V456, P926, DOI 10.1016/j.bbrc.2014.12.036	49	8	11	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149865	10.1371/journal.pone.0149865	http://dx.doi.org/10.1371/journal.pone.0149865			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901348	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100167
J	Laas, E; Mallon, P; Duhoux, FP; Hamidouche, A; Rouzier, R; Reyal, F				Laas, Enora; Mallon, Peter; Duhoux, Francois P.; Hamidouche, Amina; Rouzier, Roman; Reyal, Fabien			Low Concordance between Gene Expression Signatures in ER Positive HER2 Negative Breast Carcinoma Could Impair Their Clinical Application	PLOS ONE			English	Article							NOTTINGHAM-PROGNOSTIC-INDEX; ESTROGEN-RECEPTOR; RECURRENCE SCORE; IMMUNE-RESPONSE; CANCER PATIENTS; PREDICTION; SURVIVAL; RISK; CHEMOTHERAPY; METASTASIS	Background Numerous prognostic gene expression signatures have been recently described. Among the signatures there is variation in the constituent genes that are utilized. We aim to evaluate prognostic concordance among eight gene expression signatures, on a large dataset of ER positive HER2 negative breast cancers. Methods We analysed the performance of eight gene expression signatures on six different datasets of ER+ HER2- breast cancers. Survival analyses were performed using the Kaplan-Meier estimate of survival function. We assessed discrimination and concordance between the 8 signatures on survival and recurrence rates The Nottingham Prognostic Index (NPI) was used to to stratify the risk of recurrence/death. Results The discrimination ability of the whole signatures, showed fair discrimination performances, with AUC ranging from 0.64 (95% CI 0.55-0.73 for the 76-genes signatures, to 0.72 (95% CI 0.64-0.8) for the Molecular Prognosis Index T17. Low concordance was found in predicting events in the intermediate and high-risk group, as defined by the NPI. Low risk group was the only subgroup with a good signatures concordance. Conclusion Genomic signatures may be a good option to predict prognosis as most of them perform well at the population level. They exhibit, however, a high degree of discordance in the	[Laas, Enora; Mallon, Peter; Hamidouche, Amina; Rouzier, Roman; Reyal, Fabien] Inst Curie, Dept Surg, Paris, France; [Laas, Enora; Reyal, Fabien] Hop Tenon, Dept Gynaecol Surg, F-75970 Paris, France; [Duhoux, Francois P.; Reyal, Fabien] Inst Curie, Dept Med Oncol, Paris, France; [Duhoux, Francois P.; Reyal, Fabien] Catholic Univ Louvain, Clin Univ St Luc, Ctr Canc, B-1200 Brussels, Belgium; [Reyal, Fabien] Inst Curie, Translat Res Dept, Residual Tumor & Response Treatment, RT2Lab, Paris, France; [Reyal, Fabien] Inst Curie, UMR932, Immun & Canc, Paris, France; [Mallon, Peter] Craigavon Area Hosp, Breast Unit, Portadown BT63 5QQ, North Ireland	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite	Reyal, F (corresponding author), Inst Curie, Dept Surg, Paris, France.; Reyal, F (corresponding author), Hop Tenon, Dept Gynaecol Surg, F-75970 Paris, France.; Reyal, F (corresponding author), Inst Curie, Dept Med Oncol, Paris, France.; Reyal, F (corresponding author), Catholic Univ Louvain, Clin Univ St Luc, Ctr Canc, B-1200 Brussels, Belgium.; Reyal, F (corresponding author), Inst Curie, Translat Res Dept, Residual Tumor & Response Treatment, RT2Lab, Paris, France.; Reyal, F (corresponding author), Inst Curie, UMR932, Immun & Canc, Paris, France.	fabien.reyal@curie.fr	; Rouzier, Roman/G-2953-2018	Duhoux, Francois/0000-0002-5429-7888; Rouzier, Roman/0000-0002-8167-6808				Albain KS, 2010, LANCET ONCOL, V11, P55, DOI 10.1016/S1470-2045(09)70314-6; BALSLEV I, 1994, BREAST CANCER RES TR, V32, P281, DOI 10.1007/BF00666005; Barry WT, 2010, J CLIN ONCOL, V28, P2198, DOI 10.1200/JCO.2009.26.7245; Barton S, 2012, BRIT J CANCER, V106, P1760, DOI 10.1038/bjc.2012.166; Blamey RW, 2007, EUR J CANCER, V43, P1548, DOI 10.1016/j.ejca.2007.01.016; BROWN J, 1993, BREAST CANCER RES TR, V25, P283; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Cuzick J, 2011, J CLIN ONCOL, V29, P4273, DOI 10.1200/JCO.2010.31.2835; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Engelhardt EG, 2014, J CLIN ONCOL, V32, P238, DOI 10.1200/JCO.2013.50.3417; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Gong Y, 2007, LANCET ONCOL, V8, P203, DOI 10.1016/S1470-2045(07)70042-6; Haibe-Kains B, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-394; Haury A-C, 2010, ARXIV PREPR ARXIV100; HAYBITTLE JL, 1982, BRIT J CANCER, V45, P361, DOI 10.1038/bjc.1982.62; Hornberger J, 2012, JNCI-J NATL CANCER I, V104, P1068, DOI 10.1093/jnci/djs261; Kim SY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-147; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Millar EKA, 2011, BRIT J CANCER, V105, P272, DOI 10.1038/bjc.2011.228; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Reyal F, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2192; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Tang G, 2011, J CLIN ONCOL, V29, P4365, DOI 10.1200/JCO.2011.35.3714; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; Teschendorff AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r101; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Vliet MH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-375; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Zhao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017845	42	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148957	10.1371/journal.pone.0148957	http://dx.doi.org/10.1371/journal.pone.0148957			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895349	gold, Green Submitted, Green Published			2022-12-27	WOS:000371223400029
J	Nanni, L; Paci, M; dos Santos, FLC; Skottman, H; Juuti-Uusitalo, K; Hyttinen, J				Nanni, Loris; Paci, Michelangelo; dos Santos, Florentino Luciano Caetano; Skottman, Heli; Juuti-Uusitalo, Kati; Hyttinen, Jari			Texture Descriptors Ensembles Enable Image-Based Classification of Maturation of Human Stem Cell-Derived Retinal Pigmented Epithelium	PLOS ONE			English	Article							SUBCELLULAR STRUCTURES; FEATURE-EXTRACTION; DIFFERENTIATION; PATTERNS; COOCCURRENCE; FREQUENCY	Aims A fast, non-invasive and observer-independent method to analyze the homogeneity and maturity of human pluripotent stem cell (hPSC) derived retinal pigment epithelial (RPE) cells is warranted to assess the suitability of hPSC-RPE cells for implantation or in vitro use. The aim of this work was to develop and validate methods to create ensembles of state-of-the-art texture descriptors and to provide a robust classification tool to separate three different maturation stages of RPE cells by using phase contrast microscopy images. The same methods were also validated on a wide variety of biological image classification problems, such as histological or virus image classification. Methods For image classification we used different texture descriptors, descriptor ensembles and preprocessing techniques. Also, three new methods were tested. The first approach was an ensemble of preprocessing methods, to create an additional set of images. The second was the region-based approach, where saliency detection and wavelet decomposition divide each image in two different regions, from which features were extracted through different descriptors. The third method was an ensemble of Binarized Statistical Image Features, based on different sizes and thresholds. A Support Vector Machine (SVM) was trained for each descriptor histogram and the set of SVMs combined by sum rule. The accuracy of the computer vision tool was verified in classifying the hPSC-RPE cell maturation level. Dataset and Results The RPE dataset contains 1862 subwindows from 195 phase contrast images. The final descriptor ensemble outperformed the most recent stand-alone texture descriptors, obtaining, for the RPE dataset, an area under ROC curve (AUC) of 86.49% with the 10-fold cross validation and 91.98% with the leave-one-image-out protocol. The generality of the three proposed approaches was ascertained with 10 more biological image datasets, obtaining an average AUC greater than 97%. Conclusions Here we showed that the developed ensembles of texture descriptors are able to classify the RPE cell maturation stage. Moreover, we proved that preprocessing and region-based decomposition improves many descriptors' accuracy in biological dataset classification. Finally, we built the first public dataset of stem cell-derived RPE cells, which is publicly available to the scientific community for classification studies. The proposed tool is available at https://www.dei.unipd.it/node/2357 and the RPE dataset at http://www.biomeditech.fi/data/RPE_dataset/. Both are available at https://figshare.com/s/d6fb591f1beb4f8efa6f.	[Nanni, Loris] Univ Padua, Dept Informat Engn, Padua, Italy; [Paci, Michelangelo; dos Santos, Florentino Luciano Caetano; Hyttinen, Jari] Tampere Univ Technol, Dept Elect & Commun Engn, BioMediTech, FIN-33101 Tampere, Finland; [Skottman, Heli; Juuti-Uusitalo, Kati] Univ Tampere, BioMediTech, FIN-33101 Tampere, Finland	University of Padua; Tampere University; Tampere University	Nanni, L (corresponding author), Univ Padua, Dept Informat Engn, Padua, Italy.; Paci, M (corresponding author), Tampere Univ Technol, Dept Elect & Commun Engn, BioMediTech, FIN-33101 Tampere, Finland.	loris.nanni@unipd.it; michelangelo.paci@tut.fi	Hyttinen, Jari A/G-4280-2014; Caetano dos Santos, Florentino Luciano/D-3502-2015	Hyttinen, Jari A/0000-0003-1850-3055; Caetano dos Santos, Florentino Luciano/0000-0001-8151-3585; Juuti-Uusitalo, Kati/0000-0003-2275-5562; Skottman, Heli/0000-0002-4127-8792	Finnish Funding Agency for Technology and Innovation; Academy of Finland [252225, 218050, 137801]	Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); Academy of Finland(Academy of Finland)	This work was financially supported by the Finnish Funding Agency for Technology and Innovation (www.tekes.fi, Human Spare Parts project, MP and FLCS) and the Academy of Finland (www.aka.fi, grant numbers 252225 JH, 218050 HS and 137801 KJU). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdesselam Abdelhamid, 2013, Lecture Notes on Software Engineering, V1, P360, DOI 10.7763/LNSE.2013.V1.77; Baddeley RJ, 2006, VISION RES, V46, P2824, DOI 10.1016/j.visres.2006.02.024; Bianconi F, 2013, EXPERT SYST APPL, V40, P1636, DOI 10.1016/j.eswa.2012.09.007; Boland MV, 1998, CYTOMETRY, V33, P366; Boland MV, 2001, BIOINFORMATICS, V17, P1213, DOI 10.1093/bioinformatics/17.12.1213; Braz G, 2009, COMPUT BIOL MED, V39, P1063, DOI 10.1016/j.compbiomed.2009.08.009; Burke JM, 1996, EXP EYE RES, V62, P63, DOI 10.1006/exer.1996.0008; Chen J, 2010, IEEE T PATTERN ANAL, V32, P1705, DOI 10.1109/TPAMI.2009.155; Croze RH, 2014, STEM CELL TRANSL MED, V3, P1066, DOI 10.5966/sctm.2014-0079; Cruz-Roa A, 2011, ARTIF INTELL MED, V52, P91, DOI 10.1016/j.artmed.2011.04.010; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; DAUGMAN JG, 1985, J OPT SOC AM A, V2, P1160, DOI 10.1364/JOSAA.2.001160; dos Santos FLC, 2015, BIOSYST ENG, V138, P11, DOI 10.1016/j.biosystemseng.2015.01.005; Fathi A, 2012, PATTERN RECOGN LETT, V33, P1093, DOI 10.1016/j.patrec.2012.01.017; Fink JL, 2006, NUCLEIC ACIDS RES, V34, pD213, DOI 10.1093/nar/gkj069; Fu JJC, 2014, COMPUT MED IMAG GRAP, V38, P267, DOI 10.1016/j.compmedimag.2013.12.009; Guo YM, 2011, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2011, DOI 10.5244/C.25.119; Guo ZH, 2010, IEEE T IMAGE PROCESS, V19, P1657, DOI 10.1109/TIP.2010.2044957; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Heath M, 1998, COMP IMAG VIS, V13, P457; Hou XD, 2012, IEEE T PATTERN ANAL, V34, P194, DOI 10.1109/TPAMI.2011.146; Hu S, 2014, BIO-MED MATER ENG, V24, P129, DOI 10.3233/BME-130793; Jantzen J., 2005, P NISIS, P1; Jiang Y, 2013, INVEST OPHTH VIS SCI, V54, P7274, DOI 10.1167/iovs.13-12450; Juuti-Uusitalo K, 2013, INVEST OPHTH VIS SCI, V54, P3510, DOI 10.1167/iovs.13-11800; Juuti-Uusitalo K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030089; Kamao H, 2014, INVEST OPHTH VIS SCI, V55, P8309, DOI 10.1167/iovs.14-14694; Kannala J, 2012, INT C PATT RECOG, P1363; Kylberg G, 2011, LECT NOTES COMPUT SC, V7042, P573, DOI 10.1007/978-3-642-25085-9_68; Loukas C, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/829461; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; Manthalkar R, 2003, PATTERN RECOGN LETT, V24, P2061, DOI 10.1016/S0167-8655(03)00043-6; Nanni L., 2014, LOCAL BINARY PATTERN, P177; Nanni L, 2015, APPL COMPUT INFORM; Nanni L, 2011, EXPERT SYST APPL, V38, P6209, DOI 10.1016/j.eswa.2010.11.048; Nanni L, 2010, ARTIF INTELL MED, V49, P117, DOI 10.1016/j.artmed.2010.02.006; Nanni L, 2010, J THEOR BIOL, V264, P1024, DOI 10.1016/j.jtbi.2010.03.020; Vu NS, 2014, IMAGE VISION COMPUT, V32, P424, DOI 10.1016/j.imavis.2014.04.006; Nosaka R, 2014, PATTERN RECOGN, V47, P2428, DOI 10.1016/j.patcog.2013.09.018; Nosaka R, 2011, LECT NOTES COMPUT SC, V7088, P82, DOI 10.1007/978-3-642-25346-1_8; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Ojansivu V, 2008, LECT NOTES COMPUT SC, V5099, P236, DOI 10.1007/978-3-540-69905-7_27; Paci M, 2013, CURR BIOINFORM, V8, P208, DOI 10.2174/1574893611308020009; PUDIL P, 1994, PATTERN RECOGN LETT, V15, P1119, DOI 10.1016/0167-8655(94)90127-9; Rowland TJ, 2013, J TISSUE ENG REGEN M, V7, P642, DOI 10.1002/term.1458; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Singh R, 2013, INVEST OPHTH VIS SCI, V54, P6767, DOI 10.1167/iovs.13-11943; Skottman H, 2010, IN VITRO CELL DEV-AN, V46, P206, DOI 10.1007/s11626-010-9286-2; Sorkio A, 2014, TISSUE ENG PT A, V20, P622, DOI 10.1089/ten.TEA.2013.0049; Strandmark P, 2012, INT C PATT RECOG, P33; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Strzelecki M, 2006, COMPUT MED IMAG GRAP, V30, P95, DOI 10.1016/j.compmedimag.2005.11.004; Tan XY, 2010, IEEE T IMAGE PROCESS, V19, P1635, DOI 10.1109/TIP.2010.2042645; Toivonen S, 2013, STEM CELL TRANSL MED, V2, P83, DOI 10.5966/sctm.2012-0047; Vaajasaari H, 2011, MOL VIS, V17, P558; Vecsei A, 2011, COMPUT BIOL MED, V41, P313, DOI 10.1016/j.compbiomed.2011.03.009; Vu NS, 2013, IEEE T INF FOREN SEC, V8, P295, DOI 10.1109/TIFS.2012.2224866; Vugler A, 2008, EXP NEUROL, V214, P347, DOI 10.1016/j.expneurol.2008.09.007; Ylioinas Juha, 2013, Computer Vision - ACCV 2012. 11th Asian Conference on Computer Vision. Revised Selected Papers, P375, DOI 10.1007/978-3-642-37431-9_29; Zhao GY, 2012, IEEE T IMAGE PROCESS, V21, P1465, DOI 10.1109/TIP.2011.2175739	61	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149399	10.1371/journal.pone.0149399	http://dx.doi.org/10.1371/journal.pone.0149399			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895509	Green Published, gold, Green Submitted			2022-12-27	WOS:000371223400052
J	Zhao, YZ; Jin, RR; Yang, W; Xiang, Q; Yu, WZ; Lin, Q; Tian, FR; Mao, KL; Lv, CZ; Wang, YXJ; Lu, CT				Zhao, Ying-Zheng; Jin, Rong-Rong; Yang, Wei; Xiang, Qi; Yu, Wen-Ze; Lin, Qian; Tian, Fu-Rong; Mao, Kai-Li; Lv, Chuan-Zhu; Wang, Yi-Xiang J.; Lu, Cui-Tao			Using Gelatin Nanoparticle Mediated Intranasal Delivery of Neuropeptide Substance P to Enhance Neuro-Recovery in Hemiparkinsonian Rats	PLOS ONE			English	Article							IN-VITRO; ALPHA-SYNUCLEIN; CELL-DEATH; MODEL; BRAIN; EXPRESSION; SYSTEM; 6-HYDROXYDOPAMINE; OPTIMIZATION; ACTIVATION	Purpose Intranasal administration of phospholipid-based gelatin nanoparticles (GNP) was prepared to investigate the neuro-recovery effects of neuropeptide Substance P (SP) on hemiparkin-sonian rats. Methods The SP-loaded gelatin nanoparticles (SP-GNP) were prepared by a water-in-water emulsion method and possessed high stability, encapsulating efficiency and loading capacity. PC-12 cells were used to examine the growth enhancement of SP-GNP in vitro by MTT assays and flow cytometry (FCM). The therapeutic effects of SP-GNP on 6-hydroxydopamine (6-OHDA) induced hemiparkinsonian rats were assessed by quantifying rotational behavior and the levels of tyrosine hydroxylase (TH), phosphorylated c-Jun protein (p-cJun) and Caspase-3 (Cas-3) expressed in substantia nigra (SN) region of hemiparkinsonian rats. Results PC-12 cells under SP-GNP treatment showed better cell viability and lower degree of apoptosis than those under SP solution treatment. Hemiparkinsonian rats under intranasal SPGNP administration demonstrated better behavioral improvement, higher level of TH in SN along with much lower extent of p-c-Jun and Cas-3 than those under intranasal SP solution administration and intravenous SP-GNP administration. Conclusions With the advantages of GNP and nose-to-brain pathway, SP can be effectively delivered into the damaged SN region and exhibit its neuro-recovery function through the inhibition on JNK pathway and dopaminergic neuron apoptosis.	[Zhao, Ying-Zheng; Yang, Wei; Yu, Wen-Ze; Lin, Qian; Tian, Fu-Rong; Mao, Kai-Li; Lu, Cui-Tao] Wenzhou Med Univ, Coll Pharmaceut Sci, Wenzhou 325035, Zhejiang, Peoples R China; [Zhao, Ying-Zheng; Lu, Cui-Tao] Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou 325000, Zhejiang, Peoples R China; [Zhao, Ying-Zheng; Lv, Chuan-Zhu] Hainan Med Coll, Haikou 570102, Hainan, Peoples R China; [Jin, Rong-Rong] Taizhou Tradit Chinese Med Hosp, Taizhou 318000, Zhejiang, Peoples R China; [Xiang, Qi] Jinan Univ, Biopharmaceut R&D Ctr, Guangzhou 510000, Guangdong, Peoples R China; [Wang, Yi-Xiang J.] Chinese Univ Hong Kong, Prince Wales Hosp, Fac Med, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Hainan Medical University; Jinan University; Chinese University of Hong Kong; Prince of Wales Hospital	Lu, CT (corresponding author), Wenzhou Med Univ, Coll Pharmaceut Sci, Wenzhou 325035, Zhejiang, Peoples R China.; Lu, CT (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou 325000, Zhejiang, Peoples R China.; Wang, YXJ (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Fac Med, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China.	yixiang_wang@cuhk.edu.hk; lctuua@sina.com	Wang, Yi Xiang/I-5952-2016; Tian, Furong/AAA-6037-2020	Wang, Yi Xiang/0000-0001-5697-0717; Tian, Furong/0000-0002-4953-1131	National Natural Science Foundation of China [81360195, 81301982, 81571392, 81272160, 81302726, 81460299]; Zhejiang Provincial Foundation for Health Department [2015ZDA023, 2016139678]; Key support of high level talent innovation and technology project of Wenzhou; Major Scientific Project of Guangdong Province [2012A080201010]; Science and Technology Plan Project of Guangzhou [201508020001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Foundation for Health Department; Key support of high level talent innovation and technology project of Wenzhou; Major Scientific Project of Guangdong Province; Science and Technology Plan Project of Guangzhou	This research was supported by National Natural Science Foundation of China (Grant No. 81360195, 81301982, 81571392, 81272160, 81302726 and 81460299); Zhejiang Provincial Foundation for Health Department (Grant No. 2015ZDA023 and 2016139678), Key support of high level talent innovation and technology project of Wenzhou (Ying-Zheng Zhao, 2015); Major Scientific Project of Guangdong Province (Grant No. 2012A080201010); Science and Technology Plan Project of Guangzhou, (201508020001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2013, PROTOPLASMA, V250, P1327, DOI 10.1007/s00709-013-0516-9; Barbiero JK, 2014, PROG NEURO-PSYCHOPH, V53, P35, DOI 10.1016/j.pnpbp.2014.02.009; BARKER R, 1991, NEUROPEPTIDES, V20, P73, DOI 10.1016/0143-4179(91)90054-M; Betarbet R, 2004, EXP NEUROL, V189, P393, DOI 10.1016/j.expneurol.2004.05.041; Chambers JW, 2013, J BIOL CHEM, V288, P1079, DOI 10.1074/jbc.M112.421354; Costantino HR, 2007, INT J PHARMACEUT, V337, P1, DOI 10.1016/j.ijpharm.2007.03.025; Covenas R, 2014, HISTOL HISTOPATHOL, V29, P881, DOI 10.14670/HH-29.881; Das S, 2011, AAPS PHARMSCITECH, V12, P62, DOI 10.1208/s12249-010-9563-0; Decressac M, 2011, BRAIN, V134, P2302, DOI 10.1093/brain/awr149; Elzoghby AO, 2013, J CONTROL RELEASE, V172, P1075, DOI 10.1016/j.jconrel.2013.09.019; Fiebich BL, 2000, J IMMUNOL, V165, P5606, DOI 10.4049/jimmunol.165.10.5606; Fujita H, 2006, BRAIN RES, V1113, P10, DOI 10.1016/j.brainres.2006.06.079; Gagliardi M, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.04.020; Giuliani P, 2012, PANMINERVA MED S4, V54, P43; Illum L, 2000, EUR J PHARM SCI, V11, P1, DOI 10.1016/S0928-0987(00)00087-7; Jiang MH, 2013, NEUROREPORT, V24, P846, DOI 10.1097/WNR.0b013e3283650e3d; Kabanov AV, 2007, PROG POLYM SCI, V32, P1054, DOI 10.1016/j.progpolymsci.2007.05.014; Kemeny S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038837; Krasnova IN, 2000, NEUROSCIENCE, V95, P113; Lee E, 2014, J NEUROSCI RES, V92, P130, DOI 10.1002/jnr.23307; Lee JH, 2012, QUANT IMAGING MED SU, V2, P266, DOI 10.3978/j.issn.2223-4292.2012.12.04; Lee SJ, 2013, J CONTROL RELEASE, V172, P358, DOI 10.1016/j.jconrel.2013.09.002; Li XF, 2011, BRAIN RES, V1382, P9, DOI 10.1016/j.brainres.2011.01.015; Lochhead JJ, 2012, ADV DRUG DELIVER REV, V64, P614, DOI 10.1016/j.addr.2011.11.002; McLean JR, 2014, NEUROSCI LETT, V576, P73, DOI 10.1016/j.neulet.2014.05.044; Mistry A, 2009, INT J PHARMACEUT, V379, P146, DOI 10.1016/j.ijpharm.2009.06.019; Oh M, 2012, J NUCL MED, V53, P399, DOI 10.2967/jnumed.111.095224; Pan J, 2005, NEUROSCIENCE, V131, P147, DOI 10.1016/j.neuroscience.2004.09.031; Pan J, 2007, MOL PHARMACOL, V72, P1607, DOI 10.1124/mol.107.038463; Pardeshi CV, 2013, J MATER SCI-MATER M, V24, P2101, DOI 10.1007/s10856-013-4965-7; Patel S, 2011, J DRUG TARGET, V19, P468, DOI 10.3109/1061186X.2010.523787; Shukla AK, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.04.008; Sivera M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103675; TAQUET H, 1988, NEUROPEPTIDES, V12, P105, DOI 10.1016/0143-4179(88)90039-X; Thorne RG, 2001, CLIN PHARMACOKINET, V40, P907, DOI 10.2165/00003088-200140120-00003; Thornton E, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042630, 10.1371/journal.pone.0034138]; Thornton E, 2010, NEUROSCI LETT, V481, P64, DOI 10.1016/j.neulet.2010.06.057; Upadhyay RK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/869269; Vandelli MA, 2001, INT J PHARM, V215, P175, DOI 10.1016/S0378-5173(00)00681-5; Varshosaz J, 2010, J LIPOSOME RES, V20, P286, DOI 10.3109/08982100903443065; Varshosaz J, 2010, PHARM DEV TECHNOL, V15, P89, DOI 10.3109/10837450903013568; Vyas Tushar K., 2005, Current Drug Delivery, V2, P165, DOI 10.2174/1567201053586047; Wang YXJ, 2013, CURR PHARM DESIGN, V19, P6575; Wu AG, 2013, INT J MOL SCI, V14, P22618, DOI 10.3390/ijms141122618; Zaki NM, 2007, EUR J PHARM SCI, V32, P296, DOI 10.1016/j.ejps.2007.08.006; Zhang X, 2008, NEUROPHARMACOLOGY, V54, P1143, DOI 10.1016/j.neuropharm.2008.03.005	46	25	30	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148848	10.1371/journal.pone.0148848	http://dx.doi.org/10.1371/journal.pone.0148848			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894626	gold, Green Published, Green Submitted			2022-12-27	WOS:000371223400023
J	Rambaud, SC; Torrecillas, MJM				Cruz Rambaud, Salvador; Munoz Torrecillas, Mara Jose			Measuring Impatience in Intertemporal Choice	PLOS ONE			English	Article							TIME; PREFERENCES; DECISIONS; UTILITY; MODELS; RISK	In general terms, decreasing impatience means decreasing discount rates. This property has been usually referred to as hyperbolic discounting, although there are other discount functions which also exhibit decreasing discount rates. This paper focuses on the measurement of the impatience associated with a discount function with the aim of establishing a methodology to compare this characteristic for two different discount functions. In this way, first we define the patience associated with a discount function in an interval as its corresponding discount factor and consequently we deduce that the impatience at a given moment is the corresponding instantaneous discount rate. Second we compare the degree of impatience of discount functions belonging to the same or different families, by considering the cases in which the functions do or do not intersect.	[Cruz Rambaud, Salvador; Munoz Torrecillas, Mara Jose] Univ Almeria, Fac Ciencias Econ & Empresariales, Dept Econ & Empresa, La Canada San Urbano S-N, Almeria 04120, Spain	Universidad de Almeria	Rambaud, SC (corresponding author), Univ Almeria, Fac Ciencias Econ & Empresariales, Dept Econ & Empresa, La Canada San Urbano S-N, Almeria 04120, Spain.	scruz@ual.es	Torrecillas, María José Muñoz/ABH-2122-2020	Munoz Torrecillas, Maria Jose/0000-0002-5853-4393	project "Valoracion de proyectos gubernamentales a largo plazo: obtencion de la tasa social de descuento", Proyectos de Excelencia de la Junta de Andaluca [P09-SEJ-05404]; Fondos FEDER	project "Valoracion de proyectos gubernamentales a largo plazo: obtencion de la tasa social de descuento", Proyectos de Excelencia de la Junta de Andaluca; Fondos FEDER(European Commission)	This paper has been partially supported by the project "Valoracion de proyectos gubernamentales a largo plazo: obtencion de la tasa social de descuento", reference: P09-SEJ-05404, Proyectos de Excelencia de la Junta de Andaluca and Fondos FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellaoui M, 2010, ECON J, V120, P845, DOI 10.1111/j.1468-0297.2009.02308.x; AINSLIE G, 1975, PSYCHOL BULL, V82, P463, DOI 10.1037/h0076860; Attema AE, 2010, MANAGE SCI, V56, P2015, DOI 10.1287/mnsc.1100.1219; Benhabib J, 2010, GAME ECON BEHAV, V69, P205, DOI 10.1016/j.geb.2009.11.003; BENZION U, 1989, MANAGE SCI, V35, P270, DOI 10.1287/mnsc.35.3.270; Bleichrodt H, 2009, GAME ECON BEHAV, V66, P27, DOI 10.1016/j.geb.2008.05.007; Bohm-Bawerk EV, 1912, POSITIVE THEORIE KAP, VII, P257; Cajueiro DO, 2006, PHYSICA A, V364, P385, DOI 10.1016/j.physa.2005.08.056; Caliendo FN, 2014, ECON LETT, V122, P416, DOI 10.1016/j.econlet.2013.12.035; Chen HP, 2005, J MARKETING RES, V42, P291, DOI 10.1509/jmkr.2005.42.3.291; Cheng JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111378; Destefano N, 2011, PHYSICA A, V390, P1763, DOI 10.1016/j.physa.2011.01.016; Espin AM, 2015, FRONTIERS BEHAV NEUR, V9; Espin AM, 2012, P ROY SOC B-BIOL SCI, V279, P4923, DOI 10.1098/rspb.2012.2043; Fisher I., 1930, THEORY INTEREST; Halevy Y, 2008, AM ECON REV, V98, P1145, DOI 10.1257/aer.98.3.1145; HOCH SJ, 1991, J CONSUM RES, V17, P492, DOI 10.1086/208573; KIRBY KN, 1995, ORGAN BEHAV HUM DEC, V64, P22, DOI 10.1006/obhd.1995.1086; Kirby KN, 1997, J EXP PSYCHOL GEN, V126, P54, DOI 10.1037/0096-3445.126.1.54; KOOPMANS TC, 1960, ECONOMETRICA, V28, P287, DOI 10.2307/1907722; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; Lu Y, 2014, PHYSICA A, V409, P146, DOI 10.1016/j.physa.2014.05.015; Matta Adriana da, 2012, Psychol. Neurosci., V5, P135, DOI 10.3922/j.psns.2012.2.03; Musau A, 2014, THEOR DECIS, V76, P9, DOI 10.1007/s11238-013-9361-8; MYERSON J, 1995, J EXP ANAL BEHAV, V64, P263, DOI 10.1901/jeab.1995.64-263; Myerson J, 2001, J EXP ANAL BEHAV, V76, P235, DOI 10.1901/jeab.2001.76-235; Prelec D, 2004, SCAND J ECON, V106, P511, DOI 10.1111/j.0347-0520.2004.00375.x; Nguyen Q, 2011, J RISK UNCERTAINTY, V43, P245, DOI 10.1007/s11166-011-9130-4; Rambaud SC, 2013, PHYSICA A, V392, P3045, DOI 10.1016/j.physa.2013.03.009; Rambaud SC, 2005, ENVIRON SCI POLICY, V8, P343, DOI 10.1016/j.envsci.2005.04.003; Rambaud SC., 2006, ANALES ESTUDIOS EC E, V16, P75; Read D, 2001, J RISK UNCERTAINTY, V23, P5, DOI 10.1023/A:1011198414683; Sayman S, 2009, MANAGE SCI, V55, P470, DOI 10.1287/mnsc.1080.0942; Seinstra M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137061; Takahashi T, 2008, PHYSICA A, V387, P2066, DOI 10.1016/j.physa.2007.11.047; Takahashi T, 2008, PHYSICA A, V387, P551, DOI 10.1016/j.physa.2007.09.007; Takahashi T, 2007, PHYSICA A, V381, P338, DOI 10.1016/j.physa.2007.03.038; Takahashi T, 2009, NEUROENDOCRINOL LETT, V30, P185; Takahashi T, 2007, PHYSICA A, V385, P637, DOI 10.1016/j.physa.2007.07.020; Tanaka T, 2010, AM ECON REV, V100, P557, DOI 10.1257/aer.100.1.557; THALER R, 1981, ECON LETT, V8, P201, DOI 10.1016/0165-1765(81)90067-7	41	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149256	10.1371/journal.pone.0149256	http://dx.doi.org/10.1371/journal.pone.0149256			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3CO	26890895	Green Published, gold			2022-12-27	WOS:000371221500029
J	Eteng, AA; Rahim, SKA; Leow, CY; Chew, BW; Vandenbosch, GAE				Eteng, Akaa Agbaeze; Rahim, Sharul Kamal Abdul; Leow, Chee Yen; Chew, Beng Wah; Vandenbosch, Guy A. E.			Two-Stage Design Method for Enhanced Inductive Energy Transmission with Q-Constrained Planar Square Loops	PLOS ONE			English	Article							POWER; OPTIMIZATION; PARAMETERS; ANTENNA; COILS	Q-factor constraints are usually imposed on conductor loops employed as proximity range High Frequency Radio Frequency Identification (HF-RFID) reader antennas to ensure adequate data bandwidth. However, pairing such low Q-factor loops in inductive energy transmission links restricts the link transmission performance. The contribution of this paper is to assess the improvement that is reached with a two-stage design method, concerning the transmission performance of a planar square loop relative to an initial design, without compromise to a Q-factor constraint. The first stage of the synthesis flow is analytical in approach, and determines the number and spacing of turns by which coupling between similar paired square loops can be enhanced with low deviation from the Q-factor limit presented by an initial design. The second stage applies full-wave electromagnetic simulations to determine more appropriate turn spacing and widths to match the Q-factor constraint, and achieve improved coupling relative to the initial design. Evaluating the design method in a test scenario yielded a more than 5% increase in link transmission efficiency, as well as an improvement in the link fractional bandwidth by more than 3%, without violating the loop Q-factor limit. These transmission performance enhancements are indicative of a potential for modifying proximity HF-RFID reader antennas for efficient inductive energy transfer and data telemetry links.	[Eteng, Akaa Agbaeze; Rahim, Sharul Kamal Abdul; Leow, Chee Yen] Univ Teknol Malaysia, Wireless Commun Ctr, Johor Baharu, Malaysia; [Chew, Beng Wah] Intel Microelect, Halaman Kampung Jawa, Penang, Malaysia; [Vandenbosch, Guy A. E.] Katholieke Univ Leuven, Dept Elect Engn, Leuven, Belgium	Universiti Teknologi Malaysia; Intel Corporation; KU Leuven	Rahim, SKA (corresponding author), Univ Teknol Malaysia, Wireless Commun Ctr, Johor Baharu, Malaysia.	sharulkamal@fke.utm.my	Vandenbosch, Guy A/J-3209-2012; Eteng, Akaa/AAR-7242-2021; Eteng, Akaa/AAV-3944-2020; LEOW, CHEE YEN/J-9206-2018; rahim, sharul kamal abdul/K-6346-2012	Eteng, Akaa/0000-0002-1483-1265; LEOW, CHEE YEN/0000-0001-6418-0184; rahim, sharul kamal abdul/0000-0003-4511-1989	Collaborative Research in Engineering, Science and Technology (CREST) fund, Malaysia [4B151]; Universiti Teknologi Malaysia [05H39, 4F617]; INTEL, through CREST	Collaborative Research in Engineering, Science and Technology (CREST) fund, Malaysia; Universiti Teknologi Malaysia; INTEL, through CREST	This work was supported in part by the Collaborative Research in Engineering, Science and Technology (CREST) fund, Malaysia, under Grant Number 4B151; and Universiti Teknologi Malaysia under Grant Numbers 05H39 and 4F617. Author BWC is with Intel Microelectronics, Malaysia. INTEL, through CREST, provided support in the form of salaries for author BWC, and decision to publish, study design, data collection and analysis, or preparation of the manuscript.	Aerts W, 2008, IEEE T ANTENN PROPAG, V56, P3829, DOI 10.1109/TAP.2008.2007378; Ahn D, 2013, IEEE T IND ELECTRON, V60, P360, DOI 10.1109/TIE.2012.2188254; [Anonymous], 2012, MICR STUD BAS FIN IN; Bosshard R, 2015, IEEE J EM SEL TOP P, V3, P50, DOI 10.1109/JESTPE.2014.2311302; Covic GA, 2013, P IEEE, V101, P1276, DOI 10.1109/JPROC.2013.2244536; Esteban-Muller J, 2010, P 11 INT WORKSH SYMB, P322; Eteng AA, 2015, IEEE ANTENN WIREL PR, V14, P1762, DOI 10.1109/LAWP.2015.2423276; Eteng AA, 2015, IEEE ANTENN PROPAG M, V57, P16, DOI 10.1109/MAP.2015.2437281; FRICKEY DA, 1994, IEEE T MICROW THEORY, V42, P205, DOI 10.1109/22.275248; Gonzalez-Echevarria R., 2012, 2012 International Conference on Synthesis, Modeling, Analysis and Simulation Methods and Applications to Circuit Design (SMACD), P181, DOI 10.1109/SMACD.2012.6339447; Gonzalez-Echevarria R, 2014, IEEE T COMPUT AID D, V33, P1269, DOI 10.1109/TCAD.2014.2316092; Inagaki N, 2014, IEEE T MICROW THEORY, V62, P901, DOI 10.1109/TMTT.2014.2300033; Jankowski-Mihulowicz P, 2012, ACTA PHYS POL A, V121, P936, DOI 10.12693/APhysPolA.121.936; Jankowski-Mihulowicz P, 2015, ARCH ELECTR ENG, V64, P459, DOI 10.2478/aee-2015-0035; Jankowski-Mihulowicz P, 2012, PRZ ELEKTROTECHNICZN, V88, P70; Jow UM, 2007, IEEE T BIOMED CIRC S, V1, P193, DOI 10.1109/TBCAS.2007.913130; Kiani M, 2011, IEEE T BIOMED CIRC S, V5, P579, DOI 10.1109/TBCAS.2011.2158431; Luo YT, 2014, SCI REP-UK, V4, DOI 10.1038/srep04332; Mohan SS, 1999, IEEE J SOLID-ST CIRC, V34, P1419, DOI 10.1109/4.792620; Nagashima T, 2014, IEEE INT SYMP CIRC S, P113, DOI 10.1109/ISCAS.2014.6865078; Qusba A, 2014, IEEE SENS J, V14, P1074, DOI 10.1109/JSEN.2013.2293096; Ramo S., 1994, FIELDS WAVES COMMUNI, Vthird; Reinhold C., 2007, J COMMUNICATIONS, V2, P14, DOI DOI 10.4304/jcm.2.6.14-23; Sample AP, 2011, IEEE T IND ELECTRON, V58, P544, DOI 10.1109/TIE.2010.2046002; Strommer E., 2012, Proceedings of the 2012 4th International Workshop on Near Field Communication (NFC), P36, DOI 10.1109/NFC.2012.17; Tierney BB, 2014, IEEE T ANTENN PROPAG, V62, P3310, DOI 10.1109/TAP.2014.2314305; Waffenschmidt E, 2009, EPE: 2009 13TH EUROPEAN CONFERENCE ON POWER ELECTRONICS AND APPLICATIONS, VOLS 1-9, P3538; Zhong WX, 2013, IEEE T IND ELECTRON, V60, P261, DOI 10.1109/TIE.2011.2171176	28	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0148808	10.1371/journal.pone.0148808	http://dx.doi.org/10.1371/journal.pone.0148808			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890878	Green Published, gold			2022-12-27	WOS:000371221500013
J	Liu, W; Wang, DM; Liu, JJ; Li, DW; Yin, DX				Liu, Wei; Wang, Dongmei; Liu, Jianjun; Li, Dengwu; Yin, Dongxue			Quality Evaluation of Potentilla fruticosa L. by High Performance Liquid Chromatography Fingerprinting Associated with Chemometric Methods	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; ANTIOXIDANT ACTIVITY; COMPONENT ANALYSIS; EXTRACTION; SINENSIS; PARTS	The present study was performed to assess the quality of Potentilla fruticosa L. sampled from distinct regions of China using high performance liquid chromatography (HPLC) fingerprinting coupled with a suite of chemometric methods. For this quantitative analysis, the main active phytochemical compositions and the antioxidant activity in P. fruticosa were also investigated. Considering the high percentages and antioxidant activities of phytochemicals, P. fruticosa samples from Kangding, Sichuan were selected as the most valuable raw materials. Similarity analysis (SA) of HPLC fingerprints, hierarchical cluster analysis (HCA), principle component analysis (PCA), and discriminant analysis (DA) were further employed to provide accurate classification and quality estimates of P. fruticosa. Two principal components (PCs) were collected by PCA. PC1 separated samples from Kangding, Sichuan, capturing 57.64% of the variance, whereas PC2 contributed to further separation, capturing 18.97% of the variance. Two kinds of discriminant functions with a 100% discrimination ratio were constructed. The results strongly supported the conclusion that the eight samples from different regions were clustered into three major groups, corresponding with their morphological classification, for which HPLC analysis confirmed the considerable variation in phytochemical compositions and that P. fruticosa samples from Kangding, Sichuan were of high quality. The results of SA, HCA, PCA, and DA were in agreement and performed well for the quality assessment of P. fruticosa. Consequently, HPLC fingerprinting coupled with chemometric techniques provides a highly flexible and reliable method for the quality evaluation of traditional Chinese medicines.	[Liu, Wei; Wang, Dongmei; Li, Dengwu] Northwest A&F Univ, Coll Forestry, Yangling, Peoples R China; [Liu, Wei] Henan Univ Sci & Technol, Coll Agr, Luoyang, Peoples R China; [Liu, Jianjun] Northwest A&F Univ, Coll Landscape Architecture & Arts, Yangling, Peoples R China; [Yin, Dongxue] Henan Univ Sci & Technol, Coll Agr Engn, Luoyang, Peoples R China	Northwest A&F University - China; Henan University of Science & Technology; Northwest A&F University - China; Henan University of Science & Technology	Li, DW (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Peoples R China.; Yin, DX (corresponding author), Henan Univ Sci & Technol, Coll Agr Engn, Luoyang, Peoples R China.	dengwuli@163.com; milk2egg@163.com			Forestry Research Foundation for the Public Service Industry of China [200904004]	Forestry Research Foundation for the Public Service Industry of China	This work was supported by the program from the Forestry Research Foundation for the Public Service Industry of China (Grant numbers: 200904004; http://english.forestry.gov.cn/web/index.do). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Salces RM, 2005, FOOD CHEM, V91, P91, DOI 10.1016/j.foodchem.2004.05.049; Aryayeva M. M., 1999, Rastitel'nye Resursy, V35, P91; Bai DY, 2007, CHINESE AGR SCI B, V23, P371; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bergeron C, 1998, PHYTOCHEMISTRY, V49, P233, DOI 10.1016/S0031-9422(97)00878-9; BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; BRATCHELL N, 1989, CHEMOMETR INTELL LAB, V6, P105, DOI 10.1016/0169-7439(87)80054-0; Chen C, 2009, CHINESE J ANAL LAB, V28, P54; Davidson CG, 1995, ACTA HORTIC, P157, DOI 10.17660/ActaHortic.1995.413.24; Faria AF, 2011, FOOD CHEM, V126, P1571, DOI 10.1016/j.foodchem.2010.12.007; FEDOSEEVA GM, 1979, KHIM PRIR SOEDIN+, P575; Feng Y, 2001, TALANTA, V53, P1155, DOI 10.1016/S0039-9140(00)00594-4; Feng Y, 2006, ARTIF INTELL MED, V38, P219, DOI 10.1016/j.artmed.2006.07.005; Flora of China Editorial Committee, 2003, FLORA CHINA, V9; Fuglevand G, 1996, PLANT CELL, V8, P2347, DOI 10.1105/tpc.8.12.2347; GANENKO TV, 1988, KHIM PRIR SOEDIN+, P451; Gouveia S, 2012, PHYTOCHEM ANALYSIS, V23, P72, DOI 10.1002/pca.1326; Harwood M, 2007, FOOD CHEM TOXICOL, V45, P2179, DOI 10.1016/j.fct.2007.05.015; Heim KE, 2002, J NUTR BIOCHEM, V13, P572, DOI 10.1016/S0955-2863(02)00208-5; Helrich KC., 1965, OFFICIAL METHODS OF, V2; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Kalil SJ, 2000, PROCESS BIOCHEM, V35, P539, DOI 10.1016/S0032-9592(99)00101-6; Li BY, 2004, ANAL CHIM ACTA, V514, P69, DOI 10.1016/j.aca.2004.03.041; Li FM, 2006, CHIN J CHROMATOGR, V24, P537, DOI 10.1016/S1872-2059(06)60022-9; Li H. C., 2007, J W CHINA FORESTRY S, V36, P71; Li W, 2007, J PHARMACEUT BIOMED, V45, P38, DOI 10.1016/j.jpba.2007.05.027; Miliauskas G, 2007, MEAT SCI, V77, P703, DOI 10.1016/j.meatsci.2007.05.026; Miliauskas G, 2004, J SCI FOOD AGR, V84, P1997, DOI 10.1002/jsfa.1914; Ni YN, 2009, ANAL CHIM ACTA, V647, P149, DOI 10.1016/j.aca.2009.06.021; Nkiliza J, 1997, Fr Patent Appl, Patent No. [FR2749303A1, 2749303]; Nuntanakorn P, 2007, PHYTOCHEM ANALYSIS, V18, P219, DOI 10.1002/pca.975; Nyambaka H, 2004, TALANTA, V64, P23, DOI 10.1016/j.talanta.2004.02.037; Ong ES, 2002, J SEP SCI, V25, P825, DOI 10.1002/1615-9314(20020901)25:13&lt;825::AID-JSSC825&gt;3.0.CO;2-; Peng L, 2011, FOOD CHEM, V125, P1064, DOI 10.1016/j.foodchem.2010.09.079; Pierce KM, 2006, TALANTA, V70, P797, DOI 10.1016/j.talanta.2006.01.038; Qian K, 2011, FOOD CHEM, V127, P722, DOI 10.1016/j.foodchem.2010.12.132; Robards K, 1999, FOOD CHEM, V66, P401, DOI 10.1016/S0308-8146(99)00093-X; Sagdic O, 2011, FOOD CHEM, V126, P1749, DOI 10.1016/j.foodchem.2010.12.075; Shi XM, 2008, WORLD J MICROB BIOT, V24, P2443, DOI 10.1007/s11274-008-9766-7; Singleton VL., 1965, AM J ENOL VITICULT, V16, P144, DOI DOI 10.12691/IJEBB-2-1-5; Tomczyk M, 2010, MOLECULES, V15, P4639, DOI 10.3390/molecules15074639; Tomczyk M, 2009, J ETHNOPHARMACOL, V122, P184, DOI 10.1016/j.jep.2008.12.022; Wan JB, 2006, J PHARMACEUT BIOMED, V41, P1596, DOI 10.1016/j.jpba.2006.01.058; Wang DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096329; Wang S, 2007, TALANTA, V72, P434, DOI 10.1016/j.talanta.2006.11.006; Wannes WA, 2010, FOOD CHEM TOXICOL, V48, P1362, DOI 10.1016/j.fct.2010.03.002; WHO, 2000, GEN GUID METH RES EV; Xu SJ, 2009, J CHROMATOGR A, V1216, P2163, DOI 10.1016/j.chroma.2008.04.064; Yang DF, 2007, CHROMATOGRAPHIA, V66, P509, DOI 10.1365/s10337-007-0359-7; Yang J, 2007, J SEP SCI, V30, P1276, DOI 10.1002/jssc.200600389; Yang LC, 2013, J AGR FOOD CHEM, V61, P1772, DOI 10.1021/jf3042825; Yanhuaia Liu, 2004, World Patent Information, V26, P91, DOI 10.1016/S0172-2190(03)00110-8; YU RQ, 1992, CHEMOMETR INTELL LAB, V14, P23, DOI 10.1016/0169-7439(92)80090-Q; Yuan R, 2000, PHARMACOL THERAPEUT, V86, P191, DOI 10.1016/S0163-7258(00)00039-5; Zhang P, 2005, CHEM PHARM BULL, V53, P1582, DOI 10.1248/cpb.53.1582; Zhang YG, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0109159, 10.1371/journal.pone.0105725, 10.1371/journal.pone.0093458, 10.1371/journal.pone.0088491]; Zou YP, 2004, J AGR FOOD CHEM, V52, P5032, DOI 10.1021/jf049571r	58	14	14	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149197	10.1371/journal.pone.0149197	http://dx.doi.org/10.1371/journal.pone.0149197			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890416	Green Submitted, Green Published, gold			2022-12-27	WOS:000371221500025
J	Yamamoto, S; Matsushita, Y; Nakagawa, T; Honda, T; Hayashi, T; Noda, M; Mizoue, T				Yamamoto, Shuichiro; Matsushita, Yumi; Nakagawa, Toru; Honda, Toru; Hayashi, Takeshi; Noda, Mitsuhiko; Mizoue, Tetsuya			Visceral Fat Accumulation, Insulin Resistance, and Elevated Depressive Symptoms in Middle-Aged Japanese Men	PLOS ONE			English	Article							ADIPOSE-TISSUE; COMORBID DEPRESSION; WAIST CIRCUMFERENCE; MAJOR DEPRESSION; ABDOMINAL FAT; RISK-FACTOR; OBESITY; INFLAMMATION; ASSOCIATION; ADULTS	Objective To investigate visceral fat accumulation and markers of insulin resistance in relation to elevated depressive symptoms (EDS). Methods Participants were 4,333 male employees (mean age, 49.3 years) who underwent abdominal computed tomography scanning, measured fasting insulin, and did not self-report diabetes and mental disorders under treatment and history of cancer, myocardial infarction, and stroke. Multivariable logistic regression was used to assess the association of EDS with abdominal fat deposition and markers of insulin resistance. Results Visceral fat area (VFA) and fasting insulin were significantly, positively associated with EDS. Multivariable-adjusted odds ratios (95% confidence interval) of high VFA for the lowest through highest quartile of depression score were 1 (reference), 1.18 (0.97-1.42), 1.25 (1.02-1.54), 1.23 (1.01-1.51), respectively, and corresponding figures for high fasting insulin were 1 (reference), 0.98 (0.80-1.19), 1.12 (0.91-1.38), and 1.29 (1.06-1.57), respectively. Subcutaneous fat area was not associated with EDS. Conclusions Results suggest that EDS is related to visceral, but not subcutaneous, fat accumulation and insulin resistance in middle-aged Japanese men.	[Yamamoto, Shuichiro; Nakagawa, Toru; Honda, Toru; Hayashi, Takeshi] Hitachi Ltd, Hitachi Hlth Care Ctr, Occupat Hlth Sect, Hitachi, Ibaraki, Japan; [Matsushita, Yumi] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Clin Res, Shinjuku Ku, Tokyo, Japan; [Noda, Mitsuhiko] Saitama Med Univ, Dept Endocrinol & Diabet, Saitama, Japan; [Mizoue, Tetsuya] Natl Ctr Global Hlth & Med, Ctr Clin Sci, Dept Epidemiol & Prevent, Shinjuku Ku, Tokyo, Japan	Hitachi Limited; National Center for Global Health & Medicine - Japan; Saitama Medical University; National Center for Global Health & Medicine - Japan	Yamamoto, S (corresponding author), Hitachi Ltd, Hitachi Hlth Care Ctr, Occupat Hlth Sect, Hitachi, Ibaraki, Japan.	shuichiro.yamamoto.sr@hitachi.com	Noda, Mitsuhiko/W-3905-2019	Noda, Mitsuhiko/0000-0003-0413-4631	Ministry of Health, Labor and Welfare of Japan; Industrial Health Foundation; Japan Society for the Promotion of Science [KAKENHI 25293146]; Hitachi, Ltd.	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Industrial Health Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hitachi, Ltd.	This work was supported by Ministry of Health, Labor and Welfare of Japan: YM (http://www.mhlw.go.jp/english/); Industrial Health Foundation: TM (http://www.ihf.or.jp/); and Japan Society for the Promotion of Science: TM, KAKENHI 25293146 (http://www.jsps.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Hitachi, Ltd. provided support in the form of salaries for authors SY, TN, TH, and TH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ajilore O, 2007, NEUROPSYCHOPHARMACOL, V32, P1224, DOI 10.1038/sj.npp.1301248; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Cohen S, 2012, P NATL ACAD SCI USA, V109, P5995, DOI 10.1073/pnas.1118355109; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Engstrom G, 2003, DIABETES, V52, P2097, DOI 10.2337/diabetes.52.8.2097; Everson-Rose SA, 2009, PSYCHOSOM MED, V71, P410, DOI 10.1097/PSY.0b013e3181a20c9c; Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751; Herva A, 2006, INT J OBESITY, V30, P520, DOI 10.1038/sj.ijo.0803174; Hsieh CJ, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-49; Huber JD, 2008, CURR PHARM DESIGN, V14, P1594, DOI 10.2174/138161208784705441; Kadowaki T, 2006, INT J OBESITY, V30, P1163, DOI 10.1038/sj.ijo.0803248; Kahl KG, 2005, PSYCHOSOM MED, V67, P407, DOI 10.1097/01.psy.0000160458.95955.f4; Kan C, 2013, DIABETES CARE, V36, P480, DOI 10.2337/dc12-1442; Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668; Kivimaki M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3765; Lawlor DA, 2005, BRIT MED J, V330, P705, DOI 10.1136/bmj.38377.616921.F7; Lovell GP, 2015, NURS HEALTH SCI, V17, P134, DOI 10.1111/nhs.12147; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Masand Prakash S, 2002, Ann Clin Psychiatry, V14, P175, DOI 10.3109/10401230209147454; Matsushita Y, 2010, DIABETES CARE, V33, P2117, DOI 10.2337/dc10-0120; Miller GE, 2002, AM J CARDIOL, V90, P1279, DOI 10.1016/S0002-9149(02)02863-1; Murabito JM, 2013, OBESITY, V21, P1713, DOI 10.1002/oby.20130; Pearson S, 2010, DIABETES CARE, V33, P1128, DOI 10.2337/dc09-1940; PEDERSEN SB, 1994, J CLIN ENDOCR METAB, V78, P1354, DOI 10.1210/jc.78.6.1354; Preis SR, 2010, OBESITY, V18, P2191, DOI 10.1038/oby.2010.59; Pyykkonen AJ, 2011, DIABETES CARE, V34, P2545, DOI 10.2337/dc11-0107; REBUFFESCRIVE M, 1990, J CLIN ENDOCR METAB, V71, P1215, DOI 10.1210/jcem-71-5-1215; Remigio-Baker RA, 2014, PSYCHONEUROENDOCRINO, V47, P78, DOI 10.1016/j.psyneuen.2014.05.004; Rivenes AC, 2009, J PSYCHOSOM RES, V66, P269, DOI 10.1016/j.jpsychores.2008.07.012; Roos C, 2007, METABOLISM, V56, P825, DOI 10.1016/j.metabol.2007.01.013; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Talbot F, 2000, DIABETES CARE, V23, P1556, DOI 10.2337/diacare.23.10.1556; Thakore JH, 1997, BIOL PSYCHIAT, V41, P1140, DOI 10.1016/S0006-3223(97)85394-2; Vogelzangs N, 2010, J CLIN PSYCHIAT, V71, P391, DOI 10.4088/JCP.08m04743blu; Walker B R, 2001, Growth Horm IGF Res, V11 Suppl A, pS91, DOI 10.1016/S1096-6374(01)80015-0; Yakura N., 2009, ASIA PAC J DIS MANAG, V3, P21, DOI [10.7223/apjdm.3.21, DOI 10.7223/APJDM.3.21]; Yamamoto S, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.27; Yokoyama K, 2015, PSYCHIAT RES, V226, P494, DOI 10.1016/j.psychres.2015.01.026; Zhao GX, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-130	44	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149436	10.1371/journal.pone.0149436	http://dx.doi.org/10.1371/journal.pone.0149436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891344	Green Submitted, Green Published, gold			2022-12-27	WOS:000371221500047
J	Carmenta, R; Blackburn, GA; Davies, G; de Sassi, C; Lima, A; Parry, L; Tych, W; Barlow, J				Carmenta, Rachel; Blackburn, George Alan; Davies, Gemma; de Sassi, Claudio; Lima, Andre; Parry, Luke; Tych, Wlodek; Barlow, Jos			Does the Establishment of Sustainable Use Reserves Affect Fire Management in the Humid Tropics?	PLOS ONE			English	Article							PROTECTED AREAS; LAND-USE; CLIMATE-CHANGE; DEFORESTATION; AMAZON; FORESTS; CONSERVATION; VARIABILITY; PREVENTION; CARBON	Tropical forests are experiencing a growing fire problem driven by climatic change, agricultural expansion and forest degradation. Protected areas are an important feature of forest protection strategies, and sustainable use reserves (SURs) may be reducing fire prevalence since they promote sustainable livelihoods and resource management. However, the use of fire in swidden agriculture, and other forms of land management, may be undermining the effectiveness of SURs in meeting their conservation and sustainable development goals. We analyse MODIS derived hot pixels, TRMM rainfall data, Terra-Class land cover data, socio-ecological data from the Brazilian agro-census and the spatial extent of rivers and roads to evaluate whether the designation of SURs reduces fire occurrence in the Brazilian Amazon. Specifically, we ask (1) a. Is SUR location (i.e., de facto) or (1) b. designation (i.e. de jure) the driving factor affecting performance in terms of the spatial density of fires?, and (2), Does SUR creation affect fire management (i.e., the timing of fires in relation to previous rainfall)? We demonstrate that pre-protection baselines are crucial for understanding reserve performance. We show that reserve creation had no discernible impact on fire density, and that fires were less prevalent in SURs due to their characteristics of sparser human settlement and remoteness, rather than their status de jure. In addition, the timing of fires in relation to rainfall, indicative of local fire management and adherence to environmental law, did not improve following SUR creation. These results challenge the notion that SURs promote environmentally sensitive fire-management, and suggest that SURs in Amazonia will require special attention if they are to curtail future accidental wildfires, particularly as plans to expand the road infrastructure throughout the region are realised. Greater investment to support improved fire management by farmers living in reserves, in addition to other fire users, will be necessary to help ameliorate these threats.	[Carmenta, Rachel] Ctr Int Forestry Res, Forests & Governance, Bogor, West Java, Indonesia; [Carmenta, Rachel; Blackburn, George Alan; Davies, Gemma; Parry, Luke; Tych, Wlodek; Barlow, Jos] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England; [de Sassi, Claudio] Forests & Livelihoods, Ctr Int Forestry Res, Bogor, West Java, Indonesia; [Lima, Andre] Natl Inst Space Res, Sao Jose Dos Campos, SP, Brazil	CGIAR; Center for International Forestry Research (CIFOR); Lancaster University; CGIAR; Center for International Forestry Research (CIFOR); Instituto Nacional de Pesquisas Espaciais (INPE)	Carmenta, R (corresponding author), Ctr Int Forestry Res, Forests & Governance, Bogor, West Java, Indonesia.; Carmenta, R (corresponding author), Univ Lancaster, Lancaster Environm Ctr, Lancaster, England.	rachelcarmenta@gmail.com	Tych, Wlodek/K-6510-2012; Barlow, Jos/HGE-9486-2022; Barlow, Jos/E-7861-2014; Parry, Luke/ABD-4194-2021	Tych, Wlodek/0000-0003-1655-844X; Parry, Luke/0000-0003-0330-9516; Davies, Gemma/0000-0002-7420-2479; Carmenta, Rachel/0000-0001-8607-4147; De Sassi, Claudio/0000-0002-8811-7347	Natural Environment Research Council and Economic and Social Research Council (NERC-ESRC) [ES/F012500/1]; Darwin Initiative [17-023]; Instituto Nacional de Ciencia e Tecnologia - Biodiversidade e Uso da Terra na Amazonia [CNPq 574008/2008-0]; Norwegian Agency for Development Cooperation; Australian Agency for International Development; Natural Environment Research Council [ceh010010] Funding Source: researchfish	Natural Environment Research Council and Economic and Social Research Council (NERC-ESRC); Darwin Initiative; Instituto Nacional de Ciencia e Tecnologia - Biodiversidade e Uso da Terra na Amazonia; Norwegian Agency for Development Cooperation; Australian Agency for International Development; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by the Natural Environment Research Council and Economic and Social Research Council (NERC-ESRC grant ES/F012500/1 : RC), the Darwin Initiative (17-023: JB, LP, RC) (http://www.darwininitiative.org.uk/), the Instituto Nacional de Ciencia e Tecnologia - Biodiversidade e Uso da Terra na Amazonia (CNPq 574008/2008-0: JB, LP, RC) (http://inct.cnpq.br/web/inct-biodiversidade-e-uso-da-terra-na-amazonia), the Norwegian Agency for Development Cooperation (http://www.norad.no/en/front-page: RC), and the Australian Agency for International Development (www.ausaid.gov.au: RC).	Adeney JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005014; Aldersley A, 2011, SCI TOTAL ENVIRON, V409, P3472, DOI 10.1016/j.scitotenv.2011.05.032; Alencar A, 2011, ECOL APPL, V21, P2397, DOI 10.1890/10-1168.1; Amaral S, 2012, POPUL ENVIRON, V34, P142, DOI 10.1007/s11111-012-0168-2; [Anonymous], 2010, THE CAPTAIN TOOLBOX; Aragao LEOC, 2008, PHILOS T R SOC B, V363, P1779, DOI 10.1098/rstb.2007.0026; Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946., 10.1029/2006GL028946]; Armenteras D, 2009, BIOL CONSERV, V142, P1411, DOI 10.1016/j.biocon.2009.02.002; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Barber CP, 2012, BIOL CONSERV, V149, P6, DOI 10.1016/j.biocon.2011.08.024; Barlow J, 2006, BIOL CONSERV, V128, P182, DOI 10.1016/j.biocon.2005.09.028; Barlow J, 2012, BIOL CONSERV, V154, P1, DOI 10.1016/j.biocon.2012.03.034; Berenguer E, 2014, GLOBAL CHANGE BIOL, V20, P3713, DOI 10.1111/gcb.12627; Biswas S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124346; Bowman MS, 2008, ECOL ECON, V67, P117, DOI 10.1016/j.ecolecon.2007.12.003; Brando PM, 2014, P NATL ACAD SCI USA, V111, P6347, DOI 10.1073/pnas.1305499111; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Bueno MCD, 2011, EUR FOR GEOSTATISTIC; Cardoso Catarina, 2002, EXTRACTIVE RESERVES; Carmenta R, 2013, EARTH OBSERVATIONS E; Carmenta R, 2013, HUM ECOL, V41, P603, DOI 10.1007/s10745-013-9600-1; Carmenta R, 2011, ECOL SOC, V16; Carr DL, 2009, POPUL ENVIRON, V30, P222, DOI 10.1007/s11111-009-0090-4; Chen Y, 2011, SCIENCE, V334, P787, DOI 10.1126/science.1209472; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; Cox PM, 2004, THEOR APPL CLIMATOL, V78, P137, DOI 10.1007/s00704-004-0049-4; de Mendonca MJC, 2004, ECOL ECON, V49, P89, DOI 10.1016/j.ecolecon.2003.11.011; de Vasconcelos SS, 2013, REMOTE SENS ENVIRON, V136, P199, DOI 10.1016/j.rse.2013.05.005; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; Ehringhaus C, 2005, POSTVICTORY DILEMMAS; Fearnside PM, 2007, ENVIRON MANAGE, V39, P601, DOI 10.1007/s00267-006-0149-2; Fearnside PM, 2012, NOVOS CAD NAEA, V15, P25; Ferraro PJ, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/025011; Ferreira J, 2014, SCIENCE, V346, P706, DOI 10.1126/science.1260194; FIRMS, 2012, FIR INF RES MAN SYST; Foundation TI, 2014, INGA FDN RESTORING L; Giglio L, 2003, REMOTE SENS ENVIRON, V87, P273, DOI 10.1016/S0034-4257(03)00184-6; Herrera D, 2013, IMPACTS BRAZILIAN AM; Houghton RA, 2000, NATURE, V403, P301, DOI 10.1038/35002062; Imbens GW, 2009, J ECON LIT, V47, P5, DOI 10.1257/jel.47.1.5; Jolly WM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8537; Joppa L, 2010, ANN NY ACAD SCI, V1185, P135, DOI 10.1111/j.1749-6632.2009.05162.x; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; McDaniel J, 2005, SOC NATUR RESOUR, V18, P921, DOI 10.1080/08941920500248921; Monzon-Alvarado C, 2014, LAND USE POLICY, V39, P12, DOI 10.1016/j.landusepol.2014.03.003; Morton DC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0163; Nelson A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022722; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Nepstad DC, 2008, PHILOS T R SOC B, V363, P1737, DOI 10.1098/rstb.2007.0036; Nolte C, 2013, CONSERV BIOL, V27, P155, DOI 10.1111/j.1523-1739.2012.01930.x; Ostrom, 2015, GOVERNING COMMONS EV, DOI DOI 10.1017/CBO9780511807763; Parry L, 2010, CONSERV LETT, V3, P251, DOI 10.1111/j.1755-263X.2010.00106.x; Peres CA, 2003, CONSERV BIOL, V17, P521, DOI 10.1046/j.1523-1739.2003.01413.x; Peres CA, 2011, CONSERV BIOL, V25, P1124, DOI 10.1111/j.1523-1739.2011.01770.x; Peskett L, 2011, ENVIRON SCI POLICY, V14, P216, DOI 10.1016/j.envsci.2010.10.004; Pinheiro J, R PACKAGE VERSION; Rayn D, 2011, BIODIVERS CONSERV, V20, P1625, DOI 10.1007/s10531-011-0051-y; Rodriguez N, 2013, REG ENVIRON CHANGE, V13, P423, DOI 10.1007/s10113-012-0356-8; Roman-Cuesta RM, 2006, CONSERV BIOL, V20, P1074, DOI 10.1111/j.1523-1739.2006.00478.x; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schroeder W, 2008, REMOTE SENS ENVIRON, V112, P2711, DOI 10.1016/j.rse.2008.01.005; Schwartz NB, 2015, CLIMATE LANDOWNER RE, P144; Schwartzman S, 2000, CONSERV BIOL, V14, P1351, DOI 10.1046/j.1523-1739.2000.99329.x; Shaw E.M., 2010, HYDROLOGY PRACTICE, V4th; Silva MM, 2006, REV BRASILEIRA AGROE, V1; Silvestrini RA, 2011, ECOL APPL, V21, P1573, DOI 10.1890/10-0827.1; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Stolle F, 2004, INT J REMOTE SENS, V25, P471, DOI 10.1080/01431160310001618022; UHL C, 1985, BIOTROPICA, V17, P265, DOI 10.2307/2388588; Vadjunec JM, 2009, ECOL SOC, V14; Verissimo A, 2011, AREAS PROTEGIDAS AMA; Wong D., 2009, SAGE HDB SPATIAL ANA, P105, DOI DOI 10.4135/9780857020130.N7	74	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149292	10.1371/journal.pone.0149292	http://dx.doi.org/10.1371/journal.pone.0149292			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886207	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000371218400074
J	Gaastra, GF; Groen, Y; Tucha, L; Tucha, O				Gaastra, Geraldina F.; Groen, Yvonne; Tucha, Lara; Tucha, Oliver			The Effects of Classroom Interventions on Off-Task and Disruptive Classroom Behavior in Children with Symptoms of Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review	PLOS ONE			English	Review							DEFICIT HYPERACTIVITY DISORDER; SELF-MANAGEMENT; FOLLOW-UP; ADHD; STUDENTS; OUTCOMES; METHYLPHENIDATE; PREVALENCE; IMPROVE; YOUTH	Children with attention-deficit/hyperactivity disorder (ADHD) often exhibit problem behavior in class, which teachers often struggle to manage due to a lack of knowledge and skills to use classroom management strategies. The aim of this meta-analytic review was to determine the effectiveness of several types of classroom interventions (antecedent-based, consequence-based, self-regulation, combined) that can be applied by teachers in order to decrease off-task and disruptive classroom behavior in children with symptoms of ADHD. A second aim was to identify potential moderators (classroom setting, type of measure, students' age, gender, intelligence, and medication use). Finally, it was qualitatively explored whether the identified classroom interventions also directly or indirectly affected behavioral and academic outcomes of classmates. Separate meta-analyses were performed on standardized mean differences (SMDs) for 24 within-subjects design (WSD) and 76 single-subject design (SSD) studies. Results showed that classroom interventions reduce off-task and disruptive classroom behavior in children with symptoms of ADHD (WSDs: M-SMD = 0.92; SSDs: M-SMD = 3.08), with largest effects for consequence-based (WSDs: M-SMD = 1.82) and self-regulation interventions (SSDs: M-SMD = 3.61). Larger effects were obtained in general education classrooms than in other classroom settings. No reliable conclusions could be formulated about moderating effects of type of measure and students' age, gender, intelligence, and medication use, mainly because of power problems. Finally, classroom interventions appeared to also benefit classmates' behavioral and academic outcomes.	[Gaastra, Geraldina F.; Groen, Yvonne; Tucha, Lara; Tucha, Oliver] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands	University of Groningen	Gaastra, GF (corresponding author), Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands.	g.f.gaastra@rug.nl	Tucha, Oliver/AAD-1403-2019	Groen, Yvonne/0000-0002-7242-0317	Nationaal Regieorgaan Onderwijsonderzoek (NRO) [411-12-241]	Nationaal Regieorgaan Onderwijsonderzoek (NRO)	This work was funded by the Nationaal Regieorgaan Onderwijsonderzoek (NRO); 411-12-241; (http://www.nro.nl/); YG LT OT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Arcia E., 2000, J ATTEN DISORD, V4, P91, DOI [10.1177/108705470000400203, DOI 10.1177/108705470000400203]; Barkley RA, 2015, ATTENTION-DEFICIT HYPERACTIVITY DISORDER IN ADULTS AND CHILDREN, P53; BECKER BJ, 1988, BRIT J MATH STAT PSY, V41, P257, DOI 10.1111/j.2044-8317.1988.tb00901.x; Busk PL, 1992, METAANALYSIS SINGLE, P187; CAMPBELL SB, 1977, J CHILD PSYCHOL PSYC, V18, P239, DOI 10.1111/j.1469-7610.1977.tb00436.x; Cohen J.E., 1988, STAT POWER ANAL BEHA; Davies S, 2000, PSYCHOL SCHOOLS, V37, P135, DOI 10.1002/(SICI)1520-6807(200003)37:2<135::AID-PITS5>3.3.CO;2-L; DuPaul G, 1997, SCHOOL PSYCHOL REV, V26, P5; DuPaul G.J., 2014, ADHD SCH ASSESSMENT, V3rd ed.; DuPaul GJ, 2012, SCHOOL PSYCHOL REV, V41, P387; DuPaul GJ, 1998, J APPL BEHAV ANAL, V31, P579, DOI 10.1901/jaba.1998.31-579; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Evans SW, 2005, J ABNORM CHILD PSYCH, V33, P695, DOI 10.1007/s10802-005-7648-0; Faith MS, 1996, METAANALYSIS SINGLE, P245; Fedewa AL, 2011, AM J OCCUP THER, V65, P393, DOI 10.5014/ajot.2011.000554; Frazier TW, 2007, J LEARN DISABIL-US, V40, P49, DOI 10.1177/00222194070400010401; Greene RW, 2002, J EMOT BEHAV DISORD, V10, P79, DOI 10.1177/10634266020100020201; Gualtieri CT, 2008, J ATTEN DISORD, V11, P459, DOI 10.1177/1087054707305314; HEDGES LV, 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Hedges LV, 1981, J EDUC STAT, V6, P107, DOI [10.2307/1164588, DOI 10.2307/1164588, 10.3102/10769986006002107]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoff KE, 2013, PSYCHOL SCHOOLS, V50, P151, DOI 10.1002/pits.21666; Hong YH, 2008, EARLY CHILD DEV CARE, V178, P399, DOI 10.1080/03004430701321829; JACOB RG, 1978, J ABNORM CHILD PSYCH, V6, P47, DOI 10.1007/BF00915781; Kofler MJ, 2008, J CHILD PSYCHOL PSYC, V49, P59, DOI 10.1111/j.1469-7610.2007.01809.x; Kratochwill TR, 2013, REM SPEC EDUC, V34, P26, DOI 10.1177/0741932512452794; Langberg JM, 2012, CLIN CHILD FAM PSYCH, V15, P215, DOI 10.1007/s10567-012-0117-8; Lauth GW, 2006, BRIT J EDUC PSYCHOL, V76, P385, DOI 10.1348/000709905X43797; Lipsey MW, 2001, PRACTICAL META ANAL, DOI DOI 10.1016/J.AUTNEU.2007.06.087; Lo YY, 2006, BEHAV DISORDERS, V31, P147; Loe IM, 2007, J PEDIATR PSYCHOL, V32, P643, DOI 10.1093/jpepsy/jsl054; MAAG JW, 1992, PSYCHOL SCHOOLS, V29, P157, DOI 10.1002/1520-6807(199204)29:2<157::AID-PITS2310290211>3.0.CO;2-F; Martin A.J., 2006, ASIA-PAC J TEACH EDU, V34, P73, DOI DOI 10.1080/13598660500480100; Miller FG, 2013, J BEHAV EDUC, V22, P253, DOI 10.1007/s10864-013-9174-4; Molina BSG, 2009, J AM ACAD CHILD PSY, V48, P484, DOI 10.1097/CHI.0b013e31819c23d0; Mulligan Shelley, 2001, Physical and Occupational Therapy in Pediatrics, V20, P25, DOI 10.1300/J006v20n04_03; Murray DW, 2011, J ATTEN DISORD, V15, P638, DOI 10.1177/1087054710378234; Orwin RG, 1983, J ED STAT, V8, P157, DOI [DOI 10.2307/1164923, 10.3102/10769986008002157]; Pelham WE, 2011, J ABNORM CHILD PSYCH, V39, P1085, DOI 10.1007/s10802-011-9529-z; Platzman K.A., 1992, SCHOOL PSYCHOL QUART, V7, P155, DOI [10.1037/h0088258, DOI 10.1037/H0088258]; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Prasad V, 2013, EUR CHILD ADOLES PSY, V22, P203, DOI 10.1007/s00787-012-0346-x; Purdie N, 2002, REV EDUC RES, V72, P61, DOI 10.3102/00346543072001061; Rafferty LA, 2011, BEHAV ANAL PRACT, V4, P37; Reichow B, 2008, J AUTISM DEV DISORD, V38, P1311, DOI 10.1007/s10803-007-0517-7; Reichow B, 2011, EVIDENCE-BASED PRACTICES AND TREATMENTS FOR CHILDREN WITH AUTISM, P25, DOI 10.1007/978-1-4419-6975-0_2; REID R, 1994, J SPEC EDUC, V28, P117, DOI 10.1177/002246699402800201; Reid R, 2005, EXCEPT CHILDREN, V71, P361; Ridgway A, 2003, SCHOOL PSYCHOL QUART, V18, P253, DOI 10.1521/scpq.18.3.253.22578; Sherman J, 2008, EDUC RES-UK, V50, P347, DOI 10.1080/00131880802499803; Smith B H, 2000, Clin Child Fam Psychol Rev, V3, P243, DOI 10.1023/A:1026477121224; Sonuga-Barke EJS, 2009, J CHILD ADOL PSYCHOP, V19, P683, DOI 10.1089/cap.2009.0024; Stein MA, 2003, PEDIATRICS, V112, pE404, DOI 10.1542/peds.112.5.e404; Taylor E, 2004, EUR CHILD ADOLES PSY, V13, P7, DOI 10.1007/s00787-004-1002-x; WHEELER J, 1994, J EMOT BEHAV DISORD, V2, P2, DOI 10.1177/106342669400200101; WHITE DM, 1989, BEHAV ASSESS, V11, P281; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8	58	33	34	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148841	10.1371/journal.pone.0148841	http://dx.doi.org/10.1371/journal.pone.0148841			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3BJ	26886218	gold, Green Published, Green Submitted			2022-12-27	WOS:000371218400052
J	Nordenskjold, AM; Hammar, P; Ahlstrom, H; Bjerner, T; Duvernoy, O; Eggers, KM; Frobert, O; Hadziosmanovic, N; Lindahl, B				Nordenskjold, Anna M.; Hammar, Per; Ahlstrom, Hakan; Bjerner, Tomas; Duvernoy, Olov; Eggers, Kai M.; Frobert, Ole; Hadziosmanovic, Nermin; Lindahl, Bertil			Unrecognized Myocardial Infarction Assessed by Cardiac Magnetic Resonance Imaging - Prognostic Implications	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; TERM INDIVIDUAL VARIATION; PREVALENCE; PROGRESSION; ISCHEMIA; FREQUENT; EVENTS; SCAR; MRI	Background Clinically unrecognized myocardial infarctions (UMI) are not uncommon and may be associated with adverse outcome. The aims of this study were to determine the prognostic implication of UMI in patients with stable suspected coronary artery disease (CAD) and to investigate the associations of UMI with the presence of CAD. Methods and Findings In total 235 patients late gadolinium enhancement cardiovascular magnetic resonance (LGE-CMR) imaging and coronary angiography were performed. For each patient with UMI, the stenosis grade of the coronary branch supplying the infarcted area was determined. UMIs were present in 25% of the patients and 67% of the UMIs were located in an area supplied by a coronary artery with a stenosis grade >= 70%. In an age-and gender-adjusted model, UMI independently predicted the primary endpoint (composite of death, myocardial infarction, resuscitated cardiac arrest, hospitalization for unstable angina pectoris or heart failure within 2 years of follow-up) with an odds ratio of 2.9; 95% confidence interval 1.1-7.9. However, this association was abrogated after adjustment for age and presence of significant coronary disease. There was no difference in the primary endpoint rates between UMI patients with or without a significant stenosis in the corresponding coronary artery. Conclusions The presence of UMI was associated with a threefold increased risk of adverse events during follow up. However, the difference was no longer statistically significant after adjustments for age and severity of CAD. Thus, the results do not support that patients with suspicion of CAD should be routinely investigated by LGE-CMR for UMI. However, coronary angiography should be considered in patients with UMI detected by LGE-CMR.	[Nordenskjold, Anna M.; Frobert, Ole] Univ Orebro, Fac Hlth, Dept Cardiol, SE-70182 Orebro, Sweden; [Hammar, Per] Vastmanland Hosp Vasteras, Dept Radiol, Vasteras, Sweden; [Ahlstrom, Hakan; Bjerner, Tomas; Duvernoy, Olov] Uppsala Univ, Dept Radiol Oncol & Radiat Sci, Uppsala, Sweden; [Eggers, Kai M.; Lindahl, Bertil] Uppsala Univ, Dept Med Sci, Cardiol, Uppsala, Sweden; [Hadziosmanovic, Nermin] Uppsala Clin Res Ctr, Uppsala, Sweden; [Nordenskjold, Anna M.] Univ Orebro, Fac Hlth, Dept Cardiol, Sodra Grev Rosengatan, SE-70182 Orebro, Sweden	Orebro University; Vasteras Central Hospital; Uppsala University; Uppsala University; Uppsala University; Orebro University	Nordenskjold, AM (corresponding author), Univ Orebro, Fac Hlth, Dept Cardiol, SE-70182 Orebro, Sweden.; Nordenskjold, AM (corresponding author), Univ Orebro, Fac Hlth, Dept Cardiol, Sodra Grev Rosengatan, SE-70182 Orebro, Sweden.	anna.nordenskjold@regionorebrolan.se	Bjerner, Tomas/GLQ-7331-2022	Frobert, Ole/0000-0002-5846-345X	Regional Research Council, Uppsala-Orebro region [RFR-84261]; Center for Clinical Research in Vastmanland from Bayer Pharmaceuticals Sweden; Swedish Research Council; Swedish Heart-Lung Foundation [20140486]	Regional Research Council, Uppsala-Orebro region; Center for Clinical Research in Vastmanland from Bayer Pharmaceuticals Sweden; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation)	This work was supported by Regional Research Council, Uppsala-Orebro region (RFR-84261); Center for Clinical Research in Vastmanland, an unrestricted grant from Bayer Pharmaceuticals Sweden; the Swedish Research Council (AH) and The Swedish Heart-Lung Foundation, grant number 20140486 (AMN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, Scand Cardiovasc J, V48 Suppl 63, P2, DOI 10.3109/14017431.2014.931551; Austen W G, 1975, Circulation, V51, P5; Barbier CE, 2006, J AM COLL CARDIOL, V48, P765, DOI 10.1016/j.jacc.2006.05.041; Barbier CE, 2011, J AM COLL CARDIOL, V58, P1372, DOI 10.1016/j.jacc.2011.06.028; Baron T, 2015, HEART, V101, P101, DOI 10.1136/heartjnl-2014-306093; Beatty AL, 2015, J AM HEART ASSOC, P4; BLACKBURN H, 1960, CIRCULATION, V21, P1160, DOI 10.1161/01.CIR.21.6.1160; Boland LL, 2002, AM J CARDIOL, V90, P927, DOI 10.1016/S0002-9149(02)02655-3; Burke AP, 2001, CIRCULATION, V103, P934; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; FALK E, 1989, AM J CARDIOL, V63, pE114, DOI 10.1016/0002-9149(89)90242-7; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Hammar P, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0202-5; Jost S, 1998, INT J CARDIOL, V65, P271, DOI 10.1016/S0167-5273(98)00138-7; Kehl DW, 2011, CLIN RES CARDIOL, V100, P359, DOI 10.1007/s00392-010-0255-2; Kim HW, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000057; Kwong RY, 2006, CIRCULATION, V113, P2733, DOI 10.1161/CIRCULATIONAHA.105.570648; Kwong Raymond Y, 2008, Top Magn Reson Imaging, V19, P15, DOI 10.1097/RMR.0B013e31817d550c; LICHTLEN PR, 1992, CIRCULATION, V86, P828, DOI 10.1161/01.CIR.86.3.828; Locca D, 2010, JACC-CARDIOVASC INTE, V3, P950, DOI 10.1016/j.jcin.2010.06.015; Mann J, 1999, HEART, V82, P265, DOI 10.1136/hrt.82.3.265; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Nagel E, 1999, CIRCULATION, V99, P763, DOI 10.1161/01.CIR.99.6.763; Nordenskjold AM, 2013, CLIN CHIM ACTA, V422, P15, DOI 10.1016/j.cca.2013.03.025; Nordenskjold AM, 2013, CLIN CHEM, V59, P401, DOI 10.1373/clinchem.2012.191700; Ong P, 2008, J AM COLL CARDIOL, V52, P523, DOI 10.1016/j.jacc.2008.04.050; Pride YB, 2013, AM J CARDIOL, V111, P914, DOI 10.1016/j.amjcard.2012.11.042; Schelbert EB, 2012, JAMA-J AM MED ASSOC, V308, P890, DOI 10.1001/2012.jama.11089; Shibata T, 2015, CIRCULATION, V132, P241, DOI 10.1161/CIRCULATIONAHA.114.015134; Stergiopoulos K, 2014, JAMA INTERN MED, V174, P232, DOI 10.1001/jamainternmed.2013.12855; Turkbey EB, 2015, JAMA-J AM MED ASSOC, V314, P1945, DOI 10.1001/jama.2015.14849; Wagner A, 2003, LANCET, V361, P374, DOI 10.1016/S0140-6736(03)12389-6; Wu E, 2001, LANCET, V357, P21, DOI 10.1016/S0140-6736(00)03567-4	33	9	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148803	10.1371/journal.pone.0148803	http://dx.doi.org/10.1371/journal.pone.0148803			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885831	Green Published, Green Submitted, gold			2022-12-27	WOS:000371218400049
J	Routson, CC; Overpeck, JT; Woodhouse, CA; Kenney, WF				Routson, Cody C.; Overpeck, Jonathan T.; Woodhouse, Connie A.; Kenney, William F.			Three Millennia of Southwestern North American Dustiness and Future Implications	PLOS ONE			English	Article							WESTERN UNITED-STATES; DUST DEPOSITION; DESERT DUST; COLORADO; CLIMATE; LAKE; RECORD; ECOSYSTEMS; MOUNTAINS; IMPACTS	Two sediment records of dust deposition from Fish Lake, in southern Colorado, offer a new perspective on southwest United States (Southwest) aridity and dustiness over the last similar to 3000 years. Micro scanning X-ray fluorescence and grain size analysis provide separate measures of wind-deposited dust in the lake sediment. Together these new records confirm anomalous dustiness in the 19th and 20th centuries, associated with recent land disturbance, drought, and livestock grazing. Before significant anthropogenic influences, changes in drought frequency and aridity also generated atmospheric dust loading. Medieval times were associated with high levels of dustiness, coincident with widespread aridity. These records indicate the Southwest is naturally prone to dustiness. As global and regional temperatures rise and the Southwest shifts toward a more arid landscape, the Southwest will likely become dustier, driving negative impacts on snowpack and water availability, as well as human health.	[Routson, Cody C.] No Arizona Univ, Sch Earth Sci & Environm Sustainabil, 625 S Knoles Dr,POB 4099, Flagstaff, AZ 86011 USA; [Overpeck, Jonathan T.] Univ Arizona, Inst Environm, 1064 E Lowell St, Tucson, AZ 85721 USA; [Overpeck, Jonathan T.; Woodhouse, Connie A.] Univ Arizona, Dept Geosci, 1040 E 4th St,Room 208, Tucson, AZ 85721 USA; [Overpeck, Jonathan T.] Univ Arizona, Dept Atmospher Sci, 1118 E 4th St, Tucson, AZ 85721 USA; [Woodhouse, Connie A.] Univ Arizona, Sch Geog & Dev, 1064 E Lowell St, Tucson, AZ 85721 USA; [Woodhouse, Connie A.] Univ Arizona, Tree Ring Res Lab, 1215 E Lowell St, Tucson, AZ 85721 USA; [Kenney, William F.] Univ Florida, Land Use & Environm Change Inst, 241 Williamson Hall, Gainesville, FL 32611 USA	Northern Arizona University; University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Arizona; State University System of Florida; University of Florida	Routson, CC (corresponding author), No Arizona Univ, Sch Earth Sci & Environm Sustainabil, 625 S Knoles Dr,POB 4099, Flagstaff, AZ 86011 USA.	cody.routson@nau.edu			NOAA The Climate Program Office [NA11OAR4310162]; National Science Foundation; Science Foundation Arizona; NOAA; Colorado Scientific Society; University of Arizona Department of Geoscience; National Oceanic and Atmospheric Administration (NOAA)	NOAA The Climate Program Office; National Science Foundation(National Science Foundation (NSF)); Science Foundation Arizona; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); Colorado Scientific Society; University of Arizona Department of Geoscience; National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA)	The NOAA The Climate Program Office funded the analyses for this research, grant number NA11OAR4310162. National Science Foundation and Science Foundation Arizona graduate research fellowships respectively provided support for CCR while conducting this research. The NOAA funded Climate Assessment for the Southwest, the Colorado Scientific Society, and the University of Arizona Department of Geoscience contributed research funds to this research for conducting fieldwork.; We thank K. Routson, R. Yetman, and C. Stielstra for extensive help in the field. We thank N. Mckay, J. Betancourt, A. Cohen, E. Brown, D. Meko, J. Conroy, S. Hayes, J. Addison, and M. Sliwinski for comments and insights. The National Oceanic and Atmospheric Administration (NOAA), the National Science Foundation, the Science Foundation Arizona, the NOAA funded Climate Assessment for the Southwest, the Colorado Scientific Society, and the University of Arizona Department of Geoscience contributed funding and support for this research.	ABRUZZI WS, 1995, HUM ECOL, V23, P75, DOI 10.1007/BF01190099; Anchukaitis KJ, 2013, CLIM DYNAM, V41, P1291, DOI 10.1007/s00382-012-1483-0; Christen JA, 2010, BAYESIAN ANAL, V5, P263, DOI 10.1214/10-BA60; APPLEBY PG, 1983, HYDROBIOLOGIA, V103, P29, DOI 10.1007/BF00028424; Appleby PG, 1987, PALEOLIMNOLOGY, P21; Ault TR, 2014, J CLIMATE, V27, P7529, DOI 10.1175/JCLI-D-12-00282.1; Bales RC, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004387; Ballantyne AP, 2011, BIOGEOSCIENCES, V8, P2689, DOI 10.5194/bg-8-2689-2011; Belnap J, 1997, LAND DEGRAD DEV, V8, P355, DOI 10.1002/(SICI)1099-145X(199712)8:4<355::AID-LDR266>3.0.CO;2-H; Belnap J, 2014, AEOLIAN RES, V14, P15, DOI 10.1016/j.aeolia.2014.03.007; Binford, 1990, J PALEOLIMNOL, V3, P253, DOI DOI 10.1007/BF00219461; Blaauw M, 2011, BAYESIAN ANAL, V6, P457, DOI 10.1214/ba/1339616472; Brahney J, 2015, LIMNOL OCEANOGR, V60, P678, DOI 10.1002/lno.10050; Brahney J, 2014, BIOGEOCHEMISTRY, V120, P259, DOI 10.1007/s10533-014-9994-x; Brahney J, 2013, AEOLIAN RES, V10, P77, DOI 10.1016/j.aeolia.2013.04.003; Bryant AC, 2013, GEOPHYS RES LETT, V40, P3945, DOI 10.1002/grl.50773; Carling GT, 2012, SCI TOTAL ENVIRON, V432, P65, DOI 10.1016/j.scitotenv.2012.05.077; Chen FH, 2013, J GEOPHYS RES-ATMOS, V118, P2149, DOI 10.1002/jgrd.50140; Chu GQ, 2009, QUATERN INT, V194, P108, DOI 10.1016/j.quaint.2008.08.005; Clow DW, 1997, WATER RESOUR RES, V33, P1335, DOI 10.1029/97WR00856; Collins DQ, 2013, CLIMATE CHANGE 2013; Conroy JL, 2008, QUATERNARY SCI REV, V27, P1166, DOI 10.1016/j.quascirev.2008.02.015; Conroy JL, 2013, GLOBAL PLANET CHANGE, V107, P132, DOI 10.1016/j.gloplacha.2013.04.009; Cook BI, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400082; Cook BI, 2013, J CLIMATE, V26, P4414, DOI 10.1175/JCLI-D-12-00022.1; Cook BI, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033486; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; COOK ER, 1995, HOLOCENE, V5, P229, DOI 10.1177/095968369500500211; Cook ER, 2008, IGBP PAGESWORLD DATA, V46, P2008; Deems JS, 2013, HYDROL EARTH SYST SC, V17, P4401, DOI 10.5194/hess-17-4401-2013; Derbyshire E, 2007, AMBIO, V36, P73, DOI 10.1579/0044-7447(2007)36[73:NMDAHH]2.0.CO;2; Forman SL, 2006, QUATERNARY RES, V66, P97, DOI 10.1016/j.yqres.2005.12.003; Ghio AJ, 2014, INHAL TOXICOL, V26, P299, DOI 10.3109/08958378.2014.888109; Goudie AS, 2014, ENVIRON INT, V63, P101, DOI 10.1016/j.envint.2013.10.011; Halfen AF, 2013, AEOLIAN RES, V10, P135, DOI 10.1016/j.aeolia.2013.03.001; He Y, 2015, SCI REP; Huang XT, 2011, QUATERNARY SCI REV, V30, P3661, DOI 10.1016/j.quascirev.2011.09.011; Landry CC, 2014, WATER RESOUR RES, V50, P1773, DOI 10.1002/2013WR013711; Lawrence CR, 2013, GEOCHIM COSMOCHIM AC, V107, P27, DOI 10.1016/j.gca.2012.12.023; Lawrence CR, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001077; Lawrence CR, 2009, CHEM GEOL, V267, P46, DOI 10.1016/j.chemgeo.2009.02.005; Lipman PW, 1974, MISCILLANEOUS INVEST; Mahowald NM, 2010, ATMOS CHEM PHYS, V10, P10875, DOI 10.5194/acp-10-10875-2010; Miao XD, 2007, GEOLOGY, V35, P119, DOI 10.1130/G23133A.1; Mulitza S, 2010, NATURE, V466, P226, DOI 10.1038/nature09213; Munson SM, 2011, P NATL ACAD SCI USA, V108, P3854, DOI 10.1073/pnas.1014947108; Neff JC, 2008, NAT GEOSCI, V1, P189, DOI 10.1038/ngeo133; Neff JC, 2013, J GEOPHYS RES-ATMOS, V118, P11201, DOI 10.1002/jgrd.50855; Painter TH, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030284; Painter TH, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR011985; Painter TH, 2010, P NATL ACAD SCI USA, V107, P17125, DOI 10.1073/pnas.0913139107; Prospero JM, 2003, SCIENCE, V302, P1024, DOI 10.1126/science.1089915; Qiang MR, 2014, GEOPHYS RES LETT, V41, P589, DOI 10.1002/2013GL058806; REHEIS MC, 1995, GEOL SOC AM BULL, V107, P1003, DOI 10.1130/0016-7606(1995)107&lt;1003:QSADDI&gt;2.3.CO;2; Reimer P. J., 2009, INTCAL09 MARINE09 RA; Reynolds RL, 2014, AEOLIAN RES, V15, P73, DOI 10.1016/j.aeolia.2013.08.001; Reynolds RL, 2010, J PALEOLIMNOL, V44, P161, DOI 10.1007/s10933-009-9394-8; Routson CC, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL050015; Sayre N, 1999, J SOUTHWEST, V41, P239; Schelske C.L., 1994, J PALEOLIMNOL, V10, P115, DOI [10.1007/BF00682508, DOI 10.1007/BF00682508]; Skiles SM, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR011986; Stahle DW., 2000, EOS, V81, P121, DOI [10.1029/00EO00076, DOI 10.1029/00EO00076]; Woodhouse CA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022413; Woodhouse CA, 1998, B AM METEOROL SOC, V79, P2693, DOI 10.1175/1520-0477(1998)079<2693:YODVIT>2.0.CO;2	64	17	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149573	10.1371/journal.pone.0149573	http://dx.doi.org/10.1371/journal.pone.0149573			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886350	Green Published, gold, Green Submitted			2022-12-27	WOS:000371218400097
J	Banish, NP; Burdick, SM; Moyer, KR				Banish, Nolan P.; Burdick, Summer M.; Moyer, Katherine R.			Efficiency of Portable Antennas for Detecting Passive Integrated Transponder Tags in Stream-Dwelling Salmonids	PLOS ONE			English	Article							PIT; TRACKING; ABUNDANCE; FISH; MOVEMENT; SURVIVAL	Portable antennas have become an increasingly common technique for tracking fish marked with passive integrated transponder (PIT) tags. We used logistic regression to evaluate how species, fish length, and physical habitat characteristics influence portable antenna detection efficiency in stream-dwelling brown trout (Salmo trutta), bull trout (Salvelinus confluentus), and redband trout (Oncorhynchus mykiss newberrii) marked with 12-mm PIT tags. We redetected 56% (20/36) of brown trout, 34% (68/202) of bull trout, and 33% (20/61) of redband trout after a recovery period of 21 to 46 hours. Models indicate support for length and species and minor support for percent boulder, large woody debris, and percent cobble as parameters important for describing variation in detection efficiency, although 95% confidence intervals for estimates were large. The odds of detecting brown trout (1.5 +/- 2.2 [mean +/- SE]) are approximately four times as high as bull trout (0.4 +/- 1.6) or redband trout (0.3 +/- 1.8) and species-specific differences may be related to length. Our reported detection efficiency for brown trout falls within the range of other studies, but is the first reported for bull trout and redband trout. Portable antennas may be a relatively unbiased way of redetecting varying sizes of all three salmonid species.	[Banish, Nolan P.] US Fish & Wildlife Serv, Klamath Falls Fish & Wildlife Off, Klamath Falls, OR USA; [Burdick, Summer M.] US Geol Survey, Western Fisheries Res Ctr, Klamath Falls Field Stn, Klamath Falls, OR USA; [Moyer, Katherine R.] Chicago Bot Garden, Conservat & Land Management Internship Program, Glencoe, IL USA; [Moyer, Katherine R.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; United States Geological Survey; University of Washington; University of Washington Seattle	Banish, NP (corresponding author), US Fish & Wildlife Serv, Klamath Falls Fish & Wildlife Off, Klamath Falls, OR USA.	nolan_banish@fws.gov						Anderson D. R., 2008, MODEL BASED INFERENC; Bonneau Joseph L., 1995, North American Journal of Fisheries Management, V15, P563, DOI 10.1577/1548-8675(1995)015<0563:CMAEOJ>2.3.CO;2; Bowerman T, 2012, N AM J FISH MANAGE, V32, P1123, DOI 10.1080/02755947.2012.720644; Breen MJ, 2009, CAN J FISH AQUAT SCI, V66, P31, DOI 10.1139/F08-189; Brignon WR, 2011, J FISH WILDL MANAG, V2, P90, DOI 10.3996/052010-JFWM-012; Buchanan T.J., 1969, TECHNIQUES WATER RES; Burnett NJ, 2013, N AM J FISH MANAGE, V33, P7, DOI 10.1080/02755947.2012.734895; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cooke SJ, 2012, FISHERIES TECHNIQUES, THIRD EDITION, P819; Cucherousset J, 2005, N AM J FISH MANAGE, V25, P270, DOI 10.1577/M04-053.1; Cucherousset J, 2010, J FISH BIOL, V76, P1039, DOI 10.1111/j.1095-8649.2010.02543.x; Drasgow F., 1986, ENCY STAT SCI, VVol. 7, P68, DOI DOI 10.1002/0471667196.ESS2014.PUB2.ACCESSED; Ellis TR, 2013, T AM FISH SOC, V142, P660, DOI 10.1080/00028487.2012.754789; Hewitt DA, 2010, FISHERIES, V35, P217, DOI 10.1577/1548-8446-35.5.217; Hill MS, 2006, FISH RES, V77, P102, DOI 10.1016/j.fishres.2005.08.001; Keeler RA, 2007, T AM FISH SOC, V136, P281, DOI 10.1577/T05-131.1; Linnansaari T, 2013, CAN J FISH AQUAT SCI, V70, P1488, DOI 10.1139/cjfas-2012-0236; McKenzie J., 2012, ADV FISH TAGGING MAR; Moyle P.B., 2002, INLAND FISHES CALIFO; O'Donnell MJ, 2010, N AM J FISH MANAGE, V30, P323, DOI 10.1577/M09-008.1; Peterson JI, 2005, N AM J FISH MANAGE, V25, P732, DOI 10.1577/M04-051.1; Peterson JT, 2004, T AM FISH SOC, V133, P462, DOI 10.1577/03-044; Pine WE, 2003, FISHERIES, V28, P10, DOI 10.1577/1548-8446(2003)28[10:AROTMF]2.0.CO;2; R Core Team, 2012, R LANG ENV STAT COMP; Roussel JM, 2000, CAN J FISH AQUAT SCI, V57, P1326, DOI 10.1139/cjfas-57-7-1326; Sloat MR, 2011, N AM J FISH MANAGE, V31, P986, DOI 10.1080/02755947.2011.635486; Thurow RF, 2006, N AM J FISH MANAGE, V26, P217, DOI 10.1577/M05-054.1; Venables WN., 2002, MODERN APPL STAT S 4; Vetterling W.T., 1988, NUMERICAL RECIPES C; White G. C., 2001, WILDLIFE LAND PEOPLE, P368; Zaroban DW, 2010, WEST N AM NATURALIST, V70, P218, DOI 10.3398/064.070.0208	31	4	4	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149898	10.1371/journal.pone.0149898	http://dx.doi.org/10.1371/journal.pone.0149898			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901317	gold, Green Published, Green Submitted			2022-12-27	WOS:000371276100178
J	Li, NC; Fan, JJ; Papadopoulos, V				Li, Nancy C.; Fan, Jinjiang; Papadopoulos, Vassilios			Sterol Carrier Protein-2, a Nonspecific Lipid-Transfer Protein, in Intracellular Cholesterol Trafficking in Testicular Leydig Cells	PLOS ONE			English	Article							FATTY ACYL-COENZYME; ACID-BINDING SITE; LUTEINIZING-HORMONE; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; RAT-LIVER; EXPRESSION; PEROXISOMES; SEQUENCE; LOCALIZATION	Sterol carrier protein-2 (SCP2), also called nonspecific lipid-transfer protein, is thought to play a major role in intracellular lipid transport and metabolism, and it has been associated with diseases involving abnormalities in lipid trafficking, such as Zellweger syndrome. The Scp2 gene encodes the 58 kDa sterol carrier protein-x (SCPX) and 15 kDa pro-SCP2 proteins, both of which contain a 13 kDa SCP2 domain in their C-termini. We found that 22-NBD-cholesterol, a fluorescent analog of cholesterol and a preferred SCP2 ligands, was not localized in the peroxisomes. This raises questions about previous reports on the localization of the SCPX and SCP2 proteins and their relationship to peroxisomes and mitochondria in intracellular cholesterol transport. Immunofluorescent staining of cryosections of mouse testis and of MA-10 mouse tumor Leydig cells showed that SCPX and SCP2 are present in both mouse testicular interstitial tissue and in MA-10 cells. Fluorescent fusion proteins of SCPX and SCP2, as well as confocal live-cell imaging, were used to investigate the subcellular targeting of these proteins and the function of the putative mitochondrial targeting sequence. The results showed that SCPX and SCP2 are targeted to the peroxisomes by the C-terminal PTS1 domain, but the putative N-terminal mitochondrial targeting sequence alone is not potent enough to localize SCPX and SCP2 to the mitochondria. Homology modeling and molecular docking studies indicated that the SCP2 domain binds cholesterol, but lacks specificity of the binding and/or transport. These findings further our understanding of the role of SCPX and SCP2 in intracellular cholesterol transport, and present a new point of view on the role of these proteins in cholesterol trafficking.	[Li, Nancy C.; Fan, Jinjiang; Papadopoulos, Vassilios] McGill Univ, Ctr Hlth, Res Inst, Ctr Translat Biol, 1001 Blvd Decarie, Montreal, PQ H4A 3J1, Canada; [Li, Nancy C.; Papadopoulos, Vassilios] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1A4, Canada; [Fan, Jinjiang; Papadopoulos, Vassilios] McGill Univ, Dept Med, Montreal, PQ H3G 1A4, Canada; [Papadopoulos, Vassilios] McGill Univ, Dept Biochem, Montreal, PQ H3G 1A4, Canada	McGill University; McGill University; McGill University; McGill University	Papadopoulos, V (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Ctr Translat Biol, 1001 Blvd Decarie, Montreal, PQ H4A 3J1, Canada.; Papadopoulos, V (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1A4, Canada.; Papadopoulos, V (corresponding author), McGill Univ, Dept Med, Montreal, PQ H3G 1A4, Canada.; Papadopoulos, V (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3G 1A4, Canada.	vassilios.papadopoulos@mcgill.ca	Papadopoulos, Vassilios/AAI-2613-2019; Fan, Jinjiang/C-2010-2009	Papadopoulos, Vassilios/0000-0002-1183-8568; Fan, Jinjiang/0000-0003-3102-4833	Canadian Institutes of Health Research [MOP125983]; Canada Research Chair in Biochemical Pharmacology; Les Fonds de la Recherche du Quebec Sante	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Biochemical Pharmacology; Les Fonds de la Recherche du Quebec Sante	This work was supported by a grant from the Canadian Institutes of Health Research (MOP125983) and a Canada Research Chair in Biochemical Pharmacology. The Research Institute of the McGill University Health Centre was supported by a center grant from Les Fonds de la Recherche du Quebec Sante.	Aghazadeh Y, 2014, J BIOL CHEM, V289, P26542, DOI 10.1074/jbc.M114.569079; ASCOLI M, 1981, ENDOCRINOLOGY, V108, P88, DOI 10.1210/endo-108-1-88; Atshaves BP, 1999, J LIPID RES, V40, P610; Baum CL, 1997, J BIOL CHEM, V272, P6490, DOI 10.1074/jbc.272.10.6490; Chao H, 1999, BBA-MOL CELL BIOL L, V1439, P371, DOI 10.1016/S1388-1981(99)00109-2; Faletrov YV, 2013, J STEROID BIOCHEM, V134, P59, DOI 10.1016/j.jsbmb.2012.09.035; Fan JJ, 2015, P NATL ACAD SCI USA, V112, P7261, DOI 10.1073/pnas.1502670112; Fan JJ, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097535; Castillo AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022822; Filipp FV, 2007, BIOCHEMISTRY-US, V46, P7980, DOI 10.1021/bi6025616; Frolov A, 1997, LIPIDS, V32, P1201, DOI 10.1007/s11745-997-0154-5; Frolov A, 1996, J BIOL CHEM, V271, P31878, DOI 10.1074/jbc.271.50.31878; GADELLA TWJ, 1991, BIOCHIM BIOPHYS ACTA, V1070, P237, DOI 10.1016/0005-2736(91)90170-D; Gallegos AM, 2001, PROG LIPID RES, V40, P498, DOI 10.1016/S0163-7827(01)00015-7; Gallegos AM, 2001, BIOCHEMISTRY-US, V40, P6493, DOI 10.1021/bi010217l; Gallegos AM, 2000, CHEM PHYS LIPIDS, V105, P9, DOI 10.1016/S0009-3084(99)00128-0; Issop L, 2015, ENDOCRINOLOGY, V156, P334, DOI 10.1210/en.2014-1503; Jamin N, 2005, MOL ENDOCRINOL, V19, P588, DOI 10.1210/me.2004-0308; KELLER GA, 1989, J CELL BIOL, V108, P1353, DOI 10.1083/jcb.108.4.1353; KILGORE MW, 1990, MOL CELL ENDOCRINOL, V69, P9, DOI 10.1016/0303-7207(90)90083-K; Klipsic D, 2015, AM J PHYSIOL-GASTR L, V309, pG387, DOI 10.1152/ajpgi.00460.2014; KRISANS SK, 1992, AM J RESP CELL MOL, V7, P358, DOI 10.1165/ajrcmb/7.4.358; Martin GG, 2015, ARCH BIOCHEM BIOPHYS, V580, P41, DOI 10.1016/j.abb.2015.06.009; Mendis-Handagama SMLC, 2000, TISSUE CELL, V32, P102, DOI 10.1054/tice.1999.0092; Mendis-Handagama SMLC, 1998, TISSUE CELL, V30, P64, DOI 10.1016/S0040-8166(98)80007-4; MENDISHANDAGAMA SMLC, 1992, ENDOCRINOLOGY, V131, P2839, DOI 10.1210/en.131.6.2839; MendisHandagama SMLC, 1997, HISTOL HISTOPATHOL, V12, P869; Moncecchi D, 1996, BBA-LIPID LIPID MET, V1302, P110, DOI 10.1016/0005-2760(96)00044-6; MONCECCHI D, 1991, J BIOL CHEM, V266, P9885; MORI T, 1991, P NATL ACAD SCI USA, V88, P4338, DOI 10.1073/pnas.88.10.4338; Nenicu A, 2007, BIOL REPROD, V77, P1060, DOI 10.1095/biolreprod.107.061242; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; PAYNE AH, 1995, BIOL REPROD, V52, P217, DOI 10.1095/biolreprod52.2.217; PFEIFER SM, 1993, J STEROID BIOCHEM, V47, P167, DOI 10.1016/0960-0760(93)90071-4; PUGLIELLI L, 1995, J BIOL CHEM, V270, P18723, DOI 10.1074/jbc.270.32.18723; Rone Malena B, 2014, Biol Reprod, V91, P96, DOI 10.1095/biolreprod.114.121434; SCHROEDER F, 1995, BIOCHEMISTRY-US, V34, P11919, DOI 10.1021/bi00037a033; Schroeder F, 2000, J BIOL CHEM, V275, P25547, DOI 10.1074/jbc.M000431200; SEEDORF U, 1991, J BIOL CHEM, V266, P630; Seedorf U, 1998, GENE DEV, V12, P1189, DOI 10.1101/gad.12.8.1189; Starodub O, 2000, AM J PHYSIOL-CELL PH, V279, pC1259, DOI 10.1152/ajpcell.2000.279.4.C1259; STOCCO DM, 1990, J ENDOCRINOL, V126, P367, DOI 10.1677/joe.0.1260367; Stolowich N, 1999, J BIOL CHEM, V274, P35425, DOI 10.1074/jbc.274.50.35425; Stolowich NJ, 1997, BIOCHEMISTRY-US, V36, P1719, DOI 10.1021/bi962317a; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; VANHAREN L, 1992, BIOCHIM BIOPHYS ACTA, V1124, P288; VANHEUSDEN GPH, 1990, BIOCHIM BIOPHYS ACTA, V1046, P315, DOI 10.1016/0005-2760(90)90247-U; WESTERMAN J, 1985, BIOCHEM BIOPH RES CO, V127, P333, DOI 10.1016/S0006-291X(85)80163-7; WIRTZ KWA, 1991, ANNU REV BIOCHEM, V60, P73, DOI 10.1146/annurev.biochem.60.1.73; WIRTZ KWA, 1990, EXPERIENTIA, V46, P592, DOI 10.1007/BF01939698; YAMAMOTO R, 1991, P NATL ACAD SCI USA, V88, P463, DOI 10.1073/pnas.88.2.463	51	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149728	10.1371/journal.pone.0149728	http://dx.doi.org/10.1371/journal.pone.0149728			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901662	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100136
J	Murrison, LB; Ananthakrishnan, R; Sukumar, S; Augustine, S; Krishnan, N; Pai, M; Dowdy, DW				Murrison, Liza Bronner; Ananthakrishnan, Ramya; Sukumar, Sumanya; Augustine, Sheela; Krishnan, Nalini; Pai, Madhukar; Dowdy, David W.			How Do Urban Indian Private Practitioners Diagnose and Treat Tuberculosis? A Cross-Sectional Study in Chennai	PLOS ONE			English	Article							MANAGEMENT; QUALITY	Setting Private practitioners are frequently the first point of healthcare contact for patients with tuberculosis (TB) in India. Inappropriate TB management practices among private practitioners may contribute to delayed TB diagnosis and generate drug resistance. However, these practices are not well understood. We evaluated diagnostic and treatment practices for active TB and benchmarked practices against International Standards for TB Care (ISTC) among private medical practitioners in Chennai. Design A cross-sectional survey of 228 practitioners practicing in the private sector from January 2014 to February 2015 in Chennai city who saw at least one TB patient in the previous year. Practitioners were randomly selected from both the general community and a list of practitioners who referred patients to a public-private mix program for TB treatment in Chennai. Practitioners were interviewed using standardized questionnaires. Results Among 228 private practitioners, a median of 12 (IQR 4-28) patients with TB were seen per year. Of 10 ISTC standards evaluated, the median of standards adhered to was 4.0 (IQR 3.0-6.0). Chest physicians reported greater median ISTC adherence than other MD and MS practitioners (score 7.0 vs. 4.0, P<0.001), or MBBS practitioners (score 7.0 vs. 4.0, P< 0.001). Only 52% of all practitioners sent >5% of patients with cough for TB testing, 83% used smear microscopy for diagnosis, 33% monitored treatment response, and 22% notified TB cases to authorities. Of 228 practitioners, 68 reported referring all patients with new pulmonary TB for treatment, while 160 listed 27 different regimens; 78% (125/160) prescribed a regimen classified as consistent with ISTC. Appropriate treatment practices differed significantly between chest physicians and other MD and MS practitioners (54% vs. 87%, P<0.001). Conclusion TB management practices in India's urban private sector are heterogeneous and often suboptimal. Private providers must be better engaged to improve diagnostic capacity and decrease TB transmission in the community.	[Murrison, Liza Bronner; Dowdy, David W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Murrison, Liza Bronner; Dowdy, David W.] Johns Hopkins Univ, Ctr TB Res, Baltimore, MD USA; [Ananthakrishnan, Ramya; Sukumar, Sumanya; Augustine, Sheela; Krishnan, Nalini] REACH, Madras, Tamil Nadu, India; [Pai, Madhukar] McGill Univ, McGill Int TB Ctr, Montreal, PQ, Canada; [Pai, Madhukar] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; McGill University; McGill University	Dowdy, DW (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.; Dowdy, DW (corresponding author), Johns Hopkins Univ, Ctr TB Res, Baltimore, MD USA.	ddowdy1@jhmi.edu	Murrison, Liza/AAE-7682-2019; Pai, Madhukar/AAX-9901-2021; PAL, MRINAL/ABG-9676-2020	Pai, Madhukar/0000-0003-3667-4536; PAL, MRINAL/0000-0002-1032-272X; Bronner Murrison, Liza/0000-0002-8668-3898	Bill & Melinda Gates Foundation [OPP1061487]; Global Health Field Research Award by the Johns Hopkins Center for Global Health; Canadian Institutes of Health Research	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Global Health Field Research Award by the Johns Hopkins Center for Global Health; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by a grant by the Bill & Melinda Gates Foundation (grant OPP1061487) and by a Global Health Field Research Award grant by the Johns Hopkins Center for Global Health. Madhukar Pai was a recipient of a Tier 1 Canada Research Chair from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors received no specific funding for this work.	Achanta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071119; Bharaswadkar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097993; Bronner Murrison L, 2016, INT J TUBERC LUNG DI; Central TB Division Directorate General of Health Services Ministry of Health and Family Welfare Government of India, 2014, TB IND 2014 REV NAT; Dalal A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116798; Das J, 2015, LANCET INFECT DIS; Engel N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135112; Government of India Ministry of Home Affairs Office of the Registrar General and Census Commissioner, 2011, PRIM CENS ABSTRACT C; Jaroslawski S, 2012, J EPIDEMIOL GLOB HEA, V2, P39, DOI 10.1016/j.jegh.2011.12.001; Kapoor SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042458; Krishnan N, 2009, INT J TUBERC LUNG D, V13, P112; Miller R, 2012, INT J HEALTH PLAN M, V27, P180, DOI 10.1002/hpm.2105; Nagaraja SB, 2014, INT J TUBERC LUNG D, V18, P1353, DOI 10.5588/ijtld.13.0836; Pai M, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001805; Pai M, 2014, LANCET GLOB HEALTH, V2, pE189, DOI 10.1016/S2214-109X(14)70198-6; Pai M, 2013, NATL MED J INDIA, V26, P65; Paramasivan CN, 2010, INT J TUBERC LUNG D, V14, P243; Philip S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123286; Sachdeva KS, 2012, INDIAN J MED RES, V135, P690; Salje H, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001674; Satyanarayana S, 2015, INT J TUBERC LUNG D, V19, P751, DOI 10.5588/ijtld.15.0186; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Sreeramareddy CT, 2014, INT J TUBERC LUNG D, V18, P255, DOI 10.5588/ijtld.13.0585; TBCARE I, 2014, INT STAND TUB CAR; Thomas A, 2011, INT J TUBERC LUNG D, V15, P1323, DOI 10.5588/ijtld.10.0530; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; Uplekar M, 1998, INT J TUBERC LUNG D, V2, P324; World Health Organization, 2014, STAND TB CAR IND; World Health Organization, 2014, WHOHTMTB201408	29	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149862	10.1371/journal.pone.0149862	http://dx.doi.org/10.1371/journal.pone.0149862			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901165	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100166
J	Pagin, A; Devos, A; Figeac, M; Truant, M; Willoquaux, C; Broly, F; Lalau, G				Pagin, Adrien; Devos, Aurore; Figeac, Martin; Truant, Maryse; Willoquaux, Christelle; Broly, Franck; Lalau, Guy			Applicability and Efficiency of NGS in Routine Diagnosis: In-Depth Performance Analysis of a Complete Workflow for CFTR Mutation Analysis	PLOS ONE			English	Article							CYSTIC-FIBROSIS; DISORDERS; RECOMMENDATIONS; DELETION; GENE	Background Actually, about 2000 sequence variations have been documented in the CFTR gene requiring extensive and multi-step genetic testing in the diagnosis of cystic fibrosis and CFTR-related disorders. We present a two phases study, with validation and performance monitoring, of a single experiment methodology based on multiplex PCR and high throughput sequencing that allows detection of all variants, including large rearrangements, affecting the coding regions plus three deep intronic loci. Methods A total of 340 samples, including 257 patients and 83 previously characterized control samples, were sequenced in 17 MiSeq runs and analyzed with two bioinformatic pipelines in routine diagnostic conditions. We obtained 100% coverage for all the target regions in every tested sample. Results We correctly identified all the 87 known variants in the control samples and successfully confirmed the 62 variants identified among the patients without observing false positive results. Large rearrangements were identified in 18/18 control samples. Only 17 patient samples showed false positive signals (6.6%), 12 of which showed a borderline result for a single amplicon. We also demonstrated the ability of the assay to detect allele specific dropout of amplicons when a sequence variation occurs at a primer binding site thus limiting the risk for false negative results. Conclusions We described here the first NGS workflow for CFTR routine analysis that demonstrated equivalent diagnostic performances compared to Sanger sequencing and multiplex ligation-dependent probe amplification. This study illustrates the advantages of NGS in term of scalability, workload reduction and cost-effectiveness in combination with an improvement of the overall data quality due to the simultaneous detection of SNVs and large rearrangements.	[Pagin, Adrien; Devos, Aurore; Truant, Maryse; Willoquaux, Christelle; Broly, Franck; Lalau, Guy] Lille Univ Hosp, Biol Pathol Ctr, Dept Toxicol & Genopathy, Lille, France; [Figeac, Martin] Funct & Struct Genom Platform, Lille, France; [Broly, Franck] Univ Lille 2, Lille, France	Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille	Pagin, A (corresponding author), Lille Univ Hosp, Biol Pathol Ctr, Dept Toxicol & Genopathy, Lille, France.	adrien.pagin@chru-lille.fr		Figeac, Martin/0000-0001-8523-3708				Abou Tayoun AN, 2013, CLIN CHEM, V59, P1481, DOI 10.1373/clinchem.2013.206466; Biesecker LG, 2014, NEW ENGL J MED, V371, P1170, DOI 10.1056/NEJMc1408914; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Bombieri C, 2011, J CYST FIBROS, V10, pS86, DOI 10.1016/S1569-1993(11)60014-3; Bonini J, 2015, GENET MED, V17, P796, DOI 10.1038/gim.2014.194; Buermans HPJ, 2014, BBA-MOL BASIS DIS, V1842, P1932, DOI 10.1016/j.bbadis.2014.06.015; Castellani C, 2008, J CYST FIBROS, V7, P179, DOI 10.1016/j.jcf.2008.03.009; CHU CS, 1993, NAT GENET, V3, P151, DOI 10.1038/ng0293-151; Claustres M, 2000, HUM MUTAT, V16, P143, DOI 10.1002/1098-1004(200008)16:2<143::AID-HUMU7>3.0.CO;2-J; Costes B, 2000, CLIN CHEM, V46, P1417; Dequeker E, 2009, EUR J HUM GENET, V17, P51, DOI 10.1038/ejhg.2008.136; El-Seedy A, 2009, J MOL DIAGN, V11, P488, DOI 10.2353/jmoldx.2009.090005; Elliott Aaron M, 2012, J Biomol Tech, V23, P24, DOI 10.7171/jbt.12-2301-003; Farrell PM, 2008, J CYST FIBROS, V7, P450, DOI 10.1016/j.jcf.2008.03.007; Grody WW, 2001, GENET MED, V3, P87, DOI 10.1097/00125817-200103000-00001; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Magnani C, 1996, HUM GENET, V98, P102, DOI 10.1007/s004390050167; Masson E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073522; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nakano E, 2015, DIGEST DIS SCI, V60, P1297, DOI 10.1007/s10620-014-3476-9; Rehm HL, 2013, NAT REV GENET, V14, P295, DOI 10.1038/nrg3463; Tomaiuolo R, 2008, J CYST FIBROS, V7, P347, DOI 10.1016/j.jcf.2007.12.004; Trujillano D, 2013, J MED GENET, V50, P455, DOI 10.1136/jmedgenet-2013-101602; Trujillano D, 2015, MOL GENET GENOM MED, V3, P396, DOI 10.1002/mgg3.149	24	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149426	10.1371/journal.pone.0149426	http://dx.doi.org/10.1371/journal.pone.0149426			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900683	Green Submitted, gold, Green Published			2022-12-27	WOS:000371276100074
J	Chiou, SC; Chang, EC				Chiou, Shiau-Chuen; Chang, Erik Chihhung			Bimanual Coordination Learning with Different Augmented Feedback Modalities and Information Types	PLOS ONE			English	Article							MOTOR; KNOWLEDGE; MOVEMENT; STIMULATION; ACQUISITION; FREQUENCY; SUPPORT; RHYTHMS; MOTION	Previous studies have shown that bimanual coordination learning is more resistant to the removal of augmented feedback when acquired with auditory than with visual channel. However, it is unclear whether this differential "guidance effect" between feedback modalities is due to enhanced sensorimotor integration via the non-dominant auditory channel or strengthened linkage to kinesthetic information under rhythmic input. The current study aimed to examine how modalities (visual vs. auditory) and information types (continuous visuospatial vs. discrete rhythmic) of concurrent augmented feedback influence bimanual coordination learning. Participants either learned a 90 degrees-out-of-phase pattern for three consecutive days with Lissajous feedback indicating the integrated position of both arms, or with visual or auditory rhythmic feedback reflecting the relative timing of the movement. The results showed diverse performance change after practice when the feedback was removed between Lissajous and the other two rhythmic groups, indicating that the guidance effect may be modulated by the type of information provided during practice. Moreover, significant performance improvement in the dual-task condition where the irregular rhythm counting task was applied as a secondary task also suggested that lower involvement of conscious control may result in better performance in bimanual coordination.	[Chiou, Shiau-Chuen; Chang, Erik Chihhung] Natl Cent Univ, Inst Cognit Neurosci, Taoyuan, Taiwan	National Central University	Chang, EC (corresponding author), Natl Cent Univ, Inst Cognit Neurosci, Taoyuan, Taiwan.	auda@ncu.edu.tw	Chiou, Shiau-Chuen/R-8633-2019	Chiou, Shiau-Chuen/0000-0002-0496-8153	Ministry of Science and Technology, Taiwan [MOST-104-2420-H-008-004-MY2]; IRICE program [MOST-103-2911-I-009-101]; cross-disciplinary grant [MOST-103-2627-E009-001]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); IRICE program; cross-disciplinary grant	The study was supported by grants from the Ministry of Science and Technology, Taiwan, to ECC (MOST-104-2420-H-008-004-MY2), and in part by the IRICE program (MOST-103-2911-I-009-101), as well as a Tcross-disciplinary grant (MOST-103-2627-E009-001). The URL of MOST is http://www.most.gov.tw/mp.aspx?mp=7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias P, 2008, EXP BRAIN RES, V186, P589, DOI 10.1007/s00221-007-1263-y; Arrighi R, 2006, J VISION, V6, P260, DOI 10.1167/6.3.6; Bengtsson SL, 2009, CORTEX, V45, P62, DOI 10.1016/j.cortex.2008.07.002; Buchanan JJ, 2012, EXP BRAIN RES, V219, P305, DOI 10.1007/s00221-012-3092-x; Chen YQ, 2002, HUM MOVEMENT SCI, V21, P515, DOI 10.1016/S0167-9457(02)00138-0; FREIDES D, 1974, PSYCHOL BULL, V81, P284, DOI 10.1037/h0036331; Guadagnoli MA, 2004, J MOTOR BEHAV, V36, P212, DOI 10.3200/JMBR.36.2.212-224; Holcombe AO, 2009, TRENDS COGN SCI, V13, P216, DOI 10.1016/j.tics.2009.02.005; Hove MJ, 2013, NEUROIMAGE, V67, P313, DOI 10.1016/j.neuroimage.2012.11.032; IRWIN RJ, 1981, AUDIOLOGY, V20, P234; KEELE SW, 1968, PSYCHOL BULL, V70, P387, DOI 10.1037/h0026739; KELSO JAS, 1986, PHYS LETT A, V118, P279, DOI 10.1016/0375-9601(86)90359-2; Kovacs AJ, 2011, ACTA PSYCHOL, V136, P311, DOI 10.1016/j.actpsy.2010.12.004; Kovacs AJ, 2010, J EXP PSYCHOL HUMAN, V36, P936, DOI 10.1037/a0019259; Kovacs AJ, 2010, EXP BRAIN RES, V202, P519, DOI 10.1007/s00221-009-2154-1; Kovacs AJ, 2010, EXP BRAIN RES, V201, P249, DOI 10.1007/s00221-009-2031-y; Kovacs AJ, 2009, NEUROSCI LETT, V455, P162, DOI 10.1016/j.neulet.2009.02.046; Kovacs AJ, 2009, EXP BRAIN RES, V193, P129, DOI 10.1007/s00221-008-1676-2; LEE TD, 1995, J MOTOR BEHAV, V27, P263, DOI 10.1080/00222895.1995.9941716; Lissajous MJ., 1857, ANN CHIMIE PHYS, P51; Maslovat D, 2009, J MOTOR BEHAV, V41, P45, DOI 10.1080/00222895.2009.10125923; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Peirce JW, 2009, FRONT NEUROINFORM, V2, DOI 10.3389/neuro.11.010.2008; POSNER MI, 1976, PSYCHOL REV, V83, P157, DOI 10.1037/0033-295X.83.2.157; PROTEAU L, 1992, Q J EXP PSYCHOL-A, V44, P557, DOI 10.1080/14640749208401298; PROTEAU L, 1987, HUM MOVEMENT SCI, V6, P181, DOI 10.1016/0167-9457(87)90011-X; Ronsse R, 2011, CEREB CORTEX, V21, P1283, DOI 10.1093/cercor/bhq209; SCHMIDT RA, 1990, HUM MOVEMENT SCI, V9, P325, DOI 10.1016/0167-9457(90)90007-Z; SCHMIDT RA, 1975, PSYCHOL REV, V82, P225, DOI 10.1037/h0076770; SCHMIDT RA, 1989, J EXP PSYCHOL LEARN, V15, P352, DOI 10.1037/0278-7393.15.2.352; Schmidt RA, 1976, J HUMAN MOVEMENT STU, V2, P239; Strumillo P., 2011, ADVANCES IN SOUND LO; Swinnen SP, 1998, COGN NEUROPSYCHOL, V15, P439, DOI 10.1080/026432998381104; Swinnen SP, 1997, J EXP PSYCHOL HUMAN, V23, P1087; Swinnen SP, 1997, HUM MOVEMENT SCI, V16, P749, DOI 10.1016/S0167-9457(97)00020-1; Thaut MH, 1999, IEEE ENG MED BIOL, V18, P101, DOI 10.1109/51.752991; Thaut MH, 2010, MUSIC PERCEPT, V27, P263, DOI 10.1525/MP.2010.27.4.263; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; WINSTEIN CJ, 1990, J EXP PSYCHOL LEARN, V16, P677, DOI 10.1037/0278-7393.16.4.677; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Wulf G, 2001, RES Q EXERCISE SPORT, V72, P335, DOI 10.1080/02701367.2001.10608970; Wulf G, 2001, Q J EXP PSYCHOL-A, V54, P1143, DOI 10.1080/02724980143000118; Wulf G, 2013, INT REV SPORT EXER P, V6, P77, DOI 10.1080/1750984X.2012.723728	43	5	5	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149221	10.1371/journal.pone.0149221	http://dx.doi.org/10.1371/journal.pone.0149221			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3DG	26895286	Green Submitted, Green Published, gold			2022-12-27	WOS:000371223400039
J	Keezhupalat, SM; Naik, A; Gupta, S; Srivatsan, R; Saberwal, G				Keezhupalat, Shruthi Muralidharan; Naik, Ankeet; Gupta, Saurabh; Srivatsan, Raghunathan; Saberwal, Gayatri			An Analysis of Sponsors/Collaborators of 69,160 Drug Trials Registered with ClinicalTrials.gov	PLOS ONE			English	Article							GLOBALIZATION; CALL	Background Clinical trials have been criticized on various counts. Any attempt to improve how trials are conducted or reported requires-amongst other things-an understanding of the number, the nature and the location of those that sponsor them or collaborate on them. Here we sought to identify the nature and location of each sponsor/collaborator. Methods and Findings We examined the 'sponsor/collaborator' field for the 69,160 drug trials that were registered with ClinicalTrials.gov over a 9-year period (2005-2014). Of the 12,823 unique sponsors, 56% had sponsored only one and 27% had sponsored 2-5 trials each. Just 18% were involved with six or more trials each, and we have (arbitrarily) labeled these organizations as 'more experienced' in sponsoring/collaborating on trials. These 18% (2,266 sponsors/collaborators) were analyzed further: (a) 951 were corporate organizations and (b) 1,145 were non-corporates (including 31 individuals) with (c) 170 unclassified. Further, we identified the location of each organization in (a) and (b). Conclusions Clinical trials are an important part of a nation's research endeavors, and ultimately contribute to the health of its people. Thus, understanding the clinical trial landscape-including the number and nature of sponsors, and how active they are-is important for every country. We believe that policy makers in particular should be interested in this study to understand the current situation, and to use the numbers as a baseline for the evolving landscape, to assess the impact of their strategies in future.	[Keezhupalat, Shruthi Muralidharan; Naik, Ankeet; Srivatsan, Raghunathan; Saberwal, Gayatri] Inst Bioinformat & Appl Biotechnol, Bengaluru, Karnataka, India; [Gupta, Saurabh] Inst Bioinformat & Appl Biotechnol, GANIT Labs, Bengaluru, Karnataka, India		Saberwal, G (corresponding author), Inst Bioinformat & Appl Biotechnol, Bengaluru, Karnataka, India.	gayatri@ibab.ac.in		Gupta, Saurabh/0000-0002-5984-852X	Institute of Bioinformatics and Applied Biotechnology; Department of Biotechnology, Government of India [BTPR12422/MED/31/287/2014]	Institute of Bioinformatics and Applied Biotechnology; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by internal funding of the Institute of Bioinformatics and Applied Biotechnology, and in part by a grant from the Department of Biotechnology, Government of India (BTPR12422/MED/31/287/2014, valid November 2014 to 2017). URL: http://www.dbtindia.nic.in/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, LANCET, V378, P1976, DOI 10.1016/S0140-6736(11)61858-8; Bagla P., 2013, SCIENCE; Bloudoff-Indelicato M, 2015, NAT MED, V21, P200, DOI 10.1038/nm0315-200; Chakradhar S, 2015, NAT MED, V21, P304, DOI 10.1038/nm0415-304; Chakradhar S, 2015, NAT MED, V21, P209, DOI 10.1038/nm0315-209; Couzin-Frankel J, 2015, SCIENCE, V348, P382, DOI 10.1126/science.348.6233.382; Dal-Re R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001149; Dolgin E, 2014, NAT MED, V20, P321, DOI 10.1038/nm0414-321; Doshi P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2865; Glickman SW, 2009, NEW ENGL J MED, V360, P816, DOI 10.1056/NEJMsb0803929; Goldacre B, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001821; HERSHER R, 2012, NAT MED, V18, P186; Hoekman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045984; Kessel M, 2014, NAT BIOTECHNOL, V32, P983, DOI 10.1038/nbt.3036; Lang TD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001228; Liu GD, 2013, CTS-CLIN TRANSL SCI, V6, P196, DOI 10.1111/cts.12029; Miller FG, 2005, ACAD MED, V80, P899, DOI 10.1097/00001888-200510000-00005; Patel J, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0128-z; Schork NJ, 2015, NATURE, V520, P609, DOI 10.1038/520609a; Schulman KA, 2002, NEW ENGL J MED, V347, P1335, DOI 10.1056/NEJMsa020349; Servick K, 2014, SCIENCE, V346, P288, DOI 10.1126/science.346.6207.288; Servick K, 2014, SCIENCE, V344, P1329, DOI 10.1126/science.344.6190.1329; Shah S, 2003, INT J HEALTH SERV, V33, P29, DOI 10.2190/5FGJ-03AQ-BKW2-GLAA; Tanne JH, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3616; Thiers FA, 2008, NAT REV DRUG DISCOV, V7, P13, DOI 10.1038/nrd2441	25	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149416	10.1371/journal.pone.0149416	http://dx.doi.org/10.1371/journal.pone.0149416			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886868	Green Published, Green Submitted, gold			2022-12-27	WOS:000371218400079
J	Klaczko, J; Sherratt, E; Setz, EZF				Klaczko, Julia; Sherratt, Emma; Setz, Eleonore Z. F.			Are Diet Preferences Associated to Skulls Shape Diversification in Xenodontine Snakes?	PLOS ONE			English	Article							MORPHOLOGICAL CONVERGENCE; FEEDING SYSTEM; EVOLUTION; INTEGRATION; BEHAVIOR; HISTORY; ORIGIN; FORM	Snakes are a highly successful group of vertebrates, within great diversity in habitat, diet, and morphology. The unique adaptations for the snake skull for ingesting large prey in more primitive macrostomatan snakes have been well documented. However, subsequent diversification in snake cranial shape in relation to dietary specializations has rarely been studied (e.g. piscivory in natricine snakes). Here we examine a large clade of snakes with a broad spectrum of diet preferences to test if diet preferences are correlated to shape variation in snake skulls. Specifically, we studied the Xenodontinae snakes, a speciose clade of South American snakes, which show a broad range of diets including invertebrates, amphibians, snakes, lizards, and small mammals. We characterized the skull morphology of 19 species of xenodontine snakes using geometric morphometric techniques, and used phylogenetic comparative methods to test the association between diet and skull morphology. Using phylogenetic partial least squares analysis (PPLS) we show that skull morphology is highly associated with diet preferences in xenodontine snakes.	[Klaczko, Julia; Setz, Eleonore Z. F.] Univ Estadual Campinas, Inst Biol, Dept Biol Anim, UNICAMP, Campinas, SP, Brazil; [Sherratt, Emma] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia	Universidade de Sao Paulo; Universidade Estadual de Campinas; University of New England	Klaczko, J (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Biol Anim, UNICAMP, Campinas, SP, Brazil.	jklaczko@gmail.com	Sherratt, Emma/A-9931-2011; Klaczko, Julia/N-1406-2013; Klaczko, Julia/N-4115-2019; Setz, Eleonore Z F/C-1050-2012	Sherratt, Emma/0000-0003-2164-7877; Klaczko, Julia/0000-0002-9215-380X; Klaczko, Julia/0000-0002-9215-380X; Setz, Eleonore Z F/0000-0001-7638-7086	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/17070-6]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	JK was funded from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (grant number: 2011/17070-6) as a post-doctoral fellow; http://www.fapesp.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2014, GEOMORPH SOFTWARE GE; Adams DC, 2014, SYST BIOL, V63, P685, DOI 10.1093/sysbio/syu030; Adams DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094335; Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Alencar LRV, 2013, S AM J HERPETOL, V8, P60, DOI 10.2994/SAJH-D-13-00005.1; Bizerra A, 2005, AMPHIBIA-REPTILIA, V26, P33, DOI 10.1163/1568538053693350; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Brecko Jonathan, 2011, Mertensiella, V18, P20; Britt EJ, 2009, J HERPETOL, V43, P252, DOI 10.1670/08-109R1.1; CADLE JE, 1984, HERPETOLOGICA, V40, P8; Colston TJ, 2010, BIOL J LINN SOC, V101, P476, DOI 10.1111/j.1095-8312.2010.01502.x; Cundall David, 2000, P293, DOI 10.1016/B978-012632590-4/50010-1; De Oliveira FS, 2008, ECOLOGIA ALIMENTAR R; Franca Frederico G.R., 2006, South American Journal of Herpetology, V1, P25, DOI 10.2994/1808-9798(2006)1[25:TCSOSI]2.0.CO;2; GANS C, 1961, AM ZOOL, V1, P217; GREENE HW, 1983, AM ZOOL, V23, P431; Hampton PM, 2011, J MORPHOL, V272, P1435, DOI 10.1002/jmor.10995; HENDERSON RW, 1987, HERPETOLOGICA, V43, P241; Herrel A, 2008, J EVOLUTION BIOL, V21, P1438, DOI 10.1111/j.1420-9101.2008.01552.x; Hsiang AY, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0358-5; Jackson K, 2004, AMPHIBIA-REPTILIA, V25, P247, DOI 10.1163/1568538041975134; Klingenberg CP, 2013, HYSTRIX, V24, P43, DOI 10.4404/hystrix-24.1-6367; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2008, ANNU REV ECOL EVOL S, V39, P115, DOI 10.1146/annurev.ecolsys.37.091305.110054; Knox Andrew, 2010, Phyllomedusa, V9, P121; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larson Allan, 1996, P187; Larson PM, 2004, ZOOMORPHOLOGY, V123, P95, DOI 10.1007/s00435-003-0092-1; Losos JB, 2011, EVOLUTION, V65, P1827, DOI 10.1111/j.1558-5646.2011.01289.x; Marques Otavio Augusto Vuolo, 2009, Biota Neotrop., V9, P139, DOI 10.1590/S1676-06032009000200014; Marques Otavio Augusto Vuolo, 1994, Revista Brasileira de Biologia, V54, P253; Martins Marcio, 1999, Herpetological Natural History, V6, P78; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Monteiro LR, 2011, BMC EVOLUTIONARY BIO, V280; Oliveira L, 2013, HERP REV, V34, P251; Oliveira R.B., 2001, CUAD HERPETOL, V14, P117; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pyron RA, 2011, MOL PHYLOGENET EVOL, V58, P329, DOI 10.1016/j.ympev.2010.11.006; R Development Core Team, 2014, R LANG ENV STAT COMP; Rambaut A., 2014, TRACER V1 6; Revell LJ, 2007, EVOLUTION, V61, P2898, DOI 10.1111/j.1558-5646.2007.00225.x; Rohlf F. James, 1993, Monografias del Museo Nacional de Ciencias Naturales, V1993, P131; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ, 2008, VERSION 2 12 TPSRELW; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santana SE, 2012, EVOLUTION, V66, P2587, DOI 10.1111/j.1558-5646.2012.01615.x; SAVITZKY AH, 1983, AM ZOOL, V23, P397; SCARTOZZONI R. R., 2009, PROGRAMA POS GRADUAC; SCHLUTER D, 1984, AM NAT, V123, P175, DOI 10.1086/284196; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Serb JM, 2011, ZOOL J LINN SOC-LOND, V163, P571, DOI 10.1111/j.1096-3642.2011.00707.x; Stayton CT, 2005, J MORPHOL, V263, P47, DOI 10.1002/jmor.10288; STRUSSMANN C, 1993, STUD NEOTROP FAUNA E, V28, P157, DOI 10.1080/01650529309360900; Travaglia-Cardoso Silvia R., 2014, Herpetological Bulletin, P28; Vidal N, 2010, CR BIOL, V333, P48, DOI 10.1016/j.crvi.2009.11.003; Vincent SE, 2006, J EVOLUTION BIOL, V19, P1545, DOI 10.1111/j.1420-9101.2006.01126.x; Vincent SE, 2009, J EVOLUTION BIOL, V22, P1203, DOI 10.1111/j.1420-9101.2009.01739.x	58	31	31	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148375	10.1371/journal.pone.0148375	http://dx.doi.org/10.1371/journal.pone.0148375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886549	Green Published, gold			2022-12-27	WOS:000371218400033
J	Niyazov, Y; Vogel, C; Price, R; Lund, B; Judd, D; Akil, A; Mortonson, M; Schwartzman, J; Shron, M				Niyazov, Yuri; Vogel, Carl; Price, Richard; Lund, Ben; Judd, David; Akil, Adnan; Mortonson, Michael; Schwartzman, Josh; Shron, Max			Open Access Meets Discoverability: Citations to Articles Posted to Academia.edu	PLOS ONE			English	Article							IMPACT	Using matching and regression analyses, we measure the difference in citations between articles posted to Academia.edu and other articles from similar journals, controlling for field, impact factor, and other variables. Based on a sample size of 31,216 papers, we find that a paper in a median impact factor journal uploaded to Academia.edu receives 16% more citations after one year than a similar article not available online, 51% more citations after three years, and 69% after five years. We also found that articles also posted to Academia. edu had 58% more citations than articles only posted to other online venues, such as personal and departmental home pages, after five years.	[Niyazov, Yuri; Price, Richard; Lund, Ben; Judd, David; Akil, Adnan; Mortonson, Michael; Schwartzman, Josh] Acad Edu, San Francisco, CA USA; [Vogel, Carl; Shron, Max] Polynumeral, New York, NY USA		Price, R (corresponding author), Acad Edu, San Francisco, CA USA.	richard@academia.edu	DOĞAN, ADNAN/O-8846-2019	DOĞAN, ADNAN/0000-0002-0349-3846	Academia.edu; Polynumeral	Academia.edu; Polynumeral	Academia.edu paid its employees, contractors and an external consultancy (Polynumeral) to perform this study. Authors Yuri Niyazov, Richard Price, Ben Lund, David Judd, Adnan Akil, Michael Mortonson and Josh Schwartzman are employed by Academia.edu. Authors Carl Vogel and Max Shron are employed by Polynumeral. Academia.edu provided support in the form of salaries for authors YN, RP, BL, DJ, AA, MM and JS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section. Polynumeral provided support in the form of salaries for authors CV and MS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Academia. edu, 2013, ACADEMIA; [Anonymous], 2020, AUSTR NZ STAND RES C; Australian Research Council, 2012, EXC RES AUSTR ERA 20; Bornmann L., 2008, ETHICS SCI ENV POLIT, V2014, DOI [10.3354/esep00084, DOI 10.3354/ESEP00084]; Craig ID, 2007, J INFORMETR, V1, P239, DOI 10.1016/j.joi.2007.04.001; Davis PM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a568; Davis PM, 2011, J MED LIBR ASSOC, V99, P208, DOI 10.3163/1536-5050.99.3.008; Davis PM, 2011, FASEB J, V25, P2129, DOI 10.1096/fj.11-183988; Eysenbach G, 2006, PLOS BIOL, V4, P692, DOI 10.1371/journal.pbio.0040157; Gargouri Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013636; Gaule P, 2011, RES POLICY, V40, P1332, DOI 10.1016/j.respol.2011.05.025; Harnad S., 2004, D LIB MAGAZINE, V10; Kahn Richard, 2012, ACADEMIA; Kurtz MJ, 2005, INFORM PROCESS MANAG, V41, P1395, DOI 10.1016/j.ipm.2005.03.010; Lawrence S, 2001, NATURE, V411, P521, DOI 10.1038/35079151; Moed HF, 2007, J AM SOC INF SCI TEC, V58, P2047, DOI 10.1002/asi.20663; Schwarz GJ, 2004, ASTROPH0411275 ARXIV; SCImago, 2021, SJR SCIMAGO J COUNTR; Swan A., 2010, PREPRINT	19	57	60	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148257	10.1371/journal.pone.0148257	http://dx.doi.org/10.1371/journal.pone.0148257			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886730	gold, Green Submitted, Green Published			2022-12-27	WOS:000371218400023
J	Sugimoto, M; Ichio, A; Kondo, M				Sugimoto, Masahiko; Ichio, Atsushi; Kondo, Mineo			Importance of Central Retinal Sensitivity for Prediction of Visual Acuity after Intravitreal Bevacizumb in Eyes with Macular Edema Associated with Branch Retinal Vein Occlusion	PLOS ONE			English	Article							CENTRAL SEROUS CHORIORETINOPATHY; SCANNING LASER OPHTHALMOSCOPE; OPTICAL COHERENCE TOMOGRAPHY; ENDOTHELIAL GROWTH-FACTOR; TEST-RETEST VARIABILITY; MICROPERIMETRY; DEGENERATION; SECONDARY; TRIAMCINOLONE; IMPAIRMENT	Objective To determine whether the baseline retinal sensitivity can predict the best-corrected visual acuity (BCVA) at 1 month after intravitreal bevacizumab (IVB) in eyes with macular edema (ME) associated with a branch retinal vein occlusion (BRVO). Subjects and Methods We evaluated 16 eyes of 16 patients who had ME associated with a BRVO. The mean +/- standard deviation age was 69.1 +/- 8.9 years, and all had a single IVB injection. The BCVA, central macular thickness (CMT), integrity of the ellipsoid zone (EZ) of the photoreceptors, and retinal sensitivity were determined before (baseline) and at 1 day, 1 week, and 1 month following the IVB. The average threshold retinal sensitivity (AT) within the central 10 degrees was determined by Macular Integrity Assessment. The correlations between the BCVA at 1 month and the CMT, integrity of the EZ, and AT at each visit were determined. Results One month after IVB, the BCVA improved significantly from 0.56 +/- 0.27 logMAR units to 0.32 +/- 0.28 logMAR units, and the CMT from 611.4 +/- 209.3 mu m to 258.7 +/- 64.0 mu m (P < 0.05). The AT improved significantly from 17.9 +/- 5.3 dB to 21.2 +/- 5.0 dB (P < 0.05). At 1 day after the treatment, both the integrity of the EZ (r = 0.59) and the retinal sensitivity (r = 0.76) were moderately correlated with the BCVA at 1 month. Conclusion These results indicate that both the integrity of the EZ and the AT at 1 day after the IVB can predict the BCVA after treatment for ME associated with BRVO. There is a possibility that these parameters will predict the effectiveness of IVB for each case.	[Sugimoto, Masahiko; Ichio, Atsushi; Kondo, Mineo] Mie Univ, Grad Sch Med, Dept Ophthalmol, Tsu, Mie 514, Japan	Mie University	Sugimoto, M (corresponding author), Mie Univ, Grad Sch Med, Dept Ophthalmol, Tsu, Mie 514, Japan.	sugimochi@clin.medic.mie-u.ac.jp			Ministry of Education, Culture, Science and Technology, Japan [18591913]	Ministry of Education, Culture, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Grant support: Ministry of Education, Culture, Science and Technology (No. 18591913), Japan.	Agardh E, 2006, DIABETOLOGIA, V49, P200, DOI 10.1007/s00125-005-0072-8; Aizawa S, 2009, EYE, V23, P304, DOI 10.1038/sj.eye.6703076; Bengtsson B, 2005, DIABETOLOGIA, V48, P2494, DOI 10.1007/s00125-005-0001-x; Brown DM, 2011, OPHTHALMOLOGY, V118, P1594, DOI 10.1016/j.ophtha.2011.02.022; Campochiaro PA, 2010, OPHTHALMOLOGY, V117, P1102, DOI 10.1016/j.ophtha.2010.02.021; Campochiaro PA, 2010, OPHTHALMOLOGY, V117, P2387, DOI 10.1016/j.ophtha.2010.03.060; Chen FK, 2009, INVEST OPHTH VIS SCI, V50, P3464, DOI 10.1167/iovs.08-2926; Chen WC, 2012, RETINA-J RET VIT DIS, V32, P1733, DOI 10.1097/IAE.0b013e318242b81a; Fujiwara Atsushi, 2014, Nippon Ganka Gakkai Zasshi, V118, P15; Haller JA, 2010, OPHTHALMOLOGY, V117, P1134, DOI 10.1016/j.ophtha.2010.03.032; HEIJL A, 1989, ARCH OPHTHALMOL-CHIC, V107, P81, DOI 10.1001/archopht.1989.01070010083032; Hoh AE, 2008, OPHTHALMOLOGE, V105, P1121, DOI 10.1007/s00347-008-1759-2; Johnson MW, 2009, AM J OPHTHALMOL, V147, P11, DOI 10.1016/j.ajo.2008.07.024; Jonas JB, 2005, EYE, V19, P65, DOI 10.1038/sj.eye.6701395; Jonas JB, 2010, ACTA OPHTHALMOL, V88, pe24, DOI 10.1111/j.1755-3768.2009.01510.x; Kiss CG, 2008, BRIT J OPHTHALMOL, V92, P84, DOI 10.1136/bjo.2007.124016; Kriechbaum K, 2009, OPHTHALMOLOGY, V116, P2415, DOI 10.1016/j.ophtha.2009.05.001; Krohne TU, 2008, AM J OPHTHALMOL, V146, P508, DOI 10.1016/j.ajo.2008.05.036; Midena E, 1997, INVEST OPHTH VIS SCI, V38, P469; Mitamura Y, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/518170; Noma H, 2005, AM J OPHTHALMOL, V140, P256, DOI 10.1016/j.ajo.2005.03.003; Ozdemir H, 2008, EYE, V22, P204, DOI 10.1038/sj.eye.6702563; Park SP, 2010, RETINA-J RET VIT DIS, V30, P281, DOI 10.1097/IAE.0b013e3181b9f153; Prager F, 2009, BRIT J OPHTHALMOL, V93, P452, DOI 10.1136/bjo.2008.141085; Richter-Mueksch S, 2007, AM J OPHTHALMOL, V144, P23, DOI 10.1016/j.ajo.2007.03.045; Rohrschneider K, 2000, AM J OPHTHALMOL, V129, P27, DOI 10.1016/S0002-9394(99)00270-6; Roisman L, 2014, RETINA-J RET VIT DIS, V34, P713, DOI 10.1097/IAE.0b013e3182a323fe; Scott IU, 2009, OPHTHALMOLOGY, V116, P504, DOI 10.1016/j.ophtha.2008.10.017; Shimura M, 2008, ACTA OPHTHALMOL, V86, P377, DOI 10.1111/j.1600-0420.2007.01074.x; SJAARDA RN, 1993, OPHTHALMOLOGY, V100, P1513; Suh MH, 2009, AM J OPHTHALMOL, V147, P473, DOI 10.1016/j.ajo.2008.09.020; Vujosevic S, 2011, OPHTHALMOLOGICA, V225, P155, DOI 10.1159/000320340; Wu ZC, 2013, INVEST OPHTH VIS SCI, V54, P7378, DOI 10.1167/iovs.13-12617; Yamaike N, 2008, OPHTHALMOLOGY, V115, P355, DOI 10.1016/j.ophtha.2007.04.052; Yamaike N, 2009, RETINA-J RET VIT DIS, V29, P757, DOI 10.1097/IAE.0b013e31819d4fbf	35	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149246	10.1371/journal.pone.0149246	http://dx.doi.org/10.1371/journal.pone.0149246			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885822	Green Submitted, Green Published, gold			2022-12-27	WOS:000371218400071
J	Choueiry, N; Salamoun, T; Jabbour, H; El Osta, N; Hajj, A; Khabbaz, LR				Choueiry, Nour; Salamoun, Tracy; Jabbour, Hicham; El Osta, Nada; Hajj, Aline; Khabbaz, Lydia Rabbaa			Insomnia and Relationship with Anxiety in University Students: A Cross-Sectional Designed Study	PLOS ONE			English	Article							EXCESSIVE DAYTIME SLEEPINESS; QUALITY INDEX; SEVERITY INDEX; MENTAL-HEALTH; PRIMARY-CARE; EPIDEMIOLOGY; DISORDERS; PREVALENCE; ASSOCIATION; VALIDATION	Purpose Sleep disorders (SDs) are now recognized as a public health concern with considerable psychiatric and societal consequences specifically on the academic life of students. The aims of this study were to assess SDs in a group of university students in Lebanon and to examine the relationship between SDs and anxiety. Methods An observational cross-sectional study was conducted at Saint-Joseph University, Lebanon, during the academic year 2013-2014. Four questionnaires were face-to-face administered to 462 students after obtaining their written consent: Insomnia Severity Index (ISI), Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), and Generalized Anxiety Disorder 7-item scale (GAD-7). Results The prevalence of clinically significant insomnia was 10.6% (95% CI: 7.8-13.4%), more frequent in first year students. ISI mean score was 10.06 (SD = 3.76). 37.1% of the participants were poor sleepers. Excessive daytime sleepiness (EDS) and poor sleep were significantly more frequent among participants with clinical insomnia (p = 0.031 and 0.001 respectively). Clinically significant anxiety was more frequent in students suffering from clinical insomnia (p = 0.006) and in poor sleepers (p = 0.003). 50.8% of the participants with clinically significant anxiety presented EDS versus 30.9% of those with no clinically significant anxiety (p<0.0001). Conclusions The magnitude of SDs in this sample of Lebanese university students demonstrate the importance of examining sleep health in this population. Moreover, the link between SD and anxiety reminds us of the importance of treating anxiety as soon as detected and not simply targeting the reduction of sleep problems.	[Choueiry, Nour; Salamoun, Tracy; Hajj, Aline; Khabbaz, Lydia Rabbaa] St Joseph Univ Beirut, Fac Pharm, Beirut, Lebanon; [Jabbour, Hicham] St Joseph Univ Beirut, Dept Anesthesia & Crit Care, Hotel Dieu France Hosp, Beirut, Lebanon; [Jabbour, Hicham] St Joseph Univ Beirut, Fac Med, Beirut, Lebanon; [El Osta, Nada] St Joseph Univ, Fac Med, Dept Publ Hlth, Beirut, Lebanon; [El Osta, Nada] St Joseph Univ, Fac Med Dent, Dept Prosthodont, Beirut, Lebanon; [Hajj, Aline; Khabbaz, Lydia Rabbaa] St Joseph Univ Beirut, Fac Pharm, Lab Pharmacol Pharm Clin & Controle Qualite Medic, Beirut, Lebanon		Khabbaz, LR (corresponding author), St Joseph Univ Beirut, Fac Pharm, Beirut, Lebanon.; Khabbaz, LR (corresponding author), St Joseph Univ Beirut, Fac Pharm, Lab Pharmacol Pharm Clin & Controle Qualite Medic, Beirut, Lebanon.	lydia.khabbaz@usj.edu.lb	EL OSTA, Nada/GRS-4789-2022	Jabbour, Hicham/0000-0003-1033-850X				Alfano CA, 2010, CHILD PSYCHIAT HUM D, V41, P156, DOI 10.1007/s10578-009-0158-5; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Armstrong D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101368; Banks S, 2007, J CLIN SLEEP MED, V3, P519; Belleville G, 2011, CLIN PSYCHOL REV, V31, P638, DOI 10.1016/j.cpr.2011.02.004; Blais FC, 2001, CAN FAM PHYSICIAN, V47, P759; Buysse D J, 1989, Psychiatry Res, V28, P193; Buysse DJ, 2008, J CLIN SLEEP MED, V4, P563; Carroll JE, 2015, PSYCHONEUROENDOCRINO, V55, P184, DOI 10.1016/j.psyneuen.2015.02.010; Cho YW, 2014, J CLIN NEUROL, V10, P210, DOI 10.3988/jcn.2014.10.3.210; Chung KF, 2015, SLEEP MED, V16, P477, DOI 10.1016/j.sleep.2014.10.018; Forbes EE, 2008, J AM ACAD CHILD PSY, V47, P148, DOI 10.1097/chi.0b013e31815cd9bc; Gagnon C, 2013, J AM BOARD FAM MED, V26, P701, DOI 10.3122/jabfm.2013.06.130064; Gellis LA, 2014, BEHAV THER, V45, P806, DOI 10.1016/j.beth.2014.05.002; Goldman-Mellor S, 2014, SLEEP, V37, P1767, DOI 10.5665/sleep.4168; Gregory AM, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200208000-00015; HABTEGABR E, 1991, J CLIN EPIDEMIOL, V44, P5, DOI 10.1016/0895-4356(91)90195-F; Hasler G, 2005, J CLIN PSYCHIAT, V66, P521, DOI 10.4088/JCP.v66n0416; Hayley AC, 2015, METABOLISM, V64, P244, DOI 10.1016/j.metabol.2014.09.011; Hayley AC, 2013, AUST NZ J PSYCHIAT, V47, P772, DOI 10.1177/0004867413490036; Jansson M, 2006, BRIT J HEALTH PSYCH, V11, P501, DOI 10.1348/135910705X57412; Jansson-Frojmark M, 2008, J PSYCHOSOM RES, V64, P443, DOI 10.1016/j.jpsychores.2007.10.016; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Johnson EO, 2006, PEDIATRICS, V117, pE247, DOI 10.1542/peds.2004-2629; Johnson EO, 2006, J PSYCHIATR RES, V40, P700, DOI 10.1016/j.jpsychires.2006.07.008; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Leger D, 2010, SLEEP MED, V11, P987, DOI 10.1016/j.sleep.2010.04.019; Leistner SM, 2015, EUR J ENDOCRINOL; Mason EC, 2014, J AFFECT DISORDERS, V168, P415, DOI 10.1016/j.jad.2014.07.020; Mondal P, 2013, NAT SCI SLEEP, V5, P15, DOI 10.2147/NSS.S40608; Monti JM, 2004, SLEEP MED REV, V8, P133, DOI 10.1016/S1087-0792(02)00158-2; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Morphy H, 2007, SLEEP, V30, P274; Murthy Vasantmeghna Srinivasa, 2014, Ind Psychiatry J, V23, P23, DOI 10.4103/0972-6748.144952; National Center On Sleep Disorders Research, 2011, NAT I HLTH SLEEP DIS; Ohayon MM, 2012, SLEEP MED, V13, P52, DOI 10.1016/j.sleep.2011.06.010; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Roth T, 2007, J CLIN SLEEP MED, V3, pS7, DOI [10.5664/jcsm.26929, DOI 10.5664/JCSM.26929]; Royal College of Psychiatrists, 2011, MENT HLTH STUD HIGH; Sekercioglu N, 2015, REN FAIL, P1; Shamsuddin K, 2013, ASIAN J PSYCHIATR, V6, P318, DOI 10.1016/j.ajp.2013.01.014; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Storch EA, 2008, J ANXIETY DISORD, V22, P877, DOI 10.1016/j.janxdis.2007.09.003; Taylor DJ, 2013, BEHAV THER, V44, P339, DOI 10.1016/j.beth.2012.12.001; Thomas SJ, 2014, BEHAV SLEEP MED, V12, P169, DOI 10.1080/15402002.2013.778202	45	66	71	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149643	10.1371/journal.pone.0149643	http://dx.doi.org/10.1371/journal.pone.0149643			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26900686	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100118
J	Hall, SS; Gee, NR; Mills, DS				Hall, Sophie Susannah; Gee, Nancy R.; Mills, Daniel Simon			Children Reading to Dogs: A Systematic Review of the Literature	PLOS ONE			English	Review							ACADEMIC SELF-CONCEPT; INTRINSIC MOTIVATION; MEMORY TASK; COMPREHENSION; PERFORMANCE; SKILLS; PRESCHOOLERS; ACHIEVEMENT; ACCURACY; EXERCISE	Background Despite growing interest in the value of human-animal interactions (HAI) to human mental and physical health the quality of the evidence on which postulated benefits from animals to human psychological health are based is often unclear. To date there exist no systematic reviews on the effects of HAI in educational settings specifically focussing on the perceived benefits to children of reading to dogs. With rising popularity and implementation of these programmes in schools, it is essential that the evidence base exploring the pedagogic value of these initiatives is well documented. Methods Using PRISMA guidelines we systematically investigated the literature reporting the pedagogic effects of reading to dogs. Because research in this area is in the early stages of scientific enquiry we adopted broad inclusion criteria, accepting all reports which discussed measurable effects related to the topic that were written in English. Multiple online databases were searched during January-March 2015; grey literature searches were also conducted. The search results which met the inclusion criteria were evaluated, and discussed, in relation to the Oxford Centre for Evidence Based Medicine levels of evidence; 27 papers were classified as Level 5, 13 as Level 4, 7 as Level 2c and 1 as Level 2b. Conclusion The evidence suggests that reading to a dog may have a beneficial effect on a number of behavioural processes which contribute to a positive effect on the environment in which reading is practiced, leading to improved reading performance. However, the evidence base on which these inferences are made is of low quality. There is a clear need for the use of higher quality research methodologies and the inclusion of appropriate controls in order to draw causal inferences on whether or how reading to dogs may benefit children's reading practices. The mechanisms for any effect remain a matter of conjecture.	[Hall, Sophie Susannah; Mills, Daniel Simon] Lincoln Univ, Sch Life Sci, Lincoln, NE USA; [Gee, Nancy R.] WALTHAM Ctr Pet Nutr, Melton Mowbray, Leics, England	Mars; WALTHAM Petcare Science Institute	Hall, SS (corresponding author), Lincoln Univ, Sch Life Sci, Lincoln, NE USA.	shall@lincoln.ac.uk		Hall, Sophie/0000-0002-9847-8269; Gee, Nancy/0000-0003-2890-9884	WALTHAM Centre for Pet Nutrition	WALTHAM Centre for Pet Nutrition	NRG was employed by WALTHAM Centre for Pet Nutrition at the time of contributing to this paper. WALTHAM Centre for Pet Nutrition provided support in the form of salaries for authors [NRG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of NRG are articulated in the 'author contributions' section.	Amsterlaw J, 2009, CHILD DEV, V80, P115, DOI 10.1111/j.1467-8624.2008.01249.x; Anderson KL, 2006, ANTHROZOOS, V19, P35, DOI 10.2752/089279306785593919; Bassette LA, 2013, CHILD YOUTH CARE FOR, V42, P239, DOI 10.1007/s10566-013-9197-y; Beck AM, 2003, AM BEHAV SCI, V47, P79, DOI 10.1177/0002764203255214; Beetz A, 2012, FRONT PSYCHOL, V3, DOI [10.3389/fpsyg.2012.00234, 10.3389/fpsyg.2012.00352]; Bergesen FJ, 1989, 5 INT C REL HUM AN M; Black S, 2009, AM SCH BOARD J, V196, P36; Booten AE, 2011, THESIS MARSHALL U; Bueche S., 2003, READING TODAY, V20, P46; Burns R, 2014, READING PAWS GIVING; Chapman JW, 2000, J EDUC PSYCHOL, V92, P703, DOI 10.1037/0022-0663.92.4.703; Chapman JW, 1999, CHILDRENS SELF PERCE, P29; Clark, 2011, MAPPING INTERRELATIO, P1; Clark C., 2011, YOUNG PEOPLES READIN; Cree A., 2012, EC SOCIAL COST ILLIT; Department for Education, 2012, READ FOR PLEAS; Dunlap VM, 2010, THESIS NO MICHIGAN U; Ecklund B. K., 2008, IMPROVING READING AC; EVERSON HT, 1994, ANXIETY STRESS COPIN, V7, P85, DOI 10.1080/10615809408248395; Faver C, 2009, REFLECTIONS NARRATIV, V15, P21; Fernandez P., 2010, SOCIAL EC IMPACT ILL; Fisher B, 2014, LIT LEARN, V22, P70; Francis A, 2009, THURSDAYS MACGYVER; FRIEDMANN E, 1983, J NERV MENT DIS, V171, P461, DOI 10.1097/00005053-198308000-00002; Friedmann E, 2000, HDB ANIMAL ASSISTED, P41; Friesen L., 2012, CHILDHOOD EDUC, V88, P102, DOI [DOI 10.1080/00094056.2012.662124, 10.1080/00094056.2012.662124]; Friesen L., 2009, LEARNING LSCAPES, V3, P105; Friesen L, 2010, LANG LITER, V12, P21, DOI 10.20360/G2WC70; Gallatin E, 2014, 24 SCH ED; Gee NR, 2007, ANTHROZOOS, V20, P375, DOI 10.2752/089279307X245509; Gee NR, 2014, ANTHROZOOS, V27, P513, DOI 10.2752/089279314X14072268687763; Gee NR, 2012, ANTHROZOOS, V25, P289, DOI 10.2752/175303712X13403555186172; Gee NR, 2010, ANTHROZOOS, V23, P173, DOI 10.2752/175303710X12682332910051; Gee NR, 2009, ANTHROZOOS, V22, P267, DOI 10.2752/175303709X457603; Grandgeorge M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041739; Griess JO, 2010, THESIS U S FLORIDA; Grigore AA, 2014, SOC ANIM, P1; Guthrie J.T., 2000, HDB READING RES, VVolume 3, P403, DOI DOI 10.1023/A:1016627907001; Guthrie JT, 2001, EDUC PSYCHOL REV, V13, P283, DOI 10.1023/A:1016627907001; Hanin Y., 2000, EMOTIONS SPORT; Hanin YL, 1997, EUROPEAN YB SPORT PS, V1, P29; HENK WA, 1995, READ TEACH, V48, P470; Hergovich A, 2002, ANTHROZOOS, V15, P37, DOI 10.2752/089279302786992775; Heyer J, 2007, THESIS AUGSBURG COLL; Hidi S, 2000, REV EDUC RES, V70, P151, DOI 10.2307/1170660; Hughes K., 2002, PUBLIC LIB, V41, P328; IALONGO N, 1994, J ABNORM CHILD PSYCH, V22, P441, DOI 10.1007/BF02168084; Inklebarger T, 2014, AM LIB, V45; Intermountain Therapy Animals, 2014, READ ED ASS DOGS REA; Jalongo M. R., 2005, CHILDHOOD ED, V81, P152, DOI DOI 10.1080/00094056.2005.10522259; Jalongo MR, 2010, EARLY CHILD EDUC J, V37, P431, DOI 10.1007/s10643-010-0381-5; Jalongo MR., 2004, EARLY CHILD EDUC J, V32, P9, DOI [10.1023/B:ECEJ.0000039638.60714.5f, DOI 10.1023/B:ECEJ.0000039638.60714.5F]; Kaymen MS, THESIS DOMINICAN U C; Kennel Club, 2011, EDUCATION, V447, P5; Konarski J., MORE JUST CLASS PET; Kruger KA., 2006, HDB ANIMAL ASSISTED, V2nd ed, pp. 21, DOI 10.1177/1039856217749056; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Lane HB, 2013, READ TEACH, V67, P87, DOI 10.1002/TRTR.1204; Lang UE, 2010, EUR J INTEGR MED, V2, P123, DOI 10.1016/j.eujim.2010.07.002; le Roux MC, 2014, CHILD YOUTH CARE FOR, V43, P655, DOI 10.1007/s10566-014-9262-1; Lenihan D, BENEFITS READING ASS; Lloyd J, 2014, IM ED RES GROUP IERG; LoBue V, 2013, BRIT J DEV PSYCHOL, V31, P57, DOI 10.1111/j.2044-835X.2012.02078.x; Logan S, 2011, LEARN INDIVID DIFFER, V21, P124, DOI 10.1016/j.lindif.2010.09.011; Marsh HW, 1997, J EDUC PSYCHOL, V89, P41, DOI 10.1037/0022-0663.89.1.41; Martin F, 2002, WESTERN J NURS RES, V24, P657, DOI 10.1177/019394502320555403; Martin S, 2001, INTERACTION, V19, P7; McConnell AR, 2011, J PERS SOC PSYCHOL, V101, P1239, DOI 10.1037/a0024506; Mceachern Steven, 2003, J FURTHER HIGHER ED, V27, P3; McNicholas J., 2006, HDB ANIMAL ASSISTED, P49; Mills D, 2014, VET REC, V174, P269, DOI 10.1136/vr.g1929; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Moore EGJ, 2013, ANTHROZOOS, V26, P381, DOI 10.2752/175303713X13697429463637; New J, 2007, P NATL ACAD SCI USA, V104, P16598, DOI 10.1073/pnas.0703913104; Newlin R., 2003, SCH LIB J, V49, P43, DOI DOI 10.1023/B:ECEJ.0000039638.60714.5F; O'Haire M, 2010, J VET BEHAV, V5, P226, DOI 10.1016/j.jveb.2010.02.002; O'Haire ME, 2015, DEV PSYCHOBIOL; OECD, 2010, PISA 2009 RES LEARN, V3; Paradise J. L, 2007, THESIS U CENTRAL FLO; Petersen A, 2008, THESIS ALLIANT INT U; Pillow-Price Kathy., 2014, DIMENSIONS EARLY CHI, V1, P5; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI 10.1515/9781400876136; Ryan RM, 2000, CONTEMP EDUC PSYCHOL, V25, P54, DOI 10.1006/ceps.1999.1020; Sainsbury M, 2004, J RES READ, V27, P373, DOI 10.1111/j.1467-9817.2004.00240.x; Schuck SEB, 2013, J ATTEN DISORD; Shannon M, THESIS QUEENS COLL C; Shaw DM, 2013, READ TEACH, V66, P365, DOI 10.1002/TRTR.01136; Siegel WL., 2004, REVISION, V27, P17; Silva K, 2011, J ALTERN COMPLEM MED, V17, P655, DOI 10.1089/acm.2010.0436; Smith C.S., 2009, THESIS NATL LOUIS U, P31; Smith M. H., 2010, ALL EARS READING PRO; Snider B., 2007, EDUTOPIA; Somervill J.W., 2009, N AM J PSYCHOL, V11, P111; Tales of JOY R.E.A.D. Program, FIN DAT REP 2014 201; Tomporowski PD, 2008, EDUC PSYCHOL REV, V20, P111, DOI 10.1007/s10648-007-9057-0; Treat WA, 2013, THESIS UC SANTA CRUZ; Truett C, 2011, PUBLIC LIB, V50, P44; University of Tennessee College of Veterinary Science, 2015, CURRICULUM REV, V54, P4; VANHOUTTE BA, 1995, J APPL DEV PSYCHOL, V16, P463, DOI 10.1016/0193-3973(95)90030-6; Viau R, 2010, PSYCHONEUROENDOCRINO, V35, P1187, DOI 10.1016/j.psyneuen.2010.02.004; Walsh AE, 2014, THESIS STATE U NEW Y; Wang JHY, 2004, READ RES QUART, V39, P162, DOI 10.1598/RRQ.39.2.2; Wigfield A, 1997, J EDUC PSYCHOL, V89, P420, DOI 10.1037/0022-0663.89.3.420; Wigfield A, 1997, EDUC PSYCHOL, V32, P57; Wilson E. O., 1984, HARV U PRESS, DOI DOI 10.2307/J.CTVK12S6H; Wohlfarth R., 2014, Human-Animal Interaction Bulletin, V2, P60; Zbornik J, 2001, TODAYS SCH PSYCHOL	107	52	53	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149759	10.1371/journal.pone.0149759	http://dx.doi.org/10.1371/journal.pone.0149759			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26901412	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000371276100146
J	Joubert, M; Bellevre, D; Legallois, D; Elie, N; Coulbault, L; Allouche, S; Manrique, A				Joubert, Michael; Bellevre, Dimitri; Legallois, Damien; Elie, Nicolas; Coulbault, Laurent; Allouche, Stephane; Manrique, Alain			Hyperglycemia-Induced Hypovolemia Is Involved in Early Cardiac Magnetic Resonance Alterations in Streptozotocin-Induced Diabetic Mice: A Comparison with Furosemide-Induced Hypovolemia	PLOS ONE			English	Article							IN-VIVO; MYOCARDIAL FIBROSIS; HEART-FAILURE; CARDIOMYOPATHY; DYSFUNCTION; RAT; OVEREXPRESSION; INSULIN; TYPE-1; METABOLISM	Aims The aim of the study was to assess the early features of diabetic cardiomyopathy using cardiac magnetic resonance within the first week after streptozotocin injection in mice. We focused on the relationship between left ventricular function and hypovolemia markers in diabetic animals compared to a hypovolemic rodent model. Methods and Results Swiss mice were randomized into control (group C), streptozotocin(induced diabetes (group D) and furosemide(induced hypovolemia (group F) groups. Cardiac magnetic resonance, non(invasive blood pressure, urine volume, plasma markers of dehydration and cardiac histology were assessed in all groups. Mean blood glucose was higher in diabetic animals than in groups C and F (30.5 +/- 5.8 compared to 10.4 +/- 2.1 and 11.1 +/- 2.8 mmol/L, respectively; p < 0.01). Diuresis was increased in animals from group D and F compared to C (14650 +/- 11499 and 1533 +/- 540 compared to 192 +/- 111 mu L/24 h; p < 0.05). End diastolic and end systolic volumes were lower in group D than in group C at week 1 (1.52 +/- 0.36 vs. 1.93 +/- 0.35 and 0.54 +/- 0.22 vs. 0.75 +/- 0.18 mL/kg, p < 0.05). These left ventricular volume values in group D were comparable to those observed in the acute hypovolemia model (group F). Increased dehydration plasma markers and an absence of obvious intrinsic myocardial damage (evaluated by cardiac magnetic resonance and histology) suggest that a hemodynamic mechanism underlies the very early drop in left ventricular volumes in group D and provides a potential link to hyperglycemic osmotic diuresis. Conclusions Researchers using cardiac magnetic resonance in hyperglycemic rodent models should be aware of this hemodynamic mechanism, which may partially explain modifications in cardiac parameters in addition to diabetic myocardial damage.	[Joubert, Michael] Caen Univ Hosp, Diabet Care Unit, Caen, France; [Bellevre, Dimitri; Manrique, Alain] Caen Univ Hosp, Dept Nucl Med, Caen, France; [Legallois, Damien] Caen Univ Hosp, Cardiol Unit, Caen, France; [Elie, Nicolas] Univ Caen Normandie, IBFA, CMABIO HIQ Facil, ICORE SF4206, Caen, France; [Coulbault, Laurent; Allouche, Stephane] Caen Univ Hosp, Biochem Unit, Caen, France; [Joubert, Michael; Bellevre, Dimitri; Legallois, Damien; Coulbault, Laurent; Allouche, Stephane; Manrique, Alain] Univ Caen Normandie, EA4650, GIP Cyceron, Caen, France	CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite de Caen Normandie	Joubert, M (corresponding author), Caen Univ Hosp, Diabet Care Unit, Caen, France.; Joubert, M (corresponding author), Univ Caen Normandie, EA4650, GIP Cyceron, Caen, France.	joubert-m@chu-caen.fr	Elie, Nicolas/ABC-4069-2020	Elie, Nicolas/0000-0001-5772-8252; Allouche, stephane/0000-0003-3134-7501	AIR Association; ANABIM Association	AIR Association; ANABIM Association	MJ received a research grant form AIR Association. DB received a research grant from ANABIM Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors received no specific funding for this work.	Aneja A, 2008, AM J MED, V121, P748, DOI 10.1016/j.amjmed.2008.03.046; Aronson D, 1997, ANN INTERN MED, V126, P296, DOI 10.7326/0003-4819-126-4-199702150-00006; Becher PM, 2013, INT J MOL MED, V32, P158, DOI 10.3892/ijmm.2013.1368; Bonito P, 2005, DIABETIC MED, V22, P1720, DOI 10.1111/j.1464-5491.2005.01685.x; Boudina S, 2010, REV ENDOCR METAB DIS, V11, P31, DOI 10.1007/s11154-010-9131-7; Brands MW, 2012, AM J PHYSIOL-REG I, V303, pR1101, DOI 10.1152/ajpregu.00390.2012; Bugger H, 2009, DIS MODEL MECH, V2, P454, DOI 10.1242/dmm.001941; Bun SS, 2012, INVEST RADIOL, V47, P319, DOI 10.1097/RLI.0b013e318243e062; Bupha-Intr T, 2011, AM J PHYSIOL-HEART C, V300, pH1661, DOI 10.1152/ajpheart.00411.2010; Carrabba N, 2004, CIRCULATION, V110, P1974, DOI 10.1161/01.CIR.0000143376.64970.4A; de Jong S, 2011, J MOL CELL CARDIOL, V51, P974, DOI 10.1016/j.yjmcc.2011.08.024; Frustaci A, 2000, CIRC RES, V87, P1123, DOI 10.1161/01.RES.87.12.1123; Gaede P, 2004, DIABETES, V53, pS39, DOI 10.2337/diabetes.53.suppl_3.S39; Goode Adam, 2013, J Pathol Inform, V4, P27, DOI 10.4103/2153-3539.119005; HILSTED J, 1993, CLIN PHYSIOL, V13, P1, DOI 10.1111/j.1475-097X.1993.tb00312.x; Joffe II, 1999, J AM COLL CARDIOL, V34, P2111, DOI 10.1016/S0735-1097(99)00436-2; Kajstura J, 2001, DIABETES, V50, P1414, DOI 10.2337/diabetes.50.6.1414; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kruger M, 2010, J MOL CELL CARDIOL, V48, P910, DOI 10.1016/j.yjmcc.2010.02.012; Labombarda F, 2014, DIABETES METAB, V40, P292, DOI 10.1016/j.diabet.2014.03.007; Loganathan R, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-7; Luik PT, 2003, EUR J CLIN INVEST, V33, P787, DOI 10.1046/j.1365-2362.2003.01215.x; Maliha G, 2015, J AM SOC HYPERTENS, V9, P48, DOI 10.1016/j.jash.2014.11.001; Malone MA, 2007, METABOLISM, V56, P1118, DOI 10.1016/j.metabol.2007.04.005; Miki T, 2013, HEART FAIL REV, V18, P149, DOI 10.1007/s10741-012-9313-3; Muniyappa R, 2007, ENDOCR REV, V28, P463, DOI 10.1210/er.2007-0006; Nielsen LB, 2002, J BIOL CHEM, V277, P27014, DOI 10.1074/jbc.M203458200; Oh Se Won, 2015, Electrolyte Blood Press, V13, P17, DOI 10.5049/EBP.2015.13.1.17; Palm F, 2004, DIABETES-METAB RES, V20, P452, DOI 10.1002/dmrr.472; Radovits T, 2009, AM J PHYSIOL-HEART C, V297, pH125, DOI 10.1152/ajpheart.00165.2009; Rijzewijk LJ, 2008, J AM COLL CARDIOL, V52, P1793, DOI 10.1016/j.jacc.2008.07.062; Rijzewijk LJ, 2009, J AM COLL CARDIOL, V54, P1524, DOI 10.1016/j.jacc.2009.04.074; Setser RM, 2000, J MAGN RESON IMAGING, V12, P430, DOI 10.1002/1522-2586(200009)12:3<430::AID-JMRI8>3.0.CO;2-V; Shah AM, 2010, EUR J HEART FAIL, V12, P1229, DOI 10.1093/eurjhf/hfq179; Taylor AC, 2008, AM J PHYSIOL-REG I, V294, pR1285, DOI 10.1152/ajpregu.00003.2008; Tocci G, 2008, J HYPERTENS, V26, P1477, DOI 10.1097/HJH.0b013e3282fe1d3d; Trost SU, 2002, DIABETES, V51, P1166, DOI 10.2337/diabetes.51.4.1166; Vallee JP, 2004, MAGN RESON MATER PHY, V17, P149, DOI 10.1007/s10334-004-0066-4; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Yu XC, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-6; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	41	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149808	10.1371/journal.pone.0149808	http://dx.doi.org/10.1371/journal.pone.0149808			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901278	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100155
J	Kim, EJ; Kyeong, S; Cho, SW; Chun, JW; Park, HJ; Kim, J; Kim, J; Dolan, RJ; Kim, JJ				Kim, Eun Joo; Kyeong, Sunghyon; Cho, Sang Woo; Chun, Ji-Won; Park, Hae-Jeong; Kim, Jihye; Kim, Joohan; Dolan, Raymond J.; Kim, Jae-Jin			Happier People Show Greater Neural Connectivity during Negative Self-Referential Processing	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; LIFE SATISFACTION; SOCIAL COGNITION; ESTEEM; METAANALYSIS; PERSONALITY; BRAIN; FMRI; RESPONSES; HAPPINESS	Life satisfaction is an essential component of subjective well-being and provides a fundamental resource for optimal everyday functioning. The goal of the present study was to examine how life satisfaction influences self-referential processing of emotionally valenced stimuli. Nineteen individuals with high life satisfaction (HLS) and 21 individuals with low life satisfaction (LLS) were scanned using functional MRI while performing a face-word relevance rating task, which consisted of 3 types of face stimuli (self, public other, and unfamiliar other) and 3 types of word stimuli (positive, negative, and neutral). We found a significant group x word valence interaction effect, most strikingly in the dorsal medial prefrontal cortex. In the positive word condition dorsal medial prefrontal cortex activity was significantly higher in the LLS group, whereas in the negative word condition it was significantly higher in the HLS group. The two groups showed distinct functional connectivity of the dorsal medial prefrontal cortex with emotional processing-related regions. The findings suggest that, in response to emotional stimuli, individuals with HLS may successfully recruit emotion regulation-related regions in contrast to individuals with LLS. The difference in functional connectivity during self-referential processing may lead to an influence of life satisfaction on responses to emotion-eliciting stimuli.	[Kim, Eun Joo] Yonsei Univ, Grad Sch Educ, Seoul 120749, South Korea; [Kyeong, Sunghyon; Cho, Sang Woo; Chun, Ji-Won; Kim, Jae-Jin] Yonsei Univ, Coll Med, Inst Behav Sci Med, Seoul, South Korea; [Park, Hae-Jeong] Yonsei Univ, Coll Med, Dept Nucl Med, Seoul, South Korea; [Kim, Jihye] Yonsei Univ, Dept Psychol, Seoul 120749, South Korea; [Kim, Joohan] Yonsei Univ, Dept Commun, Seoul 120749, South Korea; [Dolan, Raymond J.] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Kim, Jae-Jin] Yonsei Univ, Dept Psychiat, Gangnam Severance Hosp, Seoul 120749, South Korea	Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; University of London; University College London; Yonsei University; Yonsei University Health System	Kim, JJ (corresponding author), Yonsei Univ, Coll Med, Inst Behav Sci Med, Seoul, South Korea.; Kim, JJ (corresponding author), Yonsei Univ, Dept Psychiat, Gangnam Severance Hosp, Seoul 120749, South Korea.	jaejkim@yonsei.ac.kr		Park, Hae-Jeong/0000-0002-4633-0756; Chun, Ji-Won/0000-0002-0629-0358; Kyeong, Sunghyon/0000-0002-9095-5219; Kim, Jae-Jin/0000-0002-1395-4562	National Research Foundation of Korea (NRF) - Korean government (MEST) [NRF-2013R1A2A2A03068342]	National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. NRF-2013R1A2A2A03068342).	ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Ayduk O, 2008, PSYCHOL SCI, V19, P229, DOI 10.1111/j.1467-9280.2008.02073.x; Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Baumeister RF, 2003, PSYCHOL SCI, P1, DOI 10.1111/1529-1006.01431; Blair KS, 2013, NEUROIMAGE, V78, P103, DOI 10.1016/j.neuroimage.2013.03.063; Caprara GV, 2009, BEHAV GENET, V39, P277, DOI 10.1007/s10519-009-9267-y; Collins AL, 2009, PSYCHOL AGING, V24, P696, DOI 10.1037/a0016777; Cummins RA., 2002, J HAPPINESS STUD, V3, P37, DOI [10.1023/A:1015678915305, DOI 10.1023/A:1015678915305, 10.1023/a:1015678915305]; D'Argembeau A, 2012, CEREB CORTEX, V22, P659, DOI 10.1093/cercor/bhr144; DeCoster J, 2009, PSYCHOL METHODS, V14, P349, DOI 10.1037/a0016956; DeNeve KM, 1998, PSYCHOL BULL, V124, P197, DOI 10.1037/0033-2909.124.2.197; Denny BT, 2012, J COGNITIVE NEUROSCI, V24, P1742, DOI 10.1162/jocn_a_00233; Diener E, 2003, ANNU REV PSYCHOL, V54, P403, DOI 10.1146/annurev.psych.54.101601.145056; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Frewen PA, 2008, CLIN PSYCHOL REV, V28, P228, DOI 10.1016/j.cpr.2007.05.002; Frewen PA, 2013, SOC COGN AFFECT NEUR, V8, P546, DOI 10.1093/scan/nss032; Frewen PA, 2011, SOC COGN AFFECT NEUR, V6, P375, DOI 10.1093/scan/nsq047; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Gannon N, 2005, PERS INDIV DIFFER, V38, P1353, DOI 10.1016/j.paid.2004.09.001; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Grecucci A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00523; Gyurak A, 2012, SOC COGN AFFECT NEUR, V7, P322, DOI 10.1093/scan/nsr014; Hampton AN, 2007, NEURON, V55, P545, DOI 10.1016/j.neuron.2007.07.022; ISEN AM, 1978, J PERS SOC PSYCHOL, V36, P1, DOI 10.1037/0022-3514.36.1.1; Kim SH, 2007, J COGNITIVE NEUROSCI, V19, P776, DOI 10.1162/jocn.2007.19.5.776; Koenigsberg HW, 2010, NEUROPSYCHOLOGIA, V48, P1813, DOI 10.1016/j.neuropsychologia.2010.03.002; Larson MJ, 2010, BIOL PSYCHOL, V83, P222, DOI 10.1016/j.biopsycho.2010.01.003; Legrand D, 2009, PSYCHOL REV, V116, P252, DOI 10.1037/a0014172; Leiberg S, 2012, HUM BRAIN MAPP, V33, P2464, DOI 10.1002/hbm.21376; Lyubomirsky S, 1998, MOTIV EMOTION, V22, P155, DOI 10.1023/A:1021396422190; Lyubomirsky S, 2006, SOC INDIC RES, V78, P363, DOI 10.1007/s11205-005-0213-y; Murray RJ, 2012, NEUROSCI BIOBEHAV R, V36, P1043, DOI 10.1016/j.neubiorev.2011.12.013; Nicolle A, 2012, NEURON, V75, P1114, DOI 10.1016/j.neuron.2012.07.023; Nohlen HU, 2014, SOC COGN AFFECT NEUR, V9, P924, DOI 10.1093/scan/nst074; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; Oikawa H, 2012, NEUROIMAGE, V59, P3668, DOI 10.1016/j.neuroimage.2011.10.098; Olsson A, 2008, TRENDS COGN SCI, V12, P65, DOI 10.1016/j.tics.2007.11.010; Onoda K, 2010, SOC COGN AFFECT NEUR, V5, P385, DOI 10.1093/scan/nsq002; Park J.Y., 2011, KOREAN FACIAL EXPRES; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; Perlman G, 2012, J AFFECT DISORDERS, V139, P75, DOI 10.1016/j.jad.2012.01.044; Pfeifer JH, 2007, J COGNITIVE NEUROSCI, V19, P1323, DOI 10.1162/jocn.2007.19.8.1323; Platek SM, 2009, NEUROPSYCHOLOGIA, V47, P849, DOI 10.1016/j.neuropsychologia.2008.12.027; Pruessner JC, 2005, NEUROIMAGE, V28, P815, DOI 10.1016/j.neuroimage.2005.06.014; Rasmussen HN, 2006, J PERS, V74, P1721, DOI 10.1111/j.1467-6494.2006.00426.x; Reich WA, 2013, J HAPPINESS STUD, V14, P293, DOI 10.1007/s10902-012-9332-8; Schimmack U, 2002, J PERS SOC PSYCHOL, V82, P582, DOI 10.1037//0022-3514.82.4.582; Schimmack U, 2004, PERS SOC PSYCHOL B, V30, P1062, DOI 10.1177/0146167204264292; Sokol-Hessner P, 2013, SOC COGN AFFECT NEUR, V8, P341, DOI 10.1093/scan/nss002; Somerville LH, 2010, CEREB CORTEX, V20, P3005, DOI 10.1093/cercor/bhq049; Tucker KL, 2007, J SOC CLIN PSYCHOL, V26, P791, DOI 10.1521/jscp.2007.26.7.791; Uddin LQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003526; Urry HL, 2009, NEUROIMAGE, V47, P852, DOI 10.1016/j.neuroimage.2009.05.069; van Buuren M, 2010, HUM BRAIN MAPP, V31, P1117, DOI 10.1002/hbm.20920; van der Meer L, 2010, NEUROSCI BIOBEHAV R, V34, P935, DOI 10.1016/j.neubiorev.2009.12.004; van Duijvenvoorde ACK, 2008, J NEUROSCI, V28, P9495, DOI 10.1523/JNEUROSCI.1485-08.2008; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; van Veen V, 2005, NEUROIMAGE, V27, P497, DOI 10.1016/j.neuroimage.2005.04.042; Waldinger RJ, 2011, COGN AFFECT BEHAV NE, V11, P426, DOI 10.3758/s13415-011-0039-9; Yang J, 2012, NEUROPSYCHOLOGIA, V50, P1267, DOI 10.1016/j.neuropsychologia.2012.02.010; Zotev V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024522	62	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149554	10.1371/journal.pone.0149554	http://dx.doi.org/10.1371/journal.pone.0149554			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26900857	gold, Green Published, Green Submitted			2022-12-27	WOS:000371276100097
J	Qiu, Y; Wang, SW; Chen, Z; Guo, YJ; Song, Y				Qiu, Yi; Wang, Shiwei; Chen, Zhi; Guo, Yajie; Song, Yuan			An Active Type I-E CRISPR-Cas System Identified in Streptomyces avermitilis	PLOS ONE			English	Article							ESCHERICHIA-COLI; DNA; ADAPTATION; SEQUENCE; IMMUNITY; TRANSCRIPTION; INFECTIONS; RESISTANCE; EFFICIENCY; MEMORY	CRISPR-Cas systems, the small RNA-dependent immune systems, are widely distributed in prokaryotes. However, only a small proportion of CRISPR-Cas systems have been identified to be active in bacteria. In this work, a naturally active type I-E CRISPR-Cas system was found in Streptomyces avermitilis. The system shares many common genetic features with the type I-E system of Escherichia coli, and meanwhile shows unique characteristics. It not only degrades plasmid DNA with target protospacers, but also acquires new spacers from the target plasmid DNA. The naive features of spacer acquisition in the type I-E system of S. avermitilis were investigated and a completely conserved PAM 5'-AAG-3' was identified. Spacer acquisition displayed differential strand bias upstream and downstream of the priming spacer, and irregular integrations of new spacers were observed. In addition, introduction of this system into host conferred phage resistance to some extent. This study will give new insights into adaptation mechanism of the type I-E systems in vivo, and meanwhile provide theoretical foundation for applying this system on the genetic modification of S. avermitilis.	[Qiu, Yi; Wang, Shiwei; Chen, Zhi; Guo, Yajie; Song, Yuan] China Agr Univ, Coll Biol Sci, Dept Microbiol, Beijing 100094, Peoples R China; [Wang, Shiwei] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China	China Agricultural University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Song, Y (corresponding author), China Agr Univ, Coll Biol Sci, Dept Microbiol, Beijing 100094, Peoples R China.	syuan@cau.edu.cn			National Natural Science Foundation of China [31570084]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by a grant from the National Natural Science Foundation of China (www.nsfc.gov.cn) to YS (31570084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslan Z, 2014, NUCLEIC ACIDS RES, V42, P7884, DOI 10.1093/nar/gku510; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Barrangou R, 2012, ANNU REV FOOD SCI T, V3, P143, DOI 10.1146/annurev-food-022811-101134; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Bondy-Denomy J, 2014, TRENDS MICROBIOL, V22, P218, DOI 10.1016/j.tim.2014.01.007; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; BURG RW, 1979, ANTIMICROB AGENTS CH, V15, P361, DOI 10.1128/AAC.15.3.361; Chen W, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-198; Cobb RE, 2015, ACS SYNTH BIOL, V4, P723, DOI 10.1021/sb500351f; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Demain AL, 1999, APPL MICROBIOL BIOT, V52, P455, DOI 10.1007/s002530051546; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; Fineran PC, 2012, VIROLOGY, V434, P202, DOI 10.1016/j.virol.2012.10.003; Guo P, 2011, ACTA BIOCH BIOPH SIN, V43, P630, DOI 10.1093/abbs/gmr052; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jiang WY, 2015, ANNU REV MICROBIOL, V69, P209, DOI 10.1146/annurev-micro-091014-104441; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Li M, 2014, NUCLEIC ACIDS RES, V42, P2483, DOI 10.1093/nar/gkt1154; Li Y., 2012, ARCH ANIM NUTR, V1, P1, DOI DOI 10.1099/VIR.0.039289-0; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Omura S, 2001, P NATL ACAD SCI USA, V98, P12215, DOI 10.1073/pnas.211433198; Pougach K, 2010, MOL MICROBIOL, V77, P1367, DOI 10.1111/j.1365-2958.2010.07265.x; Rousseau C, 2009, BIOINFORMATICS, V25, P3317, DOI 10.1093/bioinformatics/btp586; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shmakov S, 2014, NUCLEIC ACIDS RES, V42, P5907, DOI 10.1093/nar/gku226; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Wang SW, 2010, VIROLOGY, V403, P78, DOI 10.1016/j.virol.2010.03.044; Westra ER, 2010, MOL MICROBIOL, V77, P1380, DOI 10.1111/j.1365-2958.2010.07315.x; Yosef I, 2013, P NATL ACAD SCI USA, V110, P14396, DOI 10.1073/pnas.1300108110; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zeng H, 2015, APPL MICROBIOL BIOT, V99, P10575, DOI 10.1007/s00253-015-6931-4; Zhao HT, 2014, NATURE, V515, P147, DOI 10.1038/nature13733	37	13	15	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149533	10.1371/journal.pone.0149533	http://dx.doi.org/10.1371/journal.pone.0149533			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901661	Green Submitted, Green Published, gold			2022-12-27	WOS:000371276100093
J	Wang, J; Dupuis, C; Tyring, SK; Underbrink, MP				Wang, Jia; Dupuis, Crystal; Tyring, Stephen K.; Underbrink, Michael P.			Sterile a Motif Domain Containing 9 Is a Novel Cellular Interacting Partner to Low-Risk Type Human Papillomavirus E6 Proteins	PLOS ONE			English	Article							RECURRENT RESPIRATORY PAPILLOMATOSIS; ONCOPROTEIN E6; ALPHA MOTIF; DEGRADATION; P53; ASSOCIATION; INTERFERON; BINDING; SAMD9; UBIQUITINATION	Low-risk type human papillomavirus (HPV) 6 and 11 infection causes recurrent respiratory papillomatosis (RRP) and genital warts. RRP is the most common benign tumor of the larynx in children with frequent relapses. Repeated surgeries are often needed to improve vocal function and prevent life-threatening respiratory obstruction. Currently, there are no effective treatments available to completely eliminate these diseases, largely due to limited knowledge regarding their viral molecular pathogenesis. HPV E6 proteins contribute to cell immortalization by interacting with a variety of cellular proteins, which have been well studied for the high-risk type HPVs related to cancer progression. However, the functions of low-risk HPV E6 proteins are largely unknown. In this study, we report GST-pulldown coupled mass spectrometry analysis with low-risk HPV E6 proteins that identified sterile alpha motif domain containing 9 (SAMD9) as a novel interacting partner. We then confirmed the interaction between HPV-E6 and SAMD9 using co-immunoprecipitation, proximity ligation assay, and confocal immunofluorescence staining. The SAMD9 gene is down-regulated in a variety of neoplasms and deleteriously mutated in normophosphatemic familial tumoral calcinosis. Interestingly, SAMD9 also has antiviral functions against poxvirus. Our study adds to the limited knowledge of the molecular properties of low-risk HPVs and describes new potential functions for the low-risk HPV E6 protein.	[Wang, Jia; Underbrink, Michael P.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Dupuis, Crystal; Underbrink, Michael P.] Univ Texas Med Branch, Dept Otolaryngol, Galveston, TX 77555 USA; [Tyring, Stephen K.] Univ Texas Hlth Sci Ctr Houston, Dept Dermatol, Houston, TX 77030 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Health Science Center Houston	Underbrink, MP (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.; Underbrink, MP (corresponding author), Univ Texas Med Branch, Dept Otolaryngol, Galveston, TX 77555 USA.	mpunderb@utmb.edu			National Institute on Deafness and Other Communication Disorders [K08DC010337]; McLaughlin Endowment at University of Texas Medical Branch; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K08DC010337] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); McLaughlin Endowment at University of Texas Medical Branch; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was funded by a National Institute on Deafness and Other Communication Disorders grant to MU: K08DC010337, http://www.nidcd.nih.gov/Pages/default.aspx. JW was supported by a Predoctoral fellowship from McLaughlin Endowment at University of Texas Medical Branch, http://www.utmb.edu/mclaughlin/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brimer N, 2007, VIROLOGY, V358, P303, DOI 10.1016/j.virol.2006.08.038; Chefetz I, 2008, J INVEST DERMATOL, V128, P1423, DOI 10.1038/sj.jid.5701203; Chesson HW, 2012, VACCINE, V30, P6016, DOI 10.1016/j.vaccine.2012.07.056; CROOK T, 1991, CELL, V67, P547, DOI 10.1016/0092-8674(91)90529-8; Degenhardt YY, 2001, J VIROL, V75, P151, DOI 10.1128/JVI.75.1.151-160.2001; Degenhardt YY, 2001, J VIROL, V75, P11791, DOI 10.1128/JVI.75.23.11791-11802.2001; FOSTER SA, 1994, J VIROL, V68, P5698, DOI 10.1128/JVI.68.9.5698-5705.1994; Gerein V, 2005, ANN OTO RHINOL LARYN, V114, P463, DOI 10.1177/000348940511400608; Glaunsinger BA, 2000, ONCOGENE, V19, P5270, DOI 10.1038/sj.onc.1203906; Gupta S, 2003, VIROLOGY, V317, P155, DOI 10.1016/j.virol.2003.08.008; HALBERT CL, 1992, J VIROL, V66, P2125, DOI 10.1128/JVI.66.4.2125-2134.1992; HALBERT CL, 1991, J VIROL, V65, P473, DOI 10.1128/JVI.65.1.473-478.1991; HEALY GB, 1988, NEW ENGL J MED, V319, P401, DOI 10.1056/NEJM198808183190704; Howie HL, 2009, VIROLOGY, V384, P324, DOI 10.1016/j.virol.2008.11.017; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Jha S, 2010, MOL CELL, V38, P700, DOI 10.1016/j.molcel.2010.05.020; Jing M, 2007, J VIROL, V81, P2231, DOI 10.1128/JVI.01979-06; Kehmeier E, 2002, VIROLOGY, V299, P72, DOI 10.1006/viro.2002.1502; Kiyono T, 1997, P NATL ACAD SCI USA, V94, P11612, DOI 10.1073/pnas.94.21.11612; Kuhne C, 1998, J BIOL CHEM, V273, P34302, DOI 10.1074/jbc.273.51.34302; Kukimoto I, 1998, BIOCHEM BIOPH RES CO, V249, P258, DOI 10.1006/bbrc.1998.9066; Lacey CJN, 2006, VACCINE, V24, P35, DOI 10.1016/j.vaccine.2006.06.015; LEVENTHAL BG, 1991, NEW ENGL J MED, V325, P613, DOI 10.1056/NEJM199108293250904; Li CF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-92; Liu J, 2015, J VIROL, V89, P1925, DOI 10.1128/JVI.02262-14; Liu J, 2011, J VIROL, V85, P3270, DOI 10.1128/JVI.02243-10; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; Neveu G, 2012, METHODS, V58, P349, DOI 10.1016/j.ymeth.2012.07.029; Nomine Y, 2006, MOL CELL, V21, P665, DOI 10.1016/j.molcel.2006.01.024; Oh ST, 2004, J VIROL, V78, P2620, DOI 10.1128/JVI.78.5.2620-2626.2004; Park JS, 2001, INT J CANCER, V91, P822, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0; Park KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038990; Rozenblatt-Rosen O, 2012, NATURE, V487, P491, DOI 10.1038/nature11288; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Sivan G, 2015, MBIO, V6, DOI 10.1128/mBio.01122-15; Spangle JM, 2010, J VIROL, V84, P9398, DOI 10.1128/JVI.00974-10; Tanaka M, 2010, INT J CANCER, V126, P1982, DOI 10.1002/ijc.24965; Tao MF, 2003, J VIROL, V77, P13232, DOI 10.1128/JVI.77.24.13232-13247.2003; Thomas M, 1999, J GEN VIROL, V80, P1513, DOI 10.1099/0022-1317-80-6-1513; Thomas M, 2013, VIROLOGY, V435, P357, DOI 10.1016/j.virol.2012.11.004; Topaz O, 2006, AM J HUM GENET, V79, P759, DOI 10.1086/508069; Vande Pol SB, 2013, VIROLOGY, V445, P115, DOI 10.1016/j.virol.2013.04.026; White EA, 2013, VIROLOGY, V435, P57, DOI 10.1016/j.virol.2012.09.046; White EA, 2012, J VIROL, V86, P13174, DOI 10.1128/JVI.02172-12; Zanier K, 2013, SCIENCE, V339, P694, DOI 10.1126/science.1229934; Zhang GF, 2010, MOL ENDOCRINOL, V24, P1737, DOI 10.1210/me.2010-0125; zur Hausen H, 1999, P ASSOC AM PHYSICIAN, V111, P581, DOI 10.1046/j.1525-1381.1999.99723.x	48	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149859	10.1371/journal.pone.0149859	http://dx.doi.org/10.1371/journal.pone.0149859			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901061	Green Published, gold			2022-12-27	WOS:000371276100165
J	Yadava, RS; Foff, EP; Yu, Q; Gladman, JT; Zheng, TS; Mahadevan, MS				Yadava, Ramesh S.; Foff, Erin P.; Yu, Qing; Gladman, Jordan T.; Zheng, Timothy S.; Mahadevan, Mani S.			TWEAK Regulates Muscle Functions in a Mouse Model of RNA Toxicity	PLOS ONE			English	Article							SKELETAL-MUSCLE; MYOTONIC-DYSTROPHY; WEAK INDUCER; APOPTOSIS TWEAK; KAPPA-B; SIGNALING PATHWAYS; CYTOKINE; ATROPHY; REPEAT; CELLS	Myotonic dystrophy type 1 (DM1), the most common form of muscular dystrophy in adults, is caused by toxic RNAs produced from the mutant DM protein kinase (DMPK) gene. DM1 is characterized by progressive muscle wasting and weakness. Therapeutic strategies have mainly focused on targeting the toxic RNA. Previously, we found that fibroblast growth factor-inducible 14 (Fn14), the receptor for TWEAK, is induced in skeletal muscles and hearts of mouse models of RNA toxicity and that blocking TWEAK/Fn14 signaling improves muscle function and histology. Here, we studied the effect of Tweak deficiency in a RNA toxicity mouse model. The genetic deletion of Tweak in these mice significantly reduced muscle damage and improved muscle function. In contrast, administration of TWEAK in the RNA toxicity mice impaired functional outcomes and worsened muscle histopathology. These studies show that signaling via TWEAK is deleterious to muscle in RNA toxicity and support the demonstrated utility of anti-TWEAK therapeutics.	[Yadava, Ramesh S.; Yu, Qing; Gladman, Jordan T.; Mahadevan, Mani S.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Foff, Erin P.] Univ Virginia, Dept Neurol, Charlottesville, VA USA; [Zheng, Timothy S.] Biogen Idec Inc, Dept Immunol, Cambridge, MA USA	University of Virginia; University of Virginia; Biogen	Mahadevan, MS (corresponding author), Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA.	mahadevan@virginia.edu	Yadava, Ramesh S/AAZ-3099-2021	Yadava, Ramesh S/0000-0002-0092-5033	Biogen; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045992, R01AR062189, R01AR052771] Funding Source: NIH RePORTER	Biogen(Biogen); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Biogen provided salary support for Dr. Timothy S. Zheng. The funder provided support in the form of salaries for author TSZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amack JD, 1999, HUM MOL GENET, V8, P1975, DOI 10.1093/hmg/8.11.1975; Bhatnagar S, 2012, J CELL PHYSIOL, V227, P1042, DOI 10.1002/jcp.22821; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Bowerman M, 2015, HUM MOL GENET, V24, P3440, DOI 10.1093/hmg/ddv094; Brown SAN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065248; Burkly LC, 2011, IMMUNOL REV, V244, P99, DOI 10.1111/j.1600-065X.2011.01054.x; Campbell S, 2006, J IMMUNOL, V176, P1889, DOI 10.4049/jimmunol.176.3.1889; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Dogra C, 2006, J BIOL CHEM, V281, P10327, DOI 10.1074/jbc.M511131200; Dogra C, 2007, FASEB J, V21, P1857, DOI 10.1096/fj.06-7537com; Echeverria GV, 2012, BRAIN RES, V1462, P100, DOI 10.1016/j.brainres.2012.02.030; Fugier C, 2011, NAT MED, V17, P720, DOI 10.1038/nm.2374; Girgenrath M, 2006, EMBO J, V25, P5826, DOI 10.1038/sj.emboj.7601441; Hindi SM, 2014, FASEB J, V28, P1398, DOI 10.1096/fj.13-242123; Kim YK, 2014, HUM MOL GENET, V23, P293, DOI 10.1093/hmg/ddt419; Kumar M, 2009, J IMMUNOL, V182, P2439, DOI 10.4049/jimmunol.0803357; Langlois MA, 2003, MOL THER, V7, P670, DOI 10.1016/S1525-0016(03)00068-6; Li H, 2009, J BIOL CHEM, V284, P4439, DOI 10.1074/jbc.M805546200; Maecker H, 2005, CELL, V123, P931, DOI 10.1016/j.cell.2005.09.022; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mahadevan MS, 2006, NAT GENET, V38, P1066, DOI 10.1038/ng1857; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Mittel A, 2010, AM J PATHOL, V177, P1732, DOI 10.2353/ajpath.2010.100335; Morosetti R, 2012, AM J PATHOL, V180, P1603, DOI 10.1016/j.ajpath.2011.12.027; Ogura Y, 2013, J BIOL CHEM, V288, P35159, DOI 10.1074/jbc.M113.517300; Peterson JM, 2011, CURR TOP DEV BIOL, V96, P85, DOI 10.1016/B978-0-12-385940-2.00004-8; Sato S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00018; Tajrishi MM, 2014, BIOCHEM BIOPH RES CO, V446, P1219, DOI 10.1016/j.bbrc.2014.03.084; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Tang ZZ, 2012, HUM MOL GENET, V21, P1312, DOI 10.1093/hmg/ddr568; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Yadava RS, 2008, NAT GENET, V40, P61, DOI 10.1038/ng.2007.28; Yadava RS, 2015, HUM MOL GENET, V24, P2035, DOI 10.1093/hmg/ddu617	34	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0150192	10.1371/journal.pone.0150192	http://dx.doi.org/10.1371/journal.pone.0150192			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901467	Green Published, gold			2022-12-27	WOS:000371276100211
J	Gupt, A; Kaur, P; Kamraj, P; Murthy, BN				Gupt, Anadi; Kaur, Prabhdeep; Kamraj, P.; Murthy, B. N.			Out of Pocket Expenditure for Hospitalization among Below Poverty Line Households in District Solan, Himachal Pradesh, India, 2013	PLOS ONE			English	Article							HEALTH-INSURANCE; PROTECTION	Introduction Health insurance schemes, like Rashtriya Swasthya Bima Yojana (RSBY), should provide financial protection against catastrophic health costs by reducing out of pocket expenditure (OOPE) for hospitalizations. We estimated and compared the proportion and extent of OOPE among below poverty line (BPL) families beneficiaries and not beneficiaries by RSBY during hospitalizations in district Solan, H.P., India, 2013. Methods We conducted a cross sectional survey among hospitalized BPL families in the beneficiaries and non-beneficiaries groups. We compared proportion incurring OOPE and its extent during hospitalization, pre/post-hospitalization periods in different domains. Results Overall, proportion of non-beneficiaries who incurred OOPE was higher than the beneficiaries but it was not statistically significant (87.2% vs. 80.9%). The median overall OOPE was $39 (Rs 2567) in the non-beneficiaries group as compared to $11 (Rs 713) in the beneficiaries group (p<0.01). Median expenditure on in house and out house drugs and consumables was $23 (Rs 1500) in the non beneficiaries group as compared to nil in the beneficiaries group (p<0.01). Non-beneficiary status was significantly associated [OR: 2.4 (1.3-4.3)] with OOPE above median independently and also after adjusting for various covariates. Conclusion RSBY has decreased the extent of OOPE among the beneficiaries; however OOPE was incurred mainly due to purchase of drugs from outside the health facility. The treatment seeking behaviour in beneficiaries group has improved among comparatively older group with chronic conditions. RSBY has enabled beneficiaries to get more facilities such as drugs, consumables and diagnostics from the health facility.	[Gupt, Anadi; Kaur, Prabhdeep; Kamraj, P.; Murthy, B. N.] Govt Himachal Pradesh, Natl Hlth Mission, Block 6,SDA Complex, Shimla 171009, Himachal Prades, India		Gupt, A (corresponding author), Govt Himachal Pradesh, Natl Hlth Mission, Block 6,SDA Complex, Shimla 171009, Himachal Prades, India.	dranadigupt@yahoo.com	Kaur, Prabhdeep/AFO-2518-2022	Kaur, Prabhdeep/0000-0002-2605-3739	National Institute of Epidemiology	National Institute of Epidemiology	National Institute of Epidemiology partially funded this study. The rest of the funds were contributed by Dr. Anadi Gupt-first author.	Acharya A., 2012, IMPACT NATL HLTH INS; Berman P., 2010, Economic and Political Weekly, V45, P65; Bhojani U, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-990; Commission P, 2013, PRESS NOT POV EST 20 PRESS NOT POV EST 20; Devadasan N, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-43; Ekman Bjorn, 2007, Health Res Policy Syst, V5, P6, DOI 10.1186/1478-4505-5-6; Fan VY, 2012, INT J HEALTH CARE FI, V12, P189, DOI 10.1007/s10754-012-9110-5; Galarraga O, 2010, EUR J HEALTH ECON, V11, P437, DOI 10.1007/s10198-009-0180-3; Garg CC, 2009, HEALTH POLICY PLANN, V24, P116, DOI 10.1093/heapol/czn046; Ministry of Health and Family Welfare GoI, 2009, NAT HLTH ACC IND 200; Nguyen HTH, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-4; Ramani K V, 2006, J Health Organ Manag, V20, P560, DOI 10.1108/14777260610702307; Rao M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004471; Rashtriya Swasthya Bima Yojana Gol, ENR BEN 2014; Selvaraj Sakthivel, 2012, ECON POLIT WEEKLY, V47, P61; Sood N, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5114; World Health Organization (WHO), 2014, MAK FAIR CHOIC PATH	17	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149824	10.1371/journal.pone.0149824	http://dx.doi.org/10.1371/journal.pone.0149824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895419	Green Published, gold, Green Submitted			2022-12-27	WOS:000371223400084
J	Meseda, CA; Atukorale, V; Kuhn, J; Schmeisser, F; Weir, JP				Meseda, Clement A.; Atukorale, Vajini; Kuhn, Jordan; Schmeisser, Falko; Weir, Jerry P.			Percutaneous Vaccination as an Effective Method of Delivery of MVA and MVA-Vectored Vaccines	PLOS ONE			English	Article							PHASE-I TRIAL; VIRUS-ANKARA; SMALLPOX VACCINE; INFLUENZA-VIRUS; MICRONEEDLE ARRAYS; SKIN VACCINATION; ANTIGEN DELIVERY; IMMUNE-RESPONSES; CLINICAL-TRIAL; HEALTHY-ADULTS	The robustness of immune responses to an antigen could be dictated by the route of vaccine inoculation. Traditional smallpox vaccines, essentially vaccinia virus strains, that were used in the eradication of smallpox were administered by percutaneous inoculation (skin scarification). The modified vaccinia virus Ankara is licensed as a smallpox vaccine in Europe and Canada and currently undergoing clinical development in the United States. MVA is also being investigated as a vector for the delivery of heterologous genes for prophylactic or therapeutic immunization. Since MVA is replication-deficient, MVA and MVA-vectored vaccines are often inoculated through the intramuscular, intradermal or subcutaneous routes. Vaccine inoculation via the intramuscular, intradermal or subcutaneous routes requires the use of injection needles, and an estimated 10 to 20% of the population of the United States has needle phobia. Following an observation in our laboratory that a replication-deficient recombinant vaccinia virus derived from the New York City Board of Health strain elicited protective immune responses in a mouse model upon inoculation by tail scarification, we investigated whether MVA and MVA recombinants can elicit protective responses following percutaneous administration in mouse models. Our data suggest that MVA administered by percutaneous inoculation, elicited vaccinia-specific antibody responses, and protected mice from lethal vaccinia virus challenge, at levels comparable to or better than subcutaneous or intramuscular inoculation. High titers of specific neutralizing antibodies were elicited in mice inoculated with a recombinant MVA expressing the herpes simplex type 2 glycoprotein D after scarification. Similarly, a recombinant MVA expressing the hemagglutinin of attenuated influenza virus rgA/Viet Nam/1203/2004 (H5N1) elicited protective immune responses when administered at low doses by scarification. Taken together, our data suggest that MVA and MVA-vectored vaccines inoculated by scarification can elicit protective immune responses that are comparable to subcutaneous vaccination, and may allow for antigen sparing when vaccine supply is limited.	[Meseda, Clement A.; Atukorale, Vajini; Kuhn, Jordan; Schmeisser, Falko; Weir, Jerry P.] US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Meseda, CA (corresponding author), US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA.	Clement.Meseda@fda.hhs.gov	Meseda, Clement/I-6336-2019		Center for Biologics Evaluation and Research, US Food and Drug Administration; CBER/FDA	Center for Biologics Evaluation and Research, US Food and Drug Administration; CBER/FDA	The work described in this manuscript was supported by intramural research fund provided by the Center for Biologics Evaluation and Research, US Food and Drug Administration.; The authors wish to thank Drs. Bernard Moss and Linda Wyatt, NIAID/NIH, for the MVA and VV-WR viruses. We also thank Dr. Maryna Eichelberger and Dr. Alonzo Garcia, CBER/FDA, for reviewing this manuscript. This work was supported by intramural research funds from CBER/FDA.	Al-Zahrani S, 2012, EXPERT OPIN DRUG DEL, V9, P541, DOI 10.1517/17425247.2012.676038; Amato RJ, 2012, FUTURE ONCOL, V8, P231, DOI [10.2217/FON.12.7, 10.2217/fon.12.7]; Antrobus RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048322; Becker PD, 2015, VACCINE, V33, P4691, DOI 10.1016/j.vaccine.2015.04.046; Belshe RB, 2007, VACCINE, V25, P6755, DOI 10.1016/j.vaccine.2007.06.066; Blanchard TJ, 1998, J GEN VIROL, V79, P1159, DOI 10.1099/0022-1317-79-5-1159; Boukhebza H, 2012, HUM VACC IMMUNOTHER, V8, P1746, DOI 10.4161/hv.21689; Bruner DI, 2014, J EMERG MED, V46, pE85, DOI 10.1016/j.jemermed.2013.06.001; Busquets N, 2014, ANTIVIR RES, V108, P165, DOI 10.1016/j.antiviral.2014.05.020; Carey JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022442; Carroll MW, 1997, VIROLOGY, V238, P198, DOI 10.1006/viro.1997.8845; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P248; Chakrabarti S, 1997, BIOTECHNIQUES, V23, P1094, DOI 10.2144/97236st07; de Barra E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115161; de Vries RD, 2015, EMERG INFECT DIS, V21, P1086, DOI 10.3201/eid2106.150021; Di Bisceglie AM, 2014, GASTROENTEROLOGY, V147, P119, DOI 10.1053/j.gastro.2014.03.007; Drexler I, 2004, CURR OPIN BIOTECH, V15, P506, DOI 10.1016/j.copbio.2004.09.001; Drexler I, 1998, J GEN VIROL, V79, P347, DOI 10.1099/0022-1317-79-2-347; Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331; Earl PL, 2001, CURR PROTOCOLS PROTE, DOI [10.1002/0471140864.ps0512s13, DOI 10.1002/0471140864.PS0512S13]; Eckart RE, 2004, J AM COLL CARDIOL, V44, P201, DOI 10.1016/j.jacc.2004.05.004; Edens C, 2015, VACCINE, V33, P4683, DOI 10.1016/j.vaccine.2015.01.089; Edens C, 2013, VACCINE, V31, P3403, DOI 10.1016/j.vaccine.2012.09.062; Florek KR, 2014, J VIROL, V88, P13418, DOI 10.1128/JVI.01219-14; Frey SE, 2015, VACCINE, V33, P5225, DOI 10.1016/j.vaccine.2015.06.075; Garcia F, 2011, VACCINE, V29, P8309, DOI 10.1016/j.vaccine.2011.08.098; Garcia-Arriaza J, 2014, J VIROL, V88, P3527, DOI 10.1128/JVI.03418-13; Gill HS, 2007, J CONTROL RELEASE, V117, P227, DOI 10.1016/j.jconrel.2006.10.017; Giudice EL, 2006, ADV DRUG DELIVER REV, V58, P68, DOI 10.1016/j.addr.2005.12.003; Gomez CE, 2013, J VIROL, V87, P7282, DOI 10.1128/JVI.03246-12; Green CA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008748; Greenberg RN, 2008, EXPERT OPIN INV DRUG, V17, P555, DOI [10.1517/13543784.17.4.555, 10.1517/13543784.17.4.555 ]; Halsell JS, 2003, JAMA-J AM MED ASSOC, V289, P3283, DOI 10.1001/jama.289.24.3283; Hawkridge A, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2052; Hessel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016247; Hodgson SH, 2015, J INFECT DIS, V211, P1076, DOI 10.1093/infdis/jiu579; Hui EP, 2013, CANCER RES, V73, P1676, DOI 10.1158/0008-5472.CAN-12-2448; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Kamlangdee A, 2014, J VIROL, V88, P13300, DOI 10.1128/JVI.01532-14; Kennedy RB, 2009, VACCINE, V27, pD73, DOI 10.1016/j.vaccine.2009.07.103; Kenney RT, 2004, NEW ENGL J MED, V351, P2295, DOI 10.1056/NEJMoa043540; Koutsonanos DG, 2015, VACCINE, V33, P4675, DOI 10.1016/j.vaccine.2015.01.086; Koutsonanos DG, 2012, SCI REP-UK, V2, DOI 10.1038/srep00357; Kreijtz JHCM, 2009, VACCINE, V27, P6296, DOI 10.1016/j.vaccine.2009.03.020; Kreijtz JHCM, 2007, J INFECT DIS, V195, P1598, DOI 10.1086/517614; Kreijtz JHCM, 2014, LANCET INFECT DIS, V14, P1196, DOI [10.1016/s1473-3099(14)70963-6, 10.1016/S1473-3099(14)70963-6]; Kreijtz JHCM, 2010, J GEN VIROL, V91, P2745, DOI 10.1099/vir.0.024885-0; Liu LZ, 2010, NAT MED, V16, P224, DOI 10.1038/nm.2078; Longley RJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11820; MAYR A, 1978, ZBL BAKT MIK HYG B, V167, P375; Mehendale S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055831; Melamed S, 2013, VACCINE, V31, P4569, DOI 10.1016/j.vaccine.2013.07.057; Meseda CA, 2005, VIROLOGY, V339, P164, DOI 10.1016/j.virol.2005.06.002; Meseda CA, 2002, J INFECT DIS, V186, P1065, DOI 10.1086/344234; Meseda CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067984; Meyer J, 2013, VACCINE, V31, P1026, DOI 10.1016/j.vaccine.2012.12.042; Monath TP, 2004, INT J INFECT DIS, V8, pS31, DOI 10.1016/j.ijid.2004.09.002; Ndiaye BP, 2015, LANCET RESP MED, V3, P190, DOI 10.1016/S2213-2600(15)00037-5; Njuguna IN, 2014, VACCINE, V32, P5801, DOI 10.1016/j.vaccine.2014.08.034; Overton ET, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv040; Pearson FE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067888; Peters BS, 2007, VACCINE, V25, P2120, DOI 10.1016/j.vaccine.2006.11.016; Poon LLM, 2009, J IMMUNOL, V182, P3063, DOI 10.4049/jimmunol.0803467; Porter DW, 2011, VACCINE, V29, P7514, DOI 10.1016/j.vaccine.2011.03.083; Prausnitz MR, 2009, CURR TOP MICROBIOL, V333, P369, DOI 10.1007/978-3-540-92165-3_18; Quan FS, 2010, J CONTROL RELEASE, V147, P326, DOI 10.1016/j.jconrel.2010.07.125; Rice AD, 2014, J VIROL, V88, P7753, DOI 10.1128/JVI.00185-14; Rimmelzwaan GF, 2009, EXPERT REV VACCINES, V8, P447, DOI 10.1586/ERV.09.4; Rivers TM, 1935, J EXP MED, V62, P549, DOI 10.1084/jem.62.4.549; Rosales R, 2014, WORLD J CLIN ONCOL, V5, P1002, DOI 10.5306/wjco.v5.i5.1002; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Satti I, 2014, LANCET INFECT DIS, V14, P939, DOI 10.1016/S1473-3099(14)70845-X; Schmeisser F, 2012, VACCINE, V30, P3413, DOI 10.1016/j.vaccine.2012.03.033; STICKL HA, 1974, PREV MED, V3, P97, DOI 10.1016/0091-7435(74)90066-8; Stittelaar KJ, 2005, J VIROL, V79, P7845, DOI 10.1128/JVI.79.12.7845-7851.2005; Swadling L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009185; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Tapia MD, 2016, LANCET INFECT DIS, V16, P31, DOI 10.1016/S1473-3099(15)00362-X; Taylor GS, 2014, CLIN CANCER RES, V20, P5009, DOI 10.1158/1078-0432.CCR-14-1122-T; Verheust C, 2012, VACCINE, V30, P2623, DOI 10.1016/j.vaccine.2012.02.016; Vien NC, 2008, T ROY SOC TROP MED H, V102, P294, DOI 10.1016/j.trstmh.2007.11.010; Vollmar J, 2006, VACCINE, V24, P2065, DOI 10.1016/j.vaccine.2005.11.022; Volz A, 2015, J VIROL, V89, P8651, DOI 10.1128/JVI.00614-15; Vrdoljak A, 2012, J CONTROL RELEASE, V159, P34, DOI 10.1016/j.jconrel.2011.12.026; Walsh SR, 2013, J INFECT DIS, V207, P1888, DOI 10.1093/infdis/jit105; Weniger BG, 2013, VACCINE, V31, P3389, DOI 10.1016/j.vaccine.2013.05.048; Wilck MB, 2010, J INFECT DIS, V201, P1361, DOI 10.1086/651561; Wyatt LS, 2004, P NATL ACAD SCI USA, V101, P4590, DOI 10.1073/pnas.0401165101; Zitzmann-Roth EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122653	89	6	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149364	10.1371/journal.pone.0149364	http://dx.doi.org/10.1371/journal.pone.0149364			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895072	Green Submitted, Green Published, gold			2022-12-27	WOS:000371223400048
J	van der Veen, D; Heringhaus, C; de Groot, B				van der Veen, Daniel; Heringhaus, Christian; de Groot, Bas			Appropriateness, Reasons and Independent Predictors of Consultations in the Emergency Department (ED) of a Dutch Tertiary Care Center: A Prospective Cohort Study	PLOS ONE			English	Article							MORTALITY; OUTCOMES	Objective Consultations occur frequently in the emergency department (ED) of tertiary care centres and pose a threat for patient safety as they contribute to ED lengths of stay (LOS) and overcrowding. The aim of this study was to investigate reasons and appropriateness of consultations, and the relative impact of specialty and patient characteristics on the probability of a consultation, because this could help to improve efficiency of ED patient care. Methods This prospective cohort study included ED patients presenting to a Dutch tertiary care centre in a setting where ED physicians mostly treat self-referred and undifferentiated patients and other specialists treat referred patients. Consultations were defined as appropriate if the reason of consultation corresponded with the final advice, conclusion or policy of the consulted specialty. Multivariable logistic regression analysis was used to assess the relative contribution of specialty and patient characteristics on consultation. Results In the 344 (24% (95% CI 22 to 26%)) of the 1434 inclusions another specialty was consulted, resulting in a 55% increase of ED LOS. ED physicians more often consulted another specialty with a corrected odds ratio (OR) of 5.6 (4.0 to 7.8), mostly because consultations were mandatory in case of hospitalization or outpatient follow-up. Limited expertise of ED physicians was the reason for consultation in 7% (5 to 9%). The appropriateness of consultations was 84% (81 to 88%), similar between ED physicians and other specialists (P = 0.949). The patient characteristics age, comorbidity, and triage category and complaint predicted consultation. Conclusion In a Dutch tertiary care centre another specialty was consulted in 24% of the patients, mostly for an appropriate reason, and rarely because of lack of expertise. The impact of consultations on ED LOS could be reduced if mandatory consultations are abolished and predictors of a consultation are used to facilitate timely consultation.	[van der Veen, Daniel; Heringhaus, Christian; de Groot, Bas] Leiden Univ, Med Ctr, Emergency Dept, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van der Veen, D (corresponding author), Leiden Univ, Med Ctr, Emergency Dept, Leiden, Netherlands.	d.s.van.der.veen@umail.leidenuniv.nl						Asplin BR, 2003, ANN EMERG MED, V42, P173, DOI 10.1067/mem.2003.302; Brick C, 2014, EMERG MED J, V31, P134, DOI 10.1136/emermed-2012-201908; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CORTAZZO JM, 1993, AM J EMERG MED, V11, P456, DOI 10.1016/0735-6757(93)90082-M; Drummond Alan J, 2002, CJEM, V4, P91; Krochmal P, 1995, AM J EMERG MED, V12, P256; Kulstad EB, 2010, AM J EMERG MED, V28, P304, DOI 10.1016/j.ajem.2008.12.014; Lee RS, 2008, EMERG MED J, V25, DOI 10.1136/emj.2007.051631; Mackway-Jones K., 1997, EMERGENCY TRIAGE MAN; Richardson DB, 2006, MED J AUSTRALIA, V184, P213, DOI 10.5694/j.1326-5377.2006.tb00204.x; Sprivulis PC, 2006, MED J AUSTRALIA, V184, P208, DOI 10.5694/j.1326-5377.2006.tb00203.x; Sun BC, 2013, ANN EMERG MED, V61, P605, DOI 10.1016/j.annemergmed.2012.10.026; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Valley MA, 2012, ANN EMERG MED, V60, P139, DOI 10.1016/j.annemergmed.2012.01.016; van Charante EPM, 2007, BMC FAM PRACT, V8, P1, DOI 10.1186/1471-2296-8-46; Woods RA, 2008, CAN J EMERG MED, V10, P25; Yoon Philip, 2003, CJEM, V5, P155	17	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149079	10.1371/journal.pone.0149079	http://dx.doi.org/10.1371/journal.pone.0149079			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894273	Green Published, gold, Green Submitted			2022-12-27	WOS:000371223400031
J	de Araujo, RF; Garcia, VB; Leitao, RFD; Brito, GAD; Miguel, ED; Guedes, PMM; de Araujo, AA				de Araujo Junior, Raimundo Fernandes; Garcia, Vinicius Barreto; de Carvalho Leitao, Renata Ferreira; de Castro Brito, Gerly Anne; Miguel, Emilio de Castro; Matta Guedes, Paulo Marcos; de Araujo, Aurigena Antunes			Carvedilol Improves Inflammatory Response, Oxidative Stress and Fibrosis in the Alcohol-Induced Liver Injury in Rats by Regulating Kuppfer Cells and Hepatic Stellate Cells	PLOS ONE			English	Article							LIPID-PEROXIDATION; CHRONIC ETHANOL; DISEASE; EXPRESSION; CYTOKINES; SOCS; MICE; CYCLOOXYGENASE-2; MECHANISMS; SUPPRESSOR	Aim To evaluate the anti-inflammatory, anti-oxidant and antifibrotic effects of carvedilol (CARV) in rats with ethanol-induced liver injury. Methods Liver injury was induced by gavage administration of alcohol (7 g/kg) for 28 consecutive days. Eighty Wistar rats were pretreated with oral CARV at 1, 3, or 5 mg/kg or with saline 1 h before exposure to alcohol. Liver homogenates were assayed for interleukin (IL)-1 beta, IL-10, and tumor necrosis factor (TNF)-alpha level as well as for myeloperoxidase (MPO) activity and malonyldialdehyde (MDA) and glutathione (GSH) levels. Serum aspartate aminotransferase (AST) activity and liver triglyceride (TG) levels were also assayed. Immunohistochemical analyses of cyclooxygenase 2 (COX-2), receptor activator of nuclear factor kappa-B/ligand (RANK/RANKL), suppressor of cytokine signalling (SOCS1), the Kupffer cell marker IBA-1 (ionized calcium-binding adaptor molecule 1), intercellular adhesion molecule 1 (ICAM-1), superoxide dismutase (SOD-1), and glutathione peroxidase (GPx-1) expression were performed. Confocal microscopy analysis of IL-1 beta and NF-kappa B expression and real-time quantitative PCR analysis for TNF alpha, PCI, PCIII, and NF-kappa B were performed. Results CARV treatment (5 mg/kg) during the alcohol exposure protocol was associated with reduced steatosis, hepatic cord degeneration, fibrosis and necrosis, as well as reduced levels of AST (p < 0.01), ALT (p < 0.01), TG (p < 0.001), MPO (p < 0.001), MDA (p < 0.05), and proinflammatory cytokines (IL-1 beta and TNF-alpha, both p < 0.05), and increased levels of the anti-inflammatory cytokine IL-10 (p < 0.001) and GSH (p < 0.05), compared to the alcohol-only group. Treatment with CARV 5 mg/ kg also reduced expression levels of COX-2, RANK, RANKL, IBA-1, and ICAM-1 (all p < 0.05), while increasing expression of SOCS1, SOD-1, and GPx-1 (all p < 0.05) and decreasing expression of IL-1 beta and NF-kappa B (both, p < 0.05). Real-time quantitative PCR analysis showed that mRNA production of TNF-alpha, procollagen type I (PCI), procollagen type III (PCIII), and NF-kappa B were decreased in the alcohol-CARV 5 mg/kg group relative to the alcohol-only group. Conclusions CARV can reduce the stress oxidative, inflammatory response and fibrosis in ethanol-induced liver injury in a rat model by downregulating signalling of Kuppfer cells and hepatic stellate cells (HSCs) through suppression of inflammatory cytokines.	[de Araujo Junior, Raimundo Fernandes; Garcia, Vinicius Barreto] Univ Fed Rio Grande do Norte, Postgrad Program Hlth Sci, Natal, RN, Brazil; [de Araujo Junior, Raimundo Fernandes] Univ Fed Rio Grande do Norte, Dept Morphol, Postgrad Program Funct & Struct Biol, Natal, RN, Brazil; [de Carvalho Leitao, Renata Ferreira; de Castro Brito, Gerly Anne] Univ Fed Ceara, Dept Morphol, Postgrad Program Morphol, Fortaleza, Ceara, Brazil; [Miguel, Emilio de Castro] Univ Fed Ceara, Analyt Ctr, Dept Phys, Fortaleza, Ceara, Brazil; [Matta Guedes, Paulo Marcos] Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, Natal, RN, Brazil; [de Araujo, Aurigena Antunes] Univ Fed Rio Grande do Norte, Dept Biophys & Pharmacol, Postgrad Program Publ Hlth, Natal, RN, Brazil; [de Araujo, Aurigena Antunes] Univ Fed Rio Grande do Norte, Postgrad Program Pharmaceut Sci, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Ceara; Universidade Federal do Ceara; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	de Araujo, RF (corresponding author), Univ Fed Rio Grande do Norte, Postgrad Program Hlth Sci, Natal, RN, Brazil.; de Araujo, RF (corresponding author), Univ Fed Rio Grande do Norte, Dept Morphol, Postgrad Program Funct & Struct Biol, Natal, RN, Brazil.	araujojr@cb.ufrn.br	Leitao, Renata/ABG-7682-2020; Brito, Gerly/AHB-3965-2022; Araújo Júnior, Raimundo Fernandes/D-2354-2014; Leitão, Renata FC/GQI-3555-2022; de Araujo, Aurigena/ABI-8455-2020; Leitao, Renata/ABF-9158-2020; de Castro Brito, Gerly Anne/C-8597-2013; Guedes, Paulo/Y-2546-2018; de Castro Miguel, Emílio/B-5855-2018	Brito, Gerly/0000-0002-8214-4379; Araújo Júnior, Raimundo Fernandes/0000-0003-2349-2354; Leitão, Renata FC/0000-0003-0202-771X; de Castro Brito, Gerly Anne/0000-0002-8214-4379; de Castro Miguel, Emílio/0000-0003-4130-672X; Matta Guedes, Paulo Marcos/0000-0002-4564-6791; Araujo, Aurigena/0000-0001-9264-4695	CNPq (Conselho Nacional de Pesquisa) [47.6996/2013]	CNPq (Conselho Nacional de Pesquisa)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by CNPq (Conselho Nacional de Pesquisa)/Universal n. 47.6996/2013. RFAJ wishes to thank the study core in microscopy and image processing (NEMPI, UFC).	Albanesi C, 2007, J IMMUNOL, V179, P984, DOI 10.4049/jimmunol.179.2.984; Albano E, 2008, MOL ASPECTS MED, V29, P9, DOI 10.1016/j.mam.2007.09.004; Arab HH, 2013, TOXICOL APPL PHARM, V268, P241, DOI 10.1016/j.taap.2013.01.019; Arozal W, 2010, TOXICOLOGY, V274, P18, DOI 10.1016/j.tox.2010.05.003; Bautista AP, 2002, FRONT BIOSCI-LANDMRK, V7, pA117; Costa C.M., 2006, J BRAS PATOL MED LAB, V5, P345, DOI DOI 10.1590/S1676-24442006000; de Araujo RF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114923; Dey A, 2006, HEPATOLOGY, V43, pS63, DOI 10.1002/hep.20957; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; Frazier Thomas H, 2011, Therap Adv Gastroenterol, V4, P63, DOI 10.1177/1756283X10378925; Fujimoto M, 2003, TRENDS IMMUNOL, V24, P659, DOI 10.1016/j.it.2003.10.008; Gao B, 2012, J GASTROEN HEPATOL, V27, P89, DOI 10.1111/j.1440-1746.2011.07003.x; Hakucho A, 2014, HEPATOL RES, V44, P560, DOI 10.1111/hepr.12143; Hall P D, 1994, Alcohol Alcohol Suppl, V2, P303; Hamdy N, 2012, TOXICOL APPL PHARM, V261, P292, DOI 10.1016/j.taap.2012.04.012; Iimuro Y, 2000, HEPATOLOGY, V31, P391, DOI 10.1002/hep.510310219; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; KENDALL C, 1983, J IMMUNOL METHODS, V56, P329, DOI 10.1016/S0022-1759(83)80022-2; Kono H, 2001, AM J PHYSIOL-GASTR L, V280, pG1289, DOI 10.1152/ajpgi.2001.280.6.G1289; Krebs DL, 2000, J CELL SCI, V113, P2813; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Li YC, 2010, EUR J PHARMACOL, V640, P112, DOI 10.1016/j.ejphar.2010.04.037; Lieber Charles S, 2005, Clin Liver Dis, V9, P1, DOI 10.1016/j.cld.2004.10.005; Liu JY, 2012, ALCOHOL CLIN EXP RES, V36, P1587, DOI 10.1111/j.1530-0277.2012.01773.x; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Mandal P, 2010, WORLD J GASTROENTERO, V16, P1330, DOI 10.3748/wjg.v16.i11.1330; Mathurin P, 2003, HEPATOLOGY, V38, P1363, DOI 10.1016/j.hep.2003.09.038; McClain CJ, 1999, SEMIN LIVER DIS, V19, P205, DOI 10.1055/s-2007-1007110; Mendez-Sanchez Nahum, 2005, Ann Hepatol, V4, P32; Nanji AA, 1997, GASTROENTEROLOGY, V112, P943, DOI 10.1053/gast.1997.v112.pm9041257; Nanji AA MC, 1989, ALCOHOL CLIN EXP RES, V13, P5; NIEMELA O, 1994, LAB INVEST, V70, P537; Nieto N, 2000, J BIOL CHEM, V275, P20136, DOI 10.1074/jbc.M001422200; Petrasek J, 2010, GASTROENTEROL RES PR, V2010; Rajesh MG LM, 2004, NDIAN J PHARM, V36; Ronsein GE, 2005, REDOX REP, V10, P131, DOI 10.1179/135100005X38879; Rouach H, 1997, HEPATOLOGY, V25, P351; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; SCHEUER PJ, 1982, BRIT MED BULL, V38, P63, DOI 10.1093/oxfordjournals.bmb.a071735; Souza MHLP, 2003, BRAZ J MED BIOL RES, V36, P1383, DOI 10.1590/S0100-879X2003001000015; Tilg H, 2000, NEW ENGL J MED, V343, P1467, DOI 10.1056/NEJM200011163432007; Torisu T, 2008, HEPATOLOGY, V47, P1644, DOI 10.1002/hep.22214; Wu J, 2000, J GASTROENTEROL, V35, P665, DOI 10.1007/s005350070045; Zhao Feng, 2007, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V19, P606; Zhao XJ, 2008, J IMMUNOL, V181, P3049, DOI 10.4049/jimmunol.181.5.3049	47	48	48	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0148868	10.1371/journal.pone.0148868	http://dx.doi.org/10.1371/journal.pone.0148868			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891124	Green Published, Green Submitted, gold			2022-12-27	WOS:000371221500015
J	Gao, Y; He, XL; Wu, B; Long, QL; Shao, TW; Wang, Z; Wei, JH; Li, Y; Ding, WL				Gao, Yuan; He, Xiaoli; Wu, Bin; Long, Qiliang; Shao, Tianwei; Wang, Zi; Wei, Jianhe; Li, Yong; Ding, Wanlong			Time-Course Transcriptome Analysis Reveals Resistance Genes of Panax ginseng Induced by Cylindrocarpon destructans Infection Using RNA-Seq	PLOS ONE			English	Article							ROOT-ROT; SECONDARY METABOLISM; BIOSYNTHETIC GENES; EXPRESSION; JASMONATE; MICRORNAS; PATHOGEN; DEFENSE; PCR	Panax ginseng C. A. Meyer is a highly valued medicinal plant. Cylindrocarpon destructans is a destructive pathogen that causes root rot and significantly reduces the quality and yield of P. ginseng. However, an efficient method to control root rot remains unavailable because of insufficient understanding of the molecular mechanism underlying C. destructans-P. ginseng interaction. In this study, C. destructans-induced transcriptomes at different time points were investigated using RNA sequencing (RNA-Seq). De novo assembly produced 73,335 unigenes for the P. ginseng transcriptome after C. destructans infection, in which 3,839 unigenes were up-regulated. Notably, the abundance of the up-regulated unigenes sharply increased at 0.5 d postinoculation to provide effector-triggered immunity. In total, 24 of 26 randomly selected unigenes can be validated using quantitative reverse transcription (qRT)-PCR. Gene ontology enrichment analysis of these unigenes showed that "defense response to fungus", "defense response" and "response to stress" were enriched. In addition, differentially expressed transcription factors involved in the hormone signaling pathways after C. destructans infection were identified. Finally, differentially expressed unigenes involved in reactive oxygen species and ginsenoside biosynthetic pathway during C. destructans infection were indentified. To our knowledge, this study is the first to report on the dynamic transcriptome triggered by C. destructans. These results improve our understanding of disease resistance in P. ginseng and provide a useful resource for quick detection of induced markers in P. ginseng before the comprehensive outbreak of this disease caused by C. destructans.	[Li, Yong; Ding, Wanlong] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Li, Yong; Ding, Wanlong] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, Y; Ding, WL (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China.; Li, Y; Ding, WL (corresponding author), Peking Union Med Coll, Beijing 100021, Peoples R China.	liyong@implad.ac.cn; wlding@implad.ac.cn			National Science Foundation of China [81072992, 81373911]; Fundamental Research Funds for the Central Scientific Research Institutes for Public Welfare [yz-12-17]; PUMC Youth Fund [3332013113]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Scientific Research Institutes for Public Welfare; PUMC Youth Fund	This work was supported by the National Science Foundation of China (81072992 and 81373911), the Fundamental Research Funds for the Central Scientific Research Institutes for Public Welfare (yz-12-17), and the PUMC Youth Fund (3332013113). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Aparicio-Fabre R, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-26; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bassanezi RB, 2002, J PHYTOPATHOL, V150, P37, DOI 10.1046/j.1439-0434.2002.00714.x; Devoto A, 2005, PLANT MOL BIOL, V58, P497, DOI 10.1007/s11103-005-7306-5; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Fang XL, 2011, AUSTRALAS PLANT PATH, V40, P109, DOI 10.1007/s13313-010-0019-5; Fang XL, 2011, SCI HORTIC-AMSTERDAM, V131, P39, DOI 10.1016/j.scienta.2011.09.025; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Jang Chang Soon, 2010, Mycobiology, V38, P33, DOI 10.4489/MYCO.2010.38.1.033; KONING AJ, 1992, PLANT PHYSIOL, V100, P801, DOI 10.1104/pp.100.2.801; Kurth F, 2014, MOL PLANT MICROBE IN, V27, P891, DOI 10.1094/MPMI-10-13-0296-R; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li CF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-245; Liu JJ, 2006, PHYSIOL MOL PLANT P, V68, P3, DOI 10.1016/j.pmpp.2006.06.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo HM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S5-S5; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mathiyalagan R, 2013, J GINSENG RES, V37, P227, DOI 10.5142/jgr.2013.37.227; Mouekouba LDO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102690; O'Hara M, 1998, ARCH FAM MED, V7, P523, DOI 10.1001/archfami.7.6.523; Pauwels L, 2008, PLANT SIGNAL BEHAV, V3, P846, DOI 10.4161/psb.3.10.5993; Rahman M, 2005, PHYTOPATHOLOGY, V95, P1381, DOI 10.1094/PHYTO-95-1381; Rahman M, 2006, PHYTOPATHOLOGY, V96, P1179, DOI 10.1094/PHYTO-96-1179; REGO C, 2001, PHYTOPATHOL MEDITERR, V40, P343, DOI DOI 10.14601/PHYTOPATHOL_MEDITERR-1641; Rego C, 2006, PHYTOPATHOL MEDITERR, V45, pS93; Sathiyaraj G, 2010, MOL BIOL REP, V37, P3445, DOI 10.1007/s11033-009-9936-1; Shapiro LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077393; Song JY, 2014, MYCOBIOLOGY, V42, P174, DOI 10.5941/MYCO.2014.42.2.174; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Taffouo VD, 2014, MYCORRHIZA, V24, P361, DOI 10.1007/s00572-013-0544-5; Vanholme B, 2007, TRENDS PLANT SCI, V12, P239, DOI 10.1016/j.tplants.2007.04.004; Vogler BK, 1999, EUR J CLIN PHARMACOL, V55, P567, DOI 10.1007/s002280050674; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612	34	16	18	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149408	10.1371/journal.pone.0149408	http://dx.doi.org/10.1371/journal.pone.0149408			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890788	Green Published, gold, Green Submitted			2022-12-27	WOS:000371221500042
J	Lewis, MC; MacArthur, B; Tare, RS; Oreffo, ROC; Please, CP				Lewis, Miranda C.; MacArthur, Ben D.; Tare, Rahul S.; Oreffo, Richard O. C.; Please, Colin P.			Extracellular Matrix Deposition in Engineered Micromass Cartilage Pellet Cultures: Measurements and Modelling	PLOS ONE			English	Article							LOW-OXYGEN TENSION; PROTEOGLYCAN SYNTHESIS; DYNAMIC COMPOSITION; CHONDROCYTES; CELLS; GROWTH	This article explores possible mechanisms governing extracellular matrix deposition in engineered cartilaginous cell pellets. A theoretical investigation is carried out alongside an experimental study measuring proteoglycan and collagen volume fractions within murine chondrogenic (ATDC-5) cell pellets. The simple mathematical model, which adopts a nutrient-dependent proteoglycan production rate, successfully reproduces the periphery-dominated proteoglycan deposition, characteristic of the growth pattern observed experimentally within pellets after 21 days of culture. The results suggest that this inhomogeneous proteoglycan production is due to nutrient deficiencies at the pellet centre. Our model analysis further indicates that a spatially uniform distribution of proteoglycan matrix could be maintained by initiating the culture process with a smaller-sized pellet. Finally, possible extensions are put forward with an aim to improve the model predictions for the early behaviour, where different mechanisms appear to dominate the matrix production within the pellets.	[Lewis, Miranda C.; MacArthur, Ben D.] Univ Southampton, Math Sci, Southampton SO17 1BJ, Hants, England; [MacArthur, Ben D.; Tare, Rahul S.; Oreffo, Richard O. C.] Univ Southampton, Fac Med, Ctr Human Dev Stem Cells & Regenerat, Southampton SO16 6YD, Hants, England; [Please, Colin P.] Univ Oxford, Math Inst, Oxford OX2 6GG, England	University of Southampton; University of Southampton; University of Oxford	Please, CP (corresponding author), Univ Oxford, Math Inst, Oxford OX2 6GG, England.	colin.please@maths.ox.ac.uk	; Oreffo, Richard/A-4615-2011	Please, Colin/0000-0001-8917-8574; Oreffo, Richard/0000-0001-5995-6726; Tare, Rahul/0000-0001-8274-8837; MacArthur, Ben/0000-0002-5396-9750	Biotechnology and Biological Sciences Research Council (UK) [BBSRC BB/D0016681/1]; BBSRC [BB/D001668/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D001668/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (UK), grant number BBSRC BB/D0016681/1.	BUSCHMANN MD, 1992, J ORTHOPAED RES, V10, P745, DOI 10.1002/jor.1100100602; CLARK CC, 1991, J ORTHOPAED RES, V9, P477, DOI 10.1002/jor.1100090403; HANDLEY CJ, 1977, BIOCHIM BIOPHYS ACTA, V500, P132; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Malda J, 2004, OSTEOARTHR CARTILAGE, V12, P306, DOI 10.1016/j.joca.2003.12.001; Malda J, 2004, BIOTECHNOL BIOENG, V86, P9, DOI 10.1002/bit.20038; Mauck RL, 2003, OSTEOARTHR CARTILAGE, V11, P879, DOI 10.1016/j.joca.2003.08.006; Obradovic B, 2000, AICHE J, V46, P1860, DOI 10.1002/aic.690460914; Pisu M, 2004, CHEM ENG SCI, V59, P5035, DOI 10.1016/j.ces.2004.07.101; Pisu M, 2006, TISSUE ENG, V12, P2311, DOI 10.1089/ten.2006.12.2311; Razaq S, 2003, EUR SPINE J, V12, P341, DOI 10.1007/s00586-003-0582-3; Riesle J, 1998, J CELL BIOCHEM, V71, P313, DOI 10.1002/(SICI)1097-4644(19981201)71:3<313::AID-JCB1>3.0.CO;2-C; Saha A. K., 2005, Australasian Physical & Engineering Sciences in Medicine, V28, P97, DOI 10.1007/BF03178699; Saha AK, 2003, IEEE T NANOBIOSCI, V2, P89, DOI 10.1109/TNB.2003.813921; Saha AK, 2003, IEEE T NANOBIOSCI, V2, P158, DOI 10.1109/TNB.2003.816226; Saini S, 2004, TISSUE ENG, V10, P825, DOI 10.1089/1076327041348545; Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199; Sengers BG, 2005, J BIOMECH ENG-T ASME, V127, P758, DOI 10.1115/1.1993664; Tare RS, 2005, BIOCHEM BIOPH RES CO, V333, P609, DOI 10.1016/j.bbrc.2005.05.117; van der Kraan PM, 2002, OSTEOARTHR CARTILAGE, V10, P631, DOI 10.1053/joca.2002.0806; Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j; Wilson CG, 2002, ARCH BIOCHEM BIOPHYS, V408, P246, DOI 10.1016/S0003-9861(02)00562-3; Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004	23	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0147302	10.1371/journal.pone.0147302	http://dx.doi.org/10.1371/journal.pone.0147302			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26889833	Green Published, Green Accepted, gold			2022-12-27	WOS:000371221500005
J	Pan, X; Slater, M; Beacco, A; Navarro, X; Rivas, AIB; Swapp, D; Hale, J; Forbes, PAG; Denvir, C; Hamilton, AFD; Delacroix, S				Pan, Xueni; Slater, Mel; Beacco, Alejandro; Navarro, Xavi; Rivas, Anna I. Bellido; Swapp, David; Hale, Joanna; Forbes, Paul Alexander George; Denvir, Catrina; Hamilton, Antonia F. de C.; Delacroix, Sylvie			The Responses of Medical General Practitioners to Unreasonable Patient Demand for Antibiotics - A Study of Medical Ethics Using Immersive Virtual Reality	PLOS ONE			English	Article							PRIMARY-CARE; BURNOUT	Background Dealing with insistent patient demand for antibiotics is an all too common part of a General Practitioner's daily routine. This study explores the extent to which portable Immersive Virtual Reality technology can help us gain an accurate understanding of the factors that influence a doctor's response to the ethical challenge underlying such tenacious requests for antibiotics (given the threat posed by growing anti-bacterial resistance worldwide). It also considers the potential of such technology to train doctors to face such dilemmas. Experiment Twelve experienced GPs and nine trainees were confronted with an increasingly angry demand by a woman to prescribe antibiotics to her mother in the face of inconclusive evidence that such antibiotic prescription is necessary. The daughter and mother were virtual characters displayed in immersive virtual reality. The specific purposes of the study were twofold: first, whether experienced GPs would be more resistant to patient demands than the trainees, and second, to investigate whether medical doctors would take the virtual situation seriously. Results Eight out of the 9 trainees prescribed the antibiotics, whereas 7 out of the 12 GPs did so. On the basis of a Bayesian analysis, these results yield reasonable statistical evidence in favor of the notion that experienced GPs are more likely to withstand the pressure to prescribe antibiotics than trainee doctors, thus answering our first question positively. As for the second question, a post experience questionnaire assessing the participants' level of presence (together with participants' feedback and body language) suggested that overall participants did tend towards the illusion of being in the consultation room depicted in the virtual reality and that the virtual consultation taking place was really happening.	[Pan, Xueni; Hale, Joanna; Forbes, Paul Alexander George; Hamilton, Antonia F. de C.] UCL, Inst Cognit Neurosci, London, England; [Pan, Xueni] Univ London, Goldsmiths Coll, Dept Comp, London, England; [Slater, Mel; Beacco, Alejandro; Navarro, Xavi; Rivas, Anna I. Bellido] Univ Barcelona, Fac Psychol, Event Lab, Barcelona, Spain; [Slater, Mel] ICREA, Barcelona, Spain; [Slater, Mel; Swapp, David] UCL, Dept Comp Sci, London, England; [Denvir, Catrina; Delacroix, Sylvie] UCL, Fac Laws, London, England	University of London; University College London; University of London; Goldsmiths University London; University of Barcelona; ICREA; University of London; University College London; University of London; University College London	Delacroix, S (corresponding author), UCL, Fac Laws, London, England.	s.delacroix@ucl.ac.uk	Beacco, Alejandro/AAD-7459-2020; Denvir, Catrina/W-6252-2019; Hamilton, Antonia/ABC-4196-2021; Slater, Mel/M-5210-2014; Hamilton, Antonia/AAC-6648-2019	Beacco, Alejandro/0000-0001-8192-1431; Denvir, Catrina/0000-0003-2384-839X; Slater, Mel/0000-0002-6223-0050; Hamilton, Antonia/0000-0001-8000-0219; Hale, Joanna/0000-0003-3610-8411; Delacroix, Sylvie/0000-0002-8517-7782; Forbes, Paul/0000-0002-0138-8508; Swapp, David/0000-0002-9335-8663	Wellcome Trust [106351/Z/14/Z]; Health Education North Central and East London Future Workforce Funding [FWF-014]; Leverhulme Trust [PLP2010/0096]; ICREA Funding Source: Custom	Wellcome Trust(Wellcome TrustEuropean Commission); Health Education North Central and East London Future Workforce Funding; Leverhulme Trust(Leverhulme Trust); ICREA(ICREA)	Support was provided by Wellcome Trust 106351/Z/14/Z [http://www.wellcome.ac.uk/]; Health Education North Central and East London Future Workforce Funding - FWF-014 (combined bid) [https://ncel.hee.nhs.uk/]; and Leverhulme Trust PLP2010/0096 [https://www.leverhulme.ac.uk/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, ANT STEW SYST PROC E; Ashworth M, 2016, BRIT J GEN PRACT, V66, pE40, DOI 10.3399/bjgp15X688105; Battin M, 2007, PATIENT VICTIM VECTO; Blascovich J, 2002, PSYCHOL INQ, V13, P103, DOI 10.1207/S15327965PLI1302_01; BRADLEY CP, 1992, BRIT J GEN PRACT, V42, P454; Cook DA, 2009, MED EDUC, V43, P303, DOI 10.1111/j.1365-2923.2008.03286.x; Demerouti E, 2003, EUR J PSYCHOL ASSESS, V19, P12, DOI 10.1027//1015-5759.19.1.12; Enne VI, 2010, J ANTIMICROB CHEMOTH, V65, P179, DOI 10.1093/jac/dkp443; Friedman D, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00943; Hekman DR, 2009, ACAD MANAGE J, V52, P506, DOI 10.5465/AMJ.2009.41330897; Kleinsmith A, 2015, COMPUT HUM BEHAV, V52, P151, DOI 10.1016/j.chb.2015.05.033; Leibovici Leonard, 2012, J Antimicrob Chemother, V67, P12, DOI 10.1093/jac/dkr425; Littmann J, 2015, PUBLIC HEALTH ETH-UK, V8, P209, DOI 10.1093/phe/phv025; Lopez-Vazquez P, 2012, J EVAL CLIN PRACT, V18, P473, DOI 10.1111/j.1365-2753.2010.01610.x; MAEL F, 1992, J ORGAN BEHAV, V13, P103, DOI 10.1002/job.4030130202; Mangione-Smith R, 1999, PEDIATRICS, V103, P711, DOI 10.1542/peds.103.4.711; Mattick K, 2014, J ANTIMICROB CHEMOTH, V69, P2274, DOI 10.1093/jac/dku093; Mertz M, 2012, J ANTIMICROB CHEMOTH, V67, P1302, DOI 10.1093/jac/dks025; MILGRAM S., 1974, OBEDIENCE AUTHORITY; Millar M., 2012, J MED ETHICS; Pan X, 2011, P 25 BCS C HUM COMP, P46; Pan X, 2015, FRONT ROBOT AI, DOI 10.3389/frobt.2015.00001; Pan XN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032931; Plummer M., 2003, P 3 INT WORKSHOP DIS; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; Rovira A, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.059.2009; Sanchez-Vives MV, 2005, NAT REV NEUROSCI, V6, P332, DOI 10.1038/nrn1651; Slater M, 2000, PRESENCE-TELEOP VIRT, V9, P413, DOI 10.1162/105474600566925; Slater M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000039; Slater M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052766; Slater M, 2009, PHILOS T R SOC B, V364, P3549, DOI 10.1098/rstb.2009.0138; Smith GE, 2004, J PUBLIC HEALTH, V26, P359, DOI 10.1093/pubmed/fdh179; Vaz LE, 2015, PEDIATRICS; Viens AM, 2015, PUBLIC HEALTH ETH-UK, V8, P255, DOI 10.1093/phe/phv015; Weigl M, 2012, BMJ QUAL SAF, V21, P399, DOI 10.1136/bmjqs-2011-000188; Zwack J, 2013, ACAD MED, V88, P382, DOI 10.1097/ACM.0b013e318281696b	36	35	35	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0146837	10.1371/journal.pone.0146837	http://dx.doi.org/10.1371/journal.pone.0146837			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3CO	26889676	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000371221500004
J	Hayat, T; Shafique, M; Tanveer, A; Alsaedi, A				Hayat, Tasawar; Shafique, Maryam; Tanveer, Anum; Alsaedi, Ahmed			Radiative Peristaltic Flow of Jeffrey Nanofluid with Slip Conditions and Joule Heating	PLOS ONE			English	Article							MASS-TRANSFER; TRANSPORT; DUFOUR; FLUID; SORET; MHD	Mixed convection peristaltic flow of Jeffrey nanofluid in a channel with compliant walls is addressed here. The present investigation includes the viscous dissipation, thermal radiation and Joule heating. Whole analysis is performed for velocity, thermal and concentration slip conditions. Related problems through long wavelength and low Reynolds number are examined for stream function, temperature and concentration. Impacts of thermal radiation, Hartman number, Brownian motion parameter, thermophoresis, Joule heating and slip parameters are explored in detail. Clearly temperature is a decreasing function of Hartman number and radiation parameter.	[Hayat, Tasawar; Shafique, Maryam; Tanveer, Anum] Quaid I Azam Univ, Dept Math, Islamabad 44000, Pakistan; [Hayat, Tasawar; Alsaedi, Ahmed] King Abdulaziz Univ, Dept Math, NAAM Res Grp, Fac Sci, Jeddah 21589, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Tanveer, A (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad 44000, Pakistan.	anum@math.qau.edu.pk	Alsaedi, Ahmed/A-2094-2013; Hayat, Tasawar/Y-2524-2019	Alsaedi, Ahmed/0000-0003-3452-8922; 				Abbasi FM, 2015, INT J MOD PHYS B, V29, DOI 10.1142/S0217979215501519; Abbasi FM, 2015, B POL ACAD SCI-TECH, V63, P501, DOI 10.1515/bpasts-2015-0058; Abbasi FM, 2015, PHYSICA E, V67, P47, DOI 10.1016/j.physe.2014.11.002; Ali N., 2015, COMPUT METHOD BIOMEC, V59, P1; Ebaid A, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/825376; Ellahi R, 2015, J MAGN MAGN MATER, V393, P284, DOI 10.1016/j.jmmm.2015.05.071; Ellahi R, 2014, INT J HEAT MASS TRAN, V71, P706, DOI 10.1016/j.ijheatmasstransfer.2013.12.038; Gad NS, 2014, APPL MATH COMPUT, V235, P546, DOI 10.1016/j.amc.2014.02.081; Hayat T, 2015, J MAGN MAGN MATER, V395, P48, DOI 10.1016/j.jmmm.2015.07.027; Hayat T, 2014, J MOL LIQ, V194, P93, DOI 10.1016/j.molliq.2014.01.021; Hayat T, 2014, COMPUT FLUIDS, V89, P242, DOI 10.1016/j.compfluid.2013.10.038; HAYAT T, 2014, EUR PHYS J PLUS, V129, DOI DOI 10.1140/EPJP/; Hayat T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113851; Hayat T, 2014, Z NATURFORSCH A, V69, P43, DOI 10.5560/ZNA.2013-0074; Hina S, 2014, INT J BIOMATH, V7, DOI 10.1142/S1793524514500156; Latham TW., 1996, FLUID MOTION PERISTA; Mekheimer KS, 2013, APPL BIONICS BIOMECH, V10, P19, DOI [10.3233/ABB-2012-0071, 10.1155/2013/902097]; Mustafa M, 2014, J TAIWAN INST CHEM E, V45, P308, DOI 10.1016/j.jtice.2013.07.010; Nadeem S, 2010, J TAIWAN INST CHEM E, V41, P286, DOI 10.1016/j.jtice.2009.11.004; SHAPIRO AH, 1969, J FLUID MECH, V37, P799, DOI 10.1017/S0022112069000899; Sheikholeslami M, 2014, J MAGN MAGN MATER, V369, P69, DOI 10.1016/j.jmmm.2014.06.017; Srinivas S, 2011, MATH COMPUT MODEL, V54, P1213, DOI 10.1016/j.mcm.2011.03.032; Srinivas S, 2011, COMMUN NONLINEAR SCI, V16, P1845, DOI 10.1016/j.cnsns.2010.08.004; Tripathi D, 2014, INT J HEAT MASS TRAN, V70, P61, DOI 10.1016/j.ijheatmasstransfer.2013.10.044; Vajravelu K, 2013, APPL MATH COMPUT, V225, P656, DOI 10.1016/j.amc.2013.10.014	25	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148002	10.1371/journal.pone.0148002	http://dx.doi.org/10.1371/journal.pone.0148002			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886919	gold, Green Published			2022-12-27	WOS:000371218400014
J	Liu, YH; Huang, XW; Yi, XW; He, Y; Mylonakis, E; Xi, LY				Liu, Yinghui; Huang, Xiaowen; Yi, Xiuwen; He, Ya; Mylonakis, Eleftherios; Xi, Liyan			Detection of Talaromyces marneffei from Fresh Tissue of an Inhalational Murine Pulmonary Model Using Nested PCR	PLOS ONE			English	Article							PENICILLIUM-MARNEFFEI; IDENTIFICATION; AMPLIFICATION; ASPERGILLUS; INFECTION; SAMPLES	Penicilliosis marneffei, often consecutive to the aspiration of Talaromyces marneffei (Penicillium marneffei), continues to be one of the significant causes of morbidity and mortality in immunocompromised patients in endemic regions such as Southeast Asia. Improving the accuracy of diagnosing this disease would aid in reducing the mortality of associated infections. In this study, we developed a stable and reproducible murine pulmonary model that mimics human penicilliosis marneffei using a nebulizer to deliver Talaromyces marneffei (SUMS0152) conidia to the lungs of BALB/c nude mice housed in exposure chamber. Using this model, we further revealed that nested PCR was sensitive and specific for detecting Talaromyces marneffei in bronchoalveolar lavage fluid and fresh tissues. This inhalation model may provide a more representative analysis tool for studying the development of penicilliosis marneffei, in addition to revealing that nested PCR has a predictive value in reflecting pulmonary infection.	[Liu, Yinghui; Yi, Xiuwen; He, Ya; Xi, Liyan] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Dermatol, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Xiaowen] PLA, Guangzhou Mil Command, Gen Hosp, Dept Dermatol, Guangzhou, Guangdong, Peoples R China; [Mylonakis, Eleftherios] Brown Univ, Rhode Isl Hosp, Waren Alpert Med Sch, Div Infect Dis, Providence, RI 02903 USA	Sun Yat Sen University; Southern Theater Command General Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Xi, LY (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Dermatol, Guangzhou 510275, Guangdong, Peoples R China.	xiliyan@mail.sysu.edu.cn		Xi, Liyan/0000-0003-1504-0147	establishment of early diagnosis of modern technology platform of AIDS, tuberculosis and other chronic diseases with invasive fungal infections-the stablishment of early diagnosis of technology platform of Penicilliosis marneffei (sub-programed) [2013ZX10004612]	establishment of early diagnosis of modern technology platform of AIDS, tuberculosis and other chronic diseases with invasive fungal infections-the stablishment of early diagnosis of technology platform of Penicilliosis marneffei (sub-programed)	The study was supported by the funding of the establishment of early diagnosis of modern technology platform of AIDS, tuberculosis and other chronic diseases with invasive fungal infections-the stablishment of early diagnosis of technology platform of Penicilliosis marneffei (sub-programed) (2013ZX10004612). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buskirk AD, 2014, J IMMUNOTOXICOL, V11, P180, DOI 10.3109/1547691X.2013.819054; Chen RQ, 2014, MICROBES INFECT, V16, P401, DOI 10.1016/j.micinf.2014.02.005; DISALVO AF, 1973, AM J CLIN PATHOL, V60, P259; Houbraken J, 2014, ADV APPL MICROBIOL, V86, P199, DOI 10.1016/B978-0-12-800262-9.00004-4; Hu YX, 2013, MYCOPATHOLOGIA, V175, P57, DOI 10.1007/s11046-012-9577-0; Huang XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108764; Kudeken N, 1997, CLIN EXP IMMUNOL, V107, P468, DOI 10.1046/j.1365-2249.1997.d01-945.x; Kudeken N, 1996, J MED VET MYCOL, V34, P371; Lu S, 2013, MYCOPATHOLOGIA, V176, P11, DOI 10.1007/s11046-013-9650-3; Luo DQ, 2011, MYCOPATHOLOGIA, V171, P191, DOI 10.1007/s11046-010-9363-9; Pongpom M, 2009, MED MYCOL, V47, P549, DOI 10.1080/13693780802484875; Sheppard DC, 2004, ANTIMICROB AGENTS CH, V48, P1908, DOI 10.1128/AAC.48.5.1908-1911.2004; Stevens WW, 2007, J IMMUNOL METHODS, V327, P63, DOI 10.1016/j.jim.2007.07.011; Sun JF, 2014, MED MYCOL, V52, P167, DOI 10.1093/mmy/myt006; Sun JF, 2011, MYCOSES, V54, pE751, DOI 10.1111/j.1439-0507.2011.02017.x; Sun JF, 2010, FEMS IMMUNOL MED MIC, V58, P381, DOI [10.1111/j.1574-695X.2010.00647.x, 10.1111/j.1574-695X.2009.00647.x]; Zeng HX, 2009, MYCOPATHOLOGIA, V168, P31, DOI 10.1007/s11046-009-9195-7; Zhang JM, 2011, J MICROBIOL METH, V85, P33, DOI 10.1016/j.mimet.2011.01.022	18	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149634	10.1371/journal.pone.0149634	http://dx.doi.org/10.1371/journal.pone.0149634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886887	Green Published, gold, Green Submitted			2022-12-27	WOS:000371218400101
J	Sole-Padulles, C; Castro-Fornieles, J; de la Serna, E; Romero, S; Calvo, A; Sanchez-Gistau, V; Padros-Fornieles, M; Baeza, I; Bargallo, N; Frangou, S; Sugranyes, G				Sole-Padulles, Cristina; Castro-Fornieles, Josefina; de la Serna, Elena; Romero, Soledad; Calvo, Anna; Sanchez-Gistau, Vanessa; Padros-Fornieles, Marta; Baeza, Inmaculada; Bargallo, Nria; Frangou, Sophia; Sugranyes, Gisela			Altered Cortico-Striatal Connectivity in Offspring of Schizophrenia Patients Relative to Offspring of Bipolar Patients and Controls	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; FUNCTIONAL CONNECTIVITY; WORKING-MEMORY; BRAIN-FUNCTION; FAMILIAL RISK; YOUNG-PEOPLE; OULU BRAIN; DISORDER; PSYCHOSIS; METAANALYSIS	Schizophrenia (SZ) and bipolar disorder (BD) share clinical features, genetic risk factors and neuroimaging abnormalities. There is evidence of disrupted connectivity in resting state networks in patients with SZ and BD and their unaffected relatives. Resting state networks are known to undergo reorganization during youth coinciding with the period of increased incidence for both disorders. We therefore focused on characterizing resting state network connectivity in youth at familial risk for SZ or BD to identify alterations arising during this period. We measured resting -state functional connectivity in a sample of 106 youth, aged 7-19 years, comprising offspring of patients with SZ (N = 27), offspring of patients with BD (N = 39) and offspring of community control parents (N = 40). We used Independent Component Analysis to assess functional connectivity within the default mode, executive control, salience and basal ganglia networks and define their relationship to grey matter volume, clinical and cognitive measures. There was no difference in connectivity within any of the networks examined between offspring of patients with BD and offspring of community controls. In contrast, offspring of patients with SZ showed reduced connectivity within the left basal ganglia network compared to control offspring, and they showed a positive correlation between connectivity in this network and grey matter volume in the left caudate. Our findings suggest that dysconnectivity in the basal ganglia network is a robust correlate of familial risk for SZ and can be detected during childhood and adolescence.	[Sole-Padulles, Cristina; Castro-Fornieles, Josefina; Romero, Soledad; Calvo, Anna; Sanchez-Gistau, Vanessa; Baeza, Inmaculada; Sugranyes, Gisela] August Pi & Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain; [Castro-Fornieles, Josefina; Romero, Soledad; Sanchez-Gistau, Vanessa; Padros-Fornieles, Marta; Baeza, Inmaculada; Sugranyes, Gisela] Hosp Clin Barcelona, Dept Child & Adolescent Psychiat & Psychol, Inst Neurosci, SGR489, Barcelona, Spain; [Castro-Fornieles, Josefina] Univ Barcelona, Dept Psychiat & Clin Psychobiol, Barcelona, Spain; [Castro-Fornieles, Josefina; de la Serna, Elena; Romero, Soledad; Sanchez-Gistau, Vanessa; Baeza, Inmaculada; Bargallo, Nria] Biomed Res Networking Ctr Consortium CIBERSAM, Barcelona, Spain; [Calvo, Anna; Bargallo, Nria] Hosp Clin Barcelona, Magnet Resonance Imaging Core Facil, Barcelona, Spain; [Calvo, Anna] GIB UB, Bioengn Biomat & Nanomed CIBER BBN, Barcelona, Spain; [Bargallo, Nria] Hosp Clin Barcelona, CDI, Barcelona, Spain; [Frangou, Sophia] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Barcelona; Hospital Clinic de Barcelona; Icahn School of Medicine at Mount Sinai	Sugranyes, G (corresponding author), August Pi & Sunyer Biomed Res Inst IDIBAPS, Barcelona, Spain.; Sugranyes, G (corresponding author), Hosp Clin Barcelona, Dept Child & Adolescent Psychiat & Psychol, Inst Neurosci, SGR489, Barcelona, Spain.	gernest@clinic.cat	Baeza, Inmaculada/GQI-3365-2022; Solé-Padullés, Cristina/K-6984-2017; De la Serna, Elena/AAJ-7940-2021; Bargallo, Nuria/G-6854-2016	Solé-Padullés, Cristina/0000-0002-6653-1053; De la Serna, Elena/0000-0002-7869-9881; Sugranyes, Gisela/0000-0002-2545-7862; Frangou, Sophia/0000-0002-3210-6470; Bargallo, Nuria/0000-0001-6284-5402; Romero, Soledad/0000-0001-9934-5196; sanchez-gistau, vanessa/0000-0002-8635-7144	Fundacion Alicia Koplowitz Research Project; IDIBAPS start-up grant, Spanish Ministry of Economy and Competitiveness / Instituto de Salud Carlos III [FIS PI 07/0066, PI 11/00683]; European Regional Development Fund; La Marato de TV3 Foundation [091630]; Catalonia Government [2009SGR1119]	Fundacion Alicia Koplowitz Research Project; IDIBAPS start-up grant, Spanish Ministry of Economy and Competitiveness / Instituto de Salud Carlos III; European Regional Development Fund(European Commission); La Marato de TV3 Foundation; Catalonia Government	Funding for this study was provided by the Fundacion Alicia Koplowitz Research Project grant, IDIBAPS start-up grant, Spanish Ministry of Economy and Competitiveness / Instituto de Salud Carlos III (FIS PI 07/0066, PI 11/00683) / European Regional Development Fund, La Marato de TV3 Foundation (091630), Catalonia Government (2009SGR1119).	American Psychiatric Association (APA), 1994, DIAGNOSTIC AND STATI; Argyelan M, 2014, SCHIZOPHRENIA BULL, V40, P100, DOI [10.1093/schbul/sbu150, 10.1093/schbul/sbt092]; Baker JT, 2014, JAMA PSYCHIAT, V71, P109, DOI 10.1001/jamapsychiatry.2013.3469; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Bora E, 2015, SCHIZOPHRENIA BULL, V41, P1095, DOI 10.1093/schbul/sbu198; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Burgund ED, 2002, NEUROIMAGE, V17, P184, DOI 10.1006/nimg.2002.1174; Busner Joan, 2007, Psychiatry (Edgmont), V4, P28; Chai XQJ, 2011, NEUROPSYCHOPHARMACOL, V36, P2009, DOI 10.1038/npp.2011.88; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Delvecchio G, 2013, PSYCHOL MED, V43, P553, DOI 10.1017/S0033291712001432; Diwadkar VA, 2011, NEUROIMAGE, V58, P234, DOI 10.1016/j.neuroimage.2011.06.033; Diwadkar VA, 2011, PROG NEURO-PSYCHOPH, V35, P1349, DOI 10.1016/j.pnpbp.2011.04.009; Ellison-Wright I, 2010, SCHIZOPHR RES, V117, P1, DOI 10.1016/j.schres.2009.12.022; Erhardt EB, 2011, HUM BRAIN MAPP, V32, P2075, DOI 10.1002/hbm.21170; Farr OM, 2014, INT J NEUROPSYCHOPH, V17, P1177, DOI 10.1017/S1461145714000674; First MB, 2002, STRUCTURED CLIN INTE; Fornito A, 2013, JAMA PSYCHIAT, V70, P1143, DOI 10.1001/jamapsychiatry.2013.1976; Fornito Alex, 2012, Front Psychiatry, V3, P72, DOI 10.3389/fpsyt.2012.00072; Frangou S, 2014, SCHIZOPHRENIA BULL, V40, P523, DOI 10.1093/schbul/sbu017; Fusar-Poli P, 2011, Mol Psychiatry, V16, P67, DOI 10.1038/mp.2009.108; Geller B, 2001, J AM ACAD CHILD PSY, V40, P450, DOI 10.1097/00004583-200104000-00014; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Heinze K, 2015, BIOL PSYCHIAT, V77, P989, DOI 10.1016/j.biopsych.2014.10.023; Hollingshead August B., 1958, SOCIAL CLASS MENTAL; Huttunen J, 2008, BIOL PSYCHIAT, V63, P114, DOI 10.1016/j.biopsych.2007.04.017; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Jang JH, 2011, SCHIZOPHR RES, V127, P58, DOI 10.1016/j.schres.2010.12.022; Jones P B, 2013, Br J Psychiatry Suppl, V54, ps5, DOI 10.1192/bjp.bp.112.119164; Jukuri T, 2015, SCHIZOPHR RES, V161, P177, DOI 10.1016/j.schres.2014.11.003; Jukuri T, 2013, SCHIZOPHR RES, V143, P239, DOI 10.1016/j.schres.2012.11.020; Keshavan MS, 2011, SCHIZOPHR RES, V133, P250, DOI 10.1016/j.schres.2011.09.005; Khadka S, 2013, BIOL PSYCHIAT, V74, P458, DOI 10.1016/j.biopsych.2013.04.024; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Lois G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107829; Lui S, 2015, PSYCHOL MED, V45, P97, DOI 10.1017/S003329171400110X; Magioncalda P, 2015, HUM BRAIN MAPP, V36, P666, DOI 10.1002/hbm.22655; Maziade M, 2011, SCHIZOPHRENIA BULL, V37, P1218, DOI 10.1093/schbul/sbq026; Meda SA, 2012, BIOL PSYCHIAT, V71, P881, DOI 10.1016/j.biopsych.2012.01.025; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Miller TJ, 2003, SCHIZOPHRENIA BULL, V29, P703, DOI 10.1093/oxfordjournals.schbul.a007040; Nakao T, 2011, AM J PSYCHIAT, V168, P1154, DOI 10.1176/appi.ajp.2011.11020281; Ordaz SJ, 2013, J NEUROSCI, V33, P18109, DOI 10.1523/JNEUROSCI.1741-13.2013; Orliac F, 2013, SCHIZOPHR RES, V148, P74, DOI 10.1016/j.schres.2013.05.007; Porter JN, 2015, DEV COGN NEUROS-NETH, V11, P83, DOI 10.1016/j.dcn.2014.08.011; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rasic D, 2014, SCHIZOPHRENIA BULL, V40, P28, DOI 10.1093/schbul/sbt114; Sanchez-Gistau V, 2015, SCHIZOPHR RES, V168, P197, DOI 10.1016/j.schres.2015.08.034; Sato JR, 2014, J PSYCHIATR RES, V58, P89, DOI 10.1016/j.jpsychires.2014.07.004; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Singh MK, 2014, BIPOLAR DISORD, V16, P678, DOI 10.1111/bdi.12221; Strakowski SM, 2012, BIPOLAR DISORD, V14, P313, DOI 10.1111/j.1399-5618.2012.01022.x; Supekar K, 2010, NEUROIMAGE, V52, P290, DOI 10.1016/j.neuroimage.2010.04.009; Taki Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022734; Tandon N, 2013, SCHIZOPHR RES, V148, P59, DOI 10.1016/j.schres.2013.05.024; Tang JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071061; Tu PC, 2013, SCHIZOPHR RES, V147, P339, DOI 10.1016/j.schres.2013.04.011; van Buuren M, 2012, SCHIZOPHR RES, V142, P237, DOI 10.1016/j.schres.2012.09.017; Wechsler D, 1999, WECHLSER ADULT INTEL; Wechsler D, 1994, WECHSLER INTELLIGENC; Wu MJ, 2013, J PSYCHIATR NEUROSCI, V38, P232, DOI 10.1503/jpn.120073; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	65	19	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148045	10.1371/journal.pone.0148045	http://dx.doi.org/10.1371/journal.pone.0148045			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885824	Green Submitted, gold, Green Published			2022-12-27	WOS:000371218400016
J	Tiwari, V; Patel, MK; Chaturvedi, AK; Mishra, A; Jha, B				Tiwari, Vivekanand; Patel, Manish Kumar; Chaturvedi, Amit Kumar; Mishra, Avinash; Jha, Bhavanath			Functional Characterization of the Tau Class Glutathione-S-Transferases Gene (SbGSTU) Promoter of Salicornia brachiata under Salinity and Osmotic Stress	PLOS ONE			English	Article							EXTREME HALOPHYTE; SALT STRESS; HETEROLOGOUS EXPRESSION; ECTOPIC EXPRESSION; TRANSGENIC TOBACCO; CONFERS SALT; TOLERANCE; ARABIDOPSIS; DROUGHT; OVEREXPRESSION	Reactive oxygen or nitrogen species are generated in the plant cell during the extreme stress condition, which produces toxic compounds after reacting with the organic molecules. The glutathione-S-transferase (GST) enzymes play a significant role to detoxify these toxins and help in excretion or sequestration of them. In the present study, we have cloned 1023 bp long promoter region of tau class GST from an extreme halophyte Salicornia brachiata and functionally characterized using the transgenic approach in tobacco. Computational analysis revealed the presence of abiotic stress responsive cis-elements like ABRE, MYB, MYC, GATA, GT1 etc., phytohormones, pathogen and wound responsive motifs. Three 5'-deletion constructs of 730 (GP2), 509 (GP3) and 348 bp (GP4) were made from 1023 (GP1) promoter fragment and used for tobacco transformation. The single event transgenic plants showed notable GUS reporter protein expression in the leaf tissues of control as well as treated plants. The expression level of the GUS gradually decreases from GP1 to GP4 in leaf tissues, whereas the highest level of expression was detected with the GP2 construct in root and stem under control condition. The GUS expression was found higher in leaves and stems of salinity or osmotic stress treated transgenic plants than that of the control plants, but, lower in roots. An efficient expression level of GUS in transgenic plants suggests that this promoter can be used for both constitutive as well as stress inducible expression of gene(s). And this property, make it as a potential candidate to be used as an alternative promoter for crop genetic engineering.	[Tiwari, Vivekanand; Patel, Manish Kumar; Chaturvedi, Amit Kumar; Mishra, Avinash; Jha, Bhavanath] Cent Salt & Marine Chem Res Inst, CSIR, Div Marine Biotechnol & Ecol, GB Marg, Bhavnagar 364002, Gujarat, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Salt & Marine Chemical Research Institute (CSMCRI)	Mishra, A; Jha, B (corresponding author), Cent Salt & Marine Chem Res Inst, CSIR, Div Marine Biotechnol & Ecol, GB Marg, Bhavnagar 364002, Gujarat, India.	avinash@csmcri.org; bjha@csmcri.org	TIWARI, VIVEKANAND/AAD-9738-2020; Mishra, Avinash/AAG-2961-2019; Chaturvedi, Amit k/J-5187-2012; Mishra, Avinash/C-3210-2009; Patel, Manish Kumar/I-6335-2017	TIWARI, VIVEKANAND/0000-0002-0464-6031; Mishra, Avinash/0000-0003-0342-010X; Mishra, Avinash/0000-0003-0342-010X; Patel, Manish Kumar/0000-0001-5250-1008; Chaturvedi, Amit Kumar/0000-0003-0867-6542	Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi [BSC0107-PlaGen]	Council of Scientific and Industrial Research (CSIR), Government of India, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by the Council of Scientific and Industrial Research (CSIR; www.csir.res.in), Government of India, New Delhi [BSC0107-PlaGen]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2008, PLANT CELL, V20, P2117, DOI 10.1105/tpc.108.058941; Benekos K, 2010, J BIOTECHNOL, V150, P195, DOI 10.1016/j.jbiotec.2010.07.011; Bianchi MW, 2002, PHYSIOL PLANTARUM, V116, P96, DOI 10.1034/j.1399-3054.2002.1160112.x; Chaturvedi AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111379; Chaturvedi AK, 2012, GENE, V499, P280, DOI 10.1016/j.gene.2012.03.001; Dixon David P, 2010, Arabidopsis Book, V8, pe0131, DOI 10.1199/tab.0131; Flowers TJ, 2008, NEW PHYTOL, V179, P945, DOI 10.1111/j.1469-8137.2008.02531.x; Foyer CH, 2009, ANTIOXID REDOX SIGN, V11, P861, DOI 10.1089/ars.2008.2177; Frova C, 2006, BIOMOL ENG, V23, P149, DOI 10.1016/j.bioeng.2006.05.020; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Higo K, 1998, NUCLEIC ACIDS RES, V26, P358, DOI 10.1093/nar/26.1.358; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Huda KMK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057803; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jha B., 2016, GENETICALLY MODIFIED, P305, DOI [10.1016/B978-0-12-802259-7.00027-0, DOI 10.1016/B978-0-12-802259-7.00027-0]; Jha B, 2012, J AGR FOOD CHEM, V60, P4320, DOI 10.1021/jf203632v; Jha B, 2011, MOL BIOL REP, V38, P4823, DOI 10.1007/s11033-010-0625-x; Jha B, 2009, GENES GENET SYST, V84, P111, DOI 10.1266/ggs.84.111; Jiang HW, 2010, PLANT PHYSIOL, V154, P1646, DOI 10.1104/pp.110.159152; JOSHI MC, 2013, PLOS GENET, V9, DOI DOI 10.1371/JOURNAL.PONE.0071136; Joshi M, 2012, IND CROP PROD, V35, P313, DOI 10.1016/j.indcrop.2011.06.024; Kanneganti V, 2008, PLANT MOL BIOL, V66, P445, DOI 10.1007/s11103-007-9284-2; Kitamura S, 2004, PLANT J, V37, P104, DOI 10.1046/j.1365-313X.2003.01943.x; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Lo Cicero L, 2015, PHYTOCHEMISTRY, V116, P69, DOI 10.1016/j.phytochem.2015.03.004; Loyall L, 2000, PLANT CELL, V12, P1939, DOI 10.1105/tpc.12.10.1939; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mishra A, 2015, J FUNCT FOODS, V13, P21, DOI 10.1016/j.jff.2014.12.027; Mishra A, 2013, CARBOHYD POLYM, V92, P1942, DOI 10.1016/j.carbpol.2012.11.055; Moons A, 2005, VITAM HORM, V72, P155, DOI 10.1016/S0083-6729(05)72005-7; Moons A, 2003, FEBS LETT, V553, P427, DOI 10.1016/S0014-5793(03)01077-9; Pandey S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144469; Pandey S, 2013, APPL BIOCHEM BIOTECH, V171, P1, DOI 10.1007/s12010-013-0349-1; Patel MK, 2015, PLANT CELL TISS ORG, V122, P477, DOI 10.1007/s11240-015-0785-4; Peng L, 2014, ACTA PHYSIOL PLANT, V36, P2905, DOI 10.1007/s11738-014-1660-3; Potters G, 2010, PLANT PHYSIOL BIOCH, V48, P292, DOI 10.1016/j.plaphy.2009.12.007; Sharma R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092900; Singh N, 2014, GENE, V547, P119, DOI 10.1016/j.gene.2014.06.037; Singh N, 2014, MAR BIOTECHNOL, V16, P321, DOI 10.1007/s10126-013-9548-6; Taji T, 2004, PLANT PHYSIOL, V135, P1697, DOI 10.1104/pp.104.039909; Taji T, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-261; TIWARI V, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0131567; Tiwari V, 2014, PLANT CELL PHYSIOL, V55, P201, DOI 10.1093/pcp/pct172; Udawat P, 2014, GENE, V536, P163, DOI 10.1016/j.gene.2013.11.020; Umezawa T, 2006, CURR OPIN BIOTECH, V17, P113, DOI 10.1016/j.copbio.2006.02.002; Yoshida T, 2014, CURR OPIN PLANT BIOL, V21, P133, DOI 10.1016/j.pbi.2014.07.009; Youm JW, 2008, PLANTA, V228, P701, DOI 10.1007/s00425-008-0782-5	48	51	56	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148494	10.1371/journal.pone.0148494	http://dx.doi.org/10.1371/journal.pone.0148494			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885663	Green Published, gold, Green Submitted			2022-12-27	WOS:000371218400037
J	Paduano, F; Marrelli, M; White, LJ; Shakesheff, KM; Tatullo, M				Paduano, Francesco; Marrelli, Massimo; White, Lisa J.; Shakesheff, Kevin M.; Tatullo, Marco			Odontogenic Differentiation of Human Dental Pulp Stem Cells on Hydrogel Scaffolds Derived from Decellularized Bone Extracellular Matrix and Collagen Type I	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-2; EXFOLIATED DECIDUOUS TEETH; FACTOR-RELEASING HYDROGELS; SKELETAL TISSUE-REPAIR; FEMUR DEFECT MODEL; IMPERFECTA TYPE-II; 3-DIMENSIONAL SCAFFOLD; GENOMIC ORGANIZATION; VIVO; PHOSPHOPROTEIN	Objectives The aim of this study was to evaluate the level of odontogenic differentiation of dental pulp stem cells (DPSCs) on hydrogel scaffolds derived from bone extracellular matrix (bECM) in comparison to those seeded on collagen I (Col-I), one of the main components of dental pulp ECM. Methods DPSCs isolated from human third molars were characterized for surface marker expression and odontogenic potential prior to seeding into bECM or Col-I hydrogel scaffolds. The cells were then seeded onto bECM and Col-I hydrogel scaffolds and cultured under basal conditions or with odontogenic and growth factor (GF) supplements. DPSCs cultivated on tissue culture polystyrene (TCPS) with and without supplements were used as controls. Gene expression of dentin sialophosphoprotein (DSPP), dentin matrix protein 1 (DMP-1) and matrix extracellular phosphoglycoprotein (MEPE) was evaluated by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and mineral deposition was observed by Von Kossa staining. Results When DPSCs were cultured on bECM hydrogels, the mRNA expression levels of DSPP, DMP-1 and MEPE genes were significantly upregulated with respect to those cultured on Col-I scaffolds or TCPS in the absence of extra odontogenic inducers. In addition, more mineral deposition was observed on bECM hydrogel scaffolds as demonstrated by Von Kossa staining. Moreover, DSPP, DMP-1 and MEPE mRNA expressions of DPSCs cultured on bECM hydrogels were further upregulated by the addition of GFs or osteo/odontogenic medium compared to Col-I treated cells in the same culture conditions. Significance These results demonstrate the potential of the bECM hydrogel scaffolds to stimulate odontogenic differentiation of DPSCs.	[Paduano, Francesco; Tatullo, Marco] Tecnol Res Inst, Biomed Sect, Crotone, Italy; [Marrelli, Massimo] Calabrodental, Unit Maxillofacial Surg, Crotone, Italy; [White, Lisa J.; Shakesheff, Kevin M.] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England	University of Nottingham	Tatullo, M (corresponding author), Tecnol Res Inst, Biomed Sect, Crotone, Italy.	marco.tatullo@tecnologicasrl.com	Tatullo, Marco/AAI-4864-2020; White, Lisa/AAM-9012-2021; Tatullo, Marco/GRQ-7439-2022; Paduano, Francesco/A-2548-2015; Shakesheff, Kevin M/O-6371-2018; Shakesheff, Kevin/AAR-6603-2021	Tatullo, Marco/0000-0001-7340-0708; Paduano, Francesco/0000-0003-0916-8101; Shakesheff, Kevin M/0000-0003-3236-2439; White, Lisa/0000-0003-0571-999X	Engineering and Physical Sciences Research Council [EP/N006615/1] Funding Source: researchfish; EPSRC [EP/N006615/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Albuquerque MTP, 2014, J DENT RES, V93, P1222, DOI 10.1177/0022034514549809; Almushayt A, 2006, GENE THER, V13, P611, DOI 10.1038/sj.gt.3302687; APLIN HM, 1995, GENOMICS, V30, P347, DOI 10.1006/geno.1995.9867; Bonnamain V, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00357; Cordeiro MM, 2008, J ENDODONT, V34, P962, DOI 10.1016/j.joen.2008.04.009; Feng JQ, 1998, J BIOL CHEM, V273, P9457, DOI 10.1074/jbc.273.16.9457; Galler KM, 2012, TISSUE ENG PT A, V18, P176, DOI [10.1089/ten.tea.2011.0222, 10.1089/ten.TEA.2011.0222]; Galler KM, 2011, REGEN MED, V6, P191, DOI 10.2217/RME.11.3; Gothard D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145080; Gronthos S, 2006, CALCIFIED TISSUE INT, V79, P310, DOI 10.1007/s00223-006-0040-4; Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Gupte MJ, 2012, J DENT RES, V91, P227, DOI 10.1177/0022034511417441; He HX, 2008, CELL BIOL INT, V32, P827, DOI 10.1016/j.cellbi.2008.03.013; Hirst KL, 1997, GENOMICS, V42, P38, DOI 10.1006/geno.1997.4700; Huang GTJ, 2010, TISSUE ENG PT A, V16, P605, DOI [10.1089/ten.tea.2009.0518, 10.1089/ten.TEA.2009.0518]; Ishimatsu H, 2009, J ENDODONT, V35, P858, DOI 10.1016/j.joen.2009.03.049; Kim YS, 2010, J ENDODONT, V36, P1824, DOI 10.1016/j.joen.2010.08.020; Liu H, 2004, J DENT RES, V83, P496, DOI 10.1177/154405910408300612; Lu YB, 2007, DEV BIOL, V303, P191, DOI 10.1016/j.ydbio.2006.11.001; Marrelli M, 2015, J DENT RES, V94, P843, DOI 10.1177/0022034515570316; Marrelli M, 2013, INT J BIOL SCI, V9, P1070, DOI 10.7150/ijbs.6662; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Nagy MM, 2014, J ENDODONT, V40, P192, DOI 10.1016/j.joen.2013.10.027; Prescott RS, 2008, J ENDODONT, V34, P421, DOI 10.1016/j.joen.2008.02.005; Qu TJ, 2014, TISSUE ENG PT A, V20, P2422, DOI [10.1089/ten.tea.2013.0741, 10.1089/ten.TEA.2013.0741]; Qu TJ, 2013, J MATER CHEM B, V1, P4764, DOI 10.1039/c3tb21002b; Ravindran S, 2014, TISSUE ENG PT A, V20, P92, DOI [10.1089/ten.tea.2013.0192, 10.1089/ten.TEA.2013.0192]; Rosa V, 2013, J DENT RES, V92, P970, DOI 10.1177/0022034513505772; Salmon B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056749; Sawkins MJ, 2013, ACTA BIOMATER, V9, P7865, DOI 10.1016/j.actbio.2013.04.029; Smith EL, 2014, ACTA BIOMATER, V10, P4186, DOI 10.1016/j.actbio.2014.06.011; Smith EL, 2014, ACTA BIOMATER, V10, P4197, DOI 10.1016/j.actbio.2014.05.025; Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079; Suzuki S, 2009, MATRIX BIOL, V28, P221, DOI 10.1016/j.matbio.2009.03.006; Tatullo M, 2015, J BIOL REG HOMEOS AG, V29, P713; Tatullo M, 2016, INT J IMMUNOPATH PH, V29, P3, DOI 10.1177/0394632015617951; Tatullo M, 2015, INT J MED SCI, V12, P72, DOI 10.7150/ijms.10706; Tatullo M, 2015, J TISSUE ENG REGEN M, V9, P1205, DOI 10.1002/term.1899; Thesleff I, 1999, BONE, V25, P123, DOI 10.1016/S8756-3282(99)00119-2; Wang J, 2011, BIOMATERIALS, V32, P7822, DOI 10.1016/j.biomaterials.2011.04.034; Wei X, 2007, J ENDODONT, V33, P703, DOI 10.1016/j.joen.2007.02.009; Yan M, 2011, STEM CELL REV REP, V7, P161, DOI 10.1007/s12015-010-9155-0; Yang XC, 2020, J BIOMED MATER RES A, V108, P2519, DOI 10.1002/jbm.a.34064; Yang XC, 2010, J BIOMED MATER RES A, V93A, P247, DOI 10.1002/jbm.a.32535; Yu JH, 2006, TISSUE ENG, V12, P3097, DOI 10.1089/ten.2006.12.3097; Zhang HM, 2012, TISSUE ENG PT A, V18, P677, DOI [10.1089/ten.tea.2011.0269, 10.1089/ten.TEA.2011.0269]; Zhang W, 2005, TISSUE ENG, V11, P357, DOI 10.1089/ten.2005.11.357; Zhang WB, 2006, BIOMATERIALS, V27, P5658, DOI 10.1016/j.biomaterials.2006.07.013	49	101	105	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148225	10.1371/journal.pone.0148225	http://dx.doi.org/10.1371/journal.pone.0148225			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882351	Green Submitted, Green Published, gold			2022-12-27	WOS:000371219000013
J	Fukui, N; Oshima, T; Ueda, T; Ogasawara, N; Tobe, T				Fukui, Naoki; Oshima, Taku; Ueda, Takeshi; Ogasawara, Naotake; Tobe, Toru			Gene Activation through the Modulation of Nucleoid Structures by a Horizontally Transferred Regulator, Pch, in Enterohemorrhagic Escherichia coli	PLOS ONE			English	Article							H-NS; TRANSCRIPTIONAL REGULATION; PATHOGENICITY ISLAND; EXPRESSION; VIRULENCE; LER; DNA; PROMOTERS; ADHERENCE; PROTEINS	The horizontally transferred chromosomal segments, which are the main source of genetic diversity among bacterial pathogens, are bound by the nucleoid protein H-NS, resulting in the formation of a nucleoprotein complex and the silencing of gene expression. The desilencing or activation of virulence genes necessary for the colonization of enterohemorrhagic Escherichia coli is achieved mainly by the action of two regulators, Pch and Ler, which are encoded by horizontally transferred elements. Although Ler has been shown to activate transcription by counteracting H-NS silencing, the mechanism for Pch is poorly understood. We show here that Pch activates the LEE1 promoter and also enhances the Ler-mediated activation of other LEE promoters. Transcriptional activation was completely dependent on repression by the H-NS/StpA/Hha/YdgT complex, indicating that Pch-derived activation was achieved by alleviating H-NS-mediated silencing. Expression of pch reduced the binding of H-NS at LEE1 promoter and altered the nucleoprotein complex. Furthermore, in vitro reconstruction of the protein-DNA complex on LEE1 promoter DNA confirmed the exclusive effect of Pch on H-NS binding. These results demonstrated that Pch is another anti-silencing regulator and a modulator of H-NS-containing nucleoprotein complexes. Thus, the anti-silencing mechanism plays a key role in the coordinated regulation of virulence genes in EHEC.	[Fukui, Naoki; Tobe, Toru] Osaka Univ, Dept Biomed Informat, Grad Sch Med, 1-7 Yamadaoka, Suita, Osaka 5650871, Japan; [Oshima, Taku; Ueda, Takeshi; Ogasawara, Naotake] Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Nara 6300101, Japan	Osaka University; Nara Institute of Science & Technology	Tobe, T (corresponding author), Osaka Univ, Dept Biomed Informat, Grad Sch Med, 1-7 Yamadaoka, Suita, Osaka 5650871, Japan.	torutobe@sahs.med.osaka-u.ac.jp			Ministry of Education, Science, and Technology of Japan	Ministry of Education, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, and Technology of Japan.	Abe H, 2008, DNA RES, V15, P25, DOI 10.1093/dnares/dsm033; Ali SS, 2013, J BIOL CHEM, V288, P13356, DOI 10.1074/jbc.M113.455378; Bhat A, 2014, P NATL ACAD SCI USA, V111, pE2586, DOI 10.1073/pnas.1322033111; Bouffartigues E, 2007, NAT STRUCT MOL BIOL, V14, P441, DOI 10.1038/nsmb1233; Brown Nat F., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020042; Bustamante VH, 2001, MOL MICROBIOL, V39, P664, DOI 10.1046/j.1365-2958.2001.02209.x; Bustamante VH, 2011, MOL MICROBIOL, V82, P398, DOI 10.1111/j.1365-2958.2011.07819.x; Castang S, 2008, P NATL ACAD SCI USA, V105, P18947, DOI 10.1073/pnas.0808215105; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Fass E, 2009, CURR OPIN MICROBIOL, V12, P199, DOI 10.1016/j.mib.2009.01.004; Gal-Mor O, 2006, CELL MICROBIOL, V8, P1707, DOI 10.1111/j.1462-5822.2006.00794.x; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Hurme R, 1998, MOL MICROBIOL, V30, P1, DOI 10.1046/j.1365-2958.1998.01049.x; Iyoda S, 2004, MICROBIOL-SGM, V150, P2357, DOI 10.1099/mic.0.27100-0; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Knutton S, 1997, INFECT IMMUN, V65, P1644, DOI 10.1128/IAI.65.5.1644-1652.1997; KNUTTON S, 1987, INFECT IMMUN, V55, P69, DOI 10.1128/IAI.55.1.69-77.1987; Lucchini S, 2006, PLOS PATHOG, V2, P746, DOI 10.1371/journal.ppat.0020081; McDaniel TK, 1997, MOL MICROBIOL, V23, P399, DOI 10.1046/j.1365-2958.1997.2311591.x; Mellies JL, 2008, MICROBIOL-SGM, V154, P3624, DOI 10.1099/mic.0.2008/023382-0; Miyahara A, 2009, CELL MICROBIOL, V11, P337, DOI 10.1111/j.1462-5822.2008.01256.x; Nakanishi N, 2006, MOL MICROBIOL, V61, P194, DOI 10.1111/j.1365-2958.2006.05217.x; Nakanishi N, 2009, MICROBIOL-SGM, V155, P521, DOI 10.1099/mic.0.023499-0; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Oshima T, 2006, DNA RES, V13, P141, DOI 10.1093/dnares/dsl009; Porter ME, 2005, J BACTERIOL, V187, P458, DOI 10.1128/JB.187.2.458-472.2005; Reid SD, 2000, NATURE, V406, P64, DOI 10.1038/35017546; Rojas-Lopez M, 2011, J BACTERIOL, V193, P1622, DOI 10.1128/JB.01082-10; Sanchez-SanMartin C, 2001, J BACTERIOL, V183, P2823, DOI 10.1128/JB.183.9.2823-2833.2001; Sharma VK, 2005, FEMS MICROBIOL LETT, V243, P189, DOI 10.1016/j.femsle.2004.12.003; Takao M, 2014, MOL MICROBIOL, V93, P1302, DOI 10.1111/mmi.12737; Tobe T, 2005, MOL MICROBIOL, V58, P320, DOI 10.1111/j.1365-2958.2005.04828.x; TOBE T, 1993, J BACTERIOL, V175, P6142, DOI 10.1128/JB.175.19.6142-6149.1993; Torres AG, 2007, J BACTERIOL, V189, P5916, DOI 10.1128/JB.00245-07; Ueda T, 2013, DNA RES, V20, P263, DOI 10.1093/dnares/dst008; Umanski T, 2002, MICROBIOL-SGM, V148, P2735, DOI 10.1099/00221287-148-9-2735	38	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149718	10.1371/journal.pone.0149718	http://dx.doi.org/10.1371/journal.pone.0149718			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901318	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100133
J	Hadi, SIIA; Santana, H; Brunale, PPM; Gomes, TG; Oliveira, MD; Matthiensen, A; Oliveira, MEC; Silva, FCP; Brasil, BSAF				Hadi, Samed I. I. A.; Santana, Hugo; Brunale, Patricia P. M.; Gomes, Taisa G.; Oliveira, Marcia D.; Matthiensen, Alexandre; Oliveira, Marcos E. C.; Silva, Flavia C. P.; Brasil, Bruno S. A. F.			DNA Barcoding Green Microalgae Isolated from Neotropical Inland Waters	PLOS ONE			English	Article							CHLORELLA TREBOUXIOPHYCEAE; CHLOROPHYTA; SEQUENCE; ALGAE; ULVOPHYCEAE; BRAZIL; CONSERVATION; BIODIVERSITY; COLLECTION; MORPHOLOGY	This study evaluated the feasibility of using the Ribulose Bisphosphate Carboxylase Large subunit gene (rbcL) and the Internal Transcribed Spacers 1 and 2 of the nuclear rDNA (nuITS1 and nuITS2) markers for identifying a very diverse, albeit poorly known group, of green microalgae from neotropical inland waters. Fifty-one freshwater green microalgae strains isolated from Brazil, the largest biodiversity reservoir in the neotropics, were submitted to DNA barcoding. Currently available universal primers for ITS1-5.8S-ITS2 region amplification were sufficient to successfully amplify and sequence 47 (92%) of the samples. On the other hand, new sets of primers had to be designed for rbcL, which allowed 96% of the samples to be sequenced. Thirty-five percent of the strains could be unambiguously identified to the species level based either on nuITS1 or nuITS2 sequences' using barcode gap calculations. nuITS2 Compensatory Base Change (CBC) and ITS1-5.8S-ITS2 region phylogenetic analysis, together with morphological inspection, confirmed the identification accuracy. In contrast, only 6% of the strains could be assigned to the correct species based solely on rbcL sequences. In conclusion, the data presented here indicates that either nuITS1 or nuITS2 are useful markers for DNA barcoding of freshwater green microalgae, with advantage for nuITS2 due to the larger availability of analytical tools and reference barcodes deposited at databases for this marker.	[Hadi, Samed I. I. A.; Santana, Hugo; Brunale, Patricia P. M.; Silva, Flavia C. P.; Brasil, Bruno S. A. F.] Embrapa Agroenergy, Brasilia, DF, Brazil; [Hadi, Samed I. I. A.; Gomes, Taisa G.] Univ Fed Tocantins, Gurupi, TO, Brazil; [Hadi, Samed I. I. A.] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil; [Santana, Hugo] Univ Fed Bahia, Vitoria De Conquista, BA, Brazil; [Oliveira, Marcia D.] Embrapa Pantanal, Corumba, MS, Brazil; [Matthiensen, Alexandre] Embrapa Swine & Poultry, Concordia, SC, Brazil; [Oliveira, Marcos E. C.] Embrapa Amazonia Oriental, Belem, PA, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal do Tocantins (UFT); Universidade Federal de Minas Gerais; Universidade Federal da Bahia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Brasil, BSAF (corresponding author), Embrapa Agroenergy, Brasilia, DF, Brazil.	bruno.brasil@embrapa.br	Santana, Hugo/AAH-9127-2020; Brasil, Bruno S. A. F./E-8817-2012	Santana, Hugo/0000-0002-2259-4239; Brasil, Bruno S. A. F./0000-0002-8690-2157	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Financiadora de Estudos e Projetos (FINEP); Conselho Nacional de Pesquisa (CNPq)	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors are grateful to the Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Financiadora de Estudos e Projetos (FINEP) and Conselho Nacional de Pesquisa (CNPq) for supporting this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho AA, 2005, CONSERV BIOL, V19, P646, DOI 10.1111/j.1523-1739.2005.00701.x; Amengual-Morro C, 2012, J ENVIRON MANAGE, V95, pS71, DOI 10.1016/j.jenvman.2011.07.008; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Becker B, 2009, ANN BOT-LONDON, V103, P999, DOI 10.1093/aob/mcp044; Bellinger EG, 2015, FRESHWATER ALGAE: IDENTIFICATION, ENUMERATION AND USE AS BIOINDICATORS, 2ND EDITION, P1, DOI 10.1002/9781118917152; Bengtsson-Palme J, 2013, METHODS ECOL EVOL, V4, P914, DOI 10.1111/2041-210X.12073; Bock C, 2011, FOTTEA, V11, P293, DOI 10.5507/fot.2011.028; Bock C, 2010, EUR J PHYCOL, V45, P267, DOI 10.1080/09670262.2010.487920; Bonato ALV, 2002, EXTRACAO DNA GENOMIC; Buchheim MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016931; Caisova L, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-262; Carvalho DC, 2011, MITOCHONDR DNA, V22, P97, DOI 10.3109/19401736.2011.588219; Carvalho DC, 2015, FOOD CONTROL, V50, P784, DOI 10.1016/j.foodcont.2014.10.025; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Collins RA, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028381, 10.1371/journal.pone.0030581]; Costa ES, 2012, J APPL PHYCOL, V24, P1643, DOI 10.1007/s10811-012-9828-y; Darienko T, 2010, EUR J PHYCOL, V45, P79, DOI 10.1080/09670260903362820; De Clerck O, 2013, J PHYCOL, V49, P215, DOI 10.1111/jpy.12020; Drummond MG, 2013, FOOD CONTROL, V29, P131, DOI 10.1016/j.foodcont.2012.05.051; Du GY, 2014, J OCEAN U CHINA, V13, P97, DOI 10.1007/s11802-014-2197-1; Fawley MW, 2011, PHYCOLOGIA, V50, P23, DOI 10.2216/10-16.1; Francis RA, 2011, PROG PHYS GEOG, V35, P43, DOI 10.1177/0309133310385166; Freitas Lilian Cristina, 2013, Check List, V9, P1471; Gorelova OA, 2015, PROTOPLASMA, V252, P489, DOI 10.1007/s00709-014-0694-0; Guiry MD, 2012, J PHYCOL, V48, P1057, DOI 10.1111/j.1529-8817.2012.01222.x; Hall JD, 2010, CRYPTOGAMIE ALGOL, V31, P529; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hegewald E, 2013, FOTTEA, V13, P149, DOI 10.5507/fot.2013.013; Hoef-Emden K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043652; Hoshina Ryo, 2014, BMC Res Notes, V7, P592, DOI 10.1186/1756-0500-7-592; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Koetschan C, 2012, MOL PHYLOGENET EVOL, V63, P585, DOI 10.1016/j.ympev.2012.01.026; Koetschan C, 2010, NUCLEIC ACIDS RES, V38, pD275, DOI 10.1093/nar/gkp966; Krienitz L, 2004, PHYCOLOGIA, V43, P529, DOI 10.2216/i0031-8884-43-5-529.1; Krienitz L, 2015, TRENDS PLANT SCI, V20, P67, DOI 10.1016/j.tplants.2014.11.005; Krienitz L, 2012, HYDROBIOLOGIA, V698, P295, DOI 10.1007/s10750-012-1079-z; Leliaert F, 2014, EUR J PHYCOL, V49, P179, DOI 10.1080/09670262.2014.904524; Leray M, 2015, P NATL ACAD SCI USA, V112, P2076, DOI 10.1073/pnas.1424997112; Loughnane CJ, 2008, PHYCOLOGIA, V47, P416, DOI 10.2216/PH07-61.1; Luo W, 2010, PLANT BIOLOGY, V12, P545, DOI 10.1111/j.1438-8677.2009.00221.x; Muller T, 2007, RNA, V13, P1469, DOI 10.1261/rna.617107; Nascimento IA, 2013, BIOENERG RES, V6, P1, DOI 10.1007/s12155-012-9222-2; Nozaki H, 2001, EUR J PHYCOL, V36, P23, DOI 10.1080/09670260110001735158; Palhares RM, 2014, J ETHNOPHARMACOL, V155, P815, DOI 10.1016/j.jep.2014.06.040; Palhares RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127866; Pawlowski J, 2014, J FORAMIN RES, V44, P62, DOI 10.2113/gsjfr.44.1.62; Pawlowski J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001419; Pombert JF, 2005, MOL BIOL EVOL, V22, P1903, DOI 10.1093/molbev/msi182; Proschold T, 2011, ENVIRON MICROBIOL, V13, P350, DOI 10.1111/j.1462-2920.2010.02333.x; Proschold T, 2010, PHYCOL RES, V58, P1, DOI 10.1111/j.1440-1835.2009.00552.x; Proschold T, 2001, PROTIST, V152, P265, DOI 10.1078/1434-4610-00068; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Schlosser UG, 1997, BOT ACTA, V110, P424, DOI 10.1111/j.1438-8677.1997.tb00659.x; Seibel PN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-498; Seibel Philipp N, 2008, BMC Res Notes, V1, P91, DOI 10.1186/1756-0500-1-91; Skaloud P, 2006, NOVA HEDWIGIA, V83, P533, DOI 10.1127/0029-5035/2006/0083-0533; Subhadra B, 2011, J SCI FOOD AGR, V91, P2, DOI 10.1002/jsfa.4207; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timmins M, 2009, J EXP BOT, V60, P1691, DOI 10.1093/jxb/erp052; Torres MA, 2008, ECOTOX ENVIRON SAFE, V71, P1, DOI 10.1016/j.ecoenv.2008.05.009; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wolf M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066726	65	43	44	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149284	10.1371/journal.pone.0149284	http://dx.doi.org/10.1371/journal.pone.0149284			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900844	Green Submitted, Green Published, gold			2022-12-27	WOS:000371276100053
J	Monteiro, RLS; Carneiro, TKG; Fontoura, JRA; da Silva, VL; Moret, MA; Pereira, HBD				Monteiro, Roberto L. S.; Carneiro, Tereza Kelly G.; Fontoura, Jose Roberto A.; da Silva, Valeria L.; Moret, Marcelo A.; de Barros Pereira, Hernane Borges			A Model for Improving the Learning Curves of Artificial Neural Networks	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; CHEMOTAXIS; DYNAMICS	In this article, the performance of a hybrid artificial neural network (i.e. scale-free and small-world) was analyzed and its learning curve compared to three other topologies: random, scale-free and small-world, as well as to the chemotaxis neural network of the nematode Caenorhabditis Elegans. One hundred equivalent networks (same number of vertices and average degree) for each topology were generated and each was trained for one thousand epochs. After comparing the mean learning curves of each network topology with the C. elegans neural network, we found that the networks that exhibited preferential attachment exhibited the best learning curves.	[Monteiro, Roberto L. S.; da Silva, Valeria L.; Moret, Marcelo A.; de Barros Pereira, Hernane Borges] SENAI CIMATEC, Programa Modelagem Computat, Ave Orlando Gomes 1845, BR-41650010 Salvador, BA, Brazil; [Monteiro, Roberto L. S.; Fontoura, Jose Roberto A.; Moret, Marcelo A.; de Barros Pereira, Hernane Borges] Univ Estado Bahia, Salvador, BA, Brazil; [Carneiro, Tereza Kelly G.] Univ Estadual Ciencias Saude Alagoas, Maceio, Brazil	Faculdade de Tecnologia Senai Cimatec; Universidade do Estado Bahia; Universidade Estadual de Ciencias da Saude de Alagoas	Monteiro, RLS (corresponding author), SENAI CIMATEC, Programa Modelagem Computat, Ave Orlando Gomes 1845, BR-41650010 Salvador, BA, Brazil.; Monteiro, RLS (corresponding author), Univ Estado Bahia, Salvador, BA, Brazil.	roberto@souzamonteiro.com	de Barros Pereira, Hernane Borges/AAG-2785-2019; Moret, Marcelo A./O-3485-2018; Pereira, Hernane B B/D-6693-2012	de Barros Pereira, Hernane Borges/0000-0001-7476-9267; Moret, Marcelo A./0000-0003-0051-6309; Pereira, Hernane B B/0000-0001-7476-9267; Loureiro da Silva, Valeria/0000-0001-5466-7933	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq, a Federal Brazilian funding agency [304454/2014-1]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq, a Federal Brazilian funding agency	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq, a Federal Brazilian funding agency, grant no. 304454/2014-1 MAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batagelj V, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.036113; Bohland JW, 2001, NEUROCOMPUTING, V38, P489, DOI 10.1016/S0925-2312(01)00378-2; Chatterjee N, 2008, PROG BRAIN RES, V168, P145, DOI 10.1016/S0079-6123(07)68012-1; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Dunn NA, 2004, J COMPUT NEUROSCI, V17, P137, DOI 10.1023/B:JCNS.0000037679.42570.d5; Emmert-Streib F, 2006, NEUROCOMPUTING, V69, P1179, DOI 10.1016/j.neucom.2005.12.070; ERDOS P, 1960, B INT STATIST INST, V38, P343; HORN D, 1993, NEURAL COMPUT, V5, P736, DOI 10.1162/neco.1993.5.5.736; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lublin A L, 2013, Drug Discov Today Technol, V10, pe115, DOI 10.1016/j.ddtec.2012.02.002; Monteiro RLS, 2014, PHYSICA A, V403, P276, DOI 10.1016/j.physa.2014.02.019; Morita S, 2001, PHYSICA A, V298, P553, DOI 10.1016/S0378-4371(01)00266-7; Nazzal JM., 2008, WORLD APPL SCI J, V5, P546; Pereira HBB, 2011, PHYSICA A, V390, P1192, DOI 10.1016/j.physa.2010.12.001; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Puri IK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015176; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Segev R, 2000, NEURAL NETWORKS, V13, P185, DOI 10.1016/S0893-6080(99)00084-2; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; Watts DJ, 1999, AM J SOCIOL, V105, P493, DOI 10.1086/210318; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	24	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149874	10.1371/journal.pone.0149874	http://dx.doi.org/10.1371/journal.pone.0149874			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901646	gold, Green Submitted, Green Published			2022-12-27	WOS:000371276100170
J	Sprecher, KE; Riedner, BA; Smith, RF; Tononi, G; Davidson, RJ; Benca, RM				Sprecher, Kate E.; Riedner, Brady A.; Smith, Richard F.; Tononi, Giulio; Davidson, Richard J.; Benca, Ruth M.			High Resolution Topography of Age-Related Changes in Non- Rapid Eye Movement Sleep Electroencephalography	PLOS ONE			English	Article							HIGH-DENSITY EEG; SLOW-WAVE ACTIVITY; WHITE-MATTER; CORTICAL SYNCHRONIZATION; INDIVIDUAL-DIFFERENCES; COGNITIVE PERFORMANCE; GAMMA OSCILLATIONS; SPINDLE ACTIVITY; MIDDLE YEARS; MEMORY	Sleeping brain activity reflects brain anatomy and physiology. The aim of this study was to use high density (256 channel) electroencephalography (EEG) during sleep to characterize topographic changes in sleep EEG power across normal aging, with high spatial resolution. Sleep was evaluated in 92 healthy adults aged 18-65 years old using full polysomnography and high density EEG. After artifact removal, spectral power density was calculated for standard frequency bands for all channels, averaged across the NREM periods of the first 3 sleep cycles. To quantify topographic changes with age, maps were generated of the Pearson's coefficient of the correlation between power and age at each electrode. Significant correlations were determined by statistical non-parametric mapping. Absolute slow wave power declined significantly with increasing age across the entire scalp, whereas declines in theta and sigma power were significant only in frontal regions. Power in fast spindle frequencies declined significantly with increasing age frontally, whereas absolute power of slow spindle frequencies showed no significant change with age. When EEG power was normalized across the scalp, a left centro-parietal region showed significantly less agerelated decline in power than the rest of the scalp. This partial preservation was particularly significant in the slow wave and sigma bands. The effect of age on sleep EEG varies substantially by region and frequency band. This non-uniformity should inform the design of future investigations of aging and sleep. This study provides normative data on the effect of age on sleep EEG topography, and provides a basis from which to explore the mechanisms of normal aging as well as neurodegenerative disorders for which age is a risk factor.	[Sprecher, Kate E.; Riedner, Brady A.; Smith, Richard F.; Tononi, Giulio; Davidson, Richard J.; Benca, Ruth M.] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Sprecher, Kate E.; Riedner, Brady A.; Benca, Ruth M.] Univ Wisconsin, Wisconsin Ctr Sleep Med & Res, Madison, WI USA; [Sprecher, Kate E.] Univ Wisconsin, Neurosci Training Program, Madison, WI USA; [Davidson, Richard J.] Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA; [Davidson, Richard J.] Univ Wisconsin, Ctr Invest Hlth Minds, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Sprecher, KE (corresponding author), Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA.; Sprecher, KE (corresponding author), Univ Wisconsin, Wisconsin Ctr Sleep Med & Res, Madison, WI USA.; Sprecher, KE (corresponding author), Univ Wisconsin, Neurosci Training Program, Madison, WI USA.	ksprecher@wisc.edu		Davidson, Richard/0000-0002-8506-4964	National Center for Complementary and Alternative Medicine (NCAAM) [P01AT004952]; National Institute on Mental Health (NIMH) [1 P20 MH077967]; National Research Service Award (NRSA) [T32 GM007507]; Clinical and Translational Science Award (CTSA) program, through the NIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000427]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000429, UL1TR000427] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [P01AT004952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH077967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG048732] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine (NCAAM); National Institute on Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Translational Science Award (CTSA) program, through the NIH National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by The National Center for Complementary and Alternative Medicine (NCAAM) grant P01AT004952 to GT and RJD, National Institute on Mental Health (NIMH) grant 1 P20 MH077967 to RB and GT, National Research Service Award (NRSA) T32 GM007507 to KS, and the Clinical and Translational Science Award (CTSA) program, through the NIH National Center for Advancing Translational Sciences (NCATS), grant UL1TR000427. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alchanatis M, 2008, SLEEP BREATH, V12, P17, DOI 10.1007/s11325-007-0133-y; Amirjani N, 2007, MUSCLE NERVE, V35, P788, DOI 10.1002/mus.20750; Andrillon T, 2011, J NEUROSCI, V31, P17821, DOI 10.1523/JNEUROSCI.2604-11.2011; Ayalon L, 2010, AM J RESP CRIT CARE, V182, P413, DOI 10.1164/rccm.200912-1805OC; Ayoub A, 2013, SLEEP, V36, P905, DOI 10.5665/sleep.2722; Baker FC, 2012, J SLEEP RES, V21, P535, DOI 10.1111/j.1365-2869.2012.01007.x; Bendlin BB, 2010, DEV NEUROPSYCHOL, V35, P257, DOI 10.1080/87565641003696775; Bonilha L, 2009, BRAIN RES, V1305, P14, DOI 10.1016/j.brainres.2009.10.001; Buchmann A, 2011, J SLEEP RES, V20, P506, DOI 10.1111/j.1365-2869.2011.00916.x; Buchmann A, 2011, CEREB CORTEX, V21, P607, DOI 10.1093/cercor/bhq129; Campbell IG, 2011, SLEEP, V34, P1561, DOI 10.5665/sleep.1398; Carrier J, 2001, PSYCHOPHYSIOLOGY, V38, P232, DOI 10.1111/1469-8986.3820232; Carrier J, 2011, EUR J NEUROSCI, V33, P758, DOI 10.1111/j.1460-9568.2010.07543.x; Chatburn A, 2013, SLEEP, V36, P237, DOI 10.5665/sleep.2380; Chetelat G, 2013, NEUROIMAGE, V76, P167, DOI 10.1016/j.neuroimage.2013.03.009; De Gennaro L, 2005, NEUROIMAGE, V26, P114, DOI 10.1016/j.neuroimage.2005.01.020; de Vivo L, 2014, SLEEP, P37; DOUGLASS AB, 1994, SLEEP, V17, P160, DOI 10.1093/sleep/17.2.160; Dube J, 2015, J NEUROSCI, V35, P7795, DOI 10.1523/JNEUROSCI.3956-14.2015; Dumitriu D, 2010, J NEUROSCI, V30, P7507, DOI 10.1523/JNEUROSCI.6410-09.2010; Ehlers CL, 1997, J SLEEP RES, V6, P211, DOI 10.1046/j.1365-2869.1997.00041.x; Esser SK, 2007, SLEEP, V30, P1617, DOI 10.1093/sleep/30.12.1617; FEINBERG I, 1990, J THEOR BIOL, V142, P149, DOI 10.1016/S0022-5193(05)80218-8; Feinberg I, 2013, AM J PHYSIOL-REG I, V304, pR296, DOI 10.1152/ajpregu.00422.2012; Ferrarelli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073417; Ferrarelli F, 2010, AM J PSYCHIAT, V167, P1339, DOI 10.1176/appi.ajp.2010.09121731; Finelli LA, 2001, NEUROPSYCHOPHARMACOL, V25, pS57, DOI 10.1016/S0893-133X(01)00320-7; Finelli LA, 2001, EUR J NEUROSCI, V13, P2282, DOI 10.1046/j.0953-816x.2001.01597.x; Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Giorgio A, 2010, NEUROIMAGE, V51, P943, DOI 10.1016/j.neuroimage.2010.03.004; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Hughes EJ, 2012, NEUROIMAGE, V63, P1134, DOI 10.1016/j.neuroimage.2012.07.043; Iber C., 2007, AASM MANUAL SCORING; Israel B, 2012, SLEEP, V35, P1285, DOI 10.5665/sleep.2088; Jones SG, 2014, SLEEP, V37, P399, DOI 10.5665/sleep.3424; Kivipelto M, 2006, LANCET NEUROL, V5, P735, DOI 10.1016/S1474-4422(06)70537-3; Klimesch W, 1996, NEUROREPORT, V7, P1235, DOI 10.1097/00001756-199605170-00002; Kurth S, 2010, J NEUROSCI, V30, P13211, DOI 10.1523/JNEUROSCI.2532-10.2010; Landolt HP, 2001, CLIN NEUROPHYSIOL, V112, P369, DOI 10.1016/S1388-2457(00)00542-3; Landsness EC, 2011, CLIN NEUROPHYSIOL, V122, P2418, DOI 10.1016/j.clinph.2011.05.001; Langheim FJP, 2011, J SLEEP RES, V20, P496, DOI 10.1111/j.1365-2869.2011.00911.x; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Lewandowski A, 2013, J PSYCHOPHYSIOL, V27, P105, DOI 10.1027/0269-8803/a000092; Liu QY, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/5/056012; Mander B. A., 2013, CEREB CORTEX, DOI DOI 10.1093/CERCOR/BHT188; Mander BA, 2013, NAT NEUROSCI, V16, P357, DOI 10.1038/nn.3324; Martin N, 2013, NEUROBIOL AGING, V34, P468, DOI 10.1016/j.neurobiolaging.2012.05.020; Marzano C, 2011, J NEUROSCI, V31, P6674, DOI 10.1523/JNEUROSCI.0412-11.2011; Molle M, 2011, SLEEP, V34, P1411, DOI 10.5665/SLEEP.1290; Munch M, 2004, EUR J NEUROSCI, V20, P1402, DOI 10.1111/j.1460-9568.2004.03580.x; Murphy M, 2011, SLEEP, V34, P283, DOI 10.1093/sleep/34.3.283; Murphy M, 2009, P NATL ACAD SCI USA, V106, P1608, DOI 10.1073/pnas.0807933106; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; Nishida M, 2014, J CLIN NEUROPHYSIOL, V31, P402, DOI 10.1097/WNP.0000000000000068; Nunez PL, 2010, CLIN NEUROPHYSIOL, V121, P2177, DOI 10.1016/j.clinph.2010.04.029; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osipova D, 2006, J NEUROSCI, V26, P7523, DOI 10.1523/JNEUROSCI.1948-06.2006; Piantoni G, 2013, J NEUROSCI, V33, P227, DOI 10.1523/JNEUROSCI.2030-12.2013; Plante DT, 2013, J AFFECT DISORDERS, V146, P120, DOI 10.1016/j.jad.2012.06.016; Qin Y, 2010, CLIN NEUROPHYSIOL, V121, P1981, DOI 10.1016/j.clinph.2010.03.056; Raz N, 2010, NEUROIMAGE, V51, P501, DOI 10.1016/j.neuroimage.2010.03.020; Riedner BA, 2007, SLEEP, V30, P1643, DOI 10.1093/sleep/30.12.1643; Robillard R, 2010, J SLEEP RES, V19, P455, DOI 10.1111/j.1365-2869.2010.00820.x; Sederberg PB, 2003, J NEUROSCI, V23, P10809; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Steriade M, 2003, FRONT BIOSCI-LANDMRK, V8, pD878, DOI 10.2741/1043; Tinguely G, 2006, NEUROIMAGE, V32, P283, DOI 10.1016/j.neuroimage.2006.03.017; Tononi G, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/415250; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; Westerberg CE, 2012, J INT NEUROPSYCH SOC, V18, P490, DOI 10.1017/S135561771200001X	72	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149770	10.1371/journal.pone.0149770	http://dx.doi.org/10.1371/journal.pone.0149770			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901503	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100147
J	Guo, RN; Zheng, HZ; Ou, CQ; Huang, LQ; Zhou, Y; Zhang, X; Liang, CK; Lin, JY; Zhong, HJ; Song, T; Luo, HM				Guo, Ru-ning; Zheng, Hui-zhen; Ou, Chun-quan; Huang, Li-qun; Zhou, Yong; Zhang, Xin; Liang, Can-kun; Lin, Jin-yan; Zhong, Hao-jie; Song, Tie; Luo, Hui-ming			Impact of Influenza on Outpatient Visits, Hospitalizations, and Deaths by Using a Time Series Poisson Generalized Additive Model	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; SEASONAL INFLUENZA; ECONOMIC BURDEN; MORTALITY; ILLNESS	Background The disease burden associated with influenza in developing tropical and subtropical countries is poorly understood owing to the lack of a comprehensive disease surveillance system and information-exchange mechanisms. The impact of influenza on outpatient visits, hospital admissions, and deaths has not been fully demonstrated to date in south China. Methods A time series Poisson generalized additive model was used to quantitatively assess influenza-like illness (ILI) and influenza disease burden by using influenza surveillance data in Zhuhai City from 2007 to 2009, combined with the outpatient, inpatient, and respiratory disease mortality data of the same period. Results The influenza activity in Zhuhai City demonstrated a typical subtropical seasonal pattern; however, each influenza virus subtype showed a specific transmission variation. The weekly ILI case number and virus isolation rate had a very close positive correlation (r = 0.774, P < 0.0001). The impact of ILI and influenza on weekly outpatient visits was statistically significant (P < 0.05). We determined that 10.7% of outpatient visits were associated with ILI and 1.88% were associated with influenza. ILI also had a significant influence on the hospitalization rates (P < 0.05), but mainly in populations < 25 years of age. No statistically significant effect of influenza on hospital admissions was found (P > 0.05). The impact of ILI on chronic obstructive pulmonary disease (COPD) was most significant (P < 0.05), with 33.1% of COPD-related deaths being attributable to ILI. The impact of influenza on the mortality rate requires further evaluation. Conclusions ILI is a feasible indicator of influenza activity. Both ILI and influenza have a large impact on outpatient visits. Although ILI affects the number of hospital admissions and deaths, we found no consistent influence of influenza, which requires further assessment.	[Guo, Ru-ning] Ctr Dis Control & Prevent Guangdong Prov, Publ Hlth Emergency Management Off, Guangzhou, Guangdong, Peoples R China; [Zheng, Hui-zhen] Ctr Dis Control & Prevent Guangdong Prov, Inst Immunizat Programs, Guangzhou, Guangdong, Peoples R China; [Ou, Chun-quan] Southern Med Univ, Sch Publ Hlth, Dept Biostat, Guangzhou, Guangdong, Peoples R China; [Huang, Li-qun; Zhou, Yong; Liang, Can-kun] Zhuhai Municipal Ctr Dis Control & Prevent, Zhuhai, Peoples R China; [Zhang, Xin] Ctr Dis Control & Prevent Guangdong Prov, Inst Pathogen Microorganisms, Guangzhou, Guangdong, Peoples R China; [Lin, Jin-yan; Song, Tie] Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Zhong, Hao-jie] Ctr Dis Control & Prevent Guangdong Prov, Inst Infect Dis Prevent & Control, Guangzhou, Guangdong, Peoples R China; [Luo, Hui-ming] Ctr Dis Control & Prevent, Beijing, Peoples R China	Southern Medical University - China; Chinese Center for Disease Control & Prevention	Zheng, HZ (corresponding author), Ctr Dis Control & Prevent Guangdong Prov, Inst Immunizat Programs, Guangzhou, Guangdong, Peoples R China.	zhz@cdcp.org.cn		Ou, Chun-Quan/0000-0001-6866-7213	World Health Organization [WP/2008/CHN/02/CSR/PE 15.01]; Medical Research Foundation of Guangdong Province, China [A2007079]	World Health Organization(World Health Organization); Medical Research Foundation of Guangdong Province, China	The work was supported by grants from the World Health Organization (WP/2008/CHN/02/CSR/PE 15.01), and Medical Research Foundation of Guangdong Province, China (project number: A2007079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai-ping D, 2008, S CHINA J PREVENTIVE, V34, P14; Bhuiyan MU, 2014, INFLUENZA OTHER RESP, V8, P406, DOI 10.1111/irv.12254; Burton C, 2014, PEDIATR INFECT DIS J, V33, P710, DOI 10.1097/INF.0000000000000272; Chaves SS, 2014, PEDIATR INFECT DIS J, V33, P912, DOI 10.1097/INF.0000000000000321; Chiu SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092914; Chow A, 2006, EMERG INFECT DIS, V12, P114, DOI 10.3201/eid1201.050826; Chowell G, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-214; Cromer D, 2014, J INFECTION, V68, P363, DOI 10.1016/j.jinf.2013.11.013; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; Emukule GO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105543; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Guo RN, 2011, PUBLIC HEALTH, V125, P389, DOI 10.1016/j.puhe.2011.03.004; Guo RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041403; Ortiz JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113903; Ortiz JR, 2014, CRIT CARE MED, V42, P2325, DOI 10.1097/CCM.0000000000000545; Ping H, 2004, CHINESE J DIS CONTRO, V8, P144; Shortridge K F, 1992, Semin Respir Infect, V7, P11; Silva ML, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-56; Thompson WW, 2009, AM J PUBLIC HEALTH, V99, pS225, DOI 10.2105/AJPH.2008.151944; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Wang DM, 2004, CHINESE J EPIDEMIOLO, V01; WHO, PRACT GUID DES COND; WISELKA M, 1994, BRIT MED J, V308, P1341, DOI 10.1136/bmj.308.6940.1341; Wong C M, 2012, Hong Kong Med J, V18 Suppl 2, P8; Wong CM, 2004, CLIN INFECT DIS, V39, P1611, DOI 10.1086/425315; Wu AP, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000882; Yang L, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-342; Yang L, 2011, VACCINE, V29, P8909, DOI 10.1016/j.vaccine.2011.09.071; Yu H, 2012, INFLUENZA OTHER RESP, V8, P53, DOI DOI 10.1111/IRV.12205	31	13	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149468	10.1371/journal.pone.0149468	http://dx.doi.org/10.1371/journal.pone.0149468			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894876	Green Published, gold, Green Submitted			2022-12-27	WOS:000371223400057
J	Mehta, A; Farooqui, HH; Selvaraj, S				Mehta, Aashna; Farooqui, Habib Hasan; Selvaraj, Sakthivel			A Critical Analysis of Concentration and Competition in the Indian Pharmaceutical Market	PLOS ONE			English	Article								Objectives It can be argued that with several players marketing a large number of brands, the pharmaceutical market in India is competitive. However, the pharmaceutical market should not be studied as a single market but, as a sum total of a large number of individual sub-markets. This paper examines the methodological issues with respect to defining the relevant market involved in studying concentration in the pharmaceutical market in India. Further, we have examined whether the Indian pharmaceutical market is competitive. Methods Indian pharmaceutical market was studied using PharmaTrac, the sales audit data from AIOCD-AWACS, that organises formulations into 5 levels of therapeutic classification based on the EphMRA system. The Herfindahl-Hirschman Index (HHI) was used as the indicator of market concentration. We calculated HHI for the entire pharmaceutical market studied as a single market as well as at the five different levels of therapeutic classification. Results and Discussion Whereas the entire pharmaceutical market taken together as a single market displayed low concentration (HHI = 226.63), it was observed that if each formulation is defined as an individual sub-market, about 69 percent of the total market in terms of market value displayed at least moderate concentration. Market should be defined taking into account the ease of substitutability. Since, patients cannot themselves substitute the formulation prescribed by the doctor with another formulation with the same indication and therapeutic effect, owing to information asymmetry, it is appropriate to study market concentration at the narrower levels of therapeutic classification.	[Mehta, Aashna; Farooqui, Habib Hasan; Selvaraj, Sakthivel] Publ Hlth Fdn India, Delhi, India	Public Health Foundation of India	Mehta, A (corresponding author), Publ Hlth Fdn India, Delhi, India.	aashna.mehta@phfi.org	Mehta, Aashna/GQA-8753-2022; Selvaraj, Sakthivel/ABE-6897-2020; Selvaraj, Sakthivel/ABD-5873-2021; Farooqui, Habib/AAD-8818-2021	Mehta, Aashna/0000-0003-4099-9915; Farooqui, Habib/0000-0002-3081-2929; Selvaraj, Sakthivel/0000-0001-5940-1958	Seventh Framework Programme of the European Union [612889]	Seventh Framework Programme of the European Union	This work was supported by Seventh Framework Programme of the European Union, grant agreement number: 612889, http://mnemerge.com/, to SS HH AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, EPHMRA ANATOMICAL CL; [Anonymous], 2014, COMP WHO ATC CLASSIF; Baker J.B., 2007, ANTITRUST LAW J; Carlton Dennis, 2007, COMPET POLICY INT, V3, P3; CENTAD, 2010, COMP LAW IND PHARM I, P114; Jha R., 2007, ECON POLIT WEEKLY, V42, P3958; Keyte J. A., 1995, ANTITRUST LJ, V63, P697; Massey P, 2000, ECON SOC REV, V31, P309; OECD, 2011, OECD GUID COMP ASS T, V2; Roden D.M., HARRISONS PRINCIPLES, P13; U. S. Department of Justice and the Federal Trade Commission, 2015, HOR MERG GUID	11	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148951	10.1371/journal.pone.0148951	http://dx.doi.org/10.1371/journal.pone.0148951			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3DG	26895269	gold, Green Published, Green Submitted			2022-12-27	WOS:000371223400028
J	Metfies, K; von Appen, WJ; Kilias, E; Nicolaus, A; Nothig, EM				Metfies, Katja; von Appen, Wilken-Jon; Kilias, Estelle; Nicolaus, Anja; Noethig, Eva-Maria			Biogeography and Photosynthetic Biomass of Arctic Marine Pico-Eukaroytes during Summer of the Record Sea Ice Minimum 2012	PLOS ONE			English	Article							EAST GREENLAND CURRENT; PHYTOPLANKTON BLOOMS; FRAM STRAIT; DIVERSITY; SEQUENCES; OCEAN; WATER; ABUNDANCE; GROWTH; NORTH	Information on recent photosynthetic biomass distribution and biogeography of Arctic marine pico-eukaryotes (0.2-3 mu m) is needed to better understand consequences of environmental change for Arctic marine ecosystems. We analysed pico-eukaryote biomass and community composition in Fram Strait and large parts of the Central Arctic Ocean (Nansen Basin, Amundsen Basin) using chlorophyll a (Chl a) measurements, automated ribosomal intergenic spacer analysis (ARISA) and 454-pyrosequencing. Samples were collected during summer 2012, the year with the most recent record sea ice minimum. Chl a concentrations were highest in eastern Fram Strait and pico-plankton accounted for 6090% of Chl a biomass during the observation period. ARISA-patterns and 454-pyrosequencing revealed that pico-eukaryote distribution is closely related to water mass distribution in the euphotic zone of the Arctic Ocean. Phaeocystaceae, Micromonas sp., Dinophyceae and Syndiniales constitute a high proportion of sequence reads, while sequence abundance of autotrophic Phaeocystaceae and mixotrophic Micromonas sp. was inversely correlated. Highest sequence abundances of Phaeocystaceae were observed in the warm Atlantic Waters in Fram Strait, while Micromonas sp. dominated the abundant biosphere in the arctic halocline. Our results are of particular interest considering existing hypotheses that environmental conditions in Nansen Basin might become more similar to the current conditions in Fram Strait. We propose that in response, biodiversity and biomass of pico-eukaryotes in Nansen Basin could resemble those currently observed in Fram Strait in the future. This would significantly alter biogeochemical cycles in a large part of the Central Arctic Ocean.	[Metfies, Katja; Kilias, Estelle; Nicolaus, Anja; Noethig, Eva-Maria] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Div Biosci, Dept Polar Biol Oceanog, Bremerhaven, Germany; [von Appen, Wilken-Jon] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Div Climate Sci, Phys Oceanog Polar Seas, Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Metfies, K (corresponding author), Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Div Biosci, Dept Polar Biol Oceanog, Bremerhaven, Germany.	Katja.Metfies@awi.de	Nöthig, Eva-Maria/AAS-7253-2021	Nicolaus, Anja/0000-0002-2026-3540; Nothig, Eva-Maria/0000-0002-7527-7827; von Appen, Wilken-Jon/0000-0002-7200-0099	Initiative and Networking Fund of the Helmholtz Association; funds of the German Federal Ministry of Education and Research (Co-operative project RACE) [0F0651 D]	Initiative and Networking Fund of the Helmholtz Association; funds of the German Federal Ministry of Education and Research (Co-operative project RACE)	This study was accomplished within the Young Investigator Group PLANKTOSENS (VH-NG500), funded by the Initiative and Networking Fund of the Helmholtz Association. Wilken-Jon von Appen was supported by funds of the German Federal Ministry of Education and Research (Co-operative project RACE, 0F0651 D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksenov Y, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006637; [Anonymous], 1979, LE RECOMMENDATIONS M, V5; Behnke A, 2011, ENVIRON MICROBIOL, V13, P340, DOI 10.1111/j.1462-2920.2010.02332.x; Beszczynska-Moller A, 2012, ICES J MAR SCI, V69, P852, DOI 10.1093/icesjms/fss056; Booth BC, 1997, DEEP-SEA RES PT II, V44, P1607, DOI 10.1016/S0967-0645(97)00057-X; Cai P, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005595; Cherkasheva A, 2014, J MARINE SYST, V132, P196, DOI 10.1016/j.jmarsys.2013.11.008; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Comeau AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027492; Damm E, 2010, BIOGEOSCIENCES, V7, P1099, DOI 10.5194/bg-7-1099-2010; de Steur L, 2014, DEEP-SEA RES PT I, V92, P26, DOI 10.1016/j.dsr.2014.05.018; de Steur L, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL041278; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; ELWOOD HJ, 1985, MOL BIOL EVOL, V2, P399; Evans CAOR, 1980, OCEAN PULSE TECHNICA, V3; Falk-Petersen S, 1998, POLAR BIOL, V20, P41, DOI 10.1007/s003000050274; Gaebler-Schwarz S, 2010, J PHYCOL, V46, P1006, DOI 10.1111/j.1529-8817.2010.00875.x; Gosselin M, 1997, DEEP-SEA RES PT II, V44, P1623, DOI 10.1016/S0967-0645(97)00054-4; Guillou L, 2008, ENVIRON MICROBIOL, V10, P3349, DOI 10.1111/j.1462-2920.2008.01731.x; Hamilton AK, 2008, LIMNOL OCEANOGR, V53, P922, DOI 10.4319/lo.2008.53.3.0922; Hartmann DL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P159; Jaccard P., 1912, NEW PHYTOL, V11, P37, DOI [10.1111/j.1469-8137.1912.tb05611.x, DOI 10.1111/J.1469-8137.1912.TB05611.X, DOI 10.1371/journal.pbio.1001889]; Jeong Hae Jin, 2010, Ocean Science Journal, V45, P65, DOI 10.1007/s12601-010-0007-2; Jones EP, 1998, GEOPHYS RES LETT, V25, P765, DOI 10.1029/98GL00464; Kilias ES, 2015, LIMNOL OCEANOGR-METH, V13, P74, DOI 10.1002/lom3.10008; Kilias E, 2014, POLAR BIOL, V37, P1271, DOI 10.1007/s00300-014-1519-5; Kilias E, 2013, J PHYCOL, V49, P996, DOI 10.1111/jpy.12109; Kilias ES, 2014, J EUKARYOT MICROBIOL, V61, P569, DOI 10.1111/jeu.12134; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Kwok R, 2011, PHYS TODAY, V64, P36, DOI 10.1063/1.3580491; Lasternas S, 2010, POLAR BIOL, V33, P1709, DOI 10.1007/s00300-010-0877-x; Lovejoy C, 2007, J PHYCOL, V43, P78, DOI 10.1111/j.1529-8817.2006.00310.x; Lovejoy C, 2011, J PLANKTON RES, V33, P431, DOI 10.1093/plankt/fbq124; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; McKie-Krisberg ZM, 2014, ISME J, V8, P1953, DOI 10.1038/ismej.2014.16; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Miranda LN, 2012, HARMFUL ALGAE, V16, P35, DOI 10.1016/j.hal.2012.01.002; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Moran XAG, 2010, GLOBAL CHANGE BIOL, V16, P1137, DOI 10.1111/j.1365-2486.2009.01960.x; NICKRENT DL, 1991, NUCLEIC ACIDS RES, V19, P227, DOI 10.1093/nar/19.2.227; Nicolaus M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053738; Parkinson CL, 2013, GEOPHYS RES LETT, V40, DOI 10.1002/grl.50349; Peperzak L, 2012, J PHYCOL, V48, P514, DOI 10.1111/j.1529-8817.2012.01136.x; Perovich DK, 2011, OCEANOGRAPHY, V24, P162, DOI 10.5670/oceanog.2011.68; Rabe B, 2014, GEOPHYS RES LETT, V41, P961, DOI 10.1002/2013GL058121; Ramette A, 2009, APPL ENVIRON MICROB, V75, P2495, DOI 10.1128/AEM.02409-08; Rat'kova TN, 2002, J MARINE SYST, V38, P47, DOI 10.1016/S0924-7963(02)00169-0; Richardson K, 2005, DEEP-SEA RES PT I, V52, P979, DOI 10.1016/j.dsr.2004.12.005; Rudels B, 2005, J MARINE SYST, V55, P1, DOI 10.1016/j.jmarsys.2004.06.008; Sherr EB, 2003, DEEP-SEA RES PT I, V50, P557, DOI 10.1016/S0967-0637(03)00031-1; Slapeta J, 2006, MOL BIOL EVOL, V23, P23, DOI 10.1093/molbev/msj001; Sun S, 2006, OCEAN MODEL, V15, P177, DOI 10.1016/j.ocemod.2006.05.002; Vaulot D, 2008, FEMS MICROBIOL REV, V32, P795, DOI 10.1111/j.1574-6976.2008.00121.x; Wassmann P, 2005, HARMFUL ALGAE, V4, P823, DOI 10.1016/j.hal.2004.12.009; White TJ., 1990, PCR PROTOCOLS GUIDE, P315	57	53	59	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148512	10.1371/journal.pone.0148512	http://dx.doi.org/10.1371/journal.pone.0148512			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895333	Green Published, Green Submitted, gold			2022-12-27	WOS:000371223400018
J	Oguz, AK; Yilmaz, ST; Oygur, CS; Candar, T; Sayin, I; Kilicoglu, SS; Ergun, I; Ates, A; Ozdag, H; Akar, N				Oguz, Ali Kemal; Yilmaz, Seda Tasir; Oygur, Cagdas Sahap; Candar, Tuba; Sayin, Irmak; Kilicoglu, Sibel Serin; Ergun, Ihsan; Ates, Askin; Ozdag, Hilal; Akar, Nejat			Behcet's: A Disease or a Syndrome? Answer from an Expression Profiling Study	PLOS ONE			English	Article							INHIBITORY RECEPTOR; GENE-EXPRESSION; MICROARRAY DATA; GENOME; SUSCEPTIBILITY; INFLAMMATION; IDENTIFICATION; ASSOCIATION; WEBGESTALT	Behcet's disease (BD) is a chronic, relapsing, multisystemic inflammatory disorder with unanswered questions regarding its etiology/pathogenesis and classification. Distinct manifestation based subsets, pronounced geographical variations in expression, and discrepant immunological abnormalities raised the question whether Behcet's is "a disease or a syndrome". To answer the preceding question we aimed to display and compare the molecular mechanisms underlying distinct subsets of BD. For this purpose, the expression data of the gene expression profiling and association study on BD by Xavier et al (2013) was retrieved from GEO database and reanalysed by gene expression data analysis/visualization and bioinformatics enrichment tools. There were 15 BD patients (B) and 14 controls (C). Three subsets of BD patients were generated: MB (isolated mucocutaneous manifestations, n = 7), OB (ocular involvement, n = 4), and VB (large vein thrombosis, n = 4). Class comparison analyses yielded the following numbers of differentially expressed genes (DEGs); B vs C: 4, MB vs C: 5, OB vs C: 151, VB vs C: 274, MB vs OB: 215, MB vs VB: 760, OB vs VB: 984. Venn diagram analysis showed that there were no common DEGs in the intersection "MB vs C" boolean AND "OB vs C" boolean AND "VB vs C". Cluster analyses successfully clustered distinct expressions of BD. During gene ontology term enrichment analyses, categories with relevance to IL-8 production (MB vs C) and immune response to microorganisms (OB vs C) were differentially enriched. Distinct subsets of BD display distinct expression profiles and different disease associated pathways. Based on these clear discrepancies, the designation as "Behcet's syndrome" (BS) should be encouraged and future research should take into consideration the immunogenetic heterogeneity of BS subsets. Four gene groups, namely, negative regulators of inflammation (CD69, CLEC12A, CLEC12B, TNFAIP3), neutrophil granule proteins (LTF, OLFM4, AZU1, MMP8, DEFA4, CAMP), antigen processing and presentation proteins (CTSS, ERAP1), and regulators of immune response (LGALS2, BCL10, ITCH, CEACAM8, CD36, IL8, CCL4, EREG, NFKBIZ, CCR2, CD180, KLRC4, NFAT5) appear to be instrumental in BS immunopathogenesis.	[Oguz, Ali Kemal; Sayin, Irmak] Ufuk Univ, Sch Med, Dept Internal Med, Ankara, Turkey; [Oguz, Ali Kemal; Yilmaz, Seda Tasir; Ozdag, Hilal] Ankara Univ, Inst Biotechnol, TR-06100 Ankara, Turkey; [Oygur, Cagdas Sahap] Baskent Univ, Sch Med, Dept Internal Med, TR-06490 Ankara, Turkey; [Candar, Tuba] Ufuk Univ, Sch Med, Dept Biochem, Ankara, Turkey; [Kilicoglu, Sibel Serin] Ufuk Univ, Sch Med, Dept Histol & Embryol, Ankara, Turkey; [Ergun, Ihsan] Ufuk Univ, Sch Med, Dept Internal Med, Div Nephrol, Ankara, Turkey; [Ates, Askin] Ankara Univ, Sch Med, Dept Internal Med, Div Rheumatol, TR-06100 Ankara, Turkey; [Akar, Nejat] TOBB Univ Econ & Technol Hosp, Dept Pediat, Ankara, Turkey	Ufuk University; Ankara University; Baskent University; Ufuk University; Ufuk University; Ufuk University; Ankara University; TOBB Ekonomi ve Teknoloji University	Oguz, AK (corresponding author), Ufuk Univ, Sch Med, Dept Internal Med, Ankara, Turkey.; Oguz, AK (corresponding author), Ankara Univ, Inst Biotechnol, TR-06100 Ankara, Turkey.	drakoguz@gmail.com	Ates, Askin/AAG-7996-2020; Oguz, Ali Kemal/AAD-4232-2022; Akar, Nejat/H-2949-2019; Oguz, Ali Kemal/ABB-7188-2021; Taşır Yılmaz, Seda/G-6235-2019; Özdag, Hilal/C-9929-2009	Ates, Askin/0000-0003-1966-3333; Oguz, Ali Kemal/0000-0002-3939-2924; Taşır Yılmaz, Seda/0000-0001-8879-0016; Özdag, Hilal/0000-0001-7940-2499; Kilicoglu, Sibel Serin/0000-0002-7658-5186				Akkurt ZM, 2015, J CLIN LAB ANAL, V29, P317, DOI 10.1002/jcla.21772; Behcet H, 1937, DERMATOL WOCHENSCHR, V105, P1152; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; BRB-ArrayTools, INT PACK VIS STAT AN; Cho S, 2014, J EUR ACAD DERMATOL, V28, P51, DOI 10.1111/jdv.12054; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Couzin J, 2006, SCIENCE, V313, P1559; de Chambrun MP, 2012, AUTOIMMUN REV, V11, P687, DOI 10.1016/j.autrev.2011.11.026; Direskeneli H, 2001, ANN RHEUM DIS, V60, P996, DOI 10.1136/ard.60.11.996; Direskeneli H, 2010, BEHCET'S SYNDROME, P243, DOI 10.1007/978-1-4419-5641-5_14; Ehrlich GE, 1998, ANN INTERN MED, V128, P494, DOI 10.7326/0003-4819-128-6-199803150-00011; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Franke L, 2009, METHODS MOL BIOL, V573, P311, DOI 10.1007/978-1-60761-247-6_17; Galeone Massimiliano, 2012, Patholog Res Int, V2012, P595380, DOI 10.1155/2012/595380; Gur-Toy G, 2005, INT J DERMATOL, V44, P657, DOI 10.1111/j.1365-4632.2004.02184.x; Hatemi G, 2011, BEST PRACT RES CL RH, V25, P389, DOI 10.1016/j.berh.2011.05.002; Hoffmann SC, 2007, J BIOL CHEM, V282, P22370, DOI 10.1074/jbc.M704250200; International Study Group for Beh~et's Disease, 1990, LANCET, V335, P1078, DOI DOI 10.1016/0140-; International Team for the Revision of the International Criteria for Behcet's Disease (ITR-ICBD), 2006, CLIN EXP RHEUMATOL, V24, pS14; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kaneko F, 2003, ARTHRITIS RES THER, V5, pS5, DOI 10.1186/ar988; Kaneko F, 2003, ADV EXP MED BIOL, V528, P181; Kaneko F, 2008, EUR J DERMATOL, V18, P489, DOI 10.1684/ejd.2008.0484; Kapsimali VD, 2010, CLIN RHEUMATOL, V29, P1211, DOI 10.1007/s10067-010-1491-6; Karasneh J, 2005, ARTHRITIS RHEUM-US, V52, P1836, DOI 10.1002/art.21060; Kiraz S, 2002, THROMB RES, V105, P125, DOI 10.1016/S0049-3848(02)00006-3; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Lamana A, 2006, EUR J IMMUNOL, V36, P2632, DOI 10.1002/eji.200636355; Lehner T, 1979, BEHCETS SYNDROME, P1; Lehner T, 1979, BEHCETS SYNDROME CLI, P14; Lewis KA, 2007, SCAND J RHEUMATOL, V36, P1, DOI 10.1080/03009740600991927; Maalouf D, 2015, CURR OPIN HEMATOL, V22, P23, DOI 10.1097/MOH.0000000000000100; Marshall ASJ, 2004, J BIOL CHEM, V279, P14792, DOI 10.1074/jbc.M313127200; Mat MC, 2014, CLIN DERMATOL, V32, P435, DOI 10.1016/j.clindermatol.2013.11.012; Meguro A, 2010, ANN RHEUM DIS, V69, P747, DOI 10.1136/ard.2009.108571; Mukaida N, 1995, Cancer Treat Res, V80, P261; Neumann K, 2014, IMMUNITY, V40, P389, DOI 10.1016/j.immuni.2013.12.015; Oguz AK, 2015, MED HYPOTHESES, V85, P186, DOI 10.1016/j.mehy.2015.04.032; Oliveros J.C., 2007, INTERACTIVE TOOL COM; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Xavier JM, 2013, J MOL MED, V91, P1013, DOI 10.1007/s00109-013-1022-4; Yazici H, 1996, BRIT J RHEUMATOL, V35, P139; Yazici H, 2007, NAT CLIN PRACT RHEUM, V3, P148, DOI 10.1038/ncprheum0436; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhou Q, 2015, NAT GENET, DOI [10.1038/ng,3459, DOI 10.1038/NG,3459]; Zierhut M, 2003, CELL MOL LIFE SCI, V60, P1903, DOI 10.1007/s00018-003-2333-3	47	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149052	10.1371/journal.pone.0149052	http://dx.doi.org/10.1371/journal.pone.0149052			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890122	gold, Green Published, Green Submitted			2022-12-27	WOS:000371221500022
J	Xu, JP; Vilanova, G; Gomez, H				Xu, Jiangping; Vilanova, Guillermo; Gomez, Hector			A Mathematical Model Coupling Tumor Growth and Angiogenesis	PLOS ONE			English	Article							ISOGEOMETRIC ANALYSIS; NONLINEAR SIMULATION; TIP CELLS; INVASION; DYNAMICS; BLOOD; METHODOLOGY; INHIBITION; CULTURES; BLOCKADE	We present a mathematical model for vascular tumor growth. We use phase fields to model cellular growth and reaction-diffusion equations for the dynamics of angiogenic factors and nutrients. The model naturally predicts the shift from avascular to vascular growth at realistic scales. Our computations indicate that the negative regulation of the Delta-like ligand 4 signaling pathway slows down tumor growth by producing a larger density of non-functional capillaries. Our results show good quantitative agreement with experiments.	[Xu, Jiangping; Vilanova, Guillermo; Gomez, Hector] Univ A Coruna, Appl Math, La Coruna, Spain	Universidade da Coruna	Vilanova, G (corresponding author), Univ A Coruna, Appl Math, La Coruna, Spain.	gvilanovac@udc.es	Vilanova, Guillermo/L-4937-2016; Vilanova, Guillermo/H-8427-2019; Gomez, Hector/U-8002-2019	Vilanova, Guillermo/0000-0002-9650-0602; Vilanova, Guillermo/0000-0002-9650-0602; Gomez, Hector/0000-0002-2553-9091	European Research Council through the FP7 Ideas Starting Grant program [307201]	European Research Council through the FP7 Ideas Starting Grant program	This work was supported by the European Research Council through the FP7 Ideas Starting Grant program (Grant #307201; http://erc.europa.eu/starting-grants). JX, GV, and HG gratefully acknowledge this support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon T, 2003, J THEOR BIOL, V225, P257, DOI 10.1016/S0022-5193(03)00244-3; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Bentley K, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000549; Blanco R, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006569; Boondirek A., 2010, INT MATH FORUM, V5, P3023; Bouis D, 2006, PHARMACOL RES, V53, P89, DOI 10.1016/j.phrs.2005.10.006; Bueno J, 2015, COMPUT MECH, V55, P1105, DOI 10.1007/s00466-014-1098-x; Byrne H, 2003, MATH MED BIOL, V20, P341; Byrne HM, 1997, EUR J APPL MATH, V8, P639, DOI 10.1017/S0956792597003264; Byrne HM, 2003, APPL MATH LETT, V16, P567, DOI 10.1016/S0893-9659(03)00038-7; Byrne HM, 1999, J MATH BIOL, V39, P59, DOI 10.1007/s002850050163; CAHN JW, 1958, J CHEM PHYS, V28, P258, DOI 10.1063/1.1744102; Cai Y, 2011, J THEOR BIOL, V279, P90, DOI 10.1016/j.jtbi.2011.02.017; Casquero H, 2015, COMPUT METHOD APPL M, V284, P943, DOI 10.1016/j.cma.2014.10.055; CHAPLAIN MAJ, 1993, MATH BIOSCI, V115, P233, DOI 10.1016/0025-5564(93)90072-I; Chen LQ, 2002, ANNU REV MATER RES, V32, P113, DOI 10.1146/annurev.matsci.32.112001.132041; CHUNG J, 1993, J APPL MECH-T ASME, V60, P371, DOI 10.1115/1.2900803; Cristini V, 2009, J MATH BIOL, V58, P723, DOI 10.1007/s00285-008-0215-x; De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165; Duda DG, 2011, CLIN CANCER RES, V17, P2074, DOI 10.1158/1078-0432.CCR-10-2636; Emmerich H., 2003, LECT NOTES PHYS, V73; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Frieboes HB, 2007, NEUROIMAGE, V37, pS59, DOI 10.1016/j.neuroimage.2007.03.008; Frieboes HB, 2010, J THEOR BIOL, V264, P1254, DOI 10.1016/j.jtbi.2010.02.036; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gerlee P, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.051911; Gevertz JL, 2006, J THEOR BIOL, V243, P517, DOI 10.1016/j.jtbi.2006.07.002; Gomez H, 2014, J COMPUT PHYS, V262, P153, DOI 10.1016/j.jcp.2013.12.044; Gomez H, 2013, J COMPUT PHYS, V238, P217, DOI 10.1016/j.jcp.2012.12.018; Gomez H, 2012, COMPUT METHOD APPL M, V249, P52, DOI 10.1016/j.cma.2012.03.002; Gomez H, 2011, J COMPUT PHYS, V230, P5310, DOI 10.1016/j.jcp.2011.03.033; Gomez H, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046702; Gomez H, 2010, COMPUT METHOD APPL M, V199, P1828, DOI 10.1016/j.cma.2010.02.010; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hawkins-Daarud A, 2013, J MATH BIOL, V67, P1457, DOI 10.1007/s00285-012-0595-9; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Herbert SP, 2012, CURR BIOL, V22, P1789, DOI 10.1016/j.cub.2012.07.037; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Hinow P, 2009, MATH BIOSCI ENG, V6, P521, DOI 10.3934/mbe.2009.6.521; Hogea CS, 2006, J MATH BIOL, V53, P86, DOI 10.1007/s00285-006-0378-2; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; HYSTAD ME, 1994, INT J CANCER, V57, P532, DOI 10.1002/ijc.2910570416; Iruela-Arispe ML, 1999, CIRCULATION, V100, P1423, DOI 10.1161/01.CIR.100.13.1423; Kobayashi R, 2010, AIP CONF PROC, V1270, P282, DOI 10.1063/1.3476232; Kuhnert F, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-20; Lima EABF, 2014, MATH MOD METH APPL S, V24, DOI 10.1142/S0218202514500304; Lima EABF, 2015, NUMER METH PART D E, V31, P552, DOI 10.1002/num.21934; Liu J, 2013, J COMPUT PHYS, V248, P47, DOI 10.1016/j.jcp.2013.04.005; Logsdon EA, 2014, J CELL MOL MED, V18, P1491, DOI 10.1111/jcmm.12164; Macklin P, 2009, J MATH BIOL, V58, P765, DOI 10.1007/s00285-008-0216-9; Miles KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112371; Moreira J, 2002, ADV COMPLEX SYST, V5, P247, DOI [10.1142/s0219525902000572, DOI 10.1142/S0219525902000572]; Nico B, 2008, HISTOL HISTOPATHOL, V23, P601, DOI 10.14670/HH-23.601; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Oden JT, 2013, MATH MOD METH APPL S, V23, P1309, DOI 10.1142/S0218202513500103; Oden JT, 2010, MATH MOD METH APPL S, V20, P477, DOI 10.1142/S0218202510004313; Orme ME, 1996, MATH COMPUT MODEL, V23, P43, DOI 10.1016/0895-7177(96)00053-2; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Perez-Garcia VM, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.021921; Perfahl H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014790; Pismen LM, 2006, PATTERNS AND INTERFA; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Preziosi L, 2009, J MATH BIOL, V58, P625, DOI 10.1007/s00285-008-0218-7; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Sciume G, 2014, COMPUT MECH, V53, P465, DOI 10.1007/s00466-013-0956-2; Sciume G, 2013, ARCH COMPUT METHOD E, V20, P327, DOI 10.1007/s11831-013-9090-8; Sciume G, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/015005; Shan SQ, 2001, CLIN CANCER RES, V7, P2590; Sherratt JA, 2001, J MATH BIOL, V43, P291, DOI 10.1007/s002850100088; Shirinifard A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007190; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; Thompson KE, 1999, B MATH BIOL, V61, P601, DOI 10.1006/bulm.1999.0089; Thurston G, 2008, BRIT J CANCER, V99, P1204, DOI 10.1038/sj.bjc.6604484; Thurston G, 2007, NAT REV CANCER, V7, P327, DOI 10.1038/nrc2130; Travasso RDM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019989; Vilanova G, 2015, GROWTH REGRESSION RE; Vilanova G, 2014, COMPUT MECH, V53, P449, DOI 10.1007/s00466-013-0958-0; Vilanova G, 2013, INT J NUMER METH BIO, V29, P1015, DOI 10.1002/cnm.2552; Ward JP, 1997, IMA J MATH APPL MED, V14, P39; Ward JP, 1999, IMA J MATH APPL MED, V16, P171; Wartenberg M, 2001, FASEB J, V15, P995, DOI 10.1096/fj.00-0350com; Welter M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070395; Wise SM, 2008, J THEOR BIOL, V253, P524, DOI 10.1016/j.jtbi.2008.03.027; Wu M, 2013, J THEOR BIOL, V320, P131, DOI 10.1016/j.jtbi.2012.11.031; Zheng X, 2005, B MATH BIOL, V67, P211, DOI 10.1016/j.bulm.2004.08.001	88	59	62	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149422	10.1371/journal.pone.0149422	http://dx.doi.org/10.1371/journal.pone.0149422			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891163	Green Published, gold, Green Submitted			2022-12-27	WOS:000371221500045
J	Kuo, YT; Chen, CY; Liu, GC; Wang, YM				Kuo, Yu-Ting; Chen, Chiao-Yun; Liu, Gin-Chung; Wang, Yun-Ming			Development of Bifunctional Gadolinium-Labeled Superparamagnetic Nanoparticles (Gd-MnMEIO) for In Vivo MR Imaging of the Liver in an Animal Model	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; ALPHA-FETOPROTEIN; CONTRAST AGENTS; ENHANCED MRI; CANCER; EPIDEMIOLOGY; METASTASES; INFECTION; DISEASE; LESIONS	Liver tumors are common and imaging methods, particularly magnetic resonance imaging (MRI), play an important role in their non-invasive diagnosis. Previous studies have shown that detection of liver tumors can be improved by injection of two different MR contrast agents. Here, we developed a new contrast agent, Gd-manganese-doped magnetism-engineered iron oxide (Gd-MnMEIO), with enhancement effects on both T1-and T2-weighted MR images of the liver. A 3.0T clinical MR scanner equipped with transmit/receiver coil for mouse was used to obtain both T1-weighted spoiled gradient-echo and T2-weighted fast spin-echo axial images of the liver before and after intravenous contrast agent injection into Balb/c mice with and without tumors. After pre-contrast scanning, six mice per group were intravenously injected with 0.1 mmol/kg Gd-MnMEIO, or the control agents, i.e., Gd-DTPA or SPIO. The scanning time points for T1-weighted images were 0.5, 5, 10, 15, 20, 25, and 30 min after contrast administration. The post-enhanced T2-weighted images were then acquired immediately after T1-weighted acquisition. We found that T1-weighted images were positively enhanced by both Gd-DTPA and Gd-MnMEIO and negatively enhanced by SPIO. The enhancement by both Gd-DTPA and Gd-MnMEIO peaked at 0.5 min and gradually declined thereafter. Gd-MnMEIO (like Gd-DTPA) enhanced T1-weighted images and (like SPIO) T2-weighted images. Marked vascular enhancement was clearly visible on dynamic T1-weighted images with Gd-MnMEIO. In addition, the T2 signal was significantly decreased at 30 min after administration of Gd-MnMEIO. Whereas the effects of Gd-MnMEIO and SPIO on T2-weighted images were similar (p = 0.5824), those of Gd-MnMEIO and Gd-DTPA differed, with Gd-MnMEIO having a significant T2 contrast effect (p = 0.0086). Our study confirms the feasibility of synthesizing an MR contrast agent with both T1 and T2 shortening effects and using such an agent in vivo. This agent enables tumor detection and characterization in single liver MRI sections.	[Kuo, Yu-Ting] Chi Mei Hosp, Dept Med Imaging, Tainan, Taiwan; [Kuo, Yu-Ting] Kaohsiung Med Univ Hosp, Dept Organ Transplantat Ctr, Kaohsiung, Taiwan; [Chen, Chiao-Yun; Liu, Gin-Chung] Kaohsiung Med Univ Hosp, Dept Med Imaging, Kaohsiung, Taiwan; [Kuo, Yu-Ting; Chen, Chiao-Yun; Liu, Gin-Chung] Kaohsiung Med Univ, Fac Med, Coll Med, Dept Radiol, Kaohsiung, Taiwan; [Wang, Yun-Ming] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Wang, Yun-Ming] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Yang Ming Chiao Tung University; Kaohsiung Medical University	Wang, YM (corresponding author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan.; Wang, YM (corresponding author), Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan.	ymwang@mail.nctu.edu.tw			Ministry of Science and Technology, Taiwan [101-2314-B-037-046-MY2]; Ministry of Health and Welfare of the Republic of China (Taiwan) [MOHW 104-TDU-B-212-124-003]; "Aim for the Top University Plan" of the National Chiao Tung University and Ministry of Education	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Health and Welfare of the Republic of China (Taiwan); "Aim for the Top University Plan" of the National Chiao Tung University and Ministry of Education	This work was supported by 101-2314-B-037-046-MY2, Ministry of Science and Technology, Taiwan, http://www.most.gov.tw/mp.aspx?mp=7; by MOHW 104-TDU-B-212-124-003, Ministry of Health and Welfare of the Republic of China (Taiwan), http://www.mohw.gov.tw/EN/Ministry/Index.aspx; and by "Aim for the Top University Plan" of the National Chiao Tung University and Ministry of Education, http://www.edu.tw/, http://nctunews.nctu.edu.tw/index.php/en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae KH, 2010, BIOCONJUGATE CHEM, V21, P505, DOI 10.1021/bc900424u; Brown RS, 2003, LIVER TRANSPLANT, V9, pS10, DOI 10.1053/jlts.2003.50244; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cheng K, 2014, ACS NANO, V8, P9884, DOI 10.1021/nn500188y; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI 10.1038/nbt1340; Chou CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107869; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Harisinghani MG, 2003, NEW ENGL J MED, V348, P2491, DOI 10.1056/NEJMoa022749; Honary S, 2013, TROP J PHARM RES, V12, P265, DOI 10.4314/tjpr.v12i2.20; Kazmierczak PM, 2015, INVEST RADIOL, V50, P153, DOI 10.1097/RLI.0000000000000118; Kim SH, 2005, AM J ROENTGENOL, V184, P1069, DOI 10.2214/ajr.184.4.01841069; Kudo M, 2014, ONCOLOGY-BASEL, V87, P7, DOI 10.1159/000368141; Lee Y. J., 2015, RADIOLOGY, DOI [DOI 10.1148/RADIOL.14140690, 10.1148/radiol.14140690]; Lok AS, 2010, GASTROENTEROLOGY, V138, P493, DOI 10.1053/j.gastro.2009.10.031; Lutz AM, 2005, RADIOLOGY, V234, P765, DOI 10.1148/radiol.2343031172; Manfredi S, 2006, ANN SURG, V244, P254, DOI 10.1097/01.sla.0000217629.94941.cf; Nakamura S, 2013, ACTA MED OKAYAMA, V67, P239; Neuwelt A, 2015, AM J ROENTGENOL, V204, pW302, DOI 10.2214/AJR.14.12733; Park YS, 2014, INVEST RADIOL, V49, P183, DOI 10.1097/RLI.0000000000000011; Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3; Subleski JJ, 2015, J HEPATOL, V63, P1181, DOI 10.1016/j.jhep.2015.06.021; Szpak A, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2678-6; Wang FS, 2014, HEPATOLOGY, V60, P2099, DOI 10.1002/hep.27406; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Yoo HJ, 2008, INVEST RADIOL, V43, P538, DOI 10.1097/RLI.0b013e3181768d96; Yoo SH, 2013, ANN SURG ONCOL, V20, P2893, DOI 10.1245/s10434-013-3001-y; Yu MH, 2014, RADIOLOGY, V271, P748, DOI 10.1148/radiol.14131996; Yu MH, 2013, J MAGN RESON IMAGING, V38, P1020, DOI 10.1002/jmri.24088; Yu NC, 2011, CLIN GASTROENTEROL H, V9, P161, DOI 10.1016/j.cgh.2010.09.017; Zhang BH, 1999, J MED SCREEN, V6, P108, DOI 10.1136/jms.6.2.108	30	6	7	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148695	10.1371/journal.pone.0148695	http://dx.doi.org/10.1371/journal.pone.0148695			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886558	Green Submitted, Green Published, gold			2022-12-27	WOS:000371218400044
J	McNabb, J; Gray, R				McNabb, Jaimie; Gray, Rob			Staying Connected on the Road: A Comparison of Different Types of Smart Phone Use in a Driving Simulator	PLOS ONE			English	Article							CAR-FOLLOWING MODEL; PICTURE SUPERIORITY; METAANALYSIS; WARNINGS; BEHAVIOR; TACTILE; TASKS	Previous research on smart phone use while driving has primarily focused on phone calls and texting. Drivers are now increasingly using their phone for other activities during driving, in particular social media, which have different cognitive demands. The present study compared the effects of four different smart phone tasks on car-following performance in a driving simulator. Phone tasks were chosen that vary across two factors: interaction medium (text vs image) and task pacing (self-paced vs experimenter-paced) and were as follows: Text messaging with the experimenter (text/other-paced), reading Facebook posts (text/self-paced), exchanging photos with the experimenter via Snapchat (image, experimenter-paced), and viewing updates on Instagram (image, experimenter-paced). Drivers also performed a driving only baseline. Brake reaction times (BRTs) were significantly greater in the text-based conditions (Mean = 1.16 s) as compared to both the image-based conditions (Mean = 0.92 s) and the baseline (0.88 s). There was no significant difference between BRTs in the image-based and baseline conditions and there was no significant effect of task-pacing. Similar results were obtained for Time Headway variability. These results are consistent with the picture superiority effect found in memory research and suggest that image-based interfaces could provide safer ways to "stay connected" while driving than text-based interfaces.	[McNabb, Jaimie; Gray, Rob] Arizona State Univ, Human Syst Engn, Mesa, AZ USA	Arizona State University	Gray, R (corresponding author), Arizona State Univ, Human Syst Engn, Mesa, AZ USA.	robgray@asu.edu						Ahlstrom C, 2015, TRANSPORTATION RES F; Basacik D., 2012, SMARTPHONE USE DRIVI; Blattner MM, 1989, HUM-COMPUT INTERACT, V1, P11; Caird JK, 2008, ACCIDENT ANAL PREV, V40, P1282, DOI 10.1016/j.aap.2008.01.009; Caird JK, 2014, ACCIDENT ANAL PREV, V71, P311, DOI 10.1016/j.aap.2014.06.005; Crutcher RJ, 2011, MEM COGNITION, V39, P63, DOI 10.3758/s13421-010-0015-6; Fitch G., 2013, NAT HIGHW TRAFF SAF, P1; Fougine D., 2008, NEW RES SHORT TERM M; Gray R, 2011, HUM FACTORS, V53, P63, DOI 10.1177/0018720810397833; Hatfield J, 2007, ACCIDENT ANAL PREV, V39, P197, DOI 10.1016/j.aap.2006.07.001; He J., 2013, P 5 INT C AUT US INT, P124; Ho C, 2014, IEEE T HUM-MACH SYST, V44, P524, DOI 10.1109/THMS.2014.2316502; Jiang R, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.017101; Kujala T, 2013, PERS UBIQUIT COMPUT, V17, P815, DOI 10.1007/s00779-012-0517-2; Kujala T, 2011, ERGONOMICS, V54, P716, DOI 10.1080/00140139.2011.592601; Liang Y., 2014, HUMAN FACTORS J HUMA; Metz B, 2014, SAFETY SCI, V68, P195, DOI 10.1016/j.ssci.2014.04.002; Mohebbi R, 2009, HUM FACTORS, V51, P102, DOI 10.1177/0018720809333517; PAIVIO A, 1973, COGNITIVE PSYCHOL, V5, P176, DOI 10.1016/0010-0285(73)90032-7; Scott JJ, 2008, HUM FACTORS, V50, P264, DOI 10.1518/001872008X250674; Tang TQ, 2010, PHYS LETT A, V374, P3951, DOI 10.1016/j.physleta.2010.07.062; Tang TQ, 2009, INT J MOD PHYS B, V23, P743, DOI 10.1142/S0217979209051966; WELDON MS, 1989, MEM COGNITION, V17, P95, DOI 10.3758/BF03199561; Young KL, 2014, SAFETY SCI, V68, P47, DOI 10.1016/j.ssci.2014.02.018; Yu SW, 2015, MEASUREMENT, V70, P137, DOI 10.1016/j.measurement.2015.03.031; Yu SW, 2015, PHYSICA A, V421, P1, DOI 10.1016/j.physa.2014.11.008	26	12	12	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148555	10.1371/journal.pone.0148555	http://dx.doi.org/10.1371/journal.pone.0148555			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3BJ	26886099	Green Published, Green Submitted, gold			2022-12-27	WOS:000371218400040
J	Taulemesse, F; Le Gouis, J; Gouache, D; Gibon, Y; Allard, V				Taulemesse, Francois; Le Gouis, Jacques; Gouache, David; Gibon, Yves; Allard, Vincent			Bread Wheat (Triticum aestivum L.) Grain Protein Concentration Is Related to Early Post-Flowering Nitrate Uptake under Putative Control of Plant Satiety Level	PLOS ONE			English	Article							WINTER-WHEAT; NITROGEN-UPTAKE; TRANSPORTER GENE; NEGATIVE RELATIONSHIP; GLUTAMINE-SYNTHETASE; EXPRESSION PATTERNS; GENOMIC ANALYSIS; PRIMARY RESPONSE; GROWTH-STAGES; CEREAL GRAIN	The strong negative correlation between grain protein concentration (GPC) and grain yield (GY) in bread wheat complicates the simultaneous improvement of these traits. However, earlier studies have concluded that the deviation from this relationship (grain protein deviation or GPD) has strong genetic basis. Genotypes with positive GPD have an increased ability to uptake nitrogen (N) during the post-flowering period independently of the amount of N taken up before flowering, suggesting that genetic variability for N satiety could enable the breakage of the negative relationship. This study is based on two genotypes markedly contrasted for GPD grown under semi-hydroponic conditions differentiated for nitrate availability both before and after flowering. This allows exploration of the genetic determinants of post-flowering N uptake (PANU) by combining whole plant sampling and targeted gene expression approaches. The results highlights the correlation (r(2) = 0.81) with GPC of PANU occurring early during grain development (flowering-flowering + 250 degree-days) independently of GY. Early PANU was in turn correlated (r(2) = 0.80) to the stem-biomass increment after flowering through its effect on N sink activity. Differences in early PANU between genotypes, despite comparable N statuses at flowering, suggest that genetic differences in N satiety could be involved in the establishment of the GPC. Through its strong negative correlation with genes implied in N assimilation, root nitrate concentration appears to be a good marker for evaluating instantaneous plant N demand, and may provide valuable information on the genotypic N satiety level. This trait may help breeders to identify genotypes having high GPC independently of their GY.	[Taulemesse, Francois; Le Gouis, Jacques; Allard, Vincent] INRA, UMR Genet Divers & Ecophysiol Cereales 1095, 5 Chemin Beaulieu, F-63100 Clermont Ferrand, France; [Taulemesse, Francois; Le Gouis, Jacques; Allard, Vincent] Univ Blaise Pascal, UMR Genet Divers & Ecophysiol Cereales 1095, F-63178 Aubiere, France; [Taulemesse, Francois; Gouache, David] Arvalis Inst Vegetal, Stn Expt Boigneville, F-91720 Boigneville, France; [Gibon, Yves] INRA, UMR Biol Fruit & Pathol 1332, 71 Ave Edouard Bourlaux, F-33882 Villenave Dornon, France	INRAE; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); INRAE	Allard, V (corresponding author), INRA, UMR Genet Divers & Ecophysiol Cereales 1095, 5 Chemin Beaulieu, F-63100 Clermont Ferrand, France.; Allard, V (corresponding author), Univ Blaise Pascal, UMR Genet Divers & Ecophysiol Cereales 1095, F-63178 Aubiere, France.	vincent.allard@clermont.inra.fr	Gouache, David/AAX-2128-2020; Allard, Vincent/B-8806-2009	Allard, Vincent/0000-0003-1949-9158; Gibon, Yves/0000-0001-8161-1089	French "Fonds de Soutien a l'Obtention Vegetale" (FSOV) [2010F]; ANRT (Association Nationale de la Recherche et de la Technologie) [CIFRE 878/2011]	French "Fonds de Soutien a l'Obtention Vegetale" (FSOV); ANRT (Association Nationale de la Recherche et de la Technologie)(French National Research Agency (ANR))	This work was supported by the French "Fonds de Soutien a l'Obtention Vegetale" (FSOV) 2010F project (2011-2013). The authors are also grateful to the ANRT (Association Nationale de la Recherche et de la Technologie) which supports the PhD thesis (CIFRE 878/2011) during which the analyses were conducted.	[Anonymous], 2004, AZ QUANT PCR; Barbottin A, 2005, CROP SCI, V45, P1141, DOI 10.2135/cropsci2003.0361; Barneix AJ, 2007, J PLANT PHYSIOL, V164, P581, DOI 10.1016/j.jplph.2006.03.009; Bertheloot J, 2012, EUR J AGRON, V42, P11, DOI 10.1016/j.eja.2012.03.005; Bogard M, 2010, J EXP BOT, V61, P4303, DOI 10.1093/jxb/erq238; Boisson M, 2005, THEOR APPL GENET, V110, P932, DOI 10.1007/s00122-004-1913-4; Branlard G, 2001, EUPHYTICA, V119, P59, DOI 10.1023/A:1017586220359; Buchner P, 2014, J EXP BOT, V65, P5697, DOI 10.1093/jxb/eru231; CALDERINI DF, 1995, ANN BOT-LONDON, V76, P315, DOI 10.1006/anbo.1995.1101; Calderini DF, 1998, FIELD CROP RES, V57, P335, DOI 10.1016/S0378-4290(98)00080-X; Cao Y, 2008, PEDOSPHERE, V18, P664, DOI 10.1016/S1002-0160(08)60061-2; Carillo P, 2005, FUNCT PLANT BIOL, V32, P209, DOI 10.1071/FP04184; CASTLE SL, 1987, AUST J PLANT PHYSIOL, V14, P503, DOI 10.1071/PP9870503; COX MC, 1985, CROP SCI, V25, P435, DOI 10.2135/cropsci1985.0011183X002500030003x; COX MC, 1986, CROP SCI, V26, P737, DOI 10.2135/cropsci1986.0011183X002600040022x; Cross JM, 2006, PLANT PHYSIOL, V142, P1574, DOI 10.1104/pp.106.086629; Feil B., 1997, AGRONOMY, V1, P103; Forde BG, 2000, BBA-BIOMEMBRANES, V1465, P219, DOI 10.1016/S0005-2736(00)00140-1; Foulkes MJ, 2009, FIELD CROP RES, V114, P329, DOI 10.1016/j.fcr.2009.09.005; Gaju O, 2011, FIELD CROP RES, V123, P139, DOI 10.1016/j.fcr.2011.05.010; Garnett T, 2013, NEW PHYTOL, V198, P82, DOI 10.1111/nph.12166; Glass ADM, 2009, BOTANY, V87, P659, DOI 10.1139/B09-014; Gooding MJ, 2007, FIELD CROP RES, V100, P143, DOI 10.1016/j.fcr.2006.06.002; GOODING MJ, 1992, FERT RES, V32, P209, DOI 10.1007/BF01048783; GOWRI G, 1992, PLANT MOL BIOL, V18, P55, DOI 10.1007/BF00018456; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; IMSANDE J, 1994, PLANT PHYSIOL, V105, P3, DOI 10.1104/pp.105.1.3; JUSTES E, 1994, ANN BOT-LONDON, V74, P397, DOI 10.1006/anbo.1994.1133; Kichey T, 2007, FIELD CROP RES, V102, P22, DOI 10.1016/j.fcr.2007.01.002; KING BJ, 1993, PLANT PHYSIOL, V102, P1279, DOI 10.1104/pp.102.4.1279; Koekemoer FP, 1999, CEREAL RES COMMUN, V27, P107; Le Bail M, 2005, EUR J AGRON, V23, P379, DOI 10.1016/j.eja.2005.02.003; Le Gouis J, 2000, EUR J AGRON, V12, P163, DOI 10.1016/S1161-0301(00)00045-9; Lemaire G., 1997, DIAGNOSIS NITROGEN S, P3, DOI [DOI 10.1007/978-3-642-60684-7, 10.1007/978-3-642-60684-7, DOI 10.1007/978-3-642-60684-7_1]; Leran S, 2014, TRENDS PLANT SCI, V19, P5, DOI 10.1016/j.tplants.2013.08.008; Lin CM, 2000, PLANT PHYSIOL, V122, P379, DOI 10.1104/pp.122.2.379; Liu JS, 2015, CROP PASTURE SCI, V66, P671, DOI 10.1071/CP14264; Maathuis FJM, 2009, CURR OPIN PLANT BIOL, V12, P250, DOI 10.1016/j.pbi.2009.04.003; Martre P, 2003, PLANT PHYSIOL, V133, P1959, DOI 10.1104/pp.103.030585; Martre P, 2006, EUR J AGRON, V25, P138, DOI 10.1016/j.eja.2006.04.007; Masclaux-Daubresse C, 2010, ANN BOT-LONDON, V105, P1141, DOI 10.1093/aob/mcq028; MATTSSON M, 1992, J EXP BOT, V43, P25, DOI 10.1093/jxb/43.1.25; Melino VJ, 2015, FUNCT PLANT BIOL, V42, P942, DOI 10.1071/FP15041; Miller AJ, 2007, J EXP BOT, V58, P2297, DOI 10.1093/jxb/erm066; Monaghan JM, 2001, EUPHYTICA, V122, P309, DOI 10.1023/A:1012961703208; Nazoa P, 2003, PLANT MOL BIOL, V52, P689, DOI 10.1023/A:1024899808018; Olesen JE, 2002, EUR J AGRON, V16, P279, DOI 10.1016/S1161-0301(01)00134-4; OSCARSON P, 1995, PLANT SOIL, V175, P179, DOI 10.1007/BF00011353; Oscarson P, 1996, ANN BOT-LONDON, V78, P479, DOI 10.1006/anbo.1996.0145; Oscarson P, 2000, J EXP BOT, V51, P1921, DOI 10.1093/jexbot/51.352.1921; OSCARSON P, 1995, CROP SCI, V35, P1056, DOI 10.2135/cropsci1995.0011183X003500040023x; Oury FX, 2007, EUPHYTICA, V157, P45, DOI 10.1007/s10681-007-9395-5; Oury FX, 2003, J GENET BREED, P57; PALTA JA, 1995, AUST J AGR RES, V46, P519, DOI 10.1071/AR9950519; Pang JY, 2015, FUNCT PLANT BIOL, V42, P1179, DOI 10.1071/FP15215; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; R Core Team, 2012, R LANG ENV STAT COMP; REDINBAUGH MG, 1993, PLANT PHYSIOL, V101, P1249, DOI 10.1104/pp.101.4.1249; Rothstein SJ, 2007, PLANT CELL, V19, P2695, DOI 10.1105/tpc.107.053074; Sadras VO, 2010, FIELD CROP RES, V118, P297, DOI 10.1016/j.fcr.2010.06.010; Shewry PR, 2007, J CEREAL SCI, V46, P239, DOI 10.1016/j.jcs.2007.06.006; SIDDIQI MY, 1990, PLANT PHYSIOL, V93, P1426, DOI 10.1104/pp.93.4.1426; SIMMONDS NW, 1995, J SCI FOOD AGR, V67, P309, DOI 10.1002/jsfa.2740670306; Stitt M, 1999, CURR OPIN PLANT BIOL, V2, P178, DOI 10.1016/S1369-5266(99)80033-8; Taulemesse F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120291; TOTTMAN DR, 1979, ANN APPL BIOL, V93, P221, DOI 10.1111/j.1744-7348.1979.tb06534.x; Triboi E, 2006, EUR J AGRON, V25, P108, DOI 10.1016/j.eja.2006.04.004; Tsay YF, 2007, FEBS LETT, V581, P2290, DOI 10.1016/j.febslet.2007.04.047; VANSANFORD DA, 1987, CROP SCI, V27, P295, DOI 10.2135/cropsci1987.0011183X002700020035x; Vidmar JJ, 2000, PLANT PHYSIOL, V123, P307, DOI 10.1104/pp.123.1.307; WALDREN RP, 1979, AGRON J, V71, P391, DOI 10.2134/agronj1979.00021962007100030004x; Wang P, 2011, AGR SCI CHINA, V10, P695, DOI 10.1016/S1671-2927(11)60052-7; Wang RC, 2000, PLANT CELL, V12, P1491, DOI 10.1105/tpc.12.8.1491; Wang RC, 2004, PLANT PHYSIOL, V136, P2512, DOI 10.1104/pp.104.044610; Yin LP, 2007, PLANT SCI, V172, P621, DOI 10.1016/j.plantsci.2006.11.014	75	28	28	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149668	10.1371/journal.pone.0149668	http://dx.doi.org/10.1371/journal.pone.0149668			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886933	Green Published, gold			2022-12-27	WOS:000371218400102
J	Teklemariam, A; Hodson-Tole, EF; Reeves, ND; Costen, NP; Cooper, G				Teklemariam, A.; Hodson-Tole, E. F.; Reeves, N. D.; Costen, N. P.; Cooper, G.			A Finite Element Model Approach to Determine the Influence of Electrode Design and Muscle Architecture on Myoelectric Signal Properties	PLOS ONE			English	Article							SURFACE EMG MODEL; MOTOR UNIT; GASTROCNEMIUS-MEDIALIS; RECRUITMENT PATTERNS; POTENTIALS; SIMULATION	Introduction Surface electromyography (sEMG) is the measurement of the electrical activity of the skeletal muscle tissue detected at the skin's surface. Typically, a bipolar electrode configuration is used. Most muscles have pennate and/or curved fibres, meaning it is not always feasible to align the bipolar electrodes along the fibres direction. Hence, there is a need to explore how different electrode designs can affect sEMG measurements. Method A three layer finite element (skin, fat, muscle) muscle model was used to explore different electrode designs. The implemented model used as source signal an experimentally recorded intramuscular EMG taken from the biceps brachii muscle of one healthy male. A wavelet based intensity analysis of the simulated sEMG signal was performed to analyze the power of the signal in the time and frequency domain. Results The model showed muscle tissue causing a bandwidth reduction (to 20-92-Hz). The inter-electrode distance (IED) and the electrode orientation relative to the fibres affected the total power but not the frequency filtering response. The effect of significant misalignment between the electrodes and the fibres (60 degrees-90 degrees) could be reduced by increasing the IED (25-30 mm), which attenuates signal cancellation. When modelling pennated fibres, the muscle tissue started to act as a low pass filter. The effect of different IED seems to be enhanced in the pennated model, while the filtering response is changed considerably only when the electrodes are close to the signal termination within the model. For pennation angle greater than 20 degrees, more than 50% of the source signal was attenuated, which can be compensated by increasing the IED to 25 mm. Conclusion Differences in tissue filtering properties, shown in our model, indicates that different electrode designs should be considered for muscle with different geometric properties (i.e. pennated muscles).	[Teklemariam, A.] Manchester Metropolitan Univ, Sch Engn, Manchester M15 6BH, Lancs, England; [Hodson-Tole, E. F.; Reeves, N. D.] Manchester Metropolitan Univ, Sch Healthcare Sci, Manchester M15 6BH, Lancs, England; [Costen, N. P.] Manchester Metropolitan Univ, Sch Comp Math & Digital Technol, Manchester M15 6BH, Lancs, England; [Cooper, G.] Univ Manchester, Sch Mech Aerosp & Civil Engn, Manchester, Lancs, England	Manchester Metropolitan University; University of Manchester; Manchester Metropolitan University; Manchester Metropolitan University; University of Manchester	Teklemariam, A (corresponding author), Manchester Metropolitan Univ, Sch Engn, Manchester M15 6BH, Lancs, England.	aron.teklemariam@stu.mmu.ac.uk	Hodson-Tole, Emma F./H-1113-2011; Cooper, Glen/M-5232-2017	Hodson-Tole, Emma F./0000-0003-1200-1724; Cooper, Glen/0000-0002-9568-8973; Teklemariam, Aron/0000-0002-5746-5736; Reeves, Neil/0000-0001-9213-4580; Costen, Nicholas/0000-0001-9454-8840	faculty of Science and Engineering, Manchester Metropolitan Univerity, Manchester, UK	faculty of Science and Engineering, Manchester Metropolitan Univerity, Manchester, UK	This project was funded by the faculty of Science and Engineering, Manchester Metropolitan Univerity, Manchester, UK.	ANDREASSEN S, 1978, IEEE T BIO-MED ENG, V25, P501, DOI 10.1109/TBME.1978.326283; Andreuccetti D., 1997, CALCULATION DIELECTR; Basmajian JV, 1985, MUSCLES ALIVE THEIR, pxii; Blok JH, 2002, ANN BIOMED ENG, V30, P566, DOI 10.1114/1.1475345; Botter A, 1985, J APPL PHYSIOL, V115, P1203; De Luca CJ, 2012, J BIOMECH, V45, P555, DOI 10.1016/j.jbiomech.2011.11.010; DELABARRERA EJ, 1994, ELECTROEN CLIN NEURO, V93, P91, DOI 10.1016/0168-5597(94)90071-X; FUGLEVAND AJ, 1992, BIOL CYBERN, V67, P143, DOI 10.1007/BF00201021; GIELEN FLH, 1984, MED BIOL ENG COMPUT, V22, P569, DOI 10.1007/BF02443872; GOOTZEN THJM, 1989, J APPL PHYS, V66, P4504, DOI 10.1063/1.343949; Hodson-Tole EF, 2007, J EXP BIOL, V210, P2333, DOI 10.1242/jeb.004457; Hodson-Tole EF, 2013, J ELECTROMYOGR KINES, V23, P43, DOI 10.1016/j.jelekin.2012.08.003; Lieber RL, 2011, PHILOS T R SOC B, V366, P1466, DOI 10.1098/rstb.2010.0316; Lieber RL, 2000, MUSCLE NERVE, V23, P1647, DOI 10.1002/1097-4598(200011)23:11<1647::AID-MUS1>3.0.CO;2-M; Lindstrom L, 1970, Electromyography, V10, P341; Lowery MM, 2004, IEEE T BIO-MED ENG, V51, P2138, DOI 10.1109/TBME.2004.836494; Lowery MM, 2003, IEEE T BIO-MED ENG, V50, P789, DOI 10.1109/TBME.2003.812152; Lowery MM, 2002, IEEE T BIO-MED ENG, V49, P446, DOI 10.1109/10.995683; Ltd Comsol, COMS MULT 5 0 AC DC, P32; Merletti R, 1999, IEEE T BIO-MED ENG, V46, P821, DOI 10.1109/10.771191; Merletti R, 1999, IEEE T BIO-MED ENG, V46, P810, DOI 10.1109/10.771190; Merletti R, 2009, PHILOS T R SOC A, V367, P357, DOI 10.1098/rsta.2008.0235; Mesin L, 2006, IEEE T BIO-MED ENG, V53, P593, DOI 10.1109/TBME.2006.870256; Mesin L, 2004, IEEE T BIO-MED ENG, V51, P1521, DOI 10.1109/TBME.2004.827551; Mesin L, 2011, J BIOMECH, V44, P1096, DOI 10.1016/j.jbiomech.2011.01.031; Nigg BM, 2007, BIOMECHANICS MUSCULO, Vxiii; PLONSEY R, 1967, B MATH BIOPHYS, V29, P657, DOI 10.1007/BF02476917; Sherrington C, 1929, P R SOC LOND B-CONTA, V105, P332, DOI 10.1098/rspb.1929.0047; Teklemariam A, 2014, COMM SYST NETW DIG S; Trontelj JV, 2005, ELECTROMYOGRAPHY PHY, P27; Vieira TMM, 2011, J PHYSIOL-LONDON, V589, P431, DOI 10.1113/jphysiol.2010.201806; Vieira TMM, 2015, REV ANDAL MED DEPORT, V08, P17; von Tscharner V, 2000, J ELECTROMYOGR KINES, V10, P433, DOI 10.1016/S1050-6411(00)00030-4; von Tscharner V, 2013, J ELECTROMYOGR KINES, V23, P1044, DOI 10.1016/j.jelekin.2013.07.011; Wakeling JM, 2012, ANN BIOMED ENG, V40, P1708, DOI 10.1007/s10439-012-0531-6; Wakeling JM, 2009, J ELECTROMYOGR KINES, V19, P199, DOI 10.1016/j.jelekin.2007.09.006; Wakeling JM, 2002, J EXP BIOL, V205, P359; Wakeling JM, 2001, EUR J APPL PHYSIOL, V86, P40, DOI 10.1007/s004210100508; Wheeler KA, 2010, IEEE ENG MED BIO, P4258, DOI 10.1109/IEMBS.2010.5627175	39	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148275	10.1371/journal.pone.0148275	http://dx.doi.org/10.1371/journal.pone.0148275			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886908	gold, Green Submitted, Green Published			2022-12-27	WOS:000371218400025
J	Luo, T; Chen, H; Kassab, GS				Luo, Tong; Chen, Huan; Kassab, Ghassan S.			3D Reconstruction of Coronary Artery Vascular Smooth Muscle Cells	PLOS ONE			English	Article							IMAGE SEGMENTATION; LAMELLAR UNIT	Aims The 3D geometry of individual vascular smooth muscle cells (VSMCs), which are essential for understanding the mechanical function of blood vessels, are currently not available. This paper introduces a new 3D segmentation algorithm to determine VSMC morphology and orientation. Methods and Results A total of 112 VSMCs from six porcine coronary arteries were used in the analysis. A 3D semi-automatic segmentation method was developed to reconstruct individual VSMCs from cell clumps as well as to extract the 3D geometry of VSMCs. A new edge blocking model was introduced to recognize cell boundary while an edge growing was developed for optimal interpolation and edge verification. The proposed methods were designed based on Region of Interest (ROI) selected by user and interactive responses of limited key edges. Enhanced cell boundary features were used to construct the cell's initial boundary for further edge growing. A unified framework of morphological parameters (dimensions and orientations) was proposed for the 3D volume data. Virtual phantom was designed to validate the tilt angle measurements, while other parameters extracted from 3D segmentations were compared with manual measurements to assess the accuracy of the algorithm. The length, width and thickness of VSMCs were 62.9 +/- 14.9 mu m, 4.6 +/- 0.6 mu m and 6.2 +/- 1.8 mu m (mean +/- SD). In longitudinal-circumferential plane of blood vessel, VSMCs align off the circumferential direction with two mean angles of -19.4 +/- 9.3 degrees and 10.9 +/- 4.7 degrees, while an out-of-plane angle (i.e., radial tilt angle) was found to be 8 +/- 7.6 degrees with median as 5.7 degrees. Conclusions A 3D segmentation algorithm was developed to reconstruct individual VSMCs of blood vessel walls based on optical image stacks. The results were validated by a virtual phantom and manual measurement. The obtained 3D geometries can be utilized in mathematical models and leads a better understanding of vascular mechanical properties and function.	[Luo, Tong; Chen, Huan; Kassab, Ghassan S.] IUPUI, Biomed Engn, Indianapolis, IN USA; [Kassab, Ghassan S.] IUPUI, Surg, Indianapolis, IN USA; [Kassab, Ghassan S.] IUPUI, Cellular & Integrat Physiol, Indianapolis, IN USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Kassab, GS (corresponding author), IUPUI, Biomed Engn, Indianapolis, IN USA.; Kassab, GS (corresponding author), IUPUI, Surg, Indianapolis, IN USA.; Kassab, GS (corresponding author), IUPUI, Cellular & Integrat Physiol, Indianapolis, IN USA.	gkassab@iupui.edu			National Institute of Health-National Heart, Lung, and Blood Institute [1 R01 HL117990]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117990] Funding Source: NIH RePORTER	National Institute of Health-National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Health-National Heart, Lung, and Blood Institute Grant 1 R01 HL117990.	Bai XZ, 2009, PATTERN RECOGN, V42, P2434, DOI 10.1016/j.patcog.2009.04.003; Baskurt OK, 2004, CLIN HEMORHEOL MICRO, V30, P169; Bund SJ, 2003, J VASC RES, V40, P547, DOI 10.1159/000075678; Chen H, 2013, BIOMATERIALS, V34, P7575, DOI 10.1016/j.biomaterials.2013.06.035; Cheng J, 2013, 2013 35 ANN INT C IE; CLARK JM, 1985, ARTERIOSCLEROSIS, V5, P19, DOI 10.1161/01.ATV.5.1.19; Coelho LP, 2009, BIOM IM NAN MACR 200; Cui C, 2009, COMPUTATIONAL FRAMEW; Dryden IL, 2006, J APPL STAT, V33, P609, DOI 10.1080/02664760600679825; Elder JH, 2003, IEEE T PATTERN ANAL, V25, P661, DOI 10.1109/TPAMI.2003.1201818; Fernandez G, 1995, NEW PLANT CELL IMAGE; Fok YL, 1996, IEEE T MED IMAGING, V15, P353, DOI 10.1109/42.500144; FUJIWARA T, 1992, CELL TISSUE RES, V270, P165, DOI 10.1007/BF00381891; Funnell W Robert J, 2006, J Nanobiotechnology, V4, P10, DOI 10.1186/1477-3155-4-10; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; Ghita O, 2002, J ELECTRON IMAGING, V11, P479, DOI 10.1117/1.1501574; Goncalves W. N., 2012, ARXIV12013109; HANSEN TR, 1980, BLOOD VESSELS, V17, P302; Histace A, 2013, ANN BRIT MACHINE VIS, V2013, P1; Hollander Y, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003324; Hukkanen J, 2011, P EUR SIGN PROC C BA; Irvine JD, 1999, J PHARM SCI, V88, P28, DOI 10.1021/js9803205; JAIN AK, 1980, IEEE T PATTERN ANAL, V2, P232, DOI 10.1109/TPAMI.1980.4767010; JI LA, 1989, PATTERN RECOGN, V22, P519, DOI 10.1016/0031-3203(89)90021-6; Jung C, 2010, IEEE T BIO-MED ENG, V57, P2825, DOI 10.1109/TBME.2010.2060486; KANIZSA G, 1979, ORG VISION ESSAYS GE; Khan MA, 2011, MOTION TWEENING SKEL, P179; Kim YJ, 2007, CYTOM PART A, V71A, P8, DOI 10.1002/cyto.a.20334; Klemencic A, 1996, PATT REC 1996 P 13 I; Kumar S, 2006, PATTERN RECOGN, V39, P1088, DOI 10.1016/j.patcog.2005.11.014; McDonald DM, 2003, NAT MED, V9, P713, DOI 10.1038/nm0603-713; Meijering E, 2012, IEEE SIGNAL PROC MAG, V29, P140, DOI 10.1109/MSP.2012.2204190; Mishra A, 2009, COMP VIS 2009 IEEE 1; Nattkemper TW, 2004, STUD HEALTH TECHNOL, V107, P847; O'Connell MK, 2008, MATRIX BIOL, V27, P171, DOI 10.1016/j.matbio.2007.10.008; PAL NR, 1993, PATTERN RECOGN, V26, P1277, DOI 10.1016/0031-3203(93)90135-J; Peyre G, 2011, COMPUT SCI ENG, V13, P94, DOI 10.1109/MCSE.2011.71; Rohde GK, 2013, 2013 35 ANN INT C IE; Saber E, 1997, IMAGE VISION COMPUT, V15, P769, DOI 10.1016/S0262-8856(97)00019-X; Schmitt O, 2009, COMPUT VIS IMAGE UND, V113, P188, DOI 10.1016/j.cviu.2008.08.011; Slomka N, 2010, J BIOMECH, V43, P1806, DOI 10.1016/j.jbiomech.2010.02.011; Smochina C, 2011, TECHNICAL REPORT; Smochina C, 2011, P 27 SPRING C COMP G; Stahl JS, 2007, IEEE T IMAGE PROCESS, V16, P2590, DOI 10.1109/TIP.2007.904463; Taber L.A., 1995, APPL MECH REV, V48, P487, DOI [10.1115/1.3005109, DOI 10.1115/1.3005109]; TODD ME, 1983, CIRC RES, V53, P319, DOI 10.1161/01.RES.53.3.319; Vito RP, 2003, ANNU REV BIOMED ENG, V5, P413, DOI 10.1146/annurev.bioeng.5.011303.120719; Wang H, 2006, COMP VIS PATT REC WO; Wang S, 2003, IEEE T PATTERN ANAL, V25, P675, DOI 10.1109/TPAMI.2003.1201819; WOLINSKY H, 1967, CIRC RES, V20, P99, DOI 10.1161/01.RES.20.1.99; Wood ST, 2013, MED IMAGE ANAL, V17, P337, DOI 10.1016/j.media.2012.12.002	51	5	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0147272	10.1371/journal.pone.0147272	http://dx.doi.org/10.1371/journal.pone.0147272			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882342	gold, Green Published, Green Submitted			2022-12-27	WOS:000371219000003
J	Baek, JM; Song, JY; Lee, SJ; Park, EK; Jeung, IC; Kim, CJ; Lee, YS				Baek, Jong Min; Song, Jae Yen; Lee, Sung Jong; Park, Eun Kyung; Jeung, In Cheul; Kim, Chan Joo; Lee, Yong Seok			Caffeine Intake Is Associated with Urinary Incontinence in Korean Postmenopausal Women: Results from the Korean National Health and Nutrition Examination Survey	PLOS ONE			English	Article							QUALITY-OF-LIFE; RISK-FACTORS; PREVALENCE; IMPACT; ADULTS	Introduction The objective of this study was to investigate whether caffeine intake is associated with urinary incontinence (UI) and quality of life (QOL) in Korean postmenopausal women. Materials and Methods We included 4,028 postmenopausal women who had participated in the Korea National Health and Nutrition Examination Survey IV (KNHANES IV). From the KNHANES questionnaire data, we ascertained the UI status of participants, defined as self-reported or medically diagnosed UI, and calculated their total daily caffeine intake through questions regarding the frequency of food consumption. The EuroQoL-5 Dimension (EQ-5D) descriptive system was used to evaluate QOL among the study population. Results The mean age of the study population was 63.19 +/- 0.25 years. Among the 4,028 women, the prevalence of medically diagnosed UI was 2.6% (n = 151), the prevalence of self-reported UI was 11.9% (n = 483), and the lifetime prevalence of UI was 15.8% (n = 639). In the study population, the presence of UI was not significantly different by age group, but daily caffeine consumption and the percentage of caffeine consumer decreased with age (P<0.001). Higher caffeine intake led to significantly higher prevalence of both medically diagnosed UI (p = 0.012) and self-reported UI (p = 0.040) in the study population. Even after adjusting for factors including age, parity, smoking status, hypertension and diabetes in logistic regression analysis, the positive association between caffeine intake and UI prevalence was observed in both medically diagnosed UI and self-reported UI (P = 0.017) among participants. In a subgroup analysis for EQ-5D (using continuous variables) in which we categorized participants into four groups according to UI presence and caffeine consumption, the EQ-5D scores were lower in the caffeine non-user group with UI than in the caffeine consumer group with or without UI. Conclusion In a sample of Korean postmenopausal women, the prevalence of UI increased with higher caffeine consumption. Additionally, QOL was lower in caffeine non-users with UI than in the caffeine consumer groups. However, additional prospective studies are required to identify clear causation between caffeine consumption, UI prevalence and QOL.	[Baek, Jong Min] Catholic Univ Korea, Dept Gen Surg, Seoul, South Korea; [Song, Jae Yen; Lee, Sung Jong; Park, Eun Kyung; Jeung, In Cheul; Kim, Chan Joo; Lee, Yong Seok] Catholic Univ Korea, Dept Obstet & Gynecol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Lee, YS (corresponding author), Catholic Univ Korea, Dept Obstet & Gynecol, Seoul, South Korea.	gom@catholic.ac.kr			Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI14C1731]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI14C1731).	Arya LA, 2000, OBSTET GYNECOL, V96, P85, DOI 10.1016/S0029-7844(00)00808-5; Bryant Charmaine M, 2002, Br J Nurs, V11, P560; Cho YS, 2014, MOL MED REP, V10, P2931, DOI 10.3892/mmr.2014.2646; Choi H, 2015, INT NEUROUROL J, V19, P19, DOI 10.5213/inj.2015.19.1.19; Craig Benjamin M, 2009, Med Care, V47, P634, DOI 10.1097/MLR.0b013e31819432ba; DIOKNO AC, 1991, UROLOGY, V38, P39, DOI 10.1016/0090-4295(91)80010-5; Dooley Y, 2008, J UROLOGY, V179, P656, DOI 10.1016/j.juro.2007.09.081; DuBeau CE, 1998, J AM GERIATR SOC, V46, P683, DOI 10.1111/j.1532-5415.1998.tb03801.x; Fulgoni VL, 2015, AM J CLIN NUTR, V101, P1081, DOI 10.3945/ajcn.113.080077; Gleason JL, 2013, INT UROGYNECOL J, V24, P295, DOI 10.1007/s00192-012-1829-5; Hirayama Fumi, 2012, J Prev Med Public Health, V45, P204, DOI 10.3961/jpmph.2012.45.3.204; Jura YH, 2011, J UROLOGY, V185, P1775, DOI 10.1016/j.juro.2011.01.003; Ko Y, 2005, AM J MANAG CARE, V11, pS103; Kocak I, 2005, EUR UROL, V48, P634, DOI 10.1016/j.eururo.2005.04.017; Korea Ministry of Food and Drug Safety, 2015, KOR FOOD ADD COD; Kwon CS, 2014, INT NEUROUROL J, V18, P31, DOI 10.5213/inj.2014.18.1.31; Lim HS, 2015, FOOD ADDIT CONTAM A, V32, P1786, DOI 10.1080/19440049.2015.1077396; Matthews CA, 2014, CURR OPIN OBSTET GYN, V26, P393, DOI 10.1097/GCO.0000000000000094; Mishra GD, 2015, MATURITAS, V81, P456, DOI 10.1016/j.maturitas.2015.05.006; Nygaard I, 2008, JAMA-J AM MED ASSOC, V300, P1311, DOI 10.1001/jama.300.11.1311; O'Donnell M, 2005, EUR UROL, V47, P385, DOI 10.1016/j.eururo.2004.09.014; Park J, 2015, INT NEUROUROL J, V19, P99, DOI 10.5213/inj.2015.19.2.99; Phelan S, 2009, DIABETES CARE, V32, P1391, DOI 10.2337/dc09-0516; Rudolph E, 2014, EUR J CLIN NUTR, V68, P793, DOI 10.1038/ejcn.2014.50; Townsend MK, 2012, OBSTET GYNECOL, V119, P950, DOI 10.1097/AOG.0b013e31824fc604; Wood LN, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4531	26	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149311	10.1371/journal.pone.0149311	http://dx.doi.org/10.1371/journal.pone.0149311			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901426	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100058
J	Bollaerts, K; Shinde, V; Dos Santos, G; Ferreira, G; Bauchau, V; Cohet, C; Verstraeten, T				Bollaerts, Kaatje; Shinde, Vivek; Dos Santos, Gael; Ferreira, Germano; Bauchau, Vincent; Cohet, Catherine; Verstraeten, Thomas			Application of Probabilistic Multiple-Bias Analyses to a Cohort- and a Case-Control Study on the Association between Pandemrix (TM) and Narcolepsy	PLOS ONE			English	Article							SENSITIVITY-ANALYSIS; INFLUENZA VACCINE; H1N1; RISK; CHILDREN; POPULATION; DIAGNOSIS; CATAPLEXY; FRANCE	Background An increase in narcolepsy cases was observed in Finland and Sweden towards the end of the 2009 H1N1 influenza pandemic. Preliminary observational studies suggested a temporal link with the pandemic influenza vaccine Pandemrix (TM), leading to a number of additional studies across Europe. Given the public health urgency, these studies used readily available retrospective data from various sources. The potential for bias in such settings was generally acknowledged. Although generally advocated by key opinion leaders and international health authorities, no systematic quantitative assessment of the potential joint impact of biases was undertaken in any of these studies. Methods We applied bias-level multiple-bias analyses to two of the published narcolepsy studies: a pediatric cohort study from Finland and a case-control study from France. In particular, we developed Monte Carlo simulation models to evaluate a potential cascade of biases, including confounding by age, by indication and by natural H1N1 infection, selection bias, disease-and exposure misclassification. All bias parameters were evidence-based to the extent possible. Results Given the assumptions used for confounding, selection bias and misclassification, the Finnish rate ratio of 13.78 (95% CI: 5.72-28.11) reduced to a median value of 6.06 (2.5th-97.5th percentile: 2.49-15.1) and the French odds ratio of 5.43 (95% CI: 2.6-10.08) to 1.85 (2.5th-97.5th percentile: 0.85-4.08). Conclusion We illustrate multiple-bias analyses using two studies on the Pandemrix (TM)-narcolepsy association and advocate their use to better understand the robustness of study findings. Based on our multiple-bias models, the observed Pandemrix (TM)-narcolepsy association consistently persists in the Finnish study. For the French study, the results of our multiple-bias models were inconclusive.	[Bollaerts, Kaatje; Verstraeten, Thomas] P95 Pharmacovigilance & Epidemiol Serv, Koning Leopold III Laan 1, B-3001 Leuven, Belgium; [Shinde, Vivek] GSK Vaccines, 2301 Renaissance Blvd, King Of Prussia, PA 19406 USA; [Dos Santos, Gael] Business & Decis Life Sci, Rue St Lambert 141, B-1200 Brussels, Belgium; [Ferreira, Germano; Bauchau, Vincent; Cohet, Catherine] GSK Vaccines, Ave Fleming 20, B-1300 Wavre, Belgium	GlaxoSmithKline; GlaxoSmithKline	Bollaerts, K (corresponding author), P95 Pharmacovigilance & Epidemiol Serv, Koning Leopold III Laan 1, B-3001 Leuven, Belgium.	Kaatje.Bollaerts@p-95.com	bauchau, vincent g/H-3710-2012	Cohet, Catherine/0000-0002-0022-7251	GlaxoSmithKline Biologicals SA	GlaxoSmithKline Biologicals SA(GlaxoSmithKline)	This work was supported by GlaxoSmithKline Biologicals SA. GlaxoSmithKline was involved in the design of the study analysis. GlaxoSmithKline paid for all costs associated with the development and the publishing of the present manuscript.	Ahmed I, 2010, CLIN CHEST MED, V31, P371, DOI 10.1016/j.ccm.2010.02.014; Aran A, 2009, SLEEP, V32, P979, DOI 10.1093/sleep/32.8.979; Bardage C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5956; Bone A, 2010, VACCINE, V28, P8157, DOI 10.1016/j.vaccine.2010.09.096; Caille-Brillet AL, 2013, EUROSURVEILLANCE, V18, P13, DOI 10.2807/1560-7917.ES2013.18.45.20628; Dauvilliers Y, 2013, BRAIN, V136, P2486, DOI 10.1093/brain/awt187; ECDC, 2012, NARC ASS PAND INFL V; Greenland S, 1996, INT J EPIDEMIOL, V25, P1107, DOI 10.1093/ije/25.6.1107-a; Greenland S, 2005, J R STAT SOC A STAT, V168, P267, DOI 10.1111/j.1467-985X.2004.00349.x; Greenland S, 2008, MODERN EPIDEMIOLOGY, V3rd; Groenwold RHH, 2010, INT J EPIDEMIOL, V39, P107, DOI 10.1093/ije/dyp332; Han F, 2013, ANN NEUROL, V73, P560, DOI 10.1002/ana.23799; Han F, 2011, ANN NEUROL, V70, P410, DOI 10.1002/ana.22587; Heier MS, 2013, SLEEP MED, V14, P867, DOI 10.1016/j.sleep.2013.03.020; INSERM, 2012, ET NARCOFLU VF NARCO; Lakemedelsverket (Medical Products Agency), 2010, MPA INV REP NARC PAT; Lash TL, 2014, INT J EPIDEMIOL, V43, P1969, DOI 10.1093/ije/dyu149; Lash TL, 2009, APPL QUANTITATIVE BI; Llupia A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039496; Lyytikainen O, 2011, EURO SURVEILL, V16; Miller E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f794; MPA, 2011, REP EP STUD SWED VAC; MPA, 2011, 1 MPA, P1; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; O'Flanagan D, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.17.20789; Partinen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033723; Persson I, 2014, J INTERN MED, V275, P172, DOI 10.1111/joim.12150; Phillips CV, 2003, EPIDEMIOLOGY, V14, P459, DOI 10.1097/01.ede.0000072106.65262.ae; Pizza F, 2014, SLEEP MED, V15, P262, DOI 10.1016/j.sleep.2013.09.021; Poli F, 2013, VACCINE, V31, P994, DOI 10.1016/j.vaccine.2012.12.014; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Shubin M, 2014, EPIDEMIOL INFECT, V142, P964, DOI 10.1017/S0950268813002537; Steenland K, 2004, AM J EPIDEMIOL, V160, P384, DOI 10.1093/aje/kwh211; Sturkenboom MCJM, 2015, VACCINE, V33, pB6, DOI 10.1016/j.vaccine.2015.03.026; Szakacs A, 2013, NEUROLOGY, V80, P1315, DOI 10.1212/WNL.0b013e31828ab26f; Tafti M, 2014, SLEEP, V37, P19, DOI 10.5665/sleep.3300; The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP), 2010, GUID METH STAND PHAR; THL, 2010, NAT I HLTH WELF REC; Thorpy MJ, 2014, SLEEP MED, V15, P502, DOI 10.1016/j.sleep.2014.01.015; U.S. FDA: Guide for Industry and FDA Staff, 2013, BEST PRACTICES CONDU; Kerkhove MD, 2013, INFLUENZA OTHER RESP, V7, P872, DOI 10.1111/irv.12074; Verstraeten T, 2015, HUMAN VACCI IN PRESS; Vose D., 2008, RISK ANAL QUANTITATI; WHO, 2009, REC STRAT ADV GROUP; WHO, 2010, EV PAND A H1N1 2009; Wijnans L, 2013, VACCINE, V31, P1246, DOI 10.1016/j.vaccine.2012.12.015; Xu CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017919	48	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149289	10.1371/journal.pone.0149289	http://dx.doi.org/10.1371/journal.pone.0149289			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901063	Green Submitted, Green Published, gold			2022-12-27	WOS:000371276100055
J	Dentico, D; Ferrarelli, F; Riedner, BA; Smith, R; Zennig, C; Lutz, A; Tononi, G; Davidson, RJ				Dentico, Daniela; Ferrarelli, Fabio; Riedner, Brady A.; Smith, Richard; Zennig, Corinna; Lutz, Antoine; Tononi, Giulio; Davidson, Richard J.			Short Meditation Trainings Enhance Non-REM Sleep Low-Frequency Oscillations	PLOS ONE			English	Article							GAMMA-BAND ACTIVITY; PSYCHOMETRIC EVALUATION; EEG; BRAIN; VALIDATION; ATTENTION; SCALE; NIGHT; PRACTITIONERS; CONSCIOUSNESS	Study Objectives We have recently shown higher parietal-occipital EEG gamma activity during sleep in long-term meditators compared to meditation-naive individuals. This gamma increase was specific for NREM sleep, was present throughout the entire night and correlated with meditation expertise, thus suggesting underlying long-lasting neuroplastic changes induced through prolonged training. The aim of this study was to explore the neuroplastic changes acutely induced by 2 intensive days of different meditation practices in the same group of practitioners. We also repeated baseline recordings in a meditation-naive cohort to account for time effects on sleep EEG activity. Design High-density EEG recordings of human brain activity were acquired over the course of whole sleep nights following intervention. Setting Sound-attenuated sleep research room. Patients or Participants Twenty-four long-term meditators and twenty-four meditation-naive controls. Interventions Two 8-h sessions of either a mindfulness-based meditation or a form of meditation designed to cultivate compassion and loving kindness, hereafter referred to as compassion meditation. Measurements and Results We found an increase in EEG low-frequency oscillatory activities (1-12 Hz, centered around 7-8 Hz) over prefrontal and left parietal electrodes across whole night NREM cycles. This power increase peaked early in the night and extended during the third cycle to high-frequencies up to the gamma range (25-40 Hz). There was no difference in sleep EEG activity between meditation styles in long-term meditators nor in the meditation naive group across different time points. Furthermore, the prefrontal-parietal changes were dependent on meditation life experience. Conclusions This low-frequency prefrontal-parietal activation likely reflects acute, meditation-related plastic changes occurring during wakefulness, and may underlie a top-down regulation from frontal and anterior parietal areas to the posterior parietal and occipital regions showing chronic, long-lasting plastic changes in long-term meditators.	[Dentico, Daniela; Ferrarelli, Fabio; Riedner, Brady A.; Smith, Richard; Zennig, Corinna; Tononi, Giulio] Univ Wisconsin, Dept Psychiat, 6001 Res Pk Blvd, Madison, WI 53719 USA; [Dentico, Daniela; Davidson, Richard J.] Univ Wisconsin, Waisman Ctr Brain Imaging & Behav, Madison, WI 53705 USA; [Dentico, Daniela; Davidson, Richard J.] Univ Wisconsin, Ctr Hlth Minds, Madison, WI 53705 USA; [Lutz, Antoine] Univ Lyon 1, Lyon Neurosci Res Ctr, CNRS UMR5292, INSERM U1028, F-69500 Bron, France; [Lutz, Antoine; Davidson, Richard J.] Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Wisconsin System; University of Wisconsin Madison	Davidson, RJ (corresponding author), Univ Wisconsin, Waisman Ctr Brain Imaging & Behav, Madison, WI 53705 USA.; Davidson, RJ (corresponding author), Univ Wisconsin, Ctr Hlth Minds, Madison, WI 53705 USA.; Davidson, RJ (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	rjdavids@wisc.edu	Ferrarelli, Fabio/D-3219-2019; LUTZ, Antoine/AAE-5114-2020; Dentico, Daniela/AAP-6736-2020	Ferrarelli, Fabio/0000-0003-0560-0227; LUTZ, Antoine/0000-0002-0258-3233; Dentico, Daniela/0000-0003-1050-0327; Davidson, Richard/0000-0002-8506-4964	National Center for Complementary and Alternative Medicine (NCCAM) [P01AT004952]; National Institute of Mental Health (NIMH) [R01-MH43454, P50-MH084051]; Fetzer Institute; John Templeton Foundation; National Institute of Child Health and Human Development [P30 HD003352-449015]; International Re-integration Grants (IRG) [FP7-PEOPLE-2009-RG]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [P01AT004952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH043454, P50MH084051] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Fetzer Institute; John Templeton Foundation; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); International Re-integration Grants (IRG); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Center for Complementary and Alternative Medicine (NCCAM) P01AT004952 to GT, RJD and AL, grants from the National Institute of Mental Health (NIMH) R01-MH43454, P50-MH084051 to RJD, grants from the Fetzer Institute and the John Templeton Foundation to RJD, a core grant to the Waisman Center from the National Institute of Child Health and Human Development [P30 HD003352-449015], and an International Re-integration Grants (IRG), FP7-PEOPLE-2009-RG for AL.	AESCHBACH D, 1993, J SLEEP RES, V2, P70, DOI 10.1111/j.1365-2869.1993.tb00065.x; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Berkovich-Ohana A, 2012, CLIN NEUROPHYSIOL, V123, P700, DOI 10.1016/j.clinph.2011.07.048; Brefczynski-Lewis JA, 2007, P NATL ACAD SCI USA, V104, P11483, DOI 10.1073/pnas.0606552104; Buffalo EA, 2011, P NATL ACAD SCI USA, V108, P11262, DOI 10.1073/pnas.1011284108; Cahn BR, 2010, COGN PROCESS, V11, P39, DOI 10.1007/s10339-009-0352-1; Cahn BR, 2006, PSYCHOL BULL, V132, P180, DOI 10.1037/0033-2909.132.2.180; Corsi-Cabrera M, 2008, BRAIN RES, V1235, P82, DOI 10.1016/j.brainres.2008.06.052; Dentico D, 2015, 21 ANN MEEET ORG HUM; Dentico D, 2014, P 17 WORLD C PSYCH I, P94; DEROGATIS LR, 1977, BRIT J SOC CLIN PSYC, V16, P347, DOI 10.1111/j.2044-8260.1977.tb00241.x; Ermis U, 2010, J SLEEP RES, V19, P400, DOI 10.1111/j.1365-2869.2010.00831.x; FEINBERG I, 1979, PSYCHOPHYSIOLOGY, V16, P283, DOI 10.1111/j.1469-8986.1979.tb02991.x; Ferrarelli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073417; Halasz P, 2004, J SLEEP RES, V13, P1, DOI 10.1111/j.1365-2869.2004.00388.x; Hipp JF, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00338; Hollingshead AB., 1957, 2 FACTOR INDEX SOCIA; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Hung CS, 2013, SLEEP, V36, P59, DOI 10.5665/sleep.2302; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Johnson LA, 2012, P NATL ACAD SCI USA, V109, P18583, DOI 10.1073/pnas.1207532109; Jung TP, 2001, P IEEE, V89, P1107, DOI 10.1109/5.939827; Landsness E, 2011, BRAIN, V134, P2222, DOI 10.1093/brain/awr152; Lee TMC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040054; Lutz A, 2004, P NATL ACAD SCI USA, V101, P16369, DOI 10.1073/pnas.0407401101; Lutz A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001897; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; MacLean, 1992, J Sleep Res, V1, P35; Maatta S, 2010, BRAIN RES BULL, V82, P118, DOI 10.1016/j.brainresbull.2010.01.006; Martinez D, 2010, CLIN NEUROPHYSIOL, V121, P704, DOI 10.1016/j.clinph.2010.01.005; Marzano C, 2011, J NEUROSCI, V31, P6674, DOI 10.1523/JNEUROSCI.0412-11.2011; Mason LI, 1997, SLEEP, V20, P102, DOI 10.1093/sleep/20.2.102; McKinney SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017351; Murphy M, 2011, SLEEP, V34, P283, DOI 10.1093/sleep/34.3.283; Murphy M, 2009, P NATL ACAD SCI USA, V106, P1608, DOI 10.1073/pnas.0807933106; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Silber MH, 2007, J CLIN SLEEP MED, V3, P121; Slagter HA, 2007, PLOS BIOL, V5, P1228, DOI 10.1371/journal.pbio.0050138; Slagter HA, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00017; Takahara M, 2002, PSYCHIAT CLIN NEUROS, V56, P257, DOI 10.1046/j.1440-1819.2002.00999.x; Travis F, 2010, CONSCIOUS COGN, V19, P1110, DOI 10.1016/j.concog.2010.01.007; Valko PO, 2008, SLEEP, V31, P1601, DOI 10.1093/sleep/31.11.1601; Voss U, 2009, SLEEP, V32, P1191, DOI 10.1093/sleep/32.9.1191; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	45	23	23	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148961	10.1371/journal.pone.0148961	http://dx.doi.org/10.1371/journal.pone.0148961			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26900914	gold, Green Published, Green Submitted			2022-12-27	WOS:000371276100032
J	Hsiao, KL; Wang, LY; Lin, CL; Liu, HF				Hsiao, Kuang-Liang; Wang, Li-Yu; Lin, Chiung-Ling; Liu, Hsin-Fu			New Phylogenetic Groups of Torque Teno Virus Identified in Eastern Taiwan Indigenes	PLOS ONE			English	Article							TT VIRUS; MOLECULAR EPIDEMIOLOGY; HIGH PREVALENCE; MESSENGER-RNAS; DNA; INFECTION; GENOTYPES; GENOME; PCR; CLASSIFICATION	Torque teno virus (TTV) is a single-stranded DNA virus highly prevalent in the world. It has been detected in eastern Taiwan indigenes with a low prevalence of 11% by using N22 region of which known to underestimate TTV prevalence excessively. In order to clarify their realistic epidemiology, we re-analyzed TTV prevalence with UTR region. One hundred and forty serum samples from eastern Taiwanese indigenous population were collected and TTV DNA was detected in 133 (95%) samples. Direct sequencing revealed an extensive mix-infection of different TTV strains within the infected individual. Entire TTV open reading frame 1 was amplified and cloned from a TTV positive individual to distinguish mix-infected strains. Phylogenetic analysis showed eleven isolates were clustered into a monophyletic group that is distinct from all known groups. In addition, another our isolate was clustered with recently described Hebei-1 strain and formed an independent clade. Based on the distribution pattern of pairwise distances, both new clusters were placed at phylogenetic group level, designed as the 6th and 7th phylogenetic group. In present study, we showed a very high prevalence of TTV infection in eastern Taiwan indigenes and indentified new phylogenetic groups from the infected individual. Both intra-and inter-phylogenetic group mix-infections can be found from one healthy person. Our study has further broadened the field of human TTVs and proposed a robust criterion for classification of the major TTV phylogenetic groups.	[Hsiao, Kuang-Liang; Liu, Hsin-Fu] Natl Taiwan Ocean Univ, Dept Biosci & Biotechnol, Keelung, Taiwan; [Hsiao, Kuang-Liang; Lin, Chiung-Ling; Liu, Hsin-Fu] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Wang, Li-Yu] Mackay Med Coll, Dept Med, New Taipei City, Taiwan; [Liu, Hsin-Fu] Natl Taipei Univ Nursing & Hlth Sci, Dept Nursing, Taipei, Taiwan	National Taiwan Ocean University; Mackay Memorial Hospital; Mackay Medical College; National Taipei University of Nursing & Health Science (NTUNHS)	Liu, HF (corresponding author), Natl Taiwan Ocean Univ, Dept Biosci & Biotechnol, Keelung, Taiwan.; Liu, HF (corresponding author), Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan.; Liu, HF (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Dept Nursing, Taipei, Taiwan.	hsinfu@mmh.org.tw	Liu, Hsin-Fu/AAR-5960-2020	Liu, Hsin-Fu/0000-0003-0082-2269; Hsiao, Kuang-Liang/0000-0003-4397-7762	Ministry of Science and Technology, Taiwan [NSC 96-2314-B-195-010, NSC 102-2314-B-195-013-MY2]; Mackay Memorial Hospital, Taiwan [MMH-104-48]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Mackay Memorial Hospital, Taiwan	This study was supported in part by the Ministry of Science and Technology, Taiwan (grant NSC 96-2314-B-195-010, NSC 102-2314-B-195-013-MY2, https://www.most.gov.tw/en/public) and Mackay Memorial Hospital, Taiwan (grant MMH-104-48, http://eng.mmh.org.tw/dnn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biagini P, 2009, CURR TOP MICROBIOL, V331, P21; Biagini P, 2005, VIRUS TAXONOMY, P335; Dai CY, 2001, TRANSFUS APHER SCI, V24, P9, DOI 10.1016/S0955-3886(00)00121-1; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Huang LY, 2001, J MED VIROL, V64, P381, DOI 10.1002/jmv.1062; Jelcic I, 2004, J VIROL, V78, P7498, DOI 10.1128/JVI.78.14.7498-7507.2004; Kamahora T, 2000, J VIROL, V74, P9980, DOI 10.1128/JVI.74.21.9980-9986.2000; Lee HH, 2004, GENOMICS, V83, P944, DOI 10.1016/j.ygeno.2003.11.006; Lemey P, 2002, VIRUS RES, V85, P47, DOI 10.1016/S0168-1702(02)00017-5; Lo SY, 1999, J MED VIROL, V59, P198, DOI 10.1002/(SICI)1096-9071(199910)59:2&lt;198::AID-JMV12&gt;3.0.CO;2-2; Miyata H, 1999, J VIROL, V73, P3582, DOI 10.1128/JVI.73.5.3582-3586.1999; Muljono DH, 2001, ARCH VIROL, V146, P1249, DOI 10.1007/s007050170089; Nishizawa T, 1999, J VIROL, V73, P9604, DOI 10.1128/JVI.73.11.9604-9608.1999; Nishizawa T, 1997, BIOCHEM BIOPH RES CO, V241, P92, DOI 10.1006/bbrc.1997.7765; Okamoto H, 2009, CURR TOP MICROBIOL, V331, P1, DOI 10.1007/978-3-540-70972-5_1; Okamoto H, 1999, VIROLOGY, V259, P428, DOI 10.1006/viro.1999.9770; Okamoto H, 2000, BIOCHEM BIOPH RES CO, V279, P700, DOI 10.1006/bbrc.2000.4012; Peng YH, 2002, ARCH VIROL, V147, P21, DOI 10.1007/s705-002-8301-7; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Takahashi K, 1998, HEPATOL RES, V12, P233, DOI 10.1016/S1386-6346(98)00068-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vasilyev EV, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-134; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036	23	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149901	10.1371/journal.pone.0149901	http://dx.doi.org/10.1371/journal.pone.0149901			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901643	Green Submitted, gold, Green Published			2022-12-27	WOS:000371276100181
J	Kamenov, K; Cabello, M; Caballero, FF; Cieza, A; Sabariego, C; Raggi, A; Anczewska, M; Pitkanen, T; Ayuso-Mateos, JL				Kamenov, Kaloyan; Cabello, Maria; Caballero, Francisco Felix; Cieza, Alarcos; Sabariego, Carla; Raggi, Alberto; Anczewska, Marta; Pitkaenen, Tuuli; Luis Ayuso-Mateos, Jose			Factors Related to Social Support in Neurological and Mental Disorders	PLOS ONE			English	Article							QOL 8-ITEM INDEX; QUALITY-OF-LIFE; FUNCTIONAL DISABILITY; DEPRESSIVE SYMPTOMS; MULTIPLE-SCLEROSIS; PERSONALITY-TRAITS; RATING-SCALE; OLDER-ADULTS; STROKE; SCHIZOPHRENIA	Despite the huge body of research on social support, literature has been primarily focused on its beneficial role for both physical and mental health. It is still unclear why people with mental and neurological disorders experience low levels of social support. The main objective of this study was to explore what are the strongest factors related to social support and how do they interact with each other in neuropsychiatric disorders. The study used cross-sectional data from 722 persons suffering from dementia, depression, epilepsy, migraine, multiple sclerosis, Parkinson's disease, schizophrenia, stroke, and substance use disorders. Multiple linear regressions showed that disability was the strongest factor for social support. Extraversion and agreeableness were significant personality variables, but when the interaction terms between personality traits and disability were included, disability remained the only significant variable. Moreover, level of disability mediated the relationship between personality (extraversion and agreeableness) and level of social support. Moderation analysis revealed that people that had mental disorders experienced lower levels of support when being highly disabled compared to people with neurological disorders. Unlike previous literature, focused on increasing social support as the origin of improving disability, this study suggested that interventions improving day-to-day functioning or maladaptive personality styles might also have an effect on the way people perceive social support. Future longitudinal research, however, is warranted to explore causality.	[Kamenov, Kaloyan; Cabello, Maria; Caballero, Francisco Felix; Luis Ayuso-Mateos, Jose] Inst Salud Carlos III, Ctr Invest Biomed Red, CIBER, Madrid, Spain; [Cieza, Alarcos] Univ Southampton, Sch Psychol, Fac Social & Human Sci, Southampton, Hants, England; [Cieza, Alarcos; Sabariego, Carla] Univ Munich, Dept Med Informat Biometry & Epidemiol IBE, Chair Publ Hlth & Hlth Serv, Res Unit Biopsychosocial Hlth, Munich, Germany; [Cieza, Alarcos] Swiss Parapleg Res, Nottwil, Switzerland; [Raggi, Alberto] Neurol Inst C Besta IRCCS Fdn, Neurol Publ Hlth & Disabil Unit, Milan, Italy; [Anczewska, Marta] Inst Psychiat & Neurol, Dept Psychiat, Warsaw, Poland; [Pitkaenen, Tuuli] A Clin Fdn, Helsinki, Finland; [Luis Ayuso-Mateos, Jose] Univ Autonoma Madrid, Dept Psychiat, Madrid, Spain; [Luis Ayuso-Mateos, Jose] Hosp Univ Princesa, Inst Invest Princesa IIS IP, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; Instituto de Salud Carlos III; University of Southampton; University of Munich; Swiss Paraplegic Research; Institute of Psychiatry & Neurology; Autonomous University of Madrid	Ayuso-Mateos, JL (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Red, CIBER, Madrid, Spain.; Ayuso-Mateos, JL (corresponding author), Univ Autonoma Madrid, Dept Psychiat, Madrid, Spain.; Ayuso-Mateos, JL (corresponding author), Hosp Univ Princesa, Inst Invest Princesa IIS IP, Madrid, Spain.	joseluis.ayuso@uam.es	Pitkänen, Tuuli/AAH-2204-2020; Kamenov, Kaloyan/AAO-8485-2020; Raggi, Alberto/K-5787-2016; Cabello, Maria/R-5665-2019	Raggi, Alberto/0000-0002-7433-7779; Cabello, Maria/0000-0003-2362-6092; Pitkanen, Tuuli/0000-0002-2381-9436; Anczewska, Marta/0000-0001-8816-930X; Kamenov, Kaloyan/0000-0002-4355-6186; Ayuso-Mateos, Jose Luis/0000-0002-7544-826X	European Commission [HEALTH-F2-2009-241572]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This study used data for secondary analysis from the international project Psychosocial fActors Relevant to brAin DISorders in Europe (PARADISE). The project was supported by a grant of the European Commission under the Seventh Framework Programme, Grant Agreement no. HEALTH-F2-2009-241572.	Alonso J, 2011, MOL PSYCHIATR, V16, P1234, DOI 10.1038/mp.2010.101; Andrews G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008343; Baseman S, 2010, J NEUROSCI NURS, V42, P237, DOI 10.1097/JNN.0b013e3181ecafea; Buntin MB, 2004, J HEALTH ECON, V23, P525, DOI 10.1016/j.jhealeco.2003.10.005; Burkert S, 2015, EPILEPSY BEHAV E B; Chao SF, 2014, AGING MENT HEALTH, V18, P767, DOI 10.1080/13607863.2013.878308; CRESSWELL CM, 1992, PSYCHOL MED, V22, P1019, DOI 10.1017/S0033291700038587; Cukrowicz KC, 2008, AGING MENT HEALTH, V12, P662, DOI 10.1080/13607860802343258; D'Amico D, 2015, HEADACHE, V55, P636, DOI 10.1111/head.12534; da Rocha NS, 2012, VALUE HEALTH, V15, P449, DOI 10.1016/j.jval.2011.11.035; Dalgard O.S., 1996, PROMOTION MENTAL HLT, V5; Dalgard OS, 2006, SOC PSYCH PSYCH EPID, V41, P444, DOI 10.1007/s00127-006-0051-5; De Silva MJ, 2013, BRIT J PSYCHIAT, V202, P253, DOI 10.1192/bjp.bp.112.118018; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; GOLDSTEIN LB, 1989, ARCH NEUROL-CHICAGO, V46, P660, DOI 10.1001/archneur.1989.00520420080026; Hamaideh S, 2014, J PSYCHIATR MENT HLT, V21, P455, DOI 10.1111/jpm.12112; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hartley S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096890; Hobart J, 2001, J NEUROL NEUROSUR PS, V71, P363, DOI 10.1136/jnnp.71.3.363; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; IBM Corp, 2013, IBM SPSS STAT WINDOW; Santini ZI, 2015, J AFFECT DISORDERS, V175, P53, DOI 10.1016/j.jad.2014.12.049; John O, 1991, BIG 5 INVENTORY VERS; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; Jose P. E., 2012, DOING STAT MEDIATION; Jose P.E., 2013, MODGRAPH 1 PROGRAMME; Jose PE, 2013, MEDGRAPH 1 PROGRAMME; Kitamura T, 2002, PSYCHIAT CLIN NEUROS, V56, P169, DOI 10.1046/j.1440-1819.2002.00951.x; Kruithof WJ, 2013, PATIENT EDUC COUNS, V93, P169, DOI 10.1016/j.pec.2013.06.003; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lakey B, 2008, RISK FACTORS IN DEPRESSION, P385, DOI 10.1016/B978-0-08-045078-0.00017-4; Leucht S, 2005, BRIT J PSYCHIAT, V187, P366, DOI 10.1192/bjp.187.4.366; Lindfors O, 2014, PSYCHIAT RES, V216, P44, DOI 10.1016/j.psychres.2013.12.050; Luciano JV, 2010, J AFFECT DISORDERS, V121, P52, DOI 10.1016/j.jad.2009.05.008; Lynch TR, 2007, INT J GERIATR PSYCH, V22, P131, DOI 10.1002/gps.1703; McCorkle B, 2008, COMMUNITY MENT HLT J, V44, P359, DOI 10.1007/s10597-008-9137-8; MUNGAS D, 1991, GERIATRICS, V46, P54; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; REISE SP, 1993, PSYCHOL BULL, V114, P552, DOI 10.1037/0033-2909.114.3.552; Renner F, 2014, PSYCHOL MED, V44, P2913, DOI 10.1017/S0033291713003152; Rogerson P.A., 2001, STAT METHODS GEOGRAP; Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993; Schmidt S, 2006, EUR J PUBLIC HEALTH, V16, P420, DOI 10.1093/eurpub/cki155; Sinclair VG, 2004, ASSESSMENT, V11, P94, DOI 10.1177/1073191103258144; SKINNER HA, 1982, J ABNORM PSYCHOL, V91, P199, DOI 10.1037/0021-843X.91.3.199; Souza J., 2014, J SUBST USE, V1, P1; Steiger JH, 2007, PERS INDIV DIFFER, V42, P893, DOI 10.1016/j.paid.2006.09.017; Stewart WF, 1998, CEPHALALGIA, V18, P44, DOI 10.1046/j.1468-2982.1998.1801044.x; Stronks DL, 1999, CEPHALALGIA, V19, P566, DOI 10.1046/j.1468-2982.1999.019006566.x; Taylor SE, 2011, OXFORD HDB HLTH PSYC, P192, DOI 10.1093/oxfordhb/9780195342819.013 .0009; Ten Have M, 2002, PSYCHOL MED, V32, P311, DOI 10.1017/S0033291701005013; Travis LA, 2004, AM J GERIAT PSYCHIAT, V12, P265, DOI 10.1176/appi.ajgp.12.3.265; Uchino BN, 2004, SOCIAL SUPPORT PHYS; Van Orden KA, 2015, INT J GERIATR PSYCH, V30, P1085, DOI 10.1002/gps.4266; World Health Organization, 2001, WHODAS 2 DIS ASS SCH; World Health Organization, 2016, MHGAP INT GUID MENT; World Health Organization, 1992, INT CLASS DIS REL HL	57	10	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149356	10.1371/journal.pone.0149356	http://dx.doi.org/10.1371/journal.pone.0149356			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26900847	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000371276100064
J	Lin, N; Yu, X; Zhao, Y; Zhang, MX				Lin, Nan; Yu, Xi; Zhao, Ying; Zhang, Mingxia			Functional Anatomy of Recognition of Chinese Multi-Character Words: Convergent Evidence from Effects of Transposable Nonwords, Lexicality, and Word Frequency	PLOS ONE			English	Article							EYE-MOVEMENTS; BRAIN ACTIVATION; METAANALYSIS; GYRUS; FMRI; INVOLVEMENT; CHILDREN; SYSTEMS; ORDER; TEXT	This fMRI study aimed to identify the neural mechanisms underlying the recognition of Chinese multi-character words by partialling out the confounding effect of reaction time (RT). For this purpose, a special type of nonword-transposable nonword-was created by reversing the character orders of real words. These nonwords were included in a lexical decision task along with regular (non-transposable) nonwords and real words. Through conjunction analysis on the contrasts of transposable nonwords versus regular nonwords and words versus regular nonwords, the confounding effect of RT was eliminated, and the regions involved in word recognition were reliably identified. The word-frequency effect was also examined in emerged regions to further assess their functional roles in word processing. Results showed significant conjunctional effect and positive word-frequency effect in the bilateral inferior parietal lobules and posterior cingulate cortex, whereas only conjunctional effect was found in the anterior cingulate cortex. The roles of these brain regions in recognition of Chinese multi-character words were discussed.	[Lin, Nan; Zhang, Mingxia] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Yu, Xi] Boston Childrens Hosp, Dept Med, Div Dev Med, Labs Cognit Neurosci, Boston, MA 02115 USA; [Yu, Xi] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Zhao, Ying] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zhao, Ying] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Beijing Normal University; Beijing Normal University	Lin, N (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	linn@psych.ac.cn	Lin, Nan/ABN-3049-2022	Zhao, Ying/0000-0002-1601-0428; zhang, ming xia/0000-0003-1512-2513	State Key Laboratory of Cognitive Neuroscience and Learning [CNLYB1209]; Natural Science Foundation of China [31300842]; Scientific Foundation of the Institute of Psychology, Chinese Academy of Sciences [Y2CQ032005]	State Key Laboratory of Cognitive Neuroscience and Learning; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Foundation of the Institute of Psychology, Chinese Academy of Sciences	This study was supported by the Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning (CNLYB1209) (Author: NL), the Natural Science Foundation of China Grant (31300842) (Author: NL), the Scientific Foundation of the Institute of Psychology, Chinese Academy of Sciences (Y2CQ032005) (Author: NL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angele B, 2013, Q J EXP PSYCHOL, V66, P505, DOI 10.1080/17470218.2011.644572; Bai XJ, 2008, J EXP PSYCHOL HUMAN, V34, P1277, DOI 10.1037/0096-1523.34.5.1277; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Cai Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010729; Cao F, 2013, HUM BRAIN MAPP, V34, P1670, DOI 10.1002/hbm.22017; Carreiras M, 2009, HUM BRAIN MAPP, V30, P3079, DOI 10.1002/hbm.20730; Cattinelli I, 2013, J NEUROLINGUIST, V26, P214, DOI 10.1016/j.jneuroling.2012.08.001; Chinese Linguistic Data Consortium, 2003, CHINESE LEXICON CLDC; Chou TL, 2009, EXP BRAIN RES, V198, P465, DOI 10.1007/s00221-009-1942-y; Constable RT, 2004, NEUROIMAGE, V22, P11, DOI 10.1016/j.neuroimage.2004.01.001; DEJERINE J., 1892, MEMOIRES SOC BIOL, V4, P61; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; GESCHWIN.N, 1965, BRAIN, V88, P237, DOI 10.1093/brain/88.2.237; Graves WW, 2010, CEREB CORTEX, V20, P1799, DOI 10.1093/cercor/bhp245; Gu JJ, 2015, J EXP PSYCHOL HUMAN, V41, P127, DOI 10.1037/a0038639; Gu JJ, 2015, ATTEN PERCEPT PSYCHO, V77, P272, DOI 10.3758/s13414-014-0749-5; Hartwigsen G, 2010, P NATL ACAD SCI USA, V107, P16494, DOI 10.1073/pnas.1008121107; Heim S, 2013, BRAIN LANG, V125, P194, DOI 10.1016/j.bandl.2011.12.005; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Humphreys GF, 2015, CEREB CORTEX, V25, P3547, DOI 10.1093/cercor/bhu198; Humphreys GF, 2015, P NATL ACAD SCI USA, V112, P7857, DOI 10.1073/pnas.1422760112; Kinoshita S, 2013, J MEM LANG, V69, P135, DOI 10.1016/j.jml.2013.03.003; Kuo WJ, 2003, NEUROIMAGE, V18, P720, DOI 10.1016/S1053-8119(03)00015-6; Li XS, 2009, COGNITIVE PSYCHOL, V58, P525, DOI 10.1016/j.cogpsych.2009.02.003; 彭聃龄, 1999, [心理学报, Acta Psychologica Sinica], V31, P36; Modern Chinese Frequency Dictionary, 1986, MODERN CHINESE FREQU; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pagan A, 2015, PSYCHON B REV, P1; Paterson KB, 2015, DEVELOPMENTAL SCI, V18, P335, DOI 10.1111/desc.12222; Petersson KM, 2007, EUR J NEUROSCI, V26, P791, DOI 10.1111/j.1460-9568.2007.05701.x; Price AR, 2015, J NEUROSCI, V35, P3276, DOI 10.1523/JNEUROSCI.3446-14.2015; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Price CJ, 1997, J COGNITIVE NEUROSCI, V9, P727, DOI 10.1162/jocn.1997.9.6.727; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; Rayner K, 2006, PSYCHOL SCI, V17, P192, DOI 10.1111/j.1467-9280.2006.01684.x; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Stoeckel C, 2009, CORTEX, V45, P1091, DOI 10.1016/j.cortex.2008.12.004; Sun H.L., 1997, PAPER COLLECTION 5 W, P459; Taft M, 1999, J MEM LANG, V40, P498, DOI 10.1006/jmla.1998.2625; Taft M., 1985, READING RES ADV THEO, P83; Taylor JSH, 2013, PSYCHOL BULL, V139, P766, DOI 10.1037/a0030266; Thompson CK, 2007, J COGNITIVE NEUROSCI, V19, P1753, DOI 10.1162/jocn.2007.19.11.1753; White SJ, 2008, J EXP PSYCHOL HUMAN, V34, P1261, DOI 10.1037/0096-1523.34.5.1261; Wu CY, 2012, NEUROIMAGE, V63, P381, DOI 10.1016/j.neuroimage.2012.06.047; Wu JL, 2012, EXP BRAIN RES, V219, P327, DOI 10.1007/s00221-012-3094-8; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Xiao ZW, 2005, HUM BRAIN MAPP, V25, P212, DOI 10.1002/hbm.20105; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yan G, 2006, BRIT J PSYCHOL, V97, P259, DOI 10.1348/000712605X70066; Yarkoni T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004257; Zang CL, 2016, Q J EXP PSYCHOL, V69, P548, DOI 10.1080/17470218.2015.1061030; Zhan JY, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00753; Zhang JX, 2012, INT J PSYCHOPHYSIOL, V84, P240, DOI 10.1016/j.ijpsycho.2012.02.013; Zhou XL, 2009, LANG COGNITIVE PROC, V24, P1009, DOI 10.1080/01690960802174514	56	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149583	10.1371/journal.pone.0149583	http://dx.doi.org/10.1371/journal.pone.0149583			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26901644	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100104
J	Lin, YW; Huang, HC; Lin, MF; Shyu, ML; Tsai, PL; Chang, HJ				Lin, Yu-Wen; Huang, Hui-Chuan; Lin, Mei-Feng; Shyu, Meei-Ling; Tsai, Po-Li; Chang, Hsiu-Ju			Influential Factors for and Outcomes of Hospitalized Patients with Suicide-Related Behaviors: A National Record Study in Taiwan from 1997-2010	PLOS ONE			English	Article							RISK-FACTORS; FOLLOW-UP; PHYSICAL ILLNESS; PRIMARY-CARE; ALCOHOL; INDIVIDUALS; DEPRESSION; MORTALITY; DISORDER; COHORT	Background Investigating the factors related to suicide is crucial for suicide prevention. Psychiatric disorders, gender, socioeconomic status, and catastrophic illnesses are associated with increased risk of suicide. Most studies have typically focused on the separate influences of physiological or psychological factors on suicide-related behaviors, and have rarely used national data records to examine and compare the effects of major physical illnesses, psychiatric disorders, and socioeconomic status on the risk of suicide-related behaviors. Objectives To identify the characteristics of people who exhibited suicide-related behaviors and the multiple factors associated with repeated suicide-related behaviors and deaths by suicide by examining national data records. Design This is a cohort study of Taiwan's national data records of hospitalized patients with suicide-related behaviors from January 1, 1997, to December 31, 2010. Participants The study population included all people in Taiwan who were hospitalized with a code indicating suicide or self-inflicted injury (E950-E959) according to the International Classification of Disease, Ninth Revision, Clinical Modification. Results Self-poisoning was the most common method of self-inflicted injury among hospitalized patients with suicide-related behaviors who used a single method. Those who were female, had been hospitalized for suicide-related behaviors at a younger age, had a low income, had a psychiatric disorder (i.e., personality disorder, major depressive disorder, bipolar disorder, schizophrenia, alcohol-related disorder, or adjustment disorder), had a catastrophic illness, or had been hospitalized for suicide-related behaviors that involved two methods of self-inflicted injury had a higher risk of hospitalization for repeated suicide-related behaviors. Those who were male, had been hospitalized for suicide-related behaviors at an older age, had low income, had schizophrenia, showed repeated suicide-related behaviors, had a catastrophic illness, or had adopted a single lethal method had an increased risk of death by suicide. Conclusions High-risk factors should be considered when devising suicide-prevention strategies.	[Lin, Yu-Wen; Huang, Hui-Chuan; Shyu, Meei-Ling; Chang, Hsiu-Ju] Taipei Med Univ, Coll Nursing, Sch Nursing, Taipei, Taiwan; [Lin, Mei-Feng] Natl Cheng Kung Univ, Dept Nursing, Tainan 701, Taiwan; [Tsai, Po-Li] Mackay Mem Hosp, Dept Surg, Div Colon & Rectal Surg, Taipei, Taiwan	Taipei Medical University; National Cheng Kung University; Mackay Memorial Hospital	Chang, HJ (corresponding author), Taipei Med Univ, Coll Nursing, Sch Nursing, Taipei, Taiwan.	hsiuju@tmu.edu.tw		Chang, Hsiu-Ju/0000-0002-8544-0712				American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Blasco-Fontecilla H, 2009, ACTA PSYCHIAT SCAND, V119, P149, DOI 10.1111/j.1600-0447.2008.01284.x; Boisseau CL, 2013, COMPR PSYCHIAT, V54, P238, DOI 10.1016/j.comppsych.2012.07.062; Bolton JM, 2008, J CLIN PSYCHIAT, V69, P1139, DOI 10.4088/JCP.v69n0714; Cibis A, 2012, J AFFECT DISORDERS, V136, P9, DOI 10.1016/j.jad.2011.08.032; Goodwin RD, 2003, PSYCHOSOM MED, V65, P501, DOI 10.1097/01.PSY.0000041544.14277.EC; Gradus Jaimie L, 2010, Clin Epidemiol, V2, P23; Haukka J, 2008, AM J EPIDEMIOL, V167, P1155; Hawton K, 2005, BRIT J PSYCHIAT, V187, P9, DOI 10.1192/bjp.187.1.9; Hawton K, 2013, J AFFECT DISORDERS, V147, P17, DOI 10.1016/j.jad.2013.01.004; Hawton K, 2011, J AFFECT DISORDERS, V134, P320, DOI 10.1016/j.jad.2011.05.044; Holikatti P, 2010, BRIT J PSYCHIAT, V196, P415, DOI 10.1192/bjp.196.5.415; Kapur N, 2013, BRIT J PSYCHIAT, V202, P326, DOI 10.1192/bjp.bp.112.116111; Kuo CJ, 2012, BRIT J PSYCHIAT, V200, P405, DOI 10.1192/bjp.bp.111.099366; Landberg J, 2008, DRUG ALCOHOL REV, V27, P361, DOI 10.1080/09595230802093778; Logan J, 2011, ARCH GEN PSYCHIAT, V68, P935, DOI 10.1001/archgenpsychiatry.2011.85; Ministry of Health and Welfare Taiwan (R. O. C.), 2013, 10 LEAD CAUS DEATH T; Misono S, 2008, J CLIN ONCOL, V26, P4731, DOI 10.1200/JCO.2007.13.8941; Nock MK, 2010, MOL PSYCHIATR, V15, P868, DOI 10.1038/mp.2009.29; Pompili M, 2011, PSYCHIAT RES, V186, P300, DOI 10.1016/j.psychres.2010.09.003; Qin P, 2013, J INTERN MED, V273, P48, DOI 10.1111/j.1365-2796.2012.02572.x; Rudd MD, 2006, J CLIN PSYCHOL, V62, P157, DOI 10.1002/jclp.20219; Runeson B, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3222; Sher L, 2006, QJM-INT J MED, V99, P57, DOI 10.1093/qjmed/hci146; Silverman AB, 1996, CHILD ABUSE NEGLECT, V20, P709, DOI 10.1016/0145-2134(96)00059-2; Suominen K, 2004, AM J PSYCHIAT, V161, P562, DOI 10.1176/appi.ajp.161.3.562; Taiwanese Society of Suicidology, 2013, SURV AND RES; Tidemalm D, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2205; Uribe IP, 2013, J AFFECT DISORDERS, V150, P840, DOI 10.1016/j.jad.2013.03.013; Webb RT, 2012, ARCH GEN PSYCHIAT, V69, P256, DOI 10.1001/archgenpsychiatry.2011.1561; World Health Organization, 2013, HLTH TOP SUIC; Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5	32	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149559	10.1371/journal.pone.0149559	http://dx.doi.org/10.1371/journal.pone.0149559			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26900930	Green Published, gold			2022-12-27	WOS:000371276100098
J	Prendergast, ME; Rouby, H; Punnwong, P; Marchant, R; Crowther, A; Kourampas, N; Shipton, C; Walsh, M; Lambeck, K; Boivin, NL				Prendergast, Mary E.; Rouby, Helene; Punnwong, Paramita; Marchant, Robert; Crowther, Alison; Kourampas, Nikos; Shipton, Ceri; Walsh, Martin; Lambeck, Kurt; Boivin, Nicole L.			Continental Island Formation and the Archaeology of Defaunation on Zanzibar, Eastern Africa	PLOS ONE			English	Article							HOLOCENE MANGROVE DYNAMICS; SEA-LEVEL CHANGES; CAPRA-HIRCUS; VERTEBRATES; BAY; ARCHIPELAGO; RETHINKING; EVOLUTION; IMPACTS; HISTORY	With rising sea levels at the end of the Pleistocene, land-bridge or continental islands were formed around the world. Many of these islands have been extensively studied from a biogeographical perspective, particularly in terms of impacts of island creation on terrestrial vertebrates. However, a majority of studies rely on contemporary faunal distributions rather than fossil data. Here, we present archaeological findings from the island of Zanzibar (also known as Unguja) off the eastern African coast, to provide a temporal perspective on island biogeography. The site of Kuumbi Cave, excavated by multiple teams since 2005, has revealed the longest cultural and faunal record for any eastern African island. This record extends to the Late Pleistocene, when Zanzibar was part of the mainland, and attests to the extirpation of large mainland mammals in the millennia after the island became separated. We draw on modeling and sedimentary data to examine the process by which Zanzibar was most recently separated from the mainland, providing the first systematic insights into the nature and chronology of this process. We subsequently investigate the cultural and faunal record from Kuumbi Cave, which provides at least five key temporal windows into human activities and faunal presence: two at the end of the Last Glacial Maximum (LGM), one during the period of post-LGM rapid sea level rise and island formation, and two in the late Holocene (Middle Iron Age and Late Iron Age). This record demonstrates the presence of large mammals during the period of island formation, and their severe reduction or disappearance in the Kuumbi Cave sequence by the late Holocene. While various limitations, including discontinuity in the sequence, problematize attempts to clearly attribute defaunation to anthropogenic or island biogeographic processes, Kuumbi Cave offers an unprecedented opportunity to examine post-Pleistocene island formation and its long-term consequences for human and animal communities.	[Prendergast, Mary E.] St Louis Univ, Dept Sociol & Anthropol, Madrid, Spain; [Rouby, Helene] Ecole Normale Super, CNRS, UMR 8538, Geol Lab, F-75231 Paris, France; [Rouby, Helene; Lambeck, Kurt] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Punnwong, Paramita] Mahidol Univ, Fac Environm & Resource Studies, Salaya 73170, Nakhon Pathom, Thailand; [Marchant, Robert] York Inst Trop Ecosyst, Dept Environm, York, N Yorkshire, England; [Crowther, Alison] Univ Queensland, Sch Social Sci, Brisbane, Qld, Australia; [Kourampas, Nikos] Univ Edinburgh, Off Lifelong Learning, Edinburgh, Midlothian, Scotland; [Kourampas, Nikos] Univ Stirling, Biol & Environm Sci, Stirling FK9 4LA, Scotland; [Shipton, Ceri] Univ Cambridge, McDonald Inst Archaeol Res, Cambridge, England; [Shipton, Ceri] British Acad, British Inst Eastern Africa, Nairobi, Kenya; [Walsh, Martin] Univ Cambridge Wolfson Coll, Cambridge CB3 9BB, England; [Boivin, Nicole L.] Univ Oxford, Res Lab Archaeol & Hist Art, Sch Archaeol, Oxford, England; [Boivin, Nicole L.] Max Planck Inst Sci Human Hist, Jena, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Australian National University; Mahidol University; University of Queensland; University of Edinburgh; University of Stirling; University of Cambridge; University of Cambridge; University of Oxford	Prendergast, ME (corresponding author), St Louis Univ, Dept Sociol & Anthropol, Madrid, Spain.	mprendergast@post.harvard.edu	Crowther, Alison/B-7854-2016; Crowther, Alison/AAR-9872-2021	Crowther, Alison/0000-0002-2394-1917; Walsh, Martin/0000-0003-1662-286X; Marchant, Robert/0000-0001-5013-4056; BOIVIN, NICOLE/0000-0002-7783-4199	European Research Council [206148]; Natural Environmental Research Council Radiocarbon Facility [NF/2012/2/4]; European Research Council grant (ERC) [295719]; British Institute in Eastern Africa; McDonald Institute for Archaeological Research, University of Cambridge; British Academy Postdoctoral Research Fellowship; University of Queensland	European Research Council(European Research Council (ERC)European Commission); Natural Environmental Research Council Radiocarbon Facility; European Research Council grant (ERC)(European Research Council (ERC)); British Institute in Eastern Africa; McDonald Institute for Archaeological Research, University of Cambridge(University of Cambridge); British Academy Postdoctoral Research Fellowship; University of Queensland(University of Queensland)	The Sealinks Project is funded by a European Research Council grant to NB (Starter Grant 206148, 'SEALINKS'), under the 'Ideas' specific Programme of the 7th Framework Programme (FP7; http://ec.europa.eu/research/fp7/). Additional funding for analyses was contributed by a Natural Environmental Research Council Radiocarbon Facility grant to NB (NF/2012/2/4; http://www.c14.org.uk/) and a European Research Council grant (ERC no. 295719; https://erc.europa.eu/funding-and-grants). CS is funded by the British Institute in Eastern Africa (http://www.biea.ac.uk/) and the McDonald Institute for Archaeological Research, University of Cambridge (http://www.mcdonald.cam.ac.uk/). AC was funded by a British Academy Postdoctoral Research Fellowship (2010-2013; http://www.britac.ac.uk/funding/), and a University of Queensland Postdoctoral Fellowship (2015-2017; http://www.uq.edu.au/research/research-management/uq-postdoctoral-research-fellowships). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenbroad LD, 2012, QUATERN INT, V255, P2, DOI 10.1016/j.quaint.2011.03.044; Alcover Josep Antonia, 1999, P165; [Anonymous], 2016, CONSTITUTION UNION C, P15; Arthurton RS, 1999, J COASTAL RES, V15, P635; Arthurton Russell, 2003, Western Indian Ocean Journal of Marine Science, V2, P1; Athens J. S., 2002, ARCHAEOL OCEAN, V37, P57, DOI DOI 10.1002/j.1834-4453.2002.tb00507.x; BRAIN C. K, 1981, HUNTERS HUNTED INTRO; BROWN JH, 1971, AM NAT, V105, P467, DOI 10.1086/282738; Burgess N. D., 2000, Coastal forests of eastern Africa; Burney DA, 2003, P NATL ACAD SCI USA, V100, P10800, DOI 10.1073/pnas.1534700100; Camoin GF, 1997, CORAL REEFS, V16, P247, DOI 10.1007/s003380050080; Camoin GF, 2004, MAR GEOL, V206, P119, DOI 10.1016/j.margeo.2004.02.003; Castaneda IS, 2009, PALAEOGEOGR PALAEOCL, V275, P100, DOI 10.1016/j.palaeo.2009.02.008; Chami F., 2009, ZANZIBAR SWAHILI COA; Chami F., 2001, PEOPLE CONTACTS ENV; Chami F., 2006, UNITY AFRICAN ANCIEN; Cheke A., 2008, LOST LAND DODO ECOLO; Cheke A.S., 1987, P5, DOI 10.1017/CBO9780511735769.003; Cheke Anthony, 2010, Phelsuma, V18, P38; Chynoweth MW, 2013, PAC SCI, V67, P141, DOI 10.2984/67.2.1; COBLENTZ BE, 1978, BIOL CONSERV, V13, P279, DOI 10.1016/0006-3207(78)90038-1; Compton JS, 2001, HOLOCENE, V11, P395, DOI 10.1191/095968301678302832; Crowther A, 2014, AZANIA, V49, P21, DOI 10.1080/0067270X.2013.878104; Davies AM, 1927, REPORT PALAEONTOLOGY; Dewar R.E., 1984, P574; DEWAR RE, 1993, J WORLD PREHIST, V7, P417, DOI 10.1007/BF00997802; DIAMOND J M, 1975, Biological Conservation, V7, P129, DOI 10.1016/0006-3207(75)90052-X; DIAMOND JM, 1972, P NATL ACAD SCI USA, V69, P3199, DOI 10.1073/pnas.69.11.3199; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Ellis Erle C., 2013, Elementa-Science of the Anthropocene, V1, P000018, DOI 10.12952/journal.elementa.000018; Erlandson JM, 2013, ANTHROPOCENE, V4, P1, DOI 10.1016/j.ancene.2014.05.003; Erlandson JM, 2011, SCIENCE, V331, P1181, DOI 10.1126/science.1201477; Erlandson JM, 2010, ANNU REV MAR SCI, V2, P231, DOI 10.1146/annurev.marine.010908.163749; Goldman Helle V., 2002, Journal of East African Natural History, V91, P15, DOI 10.2982/0012-8317(2002)91[15:ITZLPP]2.0.CO;2; Goldman HV, 2003, J E AFR NAT HIST, V92, P4; GOODMAN SM, 1997, NATURAL CHANGE HUMAN; Greenway J. C. Jr, 1958, EXTINCT VANISHING BI; Groucutt HS, 2015, EVOL ANTHROPOL, V24, P149, DOI 10.1002/evan.21455; Grove R. H., 1995, GREEN IMPERIALISM CO; Helm R. M., 2000, AZANIA, V35, P183, DOI DOI 10.1080/00672700009511601; Hilty J. A., 2006, CORRIDOR ECOLOGY SCI; HOPE J H, 1973, Proceedings of the Royal Society of Victoria, V85, P163; Horton MC, ZANZIBAR PE IN PRESS; Hunt TL, 2007, J ARCHAEOL SCI, V34, P485, DOI 10.1016/j.jas.2006.10.003; JARITZ W, 1977, GEOLOGISCHES JB, V26, P3; Juma A, 2004, THESIS UPPSALA U; Kent P.E., 1971, GEOLOGY GEOPHYS COAS, P6; Kiage LM, 2006, PROG PHYS GEOG, V30, P633, DOI 10.1177/0309133306071146; Kourampas N, 2015, INT J SPELEOL, V44, P293, DOI 10.5038/1827-806X.44.3.7; Lambeck K, 2003, QUATERNARY SCI REV, V22, P309, DOI 10.1016/S0277-3791(02)00142-7; Lambeck K, 2014, P NATL ACAD SCI USA, V111, P15296, DOI 10.1073/pnas.1411762111; Langley MC, AZANIA IN PRESS; LAWLOR TE, 1986, BIOL J LINN SOC, V28, P99, DOI 10.1111/j.1095-8312.1986.tb01751.x; Lomolino MV, 2000, GLOBAL ECOL BIOGEOGR, V9, P1, DOI 10.1046/j.1365-2699.2000.00185.x; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Louette M, 1988, OISEAUX COMORES; Louette M, 1999, FAUNE TERRESTRE MAYO; MAC ARTHUR ROBERT H., 1967; Marchant R, 2004, EARTH-SCI REV, V66, P217, DOI 10.1016/j.earscirev.2004.01.003; Marean Curtis W., 2004, Journal of Taphonomy, V2, P69; Marti R, 2012, REV ARQUEOLOGIA, V21, P14; Martin del Molino A, 1989, AFRICA 2000, V4, P4; Masoud TS, 2004, MANGROVE MANAGEMENT AND CONSERVATION: PRESENT AND FUTURE, P280; Moreau RE, 1941, P ZOOL SOC LOND A-GE, V110, P97; Moreau RE, 1940, NATURE, V146, P462, DOI 10.1038/146462a0; Morner N., 1992, URBAN ORIGINS E AFRI, P256; Muzuka AN, 2004, B DIR GEOL MOZAMB, V43, P8; NAKADA M, 1987, GEOPHYS J INT, V90, P171, DOI 10.1111/j.1365-246X.1987.tb00680.x; Norstrom E, 2012, QUATERN INT, V260, P153, DOI 10.1016/j.quaint.2011.11.032; Pakenham R. H. W., 1983, J E AFR NAT HIST SOC, V177, P1; Patterson B.D., 1984, P247; Pluet J, 1991, WORLD ATLAS HOLOCENE; Prendergast M.E., 2009, DOCUMENTA ARCHAEOBIO, V7, P203; Punwong P, 2013, THESIS U YORK; Punwong P, 2013, VEG HIST ARCHAEOBOT, V22, P381, DOI 10.1007/s00334-012-0383-x; Punwong P, 2013, PALAEOGEOGR PALAEOCL, V379, P54, DOI 10.1016/j.palaeo.2013.04.004; Punwong P, 2013, QUATERN INT, V298, P4, DOI 10.1016/j.quaint.2013.02.007; Quintana Morales, 2013, THESIS U BRISTOL; Ramsay PJ, 2002, QUATERNARY RES, V57, P82, DOI 10.1006/qres.2001.2290; Ramsay PJ, 1996, QUATERN INT, V31, P71, DOI 10.1016/1040-6182(95)00040-P; Rick TC, 2014, BIOSCIENCE, V64, P680, DOI 10.1093/biosci/biu094; Rijsdijk KF, 2011, HOLOCENE, V21, P1179, DOI 10.1177/0959683611405236; Robertshaw P, 2009, POLITICS POWER ARCHA, P208; Rowson B, 2010, ZOOKEYS, P1, DOI 10.3897/zookeys.70.762; Rucina SM, 2010, HOLOCENE, V20, P667, DOI 10.1177/0959683609358910; Salum LA, 2009, AFR J ECOL, V47, P166, DOI 10.1111/j.1365-2028.2008.01065.x; Saunders F, 2011, CONSERV SOC, V9, P961; Sheriff Abdul, 1987, SLAVES SPICES IVORY; Sheriff Abdul, 1995, HIST CONSERVATION ZA; Shipton C, AZANIA IN PRESS; Sinclair P, 2006, STUD AFR PAST, V5, P95; Smith BD, 2013, ANTHROPOCENE, V4, P8, DOI 10.1016/j.ancene.2013.05.001; Steadman DW, 2002, HUM ECOL, V30, P339, DOI 10.1023/A:1016520602698; Stockley G. M., 1942, Geological Magazine London, V79, P233; Stockley GM, 1928, REPORT GEOLOGY ZANZI; Sutton JEG, 2002, J AFR HIST, V43, P503, DOI 10.1017/S0021853702218411; TERBORGH J, 1974, BIOSCIENCE, V24, P715, DOI 10.2307/1297090; Terborgh John, 1997, P256; Vigne JD, 1988, MAMMIFERES POSTGLACI; Walker R., 1985, GUIDE POSTCRANIAL BO; Walsh M.T., 2007, AZANIA, V42, P83, DOI [DOI 10.1080/00672700709480452, 10.1080/00672700709480452]; Williams A, 1996, POPULATION SURVEY MI; Woodroffe SA, 2005, J ASIAN EARTH SCI, V25, P29, DOI 10.1016/j.jseaes.2004.01.009; Woodroffe SA, 2015, HOLOCENE, V25, P820, DOI 10.1177/0959683615571422; Zinke J, 2003, MAR GEOL, V194, P181, DOI 10.1016/S0025-3227(02)00705-3	105	43	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149565	10.1371/journal.pone.0149565	http://dx.doi.org/10.1371/journal.pone.0149565			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DF3VL	26901050	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100099
J	Tamayo, E; Benabdellah, K; Ferrol, N				Tamayo, Elisabeth; Benabdellah, Karim; Ferrol, Nuria			Characterization of Three New Glutaredoxin Genes in the Arbuscular Mycorrhizal Fungus Rhizophagus irregularis: Putative Role of RiGRX4 and RiGRX5 in Iron Homeostasis	PLOS ONE			English	Article							MONOTHIOL GLUTAREDOXINS; GLOMUS-INTRARADICES; CALCIUM HOMEOSTASIS; YEAST; LOCALIZATION; PERCEPTION; SYSTEM; CELLS; ACCUMULATION; PROTEINS	Glutaredoxins (GRXs) are small ubiquitous oxidoreductases involved in the regulation of the redox state in living cells. In an attempt to identify the full complement of GRXs in the arbuscular mycorrhizal (AM) fungus Rhizophagus irregularis, three additional GRX homologs, besides the formerly characterized GintGRX1 (renamed here as RiGRX1), were identified. The three new GRXs (RiGRX4, RiGRX5 and RiGRX6) contain the CXXS domain of monothiol GRXs, but whereas RiGRX4 and RiGRX5 belong to class II GRXs, RiGRX6 belongs to class I together with RiGRX1. By using a yeast expression system, we observed that the newly identified homologs partially reverted sensitivity of the GRX deletion yeast strains to external oxidants. Furthermore, our results indicated that RiGRX4 and RiGRX5 play a role in iron homeostasis in yeast. Gene expression analyses revealed that RiGRX1 and RiGRX6 were more highly expressed in the intraradical (IRM) than in the extraradical mycelium (ERM). Exposure of the ERM to hydrogen peroxide induced up-regulation of RiGRX1, RiGRX4 and RiGRX5 gene expression. RiGRX4 expression was also up-regulated in the ERM when the fungus was grown in media supplemented with a high iron concentration. These data indicate the two monothiol class II GRXs, RiGRX4 and RiGRX5, might be involved in oxidative stress protection and in the regulation of fungal iron homeostasis. Increased expression of RiGRX1 and RiGRX6 in the IRM suggests that these GRXs should play a key role in oxidative stress protection of R. irregularis during its in planta phase.	[Tamayo, Elisabeth; Ferrol, Nuria] CSIC, Dept Microbiol Suelo & Sistemas Simbiot, Estn Expt Zaidin, Granada, Spain; [Benabdellah, Karim] Pfizer Univ Granada Andalusian Reg Govt, Ctr Genom & Oncol Res, GENYO, Genom Med Dept, Parque Tecnol Ciencias Salud, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Pfizer; University of Granada	Ferrol, N (corresponding author), CSIC, Dept Microbiol Suelo & Sistemas Simbiot, Estn Expt Zaidin, Granada, Spain.	nuria.ferrol@eez.csic.es	Tamayo, Elisabeth/GPP-0978-2022; Benabdellah, karim/F-4209-2016; Benabdellah, karim/L-4569-2014; Ferrol, Nuria/H-5330-2015	Tamayo, Elisabeth/0000-0001-8617-1940; Benabdellah, karim/0000-0003-2790-562X; Benabdellah, karim/0000-0003-4673-2111; Ferrol, Nuria/0000-0001-7963-3537	Spanish Ministry of Economy and Competitivity [AGL2012-35611, AGL2015-67098-R]; Spanish National Research Council (CSIC) [JAEPre_2010_00977]; Pfizer	Spanish Ministry of Economy and Competitivity(Spanish Government); Spanish National Research Council (CSIC); Pfizer(Pfizer)	This research was supported by the Spanish Ministry of Economy and Competitivity (Projects AGL2012-35611 and AGL2015-67098-R). Elisabeth Tamayo was supported by a PhD contract (I3P) from the Spanish National Research Council (CSIC) (JAEPre_2010_00977). Karim Benabdellah is employed by Genomic Medicine Department, GENYO, Centre for Genomics and Oncological Research, Pfizer-University of Granada-Andalusian Regional Government. GENYO is a public center co-financed by Pfizer, but Pfizer did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arthikala MK, 2014, NEW PHYTOL, V202, P886, DOI 10.1111/nph.12714; Arthikala MK, 2013, PLANT CELL PHYSIOL, V54, P1391, DOI 10.1093/pcp/pct089; Bandyopadhyay S, 2008, BIOCHEM SOC T, V36, P1112, DOI 10.1042/BST0361112; Barea JM, 2014, BENEFICIAL PLANT-MICROBIAL INTERACTIONS: ECOLOGY AND APPLICATIONS, P353; Belmondo S, 2016, PLANTA, V243, P251, DOI 10.1007/s00425-015-2407-0; Benabdellah K, 2009, FUNGAL GENET BIOL, V46, P94, DOI 10.1016/j.fgb.2008.09.013; Benabdellah K, 2009, NEW PHYTOL, V184, P682, DOI 10.1111/j.1469-8137.2009.02978.x; Benyamina SM, 2013, ENVIRON MICROBIOL, V15, P795, DOI 10.1111/j.1462-2920.2012.02835.x; Bonfante P, 2015, TRENDS PLANT SCI, V20, P150, DOI 10.1016/j.tplants.2014.12.002; Bucher M, 2014, NEW PHYTOL, V204, P833, DOI 10.1111/nph.12862; CHABOT S, 1992, MYCOLOGIA, V84, P315, DOI 10.2307/3760183; Chung WH, 2005, BIOCHEM BIOPH RES CO, V330, P604, DOI 10.1016/j.bbrc.2005.02.183; Couturier J, 2015, BBA-MOL CELL RES, V1853, P1513, DOI 10.1016/j.bbamcr.2014.09.018; Couturier J, 2009, CELL MOL LIFE SCI, V66, P2539, DOI 10.1007/s00018-009-0054-y; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Demaegd D, 2013, P NATL ACAD SCI USA, V110, P6859, DOI 10.1073/pnas.1219871110; Drapier JC, 1996, METHOD ENZYMOL, V269, P26; Ellerbeck M, 2013, EUKARYOT CELL, V12, P1554, DOI 10.1128/EC.00139-13; Farah ME, 2007, MOL BIOL CELL, V18, P1359, DOI 10.1091/mbc.E06-08-0718; Fester T, 2005, MYCORRHIZA, V15, P373, DOI 10.1007/s00572-005-0363-4; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Gallego C, 1997, EMBO J, V16, P7196, DOI 10.1093/emboj/16.23.7196; Garcia-Rodriguez S, 2007, PHYSIOL PLANTARUM, V129, P737, DOI 10.1111/j.1399-3054.2007.00873.x; GIOVANNETTI M, 1980, NEW PHYTOL, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Gonzalez-Guerrero M, 2010, CURR GENET, V56, P265, DOI 10.1007/s00294-010-0298-y; Gutjahr C, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00204; Haunhorst P, 2010, BIOCHEM BIOPH RES CO, V394, P372, DOI 10.1016/j.bbrc.2010.03.016; Herrero E, 2007, CELL MOL LIFE SCI, V64, P1518, DOI 10.1007/s00018-007-6554-8; Herrero E, 2010, CURR PROTEIN PEPT SC, V11, P659, DOI 10.2174/138920310794557637; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Izquierdo A, 2008, EUKARYOT CELL, V7, P1415, DOI 10.1128/EC.00133-08; Jung SC, 2012, J CHEM ECOL, V38, P651, DOI 10.1007/s10886-012-0134-6; Kiirika LM, 2012, PLANT PHYSIOL, V159, P501, DOI 10.1104/pp.112.193706; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Kloppholz S, 2011, CURR BIOL, V21, P1204, DOI 10.1016/j.cub.2011.06.044; Labbe S, 2013, CURR OPIN MICROBIOL, V16, P669, DOI 10.1016/j.mib.2013.07.007; Lanfranco L, 2005, PLANT PHYSIOL, V137, P1319, DOI 10.1104/pp.104.050435; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li HR, 2012, BIOCHEMISTRY-US, V51, P4377, DOI 10.1021/bi300393z; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Lin K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004078; Liu Y, 2013, FUNGAL BIOL-UK, V117, P22, DOI 10.1016/j.funbio.2012.11.002; Luo M, 2010, J MOL BIOL, V398, P614, DOI 10.1016/j.jmb.2010.03.029; Mapolelo DT, 2013, DALTON T, V42, P3107, DOI 10.1039/c2dt32263c; Mesecke N, 2008, MOL BIOL CELL, V19, P2673, DOI 10.1091/mbc.E07-09-0896; MINET M, 1992, PLANT J, V2, P417; Moon JS, 2005, MOL CELLS, V20, P74; Morel M, 2008, NEW PHYTOL, V180, P391, DOI 10.1111/j.1469-8137.2008.02498.x; Nanda AK, 2010, J INTEGR PLANT BIOL, V52, P195, DOI 10.1111/j.1744-7909.2010.00933.x; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Perez-Tienda Jacob, 2014, Plant Physiol Biochem, V75, P1, DOI 10.1016/j.plaphy.2013.11.029; Puigpinos J, 2015, MOL BIOL CELL, V26, P104, DOI 10.1091/mbc.E14-06-1137; Pujol-Carrion N, 2006, J CELL SCI, V119, P4554, DOI 10.1242/jcs.03229; Pujol-Carrion N, 2010, APPL ENVIRON MICROB, V76, P7826, DOI 10.1128/AEM.01755-10; Requena N, 2007, PHYTOCHEMISTRY, V68, P33, DOI 10.1016/j.phytochem.2006.09.036; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; Rouhier N, 2010, TRENDS BIOCHEM SCI, V35, P43, DOI 10.1016/j.tibs.2009.08.005; Salzer P, 1999, PLANTA, V208, P319, DOI 10.1007/s004250050565; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shenton D, 2002, J BIOL CHEM, V277, P16853, DOI 10.1074/jbc.M200559200; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; StArnaud M, 1996, MYCOL RES, V100, P328, DOI 10.1016/S0953-7562(96)80164-X; Stroher E, 2012, BIOCHEM J, V446, P333, DOI 10.1042/BJ20112131; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tisserant E, 2012, NEW PHYTOL, V193, P755, DOI 10.1111/j.1469-8137.2011.03948.x; Tisserant E, 2013, P NATL ACAD SCI USA, V110, P20117, DOI 10.1073/pnas.1313452110; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6	71	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149606	10.1371/journal.pone.0149606	http://dx.doi.org/10.1371/journal.pone.0149606			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900849	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100108
J	Wang, XF; Cheng, G; Lug, Y; Zhang, CL; Wu, XB; Han, HT; Zhao, YF; Ren, LM				Wang, Xifeng; Cheng, Gang; Lug, Yan; Zhang, Chenglin; Wu, Xiaobing; Han, Haitang; Zhao, Yaofeng; Ren, Liming			A Comprehensive Analysis of the Phylogeny, Genomic Organization and Expression of Immunoglobulin Light Chain Genes in Alligator sinensis, an Endangered Reptile Species	PLOS ONE			English	Article							ANTIBODY REPERTOIRE DEVELOPMENT; XENOPUS-LAEVIS IG; V(D)J RECOMBINATION; EVOLUTIONARY IMPLICATIONS; AMERICAN ALLIGATOR; EXTENSIVE DIVERSIFICATION; ANOLIS-CAROLINENSIS; CHANNEL CATFISH; RAINBOW-TROUT; LAMBDA-GENES	Crocodilians are evolutionarily distinct reptiles that are distantly related to lizards and are thought to be the closest relatives of birds. Compared with birds and mammals, few studies have investigated the Ig light chain of crocodilians. Here, employing an Alligator sinensis genomic bacterial artificial chromosome (BAC) library and available genome data, we characterized the genomic organization of the Alligator sinensis IgL gene loci. The Alligator sinensis has two IgL isotypes, lambda and kappa, the same as Anolis carolinensis. The Ig(lambda) locus contains 6 C-lambda genes, each preceded by a J(lambda) gene, and 86 potentially functional V-lambda genes upstream of (J(lambda)-C-lambda)(n). The Ig kappa locus contains a single C-kappa gene, 6 J(kappa)s and 62 functional V(kappa)s. All V-L genes are classified into a total of 31 families: 19 V-lambda families and 12 V-kappa families. Based on an analysis of the chromosomal location of the light chain genes among mammals, birds, lizards and frogs, the data further confirm that there are two IgL isotypes in the Alligator sinensis: Ig lambda and Ig kappa. By analyzing the cloned Ig lambda/kappa cDNA, we identified a biased usage pattern of V families in the expressed V-lambda and V-kappa. An analysis of the junctions of the recombined VJ revealed the presence of N and P nucleotides in both expressed. and. sequences. Phylogenetic analysis of the V genes revealed V families shared by mammals, birds, reptiles and Xenopus, suggesting that these conserved V families are orthologous and have been retained during the evolution of IgL. Our data suggest that the Alligator sinensis IgL gene repertoire is highly diverse and complex and provide insight into immunoglobulin gene evolution in vertebrates.	[Wang, Xifeng; Cheng, Gang; Han, Haitang; Zhao, Yaofeng; Ren, Liming] China Agr Univ, Natl Engn Lab Anim Breeding, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Lug, Yan; Zhang, Chenglin] Beijing Zoo, Beijing 100044, Peoples R China; [Wu, Xiaobing] Anhui Normal Univ, Coll Life Sci, Anhui Prov Key Lab Conservat & Exploitat Biol Res, Wuhu 241000, Peoples R China	China Agricultural University; Anhui Normal University	Ren, LM (corresponding author), China Agr Univ, Natl Engn Lab Anim Breeding, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	renlm@cau.edu.cn	Zhang, Cheng/GRS-8698-2022		National Natural Science Foundation of China [31472085, 31272433]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (URL: http://www.nsfc.gov.cn/, grant number: 31472085 and 31272433). The author Yaofeng Zhao received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIRA S, 1987, SCIENCE, V238, P1134, DOI 10.1126/science.3120312; Almagro JC, 1998, IMMUNOGENETICS, V47, P355, DOI 10.1007/s002510050370; Bao YH, 2010, FISH SHELLFISH IMMUN, V28, P40, DOI 10.1016/j.fsi.2009.09.014; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bengten E, 2000, CURR TOP MICROBIOL, V248, P189; Butler JE, 2006, DEV COMP IMMUNOL, V30, P199, DOI 10.1016/j.dci.2005.06.025; Butler JE, 1997, SCAND J IMMUNOL, V45, P455, DOI 10.1046/j.1365-3083.1997.d01-423.x; Cheng G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2317; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; Criscitiello MF, 2007, EUR J IMMUNOL, V37, P2683, DOI 10.1002/eji.200737263; DAGGFELDT A, 1993, IMMUNOGENETICS, V38, P199; Darville LNF, 2010, COMP BIOCHEM PHYS D, V5, P308, DOI 10.1016/j.cbd.2010.09.001; Das S, 2008, P NATL ACAD SCI USA, V105, P16647, DOI 10.1073/pnas.0808800105; Das S, 2010, MOL BIOL EVOL, V27, P113, DOI 10.1093/molbev/msp212; Dooley H, 2006, DEV COMP IMMUNOL, V30, P43, DOI 10.1016/j.dci.2005.06.022; Edholm ES, 2011, DEV COMP IMMUNOL, V35, P906, DOI 10.1016/j.dci.2011.01.012; Edholm ES, 2009, IMMUNOGENETICS, V61, P353, DOI 10.1007/s00251-009-0365-z; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Deza FG, 2009, MOL IMMUNOL, V46, P1679, DOI 10.1016/j.molimm.2009.02.019; Gambon-Deza F, 2008, MOL IMMUNOL, V45, P3470, DOI 10.1016/j.molimm.2008.02.027; Gambon-Deza F, 2012, DEV COMP IMMUNOL, V38, P1, DOI 10.1016/j.dci.2012.03.001; Gerdes T, 2002, IMMUNOGENETICS, V54, P62, DOI 10.1007/s00251-002-0435-y; GHAFFARI SH, 1993, J IMMUNOL, V151, P6900; Ghaffari SH, 1997, J IMMUNOL, V159, P250; GREENBERG AS, 1995, NATURE, V374, P168, DOI 10.1038/374168a0; GU H, 1990, EMBO J, V9, P2133, DOI 10.1002/j.1460-2075.1990.tb07382.x; Haire RN, 1996, J IMMUNOL, V157, P1544; Haire RN, 2000, IMMUNOGENETICS, V51, P915, DOI 10.1007/s002510000229; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hikima JI, 2011, DEV COMP IMMUNOL, V35, P924, DOI 10.1016/j.dci.2010.10.011; Huang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034346; Janke A, 1997, MOL BIOL EVOL, V14, P1266, DOI 10.1093/oxfordjournals.molbev.a025736; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kawasaki K, 2001, EUR J IMMUNOL, V31, P1017, DOI 10.1002/1521-4141(200104)31:4<1017::AID-IMMU1017>3.3.CO;2-V; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lee SS, 2002, IMMUNITY, V16, P571, DOI 10.1016/S1074-7613(02)00300-X; Lee SS, 2000, J EXP MED, V191, P1637, DOI 10.1084/jem.191.10.1637; Lefranc Marie-Paule, 2005, Immunome Res, V1, P3, DOI 10.1186/1745-7580-1-3; Lefranc MP, 1998, EXP CLIN IMMUNOGENET, V15, P1, DOI 10.1159/000019049; Li LX, 2012, J IMMUNOL, V189, P3995, DOI 10.4049/jimmunol.1200188; Litman GF, 1999, ANNU REV IMMUNOL, V17, P109, DOI 10.1146/annurev.immunol.17.1.109; Lundqvist M, 1996, J IMMUNOL, V157, P2031; Magadan-Mompo S, 2013, IMMUNOGENETICS, V65, P531, DOI 10.1007/s00251-013-0692-y; Magadan-Mompo S, 2013, IMMUNOGENETICS, V65, P227, DOI 10.1007/s00251-012-0672-7; MAGOR KE, 1994, DEV COMP IMMUNOL, V18, P523, DOI 10.1016/S0145-305X(06)80006-6; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; MCCORMACK WT, 1990, GENE DEV, V4, P548, DOI 10.1101/gad.4.4.548; Merchant ME, 2006, VET IMMUNOL IMMUNOP, V110, P221, DOI 10.1016/j.vetimm.2005.10.001; Modesto SP, 2004, SYST BIOL, V53, P815, DOI 10.1080/10635150490503026; Olivieri DN, 2014, IMMUNOGENETICS, V66, P479, DOI 10.1007/s00251-014-0784-3; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Partula S, 1996, IMMUNOGENETICS, V45, P44, DOI 10.1007/s002510050165; PARVARI R, 1987, EMBO J, V6, P97, DOI 10.1002/j.1460-2075.1987.tb04724.x; Pilstrom L, 2002, DEV COMP IMMUNOL, V26, P207, DOI 10.1016/S0145-305X(01)00066-0; Qin T, 2008, DEV COMP IMMUNOL, V32, P156, DOI 10.1016/j.dci.2007.05.007; Retief J D, 2000, Methods Mol Biol, V132, P243; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SALUK PH, 1970, P SOC EXP BIOL MED, V133, P365; SANDERS BG, 1975, BIOCHEM GENET, V13, P779, DOI 10.1007/BF00484409; SCHWAGER J, 1991, EMBO J, V10, P505, DOI 10.1002/j.1460-2075.1991.tb07976.x; Shedlock AM, 2007, P NATL ACAD SCI USA, V104, P2767, DOI 10.1073/pnas.0606204104; Sun Y, 2011, DEV COMP IMMUNOL, V35, P975, DOI 10.1016/j.dci.2010.12.010; Wang T, 2012, J IMMUNOL, V189, P3557, DOI 10.4049/jimmunol.1200212; Wei ZG, 2009, J IMMUNOL, V183, P3858, DOI 10.4049/jimmunol.0803251; Wu Q, 2010, DEV COMP IMMUNOL, V34, P579, DOI 10.1016/j.dci.2009.12.019; Xu Z, 2009, MOL IMMUNOL, V46, P2124, DOI 10.1016/j.molimm.2009.03.028; ZEZZA DJ, 1992, J IMMUNOL, V149, P3968; ZEZZA DJ, 1991, J IMMUNOL, V146, P4041	68	4	4	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0147704	10.1371/journal.pone.0147704	http://dx.doi.org/10.1371/journal.pone.0147704			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901135	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100012
J	Williams, AM; Maman, Y; Alinikula, J; Schatz, DG				Williams, Alan M.; Maman, Yaakov; Alinikula, Jukka; Schatz, David G.			Bcl6 Is Required for Somatic Hypermutation and Gene Conversion in Chicken DT40 Cells	PLOS ONE			English	Article							RNA-POLYMERASE-II; CENTER B-CELLS; TRANSCRIPTION ELONGATION-FACTOR; LYMPHOCYTE DIFFERENTIATION; AID; DNA; EXPRESSION; MECHANISMS; REPRESSION; DEAMINASE	The activation induced cytosine deaminase (AID) mediates diversification of B cell immunoglobulin genes by the three distinct yet related processes of somatic hypermutation (SHM), class switch recombination (CSR), and gene conversion (GCV). SHM occurs in germinal center B cells, and the transcription factor Bcl6 is a key regulator of the germinal center B cell gene expression program, including expression of AID. To test the hypothesis that Bcl6 function is important for the process of SHM, we compared WT chicken DT40 B cells, which constitutively perform SHM/GCV, to their Bcl6-deficient counterparts. We found that Bcl6-deficient DT40 cells were unable to perform SHM and GCV despite enforced high level expression of AID and substantial levels of AID in the nucleus of the cells. To gain mechanistic insight into the GCV/SHM dependency on Bcl6, transcriptional features of a highly expressed SHM target gene were analyzed in Bcl6-sufficient and -deficient DT40 cells. No defect was observed in the accumulation of single stranded DNA in the target gene as a result of Bcl6 deficiency. In contrast, association of Spt5, an RNA polymerase II (Pol II) and AID binding factor, was strongly reduced at the target gene body relative to the transcription start site in Bcl6-deficient cells as compared to WT cells. However, partial reconstitution of Bcl6 function substantially reconstituted Spt5 association with the target gene body but did not restore detectable SHM. Our observations suggest that in the absence of Bcl6, Spt5 fails to associate efficiently with Pol II at SHM targets, perhaps precluding robust AID action on the SHM target DNA. Our data also suggest, however, that Spt5 binding is not sufficient for SHM of a target gene even in DT40 cells with strong expression of AID.	[Williams, Alan M.; Maman, Yaakov; Alinikula, Jukka; Schatz, David G.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Schatz, David G.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Alinikula, Jukka] Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland	Yale University; Howard Hughes Medical Institute; University of Turku	Schatz, DG (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA.; Schatz, DG (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD USA.	david.schatz@yale.edu	Alinikula, Jukka/AAD-1594-2020	Alinikula, Jukka/0000-0001-9926-6439; Schatz, David/0000-0002-5669-1176	Howard Hughes Medical Institute; National Science Foundation; National Institutes of Health [T32AI007019]; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007019] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding sources were Howard Hughes Medical Institute (http://www.hhmi.org/) (YM, JA, DGS), National Science Foundation (predoctoral fellowship to AMW) (http://www.nsf.gov/), and National Institutes of Health T32AI007019 (AMW) (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alinikula J, 2011, EUR J IMMUNOL, V41, P2404, DOI 10.1002/eji.201141553; Bachl J, 2001, J IMMUNOL, V166, P5051, DOI 10.4049/jimmunol.166.8.5051; Basso K, 2012, IMMUNOL REV, V247, P172, DOI 10.1111/j.1600-065X.2012.01112.x; Blagodatski A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000332; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Brookes E, 2012, CELL STEM CELL, V10, P157, DOI 10.1016/j.stem.2011.12.017; Buerstedde JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001831; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Cheng HL, 2009, P NATL ACAD SCI USA, V106, P2717, DOI 10.1073/pnas.0812304106; Cimmino L, 2008, J IMMUNOL, V181, P2338, DOI 10.4049/jimmunol.181.4.2338; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Di Noia JM, 2004, EUR J IMMUNOL, V34, P504, DOI 10.1002/eji.200324631; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0; Geisberger R, 2009, P NATL ACAD SCI USA, V106, P6736, DOI 10.1073/pnas.0810808106; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Kohler KM, 2012, J IMMUNOL, V189, P5314, DOI 10.4049/jimmunol.1202082; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Longerich S, 2005, J EXP MED, V202, P1443, DOI 10.1084/jem.20051604; Lozano G, 2015, CURR OPIN VIROL, V12, P113, DOI 10.1016/j.coviro.2015.04.008; Maul RW, 2014, J EXP MED, V211, P2297, DOI 10.1084/jem.20131512; McDonald JJ, 2013, J IMMUNOL, V191, P1556, DOI 10.4049/jimmunol.1300969; Methot SP, 2015, J EXP MED, V212, P581, DOI 10.1084/jem.20141157; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Nera KP, 2006, IMMUNITY, V24, P283, DOI 10.1016/j.immuni.2006.02.003; Patenaude AM, 2009, NAT STRUCT MOL BIOL, V16, P517, DOI 10.1038/nsmb.1598; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Phan RT, 2007, NAT IMMUNOL, V8, P1132, DOI 10.1038/ni1508; Ranuncolo SM, 2007, NAT IMMUNOL, V8, P705, DOI 10.1038/ni1478; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; Ronai D, 2007, J EXP MED, V204, P181, DOI 10.1084/jem.20062032; Saribasak H, 2006, J IMMUNOL, V176, P365, DOI 10.4049/jimmunol.176.1.365; Selth LA, 2010, ANNU REV BIOCHEM, V79, P271, DOI 10.1146/annurev.biochem.78.062807.091425; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; Vasanwala FH, 2002, J IMMUNOL, V169, P1922, DOI 10.4049/jimmunol.169.4.1922; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Yamaguchi Y, 1999, J BIOL CHEM, V274, P8085, DOI 10.1074/jbc.274.12.8085; Yang SY, 2006, J EXP MED, V203, P2919, DOI 10.1084/jem.20061835; Yeap LS, 2015, CELL, V163, P1124, DOI 10.1016/j.cell.2015.10.042; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	48	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149146	10.1371/journal.pone.0149146	http://dx.doi.org/10.1371/journal.pone.0149146			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900682	Green Published, gold			2022-12-27	WOS:000371276100041
J	Xiao, FZ; Peng, GW; Nie, CM; Yu, LM				Xiao, Fangzhu; Peng, Guowen; Nie, Changming; Yu, Limei			Predicting Thermodynamic Properties of PBXTHs with New Quantum Topological Indexes	PLOS ONE			English	Article							QUANTITATIVE STRUCTURE; MOLECULAR DESCRIPTORS; INHIBITORS; QSPR; QSAR	Novel group quantitative structure-property relationship (QSPR) models on the thermodynamic properties of PBXTHs were presented, by the multiple linear regression (MLR) analysis method. Four thermodynamic properties were studied: the entropy (S-theta), the standard enthalpy of formation (Delta H-f(theta)), the standard Gibbs energy of formation (Delta(f)G(theta)), and the relative standard Gibbs energy of formation (Delta(R)G(theta)). The results by the formula indicate that the calculated and predicted data in this study are in good agreement with those in literature and the deviation is within the experimental errors. To validate the estimation reliability for internal samples and the predictive ability for other samples, leave-one-out (LOO) cross validation (CV) and external validation were performed, and the results show that the models are satisfactory.	[Xiao, Fangzhu] Univ South China, Sch Publ Hlth, Hengyang 421001, Peoples R China; [Peng, Guowen; Nie, Changming; Yu, Limei] Univ South China, Sch Chem & Chem Engn, Hengyang 421001, Peoples R China	University of South China; University of South China	Peng, GW (corresponding author), Univ South China, Sch Chem & Chem Engn, Hengyang 421001, Peoples R China.	pgwnh@sohu.com	NIE, Changming/X-5351-2019; Nie, Changming/ABB-8899-2021	NIE, Changming/0000-0003-2744-8924; 	National Natural Science Foundation of China [51574152, 11205084]; Foundation of Hunan Province Science and Technology Department [2014GK3079]; social development and science & technology support of Hengyang city [2014KS26]; Hunan Provincial Key Laboratory of Materials Protection for Electric Power and Transportation, Changsha University of Science & Technology, P. R. China [2016CL03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Hunan Province Science and Technology Department; social development and science & technology support of Hengyang city; Hunan Provincial Key Laboratory of Materials Protection for Electric Power and Transportation, Changsha University of Science & Technology, P. R. China	This paper was financially supported by the National Natural Science Foundation of China (No. 51574152,11205084), the Foundation of Hunan Province Science and Technology Department (2014GK3079), the social development and science & technology support of Hengyang city (No. 2014KS26), and the Hunan Provincial Key Laboratory of Materials Protection for Electric Power and Transportation (No. 2016CL03), Changsha University of Science & Technology, P. R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal VK, 2003, BIOORGAN MED CHEM, V11, P5519, DOI 10.1016/j.bmc.2003.09.025; Bajaj S, 2006, QSAR COMB SCI, V25, P813, DOI 10.1002/qsar.200430918; Dai YM, 2012, J CENT SOUTH UNIV, V19, P93, DOI 10.1007/s11771-012-0977-6; Dai YM, 2011, J CENT S U, V18, P324; Duchowicz P R, 2005, CHEM PHYS LETT, V412, P377; Gharagheizi F, 2012, CHEM ENG SCI, V76, P99, DOI 10.1016/j.ces.2012.03.033; Hu L H, 2002, J SYN CHEM, V4, P285; Kiralj R, 2003, J MOL GRAPH MODEL, V21, P435, DOI 10.1016/S1093-3263(02)00201-2; Liu FP, 2011, INT J MOL SCI, V12, P2448, DOI 10.3390/ijms12042448; Lu CH, 2006, CHEM PHYS LETT, V417, P11, DOI 10.1016/j.cplett.2005.09.051; Lucic B, 1999, J CHEM INF COMP SCI, V39, P610, DOI 10.1021/ci980161a; Netzeva TI, 2005, CHEMOSPHERE, V61, P1632, DOI 10.1016/j.chemosphere.2005.04.040; Nie C.M., 2000, J WUHAN U NAT SCI ED, V46, P176; Nie CM, 2006, CHINESE J ANAL CHEM, V34, P1560; Nie CM, 2009, J THEOR COMPUT CHEM, V8, P19, DOI 10.1142/S0219633609004447; [彭国文 Peng Guowen], 2011, [化工学报, Journal of Chemical Industry and Engineering (China)], V62, P604; [彭国文 Peng Guowen], 2010, [化学研究与应用, Chemical Research and Application], V22, P1498; Peng GW, 2011, ACTA CHIM SINICA, V69, P305; Rose K, 2002, J CHEM INF COMP SCI, V42, P651, DOI 10.1021/ci010127n; Shang G, 2010, J STRUCT CHEM, V29, P227; Xiao FZ, 2014, J MOL STRUCT, V1074, P679, DOI 10.1016/j.molstruc.2014.04.072; [肖方竹 XIAO Fangzhu], 2011, [化工学报, Journal of Chemical Industry and Engineering (China)], V62, P1808; Yang F, 2003, J CHEM INF COMP SCI, V43, P753, DOI 10.1021/ci025663+; Yang Y. B., 1995, Acta Pharmaceutica Sinica, V30, P440; Zhou CY, 2007, J COMPUT CHEM, V28, P2413, DOI 10.1002/jcc.20540; Zhou CY, 2007, B CHEM SOC JPN, V80, P1504, DOI 10.1246/bcsj.80.1504	26	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0147126	10.1371/journal.pone.0147126	http://dx.doi.org/10.1371/journal.pone.0147126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900689	Green Submitted, Green Published, gold			2022-12-27	WOS:000371276100008
J	Mustafa, M; Mushtaq, A; Hayat, T; Alsaedi, A				Mustafa, M.; Mushtaq, A.; Hayat, T.; Alsaedi, A.			Rotating Flow of Magnetite-Water Nanofluid over a Stretching Surface Inspired by Non-Linear Thermal Radiation	PLOS ONE			English	Article							CONVECTIVE HEAT-TRANSFER; BOUNDARY-LAYER-FLOW; FORCED-CONVECTION; TRANSFER ENHANCEMENT; NATURAL-CONVECTION; MHD; FLUID; FIELD; SIMULATION; FERROFLUID	Present study explores the MHD three-dimensional rotating flow and heat transfer of ferrofluid induced by a radiative surface. The base fluid is considered as water with magnetite-Fe3O4 nanoparticles. Novel concept of non-linear radiative heat flux is considered which produces a non-linear energy equation in temperature field. Conventional transformations are employed to obtain the self-similar form of the governing differential system. The arising system involves an interesting temperature ratio parameter which is an indicator of small/large temperature differences in the flow. Numerical simulations with high precision are determined by well-known shooting approach. Both uniform stretching and rotation have significant impact on the solutions. The variation in velocity components with the nanoparticle volume fraction is non-monotonic. Local Nusselt number in Fe3O4-water ferrofluid is larger in comparison to the pure fluid even at low particle concentration.	[Mustafa, M.] Natl Univ Sci & Technol, Sch Nat Sci, Islamabad 44000, Pakistan; [Mushtaq, A.] Natl Univ Sci & Technol, RCMS, Islamabad 44000, Pakistan; [Hayat, T.] Quaid I Azam Univ, Dept Math, Islamabad 44000, Pakistan; [Hayat, T.; Alsaedi, A.] King Abdulaziz Univ, Fac Sci, Dept Math, Nonlinear Anal & Appl Math NAAM Res Grp, Jeddah 21589, Saudi Arabia	National University of Sciences & Technology - Pakistan; National University of Sciences & Technology - Pakistan; Quaid I Azam University; King Abdulaziz University	Mustafa, M (corresponding author), Natl Univ Sci & Technol, Sch Nat Sci, Islamabad 44000, Pakistan.	meraj_mm@hotmail.com	Mustafa Hashmi, Meraj/P-1769-2014; Mushtaq, Ammar/O-3326-2013; Alsaedi, Ahmed/A-2094-2013; Hayat, Tasawar/Y-2524-2019	Mushtaq, Ammar/0000-0001-9548-4631; Alsaedi, Ahmed/0000-0003-3452-8922; 				Azizian R, 2014, INT J HEAT MASS TRAN, V68, P94, DOI 10.1016/j.ijheatmasstransfer.2013.09.011; Bahiraei M, 2015, J MOL LIQ, V209, P531, DOI 10.1016/j.molliq.2015.06.030; Bahiraei M, 2015, J MAGN MAGN MATER, V374, P125, DOI 10.1016/j.jmmm.2014.08.004; Bahiraei M, 2014, J SUPERCOND NOV MAGN, V27, P527, DOI 10.1007/s10948-013-2299-9; Bahiraei M, 2013, ENERG CONVERS MANAGE, V76, P1125, DOI 10.1016/j.enconman.2013.09.008; BRINKMAN HC, 1952, J CHEM PHYS, V20, P571, DOI 10.1063/1.1700493; Choi SUS., 1995, ASME PUBLICATIONS FE, P99; Cortell R, 2014, ENERGY, V74, P896, DOI 10.1016/j.energy.2014.07.069; Ellahi R, 2013, APPL MATH MODEL, V37, P1451, DOI 10.1016/j.apm.2012.04.004; Hayat T, 2008, PHYS LETT A, V372, P3264, DOI 10.1016/j.physleta.2008.01.069; Jue TC, 2006, INT COMMUN HEAT MASS, V33, P846, DOI 10.1016/j.icheatmasstransfer.2006.02.001; Khan JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116603; Khanafer K, 2003, INT J HEAT MASS TRAN, V46, P3639, DOI 10.1016/S0017-9310(03)00156-X; Kuznetsov AV, 2014, INT J THERM SCI, V77, P126, DOI 10.1016/j.ijthermalsci.2013.10.007; Malvandi A, 2014, J MAGN MAGN MATER, V362, P172, DOI 10.1016/j.jmmm.2014.03.014; Maxwell J.C., 1904, NATURE; Moraveji MK, 2013, INT COMMUN HEAT MASS, V44, P135, DOI 10.1016/j.icheatmasstransfer.2013.03.011; Mushtaq A, 2014, Z NATURFORSCH A, V69, P705, DOI 10.5560/ZNA.2014-0059; Mushtaq A, 2014, J AEROSPACE ENG, V27, DOI 10.1061/(ASCE)AS.1943-5525.0000361; Mushtaq A, 2014, J TAIWAN INST CHEM E, V45, P1176, DOI 10.1016/j.jtice.2013.11.008; Mustafa M, 2015, J MOL LIQ, V211, P119, DOI 10.1016/j.molliq.2015.06.065; Mustafa M, 2015, AIP ADV, V5, DOI 10.1063/1.4927449; Mustafa M, 2015, AIP ADV, V5, DOI 10.1063/1.4917306; Mustafa M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103946; Nanjundappa CE, 2010, INT COMMUN HEAT MASS, V37, P1246, DOI 10.1016/j.icheatmasstransfer.2010.08.011; Nazar R, 2004, MECH RES COMMUN, V31, P121, DOI 10.1016/j.mechrescom.2003.09.004; Nield DA, 2014, INT J HEAT MASS TRAN, V70, P430, DOI 10.1016/j.ijheatmasstransfer.2013.11.016; Pantokratoras A, 2014, MECCANICA, V49, P1539, DOI 10.1007/s11012-014-9911-3; Rahman MM, 2013, MECCANICA, V48, P601, DOI 10.1007/s11012-012-9618-2; RAJESWARI V, 1992, INT J ENG SCI, V30, P747, DOI 10.1016/0020-7225(92)90104-O; Rashidi MM, 2014, MECCANICA, V49, P469, DOI 10.1007/s11012-013-9805-9; Rashidi MM, 2013, INT J HEAT MASS TRAN, V62, P515, DOI 10.1016/j.ijheatmasstransfer.2013.03.004; Rosensweig RE, 2002, J MAGN MAGN MATER, V252, P370, DOI 10.1016/S0304-8853(02)00706-0; Selimefendigil F, 2014, INT J HEAT MASS TRAN, V71, P142, DOI 10.1016/j.ijheatmasstransfer.2013.12.042; Sheikholeslami M, 2015, J MOL LIQ, V212, P117, DOI 10.1016/j.molliq.2015.07.077; Sheikholeslami M, 2015, COMPUT METHOD APPL M, V294, P299, DOI 10.1016/j.cma.2015.06.010; Sheikholeslami M, 2015, INT J HEAT MASS TRAN, V89, P799, DOI 10.1016/j.ijheatmasstransfer.2015.05.110; Sheikholeslami M, 2014, J MOL LIQ, V190, P112, DOI 10.1016/j.molliq.2013.11.002; Sheikholeslami M, 2014, NEURAL COMPUT APPL, V25, P171, DOI 10.1007/s00521-013-1459-y; Sheikholeslami M, 2016, INT J HEAT MASS TRAN, V92, P339, DOI 10.1016/j.ijheatmasstransfer.2015.08.066; Sheikholeslami M, 2014, ENERGY, V75, P400, DOI 10.1016/j.energy.2014.07.089; Sheikholeslami M, 2014, J MAGN MAGN MATER, V369, P69, DOI 10.1016/j.jmmm.2014.06.017; Tangthieng C, 1999, J MAGN MAGN MATER, V201, P252, DOI 10.1016/S0304-8853(99)00062-1; Tiwari RK, 2007, INT J HEAT MASS TRAN, V50, P2002, DOI 10.1016/j.ijheatmasstransfer.2006.09.034; Turkyilmazoglu M, 2014, COMPUT FLUIDS, V94, P139, DOI 10.1016/j.compfluid.2014.02.009; WANG CY, 1988, Z ANGEW MATH PHYS, V39, P177, DOI 10.1007/BF00945764; Zaimi K, 2013, APPL MATH MECH-ENGL, V34, P945, DOI 10.1007/s10483-013-1719-9; Zhang XD, 2014, INT COMMUN HEAT MASS, V51, P31, DOI 10.1016/j.icheatmasstransfer.2014.01.011	48	45	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149304	10.1371/journal.pone.0149304	http://dx.doi.org/10.1371/journal.pone.0149304			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894690	Green Published, Green Submitted, gold			2022-12-27	WOS:000371223400045
J	Prabhu, PAJ; Geurden, I; Fontagne-Dicharry, S; Veron, V; Larroquet, L; Mariojouls, C; Schrama, JW; Kaushik, SJ				Prabhu, P. Antony Jesu; Geurden, Inge; Fontagne-Dicharry, Stephanie; Veron, Vincent; Larroquet, Laurence; Mariojouls, Catherine; Schrama, Johan W.; Kaushik, Sadasivam J.			Responses in Micro-Mineral Metabolism in Rainbow Trout to Change in Dietary Ingredient Composition and Inclusion of a Micro-Mineral Premix	PLOS ONE			English	Article							SALMON SALMO-SALAR; FISH-MEAL; ONCORHYNCHUS-MYKISS; IRON HOMEOSTASIS; WHOLE-BODY; SEA BREAM; EXPRESSION; MANGANESE; HEPCIDIN; COPPER	Responses in micro-mineral metabolism to changes in dietary ingredient composition and inclusion of a micro-mineral premix (Fe, Cu, Mn, Zn and Se) were studied in rainbow trout. In a 2 x 2 factorial design, triplicate groups of rainbow trout (initial weight: 20g) were fed over 12 weeks at 17 degrees C a fishmeal-based diet (M) or a plant-ingredient based diet (V), with or without inclusion of a mineral premix. Trout fed the V vs. M diet had lower feed intake, growth, hepato-somatic index, apparent availability coefficient (AAC) of Fe, Cu, Mn and Zn and also lower whole body Se and Zn concentration, whereas whole body Fe and Cu and plasma Fe concentrations were higher. Feeding the V diet increased intestinal ferric reductase activity; at transcriptional level, hepatic hepcidin expression was down-regulated and ferroportin 1 was up-regulated. Transcription of intestinal Cu-transporting ATPases and hepatic copper transporter1 were higher in V0 compared to other groups. Among the hepatic metaloenzyme activities assayed, only Se-dependent glutathione peroxidase was affected, being lower in V fed fish. Premix inclusion reduced the AAC of Fe, Cu and Zn; increased the whole body concentration of all micro-minerals; up-regulated hepatic hepcidin and downregulated intestinal ferroportin 1 transcription; and reduced the transcription of Cu-transporting ATPases in the intestine. Overall, the regulation of micro-mineral metabolism in rainbow trout, especially Fe and Cu, was affected both by a change in ingredient composition and micro-mineral premix inclusion.	[Prabhu, P. Antony Jesu; Geurden, Inge; Fontagne-Dicharry, Stephanie; Veron, Vincent; Larroquet, Laurence; Kaushik, Sadasivam J.] INRA, UR1067, Nutr Metab & Aquaculture NuMeA, Aquapole INRA, F-64310 St Pee Sur Nivelle, France; [Prabhu, P. Antony Jesu; Mariojouls, Catherine] AgroParisTech, Paris Inst Technol Life Food & Environm Sci, 16 Rue Claude Bernard, F-75231 Paris 5, France; [Prabhu, P. Antony Jesu; Schrama, Johan W.] Wageningen Univ, Aquaculture & Fisheries Grp, WIAS, POB 338, NL-6700 AH Wageningen, Netherlands; [Prabhu, P. Antony Jesu] Tamil Nadu Fisheries Univ, Coll Fisheries, Dept Aquaculture, Ponneri 601204, Tamil Nadu, India; [Prabhu, P. Antony Jesu] Tamil Nadu Fisheries Univ, Res Inst, Ponneri 601204, Tamil Nadu, India	INRAE; Universite de Pau et des Pays de l'Adour; AgroParisTech; Wageningen University & Research	Geurden, I (corresponding author), INRA, UR1067, Nutr Metab & Aquaculture NuMeA, Aquapole INRA, F-64310 St Pee Sur Nivelle, France.	inge.geurden@st-pee.inra.fr	Fontagné-Dicharry, Stéphanie/A-5485-2013; Prabhu, Antony Jesu/H-7571-2019	Fontagné-Dicharry, Stéphanie/0000-0002-4366-4590; Prabhu, Antony Jesu/0000-0002-2839-0704; Schrama, Johan/0000-0001-7156-8806	INRA, under the INRA-WUR aquaculture platform; EU [288925, 262336]	INRA, under the INRA-WUR aquaculture platform; EU(European Commission)	This work was part of a PhD thesis funded by INRA, under the INRA-WUR aquaculture platform. This work received funds from the EU seventh Framework Programmes ARRAINA (Advanced Research Initiatives for Nutrition & Aquaculture, FP7/2007-2013; grant agreement no 288925) and AQUAEXCEL (Aquaculture Infrastructures for Excellence in European Fish Research, FP7/2007-2012; grant agreement no 262336). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez CA, 2013, DEV COMP IMMUNOL, V41, P77, DOI 10.1016/j.dci.2013.04.002; Andrews NC, 2000, NAT REV GENET, V1, P208, DOI 10.1038/35042073; Bakke AM, 2011, FISH PHYSIOL, V30, P57, DOI 10.1016/S1546-5098(10)03002-5; Boyle D, 2009, COMP BIOCHEM PHYS A, V153A, pS78, DOI 10.1016/j.cbpa.2009.04.050; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buddington Randal K., 2000, P379, DOI 10.1016/B978-012529650-2/50029-9; Bury N, 2003, COMP BIOCHEM PHYS C, V135, P97, DOI 10.1016/S1532-0456(03)00021-8; Bury NR, 2003, J EXP BIOL, V206, P11, DOI 10.1242/jeb.00068; Bury NR, 2001, J EXP BIOL, V204, P3779; Carriquiriborde P, 2004, J EXP BIOL, V207, P75, DOI 10.1242/jeb.00712; Cooper CA, 2006, COMP BIOCHEM PHYS A, V143, P292, DOI 10.1016/j.cbpa.2005.11.024; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Dorschner MO, 1999, DNA CELL BIOL, V18, P573, DOI 10.1089/104454999315123; Douglas SE, 2003, DEV COMP IMMUNOL, V27, P589, DOI 10.1016/S0145-305X(03)00036-3; Fontagne S, 2008, BRIT J NUTR, V100, P102, DOI 10.1017/S0007114507876215; Fraenkel PG, 2005, J CLIN INVEST, V115, P1532, DOI 10.1172/JCI23780; Francis G, 2001, AQUACULTURE, V199, P197, DOI 10.1016/S0044-8486(01)00526-9; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Hambidge M, 2003, J NUTR, V133, p948S, DOI 10.1093/jn/133.3.948S; Hunt JR, 2003, AM J CLIN NUTR, V78, p633S, DOI 10.1093/ajcn/78.3.633S; Julshamn K., 1978, Fiskeridirektoratets Skrifter Serie Ernaering, V1, P117; Kaushik S, 2002, NUTR FEEDING FISH CR, P169; KNOX D, 1981, BRIT J NUTR, V46, P495, DOI 10.1079/BJN19810058; Kortner TM, 2013, BRIT J NUTR, V109, P593, DOI 10.1017/S0007114512002024; Kucukbay Z, 2006, AQUACULTURE, V257, P465, DOI 10.1016/j.aquaculture.2006.03.005; Kwong RWM, 2013, FISH PHYSIOL BIOCHEM, V39, P363, DOI 10.1007/s10695-012-9705-2; Kwong RWM, 2009, COMP BIOCHEM PHYS C, V150, P442, DOI 10.1016/j.cbpc.2009.06.011; Lall Santosh P., 2002, P259; Lin YH, 2008, AQUACULTURE, V284, P207, DOI 10.1016/j.aquaculture.2008.07.049; Lorentzen M, 1999, AQUACULT NUTR, V5, P163; Lutsenko S, 2010, CURR OPIN CHEM BIOL, V14, P211, DOI 10.1016/j.cbpa.2010.01.003; MAAGE A, 1993, AQUACULTURE, V117, P179, DOI 10.1016/0044-8486(93)90134-K; Mackenzie NC, 2004, GENE, V328, P113, DOI 10.1016/j.gene.2003.11.019; Mazoch J, 2004, EUR J BIOCHEM, V271, P553, DOI 10.1046/j.1432-1033.2003.03957.x; Minghetti M, 2008, COMP BIOCHEM PHYS C, V147, P450, DOI 10.1016/j.cbpc.2008.01.014; Minghetti M, 2010, AQUAT TOXICOL, V97, P23, DOI 10.1016/j.aquatox.2009.11.017; Nadella SR, 2011, J COMP PHYSIOL B, V181, P27, DOI 10.1007/s00360-010-0510-x; NRC, 1993, NUT REQ FISH; NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP; OGINO C, 1975, B JPN SOC SCI FISH, V41, P429; Pacitti D, 2013, AQUAT TOXICOL, V130, P97, DOI 10.1016/j.aquatox.2012.12.020; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Prabhu PAJ, 2015, FISH PHYSIOL BIOCHEM, V41, P243, DOI 10.1007/s10695-014-0020-y; Prabhu PAJ, 2014, AQUACULTURE, V430, P34, DOI 10.1016/j.aquaculture.2014.03.038; Rodrigues PNS, 2006, DEV COMP IMMUNOL, V30, P1156, DOI 10.1016/j.dci.2006.02.005; Santos EM, 2010, ENVIRON SCI TECHNOL, V44, P820, DOI 10.1021/es902558k; SATOH S, 1991, NIPPON SUISAN GAKK, V57, P99; Standal H, 1999, AQUACULT NUTR, V5, P193; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Tan XY, 2012, AQUACULTURE, V326, P68, DOI 10.1016/j.aquaculture.2011.11.013; Watanabe T, 1997, AQUACULTURE, V151, P185, DOI 10.1016/S0044-8486(96)01503-7; Wyman S, 2008, FEBS LETT, V582, P1901, DOI 10.1016/j.febslet.2008.05.010; Yeh KY, 2004, AM J PHYSIOL-GASTR L, V286, pG385, DOI 10.1152/ajpgi.00246.2003; Zhang ZQ, 2012, J ANIM VET ADV, V11, P2347, DOI 10.3923/javaa.2012.2347.2351	55	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149378	10.1371/journal.pone.0149378	http://dx.doi.org/10.1371/journal.pone.0149378			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895186	Green Published, Green Submitted, gold			2022-12-27	WOS:000371223400049
J	Brant, CO; Huertas, M; Li, K; Li, WM				Brant, Cory O.; Huertas, Mar; Li, Ke; Li, Weiming			Mixtures of Two Bile Alcohol Sulfates Function as a Proximity Pheromone in Sea Lamprey	PLOS ONE			English	Article							PETROMYZON-MARINUS; OLFACTORY SENSITIVITY; LEPIDOPTERA; IDENTIFICATION; SPECIFICITY; MOTHS; DSC	Unique mixtures of pheromone components are commonly identified in insects, and have been shown to increase attractiveness towards conspecifics when reconstructed at the natural ratio released by the signaler. In previous field studies of pheromones that attract female sea lamprey (Petromyzon marinus, L.), putative components of the male-released mating pheromone included the newly described bile alcohol 3,12-diketo-4,6-petromyzonene-24-sulfate (DkPES) and the well characterized 3-keto petromyzonol sulfate (3kPZS). Here, we show chemical evidence that unequivocally confirms the elucidated structure of DkPES, electrophysiological evidence that each component is independently detected by the olfactory epithelium, and behavioral evidence that mature female sea lamprey prefer artificial nests activated with a mixture that reconstructs the male-released component ratio of 30:1 (3kPZS:DkPES, molar:molar). In addition, we characterize search behavior (sinuosity of swim paths) of females approaching ratio treatment sources. These results suggest unique pheromone ratios may underlie reproductive isolating mechanisms in vertebrates, as well as provide utility in pheromone-integrated control of invasive sea lamprey in the Great Lakes.	[Brant, Cory O.; Huertas, Mar; Li, Ke; Li, Weiming] Michigan State Univ, Dept Fisheries & Wildlife, Room 13 Nat Resources Bldg,480 Wilson Rd, E Lansing, MI 48824 USA	Michigan State University	Li, WM (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, Room 13 Nat Resources Bldg,480 Wilson Rd, E Lansing, MI 48824 USA.	liweim@msu.edu	Huertas, Mar/K-9357-2019; Huertas, Mar/B-2898-2008; Li, Ke/I-3804-2013	Huertas, Mar/0000-0002-8042-086X; Huertas, Mar/0000-0002-8042-086X; Li, Ke/0000-0003-4869-5393	Great Lakes Fishery Commission, Ann Arbor, MI, USA	Great Lakes Fishery Commission, Ann Arbor, MI, USA	This work was funded by the Great Lakes Fishery Commission, Ann Arbor, MI, USA.	Applegate VC, 1950, NATURAL HIST SEA LAM; Bjerselius R, 2000, CAN J FISH AQUAT SCI, V57, P557, DOI 10.1139/cjfas-57-3-557; Buchinger TJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1966; CARDE RT, 1977, J CHEM ECOL, V3, P71, DOI 10.1007/BF00988135; Coracini MDA, 2001, J ECON ENTOMOL, V94, P911, DOI 10.1603/0022-0493-94.4.911; DeBose JL, 2008, J CHEM ECOL, V34, P867, DOI 10.1007/s10886-008-9493-4; GIRON D, 1995, J THERM ANAL, V44, P217, DOI 10.1007/BF02547150; HARA TJ, 1992, FISH CHEMORECEPTION, P150; Huertas M, 2007, J FISH BIOL, V70, P1907, DOI 10.1111/j.1095-8649.2007.01467.x; Johnson NS, 2015, FISH FISH SER, V37, P265, DOI 10.1007/978-94-017-9306-3_6; Johnson NS, 2012, BEHAV ECOL SOCIOBIOL, V66, P1557, DOI 10.1007/s00265-012-1409-1; Johnson NS, 2009, P NATL ACAD SCI USA, V106, P1021, DOI 10.1073/pnas.0808530106; Kang JS, 1997, J NEUROPHYSIOL, V77, P1; KARLSON P, 1959, ANNU REV ENTOMOL, V4, P39, DOI 10.1146/annurev.en.04.010159.000351; Keller-Costa T, 2014, J EXP BIOL, V217, P4203, DOI 10.1242/jeb.111518; Li K, 2015, ORG LETT, V17, P286, DOI 10.1021/ol5033893; Li K, 2012, STEROIDS, V77, P806, DOI 10.1016/j.steroids.2012.03.006; Li KR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068157, 10.1371/journal.pone.0084171, 10.1371/journal.pone.0058057, 10.1371/journal.pone.0067018, 10.1371/journal.pone.0063139]; LI WM, 1995, J GEN PHYSIOL, V105, P569, DOI 10.1085/jgp.105.5.569; Li WM, 2002, SCIENCE, V296, P138, DOI 10.1126/science.1067797; LINN CE, 1989, CHEM SENSES, V14, P421, DOI 10.1093/chemse/14.3.421; Lipschitz DL, 1999, J NEUROPHYSIOL, V82, P3160, DOI 10.1152/jn.1999.82.6.3160; MANION PJ, 1980, CAN J FISH AQUAT SCI, V37, P1635, DOI 10.1139/f80-211; Reyes-Garcia L, 2014, CIENC INVESTIG AGRAR, V41, P187, DOI 10.4067/S0718-16202014000200005; Siefkes MJ, 2005, ANIM BEHAV, V70, P1037, DOI 10.1016/j.anbehav.2005.01.024; Siefkes MJ, 2003, BIOL REPROD, V69, P125, DOI 10.1095/biolreprod.102.014472; Sorensen PW, 2005, NAT CHEM BIOL, V1, P324, DOI 10.1038/nchembio739; Steiger S, 2011, P ROY SOC B-BIOL SCI, V278, P970, DOI 10.1098/rspb.2010.2285; TEETER J, 1980, CAN J FISH AQUAT SCI, V37, P2123, DOI 10.1139/f80-254; VANDOOREN AA, 1984, INT J PHARM, V20, P217, DOI 10.1016/0378-5173(84)90170-4; Wagner CM, 2009, ANIM BEHAV, V78, P593, DOI 10.1016/j.anbehav.2009.04.027; Wyatt TD, 2010, J COMP PHYSIOL A, V196, P685, DOI 10.1007/s00359-010-0564-y	32	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149508	10.1371/journal.pone.0149508	http://dx.doi.org/10.1371/journal.pone.0149508			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885832	Green Submitted, Green Published, gold			2022-12-27	WOS:000371218400093
J	Giupponi, APD; de Miranda, GS				de Leao Giupponi, Alessandro Ponce; de Miranda, Gustavo Silva			Eight New Species of Charinus Simon, 1892 (Arachnida: Amblypygi: Charinidae) Endemic for the Brazilian Amazon, with Notes on Their Conservational Status	PLOS ONE			English	Article							HYDROELECTRIC DEVELOPMENT; WHIP SPIDERS; SARAX SIMON; XINGU RIVER; GENUS SARAX; BELO-MONTE; DEFORESTATION; IMPACTS; CHELICERATA; HIGHWAY	Eight new species of Charinus Simon, 1892 are described for the Brazilian Amazon, from the states of Para (C. bichuetteae sp. n., C. bonaldoi sp. n., C. carajas sp. n., C. ferreus sp. n., C. guto sp. n. and C. orientalis sp. n.) and Amazonas (Charinus brescoviti sp. n. and C. ricardoi sp. n.). All new species can be differentiated from the other species of the genus by the number of pseudo-articles in basitibia IV, the presence/absence of median eyes, and the shape of the female gonopod. Brazil now becomes the country with the largest diversity of Amblypygi in the world, with 25 known species. Half of the new species described here have a high degree of endangerment: C. bichuetteae sp. n. is threatened by the flood caused by the hydroelectric dam of Belo Monte, and C. carajas sp. n., C. ferreus sp. n. and C. orientalis sp. n. are endangered by the iron mining in Carajas municipality and surroundings. The Charinus species here described are endemic to the Amazon Region, so in order to assure their preservation, it is strongly recommended a special care with their habitats (type localities) which are facing increasing rates of destruction and deforestation.	[de Leao Giupponi, Alessandro Ponce; de Miranda, Gustavo Silva] Univ Fed Rio de Janeiro, Museu Nacl, Lab Aracnol, Programa Posgrad Zool,Dept Invertebrados, Rio De Janeiro, RJ, Brazil; [de Leao Giupponi, Alessandro Ponce] Fiocruz MS, IOC, CAVAISC, Lab Referencia Nacl Vetores Riquetsioses,LIRN, BR-21045900 Rio De Janeiro, RJ, Brazil; [de Miranda, Gustavo Silva] Univ Copenhagen, Zool Museum, Nat Hist Museum Denmark, Ctr Macroecol Evolut & Climate, DK-2100 Copenhagen, Denmark	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; University of Copenhagen	Giupponi, APD (corresponding author), Univ Fed Rio de Janeiro, Museu Nacl, Lab Aracnol, Programa Posgrad Zool,Dept Invertebrados, Rio De Janeiro, RJ, Brazil.; Giupponi, APD (corresponding author), Fiocruz MS, IOC, CAVAISC, Lab Referencia Nacl Vetores Riquetsioses,LIRN, BR-21045900 Rio De Janeiro, RJ, Brazil.	agiupponi@gmail.com	Giupponi, Alessandro PL/M-5692-2013; de Miranda, Gustavo Silva/C-1252-2013	de Miranda, Gustavo Silva/0000-0002-2895-9331	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [8922-13-6]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was financially supported by a grant from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (www.capes.gov.br/) to GSM (process number 8922-13-6 CAPES/Science Without Borders). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli A, 2011, TAXON, V60, P403, DOI 10.1002/tax.602010; Armas L. F., 2010, B SOC ENTOMOLOGICA A, V47, P55; Armas L.F., 2012, REV IBERICA ARACNOLO, V21, P27; Baptista R.L.C., 2003, Revista Iberica de Aracnologia, V7, P79; Baptista Renner Luiz Cerqueira, 2002, Revista Iberica de Aracnologia, V6, P105; Barni PE, 2015, ENVIRON MANAGE, V55, P259, DOI 10.1007/s00267-014-0408-6; Bates J.M., 2001, DIVERSIDADE BIOL CUL, P119; Benchimol M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129818; Bingham Alexa, 2010, POLIS J, V4, P1; Chirivi Joya Daniel, 2012, Boletin de la SEA, V50, P395; Crisp MD, 2009, NATURE, P458; Cunha DD, 2012, BRAZ J BOT, V35, P159, DOI 10.1590/S1806-99592012000200005; De Marques AAB, 2015, ORYX, V49, P25, DOI 10.1017/S0030605314000726; De Miranda GS, 2011, ZOOTAXA, P61; Drumond MA, 2002, SEM BIOD CAAT; Dunn RA, 1949, MEM NATL MUS VICTORI, V16; Dunn RA, 1949, MEM NATL MUS VICTORI, V16; Engenharia L., 2009, APROVEITAMENTO HIDRE, P117; Environmental Systems Research Institute [ESRI], 2014, ARCGIS DESKT HELP 10; Fage L., 1939, Bulletin de la Societe Entomologique de France, V44, P153; Fearnside PM, 2006, ENVIRON MANAGE, V38, P705, DOI 10.1007/s00267-005-0295-y; Fearnside PM, 2014, ENVIRON SCI POLICY, V38, P164, DOI 10.1016/j.envsci.2013.11.004; Fearnside PM, 2005, AMAZONIA REVELADA DE, P397; Ferreira J, 2014, SCIENCE, V346, P706, DOI 10.1126/science.1260194; Filho AOS, 2005, ALERTAS AS CONSEQUEN; FRAILEY C D, 1988, Acta Amazonica, V18, P119; Giupponi A.P.L., 2002, B MUSEU NACL, V477, P1; Giupponi APL, 2013, ZOOTAXA, V3647, P329, DOI 10.11646/zootaxa.3647.2.5; Giupponi APL, 2012, AN ACAD BRAS CIENC, V84, P165, DOI 10.1590/S0001-37652012000100017; Harvey MS, 2003, CATALOGUE SMALLER AR, P398; Jocque M, 2012, ZOOTAXA, P53, DOI 10.11646/zootaxa.3158.1.4; Koch L., 1867, VERH ZOOL BOT GES WI, V17, P173; Kraepelin, 1895, VERHANDLUNGEN NATURW, V13, P3; Machado ABM, 2008, LIVRO VERMELHO FAUNA; Mello-Leitao C., 1931, ARCH MUS NAC, V33; Mello-Leitao C., 1931, ARCH MUS NAC, V33; Miranda-Ribeiro A., 1935, B MUSEU NACL, V11, P1; Vasconcelos ACO, 2013, ZOOTAXA, V 3737, P488, DOI 10.11646/zootaxa.3737.4.9; Pearman PB, 2007, TRENDS ECOL EVOL, P23; Pinto-da-Rocha R, 2002, J NAT HIST, V36, P107, DOI 10.1080/00222930110110152; Pinto-da-Rocha R, 2012, ZOOLOGIA-CURITIBA, V29, P474, DOI 10.1590/S1984-46702012000500012; Quintero Arias D., 1986, P203; QUINTERO D, 1981, J ARACHNOL, V9, P117; Quintero DJ, 1983, STUD FAUNA CURACAO, V65, P1; Rahmadi C, 2010, ZOOTAXA, P1; Rahmadi C, 2010, J ARACHNOL, V38, P475, DOI 10.1636/Ha09-95.1; Rancy A., 2000, PALEOECOLOGIA AMAZON; Reveillion F, 2015, ZOOTAXA, V4032, P190, DOI 10.11646/zootaxa.4032.2.3; Rohe F, 2009, INT J PRIMATOL, V30, P533, DOI 10.1007/s10764-009-9358-x; Rossetti DD, 2005, QUATERNARY RES, V63, P78, DOI 10.1016/j.yqres.2004.10.001; Rossetti DF, 2004, QUATERNARY RES, P61; Ruegg W, 1949, B SOC GEOLOGICA PERU, V3, P1; Seiter M, 2015, ZOOTAXA, V4012, P542, DOI 10.11646/zootaxa.4012.3.8; SILVA J., 2014, INT J GEOSCIENCES, V5, P1426, DOI [10.4236/ijg.2014.512116, DOI 10.4236/IJG.2014.512116]; Skirycz A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00653; Swann ALS, 2015, AGR FOREST METEOROL, V214, P12, DOI 10.1016/j.agrformet.2015.07.006; Switkes G., 2008, AGUAS TURVAS ALERTAS; Teruel Rolando, 2011, Boletin de la SEA, V49, P15; Tourinho Ana Lucia, 2007, Zootaxa, V1540, P55; Vasconcelos ACO, 2014, J ARACHNOL, V42, P155, DOI 10.1636/H14-01.1; Vaz Sergio Maia, 2000, Revista Brasileira de Zoologia, V17, P183; Viquez Carlos, 2012, Revista Iberica de Aracnologia, V21, P56; VRBA ES, 1992, J MAMMAL, V73, P1, DOI 10.2307/1381862; WEBB SD, 1995, SCIENCE, V269, P361, DOI 10.1126/science.269.5222.361; WEYGOLDT P, 1972, Z MORPHOL TIERE, V71, P23; WEYGOLDT P, 1972, Senckenbergiana Biologica, V53, P281; Weygoldt P., 2000, WHIP SPIDERS CHELICE; Weygoldt P., 2005, SENCKENBERG BIOL, V85, P1; Weygoldt Peter, 2006, Verhandlungen des Naturwissenschaftlichen Vereins in Hamburg, P5; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Willig MR., 1983, B CARNEGIE MUSEUM NA, V23, P1	71	22	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148277	10.1371/journal.pone.0148277	http://dx.doi.org/10.1371/journal.pone.0148277			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885641	Green Published, gold, Green Submitted			2022-12-27	WOS:000371218400026
J	Lo, WC; Li, W; Jones, EF; Newitt, DC; Kornak, J; Wilmes, LJ; Esserman, LJ; Hylton, NM				Lo, Wei-Ching; Li, Wen; Jones, Ella F.; Newitt, David C.; Kornak, John; Wilmes, Lisa J.; Esserman, Laura J.; Hylton, Nola M.			Effect of Imaging Parameter Thresholds on MRI Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes	PLOS ONE			English	Article							RECURRENCE-FREE SURVIVAL; TRIAL-CALGB 150007/150012; PREOPERATIVE CHEMOTHERAPY; PROGNOSTIC VALUE; TUMOR VOLUME; ACRIN 6657; BIOMARKER	The purpose of this study is to evaluate the predictive performance of magnetic resonance imaging (MRI) markers in breast cancer patients by subtype. Sixty-four patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy were enrolled in this study. Each patient received a dynamic contrast-enhanced (DCE-MRI) at baseline, after 1 cycle of chemotherapy and before surgery. Functional tumor volume (FTV), the imaging marker measured by DCE-MRI, was computed at various thresholds of percent enhancement (PEt) and signal-enhancement ratio (SERE). Final FTV before surgery and percent changes of FTVs at the early and final treatment time points were used to predict patients' recurrence free survival. The full cohort and each subtype defined by the status of hormone receptor and human epidermal growth factor receptor 2 (HR+/HER2-, HER2+, triple negative) were analyzed. Predictions were evaluated using the Cox proportional hazard model when PEt changed from 30% to 200% in steps of 10% and SERE changed from 0 to 2 in steps of 0.2. Predictions with high hazard ratios and low p -values were considered as strong. Different profiles of FTV as predictors for recurrence -free survival were observed in each breast cancer subtype and strong associations with survival were observed at different PEE/SERE combinations that resulted in different FTVs. Findings from this retrospective study suggest that the predictive performance of imaging markers based on FTV may be improved with enhancement thresholds being optimized separately for clinically-relevant subtypes defined by HR and HER2 receptor expression.	[Lo, Wei-Ching; Li, Wen; Jones, Ella F.; Newitt, David C.; Wilmes, Lisa J.; Hylton, Nola M.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Kornak, John] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Esserman, Laura J.] Univ Calif San Francisco, Dept Surg & Radiol, San Francisco, CA 94143 USA; [Lo, Wei-Ching] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Case Western Reserve University	Jones, EF (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.	ella.jones@ucsf.edu	Jones, Ella F./W-2725-2019; Hylton, Nola/AAF-7861-2019; Jones, Ella/AAZ-6292-2020	Jones, Ella/0000-0001-8700-2129	National Institute of Health/National Cancer Institute [IUO1CA151235, RO1CA132870]; Susan G Komen [SAC110017]; NATIONAL CANCER INSTITUTE [R01CA132870, U01CA151235] Funding Source: NIH RePORTER	National Institute of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G Komen(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by National Institute of Health/National Cancer Institute: IUO1CA151235; RO1CA132870 Susan G Komen: SAC110017 www.komensf.org/. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez RH, 2010, J CLIN ONCOL, V28, P3366, DOI 10.1200/JCO.2009.25.4011; [Anonymous], 2014, R LANG ENV STAT COMP; Esserman LJ, 2012, J CLIN ONCOL, V30, P3242, DOI 10.1200/JCO.2011.39.2779; Fisher B, 1998, J CLIN ONCOL, V16, P2672, DOI 10.1200/JCO.1998.16.8.2672; Han M, 2012, AM J ROENTGENOL, V199, P921, DOI 10.2214/AJR.11.7895; Heldahl MG, 2010, ACTA RADIOL, V51, P604, DOI 10.3109/02841851003782059; Hylton N, 2006, J CLIN ONCOL, V24, P3293, DOI 10.1200/JCO.2006.06.8080; Hylton NM, 2012, RADIOLOGY, V263, P663, DOI 10.1148/radiol.12110748; Jafri NF, 2014, J MAGN RESON IMAGING, V40, P476, DOI 10.1002/jmri.24351; Jones EF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061969; Kleinbaum DG, 2012, STAT BIOL HEALTH, P1, DOI 10.1007/978-1-4419-6646-9; Loo CE, 2011, J CLIN ONCOL, V29, P660, DOI 10.1200/JCO.2010.31.1258; Miller JC, 2005, JNCI-J NATL CANCER I, V97, P172, DOI 10.1093/jnci/dji023; Mukhtar RA, 2013, ANN SURG ONCOL, V20, P3823, DOI 10.1245/s10434-013-3038-y; Padhani AR, 2005, ABDOM IMAGING, V30, P324, DOI 10.1007/s00261-004-0265-5; Partridge SC, 2005, AM J ROENTGENOL, V184, P1774, DOI 10.2214/ajr.184.6.01841774; Partridge SC, 2002, AM J ROENTGENOL, V179, P1193, DOI 10.2214/ajr.179.5.1791193; Partridge SC, 1999, ST HEAL T, V62, P259; Perez EA, 2011, ONCOLOGIST, V16, P20, DOI 10.1634/theoncologist.2011-S1-20; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pickles MD, 2009, EUR J RADIOL, V71, P498, DOI 10.1016/j.ejrad.2008.05.007; Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534; Rehman S, 2005, ONCOLOGIST, V10, P92, DOI 10.1634/theoncologist.10-2-92; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wolmark N, 2001, J Natl Cancer Inst Monogr, P96	28	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0142047	10.1371/journal.pone.0142047	http://dx.doi.org/10.1371/journal.pone.0142047			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886725	Green Published, gold			2022-12-27	WOS:000371218400001
J	Nosak, C; Silva, PN; Sollazzo, P; Moon, KM; Odisho, T; Foster, LJ; Rocheleau, JV; Volchuk, A				Nosak, Courtney; Silva, Pamuditha N.; Sollazzo, Pietro; Moon, Kyung-Mee; Odisho, Tanya; Foster, Leonard J.; Rocheleau, Jonathan V.; Volchuk, Allen			Jagn1 Is Induced in Response to ER Stress and Regulates Proinsulin Biosynthesis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; CELL-LINES; INFLAMMATION; DEFICIENCY; GOLGI	The Jagn1 protein was indentified in a SILAC proteomic screen of proteins that are increased in insulinoma cells expressing a folding-deficient proinsulin. Jagn1 mRNA was detected in primary rodent islets and in insulinoma cell lines and the levels were increased in response to ER stress. The function of Jagn1 was assessed in insulinoma cells by both knock-down and overexpression approaches. Knock-down of Jagn1 caused an increase in glucose-stimulated insulin secretion resulting from an increase in proinsulin biosynthesis. In contrast, overexpression of Jagn1 in insulinoma cells resulted in reduced cellular proinsulin and insulin levels. Our results identify a novel role for Jagn1 in regulating proinsulin biosynthesis in pancreatic beta-cells. Under ER stress conditions Jagn1 is induced which might contribute to reducing proinsulin biosynthesis, in part by helping to relieve the protein folding load in the ER in an effort to restore ER homeostasis.	[Nosak, Courtney; Odisho, Tanya; Rocheleau, Jonathan V.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Silva, Pamuditha N.; Rocheleau, Jonathan V.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Sollazzo, Pietro] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Moon, Kyung-Mee; Foster, Leonard J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Moon, Kyung-Mee; Foster, Leonard J.] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V5Z 1M9, Canada; [Volchuk, Allen] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, 30 Bond St, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University of Toronto; University of British Columbia; University of British Columbia; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Volchuk, A (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, 30 Bond St, Toronto, ON M5B 1W8, Canada.	allen.volchuk@utoronto.ca		Rocheleau, Jonathan/0000-0002-1760-2564	Canadian Institutes for Health Research (CIHR) [MOP-114992, MOP-77688]; Natural Science and Engineering Research Council of Canada (NSERC) [RGPIN371705]; Banting and Best Diabetes Centre (BBDC); BBDC-UHN Graduate Student award; NSERC	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Banting and Best Diabetes Centre (BBDC); BBDC-UHN Graduate Student award; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	The study was funded by operating grants from the Canadian Institutes for Health Research (CIHR) to AV (MOP-114992) and LJF (MOP-77688) (http://www.cihr-irsc.gc.ca/e/193.html) and the Natural Science and Engineering Research Council of Canada (NSERC) to JVR (RGPIN371705). CN was funded by a Banting and Best Diabetes Centre (BBDC) Graduate Student award. PNS was funded by a BBDC-UHN Graduate Student award and an NSERC Postgraduate scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Auweter SD, 2011, J BIOL CHEM, V286, P24023, DOI 10.1074/jbc.M111.224600; Basu A, 2014, ARTERIOSCL THROM VAS, V34, P533, DOI 10.1161/ATVBAHA.113.302573; Boztug K, 2014, NAT GENET, V46, P1021, DOI 10.1038/ng.3069; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Eizirik DL, 2013, DIABETOLOGIA, V56, P234, DOI 10.1007/s00125-012-2762-3; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Hartley T, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-59; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Lee S, 2007, J CELL BIOL, V176, P941, DOI 10.1083/jcb.200701048; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Ong SE, 2003, METHODS, V29, P124, DOI 10.1016/S1046-2023(02)00303-1; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Teodoro-Morrison T, 2013, DIABETOLOGIA, V56, P1057, DOI 10.1007/s00125-013-2855-7; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Wirnsberger G, 2014, NAT GENET, V46, P1028, DOI 10.1038/ng.3070; Zhang LL, 2010, FEBS LETT, V584, P2298, DOI 10.1016/j.febslet.2010.03.041; Zhang LL, 2009, J BIOL CHEM, V284, P5289, DOI 10.1074/jbc.M805477200	20	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149177	10.1371/journal.pone.0149177	http://dx.doi.org/10.1371/journal.pone.0149177			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882284	Green Published, gold, Green Submitted			2022-12-27	WOS:000371219000053
J	Erra, RG; Gervain, J				Erra, Ramon Guevara; Gervain, Judit			The Efficient Coding of Speech: Cross-Linguistic Differences	PLOS ONE			English	Article							LANGUAGE DISCRIMINATION; INFORMATION; STATISTICS; TIME; PERCEPTION; NEWBORNS; RHYTHM	Neural coding in the auditory system has been shown to obey the principle of efficient neural coding. The statistical properties of speech appear to be particularly well matched to the auditory neural code. However, only English has so far been analyzed from an efficient coding perspective. It thus remains unknown whether such an approach is able to capture differences between the sound patterns of different languages. Here, we use independent component analysis to derive information theoretically optimal, non-redundant codes (filter populations) for seven typologically distinct languages (Dutch, English, Japanese, Marathi, Polish, Spanish and Turkish) and relate the statistical properties of these filter populations to documented differences in the speech rhythms (Analysis 1) and consonant inventories (Analysis 2) of these languages. We show that consonant class membership plays a particularly important role in shaping the statistical structure of speech in different languages, suggesting that acoustic transience, a property that discriminates consonant classes from one another, is highly relevant for efficient coding.	[Gervain, Judit] CNRS, Lab Psychol Percept, Paris, France; Univ Paris 05, Sorbonne Paris Cite, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Gervain, J (corresponding author), CNRS, Lab Psychol Percept, Paris, France.	judit.gervain@parisdescartes.fr		Gervain, Judit/0000-0002-2125-6369	City of Paris, Emergence program; Human Frontiers Science Program [RGY-073/2014]	City of Paris, Emergence program(Region Ile-de-France); Human Frontiers Science Program(Human Frontier Science Program)	This work was supported by (1) City of Paris, Emergence program (http://next.paris.fr/pro/chercheurs/2d3es-appels-a-projets/programme-emergence-s/rub_9587_stand_79582_port_23607) and (2) Human Frontiers Science Program grant nr. RGY-073/2014 (http://www.hfsp.org/funding/research-grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amari S, 1996, ADV NEUR IN, V8, P757; [Anonymous], 2013, WORLD ATLAS LANGUAGE; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Baayen R Harald, 1993, CELEX LEXICAL DATA B; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bosch L, 1997, COGNITION, V65, P33, DOI 10.1016/S0010-0277(97)00040-1; Byers-Heinlein K, 2010, PSYCHOL SCI; Catford J. C., 1988, PRACTICAL INTRO PHON; CUTLER A, 1983, NATURE, V304, P159, DOI 10.1038/304159a0; DEBOER E, 1978, J ACOUST SOC AM, V63, P115, DOI 10.1121/1.381704; Dellwo V., 2006, LANGUAGE LANGUAGE PR, P231, DOI DOI 10.5167/UZH-111789; Eddington David, 2004, SPANISH PHONOLOGY MO; Evans E.F., 1975, HDB SENSORY PHYSL, P1; Fenk-Oczlon G., 2005, SPRACHE NATURLICHKEI; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Galves A, 2002, SPEECH PROS 2002 INT; Geffen MN, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00015; Gervain J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096278; Grabe E, 2002, PHONOL PHONET, V4-1, P515; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Lee JH, 2002, NEURAL PROCESS LETT, V15, P235, DOI 10.1023/A:1015777200976; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Lindblom B., 1988, LANGUAGE SPEECH MIND; Loukina A, 2011, J ACOUST SOC AM, V129, P3258, DOI 10.1121/1.3559709; McDermott JH, 2011, NEURON, V71, P926, DOI 10.1016/j.neuron.2011.06.032; MEHLER J, 1988, COGNITION, V29, P143, DOI 10.1016/0010-0277(88)90035-2; Mehler J, 2004, NEW COGNITIVE NEUROS, P825; MINES MA, 1978, LANG SPEECH, V21, P221, DOI 10.1177/002383097802100302; Ming VL, 2009, J ACOUST SOC AM, V126, P1312, DOI 10.1121/1.3158939; Molnar M, NONLINGUIST IN PRESS; Molnar M, 2013, INFANCY; MOON C, 1993, INFANT BEHAV DEV, V16, P495, DOI 10.1016/0163-6383(93)80007-U; Nazzi T, 1998, J EXP PSYCHOL HUMAN, V24, P756, DOI 10.1037/0096-1523.24.3.756; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Ordin M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00316; Pallier C, 1998, MEM COGNITION, V26, P844, DOI 10.3758/BF03211403; Pallier C, 1997, TRENDS COGN SCI, V1, P129, DOI 10.1016/S1364-6613(97)01044-9; Ramus F, 1999, COGNITION, V73, P265, DOI 10.1016/S0010-0277(99)00058-X; Ramus F, 1999, J ACOUST SOC AM, V105, P512, DOI 10.1121/1.424522; Ramus F, 2000, SCIENCE, V288, P349, DOI 10.1126/science.288.5464.349; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; Ruggero M. A., 1992, MAMMALIAN AUDITORY P, DOI [10.1007/978-1-4612-2838-7_2, DOI 10.1007/978-1-4612-2838-7_2]; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Smith EC, 2006, NATURE, V439, P978, DOI 10.1038/nature04485; Smits R, 2003, J ACOUST SOC AM, V113, P563, DOI 10.1121/1.1525287; Stilp CE, 2014, P M AC AC SOC AM; Stilp CE, 2010, P NATL ACAD SCI USA, V107, P12387, DOI 10.1073/pnas.0913625107; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; Wiget L, 2010, J ACOUST SOC AM, V127, P1559, DOI 10.1121/1.3293004	52	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148861	10.1371/journal.pone.0148861	http://dx.doi.org/10.1371/journal.pone.0148861			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26901527	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100026
J	Jansen, W; Merkle, M; Daun, A; Fior, M; Grabowski, NT; Klein, G				Jansen, Wiebke; Merkle, Majella; Daun, Anna; Fior, Matthias; Grabowski, Nils Th.; Klein, Guenter			The Quantity and Quality of Illegally Imported Products of Animal Origin in Personal Consignments into the European Union Seized at Two German Airports between 2010 And 2014	PLOS ONE			English	Article							FOODBORNE PATHOGENS; ESCHERICHIA-COLI; MOUTH-DISEASE; FOOD; VIRUS	The import of products of animal origin (POAO) in travellers' personal consignments presents a considerable risk of introducing animal diseases and emerging zoonoses into the European Union. The current regulation (EU) 206/2009 implements strict measures for illegally imported POAO, whereupon non-complying products have to be seized and destroyed regardless. Especially airports serve as global bottlenecks for illegally imported POAO where passenger controls of non-European flights are performed by customs and veterinary services in collaboration. Results of these control measures have to be submitted in the form of annual reports to the European Commission. However, few data on qualities and quantities of seizures have been published so far. In this study, POAO seized at two German airports between 2010 and 2014 were analysed in terms of quantities, qualitative categories and region of origin. In most years considered, more than 20 tonnes POAO were seized at each airport. However, reported amounts of seizures seem to be only the tip of the iceberg as an all-passenger control is not feasible and therefore travellers are only spot-checked. The analysis suggests that the organisational structures of both customs and official veterinary services and their different risk perceptions interfere in completing an effective ban on the illegal import of POAO.	[Jansen, Wiebke; Grabowski, Nils Th.; Klein, Guenter] Univ Vet Med Hannover, Inst Food Qual & Food Safety, Hannover, Germany; [Jansen, Wiebke] Univ Namur, Integrated Vet Res Unit, Namur, Belgium; [Merkle, Majella] Free Univ Berlin, Inst Vet Epidemiol & Biostat, Berlin, Germany; [Daun, Anna; Fior, Matthias] Fed Inst Risk Assessment, Berlin, Germany	University of Veterinary Medicine Hannover, Foundation; University of Namur; Free University of Berlin; Federal Institute for Risk Assessment	Klein, G (corresponding author), Univ Vet Med Hannover, Inst Food Qual & Food Safety, Hannover, Germany.	guenter.klein@tiho-hannover.de	Klein, Günter/G-5321-2013; Flor, Matthias/C-4953-2008	Klein, Günter/0000-0003-1931-2701; Flor, Matthias/0000-0003-0429-7457	German Federal Ministry of Education and Research [FKZ 13N12697]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was funded by the German Federal Ministry of Education and Research within the research program for civil security (http://www.bmbf.de/en/6293.php): security of food and the food chain (ZooGloW, project FKZ 13N12697). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutlich J, 2015, INT J FOOD MICROBIOL, V209, P13, DOI 10.1016/j.ijfoodmicro.2014.10.017; Chaber AL, 2015, ECOHEALTH, P1612; Chaber AL, 2010, CONSERV LETT, V3, P317, DOI 10.1111/j.1755-263X.2010.00121.x; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Costard S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061104; Daun A, 2014, ZIELGRUPPENANA UNPUB; EC to the Council the European Parliament the European Economic and Social Committee and the Committee of the Regions A new Animal Health Strategy for the European Union, 2007, COM5392007 EC COUNC; Egervarn M, 2014, INT J FOOD MICROBIOL, V171, P8, DOI 10.1016/j.ijfoodmicro.2013.11.005; European Commission, 2007, FVO AUD REP ILL IMP; European Commission, 2012, FVO AUD REP IMP CONT; European Commission Directorate-General for Health and Consumers, 2011, COM2011748; FLI, 2014, QUAL RISK ASS INTR A; Grabowski NT, 2013, CRIT REV FOOD SCI, V53, P787, DOI 10.1080/10408398.2011.560977; Hartnett E, 2007, RISK ANAL, V27, P187, DOI 10.1111/j.1539-6924.2006.00869.x; Jansen W, 2016, ZOONOSES PUBLIC HLTH, V63, P53, DOI 10.1111/zph.12204; Jansen W, 2015, J FOOD SAF FOOD QUAL, V66, P41, DOI 10.2376/0003-925X-66-41; Klein G, 2003, FOOD MICROBIOL, V20, P27, DOI 10.1016/S0740-0020(02)00106-5; Mayer-Scholl A, 2014, AMTSTIERARZTL DIEN S, P53; Noordhuizen J, 2013, VET QUART, V33, P161, DOI 10.1080/01652176.2013.826883; Peiso OO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022066; Rodriguez-Lazaro D, 2015, INT J FOOD MICROBIOL, V209, P20, DOI 10.1016/j.ijfoodmicro.2014.10.016; Schoder D, 2015, INT J FOOD MICROBIOL, V209, P3, DOI 10.1016/j.ijfoodmicro.2014.08.010; Sobrino F, 2001, EMBO REP, V2, P459, DOI 10.1093/embo-reports/kve122; Strauss A, 2014, AMTSTIERARZTL DIEN S, P52	24	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0150023	10.1371/journal.pone.0150023	http://dx.doi.org/10.1371/journal.pone.0150023			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901158	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100199
J	Wang, SY; Blachley, TS; Andrews, CA; Ayanian, JZ; Lee, PP; Stein, JD				Wang, Sophia Y.; Blachley, Taylor S.; Andrews, Chris A.; Ayanian, John Z.; Lee, Paul P.; Stein, Joshua D.			Hospitalization after Cataract Surgery in a Nationwide Managed-Care Population	PLOS ONE			English	Article							ADVERSE EVENTS; ACCURACY; PATIENT	Purpose Little is known regarding the extent by which patients undergoing outpatient cataract surgery are at risk for postoperative hospitalization. We sought to determine the percentage of patients undergoing cataract surgery who were subsequently hospitalized, the patient characteristics associated with postoperative hospitalization, and the reasons for hospitalization. Methods We identified all beneficiaries of a large U.S. managed care network age >= 40 years old who underwent >= 1 cataract surgery from 2001-2011. All enrollees who required inpatient hospitalization within 7, 14, 30, and 90 days following initial cataract surgery and the reasons for hospitalization were determined. Logistic regression was performed to assess factors that significantly impacted the odds of requiring postoperative hospitalization. Results Among the 64,981 patients who underwent cataract surgery, rates of hospitalization within 7, 14, 30, and 90 days were 0.3%, 0.5%, 1.3% and 4.2%, respectively. Among the 10,674 patients who had no major preexisting medical comorbidities, 0.1% were hospitalized within 7 days. The odds of hospitalization increased by 35% (OR = 1.35 [CI, 1.23-1.48]) with the presence of each additional comorbidity and by 14% with each additional hospitalization in the 3 years prior to cataract surgery (OR = 1.14 [CI, 1.10-1,18]). Those who were hospitalized in the 30 days prior to cataract surgery had 524% increased odds of being hospitalized within 7 days after cataract surgery (OR = 6.24, [CI, 3.37-11.57]) compared to those with no record of preoperative hospitalization. Postoperative hospitalizations were most commonly due to cardiovascular conditions, comprising over 25% of primary diagnoses associated with hospitalization. Conclusions The risk of hospitalization after cataract surgery is low, and is very low among those with no major preexisting medical comorbidities. Opportunities may exist to limit comprehensive preoperative evaluation and testing to those who have serious pre-existing medical comorbidities.	[Wang, Sophia Y.; Blachley, Taylor S.; Andrews, Chris A.; Lee, Paul P.; Stein, Joshua D.] Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI USA; [Ayanian, John Z.; Lee, Paul P.; Stein, Joshua D.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Ayanian, John Z.] Univ Michigan, Gerald R Ford Sch Publ Policy, Ann Arbor, MI 48109 USA; [Ayanian, John Z.] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Stein, Joshua D.] Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Stein, JD (corresponding author), Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI USA.; Stein, JD (corresponding author), Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA.; Stein, JD (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA.	jastein@med.umich.edu		Andrews, Chris/0000-0001-5130-6374; Wang, Sophia/0000-0003-0916-9403; Stein, Joshua/0000-0003-2937-6987	National Eye Institute [1K23EY019511]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [K23EY019511] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute (https://nei.nih.gov/) (1K23EY019511, JDS) and Research to Prevent Blindness (http://www.rpbusa.org/rpb/?) (Physician Scientist Award, JDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Medical Association, 2006, CPT 2006 CURR PROC T; BASS EB, 1995, ARCH OPHTHALMOL-CHIC, V113, P1248, DOI 10.1001/archopht.1995.01100100036025; Cavallini GM, 2004, EUR J OPHTHALMOL, V14, P369, DOI 10.1177/112067210401400502; Danielson D, 2012, PREOPERATIVE EVALUAT; De Hert S, 2011, EUR J ANAESTH, V28, P684, DOI 10.1097/EJA.0b013e3283499e3b; Fleisher LA, 2004, ARCH SURG-CHICAGO, V139, P67, DOI 10.1001/archsurg.139.1.67; Fleisher LA, 2007, J AM COLL CARDIOL, V50, P1707, DOI 10.1016/j.jacc.2007.09.001; Greenberg PB, 2010, OPHTHALMOLOGY, V117, P1894, DOI 10.1016/j.ophtha.2010.02.009; HCUP CCS, 2014, HEALTHC COST UT PROJ; Hepner David L, 2009, Cleve Clin J Med, V76 Suppl 4, pS22, DOI 10.3949/ccjm.76.s4.04; ICD-9-CM for Physicians, 2006, ICD 9 CM PHYS INT CL; JAVITT JC, 1993, ARCH OPHTHALMOL-CHIC, V111, P605, DOI 10.1001/archopht.1993.01090050039024; Katz J, 2001, OPHTHALMOLOGY, V108, P1721, DOI 10.1016/S0161-6420(01)00704-7; Keay L, 2012, COCHRANE COLLABORATI; Kosanke J, 2004, GMATCH; Lira R P, 2001, Rev Panam Salud Publica, V10, P13, DOI 10.1590/S1020-49892001000700003; Muir KW, 2013, JAMA OPHTHALMOL, V131, P119, DOI 10.1001/jamaophthalmol.2013.577; Newman-Casey PA, 2011, OPHTHALMOLOGY, V118, P1318, DOI 10.1016/j.ophtha.2010.11.022; Rutkow IM, 1997, ARCH SURG-CHICAGO, V132, P983; Schein OD, 2000, NEW ENGL J MED, V342, P168, DOI 10.1056/NEJM200001203420304; Stein JD, 2012, CURR OPIN OPHTHALMOL, V23, P219, DOI 10.1097/ICU.0b013e3283524068; Stein JD, 2011, OPHTHALMOLOGY, V118, P1716, DOI 10.1016/j.ophtha.2011.02.024; Stein JD, 2011, OPHTHALMOLOGY, V118, P1031, DOI 10.1016/j.ophtha.2010.10.024; Thilen SR, 2014, JAMA INTERN MED, V174, P380, DOI 10.1001/jamainternmed.2013.13426; VanderBeek BL, 2011, AM J OPHTHALMOL, V152, P273, DOI 10.1016/j.ajo.2011.02.004	25	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149819	10.1371/journal.pone.0149819	http://dx.doi.org/10.1371/journal.pone.0149819			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901594	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100158
J	Gedir, JV; Cain, JW; Krausman, PR; Allen, JD; Duff, GC; Morgart, JR				Gedir, Jay V.; Cain, James W., III; Krausman, Paul R.; Allen, Jamison D.; Duff, Glenn C.; Morgart, John R.			Potential Foraging Decisions by a Desert Ungulate to Balance Water and Nutrient Intake in a Water-Stressed Environment	PLOS ONE			English	Article							BIGHORN SHEEP; MOUNTAIN SHEEP; ACTIVITY PATTERNS; FECAL ANALYSIS; ORYX-LEUCORYX; OXALIC-ACID; DIETS; WILDLIFE; RAINFALL; DEER	Arid climates have unpredictable precipitation patterns, and wildlife managers often provide supplemental water to help desert ungulates endure the hottest, driest periods. When surface water is unavailable, the only source of water for ungulates comes from the forage they consume, and they must make resourceful foraging decisions to meet their requirements. We compared two desert bighorn sheep (Ovis canadensis nelsoni) populations in Arizona, USA: a treatment population with supplemental water removed during treatment, and a control population. We examined whether sheep altered their seasonal diets without supplemental water. We calculated water and nutrient intake and metabolic water production from dry matter intake and forage moisture and nitrogen content, to determine whether sheep could meet their seasonal daily water and nutrient requirements solely from forage. Diets of sheep were higher in protein (all seasons) and moisture (autumn and winter) during treatment compared to pretreatment. During treatment, sheep diet composition was similar between the treatment and control populations, which suggests, under the climatic conditions of this study, water removal did not influence sheep diets. We estimated that under drought conditions, without any surface water available (although small ephemeral potholes would contain water after rains), female and male sheep would be unable to meet their daily water requirements in all seasons, except winter, when reproductive females had a nitrogen deficit. We determined that sheep could achieve water and nutrient balances in all seasons by shifting their total diet proportions by 8-55% fromlower to higher moisture and nitrogen forage species. We elucidate how seasonal forage quality and foraging decisions by desert ungulates allow them to cope with their xeric and uncertain environment, and suggest that, with the forage conditions observed in our study area during this study period, providing supplemental water during water-stressed periods may not be necessary for desert bighorn sheep.	[Gedir, Jay V.] New Mexico State Univ, Dept Fish Wildlife & Conservat Ecol, Las Cruces, NM 88003 USA; [Cain, James W., III] New Mexico State Univ, US Geol Survey, New Mexico Cooperat Fish & Wildlife Res Unit, Dept Fish Wildlife & Conservat Ecol, Las Cruces, NM 88003 USA; [Krausman, Paul R.] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ USA; [Allen, Jamison D.; Duff, Glenn C.] Univ Arizona, Dept Anim Sci, Tucson, AZ 85721 USA; [Morgart, John R.] US Fish & Wildlife Serv, Cabeza Prieta Natl Wildlife Refuge, Ajo, AZ USA; [Allen, Jamison D.] NW Missouri State Univ, Sch Agr Sci, Maryville, MO 64468 USA; [Duff, Glenn C.] New Mexico State Univ, Dept Anim & Range Sci, Las Cruces, NM 88003 USA	New Mexico State University; New Mexico State University; United States Department of the Interior; United States Geological Survey; University of Arizona; University of Arizona; United States Department of the Interior; US Fish & Wildlife Service; New Mexico State University	Cain, JW (corresponding author), New Mexico State Univ, US Geol Survey, New Mexico Cooperat Fish & Wildlife Res Unit, Dept Fish Wildlife & Conservat Ecol, Las Cruces, NM 88003 USA.	jwcain@nmsu.edu		Cain, James/0000-0003-4743-516X	U. S. Geological Survey National Climate Change and Wildlife Science Center; U.S. Fish and Wildlife Service; Foundation for North American Wild Sheep; Arizona Desert Bighorn Sheep Society; Boone and Crockett Club; National Fish and Wildlife Foundation Budweiser Conservation Scholarship Program; Desert Bighorn Council; College of Agriculture and Life Sciences, University of Arizona; School of Natural Resources, University of Arizona; New Mexico State University Agricultural Experiment Station	U. S. Geological Survey National Climate Change and Wildlife Science Center; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Foundation for North American Wild Sheep; Arizona Desert Bighorn Sheep Society; Boone and Crockett Club; National Fish and Wildlife Foundation Budweiser Conservation Scholarship Program; Desert Bighorn Council; College of Agriculture and Life Sciences, University of Arizona; School of Natural Resources, University of Arizona; New Mexico State University Agricultural Experiment Station	This work was financially supported by U. S. Geological Survey National Climate Change and Wildlife Science Center; U.S. Fish and Wildlife Service; Foundation for North American Wild Sheep; Arizona Desert Bighorn Sheep Society; Boone and Crockett Club; National Fish and Wildlife Foundation Budweiser Conservation Scholarship Program; Desert Bighorn Council; College of Agriculture and Life Sciences, University of Arizona; School of Natural Resources, University of Arizona; and New Mexico State University Agricultural Experiment Station.	ALDERMAN JA, 1989, J WILDLIFE MANAGE, V53, P264, DOI 10.2307/3801345; Andrew N. G., 1999, CALIFORNIA WILDLIFE, V12, P1; [Anonymous], 1993, 8 C APPL CLIMATOLOGY, DOI DOI 10.1175/JCLI-D-11-00375.1; Attum O, 2014, J ARID ENVIRON, V102, P113, DOI 10.1016/j.jaridenv.2013.11.009; Augustine DJ, 2010, AFR J ECOL, V48, P1009, DOI 10.1111/j.1365-2028.2010.01207.x; AYENI J S O, 1975, East African Wildlife Journal, V13, P305; BAHARAV D, 1985, J ARID ENVIRON, V9, P167, DOI 10.1016/S0140-1963(18)31498-8; Belenguer A, 2013, ANIMAL, V7, P940, DOI 10.1017/S1751731112002455; BIGALKE R C, 1972, Zoologica Africana, V7, P333; Bleich VC, 1997, WILDLIFE MONOGR, P1; Brewer CE, 2007, SOUTHWEST NAT, V52, P97, DOI 10.1894/0038-4909(2007)52[97:DOBSIT]2.0.CO;2; Bristow KD, 1996, HABITAT USE MOVEMENT, P25; Broyles B, 1995, WILDLIFE SOC B, V23, P663; Cain III JW, 2008, WILDL MONOGR, V171; Cain JW, 2006, WILDLIFE SOC B, V34, P570, DOI 10.2193/0091-7648(2006)34[570:MOTAWB]2.0.CO;2; CANFIELD R. H., 1941, JOUR FOREST, V39, P388; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Corp N, 1998, J ZOOL, V246, P369; CUNNINGHAM SC, 1982, THESIS ARIZONA STATE; DEGEN AA, 1977, J AGR SCI, V88, P699, DOI 10.1017/S0021859600037400; DEGEN AA, 1986, J ANIM ECOL, V55, P421, DOI 10.2307/4728; DeYoung RW, 2000, RESTOR ECOL, V8, P57, DOI 10.1046/j.1526-100x.2000.80066.x; Duncan AJ, 1997, ANIM SCI, V65, P451, DOI 10.1017/S135772980000864X; Epaphras A. M., 2008, Wetlands Ecology and Management, V16, P183, DOI 10.1007/s11273-007-9065-3; Epps CW, 2004, CONSERV BIOL, V18, P102, DOI 10.1111/j.1523-1739.2004.00023.x; Etchberger RC, 1997, WILDLIFE SOC B, V25, P604; EVERITT JH, 1981, J RANGE MANAGE, V34, P506, DOI 10.2307/3898109; Martinez-Aguilar JF, 2009, J AGR FOOD CHEM, V57, P1933, DOI 10.1021/jf802141d; FITZGERALD AE, 1979, J WILDLIFE MANAGE, V43, P468, DOI 10.2307/3800357; Fox L. M., 1997, THESIS; Fracker SB, 1944, ECOLOGY, V25, P283, DOI 10.2307/1931277; Frausman P. R., 1990, Desert Plants, V10, P32; Fulbright TE, 2001, J ARID ENVIRON, V48, P49, DOI 10.1006/jare.2000.0738; GILL RB, 1983, J WILDLIFE MANAGE, V47, P902, DOI 10.2307/3808149; Guttman NB, 1999, J AM WATER RESOUR AS, V35, P311, DOI 10.1111/j.1752-1688.1999.tb03592.x; Hansen C. G., 1990, DESERT BIGHORN ITS L, P64; Harkleroad D, 2014, SOUTHWEST NAT, V59, P272, DOI 10.1894/N01-SGM-31.1; HEBERT DM, 1973, THESIS U BRIT COLUMB; Hochman V, 2006, OIKOS, V112, P547, DOI 10.1111/j.0030-1299.2006.14214.x; HOFMEYR MD, 1987, J ARID ENVIRON, V13, P137; HOLECHEK JL, 1982, J RANGE MANAGE, V35, P309, DOI 10.2307/3898308; HOLECHEK JL, 1981, J RANGE MANAGE, V34, P337, DOI 10.2307/3897865; Hoppe P.P., 1977, Veterinary Medical Review, V1977, P77; Houpt TR, 1970, DUKES PHYSL DOMESTIC, P743; IBM Corp, 2013, IBM SPSS STAT WINDOW; Ismail K, 2011, J ARID ENVIRON, V75, P125, DOI 10.1016/j.jaridenv.2010.09.017; Ivlev V.S., 1961, EXPT ECOLOGY FEEDING; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; JAMES LF, 1972, CLIN TOXICOL, V5, P231, DOI 10.3109/15563657208991002; KALIKAWA MC, 1990, AFR J ECOL, V28, P253, DOI 10.1111/j.1365-2028.1990.tb01159.x; Karsch RC, 2014, THESIS NEW MEXICO ST; KNIGHT MH, 1988, J ARID ENVIRON, V15, P269, DOI 10.1016/S0140-1963(18)31064-4; Krausman PR, 2006, WILDLIFE SOC B, V34, P563, DOI 10.2193/0091-7648(2006)34[563:DWFWSP]2.0.CO;2; KRAUSMAN PR, 1985, WILDLIFE SOC B, V13, P71; Krausman PR, 1997, J RANGE MANAGE, V50, P513, DOI 10.2307/4003707; Krausman PR, 1999, MOUNTAIN SHEEP OF NORTH AMERICA, P139; Krausman PR, 1989, WILDL MONOGR, V102; LECHOWICZ MJ, 1982, OECOLOGIA, V52, P22, DOI 10.1007/BF00349007; LESLIE DM, 1979, WILDLIFE MONOGR, P6; LEWIS JG, 1977, J AGR SCI-CAMBRIDGE, V89, P551, DOI 10.1017/S0021859600061323; Louw GN, 1982, LONGMAN ECOLOGY DESE; MANSER MB, 1995, OECOLOGIA, V102, P404, DOI 10.1007/BF00341352; Marshal JP, 2009, CAN J ZOOL, V87, P103, DOI 10.1139/Z08-142; Marshal JP, 2005, RANGELAND ECOL MANAG, V58, P360, DOI 10.2111/1551-5028(2005)058[0360:RTAFDA]2.0.CO;2; MAZAIKA R, 1992, SOUTHWEST NAT, V37, P372, DOI 10.2307/3671788; Mckinney T, 2007, SOUTHWEST NAT, V52, P520, DOI 10.1894/0038-4909(2007)52[520:DOAALO]2.0.CO;2; MCQUIVEY RP, 1978, NEVADA DEP FISH GAME, V6, P1; Mendoza J, 1976, DESERT BIGHORN COUNC, V20, P25; MILLER GD, 1989, J WILDLIFE MANAGE, V53, P597, DOI 10.2307/3809182; Mills M.G.L., 1984, Koedoe, V27, P129; Monson G, 1958, DESERT BIGHORN COUNC, V2, P64; Monson G, 1964, DESERT BIGHORN COUNC, V8, P11; Monson G., 1990, DESERT BIGHORN ITS L; NAGY KA, 1994, J MAMMAL, V75, P860, DOI 10.2307/1382468; Oehler MW, 2005, CALIF FISH GAME, V91, P149; Olech LA., 1979, DESERT BIGHORN COUNC, V23, P33; Ostrowski S, 2002, J MAMMAL, V83, P665, DOI 10.1644/1545-1542(2002)083<0665:WIAFCO>2.0.CO;2; Owen-Smith N, 2005, J ANIM ECOL, V74, P774, DOI 10.1111/j.1365-2656.2005.00974.x; OWENSMITH N, 1994, ECOLOGY, V75, P1050, DOI 10.2307/1939429; Rautenstrauch K. R., 1988, Desert Plants, V8, P172; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Rosenstock SS, 1999, J RANGE MANAGE, V52, P302, DOI 10.2307/4003538; Russo JP, 1956, AZ GAME FISH DEP B, V1; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; Seegmiller R. F., 1990, Desert Plants, V10, P87; SHACKLETON D M, 1985, Mammalian Species, P1, DOI 10.2307/3504034; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; SPARKS DR, 1968, J RANGE MANAGE, V21, P264, DOI 10.2307/3895829; STEWARTOATEN A, 1986, ECOLOGY, V67, P929, DOI 10.2307/1939815; STEWARTOATEN A, 1992, ECOLOGY, V73, P1396, DOI 10.2307/1940685; Tarango LA, 2002, J RANGE MANAGE, V55, P530, DOI 10.2307/4003995; Taylor C. R., 1968, Symposia of the Zoological Society of London, VNo. 21, P195; TAYLOR CR, 1969, SCI AM, V220, P89, DOI 10.1038/scientificamerican0169-88; Tear TH, 1997, J WILDLIFE MANAGE, V61, P1142, DOI 10.2307/3802112; TEAR TH, 1992, THESIS U IDAHO; Turner J.C., 1973, THESIS U CALIFORNIA; Turner JC, 2004, WILDLIFE SOC B, V32, P427, DOI 10.2193/0091-7648(2004)32[427:DOCHFT]2.0.CO;2; Turner JC, 1990, DESERT BIGHORN ITS L, P100; Valdez R, 1999, MOUNTAIN SHEEP OF NORTH AMERICA, P3; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; WARRICK GD, 1989, SOUTHWEST NAT, V34, P483, DOI 10.2307/3671506; Watts TJ, 1979, THESIS NEW MEXICO ST; Weaver RA, 1971, DESERT BIGHORN SHEEP; Western Regional Climate Data Center, 2005, AR CLIM SUMM; WESTON RH, 1988, AUST J AGR RES, V39, P679, DOI 10.1071/AR9880679; Wishart W., 1978, P161; Witham JH, 1983, THESIS COLORADO STAT; Zar J. H., 1996, BIOSTATISTICAL ANAL; [No title captured]; [No title captured]	110	17	18	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148795	10.1371/journal.pone.0148795	http://dx.doi.org/10.1371/journal.pone.0148795			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894504	Green Published, Green Submitted, gold			2022-12-27	WOS:000371223400022
J	Duan, XG; Cheng, S; Ai, YX; Wu, J				Duan, Xuguo; Cheng, Sheng; Ai, Yixin; Wu, Jing			Enhancing the Thermostability of Serratia plymuthica Sucrose Isomerase Using B-Factor-Directed Mutagenesis	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATION; ISOMALTULOSE SYNTHASE; STABILITY; MECHANISM; CLONING; DESIGN; ENZYME; GENE; CONVERSION; PROTEINS	The sucrose isomerase of Serratia plymuthica AS9 (AS9 PalI) was expressed in Escherichia coli BL21(DE3) and characterized. The half-life of AS9 PalI was 20 min at 45 degrees C, indicating that it was unstable. In order to improve its thermostability, six amino acid residues with higher B-factors were selected as targets for site-directed mutagenesis, and six mutants (E175N, K576D, K174D, G176D, S575D and N577K) were designed using the RosettaDesign server. The E175N and K576D mutants exhibited improved thermostability in preliminary experiments, so the double mutant E175N/K576D was constructed. These three mutants (E175N, K576D, E175N/K576D) were characterized in detail. The results indicate that the three mutants exhibit a slightly increased optimal temperature (35 degrees C), compared with that of the wild-type enzyme (30 degrees C). The mutants also share an identical pH optimum of 6.0, which is similar to that of the wild-type enzyme. The half-lives of the E175N, K576D and E175N/K576D mutants were 2.30, 1.78 and 7.65 times greater than that of the wildtype enzyme at 45 degrees C, respectively. Kinetic studies showed that the Km values for the E175N, K576D and E175N/K576D mutants decreased by 6.6%, 2.0% and 11.0%, respectively, and their k(cat)/K-m values increased by 38.2%, 4.2% and 19.4%, respectively, compared with those of the wild-type enzyme. After optimizing the conditions for isomaltulose production at 45 degrees C, we found that the E175N, K576D and E175N/K576D mutants displayed slightly improved isomaltulose yields, compared with the wild-type enzyme. Therefore, the mutants produced in this study would be more suitable for industrial biosynthesis of isomaltulose.	[Duan, Xuguo; Cheng, Sheng; Wu, Jing] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China; [Duan, Xuguo; Cheng, Sheng; Wu, Jing] Jiangnan Univ, Sch Biotechnol, Wuxi, Jiangsu, Peoples R China; [Duan, Xuguo; Cheng, Sheng; Wu, Jing] Jiangnan Univ, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Jiangsu, Peoples R China; [Ai, Yixin] South Univ Sci & Technol China, Dept Biol, Shenzhen, Guangdong, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University; Southern University of Science & Technology	Wu, J (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China.; Wu, J (corresponding author), Jiangnan Univ, Sch Biotechnol, Wuxi, Jiangsu, Peoples R China.; Wu, J (corresponding author), Jiangnan Univ, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Jiangsu, Peoples R China.	jingwu@jiangnan.edu.cn	Wu, Jing/GZK-5063-2022	Duan, Xuguo/0000-0002-2136-0449	National Science Fund for Distinguished Young Scholars [31425020]; National Natural Science Foundation of China [31271813, 31401636]; project of outstanding scientific and technological innovation group of Jiangsu Province; Natural Science Foundation of Jiangsu Province [BK20140142]; 111 Project [111-2-06]; China Postdoctoral Science Foundation Funded Project [2015M580390]; Production and Research Prospective Joint Research Project of Jiangsu Province [BY2015019-18]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); project of outstanding scientific and technological innovation group of Jiangsu Province; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); 111 Project(Ministry of Education, China - 111 Project); China Postdoctoral Science Foundation Funded Project(China Postdoctoral Science Foundation); Production and Research Prospective Joint Research Project of Jiangsu Province	This work was funded by grants from the National Science Fund for Distinguished Young Scholars (http://www.nsfc.gov.cn/publish/portal1/ #31425020), the National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal1/ #31271813 and #31401636), the project of outstanding scientific and technological innovation group of Jiangsu Province (http://www.jskjjh.gov.cn/13kjskj2/), the Natural Science Foundation of Jiangsu Province (http://www.jskjjh.gov.cn/13kjskj2/ #BK20140142), the 111 Project (http://www.dost.moe. edu.cn No. 111-2-06), the China Postdoctoral Science Foundation Funded Project (2015M580390), and the Production and Research Prospective Joint Research Project of Jiangsu Province (BY2015019-18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cha J, 2009, J APPL MICROBIOL, V107, P1119, DOI 10.1111/j.1365-2672.2009.04295.x; CHEETHAM PSJ, 1984, BIOCHEM J, V220, P213, DOI 10.1042/bj2200213; Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X; Duan XG, 2013, APPL ENVIRON MICROB, V79, P4072, DOI 10.1128/AEM.00457-13; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fu Y, 2010, PROTEIN PEPTIDE LETT, V17, P1403, DOI 10.2174/0929866511009011403; Hamada S, 2002, PURE APPL CHEM, V74, P1293, DOI 10.1351/pac200274071293; Huang JH, 1998, J IND MICROBIOL BIOT, V21, P22, DOI 10.1038/sj.jim.2900552; Hyun Sook Kim, 2010, Enzyme and Microbial Technology, V47, P1; Kim SJ, 2010, BIOTECHNOL PROGR, V26, P1038, DOI 10.1002/btpr.408; Korkegian A, 2005, SCIENCE, V308, P857, DOI 10.1126/science.1107387; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Li S, 2011, APPL BIOCHEM BIOTECH, V163, P52, DOI 10.1007/s12010-010-9015-z; Liu Y, 2006, NUCLEIC ACIDS RES, V34, pW235, DOI 10.1093/nar/gkl163; LOW NH, 1988, J FOOD SCI, V53, P558, DOI 10.1111/j.1365-2621.1988.tb07755.x; MINAMI T, 1990, ORAL MICROBIOL IMMUN, V5, P189, DOI 10.1111/j.1399-302X.1990.tb00644.x; NAGAIMIYATA Y, 1993, BIOSCI BIOTECH BIOCH, V57, P2049, DOI 10.1271/bbb.57.2049; Nauli S, 2001, NAT STRUCT BIOL, V8, P602, DOI 10.1038/89638; Park HJ, 2014, J BIOTECHNOL, V192, P66, DOI 10.1016/j.jbiotec.2014.09.014; Parthasarathy S, 2000, PROTEIN ENG, V13, P9, DOI 10.1093/protein/13.1.9; Ravaud S, 2006, ACTA CRYSTALLOGR F, V62, P74, DOI 10.1107/S1744309105041758; Ravaud S, 2005, ACTA CRYSTALLOGR F, V61, P100, DOI 10.1107/S1744309104030623; Reetz MT, 2006, ANGEW CHEM INT EDIT, V45, P7745, DOI 10.1002/anie.200602795; Rhimi M, 2008, BIOLOGIA, V63, P1020, DOI 10.2478/s11756-008-0166-0; Sevastsyanovich YR, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-69; Sevier E., 2007, ENZYME MICROB TECHNO, V40, P1221; Sockolosky JT, 2013, PROTEIN EXPRES PURIF, V87, P129, DOI 10.1016/j.pep.2012.11.002; SUZUKI Y, 1976, BIOCHIM BIOPHYS ACTA, V445, P386, DOI 10.1016/0005-2744(76)90092-9; Veronese T, 1999, ENZYME MICROB TECH, V24, P263, DOI 10.1016/S0141-0229(98)00115-X; Vieille C, 1996, TRENDS BIOTECHNOL, V14, P183, DOI 10.1016/0167-7799(96)10026-3; Watzlawick H, 2009, APPL ENVIRON MICROB, V75, P7026, DOI 10.1128/AEM.01781-09; Wu LT, 2015, FOOD CHEM, V187, P182, DOI 10.1016/j.foodchem.2015.04.072; Wu LQ, 2005, APPL ENVIRON MICROB, V71, P1581, DOI 10.1128/AEM.71.3.1581-1590.2005; Xie Y, 2014, J BIOL CHEM, V289, P7994, DOI 10.1074/jbc.M113.536045; Xu Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074788; Zhang DH, 2003, J BIOL CHEM, V278, P35428, DOI 10.1074/jbc.M302616200; Zhang DH, 2003, FEBS LETT, V534, P151, DOI 10.1016/S0014-5793(02)03835-8; Zhang DH, 2002, APPL ENVIRON MICROB, V68, P2676, DOI 10.1128/AEM.68.6.2676-2682.2002; Zhang JH, 2012, ENZYME MICROB TECH, V50, P325, DOI 10.1016/j.enzmictec.2012.03.002	39	21	23	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149208	10.1371/journal.pone.0149208	http://dx.doi.org/10.1371/journal.pone.0149208			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886729	Green Published, Green Submitted, gold			2022-12-27	WOS:000371218400067
J	Sekar, K; Gentile, AM; Bostick, JW; Tyo, KEJ				Sekar, Karthik; Gentile, Andrew M.; Bostick, John W.; Tyo, Keith E. J.			N-Terminal-Based Targeted, Inducible Protein Degradation in Escherichia coli	PLOS ONE			English	Article							END RULE SUBSTRATE; SYNTHETIC BIOLOGY; CLPS; RECOGNITION; METABOLISM; MECHANISM; DEGRADOME; PROMOTER	Dynamically altering protein concentration is a central activity in synthetic biology. While many tools are available to modulate protein concentration by altering protein synthesis rate, methods for decreasing protein concentration by inactivation or degradation rate are just being realized. Altering protein synthesis rates can quickly increase the concentration of a protein but not decrease, as residual protein will remain for a while. Inducible, targeted protein degradation is an attractive option and some tools have been introduced for higher organisms and bacteria. Current bacterial tools rely on C-terminal fusions, so we have developed an N-terminal fusion (Ntag) strategy to increase the possible proteins that can be targeted. We demonstrate Ntag dependent degradation of mCherry and beta-galactosidase and reconfigure the Ntag system to perform dynamic, exogenously inducible degradation of a targeted protein and complement protein depletion by traditional synthesis repression. Model driven analysis that focused on rates, rather than concentrations, was critical to understanding and engineering the system. We expect this tool and our model to enable inducible protein degradation use particularly in metabolic engineering, biological study of essential proteins, and protein circuits.	[Sekar, Karthik; Bostick, John W.; Tyo, Keith E. J.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA; [Gentile, Andrew M.] Northwestern Univ, Master Biotechnol Program, Evanston, IL USA; [Bostick, John W.] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA; [Bostick, John W.] Northwestern Univ, Dept Microbiol Immunol, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University	Tyo, KEJ (corresponding author), Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA.	k-tyo@northwestern.edu	Tyo, Keith/H-6227-2012; Tyo, Keith/AAM-4543-2020	Tyo, Keith/0000-0002-2342-0687; Bostick, John/0000-0001-8925-2447; Sekar, Karthik/0000-0003-2045-9364	National Science Foundation Graduate Research Fellowship Program [DGE-0824162]; National Science Foundation Early Career Award [CBET 1452549]; Achievement Rewards for College Students - Chicago Chapter Scholar Award; McCormick School of Engineering Terminal Year Fellowship; Institute for Sustainability and Energy at Northwestern Early Career Investigator award; McCormick School of Engineering; Searle Leadership Fund; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); National Science Foundation Early Career Award(National Science Foundation (NSF)); Achievement Rewards for College Students - Chicago Chapter Scholar Award; McCormick School of Engineering Terminal Year Fellowship; Institute for Sustainability and Energy at Northwestern Early Career Investigator award; McCormick School of Engineering; Searle Leadership Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge funding from the National Science Foundation (http://www.nsf.gov/) Graduate Research Fellowship Program (K.S.) (Grant no. DGE-0824162), the National Science Foundation Early Career Award (Grant no. CBET 1452549), the Achievement Rewards for College Students (https://www.arcsfoundation.org/) - Chicago Chapter Scholar Award (K.S.), a McCormick School of Engineering (https://www.mccormick.northwestern.edu/) Terminal Year Fellowship (K.S.), the Institute for Sustainability and Energy at Northwestern (http://isen.northwestern.edu/) Early Career Investigator award, the McCormick School of Engineering, and Searle Leadership Fund (http://www.research.northwestern.edu/policies/searle.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bayer TS, 2005, NAT BIOTECHNOL, V23, P337, DOI 10.1038/nbt1069; Brockman IM, 2015, BIOTECHNOL J, V10, P1360, DOI 10.1002/biot.201400422; Brockman IM, 2015, METAB ENG, V28, P104, DOI 10.1016/j.ymben.2014.12.005; Cameron DE, 2014, NAT BIOTECHNOL, V32, P1276, DOI 10.1038/nbt.3053; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Cookson NA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.94; Daringer NM, 2014, ACS SYNTH BIOL, V3, P892, DOI 10.1021/sb400128g; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Daum G, 2014, P NATL ACAD SCI USA, V111, P14619, DOI 10.1073/pnas.1406446111; Davis JH, 2011, ACS CHEM BIOL, V6, P1205, DOI 10.1021/cb2001389; De Donatis GM, 2010, J BIOL CHEM, V285, P8771, DOI 10.1074/jbc.M109.053736; DEBOER HA, 1983, P NATL ACAD SCI-BIOL, V80, P21; DENNIS PP, 1974, J MOL BIOL, V84, P407, DOI 10.1016/0022-2836(74)90449-5; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Farrell CM, 2005, MOL MICROBIOL, V57, P1750, DOI 10.1111/j.1365-2958.2005.04798.x; Flynn JM, 2001, P NATL ACAD SCI USA, V98, P10584, DOI 10.1073/pnas.191375298; Gerosa L, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.14; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Hillson NJ, 2012, ACS SYNTH BIOL, V1, P14, DOI 10.1021/sb2000116; Hintsche M, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-22; Humbard MA, 2013, J BIOL CHEM, V288, P28913, DOI 10.1074/jbc.M113.492108; Keasling JD, 2012, METAB ENG, V14, P189, DOI 10.1016/j.ymben.2012.01.004; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Klumpp S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020403; Knight J, 2014, E COMMUNICATION; LARRABEE KL, 1980, J BIOL CHEM, V255, P4125; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; McGinness KE, 2006, MOL CELL, V22, P701, DOI 10.1016/j.molcel.2006.04.027; MOSTELLER RD, 1980, J BIOL CHEM, V255, P2524; NATH K, 1971, J BIOL CHEM, V246, P6956; Ninnis RL, 2009, EMBO J, V28, P1732, DOI 10.1038/emboj.2009.134; Ortega J, 2004, J STRUCT BIOL, V146, P217, DOI 10.1016/j.jsb.2003.11.023; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Prindle A, 2014, NATURE, V508, P387, DOI 10.1038/nature13238; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Rodriguez-Limas WA, 2015, BIOTECHNOL BIOENG, V112, P376, DOI 10.1002/bit.25360; Schuenemann VJ, 2009, EMBO REP, V10, P508, DOI 10.1038/embor.2009.62; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; SKERRA A, 1994, GENE, V151, P131, DOI 10.1016/0378-1119(94)90643-2; Taxis C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.25; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Torella JP, 2013, P NATL ACAD SCI USA, V110, P11290, DOI 10.1073/pnas.1307129110; Tyo KEJ, 2010, CURR OPIN MICROBIOL, V13, P255, DOI 10.1016/j.mib.2010.02.001; VOGEL U, 1994, J BACTERIOL, V176, P2807, DOI 10.1128/JB.176.10.2807-2813.1994; Wang KH, 2008, J BIOL CHEM, V283, P24600, DOI 10.1074/jbc.M802213200; Wang KH, 2007, GENE DEV, V21, P403, DOI 10.1101/gad.1511907; Yu T, 2014, CELL RES, V24, P1214, DOI 10.1038/cr.2014.122; Zorzini V, 2015, NUCLEIC ACIDS RES, V43, P1241, DOI 10.1093/nar/gku1352	52	19	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149746	10.1371/journal.pone.0149746	http://dx.doi.org/10.1371/journal.pone.0149746			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900850	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100141
J	Zhang, WP; Tian, FJ; Zheng, JP; Li, SL; Qiang, M				Zhang, Wenping; Tian, Fengjie; Zheng, Jinping; Li, Senlin; Qiang, Mei			Chronic Administration of Benzo(a)pyrene Induces Memory Impairment and Anxiety-Like Behavior and Increases of NR2B DNA Methylation	PLOS ONE			English	Article							LONG-TERM POTENTIATION; RECEPTOR 2B SUBUNIT; NMDA RECEPTORS; BIPOLAR DISORDER; GENE-EXPRESSION; GRIN2B GENE; FEMALE MICE; F344 RATS; EXPOSURE; ASSOCIATION	Background Recently, an increasing number of human and animal studies have reported that exposure to benzo(a) pyrene (BaP) induces neurological abnormalities and is also associated with adverse effects, such as tumor formation, immunosuppression, teratogenicity, and hormonal disorders. However, the exact mechanisms underlying BaP-induced impairment of neurological function remain unclear. The aim of this study was to examine the regulating mechanisms underlying the impact of chronic BaP exposure on neurobehavioral performance. Methods C57BL mice received either BaP in different doses (1.0, 2.5, 6.25 mg/kg) or olive oil twice a week for 90 days. Memory and emotional behaviors were evaluated using Y-maze and open-field tests, respectively. Furthermore, levels of mRNA expression were measured by using qPCR, and DNA methylation of NMDA receptor 2B subunit (NR2B) was examined using bisulfate pyrosequencing in the prefrontal cortex and hippocampus. Results Compared to controls, mice that received BaP (2.5, 6.25 mg/kg) showed deficits in short-term memory and an anxiety-like behavior. These behavioral alterations were associated with a down-regulation of the NR2B gene and a concomitant increase in the level of DNA methylation in the NR2B promoter in the two brain regions. Conclusions Chronic BaP exposure induces an increase in DNA methylation in the NR2B gene promoter and down-regulates NR2B expression, which may contribute to its neurotoxic effects on behavioral performance. The results suggest that NR2B vulnerability represents a target for environmental toxicants in the brain.	[Zhang, Wenping; Tian, Fengjie; Zheng, Jinping] Shanxi Med Univ, Sch Publ Hlth, Dept Neurotoxicol, Taiyuan 030001, Shanxi, Peoples R China; [Qiang, Mei] Shanxi Med Univ, Sch Publ Hlth, Dept Children & Adolescences, Taiyuan 030001, Shanxi, Peoples R China; [Li, Senlin] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA	Shanxi Medical University; Shanxi Medical University; University of Texas System; University of Texas Health San Antonio	Qiang, M (corresponding author), Shanxi Med Univ, Sch Publ Hlth, Dept Children & Adolescences, Taiyuan 030001, Shanxi, Peoples R China.	qiang@uthscsa.edu			Science and Technology Innovation Fund of Shanxi Medical University [2010-01201006]; Shanxi Scholar Exchange Fund [2010-40]; Shanxi Scholarship Council of China [2015-051]	Science and Technology Innovation Fund of Shanxi Medical University; Shanxi Scholar Exchange Fund; Shanxi Scholarship Council of China	This work was supported by the Science and Technology Innovation Fund of Shanxi Medical University (Grant #2010-01201006 for Wenping Zhang) and the Shanxi Scholar Exchange Fund (Grant #2010-40 for Wenping Zhang) and Shanxi Scholarship Council of China (Grant #2015-051 For Mei Qiang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso P, 2012, J PSYCHIATR NEUROSCI, V37, P273, DOI 10.1503/jpn.110109; Altmann L, 2001, TOXICOL SCI, V61, P321, DOI 10.1093/toxsci/61.2.321; Baccarelli A, 2009, AM J RESP CRIT CARE, V179, P572, DOI 10.1164/rccm.200807-1097OC; Baraldi M, 2002, ENVIRON HEALTH PERSP, V110, P855, DOI 10.1289/ehp.02110s5855; Bouayed J, 2009, TOXICOLOGY, V259, P97, DOI 10.1016/j.tox.2009.02.010; Boyce-Rustay JM, 2006, PSYCHOPHARMACOLOGY, V187, P455, DOI 10.1007/s00213-006-0448-6; Brigman JL, 2010, J NEUROSCI, V30, P4590, DOI 10.1523/JNEUROSCI.0640-10.2010; Brown LA, 2007, NEUROTOXICOLOGY, V28, P965, DOI 10.1016/j.neuro.2007.05.005; Cao XH, 2007, EUR J NEUROSCI, V25, P1815, DOI 10.1111/j.1460-9568.2007.05431.x; Chen HH, 2004, ANN NY ACAD SCI, V1025, P552, DOI 10.1196/annals.1316.067; Cimino F, 2014, DRUG CHEM TOXICOL, V37, P32, DOI 10.3109/01480545.2013.806529; Cui YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020312; DAS M, 1985, B ENVIRON CONTAM TOX, V35, P500, DOI 10.1007/BF01636545; David R, 2016, ENVIRON HEALTH PERSP, V124, P88, DOI 10.1289/ehp.1409557; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Fontan-Lozano A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024915; Grova N, 2008, CHEMOSPHERE, V73, pS295, DOI 10.1016/j.chemosphere.2007.12.037; Grova N, 2007, NEUROTOXICOLOGY, V28, P630, DOI 10.1016/j.neuro.2007.01.010; IARC Monogr, 2011, IARC MONOGR EVAL CAR, P219; JAYASEKARA S, 1992, ECOTOX ENVIRON SAFE, V24, P1, DOI 10.1016/0147-6513(92)90029-3; Jiang HQ, 2009, NEUROSCI LETT, V450, P356, DOI 10.1016/j.neulet.2008.10.075; Kim SY, 2005, EXP MOL MED, V37, P58, DOI 10.1038/emm.2005.8; Kohr G, 2006, CELL TISSUE RES, V326, P439, DOI 10.1007/s00441-006-0273-6; Lett TA, 2014, BIOL PSYCHIAT, V75, P361, DOI 10.1016/j.biopsych.2013.07.026; Ma JH, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-33; Maciel ES, 2014, NEUROCHEM RES, V39, P731, DOI 10.1007/s11064-014-1261-y; Maddox SA, 2011, LEARN MEMORY, V18, P579, DOI 10.1101/lm.2243411; Martucci L, 2006, SCHIZOPHR RES, V84, P214, DOI 10.1016/j.schres.2006.02.001; McCallister MM, 2008, NEUROTOXICOLOGY, V29, P846, DOI 10.1016/j.neuro.2008.07.008; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Palaszewska-Tkacz A, 2015, MED PR, V66, P29; Patri M, 2013, J NEUROSCI RES, V91, P1450, DOI 10.1002/jnr.23265; Perera FP, 2003, ENVIRON HEALTH PERSP, V111, P201, DOI 10.1289/ehp.5742; Qiang M, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu072; Qiang M, 2011, EPIGENETICS-US, V6, P1095, DOI 10.4161/epi.6.9.16924; Qiang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008798; Qiu CY, 2013, AM J IND MED, V56, P347, DOI 10.1002/ajim.22119; Ramesh A, 2001, EXP TOXICOL PATHOL, V53, P275, DOI 10.1078/0940-2993-00192; Salazar A, 2012, HORM BEHAV, V62, P202, DOI 10.1016/j.yhbeh.2012.03.010; Saunders CR, 2002, TOXICOL LETT, V129, P33, DOI 10.1016/S0378-4274(01)00467-2; Schellenberger MT, 2013, TOXICOL APPL PHARM, V271, P175, DOI 10.1016/j.taap.2013.05.007; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Seripa D, 2008, DEMENT GERIATR COGN, V25, P287, DOI 10.1159/000118634; Stephanou P, 1998, EUR J DRUG METAB PH, V23, P475, DOI 10.1007/BF03189998; Sze CI, 2001, J NEUROL SCI, V182, P151, DOI 10.1016/S0022-510X(00)00467-6; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Verma N, 2012, PROTEOMICS, V12, P1731, DOI 10.1002/pmic.201100466; Wormley DD, 2004, CELL MOL BIOL, V50, P715; Wormley DD, 2004, TOXICOL APPL PHARM, V197, P49, DOI 10.1016/j.taap.2004.01.016; Xia YY, 2011, NEUROTOXICOLOGY, V32, P188, DOI 10.1016/j.neuro.2010.12.015; Yin XL, 2011, NEURON, V70, P310, DOI 10.1016/j.neuron.2011.02.049; Zhang XH, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-9; Zhao QA, 2011, PSYCHIAT RES, V185, P290, DOI 10.1016/j.psychres.2009.11.026	54	20	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149574	10.1371/journal.pone.0149574	http://dx.doi.org/10.1371/journal.pone.0149574			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901155	gold, Green Submitted, Green Published			2022-12-27	WOS:000371276100100
J	Zhou, HH; Lv, K; Yang, RT; Li, Z; Li, ZB				Zhou, Haihua; Lv, Kun; Yang, Rongtao; Li, Zhi; Li, Zubing			Mechanics in the Production of Mandibular Fractures: A Clinical, Retrospective Case-Control Study	PLOS ONE			English	Article							CONDYLAR FRACTURES; 3RD MOLARS; MAXILLOFACIAL FRACTURES; DENTAL INJURIES; ANGLE FRACTURE; TRAUMA; ETIOLOGY; BODY; ASSOCIATION; SYMPHYSIS	As the mandible is susceptible to fracture, the aim of this study was to use multivariate logistic regression analysis to identify and distinguish various internal factors that may influence the location of mandibular fractures. The study included 1131 patients with maxillofacial fractures during the period from January 2000 to December 2009 to evaluate the association of mandibular fracture location (unilateral symphysis, body, angle, condylar, or bilateral condylar fractures) with various internal factors. Among the 1131 patients, 869 had mandibular fractures. Data on age, sex, soft tissue injuries, dental trauma, and maxillofacial fracture type were collected and analyzed using multivariate logistic regression. In total, 387, 210, 139, 319, and 172 patients were diagnosed with unilateral symphysis, body, angle, unilateral, or bilateral condylar fractures, respectively. The dental trauma in patients with bilateral condylar fractures differed from that in patients with unilateral condylar fractures. Patients with mandibular fracture (unilateral symphysis, body, unilateral or bilateral condylar) possessed an approximately equal risk of soft tissue injuries in the mandible. Patients with either unilateral or bilateral condylar fractures were associated with a low risk of mandibular angle fracture (OR < 1). Similarly, patients with mandibular angle fracture were associated with a low risk of unilateral or bilateral condylar fractures (OR < 1). Moreover, patients with symphysis fracture were associated with a low risk of bilateral condylar fractures (90 of 387 [23.3%], OR 0.899). By contrast, patients with bilateral condylar fractures were associated with a high risk of symphysis fracture (90 of 172 [52.3%], OR 17.38). Patients with condylar fractures, particularly those with bilateral condylar fractures, were infrequently associated with secondary mandibular fractures. Mandibular fractures tended to have less of an association with midfacial fractures. The occurrence of mandibular fractures is strongly correlated with age, sex, soft tissue injuries, dental trauma, and the pattern and position of the maxillofacial fractures in patients.	[Zhou, Haihua; Lv, Kun; Yang, Rongtao; Li, Zhi; Li, Zubing] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430072, Hubei, Peoples R China; [Zhou, Haihua; Lv, Kun; Yang, Rongtao; Li, Zhi; Li, Zubing] Wuhan Univ, Sch & Hosp Stomatol, Key Lab Oral Biomed, Minist Educ, Wuhan 430072, Hubei, Peoples R China; [Zhou, Haihua; Lv, Kun; Yang, Rongtao; Li, Zhi; Li, Zubing] Wuhan Univ, Coll & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Wuhan 430072, Hubei, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Li, ZB (corresponding author), Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430072, Hubei, Peoples R China.; Li, ZB (corresponding author), Wuhan Univ, Sch & Hosp Stomatol, Key Lab Oral Biomed, Minist Educ, Wuhan 430072, Hubei, Peoples R China.; Li, ZB (corresponding author), Wuhan Univ, Coll & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Wuhan 430072, Hubei, Peoples R China.	lizubing0827@163.com	Lv, Kun/S-1265-2019	Lv, Kun/0000-0002-1329-4381	Fundamental Research Funds for the Central Universities [2042014kf0137]; National Natural Science Foundation of China [81300854, 81470718, 81271107]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Fundamental Research Funds for the Central Universities (grant no. 2042014kf0137); National Natural Science Foundation of China (grant no. 81300854; grant no. 81470718; grant no. 81271107).	COPE MR, 1985, BRIT J ORAL MAX SURG, V23, P112, DOI 10.1016/0266-4356(85)90060-9; DAFONSECA GD, 1974, INT J ORAL MAXILLOF, V3, P89, DOI 10.1016/S0300-9785(74)80040-2; Duan DH, 2008, INT J ORAL MAX SURG, V37, P25, DOI 10.1016/j.ijom.2007.07.010; Erol BE, 2004, J CRANIO MAXILL SURG, V32, P308, DOI 10.1016/j.jcms.2004.04.006; Flynn Thomas R, 2004, PETERSONS PRINCIPLE, V2nd, P277; Fuselier JC, 2002, J ORAL MAXIL SURG, V60, P514, DOI 10.1053/joms.2002.31847; Gassner R, 2003, J CRANIO MAXILL SURG, V31, P51, DOI 10.1016/S1010-5182(02)00168-3; Goodday RHB, 2013, ORAL MAXIL SURG CLIN, V25, P601, DOI 10.1016/j.coms.2013.07.002; Halazonetis J A, 1968, Br J Oral Surg, V6, P37, DOI 10.1016/S0007-117X(68)80025-3; He D, 2008, J ORAL MAXIL SURG, V66, P77, DOI 10.1016/j.joms.2007.08.013; HUELKE D F, 1964, J Oral Surg Anesth Hosp Dent Serv, V22, P396; HUELKE D F, 1962, J Oral Surg Anesth Hosp Dent Serv, V20, P478; HUELKE DF, 1961, J DENT RES, V40, P1042, DOI 10.1177/00220345610400050601; HUELKE DF, 1961, J DENT RES, V40, P1262, DOI 10.1177/00220345610400062001; IGNATIUS ET, 1992, ENDOD DENT TRAUMATOL, V8, P235; Krimmel M, 2000, J ORAL MAXIL SURG, V58, P1110, DOI 10.1053/joms.2000.9566; Lieger O, 2009, J ORAL MAXIL SURG, V67, P1680, DOI 10.1016/j.joms.2009.03.052; LINDAHL L, 1977, INT J ORAL MAXILLOF, V6, P12, DOI 10.1016/S0300-9785(77)80067-7; Mitsukawa N, 2004, J CRANIOFAC SURG, V15, P229, DOI 10.1097/00001665-200403000-00011; PETZEL JR, 1981, J MAXILLOFAC SURG, V9, P211, DOI 10.1016/S0301-0503(81)80046-X; REITZIK M, 1978, INT J ORAL MAXILLOF, V7, P100, DOI 10.1016/S0300-9785(78)80054-4; RUDDERMAN RH, 1992, CLIN PLAST SURG, V19, P11; SILVENNOINEN U, 1993, ENDOD DENT TRAUMATOL, V9, P254; Subhashraj K, 2009, J ORAL MAXIL SURG, V67, P968, DOI 10.1016/j.joms.2008.09.005; Thangavelu A, 2010, INT J ORAL MAX SURG, V39, P136, DOI 10.1016/j.ijom.2009.12.005; Zhou HH, 2013, DENT TRAUMATOL, V29, P291, DOI 10.1111/j.1600-9657.2012.01173.x; Zhou HH, 2013, DENT TRAUMATOL, V29, P285, DOI 10.1111/j.1600-9657.2012.01169.x; Zhou HH, 2013, J CRANIO MAXILL SURG, V41, P34, DOI 10.1016/j.jcms.2012.05.007; Zhou HH, 2012, J CRANIOFAC SURG, V23, pE494, DOI 10.1097/SCS.0b013e3182646525	29	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149553	10.1371/journal.pone.0149553	http://dx.doi.org/10.1371/journal.pone.0149553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900699	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100096
J	Zhu, ZF; Wang, HR; Yu, JS; Doug, J				Zhu, Zhongfan; Wang, Hongrui; Yu, Jingshan; Doug, Jie			On the Kaolinite Floc Size at the Steady State of Flocculation in a Turbulent Flow	PLOS ONE			English	Article							ACTIVATED-SLUDGE FLOCCULATION; VARIABLE FRACTAL DIMENSION; SHEAR-INDUCED FLOCCULATION; COHESIVE SEDIMENT; PARTICLE-SIZE; SETTLING VELOCITY; AGGREGATE SIZE; BREAKUP; DEPENDENCE; STRENGTH	The flocculation of cohesive fine-grained sediment plays an important role in the transport characteristics of pollutants and nutrients absorbed on the surface of sediment in estuarine and coastal waters through the complex processes of sediment transport, deposition, resuspension and consolidation. Many laboratory experiments have been carried out to investigate the influence of different flow shear conditions on the floc size at the steady state of flocculation in the shear flow. Most of these experiments reported that the floc size decreases with increasing shear stresses and used a power law to express this dependence. In this study, we performed a Couette-flow experiment to measure the size of the kaolinite floc through sampling observation and an image analysis system at the steady state of flocculation under six flow shear conditions. The results show that the negative correlation of the floc size on the flow shear occurs only at high shear conditions, whereas at low shear conditions, the floc size increases with increasing turbulent shear stresses regardless of electrolyte conditions. Increasing electrolyte conditions and the initial particle concentration could lead to a larger steady-state floc size.	[Zhu, Zhongfan; Wang, Hongrui; Yu, Jingshan] Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China; [Doug, Jie] Univ Tokyo, Dept Nat Environm Studies, Kashiwa, Chiba, Japan	Beijing Normal University; University of Tokyo	Yu, JS (corresponding author), Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China.	jingshanyubnu@163.com	Dou, Jie/K-2809-2013	Dou, Jie/0000-0001-5930-199X; Zhu, Zhongfan/0000-0003-0579-608X	National Natural Science Foundation of China [51279006, 51479003]; Fundamental Research Funds for the Central Universities in China [2013NT50]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities in China	This work received support from the National Natural Science Foundation of China (51279006, 51479003), URL: http://isisn.nsfc.gov.cn/egrantweb/. The funder had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. It also received support from the Fundamental Research Funds for the Central Universities in China (Number: 2013NT50), URL: http://kejichu.bnu.edu.cn/. This funder had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biggs CA, 2000, WATER RES, V34, P2542, DOI 10.1016/S0043-1354(99)00431-5; Bower C, 1997, COLLOID SURFACE A, V127, P105, DOI 10.1016/S0927-7757(96)03945-3; Bubakova P, 2013, POWDER TECHNOL, V235, P540, DOI 10.1016/j.powtec.2012.11.014; Camp T.R., 1943, J BOSTON SOC CIVIL E, V30, P219; Colomer J, 2005, WATER RES, V39, P2994, DOI 10.1016/j.watres.2005.04.076; Cuthbertson AJS, 2010, COAST ENG, V57, P447, DOI 10.1016/j.coastaleng.2009.11.011; Ding A, 2006, CHEM ENG SCI, V61, P63, DOI 10.1016/j.ces.2005.02.074; DYER KR, 1989, J GEOPHYS RES-OCEANS, V94, P14327, DOI 10.1029/JC094iC10p14327; Ehrl L, 2008, LANGMUIR, V24, P3070, DOI 10.1021/la7032302; Ehrl L, 2010, AICHE J, V56, P2573, DOI 10.1002/aic.12179; Ehrl L, 2009, AICHE J, V55, P3076, DOI 10.1002/aic.11923; Flesch JC, 1999, AICHE J, V45, P1114, DOI 10.1002/aic.690450518; FRANCOIS RJ, 1988, J AM WATER WORKS ASS, V80, P92; Hinze J. O., 1975, TURBULENCE; Hopkins DC, 2003, J COLLOID INTERF SCI, V264, P184, DOI 10.1016/S0021-9797(03)00446-6; Jarvis P, 2005, WATER RES, V39, P3121, DOI 10.1016/j.watres.2005.05.022; Liang C., 2004, THESIS TSINGHUA U BE; Lu SC, 1998, ADV COLLOID INTERFAC, V78, P197, DOI 10.1016/S0001-8686(98)00062-1; Maerz J, 2011, CONT SHELF RES, V31, pS84, DOI 10.1016/j.csr.2010.05.011; Maggi F, 2007, J HYDROL, V343, P43, DOI 10.1016/j.jhydrol.2007.05.035; Maggi F, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003951; Manning AJ, 1999, MAR GEOL, V160, P147, DOI 10.1016/S0025-3227(99)00013-4; Markussen TN, 2014, J SEA RES, V89, P1, DOI 10.1016/j.seares.2014.02.001; OLES V, 1992, J COLLOID INTERF SCI, V154, P351, DOI 10.1016/0021-9797(92)90149-G; PARKER DS, 1972, J SANIT ENG DIV ASCE, V98, P79; Pejrup M, 2010, ESTUAR COAST SHELF S, V87, P177, DOI 10.1016/j.ecss.2009.09.028; Rahmani NHG, 2003, AICHE J, V49, P1645, DOI 10.1002/aic.690490705; Rudraiah N., 1986, ENCY FLUID MECH SLUR, P567; Safak I, 2013, CONT SHELF RES, V53, P1, DOI 10.1016/j.csr.2012.11.015; Selomulya C, 2003, CHEM ENG SCI, V58, P327, DOI 10.1016/S0009-2509(02)00523-7; Selomulya C, 2001, J COLLOID INTERF SCI, V236, P67, DOI 10.1006/jcis.2000.7372; Serra T, 1997, J COLLOID INTERF SCI, V187, P466, DOI 10.1006/jcis.1996.4710; Serra T, 1998, J COLLOID INTERF SCI, V206, P505, DOI 10.1006/jcis.1998.5714; Serra T, 2008, WATER RES, V42, P1113, DOI 10.1016/j.watres.2007.08.027; Smoluchowski M, 1917, Z PHYS CHEM, V92; Son M, 2009, WATER RES, V43, P3582, DOI 10.1016/j.watres.2009.05.016; Son MW, 2008, ENVIRON FLUID MECH, V8, P55, DOI 10.1007/s10652-007-9050-7; Soos M, 2007, J COLLOID INTERF SCI, V307, P433, DOI 10.1016/j.jcis.2006.12.016; Spicer PT, 1996, J COLLOID INTERF SCI, V184, P112, DOI 10.1006/jcis.1996.0601; Spicer PT, 1996, AICHE J, V42, P1612, DOI 10.1002/aic.690420612; Spicer PT, 1996, WATER RES, V30, P1049, DOI 10.1016/0043-1354(95)00253-7; Stone M, 2003, WATER RES, V37, P2739, DOI 10.1016/S0043-1354(03)00082-4; TAMBO N, 1979, WATER RES, V13, P429, DOI 10.1016/0043-1354(79)90035-6; Tang S, 2001, COLLOID SURFACE A, V180, P7, DOI 10.1016/S0927-7757(00)00743-3; Thomas DN, 1999, WATER RES, V33, P1579, DOI 10.1016/S0043-1354(98)00392-3; van Leussen W, 2011, OCEAN DYNAM, V61, P387, DOI 10.1007/s10236-011-0384-9; WILLIAMS RA, 1992, POWDER TECHNOL, V73, P75, DOI 10.1016/0032-5910(92)87009-Y; Winterwerp JC, 2006, ESTUAR COAST SHELF S, V68, P195, DOI 10.1016/j.ecss.2006.02.003; Winterwerp JC, 2002, CONT SHELF RES, V22, P1339, DOI 10.1016/S0278-4343(02)00010-9; Winterwerp JC, 1998, J HYDRAUL RES, V36, P309, DOI 10.1080/00221689809498621; [杨铁笙 Yang Tiesheng], 2002, [水利学报, Journal of Hydraulic Engineering], V0, P20; Zhang JJ, 2003, AICHE J, V49, P1870, DOI 10.1002/aic.690490723; Zhang X., 1996, ADV WATER SCI, V7, P54; Zhao M., 2010, THESIS TSINGHUA U BE; Zhu Z., 2009, THESIS TSINGHUA U BE; Zhu Z., 2014, J GEOSCIENCE ENV PRO, V2, P13; Zhu ZF, 2015, WATER-SUI, V7, P4385, DOI 10.3390/w7084385	57	10	10	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148895	10.1371/journal.pone.0148895	http://dx.doi.org/10.1371/journal.pone.0148895			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901652	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100027
J	Berger, GE; Smesny, S; Schafer, MR; Milleit, B; Langbein, K; Hipler, UC; Milleit, C; Klier, CM; Schlogelhofer, M; Holub, M; Holzer, I; Berk, M; McGorry, PD; Sauer, H; Amminger, GP				Berger, Gregor E.; Smesny, Stefan; Schaefer, Miriam R.; Milleit, Berko; Langbein, Kerstin; Hipler, Uta-Christina; Milleit, Christine; Klier, Claudia M.; Schloegelhofer, Monika; Holub, Magdalena; Holzer, Ingrid; Berk, Michael; McGorry, Patrick D.; Sauer, Heinrich; Amminger, G. Paul			Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis	PLOS ONE			English	Article							FATTY-ACID; PHOSPHOLIPASE-A2 ACTIVITY; MEMBRANE ABNORMALITIES; ERYTHROCYTE-MEMBRANES; NICOTINIC-ACID; FLUSH TEST; SCHIZOPHRENIA; OMEGA-3-FATTY-ACIDS; 1ST-EPISODE; METAANALYSIS	Background Most studies provide evidence that the skin flush response to nicotinic acid (niacin) stimulation is impaired in schizophrenia. However, only little is known about niacin sensitivity in the ultra-high risk (UHR) phase of psychotic disorders. Methods We compared visual ratings of niacin sensitivity between adolescents at UHR for psychosis according to the one year transition outcome (UHR-T n = 11; UHR-NT n = 55) with healthy controls (HC n = 25) and first episode schizophrenia patients (FEP n = 25) treated with atypical antipsychotics. Results Contrary to our hypothesis niacin sensitivity of the entire UHR group was not attenuated, but significantly increased compared to the HC group, whereas no difference could be found between the UHR-T and UHR-NT groups. As expected, niacin sensitivity of FEP was attenuated compared to HC group. In UHR individuals niacin sensitivity was inversely correlated with omega-6 and -9 fatty acids (FA), but positively correlated with phospholipase A(2) (inPLA(2)) activity, a marker of membrane lipid repair/remodelling. Conclusions Increased niacin sensitivity in UHR states likely indicates an impaired balance of eicosanoids and omega-6/-9 FA at a membrane level. Our findings suggest that the emergence of psychosis is associated with an increased mobilisation of eicosanoids prior to the transition to psychosis possibly reflecting a "pro-inflammatory state", whereas thereafter eicosanoid mobilisation seems to be attenuated. Potential treatment implications for the UHR state should be further investigated.	[Berger, Gregor E.] Univ Zurich, Univ Hosp Child & Adolescent Psychiat, Neumunsterallee 9, CH-8032 Zurich, Switzerland; [Smesny, Stefan; Milleit, Berko; Langbein, Kerstin; Milleit, Christine; Sauer, Heinrich] Jena Univ Hosp, Dept Psychiat, Philosophenweg 3, D-07743 Jena, Germany; [Schaefer, Miriam R.; McGorry, Patrick D.; Amminger, G. Paul] Univ Melbourne, Orygen Youth Hlth Res Ctr, Locked Bag 10,35 Poplar Rd, Melbourne, Vic 3052, Australia; [Schaefer, Miriam R.; Klier, Claudia M.; Schloegelhofer, Monika; Amminger, G. Paul] Med Univ Vienna, Dept Child & Adolescent Psychiat, Wahringergurtel 18-20, A-1090 Vienna, Austria; [Hipler, Uta-Christina] Univ Hosp Jena, Dept Dermatol, Erfurter Str 35, D-07743 Jena, Germany; [Holub, Magdalena; Holzer, Ingrid] Univ Vienna, Dept Nutr Sci, Althanstr 14, A-1090 Vienna, Austria; [Berk, Michael] Deakin Univ Melbourne, Sch Med, Barwon Hlth, Geelong, Vic, Australia; [Berk, Michael] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia	University Children's Hospital Zurich; University of Zurich; Friedrich Schiller University of Jena; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; Medical University of Vienna; Friedrich Schiller University of Jena; University of Vienna; Deakin University; Florey Institute of Neuroscience & Mental Health	Smesny, S (corresponding author), Jena Univ Hosp, Dept Psychiat, Philosophenweg 3, D-07743 Jena, Germany.	stefan.smesny@med.uni-jena.de	McGorry, Patrick/O-4115-2019; Berk, Michael/M-3585-2019; Berger, Gregor E/AAE-1786-2021; Amminger, G. Paul/ABE-1579-2020; Berk, Michael/M-7891-2013	Berk, Michael/0000-0002-5554-6946; Amminger, G. Paul/0000-0001-8969-4595; Berk, Michael/0000-0002-5554-6946; Berger, Gregor/0000-0003-2030-141X; McGorry, Patrick/0000-0002-3789-6168; Klier, Claudia/0000-0003-0696-8904	Stanley Medical Research Institute [03T-315]; National Health and Medical Research Council, Australia [566529]	Stanley Medical Research Institute; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	The study was supported by Stanley Medical Research Institute, grant 03T-315. Dr. G. Paul Amminger was supported by grant 566529 from the National Health and Medical Research Council, Australia. The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Allen P, 2012, SCHIZOPHRENIA BULL, V38, P1268, DOI 10.1093/schbul/sbr194; Amminger GP, 2012, MOL PSYCHIATR, V17, P1150, DOI 10.1038/mp.2011.167; Amminger GP, 2010, ARCH GEN PSYCHIAT, V67, P146, DOI 10.1001/archgenpsychiatry.2009.192; Assies J, 2014, ACTA PSYCHIAT SCAND, V130, P163, DOI 10.1111/acps.12265; Bazan NG, 2005, MOL NEUROBIOL, V32, P89, DOI 10.1385/MN:32:1:089; Berger GE, 2008, NEUROPSYCHOPHARMACOL, V33, P2467, DOI 10.1038/sj.npp.1301628; Berger Gregor E, 2003, Psychopharmacol Bull, V37, P79; Berger GE, 2012, CURR PHARM DESIGN, V18, P570; Bodatsch M, 2011, BIOL PSYCHIAT, V69, P959, DOI 10.1016/j.biopsych.2010.09.057; Borgwardt S, 2013, SCHIZOPHRENIA BULL, V39, P1105, DOI 10.1093/schbul/sbs095; Buretic-Tomljanovic A, 2008, PSYCHIAT DANUB, V20, P372; Byun MS, 2009, PSYCHIAT INVEST, V6, P264, DOI 10.4306/pi.2009.6.4.264; Chang SS, 2009, SCHIZOPHRENIA BULL, V35, P213, DOI 10.1093/schbul/sbm153; Do KQ, 2009, CURR OPIN NEUROBIOL, V19, P220, DOI 10.1016/j.conb.2009.05.001; Do KQ, 2000, EUR J NEUROSCI, V12, P3721, DOI 10.1046/j.1460-9568.2000.00229.x; DWORKIN RH, 1994, SCHIZOPHRENIA BULL, V20, P235, DOI 10.1093/schbul/20.2.235; Eisenacher S, 2015, PSYCHOL MED, V45, P3329, DOI 10.1017/S0033291715001373; Emsley R, 2003, CNS DRUGS, V17, P1081, DOI 10.2165/00023210-200317150-00003; Farooqui AA, 1998, CELL MOL NEUROBIOL, V18, P599, DOI 10.1023/A:1020261600498; Farooqui AA, 2004, PROSTAG LEUKOTR ESS, V71, P161, DOI 10.1016/j.plefa.2004.03.004; FAROOQUI AA, 1994, J NEUROSCI RES, V38, P6, DOI 10.1002/jnr.490380103; FAROOQUI AA, 1987, NEUROCHEM PATHOL, V7, P99, DOI 10.1007/BF02834212; Fenton WS, 2000, BIOL PSYCHIAT, V47, P8, DOI 10.1016/S0006-3223(99)00092-X; Fusar-Poli P, 2014, SCHIZOPHRENIA BULL, V40, P120, DOI 10.1093/schbul/sbs136; GATTAZ WF, 1987, BIOL PSYCHIAT, V22, P421, DOI 10.1016/0006-3223(87)90164-8; Hermesh H, 2000, AM J PSYCHIAT, V157, P1327, DOI 10.1176/appi.ajp.157.8.1327; HOFFER A, 1964, ACTA PSYCHIAT SCAND, V40, P171, DOI 10.1111/j.1600-0447.1964.tb05744.x; HOFFER A, 1969, J AMER MED ASSOC, V207, P1355, DOI 10.1001/jama.1969.03150200121025; HORROBIN DF, 1980, J ORTHOMOL MED, V9, P33; HORROBIN DF, 1977, LANCET, V1, P936; HORROBIN DF, 1994, SCHIZOPHR RES, V13, P195, DOI 10.1016/0920-9964(94)90043-4; Horrobin DF, 1999, SEARCH FOR THE CAUSES OF SCHIZOPHRENIA, VOL IV, P261; Hudson CJ, 1997, BIOL PSYCHIAT, V41, P507, DOI 10.1016/S0006-3223(96)00112-6; Kerr M, 2008, PROSTAG LEUKOTR ESS, V79, P15, DOI 10.1016/j.plefa.2008.06.001; KLEIJNEN J, 1991, BIOL PSYCHIAT, V29, P931, DOI 10.1016/0006-3223(91)90060-Y; Klosterkotter J, 1996, EUR ARCH PSY CLIN N, V246, P147, DOI 10.1007/BF02189116; Law MH, 2006, MOL PSYCHIATR, V11, P547, DOI 10.1038/sj.mp.4001819; McGorry PD, 2014, LANCET PSYCHIAT, V1, P559, DOI 10.1016/S2215-0366(14)00082-0; Messamore E, 2003, SCHIZOPHR RES, V62, P251, DOI 10.1016/S0920-9964(02)00311-0; Miller T J, 2000, Conn Med, V64, P339; Mocking RJT, 2015, PSYCHONEUROENDOCRINO, V59, P1, DOI 10.1016/j.psyneuen.2015.04.027; Morrison AP, 2015, PSYCHOL MED, V45, P2675, DOI 10.1017/S0033291715000689; Muller N, 2012, PSYCHIAT RES, V198, P341, DOI 10.1016/j.psychres.2011.12.049; MURRELL TW, 1959, ARCH DERMATOL, V79, P545, DOI 10.1001/archderm.1959.01560170043008; Nadalin S, 2010, PSYCHIAT DANUB, V22, P14; Nieminen LRG, 2006, PROSTAG LEUKOTR ESS, V75, P309, DOI 10.1016/j.plefa.2006.07.012; Oken RJ, 1999, SCHIZOPHRENIA BULL, V25, P625, DOI 10.1093/oxfordjournals.schbul.a033407; Olabi B, 2011, BIOL PSYCHIAT, V70, P88, DOI 10.1016/j.biopsych.2011.01.032; PIOMELLI D, 1994, CRIT REV NEUROBIOL, V8, P65; Potvin S, 2008, BIOL PSYCHIAT, V63, P801, DOI 10.1016/j.biopsych.2007.09.024; Puri BK, 2002, PROG NEURO-PSYCHOPH, V26, P49, DOI 10.1016/S0278-5846(01)00220-2; Puri BK, 2001, INT J CLIN PRACT, V55, P368; Ross BM, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-21; Ross BM, 2009, PROSTAG LEUKOTR ESS, V81, P309, DOI 10.1016/j.plefa.2009.10.004; Schultze-Lutter F, 2012, CURR PHARM DESIGN, V18, P351, DOI 10.2174/138161212799316064; Seidman LJ, 2010, ARCH GEN PSYCHIAT, V67, P578, DOI 10.1001/archgenpsychiatry.2010.66; Smesny S, 2005, PROSTAG LEUKOTR ESS, V72, P393, DOI 10.1016/j.plefa.2005.02.007; Smesny S, 2004, J PSYCHIAT RES, V38, P537, DOI 10.1016/j.jpsychires.2004.01.007; Smesny S, 2014, MOL PSYCHIATR, V19, P317, DOI 10.1038/mp.2013.7; Smesny S, 2003, J PSYCHIAT RES, V37, P237, DOI 10.1016/S0022-3956(03)00006-2; Smesny S, 2007, PROSTAG LEUKOTR ESS, V77, P79, DOI 10.1016/j.plefa.2007.08.006; Smesny S, 2007, NEUROPSYCHOPHARMACOL, V32, P2067, DOI 10.1038/sj.npp.1301343; Smesny S, 2010, J AFFECT DISORDERS, V124, P335, DOI 10.1016/j.jad.2009.12.017; Tassoni D, 2008, ASIA PAC J CLIN NUTR, V17, P220; Tavares H, 2003, SCHIZOPHR RES, V61, P1, DOI 10.1016/S0920-9964(02)00281-5; van der Kemp WJM, 2012, SCHIZOPHR RES, V141, P153, DOI 10.1016/j.schres.2012.08.014; Ward PE, 1998, SCHIZOPHR RES, V29, P269, DOI 10.1016/S0920-9964(97)00100-X; WILLIAMS JH, 1989, NATURE, V341, P739, DOI 10.1038/341739a0; Wood SJ, 2008, SCHIZOPHRENIA BULL, V34, P322, DOI 10.1093/schbul/sbm149; Wood SJ, 2010, PSYCHIAT RES-NEUROIM, V182, P180, DOI 10.1016/j.pscychresns.2009.12.003; Yao JK, 2006, DIS MARKERS, V22, P83, DOI 10.1155/2006/248387; Yao JK, 2011, ANTIOXID REDOX SIGN, V15, P2011, DOI 10.1089/ars.2010.3603; Yao Jeffrey K, 2002, ScientificWorldJournal, V2, P1922; Yao JK, 2004, PROSTAG LEUKOTR ESS, V71, P171, DOI 10.1016/j.plefa.2004.03.011; Yung AR, 2012, CURR PHARM DESIGN, V18, P346; Yung AR, 2012, AUST NZ J PSYCHIAT, V46, P7, DOI 10.1177/0004867411432205; Yung AR, 2003, SCHIZOPHR RES, V60, P21, DOI 10.1016/S0920-9964(02)00167-6	77	20	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148429	10.1371/journal.pone.0148429	http://dx.doi.org/10.1371/journal.pone.0148429			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894921	Green Published, Green Accepted, gold			2022-12-27	WOS:000371223400014
J	Chamnan, P; Simmons, RK; Sharp, SJ; Khaw, KT; Wareham, NJ; Griffin, SJ				Chamnan, Parinya; Simmons, Rebecca K.; Sharp, Stephen J.; Khaw, Kay-Tee; Wareham, Nicholas J.; Griffin, Simon J.			Repeat Cardiovascular Risk Assessment after Four Years: Is There Improvement in Risk Prediction?	PLOS ONE			English	Article							PRIMARY PREVENTION; PRIMARY-CARE; DISEASE; 10-YEAR; ADULTS; SCORE	Background Framingham risk equations are widely used to predict cardiovascular disease based on health information from a single time point. Little is known regarding use of information from repeat risk assessments and temporal change in estimated cardiovascular risk for prediction of future cardiovascular events. This study was aimed to compare the discrimination and risk reclassification of approaches using estimated cardiovascular risk at single and repeat risk assessments Methods Using data on 12,197 individuals enrolled in EPIC-Norfolk cohort, with 12 years of follow-up, we examined rates of cardiovascular events by levels of estimated absolute risk (Framingham risk score) at the first and second health examination four years later. We calculated the area under the receiver operating characteristic curve (aROC) and risk reclassification, comparing approaches using information from single and repeat risk assessments (i.e., estimated risk at different time points). Results The mean Framingham risk score increased from 15.5% to 17.5% over a mean of 3.7 years from the first to second health examination. Individuals with high estimated risk (>= 20%) at both health examinations had considerably higher rates of cardiovascular events than those who remained in the lowest risk category (< 10%) in both health examinations (34.0 [95% CI 31.7-36.6] and 2.7 [2.2-3.3] per 1,000 person-years respectively). Using information from the most up-to-date risk assessment resulted in a small non-significant change in risk classification over the previous risk assessment (net reclassification improvement of -4.8%, p > 0.05). Using information from both risk assessments slightly improved discrimination compared to information from a single risk assessment (aROC 0.76 and 0.75 respectively, p < 0.001). Conclusions Using information from repeat risk assessments over a period of four years modestly improved prediction, compared to using data from a single risk assessment. However, this approach did not improve risk classification.	[Chamnan, Parinya; Simmons, Rebecca K.; Sharp, Stephen J.; Wareham, Nicholas J.; Griffin, Simon J.] Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England; [Chamnan, Parinya] Sanpasitthiprasong Hosp, Dept Social Med, Cardiometab Res Grp, Ubon Ratchathani, Thailand; [Khaw, Kay-Tee] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Clin Gerontol Unit, Cambridge CB2 2QQ, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Chamnan, P (corresponding author), Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England.; Chamnan, P (corresponding author), Sanpasitthiprasong Hosp, Dept Social Med, Cardiometab Res Grp, Ubon Ratchathani, Thailand.	parinya.chamnan@cardiomet-res.org		Chamnan, Parinya/0000-0002-5202-4149; Simmons, Rebecca/0000-0002-7726-8529	National Institute for Health Research (NIHR) Programme Grant [RP-PG-0606-1259]; MRC [MC_UU_12015/1, MC_UU_12015/4]; Medical Research Council [MC_U106179474, G0401527, MR/N003284/1, MC_UU_12015/4, MC_UU_12015/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114, NF-SI-0512-10135] Funding Source: researchfish; MRC [MR/N003284/1, MC_U106179474] Funding Source: UKRI	National Institute for Health Research (NIHR) Programme Grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Dr. Griffin receives support from the National Institute for Health Research (NIHR) Programme Grant funding scheme (RP-PG-0606-1259). This work was also supported by MRC grants (MC_UU_12015/1 and MC_UU_12015/4). The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boekholdt MS, 2004, AM J MED, V117, P390, DOI 10.1016/j.amjmed.2004.04.010; Brindle P, 2006, HEART, V92, P1752, DOI 10.1136/hrt.2006.087932; Chamnan P, 2009, DIABETOLOGIA, V52, P2001, DOI 10.1007/s00125-009-1454-0; Chamnan P, 2011, DIABETES CARE, V34, P950, DOI 10.2337/dc09-2326; CUPPLES LA, 1988, STAT MED, V7, P205, DOI 10.1002/sim.4780070122; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Day N, 1999, BRIT J CANCER, V80, P95; *DEP HLTH, 2008, PUTTING PREVENTION F, P68431; Department of Health, 2008, EC MOD VASC CHECKS; Gaziano JM, 2012, JAMA-J AM MED ASSOC, V308, P816, DOI 10.1001/2012.jama.10456; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Greenland P, 2010, CIRCULATION, V122, pE584, DOI 10.1161/CIR.0b013e3182051b4c; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hingorani AD, 2009, JAMA-J AM MED ASSOC, V302, P2144, DOI 10.1001/jama.2009.1698; Hippisley-Cox J, 2011, BMJ-BRIT MED J, V341, pc6624; Jackson R, 2011, BMJ-BRIT MED J, V341, pc7379; Karp I, 2004, AM J EPIDEMIOL, V160, P707, DOI 10.1093/aje/kwh258; Lloyd-Jones DM, 2004, AM J CARDIOL, V94, P20, DOI 10.1016/j.amjcard.2004.03.023; Lloyd-Jones DM, 2010, CIRCULATION, V121, P1768, DOI 10.1161/CIRCULATIONAHA.109.849166; Lloyd-Jones DM, 2006, CURR OPIN LIPIDOL, V17, P619, DOI 10.1097/MOL.0b013e3280108740; Marma AK, 2010, CIRC-CARDIOVASC QUAL, V3, P8, DOI 10.1161/CIRCOUTCOMES.109.869727; National Institute for Health and Clinical Excellence, 2008, CARD RISK ASS MOD BL; Persell SD, 2010, ARCH INTERN MED, V170, P470, DOI 10.1001/archinternmed.2009.525; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988	25	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0147417	10.1371/journal.pone.0147417	http://dx.doi.org/10.1371/journal.pone.0147417			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895071	Green Published, Green Submitted, gold			2022-12-27	WOS:000371223400004
J	Lemma, S; Avnet, S; Salerno, M; Chano, T; Baldini, N				Lemma, Silvia; Avnet, Sofia; Salerno, Manuela; Chano, Tokuhiro; Baldini, Nicola			Identification and Validation of Housekeeping Genes for Gene Expression Analysis of Cancer Stem Cells	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; TIME QUANTITATIVE PCR; DIFFERENTIATING HUMAN; BETA-ACTIN; TUMORS; SELECTION; SARCOMAS; NORMALIZATION; MANAGEMENT; QPCR	The characterization of cancer stem cell (CSC) subpopulation, through the comparison of the gene expression signature in respect to the native cancer cells, is particularly important for the identification of novel and more effective anticancer strategies. However, CSC have peculiar characteristics in terms of adhesion, growth, and metabolism that possibly implies a different modulation of the expression of the most commonly used housekeeping genes (HKG), like b-actin (ACTB). Although it is crucial to identify which are the most stable HKG genes to normalize the data derived from quantitative Real-Time PCR analysis to obtain robust and consistent results, an exhaustive validation of reference genes in CSC is still missing. Here, we isolated CSC spheres from different musculoskeletal sarcomas and carcinomas as a model to investigate on the stability of the mRNA expression of 15 commonly used HKG, in respect to the native cells. The selected genes were analysed for the variation coefficient and compared using the popular algorithms NormFinder and geNorm to evaluate stability ranking. As a result, we found that: 1) Tata Binding Protein (TBP), Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta polypeptide (YWHAZ), Peptidylprolyl isomerase A (PPIA), and Hydroxymethylbilane synthase (HMBS) are the most stable HKG for the comparison between CSC and native cells; 2) at least four reference genes should be considered for robust results; 3) the use of ACTB should not be recommended, 4) specific HKG should be considered for studies that are focused only on a specific tumor type, like sarcoma or carcinoma. Our results should be taken in consideration for all the studies of gene expression analysis of CSC, and will substantially contribute for future investigations aimed to identify novel anticancer therapy based on CSC targeting.	[Lemma, Silvia; Avnet, Sofia; Salerno, Manuela; Baldini, Nicola] Ist Ortoped Rizzoli, Lab Orthopaed Pathophysiol & Regenerat Med, Bologna, Italy; [Lemma, Silvia; Baldini, Nicola] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Chano, Tokuhiro] Shiga Univ Med Sci, Dept Clin Lab Med, Otsu, Shiga 52021, Japan	IRCCS Istituto Ortopedico Rizzoli; University of Bologna; Shiga University of Medical Science	Lemma, S (corresponding author), Ist Ortoped Rizzoli, Lab Orthopaed Pathophysiol & Regenerat Med, Bologna, Italy.; Lemma, S (corresponding author), Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy.	silvia.lemma@ior.it	Baldini, Nicola/J-4806-2016; Chano, Tokuhiro/F-5816-2018; Lemma, Silvia/O-1119-2017; Lemma, Silvia/AAY-3835-2020; Avnet, Sofia/B-3220-2018	Baldini, Nicola/0000-0003-2228-3833; Chano, Tokuhiro/0000-0002-9959-1183; Lemma, Silvia/0000-0003-0714-3138; Avnet, Sofia/0000-0002-7843-0591	Italian Ministry of Education, University and Research [FIRB RBAP10447J]; Italian Association for Cancer Research (AIRC) [IG11426]; Italian Ministry of the Health	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of the Health(Ministry of Health, Italy)	This work was supported by grant (FIRB RBAP10447J to NB) from the Italian Ministry of Education, University and Research, by the Italian Association for Cancer Research (AIRC IG11426 to NB), and by the Italian Ministry of the Health, Financial Support for Scientific Research "5 per mille 2012" (to NB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Crea F, 2009, EPIGENOMICS-UK, V1, P63, DOI 10.2217/EPI.09.4; Curtis KM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-61; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Deindl E, 2002, MOL CELL BIOCHEM, V236, P139, DOI 10.1023/A:1016166127465; Gibbs CP, 2005, NEOPLASIA, V7, P967, DOI 10.1593/neo.05394; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hermann PC, 2008, CELL CYCLE, V7, P188, DOI 10.4161/cc.7.2.5326; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Huang YS, 2012, APOPTOSIS, V17, P749, DOI 10.1007/s10495-012-0734-1; Kowalewska M, 2012, CLIN BIOCHEM, V45, P368, DOI 10.1016/j.clinbiochem.2012.01.001; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luis AM, 2010, CLIN TRANSL ONCOL, V12, P543, DOI 10.1007/s12094-010-0552-2; Monument MJ, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00024; Mueller Maria-Theresa, 2010, Front Biosci (Elite Ed), V2, P602, DOI 10.2741/e117; Oktem G, 2014, ONCOL LETT, V7, P2103, DOI 10.3892/ol.2014.1992; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Ragni E, 2013, J CELL MOL MED, V17, P168, DOI 10.1111/j.1582-4934.2012.01660.x; Rho HW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-240; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Salerno M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110340; Salerno M, 2013, INT J ONCOL, V43, P95, DOI 10.3892/ijo.2013.1927; Selvey S, 2001, MOL CELL PROBE, V15, P307, DOI 10.1006/mcpr.2001.0376; Siclari VA, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-78; Singh SK, 2003, CANCER RES, V63, P5821; Suva ML, 2009, CANCER RES, V69, P1776, DOI 10.1158/0008-5472.CAN-08-2242; Synnergren J, 2007, STEM CELLS, V25, P473, DOI 10.1634/stemcells.2006-0247; Szabo A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r59; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Walker NJ, 2002, SCIENCE, V296, P557, DOI 10.1126/science.296.5567.557; Walter D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019506; Willems E, 2006, INT J DEV BIOL, V50, P627, DOI 10.1387/ijdb.052130ew	42	39	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149481	10.1371/journal.pone.0149481	http://dx.doi.org/10.1371/journal.pone.0149481			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894994	Green Submitted, Green Published, gold			2022-12-27	WOS:000371223400058
J	Ndejjo, R; Mukama, T; Musabyimana, A; Musoke, D				Ndejjo, Rawlance; Mukama, Trasias; Musabyimana, Angele; Musoke, David			Uptake of Cervical Cancer Screening and Associated Factors among Women in Rural Uganda: A Cross Sectional Study	PLOS ONE			English	Article							PAP-SMEAR; KNOWLEDGE; ATTITUDES; RISK	Background In developing countries, inadequate access to effective screening for cervical cancer often contributes to the high morbidity and mortality caused by the disease. The largest burden of this falls mostly on underserved populations in rural areas, where health care access is characterized by transport challenges, ill equipped health facilities, and lack of information access. This study assessed uptake of cervical cancer screening and associated factors among women in rural Uganda. Methods This descriptive cross sectional study was carried out in Bugiri and Mayuge districts in eastern Uganda and utilised quantitative data collection methods. Data were collected using a semi-structured questionnaire on cervical cancer screening among females aged between 25 and 49 years who had spent six or more months in the area. Data were entered in Epi-data 3.02 and analysed in STATA 12.0 statistical software. Univariate, bivariate and multivariate analyses were performed. Results Of the 900 women, only 43 (4.8%) had ever been screened for cervical cancer. Among respondents who were screened, 21 (48.8%) did so because they had been requested by a health worker, 17 (39.5%) had certain signs and symptoms they associated with cervical cancer while 16 (37.2%) did it voluntarily to know their status. Barriers to cervical cancer screening were negative individual perceptions 553 (64.5%) and health facility related challenges 142 (16.6%). Other respondents said they were not aware of the screening service 416 (48.5%). The independent predictors of cervical cancer screening were: being recommended by a health worker [AOR = 87.85, p<0.001], knowing where screening services were offered [AOR = 6.24, p = 0.004], and knowing someone who had ever been screened [AOR = 9.48, p = 0.001]. Conclusion The prevalence of cervical cancer screening is very low in rural Uganda. Interventions to increase uptake of cervical cancer screening should be implemented so as to improve access to the service in rural areas.	[Ndejjo, Rawlance; Mukama, Trasias; Musoke, David] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda; [Musabyimana, Angele] Univ Rwanda, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Community Hlth, Kigali, Rwanda	Makerere University; University of Rwanda	Ndejjo, R (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda.	rndejjo@musph.ac.ug	Mukama, Trasias/U-7179-2019; Musabyimana, Angèle/GLR-9496-2022	Mukama, Trasias/0000-0002-6520-5272; Musabyimana, Angèle/0000-0001-9708-3137; Musoke, David/0000-0003-3262-3918; Ndejjo, Rawlance/0000-0001-9263-557X	Training Health Researchers into Vocational Excellence in East Africa (THRiVE) - Wellcome Trust [087540]	Training Health Researchers into Vocational Excellence in East Africa (THRiVE) - Wellcome Trust	This work was supported by Training Health Researchers into Vocational Excellence in East Africa (THRiVE), grant number 087540 funded by the Wellcome Trust. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the supporting offices. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi A, 2009, PUBLIC HEALTH, V123, P680, DOI 10.1016/j.puhe.2009.09.011; [Anonymous], 1986, B WORLD HEALTH ORGAN, V64, P607; Ayinde O A, 2003, J Obstet Gynaecol, V23, P59, DOI 10.1080/0144361021000043272; Bessler Patricia, 2007, Cancer Control, V14, P396; Bingham A, 2003, SALUD PUBLICA MEXICO, V45, pS408; Bruni L, 2019, ICO IARC INFORM CTR; Cristina Herdman JS, 2000, PLANNING APPROPRIATE; Cunningham MS, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005828; Gakidou E, 2008, PLOS MED, V5, P863, DOI 10.1371/journal.pmed.0050132; Gamarra CJ, 2009, PUBLIC HEALTH NURS, V26, P269, DOI 10.1111/j.1525-1446.2009.00779.x; Gharoro EP, 2006, INT J GYNECOL CANCER, V16, P1063, DOI 10.1111/j.1525-1438.2006.00579.x; Gichangi P, 2003, INT J GYNECOL CANCER, V13, P827, DOI 10.1111/j.1525-1438.2003.13612.x; Hatcher J, 2011, J HEALTH CARE POOR U, V22, P176, DOI 10.1353/hpu.2011.0021; Hogg M. A., 2010, HDB SOCIAL PSYCHOL; Holowaty P, 1999, JNCI-J NATL CANCER I, V91, P252, DOI 10.1093/jnci/91.3.252; Holroyd E, 2004, J ADV NURS, V46, P42, DOI 10.1111/j.1365-2648.2003.02964.x; Kish L, 1965, SURVEY SAMPLING; Lyimo FS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-22; Ministry of Health, 2010, STRAT PLAN CERV CANC; Mukama T, 2015, WOMENS KNOWLEDGE ATT; Mupepi SC, 2011, J WOMENS HEALTH, V20, P943, DOI 10.1089/jwh.2010.2062; Mutyaba Twaha, 2006, BMC Med Educ, V6, P13, DOI 10.1186/1472-6920-6-13; Mutyaba Twaha, 2007, Reprod Health, V4, P4, DOI 10.1186/1742-4755-4-4; Ncube B, 2015, N AM J MED SCI, V7, P104, DOI 10.4103/1947-2714.153922; Ndikom C. M., 2011, INT J NURSING MIDWIF, V3, P158; Sankaranarayanan R, 2007, LANCET, V370, P398, DOI 10.1016/S0140-6736(07)61195-7; Sudenga SL, 2013, INT J GYNECOL CANCER, V23, P895, DOI 10.1097/IGC.0b013e31828e425c; Twinomujuni C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128498; UBOS, 2014, NATL POPULATION HOUS; Waller J, 2004, BRIT J PSYCHOL, V95, P219, DOI 10.1348/000712604773952430; Wellensiek N, 2002, INT J GYNECOL CANCER, V12, P376, DOI 10.1046/j.1525-1438.2002.01114.x; Were E, 2011, AFR HEALTH SCI, V11, P58; WHO, 2006, COMPR CERV CANC CONT; World Health Organization, 2003, HUM PAP VIR INF CERV; World Health Organization (WHO), 2010, HUM PAP REL CANC	35	70	70	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149696	10.1371/journal.pone.0149696	http://dx.doi.org/10.1371/journal.pone.0149696			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3DG	26894270	Green Submitted, gold, Green Published			2022-12-27	WOS:000371223400075
J	Robusto, F; Lepore, V; D'Ettorre, A; Lucisano, G; De Berardis, G; Bisceglia, L; Tognoni, G; Nicolucci, A				Robusto, Fabio; Lepore, Vito; D'Ettorre, Antonio; Lucisano, Giuseppe; De Berardis, Giorgia; Bisceglia, Lucia; Tognoni, Gianni; Nicolucci, Antonio			The Drug Derived Complexity Index (DDCI) Predicts Mortality, Unplanned Hospitalization and Hospital Readmissions at the Population Level	PLOS ONE			English	Article							MULTIPLE CHRONIC CONDITIONS; HIGH-RISK; PHARMACY DATA; CARE; DISEASE; QUALITY; COSTS; VALIDATION; ADJUSTMENT; ADMISSION	Objective to develop and validate the Drug Derived Complexity Index (DDCI), a predictive model derived from drug prescriptions able to stratify the general population according to the risk of death, unplanned hospital admission, and readmission, and to compare the new predictive index with the Charlson Comorbidity Index (CCI). Design Population-based cohort study, using a record-linkage analysis of prescription databases, hospital discharge records, and the civil registry. The predictive model was developed based on prescription patterns indicative of chronic diseases, using a random sample of 50% of the population. Multivariate Cox proportional hazards regression was used to assess weights of different prescription patterns and drug classes. The predictive properties of the DDCI were confirmed in the validation cohort, represented by the other half of the population. The performance of DDCI was compared to the CCI in terms of calibration, discrimination and reclassification. Setting 6 local health authorities with 2.0 million citizens aged 40 years or above. Results One year and overall mortality rates, unplanned hospitalization rates and hospital readmission rates progressively increased with increasing DDCI score. In the overall population, the model including age, gender and DDCI showed a high performance. DDCI predicted 1-year mortality, overall mortality and unplanned hospitalization with an accuracy of 0.851, 0.835, and 0.584, respectively. If compared to CCI, DDCI showed discrimination and reclassification properties very similar to the CCI, and improved prediction when used in combination with the CCI. Conclusions and Relevance DDCI is a reliable prognostic index, able to stratify the entire population into homogeneous risk groups. DDCI can represent an useful tool for risk-adjustment, policy planning, and the identification of patients needing a focused approach in everyday practice.	[Robusto, Fabio; Lepore, Vito; D'Ettorre, Antonio] Mario Negri Sud Fdn, Dept Clin Pharmacol & Epidemiol, Santa Maria Imbaro, CH, Italy; [Bisceglia, Lucia] Reg Hlth Agcy Puglia, Bari, BA, Italy; [Lucisano, Giuseppe; De Berardis, Giorgia; Nicolucci, Antonio] Ctr Outcomes Res & Clin Epidemiol, Pescara, PE, Italy; [Tognoni, Gianni] IRRCS Mario Negri Milano, Milan, MI, Italy		Robusto, F (corresponding author), Mario Negri Sud Fdn, Dept Clin Pharmacol & Epidemiol, Santa Maria Imbaro, CH, Italy.	fabiorobusto@libero.it	D'Ettorre, Antonio/ABG-2375-2020; Lepore, Vito/ABG-4356-2020	D'Ettorre, Antonio/0000-0002-5880-4234; Lepore, Vito/0000-0002-5466-780X; Bisceglia, Lucia/0000-0001-6256-3747; Robusto, Fabio/0000-0002-4932-1636	ASSEHS (Activation of Stratification Strategies and Results of the intervention on frail patients of Healthcare Services) EU project [2013 12 04]; European Community's Seventh Framework Programme (FR7/EU project-the ASSEHS project (Activation of Stratification Strategies and Results of the intervention on frail patients of Healthcare Services) [2013 12 04]	ASSEHS (Activation of Stratification Strategies and Results of the intervention on frail patients of Healthcare Services) EU project; European Community's Seventh Framework Programme (FR7/EU project-the ASSEHS project (Activation of Stratification Strategies and Results of the intervention on frail patients of Healthcare Services)	This study was developed as a part of ASSEHS (Activation of Stratification Strategies and Results of the intervention on frail patients of Healthcare Services) EU project (2013 12 04), with no direct funding for its implementation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Regional Health Agency and the Department of Health of the Puglia Region for the cooperation, general interest, and provision of data. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FR7/EU project (2013 12 04)-the ASSEHS project (Activation of Stratification Strategies and Results of the intervention on frail patients of Healthcare Services).	Adie E, 2006, SPARRA SCOTTISH PATI; Bernabeu-Wittel M, 2011, EUR J INTERN MED, V22, P311, DOI 10.1016/j.ejim.2010.11.012; Billings J, 2012, IMPROVING MANAGEMENT; Billings J, 2006, BRIT MED J, V333, P327, DOI 10.1136/bmj.38870.657917.AE; Bisharat N, 2012, EUR J INTERN MED, V23, P457, DOI 10.1016/j.ejim.2012.03.004; BOULT C, 1993, J AM GERIATR SOC, V41, P811, DOI 10.1111/j.1532-5415.1993.tb06175.x; Castlefields Health Centre, CHRON DIS MAN; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Cousins Michael S, 2003, Dis Manag, V6, P207, DOI 10.1089/109350703322682522; Cousins MS, 2002, DIS MANAG, V5, P157, DOI DOI 10.1089/109350702760301448; Curry N, 2005, PREDICTIVE RISK PROJ; D'Agostino RB, 2004, HDB STAT, V23; De Berardis G, 2012, NUTR METAB CARDIOVAS, V22, P605, DOI 10.1016/j.numecd.2010.10.016; De Berardis G, 2012, JAMA-J AM MED ASSOC, V307, P2286, DOI 10.1001/jama.2012.5034; De Lepeleire J, 2009, BRIT J GEN PRACT, V59, P364, DOI 10.3399/bjgp09X420653; Keenoy ED, 2014, EUR GERIATR MED, V5, P342, DOI 10.1016/j.eurger.2014.07.011; Department of Health, 2004, LEARN DIST CHRON DIS; DHoore W, 1996, J CLIN EPIDEMIOL, V49, P1429, DOI 10.1016/S0895-4356(96)00271-5; Dudley RA, 2003, MED CARE, V41, P56; Erviti J, 2013, BMJ OPEN, V3, DOI [10.1136/bmjopen-2012-002084, 10.1136/bmjopen-2012-002091]; Falasca P, 2011, ANN I SUPER SANITA, V47, P220, DOI 10.4415/ANN_11_02_15; Fishman PA, 2003, MED CARE, V41, P84, DOI 10.1097/00005650-200301000-00011; Gagne JJ, 2011, J CLIN EPIDEMIOL, V64, P749, DOI 10.1016/j.jclinepi.2010.10.004; George J, 2006, ANN PHARMACOTHER, V40, P645, DOI 10.1345/aph.1G204; Gorman J, 2010, IRISH J MED SCI, V179, P255, DOI 10.1007/s11845-009-0452-z; HARP, CHRON DIS MAN; Hsot MW., 2006, RAPID OVERVIEW EVIDE; InterRAI, INT SUIT INSTR; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Macchia A, 2007, EUR J HEART FAIL, V9, P942, DOI 10.1016/j.ejheart.2007.06.004; Maio V, 2006, J HEALTH SERV RES PO, V10, P232; Monte S, 2006, G ITAL CARDIOL, V7, P206, DOI 10.1714/694.7990; Monte S, 2006, EUR HEART J, V27, P2217, DOI 10.1093/eurheartj/ehl208; Naessens JM, 2011, AM J MANAG CARE, V17, P118; PACALA JT, 1995, J AM GERIATR SOC, V43, P374, DOI 10.1111/j.1532-5415.1995.tb05810.x; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Polder JJ, 2006, SOC SCI MED, V63, P1720, DOI 10.1016/j.socscimed.2006.04.018; Scurti V, 2005, ITAL J CLIN PHARM, V19, P102; Tsai TC, 2013, NEW ENGL J MED, V369, P1134, DOI 10.1056/NEJMsa1303118; *US DEP HHS, 1998, INT CLASS DIS; van Walraven Carl, 2012, Open Med, V6, pe80; van Walraven C, 2010, CAN MED ASSOC J, V182, P551, DOI 10.1503/cmaj.091117; Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1; von Walraven C, 2010, CMAJ, V182, P551, DOI [10.1503/cmaj.091117, DOI 10.1503/CMAJ.091117]; VONKORFF M, 1992, J CLIN EPIDEMIOL, V45, P197, DOI 10.1016/0895-4356(92)90016-G; Wennberg D, 2006, COMBINED PREDICTIVE; Wennberg JE, 2002, MED CARE, V40, P853, DOI 10.1097/00005650-200210000-00003; WHO Collaborating Centre for Drug Statistics Methodology, 2003, ATC IND WITH DDDS; Wong ELY, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-149; Yurkovich M, 2015, J CLIN EPIDEMIOL, V68, P3, DOI 10.1016/j.jclinepi.2014.09.010; Zekry D, 2012, J AM MED DIR ASSOC, V13, P272, DOI 10.1016/j.jamda.2010.11.011	51	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149203	10.1371/journal.pone.0149203	http://dx.doi.org/10.1371/journal.pone.0149203			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895073	gold, Green Published, Green Submitted			2022-12-27	WOS:000371223400037
J	Kim, J; Oh, B; Lim, JE; Kim, MK				Kim, Jihye; Oh, Bermseok; Lim, Ji Eun; Kim, Mi Kyung			No Interaction with Alcohol Consumption, but Independent Effect of C12orf51 (HECTD4) on Type 2 Diabetes Mellitus in Korean Adults Aged 40-69 Years: The KoGES_Ansan and Ansung Study	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE GENOTYPES; GENOME-WIDE ASSOCIATION; DRINKING BEHAVIOR; INSULIN-RESISTANCE; SYNTAXIN 8; ALDH2; RISK; METAANALYSIS; JAPANESE; CHINESE	Previously, genetic polymorphisms of C12orf51 (HECTD4) (rs2074356 and/or rs11066280) have been shown to be related to alcohol consumption and type 2 diabetes (T2D). This study aimed to prospectively examine whether C12orf51 had an interaction with or independent effect on alcohol consumption and the risk of T2D. The present study included 3,244 men and 3,629 women aged 40 to 69 years who participated in the Korean Genome and Epidemiology Study (KoGES)_Ansan and Ansung Study. Cox proportional hazards models were used to estimate HRs and 95% CIs for T2D. rs2074356 and rs11066280 were associated with the risk of T2D after adjusting for alcohol consumption (rs2074356 for AA: HR = 0.39 and 95% CI = 0.17-0.87 in men, and HR = 0.36 and 95% CI = 0.13-0.96 in women; rs11066280 for AA: HR = 0.44 and 95% CI = 0.23-0.86 in men, and HR = 0.39 and 95% CI = 0.16-0.94 in women). We identified that the association of each variant (rs2074356 and rs11065756) in C12orf51 was nearly unchanged after adjusted for alcohol consumption. Therefore, the association of 2 SNPs in C12orf51 with diabetes may not be mediated by alcohol use. There was no interaction effect between alcohol consumption and the SNPs with T2D. However, even in never-drinkers, minor allele homozygote strongly influenced T2D risk reduction (rs2074356 for AA: HR = 0.35, 95% CI = 0.14-0.90, and p-trend = 0.0035 in men and HR = 0.34, 95% CI = 0.13-0.93, and p-trend = 0.2348 in women; rs11066280 for AA: HR = 0.36, 95% CI = 0.16-0.82, and p-trend = 0.0014 in men and HR = 0.39, 95% CI = 0.16-0.95, and p-trend = 0.3790 in women), while alcohol consumption did not influence the risk of T2D within each genotype. rs2074356 and rs11066280 in or near C12orf51, which is related to alcohol drinking behavior, may longitudinally decrease the risk of T2D, but not through regulation of alcohol consumption.	[Kim, Jihye; Kim, Mi Kyung] Hanyang Univ, Coll Med, Dept Prevent Med, Seoul 133791, South Korea; [Kim, Jihye; Kim, Mi Kyung] Hanyang Univ, Inst Hlth & Soc, Seoul 133791, South Korea; [Oh, Bermseok; Lim, Ji Eun] Kyung Hee Univ, Sch Med, Dept Biochem & Mol Biol, Seoul, South Korea	Hanyang University; Hanyang University; Kyung Hee University	Kim, MK (corresponding author), Hanyang Univ, Coll Med, Dept Prevent Med, Seoul 133791, South Korea.; Kim, MK (corresponding author), Hanyang Univ, Inst Hlth & Soc, Seoul 133791, South Korea.	kmkkim@hanyang.ac.kr			Research of Korea Centers for Disease Control and Prevention [HD14B0005]; Korea Centers for Disease Control & Prevention, Republic of Korea	Research of Korea Centers for Disease Control and Prevention; Korea Centers for Disease Control & Prevention, Republic of Korea	This research was supported by a fund (HD14B0005) by Research of Korea Centers for Disease Control and Prevention and MKK received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was provided with biospecimens and data from the Korean Genome Analysis Projects (4845-301), the Korean Genome and Epidemiology (4845-302) and Korea Biobank Project (4851-307, KBP-2014-000) that were supported by the Korea Centers for Disease Control & Prevention, Republic of Korea.	Aguiree F., 2013, IDF DIABETES ATLAS; Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657; Andre P, 2006, DIABETOLOGIA, V49, P2599, DOI 10.1007/s00125-006-0418-x; [Anonymous], 2013, 2013 STAT RESULTS CA; Baik I, 2008, ARCH INTERN MED, V168, P167, DOI 10.1001/archinternmed.2007.8; Baik I, 2011, AM J CLIN NUTR, V93, P809, DOI 10.3945/ajcn.110.001776; Baliunas DO, 2009, DIABETES CARE, V32, P2123, DOI 10.2337/dc09-0227; Bray GA., 2014, HDB OBESITY EPIDEMIO; Bu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139039; Carlsson S, 2005, DIABETOLOGIA, V48, P1051, DOI 10.1007/s00125-005-1768-5; Chen CH, 2014, PHYSIOL REV, V94, P1, DOI 10.1152/physrev.00017.2013; Chen T, 2010, DIABETES RES CLIN PR, V90, P352, DOI 10.1016/j.diabres.2010.09.017; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Doran N, 2007, J STUD ALCOHOL DRUGS, V68, P789, DOI 10.15288/jsad.2007.68.789; Faerch K, 2010, DIABETOLOGIA, V53, P858, DOI 10.1007/s00125-010-1673-4; Firlej M., 2008, DIABETOLOGIA DOSWIAD, V8, P143; Freemantle N, 2008, INT J CLIN PRACT, V62, P1391, DOI 10.1111/j.1742-1241.2008.01805.x; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Go MJ, 2014, DIABETES METAB J, V38, P375, DOI 10.4093/dmj.2014.38.5.375; Go MJ, 2013, J HUM GENET, V58, P362, DOI 10.1038/jhg.2013.14; Higuchi S, 1996, ALCOHOL CLIN EXP RES, V20, P493, DOI 10.1111/j.1530-0277.1996.tb01080.x; HIGUCHI S, 1994, LANCET, V343, P741, DOI 10.1016/S0140-6736(94)91629-2; Hilawe EH, 2013, B WORLD HEALTH ORGAN, V91, P671, DOI 10.2471/BLT.12.113415; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Joosten MM, 2008, DIABETOLOGIA, V51, P1375, DOI 10.1007/s00125-008-1031-y; Kiage J. N., 2014, Current Nutrition Reports, V3, P213; Kim KS, 1972, J KOREAN DIABETES AS, V1, P17; Kim TH, 2012, J KOREAN MED SCI, V27, P876, DOI 10.3346/jkms.2012.27.8.876; Kim YJ, 2011, NAT GENET, V43, P990, DOI 10.1038/ng.939; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; Lancha A, 2015, ARCH MED RES, V46, P47, DOI 10.1016/j.arcmed.2014.12.003; Luczak SE, 2006, PSYCHOL BULL, V132, P607, DOI 10.1037/0033-2909.132.4.607; Ministry of Health and Welfare KCfDCaP, 2013, KOR HLTH STAT 2013 K; MURAMATSU T, 1995, HUM GENET, V96, P151, DOI 10.1007/BF00207371; Okamoto K, 2001, ALCOHOL CLIN EXP RES, V25, p19S, DOI 10.1097/00000374-200106001-00006; Park K, 2009, DIABETES CARE, V32, P1302, DOI 10.2337/dc09-0259; Shin S, 2010, INT J GERIATR PSYCH, V25, P441, DOI 10.1002/gps.2358; The Korean Nutrition Society, 2000, RECOMMENDED DIETARY, V7th; Willett W., 2013, NUTR EPIDEMIOLOGY, V3rd, DOI DOI 10.1093/ACPROF:OSO/9780199754038.001.0001; World Health Organization, 2006, DEF DIAGN DIAB MELL; Yang XL, 2013, AM J CLIN NUTR, V97, P545, DOI 10.3945/ajcn.112.046482; Yin G, 2010, EPIDEMIOLOGY RES INT; Zhang LS, 2009, CELL MOL NEUROBIOL, V29, P115, DOI 10.1007/s10571-008-9303-0	44	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149321	10.1371/journal.pone.0149321	http://dx.doi.org/10.1371/journal.pone.0149321			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891264	Green Published, Green Submitted, gold			2022-12-27	WOS:000371221500033
J	von Bomhard, A; Elsasser, A; Ritschl, LM; Schwarz, S; Rotter, N				von Bomhard, Achim; Elsaesser, Alexander; Ritschl, Lucas Maximilian; Schwarz, Silke; Rotter, Nicole			Cryopreservation of Endothelial Cells in Various Cryoprotective Agents and Media - Vitrification versus Slow Freezing Methods	PLOS ONE			English	Article							ORGAN PRESERVATION; COLD-STORAGE; LIVING CELLS; DYSFUNCTION; PERFUSION; INJURY; HEPATOCYTES; PREVENTION; TOXICITY; HYPOXIA	Vitrification of endothelial cells (MHECT-5) has not previously been compared with controlled slow freezing methods under standardized conditions. To identify the best cryopreservation technique, we evaluated vitrification and standardized controlled-rate -1 degrees C/minute cell freezing in a -80 degrees C freezer and tested four cryoprotective agents (CPA), namely dimethyl sulfoxide (DMSO), ethylene glycol (EG), propylene glycol (PG), and glycerol (GLY), and two media, namely Dulbecco's modified Eagle medium Ham's F-12 (DMEM) and K+-modified TiProtec (K+TiP), which is a high-potassium-containing medium. Numbers of viable cells in proliferation were evaluated by the CellTiter 96 (R) A(Queous) One Solution Cell Proliferation Assay (Promega Corporation, Mannheim, Germany). To detect the exact frozen cell number per cryo vial, DNA content was measured by using Hoechst 33258 dye prior to analysis. Thus, results could be evaluated unconstrained by absolute cell number. Thawed cells were cultured in 25 cm(2) cell culture flasks to confluence and examined daily by phase contrast imaging. With regard to cell recovery immediately after thawing, DMSO was the most suitable CPA combined with K+TiP in vitrification (99 +/- 0.5%) and with DMEM in slow freezing (92 +/- 1.6%). The most viable cells in proliferation after three days of culture were obtained in cells vitrificated by using GLY with K+TiP (308 +/- 34%) and PG with DMEM in slow freezing (280 +/- 27%).	[von Bomhard, Achim; Ritschl, Lucas Maximilian] Tech Univ Munich, Dept Maxillofacial Surg, Langerstr 3, D-81675 Munich, Germany; [Elsaesser, Alexander; Schwarz, Silke; Rotter, Nicole] Univ Med Ctr Ulm, Dept Otorhinolaryngol, Frauensteige 12, D-89075 Ulm, Germany	Technical University of Munich; Ulm University	von Bomhard, A (corresponding author), Tech Univ Munich, Dept Maxillofacial Surg, Langerstr 3, D-81675 Munich, Germany.	achimvonbomhard@gmail.com		Rotter, Nicole/0000-0003-1537-8340				BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; COLLINS GM, 1969, LANCET, V2, P1219, DOI 10.1016/S0140-6736(69)90753-3; DALESSANDRO AM, 1994, SURG CLIN N AM, V74, P1083, DOI 10.1016/S0039-6109(16)46434-0; DAVIS JM, 1990, BLOOD, V75, P781; Fan WX, 2009, CRYOBIOLOGY, V58, P28, DOI 10.1016/j.cryobiol.2008.10.124; Janz Fde L., 2012, J BIOMED BIOTECHNOL, V2012, DOI DOI 10.1155/2012/649353; Katkov II, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/981606; Kawakami Y, 2012, J ANIM SCI, V90, P4256, DOI 10.2527/jas.2011-4884; KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5; Kirkpatrick CJ, 1996, VIRCHOWS ARCH, V427, P461; Krump-Konvalinkova V, 2001, LAB INVEST, V81, P1717, DOI 10.1038/labinvest.3780385; Lang F, 2005, J MEMBRANE BIOL, V205, P147, DOI 10.1007/s00232-005-0780-5; Lehr HA, 2000, THE JOURNAL OF PATHO, V190, P373, DOI [10.1002/(SICI)1096-9896(200002)190:3&LT;373::AID-PATH593&GT;3.0.CO;2-3, DOI 10.1002/(SICI)1096-9896(200002)190:3<373::AID-PATH593>3.0.CO;2-3]; LOVELOCK JE, 1959, NATURE, V183, P1394, DOI 10.1038/1831394a0; MERTENS S, 1990, AM J PHYSIOL, V258, pH689, DOI 10.1152/ajpheart.1990.258.3.H689; MERYMAN HT, 1974, ANNU REV BIOPHYS BIO, V3, P341, DOI 10.1146/annurev.bb.03.060174.002013; Moon JH, 2008, HUM REPROD, V23, P1760, DOI 10.1093/humrep/den202; Nishimura Y, 1998, HEPATOLOGY, V27, P1039, DOI 10.1002/hep.510270420; POLGE C, 1949, NATURE, V164, P666, DOI 10.1038/164666a0; PREUSSE CJ, 1981, THORAC CARDIOV SURG, V29, P71, DOI 10.1055/s-2007-1023446; Rauen U, 2004, J INVEST MED, V52, P299, DOI 10.1136/jim-52-05-29; Rauen U, 1999, FASEB J, V13, P155, DOI 10.1096/fasebj.13.1.155; Rauen U, 2007, CRYOBIOLOGY, V54, P77, DOI 10.1016/j.cryobiol.2006.11.008; SCHEFFEN B, 1986, CRYO-LETT, V7, P260; SUTTON RL, 1992, CRYOBIOLOGY, V29, P585, DOI 10.1016/0011-2240(92)90063-8; Syme R, 2004, BIOL BLOOD MARROW TR, V10, P135, DOI 10.1016/j.bbmt.2003.09.016; Verma S, 2002, CIRCULATION, V105, P546, DOI 10.1161/hc0502.104540; Wille T, 2008, J VASC SURG, V47, P422, DOI 10.1016/j.jvs.2007.09.048; Wu SL, 2009, J INVEST SURG, V22, P340, DOI 10.1080/08941930903214735; Yokoyama Wayne M, 2012, Curr Protoc Immunol, VAppendix 3, p3G, DOI 10.1002/0471142735.ima03gs99	30	16	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149660	10.1371/journal.pone.0149660	http://dx.doi.org/10.1371/journal.pone.0149660			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890410	Green Published, gold			2022-12-27	WOS:000371221500069
J	Buckley, RC; Morrison, C; Castley, JG				Buckley, Ralf C.; Morrison, Clare; Castley, J. Guy			Net Effects of Ecotourism on Threatened Species Survival	PLOS ONE			English	Article							PENGUINS SPHENISCUS-DEMERSUS; ZEALAND SEA LIONS; GLOBAL BIODIVERSITY; FOOD AVAILABILITY; CONSERVATION; MANAGEMENT; TOURISM; ISLAND; BOULDERS; SIZE	Many threatened species rely on ecotourism for conservation funding, but simultaneously suffer direct ecological impacts from ecotourism. For a range of IUCN-Redlisted terrestrial and marine bird and mammal species worldwide, we use population viability analyses to calculate the net effects of ecotourism on expected time to extinction, in the presence of other anthropogenic threats such as poaching, primary industries and habitat loss. Species for which these calculations are currently possible, for one or more subpopulations, include: orangutan, hoolock gibbon, golden lion tamarin, cheetah, African wild dog, New Zealand sealion, great green macaw, Egyptian vulture, and African penguin. For some but not all of these species, tourism can extend expected survival time, i.e., benefits outweigh impacts. Precise outcomes depend strongly on population parameters and starting sizes, predation, and ecotourism scale and mechanisms. Tourism does not currently overcome other major conservation threats associated with natural resource extractive industries. Similar calculations for other threatened species are currently limited by lack of basic population data.	[Buckley, Ralf C.; Morrison, Clare; Castley, J. Guy] Griffith Univ, Sch Environm, Gold Coast, Australia	Griffith University	Buckley, RC (corresponding author), Griffith Univ, Sch Environm, Gold Coast, Australia.	r.buckley@griffith.edu.au	Castley, James Guy/A-7056-2010	Castley, James Guy/0000-0002-8418-5828				[Anonymous], 2010, CONSERVATION TOURISM; Bach LA, 2010, J NAT CONSERV, V18, P237, DOI 10.1016/j.jnc.2009.09.001; Balmford Andrew, 2012, WILD HOPE FRONT LINE; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Birdlife International, 2012, SPEC FACTSH NEOPHR P; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Buckley R, 2014, SCIENCE, V344, P358, DOI 10.1126/science.344.6182.358-b; Buckley R, 2011, ANNU REV ENV RESOUR, V36, P397, DOI 10.1146/annurev-environ-041210-132637; Buckley RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044134; Buckley RC, 2012, NATURE, V489, P33, DOI 10.1038/489033b; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cassini MH, 2004, J ETHOL, V22, P127, DOI 10.1007/s10164-003-0112-0; Chassot O., 2012, PARKS, V18, P61; Chilvers BL, 2012, POLAR BIOL, V35, P1607, DOI 10.1007/s00300-011-1143-6; Chilvers B. Louise, 2008, Endangered Species Research, V5, P193, DOI 10.3354/esr00086; Coetzee BWT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105824; Coulson T, 2001, TRENDS ECOL EVOL, V16, P219, DOI 10.1016/S0169-5347(01)02137-1; Crawford RJM, 2006, BIOL CONSERV, V132, P119, DOI 10.1016/j.biocon.2006.03.019; Crawford Robert J. M., 1999, Marine Ornithology, V27, P139; Curtin S, 2009, CURR ISSUES TOUR, V12, P59, DOI 10.1080/13683500802295663; Di Minin E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071788; Dobson A, 2008, TRENDS ECOL EVOL, V23, P177, DOI 10.1016/j.tree.2007.08.019; Ferraro PJ, 2014, P NATL ACAD SCI USA, V111, P4332, DOI 10.1073/pnas.1307712111; Garcia-Ripolles C, 2011, J ORNITHOL, V152, P879, DOI 10.1007/s10336-011-0671-8; GERRODETTE T, 1990, CONSERV BIOL, V4, P423, DOI 10.1111/j.1523-1739.1990.tb00317.x; Great Plains Foundation, 2014, ZER RHIN; Gusset M, 2009, BIOL CONSERV, V142, P2774, DOI 10.1016/j.biocon.2009.07.007; Hilborn R, 2006, SCIENCE, V314, P1266, DOI 10.1126/science.1132780; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Holst B, 2006, LION TAMARIN POPULAT; Karanth KU, 2011, SCIENCE, V332, P791, DOI 10.1126/science.332.6031.791-a; Karanth KK, 2010, BIOL CONSERV, V143, P2865, DOI 10.1016/j.biocon.2010.05.002; Kiss A, 2004, TRENDS ECOL EVOL, V19, P232, DOI 10.1016/j.tree.2004.03.010; Le Saout S, 2013, SCIENCE, V342, P803, DOI 10.1126/science.1239268; Lewa Wildlife Conservancy, 2014, UNESCO WORLD HER SIT; Lewis SEF, 2012, AFR J MAR SCI, V34, P497, DOI 10.2989/1814232X.2012.716008; Lindsey P., 2009, CHEETAH ACINONYX JUB; Mace GM, 2014, SCIENCE, V345, P1558, DOI 10.1126/science.1254704; Macfie EJ, 2010, BEST PRACTICE GUIDEL; McCarthy DP, 2012, SCIENCE, V338, P946, DOI 10.1126/science.1229803; Monge G, 2009, TALLER CONSERVACION; Morrison C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043757; NACSO, 2013, COMM CONS NAM 2012 A; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Perrings C, 2011, SCIENCE, V331, P1139, DOI 10.1126/science.1202400; Petersen SL, 2006, IBIS, V148, P14, DOI 10.1111/j.1474-919X.2006.00459.x; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Pollak JP, 2013, VORTEX STOCHASTIC SI; RANDALL RM, 1987, J FIELD ORNITHOL, V58, P445; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Saterberg T, 2013, NATURE, V499, P468, DOI 10.1038/nature12277; Schwitzer C, 2014, SCIENCE, V343, P842, DOI 10.1126/science.1245783; Singleton I., 2004, ORANGUTAN POPULATION; Smith RK, 2010, CONSERV BIOL, V24, P820, DOI 10.1111/j.1523-1739.2009.01421.x; Steven R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062598; Traill LW, 2007, BIOL CONSERV, V139, P159, DOI 10.1016/j.biocon.2007.06.011; Waldron A, 2013, P NATL ACAD SCI USA, V110, P12144, DOI 10.1073/pnas.1221370110; Walker S, 2005, CONSERVATION W HOOLO; WHITTINGTON PA, 2000, AFRICAN PENGUIN POPU; World Tourism Organization (UNWTO) United Nations Environmental Programme (UNEP), 2002, WORLD EC SUMM FIN RE	61	54	56	4	194	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0147988	10.1371/journal.pone.0147988	http://dx.doi.org/10.1371/journal.pone.0147988			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886876	Green Published, gold, Green Submitted			2022-12-27	WOS:000371218400013
J	Chapman, JR; Helin, AS; Wille, M; Atterby, C; Jarhult, JD; Fridlund, JS; Waldenstrom, J				Chapman, Joanne R.; Helin, Anu S.; Wille, Michelle; Atterby, Clara; Jarhult, Josef D.; Fridlund, Jimmy S.; Waldenstrom, Jonas			A Panel of Stably Expressed Reference Genes for Real-Time qPCR Gene Expression Studies of Mallards (Anas platyrhynchos)	PLOS ONE			English	Article							AVIAN INFLUENZA-VIRUS; INNATE IMMUNE-RESPONSES; TRANSCRIPTION-PCR DATA; SERUM-ALBUMIN; QUANTITATIVE PCR; INTERNAL CONTROL; PEKIN DUCKS; RT-QPCR; INFECTION; QUANTIFICATION	Determining which reference genes have the highest stability, and are therefore appropriate for normalising data, is a crucial step in the design of real-time quantitative PCR (qPCR) gene expression studies. This is particularly warranted in non-model and ecologically important species for which appropriate reference genes are lacking, such as the mallard-a key reservoir of many diseases with relevance for human and livestock health. Previous studies assessing gene expression changes as a consequence of infection in mallards have nearly universally used beta-actin and/or GAPDH as reference genes without confirming their suitability as normalisers. The use of reference genes at random, without regard for stability of expression across treatment groups, can result in erroneous interpretation of data. Here, eleven putative reference genes for use in gene expression studies of the mallard were evaluated, across six different tissues, using a low pathogenic avian influenza A virus infection model. Tissue type influenced the selection of reference genes, whereby different genes were stable in blood, spleen, lung, gastrointestinal tract and colon. beta-actin and GAPDH generally displayed low stability and are therefore inappropriate reference genes in many cases. The use of different algorithms (GeNorm and NormFinder) affected stability rankings, but for both algorithms it was possible to find a combination of two stable reference genes with which to normalise qPCR data in mallards. These results highlight the importance of validating the choice of normalising reference genes before conducting gene expression studies in ducks. The fact that nearly all previous studies of the influence of pathogen infection on mallard gene expression have used a single, non-validated reference gene is problematic. The toolkit of putative reference genes provided here offers a solid foundation for future studies of gene expression in mallards and other waterfowl.	[Chapman, Joanne R.; Helin, Anu S.; Wille, Michelle; Fridlund, Jimmy S.; Waldenstrom, Jonas] Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst, Kalmar, Sweden; [Wille, Michelle; Atterby, Clara; Jarhult, Josef D.] Uppsala Univ, Dept Med Biochem & Microbiol, Zoonosis Sci Ctr, Uppsala, Sweden; [Jarhult, Josef D.] Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden	Linnaeus University; Uppsala University; Uppsala University	Chapman, JR; Waldenstrom, J (corresponding author), Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst, Kalmar, Sweden.	joanne.chapman@lnu.se; jonas.waldenstrom@lnu.se	Jarhult, Josef D./ABE-8149-2020; Wille, Michelle/F-4819-2013; Chapman, Joanne/B-9783-2011; Waldenström, Jonas/E-4460-2013	Jarhult, Josef D./0000-0002-7075-1059; Wille, Michelle/0000-0002-5629-0196; Chapman, Joanne/0000-0003-2849-1094; Waldenström, Jonas/0000-0002-1152-4235	Linnaeus University (EEMiS); Swedish Research Council VR [2011-3568]; Swedish Research Council FORMAS [211-2013-1320]	Linnaeus University (EEMiS); Swedish Research Council VR(Swedish Research Council); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	Funding was provided by Linnaeus University (EEMiS), the Swedish Research Councils VR (2011-3568; vr.se) and FORMAS (211-2013-1320, formas.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SC, 2009, MOL IMMUNOL, V46, P1744, DOI 10.1016/j.molimm.2009.01.025; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bailey LO, 2004, J BIOMED MATER RES A, V69A, P305, DOI 10.1002/jbm.a.20134; Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Burch AD, 2005, J VIROL, V79, P10740, DOI 10.1128/JVI.79.16.10740-10749.2005; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin Stephen A, 2014, Biomol Detect Quantif, V2, P35; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cagle C, 2012, AVIAN DIS, V56, P479, DOI 10.1637/10030-120511-Reg.1; Chapman JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141853; Cheng YQ, 2015, J VET SCI, V16, P37, DOI [10.4142/jvs.2015.16.1.37, 10.4142/jvs.2015.16.1.31]; Cherry P, 2008, DOMESTIC DUCK PRODUCTION: SCIENCE AND PRACTICE, P1, DOI 10.1079/9780851990545.0000; Cornelissen JBWJ, 2013, AVIAN PATHOL, V42, P347, DOI 10.1080/03079457.2013.807325; Cornelissen JBWJ, 2012, AVIAN PATHOL, V41, P519, DOI 10.1080/03079457.2012.732691; Cramp S., 1980, HDB BIRDS EUROPE MID, V1st; Cui Z, 2014, ARCH VIROL, V159, P339, DOI 10.1007/s00705-013-1820-6; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Fleming-Canepa X, 2011, MOL IMMUNOL, V48, P1950, DOI 10.1016/j.molimm.2011.05.025; Fredericksen F, 2015, GENE, V569, P95, DOI 10.1016/j.gene.2015.05.050; Geller R, 2012, BBA-MOL CELL RES, V1823, P698, DOI 10.1016/j.bbamcr.2011.11.007; Giles S, 2003, INFECT IMMUN, V71, P6648, DOI 10.1128/IAI.71.11.6648-6652.2003; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Gu CQ, 2012, POULTRY SCI, V91, P583, DOI 10.3382/ps.2011-01743; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hellemans J, 2014, METHODS MOL BIOL, V1160, P19, DOI 10.1007/978-1-4939-0733-5_3; Hildyard John C W, 2014, PLoS Curr, V6, DOI 10.1371/currents.md.faafdde4bea8df4aa7d06cd5553119a6; Hong YH, 2006, VET IMMUNOL IMMUNOP, V114, P259, DOI 10.1016/j.vetimm.2006.08.006; Hu J, 2013, J VIROL, V87, P11063, DOI 10.1128/JVI.00760-13; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Jarhult JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024742; Jiang HJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-447; Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143; Klein D, 2002, TRENDS MOL MED, V8, P257, DOI 10.1016/S1471-4914(02)02355-9; Kuchipudi SV, 2014, VET RES, V45, DOI 10.1186/s13567-014-0118-3; Kuchipudi SV, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-230; Kuiken T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0990; Kulikova IV, 2005, AUK, V122, P949, DOI 10.1642/0004-8038(2005)122[0949:POTMAP]2.0.CO;2; Latham GJ, 2010, METHODS MOL BIOL, V667, P19, DOI 10.1007/978-1-60761-811-9_2; Li N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00425; Li R, 2013, MEM I OSWALDO CRUZ, V108, P865, DOI 10.1590/0074-0276130659; Liang QL, 2011, MOL IMMUNOL, V48, P924, DOI 10.1016/j.molimm.2010.12.011; Manger ID, 2000, CURR OPIN IMMUNOL, V12, P215, DOI 10.1016/S0952-7915(99)00077-1; Maughan MN, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-94; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Overbergh L, 2003, J Biomol Tech, V14, P33; Pantin-Jackwood MJ, 2012, VIRUS RES, V167, P196, DOI 10.1016/j.virusres.2012.04.015; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Sarmento L, 2010, AVIAN DIS, V54, P532, DOI 10.1637/8917-050409-Reg.1; Selvey S, 2001, MOL CELL PROBE, V15, P307, DOI 10.1006/mcpr.2001.0376; Sheng XD, 2014, POULTRY SCI, V93, P527, DOI 10.3382/ps.2013-03510; Solanas M, 2001, ANAL BIOCHEM, V288, P99, DOI 10.1006/abio.2000.4889; Song CP, 2014, ARCH VIROL, V159, P905, DOI 10.1007/s00705-013-1900-7; Soubies SM, 2010, J VIROL, V84, P6733, DOI 10.1128/JVI.02427-09; Stordeur P, 2003, J IMMUNOL METHODS, V276, P69, DOI 10.1016/S0022-1759(03)00074-7; Tadiso TM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-141; Tang CK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060038, 10.1371/journal.pone.0075307, 10.1371/journal.pone.0061093]; Tolf C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061201; Vanderven HA, 2012, MOL IMMUNOL, V51, P316, DOI 10.1016/j.molimm.2012.03.034; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Volmer C, 2011, J GEN VIROL, V92, P534, DOI 10.1099/vir.0.026443-0; Wang SH, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00588; Wolf JM, 2012, CELL MICROBIOL, V14, P762, DOI 10.1111/j.1462-5822.2012.01757.x; Xu Huaisheng, 2015, BMC Res Notes, V8, P58, DOI 10.1186/s13104-015-0973-7; Xu Q, 2015, MOL BIOL REP, V42, P431, DOI 10.1007/s11033-014-3784-3; Xu Q, 2014, MOL BIOL REP, V41, P6233, DOI 10.1007/s11033-014-3503-0; Xu Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088023; Xu Q, 2014, GENE, V533, P280, DOI 10.1016/j.gene.2013.09.047; Yang Falong, 2013, BMC Res Notes, V6, P402, DOI 10.1186/1756-0500-6-402; Yue Hua, 2010, Virologica Sinica, V25, P425, DOI 10.1007/s12250-010-3114-4; Zhang XZ, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-4; Zhong ZF, 2015, GENE, V570, P100, DOI 10.1016/j.gene.2015.06.003; Zhou ZT, 2013, AVIAN PATHOL, V42, P129, DOI 10.1080/03079457.2013.770127	75	19	19	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149454	10.1371/journal.pone.0149454	http://dx.doi.org/10.1371/journal.pone.0149454			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886224	Green Published, Green Submitted, gold			2022-12-27	WOS:000371218400085
J	Olivier, CB; Meyer, M; Bauer, H; Schnabel, K; Weik, P; Zhou, Q; Bode, C; Moser, M; Diehl, P				Olivier, Christoph B.; Meyer, Melanie; Bauer, Hans; Schnabel, Katharina; Weik, Patrick; Zhou, Qian; Bode, Christoph; Moser, Martin; Diehl, Philipp			The Ratio of ADP- to TRAP-Induced Platelet Aggregation Quantifies P2Y(12)-Dependent Platelet Inhibition Independently of the Platelet Count	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; THROMBIN RECEPTOR; CLOPIDOGREL; REACTIVITY; THERAPY; IMPLANTATION; DEFINITION; PRASUGREL; CONSENSUS	Objective This study aimed to assess the association of clinical factors with P2Y(12)-dependent platelet inhibition as monitored by the ratio of ADP-to TRAP-induced platelet aggregation and conventional ADP-induced aggregation, respectively. Background Controversial findings to identify and overcome high platelet reactivity (HPR) after coronary stent-implantation and to improve clinical outcome by tailored anti-platelet therapy exist. Monitoring anti-platelet therapy ex vivo underlies several confounding parameters causing that ex vivo platelet aggregation might not reflect in vivo platelet inhibition. Methods In a single centre observational study, multiple electrode aggregometry was performed in whole blood of patients after recent coronary stent-implantation. Relative ADP-induced aggregation (r-ADP-agg) was defined as the ratio of ADP-to TRAP-induced aggregation reflecting the individual degree of P2Y(12)-mediated platelet reactivity. Results Platelet aggregation was assessed in 359 patients. Means (+/- SD) of TRAP-, ADP-induced aggregation and r-ADP-agg were 794 +/- 239 AU* min, 297 +/- 153 AU* min and 37 +/- 14%, respectively. While ADP-and TRAP-induced platelet aggregation correlated significantly with platelet count (ADP: r = 0.302; p< 0.001; TRAP: r = 0.509 p< 0.001), r-ADP-agg values did not (r = -0.003; p = 0.960). These findings were unaltered in multivariate analyses adjusting for a range of factors potentially influencing platelet aggregation. The presence of an acute coronary syndrome and body weight were found to correlate with both ADP-induced platelet aggregation and r-ADP-agg. Conclusion The ratio of ADP-to TRAP-induced platelet aggregation quantifies P2Y(12)-dependent platelet inhibition independently of the platelet count in contrast to conventional ADP-induced aggregation. Furthermore, r-ADP-agg was associated with the presence of an acute coronary syndrome and body weight as well as ADP-induced aggregation. Thus, the r-ADP-agg is a more valid reflecting platelet aggregation and potentially prognosis after coronary stent-implantation in P2Y(12)-mediated HPR than conventional ADP-induced platelet aggregation.	[Olivier, Christoph B.; Meyer, Melanie; Schnabel, Katharina; Weik, Patrick; Zhou, Qian; Bode, Christoph; Moser, Martin; Diehl, Philipp] Univ Freiburg, Ctr Heart, Cardiol & Angiol 1, Hugstetter Str 55, D-79106 Freiburg, Germany; [Bauer, Hans] Munich Univ Hosp, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany	University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich	Olivier, CB (corresponding author), Univ Freiburg, Ctr Heart, Cardiol & Angiol 1, Hugstetter Str 55, D-79106 Freiburg, Germany.	Christoph.Olivier@universitaets-herzzentrum.de	Olivier, Christoph/AAK-2882-2021		German Research Foundation [OL371/1-1]; German Research Foundation (DFG); Albert Ludwigs University Freiburg	German Research Foundation(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	This work was supported by the German Research Foundation OL371/1-1. The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding program Open Access Publishing.	Bonello L, 2010, J AM COLL CARDIOL, V56, P919, DOI 10.1016/j.jacc.2010.04.047; Chung AWY, 2002, BRIT J PHARMACOL, V135, P1123, DOI 10.1038/sj.bjp.0704559; Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979; Eslam RB, 2013, INT J CARDIOL, V168, P403, DOI 10.1016/j.ijcard.2012.09.103; Furman MI, 1998, P NATL ACAD SCI USA, V95, P3082, DOI 10.1073/pnas.95.6.3082; Gremmel T, 2011, THROMB RES, V128, P352, DOI 10.1016/j.thromres.2011.05.008; Gremmel T, 2010, PLATELETS, V21, P515, DOI 10.3109/09537104.2010.493587; Gurbel PA, 2012, JAMA-J AM MED ASSOC, V308, P1785, DOI 10.1001/jama.2012.17312; Hazarbasanov D, 2012, J THROMB THROMBOLYS, V34, P85, DOI 10.1007/s11239-012-0684-z; Ignjatovic V, 2016, J CARDIOVASC PHARM T, V21, P44, DOI 10.1177/1074248415581175; Iyu D, 2011, THROMB HAEMOSTASIS, V105, P96, DOI 10.1160/TH10-07-0482; Kosoglou T, 2012, EUR J CLIN PHARMACOL, V68, P249, DOI 10.1007/s00228-011-1120-6; Olivier C, 2013, CARDIOL THER, V2, P57, DOI 10.1007/s40119-013-0013-4; Olivier CB, 2016, THROMB RES, V138, P63, DOI 10.1016/j.thromres.2015.10.038; Olivier CB, 2014, CLIN RES CARDIOL, V103, P968, DOI 10.1007/s00392-014-0737-8; Olivier CB, 2014, THROMB HAEMOSTASIS, V111, P266, DOI 10.1160/TH13-06-0508; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Siller-Matula JM, 2013, JACC-CARDIOVASC INTE, V6, P1111, DOI 10.1016/j.jcin.2013.06.011; Siller-Matula JM, 2013, INT J CARDIOL, V167, P2018, DOI 10.1016/j.ijcard.2012.05.040; Sofi F, 2010, THROMB HAEMOSTASIS, V103, P841, DOI 10.1160/TH09-06-0418; Tantry US, 2013, J AM COLL CARDIOL, V62, P2261, DOI 10.1016/j.jacc.2013.07.101; Trenk D, 2012, J AM COLL CARDIOL, V59, P2159, DOI 10.1016/j.jacc.2012.02.026; Varenhorst C, 2009, AM HEART J, V157, DOI 10.1016/j.ahj.2008.11.021; Voisin S, 2011, THROMB HAEMOSTASIS, V106, P227, DOI 10.1160/TH11-01-0046	24	6	6	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149053	10.1371/journal.pone.0149053	http://dx.doi.org/10.1371/journal.pone.0149053			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885820	Green Published, gold, Green Submitted			2022-12-27	WOS:000371218400060
J	Rendon, J; Hoyos, MC; di Filippo, D; Cortes-Mancera, F; Mantilla, C; Velasquez, MM; Sepulveda, ME; Restrepo, JC; Jaramillo, S; Arbelaez, MP; Correa, G; Navas, MC				Rendon, Julio; Cristina Hoyos, Maria; di Filippo, Diana; Cortes-Mancera, Fabian; Mantilla, Carolina; Mercedes Velasquez, Maria; Elsy Sepulveda, Maria; Carlos Restrepo, Juan; Jaramillo, Sergio; Patricia Arbelaez, Maria; Correa, Gonzalo; Navas, Maria-Cristina			Hepatitis E Virus Genotype 3 in Colombia: Survey in Patients with Clinical Diagnosis of Viral Hepatitis	PLOS ONE			English	Article							PIG LIVERS; ANTI-HEV; INFECTION; SWINE; PREVALENCE; STRAINS; IDENTIFICATION; COINFECTION; CIRCULATION; VARIANTS	Background Hepatitis E virus is a major cause of outbreaks as well as sporadic hepatitis cases worldwide. The epidemiology of this enterically transmitted infection differs between developing and developed countries. The aims of this study were to describe HEV infection in Colombian patients and to characterize the genotype. Methods A prospective study was carried out on 40 patients aged over 15 with a clinical diagnosis of viral hepatitis, recruited from five primary health units in the city of Medellin, Colombia. Fecal samples obtained from the 40 consecutives cases were analyzed for HEV RNA using nested reverse transcription PCR for both ORF1 and ORF2-3. The amplicons were sequenced for phylogenetic analyses. Results Nine (22.5%) cases of HEV infection were identified in the study population. Three HEV strains obtained from patients were classified as genotype 3. No significant association was found between cases of Hepatitis E and the variables water drinking source, garbage collection system and contact with pigs. Conclusions This is the first prospective study of hepatitis E in Colombian patients. The circulation of the genotype 3 in this population is predictable considering the reports of the region and the identification of this genotype from pigs in the state of Antioquia, of which Medellin is the capital. Further studies are necessary to establish whether zoonotic transmission of HEV is important in Colombia.	[Rendon, Julio; Cristina Hoyos, Maria; di Filippo, Diana; Cortes-Mancera, Fabian; Mantilla, Carolina; Mercedes Velasquez, Maria; Elsy Sepulveda, Maria; Carlos Restrepo, Juan; Correa, Gonzalo; Navas, Maria-Cristina] Univ Antioquia, Grp Gastrohepatol, Fac Med, Medellin, Colombia; [Cortes-Mancera, Fabian] Inst Tecnol Metropolitano, Fac Ciencias Exactas & Aplicadas, GI2B, Medellin, Colombia; [Elsy Sepulveda, Maria; Carlos Restrepo, Juan; Jaramillo, Sergio] Hosp Pablo Tobon Uribe, Medellin, Colombia; [Patricia Arbelaez, Maria] Univ Antioquia, Fac Nacl Salud Publ, Grp Epidemiol, Medellin, Colombia	Universidad de Antioquia; Universidad de Antioquia	Navas, MC (corresponding author), Univ Antioquia, Grp Gastrohepatol, Fac Med, Medellin, Colombia.	maria.navas@udea.edu.co	Navas, Maria Cristina/AAE-2528-2022; Mancera, Fabian Mauricio Cortes/R-6438-2018	Mancera, Fabian Mauricio Cortes/0000-0002-1475-3746; Arbelaez Montoya, Maria Patricia/0000-0003-2435-4658; Mantilla Rojas, Carolina/0000-0002-3320-2122; Rendon, Julio Cesar/0000-0002-4054-3582; Restrepo-Gutierrez, Juan Carlos/0000-0002-1793-5756	Departmento Nacional de Ciencia, Innovacion y Tecnologia, Colciencias [1115 408 20570]; Universidad de Anitioquia, Proyecto Sostenibilidad	Departmento Nacional de Ciencia, Innovacion y Tecnologia, Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Universidad de Anitioquia, Proyecto Sostenibilidad	Support was provided by the Departmento Nacional de Ciencia, Innovacion y Tecnologia, Colciencias (Grant 1115 408 20570) and the Universidad de Anitioquia, Proyecto Sostenibilidad. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aggarwal R, 2000, LANCET, V356, P1081, DOI 10.1016/S0140-6736(00)02737-9; Aggarwal R, 2011, HEPATOLOGY, V54, P2218, DOI 10.1002/hep.24674; Alvarado-Esquivel C, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.16876; Cantu-Martinez MA, 2013, SALUD PUBLICA MEXICO, V55, P193, DOI 10.1590/S0036-36342013000200011; Betancur Carlos Alberto, 2013, Acta Med Colomb, V38, P68; Bouquet J, 2011, EMERG INFECT DIS, V17, P2018, DOI 10.3201/eid1711.110616; Gutierrez-Vergara CC, 2015, IATREIA, V28, P248, DOI 10.17533/udea.iatreia.v28n3a03; Chandra NS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-213; Cooper K, 2005, J CLIN MICROBIOL, V43, P1684, DOI 10.1128/JCM.43.4.1684-1688.2005; Lana MVD, 2014, TROP ANIM HEALTH PRO, V46, P399, DOI 10.1007/s11250-013-0503-3; Dell'Amico MC, 2011, EMERG INFECT DIS, V17, P1488, DOI 10.3201/eid1708.100769; Direccion Seccional de Salud de Antioquia (Gobernacion de Antioquia), 2006, DIRECCION SECCIONAL; Echevarria JM, 2013, J MED VIROL, V85, P1037, DOI 10.1002/jmv.23526; Fogeda M, 2009, J MED VIROL, V81, P1743, DOI 10.1002/jmv.21564; Forero J. E, 2014, Rev. Med. Vet. Zoot., V61, P221, DOI 10.15446/rfmvz.v61n3.46868; Garcia CG, 2012, J MED VIROL, V84, P1025, DOI 10.1002/jmv.23277; Gutierrez-Vergara C, 2015, GENET MOL RES, V14, P2890, DOI 10.4238/2015.March.31.20; Haagsma EB, 2008, LIVER TRANSPLANT, V14, P547, DOI 10.1002/lt.21480; Hakze-van der Honing RW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022673; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Ibarra H, 2007, REV MED CHILE, V135, P997; Inoue J, 2006, J VIROL METHODS, V137, P325, DOI 10.1016/j.jviromet.2006.07.004; Inoue J, 2009, J GASTROENTEROL, V44, P329, DOI 10.1007/s00535-009-0012-3; Joon A, 2015, INDIAN J MED MICROBI, V33, pS102, DOI 10.4103/0255-0857.150908; Kamar N, 2014, CLIN MICROBIOL REV, V27, P116, DOI 10.1128/CMR.00057-13; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Kase JA, 2008, INT J ENVIRON HEAL R, V18, P165, DOI 10.1080/09603120701498311; Kmush B, 2013, SEMIN LIVER DIS, V33, P15, DOI 10.1055/s-0033-1338111; Krain LJ, 2014, CLIN MICROBIOL REV, V27, P139, DOI 10.1128/CMR.00062-13; dos Santos DRL, 2011, VET MICROBIOL, V149, P236, DOI 10.1016/j.vetmic.2010.10.024; dos Santos DRL, 2010, J CLIN VIROL, V47, P276, DOI 10.1016/j.jcv.2009.12.021; dos Santos DRL, 2009, VET J, V182, P474, DOI 10.1016/j.tvjl.2008.08.001; Martinez-Vargas D, 2015, 6 S COL VIR BIOM, P41; Meng X.J., 2012, VIRUS TAXONOMY CLASS; Meng XJ, 2011, VIRUS RES, V161, P23, DOI 10.1016/j.virusres.2011.01.016; Mirazo S, 2014, EMERG INFECT DIS, V20, P171, DOI 10.3201/eid2001.131471; Mirazo S, 2013, VIRUS RES, V173, P364, DOI 10.1016/j.virusres.2013.01.005; Mirazo S, 2011, ARCH VIROL, V156, P1451, DOI 10.1007/s00705-011-0991-2; Munne MS, 2006, J MED VIROL, V78, P1579, DOI 10.1002/jmv.20741; Munne MS, 2014, ANN HEPATOL, V13, P496, DOI 10.1016/S1665-2681(19)31248-7; Munne Maria Silvina, 2006, Acta Gastroenterol Latinoam, V36, P125; National Department of Statistics, FICH TECN CENS ACT P; Pelaez D, 2014, BIOMEDICA, V34, P354, DOI [10.7705/biomedica.v34i3.2236, 10.1590/S0120-41572014000300006]; Pischke S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085330; Purdy MA, 2012, EMERG INFECT DIS, V18, P339, DOI 10.3201/eid1802.111453; Rasheeda CA, 2008, EUR J GASTROEN HEPAT, V20, P362, DOI 10.1097/MEG.0b013e3282f246d6; Rein DB, 2012, HEPATOLOGY, V55, P988, DOI 10.1002/hep.25505; Lay LDLAR, 2008, J MED VIROL, V80, P798, DOI 10.1002/jmv.21147; Schlauder GG, 1998, J GEN VIROL, V79, P447, DOI 10.1099/0022-1317-79-3-447; Munne MS, 2011, J CLIN VIROL, V52, P138, DOI 10.1016/j.jcv.2011.06.015; de Souza AJS, 2012, COMP IMMUNOL MICROB, V35, P477, DOI 10.1016/j.cimid.2012.04.004; TAM AW, 1991, VIROLOGY, V185, P120, DOI 10.1016/0042-6822(91)90760-9; Tesse S, 2012, J CLIN VIROL, V54, P197, DOI 10.1016/j.jcv.2012.02.007; VELAZQUEZ O, 1990, JAMA-J AM MED ASSOC, V263, P3281, DOI 10.1001/jama.263.24.3281; World Health Organization, 2014, HEP E; Zaki ME, 2008, J MICROBIOL IMMUNOL, V41, P254; Zhai LJ, 2006, VIRUS RES, V120, P57, DOI 10.1016/j.virusres.2006.01.013	57	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148417	10.1371/journal.pone.0148417	http://dx.doi.org/10.1371/journal.pone.0148417			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886728	Green Submitted, Green Published, gold			2022-12-27	WOS:000371218400034
J	Yang, YL; Liu, WR; Ding, RF; Xiong, LL; Dou, RK; Zhang, YM; Guo, ZY				Yang, Yalan; Liu, Wenrong; Ding, Ruofan; Xiong, Lili; Dou, Rongkun; Zhang, Yiming; Guo, Zhiyun			Comprehensive Expression Profiling and Functional Network Analysis of p53-Regulated MicroRNAs in HepG2 Cells Treated with Doxorubicin	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; FACTOR-BINDING-SITES; GENOMIC ANALYSIS; DNA-DAMAGE; P53; CANCER; PROLIFERATION; APOPTOSIS; GROWTH; TRANSCRIPTS	Acting as a sequence-specific transcription factor, p53 tumor suppressor involves in a variety of biological processes after being activated by cellular stresses such as DNA damage. In recent years, microRNAs (miRNAs) have been confirmed to be regulated by p53 in several cancer types. However, it is still unclear how miRNAs orchestrate their regulation and function in p53 network after p53 activation in hepatocellular carcinoma (HCC). In this study, we used small RNA sequencing and systematic bioinformatic analysis to characterize the regulatory networks of differentially expressed miRNAs after the p53 activation in HepG2. Here, 33 miRNAs significantly regulated by p53 (12 up-regulated and 21 down-regulated) were detected between the doxorubicin-treated and untreated HepG2 cells in two biological replicates for small RNA sequencing and 8 miRNAs have been reported previously to be associated with HCC. Gene ontology (GO) and KEGG pathway enrichment analysis showed that 87.9% (29 out of 33) and 90.9% (30 out of 33) p53-regulated miRNAs were involved in p53-related biological processes and pathways with significantly low p-value, respectively. Remarkably, 18 out of 33 p53-regulated miRNAs were identified to contain p53 binding sites around their transcription start sites (TSSs). Finally, comprehensive p53-miRNA regulatory networks were constructed and analyzed. These observations provide a new insight into p53-miRNA co-regulatory network in the context of HCC.	[Yang, Yalan; Liu, Wenrong; Ding, Ruofan; Xiong, Lili; Dou, Rongkun; Zhang, Yiming; Guo, Zhiyun] Southwest Jiaotong Univ, Sch Life Sci & Bioengn, Chengdu, Sichuan, Peoples R China	Southwest Jiaotong University	Guo, ZY (corresponding author), Southwest Jiaotong Univ, Sch Life Sci & Bioengn, Chengdu, Sichuan, Peoples R China.	zhiyunguo@gmail.com	Guo, Zhiyun/H-3394-2017	Guo, Zhiyun/0000-0003-2680-785X; Yiming, Zhang/0000-0002-5099-3894				Alexiou P, 2010, NUCLEIC ACIDS RES, V38, pD137, DOI 10.1093/nar/gkp888; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Botcheva K, 2011, CELL CYCLE, V10, P4237, DOI 10.4161/cc.10.24.18383; Collins AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069090; Connolly E, 2008, AM J PATHOL, V173, P856, DOI 10.2353/ajpath.2008.080096; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Dang YW, 2014, ASIAN PAC J CANCER P, V15, P4969, DOI 10.7314/APJCP.2014.15.12.4969; Fabregat I, 2009, WORLD J GASTROENTERO, V15, P513, DOI 10.3748/wjg.15.513; Fang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073004; Gokhale A, 2010, J CANCER RES THER, V6, P521, DOI 10.4103/0973-1482.77072; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jung HM, 2015, J CELL BIOCHEM, V116, P836, DOI 10.1002/jcb.25039; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Kong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019518; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li S, 2015, CHINESE MED J-PEKING, V128, P941, DOI 10.4103/0366-6999.154302; Liu WH, 2009, GASTROENTEROLOGY, V136, P683, DOI 10.1053/j.gastro.2008.10.029; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Motola-Kuba Daniel, 2006, Ann Hepatol, V5, P16; Piriyapongsa J, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-61; Powrozek T, 2015, TRANSL RES, V166, P315, DOI 10.1016/j.trsl.2015.05.009; Ren ZJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.327; Ruffalo M, 2011, BIOINFORMATICS, V27, P2790, DOI 10.1093/bioinformatics/btr477; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Scheibner KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050895; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tormo E, 2015, J CELL BIOCHEM, V116, P2061, DOI 10.1002/jcb.25162; Ugalde AP, 2011, EMBO J, V30, P2219, DOI 10.1038/emboj.2011.124; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wu XJ, 2013, ASIAN PAC J CANCER P, V14, P885, DOI 10.7314/APJCP.2013.14.2.885; Xi YG, 2006, CLIN CANCER RES, V12, P2014, DOI 10.1158/1078-0432.CCR-05-1853; Yan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073656; Yan HL, 2009, EMBO J, V28, P2719, DOI 10.1038/emboj.2009.214; Yang MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037205; Younger ST, 2015, NUCLEIC ACIDS RES, V43, P4447, DOI 10.1093/nar/gkv284; Zeron-Medina J, 2013, CELL, V155, P410, DOI 10.1016/j.cell.2013.09.017; Zhang BH, 2009, GENE, V443, P100, DOI 10.1016/j.gene.2009.04.027; Zhang Qi, 2011, Zhonghua Zhong Liu Za Zhi, V33, P885	45	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149227	10.1371/journal.pone.0149227	http://dx.doi.org/10.1371/journal.pone.0149227			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886852	gold, Green Published, Green Submitted			2022-12-27	WOS:000371218400068
J	Lan, BL; Masoller, C				Lan, Boon Leong; Masoller, Cristina			Heavy-Tailed Fluctuations in the Spiking Output Intensity of Semiconductor Lasers with Optical Feedback	PLOS ONE			English	Article							LONG-RANGE ANTICORRELATIONS; NON-GAUSSIAN BEHAVIOR; SYSTEMS; HEARTBEAT; DYNAMICS	Although heavy-tailed fluctuations are ubiquitous in complex systems, a good understanding of the mechanisms that generate them is still lacking. Optical complex systems are ideal candidates for investigating heavy-tailed fluctuations, as they allow recording large datasets under controllable experimental conditions. A dynamical regime that has attracted a lot of attention over the years is the so-called low-frequency fluctuations (LFFs) of semiconductor lasers with optical feedback. In this regime, the laser output intensity is characterized by abrupt and apparently random dropouts. The statistical analysis of the inter-dropout-intervals (IDIs) has provided many useful insights into the underlying dynamics. However, the presence of large temporal fluctuations in the IDI sequence has not yet been investigated. Here, by applying fluctuation analysis we show that the experimental distribution of IDI fluctuations is heavy-tailed, and specifically, is well-modeled by a non-Gaussian stable distribution. We find a good qualitative agreement with simulations of the Lang-Kobayashi model. Moreover, we uncover a transition from a less-heavy-tailed state at low pump current to a more-heavy-tailed state at higher pump current. Our results indicate that fluctuation analysis can be a useful tool for investigating the output signals of complex optical systems; it can be used for detecting underlying regime shifts, for model validation and parameter estimation.	[Lan, Boon Leong] Monash Univ, Sch Engn, Elect & Comp Syst Engn, Bandar Sunway 47500, Malaysia; [Masoller, Cristina] Univ Politecn Cataluna, Dept Fis, Colom 11, Barcelona 08222, Spain	Monash University; Monash University Sunway; Universitat Politecnica de Catalunya	Lan, BL (corresponding author), Monash Univ, Sch Engn, Elect & Comp Syst Engn, Bandar Sunway 47500, Malaysia.	lan.boon.leong@monash.edu	Masoller, Cristina/M-3696-2014	Masoller, Cristina/0000-0003-0768-2019	Spanish Ministerio de Ciencia e Innovacion [FIS2012-37655-C02-01]; TWAS-UNESCO as an Associate at the Institute of Physics, Faculty of Science, University of the Republic, Uruguay	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); TWAS-UNESCO as an Associate at the Institute of Physics, Faculty of Science, University of the Republic, Uruguay	This study was supported in part by the Spanish Ministerio de Ciencia e Innovacion (FIS2012-37655-C02-01), to CM. BLL was supported by TWAS-UNESCO as an Associate at the Institute of Physics, Faculty of Science, University of the Republic, Uruguay, where part of the work was completed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragoneses A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04696; Aragoneses A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01778; Campos-Mejia A, 2015, OPT EXPRESS, V23, P10428, DOI 10.1364/OE.23.010428; HENRY CH, 1986, IEEE J QUANTUM ELECT, V22, P294, DOI 10.1109/JQE.1986.1072959; Lan BL, 2007, PHYSICA A, V375, P605, DOI 10.1016/j.physa.2006.10.028; Lan BL, 2013, EPL-EUROPHYS LETT, V102, DOI 10.1209/0295-5075/102/18002; Lan BL, 2011, PHYSICA A, V390, P1289, DOI 10.1016/j.physa.2010.11.015; Lan BL, 2010, FLUCT NOISE LETT, V9, P245, DOI 10.1142/S0219477510000186; Lang L, 1980, IEEE J QUANTUM ELECT, V16, P347, DOI [10.1109/JQE.1980.1070479, DOI 10.1109/JQE.1980.1070479]; Mandelbrot B, 1997, FRACTALS SCALING FIN; McCulloch J. H., 1996, HDB STAT, V14, P393; Nolan JP, 2001, LEVY PROCESSES: THEORY AND APPLICATIONS, P379; Nolan JP, PROGRAM STABLE; Nolan JP, STABLE DISTRIBUTIONS; PENG CK, 1993, PHYS REV LETT, V70, P1343, DOI 10.1103/PhysRevLett.70.1343; PENNA TJP, 1995, PHYS REV E, V52, pR2168, DOI 10.1103/PhysRevE.52.R2168; Plerou V, 2000, PHYSICA A, V279, P443, DOI 10.1016/S0378-4371(00)00010-8; Rubido N, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.026202; SANO T, 1994, PHYS REV A, V50, P2719, DOI 10.1103/PhysRevA.50.2719; Segura AM, 2013, OIKOS, V122, P1739, DOI 10.1111/j.1600-0706.2013.00493.x; Stanley HE, 2000, PHYSICA A, V283, P31, DOI 10.1016/S0378-4371(00)00256-9; Tiana-Alsina J, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.013819; Toomey JP, 2014, OPT EXPRESS, V22, P1713, DOI 10.1364/OE.22.001713; Torcini A, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.063801; Vaschenko G, 1998, PHYS REV LETT, V81, P5536, DOI 10.1103/PhysRevLett.81.5536; Yacomotti AM, 1999, PHYS REV LETT, V83, P292, DOI 10.1103/PhysRevLett.83.292; Zamora-Munt J, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.033820	27	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0150027	10.1371/journal.pone.0150027	http://dx.doi.org/10.1371/journal.pone.0150027			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901346	Green Submitted, Green Published, gold			2022-12-27	WOS:000371276100200
J	Oros, J; Montesdeoca, N; Camacho, M; Arencibia, A; Calabuig, P				Oros, Jorge; Montesdeoca, Natalia; Camacho, Maria; Arencibia, Alberto; Calabuig, Pascual			Causes of Stranding and Mortality, and Final Disposition of Loggerhead Sea Turtles (Caretta caretta) Admitted to a Wildlife Rehabilitation Center in Gran Canaria Island, Spain (1998-2014): A Long-Term Retrospective Study	PLOS ONE			English	Article							CHELONIA-MYDAS; GREEN TURTLES; MARINE TURTLES; HAWAIIAN-ISLANDS; FIBROPAPILLOMATOSIS; PATHOLOGY; FLORIDA; SPIRORCHIDIASIS; JUVENILE; ATLANTIC	Aims The aims of this study were to analyze the causes of stranding of 1,860 loggerhead turtles (Caretta caretta) admitted at the Tafira Wildlife Rehabilitation Center in Gran Canaria Island, Spain, from 1998 to 2014, and to analyze the outcomes of the rehabilitation process to allow meaningful auditing of its quality. Methods Primary causes of morbidity were classified into seven categories: entanglement in fishing gear and/or plastics, ingestion of hooks and monofilament lines, trauma, infectious disease, crude oil, other causes, and unknown/undetermined. Final dispositions were calculated as euthanasia (Er), unassisted mortality (Mr), and release (Rr) rates. Time to death (Td) for euthanized and dead turtles, and length of stay for released (Tr) turtles were evaluated. Results The most frequent causes of morbidity were entanglement in fishing gear and/or plastics (50.81%), unknown/undetermined (20.37%), and ingestion of hooks (11.88%). The final disposition of the 1,634 loggerhead turtles admitted alive were: Er = 3.37%, Mr = 10.34%, and Rr = 86.29%. Er was significantly higher in the trauma category (18.67%) compared to the other causes of admission. The highest Mr was observed for turtles admitted due to trauma (30.67%). The highest R-r was observed in the crude oil (93.87%) and entanglement (92.38%) categories. The median T-r ranged from 12 days (unknown) to 70 days (trauma). Conclusions This survey is the first large-scale epidemiological study on causes of stranding and mortality of Eastern Atlantic loggerheads and demonstrates that at least 71.72% of turtles stranded due to anthropogenic causes. The high R-r (86.29%) emphasizes the importance of marine rehabilitation centers for conservation purposes. The stratified analysis by causes of admission of the three final disposition rates, and the parameters T-d and T-r should be included in the outcome research of the rehabilitation process of sea turtles in order to allow comparative studies between marine rehabilitation centers around the world.	[Oros, Jorge; Arencibia, Alberto] Univ Las Palmas Gran Canaria, Fac Vet, Dept Morphol, Arucas, Las Palmas, Spain; [Montesdeoca, Natalia] Univ Las Palmas Gran Canaria, Fac Vet, Dept Anim Pathol, Arucas, Las Palmas, Spain; [Camacho, Maria] Univ Las Palmas Gran Canaria, Fac Vet, Dept Clin Sci, Arucas, Las Palmas, Spain; [Calabuig, Pascual] Tafira Wildlife Rehabil Ctr, Tafira Baja, Las Palmas De G, Spain	Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria	Oros, J (corresponding author), Univ Las Palmas Gran Canaria, Fac Vet, Dept Morphol, Arucas, Las Palmas, Spain.	jorge.oros@ulpgc.es	Orós, Jorge/G-8824-2015; CAMACHO, MARIA/H-5085-2015; Calabuig, Pascual/AAB-1723-2019; Arencibia, Alberto/H-5218-2015	Orós, Jorge/0000-0002-8346-5393; CAMACHO, MARIA/0000-0003-2891-1474; Arencibia, Alberto/0000-0001-6797-8220				Aguirre AA, 1998, J WILDLIFE DIS, V34, P91, DOI 10.7589/0090-3558-34.1.91; Bas C., 1995, PESCA CANARIAS AREAS; Bjorndal KA, 2000, MAR ECOL PROG SER, V202, P265, DOI 10.3354/meps202265; Bjorndal KA, 2003, ECOLOGY, V84, P1237, DOI 10.1890/0012-9658(2003)084[1237:CGIOLS]2.0.CO;2; Blanco J. C., 1992, LIBRO ROJO VERTEBRAD; Bolten Alan F., 1993, Arquipelago Boletim da Universidade dos Acores Ciencias Biologicas e Marinhas, V11A, P49; Camacho M, 2013, J WILDLIFE DIS, V49, P637, DOI 10.7589/2012-03-093; Casal AB, 2009, VET CLIN PATH, V38, P213, DOI 10.1111/j.1939-165X.2008.00106.x; Casale P, 2010, AQUAT CONSERV, V20, P611, DOI 10.1002/aqc.1133; Castro JJ, 1995, PESCA CANARIAS AREAS, P153; Chaloupka M, 2008, MAR BIOL, V154, P887, DOI 10.1007/s00227-008-0981-4; Conant TA., 2009, LOGGERHEAD SEA TURTL; Cooper JE, 2006, IN PRACTICE, V28, P2, DOI 10.1136/inpract.28.1.2; Santos MRD, 2015, DIS AQUAT ORGAN, V115, P193, DOI 10.3354/dao02883; Dellinger T, 2007, MARINE TURTLES RECOV, P97; Duguy R, 1998, OCEANOL ACTA, V21, P383, DOI 10.1016/S0399-1784(98)80025-X; Epperly SP, 1996, B MAR SCI, V59, P289; Flint M, 2010, ECOHEALTH, V7, P135, DOI 10.1007/s10393-010-0300-7; Foley Allen M., 2007, Gulf of Mexico Science, V25, P131; Foley AM, 2005, J WILDLIFE DIS, V41, P29, DOI 10.7589/0090-3558-41.1.29; George Robert H., 1997, P363; GLAZEBROOK JS, 1989, J COMP PATHOL, V101, P231, DOI 10.1016/0021-9975(89)90033-9; GLAZEBROOK JS, 1990, DIS AQUAT ORGAN, V9, P97, DOI 10.3354/dao009097; GORDON AN, 1993, J WILDLIFE DIS, V29, P490, DOI 10.7589/0090-3558-29.3.490; Gordon AN, 1998, VET PATHOL, V35, P21, DOI 10.1177/030098589803500102; GRACZYK TK, 1995, J PARASITOL, V81, P416, DOI 10.2307/3283824; Greenblatt RJ, 2005, J ZOO WILDLIFE MED, V36, P527, DOI 10.1638/04-051.1; Gutierrez C, 1998, 2 JORN INT SEOC VIT, P349; Herbst LH, 1998, J WILDLIFE DIS, V34, P496, DOI 10.7589/0090-3558-34.3.496; HERNANDEZGARCIA V, 1995, FISH B-NOAA, V93, P403; IMO, 2007, PSSA PART SENS SEA A, V2007th; INTERNATIONAL UNION FOR CONSERVATION OF NATURE SPECIES SURVIVAL COMMISSION [IUCN SSC] AMPHIBIAN SPECIALIST GROUP, 2015, IUCN RED LIST THREAT; Jacobson ER, 2006, DIS AQUAT ORGAN, V70, P139, DOI 10.3354/dao070139; JACOBSON ER, 1989, J COMP PATHOL, V101, P39, DOI 10.1016/0021-9975(89)90075-3; Lizana M., 1997, DISTRIBUCION BIOGEOG, P477; Llinas O, 2007, MARINE TURTLES RECOV, P35; Lutcavage Molly E., 1997, P387; Miller E.A., 2012, MINIMUM STANDARDS WI, V4th ed.; Molina-Lopez RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060242; Monzon-Arguello C, 2009, J EXP MAR BIOL ECOL, V373, P79, DOI 10.1016/j.jembe.2009.03.007; Oros J, 2005, DIS AQUAT ORGAN, V63, P13, DOI 10.3354/dao063013; Oros J, 2004, VET REC, V155, P169, DOI 10.1136/vr.155.6.169; Pritchard P.C.H.P., 1997, BIOL SEA TURTLES, VI, P1; Raidal SR, 1998, AUST VET J, V76, P415, DOI 10.1111/j.1751-0813.1998.tb12392.x; Seminoff Jeffrey A., 2004, Herpetological Review, V35, P24; Sleeman Jonathan M., 2008, P97; SMITH G. M., 1938, ZOOLOGICA [NEW YORK], V23, P93; Smith J. W., 1997, Helminthological Abstracts, V66, P255; Stacy BA, 2008, VET MICROBIOL, V126, P63, DOI 10.1016/j.vetmic.2007.07.002; Stacy BA, 2010, J PARASITOL, V96, P752, DOI 10.1645/GE-2382.1; Stacy BA, 2010, DIS AQUAT ORGAN, V89, P237, DOI 10.3354/dao02195; TEWG [Turtle Expert Working Group], 2009, ASS LOGG TURTL POP W; WITHERINGTON BE, 1989, COPEIA, P696; Witherington B, 2009, ECOL APPL, V19, P30, DOI 10.1890/08-0434.1; WOLKE RE, 1982, J WILDLIFE DIS, V18, P175, DOI 10.7589/0090-3558-18.2.175; Woodford M.H., 2000, QUARANTINE HLTH SCRE; Work TM, 2015, DIS AQUAT ORGAN, V115, P103, DOI 10.3354/dao02890; Work TM, 2010, J WILDLIFE DIS, V46, P422, DOI 10.7589/0090-3558-46.2.422; Work TM, 2005, J PARASITOL, V91, P871, DOI 10.1645/GE-454R.1; Work TM, 2004, DIS AQUAT ORGAN, V62, P163, DOI 10.3354/dao062163; Work TM, 2003, DIS AQUAT ORGAN, V53, P41, DOI 10.3354/dao053041; Wyneken JE., 2006, REPTILE MED SURG, P972	62	34	35	4	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149398	10.1371/journal.pone.0149398	http://dx.doi.org/10.1371/journal.pone.0149398			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901623	gold, Green Published, Green Submitted			2022-12-27	WOS:000371276100069
J	Zhou, Y; Yang, QY; Xu, H; Zhang, JM; Deng, H; Gao, HY; Yang, J; Zhao, DY; Liu, F				Zhou, Yao; Yang, Qianyuan; Xu, Hong; Zhang, Jiamin; Deng, Huan; Gao, Haiyan; Yang, Jin; Zhao, Deyu; Liu, Feng			miRNA-221-3p Enhances the Secretion of Interleukin-4 in Mast Cells through the Phosphatase and Tensin Homolog/p38/Nuclear Factor-kappaB Pathway	PLOS ONE			English	Article							ASTHMA; LYMPHOCYTES; AKT	Mast cells play a central role in asthma. Moreover, serum miRNA-221-3p (miR-221) has been shown to be markedly increased in children with asthma. In the current study, we aimed to examine miR-221 expression in an asthma model and elucidate the mechanisms regulating interleukin (IL)-4 secretion in mast cells. Using polymerase chain reaction, we found that miR-221 was upregulated in a murine asthma model and in P815 mast cells after lipopolysaccharide (LPS) stimulation. Moreover, miR-221 upregulated IL-4 secretion from P815 cells, as shown by enzyme-linked immunosorbent assays. Bioinformatics analysis, luciferase reporter gene assays, and western blotting showed that phosphatase and tensin homolog (PTEN) was a target of miR-221 and could block IL-4 secretion stimulated by miR-221. The phosphorylation of p38 (protein) and activity of nuclear factor-kappaB (NF-kappa B) were increased after overexpression of miR-221, as shown by electrophoretic mobility shift assays. Finally, treatment with specific inhibitors could block IL-4 secretion. In conclusion, miR-221, which was overexpressed in a murine asthma model, stimulated IL-4 secretion in mast cells through a pathway involving PTEN, p38, and NF-kappa B.	[Zhou, Yao; Yang, Qianyuan; Xu, Hong; Zhang, Jiamin; Deng, Huan; Gao, Haiyan; Yang, Jin; Zhao, Deyu; Liu, Feng] Nanjing Med Univ, Nanjing Childrens Hosp, Dept Resp Med, Nanjing 210008, Jiangsu, Peoples R China; [Yang, Jin] Jiangsu Huaian Matern & Childrens Hosp, Dept Pediat, Huaian 223002, Jiangsu, Peoples R China	Nanjing Medical University	Zhao, DY; Liu, F (corresponding author), Nanjing Med Univ, Nanjing Childrens Hosp, Dept Resp Med, Nanjing 210008, Jiangsu, Peoples R China.	zhaodeyu98@126.com; axsliu@163.com			National Natural Science Foundation of China [81200012, 81370132]; Nanjing Medical Science and Technique Development Foundation; Nanjing Public Health Bureau [ZKX11012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Medical Science and Technique Development Foundation; Nanjing Public Health Bureau	The current research was supported by the National Natural Science Foundation of China (81200012, Feng Liu; 81370132, Deyu Zhao; http://www.nsfc.gov.cn/), by Nanjing Medical Science and Technique Development Foundation (http://se.njh.gov.cn/index/index.do) and by Nanjing Public Health Bureau (ZKX11012, Deyu Zhao; http://www.njh.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2007, J IMMUNOL, V179, P8105, DOI 10.4049/jimmunol.179.12.8105; Bijani FM, 2012, INT REV IMMUNOL, V31, P379, DOI 10.3109/08830185.2012.706761; Bradding P, 2006, J ALLERGY CLIN IMMUN, V117, P1277, DOI 10.1016/j.jaci.2006.02.039; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Bredeloux P, 2007, BRIT J PHARMACOL, V150, P711, DOI 10.1038/sj.bjp.0707151; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Brightling C, 2008, J ALLERGY CLIN IMMUN, V121, P5, DOI 10.1016/j.jaci.2007.10.028; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Corominas M, 1998, CLIN EXP IMMUNOL, V112, P276; Hui ABY, 2009, LAB INVEST, V89, P597, DOI 10.1038/labinvest.2009.12; IRANI AMA, 1989, CLIN EXP ALLERGY, V19, P143, DOI 10.1111/j.1365-2222.1989.tb02357.x; Lin CF, 2013, IMMUNOPHARM IMMUNOT, V35, P669, DOI 10.3109/08923973.2013.837059; Liu F, 2012, MOL MED REP, V6, P1178, DOI 10.3892/mmr.2012.1030; Mayoral RJ, 2009, J IMMUNOL, V182, P433, DOI 10.4049/jimmunol.182.1.433; Medvedev AE, 2013, J INTERF CYTOK RES, V33, P467, DOI 10.1089/jir.2012.0140; OGARRA A, 1986, P NATL ACAD SCI USA, V83, P5228, DOI 10.1073/pnas.83.14.5228; Panganiban RPL, 2012, AM J CLIN EXP IMMUNO, V1, P154; Rane MJ, 2010, AM J PHYSIOL-RENAL, V298, pF49, DOI 10.1152/ajprenal.00032.2009; Rodriguez D, 2003, J IMMUNOL, V171, P1001, DOI 10.4049/jimmunol.171.2.1001; Saluja R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043547; Sundaramurthy P, 2009, BIOINFORMATION, V3, P250, DOI 10.6026/97320630003250; Takenaka H, 2010, BIOCHEM BIOPH RES CO, V391, P471, DOI 10.1016/j.bbrc.2009.11.082; Zheng C, 2012, MED ONCOL, V29, P815, DOI 10.1007/s12032-011-9934-8; Zhou Y, 2014, TUMOR BIOL, V35, P9269, DOI 10.1007/s13277-014-1901-5	24	27	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148821	10.1371/journal.pone.0148821	http://dx.doi.org/10.1371/journal.pone.0148821			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901347	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100024
J	Hung, MH; Liu, CJ; Teng, CJ; Hu, YW; Yeh, CM; Chen, SC; Chien, SH; Hung, YP; Shen, CC; Chen, TJ; Tzeng, CH; Liu, CY				Hung, Man-Hsin; Liu, Chia-Jen; Teng, Chung-Jen; Hu, Yu-Wen; Yeh, Chiu-Mei; Chen, San-Chi; Chien, Sheng-Hsuan; Hung, Yi-Ping; Shen, Cheng-Che; Chen, Tzeng-Ji; Tzeng, Cheng-Hwai; Liu, Chun-Yu			Risk of Second Non-Breast Primary Cancer in Male and Female Breast Cancer Patients: A Population-Based Cohort Study	PLOS ONE			English	Article							GLOBAL BURDEN; YOUNG AGE; MALIGNANCIES; WOMEN; EPIDEMIOLOGY; DIAGNOSIS; SURVIVAL; TRENDS	Female breast cancer patients have an increased risk of developing subsequent malignant diseases, but this issue is rarely discussed in regards to male breast cancer patients. Thus, we conducted a national survey that included 100,915 female and 578 male breast cancer patients to investigate the risk of second primary malignancy (SPM). During a follow-up period that included 529,782 person-years, 3,153 cases of SPM developed. Compared with the general population, the standardized incidence ratio (SIR) of SPM in breast cancer patients was 1.51 [95% confidence interval (CI): 1.46-1.56]. The observed risk was significantly higher in male patients (SIR 2.17, 95% CI 1.70-2.73) and in patients whose age at breast cancer diagnosis was 40 years or younger (SIR 3.39, 95% CI 2.80-4.07), comparing to age-matched general population. Compared with the overall female population, the SIRs of female breast cancer patients with uterine (SIR: 2.66, 95% CI: 2.37-2.98), thyroid (SIR: 2.30, 95% CI: 2.02-2.62), and bone and soft tissue (SIR: 2.16, 95% CI: 1.56-2.91) cancers were significantly increased. Male breast cancer patients also displayed significantly higher SIRs for thyroid (SIR: 13.2, 95% CI: 1.60-47.69), skin (SIR: 8.24, 95% CI: 3.02-17.94) and head and neck (SIR: 4.41, 95% CI: 2.35-7.54) cancers. Among breast cancer patients, risk factors significantly associated with SPM included male gender, older age, chemotherapy treatment and comorbidity with liver cirrhosis. From our analysis, we concluded that the risk of SPM was significantly higher for both male and female breast cancer patients compared with the general population, suggesting that more intensive surveillance may be needed, especially in high-risk patients.	[Hung, Man-Hsin; Hu, Yu-Wen; Hung, Yi-Ping; Liu, Chun-Yu] Taipei Vet Gen Hosp, Dept Oncol, Taipei, Taiwan; [Liu, Chia-Jen; Chen, San-Chi; Chien, Sheng-Hsuan; Tzeng, Cheng-Hwai] Taipei Vet Gen Hosp, Div Hematol & Oncol, Dept Med, Taipei, Taiwan; [Yeh, Chiu-Mei; Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Hung, Man-Hsin; Teng, Chung-Jen; Hu, Yu-Wen; Chen, San-Chi; Chien, Sheng-Hsuan; Hung, Yi-Ping; Tzeng, Cheng-Hwai; Liu, Chun-Yu] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Hung, Man-Hsin] Natl Yang Ming Univ, Sch Life Sci, Program Mol Med, Taipei 112, Taiwan; [Hung, Man-Hsin] Acad Sinica, Taipei 115, Taiwan; [Liu, Chia-Jen] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Liu, Chun-Yu] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan; [Teng, Chung-Jen] Far Eastern Mem Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan; [Shen, Cheng-Che] Taichung Vet Gen Hosp, Chiayi Branch, Dept Psychiat, Chiayi, Taiwan; [Shen, Cheng-Che] Natl Chung Cheng Univ, Dept Informat Management, Chiayi 621, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Far Eastern Memorial Hospital; Taichung Veterans General Hospital; National Chung Cheng University	Liu, CY (corresponding author), Taipei Vet Gen Hosp, Dept Oncol, Taipei, Taiwan.; Liu, CY (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan.; Liu, CY (corresponding author), Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan.	cyliu3@vghtpe.gov.tw	Chien, Sheng-Hsuan/HDM-2486-2022; Chen, TJ/AAH-8430-2021	Hu, Yu-Wen/0000-0002-7983-415X	Taiwan Clinical Oncology Research Foundation; Ministry of Science and Technology (Formerly National Science Council), Taiwan [103-2325-B-075-002, 104-2628-B-075-001-MY3]; Center of Excellence for Cancer Research at Taipei Veterans General [MOHW103-TD-B-111-02, MOHW104-TDU-B-211-124-001, MOHW105-TDU-B-211-134003]; Ministry of Health and Welfare, Executive Yuan, Taiwan; Taipei Veterans General Hospital-National Yang-Ming University Excellent Physician Scientists Cultivation Program from Taipei Veterans General Hospital [103-V-B-025, V103C-141, V103B-022, V103E10-001, V104C-151, V105C-067, V104A-001]	Taiwan Clinical Oncology Research Foundation; Ministry of Science and Technology (Formerly National Science Council), Taiwan; Center of Excellence for Cancer Research at Taipei Veterans General; Ministry of Health and Welfare, Executive Yuan, Taiwan; Taipei Veterans General Hospital-National Yang-Ming University Excellent Physician Scientists Cultivation Program from Taipei Veterans General Hospital	This study is supported partially by Taiwan Clinical Oncology Research Foundation and grants 103-2325-B-075-002, 104-2628-B-075-001-MY3 from the Ministry of Science and Technology (Formerly National Science Council), Taiwan; MOHW103-TD-B-111-02, MOHW104-TDU-B-211-124-001, and MOHW105-TDU-B-211-134003 from the Center of Excellence for Cancer Research at Taipei Veterans General, the Ministry of Health and Welfare, Executive Yuan, Taiwan; Taipei Veterans General Hospital-National Yang-Ming University Excellent Physician Scientists Cultivation Program, No. 103-V-B-025, V103C-141, V103B-022, V103E10-001, V104C-151, V105C-067 and V104A-001 from Taipei Veterans General Hospital. The study is based in part on data from the National Health Insurance Research Database provided by the Bureau of National Health Insurance, Department of Health and managed by National Health Research Institutes. The interpretation and conclusions contained herein do not represent those of Bureau of National Health Insurance, Department of Health or National Health Research Institutes.	Chen SC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116384; Coughlin SS, 2009, CANCER EPIDEMIOL, V33, P315, DOI 10.1016/j.canep.2009.10.003; Curtis R, 2006, NEW MALIGNANCIES CAN; Edwards B. K., 2013, CANCER; El Saghir NS, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-194; Fredholm H, 2009, PLOS ONE, V4, pA38, DOI 10.1371/journal.pone.0007695; Giordano SH, 2005, ONCOLOGIST, V10, P471, DOI 10.1634/theoncologist.10-7-471; Hashibe M, 2007, J NATL CANCER I, V99, P777, DOI 10.1093/jnci/djk179; Kalaitzakis E, 2011, CLIN GASTROENTEROL H, V9, P168, DOI 10.1016/j.cgh.2010.10.014; Kroger N, 2003, BONE MARROW TRANSPL, V32, P1153, DOI 10.1038/sj.bmt.1704291; Lee KD, 2008, CANCER EPIDEM BIOMAR, V17, P2647, DOI 10.1158/1055-9965.EPI-08-0109; Malone KE, 2010, J CLIN ONCOL, V28, P2404, DOI 10.1200/JCO.2009.24.2495; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Mellemkjaer L, 2006, INT J CANCER, V118, P2285, DOI 10.1002/ijc.21651; Mellemkjaer L, 2011, CANCER EPIDEM BIOMAR, V20, P1784, DOI 10.1158/1055-9965.EPI-11-0009; Nelson H. D., 2013, US PREVENTIVE SERVIC; Obedian E, 2000, J CLIN ONCOL, V18, P2406, DOI 10.1200/JCO.2000.18.12.2406; Parkin DM, 2006, BREAST J, V12, pS70, DOI 10.1111/j.1075-122X.2006.00205.x; Schaapveld M, 2008, J CLIN ONCOL, V26, P1239, DOI 10.1200/JCO.2007.11.9081; Shaitelman SF, 2011, INT J RADIAT ONCOL, V81, P1244, DOI 10.1016/j.ijrobp.2010.07.2005; Shen YC, 2005, CANCER EPIDEM BIOMAR, V14, P1986, DOI 10.1158/1055-9965.EPI-04-0932; Tutluer S, 2012, MED ONCOL, V29, P1365, DOI 10.1007/s12032-011-9896-x; Wang YP, 2012, CAN MED ASSOC J, V184, pE804, DOI 10.1503/cmaj.120518; Weiss JR, 2005, CANCER EPIDEM BIOMAR, V14, P20, DOI 10.1158/1055-9965.EPI-05-0414; Wernberg JA, 2009, J SURG ONCOL, V99, P16, DOI 10.1002/jso.21153	25	15	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148597	10.1371/journal.pone.0148597	http://dx.doi.org/10.1371/journal.pone.0148597			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894298	Green Published, gold, Green Submitted			2022-12-27	WOS:000371223400020
J	Hecksteden, A; Skorski, S; Schwindling, S; Hammes, D; Pfeiffer, M; Kellmann, M; Ferrauti, A; Meyer, T				Hecksteden, Anne; Skorski, Sabrina; Schwindling, Sascha; Hammes, Daniel; Pfeiffer, Mark; Kellmann, Michael; Ferrauti, Alexander; Meyer, Tim			Blood-Borne Markers of Fatigue in Competitive Athletes - Results from Simulated Training Camps	PLOS ONE			English	Article							OVERTRAINING SYNDROME; IMMUNE-SYSTEM; PERFORMANCE; CYCLISTS; REPRODUCIBILITY; DIAGNOSIS; EXERCISE; SCIENCE; SPORTS	Assessing current fatigue of athletes to fine-tune training prescriptions is a critical task in competitive sports. Blood-borne surrogate markers are widely used despite the scarcity of validation trials with representative subjects and interventions. Moreover, differences between training modes and disciplines (e.g. due to differences in eccentric force production or calorie turnover) have rarely been studied within a consistent design. Therefore, we investigated blood-borne fatigue markers during and after discipline-specific simulated training camps. A comprehensive panel of blood-born indicators was measured in 73 competitive athletes (28 cyclists, 22 team sports, 23 strength) at 3 time-points: after a run-in resting phase (d 1), after a 6-day induction of fatigue (d 8) and following a subsequent 2-day recovery period (d 11). Venous blood samples were collected between 8 and 10 a. m. Courses of blood-borne indicators are considered as fatigue dependent if a significant deviation from baseline is present at day 8 (Delta fatigue) which significantly regresses towards baseline until day 11 (Delta recovery). With cycling, a fatigue dependent course was observed for creatine kinase (CK;Delta fatigue 54 +/- 84 U/l;Delta recovery -60 +/- 83 U/l), urea (Delta fatigue 11 +/- 9 mg/dl;.recovery -10 +/- 10 mg/dl), free testosterone (Delta fatigue -1.3 +/- 2.1 pg/ml;Delta recovery 0.8 +/- 1.5 pg/ml) and insulin linke growth factor 1 (IGF-1;Delta fatigue -56 +/- 28 ng/ml;Delta recovery 53 +/- 29 ng/ml). For urea and IGF-1 95% confidence intervals for days 1 and 11 did not overlap with day 8. With strength and high-intensity interval training, respectively, fatigue-dependent courses and separated 95% confidence intervals were present for CK (strength:Delta fatigue 582 +/- 649 U/l;Delta recovery -618 +/- 419 U/l; HIIT:Delta fatigue 863 +/- 952 U/l;Delta recovery -741 +/- 842 U/l) only. These results indicate that, within a comprehensive panel of blood-borne markers, changes in fatigue are most accurately reflected by urea and IGF-1 for cycling and by CK for strength training and team sport players.	[Hecksteden, Anne; Skorski, Sabrina; Schwindling, Sascha; Hammes, Daniel; Meyer, Tim] Univ Saarland, Inst Sports & Prevent Med, D-66123 Saarbrucken, Germany; [Pfeiffer, Mark] Johannes Gutenberg Univ Mainz, Inst Sports Sci, D-55122 Mainz, Germany; [Kellmann, Michael; Ferrauti, Alexander] Ruhr Univ Bochum, Fac Sports Sci, Univ Str 150, Bochum, Germany; [Kellmann, Michael] Univ Queensland, Sch Human Movement Studies, Brisbane, Qld 4072, Australia; [Kellmann, Michael] Univ Queensland, Sch Psychol, Brisbane, Qld 4072, Australia	Saarland University; Johannes Gutenberg University of Mainz; Ruhr University Bochum; University of Queensland; University of Queensland	Hecksteden, A (corresponding author), Univ Saarland, Inst Sports & Prevent Med, D-66123 Saarbrucken, Germany.	a.hecksteden@mx.uni-saarland.de	; Kellmann, Michael/J-3508-2014	Pfeiffer, Mark/0000-0002-9287-5343; Kellmann, Michael/0000-0003-1699-9624; Hammes, Daniel/0000-0002-3304-2528; Alexander, Ferrauti/0000-0001-9807-2755	German Institute of Sport Science; project "RegMan - Management of Regeneration in Elite Sports" [IIA1-081901/12-16]	German Institute of Sport Science; project "RegMan - Management of Regeneration in Elite Sports"	The present study was funded by the German Institute of Sport Science. The research was realized within the project "RegMan - Management of Regeneration in Elite Sports" (IIA1-081901/12-16).	Areces F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138376; Buchheit M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00073; Faria EW, 2005, SPORTS MED, V35, P285, DOI 10.2165/00007256-200535040-00002; Fernandez-Garcia B, 2002, INT J SPORTS MED, V23, P555, DOI 10.1055/s-2002-35532; Gabriel HHW, 1998, MED SCI SPORT EXER, V30, P1151, DOI 10.1097/00005768-199807000-00021; Halson SL, 2002, J APPL PHYSIOL, V93, P947, DOI 10.1152/japplphysiol.01164.2001; Hecksteden A, 1985, J APPL PHYSL; Jeukendrup A, 1996, MED SCI SPORT EXER, V28, P266, DOI 10.1097/00005768-199602000-00017; Kaikkonen P, 2008, SCAND J MED SCI SPOR, V18, P511, DOI 10.1111/j.1600-0838.2007.00728.x; Kellmann M, 2010, SCAND J MED SCI SPOR, V20, P95, DOI 10.1111/j.1600-0838.2010.01192.x; Lamberts RP, 2010, EUR J APPL PHYSIOL, V108, P183, DOI 10.1007/s00421-009-1291-3; Laursen PB, 2003, INT J SPORTS MED, V24, P481; Meeusen R, 2013, MED SCI SPORT EXER, V45, P186, DOI 10.1249/MSS.0b013e318279a10a; Meyer T, 2004, MED SCI SPORT EXER, V36, P1743, DOI 10.1249/01.MSS.0000142422.87805.74; Palmer GS, 1996, INT J SPORTS MED, V17, P293, DOI 10.1055/s-2007-972849; PARRYBILLINGS M, 1992, MED SCI SPORT EXER, V24, P1353; Paton CD, 2001, SPORTS MED, V31, P489, DOI 10.2165/00007256-200131070-00004; Sassi A, 2008, APPL PHYSIOL NUTR ME, V33, P735, DOI 10.1139/H08-046; Smith DJ, 2000, MED SCI SPORT EXER, V32, P684, DOI 10.1097/00005768-200003000-00020; Sottas PE, 2007, BIOSTATISTICS, V8, P285, DOI 10.1093/biostatistics/kxl009; Sottas PE, 2012, BIOANALYSIS, V4, P1645, DOI [10.4155/BIO.12.130, 10.4155/bio.12.130]; Steinacker JM, 2004, EUR J APPL PHYSIOL, V91, P382, DOI 10.1007/s00421-003-0960-x; Urhausen A, 2002, SPORTS MED, V32, P95, DOI 10.2165/00007256-200232020-00002; URHAUSEN A, 1995, SPORTS MED, V20, P251, DOI 10.2165/00007256-199520040-00004; Urhausen A, 1998, MED SCI SPORT EXER, V30, P407, DOI 10.1097/00005768-199803000-00011	25	39	39	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0148810	10.1371/journal.pone.0148810	http://dx.doi.org/10.1371/journal.pone.0148810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891051	Green Submitted, Green Published, gold			2022-12-27	WOS:000371221500014
J	Li, B; Zhang, JX; Wang, ZM; Chen, SL				Li, Bing; Zhang, Junxia; Wang, Zhimei; Chen, Shaoliang			Ivabradine Prevents Low Shear Stress Induced Endothelial Inflammation and Oxidative Stress via mTOR/eNOS Pathway	PLOS ONE			English	Article							HEART-RATE REDUCTION; STIMULATES PHOSPHORYLATION; DYSFUNCTION; ATHEROSCLEROSIS; ATHEROGENESIS; FAILURE; DISEASE; MTOR; RATS; MICE	Ivabradine not only reduces heart rate but has other cardiac and vascular protective effects including anti-inflammation and anti-oxidation. Since endothelial nitric oxide synthase (eNOS) is a crucial enzyme in maintaining endothelial activity, we aimed to investigate the impact of ivabradine in low shear stress (LSS) induced inflammation and endothelial injury and the role of eNOS played in it. Endothelial cells (ECs) were subjected to LSS at 2dyne/cm(2), with 1 hour of ivabradine (0.04 mu M) or LY294002 (10 mu M) pre-treatment. The mRNA expression of IL-6, VCAM-1 along with eNOS were measured by QPCR. Reactive oxygen species (ROS) was detected by dihydroethidium (DHE) and DCF, and protein phosphorylation was detected by western blot. It demonstrated that ivabradine decreased LSS induced inflammation and oxidative stress in endothelial cells. Western blot showed reduced rictor and Akt-Ser473 as well as increased eNOS-Thr495 phosphorylation. However, mTORC1 pathway was only increased when LSS applied within 30 minutes. These effects were reversed by ivabradine. It would appear that ivabradine diminish ROS generation by provoking mTORC2/Akt phosphorylation and repressing mTORC1 induced eNOS-Thr495 activation. These results together suggest that LSS induced endothelial inflammation and oxidative stress are suppressed by ivabradine via mTORC2/Akt activation and mTORC1/eNOS reduction.	[Li, Bing; Zhang, Junxia; Wang, Zhimei; Chen, Shaoliang] Nanjing Med Univ, Nanjing Hosp 1, Dept Cardiol, 68 Changle Rd, Nanjing 210006, Jiangsu, Peoples R China	Nanjing Medical University	Chen, SL (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Cardiol, 68 Changle Rd, Nanjing 210006, Jiangsu, Peoples R China.	chmengx@126.com			National Natural Science Foundation of China [81270191]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (Grant No. 81270191) http://www.nsfc.gov.cn/.	Boo YC, 2002, AM J PHYSIOL-HEART C, V283, pH1819, DOI 10.1152/ajpheart.00214.2002; Castier Y, 2005, CIRC RES, V97, P533, DOI 10.1161/01.RES.0000181759.63239.21; Danchin N, 2006, ADV CARDIOL, V43, P45, DOI 10.1159/000095405; Drouin A, 2008, BRIT J PHARMACOL, V154, P749, DOI 10.1038/bjp.2008.116; Fang YH, 2012, J CARDIOVASC PHARM, V59, P260, DOI 10.1097/FJC.0b013e31823e5e01; Fox K, 2008, LANCET, V372, P807, DOI 10.1016/S0140-6736(08)61170-8; Heo KS, 2013, CIRC RES, V112, P911, DOI 10.1161/CIRCRESAHA.111.300179; Herranz B, 2012, CIRC RES, V110, P439, DOI 10.1161/CIRCRESAHA.111.253948; Huang CF, 2012, EXP CELL RES, V318, P1075, DOI 10.1016/j.yexcr.2012.03.011; Lee DY, 2010, J BIOL CHEM, V285, P30, DOI 10.1074/jbc.M109.010512; Li XH, 2014, DNA CELL BIOL, V33, P830, DOI 10.1089/dna.2014.2480; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Moore JP, 2010, ARTERIOSCL THROM VAS, V30, P561, DOI 10.1161/ATVBAHA.109.199554; Owczarek J, 2012, ARCH MED SCI, V8, P549, DOI 10.5114/aoms.2012.29411; Rajapakse AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019237; Ramkhelawon B, 2009, CIRC RES, V105, P869, DOI 10.1161/CIRCRESAHA.109.204040; Sargento L, 2013, CLIN CARDIOL, V36, P677, DOI 10.1002/clc.22183; Sciarretta S, 2014, CIRC RES, V114, P549, DOI 10.1161/CIRCRESAHA.114.302022; Suffredini S, 2012, BRIT J PHARMACOL, V165, P1457, DOI 10.1111/j.1476-5381.2011.01627.x; Swedberg K, 2010, LANCET, V376, P875, DOI 10.1016/S0140-6736(10)61198-1; Vion AC, 2013, CIRC RES, V112, P1323, DOI 10.1161/CIRCRESAHA.112.300818; Voelkers M, 2013, CIRCULATION, V128, P2132, DOI 10.1161/CIRCULATIONAHA.113.003638; Walcher T, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/751313; Wang WY, 2010, BLOOD, V115, P2971, DOI 10.1182/blood-2009-05-224824; Zaragoza C, 2012, CURR OPIN LIPIDOL, V23, P446, DOI 10.1097/MOL.0b013e328357e837; Zhou J, 2014, ARTERIOSCL THROM VAS, V34, P2191, DOI 10.1161/ATVBAHA.114.303422; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	27	22	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149694	10.1371/journal.pone.0149694	http://dx.doi.org/10.1371/journal.pone.0149694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890696	Green Published, Green Submitted, gold			2022-12-27	WOS:000371221500071
J	Pullinger, GD; Busquets, MG; Nomikou, K; Boyce, M; Attoui, H; Mertens, PP				Pullinger, Gillian D.; Busquets, Marc Guimera; Nomikou, Kyriaki; Boyce, Mark; Attoui, Houssam; Mertens, Peter P.			Identification of the Genome Segments of Bluetongue Virus Serotype 26 (Isolate KUW2010/02) that Restrict Replication in a Culicoides sonorensis Cell Line (KC Cells)	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; AFRICAN HORSE SICKNESS; ORBIVIRUS; PROTEINS; INFECTION; EUROPE; VECTOR; CORE; RNA; EVOLUTION	Bluetongue virus (BTV) can infect most ruminant species and is usually transmitted by adult, vector-competent biting midges (Culicoides spp.). Infection with BTV can cause severe clinical signs and can be fatal, particularly in naive sheep and some deer species. Although 24 distinct BTV serotypes were recognized for several decades, additional 'types' have recently been identified, including BTV-25 (from Switzerland), BTV-26 (from Kuwait) and BTV-27 from France (Corsica). Although BTV-25 has failed to grow in either insect or mammalian cell cultures, BTV-26 (isolate KUW2010/02), which can be transmitted horizontally between goats in the absence of vector insects, does not replicate in a Culicoides sonorensis cell line (KC cells) but can be propagated in mammalian cells (BSR cells). The BTV genome consists of ten segments of linear dsRNA. Mono-reassortant viruses were generated by reverse-genetics, each one containing a single BTV-26 genome segment in a BTV-1 genetic-background. However, attempts to recover a mono-reassortant containing genome-segment 2 (Seg-2) of BTV-26 (encoding VP2), were unsuccessful but a triple-reassortant was successfully generated containing Seg-2, Seg-6 and Seg-7 (encoding VP5 and VP7 respectively) of BTV-26. Reassortants were recovered and most replicated well in mammalian cells (BSR cells). However, mono-reassortants containing Seg-1 or Seg-3 of BTV-26 (encoding VP1, or VP3 respectively) and the triple reassortant failed to replicate, while a mono-reassortant containing Seg-7 of BTV-26 only replicated slowly in KC cells.	[Pullinger, Gillian D.; Busquets, Marc Guimera; Nomikou, Kyriaki; Boyce, Mark; Attoui, Houssam; Mertens, Peter P.] Pirbright Inst, Vector Borne Viral Dis Programme, Woking, Surrey, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Pullinger, GD (corresponding author), Pirbright Inst, Vector Borne Viral Dis Programme, Woking, Surrey, England.	gillian.pullinger@pirbright.ac.uk	Nomikou, Kyriaki/P-1840-2018; Nomikou, Kyriaki/Q-5555-2016	Nomikou, Kyriaki/0000-0002-7013-1853; Nomikou, Kyriaki/0000-0002-7013-1853; Attoui, Houssam/0000-0001-9639-9981; Mertens, Peter/0000-0002-3438-3738	EU EMIDA [BB/I017259/1]; BBSRC [BB/I017259/1, BBS/E/I/00001446, BBS/E/I/00001700, BBS/E/I/00001876] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001700, BB/I017259/1, BBS/E/I/00001876, BBS/E/I/00001446] Funding Source: researchfish	EU EMIDA; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grant BB/I017259/1 from EU EMIDA (Coordination of European research on emerging and major infectious diseases of livestock) awarded to PPM.	ALEXANDER KA, 1994, AM J TROP MED HYG, V51, P568, DOI 10.4269/ajtmh.1994.51.568; Anbalagan S, 2014, J GEN VIROL, V95, P434, DOI 10.1099/vir.0.059659-0; Attoui H, 2000, J VIROL METHODS, V89, P147, DOI 10.1016/S0166-0934(00)00212-3; Attoui H, 2005, J GEN VIROL, V86, P3409, DOI 10.1099/vir.0.81258-0; Attoui H, 2009, VIROLOGY, V394, P298, DOI 10.1016/j.virol.2009.08.032; Batten CA, 2013, VET MICROBIOL, V162, P62, DOI 10.1016/j.vetmic.2012.08.014; Batten C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096049; Belhouchet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025697; Belhouchet M, 2010, J GEN VIROL, V91, P2985, DOI 10.1099/vir.0.024760-0; Boyce M, 2008, J VIROL, V82, P8339, DOI 10.1128/JVI.00808-08; Chaignat V, 2010, SMALL RUMINANT RES, V93, P157, DOI 10.1016/j.smallrumres.2010.05.016; Chaignat V, 2009, VET MICROBIOL, V138, P11, DOI 10.1016/j.vetmic.2009.02.003; Darpel KE, 2007, VET REC, V161, P253, DOI 10.1136/vr.161.8.253; Feenstra F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092377; Firth AE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-48; GOULD AR, 1987, VIRUS RES, V7, P169, DOI 10.1016/0168-1702(87)90078-5; Grimes JM, 1997, STRUCTURE, V5, P885, DOI 10.1016/S0969-2126(97)00243-8; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; GUMM ID, 1982, ARCH VIROL, V72, P83, DOI 10.1007/BF01314453; Hofmann MA, 2008, EMERG INFECT DIS, V14, P1855, DOI 10.3201/eid1412.080818; HOWERTH EW, 1988, AM J VET RES, V49, P1906; Huismans H, 2004, Vet Ital, V40, P417; HUISMANS H, 1981, ONDERSTEPOORT J VET, V48, P51; HUISMANS H, 1987, J VIROL, V61, P3589, DOI 10.1128/JVI.61.11.3589-3595.1987; HUISMANS H, 1979, VIROLOGY, V92, P397, DOI 10.1016/0042-6822(79)90144-2; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; Jenckel M, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00016-15; Karber G, 1931, EXP PATHOL PHARM, V162, P480; King B M, 1985, Prog Clin Biol Res, V178, P289; Maan NS, 2015, J VIROL METHODS, V213, P118, DOI 10.1016/j.jviromet.2014.11.012; Maan S, 2007, J GEN VIROL, V88, P621, DOI 10.1099/vir.0.82456-0; Maan S, 2011, PLOS ONE, V6; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Maan S, 2007, J VIROL METHODS, V143, P132, DOI 10.1016/j.jviromet.2007.02.016; Maan S, 2011, EMERG INFECT DIS, V17, P886, DOI 10.3201/eid1705.101742; Maan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010323; MacLachlan NJ, 2010, VET RES, V41, DOI 10.1051/vetres/2010007; Matsuo E, 2013, J VIROL, V87, P882, DOI 10.1128/JVI.02363-12; Mertens PPC, 1996, VIROLOGY, V217, P582, DOI 10.1006/viro.1996.0153; MERTENS PPC, 1984, VIROLOGY, V135, P207, DOI 10.1016/0042-6822(84)90131-4; Mertens PPC., 2005, VIRUS TAXONOMY, P466; Meyer G, 2009, EMERG INFECT DIS, V15, P608, DOI 10.3201/eid1504.081514; Nomikou K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006437; Nunes SF, 2014, J VIROL, V88, P12222, DOI 10.1128/JVI.02183-14; PRITCHARD LI, 1995, VIRUS RES, V35, P247, DOI 10.1016/0168-1702(94)00072-K; Purse BV, 2008, REV SCI TECH OIE, V27, P427, DOI 10.20506/rst.27.2.1801; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Quan M, 2008, J GEN VIROL, V89, P1159, DOI 10.1099/vir.0.83502-0; Ratinier M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002477; ROY P, 1992, J GEN VIROL, V73, P3051, DOI 10.1099/0022-1317-73-12-3051; ROY P, 1989, VIRUS RES, V13, P179, DOI 10.1016/0168-1702(89)90015-4; Roy P, 2008, CELL BIOCHEM BIOPHYS, V50, P143, DOI 10.1007/s12013-008-9009-4; Ruiz-Fons F, 2008, EMERG INFECT DIS, V14, P951, DOI 10.3201/eid1406.071586; SATO M, 1977, ARCH VIROL, V53, P269, DOI 10.1007/BF01314672; Shaw AE, 2013, J VIROL, V87, P543, DOI 10.1128/JVI.02266-12; Shaw AE, 2012, J VIROL, V86, P9015, DOI 10.1128/JVI.00131-12; Stewart M, 2015, J GEN VIROL, V96, P3280, DOI 10.1099/jgv.0.000267; STOTT JL, 1985, AM J VET RES, V46, P1197; Tabachnick WJ, 2010, J EXP BIOL, V213, P946, DOI 10.1242/jeb.037564; Tan BH, 2001, J VIROL, V75, P3937, DOI 10.1128/JVI.75.8.3937-3947.2001; van Gennip RGP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085788; van Gennip RGP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044619; van Gennip RGP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030540; Weaver SC, 2006, CURR TOP MICROBIOL, V299, P285; WECHSLER SJ, 1989, J INVERTEBR PATHOL, V54, P385, DOI 10.1016/0022-2011(89)90123-7; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091; Zhang X, 2010, P NATL ACAD SCI USA, V107, P6292, DOI 10.1073/pnas.0913403107	67	18	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149709	10.1371/journal.pone.0149709	http://dx.doi.org/10.1371/journal.pone.0149709			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890863	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000371221500072
J	Fang, KF; Gao, S; Zhang, WW; Xing, Y; Cao, QQ; Qin, L				Fang, Kefeng; Gao, Sai; Zhang, Weiwei; Xing, Yu; Cao, Qingqin; Qin, Ling			Addition of Phenylboronic Acid to Malus domestica Pollen Tubes Alters Calcium Dynamics, Disrupts Actin Filaments and Affects Cell Wall Architecture	PLOS ONE			English	Article							RHAMNOGALACTURONAN-II; ARABINOGALACTAN PROTEINS; BORON DEFICIENCY; CROSS-LINKING; GROWTH; ROOT; CA2+; GERMINATION; ELONGATION; EXPRESSION	A key role of boron in plants is to cross-link the cell wall pectic polysaccharide rhamnogalacturonan-II (RG-II) through borate diester linkages. Phenylboronic acid (PBA) can form the same reversible ester bonds but cannot cross-link two molecules, so can be used as an antagonist to study the function of boron. This study aimed to evaluate the effect of PBA on apple (Malus domestica) pollen tube growth and the underlying regulatory mechanism. We observed that PBA caused an inhibition of pollen germination, tube growth and led to pollen tube morphological abnormalities. Fluorescent labeling, coupled with a scanning ion-selective electrode technique, revealed that PBA induced an increase in extracellular Ca2+ influx, thereby elevating the cytosolic Ca2+ concentration [Ca2+]c and disrupting the [Ca2+]c gradient, which is critical for pollen tube growth. Moreover the organization of actin filaments was severely perturbed by the PBA treatment. Immunolocalization studies and fluorescent labeling, together with Fourier-transform infrared analysis (FTIR) suggested that PBA caused an increase in the abundance of callose, de-esterified pectins and arabinogalactan proteins (AGPs) at the tip. However, it had no effect on the deposition of the wall polymers cellulose. These effects are similar to those of boron deficiency in roots and other organs, indicating that PBA can induce boron deficiency symptoms. The results provide new insights into the roles of boron in pollen tube development, which likely include regulating [Ca2+]c and the formation of the actin cytoskeleton, in addition to the synthesis and assembly of cell wall components.	[Fang, Kefeng; Gao, Sai; Zhang, Weiwei; Xing, Yu; Cao, Qingqin; Qin, Ling] Beijing Agr Univ, Coll Plant Sci & Technol, Beijing Key Lab Agr Applicat & New Tech, Beijing 102206, Peoples R China	Beijing University of Agriculture	Qin, L (corresponding author), Beijing Agr Univ, Coll Plant Sci & Technol, Beijing Key Lab Agr Applicat & New Tech, Beijing 102206, Peoples R China.	qinlingbac@126.com	cao, qingqin/W-5009-2019	Qin, Ling/0000-0002-9814-5771	National Natural Science Foundation of China [31270719, 30800874]; Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions [CITTCD201304095]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions	This work was supported by the National Natural Science Foundation of China (31270719, 30800874) to KFF, http://www.nsfc.gov.cn/, the Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions (CIT&TCD201304095) to KFF, http://www.bjedu.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves M.A.M., 2010, THESIS I TECNOLOGIA; Atmodjo MA, 2013, ANNU REV PLANT BIOL, V64, P747, DOI 10.1146/annurev-arplant-042811-105534; Bassil E, 2004, PLANT PHYSIOL, V136, P3383, DOI 10.1104/pp.104.040527; Braccini I, 2001, BIOMACROMOLECULES, V2, P1089, DOI 10.1021/bm010008g; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Cai G, 2011, PLANT PHYSIOL, V155, P1169, DOI 10.1104/pp.110.171371; Camacho-Cristobal JJ, 2008, J INTEGR PLANT BIOL, V50, P1247, DOI 10.1111/j.1744-7909.2008.00742.x; Cardenas L, 2008, PLANT PHYSIOL, V146, P1611, DOI 10.1104/pp.107.113035; Chebli Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058246; Chebli Y, 2012, PLANT PHYSIOL, V160, P1940, DOI 10.1104/pp.112.199729; Chen T, 2007, PLANT CELL PHYSIOL, V48, P19, DOI 10.1093/pcp/pcl036; Chen T, 2009, PLANT PHYSIOL, V149, P1111, DOI 10.1104/pp.108.127514; Dumont M, 2014, ANN BOT-LONDON, V114, P1177, DOI 10.1093/aob/mcu093; Fu Y, 2015, CURR OPIN PLANT BIOL, V28, P111, DOI 10.1016/j.pbi.2015.10.004; Gao S., 2014, J AGR, V4, P77; GLUSENKAMP KH, 1997, BORON SOILS PLANTS, P229; Gonzalez-Fontes A, 2014, PLANT SCI, V217, P135, DOI 10.1016/j.plantsci.2013.12.011; Hao HQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076660; Hepler PK, 2012, TRENDS PLANT SCI, V17, P32, DOI 10.1016/j.tplants.2011.10.007; Ishii T, 2001, PHYTOCHEMISTRY, V57, P969, DOI 10.1016/S0031-9422(01)00047-4; Iwai H, 2006, P NATL ACAD SCI USA, V103, P16592, DOI 10.1073/pnas.0605141103; Koshiba T, 2010, PLANT CELL PHYSIOL, V51, P323, DOI 10.1093/pcp/pcp179; Lamport DTA, 2014, ANN BOT-LONDON, V114, P1069, DOI 10.1093/aob/mcu161; Lamport DTA, 2013, NEW PHYTOL, V197, P58, DOI 10.1111/nph.12005; Lazzaro MD, 2003, PROTOPLASMA, V220, P201, DOI 10.1007/s00709-002-0042-7; Li YQ, 2002, PLANTA, V214, P734, DOI 10.1007/s004250100664; MARTINI F, 1993, PLANT PHYSIOL BIOCH, V31, P777; MCCANN MC, 1992, PLANT PHYSIOL, V100, P1940, DOI 10.1104/pp.100.4.1940; Miwa K, 2013, PLANT PHYSIOL, V163, P1699, DOI 10.1104/pp.113.225995; Moscatelli A, 2009, J INTEGR PLANT BIOL, V51, P727, DOI 10.1111/j.1744-7909.2009.00842.x; Nguema-Ona E, 2012, ANN BOT-LONDON, V110, P383, DOI 10.1093/aob/mcs143; Pereira AM, 2014, J EXP BOT, V65, P5459, DOI 10.1093/jxb/eru300; Qu XL, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00786; Quiles-Pando C, 2013, PLANT PHYSIOL BIOCH, V65, P55, DOI 10.1016/j.plaphy.2013.01.004; Redondo-Nieto M, 2012, NEW PHYTOL, V195, P14, DOI 10.1111/j.1469-8137.2012.04176.x; Rodriguez-Riano T, 2000, SEX PLANT REPROD, V12, P241, DOI 10.1007/s004970050008; Shi DQ, 2010, PLANT DEVELOPMENTAL BIOLOGY - BIOTECHNOLOGICAL PERSPECTIVES, VOL 1, P245, DOI 10.1007/978-3-642-02301-9_13; Springsteen G, 2002, TETRAHEDRON, V58, P5291, DOI 10.1016/S0040-4020(02)00489-1; Taylor LP, 1997, ANNU REV PLANT PHYS, V48, P461, DOI 10.1146/annurev.arplant.48.1.461; Tenhaken R, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00771; Voxeur A, 2014, PLANT J, V79, P139, DOI 10.1111/tpj.12547; Wang QL, 2003, TREE PHYSIOL, V23, P345, DOI 10.1093/treephys/23.5.345; Wolf S, 2012, PROTOPLASMA, V249, P169, DOI 10.1007/s00709-011-0371-5; Yu GH, 2014, J EXP BOT, V65, P3235, DOI 10.1093/jxb/eru171; Yu Q, 2003, PHYSIOL PLANTARUM, V117, P270, DOI 10.1034/j.1399-3054.2003.00029.x; Zhang WH, 1998, PLANT J, V15, P147, DOI 10.1046/j.1365-313X.1998.00188.x; Zhang Y, 2010, PLANT PHYSIOL, V152, P2200, DOI 10.1104/pp.109.142349	47	9	10	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149232	10.1371/journal.pone.0149232	http://dx.doi.org/10.1371/journal.pone.0149232			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886907	gold, Green Published, Green Submitted			2022-12-27	WOS:000371218400069
J	Yamamoto, T; Tateno, F; Sakakibara, R; Furukawa, S; Asahina, M; Uchiyama, T; Hirano, S; Yamanaka, Y; Fuse, M; Koga, Y; Yanagisawa, M; Kuwabara, S				Yamamoto, Tatsuya; Tateno, Fuyuki; Sakakibara, Ryuji; Furukawa, Shogo; Asahina, Masato; Uchiyama, Tomoyuki; Hirano, Shigeki; Yamanaka, Yoshitaka; Fuse, Miki; Koga, Yasuko; Yanagisawa, Mitsuru; Kuwabara, Satoshi			Urinary Dysfunction in Progressive Supranuclear Palsy Compared with Other Parkinsonian Disorders	PLOS ONE			English	Article							MULTIPLE SYSTEM ATROPHY; CLINICAL-FEATURES; NEURAL-CONTROL; ONUFS NUCLEUS; STIMULATION; DIAGNOSIS; AREA; PSP	Background Autonomic urinary dysfunction affects patients with progressive supranuclear palsy (PSP); however, the severity and prevalence of urinary dysfunctions in these patients compared with those observed in patients with Parkinson's disease (PD) and multiple system atrophy (MSA) are unknown. Objective We compared urinary dysfunction characteristics in patients with PSP, PD, and MSA. Patients and Methods Forty-seven patients who satisfied the probable or possible criteria of the National Institute for Neurological Diseases and Stroke and Society for PSP were assessed using the urinary symptoms questionnaire and the urodynamic study at Chiba and Toho Universities (n = 26 and 21, respectively). The results were compared with those of patients with PD and MSA (n = 218 and 193, respectively). Results The mean disease duration of PSP and the mean age were 2.97 +/- 0.26 and 71.4 +/- 0.88 years, respectively. The mini-mental state examination and frontal assessment battery scores were 22.6 +/- 0.70 and 10.7 +/- 0.49, respectively. Urinary storage and voiding symptoms were observed in 57% and 56% of patients with PSP, respectively. Detrusor overactivity in the urodynamic study was detected in 81% of patients with PSP, which was slightly more than that found in patients with PD (69%) and MSA (67%); however, this was not statistically significant. Postvoid residual volume in patients with PSP was significantly more than that in patients with PD (P < 0.01), but was equivalent to that in patients with MSA. Conclusions The present study demonstrated that patients with PSP experienced various urinary dysfunctions. Urinary storage dysfunction in patients with PSP was not different from that in patients with PD or MSA, whereas urinary voiding dysfunction in patients with PSP was milder than that in patients with MSA and more severe than that in patients with PD. These features should be taken into account for the differentiation of PSP from PD and MSA.	[Yamamoto, Tatsuya; Sakakibara, Ryuji; Furukawa, Shogo; Asahina, Masato; Uchiyama, Tomoyuki; Hirano, Shigeki; Yamanaka, Yoshitaka; Kuwabara, Satoshi] Chiba Univ, Grad Sch Med, Dept Neurol, Chiba, Japan; [Fuse, Miki; Yanagisawa, Mitsuru] Chiba Univ, Grad Sch Med, Dept Urol, Chiba, Japan; [Koga, Yasuko] Chiba Univ, Grad Sch Med, Dept Mol Diag, Chiba, Japan; [Tateno, Fuyuki; Sakakibara, Ryuji] Toho Univ, Sakura Med Ctr, Div Neurol, Dept Internal Med, Sakura, Japan; [Uchiyama, Tomoyuki] Dokkyo Med Univ, Dept Neurol, Continence Ctr, Dokkyo, Tochigi, Japan	Chiba University; Chiba University; Chiba University; Toho University; Dokkyo Medical University	Yamamoto, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Neurol, Chiba, Japan.	tatsuya-yamamoto@mbc.nifty.com	Sakakibara, Ryuji/AAE-3829-2019	Sakakibara, Ryuji/0000-0002-5803-169X; Yamamoto, Tatsuya/0000-0003-4297-6354; Kuwabara, Satoshi/0000-0002-4716-8578; Asahina, Masato/0000-0002-4177-2379				ANDREW J, 1964, BRAIN, V87, P233, DOI 10.1093/brain/87.2.233; de Groat WC, 2015, COMPR PHYSIOL, V5, P327, DOI 10.1002/cphy.c130056; Fowler CJ, 2008, NAT REV NEUROSCI, V9, P453, DOI 10.1038/nrn2401; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; GJONE R, 1963, ACTA PHYSIOL SCAND, V59, P337, DOI 10.1111/j.1748-1716.1963.tb02749.x; Kaat LD, 2007, NEUROLOGY, V69, P723, DOI 10.1212/01.wnl.0000267643.24870.26; Lee SW, 2012, J MOV DISORD, V5, P42, DOI 10.14802/jmd.12010; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Liu Z, 2004, NEUROSCIENCE, V126, P1075, DOI 10.1016/j.neuroscience.2004.04.033; Mannen T, 2000, NEUROPATHOLOGY, V20, pS30; O'Sullivan SS, 2008, BRAIN, V131, P1362, DOI 10.1093/brain/awn065; Sakakibara R, 2003, NEUROSCIENCE, V120, P871, DOI 10.1016/S0306-4522(03)00319-1; Sakakibara R, 2002, AUTON NEUROSCI-BASIC, V102, P30, DOI 10.1016/S1566-0702(02)00180-7; Sakakibara R, 2012, NEUROBIOL DIS, V46, P565, DOI 10.1016/j.nbd.2011.10.002; Sakakibara R, 2009, CLIN AUTON RES, V19, P20, DOI 10.1007/s10286-008-0489-5; Scaravilli T, 2000, ANN NEUROL, V48, P97; Schafer W, 2002, NEUROUROL URODYNAM, V21, P261, DOI 10.1002/nau.10066; Slawek J, 2001, Nucl Med Rev Cent East Eur, V4, P73; Tateno F, 2011, CLIN AUTON RES, V21, P173, DOI 10.1007/s10286-010-0100-8; Uchiyama T, 2011, J NEUROL NEUROSUR PS, V82, P1382, DOI 10.1136/jnnp.2011.241075; Watanabe H, 2002, BRAIN, V125, P1070, DOI 10.1093/brain/awf117; Williams DR, 2010, MOVEMENT DISORD, V25, P357, DOI 10.1002/mds.22977; Williams DR, 2009, LANCET NEUROL, V8, P270, DOI 10.1016/S1474-4422(09)70042-0; Xie T, 2015, NPJ PARKINSON DIS, V1, DOI 10.1038/npjparkd.2015.7; Yamamoto T, 2014, NEUROUROL URODYNAM, V33, P516, DOI 10.1002/nau.22441; Yamamoto T, 2010, NEUROSCI LETT, V473, P42, DOI 10.1016/j.neulet.2010.02.015; Yamamoto T, 2009, NEUROUROL URODYNAM, V28, P549, DOI 10.1002/nau.20682	28	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149278	10.1371/journal.pone.0149278	http://dx.doi.org/10.1371/journal.pone.0149278			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886104	Green Published, gold, Green Submitted			2022-12-27	WOS:000371218400073
J	Chan, EC; Kuo, SM; Kong, AM; Morrison, WA; Dusting, GJ; Mitchell, GM; Lim, SY; Liu, GS				Chan, Elsa C.; Kuo, Shyh-Ming; Kong, Anne M.; Morrison, Wayne A.; Dusting, Gregory J.; Mitchell, Geraldine M.; Lim, Shiang Y.; Liu, Guei-Sheung			Three Dimensional Collagen Scaffold Promotes Intrinsic Vascularisation for Tissue Engineering Applications	PLOS ONE			English	Article							STEM-CELLS; IN-VITRO; ENHANCES SURVIVAL; ENDOTHELIAL-CELLS; CARDIAC TISSUE; ANGIOGENESIS; VIVO; MATRIX; DIFFERENTIATION; POPULATION	Here, we describe a porous 3-dimensional collagen scaffold material that supports capillary formation in vitro, and promotes vascularization when implanted in vivo. Collagen scaffolds were synthesized from type I bovine collagen and have a uniform pore size of 80 mu m. In vitro, scaffolds seeded with primary human microvascular endothelial cells suspended in human fibrin gel formed CD31 positive capillary-like structures with clear lumens. In vivo, after subcutaneous implantation in mice, cell-free collagen scaffolds were vascularized by host neovessels, whilst a gradual degradation of the scaffold material occurred over 8 weeks. Collagen scaffolds, impregnated with human fibrinogen gel, were implanted subcutaneously inside a chamber enclosing the femoral vessels in rats. Angiogenic sprouts from the femoral vessels invaded throughout the scaffolds and these degraded completely after 4 weeks. Vascular volume of the resulting constructs was greater than the vascular volume of constructs from chambers implanted with fibrinogen gel alone (42.7 +/- 5.0 mu L in collagen scaffold vs 22.5 +/- 2.3 mu L in fibrinogen gel alone; p < 0.05, n = 7). In the same model, collagen scaffolds seeded with human adipose-derived stem cells (ASCs) produced greater increases in vascular volume than did cell-free collagen scaffolds (42.9 +/- 4.0 mu L in collagen scaffold with human ASCs vs 25.7 +/- 1.9 mu L in collagen scaffold alone; p < 0.05, n = 4). In summary, these collagen scaffolds are biocompatible and could be used to grow more robust vascularized tissue engineering grafts with improved the survival of implanted cells. Such scaffolds could also be used as an assay model for studies on angiogenesis, 3-dimensional cell culture, and delivery of growth factors and cells in vivo.	[Chan, Elsa C.; Dusting, Gregory J.; Liu, Guei-Sheung] Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, East Melbourne, Vic, Australia; [Chan, Elsa C.; Dusting, Gregory J.; Liu, Guei-Sheung] Univ Melbourne, Dept Surg, Ophthalmol, East Melbourne, Vic, Australia; [Kuo, Shyh-Ming] I Shou Univ, Dept Biomed Engn, Kaohsiung, Taiwan; [Kong, Anne M.; Morrison, Wayne A.; Dusting, Gregory J.; Mitchell, Geraldine M.; Lim, Shiang Y.] St Vincents Inst Med Res, OBrien Inst Dept, 41 Victoria Parade, Fitzroy, Vic 3065, Australia; [Morrison, Wayne A.; Mitchell, Geraldine M.; Lim, Shiang Y.] Univ Melbourne, St Vincents Hosp Melbourne, Dept Surg, Fitzroy, Vic 3065, Australia; [Morrison, Wayne A.; Mitchell, Geraldine M.] Australian Catholic Univ, Fac Hlth Sci, Fitzroy, Vic, Australia	Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; I Shou University; St. Vincent's Institute of Medical Research; St Vincent's Hospital Melbourne; University of Melbourne; Australian Catholic University	Liu, GS (corresponding author), Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, East Melbourne, Vic, Australia.; Liu, GS (corresponding author), Univ Melbourne, Dept Surg, Ophthalmol, East Melbourne, Vic, Australia.; Lim, SY (corresponding author), St Vincents Inst Med Res, OBrien Inst Dept, 41 Victoria Parade, Fitzroy, Vic 3065, Australia.; Lim, SY (corresponding author), Univ Melbourne, St Vincents Hosp Melbourne, Dept Surg, Fitzroy, Vic 3065, Australia.	mlim@svi.edu.au; guei-sheung@unimelb.edu.au	Lim, Shiang Y/AAG-5161-2020; Liu, Guei-Sheung/Q-6472-2018	Lim, Shiang Y/0000-0002-0442-3655; Liu, Guei-Sheung/0000-0003-3379-724X	National Health and Medical Research Council of Australia [1061912, 1003113]; Research Endowment Fund- St Vincent's Hospital Melbourne; Jack Brockhoff Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Research Endowment Fund- St Vincent's Hospital Melbourne; Jack Brockhoff Foundation	This work was supported by grants from the National Health and Medical Research Council of Australia (#1061912-GJD, GSL; and #1003113-GJD), the Research Endowment Fund- St Vincent's Hospital Melbourne (SYL, GMM) and the Jack Brockhoff Foundation (GMM). The Centre for Eye Research Australia and the O'Brien Institute Department of St Vincent's Institute of Medical Research receive Operational Infrastructure Support from the Victorian Government.	Abou Neel EA, 2013, ADV DRUG DELIVER REV, V65, P429, DOI 10.1016/j.addr.2012.08.010; Birla RK, 2005, TISSUE ENG, V11, P803, DOI 10.1089/ten.2005.11.803; Bitto FF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/935046; Brougham CM, 2015, ACTA BIOMATER; Chan BP, 2008, EUR SPINE J, V17, pS467, DOI 10.1007/s00586-008-0745-3; Chan EC, 2013, BIOCHEM BIOPH RES CO, V430, P918, DOI 10.1016/j.bbrc.2012.11.138; Chen CH, 2012, BIOCHEM BIOPH RES CO, V428, P68, DOI 10.1016/j.bbrc.2012.10.007; Chiu LLY, 2012, P NATL ACAD SCI USA, V109, pE3414, DOI 10.1073/pnas.1210580109; Conconi MT, 2010, J PEPT SCI, V16, P349, DOI 10.1002/psc.1251; Dietrich M, 2013, TISSUE ENG PART C-ME, V19, P216, DOI [10.1089/ten.tec.2011.0473, 10.1089/ten.TEC.2011.0473]; Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871; Haase T, 2015, J TISSUE ENG REGEN M; Higuchi M, 2013, STEM CELLS DEV, V22, P878, DOI 10.1089/scd.2012.0306; Hsiao STF, 2012, STEM CELLS DEV, V21, P2189, DOI 10.1089/scd.2011.0674; Jiang B, 2014, ACTA BIOMATER, V10, P1177, DOI 10.1016/j.actbio.2013.11.029; Kannan RY, 2005, BIOMATERIALS, V26, P1857, DOI 10.1016/j.biomaterials.2004.07.006; Kofidis T, 2003, BIOMATERIALS, V24, P5009, DOI 10.1016/S0142-9612(03)00429-0; Kuraitis D, 2011, J MOL CELL CARDIOL, V51, P187, DOI 10.1016/j.yjmcc.2011.04.011; Lim SY, 2013, STEM CELL TRANSL MED, V2, P715, DOI 10.5966/sctm.2012-0161; Lim SY, 2012, TISSUE ENG PT A, V18, P2210, DOI [10.1089/ten.TEA.2011.0719, 10.1089/ten.tea.2011.0719]; Montano I, 2010, TISSUE ENG PT A, V16, P269, DOI [10.1089/ten.tea.2008.0550, 10.1089/ten.TEA.2008.0550]; Morin KT, 2013, EXP CELL RES, V319, P2409, DOI 10.1016/j.yexcr.2013.06.006; Nomi Masashi, 2006, Curr Stem Cell Res Ther, V1, P333; Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004; Roelofs LAJ, 2008, FETAL DIAGN THER, V24, P7, DOI 10.1159/000132399; Roelofs LAJ, 2014, BJU INT, V114, P447, DOI 10.1111/bju.12591; SCHERLE W, 1970, Mikroskopie, V26, P57; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Shiose S, 2004, GRAEF ARCH CLIN EXP, V242, P777, DOI 10.1007/s00417-004-0910-2; Stubbs SL, 2012, STEM CELLS DEV, V21, P1887, DOI 10.1089/scd.2011.0289; Sukmana I, 2012, J ARTIF ORGANS, V15, P215, DOI 10.1007/s10047-012-0644-6; Tian L, 2011, J CARDIOVASC TRANSL, V4, P685, DOI 10.1007/s12265-011-9301-3; Wan Y, 2009, J MATER SCI-MATER M, V20, P719, DOI 10.1007/s10856-008-3622-z; Wang K, 2015, ACTA BIOMATER, V15, P65, DOI 10.1016/j.actbio.2014.12.025; Xiao X, 2015, SCI REP-UK, V5, DOI 10.1038/srep09409; Yannas IV, 2010, PHILOS T R SOC A, V368, P2123, DOI 10.1098/rsta.2010.0015; Zhang Y, 2015, STEM CELLS, V33, P3100, DOI 10.1002/stem.2101	37	93	94	5	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149799	10.1371/journal.pone.0149799	http://dx.doi.org/10.1371/journal.pone.0149799			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900837	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100152
J	Huang, CY; Hsu, CW; Chuang, CR; Lee, CC				Huang, Chih-Yuan; Hsu, Chia-Wen; Chuang, Chi-Rou; Lee, Ching-Chih			Pre-Dialysis Visits to a Nephrology Department and Major Cardiovascular Events in Patients Undergoing Dialysis	PLOS ONE			English	Article							INSURANCE RESEARCH DATABASE; CHRONIC KIDNEY-DISEASE; PRE-ESRD CARE; INITIATION; MORTALITY; SURVIVAL; TAIWAN; HEMODIALYSIS; VALIDATION; COHORT	Background and Objectives Pre-dialysis care by a nephrology out-patient department (OPD) may affect the outcomes of patients who ultimately undergo maintenance dialysis. This study examined the effect of pre-dialysis care by a nephrology OPD on the incidence of one-year major cardiovascular events after initiation of dialysis. Design, Setting Participants, & Measurements The study consisted of Taiwanese patients with chronic kidney disease (CKD) who commenced dialysis from 2006 to 2008. The number of nephrology OPD visits during the critical care period (within 6 months of initiation of dialysis) and the early care period (6-36 months before initiation of dialysis) were analyzed. The primary outcome measure was one-year major cardiovascular events. Results A total of 1191 CKD patients who initiated dialysis from 2006 to 2008 were included. Binary logistic regression showed that patients with. 3 visits during the critical care period and those with. 11 visits during the early care period had fewer composite major cardiovascular events than those with 0 visits. Patients with early referral are less likely to experience composite major cardiovascular events than those with late referral, with aOR 0.574 (95% CI = 0.43-0.77, P<0.001). Patients with both. 3 visits during critical care period and. 11 visits during early care period were less likely to experience composite major cardiovascular events (aOR = 0.25, 95% CI = 0.16-0.39, P < 0.001). Conclusions Patients with adequate pre-dialysis nephrology OPD visits, not just early referral, may had fewer one-year composite major cardiovascular events after initiation of dialysis. This information may be important to medical care providers and public health policy makers in their efforts to improve the well-being of CKD patients.	[Huang, Chih-Yuan] Ditmanson Med Fdn, Chia Yi Christian Hosp, Dept Internal Med, Div Nephrol, Chiayi, Taiwan; [Hsu, Chia-Wen] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Med Res, Chiayi, Taiwan; [Chuang, Chi-Rou] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Obstet & Gynecol, Chiayi, Taiwan; [Lee, Ching-Chih] Kaohsiung Vet Gen Hosp, Dept Otorhinolaryngol Head & Neck Surg, Kaohsiung, Taiwan; [Lee, Ching-Chih] Natl Def Med Ctr, Sch Med, Taipei, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Kaohsiung Veterans General Hospital; National Defense Medical Center	Chuang, CR (corresponding author), Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Obstet & Gynecol, Chiayi, Taiwan.; Lee, CC (corresponding author), Kaohsiung Vet Gen Hosp, Dept Otorhinolaryngol Head & Neck Surg, Kaohsiung, Taiwan.; Lee, CC (corresponding author), Natl Def Med Ctr, Sch Med, Taipei, Taiwan.	alexleelab@hotmail.com; hematcd@hotmail.com	Huang, Chih Yuan/G-5328-2015	Huang, Chih Yuan/0000-0002-7253-6301				Agrawal V, 2009, CLIN J AM SOC NEPHRO, V4, P323, DOI 10.2215/CJN.03510708; Avron J, 2002, ARCH INTERN MED, V162, P2002; Boulware LE, 2006, AM J KIDNEY DIS, V48, P192, DOI 10.1053/j.ajkd.2006.04.073; Buck J, 2007, NEPHROL DIAL TRANSPL, V22, P3240, DOI 10.1093/ndt/gfm387; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; de Jager DJ, 2011, NEPHROL DIAL TRANSPL, V26, P652, DOI 10.1093/ndt/gfq438; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Hasegawa T, 2009, CLIN J AM SOC NEPHRO, V4, P595, DOI 10.2215/CJN.03540708; Heatley SA, 2009, PERITON DIALYSIS INT, V29, pS128; Hommel K, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-108; Inaguma D, 2011, CLIN EXP NEPHROL, V15, P738, DOI 10.1007/s10157-011-0472-7; Jungers P, 2001, NEPHROL DIAL TRANSPL, V16, P2357, DOI 10.1093/ndt/16.12.2357; KDIGO-group, 2013, KIDNEY INT S, V3, P112; Khan SS, 2005, KIDNEY INT, V67, P1038, DOI 10.1111/j.1523-1755.2005.00168.x; Kip KE, 2008, J AM COLL CARDIOL, V51, P701, DOI 10.1016/j.jacc.2007.10.034; McClellan WM, 2009, J AM SOC NEPHROL, V20, P1078, DOI 10.1681/ASN.2008060624; Mendelssohn DC, 2011, NEPHROL DIAL TRANSPL, V26, P2959, DOI 10.1093/ndt/gfq843; Roderick P, 2002, NEPHROL DIAL TRANSPL, V17, P1252, DOI 10.1093/ndt/17.7.1252; Singhal R, 2014, KIDNEY INT, V86, P399, DOI 10.1038/ki.2014.16; Smart NA, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007333.pub2; Stack AG, 2003, AM J KIDNEY DIS, V41, P310, DOI 10.1053/ajkd.2003.50038; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6	23	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0147508	10.1371/journal.pone.0147508	http://dx.doi.org/10.1371/journal.pone.0147508			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900915	Green Submitted, gold, Green Published			2022-12-27	WOS:000371276100010
J	Jaiser, SR; Baker, MR; Baker, SN				Jaiser, Stephan R.; Baker, Mark R.; Baker, Stuart N.			Intermuscular Coherence in Normal Adults: Variability and Changes with Age	PLOS ONE			English	Article							MONKEY MOTOR CORTEX; CORTICOMUSCULAR COHERENCE; HAND-MUSCLE; ISOMETRIC CONTRACTION; INTRACORTICAL INHIBITION; CORTICOSPINAL SYSTEM; EMG COHERENCE; EEG-EMG; OSCILLATIONS; TASK	We investigated beta-band intermuscular coherence (IMC) in 92 healthy adults stratified by decade of age, and analysed variability between and within subjects. In the dominant upper limb, IMC was estimated between extensor digitorum communis and first dorsal interosseous as well as between flexor digitorum superficialis and first dorsal interosseous. In the ipsilateral lower limb, IMC was measured between medial gastrocnemius and extensor digitorum brevis as well as between tibialis anterior and extensor digitorum brevis. Age-related changes in IMC were analysed with age as a continuous variable or binned by decade. Intrasession variance of IMC was examined by dividing sessions into pairs of epochs and comparing coherence estimates between these pairs. Eight volunteers returned for a further session after one year, allowing us to compare intrasession and intersession variance. We found no age-related changes in IMC amplitude across almost six decades of age, allowing us to collate data from all ages into an aggregate normative dataset. Interindividual variability ranged over two orders of magnitude. Intrasession variance was significantly greater than expected from statistical variability alone, and intersession variance was even larger. Potential contributors include fluctuations in task performance, differences in electrode montage and short-term random variation in central coupling. These factors require further exploration and, where possible, minimisation. This study provides evidence that coherence is remarkably robust to senescent changes in the nervous system and provides a large normative dataset for future applications of IMC as a biomarker in disease states.	[Jaiser, Stephan R.; Baker, Mark R.; Baker, Stuart N.] Newcastle Univ, Sch Med, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Jaiser, Stephan R.; Baker, Mark R.] Royal Victoria Infirm, Dept Neurol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Baker, Mark R.] Royal Victoria Infirm, Dept Clin Neurophysiol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Jaiser, SR (corresponding author), Newcastle Univ, Sch Med, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.; Jaiser, SR (corresponding author), Royal Victoria Infirm, Dept Neurol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	stephan.jaiser@ncl.ac.uk		Baker, Stuart/0000-0001-8118-4048; Baker, Mark/0000-0001-6916-1329	Wellcome Trust [WT089893MA, WT101002MA]; National Institute for Health Research; MRC [MC_PC_13071] Funding Source: UKRI; Medical Research Council [MC_PC_13071] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by grants from the Wellcome Trust (www.wellcome.ac.uk, grant number WT089893MA, SRJ; and grant number WT101002MA, SNB) and the National Institute for Health Research (www.nihr.ac.uk, MRB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson B, 1996, BRAIN, V119, P1983, DOI 10.1093/brain/119.6.1983; Baker MR, 2003, J PHYSIOL-LONDON, V546, P931, DOI 10.1113/jphysiol.2002.029553; Baker SN, 2003, J NEUROPHYSIOL, V89, P1941, DOI 10.1152/jn.00832.2002; Baker SN, 1997, J PHYSIOL-LONDON, V501, P225, DOI 10.1111/j.1469-7793.1997.225bo.x; CLAUS D, 1990, MUSCLE NERVE, V13, P1125, DOI 10.1002/mus.880131207; Conway BA, 1995, J PHYSIOL-LONDON, V489, P917, DOI 10.1113/jphysiol.1995.sp021104; Evans CMB, 2003, EUR J NEUROSCI, V18, P453, DOI 10.1046/j.1460-9568.2003.02751.x; Eyre JA, 2000, BRAIN, V123, P51, DOI 10.1093/brain/123.1.51; EYRE JA, 1991, J PHYSIOL-LONDON, V434, P441, DOI 10.1113/jphysiol.1991.sp018479; FARMER SF, 1993, J PHYSIOL-LONDON, V470, P127, DOI 10.1113/jphysiol.1993.sp019851; Farmer SF, 2007, J PHYSIOL-LONDON, V579, P389, DOI 10.1113/jphysiol.2006.123174; Fisher KM, 2012, BRAIN, V135, P2849, DOI 10.1093/brain/aws150; Gibbs J, 1997, J PHYSIOL-LONDON, V499, P255, DOI 10.1113/jphysiol.1997.sp021924; Gilbertson T, 2005, J NEUROSCI, V25, P7771, DOI 10.1523/JNEUROSCI.1762-05.2005; Graziadio S, 2010, J NEUROSCI, V30, P3663, DOI 10.1523/JNEUROSCI.5621-09.2010; Grosse P, 2002, CLIN NEUROPHYSIOL, V113, P1523, DOI 10.1016/S1388-2457(02)00223-7; Halliday DM, 1998, NEUROSCI LETT, V241, P5, DOI 10.1016/S0304-3940(97)00964-6; HAUG H, 1991, NEUROBIOL AGING, V12, P336, DOI 10.1016/0197-4580(91)90013-A; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Incel NA, 2009, INT J REHABIL RES, V32, P213, DOI 10.1097/MRR.0b013e3283298226; James LM, 2008, EUR J NEUROSCI, V27, P3369, DOI 10.1111/j.1460-9568.2008.06277.x; Kamp D, 2013, AGE, V35, P49, DOI 10.1007/s11357-011-9329-y; Keenan KG, 2011, J NEUROSCI METH, V195, P10, DOI 10.1016/j.jneumeth.2010.10.018; Kilner JM, 2000, J NEUROSCI, V20, P8838; Kong X, 2010, COMPUT METH PROG BIO, V97, P1, DOI 10.1016/j.cmpb.2009.05.002; Krampe RT, 2002, NEUROSCI BIOBEHAV R, V26, P769, DOI 10.1016/S0149-7634(02)00064-7; Mall V, 2004, NEUROPEDIATRICS, V35, P120, DOI 10.1055/s-2004-815834; Matsuya R, 2013, J APPL PHYSIOL, V114, P896, DOI 10.1152/japplphysiol.00942.2012; Mima T, 1999, NEUROSCI LETT, V275, P77, DOI 10.1016/S0304-3940(99)00734-X; Moscufo N, 2011, NEUROBIOL AGING, V32, P646, DOI 10.1016/j.neurobiolaging.2009.04.010; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; Ohara S, 2000, CLIN NEUROPHYSIOL, V111, P2014, DOI 10.1016/S1388-2457(00)00448-X; Omlor W, 2007, NEUROIMAGE, V34, P1191, DOI 10.1016/j.neuroimage.2006.10.018; Pauluis Q, 1999, J COMPUT NEUROSCI, V6, P27, DOI 10.1023/A:1008804916112; Peinemann A, 2001, NEUROSCI LETT, V313, P33, DOI 10.1016/S0304-3940(01)02239-X; PFURTSCHELLER G, 1981, ELECTROEN CLIN NEURO, V51, P253, DOI 10.1016/0013-4694(81)90139-5; Pohja M, 2005, NEUROIMAGE, V26, P764, DOI 10.1016/j.neuroimage.2005.02.031; Raz N, 2006, NEUROSCI BIOBEHAV R, V30, P730, DOI 10.1016/j.neubiorev.2006.07.001; Riddle CN, 2006, NEUROIMAGE, V33, P618, DOI 10.1016/j.neuroimage.2006.07.027; Rivner MH, 2001, MUSCLE NERVE, V24, P1134, DOI 10.1002/mus.1124; Roos MR, 1997, MUSCLE NERVE, V20, P679; ROSENBERG JR, 1989, PROG BIOPHYS MOL BIO, V53, P1, DOI 10.1016/0079-6107(89)90004-7; ROSSINI PM, 1992, BRAIN RES, V593, P14, DOI 10.1016/0006-8993(92)91256-E; SALMELIN R, 1994, ELECTROEN CLIN NEURO, V91, P237, DOI 10.1016/0013-4694(94)90187-2; SANES JN, 1993, P NATL ACAD SCI USA, V90, P4470, DOI 10.1073/pnas.90.10.4470; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; Semmler JG, 2003, J NEUROPHYSIOL, V90, P1346, DOI 10.1152/jn.00941.2002; Silverman B.W., 1986, DENSITY ESTIMATION S; Ushiyama J, 2011, J NEUROPHYSIOL, V106, P1379, DOI 10.1152/jn.00193.2011; Williams ER, 2010, P NATL ACAD SCI USA, V107, P11098, DOI 10.1073/pnas.0913373107; Witham CL, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00038; Witham CL, 2011, J PHYSIOL-LONDON, V589, P3789, DOI 10.1113/jphysiol.2011.211045	52	29	30	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149029	10.1371/journal.pone.0149029	http://dx.doi.org/10.1371/journal.pone.0149029			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901129	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100034
J	Kevany, S; Khumalo-Sakutukwa, G; Singh, B; Chingono, A; Morin, S				Kevany, Sebastian; Khumalo-Sakutukwa, Gertrude; Singh, Basant; Chingono, Alfred; Morin, Stephen		NIMH Project Accept Study Team	Global Health Diplomacy, Monitoring & Evaluation, and the Importance of Quality Assurance & Control: Findings from NIMH Project Accept (HPTN 043): A Phase III Randomized Controlled Trial of Community Mobilization, Mobile Testing, Same-Day Results, and Post-Test Support for HIV in Sub-Saharan Africa and Thailand	PLOS ONE			English	Article							INTEGRITY	Background Provision and scale-up of high quality, evidence-based services is essential for successful international HIV prevention interventions in order to generate and maintain intervention uptake, study integrity and participant trust, from both health service delivery and diplomatic perspectives. Methods We developed quality assurance (QAC) procedures to evaluate staff fidelity to a cluster-randomized trial of the NIMH Project Accept (HPTN 043) assessing the effectiveness of a community-based voluntary counseling and testing strategy. The intervention was comprised of three components-Mobile Voluntary Counseling and Testing (MVCT), Community Mobilization (CM) and Post-Test Support Services (PTSS). QAC procedures were based on standardized criteria, and were designed to assess both provider skills and adherence to the intervention protocol. Supervisors observed a random sample of 5% to 10% of sessions each month and evaluated staff against multiple criteria on scales of 1-5. A score of 5 indicated 100% adherence, 4 indicated 95% adherence, and 3 indicated 90% adherence. Scores below 3 were considered unsatisfactory, and protocol deviations were discussed with the respective staff. Results During the first year of the intervention, the mean scores of MVCT and CM staff across the 5 study sites were 4 (95% adherence) or greater and continued to improve over time. Mean QAC scores for the PTSS component were lower and displayed greater fluctuations. Challenges to PTSS staff were identified as coping with the wide range of activities in the PTSS component and the novelty of the PTSS process. QAC fluctuations for PTSS were also associated with new staff hires or changes in staff responsibilities. Through constant staff monitoring and support, by Year 2, QAC scores for PTSS activities had reached those of MVCT and CM. Conclusions The implementation of a large-sale, evidence based HIV intervention requires extensive QAC to ensure implementation effectiveness. Ongoing appraisal of study staff across sites ensures consistent and high quality delivery of all intervention components, in keeping with the goals of the study protocol, while also providing a forum for corrective feedback, additional supervision and retraining of staff. QAC ensures staff fidelity to study procedures and is critical to the successful delivery of multi-site HIV prevention interventions, as well as the delivery of services scaled up in programmatic situations.	[Kevany, Sebastian; Khumalo-Sakutukwa, Gertrude; Morin, Stephen] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Singh, Basant] Med Univ S Carolina, Charleston, SC 29425 USA; [Chingono, Alfred] Univ Zimbabwe, Harare, Zimbabwe	University of California System; University of California San Francisco; Medical University of South Carolina; University of Zimbabwe	Kevany, S (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	sebastian.kevany@ucsf.edu	Singh, Basant/AAR-9108-2020; Urzua, Andrea Silva/AAS-7284-2020	Singh, Basant/0000-0002-7448-1906; 	U.S. National Institute of Mental Health [U01MH066687, U01MH066688, U01MH066701, U01MH066702]; HIV Prevention Trials Network of the Division of AIDS of the U.S. National Institute of Allergy and Infectious Diseases; Office of AIDS Research of the U.S. National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH066687, U01MH066702, P30MH062246, U01MH066688, U01MH066701] Funding Source: NIH RePORTER	U.S. National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); HIV Prevention Trials Network of the Division of AIDS of the U.S. National Institute of Allergy and Infectious Diseases; Office of AIDS Research of the U.S. National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was sponsored by the U.S. National Institute of Mental Health as a cooperative agreement, through contracts U01MH066687 (Johns Hopkins University), U01MH066688 (Medical University of South Carolina), U01MH066701 (University of California, Los Angeles), and U01MH066702 (University of California, San Francisco). In addition, this work was supported by the HIV Prevention Trials Network (HPTN Protocol 043) of the Division of AIDS of the U.S. National Institute of Allergy and Infectious Diseases, and by the Office of AIDS Research of the U.S. National Institutes of Health.	Carroll KM, 2002, CLIN PSYCHOL-SCI PR, P9; CDC, 2001, REV GUID HIV COUNS T; CDC, 2007, QUAL ASS GUID TEST U; Coates TJ, 2014, LANCET GLOB HEALTH, V2, pE267, DOI 10.1016/S2214-109X(14)70032-4; Fidler D, 2007, B WHO; Gresham F. M., 2000, LEARNING DISABILITIE, V15, P198, DOI [10.1207/SLDRP1504_4, DOI 10.1207/SLDRP1504_4]; Gresham F. M., 1997, DESIGN ANAL SINGLE C, P93; Kevany Sebastian, 2012, Med Confl Surviv, V28, P247, DOI 10.1080/13623699.2012.714654; Khumalo-Sakutukwa G, 2008, JAIDS-J ACQ IMM DEF, V49, P422, DOI 10.1097/QAI.0b013e31818a6cb5; PEPFAR, 2009, PEPFAR PREV CAR TREA; Perepletchikova F, 2007, J CONSULT CLIN PSYCH, V75, P829, DOI 10.1037/0022-006X.75.6.829; Schlosser R. W., 2002, AUGMENTATIVE ALTERNA, V18, P36, DOI [DOI 10.1080/aac.18.1.36.44, 10.1080/aac.18.1.36.44?needAccess=true]; WALTZ J, 1993, J CONSULT CLIN PSYCH, V61, P620, DOI 10.1037/0022-006X.61.4.620; World Health Organization (WHO), 2005, SCAL UP HIV TEST COU	14	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149335	10.1371/journal.pone.0149335	http://dx.doi.org/10.1371/journal.pone.0149335			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26901519	Green Published, gold			2022-12-27	WOS:000371276100059
J	Qian, Y; Zhang, ZY				Qian, Yu; Zhang, Zhaoyang			The Fundamental Structure and the Reproduction of Spiral Wave in a Two-Dimensional Excitable Lattice	PLOS ONE			English	Article							HODGKIN-HUXLEY NEURONS; VENTRICULAR-FIBRILLATION; COMPLEX NETWORKS; DYNAMICS; MEDIA; NOISE; TURBULENCE; OSCILLATIONS; TRANSITION; NEOCORTEX	In this paper we have systematically investigated the fundamental structure and the reproduction of spiral wave in a two-dimensional excitable lattice. A periodically rotating spiral wave is introduced as the model to reproduce spiral wave artificially. Interestingly, by using the dominant phase-advanced driving analysis method, the fundamental structure containing the loop structure and the wave propagation paths has been revealed, which can expose the periodically rotating orbit of spiral tip and the charity of spiral wave clearly. Furthermore, the fundamental structure is utilized as the core for artificial spiral wave. Additionally, the appropriate parameter region, in which the artificial spiral wave can be reproduced, is studied. Finally, we discuss the robustness of artificial spiral wave to defects.	[Qian, Yu] Baoji Univ Arts & Sci, Nonlinear Res Inst, Baoji, Shaanxi, Peoples R China; [Zhang, Zhaoyang] Ningbo Univ, Fac Sci, Dept Phys, Ningbo 315211, Zhejiang, Peoples R China	Baoji University of Arts & Sciences; Ningbo University	Qian, Y (corresponding author), Baoji Univ Arts & Sci, Nonlinear Res Inst, Baoji, Shaanxi, Peoples R China.	qianyu0272@163.com			National Natural Science Foundation of China [11105003]; Natural Science Basic Research Plan in Shaanxi Province of China [2014JQ2-1001]; China Postdoctoral Science Foundation [2015M581905]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Basic Research Plan in Shaanxi Province of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (Grant No. 11105003), the Natural Science Basic Research Plan in Shaanxi Province of China (Grant No. 2014JQ2-1001), and the China Postdoctoral Science Foundation (Grant No. 2015M581905).	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Allexandre D, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.061903; Alonso S, 2003, SCIENCE, V299, P1722, DOI 10.1126/science.1080207; BAR M, 1993, PHYS REV E, V48, pR1635; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Chen JX, 2014, CHAOS, V24, DOI 10.1063/1.4886356; Chen JX, 2014, EPL-EUROPHYS LETT, V107, DOI 10.1209/0295-5075/107/38001; Cross C, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; Garfinkel A, 2000, P NATL ACAD SCI USA, V97, P6061, DOI 10.1073/pnas.090492697; Gray RA, 1998, NATURE, V392, P75, DOI 10.1038/32164; Hu BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069251; Huang XY, 2010, NEURON, V68, P978, DOI 10.1016/j.neuron.2010.11.007; Huang XY, 2004, J NEUROSCI, V24, P9897, DOI 10.1523/JNEUROSCI.2705-04.2004; Jahnke W, 1991, INT J BIFURCAT CHAOS, V1, P445, DOI 10.1142/S0218127491000348; Kanakov OI, 2007, CHAOS, V17, DOI 10.1063/1.2437581; Liao XH, 2011, FRONT PHYS-BEIJING, V6, P124, DOI 10.1007/s11467-010-0152-1; Liao XH, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056204; Lou Q, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026213; Ma J, 2012, COMMUN NONLINEAR SCI, V17, P4281, DOI 10.1016/j.cnsns.2012.03.009; Ma J, 2011, CHINESE SCI BULL, V56, P151, DOI 10.1007/s11434-010-4281-2; Ma J, 2010, APPL MATH COMPUT, V217, P3844, DOI 10.1016/j.amc.2010.09.043; Ma J, 2010, COMMUN NONLINEAR SCI, V15, P1768, DOI 10.1016/j.cnsns.2009.07.013; Ma J, 2008, CHINESE PHYS LETT, V25, P4325, DOI 10.1088/0256-307X/25/12/039; MERON E, 1992, PHYS REP, V218, P1, DOI 10.1016/0370-1573(92)90098-K; Mi YY, 2013, P NATL ACAD SCI USA, V110, pE4931, DOI 10.1073/pnas.1304680110; Muller-Linow M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000190; Perc M, 2005, CHEM PHYS LETT, V410, P49, DOI 10.1016/j.cplett.2005.05.042; Perc M, 2007, CHEM PHYS LETT, V437, P143, DOI 10.1016/j.cplett.2007.02.003; Perc M, 2007, CHAOS SOLITON FRACT, V31, P280, DOI 10.1016/j.chaos.2005.10.018; Qian Y, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.032807; Qian Y, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.026107; Qian Y, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036101; Rappel WJ, 1999, PHYS REV LETT, V83, P456, DOI 10.1103/PhysRevLett.83.456; Riecke H, 2007, CHAOS, V17, DOI 10.1063/1.2743611; Roxin A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198101; Schiff S. J., 2007, BMC NEUROSCI, V8, pP61, DOI [DOI 10.1186/1471-2202-8-S2-P61, 10.1186/1471-2202-8-S2-P61]; Sinha S, 2001, PHYS REV LETT, V86, P3678, DOI 10.1103/PhysRevLett.86.3678; Sinha S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.015101; Steele AJ, 2006, CHAOS, V16, DOI 10.1063/1.2177569; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Tinsley M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.038306; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; Vogels TP, 2005, ANNU REV NEUROSCI, V28, P357, DOI 10.1146/annurev.neuro.28.061604.135637; Wang QY, 2008, PHYS LETT A, V372, P5681, DOI 10.1016/j.physleta.2008.07.005; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weiss JN, 2000, CIRC RES, V87, P1103, DOI 10.1161/01.RES.87.12.1103; Winfree AT, 1987, TIME BREAKS; Wu XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055403; Zhang H, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.188301; Zhang H, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026134	53	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149842	10.1371/journal.pone.0149842	http://dx.doi.org/10.1371/journal.pone.0149842			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900841	gold, Green Published			2022-12-27	WOS:000371276100163
J	Suh, E; Choe, DH; Saveer, AM; Zwiebel, LJ				Suh, Eunho; Choe, Dong-Hwan; Saveer, Ahmed M.; Zwiebel, Laurence J.			Suboptimal Larval Habitats Modulate Oviposition of the Malaria Vector Mosquito Anopheles coluzzii	PLOS ONE			English	Article							AEDES-AEGYPTI; GAMBIAE-S.S.; DENSITY-DEPENDENCE; SITE SELECTION; CHEMICAL CUES; CULICIDAE; RESPONSES; DIPTERA; IDENTIFICATION; ATTRACTANTS	Selection of oviposition sites by gravid females is a critical behavioral step in the reproductive cycle of Anopheles coluzzii, which is one of the principal Afrotropical malaria vector mosquitoes. Several studies suggest this decision is mediated by semiochemicals associated with potential oviposition sites. To better understand the chemosensory basis of this behavior and identify compounds that can modulate oviposition, we examined the generally held hypothesis that suboptimal larval habitats give rise to semiochemicals that negatively influence the oviposition preference of gravid females. Dual-choice bioassays indicated that oviposition sites conditioned in this manner do indeed foster significant and concentration dependent aversive effects on the oviposition site selection of gravid females. Headspace analyses derived from aversive habitats consistently noted the presence of dimethyl disulfide (DMDS), dimethyl trisulfide (DMTS) and 6-methyl-5-hepten-2-one (sulcatone) each of which unitarily affected An. coluzzii oviposition preference. Electrophysiological assays across the antennae, maxillary palp, and labellum of gravid An. coluzzii revealed differential responses to these semiochemicals. Taken together, these findings validate the hypothesis in question and suggest that suboptimal environments for An. coluzzii larval development results in the release of DMDS, DMTS and sulcatone that impact the response valence of gravid females.	[Suh, Eunho; Saveer, Ahmed M.; Zwiebel, Laurence J.] Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Choe, Dong-Hwan] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Zwiebel, Laurence J.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Vanderbilt Brain Inst,Program Dev Biol, Nashville, TN 37232 USA; [Zwiebel, Laurence J.] Vanderbilt Univ, Med Ctr, Inst Chem Biol & Global Hlth, Nashville, TN USA	Vanderbilt University; University of California System; University of California Riverside; Vanderbilt University; Vanderbilt University	Zwiebel, LJ (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.; Zwiebel, LJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, Vanderbilt Brain Inst,Program Dev Biol, Nashville, TN 37232 USA.; Zwiebel, LJ (corresponding author), Vanderbilt Univ, Med Ctr, Inst Chem Biol & Global Hlth, Nashville, TN USA.	l.zwiebel@vanderbilt.edu	Ahmed, Mohamed Saveer/H-6589-2016	Ahmed, Mohamed Saveer/0000-0002-4587-5578; Zwiebel, Laurence/0000-0001-6686-7289	Vanderbilt University; National Institutes of Health (NIAID) [AI056402]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056402] Funding Source: NIH RePORTER	Vanderbilt University; National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was conducted with the support of Vanderbilt University and a grant from the National Institutes of Health (NIAID, AI056402) to LJZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afify A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-315; Agnew P, 2002, ECOL ENTOMOL, V27, P396, DOI 10.1046/j.1365-2311.2002.00430.x; Albeny-Simoes D, 2014, OECOLOGIA, V175, P481, DOI 10.1007/s00442-014-2910-1; Artis ML, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-163; BENTLEY MD, 1989, ANNU REV ENTOMOL, V34, P401, DOI 10.1146/annurev.en.34.010189.002153; Birkett MA, 2004, MED VET ENTOMOL, V18, P313, DOI 10.1111/j.0269-283X.2004.00528.x; Blackwell A, 2000, ANN TROP MED PARASIT, V94, P389, DOI 10.1080/00034983.2000.11813554; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Chobu M, 2015, ACTA TROP, V142, P131, DOI 10.1016/j.actatropica.2014.11.012; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; Eilers EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041357; El-Moamly AA, 2013, J INFECT DEV COUNTR, V7, P769, DOI 10.3855/jidc.3079; Ellis AM, 2008, J ANIM ECOL, V77, P247, DOI 10.1111/j.1365-2656.2007.01345.x; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; Fillinger U, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-62; Fritz Megan L, 2008, J Circadian Rhythms, V6, P2, DOI 10.1186/1740-3391-6-2; Harraca V, 2012, J EXP BIOL, V215, P623, DOI 10.1242/jeb.065748; Huang J, 2005, MED VET ENTOMOL, V19, P442, DOI 10.1111/j.1365-2915.2005.00588.x; Huang J, 2006, J MED ENTOMOL, V43, P498, DOI 10.1603/0022-2585(2006)43[498:AGDCOI]2.0.CO;2; Huang J, 2007, PHYSIOL ENTOMOL, V32, P34, DOI 10.1111/j.1365-3032.2006.00538.x; Kershenbaum A, 2012, EVOL ECOL, V26, P955, DOI 10.1007/s10682-011-9548-9; Koenraadt CJM, 2004, ENTOMOL EXP APPL, V112, P125, DOI 10.1111/j.0013-8703.2004.00186.x; Koenraadt CJM, 2003, MED VET ENTOMOL, V17, P61, DOI 10.1046/j.1365-2915.2003.00409.x; Koffi AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082387; KRAMER WL, 1979, ENVIRON ENTOMOL, V8, P1111, DOI 10.1093/ee/8.6.1111; Kugimiya S, 2010, J CHEM ECOL, V36, P620, DOI 10.1007/s10886-010-9802-6; Kwon HW, 2006, P NATL ACAD SCI USA, V103, P13526, DOI 10.1073/pnas.0601107103; Lindh JM, 2008, J MED ENTOMOL, V45, P1039, DOI 10.1603/0022-2585(2008)45[1039:OROAGS]2.0.CO;2; Lindh JM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0636-0; Logan JG, 2008, J CHEM ECOL, V34, P308, DOI 10.1007/s10886-008-9436-0; Logan JG, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-239; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Majambere S, 2008, AM J TROP MED HYG, V79, P19, DOI 10.4269/ajtmh.2008.79.19; MAYER MS, 1984, J INSECT PHYSIOL, V30, P757, DOI 10.1016/0022-1910(84)90041-6; McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964; MCCRAE AWR, 1984, ANN TROP MED PARASIT, V78, P307, DOI 10.1080/00034983.1984.11811821; Menger DJ, 2014, MED VET ENTOMOL, V28, P407, DOI 10.1111/mve.12061; Miller JR, 2007, NATURWISSENSCHAFTEN, V94, P195, DOI 10.1007/s00114-006-0178-y; Minakawa N, 2004, MED VET ENTOMOL, V18, P301, DOI 10.1111/j.0269-283X.2004.00503.x; Munga S, 2006, J MED ENTOMOL, V43, P221, DOI 10.1603/0022-2585(2006)043[0221:EOLCAP]2.0.CO;2; Munga S, 2005, J MED ENTOMOL, V42, P993, DOI 10.1603/0022-2585(2005)042[0993:OSPAEH]2.0.CO;2; Muriu SM, 2013, J ANIM ECOL, V82, P166, DOI 10.1111/1365-2656.12002; Okal MN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-365; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Pickett JA, 1996, CIBA F SYMP, V200, P109; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; Ponnusamy L, 2008, P NATL ACAD SCI USA, V105, P9262, DOI 10.1073/pnas.0802505105; Rinker DC, 2013, P NATL ACAD SCI USA, V110, P8260, DOI 10.1073/pnas.1302562110; Rund SSC, 2013, SCI REP-UK, V3, DOI 10.1038/srep02494; Seenivasagan T, 2009, PARASITOL RES, V104, P827, DOI 10.1007/s00436-008-1263-2; Stensmyr MC, 2002, NATURE, V420, P625, DOI 10.1038/420625a; Su CY, 2012, NATURE, V492, P66, DOI 10.1038/nature11712; Suh E, 2014, CURR OPIN INSECT SCI, V6, P86, DOI 10.1016/j.cois.2014.10.006; Sumba LA, 2008, J CHEM ECOL, V34, P1430, DOI 10.1007/s10886-008-9549-5; Sumba Leunita A., 2004, International Journal of Tropical Insect Science, V24, P260, DOI 10.1079/IJT200433; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Tauxe GM, 2013, CELL, V155, P1365, DOI 10.1016/j.cell.2013.11.013; Verhulst NO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015829; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Warburg A, 2011, J VECTOR ECOL, V36, P421, DOI 10.1111/j.1948-7134.2011.00183.x; Wasserberg G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092658; Wong J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001015; Yoshioka M, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-225; Zahiri N, 1998, J MED ENTOMOL, V35, P782, DOI 10.1093/jmedent/35.5.782	64	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149800	10.1371/journal.pone.0149800	http://dx.doi.org/10.1371/journal.pone.0149800			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900947	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100153
J	Drachler, MD; Drachler, CW; Teixeira, LB; Leite, JCD				Drachler, Maria de Lourdes; Drachler, Carlos Wietzke; Teixeira, Luciana Barcellos; de Carvalho Leite, Jose Carlos			The Scale of Self-Efficacy Expectations of Adherence to Antiretroviral Treatment: A Tool for Identifying Risk for Non-Adherence to Treatment for HIV	PLOS ONE			English	Article							ADOLESCENTS; THERAPY	Background Identification of risk for non-adherence to treatment is a challenge for personalized care for people living with HIV. Standardized questionnaires of patients' expectations of their capability to overcome obstacles for treatment adherence may be used as a pre-screening for risk identification. A scale of self-efficacy expectations of adherence to antiretroviral treatment (SEA-ART scale) was previously developed. This study assesses the scale validity in predicting non-adherence to ART in adults living with HIV. Methods and Findings A prospective cohort study applied a 21-item SEA-ART scale to 275 adults in ART treatment at an outpatient public service for HIV in Southern Brazil. ART medications taken were assessed at one-month follow-up; ART adherence was devised as an intake of 95% and more of the prescribed medication. A SEA-ART score was calculated by adding up the scores of all items. Multivariable logistic regression and the Area Under the Receiver-Operating-Characteristic Curve (AUROC) were applied to examine the ability of the SEA-ART score to predict non-adherence at follow-up. The SEA-ART score varied from 21 to 105; mean 93.9; median 103.0. Non-adherence was 30.3%(n = 81/267). The odds of non-adherence was 8% lower for each unit increase of the SEA-ART score; after adjustment for age, sex, formal education and time in treatment (OR = 0.92; 95% CI 0.90-0.95; LRT for linear trend, p = 0.002). The AUROC was 0.80 (95% CI 0.73-0.87; p < 0.001). The SEA-ART optimal cut-off value was 101, providing a sensitivity of 76.5%, a specificity of 73.1%, a positive predictive value of 55.4% and a negative predictive value of 87.7%. There was no evidence of difference in sensitivity, and specificity among groups organized by age, gender, formal education and time in treatment. Conclusions The SEA-ART scale appears to have a good capacity to discriminate between adherents and non-adherents at one-month follow-up. Further studies should confirm these results in other populations.	[Drachler, Maria de Lourdes] Governo Estado Rio Grande do Sul, Secretaria Saude Estado Rio Grande do Sul, Ave Bento Goncalves 3722, BR-90650001 Porto Alegre, RS, Brazil; [Drachler, Carlos Wietzke] Univ Fed Rio Grande do Sul, Rede Governo Colaborativo Saude, Ave Joao Pessoa 155, BR-90040001 Porto Alegre, RS, Brazil; [Teixeira, Luciana Barcellos] Univ Fed Rio Grande do Sul, Escola Enfermagem, Programa Posgrad Saude Colet, Rua Sao Manoel 963, BR-90620110 Porto Alegre, RS, Brazil; [de Carvalho Leite, Jose Carlos] Ctr Univ La Salle, Saude & Desenvolvimento Humano, Ave Victor Barreto 2288, BR-92010000 Canoas, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Centro Universitario La Salle	Leite, JCD (corresponding author), Ctr Univ La Salle, Saude & Desenvolvimento Humano, Ave Victor Barreto 2288, BR-92010000 Canoas, RS, Brazil.	jcdc.leite@gmail.com			CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTIFICO E TECNOLOGICO - CNPq, Brazilian Government [478282/2010-9]; Universidade Federal do Rio Grande do Sul, Escola de Enfermagem	CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTIFICO E TECNOLOGICO - CNPq, Brazilian Government(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universidade Federal do Rio Grande do Sul, Escola de Enfermagem	This work was supported by CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTIFICO E TECNOLOGICO - CNPq, Brazilian Government, Protocol no. 478282/2010-9 (http://www.cnpq.br/). Financial support for publication was provided by Universidade Federal do Rio Grande do Sul, Escola de Enfermagem. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Chun J, 2015, CHILD YOUTH SERV REV, V50, P83, DOI 10.1016/j.childyouth.2015.01.009; Costa LS, 2008, J PEDIAT-BRAZIL, V84, P41, DOI [10.2223/JPED.1751, 10.1590/S0021-75572008000100008]; Faustino Quintino de Medeiros, 2010, Psic.: Teor. e Pesq., V26, P121, DOI 10.1590/S0102-37722010000100014; Seidl EMF, 2007, CAD SAUDE PUBLICA, V23, P2305, DOI 10.1590/S0102-311X2007001000006; Gill CJ, 2010, AIDS BEHAV, V14, P785, DOI 10.1007/s10461-009-9555-9; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Kim Youngmee, 2010, Nephrol Nurs J, V37, P271; Leite José Carlos de Carvalho, 2002, Psicol. Reflex. Crit., V15, P121, DOI 10.1590/S0102-79722002000100014; Ministerio da Saude, 2014, B EP AIDS DST; Nokes K, 2012, J NURS SCHOLARSHIP, V44, P403, DOI 10.1111/j.1547-5069.2012.01476.x; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Rollnick S., 2008, MOTIVATIONAL INTERVI; Silveira Marysabel Pinto Telis, 2002, Braz J Infect Dis, V6, P164, DOI 10.1590/S1413-86702002000400003; SPSS Inc, 2013, SPSS STAT BAS 22 0 U; Thapinta D, 2012, CHIANG MAI MED J, V5, P1; Torres TDL, 2008, PSYCHOL THEORY PRACT, V10, P64; Veinot TC, 2006, J ADOLESCENT HEALTH, V38, P261, DOI 10.1016/j.jadohealth.2005.03.008; Wagner GJ, 2006, AIDS, V20, P1295, DOI 10.1097/01.aids.0000232238.28415.d2; Wang XQ, 2007, AIDS, V21, pS149, DOI 10.1097/01.aids.0000304711.87164.99; World Health Organization, 2010, UN ACC SCAL PRIOR HI; Yehia BR, 2012, AIDS, V26, P1131, DOI 10.1097/QAD.0b013e3283528afa	22	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0147443	10.1371/journal.pone.0147443	http://dx.doi.org/10.1371/journal.pone.0147443			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895270	Green Published, Green Submitted, gold			2022-12-27	WOS:000371223400006
J	Liu, S; Guo, W; Han, X; Dai, WD; Diao, ZL; Liu, WH				Liu, Sha; Guo, Wang; Han, Xue; Dai, Wendi; Diao, Zongli; Liu, Wenhu			Role of UBIAD1 in Intracellular Cholesterol Metabolism and Vascular Cell Calcification	PLOS ONE			English	Article							CRYSTALLINE CORNEAL-DYSTROPHY; CHRONIC KIDNEY-DISEASE; SXR TARGET GENES; SMOOTH-MUSCLE-CELLS; TERE1; PHOSPHATE; PRENYLTRANSFERASE; MUTATIONS; CARCINOMA; BLADDER	Vascular calcification is an important risk factor associated with mortality among patients with chronic kidney disease. Intracellular cholesterol metabolism is involved in the process of vascular cell calcification. In this study, we investigated the role of UbiA prenyltransferase domain containing 1 (UBIAD1) in intracellular cholesterol metabolism and vascular cell calcification, and identified its subcellular location. Primary human umbilical vein smooth muscle cells (HUVSMCs) were incubated with either growth medium (1.4 mmol/L Pi) or calcification medium (CM) (3.0 mmol/L Pi). Under treatment with CM, HUVSMCs were further incubated with exogenous cholesterol, or menaquinone-4, a product of UBIAD1. The plasmid and small interfering RNA were transfected in HUVSMCs to alter the expression of UBIAD1. Matrix calcium quantitation, alkaline phosphatase activity, intracellular cholesterol level and menaquinone-4 level were measured. The expression of several genes involved in cholesterol metabolism were analyzed. Using an anti-UBIAD1 antibody, an endoplasmic reticulum marker and a Golgi marker, the subcellular location of UBIAD1 in HUVSMCs was analyzed. CM increased matrix calcium, alkaline phosphatase activity and intracellular cholesterol level, and reduced UBIAD1 expression and menaquinone-4 level. Addition of cholesterol contributed to increased matrix calcification and alkaline phosphatase activity in a dose-dependent manner. Elevated expression of UBIAD1 or menaquinone-4 in HUVSMCs treated with CM significantly reduced intracellular cholesterol level, matrix calcification and alkaline phosphatase activity, but increased menaquinone-4 level. Elevated expression of UBIAD1 or menaquinone-4 reduced the gene expression of sterol regulatory element-binding protein-2, and increased gene expression of ATP binding cassette transporters A1, which are in charge of cholesterol synthesis and efflux. UBIAD1 co-localized with the endoplasmic reticulum marker and the Golgi marker in HUVSMCs. In conclusion, high intracellular cholesterol content contributes to phosphate-induced vascular cell differentiation and calcification. UBIAD1 or menaquinone-4 could decrease vascular cell differentiation and calcification, probably via its potent role of inversely modulating cellular cholesterol.	[Liu, Sha; Guo, Wang; Han, Xue; Dai, Wendi; Diao, Zongli; Liu, Wenhu] Capital Med Univ, Fac Nephrol, Beijing Friendship Hosp, Dept Nephrol, Beijing, Peoples R China	Capital Medical University	Liu, WH (corresponding author), Capital Med Univ, Fac Nephrol, Beijing Friendship Hosp, Dept Nephrol, Beijing, Peoples R China.	liuwenhu2013@163.com			National Natural Science Foundation of China [81300607, 81570660]; Beijing Municipal Science and Technology Commission Fund [D131100004713001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology Commission Fund	This study received financial support from the National Natural Science Foundation of China (81300607, 81570660) and Beijing Municipal Science and Technology Commission Fund (D131100004713001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; Burns MP, 2010, BBA-MOL CELL BIOL L, V1801, P853, DOI 10.1016/j.bbalip.2010.03.004; Fredericks WJ, 2013, ONCOTARGET, V4, P1075, DOI 10.18632/oncotarget.1103; Fredericks WJ, 2013, J CELL BIOCHEM, V114, P2170, DOI 10.1002/jcb.24567; Fredericks WJ, 2013, INT J ONCOL, V43, P638, DOI 10.3892/ijo.2013.1985; Fredericks WJ, 2011, DNA CELL BIOL, V30, P851, DOI 10.1089/dna.2011.1315; Geng YF, 2011, J BIOL CHEM, V286, P33701, DOI 10.1074/jbc.M111.269639; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Graciolli FG, 2009, NEPHROL DIAL TRANSPL, V24, P1416, DOI 10.1093/ndt/gfn686; Huang MS, 2008, BIOCHEM BIOPH RES CO, V374, P553, DOI 10.1016/j.bbrc.2008.07.062; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Jono S, 2006, J BONE MINER METAB, V24, P176, DOI 10.1007/s00774-005-0668-6; Kapustin A, 2009, CURR OPIN PHARMACOL, V9, P84, DOI 10.1016/j.coph.2008.12.004; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Makishima M, 2005, J PHARMACOL SCI, V97, P177, DOI 10.1254/jphs.FMJ04008X4; McGarvey TW, 2005, J CELL BIOCHEM, V95, P419, DOI 10.1002/jcb.20432; McGarvey TW, 2003, PROSTATE, V54, P144, DOI 10.1002/pros.10174; McGarvey TW, 2001, ONCOGENE, V20, P1042, DOI 10.1038/sj.onc.1204143; Mizobuchi M, 2006, NEPHROL DIAL TRANSPL, V21, P911, DOI 10.1093/ndt/gfk008; Mugoni V, 2013, CELL, V152, P504, DOI 10.1016/j.cell.2013.01.013; Nakagawa K, 2010, NATURE, V468, P117, DOI 10.1038/nature09464; Nickerson ML, 2013, HUM MUTAT, V34, P317, DOI 10.1002/humu.22230; Nickerson ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010760; Orr A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000685; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Schumacher MM, 2015, ELIFE, V4; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Shearer MJ, 2014, J LIPID RES, V55, P345, DOI 10.1194/jlr.R045559; Suhara Y, 2006, BIOORGAN MED CHEM, V14, P6601, DOI 10.1016/j.bmc.2006.06.004; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Wang X. S., 2013, INT J DISTRIB SENS N, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0072015; Weiss JS, 2008, AM J MED GENET A, V146A, P271, DOI 10.1002/ajmg.a.32201; Weiss JS, 2007, INVEST OPHTH VIS SCI, V48, P5007, DOI 10.1167/iovs.07-0845; Weiss JS, 2010, CORNEA, V29, P777, DOI 10.1097/ICO.0b013e3181c84bcf; Yellore VS, 2007, MOL VIS, V13, P1777; Yoshida T, 2012, J BIOL CHEM, V287, P25706, DOI 10.1074/jbc.M112.361360	37	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149639	10.1371/journal.pone.0149639	http://dx.doi.org/10.1371/journal.pone.0149639			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890002	Green Published, Green Submitted, gold			2022-12-27	WOS:000371221500066
J	Tan, Y; Liu, XR; Zhou, K; He, XJ; Lu, C; He, B; Niu, XY; Xiao, C; Xu, G; Bian, ZX; Zu, XP; Zhang, G; Zhang, WD; Lu, AP				Tan, Yong; Liu, Xinru; Zhou, Ke; He, Xiaojuan; Lu, Cheng; He, Bing; Niu, Xuyan; Xiao, Cheng; Xu, Gang; Bian, Zhaoxiang; Zu, Xianpeng; Zhang, Ge; Zhang, Weidong; Lu, Aiping			The Potential Biomarkers to Identify the Development of Steatosis in Hyperuricemia	PLOS ONE			English	Article							FATTY LIVER-DISEASE; SERUM URIC-ACID; TRADITIONAL CHINESE MEDICINE; INSULIN-RESISTANCE; OXIDATIVE STRESS; METABOLIC SYNDROME; PHOSPHOLIPASE-D; ANTIOXIDANT CAPACITY; PHOSPHATIDIC-ACID; RADIX-ACONITI	Hyperuricemia (HU) often progresses to combine with non-alcoholic fatty liver disease (NAFLD) in the clinical scenario, which further exacerbates metabolic disorders; early detection of biomarkers, if obtained during the HU progression, may be beneficial for preventing its combination with NAFLD. This study aimed to decipher the biomarkers and mechanisms of the development of steatosis in HU. Four groups of subjects undergoing health screening, including healthy subjects, subjects with HU, subjects with HU combined with NAFLD (HU+NAFLD) and subjects with HU initially and then with HU+NAFLD one year later (HU -> HU+NAFLD), were recruited in this study. The metabolic profiles of all subjects' serum were analyzed by liquid chromatography quadruple time-of-flight mass spectrometry. The metabolomic data from subjects with HU and HU+NAFLD were compared, and the biomarkers for the progression from HU to HU+NAFLD were predicted. The metabolomic data from HU -> HU+NAFLD subjects were collected for further verification. The results showed that the progression was associated with disturbances of phospholipase metabolism, purine nucleotide degradation and Liver X receptor/retinoic X receptor activation as characterized by up-regulated phosphatidic acid, cholesterol ester (18:0) and down-regulated inosine. These metabolic alterations may be at least partially responsible for the development of steatosis in HU. This study provides a new paradigm for better understanding and further prevention of disease progression.	[Tan, Yong; He, Xiaojuan; Lu, Cheng; Niu, Xuyan; Lu, Aiping] China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China; [Liu, Xinru; Zu, Xianpeng; Zhang, Weidong] Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China; [Zhou, Ke] Hunan Univ Chinese Med, Affiliated Hosp 2, Changsha, Hunan, Peoples R China; [He, Bing; Xu, Gang; Bian, Zhaoxiang; Zhang, Ge; Zhang, Weidong; Lu, Aiping] Hong Kong Baptist Univ, Sch Chinese Med, Inst Adv Translat Med Bone & Joint Dis, Hong Kong, Hong Kong, Peoples R China; [Xiao, Cheng] China Japan Friendship Hosp, Beijing, Peoples R China; [Lu, Aiping] Shanghai Municipal Educ Commiss, E Inst, Shanghai, Peoples R China	China Academy of Chinese Medical Sciences; Institute of Basic Research In Clinical Medicine, CACMS; Naval Medical University; Hunan University of Chinese Medicine; Hong Kong Baptist University; China-Japan Friendship Hospital; Shanghai Municipal Education Commission (SHMEC)	Lu, AP (corresponding author), China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China.; Zhang, WD (corresponding author), Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China.; Zhang, G; Lu, AP (corresponding author), Hong Kong Baptist Univ, Sch Chinese Med, Inst Adv Translat Med Bone & Joint Dis, Hong Kong, Hong Kong, Peoples R China.; Lu, AP (corresponding author), Shanghai Municipal Educ Commiss, E Inst, Shanghai, Peoples R China.	zhangge@hkbu.edu.hk; wdzhangy@hotmail.com; aipinglu@hkbu.edu.hk	Zhang, Ge/K-9118-2019; Zu, Xian-peng/AAW-6011-2021; Xiao, Cheng/AAM-7764-2020	Zhang, Ge/0000-0002-7807-7695; Zu, Xian-peng/0000-0003-2682-0755; He, Bing/0000-0003-1719-9290	National Science Foundation of China [81230090]; Hong Kong Baptist University Strategic Development Fund [SDF13-1209-P01]; Interdisciplinary Research Matching Scheme of Hong Kong Baptist University [RC-IRMS/12-13/02]; China Postdoctoral Science Foundation [2013M541158]; E-Institutes of the Shanghai Municipal Education Commission [E03008]; Professor of Chang Jiang Scholars Program	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hong Kong Baptist University Strategic Development Fund; Interdisciplinary Research Matching Scheme of Hong Kong Baptist University; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); E-Institutes of the Shanghai Municipal Education Commission; Professor of Chang Jiang Scholars Program	This study was supported by the following sources of funding: National Science Foundation of China (no. 81230090; http://npd.nsfc.gov.cn/), the author who received the funding: WDZ; Hong Kong Baptist University Strategic Development Fund (no. SDF13-1209-P01; http://scm.hkbu.edu.hk/tc/home/index.php), the author who received the funding: APL; Interdisciplinary Research Matching Scheme of Hong Kong Baptist University (no. RC-IRMS/12-13/02; http://scm.hkbu.edu.hk/tc/home/index.php), the author who received the funding: APL; China Postdoctoral Science Foundation (no. 2013M541158; http://www.chinapostdoctor.org.cn/), the author who received the funding: KZ; E-Institutes of the Shanghai Municipal Education Commission (no. E03008; http://www.shmec.gov.cn/), the author who received the funding: WDZ; the Professor of Chang Jiang Scholars Program (http://www.moe.edu.cn/publicfiles/business/htmlfiles/moe/A04_ndgzyd/), the author who received the funding: WDZ.	Abuja PM, 1999, FEBS LETT, V446, P305, DOI 10.1016/S0014-5793(99)00231-8; Ahn SB, 2014, DIGEST DIS SCI, V59, P2975, DOI 10.1007/s10620-014-3289-x; Albano E, 2005, ALIMENT PHARM THER, V22, P71, DOI 10.1111/j.1365-2036.2005.02601.x; Athenstaedt K, 1999, EUR J BIOCHEM, V266, P1, DOI 10.1046/j.1432-1327.1999.00822.x; Bao Y, 2011, ELECTROPHORESIS, V32, P1515, DOI 10.1002/elps.201100040; Baranowski M, 2008, J PHYSIOL PHARMACOL, V59, P31; Cai W, 2013, ARQ BRAS ENDOCRINOL, V57, P617, DOI 10.1590/S0004-27302013000800006; Chalimoniuk Malgorzata, 2012, Postepy Biochem, V58, P204; Csupor D, 2011, PHARM BIOL, V49, P1097, DOI 10.3109/13880209.2011.595011; Dai HF, 2008, HEPATOB PANCREAT DIS, V7, P373; Dawson J, 2006, BRIT J CLIN PHARMACO, V62, P633, DOI 10.1111/j.1365-2125.2006.02785.x; Delon C, 2004, J BIOL CHEM, V279, P44763, DOI 10.1074/jbc.M405771200; Garcia-Ruiz I, 2006, HEPATOLOGY, V44, P581, DOI 10.1002/hep.21313; Ghaemi-Oskouie F, 2011, CURR RHEUMATOL REP, V13, P160, DOI 10.1007/s11926-011-0162-1; Hayden Melvin R, 2004, Nutr Metab (Lond), V1, P10, DOI 10.1186/1743-7075-1-10; Hediger MA, 2005, PHYSIOLOGY, V20, P125, DOI 10.1152/physiol.00039.2004; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Katsiki N, 2011, CURR VASC PHARMACOL, V9, P698, DOI 10.2174/157016111797484152; KENT C, 1995, ANNU REV BIOCHEM, V64, P315, DOI 10.1146/annurev.bi.64.070195.001531; Kuo CF, 2010, SCAND J RHEUMATOL, V39, P466, DOI 10.3109/03009741003742797; Kurotani K, 2012, NUTR RES, V32, P669, DOI 10.1016/j.nutres.2012.07.004; Kurtz TA, 2004, METABOLISM, V53, P138, DOI 10.1016/j.metabol.2003.09.004; Lee JW, 2010, GUT LIVER, V4, P378, DOI 10.5009/gnl.2010.4.3.378; Lee YJ, 2014, INTERN MED J, V44, P1210, DOI 10.1111/imj.12588; Llorach R, 2010, J PROTEOME RES, V9, P5859, DOI 10.1021/pr100639v; Matsuo H, 2014, SCI REP-UK, V4, DOI 10.1038/srep03755; MODAN M, 1987, DIABETOLOGIA, V30, P713, DOI 10.1007/BF00296994; Nieto FJ, 2000, ATHEROSCLEROSIS, V148, P131, DOI 10.1016/S0021-9150(99)00214-2; Pagano G, 2002, HEPATOLOGY, V35, P367, DOI 10.1053/jhep.2002.30690; Park SH, 2004, J GASTROEN HEPATOL, V19, P694, DOI 10.1111/j.1440-1746.2004.03362.x; Patterson RA, 2003, J LIPID RES, V44, P512, DOI 10.1194/jlr.M200407-JLR200; Petta S, 2011, ALIMENT PHARM THER, V34, P757, DOI 10.1111/j.1365-2036.2011.04788.x; Petta S, 2009, DIGEST LIVER DIS, V41, P615, DOI 10.1016/j.dld.2009.01.004; Rosenson RS, 2012, J LIPID RES, V53, P1767, DOI 10.1194/jlr.R024190; Shen W, 2013, J NUTR, V143, P584, DOI 10.3945/jn.112.173161; Sirota JC, 2013, METABOLISM, V62, P392, DOI 10.1016/j.metabol.2012.08.013; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; SUCHARD SJ, 1994, J BIOL CHEM, V269, P8063; Sun GY, 2005, MOL NEUROBIOL, V31, P27, DOI 10.1385/MN:31:1-3:027; Tan Y, 2013, J PROTEOME RES, V12, P513, DOI 10.1021/pr300965d; Tappia PS, 2006, FREE RADICAL BIO MED, V41, P349, DOI 10.1016/j.freeradbiomed.2006.03.025; Tsutsui H, 2011, CLIN CHIM ACTA, V412, P861, DOI 10.1016/j.cca.2010.12.023; Voruganti VS, 2014, EUR J HUM GENET, V22, P938, DOI 10.1038/ejhg.2013.264; Vos MB, 2012, J PEDIATR GASTR NUTR, V54, P90, DOI 10.1097/MPG.0b013e318229da1a; VUORINENMARKKOLA H, 1994, J CLIN ENDOCR METAB, V78, P25, DOI 10.1210/jc.78.1.25; Waring WS, 2001, J CARDIOVASC PHARM, V38, P365, DOI 10.1097/00005344-200109000-00005; Xie C, 2012, BIOANALYSIS, V4, P937, DOI [10.4155/BIO.12.43, 10.4155/bio.12.43]; Xie YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067152; Zhang AH, 2010, PLANTA MED, V76, P2026, DOI 10.1055/s-0030-1250542; Zhang ZX, 2014, J PROTEOME RES, V13, P925, DOI 10.1021/pr400968c; Zhao X, 2012, RAPID COMMUN MASS SP, V26, P2443, DOI 10.1002/rcm.6360	51	9	10	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149043	10.1371/journal.pone.0149043	http://dx.doi.org/10.1371/journal.pone.0149043			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890003	Green Submitted, Green Published, gold			2022-12-27	WOS:000371221500021
J	Guerra-Perez, N; Aravantinou, M; Veglia, F; Goode, D; Truong, R; Derby, N; Blanchard, J; Grasperge, B; Gettie, A; Robbiani, M; Martinelli, E				Guerra-Perez, Natalia; Aravantinou, Meropi; Veglia, Filippo; Goode, Diana; Truong, Rosaline; Derby, Nina; Blanchard, James; Grasperge, Brooke; Gettie, Agegnehu; Robbiani, Melissa; Martinelli, Elena			Rectal HSV-2 Infection May Increase Rectal SIV Acquisition Even in the Context of SIV Delta nef Vaccination	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; ATTENUATED SIV; RHESUS MACAQUES; CONTROL REPLICATION; VAGINAL CHALLENGE; HIV-1 ACQUISITION; NEGATIVE MEN; LIVE; HERPES; PROTECTION	Prevalent HSV-2 infection increases the risk of HIV acquisition both in men and women even in asymptomatic subjects. Understanding the impact of HSV-2 on the mucosal micro-environment may help to identify determinants of susceptibility to HIV. Vaginal HSV-2 infection increases the frequency of cells highly susceptible to HIV in the vaginal tissue of women and macaques and this correlates with increased susceptibility to vaginal SHIV infection in macaques. However, the effect of rectal HSV-2 infection on HIV acquisition remains understudied. We developed a model of rectal HSV-2 infection in macaques in combination with rectal SIVmac239 Delta nef (SIV Delta nef) vaccination and our results suggest that rectal HSV-2 infection may increase the susceptibility of macaques to rectal SIVmac239 wild-type (wt) infection even in SIV Delta nef-infected animals. Rectal SIV Delta nef infection/vaccination protected 7 out of 7 SIV Delta nef-infected macaques from SIVmac239wt rectal infection (vs 12 out of 16 SIV Delta nef-negative macaques), while 1 out of 3 animals co-infected with SIV Delta nef and HSV-2 acquired SIVmac239wt infection. HSV-2/SIVmac239wt co-infected animals had increased concentrations of inflammatory factors in their plasma and rectal fluids and a tendency toward higher acute SIVmac239wt plasma viral load. However, they had higher blood CD4 counts and reduced depletion of CCR5+ CD4+ T cells compared to SIV-mac239wt-only infected animals. Thus, rectal HSV-2 infection generates a pro-inflammatory environment that may increase susceptibility to rectal SIV infection and may impact immunological and virological parameters during acute SIV infection. Studies with larger number of animals are needed to confirm these findings.	[Guerra-Perez, Natalia; Aravantinou, Meropi; Veglia, Filippo; Goode, Diana; Truong, Rosaline; Derby, Nina; Robbiani, Melissa; Martinelli, Elena] Populat Council, Ctr Biomed Res, 1230 York Ave, New York, NY 10021 USA; [Blanchard, James; Grasperge, Brooke] Tulane Univ, Tulane Natl Primate Res Ctr, Covington, LA USA; [Gettie, Agegnehu] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, 1230 York Ave, New York, NY 10021 USA; [Veglia, Filippo] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA	Population Council; Tulane University; Rockefeller University; The Wistar Institute	Martinelli, E (corresponding author), Populat Council, Ctr Biomed Res, 1230 York Ave, New York, NY 10021 USA.	emartinelli@popcouncil.org	Guerra-Pérez, Natalia/I-1879-2017	Guerra-Pérez, Natalia/0000-0002-4851-3361; Martinelli, Elena/0000-0002-3416-9627; Veglia, Filippo/0000-0001-6710-1584	NIH [R37 AI040877-18, R01 AI098456-04, OD011104]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U24AI126683, R37AI040877, R01AI040877] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104, T32OD011124] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants R37 AI040877-18, R01 AI098456-04, OD011104.	Abel K, 2004, J INFECT DIS, V190, P1697, DOI 10.1086/424600; Abu-Raddad LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002230; Alvarez Y, 2013, J VIROL, V87, P10843, DOI 10.1128/JVI.01838-13; Arnold KB, 2016, MUCOSAL IMMUNOL, V9, P194, DOI 10.1038/mi.2015.51; Aurelian, 1992, HERPES SIMPLEX VIRUS, P473; Baba TW, 1999, NAT MED, V5, P194, DOI 10.1038/5557; BABA TW, 1995, SCIENCE, V267, P1820, DOI 10.1126/science.7892606; Barnabas RV, 2011, JAIDS-J ACQ IMM DEF, V57, P238, DOI 10.1097/QAI.0b013e31821acb5; Cline AN, 2005, J MED PRIMATOL, V34, P303; Connor RI, 1998, J VIROL, V72, P7501, DOI 10.1128/JVI.72.9.7501-7509.1998; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; Cranage MP, 1997, VIROLOGY, V229, P143, DOI 10.1006/viro.1996.8419; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Fukazawa Y, 2012, NAT MED, V18, P1673, DOI 10.1038/nm.2934; Goode D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004567; Gray RH, 2004, J INFECT DIS, V189, P1209, DOI 10.1086/382750; Johnson RP, 1999, J VIROL, V73, P4952, DOI 10.1128/JVI.73.6.4952-4961.1999; Johnson RP, 1997, J VIROL, V71, P7711, DOI 10.1128/JVI.71.10.7711-7718.1997; Kaul R, 2015, CURR HIV-AIDS REP, V12, P216, DOI 10.1007/s11904-015-0269-5; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; Krone MR, 1998, J INFECT DIS, V178, P978, DOI 10.1086/515666; Krone MR, 2000, CLIN INFECT DIS, V30, P261, DOI 10.1086/313647; Martinelli E, 2013, JAIDS-J ACQ IMM DEF, V64, P325, DOI 10.1097/QAI.0b013e31829f6e1a; Martinelli E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002109; Marx PA, 1996, NAT MED, V2, P1084, DOI 10.1038/nm1096-1084; McKinnon LR, 2015, AIDS BEHAV, V19, P2204, DOI 10.1007/s10461-015-1118-7; Miller CJ, 1997, J VIROL, V71, P1911, DOI 10.1128/JVI.71.3.1911-1921.1997; Rajagopal S, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu043; Reynolds MR, 2008, J EXP MED, V205, P2537, DOI 10.1084/jem.20081524; Reynolds MR, 2010, J VIROL, V84, P9190, DOI 10.1128/JVI.00041-10; Salisch NC, 2010, J IMMUNOL, V184, P476, DOI 10.4049/jimmunol.0902781; Schacker T, 2001, Herpes, V8, P46; Shannon B, 2014, J IMMUNOL, V192, P5074, DOI 10.4049/jimmunol.1302916; Singer R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003936; Stahl-Hennig C, 2002, J VIROL, V76, P688, DOI 10.1128/JVi.76.2.688-696.2002; Stahl-Hennig C, 2007, FRONT BIOSCI, V12, P2107, DOI 10.2741/2215; Van Kemseke C, 2009, ACTA GASTRO-ENT BELG, V72, P413; Wyand MS, 1999, J VIROL, V73, P8356, DOI 10.1128/JVI.73.10.8356-8363.1999; Wyand MS, 1996, J VIROL, V70, P3724, DOI 10.1128/JVI.70.6.3724-3733.1996; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006	41	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149491	10.1371/journal.pone.0149491	http://dx.doi.org/10.1371/journal.pone.0149491			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886938	Green Published, Green Submitted, gold			2022-12-27	WOS:000371218400091
J	Hong, M; Wang, Q; Tang, ZD; Wang, YP; Gu, YF; Lou, YL; Zheng, MQ				Hong, Meng; Wang, Qian; Tang, Zhide; Wang, Youpei; Gu, Yunfeng; Lou, Yongliang; Zheng, Meiqin			Association of Genotyping of Bacillus cereus with Clinical Features of Post-Traumatic Endophthalmitis	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENE; PCR; ANTHRACIS; PATHOGEN; SURGERY	Bacillus cereus is the second most frequent cause of post-traumatic bacterial endophthalmitis. Although genotyping of B. cereus associated with gastrointestinal infections has been reported, little is known about the B. cereus clinical isolates associated with post-traumatic endophthalmitis. This is largely due to the limited number of clinical strains available isolated from infected tissues of patients with post-traumatic endophthalmitis. In this study, we report successful isolation of twenty-four B. cereus strains from individual patients with different disease severity of post-traumatic endophthalmitis. Phylogenetic analysis showed that all strains could be categorized into three genotypes (GTI, GTII and GTIII) and the clinical score showed significant differences among these groups. We then further performed genotyping using the vrrA gene, and evaluated possible correlation of genotype with the clinical features of B. cereus-caused post-traumatic endophthalmitis, and with the prognosis of infection by conducting follow-up with patients for up to 2 months. We found that the disease of onset and final vision acuity were significantly different among the three groups. These results suggested that the vrrA gene may play a significant role in the pathogenesis of endophthalmitis, and genotyping of B. cereus has the potential for predicting clinical manifestation and prognosis of endophthalmitis. To the best of our knowledge, this is the first report of isolation of large numbers of clinical isolates of B. cereus from patients with endophthalmitis. This work sets the foundation for future investigation of the pathogenesis endophthalmitis caused by B. cereus infection.	[Hong, Meng; Tang, Zhide; Wang, Youpei; Gu, Yunfeng; Zheng, Meiqin] Wenzhou Med Univ, Dept Clin Lab Med, Affiliated Eye Hosp, Wenzhou 325027, Peoples R China; [Hong, Meng; Wang, Qian; Lou, Yongliang] Wenzhou Med Univ, Zhejiang Prov Key Lab Med Genet, Minist Educ, Key Lab Lab Med, Wenzhou 325035, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Zheng, MQ (corresponding author), Wenzhou Med Univ, Dept Clin Lab Med, Affiliated Eye Hosp, Wenzhou 325027, Peoples R China.; Lou, YL (corresponding author), Wenzhou Med Univ, Zhejiang Prov Key Lab Med Genet, Minist Educ, Key Lab Lab Med, Wenzhou 325035, Zhejiang, Peoples R China.	louyongliang2013@163.com; zmqlyllh@126.com			National Natural Science Foundation of China [81171611]; Zhejiang Provincial Natural Science foundation of China [Y2090468, LY13H120006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science foundation of China(Natural Science Foundation of Zhejiang Province)	This work was funded by the following: 1. National Natural Science Foundation of China (81171611),lyl,http://www.letpub.com.cn/?page=grant & 2. Zhejiang Provincial Natural Science foundation of China (Y2090468).lyl.http://www.zjnsf.gov.cn/1/xm/lx.aspx; and 3. Zhejiang Provincial Natural Science foundation of China (LY13H120006).zmq.http://www.zjnsf.gov.cn/1/xm/lx.aspx.	Alfaro DV, 1996, BRIT J OPHTHALMOL, V80, P755, DOI 10.1136/bjo.80.8.755; BEER PM, 1990, AM J OPHTHALMOL, V110, P212, DOI 10.1016/S0002-9394(14)76999-5; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Brumlik MJ, 2001, APPL ENVIRON MICROB, V67, P3021, DOI 10.1128/AEM.67.7.3021-3028.2001; Callegan MC, 2007, PROG RETIN EYE RES, V26, P189, DOI 10.1016/j.preteyeres.2006.12.001; Chan WM, 2003, CLIN INFECT DIS, V37, pE31, DOI 10.1086/375898; Chang YH, 2003, APPL ENVIRON MICROB, V69, P4502, DOI 10.1128/AEM.69.8.4502-4510.2003; Durand ML, 2013, CLIN MICROBIOL INFEC, V19, P227, DOI 10.1111/1469-0691.12118; Hoffmaster AR, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-191; Kim JY, 2011, INVEST OPHTH VIS SCI, V52, P1742, DOI 10.1167/iovs.10-5231; Kim W, 2002, FEMS MICROBIOL LETT, V207, P21, DOI 10.1111/j.1574-6968.2002.tb11022.x; Ko KS, 2004, INFECT IMMUN, V72, P5253, DOI 10.1128/IAI.72.9.5253-5261.2004; Melo GB, 2011, J CATARACT REFR SURG, V37, P1244, DOI 10.1016/j.jcrs.2011.01.025; Priest FG, 2004, J BACTERIOL, V186, P7959, DOI 10.1128/JB.186.23.7959-7970.2004; Seal D, 2008, J CATARACT REFR SURG, V34, P1439, DOI 10.1016/j.jcrs.2008.05.043; van Belkum A, 1999, CELL MOL LIFE SCI, V56, P729, DOI 10.1007/s000180050019; Wiskur BJ, 2008, INVEST OPHTH VIS SCI, V49, P1480, DOI 10.1167/iovs.07-1303; Zahner V, 2005, APPL ENVIRON MICROB, V71, P8107, DOI 10.1128/AEM.71.12.8107-8114.2005	18	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0147878	10.1371/journal.pone.0147878	http://dx.doi.org/10.1371/journal.pone.0147878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886446	Green Published, gold			2022-12-27	WOS:000371218400010
J	Tsaousi, A; Hayes, EM; Di Gregoli, K; Bond, AR; Bevan, L; Thomas, AC; Newby, AC				Tsaousi, Aikaterini; Hayes, Elaine M.; Di Gregoli, Karina; Bond, Andrew R.; Bevan, Laura; Thomas, Anita C.; Newby, Andrew C.			Plaque Size Is Decreased but M1 Macrophage Polarization and Rupture Related Metalloproteinase Expression Are Maintained after Deleting T-Bet in ApoE Null Mice	PLOS ONE			English	Article							HUMAN ATHEROSCLEROTIC PLAQUES; E-KNOCKOUT MICE; LOW-DENSITY-LIPOPROTEIN; FOAM-CELL MACROPHAGES; APOLIPOPROTEIN-E; IFN-GAMMA; TRANSCRIPTION FACTOR; INTERFERON-GAMMA; IMMUNE-RESPONSE; DEFICIENT MICE	Background Thelper1 (Th1) lymphocytes have been previously implicated in atherosclerotic plaque growth but their role in plaque vulnerability to rupture is less clear. We investigated whether T-bet knockout that prevents Th1 lymphocyte differentiation modulates classical (M1) macrophage activation or production of matrix degrading metalloproteinases (MMPs) and their tissue inhibitors, TIMPs. Methods & Results We studied the effect of T-bet deletion in apolipoproteinE (ApoE) knockout mice fed a high fat diet (HFD) or normal chow diet (ND). Transcript levels of M1/M2 macrophage polarization markers, selected MMPs and TIMPs were measured by RT-qPCR in macrophages isolated from subcutaneous granulomas or in whole aortae. Immunohistochemistry of aortic sinus (AS) and brachiocephalic artery (BCA) plaques was conducted to quantify protein expression of the same factors. Deletion of T-bet decreased mRNA for the M1 marker NOS-2 in granuloma macrophages but levels of M2 markers (CD206, arginase-1 and Ym-1), MMPs-2, -9, -12, -13, -14 and -19 or TIMPs-1 to -3 were unchanged. No mRNA differences were observed in aortic extracts from mice fed a HFD for 12 weeks. Moreover, AS and BCA plaques were similarly sized between genotypes, and had similar areas stained for NOS-2, COX-2, MMP-12 and MMP-14 proteins. T-bet deletion increased MMP-13, MMP-14 and arginase-1 in AS plaques. After 35 weeks of ND, T-bet deletion reduced the size of AS and BCA plaques but there were no differences in the percentage areas stained for M1 or M2 markers, MMPs-12, -13, -14, or TIMP-3. Conclusions Absence of Th1 lymphocytes is associated with reduced plaque size in ApoE knockout mice fed a normal but not high fat diet. In either case, M1 macrophage polarization and expression of several MMPs related to plaque instability are either maintained or increased.	[Tsaousi, Aikaterini; Hayes, Elaine M.; Di Gregoli, Karina; Bond, Andrew R.; Bevan, Laura; Thomas, Anita C.; Newby, Andrew C.] Univ Bristol, Sch Clin Sci, Bristol, Avon, England	University of Bristol	Tsaousi, A (corresponding author), Univ Bristol, Sch Clin Sci, Bristol, Avon, England.	a.tsaousi@bristol.ac.uk	Thomas, Anita C/E-1743-2011; Bond, Andrew/AAC-5941-2020	Thomas, Anita C/0000-0002-3792-2653; Bond, Andrew/0000-0002-4255-4488	British Heart Foundation Programme [RG/09/006/27918]; British Heart Foundation [RG/09/006/27918] Funding Source: researchfish	British Heart Foundation Programme(British Heart Foundation); British Heart Foundation(British Heart Foundation)	Funding was provided by British Heart Foundation Programme Grant No. RG/09/006/27918. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Buono C, 2005, P NATL ACAD SCI USA, V102, P1596, DOI 10.1073/pnas.0409015102; Buono C, 2003, ARTERIOSCL THROM VAS, V23, P454, DOI 10.1161/01.ATV.0000059419.11002.6E; Cardilo-Reis L, 2012, EMBO MOL MED, V4, P1072, DOI 10.1002/emmm.201201374; Casagrande V, 2012, ARTERIOSCL THROM VAS, V32, P74, DOI 10.1161/ATVBAHA.111.238402; Castrillo A, 2003, J BIOL CHEM, V278, P10443, DOI 10.1074/jbc.M213071200; Chase AJ, 2002, ARTERIOSCL THROM VAS, V22, P765, DOI 10.1161/01.ATV.0000015078.09208.92; Dansky HM, 1997, P NATL ACAD SCI USA, V94, P4642, DOI 10.1073/pnas.94.9.4642; Daugherty A, 1997, J CLIN INVEST, V100, P1575, DOI 10.1172/JCI119681; Di Gregoli K, 2014, ARTERIOSCL THROM VAS, V34, P1990, DOI 10.1161/ATVBAHA.114.304088; Frostegard J, 1999, ATHEROSCLEROSIS, V145, P33, DOI 10.1016/S0021-9150(99)00011-8; Gupta S, 1997, J CLIN INVEST, V99, P2752, DOI 10.1172/JCI119465; HANSSON GK, 1991, ARTERIOSCLER THROMB, V11, P745, DOI 10.1161/01.ATV.11.3.745; HANSSON GK, 1988, CIRC RES, V63, P712, DOI 10.1161/01.RES.63.4.712; HANSSON GK, 1989, AM J PATHOL, V135, P169; Hartley CJ, 2000, AM J PHYSIOL-HEART C, V279, pH2326, DOI 10.1152/ajpheart.2000.279.5.H2326; Hayes EM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00537; Huang WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042507; Johnson J, 2005, CIRCULATION, V111, P1422, DOI 10.1161/01.CIR.0000158435.98035.8D; Johnson J. L., 2014, MEDIAT INFLAMM, V2014, DOI DOI 10.1155/2014/276457; Johnson JL, 2008, ARTERIOSCL THROM VAS, V28, P1647, DOI 10.1161/ATVBAHA.108.170548; Johnson JL, 2011, ARTERIOSCL THROM VAS, V31, P528, DOI 10.1161/ATVBAHA.110.219147; Johnson JL, 2005, P NATL ACAD SCI USA, V102, P15575, DOI 10.1073/pnas.0506201102; Joven J, 2007, ATHEROSCLEROSIS, V195, pE85, DOI 10.1016/j.atherosclerosis.2007.06.012; Kadl A, 2010, CIRC RES, V107, P737, DOI 10.1161/CIRCRESAHA.109.215715; Klingenberg R, 2013, J CLIN INVEST, V123, P1323, DOI 10.1172/JCI63891; Koltsova EK, 2013, CURR OPIN LIPIDOL, V24, P371, DOI 10.1097/MOL.0b013e328363d298; Libby P, 2013, J CLIN INVEST, V123, P3201, DOI 10.1172/JCI67526; Libby P, 2013, IMMUNITY, V38, P1092, DOI 10.1016/j.immuni.2013.06.009; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lugo-Villarino G, 2003, P NATL ACAD SCI USA, V100, P7749, DOI 10.1073/pnas.1332767100; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lundberg AM, 2011, CURR OPIN LIPIDOL, V22, P343, DOI 10.1097/MOL.0b013e32834ada80; Lutgens E, 2010, J EXP MED, V207, P391, DOI 10.1084/jem.20091293; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Naura AS, 2009, LAB INVEST, V89, P1243, DOI 10.1038/labinvest.2009.98; Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898; Newby AC, 2014, CURR OPIN LIPIDOL, V25, P358, DOI 10.1097/MOL.0000000000000111; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; PAIGEN B, 1990, ARTERIOSCLEROSIS, V10, P316, DOI 10.1161/01.ATV.10.2.316; Paulson KE, 2010, CIRC RES, V106, P383, DOI 10.1161/CIRCRESAHA.109.210781; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Quillard T, 2014, ARTERIOSCL THROM VAS, V34, P1179, DOI 10.1161/ATVBAHA.114.303326; Quillard T, 2011, ARTERIOSCL THROM VAS, V31, P2464, DOI 10.1161/ATVBAHA.111.231563; Robbins CS, 2012, CIRCULATION, V125, P364, DOI 10.1161/CIRCULATIONAHA.111.061986; Romagnani S, 2000, ANN ALLERG ASTHMA IM, V85, P9, DOI 10.1016/S1081-1206(10)62426-X; Rong JX, 2003, P NATL ACAD SCI USA, V100, P13531, DOI 10.1073/pnas.1735526100; Rossmann A, 2008, EXP GERONTOL, V43, P229, DOI 10.1016/j.exger.2007.11.009; Schneider F, 2008, CIRCULATION, V117, P931, DOI 10.1161/CIRCULATIONAHA.107.707448; SMITH JD, 1995, P NATL ACAD SCI USA, V92, P8264, DOI 10.1073/pnas.92.18.8264; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; STEMME S, 1992, ARTERIOSCLER THROMB, V12, P206, DOI 10.1161/01.ATV.12.2.206; STEMME S, 1995, P NATL ACAD SCI USA, V92, P3893, DOI 10.1073/pnas.92.9.3893; Stohr R, 2014, ATHEROSCLEROSIS, V235, P438, DOI 10.1016/j.atherosclerosis.2014.05.946; Stolarczyk E, 2013, CELL METAB, V17, P520, DOI 10.1016/j.cmet.2013.02.019; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Thale C, 2005, IMMUNOBIOLOGY, V210, P673, DOI 10.1016/j.imbio.2005.07.003; Thomas AC, 2007, ARTERIOSCL THROM VAS, V27, P571, DOI 10.1161/01.ATV.0000256470.23842.94; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Wang YN, 2007, CIRC RES, V101, P560, DOI 10.1161/CIRCRESAHA.107.151068; Whitman SC, 2002, J INTERF CYTOK RES, V22, P661, DOI 10.1089/10799900260100141; Wick G, 2004, ANNU REV IMMUNOL, V22, P361, DOI 10.1146/annurev.immunol.22.012703.104644; Xu W, 2007, EUR J IMMUNOL, V37, P1594, DOI 10.1002/eji.200737042; Zhou XH, 2000, CIRCULATION, V102, P2919; Zhou XH, 2003, BIOMED PHARMACOTHER, V57, P287, DOI 10.1016/S0753-3322(03)00082-9; Zhou XH, 1998, J CLIN INVEST, V101, P1717, DOI 10.1172/JCI1216; Zhou XH, 1996, AM J PATHOL, V149, P359	73	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148873	10.1371/journal.pone.0148873	http://dx.doi.org/10.1371/journal.pone.0148873			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886778	Green Published, Green Submitted, gold			2022-12-27	WOS:000371218400056
J	Axenov-Gibanov, DV; Voytsekhovskaya, IV; Tokovenko, BT; Protasov, ES; Gamaiunov, SV; Rebets, YV; Luzhetskyy, AN; Timofeyev, MA				Axenov-Gibanov, Denis V.; Voytsekhovskaya, Irina V.; Tokovenko, Bogdan T.; Protasov, Eugeniy S.; Gamaiunov, Stanislav V.; Rebets, Yuriy V.; Luzhetskyy, Andriy N.; Timofeyev, Maxim A.			Actinobacteria Isolated from an Underground Lake and Moonmilk Speleothem from the Biggest Conglomeratic Karstic Cave in Siberia as Sources of Novel Biologically Active Compounds	PLOS ONE			English	Article							NATURAL-PRODUCTS; SP NOV.; DIVERSITY; ALTAMIRA; CHAXAMYCINS; DESERT	Actinobacteria isolated from unstudied ecosystems are one of the most interesting and promising sources of novel biologically active compounds. Cave ecosystems are unusual and rarely studied. Here, we report the isolation and characterization of ten new actinobacteria strains isolated from an ancient underground lake and moonmilk speleothem from the biggest conglomeratic karstic cave in Siberia with a focus on the biological activity of the obtained strains and the metabolite dereplication of one active strain. Streptomyces genera isolates from moonmilk speleothem demonstrated antibacterial and antifungal activities. Some of the strains were able to inhibit the growth of pathogenic Candida albicans.	[Axenov-Gibanov, Denis V.; Voytsekhovskaya, Irina V.; Protasov, Eugeniy S.; Gamaiunov, Stanislav V.; Timofeyev, Maxim A.] Irkutsk State Univ, Inst Biol, Irkutsk 664003, Russia; [Tokovenko, Bogdan T.; Rebets, Yuriy V.; Luzhetskyy, Andriy N.] Helmholtz Inst Pharmaceut Res Saarland HIPS, Saarbrucken, Germany; [Luzhetskyy, Andriy N.] Univ Saarland, Pharmazeut Biotechnol, D-81310 Saarbrucken, Germany	Irkutsk State University; Helmholtz Association; Saarland University	Axenov-Gibanov, DV (corresponding author), Irkutsk State Univ, Inst Biol, Irkutsk 664003, Russia.	Denis.axengri@gmail.com	Axenov-Gribanov, Denis/J-5204-2019; Timofeyev, Maxim/F-2071-2010; Axenov-Gribanov, Denis V./F-7360-2017	Axenov-Gribanov, Denis/0000-0003-2020-6084; Timofeyev, Maxim/0000-0002-5250-6818; Axenov-Gribanov, Denis V./0000-0003-2020-6084; Protasov, Evgenii/0000-0003-1402-0224; Rebets, Yuriy/0000-0001-5071-8430	Ministry of education and science of Russian Federation as a part of Goszadanie projects [6.382.2014/K]; Russian science foundation [N 14-14-00400]; Russian foundation for basic research [N 14-04-00501, 15-54-04062, 16-34-60060, 16-34-00686]; Grants of Irkutsk State University; Deutscher Akademischer Austauschdienst	Ministry of education and science of Russian Federation as a part of Goszadanie projects; Russian science foundation(Russian Science Foundation (RSF)); Russian foundation for basic research(Russian Foundation for Basic Research (RFBR)); Grants of Irkutsk State University; Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD))	This research was supported by the Ministry of education and science of Russian Federation as a part of Goszadanie projects (no. 6.382.2014/K), Russian science foundation (project N 14-14-00400), Russian foundation for basic research (projects N 14-04-00501, 15-54-04062, 16-34-60060, 16-34-00686), Grants of Irkutsk State University for young researchers and Deutscher Akademischer Austauschdienst.	Abdelmohsen UR, 2014, NAT PROD REP, V31, P381, DOI 10.1039/c3np70111e; Alvin A, 2014, MICROBIOL RES, V169, P483, DOI 10.1016/j.micres.2013.12.009; [Anonymous], 2000, PRACTICAL STREPTOMYC; Barton H.A., 2007, MICROBE, V2, P132; Barton HA, 2005, J CAVE KARST STUD, V67, P28; Barton HA, 2007, INT J SPELEOL, V36, P93, DOI 10.5038/1827-806X.36.2.5; Barton HA, 2007, J CAVE KARST STUD, V69, P163; Busarakam K, 2014, ANTON LEEUW INT J G, V105, P849, DOI 10.1007/s10482-014-0139-y; Canaveras JC, 2006, NATURWISSENSCHAFTEN, V93, P27, DOI 10.1007/s00114-005-0052-3; Culver David C., 2000, Journal of Caves and Karst Studies, V62, P11; Engel AS, 2001, GEOMICROBIOL J, V18, P259, DOI 10.1080/01490450152467787; Gonzalez JM, 2006, NATURWISSENSCHAFTEN, V93, P42, DOI 10.1007/s00114-005-0060-3; Grady F, 2005, VERTEBRATE PALEONTOL; Groth I, 1999, J MICROBIOL METH, V36, P115, DOI 10.1016/S0167-7012(99)00016-0; Groth I, 1999, INT J SYST BACTERIOL, V49, P1733, DOI 10.1099/00207713-49-4-1733; Holsinger JR, 2000, ECOSYSTEMS WORLD; Hopwood DA, 2007, MOL MICROBIOL, V63, P937, DOI 10.1111/j.1365-2958.2006.05584.x; Jurado V, 2005, INT J SYST EVOL MICR, V55, P1897, DOI 10.1099/ijs.0.63637-0; Katoh S, 2007, MOL BIOL EVOL, V30, P772; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khizhnyak SV, 2003, RUSS J ECOL+, V34, P231, DOI 10.1023/A:1024537513439; Klimchouk A.B., 2007, HYPOGENE SPELEOGENES; Laiz L, 1999, J MICROBIOL METH, V36, P129, DOI 10.1016/S0167-7012(99)00018-4; Maciejewska M, 2015, ANTON LEEUW INT J G, V107, P519, DOI 10.1007/s10482-014-0348-4; MAZINA SE, 2010, CAVES, V33, P34; Meisinger DB, 2007, ENVIRON MICROBIOL, V9, P1523, DOI 10.1111/j.1462-2920.2007.01271.x; Micheletti AC, 2011, QUIM NOVA, V34, P1014, DOI 10.1590/S0100-40422011000600019; Monciardini P, 2014, MICROB BIOTECHNOL, V7, P209, DOI 10.1111/1751-7915.12123; Nikapitiya C, 2012, ADV FOOD NUTR RES, V65, P363, DOI 10.1016/B978-0-12-416003-3.00024-X; Northup DE, 2001, GEOMICROBIOL J, V18, P199, DOI 10.1080/01490450152467750; Okoro CK, 2009, ANTON LEEUW INT J G, V95, P121, DOI 10.1007/s10482-008-9295-2; Patel K, 2010, EXTRACTION METABOLIT; Prajapati AK, 2011, QUIM NOVA, V34, P771, DOI 10.1590/S0100-40422011000500008; Rateb ME, 2011, J NAT PROD, V74, P1491, DOI 10.1021/np200320u; Rebets Y, 2015, ANGEW CHEM INT EDIT, V54, P2280, DOI 10.1002/anie.201408901; Reinbacher W.R., 1994, NSS B, V56, P1; Reitner J., 2011, ENCY GEOBIOLOGY; Ruangpan L., 2004, LAB MANUAL STANDARDI; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; STROHL WR, 1997, BIOTECHNOLOGY ANTIBI; Tomoda H, 2001, SCREENING INHIBITORS; Whittle M, 2003, J CHEM INF COMP SCI, V43, P449, DOI 10.1021/ci025591m	42	35	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149216	10.1371/journal.pone.0149216	http://dx.doi.org/10.1371/journal.pone.0149216			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901168	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100045
J	da Silva, TA; Mariano, VS; Sardinha-Silva, A; de Souza, MA; Mineo, TWP; Roque-Barreira, MC				da Silva, Thiago Aparecido; Mariano, Vania Sammartino; Sardinha-Silva, Aline; de Souza, Maria Aparecida; Patriarca Mineo, Tiago Wilson; Roque-Barreira, Maria Cristina			IL-17 Induction by ArtinM is Due to Stimulation of IL-23 and IL-1 Release and/or Interaction with CD3 in CD4(+) T Cells	PLOS ONE			English	Article							PARACOCCIDIOIDES-BRASILIENSIS INFECTION; ARTOCARPUS-INTEGRIFOLIA; CANDIDA-ALBICANS; C57BL/6 MICE; BALB/C MICE; KM PLUS; LECTIN; TH17; LINEAGE; BINDING	ArtinM is a D-mannose-binding lectin extracted from the seeds of Artocarpus heterophyllus that interacts with TLR2 N-glycans and activates antigen-presenting cells (APCs), as manifested by IL-12 production. In vivo ArtinM administration induces Th1 immunity and confers protection against infection with several intracellular pathogens. In the murine model of Candida albicans infection, it was verified that, in addition to Th1, ArtinM induces Th17 immunity manifested by high IL-17 levels in the treated animals. Herein, we investigated the mechanisms accounting for the ArtinM-induced IL-17 production. We found that ArtinM stimulates the IL-17 production by spleen cells in BALB/c or C57BL/6 mice, a response that was significantly reduced in the absence of IL-23, MyD88, or IL-1R. Furthermore, we showed that ArtinM directly induced the IL-23 mRNA expression and the IL-1 production by macrophages. Consistently, in cell suspensions depleted of macrophages, the IL-17 production stimulated by ArtinM was reduced by 53% and the exogenous IL-23 acted synergistically with ArtinM in promoting IL-17 production by spleen cell suspensions. We verified that the absence of IL-23, IL-1R, or MyD88 inhibited, but did not block, the IL-17 production by ArtinM-stimulated spleen cells. Therefore, we investigated whether ArtinM exerts a direct effect on CD4(+) T cells in promoting IL-17 production. Indeed, spleen cell suspensions depleted of CD4(+) T cells responded to ArtinM with very low levels of IL-17 release. Likewise, isolated CD4(+) T cells under ArtinM stimulus augmented the expression of TGF-beta mRNA and released high levels of IL-17. Considering the observed synergism between IL-23 and ArtinM, we used cells from IL-23 KO mice to assess the direct effect of lectin on CD4(+) T cells. We verified that ArtinM increased the IL-17 production significantly, a response that was inhibited when the CD4(+) T cells were pre-incubated with anti-CD3 antibody. In conclusion, ArtinM stimulates the production of IL-17 by CD4(+) T cells in two major ways: (I) through the induction of IL-23 and IL-1 by APCs and (II) through the direct interaction with CD3 on the CD4(+) T cells. This study contributes to elucidation of mechanisms accounting for the property of ArtinM in inducing Th17 immunity and opens new perspectives in designing strategies for modulating immunity by using carbohydrate recognition agents.	[da Silva, Thiago Aparecido; Mariano, Vania Sammartino; Sardinha-Silva, Aline; de Souza, Maria Aparecida; Roque-Barreira, Maria Cristina] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, BR-14049 Ribeirao Preto, SP, Brazil; [Patriarca Mineo, Tiago Wilson] Univ Fed Uberlandia, Inst Ciencias Biomed, Av Engenheiro Dinz 1178,CP 593, BR-38400 Uberlandia, MG, Brazil	Universidade de Sao Paulo; Universidade Federal de Uberlandia	Roque-Barreira, MC (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, BR-14049 Ribeirao Preto, SP, Brazil.	mcrbarre@fmrp.usp.br	da Silva, Thiago Aparecido/I-2315-2015; Roque-Barreira, Maria-Cristina/A-4552-2008; Mariano, Vânia Sammartino/AAV-1851-2020; Mariano, Vania/O-1133-2016; Mineo, Tiago W. P./B-4153-2009	da Silva, Thiago Aparecido/0000-0001-5017-6539; Roque-Barreira, Maria-Cristina/0000-0001-7425-0908; Mariano, Vânia Sammartino/0000-0002-5399-5676; Mineo, Tiago W. P./0000-0002-2339-2743	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2006/60642-2, 2007/558879-7, 2010/51763-6, 2012/12950-0, 2012/09611-0, 2013/04088-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [475357/2013-2]; Financiadora de Estudos e Projetos [0110045900]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade deMedicina de Ribeirao Preto	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos(Financiadora de Inovacao e Pesquisa (Finep)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade deMedicina de Ribeirao Preto	This research was financially supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (grant numbers 2006/60642-2, 2007/558879-7, 2010/51763-6, 2012/12950-0, 2012/09611-0 and 2013/04088-0), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (475357/2013-2), Financiadora de Estudos e Projetos (0110045900), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior and Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade deMedicina de Ribeirao Preto.	Cardoso MRD, 2011, VACCINE, V29, P9183, DOI 10.1016/j.vaccine.2011.09.136; Chang J, 2013, P NATL ACAD SCI USA, V110, P2270, DOI 10.1073/pnas.1206048110; Chen X, 2005, J LEUKOCYTE BIOL, V78, P114, DOI 10.1189/jlb.0604341; Chien YH, 2006, CELL MOL LIFE SCI, V63, P2089, DOI 10.1007/s00018-006-6020-z; Coltri KC, 2008, AM J PATHOL, V173, P423, DOI 10.2353/ajpath.2008.080126; Coltri KC, 2010, MED MYCOL, V48, P792, DOI 10.3109/13693780903501671; Corfield AP, 2015, TRENDS BIOCHEM SCI, V40, P351, DOI 10.1016/j.tibs.2015.04.004; Custodio LA, 2011, INT IMMUNOPHARMACOL, V11, P1510, DOI 10.1016/j.intimp.2011.05.005; da Silva TA, 2014, CELL TISSUE RES, V357, P719, DOI 10.1007/s00441-014-1879-8; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Ganiko L, 1998, GLYCOCONJUGATE J, V15, P527; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gu Y, 2008, EUR J IMMUNOL, V38, P1807, DOI 10.1002/eji.200838331; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liu T, 2002, INFECT IMMUN, V70, P6638, DOI 10.1128/IAI.70.12.6638-6645.2002; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mariano VS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098512; Mechref Y, 2000, GLYCOBIOLOGY, V10, P231, DOI 10.1093/glycob/10.3.231; Moreno AN, 2003, INT ARCH ALLERGY IMM, V132, P221, DOI 10.1159/000074303; Panunto-Castelo A, 2001, GLYCOBIOLOGY, V11, P1035, DOI 10.1093/glycob/11.12.1035; Pereira-Da-Silva G, 2006, BBA-GEN SUBJECTS, V1760, P86, DOI 10.1016/j.bbagen.2005.09.011; Reynolds JM, 2010, CYTOKINE GROWTH F R, V21, P413, DOI 10.1016/j.cytogfr.2010.10.002; Ruddy MJ, 2004, J BIOL CHEM, V279, P2559, DOI 10.1074/jbc.M308809200; de Oliveira PSS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/263968; SANTOSDEOLIVEIRA R, 1994, J IMMUNOL, V153, P1798; Teixeira CR, 2006, VACCINE, V24, P3001, DOI 10.1016/j.vaccine.2005.11.067; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	33	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149721	10.1371/journal.pone.0149721	http://dx.doi.org/10.1371/journal.pone.0149721			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901413	Green Published, gold			2022-12-27	WOS:000371276100134
J	de Lima, DS; Ogusku, MM; dos Santos, MP; Silva, CMD; de Almeida, VA; Antunes, IA; Boechat, AL; Ramasawmy, R; Sadahiro, A				de Lima, Dhemerson Souza; Ogusku, Mauricio Morishi; dos Santos, Maisa Porto; de Melo Silva, Claudia Maria; de Almeida, Vanessa Alves; Antunes, Irineide Assumpcao; Boechat, Antonio Luiz; Ramasawmy, Rajendranath; Sadahiro, Aya			Alleles of HLA-DRB1*04 Associated with Pulmonary Tuberculosis in Amazon Brazilian Population	PLOS ONE			English	Article							HLA-CLASS-II; HUMAN-LEUKOCYTE ANTIGEN; GENETIC SUSCEPTIBILITY; RHEUMATOID-ARTHRITIS; MOLECULAR ANALYSIS; RISK-FACTOR; POLYMORPHISMS; DISEASE; DRB; FREQUENCIES	Immunogenetic host factors are associated with susceptibility or protection to tuberculosis (TB). Strong associations of HLA class II genes with TB are reported. We analyzed the HLA-DRB1*04 alleles to identify subtypes associated with pulmonary TB and their interaction with risk factors such as alcohol, smoking, and gender in 316 pulmonary TB patients and 306 healthy individuals from the Brazilian Amazon. The HLA-DRB1*04 was prevalent in patients with pulmonary TB (p<0.0001; OR = 2.94; 95% CI = 2.12 to 4.08). Direct nucleotide sequencing of DRB1 exon 2 identified nine subtypes of HLA-DRB1*04. The subtype HLA-DRB1*04: 11: 01 (p = 0.0019; OR = 2.23; 95% CI = 1.34 to 3.70) was associated with susceptibility to pulmonary TB while DRB1*04: 07: 01 (p<0.0001; OR = 0.02; 95% CI = 0.001 to 0.33) to protection. Notably, the interaction between alcohol and HLA-DRB1*04: 11: 01 increased the risk for developing pulmonary TB (p = 0.0001; OR = 51.3; 95% CI = 6.81 to 386). Multibacillary pulmonary TB, the clinical presentation of disease transmission, was strongly associated with interaction to alcohol (p = 0.0026; OR = 11.1; 95% CI = 3.99 to 30.9), HLA-DRB1*04: 11: 01 (p = 0.0442; OR = 2.01; 95% CI = 1.03 to 3.93) and DRB1*04: 92 (p = 0.0112; OR = 8.62; 95% CI = 1.63 to 45.5). These results show that HLA-DRB1*04 are associated with pulmonary TB. Interestingly, three subtypes, DRB1*04: 07: 01, DRB1*04: 11: 01 and DRB1*04: 92 of the HLA-DRB1*04 could be potential immunogenetic markers that may help to explain mechanisms involved in disease development.	[de Lima, Dhemerson Souza; de Almeida, Vanessa Alves; Boechat, Antonio Luiz; Ramasawmy, Rajendranath; Sadahiro, Aya] Univ Fed Amazonas UFAM, Inst Ciencias Biol, Programa Posgrad Imunol Basica & Aplicada, Manaus, Amazonas, Brazil; [Ogusku, Mauricio Morishi; dos Santos, Maisa Porto] INPA, Lab Micobacteriol, Manaus, Amazonas, Brazil; [de Melo Silva, Claudia Maria] FCF, Programa Posgrad Ciencias Farmaceut, Manaus, Amazonas, Brazil; [Antunes, Irineide Assumpcao] Policlin Cardoso Fontes, Manaus, Amazonas, Brazil; [Ramasawmy, Rajendranath] Fundacao Med Trop Doutor Heitor Vieira Dourado FM, Manaus, Amazonas, Brazil; [Ramasawmy, Rajendranath] Univ Nilton Lins, Manaus, Amazonas, Brazil	Universidade Federal de Amazonas; Institute Nacional de Pesquisas da Amazonia; Centro Universitario Nilton Lins	de Lima, DS (corresponding author), Univ Fed Amazonas UFAM, Inst Ciencias Biol, Programa Posgrad Imunol Basica & Aplicada, Manaus, Amazonas, Brazil.	dhemersonsouzalima@gmail.com	souza, Dhemerson/K-2907-2015; Ramasawmy, Rajendranath/V-4926-2019; Boechat, A.L./H-8484-2019	Boechat, A.L./0000-0001-5597-7343; Souza de Lima, Dhemerson/0000-0002-1040-627X; Ogusku, Mauricio Morishi/0000-0003-0173-6266	PPSUS - Programa de Pesquisa para o SUS: Gestao compartilhada em Saude; FAPEAM - Fundacao de Amparo a Pesquisa do Estado do Amazonas [Edital 007/2009, Edital 009/2007]; PIPT-Programa Integrado de Pesquisa Cientifica e Tecnologica; MCT - Ministerio da Ciencia e Tecnologia/CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Universal [473484/2007-2, MCT/CNPq 15/2007]	PPSUS - Programa de Pesquisa para o SUS: Gestao compartilhada em Saude; FAPEAM - Fundacao de Amparo a Pesquisa do Estado do Amazonas; PIPT-Programa Integrado de Pesquisa Cientifica e Tecnologica; MCT - Ministerio da Ciencia e Tecnologia/CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Universal	The work was supported by the PPSUS - Programa de Pesquisa para o SUS: Gestao compartilhada em Saude, FAPEAM - Fundacao de Amparo a Pesquisa do Estado do Amazonas (Edital 007/2009), PIPT-Programa Integrado de Pesquisa Cientifica e Tecnologica, FAPEAM - Fundacao de Amparo a Pesquisa do Estado do Amazonas (Edital 009/2007) and MCT - Ministerio da Ciencia e Tecnologia/CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Universal, Processo No. 473484/2007-2 (Edital MCT/CNPq 15/2007).	Amirzargar AA, 2004, INT J TUBERC LUNG D, V8, P1017; Bekker LG, 2010, CLIN INFECT DIS, V50, pS208, DOI 10.1086/651493; Bellamy R, 1998, THORAX, V53, P588, DOI 10.1136/thx.53.7.588; Bhargava A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077979; Boechat ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041588; BRASIL, 2014, PESQ NAC SAUD 2013 P; BRASIL, 2015, B EP MIN SAUD, V46; BRASIL, 2008, MAN NAC VIG LAB TUB, V1, P434; Cardoso MS, 1990, J PNEUMOL, V16, P133; Cegielski JP, 2012, AM J EPIDEMIOL, V176, P409, DOI 10.1093/aje/kws007; Cois A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-871; den Boon S, 2005, THORAX, V60, P555, DOI 10.1136/thx.2004.030924; Dobler CC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000666; Duarte R, 2011, REV PORT PNEUMOL, V17, P15; Dubaniewicz A, 2005, TUBERCULOSIS, V85, P259, DOI 10.1016/j.tube.2004.12.003; El Baghdadi J, 2013, PATHOL BIOL, V61, P11, DOI 10.1016/j.patbio.2013.01.004; Forrellad MA, 2013, VIRULENCE, V4, P3, DOI 10.4161/viru.22329; Gambhir HS, 2010, INT HEALTH, V2, P216, DOI 10.1016/j.inhe.2010.07.001; Garcia-Ortiz JE, 2006, TISSUE ANTIGENS, V68, P135, DOI 10.1111/j.1399-0039.2006.00636.x; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Godkin AJ, 2001, J IMMUNOL, V166, P6720, DOI 10.4049/jimmunol.166.11.6720; Goldfeld AE, 2004, TUBERCULOSIS, V84, P76, DOI 10.1016/j.tube.2003.08.007; Goldhaber-Fiebert JD, 2011, INT J EPIDEMIOL, V40, P417, DOI 10.1093/ije/dyq238; Gonzalez-Galarza FF, 2015, NUCLEIC ACIDS RES, V43, pD784, DOI 10.1093/nar/gku1166; Gragert L, 2013, HUM IMMUNOL, V74, P1313, DOI 10.1016/j.humimm.2013.06.025; Guha Pokhraj, 2013, Frontiers in Genetics, V4, P155, DOI 10.3389/fgene.2013.00155; GUSTINCICH S, 1991, BIOTECHNIQUES, V11, P298; IEDB, 2015, IMM EP DAT AN RES; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Jones EY, 2006, NAT REV IMMUNOL, V6, P271, DOI 10.1038/nri1805; Kim HS, 2005, HUM IMMUNOL, V66, P1074, DOI 10.1016/j.humimm.2005.08.242; Kuranov AB, 2014, TISSUE ANTIGENS, V83, P106, DOI 10.1111/tan.12279; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lin L, 2007, BIOCHEM CELL BIOL, V85, P227, DOI 10.1139/O06-204; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Lombard Z, 2006, HUM IMMUNOL, V67, P643, DOI 10.1016/j.humimm.2006.04.008; Lu JQ, 2014, GENE, V543, P140, DOI 10.1016/j.gene.2014.03.042; Lucena-Silva N, 2010, J EPIDEMIOL COMMUN H, V64, P513, DOI 10.1136/jech.2008.086801; Ma MJ, 2010, HUM IMMUNOL, V71, P1005, DOI 10.1016/j.humimm.2010.07.009; Magira EE, 2012, HUM IMMUNOL, V73, P641, DOI 10.1016/j.humimm.2012.03.008; Mason CM, 2004, INFECT IMMUN, V72, P2556, DOI 10.1128/IAI.72.5.2556-2563.2004; Mishra G, 2014, INFECT GENET EVOL, V22, P175, DOI 10.1016/j.meegid.2013.08.019; Mourad J, 2013, REV BRAS REUMATOL, V53, P47, DOI 10.1016/S2255-5021(13)70005-1; Nielsen M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000107; Patra J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096433; PETZLERLER ML, 1994, HUM IMMUNOL, V41, P180, DOI 10.1016/0198-8859(94)90034-5; Qu HQ, 2011, J HUM GENET, V56, P177, DOI 10.1038/jhg.2010.164; Ravikumar M., 1999, Tubercle and Lung Disease, V79, P309, DOI 10.1054/tuld.1999.0213; Reed GW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058044; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; Rojas-Villarraga A, 2010, AUTOIMMUN REV, V9, P666, DOI 10.1016/j.autrev.2010.05.016; Ruggiero G, 2004, IMMUNOLOGY, V111, P318, DOI 10.1111/j.1365-2567.2004.01811.x; Sahiratmadja E, 2007, TUBERCULOSIS, V87, P303, DOI 10.1016/j.tube.2007.02.001; Salem Julia Ignez, 2007, Acta Amaz., V37, P419, DOI 10.1590/S0044-59672007000300013; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Selvaraj P, 2008, CYTOKINE, V43, P26, DOI 10.1016/j.cyto.2008.04.011; Shi GL, 2011, GENET MOL RES, V10, P1331, DOI 10.4238/vol10-3gmr1132; Teran-Escandon D, 1999, CHEST, V115, P428, DOI 10.1378/chest.115.2.428; Tong X, 2015, LUNG, V193, P309, DOI 10.1007/s00408-015-9692-z; Tsuneto LT, 2003, TISSUE ANTIGENS, V62, P512, DOI 10.1046/j.1399-0039.2003.00139.x; Vandiedonck Claire, 2009, Briefings in Functional Genomics & Proteomics, V8, P379, DOI 10.1093/bfgp/elp010; Vargas-Alarcon G, 2000, HUM IMMUNOL, V61, P341, DOI 10.1016/S0198-8859(99)00180-9; Wang LX, 2010, VACCINE, V28, P2026, DOI 10.1016/j.vaccine.2009.10.063; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Zanelli E, 2000, HUM IMMUNOL, V61, P1254, DOI 10.1016/S0198-8859(00)00185-3; Zhang ZJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-328	67	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0147543	10.1371/journal.pone.0147543	http://dx.doi.org/10.1371/journal.pone.0147543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901036	gold, Green Published, Green Submitted			2022-12-27	WOS:000371276100011
J	Sreekanth, GP; Chuncharunee, A; Sirimontaporn, A; Panaampon, J; Noisakran, S; Yenchitsomanus, PT; Limjindaporn, T				Sreekanth, Gopinathan Pillai; Chuncharunee, Aporn; Sirimontaporn, Aunchalee; Panaampon, Jutatip; Noisakran, Sansanee; Yenchitsomanus, Pa-thai; Limjindaporn, Thawornchai			SB203580 Modulates p38 MAPK Signaling and Dengue Virus-Induced Liver Injury by Reducing MAPKAPK2, HSP27, and ATF2 Phosphorylation	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; PRO-INFLAMMATORY CYTOKINES; PROTEIN-KINASE INHIBITOR; HEMORRHAGIC-FEVER; CELL-DEATH; TNF-ALPHA; INDUCED APOPTOSIS; VASCULAR LEAKAGE; AG129 MICE; HEAT-SHOCK	Dengue virus (DENV) infection causes organ injuries, and the liver is one of the most important sites of DENV infection, where viral replication generates a high viral load. The molecular mechanism of DENV-induced liver injury is still under investigation. The mitogen activated protein kinases (MAPKs), including p38 MAPK, have roles in the hepatic cell apoptosis induced by DENV. However, the in vivo role of p38 MAPK in DENV-induced liver injury is not fully understood. In this study, we investigated the role of SB203580, a p38 MAPK inhibitor, in a mouse model of DENV infection. Both the hematological parameters, leucopenia and thrombocytopenia, were improved by SB203580 treatment and liver transaminases and histopathology were also improved. We used a real-time PCR microarray to profile the expression of apoptosis-related genes. Tumor necrosis factor a, caspase 9, caspase 8, and caspase 3 proteins were significantly lower in the SB203580-treated DENV-infected mice than that in the infected control mice. Increased expressions of cytokines including TNF-alpha, IL-6 and IL-10, and chemokines including RANTES and IP-10 in DENV infection were reduced by SB203580 treatment. DENV infection induced the phosphorylation of p38MAPK, and its downstream signals including MAPKAPK2, HSP27 and ATF-2. SB203580 treatment did not decrease the phosphorylation of p38 MAPK, but it significantly reduced the phosphorylation of MAPKAPK2, HSP27, and ATF2. Therefore, SB203580 modulates the downstream signals to p38 MAPK and reduces DENV-induced liver injury.	[Sreekanth, Gopinathan Pillai; Chuncharunee, Aporn; Sirimontaporn, Aunchalee; Panaampon, Jutatip; Limjindaporn, Thawornchai] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Anat, Bangkok 10700, Thailand; [Noisakran, Sansanee] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Med Biotechnol Unit, Bangkok, Thailand; [Yenchitsomanus, Pa-thai] Mahidol Univ, Fac Med, Siriraj Hosp, Div Mol Med,Dept Res & Dev, Bangkok 10700, Thailand	Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University	Limjindaporn, T (corresponding author), Mahidol Univ, Fac Med, Siriraj Hosp, Dept Anat, Bangkok 10700, Thailand.	thawornchai.lim@mahidol.ac.th	Noisakran, Sansanee/H-5186-2011; Sreekanth, Gopinathan Pillai/F-3715-2010	Noisakran, Sansanee/0000-0002-9336-3331; Sreekanth, Gopinathan Pillai/0000-0002-0278-8642	Mahidol University, Mahidol University, Thailand [R015810002]	Mahidol University, Mahidol University, Thailand	This study was supported by Mahidol University Grant No. R015810002, Mahidol University, Thailand. TL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebayo D, 2015, LIVER INT, V35, P2564, DOI 10.1111/liv.12850; Alagarasu K, 2013, HUM IMMUNOL, V74, P610, DOI 10.1016/j.humimm.2013.01.027; Albarnaz JD, 2014, ANTIVIR RES, V111, P82, DOI 10.1016/j.antiviral.2014.09.004; Villar LA, 2013, BIOMEDICA, V33, P108, DOI 10.7705/biomedica.v33i0.733; Arias J, 2014, VIROLOGY, V452, P42, DOI 10.1016/j.virol.2013.12.027; Ashraf MI, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-6; Atrasheuskaya A, 2003, FEMS IMMUNOL MED MIC, V35, P33, DOI 10.1111/j.1574-695X.2003.tb00646.x; Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949; Barreto D. F., 2004, Journal of Submicroscopic Cytology and Pathology, V36, P121; Barth OM, 2006, MEM I OSWALDO CRUZ, V101, P905, DOI 10.1590/S0074-02762006000800014; Butt N, 2008, JCPSP-J COLL PHYSICI, V18, P282, DOI 05.2008/JCPSP.282285; Cabello-Guterrez C, 2009, THROMB HAEMOSTASIS, V101, P916, DOI 10.1160/TH08-04-0271; Cardier JE, 2005, CYTOKINE, V30, P359, DOI 10.1016/j.cyto.2005.01.021; Ceballos-Olvera I, 2010, VIROLOGY, V396, P30, DOI 10.1016/j.virol.2009.10.019; Chen HC, 2004, J MED VIROL, V73, P419, DOI 10.1002/jmv.20108; Chongsrisawat V, 2009, SE ASIAN J TROP MED, V40, P47; Chuturgoon AA, 2015, TOXICOL LETT, V235, P67, DOI 10.1016/j.toxlet.2015.03.006; Cross TG, 2000, EXP CELL RES, V256, P34, DOI 10.1006/excr.2000.4836; De Castro RAC, 2007, AM J TROP MED HYG, V76, P737, DOI 10.4269/ajtmh.2007.76.737; de Miranda AS, 2012, BEHAV BRAIN RES, V230, P237, DOI 10.1016/j.bbr.2012.02.020; Franca RFD, 2010, EXP MOL PATHOL, V89, P321, DOI 10.1016/j.yexmp.2010.07.007; Dinh TT, 2010, AM J TROP MED HYG, V83, P774, DOI 10.4269/ajtmh.2010.10-0090; Enslen H, 1998, J BIOL CHEM, V273, P1741, DOI 10.1074/jbc.273.3.1741; Fernandez-Mestre MT, 2004, TISSUE ANTIGENS, V64, P469, DOI 10.1111/j.1399-0039.2004.00304.x; French SW, 2011, EXP MOL PATHOL, V91, P653, DOI 10.1016/j.yexmp.2011.07.004; Fu YL, 2014, ANTIVIR RES, V110, P151, DOI 10.1016/j.antiviral.2014.08.004; Green S, 1999, J MED VIROL, V59, P329, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G; Guabiraba R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015680; Gusev NB, 2002, BIOCHEMISTRY-MOSCOW+, V67, P511, DOI 10.1023/A:1015549725819; Halstead SB, 2013, CLIN INFECT DIS, V56, P900, DOI 10.1093/cid/cis1047; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Hashem AM, 2014, J IMMUNOL, V193, P722, DOI 10.4049/jimmunol.1300093; HOBER D, 1993, AM J TROP MED HYG, V48, P324, DOI 10.4269/ajtmh.1993.48.324; Hsu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079518; Huerta-Zepeda A, 2008, THROMB HAEMOSTASIS, V99, P936, DOI [10.1160/TH07-08-0483, 10.1160/TH07-08-0438]; Hui KPY, 2009, J IMMUNOL, V182, P1088, DOI 10.4049/jimmunol.182.2.1088; Jirakanjanakit N, 1997, T ROY SOC TROP MED H, V91, P614, DOI 10.1016/S0035-9203(97)90050-X; Johnson JC, 2014, ANTIVIR RES, V107, P102, DOI 10.1016/j.antiviral.2014.04.014; Juffrie M, 2001, AM J TROP MED HYG, V65, P70, DOI 10.4269/ajtmh.2001.65.70; Kalayanarooj Siripen, 2003, J Med Assoc Thai, V86 Suppl 3, pS673; Kan H, 2004, AM J PHYSIOL-CELL PH, V286, pC1, DOI 10.1152/ajpcell.00059.2003; Kharya G, 2011, PEDIATR HEMAT ONCOL, V28, P727, DOI 10.3109/08880018.2011.609581; Khunchai S, 2015, VIRUS RES, V197, P92, DOI 10.1016/j.virusres.2014.12.007; Kim E, 2014, TRANSPL P, V46, P1180, DOI 10.1016/j.transproceed.2013.11.028; Klomporn P, 2011, VIROLOGY, V409, P189, DOI 10.1016/j.virol.2010.10.010; Kumar PR, 2005, J BIOL CHEM, V280, P8553, DOI 10.1074/jbc.M407863200; Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454; KUO CH, 1992, AM J TROP MED HYG, V47, P265, DOI 10.4269/ajtmh.1992.47.265; Lahti A, 2002, EUR J PHARMACOL, V454, P115, DOI 10.1016/S0014-2999(02)02490-1; Lee CJ, 2005, J VIROL, V79, P8388, DOI 10.1128/JVI.79.13.8388-8399.2005; Lee YR, 2007, VIRUS RES, V126, P216, DOI 10.1016/j.virusres.2007.03.003; Li R, 2014, J SURG RES, V192, P195, DOI 10.1016/j.jss.2014.05.042; Liao HW, 2010, J MED VIROL, V82, P1392, DOI 10.1002/jmv.21815; Liew KJL, 2006, J VIROL METHODS, V131, P47, DOI 10.1016/j.jviromet.2005.07.003; Lim EJ, 2014, J GEN VIROL, V95, P2204, DOI 10.1099/vir.0.065862-0; Limjindaporn T, 2007, BIOCHEM BIOPH RES CO, V362, P334, DOI 10.1016/j.bbrc.2007.07.194; Limonta D, 2007, J CLIN VIROL, V40, P50, DOI 10.1016/j.jcv.2007.04.024; Limonta D, 2008, DIABETES VASC DIS RE, V5, P213, DOI 10.3132/dvdr.2008.034; Lin CF, 2008, LAB INVEST, V88, P1079, DOI 10.1038/labinvest.2008.70; Ling LM, 2007, J CLIN VIROL, V38, P265, DOI 10.1016/j.jcv.2006.12.011; Liu XW, 2014, MOL MED REP, V10, P1942, DOI 10.3892/mmr.2014.2402; Malavige GN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050387; Matsuda T, 2005, J GEN VIROL, V86, P1055, DOI 10.1099/vir.0.80531-0; Mohan B, 2000, J TROP PEDIATRICS, V46, P40, DOI 10.1093/tropej/46.1.40; Morchang A, 2011, VIRUS RES, V156, P25, DOI 10.1016/j.virusres.2010.12.012; Morley SJ, 2003, CELL SIGNAL, V15, P741, DOI 10.1016/S0898-6568(03)00008-1; Nagila A, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-105; Nasirudeen AMA, 2008, MICROBES INFECT, V10, P1124, DOI 10.1016/j.micinf.2008.06.005; Nasirudeen AMA, 2009, J MED VIROL, V81, P1069, DOI 10.1002/jmv.21486; Nguyen TL, 1997, RES VIROLOGY, V148, P273, DOI 10.1016/S0923-2516(97)88364-1; Oliveira ERA, 2016, VIROLOGY, V489, P95, DOI 10.1016/j.virol.2015.12.006; Otahal P, 2007, J IMMUNOL, V179, P6686, DOI 10.4049/jimmunol.179.10.6686; Paes MV, 2009, LAB INVEST, V89, P1140, DOI 10.1038/labinvest.2009.83; Paes MV, 2005, VIROLOGY, V338, P236, DOI 10.1016/j.virol.2005.04.042; Pham TB, 2009, J CLIN VIROL, V45, P276, DOI 10.1016/j.jcv.2009.04.004; Pinto LMO, 1999, MEM I OSWALDO CRUZ, V94, P387, DOI 10.1590/S0074-02761999000300019; Povoa TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083386; Qi YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132743; Rahaus M, 2004, J GEN VIROL, V85, P3529, DOI 10.1099/vir.0.80347-0; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Rajmane Y, 2013, VIRUS RES, V173, P386, DOI 10.1016/j.virusres.2013.01.002; Ramzan Mohammed, 2013, Hematol Oncol Stem Cell Ther, V6, P65, DOI 10.1016/j.hemonc.2013.05.005; Rattanaburee T, 2015, ANTIVIR RES, V124, P83, DOI 10.1016/j.antiviral.2015.10.005; Regan AD, 2009, VIROLOGY, V384, P135, DOI 10.1016/j.virol.2008.11.006; Reimold AM, 2001, INT IMMUNOL, V13, P241, DOI 10.1093/intimm/13.2.241; Robles-Diaz M, 2015, LIVER INT, V35, P2474, DOI 10.1111/liv.12834; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Sarathy VV, 2015, J VIROL, V89, P1254, DOI 10.1128/JVI.01320-14; Sheng M, 2015, TRANSPL P, V47, P275, DOI 10.1016/j.transproceed.2015.01.010; Singh D, 2007, AM J PHYSIOL-LUNG C, V293, pL436, DOI 10.1152/ajplung.00097.2007; Sitati E, 2007, J VIROL, V81, P9801, DOI 10.1128/JVI.00941-07; Souza Luiz José de, 2004, Braz J Infect Dis, V8, P156, DOI 10.1590/S1413-86702004000200006; Sreekanth GP, 2014, VIRUS RES, V188, P15, DOI 10.1016/j.virusres.2014.03.025; Sridharan A, 2013, J VIROL, V87, P11648, DOI 10.1128/JVI.01156-13; Srikiatkhachorn A, 2014, CELL TISSUE RES, V355, P621, DOI 10.1007/s00441-014-1841-9; Stein B, 1996, J BIOL CHEM, V271, P11427, DOI 10.1074/jbc.271.19.11427; Stirling DP, 2008, NEUROSCIENCE, V155, P128, DOI 10.1016/j.neuroscience.2008.05.007; Suksanpaisan L, 2007, J MED VIROL, V79, P300, DOI 10.1002/jmv.20798; Sun PF, 2006, J IMMUNOL, V177, P6497, DOI 10.4049/jimmunol.177.9.6497; Thepparit Chutima, 2013, BMC Res Notes, V6, P372, DOI 10.1186/1756-0500-6-372; Thongtan T, 2004, J MED VIROL, V72, P436, DOI 10.1002/jmv.20004; Tian ZQ, 2012, EXP THER MED, V4, P255, DOI 10.3892/etm.2012.575; Torrentes-Carvalho A, 2009, MEM I OSWALDO CRUZ, V104, P1091, DOI 10.1590/S0074-02762009000800005; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Ochoa MV, 2009, ARCH VIROL, V154, P919, DOI 10.1007/s00705-009-0396-7; Viprakasit V, 2014, ACTA HAEMATOL-BASEL, V131, P88, DOI 10.1159/000353119; Visuthranukul J, 2009, INFECT DIS REP, V1, DOI 10.4081/idr.2009.e3; Wati S, 2011, J GEN VIROL, V92, P807, DOI 10.1099/vir.0.028159-0; Wiwanitkit V, 2004, CLIN APPL THROMB-HEM, V10, P65, DOI 10.1177/107602960401000111; WU A, 1976, AM J GASTROENTEROL, V65, P318; Yu G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139015; Zhang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113107; Zickovich JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106060	113	53	59	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149486	10.1371/journal.pone.0149486	http://dx.doi.org/10.1371/journal.pone.0149486			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901653	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100082
J	Park, SE; Park, CY; Choi, JM; Chang, E; Rhee, EJ; Lee, WY; Oh, KW; Park, SW; Kang, ES; Lee, HC; Cha, BS				Park, Se Eun; Park, Cheol-Young; Choi, Jung Mook; Chang, Eugene; Rhee, Eun-Jung; Lee, Won-Young; Oh, Ki Won; Park, Sung Woo; Kang, Eun Seok; Lee, Hyun Chul; Cha, Bong Soo			Depot-Specific Changes in Fat Metabolism with Aging in a Type 2 Diabetic Animal Model	PLOS ONE			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; ADIPOSE-TISSUE; BODY-COMPOSITION; GENE-EXPRESSION; GLUCOSE-UPTAKE; ELDERLY-MEN; ZUCKER RATS; ACID UPTAKE; MECHANISMS; THIAZOLIDINEDIONES	Visceral fat accretion is a hallmark of aging and is associated with aging-induced metabolic dysfunction. PPAR gamma agonist was reported to improve insulin sensitivity by redistributing fat from visceral fat to subcutaneous fat. The purpose of this study was to investigate the underlying mechanisms by which aging affects adipose tissue remodeling in a type 2 diabetic animal model and through which PPAR gamma activation modulates aging-related fat tissue distribution. At the ages of 21, 31 and 43 weeks, OLETF rats as an animal model of type 2 diabetes were evaluated for aging-related effects on adipose tissue metabolism in subcutaneous and visceral fat depots. During aging, the ratio of visceral fat weight to subcutaneous fat weight (V/S ratio) increased. Aging significantly increased the mRNA expression of genes involved in lipogenesis such as lipoprotein lipase, fatty acid binding protein aP2, lipin 1, and diacylglycerol acyltransferase 1, which were more prominent in visceral fat than subcutaneous fat. The mRNA expression of adipose triglyceride lipase, which is involved in basal lipolysis and fatty acid recycling, was also increased, more in visceral fat compared to subcutaneous fat during aging. The mRNA levels of the genes associated with lipid oxidation were increased, whereas the mRNA levels of genes associated with energy expenditure showed no significant change during aging. PPAR gamma agonist treatment in OLETF rats resulted in fat redistribution with a decreasing V/S ratio and improved glucose intolerance. The genes involved in lipogenesis decreased in visceral fat of the PPAR gamma agonist-treated rats. During aging, fat distribution was changed by stimulating lipid uptake and esterification in visceral fat rather than subcutaneous fat, and by altering the lipid oxidation.	[Park, Se Eun; Park, Cheol-Young; Rhee, Eun-Jung; Lee, Won-Young; Oh, Ki Won; Park, Sung Woo] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Div Endocrinol & Metab,Dept Internal Med, Seoul, South Korea; [Choi, Jung Mook; Chang, Eugene] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Diabet Res Inst, Seoul, South Korea; [Kang, Eun Seok; Lee, Hyun Chul; Cha, Bong Soo] Yonsei Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University Health System	Park, CY (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Div Endocrinol & Metab,Dept Internal Med, Seoul, South Korea.; Cha, BS (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea.	cydoctor@chol.com; bscha@yuhs.ac	Rhee, Eun-Jung/M-9294-2015; LEE, WON-YOUNG/C-7249-2018	Rhee, Eun-Jung/0000-0002-6108-7758; LEE, WON-YOUNG/0000-0002-1082-7592; Kang, Eun Seok/0000-0002-0364-4675; Cha, Bong-Soo/0000-0003-0542-2854	Samsung Biomedical Research Institute grant [SMR1130311, SMX1132381]; Medical Research Funds from Kangbuk Samsung Hospital; Korean Diabetes Association	Samsung Biomedical Research Institute grant(Samsung); Medical Research Funds from Kangbuk Samsung Hospital(Samsung); Korean Diabetes Association	This work was supported by Samsung Biomedical Research Institute grant (SMR1130311, SMX1132381, CYP), Medical Research Funds from Kangbuk Samsung Hospital, and the grant (P.S.E., 2009) from the Korean Diabetes Association.	Bays Harold E, 2008, Expert Rev Cardiovasc Ther, V6, P343, DOI 10.1586/14779072.6.3.343; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Boden G, 2005, DIABETES, V54, P880, DOI 10.2337/diabetes.54.3.880; Cadoudal T, 2008, DIABETES, V57, P2272, DOI 10.2337/db08-0477; Cartwright MJ, 2007, EXP GERONTOL, V42, P463, DOI 10.1016/j.exger.2007.03.003; Chen HC, 2002, DIABETES, V51, P3189, DOI 10.2337/diabetes.51.11.3189; Coort SLM, 2005, J LIPID RES, V46, P1295, DOI 10.1194/jlr.M400426-JLR200; DeNino WF, 2001, DIABETES CARE, V24, P925, DOI 10.2337/diacare.24.5.925; Festuccia WT, 2006, DIABETOLOGIA, V49, P2427, DOI 10.1007/s00125-006-0336-y; Festuccia WT, 2009, J LIPID RES, V50, P1185, DOI 10.1194/jlr.M800620-JLR200; Goodpaster BH, 2003, DIABETES CARE, V26, P372, DOI 10.2337/diacare.26.2.372; Goodpaster BH, 2005, ARCH INTERN MED, V165, P777, DOI 10.1001/archinte.165.7.777; Guo SS, 1999, AM J CLIN NUTR, V70, P405; Harris RBS, 1998, ENDOCRINOLOGY, V139, P8, DOI 10.1210/en.139.1.8; Herrero-Gonzalez S, 2009, GLIA, V57, P222, DOI 10.1002/glia.20748; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Hughes VA, 2004, AM J CLIN NUTR, V80, P475, DOI 10.1093/ajcn/80.2.475; Kalderon B, 2003, AM J PHYSIOL-ENDOC M, V284, pE795, DOI 10.1152/ajpendo.00368.2002; Kanety H, 1996, J BIOL CHEM, V271, P9895, DOI 10.1074/jbc.271.17.9895; Lam TKT, 2003, AM J PHYSIOL-ENDOC M, V284, pE863, DOI 10.1152/ajpendo.00033.2003; Laplante M, 2003, DIABETES, V52, P291, DOI 10.2337/diabetes.52.2.291; Laplante M, 2006, DIABETES, V55, P2771, DOI 10.2337/db06-0551; Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516; Lyon CJ, 2003, ENDOCRINOLOGY, V144, P2195, DOI 10.1210/en.2003-0285; Miyazaki Y, 2002, J CLIN ENDOCR METAB, V87, P2784, DOI 10.1210/jc.87.6.2784; Oakes ND, 2001, DIABETES, V50, P1158, DOI 10.2337/diabetes.50.5.1158; Ravaglia G, 1999, J GERONTOL A-BIOL, V54, pM70, DOI 10.1093/gerona/54.2.M70; Reue K, 2008, FEBS LETT, V582, P90, DOI 10.1016/j.febslet.2007.11.014; Shima K, 1999, OBESITY NIDDM LESSON, P4; Smith SR, 2005, METABOLISM, V54, P24, DOI 10.1016/j.metabol.2004.07.008; Tordjman J, 2003, J BIOL CHEM, V278, P18785, DOI 10.1074/jbc.M206999200; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zamboni M, 1997, AM J CLIN NUTR, V66, P111, DOI 10.1093/ajcn/66.1.111; Zou ZG, 2001, NATURE, V414, P625, DOI 10.1038/414625a	35	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148141	10.1371/journal.pone.0148141	http://dx.doi.org/10.1371/journal.pone.0148141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894429	Green Published, gold, Green Submitted			2022-12-27	WOS:000371223400010
J	Peng, YG; Li, W; Wang, Y; Chen, H; Bo, J; Wang, XY; Liu, LS				Peng, Yaguang; Li, Wei; Wang, Yang; Chen, Hui; Bo, Jian; Wang, Xingyu; Liu, Lisheng			Validation and Assessment of Three Methods to Estimate 24-h Urinary Sodium Excretion from Spot Urine Samples in Chinese Adults	PLOS ONE			English	Article							BLOOD-PRESSURE; POTASSIUM EXCRETION; SALT INTAKE; STATISTICAL-METHODS; DIETARY-SODIUM; REDUCTION; CREATININE; TRIALS	24-h urinary sodium excretion is the gold standard for evaluating dietary sodium intake, but it is often not feasible in large epidemiological studies due to high participant burden and cost. Three methods-Kawasaki, INTERSALT, and Tanaka-have been proposed to estimate 24-h urinary sodium excretion from a spot urine sample, but these methods have not been validated in the general Chinese population. This aim of this study was to assess the validity of three methods for estimating 24-h urinary sodium excretion using spot urine samples against measured 24-h urinary sodium excretion in a Chinese sample population. Data are from a substudy of the Prospective Urban Rural Epidemiology (PURE) study that enrolled 120 participants aged 35 to 70 years and collected their morning fasting urine and 24-h urine specimens. Bias calculations (estimated values minus measured values) and Bland-Altman plots were used to assess the validity of the three estimation methods. 116 participants were included in the final analysis. Mean bias for the Kawasaki method was -740 mg/day (95% CI: -1219, 262 mg/day), and was the lowest among the three methods. Mean bias for the Tanaka method was -2305 mg/day (95% CI: -2735, 1875 mg/day). Mean bias for the INTERSALT method was -2797 mg/day (95% CI: -3245, 2349 mg/day), and was the highest of the three methods. Bland-Altman plots indicated that all three methods underestimated 24-h urinary sodium excretion. The Kawasaki, INTERSALT and Tanaka methods for estimation of 24-h urinary sodium excretion using spot urines all underestimated true 24-h urinary sodium excretion in this sample of Chinese adults. Among the three methods, the Kawasaki method was least biased, but was still relatively inaccurate. A more accurate method is needed to estimate the 24-h urinary sodium excretion from spot urine for assessment of dietary sodium intake in China.	[Peng, Yaguang; Li, Wei; Wang, Yang; Chen, Hui; Bo, Jian; Liu, Lisheng] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Peng, Yaguang; Li, Wei; Wang, Yang; Chen, Hui; Bo, Jian; Liu, Lisheng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Xingyu] Beijing Hypertens League Inst, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Hypertension League	Li, W (corresponding author), Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China.; Li, W (corresponding author), Peking Union Med Coll, Beijing 100021, Peoples R China.	liwei@mrbc-nccd.com		Peng, Yaguang/0000-0002-7987-6464	Canadian Institutes of Health Research; Heart and Stroke Foundation of Ontario; National Center for Cardiovascular Diseases in China	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); National Center for Cardiovascular Diseases in China	The PURE-China study was funded by the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Ontario, and National Center for Cardiovascular Diseases in China.	Anderson CAM, 2010, J AM DIET ASSOC, V110, P736, DOI 10.1016/j.jada.2010.02.007; [Anonymous], 1988, BMJ, V297, P319; ARROYAVE G, 1961, AM J CLIN NUTR, V9, P170, DOI 10.1093/ajcn/9.2.170; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brown IJ, 2013, AM J EPIDEMIOL, V177, P1180, DOI 10.1093/aje/kwt066; Cogswell ME, 2013, AM J CLIN NUTR, V98, P1502, DOI 10.3945/ajcn.113.059436; Conlin PR, 2007, CIRCULATION, V116, P1530, DOI 10.1161/CIRCULATIONAHA.107.729574; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; Corsi DJ, 2013, AM HEART J, V166, P636, DOI 10.1016/j.ahj.2013.04.019; Cutler JA, 1997, AM J CLIN NUTR, V65, P643, DOI 10.1093/ajcn/65.2.643S; Dyer AR, 1998, J HUM HYPERTENS, V12, P363, DOI 10.1038/sj.jhh.1000601; Eckel RH, 2014, J AM COLL CARDIOL, V63, P2960, DOI 10.1016/j.jacc.2013.11.003; Elliott P, 2006, ARCH INTERN MED, V166, P79, DOI 10.1001/archinte.166.1.79; Elliott P, 2007, CIRCULATION, V116, P1563, DOI 10.1161/CIRCULATIONAHA.106.675579; He FJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004937.pub2; He JA, 2000, HYPERTENSION, V35, P544, DOI 10.1161/01.HYP.35.2.544; Ji C, 2014, NUTR METAB CARDIOVAS, V24, P140, DOI 10.1016/j.numecd.2013.06.011; Kawasaki T, 1991, Nihon Koshu Eisei Zasshi, V38, P567; KAWASAKI T, 1993, CLIN EXP PHARMACOL P, V20, P7, DOI 10.1111/j.1440-1681.1993.tb01496.x; LAW MR, 1991, BMJ-BRIT MED J, V302, P819, DOI 10.1136/bmj.302.6780.819; Leiba A, 2005, NUTRITION, V21, P462, DOI 10.1016/j.nut.2004.08.021; Lerchl K, 2015, HYPERTENSION, V66, P850, DOI 10.1161/HYPERTENSIONAHA.115.05851; Li Li-ming, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P478; LIU K, 1978, J CHRON DIS, V31, P399, DOI 10.1016/0021-9681(78)90004-8; Mancia G, 2014, BLOOD PRESSURE, V23, P3, DOI 10.3109/08037051.2014.868629; Mente A, 2014, J HYPERTENS, V32, P1005, DOI 10.1097/HJH.0000000000000122; POLLACK H, 1970, AM J CLIN NUTR, V23, P865; Rakova N, 2013, CELL METAB, V17, P125, DOI 10.1016/j.cmet.2012.11.013; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Tanaka T, 2002, J HUM HYPERTENS, V16, P97, DOI 10.1038/sj.jhh.1001307; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; WATSON RL, 1970, AM J CLIN NUTR, V23, P290; World Health Organization, 2007, PREV CARD DIS GUID A; Zhai Feng-ying, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P485	35	64	68	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149655	10.1371/journal.pone.0149655	http://dx.doi.org/10.1371/journal.pone.0149655			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895296	gold, Green Published, Green Submitted			2022-12-27	WOS:000371223400072
J	Wang, TT; Li, WH; Wu, XR; Yin, B; Chu, CT; Ding, M; Cui, YF				Wang, Tingting; Li, Wenhua; Wu, Xiangru; Yin, Bing; Chu, Caiting; Ding, Ming; Cui, Yanfen			Tubo-Ovarian Abscess (with/without Pseudotumor Area) Mimicking Ovarian Malignancy: Role of Diffusion-Weighted MR Imaging with Apparent Diffusion Coefficient Values	PLOS ONE			English	Article							PELVIC-INFLAMMATORY-DISEASE; EPITHELIAL TUMORS; BENIGN	Objective To assess the added value of diffusion-weighted magnetic resonance imaging (DWI) with apparent diffusion coefficient (ADC) values compared to MRI, for characterizing the tuboovarian abscesses (TOA) mimicking ovarian malignancy. Materials and Methods Patients with TOA (or ovarian abscess alone; n = 34) or ovarian malignancy (n = 35) who underwent DWI and MRI were retrospectively reviewed. The signal intensity of cystic and solid component of TOAs and ovarian malignant tumors on DWI and the corresponding ADC values were evaluated, as well as clinical characteristics, morphological features, MRI findings were comparatively analyzed. Receiver operating characteristic (ROC) curve analysis based on logistic regression was applied to identify different imaging characteristics between the two patient groups and assess the predictive value of combination diagnosis with area under the curve (AUC) analysis. Results The mean ADC value of the cystic component in TOA was significantly lower than in malignant tumors (1.04 +/- 0.41 x 10(-3) mm(2)/s vs. 2.42 +/- 0.38 x 10(-3) mm(2)/s; p < 0.001). The mean ADC value of the enhanced solid component in 26 TOAs was 1.43 +/- 0.16x10(-3) mm(2)/s, and 46.2% (12 TOAs; pseudotumor areas) showed significantly higher signal intensity on DW-MRI than in ovarian malignancy (mean ADC value 1.44 +/- 0.20x10(-3) mm(2)/s vs. 1.18 +/- 0.36 x 10(-3) mm(2)/s; p = 0.043). The combination diagnosis of ADC value and dilated tubal structure achieved the best AUC of 0.996. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of MRI vs. DWI with ADC values for predicting TOA were 47.1%, 91.4%, 84.2%, 64%, and 69.6% vs. 100%, 97.1%, 97.1%, 100%, and 98.6%, respectively. Conclusions DW-MRI is superior to MRI in the assessment of TOA mimicking ovarian malignancy, and the ADC values aid in discriminating the pseudotumor area of TOA from the solid portion of ovarian malignancy.	[Wang, Tingting; Li, Wenhua; Yin, Bing; Chu, Caiting; Ding, Ming; Cui, Yanfen] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Radiol, 1665 Kong Jiang Rd, Shanghai 200092, Peoples R China; [Wu, Xiangru] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Pathol, 1665 Kong Jiang Rd, Shanghai 200092, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Li, WH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Radiol, 1665 Kong Jiang Rd, Shanghai 200092, Peoples R China.	wenhualimd@126.com	wang, tingting/AAK-2640-2020		 [15ZR1427500]		This work was supported by grant number: 15ZR1427500, URL: http://www.stcsm.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chou CP, 2012, CLIN IMAG, V36, P532, DOI 10.1016/j.clinimag.2011.11.018; Goto Y, 2015, INT J SURG CASE REP, V10, P59, DOI 10.1016/j.ijscr.2015.03.012; Harish S, 2011, SKELETAL RADIOL, V40, P285, DOI 10.1007/s00256-010-0986-1; Holzapfel K, 2007, ABDOM IMAGING, V32, P538, DOI 10.1007/s00261-007-9231-3; Kim MY, 2009, RADIOGRAPHICS, V29, P495, DOI 10.1148/rg.292085070; Koc Z, 2012, J MAGN RESON IMAGING, V35, P650, DOI 10.1002/jmri.22871; Lareau SM, 2008, INFECT DIS CLIN N AM, V22, P693, DOI 10.1016/j.idc.2008.05.008; Lee SW, 2015, GYNECOL OBSTET INVES; Li WH, 2013, ABDOM IMAGING, V38, P193, DOI 10.1007/s00261-012-9896-0; Li WH, 2012, ABDOM IMAGING, V37, P897, DOI 10.1007/s00261-011-9814-x; Luthra G, 2007, AM J NEURORADIOL, V28, P1332, DOI 10.3174/ajnr.A0548; Neubauer H, 2012, WORLD J PEDIATR, V8, P229, DOI 10.1007/s12519-012-0362-4; Orton MR, 2015, EUR RADIOL, V8; Rakheja R, 2011, NUCL MED MOLEC IMAG, V45, P223, DOI 10.1007/s13139-011-0089-5; Sepahdari Ali R, 2009, AJR Am J Roentgenol, V193, pW244, DOI 10.2214/AJR.08.1838; Sordia-Hernandez LH, 2015, INT J GYNECOLOGY OBS; Thoeny HC, 2012, RADIOLOGY, V263, P326, DOI 10.1148/radiol.12110446; Thomassin-Naggara I, 2009, EUR RADIOL, V19, P1544, DOI 10.1007/s00330-009-1299-4; Nguyen TLF, 2013, J COMPUT ASSIST TOMO, V37, P971, DOI 10.1097/RCT.0b013e31828bea16; Tukeva TA, 1999, RADIOLOGY, V210, P209, DOI 10.1148/radiology.210.1.r99ja04209; Ueda Hiroyuki, 2002, Magn Reson Med Sci, V1, P207; Umemoto M, 2006, J OBSTET GYNAECOL RE, V32, P195, DOI 10.1111/j.1447-0756.2006.00381.x; Unal O, 2011, EUR J RADIOL, V77, P490, DOI 10.1016/j.ejrad.2009.08.025; Velcani A, 2010, J RADIOL CASE REP, V4, P9, DOI 10.3941/jrcr.v4i2.133; Zhang Y, 2012, J OBSTET GYNAECOL, V32, P199, DOI 10.3109/01443615.2011.621560; Zhao SH, 2014, EUR RADIOL, V24, P2292, DOI 10.1007/s00330-014-3236-4	26	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149318	10.1371/journal.pone.0149318	http://dx.doi.org/10.1371/journal.pone.0149318			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894926	Green Published, gold, Green Submitted			2022-12-27	WOS:000371223400047
J	Koh, SJ; Choi, Y; Kim, BG; Lee, KL; Kim, DW; Kim, JH; Kim, JW; Kim, JS				Koh, Seong-Joon; Choi, Younjeong; Kim, Byeong Gwan; Lee, Kook Lae; Kim, Dae Woo; Kim, Jung Ho; Kim, Ji Won; Kim, Joo Sung			Matricellular Protein Periostin Mediates Intestinal Inflammation through the Activation of Nuclear Factor kappa B Signaling	PLOS ONE			English	Article							SONGPA-KANGDONG DISTRICT; BOWEL-DISEASE; DOSE INTENSIFICATION; MAINTENANCE THERAPY; ULCERATIVE-COLITIS; EPITHELIAL-CELLS; CROHNS-DISEASE; INFLIXIMAB; BURDEN; HEALTH	Periostin is a matricellular protein that interacts with various integrin molecules on the cell surface. Although periostin is expressed in inflamed colonic mucosa, its role in the regulation of intestinal inflammation remains unclear. We investigated the role of periostin in intestinal inflammation using Postn-deficient (Postn(-/-)) mice. Intestinal epithelial cells (IECs) were transfected by Postn small interfering RNAs. Periostin expression was determined in colon tissue samples from ulcerative colitis (UC) patients. Oral administration of dextran sulfate sodium (DSS) or rectal administration of trinitrobenzene sulfonic acid, induced severe colitis in wildtype mice, but not in Postn(-/-) mice. Administration of recombinant periostin induced colitis in Postn(-/-) mice. The periostin neutralizing-antibody ameliorated the severity of colitis in DSS-treated wild-type mice. Silencing of Postn inhibited inteleukin (IL)-8 mRNA expression and NF-kappa B DNA-binding activity in IECs. Tumor necrosis factor (TNF)-alpha upregulated mRNA expression of Postn in IECs, and recombinant periostin strongly enhanced IL-8 expression in combination with TNF-alpha, which was suppressed by an antibody against integrin a(v) (CD51). Periostin and CD51 were expressed at significantly higher levels in UC patients than in controls. Periostin mediates intestinal inflammation through the activation of NF-kappa B signaling, which suggests that periostin is a potential therapeutic target for inflammatory bowel disease.	[Koh, Seong-Joon; Choi, Younjeong; Kim, Byeong Gwan; Lee, Kook Lae; Kim, Ji Won] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Gastroenterol,Boramae Hosp, Seoul 151, South Korea; [Kim, Dae Woo] Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Boramae Hosp, Seoul, South Korea; [Kim, Jung Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Boramae Hosp, Seoul 151, South Korea; [Kim, Joo Sung] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kim, Joo Sung] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kim, JW (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Div Gastroenterol,Boramae Hosp, Seoul 151, South Korea.; Kim, JS (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.; Kim, JS (corresponding author), Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea.	kjwjor@snu.ac.kr; jooskim@snu.ac.kr		Kim, Jung Ho/0000-0002-6031-3629	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2014R1A1A2057695]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education [grant number NRF-2014R1A1A2057695 (S-JK)].	Adams DH, 2006, NAT REV IMMUNOL, V6, P244, DOI 10.1038/nri1784; Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Benchimol EI, 2014, GASTROENTEROLOGY, V147, P803, DOI 10.1053/j.gastro.2014.06.023; Bentley JK, 2014, J ALLERGY CLIN IMMUN, V134, P1433, DOI 10.1016/j.jaci.2014.05.029; Bernstein CN, 2015, AM J GASTROENTEROL, V110, P114, DOI 10.1038/ajg.2014.357; Billioud V, 2011, AM J GASTROENTEROL, V106, P674, DOI 10.1038/ajg.2011.60; Blumberg RS, 2008, MUCOSAL IMMUNOL, V1, P330, DOI 10.1038/mi.2008.29; Burisch J, 2013, J CROHNS COLITIS, V7, P322, DOI 10.1016/j.crohns.2013.01.010; Cheon JH, 2006, INFLAMM BOWEL DIS, V12, P1152, DOI 10.1097/01.mib.0000235830.94057.c6; Danese S, 2012, GUT, V61, P918, DOI 10.1136/gutjnl-2011-300904; Di Sabatino A, 2008, GUT, V57, P605, DOI 10.1136/gut.2007.130922; Elliott CG, 2012, J CELL SCI, V125, P121, DOI 10.1242/jcs.087841; Gisbert JP, 2009, AM J GASTROENTEROL, V104, P760, DOI 10.1038/ajg.2008.88; Hamilton DW, 2008, J CELL COMMUN SIGNAL, V2, P9, DOI 10.1007/s12079-008-0023-5; Huang Y, 2014, AM J PATHOL, V3, P786; Jobin C, 2000, AM J PHYSIOL-CELL PH, V278, pC451, DOI 10.1152/ajpcell.2000.278.3.C451; Kikuchi Y, 2008, J HISTOCHEM CYTOCHEM, V56, P753, DOI 10.1369/jhc.2008.951061; Koh SJ, 2014, J GASTROEN HEPATOL, V29, P502, DOI 10.1111/jgh.12435; Koh SJ, 2011, AM J PHYSIOL-GASTR L, V301, pG9, DOI 10.1152/ajpgi.00267.2010; Kudo A, 2011, CELL MOL LIFE SCI, V68, P3201, DOI 10.1007/s00018-011-0784-5; Lacy-Hulbert A, 2007, P NATL ACAD SCI USA, V104, P15823, DOI 10.1073/pnas.0707421104; Lee SH, 2015, INTEST RES, V13, P11, DOI 10.5217/ir.2015.13.1.11; Leiman DA, 2014, CURR OPIN GASTROEN, V30, P385, DOI 10.1097/MOG.0000000000000077; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lohr K, 2012, INFLAMM BOWEL DIS, V18, P143, DOI 10.1002/ibd.21713; Lu Y, 2014, J CLIN INVEST, V124, P3501, DOI 10.1172/JCI74438; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Masuoka M, 2012, J CLIN INVEST, V122, P2590, DOI 10.1172/JCI58978; Merle B, 2012, OSTEOPOROSIS INT, V23, P1199, DOI 10.1007/s00198-011-1892-7; Peyrin-Biroulet L, 2011, ALIMENT PHARM THER, V33, P870, DOI 10.1111/j.1365-2036.2011.04599.x; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Ruan K, 2009, CELL MOL LIFE SCI, V66, P2219, DOI 10.1007/s00018-009-0013-7; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Sands BE, 2004, NEW ENGL J MED, V350, P876, DOI 10.1056/NEJMoa030815; Snider P, 2008, CIRC RES, V102, P752, DOI 10.1161/CIRCRESAHA.107.159517; Travis MA, 2007, NATURE, V449, P361, DOI 10.1038/nature06110; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Yang SK, 2000, J GASTROEN HEPATOL, V15, P1037, DOI 10.1046/j.1440-1746.2000.02252.x; Yang SK, 2008, INFLAMM BOWEL DIS, V14, P542, DOI 10.1002/ibd.20310	42	30	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149652	10.1371/journal.pone.0149652	http://dx.doi.org/10.1371/journal.pone.0149652			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890265	gold, Green Published, Green Submitted			2022-12-27	WOS:000371221500068
J	Radford, CA; Ghazali, SM; Montgomery, JC; Jeffs, AG				Radford, Craig A.; Ghazali, Shahriman M.; Montgomery, John C.; Jeffs, Andrew G.			Vocalisation Repertoire of Female Bluefin Gurnard (Chelidonichthys kumu) in Captivity: Sound Structure, Context and Vocal Activity	PLOS ONE			English	Article							TOADFISH HALOBATRACHUS-DIDACTYLUS; ACOUSTIC COMMUNICATION; LUSITANIAN TOADFISH; POLLIMYRUS-ISIDORI; BIOLOGICAL ORIGIN; CYNOSCION-REGALIS; SPAWNING SOUNDS; HAURAKI GULF; GREY GURNARD; NEW-ZEALAND	Fish vocalisation is often a major component of underwater soundscapes. Therefore, interpretation of these soundscapes requires an understanding of the vocalisation characteristics of common soniferous fish species. This study of captive female bluefin gurnard, Chelidonichthys kumu, aims to formally characterise their vocalisation sounds and daily pattern of sound production. Four types of sound were produced and characterised, twice as many as previously reported in this species. These sounds fit two aural categories; grunt and growl, the mean peak frequencies for which ranged between 129 to 215 Hz. This species vocalized throughout the 24 hour period at an average rate of (18.5 +/- 2.0 sounds fish(-1) h(-1)) with an increase in vocalization rate at dawn and dusk. Competitive feeding did not elevate vocalisation as has been found in other gurnard species. Bluefin gurnard are common in coastal waters of New Zealand, Australia and Japan and, given their vocalization rate, are likely to be significant contributors to ambient underwater soundscape in these areas.	[Radford, Craig A.; Ghazali, Shahriman M.; Montgomery, John C.; Jeffs, Andrew G.] Univ Auckland, Leigh Marine Lab, POB 349, Warkworth 0941, New Zealand; [Ghazali, Shahriman M.] Univ Kebangsaan Malaysia, Fac Sci & Technol, Marine Ecosyst Res Ctr EKOMAR, Bangii, Malaysia; [Ghazali, Shahriman M.] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Environm Sci & Nat Resources, Bangii, Malaysia	University of Auckland; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Radford, CA (corresponding author), Univ Auckland, Leigh Marine Lab, POB 349, Warkworth 0941, New Zealand.	c.radford@auckland.ac.nz	Jeffs, Andrew G/D-9474-2012; Montgomery, John C/D-4310-2009	Montgomery, John C/0000-0002-7451-3541; Radford, Craig/0000-0001-7949-9497; Jeffs, Andrew/0000-0002-8504-1949	Glenn Family Foundation; Government of Malaysia; Rutherford Discovery Fellowship; UKM	Glenn Family Foundation; Government of Malaysia; Rutherford Discovery Fellowship; UKM	This work was supported by Glenn Family Foundation to AGJ, Government of Malaysia and UKM to SG, and Rutherford Discovery Fellowship to CAR.; The authors are thankful to staff and students at the University of Auckland's Leigh Marine Laboratory for technical assistance, and funding support from the Glenn Family Foundation. The study was made possible by a PhD scholarship to SMG by the Government of Malaysia and UKM. The study was conducted under University of Auckland Animal Ethics Committee approval #AEC727.	Akamatsu T, 2002, J ACOUST SOC AM, V112, P3073, DOI 10.1121/1.1515799; Amorim MCP, 2008, J MAR BIOL ASSOC UK, V88, P1069, DOI 10.1017/S0025315408001677; Amorim MCP, 2008, J FISH BIOL, V73, P1267, DOI 10.1111/j.1095-8649.2008.01974.x; Amorim MCP, 2006, J FISH BIOL, V69, P1892, DOI 10.1111/j.1095-8649.2006.01247.x; Amorim M. Clara P., 2005, Acta Zoologica Sinica, V51, P1013; Amorim MCP, 2015, ANIM SIG COMM, V4, P1, DOI 10.1007/978-3-7091-1846-7_1; Amorim Maria Clara P., 2006, P71; Amorim MCP, 2000, J FISH BIOL, V57, P895, DOI 10.1006/jfbi.2000.1356; Amorim MCP, 2005, ETHOLOGY, V111, P255, DOI 10.1111/j.1439-0310.2004.01061.x; Amorim MCP, 2004, J FISH BIOL, V65, P182, DOI 10.1111/j.0022-1112.2004.00443.x; Bass AH, 2003, PROG NEUROBIOL, V69, P1, DOI 10.1016/S0301-0082(03)00004-2; BAYOUMI A R, 1970, Marine Biology (Berlin), V5, P77, DOI 10.1007/BF00352495; CATO DH, 1980, J ACOUST SOC AM, V68, P1056, DOI 10.1121/1.384989; CLEARWATER SJ, 1994, AUST J MAR FRESH RES, V45, P131; CONNAUGHTON MA, 1995, ENVIRON BIOL FISH, V42, P233, DOI 10.1007/BF00004916; Connaughton MA, 2004, J EXP BIOL, V207, P1643, DOI 10.1242/jeb.00928; CRAWFORD JD, 1986, J COMP PHYSIOL A, V159, P297, DOI 10.1007/BF00603976; Crawford JD, 1997, BEHAVIOUR, V134, P677, DOI 10.1163/156853997X00034; Crawford JD, 1997, MAR FRESHW BEHAV PHY, V29, P65, DOI 10.1080/10236249709379001; Fay R, 2009, INTEGR ZOOL, V4, P26, DOI 10.1111/j.1749-4877.2008.00132.x; Fine ML, 2015, ANIM SIG COMM, V4, P77, DOI 10.1007/978-3-7091-1846-7_3; Hawkins AD, 2000, ENVIRON BIOL FISH, V59, P29, DOI 10.1023/A:1007615517287; Heemstra P.C., 1986, P486; Kaatz Ingrid M., 2002, Bioacoustics, V12, P230; Kasumyan A.O., 2009, J ICHTHYOL, V49, P963, DOI [10.1134/S0032945209110010, DOI 10.1134/S0032945209110010]; Kasumyan A.O., 2008, J ICHTHYOL, V48, P981, DOI [10.1134/S0032945208110039, DOI 10.1134/S0032945208110039]; Kendrick TH, 2002, NEW ZEAL J MAR FRESH, V36, P699, DOI 10.1080/00288330.2002.9517124; Kendrick TH, 2004, 200421 NZ FISH TROPH, P1; Ladich F, 2006, FISH COMMUNICATION, P121; Ladich Friedrich, 2006, P3; Locascio JV, 2008, T AM FISH SOC, V137, P606, DOI 10.1577/T06-069.1; Luczkovich JJ, 2008, T AM FISH SOC, V137, P533, DOI 10.1577/T06-258.1; Maruska KP, 2009, ENVIRON BIOL FISH, V84, P325, DOI 10.1007/s10641-009-9446-y; MOK HK, 1983, B I ZOOL ACAD SINICA, V22, P157; MOULTON JM, 1956, BIOL BULL, V111, P393, DOI 10.2307/1539146; Nordeide JT, 1999, ICES J MAR SCI, V56, P326, DOI 10.1006/jmsc.1999.0473; Olivier D, 2014, FRONTIERS ZOOLOGY, V11, P1; Parmentier E, 2013, J EXP BIOL, V216, P3189, DOI 10.1242/jeb.087205; Radford CA, 2010, MAR ECOL PROG SER, V401, P21, DOI 10.3354/meps08451; Radford CA, 2008, OECOLOGIA, V156, P921, DOI 10.1007/s00442-008-1041-y; Rice AN, 2009, J EXP BIOL, V212, P1377, DOI 10.1242/jeb.028506; Sebastianutto L, 2008, ACTA ETHOL, V11, P115, DOI 10.1007/s10211-008-0048-z; Simoes JM, 2008, J ACOUST SOC AM, V124, P1332, DOI 10.1121/1.2945712; Sirovic A, 2009, ICES J MAR SCI, V66, P981, DOI 10.1093/icesjms/fsp064; Sprague MW, 2001, COPEIA, P854, DOI 10.1643/0045-8511(2001)001[0854:DSCEOM]2.0.CO;2; Thorson RF, 2002, ENVIRON BIOL FISH, V63, P321, DOI 10.1023/A:1014334425821; Ueng JP, 2007, ZOOL STUD, V46, P103	47	5	5	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149338	10.1371/journal.pone.0149338	http://dx.doi.org/10.1371/journal.pone.0149338			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890124	Green Published, gold, Green Submitted			2022-12-27	WOS:000371221500037
J	Zhou, Z; Li, XD; Li, H; Guo, MZ; Liu, SG; Li, CG				Zhou, Zheng; Li, Xinde; Li, Hua; Guo, Mingzhen; Liu, Shiguo; Li, Changgui			Genetic Analysis of IL-17 Gene Polymorphisms in Gout in a Male Chinese Han Population	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; INTERLEUKIN-17; ASSOCIATION; TH17; SUSCEPTIBILITY; DISEASE; ASTHMA; SPUTUM; CELLS	Interleukin (IL)-17 is a proinflammatory cytokine mainly secreted by activated T helper 17 cells and involved in inflammatory immune responses. This study aimed to investigate the association between IL-17 variants as well as serum IL-17 levels with gout in male Chinese Han individuals. A total of 1,101 male gout patients and 1,239 ethic-matched controls were enrolled. Genetic distributions of three variants (rs2275913 in IL-17A, rs763780 in IL-17F, and rs4819554 in IL-17RA) were detected by real-time polymerase chain reaction using the Taqman probe method. The plasma concentrations of IL-17A and IL-17F were measured in 228 gout patients and 198 controls that came from above samples by an enzyme-linked immunosorbent assay. No significant differences were observed in the genetic distribution of these polymorphisms between cases and controls (rs2275913: chi(2) = 0.15, p = 0.928 by genotype, chi(2) = 0.14, p = 0.711 by allele; rs763780:. 2 = 2.24, p = 0.326 by genotype,. 2 = 0.26, p = 0.609 by allele; rs4819554:. 2 = 1.79, p = 0.409 by genotype, chi(2) = 1.46, p = 0.227 by allele). Levels of serum IL-17A and IL-17F were significantly decreased in gout patients (both p<0.001). However, no difference was observed in acute gout patients between different genotypic carriers of rs2275913 and rs763780 regarding serum IL-17A and IL-17F levels (p>0.05). Although the genetic variants in IL-17 we studied in this research do not appear to be involved in the development of gout in male Chinese Han individuals, the IL-17 cytokine family may participate in gouty inflammation in an undefined way, which requires further validation.	[Zhou, Zheng; Li, Xinde; Li, Changgui] Qingdao Univ, Affiliated Hosp, Shandong Prov Key Lab Metab Dis, Qingdao 266071, Peoples R China; [Li, Hua] Qingdao Univ, Affiliated Hosp, Dept Rheumatol, Qingdao 266071, Peoples R China; [Guo, Mingzhen; Liu, Shiguo] Qingdao Univ, Affiliated Hosp, Prenatal Diag Ctr, Qingdao 266071, Peoples R China	Qingdao University; Qingdao University; Qingdao University	Liu, SG (corresponding author), Qingdao Univ, Affiliated Hosp, Prenatal Diag Ctr, Qingdao 266071, Peoples R China.	lichanggui@medmail.com.cn			National Science Foundation of China [31371272]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China (31371272), and the funder played no role in the research.	Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Gaffen SL, 2008, CYTOKINE, V43, P402, DOI 10.1016/j.cyto.2008.07.017; Hayashi R, 2013, CLIN EXP MED, V13, P239, DOI 10.1007/s10238-012-0206-5; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; Kageyama Y, 2007, RHEUMATOL INT, V28, P137, DOI 10.1007/s00296-007-0388-4; Kawaguchi M, 2006, J ALLERGY CLIN IMMUN, V117, P795, DOI 10.1016/j.jaci.2005.12.1346; Kingsbury SR, 2011, J INFLAMM RES, V4, P39, DOI 10.2147/JIR.S11330; Landis R C, 2001, Curr Rheumatol Rep, V3, P36, DOI 10.1007/s11926-001-0049-7; Liu S, 2013, SCAND J RHEUMATOL, V42, P150, DOI 10.3109/03009742.2012.726372; Liu SG, 2015, MOD RHEUMATOL, V25, P449, DOI 10.3109/14397595.2014.964823; Malawista SE, 2011, FASEB J, V25, P4073, DOI 10.1096/fj.11-1201ufm; Miao ZM, 2008, J RHEUMATOL, V35, P1859; Mills KHG, 2013, J LEUKOCYTE BIOL, V93, P489, DOI 10.1189/jlb.1012543; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; Mylona EE, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3898; Najafi S, 2014, J ASSIST REPROD GEN, V31, P1491, DOI 10.1007/s10815-014-0294-0; Nordang GBN, 2009, RHEUMATOLOGY, V48, P367, DOI 10.1093/rheumatology/ken512; Popa-Nita O, 2010, IMMUNOL CELL BIOL, V88, P32, DOI 10.1038/icb.2009.98; Shen L, 2015, GENE, V566, P18, DOI 10.1016/j.gene.2015.04.028; Shu QM, 2010, HUM IMMUNOL, V71, P988, DOI 10.1016/j.humimm.2010.06.020; Sun YC, 2005, CHINESE MED J-PEKING, V118, P953; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Vanltallie TB, 2010, METABOLISM, V59, pS32, DOI 10.1016/j.metabol.2010.07.009; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; Wang SX, 2014, J NEUROL SCI, V342, P133, DOI 10.1016/j.jns.2014.05.004; Zhang W, 2006, ANN RHEUM DIS, V65, P1301, DOI 10.1136/ard.2006.055251; Zhang Y, 2015, APMIS, V123, P659, DOI 10.1111/apm.12399; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520	30	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0148082	10.1371/journal.pone.0148082	http://dx.doi.org/10.1371/journal.pone.0148082			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890073	gold, Green Published, Green Submitted			2022-12-27	WOS:000371221500007
J	Altemimi, A; Watson, DG; Choudhary, R; Dasari, MR; Lightfoot, DA				Altemimi, Ammar; Watson, Dennis G.; Choudhary, Ruplal; Dasari, Mallika R.; Lightfoot, David A.			Ultrasound Assisted Extraction of Phenolic Compounds from Peaches and Pumpkins	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; OPTIMIZATION; L.; FLAVONOIDS; POLYSACCHARIDES; CAROTENOIDS; CAPACITIES; CULTIVARS	The ultrasound-assisted extraction (UAE) method was used to optimize the extraction of phenolic compounds from pumpkins and peaches. The response surface methodology (RSM) was used to study the effects of three independent variables each with three treatments. They included extraction temperatures (30, 40 and 50 degrees C), ultrasonic power levels (30, 50 and 70%) and extraction times (10, 20 and 30min). The optimal conditions for extractions of total phenolics from pumpkins were inferred to be a temperature of 41.45 degrees C, a power of 44.60% and a time of 25.67min. However, an extraction temperature of 40.99 degrees C, power of 56.01% and time of 25.71min was optimal for recovery of free radical scavenging activity (measured by 1, 1-diphenyl-2-picrylhydrazyl (DPPH) reduction). The optimal conditions for peach extracts were an extraction temperature of 41.53 degrees C, power of 43.99% and time of 27.86 min for total phenolics. However, an extraction temperature of 41.60 degrees C, power of 44.88% and time of 27.49 min was optimal for free radical scavenging activity (judged by from DPPH reduction). Further, the UAE processes were significantly better than solvent extractions without ultrasound. By electron microscopy it was concluded that ultrasonic processing caused damage in cells for all treated samples (pumpkin, peach). However, the FTIR spectra did not show any significant changes in chemical structures caused by either ultrasonic processing or solvent extraction.	[Altemimi, Ammar; Watson, Dennis G.; Choudhary, Ruplal; Lightfoot, David A.] So Illinois Univ, Dept Plant Soil & Agr Syst, Carbondale, IL 62901 USA; [Altemimi, Ammar] Univ Basrah, Coll Agr, Dept Food Sci & Biotechnol, Basrah, Basrah Province, Iraq; [Dasari, Mallika R.] So Illinois Univ, Dept Chem & Biochem, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University; University of Basrah; Southern Illinois University System; Southern Illinois University	Lightfoot, DA (corresponding author), So Illinois Univ, Dept Plant Soil & Agr Syst, Carbondale, IL 62901 USA.	ga4082@siu.edu	Altemimi, B./D-7342-2017	Altemimi, B./0000-0001-7750-5988; Lightfoot, David/0000-0002-5725-4381	Government of Iraq; Higher Committee for Education Development in Iraq (HCED)	Government of Iraq; Higher Committee for Education Development in Iraq (HCED)	This work was funded by Government of Iraq to AA.; The authors like to thank the Higher Committee for Education Development in Iraq (HCED) for the financial support to achieve this work. Also, the authors are thankful to Dr. Alan Walters for providing pumpkin and peach samples. We also are grateful to Dr. Rebecca Atkinson and Dr. John Haddock for providing some of the equipment and facilities used in this study. The OECD is thanked for a 2012 Visiting Fellow Award to DAL to visit CRAG at UAB, Catalunia, Spain.	Altemimi A, 2015, MOLECULES, V20, P6611, DOI 10.3390/molecules20046611; Altemimi A, 2015, CHEM CENT J, V9, DOI 10.1186/s13065-015-0113-4; Altemimi A, 2015, ULTRASON SONOCHEM, V24, P247, DOI 10.1016/j.ultsonch.2014.10.023; Atrooz Omar M, 2009, Pak J Biol Sci, V12, P1063, DOI 10.3923/pjbs.2009.1063.1068; Ben-Amotz A, 1998, FOOD CHEM, V62, P515, DOI 10.1016/S0308-8146(97)00196-9; Braca A, 2002, J ETHNOPHARMACOL, V79, P379, DOI 10.1016/S0378-8741(01)00413-5; CHANG SS, 1977, J FOOD SCI, V42, P1102, DOI 10.1111/j.1365-2621.1977.tb12676.x; Chemat F, 2011, ULTRASON SONOCHEM, V18, P813, DOI 10.1016/j.ultsonch.2010.11.023; Dong JN, 2010, ULTRASON SONOCHEM, V17, P61, DOI 10.1016/j.ultsonch.2009.05.006; El-Shemy HA, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/801501; Escribano-Bailon MT, 2002, METHODS IN POLYPHENOL ANALYSIS, P1; Firuzi O, 2011, CURR MED CHEM, V18, P3871, DOI 10.2174/092986711803414368; Ghasemzadeh A, 2015, MOLECULES, V20, P10822, DOI 10.3390/molecules200610822; Gil MI, 2002, J AGR FOOD CHEM, V50, P4976, DOI 10.1021/jf020136b; Hossain MB, 2012, ULTRASON SONOCHEM, V19, P582, DOI 10.1016/j.ultsonch.2011.11.001; Jerman T, 2010, FOOD CHEM, V123, P175, DOI 10.1016/j.foodchem.2010.04.006; Kikuchi T., 2011, Journal of Physics: Conference Series, V279, DOI 10.1088/1742-6596/279/1/012012; Kurz C, 2008, FOOD CHEM, V106, P421, DOI 10.1016/j.foodchem.2007.05.078; Liu BG, 2013, TROP J PHARM RES, V12, P1045, DOI 10.4314/tjpr.v12i6.27; Ma YQ, 2008, J AGR FOOD CHEM, V56, P5682, DOI 10.1021/jf072474o; Muniz-Marquez DB, 2013, ULTRASON SONOCHEM, V20, P1149, DOI 10.1016/j.ultsonch.2013.02.008; Murkovic M, 2002, J FOOD COMPOS ANAL, V15, P633, DOI 10.1006/jfca.2002.1052; Nassr-Allah AA, 2009, J MED PLANTS RES, V3, P799; Ozsoy N, 2008, FOOD CHEM, V110, P571, DOI 10.1016/j.foodchem.2008.02.037; Pan GY, 2012, ULTRASON SONOCHEM, V19, P486, DOI 10.1016/j.ultsonch.2011.11.006; Prasad KN, 2011, FOOD CHEM, V128, P1121, DOI 10.1016/j.foodchem.2011.03.105; Qu CL, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-160; Raso J, 1999, ULTRASON SONOCHEM, V5, P157, DOI 10.1016/S1350-4177(98)00042-X; Singleton VL., 1965, AM J ENOL VITICULT, V16, P144, DOI DOI 10.12691/IJEBB-2-1-5; Song W, 2010, J AGR FOOD CHEM, V58, P6621, DOI 10.1021/jf9035832; Toma M, 2001, ULTRASON SONOCHEM, V8, P137, DOI 10.1016/S1350-4177(00)00033-X; Versari A, 2002, FOOD CHEM, V76, P181, DOI 10.1016/S0308-8146(01)00261-8; Vilkhu K, 2008, INNOV FOOD SCI EMERG, V9, P161, DOI 10.1016/j.ifset.2007.04.014; Wu JY, 2001, ULTRASON SONOCHEM, V8, P347, DOI 10.1016/S1350-4177(01)00066-9; Xanthopoulou MN, 2009, FOOD RES INT, V42, P641, DOI 10.1016/j.foodres.2009.02.003; Yang ZD, 2010, INNOV FOOD SCI EMERG, V11, P470, DOI 10.1016/j.ifset.2010.03.003; Zahin M., 2009, INT J PHARM PHARM SC, V1, P88, DOI DOI 10.1371/J0URNAL.P0NE.0028499; Zhong K, 2010, INT J BIOL MACROMOL, V47, P356, DOI 10.1016/j.ijbiomac.2010.05.022	38	85	87	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148758	10.1371/journal.pone.0148758	http://dx.doi.org/10.1371/journal.pone.0148758			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885655	Green Published, Green Submitted, gold			2022-12-27	WOS:000371218400048
J	Pu, XK; Gao, G; Fan, YB; Wang, M				Pu, Xiangke; Gao, Ge; Fan, Yubo; Wang, Mian			Parameter Estimation in Stratified Cluster Sampling under Randomized Response Models for Sensitive Question Survey	PLOS ONE			English	Article								Randomized response is a research method to get accurate answers to sensitive questions in structured sample survey. Simple random sampling is widely used in surveys of sensitive questions but hard to apply on large targeted populations. On the other side, more sophisticated sampling regimes and corresponding formulas are seldom employed to sensitive question surveys. In this work, we developed a series of formulas for parameter estimation in cluster sampling and stratified cluster sampling under two kinds of randomized response models by using classic sampling theories and total probability formulas. The performances of the sampling methods and formulas in the survey of premarital sex and cheating on exams at Soochow University were also provided. The reliability of the survey methods and formulas for sensitive question survey was found to be high.	[Pu, Xiangke] Changzhou Third Peoples Hosp, Inst Hepatol, Changzhou 213001, Jiangsu, Peoples R China; [Gao, Ge; Fan, Yubo] Soochow Univ, Sch Publ Hlth, Coll Med, Suzhou 215123, Jiangsu, Peoples R China; [Wang, Mian] Cent S Univ, Sch Publ Hlth, Changsha 410078, Hunan, Peoples R China	Soochow University - China; Central South University	Gao, G (corresponding author), Soochow Univ, Sch Publ Hlth, Coll Med, Suzhou 215123, Jiangsu, Peoples R China.	gaoge@suda.edu.cn			National Natural Science Foundation of China [81273188]; Preventive Medicine Research Project of Jiangsu Province [Y2012072]; Applied Basic Research Program of Changzhou [CJ20112013]; Jiangsu Health International Exchange Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Preventive Medicine Research Project of Jiangsu Province; Applied Basic Research Program of Changzhou; Jiangsu Health International Exchange Program	This study was supported by the National Natural Science Foundation of China (No. 81273188, to Ge Gao), the Preventive Medicine Research Project of Jiangsu Province (Y2012072, to Xiangke Pu), and the Applied Basic Research Program of Changzhou (CJ20112013, to Xiangke Pu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Yongzhong Wang, Chunhua Chen, Shuangrong Hang, Hongyu Shen, and Chuanyin Shi, for their help and encouragement. We are grateful for the support of the Jiangsu Health International Exchange Program (2013). We also thank the referees and editors for their suggestions and help.	Cochran W. G, 1977, SAMPLING TECHNIQUES, V3rd, P280; Ding Y, 2008, HLTH STAT, P13; GREENBERG BG, 1969, J AM STAT ASSOC, V64, P520, DOI 10.2307/2283636; Guo X, 2005, PRACTICAL MED SURVEY, P39; Horvitz DG, 1967, P SOC STAT SECT AM S, P65; Lensvelt-Mulders GJLM, 2005, SOCIOL METHOD RES, V33, P319, DOI 10.1177/0049124104268664; Liu W, 2010, SUZHOU U J MED SCI, V30, P776; [刘雯 Liu Wen], 2010, [苏州大学学报. 医学版, Suzhou University Journal of Medical Science], V30, P759; Lv X, 2011, J INNER MONGOLIA AGR, V32, P313; Meng B, 2012, J BEIJING UNION U, V26, P10; Raghunath A, 2006, STAT PAP, V48, P131; Su L.J., 2007, ADV MATH STAT; Sun S, 2004, SAMPLING SURVEY, P177; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; Wang J, 2003, PRACTICAL MED RES ME, P420; Wang YY, 2006, T NONFERR METAL SOC, V16, P178, DOI 10.1016/S1003-6326(06)60032-0; WARNER SL, 1965, J AM STAT ASSOC, V60, P63, DOI 10.2307/2283137	17	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148267	10.1371/journal.pone.0148267	http://dx.doi.org/10.1371/journal.pone.0148267			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886857	Green Published, Green Submitted, gold			2022-12-27	WOS:000371218400024
J	Twarog, NR; Low, JA; Currier, DG; Miller, G; Chen, TS; Shelat, AA				Twarog, Nathaniel R.; Low, Jonathan A.; Currier, Duane G.; Miller, Greg; Chen, Taosheng; Shelat, Anang A.			Robust Classification of Small-Molecule Mechanism of Action Using a Minimalist High-Content Microscopy Screen and Multidimensional Phenotypic Trajectory Analysis	PLOS ONE			English	Article							INHIBITOR; POTENT	Phenotypic screening through high-content automated microscopy is a powerful tool for evaluating the mechanism of action of candidate therapeutics. Despite more than a decade of development, however, high content assays have yielded mixed results, identifying robust phenotypes in only a small subset of compound classes. This has led to a combinatorial explosion of assay techniques, analyzing cellular phenotypes across dozens of assays with hundreds of measurements. Here, using a minimalist three-stain assay and only 23 basic cellular measurements, we developed an analytical approach that leverages informative dimensions extracted by linear discriminant analysis to evaluate similarity between the phenotypic trajectories of different compounds in response to a range of doses. This method enabled us to visualize biologically-interpretable phenotypic tracks populated by compounds of similar mechanism of action, cluster compounds according to phenotypic similarity, and classify novel compounds by comparing them to phenotypically active exemplars. Hierarchical clustering applied to 154 compounds from over a dozen different mechanistic classes demonstrated tight agreement with published compound mechanism classification. Using 11 phenotypically active mechanism classes, classification was performed on all 154 compounds: 78% were correctly identified as belonging to one of the 11 exemplar classes or to a different unspecified class, with accuracy increasing to 89% when less phenotypically active compounds were excluded. Importantly, several apparent clustering and classification failures, including rigosertib and 5-fluoro-2'-deoxycytidine, instead revealed more complex mechanisms or off-target effects verified by more recent publications. These results show that a simple, easily replicated, minimalist high-content assay can reveal subtle variations in the cellular phenotype induced by compounds and can correctly predict mechanism of action, as long as the appropriate analytical tools are used.	[Twarog, Nathaniel R.; Low, Jonathan A.; Currier, Duane G.; Miller, Greg; Chen, Taosheng; Shelat, Anang A.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Shelat, AA (corresponding author), St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA.	anang.shelat@stjude.org	Shelat, Anang/J-4995-2013; Chen, Taosheng/I-6351-2013	Shelat, Anang/0000-0002-6266-2910; Chen, Taosheng/0000-0001-6420-3809; Currier, Duane/0000-0002-0123-0233	American Lebanese Syrian Associated Charities (ALSAC)	American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC))	American Lebanese Syrian Associated Charities (ALSAC, www.stjude.org) provides funds to St. Jude faculty to conduct research. There is no grant number. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Y, 2014, J BIOMOL SCREEN, V19, P628, DOI 10.1177/1087057114524987; Beumer JH, 2006, CLIN CANCER RES, V12, P7483, DOI 10.1158/1078-0432.CCR-06-1250; Caie PD, 2010, MOL CANCER THER, V9, P1913, DOI 10.1158/1535-7163.MCT-09-1148; Cavalcante LD, 2014, EUR J PHARMACOL, V741, P8, DOI [10.1010/j.ejphar.2014.07.041, 10.1016/j.ejphar.2014.07.041]; Drexler HCA, 1997, P NATL ACAD SCI USA, V94, P855, DOI 10.1073/pnas.94.3.855; Feng Y, 2009, NAT REV DRUG DISCOV, V8, P567, DOI 10.1038/nrd2876; Freeley M, 2010, J BIOMOL SCREEN, V15, P541, DOI 10.1177/1087057110369703; Grinstein E, 2002, ONCOGENE, V21, P1485, DOI 10.1038/sj.onc.1205211; Gumireddy K, 2005, CANCER CELL, V7, P275, DOI 10.1016/j.ccr.2005.02.009; KAYSEN J, 1986, CANCER RES, V46, P4534; Loo LH, 2007, NAT METHODS, V4, P445, DOI 10.1038/NMETH1032; Lu TG, 2015, MOL PHARMACOL, V87, P18, DOI 10.1124/mol.114.093245; Newman E. M., 2002, P AN M AM SOC CLIN, V21, p108a; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; RAO CR, 1948, J ROY STAT SOC B, V10, P159; Rauch A, 2014, BBA-REV CANCER, V1845, P202, DOI 10.1016/j.bbcan.2014.01.003; Reisen F, 2013, J BIOMOL SCREEN, V18, P1284, DOI 10.1177/1087057113501390; Schmidinger M, 2008, J CLIN ONCOL, V26, P5204, DOI 10.1200/JCO.2007.15.6331; Sokal RR, 1958, U KANSAS SCI B, V38, pl409; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Tanaka M, 2005, PLOS BIOL, V3, P764, DOI 10.1371/journal.pbio.0030128; Watanabe SI, 1996, BBA-MOL CELL RES, V1312, P99, DOI 10.1016/0167-4889(96)00024-9; Wilson CJ, 2006, J BIOMOL SCREEN, V11, P21, DOI 10.1177/1087057105280726; Wolpaw AJ, 2014, METHOD ENZYMOL, V545, P265, DOI 10.1016/B978-0-12-801430-1.00011-1; Xia XF, 2010, CANCER RES, V70, P7723, DOI 10.1158/0008-5472.CAN-09-4360; Young DW, 2008, NAT CHEM BIOL, V4, P59, DOI 10.1038/nchembio.2007.53	27	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149439	10.1371/journal.pone.0149439	http://dx.doi.org/10.1371/journal.pone.0149439			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886014	Green Published, Green Submitted, gold			2022-12-27	WOS:000371218400083
J	Gordo-Gilart, R; Andueza, S; Hierro, L; Jara, P; Alvarez, L				Gordo-Gilart, Raquel; Andueza, Sara; Hierro, Loreto; Jara, Paloma; Alvarez, Luis			Functional Rescue of Trafficking-Impaired ABCB4 Mutants by Chemical Chaperones	PLOS ONE			English	Article							INTRAHEPATIC CHOLESTASIS TYPE-2; CANALICULAR TRANSPORT DEFECTS; DISEASE-CAUSING MUTATIONS; ER-ASSOCIATED DEGRADATION; PLASMA-MEMBRANE; 4-PHENYLBUTYRATE THERAPY; SODIUM 4-PHENYLBUTYRATE; MISSENSE MUTATION; FOLDING DEFECTS; P-GLYCOPROTEIN	Multidrug resistance protein 3 (MDR3, ABCB4) is a hepatocellular membrane protein that mediates biliary secretion of phosphatidylcholine. Null mutations in ABCB4 gene give rise to severe early-onset cholestatic liver disease. We have previously shown that the disease-associated mutations p.G68R, p.G228R, p.D459H, and p.A934T resulted in retention of ABCB4 in the endoplasmic reticulum, thus failing to target the plasma membrane. In the present study, we tested the ability of two compounds with chaperone-like activity, 4-phenylbutyrate and curcumin, to rescue these ABCB4 mutants by assessing their effects on subcellular localization, protein maturation, and phospholipid efflux capability. Incubation of transfected cells at a reduced temperature (30 degrees C) or exposure to pharmacological doses of either 4-PBA or curcumin restored cell surface expression of mutants G228R and A934T. The delivery of these mutants to the plasma membrane was accompanied by a switch in the ratio of mature to inmature protein forms, leading to a predominant expression of the mature protein. This effect was due to an improvement in the maturation rate and not to the stabilization of the mature forms. Both mutants were also functionally rescued, displaying bile salt-dependent phospholipid efflux activity after addition of 4-PBA or curcumin. Drug-induced rescue was mutant specific, given neither 4-PBA nor curcumin had an effect on the ABCB4 mutants G68R and A934T. Collectively, these data indicate that the functionality of selected trafficking-defective ABCB4 mutants can be recovered by chemical chaperones through restoration of membrane localization, suggesting a potential treatment for patients carrying such mutations.	[Gordo-Gilart, Raquel; Andueza, Sara; Hierro, Loreto; Jara, Paloma; Alvarez, Luis] La Paz Univ Hosp Hlth Res Inst IdiPAZ, Madrid, Spain; [Hierro, Loreto; Jara, Paloma] La Paz Childrens Univ Hosp, Pediat Liver Serv, Madrid, Spain		Alvarez, L (corresponding author), La Paz Univ Hosp Hlth Res Inst IdiPAZ, Madrid, Spain.	luis.alvarez@salud.madrid.org		Jara Vega, Paloma/0000-0002-4669-7929; Hierro, Loreto/0000-0002-6173-4716	Instituto de Salud Carlos III (ISCIII)-Fondo Europeo de Desarrollo Regional (FEDER) [FIS PI12/01196]; Fundacion ACS	Instituto de Salud Carlos III (ISCIII)-Fondo Europeo de Desarrollo Regional (FEDER); Fundacion ACS	This work was supported by grants from the Instituto de Salud Carlos III (ISCIII)-Fondo Europeo de Desarrollo Regional (FEDER) (FIS PI12/01196) and from Fundacion ACS.	Andress EJ, 2014, HEPATOLOGY, V59, P1921, DOI 10.1002/hep.26970; Brostrom MA, 2003, CELL CALCIUM, V34, P345, DOI 10.1016/S0143-4160(03)00127-1; Brown CR, 1997, J CLIN INVEST, V99, P1432, DOI 10.1172/JCI119302; Cheong N, 2006, J BIOL CHEM, V281, P9791, DOI 10.1074/jbc.M507515200; Davit-Spraul A, 2010, SEMIN LIVER DIS, V30, P134, DOI 10.1055/s-0030-1253223; Degiorgio D, 2014, EUR J HUM GENET, V22, P633, DOI 10.1038/ejhg.2013.214; Delaunay JL, 2016, HEPATOLOGY, V63, P1620, DOI 10.1002/hep.28300; Delaunay JL, 2009, HEPATOLOGY, V49, P1218, DOI 10.1002/hep.22775; Dixon PH, 2000, HUM MOL GENET, V9, P1209, DOI 10.1093/hmg/9.8.1209; Frider B, 2015, ANN HEPATOL, V14, P745, DOI 10.1016/S1665-2681(19)30771-9; Gautherot J, 2014, HEPATOLOGY, V60, P610, DOI 10.1002/hep.27170; Gautherot J, 2012, J BIOL CHEM, V287, P5070, DOI 10.1074/jbc.M111.275438; Gondcaille C, 2005, J CELL BIOL, V169, P93, DOI 10.1083/jcb.200501036; Gonzales E, 2015, HEPATOLOGY, V62, P558, DOI 10.1002/hep.27767; Gonzales E, 2012, J HEPATOL, V57, P695, DOI 10.1016/j.jhep.2012.04.017; Gonzales E, 2010, J HEPATOL, V53, P385, DOI 10.1016/j.jhep.2010.03.012; Gordo-Gilart R, 2016, LIVER INT, V36, P258, DOI 10.1111/liv.12910; Gordo-Gilart R, 2015, GUT, V64, P147, DOI 10.1136/gutjnl-2014-306896; Groen A, 2011, GASTROENTEROLOGY, V141, P1927, DOI 10.1053/j.gastro.2011.07.042; Gupta SC, 2013, AAPS J, V15, P195, DOI 10.1208/s12248-012-9432-8; Hasegawa Y, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-89; Hayashi H, 2007, HEPATOLOGY, V45, P1506, DOI 10.1002/hep.21630; Hayashi H, 2016, HEPATOL RES, V46, P192, DOI 10.1111/hepr.12561; Iannitti T, 2011, DRUGS R&D, V11, P227, DOI 10.2165/11591280-000000000-00000; Kim TH, 2013, KOREAN J PHYSIOL PHA, V17, P525, DOI 10.4196/kjpp.2013.17.6.525; Kluth M, 2015, J BIOL CHEM, V290, P4896, DOI 10.1074/jbc.M114.588566; Kolb PS, 2015, INT J BIOCHEM CELL B, V61, P45, DOI 10.1016/j.biocel.2015.01.015; Kostova Z, 2005, J CELL SCI, V118, P1485, DOI 10.1242/jcs.01740; Lam P, 2007, AM J PHYSIOL-CELL PH, V293, pC1709, DOI 10.1152/ajpcell.00327.2007; Le Saux O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024738; Marin JJG, 2015, GUT, V64, P6, DOI 10.1136/gutjnl-2014-307014; Naoi S, 2014, J PEDIATR-US, V164, P1219, DOI 10.1016/j.jpeds.2013.12.032; OUDE ERP, 2006, PFLUGERS ARCH, V453, P601; Robben JH, 2006, MOL BIOL CELL, V17, P379, DOI 10.1091/mbc.E05-06-0579; Rubenstein RC, 1997, J CLIN INVEST, V100, P2457, DOI 10.1172/JCI119788; Rudashevskaya Elena L, 2014, Drug Discov Today Technol, V12, pe87, DOI 10.1016/j.ddtec.2014.03.009; RUETZ S, 1994, CELL, V77, P1071, DOI 10.1016/0092-8674(94)90446-4; SMITH AJ, 1994, FEBS LETT, V354, P263, DOI 10.1016/0014-5793(94)01135-4; Sorrenson B, 2013, J LIPID RES, V54, P55, DOI 10.1194/jlr.M027193; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Stapelbroek JM, 2010, J HEPATOL, V52, P258, DOI 10.1016/j.jhep.2009.11.012; Thompson RJ, 2015, HEPATOLOGY, V62, P349, DOI 10.1002/hep.27817; van den Berghe PVE, 2009, HEPATOLOGY, V50, P1783, DOI 10.1002/hep.23209; van der Velden LM, 2010, HEPATOLOGY, V51, P286, DOI 10.1002/hep.23268; vanHelvoort A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7; Varela-Nieto I, 1993, HDB ENDOCRINE RES TE, P391; Zhang SQ, 2011, HUM MOL GENET, V20, P3176, DOI 10.1093/hmg/ddr223	47	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0150098	10.1371/journal.pone.0150098	http://dx.doi.org/10.1371/journal.pone.0150098			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900700	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100206
J	Norlander, A; Carlstedt, E; Jonsson, AC; Lexell, EM; Stahl, A; Lindgren, A; Iwarsson, S				Norlander, Anna; Carlstedt, Emma; Jonsson, Ann-Cathrin; Lexell, Eva M.; Stahl, Agneta; Lindgren, Arne; Iwarsson, Susanne			Long-Term Predictors of Social and Leisure Activity 10 Years after Stroke	PLOS ONE			English	Article							MINI-MENTAL-STATE; LIFE SATISFACTION; SWEDISH VERSION; PROXY RESPONSES; RISK-FACTORS; POST STROKE; LUND STROKE; PARTICIPATION; COMMUNITY; PATIENT	Background Restrictions in social and leisure activity can have negative consequences for the health and well-being of stroke survivors. To support the growing number of people who are ageing with stroke, knowledge is needed about factors that influence such activity in a long-term perspective. Aim To identify long-term predictors of the frequency of social and leisure activities 10 years after stroke. Method 145 stroke survivors in Sweden were followed-up at16 months and 10 years after a first-ever stroke. Data representing body functions, activities & participation, environmental factors and personal factors at 16 months after stroke, were used in multiple linear regression analyses to identify predictors of the activity frequency after 10 years, as assessed by the 'Community, social and civic life' sub-domain of the Frenchay Activities Index (FAICSC). Results At the 10-year follow-up the frequency of social and leisure activities varied considerably among the participants, with FAI-CSC scores spanning the entire score range 0-9 (mean/median 4.9/5.0). Several factors at 16 months post stroke were independently related to the long-term activity frequency. The final regression model included four significant explanatory variables. Driving a car (B = 0.999), ability to walk a few hundred meters (B = 1.698) and extent of social network (B = 1.235) had a positive effect on activity frequency, whereas an age >= 75 years had a negative effect (B = -1.657). This model explained 36.9% of the variance in the FAI-CSC (p<0.001). Conclusion Stroke survivors who drive a car, have the ability to walk a few hundred meters and have a wide social network at 16 months after a first-ever stroke are more likely to have a high frequency of social and leisure activities after 10 years, indicating that supporting outdoor mobility and social anchorage of stroke survivors during rehabilitation is important to counteract long-term inactivity.	[Norlander, Anna; Carlstedt, Emma; Jonsson, Ann-Cathrin; Lexell, Eva M.; Iwarsson, Susanne] Lund Univ, Dept Hlth Sci, Lund, Sweden; [Lexell, Eva M.; Lindgren, Arne] Skane Univ Hosp, Dept Neurol & Rehabil Med, Lund, Sweden; [Stahl, Agneta] Lund Univ, Dept Technol & Soc, Lund, Sweden; [Lindgren, Arne] Lund Univ, Dept Clin Sci, Neurol, Lund, Sweden	Lund University; Lund University; Skane University Hospital; Lund University; Lund University	Norlander, A (corresponding author), Lund Univ, Dept Hlth Sci, Lund, Sweden.	anna.norlander@med.lu.se	Norlander, Anna/ADQ-9060-2022; Iwarsson, Susanne/I-7517-2013	Mansson Lexell, Eva/0000-0002-7243-4348; Iwarsson, Susanne/0000-0002-6670-7952	Freemasons Lodge of Instruction EOS in Lund, King Gustaf V and Queen Victoria's Foundation; Faculty of Medicine, Lund University; Skane University Hospital; Region Skane; Ribbingska Foundation in Lund; Swedish Heart and Lung Foundation; Swedish Stroke Association; Greta and Johan Kock's Foundation; Swedish Research Council for Health, Working Life and Welfare (FORTE)	Freemasons Lodge of Instruction EOS in Lund, King Gustaf V and Queen Victoria's Foundation; Faculty of Medicine, Lund University; Skane University Hospital; Region Skane; Ribbingska Foundation in Lund; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Stroke Association; Greta and Johan Kock's Foundation; Swedish Research Council for Health, Working Life and Welfare (FORTE)	Funding was provided from the Freemasons Lodge of Instruction EOS in Lund, King Gustaf V and Queen Victoria's Foundation; Faculty of Medicine, Lund University; Skane University Hospital; Region Skane; the Ribbingska Foundation in Lund; the Swedish Heart and Lung Foundation; the Swedish Stroke Association; and Greta and Johan Kock's Foundation. This study was accomplished in the context of Centre for Ageing and Supportive Environments (CASE), financed by the Swedish Research Council for Health, Working Life and Welfare (FORTE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson Joy, 2004, J Stroke Cerebrovasc Dis, V13, P171, DOI 10.1016/j.jstrokecerebrovasdis.2004.06.003; Agahi N, 2006, J GERONTOL B-PSYCHOL, V61, pS340, DOI 10.1093/geronb/61.6.S340; Anderson S, 2013, SCAND J CARING SCI, V27, P820, DOI 10.1111/j.1471-6712.2012.01086.x; Anderson S, 2011, TOP STROKE REHABIL, V18, P509, DOI 10.1310/tsr1805-509; Boosman H, 2011, CLIN REHABIL, V25, P460, DOI 10.1177/0269215510388314; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Brunborg B, 2014, J CLIN NURS, V23, P1055, DOI 10.1111/jocn.12324; Capelle LG, 2011, ACTA NEUROL SCAND, V123, P160, DOI 10.1111/j.1600-0404.2010.01389.x; COLANTONIO A, 1993, J GERONTOL, V48, pS261, DOI 10.1093/geronj/48.5.S261; Combs SA, 2013, DISABIL REHABIL, V35, P860, DOI 10.3109/09638288.2012.717575; Cooper CL, 2014, BR J CLIN PSYCHOL; Desrosiers J, 2006, DISABIL REHABIL, V28, P221, DOI 10.1080/09638280500158372; Desrosiers J, 2008, NEUROREHAB NEURAL RE, V22, P288, DOI 10.1177/1545968307307116; Edwards DF, 2006, NEUROUROL URODYNAM, V25, P39, DOI 10.1002/nau.20199; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gadidi V, 2011, ARCH PHYS MED REHAB, V92, P1802, DOI 10.1016/j.apmr.2011.06.014; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gottfries GG, 1997, INT J GERIATR PSYCH, V12, P1029; Hallstrom B, 2007, ACTA NEUROL SCAND, V115, P49, DOI 10.1111/j.1600-0404.2006.00738.x; HANSON BS, 1987, SOC SCI MED, V25, P849, DOI 10.1016/0277-9536(87)90043-8; Hardie K, 2004, STROKE, V35, P731, DOI 10.1161/01.STR.0000116183.50167.D9; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Iverson GL, 1998, INT J GERIATR PSYCH, V13, P661, DOI 10.1002/(SICI)1099-1166(1998100)13:10<661::AID-GPS838>3.0.CO;2-0; Jansen HE, 2012, J REHABIL MED, V44, P47, DOI 10.2340/16501977-0908; Jette AM, 2012, STROKE, V43, P824, DOI 10.1161/STROKEAHA.111.619643; Jonsson AC, 2005, STROKE, V36, P803, DOI 10.1161/01.STR.0000160873.32791.20; Jonsson AC, 2014, STROKE, V45, P1784, DOI 10.1161/STROKEAHA.114.005164; Kiyohara Y, 2003, STROKE, V34, P2343, DOI 10.1161/01.STR.0000091845.14833.43; Klingbeil H, 2004, ARCH PHYS MED REHAB, V85, pS68, DOI 10.1016/j.apmr.2004.03.014; Knapp P., 1998, PSYCHOL HEALTH MED, V3, P275, DOI [10.1080/13548509808400602, DOI 10.1080/13548509808400602]; Kuluski K, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.22252; Lees KR, 2004, LANCET, V363, P439, DOI 10.1016/S0140-6736(04)15490-1; Liddle J, 2009, BRAIN IMPAIR, V10, P271, DOI 10.1375/brim.10.3.271; Lindstrom M, 2001, SOC SCI MED, V52, P441, DOI 10.1016/S0277-9536(00)00153-2; MAHONEY F I, 1965, Md State Med J, V14, P61; Marottoli RA, 2000, J GERONTOL B-PSYCHOL, V55, pS334, DOI 10.1093/geronb/55.6.S334; Molton IR, 2010, PHYS MED REH CLIN N, V21, P253, DOI 10.1016/j.pmr.2009.12.012; Norlander A JA, 2015, DISABIL REH IN PRESS; Obembe AO, 2015, NEUROREHAB NEURAL RE; Ovbiagele B, 2013, STROKE, V44, P2361, DOI 10.1161/STR.0b013e31829734f2; Persson J, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-341; Piercy W, 2000, CLIN REHABIL, V14, P433, DOI 10.1191/0269215500cr327oa; Rosengren A, 2013, STROKE, V44, P2388, DOI 10.1161/STROKEAHA.113.001170; Schepers VP, 2005, ARCH PHYS MED REHAB, V86, P1472, DOI 10.1016/j.apmr.2004.11.039; Skolarus LE, 2014, STROKE, V45, P224, DOI 10.1161/STROKEAHA.113.002874; Sohrabji F, 2013, NEUROCHEM INT, V63, P291, DOI 10.1016/j.neuint.2013.06.013; SULLIVAN M, 1995, SOC SCI MED, V41, P1349, DOI 10.1016/0277-9536(95)00125-Q; Sveen U, 2004, CLIN REHABIL, V18, P267, DOI 10.1191/0269215504cr719oa; Swedish Stroke Register (Riksstroke), 2013, AR EFT STROK 1 ARS 2; Venna VR, 2015, METAB BRAIN DIS, V30, P497, DOI 10.1007/s11011-014-9544-1; Wade D T, 1985, Int Rehabil Med, V7, P176; Walsh M, 2014, IRISH J MED SCI, V183, pS303; Walsh ME, 2015, DISABIL REHABIL, V37, P1599, DOI 10.3109/09638288.2014.974834; Wendel KA, 2013, EUR J AGEING, V10, P247, DOI 10.1007/s10433-013-0259-7; White JH, 2012, DISABIL REHABIL, V34, P831, DOI 10.3109/09638288.2011.623754; WHO, 2001, WHO INT CLASS FUNCT; Wolfe C, 2007, TOP 10 PRIORITIES ST; Wolfe CDA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001033; Woodman P, 2014, DISABIL REHABIL, V36, P2031, DOI 10.3109/09638288.2014.887796; Zhang YN, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/436125	60	37	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149395	10.1371/journal.pone.0149395	http://dx.doi.org/10.1371/journal.pone.0149395			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26901501	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100068
J	Rogal, SS; Arnold, RM; Chapko, M; Hanusa, BV; Youk, A; Switzer, GE; Sevick, MA; Bayliss, NK; Zook, CL; Chidi, A; Obrosky, DS; Zickmund, SL				Rogal, Shari S.; Arnold, Robert M.; Chapko, Michael; Hanusa, Barbara V.; Youk, Ada; Switzer, Galen E.; Sevick, Mary Ann; Bayliss, Nichole K.; Zook, Carolyn L.; Chidi, Alexis; Obrosky, David S.; Zickmund, Susan L.			The Patient-Provider Relationship Is Associated with Hepatitis C Treatment Eligibility: A Prospective Mixed-Methods Cohort Study	PLOS ONE			English	Article							DRUG-USE DISORDERS; QUALITY-OF-LIFE; ANTIVIRAL THERAPY; US VETERANS; CARE; STIGMATIZATION; ADHERENCE; OUTCOMES; PREFERENCES; MANAGEMENT	Hepatitis C virus (HCV) treatment has the potential to cure the leading cause of cirrhosis and hepatocellular carcinoma. However, only those deemed eligible for treatment have the possibility of this cure. Therefore, understanding the determinants of HCV treatment eligibility is critical. Given that effective communication with and trust in healthcare providers significantly influences treatment eligibility decisions in other diseases, we aimed to understand patient-provider interactions in the HCV treatment eligibility process. This prospective cohort study was conducted in the VA Pittsburgh Healthcare System. Patients were recruited after referral for gastroenterology consultation for HCV treatment with interferon and ribavirin. Consented patients completed semi-structured interviews and validated measures of depression, substance and alcohol use, and HCV knowledge. Two coders analyzed the semi-structured interviews. Factors associated with patient eligibility for interferon-based therapy were assessed using multivariate logistic regression. Of 339 subjects included in this analysis, only 56 (16.5%) were deemed eligible for HCV therapy by gastroenterology (GI) providers. In the multivariate logistic regression, patients who were older (OR = 0.96, 95% CI = 0.92-0.99, p = .049), reported concerns about the GI provider (OR = 0.40, 95% CI = 0.10-0.87, p = 0.02) and had depression symptoms (OR = 0.32, 95% CI = 0.17-0.63, p = 0.001) were less likely to be eligible. Patients described barriers that included feeling stigmatized and poor provider interpersonal or communication skills. In conclusion, we found that patients' perceptions of the relationship with their GI providers were associated with treatment eligibility. Establishing trust and effective communication channels between patients and providers may lower barriers to potential HCV cure.	[Rogal, Shari S.; Hanusa, Barbara V.; Youk, Ada; Switzer, Galen E.; Bayliss, Nichole K.; Obrosky, David S.; Zickmund, Susan L.] Pittsburgh Healthcare Serv, Ctr Hlth Equ Res & Promot, Vet Adm, Pittsburgh, PA USA; [Rogal, Shari S.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Arnold, Robert M.; Switzer, Galen E.; Chidi, Alexis; Obrosky, David S.; Zickmund, Susan L.] Univ Pittsburgh, Div Gen Internal Med, Pittsburgh, PA USA; [Chapko, Michael] Vet Adm Healthcare Serv, Seattle Ctr Innovat Veteran Ctr & Value Driven Ca, Seattle, WA USA; [Youk, Ada] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Sevick, Mary Ann] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Zook, Carolyn L.] Oregon Hlth & Sci Univ, Sch Med, Portland, OR USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; New York University; Oregon Health & Science University	Rogal, SS (corresponding author), Pittsburgh Healthcare Serv, Ctr Hlth Equ Res & Promot, Vet Adm, Pittsburgh, PA USA.; Rogal, SS (corresponding author), Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA.	rogalss@upmc.edu	Sevick, Mary/V-6503-2019	Youk, Ada/0000-0001-6912-9759	VA HSR&D Merit Review Award [IIR 05-281]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000145] Funding Source: NIH RePORTER	VA HSR&D Merit Review Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by VA HSR&D Merit Review Award #IIR 05-281.	Allen JP, 1997, ALCOHOL CLIN EXP RES, V21, P613, DOI 10.1111/j.1530-0277.1997.tb03811.x; Bakken S, 2000, AIDS PATIENT CARE ST, V14, P189, DOI 10.1089/108729100317795; Batki SL, 2011, AM J ADDICTION, V20, P312, DOI 10.1111/j.1521-0391.2011.00139.x; Beach MC, 2006, J GEN INTERN MED, V21, P661, DOI 10.1111/j.1525-1497.2006.00399.x; Beste LA, 2009, ALIMENT PHARM THER, V30, P275, DOI 10.1111/j.1365-2036.2009.04036.x; Bini EJ, 2007, AM J GASTROENTEROL, V102, P2434, DOI 10.1111/j.1572-0241.2007.01418.x; Bini EJ, 2005, AM J GASTROENTEROL, V100, P1772, DOI 10.1111/j.1572-0241.2005.41860.x; Bonner JE, 2012, DIGEST DIS SCI, V57, P1469, DOI 10.1007/s10620-012-2141-4; Butt AA, 2007, GUT, V56, P385, DOI 10.1136/gut.2006.099150; Cartwright Emily J, 2014, BMC Res Notes, V7, P449, DOI 10.1186/1756-0500-7-449; Cawthorne CH, 2002, AM J GASTROENTEROL, V97, P149, DOI 10.1111/j.1572-0241.2002.05439.x; Clark CH, 2002, J ADV NURS, V40, P361, DOI 10.1046/j.1365-2648.2002.02378.x; Conti F, 2014, EXPERT OPIN PHARMACO, V15, P2019, DOI 10.1517/14656566.2014.945422; Dominitz JA S-TK, 2003, IMPACT GROUP ED KNOW; Evren C, 2014, J PSYCHOACTIVE DRUGS, V46, P140, DOI 10.1080/02791072.2014.887162; Fraenkel L, 2010, MED DECIS MAKING, V30, P45, DOI 10.1177/0272989X09341588; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Giannini EG, 2012, LIVER INT, V32, P1113, DOI 10.1111/j.1478-3231.2012.02798.x; Hare CB, 2006, PHARMACOEPIDEM DR S, V15, P71, DOI 10.1002/pds.1146; Hauber AB, 2011, J VIRAL HEPATITIS, V18, P619, DOI 10.1111/j.1365-2893.2010.01343.x; Ho SB, 2008, AM J GASTROENTEROL, V103, P1810, DOI 10.1111/j.1572-0241.2008.01877.x; Kelley JM, 2009, PSYCHOSOM MED, V71, P789, DOI 10.1097/PSY.0b013e3181acee12; Kramer JR, 2011, AM J GASTROENTEROL, V106, P483, DOI 10.1038/ajg.2010.430; Livingston SE, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.18445; Lotrich Francis, 2010, Curr Hepat Rep, V9, P113, DOI 10.1007/s11901-010-0035-5; Maisto SA, 2000, PSYCHOL ASSESSMENT, V12, P186, DOI 10.1037/1040-3590.12.2.186; Markowitz JS, 2005, J VIRAL HEPATITIS, V12, P176, DOI 10.1111/j.1365-2893.2005.00607.x; Miller WaC B. F., 1992, PRIMARY CARE RES MUL; Rifai MA, 2006, PSYCHIAT SERV, V57, P570, DOI 10.1176/appi.ps.57.4.570; Schafer A, 2005, EUR J GASTROEN HEPAT, V17, P1387, DOI 10.1097/00042737-200512000-00019; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Straits-Troster K KD, 2003, HEPATITIS C VIRUS HC; Treloar C, 2013, CLIN INFECT DIS, V57, pS51, DOI 10.1093/cid/cit263; Tsui JI, 2008, DIGEST DIS SCI, V53, P809, DOI 10.1007/s10620-007-9926-x; Ward John W, 2012, Hepatology, V55, P307, DOI 10.1002/hep.24797; Ware JE, 1999, HEPATOLOGY, V30, P550, DOI 10.1002/hep.510300203; Zacks S, 2006, J CLIN GASTROENTEROL, V40, P220, DOI 10.1097/00004836-200603000-00009; Zickmund S, 2004, HEPATOLOGY, V39, P999, DOI 10.1002/hep.20132; Zickmund S, 2003, J GEN INTERN MED, V18, P835, DOI 10.1046/j.1525-1497.2003.20826.x	39	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148596	10.1371/journal.pone.0148596	http://dx.doi.org/10.1371/journal.pone.0148596			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26900932	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000371276100021
J	Nguyen, TH; Than, VT; Thanh, HD; Hung, VK; Nguyen, DT; Kim, W				Tinh Huu Nguyen; Van Thai Than; Hien Dang Thanh; Vu-Khac Hung; Duc Tan Nguyen; Kim, Wonyong			Intersubtype Reassortments of H5N1 Highly Pathogenic Avian Influenza Viruses Isolated from Quail	PLOS ONE			English	Article							A H5N1; HONG-KONG; MOLECULAR CHARACTERIZATION; INTERSPECIES TRANSMISSION; UPDATED NOMENCLATURE; MULTIPLE SUBLINEAGES; DOMESTIC POULTRY; SOUTHERN CHINA; EVOLUTION; VIETNAM	H5N1 highly pathogenic avian influenza (HPAI) viruses are considered a threat to national animal industries, causing production losses and high mortality in domestic poultry. In recent years, quail has become a popular terrestrial poultry species raised for production of meat and eggs in Asia. In this study, to better understand the roles of quail in H5N1 viral evolution, two H5N1-positive samples, designated A/quail/Vietnam/CVVI-49/2010 (CVVI-49/2010) and A/quail/Vietnam/CVVI-50/2014 (CVVI-50/2014), were isolated from quail during H5N1 outbreaks in Vietnam, and their whole genome were analyzed. The phylogenetic analysis reveals new evolutionary variation in the worldwide H5N1 viruses. The quail HA genes were clustered into clades 1.1.1 (CVVI-49/2010) and clade 2.3.2.1c (CVVI-50/2014), which may have evolved from viruses circulating from chickens and/or ducks in Cambodia, mainland of China, Taiwan, Indonesia, and South Korea in recent years. Interestingly, the M2 gene of the CVVI-49/2010 strain contained amino acid substitutions at position 26(L-I) and 31(S-N) that are related to amantadine-resistance. In particular, the CVVI-50/2014 strain revealed evidence of multiple intersubtype reassortment events between virus clades 2.3.2.1c, 2.3.2.1b, and 2.3.2.1a. Data from this study supports the possible role of quail as an important intermediate host in avian influenza virus evolution. Therefore, additional surveillance is needed to monitor these HPAI viruses both serologically and virologically in quail.	[Tinh Huu Nguyen; Van Thai Than; Hien Dang Thanh; Kim, Wonyong] Chung Ang Univ, Coll Med, Dept Microbiol, Seoul 156756, South Korea; [Tinh Huu Nguyen; Hien Dang Thanh; Vu-Khac Hung; Duc Tan Nguyen] Cent Vietnam Vet Inst, Nha Trang, Vietnam	Chung Ang University; Chung Ang University Hospital	Kim, W (corresponding author), Chung Ang Univ, Coll Med, Dept Microbiol, Seoul 156756, South Korea.	kimwy@cau.ac.kr	Than, Van-Thai/GPX-9664-2022; Than, Van Thai/AAX-2106-2021	Dang Thanh, Hien/0000-0002-1007-4041	National Research Foundation of Korea (NRF); Ministry of Education [2013R1A1A2A10012148]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (2013R1A1A2A10012148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Creanga A, 2013, VIROLOGY, V444, P12, DOI 10.1016/j.virol.2013.06.005; de Jong MD, 2006, J CLIN VIROL, V35, P2, DOI 10.1016/j.jcv.2005.09.002; Dong GY, 2014, VIRUS GENES, V49, P223, DOI 10.1007/s11262-014-1084-6; Felsenstein J., 1993, PHYLIP PHYLOGENETIC; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Gascuel O, 2006, MOL BIOL EVOL, V23, P1997, DOI 10.1093/molbev/msl072; Govorkova EA, 2013, ANTIVIR RES, V98, P297, DOI 10.1016/j.antiviral.2013.02.013; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hulse-Post DJ, 2005, P NATL ACAD SCI USA, V102, P10682, DOI 10.1073/pnas.0504662102; Hurt Aeron C, 2006, Expert Rev Anti Infect Ther, V4, P795, DOI 10.1586/14787210.4.5.795; Jiao PR, 2008, J VIROL, V82, P1146, DOI 10.1128/JVI.01698-07; JUKES T H, 1969, P21; Kim HR, 2012, EMERG INFECT DIS, V18, P480, DOI [10.3201/eid1803.111490, 10.3201/1803.111490]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Le TH, 2014, CLIN EXP VACCINE RES, V3, P117, DOI 10.7774/cevr.2014.3.2.117; Leang SK, 2014, INFLUENZA OTHER RESP, V8, P135, DOI 10.1111/irv.12187; Lee EK, 2015, POULTRY SCI, V94, P650, DOI 10.3382/ps/pev036; Lee YJ, 2008, EMERG INFECT DIS, V14, P487, DOI 10.3201/eid1403.070767; Li OTW, 2007, J VIROL METHODS, V142, P218, DOI 10.1016/j.jviromet.2007.01.015; Li ZJ, 2006, J VIROL, V80, P11115, DOI 10.1128/JVI.00993-06; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Long JX, 2008, VIRUS GENES, V36, P471, DOI 10.1007/s11262-007-0187-8; Long NT, 2011, TRANSBOUND EMERG DIS, V58, P537, DOI 10.1111/j.1865-1682.2011.01229.x; Makarova NV, 2003, VIROLOGY, V310, P8, DOI 10.1016/S0042-6822(03)00094-1; Muramoto Y, 2006, J VET MED SCI, V68, P527, DOI 10.1292/jvms.68.527; Nguyen DC, 2005, J VIROL, V79, P4201, DOI 10.1128/JVI.79.7.4201-4212.2005; Nguyen TD, 2008, EMERG INFECT DIS, V14, P632, DOI 10.3201/eid1404.071343; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Okamatsu M, 2010, VIRUS GENES, V41, P351, DOI 10.1007/s11262-010-0530-3; Perez DR, 2003, J VIROL, V77, P3148, DOI 10.1128/JVI.77.5.3148-3156.2003; Saito T, 2009, VET MICROBIOL, V133, P65, DOI 10.1016/j.vetmic.2008.06.020; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smith GJD, 2006, VIROLOGY, V350, P258, DOI 10.1016/j.virol.2006.03.048; Smith GJD, 2014, INFLUENZA OTHER RESP, V8, P384, DOI 10.1111/irv.12230; Smith GJD, 2012, INFLUENZA OTHER RESP, V6, P1, DOI 10.1111/j.1750-2659.2011.00298.x; Sonnberg S, 2013, VIRUS RES, V178, P63, DOI 10.1016/j.virusres.2013.05.009; Thontiravong A, 2012, J VET SCI, V13, P395, DOI 10.4142/jvs.2012.13.4.395; Thontiravong A, 2012, VET MICROBIOL, V160, P305, DOI 10.1016/j.vetmic.2012.05.043; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Nguyen T, 2012, VIROLOGY, V432, P405, DOI 10.1016/j.virol.2012.06.021; Uchida Y, 2008, VIRUS RES, V138, P70, DOI 10.1016/j.virusres.2008.08.007; Uno Y, 2013, J VET MED SCI, V75, P451, DOI 10.1292/jvms.12-0433; Wan HQ, 2006, VIROLOGY, V346, P278, DOI 10.1016/j.virol.2005.10.035; Wan XF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003462; Wang J, 2008, J VIROL, V82, P3405, DOI 10.1128/JVI.02468-07; WEBSTER RG, 1995, AM J RESP CRIT CARE, V152, pS25, DOI 10.1164/ajrccm/152.4_Pt_2.S25; Wei KF, 2013, VET MICROBIOL, V167, P383, DOI 10.1016/j.vetmic.2013.09.030; WHO, RECOMMENDATIONS AND; WHO, 2014, CAND VACC VIR POT TE; WHO, H5N1 AV INFL TIM MAJ; World Health Organization, 2002, WHO MAN AN INFL DIAG; World Health Organization, AV INFL FACT SHEET; World Health Organization, CUM NUMB CONF HUM CA; World Health Organization (WHO), INFL HUM AN INT; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Zhou HB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006277; Zhou NN, 1999, J VIROL, V73, P3366, DOI 10.1128/JVI.73.4.3366-3374.1999	64	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149608	10.1371/journal.pone.0149608	http://dx.doi.org/10.1371/journal.pone.0149608			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900963	Green Published, gold			2022-12-27	WOS:000371276100109
J	Fan, GQ; Li, XY; Deng, MJ; Zhao, ZL; Yang, L				Fan, Guoqiang; Li, Xiaoyu; Deng, Minjie; Zhao, Zhenli; Yang, Lu			Comparative Analysis and Identification of miRNAs and Their Target Genes Responsive to Salt Stress in Diploid and Tetraploid Paulownia fortunei Seedlings	PLOS ONE			English	Article							BZIP TRANSCRIPTION FACTOR; EXPRESSION ANALYSIS; DROUGHT STRESS; DISEASE RESISTANCE; F-BOX; TOLERANCE; MICRORNAS; FAMILY; PROTEIN; PLANTS	Salt stress is a global environmental problem that affects plant growth and development. Paulownia fortunei is an adaptable and fast-growing deciduous tree native to China that is environmentally and economically important. MicroRNAs (miRNAs) play important regulatory roles in growth, development, and stress responses in plants. MiRNAs that respond to biotic stresses have been identified; however, how miRNAs in P. fortunei respond to salt stress has not yet been reported. To identify salt-stress-responsive miRNAs and predict their target genes, four small RNA and four degradome libraries were constructed from NaCl-treated and NaCl-free leaves of P. fortunei seedlings. The results indicated that salt stress had different physiological effects on diploid and tetraploid P. fortunei. We detected 53 conserved miRNAs belonging to 17 miRNA families and 134 novel miRNAs in P. fortunei. Comparing their expression levels in diploid and tetraploid P. fortunei, we found 10 conserved and 10 novel miRNAs that were significantly differentially expressed under salt treatment, among them eight were identified as miRNAs probably associated with higher salt tolerance in tetraploid P. fortunei than in diploid P. fortunei. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses were performed to predict the functions of the target genes of the conserved and novel miRNAs. The expressions of 10 differentially expressed miRNAs were validated by quantitative real-time polymerase chain reaction (qRT-PCR). This is the first report on P. fortunei miRNAs and their target genes under salt stress. The results provided information at the physiological and molecular levels for further research into the response mechanisms of P. fortunei to salt stress.	[Fan, Guoqiang; Li, Xiaoyu; Deng, Minjie; Zhao, Zhenli; Yang, Lu] Henan Agr Univ, Inst Paulownia, Zhengzhou 450002, Henan, Peoples R China	Henan Agricultural University	Fan, GQ (corresponding author), Henan Agr Univ, Inst Paulownia, Zhengzhou 450002, Henan, Peoples R China.	zlxx64@126.com			National Natural Science Foundation of China [30271082, 30571496, U1204309]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Support was provided by the National Natural Science Foundation of China (grant no. 30271082, 30571496, U1204309). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowski M, 2015, PLANT CELL, V27, P20, DOI 10.1105/tpc.114.134874; Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Banerjee A, 2017, PROTOPLASMA, V254, P3, DOI 10.1007/s00709-015-0920-4; Bouktila D, 2015, MOL GENET GENOMICS, V290, P257, DOI 10.1007/s00438-014-0909-2; Budak H, 2014, COMP BIOCHEM PHYS C, V166, P44, DOI 10.1016/j.cbpc.2014.07.002; Canto-Pastor A, 2015, PLANT BIOLOGY, V17, P59, DOI 10.1111/plb.12215; Cesari S, 2014, EMBO J, V33, P1941, DOI 10.15252/embj.201487923; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen H, 2012, PLANT SCI, V193, P8, DOI 10.1016/j.plantsci.2012.05.003; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Chen RG, 2014, INT J MOL SCI, V15, P2413, DOI 10.3390/ijms15022413; Cheng TL, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00030; Daviere JM, 2013, DEVELOPMENT, V140, P1147, DOI 10.1242/dev.087650; [邓敏捷 Deng Minjie], 2013, [河南农业大学学报, Journal of Henan Agricultural University], V47, P698; [邓敏捷 Deng Minjie], 2013, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V33, P42; Deng MinJie, 2013, Scientia Silvae Sinicae, V49, P30; Dietrich K, 2011, PLANT CELL, V23, P381, DOI 10.1105/tpc.110.075390; Dong YP, 2014, GENOMICS, V104, P295, DOI 10.1016/j.ygeno.2014.08.008; Dong YP, 2014, FUNCT INTEGR GENOMIC, V14, P479, DOI 10.1007/s10142-014-0373-4; Fahrentrapp J, 2013, TREE GENET GENOMES, V9, P237, DOI 10.1007/s11295-012-0550-3; Fan GQ, 2014, BIOCHIMIE, V102, P68, DOI 10.1016/j.biochi.2014.02.008; [范国强 Fan Guoqiang], 2007, [林业科学, Scientia Silvae Sinicae], V43, P31; Finet C, 2013, MOL BIOL EVOL, V30, P45, DOI 10.1093/molbev/mss220; Gangappa SN, 2013, PLANT CELL, V25, P1243, DOI 10.1105/tpc.113.109751; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Gibalova A, 2009, PLANT MOL BIOL, V70, P581, DOI 10.1007/s11103-009-9493-y; Golldack D, 2011, PLANT CELL REP, V30, P1383, DOI 10.1007/s00299-011-1068-0; Higuchi Y, 2013, P NATL ACAD SCI USA, V110, P17137, DOI 10.1073/pnas.1307617110; Hsieh TH, 2010, PLANTA, V231, P1459, DOI 10.1007/s00425-010-1147-4; Huang X, 2012, PLANT CELL, V24, P4590, DOI 10.1105/tpc.112.103994; Iven T, 2010, PLANT J, V63, P155, DOI 10.1111/j.1365-313X.2010.04230.x; Ji XY, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00025; Ji XY, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-151; Jiang Wen-Bo, 2009, Acta Botanica Yunnanica, V31, P427, DOI 10.3724/SP.J.1143.2009.09046; Kamata N, 2013, PLANT J, V75, P430, DOI 10.1111/tpj.12211; Kessens R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108159; Lei P, 2015, APPL PLANT SCI, V3; Li SZ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-114; Li WF, 2013, PLANT CELL TISS ORG, V113, P131, DOI [10.1007/s11240-012-0233-7, 10.1007/s11240-012-0221-y]; Li XY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2196-7; Lim CW, 2015, MOL PLANT MICROBE IN, V28, P825, DOI 10.1094/MPMI-10-14-0313-R; Liu CT, 2014, PLANT MOL BIOL, V84, P19, DOI 10.1007/s11103-013-0115-3; Liu CT, 2012, PLANTA, V235, P1157, DOI 10.1007/s00425-011-1564-z; Liu GT, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-174; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Liu J, 2011, PLANT PHYSL EXPT TUT; Liu N, 2014, J EXP BOT, V65, P2507, DOI 10.1093/jxb/eru141; Lu W, 2012, PLANT PHYSL EXPT TUT; Luo X, 2013, J EXP BOT, V64, P2155, DOI 10.1093/jxb/ert073; Ma XianFa, 2011, Science & Technology Review, V29, P76; Mace E, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0253-z; Mackowiak Sebastian D, 2011, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1210s36; Marone D, 2013, INT J MOL SCI, V14, P7302, DOI 10.3390/ijms14047302; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Neilson EH, 2013, TRENDS PLANT SCI, V18, P250, DOI 10.1016/j.tplants.2013.01.001; Nijhawan A, 2008, PLANT PHYSIOL, V146, P333, DOI 10.1104/pp.107.112821; Niu SY, 2014, PLANT CELL TISS ORG, V119, P457, DOI 10.1007/s11240-014-0546-9; Niu SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106736; Niu SuYan, 2013, Scientia Silvae Sinicae, V49, P77; Paul S, 2011, PLANT CELL TISS ORG, V105, P233, DOI 10.1007/s11240-010-9857-7; Qiu YP, 2009, ENVIRON EXP BOT, V65, P35, DOI 10.1016/j.envexpbot.2008.07.002; Ren YY, 2013, BIOCHIMIE, V95, P743, DOI 10.1016/j.biochi.2012.10.025; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Shaikhali J, 2015, PROTOPLASMA, V252, P867, DOI 10.1007/s00709-014-0726-9; Shen CJ, 2015, FRONT PLANT SCI, V6, P1, DOI 10.3389/fpls.2015.00073; Sleimi N, 2015, ECOL INDIC, V48, P570, DOI 10.1016/j.ecolind.2014.08.035; Song JB, 2015, FUNCT INTEGR GENOMIC, V15, P495, DOI 10.1007/s10142-015-0438-z; Song Y, 2010, J BIOSCIENCES, V35, P459, DOI 10.1007/s12038-010-0051-1; Tan FQ, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0450-4; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang Chen, 2011, Journal of Nanjing Forestry University (Natural Sciences Edition), V35, P20; Wang JZ, 2011, J INTEGR PLANT BIOL, V53, P212, DOI 10.1111/j.1744-7909.2010.01017.x; Wang ZM, 2013, INT J MOL SCI, V14, P20299, DOI 10.3390/ijms141020299; Wei KF, 2012, DNA RES, V19, P463, DOI 10.1093/dnares/dss026; Xia R, 2015, PLANT PHYSL, V169; Xu EK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113313; Xu GY, 2014, MOL BREEDING, V34, P1055, DOI 10.1007/s11032-014-0096-1; Xue H, 2015, SCI HORTIC-AMSTERDAM, V190, P24, DOI 10.1016/j.scienta.2015.04.009; Yang JW, 2014, COMPUT BIOL CHEM, V53, P204, DOI 10.1016/j.compbiolchem.2014.09.009; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; [翟晓巧 Zhai Xiaoqiao], 2012, [河南农业大学学报, Journal of Henan Agricultural University], V46, P651; Zhang BH, 2015, J EXP BOT, V66, P1749, DOI 10.1093/jxb/erv013; Zhang BH, 2015, J CELL PHYSIOL, V230, P1, DOI 10.1002/jcp.24685; Zhang Li, 2010, Journal of Southwest Forestry University, V30, P82; Zhang XS, 2014, INT J MOL SCI, V15, P5079, DOI 10.3390/ijms15035079; [张晓申 Zhang Xiaoshen], 2013, [河南农业大学学报, Journal of Henan Agricultural University], V47, P543; [张晓申 Zhang Xiaoshen], 2012, [河南农业大学学报, Journal of Henan Agricultural University], V46, P646; Zhao H, 2015, GENE, V565, P130, DOI 10.1016/j.gene.2015.04.002; Zhou P, 2014, PLANT PHYSIOL, V164, P841, DOI 10.1104/pp.113.227231	91	20	25	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149617	10.1371/journal.pone.0149617	http://dx.doi.org/10.1371/journal.pone.0149617			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894691	Green Published, gold			2022-12-27	WOS:000371223400067
J	Hametner, S; Ferlitsch, A; Ferlitsch, M; Etschmaier, A; Schofl, R; Ziachehabi, A; Maieron, A				Hametner, Stephanie; Ferlitsch, Arnulf; Ferlitsch, Monika; Etschmaier, Alexandra; Schoefl, Rainer; Ziachehabi, Alexander; Maieron, Andreas			The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; CHRONIC LIVER-DISEASE; ENDOTHELIAL DYSFUNCTION; STIFFNESS MEASUREMENT; GENOTYPES 1; CIRRHOSIS; PRESSURE; THERAPY; PERTURBATION; PREDICTOR	Background Clinically significant portal hypertension (CSPH), defined as hepatic venous pressure gradient (HVPG) >= 10 mmHg, causes major complications. HVPG is not always available, so a non-invasive tool to diagnose CSPH would be useful. VWF-Ag can be used to diagnose. Using the VITRO score (the VWF-Ag/platelet ratio) instead of VWF-Ag itself improves the diagnostic accuracy of detecting cirrhosis/fibrosis in HCV patients. Aim This study tested the diagnostic accuracy of VITRO score detecting CSPH compared to HVPG measurement. Methods All patients underwent HVPG testing and were categorised as CSPH or no CSPH. The following patient data were determined: CPS, D'Amico stage, VITRO score, APRI and transient elastography (TE). Results The analysis included 236 patients; 170 (72%) were male, and the median age was 57.9 (35.2-76.3; 95% CI). Disease aetiology included ALD (39.4%), HCV (23.4%), NASH (12.3%), other (8.1%) and unknown (11.9%). The CPS showed 140 patients (59.3%) with CPS A; 56 (23.7%) with CPS B; and 18 (7.6%) with CPS C. 136 patients (57.6%) had compensated and 100 (42.4%) had decompensated cirrhosis; 83.9% had HVPG >= 10 mmHg. The VWF-Ag and the VITRO score increased significantly with worsening HVPG categories (P<0.0001). ROC analysis was performed for the detection of CSPH and showed AUC values of 0.92 for TE, 0.86 for VITRO score, 0.79 for VWF-Ag, 0.68 for ELF and 0.62 for APRI. Conclusion The VITRO score is an easy way to diagnose CSPH independently of CPS in routine clinical work and may improve the management of patients with cirrhosis.	[Hametner, Stephanie; Schoefl, Rainer; Ziachehabi, Alexander; Maieron, Andreas] Elisabeth Hosp, Div Internal Med 4, Dept Gastroenterol & Hepatol, Linz, Austria; [Ferlitsch, Arnulf; Ferlitsch, Monika; Etschmaier, Alexandra] Med Univ Vienna, Div Internal Med 3, Dept Gastroenterol & Hepatol, Vienna, Austria	Ordensklinikum Linz Elisabethinen; Medical University of Vienna	Maieron, A (corresponding author), Elisabeth Hosp, Div Internal Med 4, Dept Gastroenterol & Hepatol, Linz, Austria.	andreas.maieron@elisabethinen.or.at						Afdhal N, 2008, J HEPATOL, V48, P1000, DOI 10.1016/j.jhep.2008.03.009; Ahmad W, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-44; Augustin S, 2014, J HEPATOL, V60, P561, DOI 10.1016/j.jhep.2013.10.027; Bosch J, 2006, SEMIN LIVER DIS, V26, P348, DOI 10.1055/s-2006-951603; Bosch J, 2009, NAT REV GASTRO HEPAT, V6, P573, DOI 10.1038/nrgastro.2009.149; Boursier J, 2013, HEPATOLOGY, V57, P1182, DOI 10.1002/hep.25993; Catanzaro R, 2013, HEPATOB PANCREAT DIS, V12, P500, DOI 10.1016/S1499-3872(13)60079-X; de Franchis R, 2015, J HEPATOL, V63, P743, DOI 10.1016/j.jhep.2015.05.022; de Franchis R, 2010, J HEPATOL, V53, P762, DOI 10.1016/j.jhep.2010.06.004; Ferenci P, 2010, GASTROENTEROLOGY, V138, P503, DOI 10.1053/j.gastro.2009.10.058; Ferlitsch A, 2007, AM J GASTROENTEROL, V102, P2495, DOI 10.1111/j.1572-0241.2007.01530.x; Ferlitsch M, 2012, HEPATOLOGY, V56, P1439, DOI 10.1002/hep.25806; Ferro D, 1996, HEPATOLOGY, V23, P1377, DOI 10.1053/jhep.1996.v23.pm0008675154; Homoncik M, 2005, ALIMENT PHARM THER, V21, P49, DOI 10.1111/j.1365-2036.2004.02305.x; Hubbard AR, 2004, J THROMB HAEMOST, V2, P1380, DOI 10.1111/j.1538-7836.2004.00838.x; Iannacone M, 2005, NAT MED, V11, P1167, DOI 10.1038/nm1317; Iwakiri Y, 2007, J HEPATOL, V46, P927, DOI 10.1016/j.jhep.2007.02.006; La Mura V, 2011, GUT, V60, P1133, DOI 10.1136/gut.2010.235689; Lichtinghagen R, 2013, J HEPATOL, V59, P236, DOI 10.1016/j.jhep.2013.03.016; Maieron A, 2014, ALIMENT PHARM THER, V39, P331, DOI 10.1111/apt.12564; Matei V, 2006, HEPATOLOGY, V44, P44, DOI 10.1002/hep.21228; Papatheodoridis GV, 2003, GUT, V52, P404, DOI 10.1136/gut.52.3.404; Peck-Radosavljevic M, 2013, WIEN KLIN WOCHENSCHR, V125, P200, DOI 10.1007/s00508-013-0337-z; Pramhas S, 2010, ANTIVIR THER, V15, P831, DOI 10.3851/IMP1654; Qamar AA, 2009, CLIN GASTROENTEROL H, V7, P689, DOI 10.1016/j.cgh.2009.02.021; Reiberger T, 2012, J GASTROENTEROL, V47, P561, DOI 10.1007/s00535-011-0517-4; Reiberger T, 2011, CLIN GASTROENTEROL H, V9, P602, DOI 10.1016/j.cgh.2011.03.002; Ripoll C, 2009, J HEPATOL, V50, P923, DOI 10.1016/j.jhep.2009.01.014; Schwabl P, 2015, LIVER INT, V35, P381, DOI 10.1111/liv.12623; Thabut D, 2011, HEPATOLOGY, V53, P683, DOI 10.1002/hep.24129; van Mourik JA, 1999, BLOOD, V94, P179, DOI 10.1182/blood.V94.1.179.413k18_179_185; Vizzutti F, 2007, HEPATOLOGY, V45, P1290, DOI 10.1002/hep.21665; Wahl K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051906; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wang JH, 2014, LIVER INT, V34, P1340, DOI 10.1111/liv.12525	35	34	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149230	10.1371/journal.pone.0149230	http://dx.doi.org/10.1371/journal.pone.0149230			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895398	gold, Green Published, Green Submitted			2022-12-27	WOS:000371223400040
J	Kierdorf, U; Death, C; Hufschmid, J; Witzel, C; Kierdorf, H				Kierdorf, Uwe; Death, Clare; Hufschmid, Jasmin; Witzel, Carsten; Kierdorf, Horst			Developmental and Post-Eruptive Defects in Molar Enamel of Free-Ranging Eastern Grey Kangaroos (Macropus giganteus) Exposed to High Environmental Levels of Fluoride	PLOS ONE			English	Article							FLUOROSED DENTAL ENAMEL; HYPOPLASTIC ENAMEL; TEETH; SHEEP; MICROHARDNESS; FEATURES; LESIONS; AREAS; PERIODICITY; MECHANISMS	Dental fluorosis has recently been diagnosed in wild marsupials inhabiting a high-fluoride area in Victoria, Australia. Information on the histopathology of fluorotic marsupial enamel has thus far not been available. This study analyzed the developmental and post-eruptive defects in fluorotic molar enamel of eastern grey kangaroos (Macropus giganteus) from the same high-fluoride area using light microscopy and backscattered electron imaging in the scanning electron microscope. The fluorotic enamel exhibited a brownish to blackish discolouration due to post-eruptive infiltration of stains fromthe oral cavity and was less resistant to wear than normally mineralized enamel of kangaroos from low-fluoride areas. Developmental defects of enamel included enamel hypoplasia and a pronounced hypomineralization of the outer (sub-surface) enamel underneath a thin rim of well-mineralized surface enamel. While the hypoplastic defects denote a disturbance of ameloblast function during the secretory stage of amelogenesis, the hypomineralization is attributed to an impairment of enamelmaturation. In addition to hypoplastic defects, the fluorotic molars also exhibited numerous posteruptive enamel defects due to the flaking-off of portions of the outer, hypomineralized enamel layer during mastication. The macroscopic and histopathological lesions in fluorotic enamel of M. giganteus match those previously described for placental mammals. It is therefore concluded that there exist no principal differences in the pathogenic mechanisms of dental fluorosis between marsupial and placentalmammals. The regular occurrence of hypomineralized, opaque outer enamel in the teeth of M. giganteus and other macropodids must be considered in the differential diagnosis of dental fluorosis in these species.	[Kierdorf, Uwe; Witzel, Carsten; Kierdorf, Horst] Univ Hildesheim, Dept Biol, D-31141 Hildesheim, Germany; [Death, Clare; Hufschmid, Jasmin] Univ Melbourne, Fac Vet & Agr Sci, Werribee, Vic, Australia	University of Hildesheim; University of Melbourne	Kierdorf, U (corresponding author), Univ Hildesheim, Dept Biol, D-31141 Hildesheim, Germany.	uwe.kierdorf@uni-hildesheim.de	Hufschmid, Jasmin/Y-9079-2019; Kierdorf, Uwe/F-2539-2012; Death, Clare/ABE-2987-2020; Witzel, Carsten/AAD-9498-2022	Hufschmid, Jasmin/0000-0001-9427-7702; Kierdorf, Uwe/0000-0003-0531-2460; Death, Clare/0000-0003-4540-1214; Witzel, Carsten/0000-0002-1663-7618; Kierdorf, Horst/0000-0001-6411-9631	Australian Postgraduate Award Industry Scholarship; Alcoa Portland Aluminium Pty Ltd; Holsworth Wildlife Endowment Fund; German Academic Exchange Service (DAAD)	Australian Postgraduate Award Industry Scholarship(Australian Government); Alcoa Portland Aluminium Pty Ltd; Holsworth Wildlife Endowment Fund; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	Clare Death was funded by an Australian Postgraduate Award Industry Scholarship in collaboration with Alcoa Portland Aluminium Pty Ltd, and the Holsworth Wildlife Endowment Fund. The funders are supportive of publication, but had no role in study design, data analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge University of Melbourne travel scholarships and a grant from the German Academic Exchange Service (DAAD) to C. Death. We further thank D. Klosa for his skilful technical assistance, G. Coulson for his macropodid ecology expertise and support, and the reviewers for their helpful comments on the manuscript.	ANGMARMANSSON B, 1982, CARIES RES, V16, P334, DOI 10.1159/000260617; ANGMARMANSSON B, 1984, CARIES RES, V18, P25, DOI 10.1159/000260743; Antoine D, 2009, J ANAT, V214, P45, DOI 10.1111/j.1469-7580.2008.01010.x; Aoba T, 2002, CRIT REV ORAL BIOL M, V13, P155, DOI 10.1177/154411130201300206; Beniash E, 2009, J STRUCT BIOL, V166, P133, DOI 10.1016/j.jsb.2009.02.001; Best EC, 2013, J MAMMAL, V94, P1237, DOI 10.1644/13-MAMM-A-054.1; Boulton IC, 1997, J MORPHOL, V232, P155; BOYDE A, 1967, Z ZELLFORSCH MIK ANA, V82, P558, DOI 10.1007/BF00337122; BOYDE A, 1983, ANAT EMBRYOL, V168, P211, DOI 10.1007/BF00315817; Boyde A., 1989, HDB MICROSCOPIC ANAT, P309; Bronckers ALJJ, 2009, J DENT RES, V88, P877, DOI 10.1177/0022034509343280; Chen J, 2014, ENVIRON GEOCHEM HLTH, V36, P735, DOI 10.1007/s10653-013-9592-1; Clarke E, 2006, J ZOO WILDLIFE MED, V37, P477, DOI 10.1638/05-053.1; Coulson Graeme, 2000, P360; Cutress T W, 1990, J Dent Res, V69 Spec No, P714; Dean HT, 1936, J AMER MED ASSOC, V107, P1269, DOI 10.1001/jama.1936.02770420007002; Dean M.C., 2000, P119, DOI 10.1017/CBO9780511542626.009; Death C, 2015, SCI TOTAL ENVIRON, V533, P528, DOI 10.1016/j.scitotenv.2015.06.054; Everett ET, 2011, J DENT RES, V90, P552, DOI 10.1177/0022034510384626; FEJERSKO.O, 1974, SCAND J DENT RES, V82, P357; FEJERSKOV O, 1979, ARCH ORAL BIOL, V24, P123, DOI 10.1016/0003-9969(79)90060-8; FEJERSKOV O, 1975, CARIES RES, V9, P190, DOI 10.1159/000260157; FEJERSKOV O, 1977, SCAND J DENT RES, V85, P510; Fejerskov O., 1988, DENT FLUOROSIS HDB H; Flueck WT, 2013, J WILDLIFE DIS, V49, P355, DOI 10.7589/2012-11-272; Garrott RA, 2002, ECOSYSTEMS, V5, P659, DOI 10.1007/s10021-002-0211-8; Goldstein J., 2018, SCANNING ELECT MICRO, V4th ed.; Gustavsen F, 1972, THESIS U BERGEN NORW; Hillson S, 1997, AM J PHYS ANTHROPOL, V104, P89, DOI 10.1002/(SICI)1096-8644(199709)104:1<89::AID-AJPA6>3.0.CO;2-8; Hillson S, 2014, TOOTH DEVELOPMENT IN HUMAN EVOLUTION AND BIOARCHAEOLOGY, P1, DOI 10.1017/CBO9780511894916; Hillson S., 2005, TEETH; Hufschmid J, 2015, J COMP PATHOL, V153, P167, DOI 10.1016/j.jcpa.2015.06.002; Hufschmid J, 2011, ECOTOXICOLOGY, V20, P1378, DOI 10.1007/s10646-011-0695-0; Hume I.D., 1999, MARSUPIAL NUTR; Karstad L., 1967, B WILDLIFE DIS ASSOC, V3, P42, DOI DOI 10.7589/0090-3558-3.2.42; Kierdorf H, 2005, ANAT EMBRYOL, V209, P281, DOI 10.1007/s00429-004-0442-x; Kierdorf H, 2004, ANAT EMBRYOL, V207, P463, DOI 10.1007/s00429-003-0368-8; Kierdorf H, 2012, J ANAT, V220, P484, DOI 10.1111/j.1469-7580.2012.01482.x; Kierdorf H, 1997, CELL TISSUE RES, V289, P125, DOI 10.1007/s004410050858; Kierdorf H, 1997, ANN ANAT, V179, P405, DOI 10.1016/S0940-9602(97)80032-5; Kierdorf H, 2000, ANAT RECORD, V259, P12; Kierdorf H, 2014, ANAT REC, V297, P1935, DOI 10.1002/ar.22951; Kierdorf H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074597; Kierdorf U, 1996, J ANAT, V188, P183; KIERDORF U, 1993, ARCH ORAL BIOL, V38, P1071, DOI 10.1016/0003-9969(93)90169-M; KIERDORF U, 1989, VET PATHOL, V26, P209, DOI 10.1177/030098588902600304; Kirkpatrick TH., 1969, THESIS U QUEENSLAND; Kirkpatrick TH, 1965, QUEENSL J AGR ANIM S, V209, P169; LeGeros R Z, 1996, Adv Dent Res, V10, P225; LUCKETT WP, 1993, MAMMAL PHYLOGENY, P182; Lyaruu DM, 2014, J DENT RES, V93, P96, DOI 10.1177/0022034513510944; Lyaruu DM, 2012, CARIES RES, V46, P575, DOI 10.1159/000341802; Lyaruu DM, 2011, ARCH ORAL BIOL, V56, P238, DOI 10.1016/j.archoralbio.2010.10.006; LYARUU DM, 1989, J HISTOCHEM CYTOCHEM, V37, P581, DOI 10.1177/37.5.2703697; Nanci A., 2013, 10 CATES ORAL HISTOL, P122; O'Connor J. A., 1982, Fluoride emissions. Their monitoring and effects on vegetation and ecosystems, P77; Owen R., ODONTOGRAPHY TREATIS, VI, P1840; PALAMARA J, 1984, CELL TISSUE RES, V238, P329; PALAMARA J, 1981, CELL TISSUE RES, V221, P405, DOI 10.1007/BF00216744; PARANJPE MG, 1994, TOXICOL PATHOL, V22, P569, DOI 10.1177/019262339402200601; Pasteris JD, 2008, ELEMENTS, V4, P97, DOI 10.2113/GSELEMENTS.4.2.97; POOLE W E, 1982, Mammalian Species, P1, DOI 10.2307/3504005; PURDELLLEWIS DJ, 1987, J BIOL BUCCALE, V15, P119; Rafferty DP, 2000, J WILDLIFE DIS, V36, P636, DOI 10.7589/0090-3558-36.4.636; RICHARDS A, 1986, J DENT RES, V65, P1406, DOI 10.1177/00220345860650120501; RICHARDS A, 1992, CARIES RES, V26, P328, DOI 10.1159/000261463; Risnes S, 1998, J HUM EVOL, V35, P331, DOI 10.1006/jhev.1998.0229; Roholm K., 1937, FLUORINE INTOXICATIO; Roschger P, 1998, BONE, V23, P319, DOI 10.1016/S8756-3282(98)00112-4; Saunders S.R., 2008, BIOL ANTHR HUMAN SKE, P237; Sharma R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010895; SHEARER TR, 1978, AM J VET RES, V39, P597; SHINODA H, 1978, CALC TISS RES, V25, P75, DOI 10.1007/BF02010754; Shupe J. L., 1983, FLUORIDES EFFECTS VE, P319; SHUPE JL, 1984, J AM VET MED ASSOC, V185, P1295; Simmer JP, 2010, J DENT RES, V89, P1024, DOI 10.1177/0022034510375829; Smedley PL, 2013, ESSENTIALS MED GEOLO, P311, DOI DOI 10.1007/978-94-007-4375-5_13; Smith CE, 2005, J BONE MINER RES, V20, P240, DOI 10.1359/JBMR.041002; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Smith TM, 2008, J HUM EVOL, V54, P205, DOI 10.1016/j.jhevol.2007.09.020; Smith TM, 2006, J ANAT, V208, P99, DOI 10.1111/j.1469-7580.2006.00499.x; SUCKLING G, 1984, ARCH ORAL BIOL, V29, P165, DOI 10.1016/0003-9969(84)90050-5; SUCKLING G, 1988, ARCH ORAL BIOL, V33, P361, DOI 10.1016/0003-9969(88)90070-2; Suckling G W, 1989, Adv Dent Res, V3, P87; SUCKLING GW, 1982, CARIES RES, V16, P227, DOI 10.1159/000260602; Suga S, 1983, MECHANISMS TOOTH ENA, P167; SUNDSTROM B, 1980, CARIES RES, V14, P381, DOI 10.1159/000260480; SUTTIE JS, 1987, J WILDLIFE DIS, V23, P135, DOI 10.7589/0090-3558-23.1.135; Suzuki Masatsugu, 2003, Anatomical Science International, V78, P53, DOI 10.1046/j.0022-7722.2003.00039.x; THYLSTRUP A, 1978, ARCH ORAL BIOL, V23, P373, DOI 10.1016/0003-9969(78)90095-X; THYLSTRUP A, 1979, SCAND J DENT RES, V87, P105; Tomes J., 1849, PHILOS T R SOC LOND, V139, P403; Vikoren T, 1996, J WILDLIFE DIS, V32, P181, DOI 10.7589/0090-3558-32.2.181; von Koenigswald W., 2000, P107, DOI 10.1017/CBO9780511542626.008; WALTON KC, 1987, SCI TOTAL ENVIRON, V65, P257, DOI 10.1016/0048-9697(87)90178-1; Warshawsky H., 1988, CELL TISSUE BIOL TXB, P595; Weinstein L.H., 2004, FLUORIDES ENV; Whitford GM, 1996, MONOGR ORAL SCI, V16, P1; WHO (World Health Organization), 2002, ENV HLTH CRIT, V227; Witzel C, 2008, AM J PHYS ANTHROPOL, V136, P400, DOI 10.1002/ajpa.20822	100	13	15	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0147427	10.1371/journal.pone.0147427	http://dx.doi.org/10.1371/journal.pone.0147427			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895178	Green Published, gold			2022-12-27	WOS:000371223400005
J	Osawa, K; Miyoshi, T; Miki, T; Koyama, Y; Sato, S; Kanazawa, S; Ito, H				Osawa, Kazuhiro; Miyoshi, Toru; Miki, Takashi; Koyama, Yasushi; Sato, Shuhei; Kanazawa, Susumu; Ito, Hiroshi			Diagnostic Performance of First-Pass Myocardial Perfusion Imaging without Stress with Computed Tomography (CT) Compared with Coronary CT Angiography Alone, with Fractional Flow Reserve as the Reference Standard	PLOS ONE			English	Article							NXT TRIAL ANALYSIS; ARTERY-DISEASE; ISCHEMIA; STENOSIS; REVASCULARIZATION; INTERVENTION; GUIDELINES; MANAGEMENT; CARDIOLOGY; SOCIETY	Coronary computed tomography angiography (CCTA) in combination with first-pass CT myocardial perfusion imaging (MPI) has a better diagnostic performance than CCTA alone, compared with invasive coronary angiography as the reference standard. The aim of this study was to investigate the additional diagnostic value of first-pass CT-MPI without stress for detecting hemodynamic significance of coronary stenosis, compared with invasive fractional flow reserve (FFR). We recruited 53 patients with suspected coronary artery disease undergoing both CCTA and first-pass CT-MPI without stress and invasive FFR, and 75 vessels were analyzed. We used the same raw data for CCTA and CT-MPI. First-pass CT-MPI was reconstructed by examining the diastolic signal densities as a bull's eye map. Invasive FFR <0.8 was considered as positive. On per-vessel analysis, the area under the receiver operating characteristic curve for CCTA plus first-pass CT-MPI and CCTA alone was 0.81 (0.73-0.90) and 0.70 (0.61-0.81), respectively (P = 0.036). CCTA plus first-pass CT-MPI without stress showed 0.73 sensitivity, 0.74 specificity, 0.53 positive predictive value, and 0.87 negative predictive value for detecting hemodynamically significant coronary stenosis. First-pass CT-MPI without stress correctly reclassified 38% of CCTA false-positive vessels as true negative. First-pass CT-MPI without stress combined with CCTA demonstrated excellent diagnostic accuracy, compared with invasive FFR as the reference standard. This technique could complement CCTA for diagnosis of coronary artery disease.	[Osawa, Kazuhiro; Miyoshi, Toru; Miki, Takashi; Ito, Hiroshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, Okayama, Japan; [Koyama, Yasushi] Sakurabashi Watanabe Hosp, Dept Cardiol, Osaka, Japan; [Sato, Shuhei; Kanazawa, Susumu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Radiol, Okayama, Japan	Okayama University; Okayama University	Miyoshi, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, Okayama, Japan.	miyoshit@cc.okayama-u.ac.jp	Osawa, Kazuhiro/ABE-7537-2020		 [24591053]		This research was supported by the Grant-in-Aid for Scientific Research (C), number 24591053.	Bamberg F, 2011, RADIOLOGY, V260, P689, DOI 10.1148/radiol.11110638; Blankstein R, 2009, J AM COLL CARDIOL, V54, P1072, DOI 10.1016/j.jacc.2009.06.014; Cerqueira MD, 2002, INT J CARDIOVAS IMAG, V18, P539; Curzen N, 2014, CIRC-CARDIOVASC INTE, V7, P248, DOI 10.1161/CIRCINTERVENTIONS.113.000978; Douglas PS, 2015, EUR HEART J, V36, P3359, DOI 10.1093/eurheartj/ehv444; Gaur S, 2013, J CARDIOVASC COMPUT, V7, P279, DOI 10.1016/j.jcct.2013.09.003; George RT, 2012, CIRC-CARDIOVASC IMAG, V5, P333, DOI 10.1161/CIRCIMAGING.111.969303; Hamilos M, 2009, CIRCULATION, V120, P1505, DOI 10.1161/CIRCULATIONAHA.109.850073; Kim YH, 2013, CIRC J, V77, P1967, DOI 10.1253/circj.CJ-13-0376; Ko BS, 2012, EUR HEART J, V33, P67, DOI 10.1093/eurheartj/ehr268; Koo BK, 2011, J AM COLL CARDIOL, V58, P1989, DOI 10.1016/j.jacc.2011.06.066; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P636, DOI 10.1016/j.jacc.2008.05.024; Min JK, 2015, JACC-CARDIOVASC IMAG, V8, P1209, DOI 10.1016/j.jcmg.2015.08.006; Min JK, 2012, JAMA-J AM MED ASSOC, V308, P1237, DOI 10.1001/2012.jama.11274; Miyoshi T, 2015, CIRC J, V79, P406, DOI 10.1253/circj.CJ-14-1051; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Norgaard BL, 2014, J AM COLL CARDIOL, V63, P1145, DOI 10.1016/j.jacc.2013.11.043; NOTO TJ, 1991, CATHETER CARDIO DIAG, V24, P75, DOI 10.1002/ccd.1810240202; Osawa K, 2014, HEART, V100, P1008, DOI 10.1136/heartjnl-2013-305468; Patel Manesh R, 2012, J Am Coll Cardiol, V59, P857, DOI 10.1016/j.jacc.2011.12.001; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Rochitte CE, 2014, EUR HEART J, V35, P1120, DOI 10.1093/eurheartj/eht488; Stuijfzand WJ, 2014, JACC-CARDIOVASC IMAG, V7, P374, DOI 10.1016/j.jcmg.2013.12.013; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Vavere AL, 2011, RADIOLOGY, V261, P100, DOI 10.1148/radiol.11110537; Yamada M, 2011, CIRC J, V75, P472, DOI 10.1253/circj.CJ-10-0636; Yoshioka K, 2015, INT J CARDIOVAS IMAG, V31, P51, DOI 10.1007/s10554-015-0630-1; Zoghbi GJ, 2008, J AM COLL CARDIOL, V52, P401, DOI 10.1016/j.jacc.2008.04.035	29	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149170	10.1371/journal.pone.0149170	http://dx.doi.org/10.1371/journal.pone.0149170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894686	Green Submitted, Green Published, gold			2022-12-27	WOS:000371223400034
J	Eich, C; Lasonder, E; Cruz, LJ; Reinieren-Beeren, I; Cambi, A; Figdor, CG; Buschow, SI				Eich, Christina; Lasonder, Edwin; Cruz, Luis J.; Reinieren-Beeren, Inge; Cambi, Alessandra; Figdor, Carl G.; Buschow, Sonja I.			Proteome Based Construction of the Lymphocyte Function-Associated Antigen 1 (LFA-1) Interactome in Human Dendritic Cells	PLOS ONE			English	Article							T-CELL; INTEGRIN; RECEPTOR; ADHESION; ACTIVATION; ORGANIZATION; MIGRATION; TALIN; RECRUITMENT; REGULATOR	The beta 2-integrin lymphocyte function-associated antigen 1 (LFA-1) plays an important role in the migration, adhesion and intercellular communication of dendritic cells (DCs). During the differentiation of human DCs from monocyte precursors, LFA-1 ligand binding capacity is completely lost, even though its expression levels were remained constant. Yet LFA-1-mediated adhesive capacity on DCs can be regained by exposing DCs to the chemokine CCL21, suggesting a high degree of regulation of LFA-1 activity during the course of DC differentiation. The molecular mechanisms underlying this regulation of LFA-1 function in DCs, however, remain elusive. To get more insight we attempted to identify specific LFA-1 binding partners that may play a role in regulating LFA-1 activity in DCs. We used highly sensitive label free quantitative mass-spectrometry to identify proteins co-immunoprecipitated (co-IP) with LFA-1 from ex vivo generated DCs. Among the potential binding partners we identified not only established components of integrin signalling pathways and cytoskeletal proteins, but also several novel LFA-1 binding partners including CD13, galectin-3, thrombospondin-1 and CD44. Further comparison to the LFA-1 interaction partners in monocytes indicated that DC differentiation was accompanied by an overall increase in LFA-1 associated proteins, in particular cytoskeletal, signalling and plasma membrane (PM) proteins. The here presented LFA-1 interactome composed of 78 proteins thus represents a valuable resource of potential regulators of LFA-1 function during the DC lifecycle.	[Eich, Christina; Reinieren-Beeren, Inge; Cambi, Alessandra; Figdor, Carl G.; Buschow, Sonja I.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Tumor Immunol, NL-6525 ED Nijmegen, Netherlands; [Lasonder, Edwin] Radboud Univ Nijmegen, Med Ctr, CMBI, Radboud Inst Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Cruz, Luis J.] Leiden Univ, Med Ctr, Dept Radiol, Nanomed & Mol Imaging, Leiden, Netherlands; [Eich, Christina] Erasmus MC, Stem Cell Inst, Dept Cell Biol, Rotterdam, Netherlands; [Lasonder, Edwin] Univ Plymouth, Sch Biomed & Healthcare Sci, Plymouth PL4 8AA, Devon, England; [Buschow, Sonja I.] Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; University of Plymouth; Erasmus University Rotterdam; Erasmus MC	Figdor, CG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Tumor Immunol, NL-6525 ED Nijmegen, Netherlands.	carl.figdor@radboudumc.nl	Figdor, Carl G/A-4232-2010; Buschow, Sonja/AAD-3567-2020; Cambi, Alessandra/L-4242-2015	Figdor, Carl G/0000-0002-2366-9212; Lasonder, Edwin/0000-0003-2582-3444; Eich, Christina/0000-0001-7839-0932; Buschow, Sonja/0000-0002-7907-8315; Cambi, Alessandra/0000-0003-1597-1582	EU [MRTN-CT-2006-035946]; EU-Mexico grant FONCICYT; Netherlands Organization for Scientific Research grant [Meervoud 836.09.002]; Netherlands Organization for Scientific Research Spinoza Prize; ERC Adv Grant PATHFINDER [269019]; KWO award of the Dutch Cancer Society [KUN2009-4402]	EU(European Commission); EU-Mexico grant FONCICYT; Netherlands Organization for Scientific Research grant(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research Spinoza Prize; ERC Adv Grant PATHFINDER; KWO award of the Dutch Cancer Society	This work was financially supported by the EU grant Immunanomap, MRTN-CT-2006-035946 (to CGF, http://ec.europa.eu/research/participants/portal/desktop/en/home.html), the EU-Mexico grant FONCICYT (to CGF) and the Netherlands Organization for Scientific Research grant Meervoud 836.09.002 (to AC, www.nwo.nl). CGF is recipient of the Netherlands Organization for Scientific Research Spinoza Prize, ERC Adv Grant PATHFINDER (269019) and KWO award KUN2009-4402 of the Dutch Cancer Society (www.kwf.nl).	Abdel-Latif MMM, 2005, BRIT J PHARMACOL, V146, P1139, DOI 10.1038/sj.bjp.0706421; Alon R, 2007, IMMUNITY, V26, P17, DOI 10.1016/j.immuni.2007.01.002; Arana E, 2008, IMMUNITY, V28, P88, DOI 10.1016/j.immuni.2007.12.003; Attanasio F, 2011, EUR J CELL BIOL, V90, P115, DOI 10.1016/j.ejcb.2010.05.004; Bakker GJ, 2012, PNAS IN PRESS; Bernardini G, 2005, FASEB J, V19, P1305, DOI 10.1096/fj.04-3352fje; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Borgman KJE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099589; Buschow SI, 2010, J PROTEOME RES, V9, P1727, DOI 10.1021/pr9008546; Cambi A, 2006, MOL BIOL CELL, V17, P4270, DOI 10.1091/mbc.E05-12-1098; Cervero P, 2012, EUR J CELL BIOL, V91, P908, DOI 10.1016/j.ejcb.2012.05.005; Choi EY, 2008, BLOOD, V111, P3607, DOI 10.1182/blood-2007-07-103077; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Eich C, 2011, IMMUNOL CELL BIOL, V89, P458, DOI 10.1038/icb.2010.103; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Fengos G, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-23; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Geiger T, 2012, CURR OPIN CELL BIOL, V24, P562, DOI 10.1016/j.ceb.2012.05.004; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Gonzalo P, 2010, BIOFACTORS, V36, P248, DOI 10.1002/biof.99; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Humphries JD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000396; Jacquemet Guillaume, 2013, Small GTPases, V4, P199, DOI 10.4161/sgtp.27451; Johnson LA, 2008, ANN NY ACAD SCI, V1131, P119, DOI 10.1196/annals.1413.011; Katagiri K, 2002, MOL CELL BIOL, V22, P1001, DOI 10.1128/MCB.22.4.1001-1015.2002; KEIZER GD, 1985, EUR J IMMUNOL, V15, P1142, DOI 10.1002/eji.1830151114; Krauss K, 1999, J BIOL CHEM, V274, P36921, DOI 10.1074/jbc.274.52.36921; Kueh HY, 2008, J CELL BIOL, V182, P341, DOI 10.1083/jcb.200801027; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Lakshminarayan R, 2014, NAT CELL BIOL, V16, P592, DOI 10.1038/ncb2970; Lasserre R, 2008, NAT CHEM BIOL, V4, P538, DOI 10.1038/nchembio.103; Laudanna C, 2009, WIRES SYST BIOL MED, V1, P116, DOI 10.1002/wsbm.9; Mina-Osorio P, 2008, J LEUKOCYTE BIOL, V84, P448, DOI 10.1189/jlb.1107802; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Ono S, 2004, J BIOL CHEM, V279, P14207, DOI 10.1074/jbc.M313418200; PETER K, 1995, J EXP MED, V181, P315, DOI 10.1084/jem.181.1.315; Pontier SM, 2008, J BIOL CHEM, V283, P24659, DOI 10.1074/jbc.M800778200; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Sampath R, 1998, J BIOL CHEM, V273, P33588, DOI 10.1074/jbc.273.50.33588; Saravanan C, 2009, J CELL SCI, V122, P3684, DOI 10.1242/jcs.045674; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Tsukamoto N, 1999, J BIOL CHEM, V274, P18463, DOI 10.1074/jbc.274.26.18463; van Zanten TS, 2009, P NATL ACAD SCI USA, V106, P18557, DOI 10.1073/pnas.0905217106; Ye F, 2014, CELL, V156, DOI 10.1016/j.cell.2014.02.048; Zaidel-Bar R, 2009, J CELL BIOL, V186, P317, DOI 10.1083/jcb.200811067; Zarbock A, 2007, BLOOD, V110, P3773, DOI 10.1182/blood-2007-06-094565; Zarbock A, 2007, IMMUNITY, V26, P773, DOI 10.1016/j.immuni.2007.04.011; Zhang YB, 2012, IMMUNOLOGY, V135, P268, DOI 10.1111/j.1365-2567.2011.03549.x	55	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149637	10.1371/journal.pone.0149637	http://dx.doi.org/10.1371/journal.pone.0149637			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26889827	gold, Green Accepted, Green Published			2022-12-27	WOS:000371221500065
J	Tobita, T; Guzman-Lepe, J; Takeishi, K; Nakao, T; Wang, Y; Meng, FY; Deng, CX; Collin de l'Hortet, A; Soto-Gutierrez, A				Tobita, Takamasa; Guzman-Lepe, Jorge; Takeishi, Kazuki; Nakao, Toshimasa; Wang, Yang; Meng, Fanying; Deng, Chu-Xia; Collin de l'Hortet, Alexandra; Soto-Gutierrez, Alejandro			SIRT1 Disruption in Human Fetal Hepatocytes Leads to Increased Accumulation of Glucose and Lipids	PLOS ONE			English	Article							FATTY LIVER-DISEASE; INSULIN-RESISTANCE; HEPATIC STEATOSIS; RESTRICTION LEADS; METABOLISM; EXPRESSION; MICE; DIET; GLUCONEOGENESIS; PROTECTS	There are unprecedented epidemics of obesity, such as type II diabetes and non-alcoholic fatty liver diseases (NAFLD) in developed countries. A concerning percentage of American children are being affected by obesity and NAFLD. Studies have suggested that the maternal environment in utero might play a role in the development of these diseases later in life. In this study, we documented that inhibiting SIRT1 signaling in human fetal hepatocytes rapidly led to an increase in intracellular glucose and lipids levels. More importantly, both de novo lipogenesis and gluconeogenesis related genes were upregulated upon SIRT1 inhibition. The AKT/FOXO1 pathway, a major negative regulator of gluconeogenesis, was decreased in the human fetal hepatocytes inhibited for SIRT1, consistent with the higher level of gluconeogenesis. These results indicate that SIRT1 is an important regulator of lipid and carbohydrate metabolisms within human fetal hepatocytes, acting as an adaptive transcriptional response to environmental changes.	[Tobita, Takamasa; Guzman-Lepe, Jorge; Takeishi, Kazuki; Nakao, Toshimasa; Wang, Yang; Meng, Fanying; Collin de l'Hortet, Alexandra; Soto-Gutierrez, Alejandro] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Soto-Gutierrez, Alejandro] Univ Pittsburgh, Thomas E Starzl Transplant Inst, Pittsburgh, PA USA; [Soto-Gutierrez, Alejandro] McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Wang, Yang] Peking Univ, Peoples Hosp, Dept Hepatobiliary Surg, Beijing 100871, Peoples R China; [Deng, Chu-Xia] Univ Macau, Fac Hlth Sci, Ave Univ, Taipa, Macau, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Peking University; University of Macau	Collin de l'Hortet, A; Soto-Gutierrez, A (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA.; Soto-Gutierrez, A (corresponding author), Univ Pittsburgh, Thomas E Starzl Transplant Inst, Pittsburgh, PA USA.; Soto-Gutierrez, A (corresponding author), McGowan Inst Regenerat Med, Pittsburgh, PA USA.	alexandra.collin@pitt.edu; sotogutierreza@upmc.edu	deng, chuxia/N-6713-2016; Collin de l'Hortet, Alexandra/D-6025-2016; Takeishi, Kazuki/AAC-9087-2019	Collin de l'Hortet, Alexandra/0000-0002-9437-7030; Takeishi, Kazuki/0000-0002-8448-5396	US National Institutes of Health [DK099257, UH3TR000503, ES022606]; Competitive Medical Research Fund Program from UPMC Health System; NIH from the Eunice Kennedy Shriver National Institute of Child Health AMP; Human Development [5R24HD000836]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD000836] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH3TR000503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022606] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Competitive Medical Research Fund Program from UPMC Health System; NIH from the Eunice Kennedy Shriver National Institute of Child Health AMP; Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding from the US National Institutes of Health (DK099257 to A.S.-G., UH3TR000503 and ES022606 subcontract to A.S.-G.), and the Competitive Medical Research Fund Program from UPMC Health System to A.S.-G. Laboratory of Developmental Biology was supported by NIH Award Number 5R24HD000836 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development.	Alisi A, 2012, NAT REV GASTRO HEPAT, V9, P152, DOI 10.1038/nrgastro.2011.273; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Borengasser SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084209; Brenseke B, 2015, ENDOCRINOLOGY, V156, P182, DOI 10.1210/en.2014-1523; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Chang HC, 2014, TRENDS ENDOCRIN MET, V25, P138, DOI 10.1016/j.tem.2013.12.001; Chatelain F, 1996, EUR J BIOCHEM, V235, P789, DOI 10.1111/j.1432-1033.1996.00789.x; Christopher L., 2009, NATURE REV CANC, V9; Clayton ZE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141962; Clive J., 2001, INT J EXPT DIABETES, V2, P139; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Deng XQ, 2007, LIVER INT, V27, P708, DOI 10.1111/j.1478-3231.2007.01497.x; Erion DM, 2009, P NATL ACAD SCI USA, V106, P11288, DOI 10.1073/pnas.0812931106; Fernandez-Twinn DS, 2005, AM J PHYSIOL-REG I, V288, pR368, DOI 10.1152/ajpregu.00206.2004; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Joseph T., 2005, NATURE, V434, P113, DOI [10.1038/nature03314, DOI 10.1038/NATURE03314]; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Li Y, 2011, FASEB J, V25, P1664, DOI 10.1096/fj.10-173492; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nobili V, 2015, JAMA PEDIATR, V169, P170, DOI 10.1001/jamapediatrics.2014.2702; Ozanne SE, 2003, J ENDOCRINOL, V177, P235, DOI 10.1677/joe.0.1770235; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rando OJ, 2015, CELL, V161, P93, DOI 10.1016/j.cell.2015.02.021; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Schug TT, 2011, ANN MED, V43, P198, DOI 10.3109/07853890.2010.547211; Suter MA, 2012, FASEB J, V26, P5106, DOI 10.1096/fj.12-212878; VALDEZ R, 1994, DIABETOLOGIA, V37, P624, DOI 10.1007/s001250050157; Wang RH, 2011, J CLIN INVEST, V121, P4477, DOI 10.1172/JCI46243; Wang RH, 2010, INT J BIOL SCI, V6, P682; Yamamoto M, 2013, P NATL ACAD SCI USA, V110, P14948, DOI 10.1073/pnas.1220606110	36	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149344	10.1371/journal.pone.0149344	http://dx.doi.org/10.1371/journal.pone.0149344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890260	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000371221500038
J	Zhang, LB; Yang, L; Luo, TJ				Zhang, Libo; Yang, Lin; Luo, Tiejian			Unified Saliency Detection Model Using Color and Texture Features	PLOS ONE			English	Article							BOTTOM-UP; REGION DETECTION; RECOGNITION; IMAGE	Saliency detection attracted attention of many researchers and had become a very active area of research. Recently, many saliency detection models have been proposed and achieved excellent performance in various fields. However, most of these models only consider low-level features. This paper proposes a novel saliency detection model using both color and texture features and incorporating higher-level priors. The SLIC superpixel algorithm is applied to form an over-segmentation of the image. Color saliency map and texture saliency map are calculated based on the region contrast method and adaptive weight. Higher-level priors including location prior and color prior are incorporated into the model to achieve a better performance and full resolution saliency map is obtained by using the up-sampling method. Experimental results on three datasets demonstrate that the proposed saliency detection model outperforms the state-of-the-art models.	[Zhang, Libo; Yang, Lin; Luo, Tiejian] Univ Chinese Acad Sci, Sch Comp & Control, Beijing, Peoples R China; [Zhang, Libo; Yang, Lin; Luo, Tiejian] Youth Apartment 80 Zhongguancun East Rd, Beijing 100090, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, LB (corresponding author), Youth Apartment 80 Zhongguancun East Rd, Beijing 100090, Peoples R China.	zsmj@hotmail.com						Achanta R, 2010, IM PROC ICIP 2010 17; Achanta R, 2008, LECT NOTES COMPUT SC, V5008, P66; Achanta R, 2012, IEEE T PATTERN ANAL, V34, P2274, DOI 10.1109/TPAMI.2012.120; Achanta Radhakrishna, 2009, COMP VIS PATT REC 20, P1597; Alexe B., 2010, COMP VIS PATT REC CV; [Anonymous], 2007, COMP VIS PATT REC 20; Avidan S, 2007, ACM T GRAPHIC, V26, DOI 10.1145/1239451.1239461; Bruce N., 2005, ADV NEURAL INFORM PR; Chen ZZ, 2013, IEEE SIGNAL PROC LET, V20, P95, DOI 10.1109/LSP.2012.2230442; Cheng MM, 2015, IEEE T PATTERN ANAL, V37, P569, DOI 10.1109/TPAMI.2014.2345401; Deng T, 2014, INT TRANSP SYST ITSC; Donoser M, 2009, COMP VIS 2009 IEEE 1; Gao Y, 2013, IEEE T IMAGE PROCESS, V22, P363, DOI 10.1109/TIP.2012.2202676; Goferman S, 2012, IEEE T PATTERN ANAL, V34, P1915, DOI 10.1109/TPAMI.2011.272; Guo CL, 2010, IEEE T IMAGE PROCESS, V19, P185, DOI 10.1109/TIP.2009.2030969; Harel J., PROC, V733; HU M, 1962, IRE T INFORM THEOR, V8, P179, DOI 10.1109/tit.1962.1057692; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Judd Tilke, 2009, COMP VIS 2009 IEEE 1; Jung C, 2012, IEEE T IMAGE PROCESS, V21, P1272, DOI 10.1109/TIP.2011.2164420; Li J, 2015, IEEE T PATTERN ANAL, V37, P2428, DOI 10.1109/TPAMI.2015.2424870; Li Y., 2014, P IEEE C COMP VIS PA; Liu T, 2011, IEEE T PATTERN ANAL, V33, P353, DOI 10.1109/TPAMI.2010.70; Ma Q, 2010, J ELECTRON IMAGING, V19, DOI 10.1117/1.3302129; Marchesotti L, 2009, COMP VIS 2009 IEEE 1; Murray N, 2011, COMP VIS PATT REC CV; Ninassi A, 2007, IM PROC 2007 ICIP 20; Perazzi F, 2012, COMP VIS PATT REC CV; Ren Y-F, 2014, MACH LEARN CYB ICMLC; Ren ZX, 2014, IEEE T CIRC SYST VID, V24, P769, DOI 10.1109/TCSVT.2013.2280096; Rutishauser U, 2004, COMP VIS PATT REC 20; Tatler BW, 2005, VISION RES, V45, P643, DOI 10.1016/j.visres.2004.09.017; Tian HW, 2014, IEEE T IMAGE PROCESS, V23, P4389, DOI 10.1109/TIP.2014.2350914; Tian YH, 2015, INT J COMPUT VISION, V111, P153, DOI 10.1007/s11263-014-0737-1; Walther D, 2005, COMPUT VIS IMAGE UND, V100, P41, DOI 10.1016/j.cviu.2004.09.004; Xia C, 2015, PATTERN RECOGN, V48, P1337, DOI 10.1016/j.patcog.2014.10.007; Xiaoguang Cui, 2014, Journal of Multimedia, V9, P173, DOI 10.4304/jmm.9.1.173-180; Zhou L, 2015, IEEE T IMAGE PROCESS, V24, DOI 10.1109/TIP.2015.2438546; Zhu GK, 2014, COMPUT VIS IMAGE UND, V118, P40, DOI 10.1016/j.cviu.2013.07.011; Zhu L, 2014, IEEE T IMAGE PROCESS, V23, P5094, DOI 10.1109/TIP.2014.2361024	41	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149328	10.1371/journal.pone.0149328	http://dx.doi.org/10.1371/journal.pone.0149328			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26889826	Green Published, Green Submitted, gold			2022-12-27	WOS:000371221500035
J	Brostrom, L; Bolk, J; Padilla, N; Skiold, B; Eklof, E; Martensson, G; Vollmer, B; Aden, U				Brostrom, Lina; Bolk, Jenny; Padilla, Nelly; Skiold, Beatrice; Eklof, Eva; Martensson, Gustaf; Vollmer, Brigitte; Aden, Ulrika			Clinical Implications of Diffuse Excessive High Signal Intensity (DEHSI) on Neonatal MRI in School Age Children Born Extremely Preterm	PLOS ONE			English	Article							TERM-EQUIVALENT AGE; CEREBRAL WHITE-MATTER; NEURODEVELOPMENTAL OUTCOMES; DIFFICULTIES QUESTIONNAIRE; PREMATURE-INFANTS; BRAIN; BIRTH; ABNORMALITY; STRENGTHS; COHORT	Objective Magnetic resonance imaging (MRI) of the brain carried out during the neonatal period shows that 55-80% of extremely preterm infants display white matter diffuse excessive high signal intensity (DEHSI). Our aim was to study differences in developmental outcome at the age of 6.5 years in children born extremely preterm with and without DEHSI. Study Design This was a prospective cohort study of 83 children who were born in Stockholm, Sweden, between 2004 and 2007, born at gestational age of <27 weeks + 0 days and who underwent an MRI scan of their brain at term equivalent age. The outcome measures at 6.5 years included testing 66 children with the modified Touwen neurology examination, the Movement Assessment Battery for Children 2, the Wechsler Intelligence Scale for Children-Fourth Edition, Beery Visual-motor Integration test-Sixth Edition, and the Strengths and Difficulties Questionnaire. Group-wise comparisons were done between children with and without DEHSI using Student t-test, Mann Whitney U test, Chi square test and regression analysis. Results DEHSI was detected in 39 (59%) of the 66 children who were assessed at 6.5 years. The presence of DEHSI was not associated with mild neurological dysfunction, scores on M-ABC assessment, cognition, visual-motor integration, or behavior at 6.5 years. Conclusion The presence of qualitatively defined DEHSI on neonatal MRI did not prove to be a useful predictor of long-term impairment in children born extremely preterm.	[Brostrom, Lina; Bolk, Jenny; Padilla, Nelly; Skiold, Beatrice; Eklof, Eva; Martensson, Gustaf; Vollmer, Brigitte; Aden, Ulrika] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Bolk, Jenny] Sachs Children & Youth Hosp, Neonatal Unit, Stockholm, Sweden; [Skiold, Beatrice; Aden, Ulrika] Karolinska Univ Hosp, Neonatal Unit, Stockholm, Sweden; [Vollmer, Brigitte] Univ Southampton, Clin Neurosci Clin & Expt Sci, Southampton, Hants, England	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Southampton	Brostrom, L (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.	lina.brostrom@ki.se	Padilla, Nelly/T-9998-2019; vollmer, brigitte/AAB-3132-2020	vollmer, brigitte/0000-0003-4088-5336; Eklof, Eva/0000-0001-6692-8635; Bolk, Jenny/0000-0002-4240-261X	Swedish Medical Research Council [523-2011-3981]; Stockholm County Council [ALF-20140316]; Karolinska Institutet [ALF-20140316]; Marianne and Marcus Wallenberg foundation [2011.0085]; Swedish Order of Freemasons in Stockholm; Swedish Medical Society; Swedish Brain Foundation [FP2014-0135]; Sallskapet Barnavard	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Marianne and Marcus Wallenberg foundation; Swedish Order of Freemasons in Stockholm; Swedish Medical Society; Swedish Brain Foundation; Sallskapet Barnavard	This work was supported by the Swedish Medical Research Council (grant numbers, 523-2011-3981), the regional agreement on medical training and clinical research (grant number, ALF-20140316) between Stockholm County Council and the Karolinska Institutet, the Marianne and Marcus Wallenberg foundation (grant number, 2011.0085), the Swedish Order of Freemasons in Stockholm, the Swedish Medical Society, the Swedish Brain Foundation (grant number, FP2014-0135) and Sallskapet Barnavard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D.G., 1991, PRACTICAL STATISTIC; Beery K. E, 2006, BEERY VMI BEERY BUKT; Calloni SF, 2015, RADIOL MED, V120, P1056, DOI 10.1007/s11547-015-0540-2; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; Cheong JLY, 2009, AM J NEURORADIOL, V30, P623, DOI 10.3174/ajnr.A1399; COCKBURN F, 1993, LANCET, V342, P193; Counsell SJ, 2006, PEDIATRICS, V117, P376, DOI 10.1542/peds.2005-0820; Counsell SJ, 2003, PEDIATRICS, V112, P1, DOI 10.1542/peds.112.1.1; de Bruine FT, 2011, RADIOLOGY, V261, P899, DOI 10.1148/radiol.11110797; De Rose P, 2013, EARLY HUM DEV, V89, P809, DOI 10.1016/j.earlhumdev.2013.07.001; Dyet LE, 2006, PEDIATRICS, V118, P536, DOI 10.1542/peds.2005-1866; Fily A, 2003, ACTA PAEDIATR, V92, P1433, DOI 10.1080/08035250310006926; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Hadders-Algra M, 2002, DEV MED CHILD NEUROL, V44, P561; Hagmann CF, 2009, RADIOLOGY, V252, P209, DOI 10.1148/radiol.2522080589; Hart A, 2011, PEDIATR RADIOL, V41, P1284, DOI 10.1007/s00247-011-2155-7; Henderson S. E., 2007, MOVEMENT ABC MOVEMEN, Vsecond; Inder TE, 2003, J PEDIATR-US, V143, P171, DOI 10.1067/S0022-3476(03)00357-3; Iwata S, 2007, INT J DEV NEUROSCI, V25, P523, DOI 10.1016/j.ijdevneu.2007.09.009; Iwata S, 2012, PEDIATRICS, V129, pE1138, DOI 10.1542/peds.2011-1735; Jeon TY, 2012, RADIOLOGY, V263, P518, DOI 10.1148/radiol.12111615; Kidokoro H, 2011, AM J NEURORADIOL, V32, P2005, DOI 10.3174/ajnr.A2703; Kostovic I, 2014, BRAIN STRUCT FUNCT, V219, P231, DOI 10.1007/s00429-012-0496-0; Krishnan ML, 2007, PEDIATRICS, V120, pE604, DOI 10.1542/peds.2006-3054; Larroque B, 2008, LANCET, V371, P813, DOI 10.1016/S0140-6736(08)60380-3; Leitner Y, 2014, NEURORADIOLOGY, V56, P669, DOI 10.1007/s00234-014-1373-8; Lind A, 2011, DEV MED CHILD NEUROL, V53, P256, DOI 10.1111/j.1469-8749.2010.03828.x; Maalouf EF, 1999, J PEDIATR-US, V135, P351, DOI 10.1016/S0022-3476(99)70133-2; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Parikh NA, 2013, PEDIATR NEUROL, V49, P424, DOI 10.1016/j.pediatrneurol.2013.08.026; Sannia A, 2015, J MATERN-FETAL NEO M, V28, P2268, DOI 10.3109/14767058.2013.796166; Skiold B, 2010, ACTA PAEDIATR, V99, P842, DOI 10.1111/j.1651-2227.2009.01634.x; Smedje H, 1999, EUR CHILD ADOLES PSY, V8, P63, DOI 10.1007/s007870050086; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wechsler D, 1974, WECHSLER INTELLIGENC; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792	36	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149578	10.1371/journal.pone.0149578	http://dx.doi.org/10.1371/journal.pone.0149578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886451	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000371218400098
J	Mariani, J; Macchia, A; De Abreu, M; Monte, GGV; Tajer, C				Mariani, Javier; Macchia, Alejandro; De Abreu, Maximiliano; Villa Monte, Gabriel Gonzalez; Tajer, Carlos			Multivessel versus Single Vessel Angioplasty in Non-ST Elevation Acute Coronary Syndromes: A Systematic Review and Metaanalysis	PLOS ONE			English	Review							UNSTABLE ANGINA; PERCUTANEOUS REVASCULARIZATION; MYOCARDIAL-INFARCTION; AMERICAN-COLLEGE; ARTERY-DISEASE; INTERVENTION; PCI; ERA	Background Multivessel disease is common in acute coronary syndrome patients. However, if multivessel percutaneous coronary intervention is superior to culprit-vessel angioplasty has not been systematically addressed. Methods A metaanalysis was conducted including studies that compared multivessel angioplasty with culprit-vessel angioplasty among non-ST elevation ACS patients. Since all studies were observational adjusted estimates of effects were used. Pooled estimates of effects were computed using the generic inverse of variance with a random effects model. Results Twelve studies were included (n = 117,685). Median age was 64.1 years, most patients were male, 29.3% were diabetic and 36,9% had previous myocardial infarction. Median follow-up was 12 months. There were no significant differences in mortality risk (HR 0.79; 95% CI 0.58 to 1.09; I-2 67.9%), with moderate inconsistency. Also, there were no significant differences in the risk of death or MI (HR 0.90; 95% CI 0.69 to 1.17; I-2 62.3%), revascularization (HR 0.76; 95% CI 0.55 to 1.05; I-2 49.9%) or in the combined incidence of death, myocardial infarction or revascularization (HR 0.83; 95% CI 0.66 to 1.03; I-2 70.8%). All analyses exhibited a moderate degree of inconsistency. Subgroup analyses by design reduced the inconsistency of the analyses on death or myocardial infarction, revascularization and death, myocardial infarction or revascularization. There was evidence of publication bias (Egger's test p = 0.097). Conclusion Routine multivessel angioplasty in non-ST elevation acute coronary syndrome patients with multivessel disease was not superior to culprit-vessel angioplasty. Randomized controlled trials comparing safety and effectiveness of both strategies in this setting are needed.	[Mariani, Javier; De Abreu, Maximiliano; Villa Monte, Gabriel Gonzalez; Tajer, Carlos] Hosp El Cruce Nestor Carlos Kirchner, Dept Cardiol, Av Calchaqui 5401,B1888AAE, Buenos Aires, DF, Argentina; [Mariani, Javier; Macchia, Alejandro] Fdn GESICA, Av Rivadavia 2358,C1034ACP, Buenos Aires, DF, Argentina		Mariani, J (corresponding author), Hosp El Cruce Nestor Carlos Kirchner, Dept Cardiol, Av Calchaqui 5401,B1888AAE, Buenos Aires, DF, Argentina.; Mariani, J (corresponding author), Fdn GESICA, Av Rivadavia 2358,C1034ACP, Buenos Aires, DF, Argentina.	ja_mariani@hotmail.com	Macchia, Alejandro/AAV-9665-2020; Mariani, Javier/P-9144-2018; Villa, Mauro/C-9883-2009	Macchia, Alejandro/0000-0002-5424-5009; Villa, Mauro/0000-0002-9181-8048; de Abreu, Maximiliano/0000-0002-8044-2452; Tajer, Carlos/0000-0002-6787-6651				Amsterdam EA, 2014, CIRCULATION, V130, pE344, DOI [10.1161/CIR.0000000000000134, 10.1161/CIR.0000000000000151]; Bauer T, 2013, INT J CARDIOL, V166, P596, DOI 10.1016/j.ijcard.2011.11.024; Bhatt DL, 2005, CIRCULATION, V112, P906, DOI 10.1161/CIRCULATIONAHA.104.483297; Brener SJ, 2002, AM J CARDIOL, V90, P631, DOI 10.1016/S0002-9149(02)02569-9; Brener SJ, 2008, AM HEART J, V155, P140, DOI 10.1016/j.ahj.2007.09.007; Buffon A, 2002, NEW ENGL J MED, V347, P5, DOI 10.1056/NEJMoa012295; DEFEYTER PJ, 1986, EUR HEART J, V7, P460, DOI 10.1093/oxfordjournals.eurheartj.a062092; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hannan EL, 2009, JACC-CARDIOVASC INTE, V2, P17, DOI 10.1016/j.jcin.2008.08.021; Hassanin A, 2015, EUROINTERVENTION, V11, P293, DOI 10.4244/EIJY14M08_05; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ijsselmuiden AJJ, 2004, AM HEART J, V148, P467, DOI 10.1016/j.ahj.2004.03.026; Kim MC, 2011, INT J CARDIOL, V153, P148, DOI 10.1016/j.ijcard.2010.08.044; Lee HJ, 2011, CLIN CARDIOL, V34, P160, DOI 10.1002/clc.20858; Loh JP, 2014, AM HEART J, V168, P248, DOI 10.1016/j.ahj.2014.05.018; Mariani G, 2001, CATHETER CARDIO INTE, V54, P448, DOI 10.1002/ccd.1309; Nikolsky Eugenia, 2004, J Invasive Cardiol, V16, P102; Onuma Y, 2013, EUROINTERVENTION, V9, P916, DOI 10.4244/EIJV9I8A154; Palmer N D, 2004, J Invasive Cardiol, V16, P185; Schwarzer G., 2015, META GEN PACKAGE MET; Senoo T, 2010, AM J CARDIOL, V105, P624, DOI 10.1016/j.amjcard.2009.10.044; Shishehbor MH, 2007, J AM COLL CARDIOL, V49, P849, DOI 10.1016/j.jacc.2006.10.054; Shishelibor MH, 2006, AM J CARDIOL, V97, P1585, DOI 10.1016/j.amjcard.2005.12.049; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Wallentin L, 1999, LANCET, V354, P708; Zapata GO, 2009, J INTERV CARDIOL, V22, P329, DOI 10.1111/j.1540-8183.2009.00477.x; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	31	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148756	10.1371/journal.pone.0148756	http://dx.doi.org/10.1371/journal.pone.0148756			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886918	Green Published, gold, Green Submitted			2022-12-27	WOS:000371218400047
J	Romer, M; Eichner, J; Drager, A; Wrzodek, C; Wrzodek, F; Zell, A				Roemer, Michael; Eichner, Johannes; Draeger, Andreas; Wrzodek, Clemens; Wrzodek, Finja; Zell, Andreas			ZBIT Bioinformatics Toolbox: A Web-Platform for Systems Biology and Expression Data Analysis	PLOS ONE			English	Article							GENE-EXPRESSION; PATHWAY DATA; ARRAY DATA; SBML; MODELS; MICROARRAY; IDENTIFICATION; TOXICITY; CLASSIFICATION; REPRESENTATION	Bioinformatics analysis has become an integral part of research in biology. However, installation and use of scientific software can be difficult and often requires technical expert knowledge. Reasons are dependencies on certain operating systems or required third-party libraries, missing graphical user interfaces and documentation, or nonstandard input and output formats. In order to make bioinformatics software easily accessible to researchers, we here present a web-based platform. The Center for Bioinformatics Tuebingen (ZBIT) Bioinformatics Toolbox provides web-based access to a collection of bioinformatics tools developed for systems biology, protein sequence annotation, and expression data analysis. Currently, the collection encompasses software for conversion and processing of community standards SBML and BioPAX, transcription factor analysis, and analysis of microarray data from transcriptomics and proteomics studies. All tools are hosted on a customized Galaxy instance and run on a dedicated computation cluster. Users only need a web browser and an active internet connection in order to benefit from this service. The web platform is designed to facilitate the usage of the bioinformatics tools for researchers without advanced technical background. Users can combine tools for complex analyses or use predefined, customizable workflows. All results are stored persistently and reproducible. For each tool, we provide documentation, tutorials, and example data to maximize usability. The ZBIT Bioinformatics Toolbox is freely available at https://webservices.cs.uni-tuebingen.de/.	[Roemer, Michael; Eichner, Johannes; Draeger, Andreas; Wrzodek, Clemens; Wrzodek, Finja; Zell, Andreas] Univ Tubingen, Dept Comp Sci, Tubingen, Germany; [Draeger, Andreas] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA	Eberhard Karls University of Tubingen; University of California System; University of California San Diego	Romer, M (corresponding author), Univ Tubingen, Dept Comp Sci, Tubingen, Germany.	michael.roemer@uni-tuebingen.de	Dräger, Andreas/F-5620-2015	Dräger, Andreas/0000-0002-1240-5553; Wrzodek, Clemens/0000-0003-4995-780X; Wrzodek, Finja/0000-0001-5031-1016	Innovative Medicine Initiative Joint Undertaking (IMI JU) [115001]; Marie Curie International Outgoing Fellowship within the EU 7th Framework Program for Research and Technological Development (project AMBiCon) [332020]; German Research Foundation (DFG); University of Tuebingen	Innovative Medicine Initiative Joint Undertaking (IMI JU); Marie Curie International Outgoing Fellowship within the EU 7th Framework Program for Research and Technological Development (project AMBiCon); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Tuebingen	The research leading to this work was funded by the Innovative Medicine Initiative Joint Undertaking (IMI JU) under grant agreement nr. 115001 (MARCAR project) and a Marie Curie International Outgoing Fellowship within the EU 7th Framework Program for Research and Technological Development (project AMBiCon, 332020). The authors acknowledge support by the German Research Foundation (DFG) and the Open Access Publishing Fund of the University of Tuebingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1975, MUTAT RES, V31, P347, DOI 10.1016/0165-1161(75)90046-1; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brazma A, 2000, FEBS LETT, V480, P17, DOI 10.1016/S0014-5793(00)01772-5; Buchel F, 2013, BMC SYSTEMS BIOL, V7; Buchel F, 2012, BIOINFORMATICS, V28, P2648, DOI 10.1093/bioinformatics/bts508; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chaouiya C, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-135; Chelliah V, 2015, NUCLEIC ACIDS RES, V43, pD542, DOI 10.1093/nar/gku1181; Courtot M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.77; Demir E, 2010, NAT BIOTECHNOL, V28, P935, DOI 10.1038/nbt.1666; Dogrusoz U, 2006, BIOINFORMATICS, V22, P374, DOI 10.1093/bioinformatics/bti776; Drager A, 2009, BIOINFORMATICS, V25, P1455, DOI 10.1093/bioinformatics/btp170; Drager A, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-39; Drager Andreas, 2014, Front Bioeng Biotechnol, V2, P61, DOI 10.3389/fbioe.2014.00061; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eichner J, 2014, BIOSYSTEMS, V122, P19, DOI 10.1016/j.biosystems.2014.06.009; Eichner J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082238; Gallagher RI, 2014, MOL DIAGN THER, V18, P619, DOI 10.1007/s40291-014-0122-3; Ganter B, 2005, J BIOTECHNOL, V119, P219, DOI 10.1016/j.jbiotec.2005.03.022; Ganter M, 2013, BIOINFORMATICS, V29, P815, DOI 10.1093/bioinformatics/btt036; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gupta MK, 2013, NETW MODEL ANAL HLTH, V2, P45, DOI 10.1007/s13721-013-0023-0; Haimovitz-Friedman A, 1997, BRIT MED BULL, V53, P539; Hildebrandt AK, 2015, BIOINFORMATICS, V31, P121, DOI 10.1093/bioinformatics/btu574; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; King ZA, 2015, NUCLEIC ACIDS RES; King ZA, 2015, BIGG MODELS ID SPECI; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Konig M, 2012, BIOINFORMATICS, V28, P2402, DOI 10.1093/bioinformatics/bts432; Krause F, 2010, BIOINFORMATICS, V26, P421, DOI 10.1093/bioinformatics/btp642; Li C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-92; Lima BS, 2000, REGUL TOXICOL PHARM, V32, P135; List M, 2014, BIOINFORMATICS, V30, pI631, DOI 10.1093/bioinformatics/btu473; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106691; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Narang P, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0130-2; Nystrom-Persson J, 2013, BIOINFORMATICS, V29, P3080, DOI 10.1093/bioinformatics/btt531; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Pan JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080747; Pan JB, 2012, BIOINFORMATICS, V28, P1544, DOI 10.1093/bioinformatics/bts169; Pathak RK, 2013, BIOINFORMATION, V9, P443, DOI 10.6026/97320630009443; R Core Team, 2013, R LANG ENV STAT COMP; Romer M, 2014, INT J MOL SCI, V15, P19037, DOI 10.3390/ijms151019037; Romer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097640; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schroder A, 2011, BIOINFORMATICS, V27, P2473, DOI 10.1093/bioinformatics/btr416; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Song L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-298; Uehara T, 2010, MOL NUTR FOOD RES, V54, P218, DOI 10.1002/mnfr.200900169; Unterberger EB, 2014, INT J CANCER, V135, P1574, DOI 10.1002/ijc.28798; Wachter Astrid, 2015, Microarrays (Basel), V4, P520, DOI 10.3390/microarrays4040520; Wan FY, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000067; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Waters MD, 2010, MUTAT RES-REV MUTAT, V705, P184, DOI 10.1016/j.mrrev.2010.04.005; Wittig U, 2012, NUCLEIC ACIDS RES, V40, pD790, DOI 10.1093/nar/gkr1046; Wrzodek C, 2013, BIOINFORMATICS, V29, P506, DOI 10.1093/bioinformatics/bts709; Xing L, 2014, J APPL TOXICOL, V34, P805, DOI 10.1002/jat.2923; Zou Q, 2014, BRIEF BIOINFORM, V15, P637, DOI 10.1093/bib/bbs088	62	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149263	10.1371/journal.pone.0149263	http://dx.doi.org/10.1371/journal.pone.0149263			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882475	Green Published, gold			2022-12-27	WOS:000371219000063
J	Chaabna, K; Kouyoumjian, SP; Abu-Raddad, LJ				Chaabna, Karima; Kouyoumjian, Silva P.; Abu-Raddad, Laith J.			Hepatitis C Virus Epidemiology in Djibouti, Somalia, Sudan, and Yemen: Systematic Review and Meta-Analysis	PLOS ONE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; CHRONIC LIVER-DISEASE; VIRAL-HEPATITIS; HEPATOCELLULAR-CARCINOMA; BLOOD-DONORS; HEMODIALYSIS-PATIENTS; GLOBAL EPIDEMIOLOGY; INJECT DRUGS; MIDDLE-EAST; B-VIRUS	Objectives To characterize hepatitis C virus (HCV) epidemiology and assess country-specific population-level HCV prevalence in four countries in the Middle East and North Africa (MENA) region: Djibouti, Somalia, Sudan, and Yemen. Methods Reports of HCV prevalence were systematically reviewed as per PRISMA guidelines. Pooled HCV prevalence estimates in different risk populations were conducted when the number of measures per risk category was at least five. Results We identified 101 prevalence estimates. Pooled HCV antibody prevalence in the general population in Somalia, Sudan and Yemen was 0.9% (95% confidence interval [95% CI]: 0.3%-1.9%), 1.0% (95% CI: 0.3%-1.9%) and 1.9% (95% CI: 1.4%-2.6%), respectively. The only general population study from Djibouti reported a prevalence of 0.3% (CI: 0.2%-0.4%) in blood donors. In high-risk populations (e.g., haemodialysis and haemophilia patients), pooled HCV prevalence was 17.3%(95% CI: 8.6%-28.2%) in Sudan. In Yemen, three studies of haemodialysis patients reported HCV prevalence between 40.0%-62.7%. In intermediate-risk populations (e.g.. healthcare workers, in patients and men who have sex with men), pooled HCV prevalence was 1.7% (95% CI: 0.0%-4.9%) in Somalia and 0.6% (95% CI: 0.4%-0.8%) in Sudan. Conclusion National HCV prevalence in Yemen appears to be higher than in Djibouti, Somalia, and Sudan as well as most other MENA countries; but otherwise prevalence levels in this subregion are comparable to global levels. The high HCV prevalence in patients who have undergone clinical care appears to reflect ongoing transmission in clinical settings. HCV prevalence in people who inject drugs remains unknown.	[Chaabna, Karima; Kouyoumjian, Silva P.; Abu-Raddad, Laith J.] Cornell Univ, Weill Cornell Med Coll Qatar, Qatar Fdn Educ City, Infect Dis Epidemiol Grp, Doha, Qatar; [Chaabna, Karima; Abu-Raddad, Laith J.] Cornell Univ, Dept Healthcare Policy & Res, Weill Cornell Med Coll, New York, NY 10021 USA; [Abu-Raddad, Laith J.] Hamad bin Khalifa Univ, Coll Publ Hlth, Doha, Qatar	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar	Chaabna, K (corresponding author), Cornell Univ, Weill Cornell Med Coll Qatar, Qatar Fdn Educ City, Infect Dis Epidemiol Grp, Doha, Qatar.; Chaabna, K (corresponding author), Cornell Univ, Dept Healthcare Policy & Res, Weill Cornell Med Coll, New York, NY 10021 USA.	kac2047@qatar-med.cornell.edu	Abu-Raddad, Laith J/AAY-1441-2020; Kouyoumjian, Silva/AEQ-8876-2022; Chaabna, Karima/H-9986-2019; Kouyoumjian, Silva/AAG-9767-2022	Abu-Raddad, Laith J/0000-0003-0790-0506; Chaabna, Karima/0000-0002-1443-207X; Kouyoumjian, Silva/0000-0003-1675-6067	NPRP from the Qatar National Research Fund (a member of Qatar Foundation) [4-924-3-251]; Biostatistics, Epidemiology, and Biomathematics Research Core at the Weill Cornell Medical College in Qatar	NPRP from the Qatar National Research Fund (a member of Qatar Foundation); Biostatistics, Epidemiology, and Biomathematics Research Core at the Weill Cornell Medical College in Qatar	This publication was made possible by NPRP grant number 4-924-3-251 from the Qatar National Research Fund (a member of Qatar Foundation), url: http://www.qnrf.org/en-us/. Additional support was provided by the Biostatistics, Epidemiology, and Biomathematics Research Core at the Weill Cornell Medical College in Qatar, url: http://qatar-weill.cornell.edu/research/laboratories/biostatistics.html. The statements made herein are solely the responsibility of the authors. The funders had no role in the design, conduct, or analysis of the study.	Abd El-Wahab EW, 2014, IRAN J PUBLIC HEALTH, V43, P1510; Abou MAA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-227; Abu-Raddad LJ, 2010, AIDS, V24, pS5, DOI 10.1097/01.aids.0000386729.56683.33; ACETI A, 1993, AM J TROP MED HYG, V48, P581, DOI 10.4269/ajtmh.1993.48.581; Ahmed RE, 2008, J MED VIROL, V80, P1747, DOI 10.1002/jmv.21284; Al-Jarba AS, 2003, SAUDI MED J, V24, P1031; Al-Mansoob AS, 2013, SUDAN MED J, V49, P168; Al-Moslih M I, 2001, East Mediterr Health J, V7, P771; Al-Selwi AHA, 2009, SUDAN J MED SCI, V4, P237; Al-Shamiri AH, 2011, ASIAN PAC J TROP MED, V4, P404, DOI 10.1016/S1995-7645(11)60113-2; Al-Waleedi A. A., 2012, Eastern Mediterranean Health Journal, V18, P624; Ali SA, 2009, INT J INFECT DIS, V13, P9, DOI 10.1016/j.ijid.2008.06.019; Alodini A. Q., 2012, Yemeni Journal for Medical Sciences, V6, P16; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Aman K, 2015, SAUDI J KIDNEY DIS T, V26, P380, DOI 10.4103/1319-2442.152555; [Anonymous], 2015, SUDAN MED J; [Anonymous], 2015, INT AIDS SOC C; [Anonymous], 2015, SUDAN J MED SCI; [Anonymous], 2015, YEMENI J MED SCI; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Arya SC, 1996, ANN SAUDI MED, V16, P229; Bakhubaira S., 2009, ABSTRACTS RES, V13; Benova L, 2015, HEPATOLOGY, V61, P834, DOI 10.1002/hep.27596; BILE K, 1992, AM J TROP MED HYG, V47, P357, DOI 10.4269/ajtmh.1992.47.357; BILE K, 1993, SCAND J INFECT DIS, V25, P559, DOI 10.3109/00365549309008543; Selm SB, 2010, SAUDI J KIDNEY DIS T, V21, P1165; Borenstein M., 2009, INTRO METAANALYSIS, VXXVIII, P421; Bradshaw D, 2013, CURR OPIN INFECT DIS, V26, P66, DOI 10.1097/QCO.0b013e32835c2120; Chaabna K, 2014, PROTOCOL SYSTEMATIC; Chaabna K, 2014, SYST REV, V3, DOI 10.1186/2046-4053-3-146; Chemaitelly H, 2015, EPIDEMIOLOG IN PRESS; Chemaitelly H, 2015, INT J INFECT DIS, V40, P54, DOI 10.1016/j.ijid.2015.09.011; Chemaitelly H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135281; Chemaitelly H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069803; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Cornberg M, 2011, LIVER INT, V31, P30, DOI 10.1111/j.1478-3231.2011.02539.x; Cousien A, 2016, HEPATOLOGY, V63, P1090, DOI 10.1002/hep.28227; Cuadros DF, 2014, HEPATOLOGY, V60, P1150, DOI 10.1002/hep.27248; Daw MA, 2012, SCI WORLD J, DOI 10.1100/2012/719494; DENIS F, 1994, J MED VIROL, V43, P1, DOI 10.1002/jmv.1890430102; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dray X, 2005, Med Trop (Mars), V65, P39; El-Amin HH, 2007, SAUDI J KIDNEY DIS T, V18, P101; El-Zanaty F., 2009, EGYPT DEMOGRAPHIC HL, DOI DOI 10.1177/0049475514561330; Elfaki AMH, 2008, SUDAN J MED SCI, V3, P333; ELGUNEID AM, 1993, J MED VIROL, V40, P330, DOI 10.1002/jmv.1890400413; Elsheikh RM, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-104; Fadlalla FA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121873; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756; Gacche RN, 2012, HEPAT RES TREAT, V2012, DOI [10.1155/2012/689726, DOI 10.1155/2012/689726]; Gadour MO, 2011, SUDAN J MED SCI, V6, P233; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Gasim GI, 2012, J MED VIROL, V84, P52, DOI 10.1002/jmv.22256; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Gray GC, 1999, TROP DOCT, V29, P212, DOI 10.1177/004947559902900408; Guerra J, 2012, J VIRAL HEPATITIS, V19, P560, DOI 10.1111/j.1365-2893.2011.01576.x; Gunaid AA, 1997, J MED VIROL, V51, P64, DOI 10.1002/(SICI)1096-9071(199701)51:1&lt;64::AID-JMV10&gt;3.0.CO;2-4; Haidar NA, 2002, SAUDI MED J, V23, P1090; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Heijnen M, STATUS HIV HEP UNPUB; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; IBBS National Team, 2013, INT BIOB HIV SURV IB; KIYOSAWA K, 1994, GASTROENTEROLOGY, V106, P1596, DOI 10.1016/0016-5085(94)90416-2; Larney S, 2013, HEPATOLOGY, V58, P1215, DOI 10.1002/hep.26387; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Madhava V, 2002, LANCET INFECT DIS, V2, P293, DOI 10.1016/S1473-3099(02)00264-5; Mahmud S, 2015, EPIDEMIOLOG IN PRESS; Martin NK, 2015, CURR OPIN HIV AIDS, V10, P374, DOI 10.1097/COH.0000000000000179; MCCARTHY MC, 1994, T ROY SOC TROP MED H, V88, P534, DOI 10.1016/0035-9203(94)90150-3; Miller FD, 2010, P NATL ACAD SCI USA, V107, P14757, DOI 10.1073/pnas.1008877107; MILLER JJ, 1978, AM STAT, V32, P138, DOI 10.2307/2682942; Mohamed HI, 2013, J INFECT PUBLIC HEAL, V6, P186, DOI 10.1016/j.jiph.2012.12.003; Mohamedani A, 2014, END EM VIR DIS PRIOR, P86; Mohamoud YA, 2015, EPIDEMIOLOG IN PRESS; Mohamoud YA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-288; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Mudawi HMY, 2007, J MED VIROL, V79, P1322, DOI 10.1002/jmv.20865; Mudawi H, 2014, INT J INFECT DIS, V29, P65, DOI 10.1016/j.ijid.2014.07.004; Mudawi HMY, 2007, J MED VIROL, V79, P383, DOI 10.1002/jmv.20780; Mudawi HMY, 2008, CLIN EXP GASTROENTER, V1, P9; Mumtaz G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000444; Mumtaz GR, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20582; Mumtaz GR, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001663; Murad EA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-127; Nagi AM, 2007, RES J MED SCI, V2, P122; Nail A, 2008, SUDAN J MED SCI, V3, P201; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; NIH, 2014, END EM VIR DIS PRIOR; Nur YA, 2000, EPIDEMIOL INFECT, V124, P137, DOI 10.1017/S0950268899003441; Omer HH, 2010, ABSTRACTS RES, V14, P7; Omer RE, 2001, T ROY SOC TROP MED H, V95, P487, DOI 10.1016/S0035-9203(01)90013-6; Oshaish HA, 2008, ASSIUT MED J, V32, P163; Osman AMM, 2014, SUDAN J MED SCI, V9, P91; Rao VB, 2015, LANCET INFECT DIS, V15, P819, DOI 10.1016/S1473-3099(15)00006-7; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Riou J, 2016, J VIRAL HEPATITIS, V23, P244, DOI 10.1111/jvh.12481; Saeed NM, 2012, ASIAN PAC J CANCER P, V13, P3663, DOI 10.7314/APJCP.2012.13.8.3663; Saghir SAM, 2012, TROP J PHARM RES, V11, P132, DOI 10.4314/tjpr.v11i1.17; Salem A. K., 2012, Eastern Mediterranean Health Journal, V18, P693; Salem A K, 2009, Gulf J Oncolog, P22; Sallam TA, 2003, EPIDEMIOL INFECT, V131, P771, DOI 10.1017/S0950268803008653; Schwarzer G., 2015, GEN PACKAGE METAANAL; SCOTT DA, 1992, AM J TROP MED HYG, V46, P63, DOI 10.4269/ajtmh.1992.46.63; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shidrawi R, 2004, J MED VIROL, V73, P562, DOI 10.1002/jmv.20126; Shire AM, 2012, MAYO CLIN PROC, V87, P17, DOI 10.1016/j.mayocp.2011.08.001; Stata/se 13.1. StataCorp, 2013, STAT SE 13 1 STAT RE; Strickland GT, 2006, HEPATOLOGY, V43, P915, DOI 10.1002/hep.21173; Suliman S M, 1995, Saudi J Kidney Dis Transpl, V6, P154; Umar M, 2010, HEPAT MON, V10, P205; WATTS DM, 1994, T ROY SOC TROP MED H, V88, P55, DOI 10.1016/0035-9203(94)90495-2; WHO, WHO IND MED E MED RE; WHO, 2011, EMRO ANN HIV STI REP; WHO, WHO AFR IND MED AIM; WHO, 2015, HEP B; WHO, 2015, WHO CALLS WORLDW US; World Health Organization, 2015, HEP C; World Health Organization, 2015, WHO GUID US SAF ENG; Zou SM, 2010, TRANSFUSION, V50, P1495, DOI 10.1111/j.1537-2995.2010.02622.x	124	37	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149966	10.1371/journal.pone.0149966	http://dx.doi.org/10.1371/journal.pone.0149966			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900839	Green Submitted, Green Published, gold			2022-12-27	WOS:000371276100196
J	Foster, J; Luo, B; Nakata, PA				Foster, Justin; Luo, Bin; Nakata, Paul A.			An Oxalyl-CoA Dependent Pathway of Oxalate Catabolism Plays a Role in Regulating Calcium Oxalate Crystal Accumulation and Defending against Oxalate-Secreting Phytopathogens in Medicago truncatula	PLOS ONE			English	Article							SCLEROTINIA-SCLEROTIORUM; TRANSIENT EXPRESSION; ACID; MUTANTS; PLANTS; GERMIN; TRANSFORMATION; SYNTHETASE; COENZYME; ENZYMES	Considering the widespread occurrence of oxalate in nature and its broad impact on a host of organisms, it is surprising that so little is known about the turnover of this important acid. In plants, oxalate oxidase is the most well studied enzyme capable of degrading oxalate, but not all plants possess this activity. Recently, an Acyl Activating Enzyme 3 (AAE3), encoding an oxalyl-CoA synthetase, was identified in Arabidopsis. AAE3 has been proposed to catalyze the first step in an alternative pathway of oxalate degradation. Whether this enzyme and proposed pathway is important to other plants is unknown. Here, we identify the Medicago truncatula AAE3 (MtAAE3) and show that it encodes an oxalyl-CoA synthetase activity exhibiting high activity against oxalate with a Km = 81 +/- 9 mu M and Vmax = 19 +/- 0.9 mu moles min(-1)mg protein(-1). GFP-MtAAE3 localization suggested that this enzyme functions within the cytosol of the cell. Mtaae3 knock-down line showed a reduction in its ability to degrade oxalate into CO2. This reduction in the capacity to degrade oxalate resulted in the accumulation of druse crystals of calcium oxalate in the Mtaae3 knock-down line and an increased susceptibility to oxalate-secreting phytopathogens such as Sclerotinia sclerotiorum. Taken together, these results suggest that AAE3 dependent turnover of oxalate is important to different plants and functions in the regulation of tissue calcium oxalate crystal accumulation and in defense against oxalate-secreting phytopathogens.	[Foster, Justin; Luo, Bin; Nakata, Paul A.] Baylor Coll Med, USDA ARS, Childrens Nutr Res Ctr, Dept Pediat, Houston, TX 77030 USA	Baylor College of Medicine; United States Department of Agriculture (USDA)	Nakata, PA (corresponding author), Baylor Coll Med, USDA ARS, Childrens Nutr Res Ctr, Dept Pediat, Houston, TX 77030 USA.	paul.nakata@ars.usda.gov		Nakata, Paul/0000-0002-6331-9700	U.S. Department of Agriculture, Agricultural Research Service [58-3092-5-001]; ARS [ARS-0426342] Funding Source: Federal RePORTER	U.S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the U.S. Department of Agriculture, Agricultural Research Service, under Cooperative agreement number 58-3092-5-001.	BATEMAN DF, 1965, PHYTOPATHOLOGY, V55, P204; Blobel F, 1996, EUR J BIOCHEM, V240, P468, DOI 10.1111/j.1432-1033.1996.0468h.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cosson V, 2006, METH MOL B, V343, P115; Dong XB, 2008, PLANTA, V228, P331, DOI 10.1007/s00425-008-0740-2; Druka A, 2002, P NATL ACAD SCI USA, V99, P850, DOI 10.1073/pnas.022627999; Dutton MV, 1996, CAN J MICROBIOL, V42, P881, DOI 10.1139/m96-114; Foster J, 2014, FEBS LETT, V588, P160, DOI 10.1016/j.febslet.2013.11.026; Foster J, 2012, PLANT CELL, V24, P1217, DOI 10.1105/tpc.112.096032; Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106; Franceschi VR, 1995, CALCIUM OXALATE BIOL, P113; GIOVANELLI J, 1966, BIOCHIM BIOPHYS ACTA, V118, P124, DOI 10.1016/S0926-6593(66)80151-0; GIOVANELLI J, 1961, NATURE, V190, P1006, DOI 10.1038/1901006a0; Girish V, 2004, AFFORDABLE IMAGE ANA; GODOY G, 1990, PHYSIOL MOL PLANT P, V37, P179, DOI 10.1016/0885-5765(90)90010-U; Guimaraes RL, 2004, PLANT PHYSIOL, V136, P3703, DOI 10.1104/pp.104.049650; Hegedus DD, 2005, FEMS MICROBIOL LETT, V251, P177, DOI 10.1016/j.femsle.2005.07.040; Hoffmann B, 1997, MOL PLANT MICROBE IN, V10, P307, DOI 10.1094/MPMI.1997.10.3.307; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; Kakar K, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-18; Kim KS, 2008, MOL PLANT MICROBE IN, V21, P605, DOI 10.1094/MPMI-21-5-0605; Korth KL, 2006, PLANT PHYSIOL, V141, P188, DOI 10.1104/pp.106.076737; LANE BG, 1993, J BIOL CHEM, V268, P12239; Lane BG, 2002, IUBMB LIFE, V53, P67, DOI 10.1080/15216540211474; LUMSDEN RD, 1976, CAN J BOT, V54, P2630, DOI 10.1139/b76-283; Luo B, 2012, PLANT SCI, V188, P19, DOI 10.1016/j.plantsci.2012.02.006; Ma JF, 1998, PLANT PHYSIOL, V117, P753, DOI 10.1104/pp.117.3.753; Membre N, 1997, PLANT MOL BIOL, V35, P459, DOI 10.1023/A:1005833028582; Membre N, 2000, PLANTA, V211, P345, DOI 10.1007/s004250000277; Morris J, 2007, PLANT MOL BIOL, V64, P613, DOI 10.1007/s11103-007-9180-9; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakata P. A., 2012, FRONT BIOL, V7, P254, DOI DOI 10.1007/S11515-012-1224-0; Nakata PA, 2000, PLANT PHYSIOL, V124, P1097, DOI 10.1104/pp.124.3.1097; Nakata PA, 2003, PLANT SCI, V164, P901, DOI 10.1016/S0168-9452(03)00120-1; Nakata PA, 2003, PLANT PHYSIOL BIOCH, V41, P325, DOI 10.1016/S0981-9428(03)00026-3; Nakata PA, 2007, PLANT PHYSIOL BIOCH, V45, P216, DOI 10.1016/j.plaphy.2007.01.013; Nakata PA, 2007, PLANT SCI, V172, P958, DOI 10.1016/j.plantsci.2007.01.005; Nakata PA, 2006, FUNCT PLANT BIOL, V33, P703, DOI 10.1071/FP06068; Park SH, 2009, ENTOMOL EXP APPL, V131, P208, DOI 10.1111/j.1570-7458.2009.00846.x; Scheid C, 1996, KIDNEY INT, V49, P413, DOI 10.1038/ki.1996.60; Shen JB, 2013, MOL PLANT, V6, P1419, DOI 10.1093/mp/sst079; Shockey J, 2011, PLANT J, V66, P143, DOI 10.1111/j.1365-313X.2011.04512.x; Shockey JM, 2003, PLANT PHYSIOL, V132, P1065, DOI 10.1104/pp.103.020552; SMITH FW, 1972, AUST J AGR RES, V23, P969, DOI 10.1071/AR9720969; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Svedruzic D, 2005, ARCH BIOCHEM BIOPHYS, V433, P176, DOI 10.1016/j.abb.2004.08.032; van Roermund CWT, 2004, J CELL SCI, V117, P4231, DOI 10.1242/jcs.01305; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; WEAVER CM, 1987, J NUTR, V117, P1903, DOI 10.1093/jn/117.11.1903; Williams B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002107; YOSHIHARA T, 1980, ENTOMOL EXP APPL, V27, P149, DOI 10.1007/BF00573889; ZIEGLER K, 1987, ARCH MICROBIOL, V149, P62, DOI 10.1007/BF00423138	53	21	22	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149850	10.1371/journal.pone.0149850	http://dx.doi.org/10.1371/journal.pone.0149850			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900946	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100164
J	Glat, MJ; Ben-Zur, T; Barhum, Y; Offen, D				Glat, Micaela Johanna; Ben-Zur, Tali; Barhum, Yael; Offen, Daniel			Neuroprotective Effect of a DJ-1 Based Peptide in a Toxin Induced Mouse Model of Multiple System Atrophy	PLOS ONE			English	Article							PARKINSONS-DISEASE; OXIDATIVE STRESS; 3-NITROPROPIONIC ACID; MITOCHONDRIAL-FUNCTION; ENVIRONMENTAL TOXINS; CONSENSUS STATEMENT; DOPAMINE TOXICITY; ALPHA-SYNUCLEIN; PROTEIN DJ-1; PATHWAY	Multiple System Atrophy (MSA) is a sporadic neurodegenerative disorder characterized by parkinsonism, cerebellar ataxia and dysautonomia, in various combinations. In MSA with parkinsonism (MSA-P), the degeneration is mainly restricted to the substantia nigra pars compacta and putamen. Studies have identified alterations in DJ-1 (PARK7), a key component of the anti-oxidative stress response, in Parkinson's disease (PD) and MSA patients. Previously we have shown that a short DJ-1-based peptide named ND-13, protected cultured cells against neurotoxic insults and improved behavioral outcome in animal models of Parkinson's disease (PD). In this study, we used the 3-Nitropropionic acid (3-NP)-induced mouse model of MSA and treated the animals with ND-13 in order to evaluate its therapeutic effects. Our results show that ND-13 protects cultured cells against oxidative stress generated by the mitochondrial inhibitor, 3-NP. Moreover, we show that ND-13 attenuates nigrostriatal degeneration and improves performance in motor-related behavioral tasks in 3-NP-treated mice. Our findings suggest a rationale for using ND-13 as a promising therapeutic approach for treatment of MSA.	[Glat, Micaela Johanna; Offen, Daniel] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Ben-Zur, Tali; Barhum, Yael; Offen, Daniel] Tel Aviv Univ, Sackler Sch Med, Felsenstein Med Res Ctr, Petah Tiqwa, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Offen, D (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel.; Offen, D (corresponding author), Tel Aviv Univ, Sackler Sch Med, Felsenstein Med Res Ctr, Petah Tiqwa, Israel.	danioffen@gmail.com		Glat, Micaela Johanna/0000-0001-8332-1667	UGH Pharma, Inc.	UGH Pharma, Inc.	UGH Pharma, Inc. supplied the peptide (ND-13) used in the studies. This study also received funds as a scholarship from Mr. Martin Davis, a private donor. Other than the peptide (ND-13) which was supplied by UGH Pharma, Inc., and these scholarship funds, the authors received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja M, 2008, TOXICOL MECH METHODS; Aleyasin H, 2010, P NATL ACAD SCI USA, V107, P3186, DOI 10.1073/pnas.0914876107; Ariga H, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/683920; BEAL MF, 1993, J NEUROSCI, V13, P4181; Bjornsdottir A, 2013, J NEUROL NEUROSUR PS, V84, P136, DOI 10.1136/jnnp-2012-302500; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Chen XL, 2006, AM J PHYSIOL-HEART C, V290, pH1862, DOI 10.1152/ajpheart.00651.2005; Chen XL, 2004, CURR PHARM DESIGN, V10, P879, DOI 10.2174/1381612043452901; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Doeppner TR, 2010, EXP NEUROL, V223, P548, DOI 10.1016/j.expneurol.2010.02.001; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Gilman S, 1999, J NEUROL SCI, V163, P94, DOI 10.1016/S0022-510X(98)00304-9; Hanna PA, 1999, ARCH NEUROL-CHICAGO, V56, P90, DOI 10.1001/archneur.56.1.90; Hao LY, 2010, P NATL ACAD SCI USA, V107, P9747, DOI 10.1073/pnas.0911175107; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Kikuchi A, 2002, NEUROBIOL DIS, V9, P244, DOI 10.1006/nbdi.2002.0466; Kim GW, 2000, J CEREBR BLOOD F MET, V20, P119, DOI 10.1097/00004647-200001000-00016; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Lev N, 2008, NEUROTOXICOLOGY, V29, P397, DOI 10.1016/j.neuro.2008.01.007; Lev N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127549; Lev N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117190; Lev N, 2013, J GERONTOL A-BIOL, V68, P215, DOI 10.1093/gerona/gls147; Lev N, 2009, J NEURAL TRANSM, V116, P151, DOI 10.1007/s00702-008-0134-4; Lin DJ, 2016, CEREBELLUM, V15, P663, DOI 10.1007/s12311-015-0728-y; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Mccoy MK, 2011, AUTOPHAGY, V7, P531, DOI 10.4161/auto.7.5.14684; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Neumann M, 2004, ACTA NEUROPATHOL, V107, P489, DOI 10.1007/s00401-004-0834-2; Rannikko EH, 2013, J NEUROCHEM, V125, P314, DOI 10.1111/jnc.12126; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schulz JB, 1996, NEUROCHEM INT, V29, P167, DOI 10.1016/0197-0186(95)00122-0; Stefanova N, 2005, AM J PATHOL, V166, P869, DOI 10.1016/S0002-9440(10)62307-3; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Tao F, 2008, MOL THER, V16, P1776, DOI 10.1038/mt.2008.192; Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430; Ubhi K, 2009, J NEUROSCI RES, V87, P2728, DOI 10.1002/jnr.22089; Vanacore N, 2005, J NEURAL TRANSM, V112, P1605, DOI 10.1007/s00702-005-0380-7; Vasseur S, 2009, P NATL ACAD SCI USA, V106, P1111, DOI 10.1073/pnas.0812745106; Waldner R, 2001, NEUROSCIENCE, V102, P581, DOI 10.1016/S0306-4522(00)00500-5; Wenning GK, 2004, LANCET NEUROL, V3, P93, DOI 10.1016/S1474-4422(03)00662-8; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211	41	13	13	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148170	10.1371/journal.pone.0148170	http://dx.doi.org/10.1371/journal.pone.0148170			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901405	Green Published, gold			2022-12-27	WOS:000371276100014
J	Jung, B; Padula, D; Burtscher, I; Landerer, C; Lutter, D; Theis, F; Messias, AC; Geerlof, A; Sattler, M; Kremmer, E; Boldt, K; Ueffing, M; Lickert, H				Jung, Bomi; Padula, Daniela; Burtscher, Ingo; Landerer, Cedric; Lutter, Dominik; Theis, Fabian; Messias, Ana C.; Geerlof, Arie; Sattler, Michael; Kremmer, Elisabeth; Boldt, Karsten; Ueffing, Marius; Lickert, Heiko			Pitchfork and Gprasp2 Target Smoothened to the Primary Cilium for Hedgehog Pathway Activation	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; INTRAFLAGELLAR TRANSPORT PROTEINS; EMBRYONIC STEM-CELLS; NEURONAL CILIA; LOCALIZATION; MICE; IDENTIFICATION; CILIOPATHIES; CILIOGENESIS; TRAFFICKING	The seven-transmembrane receptor Smoothened (Smo) activates all Hedgehog (Hh) signaling by translocation into the primary cilia (PC), but how this is regulated is not well understood. Here we show that Pitchfork (Pifo) and the G protein-coupled receptor associated sorting protein 2 (Gprasp2) are essential components of an Hh induced ciliary targeting complex able to regulate Smo translocation to the PC. Depletion of Pifo or Gprasp2 leads to failure of Smo translocation to the PC and lack of Hh target gene activation. Together, our results identify a novel protein complex that is regulated by Hh signaling and required for Smo ciliary trafficking and Hh pathway activation.	[Jung, Bomi; Padula, Daniela; Burtscher, Ingo; Lickert, Heiko] Helmholtz Zentrum Munchen, Inst Diabet & Regenerat Res, Munich, Germany; [Jung, Bomi; Padula, Daniela; Burtscher, Ingo; Lickert, Heiko] Helmholtz Zentrum Munchen, Inst Stem Cell Res, Munich, Germany; [Landerer, Cedric; Lutter, Dominik; Theis, Fabian] Helmholtz Zentrum Munchen, Inst Computat Biol, Munich, Germany; [Lutter, Dominik] Helmholtz Zentrum Munchen, Inst Diabet & Adipositas, Munich, Germany; [Messias, Ana C.; Geerlof, Arie; Sattler, Michael] Helmholtz Zentrum Munchen, Inst Biol Struct, Munich, Germany; [Kremmer, Elisabeth] Helmholtz Zentrum Munchen, Inst Mol Immunol, Munich, Germany; [Boldt, Karsten; Ueffing, Marius] Helmholtz Zentrum Munchen, Dept Prot Sci, Munich, Germany; [Jung, Bomi; Padula, Daniela; Burtscher, Ingo; Lickert, Heiko] German Ctr Diabet Res DZD, D-85764 Munich, Germany; [Messias, Ana C.; Sattler, Michael] Tech Univ Munich, Biomol NMR Spect, Ctr Integrated Prot Sci Munich, Dept Chem, D-85747 Garching, Germany; [Boldt, Karsten; Ueffing, Marius] Univ Tubingen, Inst Ophthalmol Res, Ctr Ophthalmol, D-72076 Tubingen, Germany; [Landerer, Cedric] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Tennessee System; University of Tennessee Knoxville	Lickert, H (corresponding author), Helmholtz Zentrum Munchen, Inst Diabet & Regenerat Res, Munich, Germany.; Lickert, H (corresponding author), Helmholtz Zentrum Munchen, Inst Stem Cell Res, Munich, Germany.; Lickert, H (corresponding author), German Ctr Diabet Res DZD, D-85764 Munich, Germany.	heiko.lickert@helmholtz-muenchen.de	Lutter, Dominik RL/B-7790-2013; Theis, Fabian J/ABD-5212-2021; Sattler, Michael/A-2407-2012	Lutter, Dominik RL/0000-0002-8800-0683; Theis, Fabian J/0000-0002-2419-1943; Sattler, Michael/0000-0002-1594-0527; Messias, Ana/0000-0002-5449-9922	German Center for Diabetes Research (DZD e.V.); Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases; Emmy-Noether fellowship from the German Research Foundation; ERC	German Center for Diabetes Research (DZD e.V.); Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases; Emmy-Noether fellowship from the German Research Foundation; ERC(European Research Council (ERC)European Commission)	This work was funded in part by the German Center for Diabetes Research (DZD e.V.) and the Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases. Financial support was additionally provided by an Emmy-Noether fellowship from the German Research Foundation and an ERC starting grant awarded to HL.	Barakat MT, 2010, TRENDS MOL MED, V16, P337, DOI 10.1016/j.molmed.2010.05.003; Bendall SC, 2008, MOL CELL PROTEOMICS, V7, P1587, DOI 10.1074/mcp.M800113-MCP200; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Boldt K, 2011, J CLIN INVEST, V121, P2169, DOI 10.1172/JCI45627; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Brailov I, 2000, BRAIN RES, V872, P271, DOI 10.1016/S0006-8993(00)02519-1; Butterfield NC, 2010, CURR TOP DEV BIOL, V90, P319, DOI 10.1016/S0070-2153(10)90009-4; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Chen Y, 2011, AESTIMATIO, P2; Conner DA, 1997, CIRC RES, V81, P1021; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dessaud E, 2008, DEVELOPMENT, V135, P2489, DOI 10.1242/dev.009324; Dorn KV, 2012, DEV CELL, V23, P823, DOI 10.1016/j.devcel.2012.07.004; Dwyer ND, 2001, NEURON, V31, P277, DOI 10.1016/S0896-6273(01)00361-0; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Gaertig J, 2008, CURR TOP DEV BIOL, V85, P83, DOI 10.1016/S0070-2153(08)00804-1; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Gloeckner Christian Johannes, 2009, Curr Protoc Protein Sci, VChapter 19, DOI 10.1002/0471140864.ps1920s57; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Horn SC, 2006, J NEURAL TRANSM, V113, P1081, DOI 10.1007/s00702-006-0514-6; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Kim J, 2009, P NATL ACAD SCI USA, V106, P21666, DOI 10.1073/pnas.0912180106; Kinzel D, 2010, DEV CELL, V19, P66, DOI 10.1016/j.devcel.2010.06.005; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Mazelova J, 2009, J CELL SCI, V122, P2003, DOI 10.1242/jcs.039982; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Moser E, 2010, PHARMACOLOGY, V86, P22, DOI 10.1159/000314161; Ocbina PJR, 2008, DEV DYNAM, V237, P2030, DOI 10.1002/dvdy.21551; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Pan JM, 2007, CELL, V129, P1255, DOI 10.1016/j.cell.2007.06.018; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Parathath SR, 2010, CELL CYCLE, V9, P4013, DOI 10.4161/cc.9.19.13325; Pazour GJ, 2002, TRENDS CELL BIOL, V12, P551, DOI 10.1016/S0962-8924(02)02410-8; Pazour GJ, 2008, CURR TOP DEV BIOL, V85, P115, DOI 10.1016/S0070-2153(08)00805-3; Raue A, 2009, BIOINFORMATICS, V25, P1923, DOI 10.1093/bioinformatics/btp358; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Ryan KE, 2012, J BIOL CHEM, V287, P17905, DOI 10.1074/jbc.R112.356006; Santos N, 2008, DEV DYNAM, V237, P1972, DOI 10.1002/dvdy.21540; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Seeley ES, 2010, J CELL SCI, V123, P511, DOI 10.1242/jcs.061093; Simonin F, 2004, J NEUROCHEM, V89, P766, DOI 10.1111/j.1471-4159.2004.02411.x; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tamplin OJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-511; Tobin JL, 2009, GENET MED, V11, P386, DOI 10.1097/GIM.0b013e3181a02882; Toriello HV, 2009, AM J MED GENET C, V151C, P261, DOI 10.1002/ajmg.c.30230; Uetzmann L, 2008, GENESIS, V46, P515, DOI 10.1002/dvg.20410; Vaegter CB, 2011, NAT NEUROSCI, V14, P54, DOI 10.1038/nn.2689; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Wu VM, 2012, P NATL ACAD SCI USA, V109, P13644, DOI 10.1073/pnas.1207170109; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3	65	19	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149477	10.1371/journal.pone.0149477	http://dx.doi.org/10.1371/journal.pone.0149477			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901434	Green Published, gold			2022-12-27	WOS:000371276100080
J	Nooshabadi, F; Yang, HJ; Bixler, JN; Kong, Y; Cirillo, JD; Maitland, KC				Nooshabadi, Fatemeh; Yang, Hee-Jeong; Bixler, Joel N.; Kong, Ying; Cirillo, Jeffrey D.; Maitland, Kristen C.			Intravital Fluorescence Excitation in Whole-Animal Optical Imaging	PLOS ONE			English	Article							BACTERIAL-INFECTION; TUBERCULOSIS; AUTOFLUORESCENCE; TOMOGRAPHY; PROTEIN; MICE	Whole-animal fluorescence imaging with recombinant or fluorescently-tagged pathogens or cells enables real-time analysis of disease progression and treatment response in live animals. Tissue absorption limits penetration of fluorescence excitation light, particularly in the visible wavelength range, resulting in reduced sensitivity to deep targets. Here, we demonstrate the use of an optical fiber bundle to deliver light into the mouse lung to excite fluorescent bacteria, circumventing tissue absorption of excitation light in whole-animal imaging. We present the use of this technology to improve detection of recombinant reporter strains of tdTomato-expressing Mycobacterium bovis BCG (Bacillus Calmette Guerin) bacteria in the mouse lung. A microendoscope was integrated into a whole-animal fluorescence imager to enable intravital excitation in the mouse lung with whole-animal detection. Using this technique, the threshold of detection was measured as 10(3) colony forming units (CFU) during pulmonary infection. In comparison, the threshold of detection for whole-animal fluorescence imaging using standard epi-illumination was greater than 10(6) CFU.	[Nooshabadi, Fatemeh; Bixler, Joel N.; Maitland, Kristen C.] Texas A&M Univ, Dept Biomed Engn, College Stn, TX USA; [Yang, Hee-Jeong; Kong, Ying; Cirillo, Jeffrey D.] Texas A&M Univ, Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, Bryan, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Maitland, KC (corresponding author), Texas A&M Univ, Dept Biomed Engn, College Stn, TX USA.	kmaitland@tamu.edu	Maitland, Kristen/D-6961-2011; Maitland, Kristen/N-9171-2019; Cirillo, Jeffrey D./L-4286-2019	Maitland, Kristen/0000-0003-0931-0622; Maitland, Kristen/0000-0003-0931-0622; Cirillo, Jeffrey D./0000-0003-3058-2702; Nooshabadi, Fatemeh/0000-0001-6351-5229; Yang, Hee-Jeong/0000-0002-7351-8404	Bill and Melinda Gates Foundation [48523]; National Science Foundation [CBET-1254767]; National Institute of Allergy and Infectious Diseases [1R01 AI104960]; Div Of Chem, Bioeng, Env, & Transp Sys [1254767] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104960] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Science Foundation(National Science Foundation (NSF)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Bill and Melinda Gates Foundation grant no. 48523 to JDC, http://www.gatesfoundation.org/; the National Science Foundation grant no. CBET-1254767 to KCM, http://www.nsf.gov; and the National Institute of Allergy and Infectious Diseases grant no. 1R01 AI104960 to JDC, https://www.niaid.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu N, 2011, FEMS MICROBIOL REV, V35, P360, DOI 10.1111/j.1574-6976.2010.00252.x; Baker M, 2010, NATURE, V463, P977, DOI 10.1038/463977a; Bao HC, 2010, OPT EXPRESS, V18, P1255, DOI 10.1364/OE.18.001255; Bernaerts A, 2003, EUR RADIOL, V13, P1876, DOI 10.1007/s00330-002-1608-7; Bhaumik S, 2007, LAB ANIMAL, V36, P40, DOI 10.1038/laban0907-40; Billinton N, 2001, ANAL BIOCHEM, V291, P175, DOI 10.1006/abio.2000.5006; Bird-Lieberman EL, 2012, NAT MED, V18, P315, DOI 10.1038/nm.2616; Brown CM, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.4.040505; Capoulade J, 2011, NAT BIOTECHNOL, V29, P835, DOI 10.1038/nbt.1928; Chang MH, 2011, JOVE-J VIS EXP, DOI 10.3791/2547; Chen JQ, 2002, CIRCULATION, V105, P2766, DOI 10.1161/01.CIR.0000017860.20619.23; Cheng SN, 2013, OPT LETT, V38, P1515, DOI 10.1364/OL.38.001515; Choi Y, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.203901; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Dedecker P, 2012, P NATL ACAD SCI USA, V109, P10909, DOI 10.1073/pnas.1204917109; Demsar J, 2006, J MACH LEARN RES, V7, P1; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Flusberg BA, 2005, NAT METHODS, V2, P941, DOI 10.1038/NMETH820; Garcia S, 2010, INFORM SCIENCES, V180, P2044, DOI 10.1016/j.ins.2009.12.010; Gee JM, 2014, NEURON, V83, P1058, DOI 10.1016/j.neuron.2014.07.024; Goldgeier M, 2003, DERMATOL SURG, V29, P205, DOI 10.1046/j.1524-4725.2003.29050.x; GORDON S, 1994, IMMUNOBIOLOGY, V191, P369, DOI 10.1016/S0171-2985(11)80442-0; GUPTA PK, 1989, NEUROSURGERY, V25, P830, DOI 10.1227/00006123-198911000-00025; Iftimia N, 2012, BIOMED OPT EXPRESS, V3, P178, DOI 10.1364/BOE.3.000178; Inoue Y, 2008, MOL IMAGING, V7, P21, DOI 10.2310/7290.2008.0003; Jabbour JM, 2012, ANN BIOMED ENG, V40, P378, DOI 10.1007/s10439-011-0426-y; Keahey PA, 2015, BIOMED OPT EXPRESS, V6, P870, DOI 10.1364/BOE.6.000870; Kong Y, 2011, WHOLE BODY IMAGING I; Kong Y, 2011, CURRENT PROTOCOLS MI; Kong Y, 2010, P NATL ACAD SCI USA, V107, P12239, DOI 10.1073/pnas.1000643107; Kong Y, 2009, TUBERCULOSIS, V89, pS15, DOI 10.1016/S1472-9792(09)70006-X; Leblond F, 2010, J PHOTOCH PHOTOBIO B, V98, P77, DOI 10.1016/j.jphotobiol.2009.11.007; Lee CM, 2010, J BIOPHOTONICS, V3, P385, DOI 10.1002/jbio.200900087; Lorenser D, 2013, OPT LETT, V38, P266, DOI 10.1364/OL.38.000266; MacLaurin SA, 2006, SOC MOL IM ANN M HAW; Miller SJ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.2.021103; Mufti N, 2011, BIOMED OPT EXPRESS, V2, P1121, DOI 10.1364/BOE.2.001121; Muldoon TJ, 2008, GASTROINTEST ENDOSC, V68, P737, DOI 10.1016/j.gie.2008.05.018; Muldoon TJ, 2007, OPT EXPRESS, V15, P16413, DOI 10.1364/OE.15.016413; Ntziachristos V, 2002, NAT MED, V8, P757, DOI 10.1038/nm729; Nuiachristos V, 2006, ANNU REV BIOMED ENG, V8, P1, DOI 10.1146/annurev.bioeng.8.061505.095831; Oh G, 2013, OPT FIBER TECHNOL, V19, P760, DOI 10.1016/j.yofte.2013.07.008; Pierce M, 2011, JOVE-J VIS EXP, DOI 10.3791/2306; Sevick-Muraca EM, 2012, ANNU REV MED, V63, P217, DOI 10.1146/annurev-med-070910-083323; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sosnovik DE, 2007, CIRCULATION, V115, P1384, DOI 10.1161/CIRCULATIONAHA.106.663351; Tamguney G, 2009, P NATL ACAD SCI USA, V106, P15002, DOI 10.1073/pnas.0907339106; Torres RM, 2004, AM J OPHTHALMOL, V138, P1048, DOI 10.1016/j.ajo.2004.06.020; TRAVIS LW, 1976, LARYNGOSCOPE, V86, P549, DOI 10.1288/00005537-197604000-00011; Troy Tamara, 2004, Mol Imaging, V3, P9, DOI 10.1162/153535004773861688; Wagnieres GA, 1998, PHOTOCHEM PHOTOBIOL, V68, P603; White AG, 2010, BIOCONJUGATE CHEM, V21, P1297, DOI 10.1021/bc1000998; World Health Organization, 2014, GLOB TUB REP; Yuste R, 2005, NAT METHODS, V2, P902, DOI 10.1038/nmeth1205-902; Zhang YY, 2012, P NATL ACAD SCI USA, V109, P12878, DOI 10.1073/pnas.1121495109	56	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149932	10.1371/journal.pone.0149932	http://dx.doi.org/10.1371/journal.pone.0149932			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901051	Green Submitted, gold, Green Published			2022-12-27	WOS:000371276100187
J	Wang, XH; Yu, Y; Huang, T; Qin, WC; Su, LM; Zhao, YH				Wang, Xiao H.; Yu, Yang; Huang, Tao; Qin, Wei C.; Su, Li M.; Zhao, Yuan H.			Comparison of Toxicities to Vibrio fischeri and Fish Based on Discrimination of Excess Toxicity from Baseline Level	PLOS ONE			English	Article							NONPOLAR NARCOSIS; FATHEAD MINNOW; STRUCTURAL ALERTS; CHEMICALS; BIOCONCENTRATION; CLASSIFICATION; QSAR; MODES; POLAR; QUANTIFICATION	Investigations on the relationship of toxicities between species play an important role in the understanding of toxic mechanisms to environmental organisms. In this paper, the toxicity data of 949 chemicals to fish and 1470 chemicals to V. fischeri were used to investigate the modes of action (MOAs) between species. The results show that although there is a positive interspecies correlation, the relationship is poor. Analysis on the excess toxicity calculated from toxic ratios (TR) shows that many chemicals have close toxicities and share the same MOAs between the two species. Linear relationships between the toxicities and octanol/water partition coefficient (log K-OW) for baseline and less inert compounds indicate that the internal critical concentrations (CBRs) approach a constant both to fish and V. fischeri for neutral hydrophobic compounds. These compounds share the same toxic mechanisms and bio-uptake processes between species. On the other hand, some hydrophilic compounds exhibit different toxic effects with greatly different log TR values between V. fischeri and fish species. These hydrophilic compounds were identified as reactive MOAs to V. fischeri, but not to fish. The interspecies correlation is improved by adding a hydrophobic descriptor into the correlation equation. This indicates that the differences in the toxic ratios between fish and V. fischeri for these hydrophilic compounds can be partly attributed to the differences of bioconcentration between the two species, rather than the differences of reactivity with the target macromolecules. These hydrophilic compounds may more easily pass through the cell membrane of V. fischeri than the gill and skin of fish, react with the target macromolecules and exhibit excess toxicity. The compounds with log K-OW >7 exhibiting very low toxicity (log TR < -1) to both species indicate that the bioconcentration potential of a chemical plays a very important role in the identification of excess toxicity and MOAs.	[Wang, Xiao H.; Yu, Yang; Huang, Tao; Qin, Wei C.; Su, Li M.; Zhao, Yuan H.] NE Normal Univ, State Environm Protect Key Lab Wetland Ecol & Veg, Sch Environm, Changchun, Jilin, Peoples R China	Northeast Normal University - China	Zhao, YH (corresponding author), NE Normal Univ, State Environm Protect Key Lab Wetland Ecol & Veg, Sch Environm, Changchun, Jilin, Peoples R China.	zhaoyh@nenu.edu.cn	ZHAO, YUAN/HCI-5831-2022		National Natural Science Foundation of China [21377022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by the National Natural Science Foundation of China, 21377022,(http://www.nsfc.gov.cn/) to YHZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnot JA, 2006, ENVIRON REV, V14, P257, DOI 10.1139/a06-005; Arnot Jon A., 2010, Integrated Environmental Assessment and Management, V6, P210, DOI 10.1897/IEAM_2009-051.1; Aruoja V, 2011, CHEMOSPHERE, V84, P1310, DOI 10.1016/j.chemosphere.2011.05.023; Cronin MTD, 1998, ECOTOX ENVIRON SAFE, V39, P65, DOI 10.1006/eesa.1997.1618; CRONIN MTD, 1995, QUANT STRUCT-ACT REL, V14, P1, DOI 10.1002/qsar.19950140102; Cronin MTD, 2000, SAR QSAR ENVIRON RES, V11, P301, DOI 10.1080/10629360008033237; Dearden JC, 2000, QUANT STRUCT-ACT REL, V19, P3; Deng ZQ, 2012, ENVIRON SCI TECHNOL, V46, P7746, DOI 10.1021/es203490f; Enoch SJ, 2011, CRIT REV TOXICOL, V41, P783, DOI 10.3109/10408444.2011.598141; Jones D, 2011, ENVIRON SCI TECHNOL, V45, P9776, DOI 10.1021/es201948j; Jonker MTO, 2007, ENVIRON SCI TECHNOL, V41, P7363, DOI 10.1021/es0709977; KAISER K L E, 1991, Water Pollution Research Journal of Canada, V26, P361; KONEMANN H, 1981, TOXICOLOGY, V19, P209, DOI 10.1016/0300-483X(81)90130-X; Li JJ, 2015, CHEMOSPHERE, V120, P660, DOI 10.1016/j.chemosphere.2014.10.013; Maeder V, 2004, ENVIRON SCI TECHNOL, V38, P3659, DOI 10.1021/es0351591; MCCARTY LS, 1993, ENVIRON SCI TECHNOL, V27, P1719, DOI 10.1021/es00046a001; MCCARTY LS, 1992, ENVIRON TOXICOL CHEM, V11, P917, DOI 10.1002/etc.5620110705; Meylan WM, 1999, ENVIRON TOXICOL CHEM, V18, P664, DOI 10.1002/etc.5620180412; Neuwoehner J, 2010, AQUAT TOXICOL, V97, P58, DOI 10.1016/j.aquatox.2009.12.005; Nobels I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024139; OECD (Organisation for Economic Cooperation and Development), 1996, GUID TEST CHEM PROP; Pavan M, 2008, QSAR COMB SCI, V27, P21, DOI 10.1002/qsar.200710102; Qin WC, 2010, SAR QSAR ENVIRON RES, V21, P389, DOI 10.1080/1062936X.2010.501143; Raevsky OA, 2009, QSAR COMB SCI, V28, P163, DOI 10.1002/qsar.200860016; Raevsky OA, 2008, QSAR COMB SCI, V27, P1274, DOI 10.1002/qsar.200860014; Russom CL, 1997, ENVIRON TOXICOL CHEM, V16, P948, DOI 10.1002/etc.5620160514; Schramm F, 2011, ENVIRON SCI TECHNOL, V45, P5812, DOI 10.1021/es200081n; Schultz TW, 2006, SAR QSAR ENVIRON RES, V17, P413, DOI 10.1080/10629360600884371; Schwobel JAH, 2011, CHEM REV, V111, P2562, DOI 10.1021/cr100098n; Su LM, 2014, SCI TOTAL ENVIRON, V484, P137, DOI 10.1016/j.scitotenv.2014.03.040; VERHAAR HJM, 1992, CHEMOSPHERE, V25, P471, DOI 10.1016/0045-6535(92)90280-5; Vighi M, 2009, ECOTOX ENVIRON SAFE, V72, P154, DOI 10.1016/j.ecoenv.2008.05.008; Villa S, 2012, ECOTOX ENVIRON SAFE, V86, P93, DOI 10.1016/j.ecoenv.2012.08.030; von der Ohe PC, 2005, CHEM RES TOXICOL, V18, P536, DOI 10.1021/tx0497954; Wang Y, 2014, ENVIRON TOXICOL PHAR, V38, P388, DOI 10.1016/j.etap.2014.07.003; Wen Y, 2015, WATER AIR SOIL POLL, V226, DOI 10.1007/s11270-015-2427-1; Zhang XJ, 2010, SCI TOTAL ENVIRON, V408, P4549, DOI 10.1016/j.scitotenv.2010.07.022; Zhao YH, 1998, QUANT STRUCT-ACT REL, V17, P131, DOI 10.1002/(SICI)1521-3838(199804)17:02<131::AID-QSAR131>3.3.CO;2-C	38	10	10	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0150028	10.1371/journal.pone.0150028	http://dx.doi.org/10.1371/journal.pone.0150028			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901437	gold, Green Published, Green Submitted			2022-12-27	WOS:000371276100201
J	Yao, LY; Abe, M; Kawasaki, K; Akbar, SMF; Matsuura, B; Onji, M; Hiasa, Y				Yao, Liying; Abe, Masanori; Kawasaki, Keitarou; Akbar, Sheikh Mohammad Fazle; Matsuura, Bunzo; Onji, Morikazu; Hiasa, Yoichi			Characterization of Liver Monocytic Myeloid-Derived Suppressor Cells and Their Role in a Murine Model of Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							REGULATORY T-CELLS; HEPATIC STEATOSIS; NITRIC-OXIDE; IMMUNE-RESPONSE; DOWN-REGULATION; INFLAMMATION; DIET; GAMMA; IDENTIFICATION; ACCUMULATION	Myeloid-Myeloid-derived suppressor cells (MDSCs) are potent suppressors of T cell immunity in tumors and inflammatory diseases. They are identified by surface expression of CD11b(+)Gr1(+) in mice, and CD11b(+)Gr1(+) cells accumulate in the livers of obese mice. However, many myeloid cells share these CD11b(+)Gr1(+) markers. Accordingly, the aim of this study was to identify the authentic phenotype of MDSCs and investigate their functions in non-alcoholic fatty liver disease (NAFLD). C57BL/6J mice were divided into 2 diet groups: a normal control group and high-fat group to induce NAFLD. We demonstrated that monocytic CD11b(+)Gr1(dim) cells could be further divided into 2 populations based on side scatter (SSC) during flow cytometry. We found that SSC(low)CD11b(+)Gr1(dim) cells accumulated in the livers of NAFLD mice over time, and that these cells were recruited by the chemokine CCL2 and its receptor CCR2 and might expand in the liver via macrophage colony-stimulating factor stimulation. Furthermore, SSC(low)CD11b(+)Gr1(dim) cells had a strong suppressive ability on T cells; this effect was not observed for SSC(high)CD11b(+)Gr1(dim) cells, and was dependent on nitric oxide production by inducible nitric oxide synthase. Our findings demonstrate that SSC(low)CD11b(+)Gr1(dim) cells represent authentic MDSCs in NAFLD livers, and might serve an important negative feedback function in liver inflammation.	[Yao, Liying; Abe, Masanori; Kawasaki, Keitarou; Matsuura, Bunzo; Hiasa, Yoichi] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime, Japan; [Akbar, Sheikh Mohammad Fazle] Toshiba Gen Hosp, Dept Med Sci, Shinagawa Ku, Tokyo, Japan; [Onji, Morikazu] Imabari Saiseikai Med Welfare Ctr, Dept Internal Med, Imabari, Ehime, Japan	Ehime University; Toshiba Corporation	Abe, M (corresponding author), Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime, Japan.	masaben@m.ehime-u.ac.jp	Hiasa, Yoichi/ABD-2759-2021	Hiasa, Yoichi/0000-0003-4117-339X	Japanese Ministry of Education, Culture, Sports, Science and Technology [15K09007, 15K09006]; Japanese Ministry of Health, Labor and Welfare	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by Grants-in-Aid for Scientific Research (JSPS KAKENHI 15K09007 to MA and 15K09006 to YH) from the Japanese Ministry of Education, Culture, Sports, Science and Technology, as well as a Grant-in-Aid for Scientific Research and Development from the Japanese Ministry of Health, Labor and Welfare (to MA and YH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; Boelte KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018534; Bronte V, 2000, BLOOD, V96, P3838, DOI 10.1182/blood.V96.12.3838.h8003838_3838_3846; Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Chen S, 2011, CLIN EXP IMMUNOL, V166, P134, DOI 10.1111/j.1365-2249.2011.04445.x; Chen S, 2015, OBES RES CLIN PRACT, V9, P35, DOI 10.1016/j.orcp.2013.12.006; Cripps JG, 2010, HEPATOLOGY, V52, P1350, DOI 10.1002/hep.23841; Deng ZB, 2009, HEPATOLOGY, V50, P1412, DOI 10.1002/hep.23148; Feldstein AE, 2003, J HEPATOL, V39, P978, DOI 10.1016/S0168-8278(03)00460-4; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Hale M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118784; Harari O, 2004, CURR PHARM DESIGN, V10, P893, DOI 10.2174/1381612043452893; Hassan MM, 2015, GASTROENTEROLOGY, V149, P119, DOI 10.1053/j.gastro.2015.03.044; Hegde VL, 2015, J IMMUNOL, V194, P5211, DOI 10.4049/jimmunol.1401844; Hochst B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119662; Huang B, 2007, CANCER LETT, V252, P86, DOI 10.1016/j.canlet.2006.12.012; Kapanadze T, 2013, J HEPATOL, V59, P1007, DOI 10.1016/j.jhep.2013.06.010; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Kawasaki K, 2013, LAB INVEST, V93, P311, DOI 10.1038/labinvest.2012.176; Kong XH, 2014, J IMMUNOL, V193, P1645, DOI 10.4049/jimmunol.1303432; Ma SB, 2014, CANCER RES, V74, P1969, DOI 10.1158/0008-5472.CAN-13-2534; Ma X, 2007, HEPATOLOGY, V46, P1519, DOI 10.1002/hep.21823; Mazzoni A, 2002, J IMMUNOL, V168, P689, DOI 10.4049/jimmunol.168.2.689; Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183; Mok S, 2014, CANCER RES, V74, P153, DOI 10.1158/0008-5472.CAN-13-1816; Morosawa T, 2015, HEPATOLOGY, V62, p1264A; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Pollard JW, 1997, MOL REPROD DEV, V46, P54, DOI 10.1002/(SICI)1098-2795(199701)46:1&lt;54::AID-MRD9&gt;3.0.CO;2-Q; Rivoltini L, 2002, IMMUNOL REV, V188, P97, DOI 10.1034/j.1600-065X.2002.18809.x; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Shen P, 2014, HEPATOL RES, V44, P639, DOI 10.1111/hepr.12167; Sosroseno W, 2009, ANAEROBE, V15, P95, DOI 10.1016/j.anaerobe.2009.01.002; Sutti S, 2014, HEPATOLOGY, V59, P886, DOI 10.1002/hep.26749; Tam JW, 2014, INFECT IMMUN, V82, P2606, DOI 10.1128/IAI.01590-13; Tang Y, 2011, CLIN EXP IMMUNOL, V166, P281, DOI 10.1111/j.1365-2249.2011.04471.x; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Wan JH, 2014, HEPATOLOGY, V59, P130, DOI 10.1002/hep.26607; Xia S, 2011, J BIOL CHEM, V286, P23591, DOI 10.1074/jbc.M111.237123; Xiong XL, 2014, J HEPATOL, V60, P847, DOI 10.1016/j.jhep.2013.12.003; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Zeng QL, 2014, MOL CELLS, V37, P66, DOI 10.14348/molcells.2014.2282	43	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149948	10.1371/journal.pone.0149948	http://dx.doi.org/10.1371/journal.pone.0149948			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901500	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100191
J	Sultana, R; Tanneeru, K; Kumar, ABR; Guruprasad, L				Sultana, Rafiya; Tanneeru, Karunakar; Kumar, Ashwin B. R.; Guruprasad, Lalitha			Prediction of Certain Well-Characterized Domains of Known Functions within the PE and PPE Proteins of Mycobacteria	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; NONRIBOSOMAL PEPTIDE SYNTHETASE; CELLULOSE-BINDING DOMAIN; PE/PPE MULTIGENE FAMILY; CELL-SURFACE; 3-DIMENSIONAL STRUCTURE; TUBERCULOSIS GENES; CRYSTAL-STRUCTURE; CLASSIFICATION; VIRULENCE	The PE and PPE protein family are unique to mycobacteria. Though the complete genome sequences for over 500 M. tuberculosis strains and mycobacterial species are available, few PE and PPE proteins have been structurally and functionally characterized. We have therefore used bioinformatics tools to characterize the structure and function of these proteins. We selected representative members of the PE and PPE protein family by phylogeny analysis and using structure-based sequence annotation identified ten well-characterized protein domains of known function. Some of these domains were observed to be common to all mycobacterial species and some were species specific.	[Sultana, Rafiya; Tanneeru, Karunakar; Kumar, Ashwin B. R.; Guruprasad, Lalitha] Univ Hyderabad, Sch Chem, Hyderabad 500046, Andhra Pradesh, India	University of Hyderabad	Guruprasad, L (corresponding author), Univ Hyderabad, Sch Chem, Hyderabad 500046, Andhra Pradesh, India.	lalitha.guruprasad@uohyd.ac.in	Tanneeru, Karunakar/C-8200-2019	Tanneeru, PhD, FICS, Dr. Karunakar/0000-0002-9250-6476	DBT; Council of Scientific and Industrial Research; DSK Kothari, UGC	DBT(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); DSK Kothari, UGC	LGP thanks DBT for the Fast Track Fellowship and University with Potential for Excellence-2, University of Hyderabad for research facilities. RS thanks the Council of Scientific and Industrial Research for the Senior Research Fellowship. KT thanks DSK Kothari, UGC for the post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; LGP thanks DBT for Fast Track fellowship and University with Potential for Excellence-2, University of Hyderabad for research facilities. RS thanks Council of Scientific and Industrial Research for Senior Research Fellowship. KT thanks DSK Kothari, UGC for post-doctoral fellowship. The authors also thank the anonymous reviewers and the Academic Editor for very useful comments to improve the manuscript.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Adindla S, 2003, J BIOSCIENCES, V28, P169, DOI 10.1007/BF02706216; Adindla S, 2013, BIOINFORMATICS P AND, P125; Adindla S, 2007, INT J BIOL MACROMOL, V41, P454, DOI 10.1016/j.ijbiomac.2007.06.004; Akhter Y, 2012, BIOCHIMIE, V94, P110, DOI 10.1016/j.biochi.2011.09.026; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anand P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027044; Barathy DV, 2013, FEBS OPEN BIO, V3, P256, DOI 10.1016/j.fob.2013.05.004; Bentley SD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001552; Brohawn SG, 2009, NAT STRUCT MOL BIOL, V16, P1173, DOI 10.1038/nsmb.1713; Brown K, 2000, NAT STRUCT BIOL, V7, P191; Brown K, 2000, J BIOL CHEM, V275, P41133, DOI 10.1074/jbc.M008617200; Cascioferro A, 2007, MOL MICROBIOL, V66, P1536, DOI 10.1111/j.1365-2958.2007.06023.x; Cascioferro A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027713; Chen CKM, 2011, TRENDS BIOCHEM SCI, V36, P553, DOI 10.1016/j.tibs.2011.07.004; COLE ST, 1995, EUR RESPIR J, V8, pS701; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COLMAN PM, 1994, PROTEIN SCI, V3, P1687, DOI 10.1002/pro.5560031007; Cooper JB, 2002, CURR DRUG TARGETS, V3, P155, DOI 10.2174/1389450024605382; Cryle MJ, 2011, METALLOMICS, V3, P323, DOI 10.1039/c0mt00081g; Daleke MH, 2011, J BIOL CHEM, V286, P19024, DOI 10.1074/jbc.M110.204966; Danielson PB, 2002, CURR DRUG METAB, V3, P561, DOI 10.2174/1389200023337054; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies G, 1997, COMPREHENSIVE BBIOLO, P119; Deng WY, 2014, CELL PHYSIOL BIOCHEM, V33, P273, DOI 10.1159/000356668; DIN N, 1994, P NATL ACAD SCI USA, V91, P11383, DOI 10.1073/pnas.91.24.11383; DIN N, 1991, BIO-TECHNOL, V9, P1096, DOI 10.1038/nbt1191-1096; Doxey AC, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-23; Dubnau E, 2002, INFECT IMMUN, V70, P2787, DOI 10.1128/IAI.70.6.2787-2795.2002; Dunn B, 1989, PROTEOLITIC ENZYMES; Ehebauer MT, 2011, PROTEOMICS, V11, P3128, DOI 10.1002/pmic.201000787; Fishbein S, 2015, MOL MICROBIOL, V96, P901, DOI 10.1111/mmi.12981; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Garrett CK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135447; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Gordon EHJ, 2003, J BIOL CHEM, V278, P11773, DOI 10.1074/jbc.M211886200; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; Hotelier T, 2004, NUCLEIC ACIDS RES, V32, pD145, DOI 10.1093/nar/gkh141; Hur GH, 2012, NAT PROD REP, V29, P1074, DOI 10.1039/c2np20025b; Iantomasi R, 2012, CELL MICROBIOL, V14, P356, DOI 10.1111/j.1462-5822.2011.01721.x; Ishikawa J, 2004, P NATL ACAD SCI USA, V101, P14925, DOI 10.1073/pnas.0406410101; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Johnson PE, 1996, BIOCHEMISTRY-US, V35, P14381, DOI 10.1021/bi961612s; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim BS, 2012, J BACTERIOL, V194, P4441, DOI 10.1128/JB.00848-12; Kohli S, 2012, NUCLEIC ACIDS RES, V40, P7113, DOI 10.1093/nar/gks465; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Li LL, 2005, P NATL ACAD SCI USA, V102, P12344, DOI 10.1073/pnas.0505662102; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; LIETZKE SE, 1994, PLANT PHYSIOL, V106, P849, DOI 10.1104/pp.106.3.849; Lin DYW, 2012, P NATL ACAD SCI USA, V109, P1925, DOI 10.1073/pnas.1115025109; Lin DYW, 2011, J BIOL CHEM, V286, P441, DOI 10.1074/jbc.M110.167643; Mackenzie N, 2009, J CLIN MICROBIOL, V47, P1002, DOI 10.1128/JCM.01313-08; McEvoy CRE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030593; Mitraki A, 2002, J STRUCT BIOL, V137, P236, DOI 10.1006/jsbi.2002.4447; Nair Shiny, 2014, Proceedings of the Indian National Science Academy, V80, P1055; Narita M, 1998, AM J RESP CRIT CARE, V158, P157, DOI 10.1164/ajrccm.158.1.9712001; Pearson WR, 2013, INTRO SEQUENCE SIMIL; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Pohle S, 2011, J AM CHEM SOC, V133, P6194, DOI 10.1021/ja108971p; POULSEN K, 1976, BIOCHIM BIOPHYS ACTA, V452, P533, DOI 10.1016/0005-2744(76)90205-9; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; Singh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115020; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; SNIDER DE, 1994, J INFECT DIS, V169, P1189, DOI 10.1093/infdis/169.6.1189; SONG WC, 1993, P NATL ACAD SCI USA, V90, P8519, DOI 10.1073/pnas.90.18.8519; Srivastava V, 2007, MICROBIOL-SGM, V153, P659, DOI 10.1099/mic.0.2006/000547-0; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Sultana R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055320; Sultana R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016745; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor NR, 1998, J MED CHEM, V41, P798, DOI 10.1021/jm9703754; Tormo J, 1996, EMBO J, V15, P5739, DOI 10.1002/j.1460-2075.1996.tb00960.x; TORRONEN A, 1994, EMBO J, V13, P2493, DOI 10.1002/j.1460-2075.1994.tb06536.x; Tundup S, 2006, FEBS LETT, V580, P1285, DOI 10.1016/j.febslet.2006.01.042; Tundup S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003586; Uhlmann S, 2013, ACS CHEM BIOL, V8, P2586, DOI 10.1021/cb400555e; van Helden P., 2008, HDB TUBERCULOSIS CLI; Vissa V. D., 2001, Genome Biology, V2, P1023, DOI 10.1186/gb-2001-2-8-reviews1023; World Health Organization, 2006, GUID PROGR MAN DRUG; Wu HM, 2009, J BIOL CHEM, V284, P26708, DOI 10.1074/jbc.M109.010983; Zaman K, 2010, J HEALTH POPUL NUTR, V28, P111; Zheng QQ, 2014, J BIOL CHEM, V289, P21242, DOI 10.1074/jbc.M114.569913; Zumbo A, 2013, PATHOG DIS, V69, P232, DOI 10.1111/2049-632X.12096	88	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0146786	10.1371/journal.pone.0146786	http://dx.doi.org/10.1371/journal.pone.0146786			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891364	Green Published, Green Submitted, gold			2022-12-27	WOS:000371221500002
J	Wilkie, H; Gossner, A; Bishop, S; Hopkins, J				Wilkie, Hazel; Gossner, Anton; Bishop, Stephen; Hopkins, John			Variations in T Cell Transcription Factor Sequence and Expression Associated with Resistance to the Sheep Nematode Teladorsagia circumcincta	PLOS ONE			English	Article							RECEPTOR ROR-ALPHA; GENE-EXPRESSION; GENOMIC STRUCTURE; DNA-BINDING; INFECTION; GATA3; LAMBS; BET; DIFFERENTIATION; ISOFORM	This study used selected lambs that varied in their resistance to the gastrointestinal parasite Teladorsagia circumcincta. Infection over 12 weeks identified susceptible (high adult worm count, AWC; high fecal egg count, FEC; low body weight, BW; low IgA) and resistant sheep (no/low AWC and FEC, high BW and high IgA). Resistance is mediated largely by a Th2 response and IgA and IgE antibodies, and is a heritable characteristic. The polarization of T cells and the development of appropriate immune responses is controlled by the master regulators, T-bet (TBX21), GATA-3 (GATA3), ROR gamma t (RORC2) and ROR alpha (RORA); and several inflammatory diseases of humans and mice are associated with allelic or transcript variants of these transcription factors. This study tested the hypothesis that resistance of sheep to T. circumcincta is associated with variations in the structure, sequence or expression levels of individual master regulator transcripts. We have identified and sequenced one variant of sheep TBX21, two variants of GATA3 and RORC2 and five variants of RORA from lymph node mRNA. Relative RT-qPCR analysis showed that TBX21, GATA3 and RORC2 were not significantly differentially-expressed between the nine most resistant (AWC, 0; FEC, 0) and the nine most susceptible sheep (AWC, mean 6078; FEC, mean 350). Absolute RT-qPCR on all 45 animals identified RORVv5 as being significantly differentially-expressed (p = 0.038) between resistant, intermediate and susceptible groups; RORCv2 was not differentially-expressed (p = 0.77). Spearman's rank analysis showed that RORAv5 transcript copy number was significantly negatively correlated with parameters of susceptibility, AWC and FEC; and was positively correlated with BW. RORCv2 was not correlated with AWC, FEC or BW but was significantly negatively correlated with IgA antibody levels. This study identifies the full length RORA variant (RORAv5) as important in controlling the protective immune response to T. circumcincta infection in sheep.	[Hopkins, John] Univ Edinburgh, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland; Univ Edinburgh, RDSVS, Easter Bush EH25 9RG, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Hopkins, J (corresponding author), Univ Edinburgh, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland.	john.hopkins@ed.ac.uk	Hopkins, John/C-7756-2013	Hopkins, John/0000-0002-9530-8037; Wilkie, Hazel/0000-0002-6586-4518	Biotechnology and Biological Sciences Research Council (BBSRC) Institute Strategic Programme Grant; BBSRC Industrial CASE scholarship; Sheep Improved Genetics Ltd; AHDB Beef and Lamb [BB/J012653/1]; Natural Environment Research Council (NERC) [NE/D000645/1]; Sheep Improved Genetics Ltd (SIG); BBSRC CASE Scholarship; BBSRC; AHDN Animal Health Beef and Lamb (Eblex); BBSRC [BBS/E/D/20231760, BBS/E/D/20231759] Funding Source: UKRI; NERC [NE/D000645/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20231759, 1232400, BBS/E/D/20231760] Funding Source: researchfish; Natural Environment Research Council [NE/D000645/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) Institute Strategic Programme Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Industrial CASE scholarship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Sheep Improved Genetics Ltd; AHDB Beef and Lamb; Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Sheep Improved Genetics Ltd (SIG); BBSRC CASE Scholarship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); AHDN Animal Health Beef and Lamb (Eblex); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) Institute Strategic Programme Grant to The Roslin Institute and by a BBSRC Industrial CASE scholarship to JH and SB, for HW, sponsored by Sheep Improved Genetics Ltd and AHDB Beef and Lamb (Grant BB/J012653/1). The initial work was funded by the Natural Environment Research Council (NERC) through its 'PostGenomics and Proteomics' programme (grant NE/D000645/1). No funding was obtained from Sheep Improved Genetics Ltd (SIG). Their support was essential to obtain the BBSRC CASE Scholarship, but all the funds came from either BBSRC or AHDN Animal Health Beef and Lamb (originally called Eblex). SIG had no influence on the design of the experiments and have no rights to the data.	Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Aschrafi A, 2006, BBA-MOL CELL RES, V1763, P805, DOI 10.1016/j.bbamcr.2006.05.006; Beraldi D, 2008, INT J PARASITOL, V38, P1567, DOI 10.1016/j.ijpara.2008.04.011; Besnard S, 2002, FEBS LETT, V511, P36, DOI 10.1016/S0014-5793(01)03275-6; Brunsdon RV, 1988, EC IMPORTANCE PARASI, V1, P4; Davies G, 2006, HEREDITY, V96, P252, DOI 10.1038/sj.hdy.6800788; Delerive P, 2001, EMBO REP, V2, P42, DOI 10.1093/embo-reports/kve007; Diez-Tascon C, 2005, PHYSIOL GENOMICS, V21, P59, DOI 10.1152/physiolgenomics.00257.2004; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; Gossner A, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-68; Gossner AG, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-26; Halliday AM, 2010, PARASITE IMMUNOL, V32, P81, DOI 10.1111/j.1365-3024.2009.01173.x; Huebner M, 2008, J ALLERGY CLIN IMMUN, V121, P408, DOI 10.1016/j.jaci.2007.09.020; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kanai T, 2012, MUCOSAL IMMUNOL, V5, P240, DOI 10.1038/mi.2012.6; Knight PA, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-78; Lazarevic V, 2013, NAT REV IMMUNOL, V13, P777, DOI 10.1038/nri3536; Lazarevic V, 2011, NAT IMMUNOL, V12, P597, DOI 10.1038/ni.2059; LEE CH, 1995, GENOMICS, V30, P46, DOI 10.1006/geno.1995.0007; Maizels RM, 2009, J EXP MED, V206, P2059, DOI 10.1084/jem.20091903; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Matsuoka K, 2004, GUT, V53, P1303, DOI 10.1136/gut.2003.024190; Medvedev A, 1997, GENOMICS, V46, P93, DOI 10.1006/geno.1997.4980; Migita H, 2004, FEBS LETT, V557, P269, DOI 10.1016/S0014-5793(03)01502-3; Murphy L, 2010, PARASITOLOGY, V137, P1249, DOI 10.1017/S0031182010000028; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nisbet AJ, 2009, PARASITE IMMUNOL, V31, P32, DOI 10.1111/j.1365-3024.2008.01070.x; Ohtani K, 2010, PEDIATR INT, V52, P584, DOI 10.1111/j.1442-200X.2009.03019.x; Pemberton JM, 2011, MOL ECOL, V20, P910, DOI 10.1111/j.1365-294X.2010.04992.x; Pykalainen M, 2005, J ALLERGY CLIN IMMUN, V115, P80, DOI 10.1016/j.jaci.2004.10.006; Rauen T, 2012, GENES IMMUN, V13, P346, DOI 10.1038/gene.2011.85; Rowe A, 2008, VET PARASITOL, V154, P71, DOI 10.1016/j.vetpar.2008.02.014; Sayers G., 2005, Animal Health Research Reviews, V6, P159, DOI 10.1079/AHR2005108; Shaw RJ, 2012, VET PARASITOL, V186, P109, DOI 10.1016/j.vetpar.2011.11.051; Shinnakasu R, 2006, J IMMUNOL, V177, P5801, DOI 10.4049/jimmunol.177.9.5801; SMITH WD, 1986, RES VET SCI, V41, P300, DOI 10.1016/S0034-5288(18)30620-9; Stear MJ, 1999, INT J PARASITOL, V29, P51, DOI 10.1016/S0020-7519(98)00179-9; Stear MJ, 1999, VET IMMUNOL IMMUNOP, V72, P213, DOI 10.1016/S0165-2427(99)00134-8; Steinmayr M, 1998, P NATL ACAD SCI USA, V95, P3960, DOI 10.1073/pnas.95.7.3960; Urquhart GM, 1987, VET PARASITOLOGY AVO; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wojno EDT, 2012, CELL HOST MICROBE, V12, P445, DOI 10.1016/j.chom.2012.10.003; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2006, CELL RES, V16, P3, DOI 10.1038/sj.cr.7310002; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	50	7	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149644	10.1371/journal.pone.0149644	http://dx.doi.org/10.1371/journal.pone.0149644			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890074	Green Published, Green Submitted, gold			2022-12-27	WOS:000371221500067
J	Ibanez, M; Carbonell-Caballero, J; Garcia-Alonso, L; Such, E; Jimenez-Almazan, J; Vidal, E; Barragan, E; Lopez-Pavia, M; LLop, M; Martin, I; Gomez-Segui, I; Montesinos, P; Sanz, MA; Dopazo, J; Cervera, J				Ibanez, Mariam; Carbonell-Caballero, Jose; Garcia-Alonso, Luz; Such, Esperanza; Jimenez-Almazan, Jorge; Vidal, Enrique; Barragan, Eva; Lopez-Pavia, Maria; LLop, Marta; Martin, Ivan; Gomez-Segui, Ines; Montesinos, Pau; Sanz, Miguel A.; Dopazo, Joaquin; Cervera, Jose			The Mutational Landscape of Acute Promyelocytic Leukemia Reveals an Interacting Network of Co-Occurrences and Recurrent Mutations	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; ACUTE MYELOID-LEUKEMIA; SOMATIC MUTATIONS; TOOL	Preliminary Acute Promyelocytic Leukemia (APL) whole exome sequencing (WES) studies have identified a huge number of somatic mutations affecting more than a hundred different genes mainly in a non-recurrent manner, suggesting that APL is a heterogeneous disease with secondary relevant changes not yet defined. To extend our knowledge of subtle genetic alterations involved in APL that might cooperate with PML/RARA in the leukemogenic process, we performed a comprehensive analysis of somatic mutations in APL combining WES with sequencing of a custom panel of targeted genes by next-generation sequencing. To select a reduced subset of high confidence candidate driver genes, further in silico analysis were carried out. After prioritization and network analysis we found recurrent deleterious mutations in 8 individual genes (STAG2, U2AF1, SMC1A, USP9X, IKZF1, LYN, MYCBP2 and PTPN11) with a strong potential of being involved in APL pathogenesis. Our network analysis of multiple mutations provides a reliable approach to prioritize genes for additional analysis, improving our knowledge of the leukemogenesis interactome. Additionally, we have defined a functional module in the interactome of APL. The hypothesis is that the number, or the specific combinations, of mutations harbored in each patient might not be as important as the disturbance caused in biological key functions, triggered by several not necessarily recurrent mutations.	[Ibanez, Mariam; Such, Esperanza; Lopez-Pavia, Maria; Martin, Ivan; Gomez-Segui, Ines; Montesinos, Pau; Sanz, Miguel A.; Cervera, Jose] Hosp Univ & Politecn La Fe, Hematol Serv, Valencia, Spain; [Carbonell-Caballero, Jose; Garcia-Alonso, Luz; Jimenez-Almazan, Jorge; Vidal, Enrique; Dopazo, Joaquin] Ctr Invest Principe Felipe, Computat Genom Dept, Valencia, Spain; [Barragan, Eva; LLop, Marta] Hosp Univ La Fe, Dept Clin Chem, Mol Biol Lab, Valencia, Spain; [Dopazo, Joaquin] CIPF, Spanish Natl Inst Bioinformat, Funct Genom Node, Valencia 46012, Spain; [Dopazo, Joaquin] CIBER Enfermedades Raras CIBERER, Bioinformat Rare Dis BIER, Valencia, Spain; [Cervera, Jose] Hosp Univ & Politecn La Fe, Genet Unit, Valencia, Spain	Hospital Universitari i Politecnic La Fe; Prince Felipe Research Center; Hospital Universitari i Politecnic La Fe; Prince Felipe Research Center; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitari i Politecnic La Fe	Cervera, J (corresponding author), Hosp Univ & Politecn La Fe, Hematol Serv, Valencia, Spain.; Dopazo, J (corresponding author), Ctr Invest Principe Felipe, Computat Genom Dept, Valencia, Spain.; Dopazo, J (corresponding author), CIPF, Spanish Natl Inst Bioinformat, Funct Genom Node, Valencia 46012, Spain.; Dopazo, J (corresponding author), CIBER Enfermedades Raras CIBERER, Bioinformat Rare Dis BIER, Valencia, Spain.; Cervera, J (corresponding author), Hosp Univ & Politecn La Fe, Genet Unit, Valencia, Spain.	jdopazo@cipf.es; cervera_jos@gva.es	Martin, Ivan/K-9286-2016; Cervera, Jose/ABF-2143-2020; Sanz, Miguel A./F-7485-2018; Martín, Iván/AAL-7783-2021; IBAÑEZ COMPANY, MARIAM/AAW-9082-2021; Dopazo, Joaquin/A-9270-2014; Seguí, Inés Gómez/ABH-5290-2020	Cervera, Jose/0000-0001-8252-1106; Sanz, Miguel A./0000-0003-1489-1177; IBAÑEZ COMPANY, MARIAM/0000-0002-7486-4659; Dopazo, Joaquin/0000-0003-3318-120X; Carbonell Caballero, Jose/0000-0002-9170-0533; Montesinos, Pau/0000-0002-3275-5593; Llop, Marta/0000-0002-0106-7296; Lopez Pavia, Maria/0000-0002-8529-4372; Such, Esperanza/0000-0001-6892-403X; Garcia-Alonso, Luz/0000-0002-7863-9619	Fundacion Espanola de Hematologia (FEHH); Red Tematica de Investigacion Cooperativa en Cancer [RD12/0036/0014]; Instituto de Salud Carlos III [PI12/01047, PI13/01640, PT13/0010/0026, PIE13/00046]; "Conselleria de Educacion, Cultura y Deporte" of the Valencian Community [PROMETEOII/2014/025, PROMETEOII/2015/008]; Spanish Ministry of Economy and Competitiveness [BIO2014-57291-R]	Fundacion Espanola de Hematologia (FEHH); Red Tematica de Investigacion Cooperativa en Cancer; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); "Conselleria de Educacion, Cultura y Deporte" of the Valencian Community; Spanish Ministry of Economy and Competitiveness(Spanish Government)	This study was supported in part by research funding from "Fundacion Espanola de Hematologia (FEHH)"; "Red Tematica de Investigacion Cooperativa en Cancer" grant (RD12/0036/0014); "Instituto de Salud Carlos III" grants PI12/01047, PI13/01640, PT13/0010/0026 and PIE13/00046; from the "Conselleria de Educacion, Cultura y Deporte" of the Valencian Community (PROMETEOII/2014/025 and PROMETEOII/2015/008) and from the Spanish Ministry of Economy and Competitiveness (BIO2014-57291-R).	Akagi T, 2009, BLOOD, V113, P1741, DOI 10.1182/blood-2007-12-130260; Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Alonso R, 2015, NUCLEIC ACIDS RES, V43, pW117, DOI 10.1093/nar/gkv384; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Dolnik A, 2012, BLOOD, V120, pE83, DOI 10.1182/blood-2011-12-401471; Garcia-Alonso L, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145222; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gomez-Segui I, 2012, ANN HEMATOL, V91, P19, DOI 10.1007/s00277-011-1331-z; Gonzalez-Perez A, 2013, NAT METHODS, V10, P1081, DOI [10.1038/NMETH.2642, 10.1038/nmeth.2642]; Greif PA, 2011, LEUKEMIA, V25, P1519, DOI 10.1038/leu.2011.114; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Minguez P, 2009, NUCLEIC ACIDS RES, V37, pW109, DOI 10.1093/nar/gkp402; Mitra K, 2013, NAT REV GENET, V14, P719, DOI 10.1038/nrg3552; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Patel VN, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003237; Porta-Pardo E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004518; Riva L, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.46; Stoll G, 2013, NUCLEIC ACIDS RES, V41, P8853, DOI 10.1093/nar/gkt678; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Welch JS, 2011, JAMA-J AM MED ASSOC, V305, P1577, DOI 10.1001/jama.2011.497; Zimonjic DB, 2000, P NATL ACAD SCI USA, V97, P13306, DOI 10.1073/pnas.97.24.13306	23	20	21	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148346	10.1371/journal.pone.0148346	http://dx.doi.org/10.1371/journal.pone.0148346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886259	gold, Green Submitted, Green Published			2022-12-27	WOS:000371218400031
J	de Almeida, LFR; Portella, RD; Bufalo, J; Marques, MOM; Facanali, R; Frei, F				Rolim de Almeida, Luiz Fernando; Portella, Roberto de Oliveira; Bufalo, Jennifer; Mayo Marques, Marcia Ortiz; Facanali, Roselaine; Frei, Fernando			Non-Oxygenated Sesquiterpenes in the Essential Oil of Copaifera langsdorffii Desf. Increase during the Day in the Dry Season	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; ANTIMICROBIAL ACTIVITY; BIOLOGICAL-ACTIVITIES; L.; TEMPERATURE; EMISSIONS; LEAVES; CONSTITUENTS; OLEORESINS; COMPONENTS	The present study aimed to evaluate the effect of seasonal and diurnal events on the chemical profile of the essential oil obtained from the leaves of Copaifera langsdorffii Desf. This study was performed in a Brazilian savanna named Cerrado. We identified the best harvesting period for obtaining the highest amount of compounds used for commercial and industrial purposes. The chemical profile of the essential oils was evaluated by GC-FID and GC-MS, and the results were assessed through multivariate analyses. The data showed that the time of day and seasonal variations affect the quality of the essential oil obtained. Leaves harvested at the end of the day (5: 00 pm) in the dry season resulted in richer essential oils with higher amounts of non-oxygenated sesquiterpenes. To the best of our knowledge, environmental conditions induce metabolic responses in the leaves of C. langsdorffii, which changes the patterns of sesquiterpene production. Therefore, these factors need to be considered to obtain better concentrations of bioactive compounds for pharmacological studies.	[Rolim de Almeida, Luiz Fernando; Portella, Roberto de Oliveira; Bufalo, Jennifer] Univ Estadual Paulista UNESP, Dept Bot, Inst Biosci Botucatu, POB 510, BR-18618970 Sao Paulo, Brazil; [Mayo Marques, Marcia Ortiz; Facanali, Roselaine] IAC, Inst Agron, POB 28, BR-13001970 Sao Paulo, Brazil; [Frei, Fernando] Univ Estadual Paulista UNESP, Dept Biol Sci, BR-19800000 Sao Paulo, Brazil	Universidade Estadual Paulista; Instituto Agronomico de Campinas (IAC); Universidade Estadual Paulista	Bufalo, J (corresponding author), Univ Estadual Paulista UNESP, Dept Bot, Inst Biosci Botucatu, POB 510, BR-18618970 Sao Paulo, Brazil.	jenniferbufalo@yahoo.com.br	Portella, Roberto O/O-8392-2015; Marques, Marcia O.M./E-1283-2019; de Oliveira Portella, Roberto/AAT-7276-2020	Portella, Roberto O/0000-0002-8668-3425; Marques, Marcia O.M./0000-0001-8270-4308; ROLIM ALMEIDA, LUIZ FERNANDO/0000-0002-2961-2794	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Roberto Oliveira Portela [2013/07629-1];  [2010/15585-6]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Roberto Oliveira Portela; 	This research was funded by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). Luiz Fernando Rolim de Almeida received financial support process no 2010/15585-6 and Roberto Oliveira Portela scholarship process no 2013/07629-1 (http://www.fapesp.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R.P., 2007, IDENTIFICATION ESSEN, V4th; Angelopoulou D, 2002, BIOCHEM SYST ECOL, V30, P189, DOI 10.1016/S0305-1978(01)00074-6; Asghari G, 2014, JUNDISHAPUR J NAT PH, V9, P35, DOI 10.17795/jjnpp-12229; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Cascon V, 2000, PHYTOCHEMISTRY, V55, P773, DOI 10.1016/S0031-9422(00)00284-3; Chen F, 2009, PLANT PHYSIOL BIOCH, V47, P1017, DOI 10.1016/j.plaphy.2009.07.005; Christensen CS, 2000, ATMOS ENVIRON, V34, P3057, DOI 10.1016/S1352-2310(99)00502-6; Coutinho Leopoldo Magno, 2006, Acta Bot. Bras., V20, P13, DOI 10.1590/S0102-33062006000100002; Del-Vechio-Vieira G, 2009, REC NAT PROD, V3, P52; Duhl TR, 2008, BIOGEOSCIENCES, V5, P761, DOI 10.5194/bg-5-761-2008; Figueiredo AC, 2008, FLAVOUR FRAG J, V23, P213, DOI 10.1002/ffj.1875; FREITAS CRISTIANE V., 2002, Braz. J. Bot., V25, P311, DOI 10.1590/S0100-84042002000300007; Fuentes JD, 1996, J ATMOS CHEM, V25, P67, DOI 10.1007/BF00053286; Gawronska K, 2013, J PLANT PHYSIOL, V170, P129, DOI 10.1016/j.jplph.2012.09.019; Gelmini F, 2013, INT J PHARMACEUT, V440, P170, DOI 10.1016/j.ijpharm.2012.08.021; Gramosa MV, 2005, J ESSENT OIL RES, V17, P130; Helmig D, 2006, ATMOS ENVIRON, V40, P4150, DOI 10.1016/j.atmosenv.2006.02.035; Hussain AI, 2008, FOOD CHEM, V108, P986, DOI 10.1016/j.foodchem.2007.12.010; Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x; Kobaisy M, 2002, PHYTOCHEMISTRY, V61, P37, DOI 10.1016/S0031-9422(02)00207-8; Kucukbay FZ, 2012, NAT PROD RES, V26, P1668, DOI 10.1080/14786419.2011.599808; Kumar R, 2013, SCI HORTIC-AMSTERDAM, V154, P102, DOI 10.1016/j.scienta.2013.02.002; Leandro LM, 2012, MOLECULES, V17, P3866, DOI 10.3390/molecules17043866; LINCOLN DE, 1978, BIOCHEM SYST ECOL, V6, P21, DOI 10.1016/0305-1978(78)90021-2; McGimpsey Jennifer A., 1994, Flavour and Fragrance Journal, V9, P347, DOI 10.1002/ffj.2730090613; McLafferty F.W., 1989, WILEY NBS REGISTRY M, V1; Michel CG, 2011, J ETHNOPHARMACOL, V133, P53, DOI 10.1016/j.jep.2010.09.001; Nagappan T, 2011, MOLECULES, V16, P9651, DOI 10.3390/molecules16119651; Nascimento ME, 2012, BIOCH SYST ECOL, V43, P1; Oliveira PS, 2002, CERRADOS BRAZIL ECOL, P289; Paolini J, 2010, BIOCHEM SYST ECOL, V38, P865, DOI 10.1016/j.bse.2010.07.009; Ribeiro AF, 2014, BIOCHEM SYST ECOL, V55, P249, DOI 10.1016/j.bse.2014.03.014; Ribeiro DA, 2014, J ETHNOPHARMACOL, V155, P1522, DOI 10.1016/j.jep.2014.07.042; Ribeiro JF., 1998, CERRADO AMBIENTE FLO, P89; Rigano D, 2011, NAT PROD RES, V25, P614, DOI 10.1080/14786419.2010.488623; Rodilla JM, 2008, BIOCHEM SYST ECOL, V36, P167, DOI 10.1016/j.bse.2007.09.001; Rodrigues TM, 2014, TREES-STRUCT FUNCT, V28, P613, DOI 10.1007/s00468-013-0976-8; de Almeida LFR, 2014, J ESSENT OIL RES, V26, P292, DOI 10.1080/10412905.2014.889050; Sangwan NS, 2001, PLANT GROWTH REGUL, V34, P3, DOI 10.1023/A:1013386921596; Sartor T, 2013, IND CROP PROD, V51, P355, DOI 10.1016/j.indcrop.2013.09.018; SILVA EF, 2007, R BRAS BIOCI, V5, P948; Telci I, 2011, IND CROP PROD, V34, P1193, DOI 10.1016/j.indcrop.2011.04.010; Toncer O, 2009, NOT BOT HORTI AGROBO, V37, P177; Vallat A, 2005, PHYTOCHEMISTRY, V66, P1540, DOI 10.1016/j.phytochem.2005.04.038; VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X; Veiga VF, 2006, J ESSENT OIL RES, V18, P430, DOI 10.1080/10412905.2006.9699132; Veiga VF, 2002, QUIM NOVA, V25, P273, DOI 10.1590/S0100-40422002000200016; Vidovic M, 2015, PLANT PHYSIOL BIOCH, V93, P44, DOI 10.1016/j.plaphy.2015.01.008; VOIRIN B, 1990, PHYTOCHEMISTRY, V29, P749, DOI 10.1016/0031-9422(90)80012-6; VON RUDLOFF E., 1965, PHYTOCHEMISTRY, V4, P11, DOI 10.1016/S0031-9422(00)86141-5; Wang HW, 2012, IND CROP PROD, V36, P229, DOI 10.1016/j.indcrop.2011.09.011; Zoghbi MDB, 2009, J ESSENT OIL RES, V21, P403	52	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149332	10.1371/journal.pone.0149332	http://dx.doi.org/10.1371/journal.pone.0149332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886431	gold, Green Submitted, Green Published			2022-12-27	WOS:000371218400076
J	Vilar, JM; Rubio, M; Spinella, G; Cuervo, B; Sopena, J; Cugat, R; Garcia-Balletbo, M; Dominguez, JM; Granados, M; Tvarijonaviciute, A; Ceron, JJ; Carrillo, JM				Vilar, Jose M.; Rubio, Monica; Spinella, Giuseppe; Cuervo, Belen; Sopena, Joaquin; Cugat, Ramon; Garcia-Balletbo, Montserrat; Dominguez, Juan M.; Granados, Maria; Tvarijonaviciute, Asta; Ceron, Jose J.; Carrillo, Jose M.			Serum Collagen Type II Cleavage Epitope and Serum Hyaluronic Acid as Biomarkers for Treatment Monitoring of Dogs with Hip Osteoarthritis	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; FORCE PLATFORM ANALYSIS; SYNOVIAL-FLUID; INTRAARTICULAR INJECTION; KERATAN SULFATE; GROWTH-FACTORS; CANINE; DEGRADATION; THERAPY; DISEASE	The aim of this study was to evaluate the use of serum type II collagen cleavage epitope and serum hyaluronic acid as biomarkers for treatment monitoring in osteoarthritic dogs. For this purpose, a treatment model based on mesenchymal stem cells derived from adipose tissue combined with plasma rich in growth factors was used. This clinical study included 10 dogs with hip osteoarthritis. Both analytes were measured in serum at baseline, just before applying the treatment, and 1, 3, and 6 months after treatment. These results were compared with those obtained from force plate analysis using the same animals during the same study period. Levels of type II collagen cleavage epitope decreased and those of hyaluronic acid increased with clinical improvement objectively verified via force plate analysis, suggesting these two biomarkers could be effective as indicators of clinical development of joint disease in dogs.	[Vilar, Jose M.] Univ Palmas Gran Canaria, Dept Patol Anim, Arucas, Las Palmas, Spain; [Rubio, Monica; Cuervo, Belen; Sopena, Joaquin; Carrillo, Jose M.] Univ CEU Cardenal Herrera, Dept Med & Cirugia Anim, Catedra Garcia Cugat, Valencia, Spain; [Spinella, Giuseppe] Univ Bologna, Dept Vet Med Sci, Bologna, Italy; [Cugat, Ramon; Garcia-Balletbo, Montserrat] Hosp Quiron, Artroscopia GC, Barcelona, Spain; [Dominguez, Juan M.; Granados, Maria] Univ Cordoba, Dept Med & Cirugia Anim, Cordoba, Spain; [Tvarijonaviciute, Asta; Ceron, Jose J.] Univ Murcia, Dept Med & Cirugia Anim, Murcia, Spain	Universidad de Las Palmas de Gran Canaria; Universidad CEU Cardenal Herrera; University of Bologna; Universidad de Cordoba; University of Murcia	Vilar, JM (corresponding author), Univ Palmas Gran Canaria, Dept Patol Anim, Arucas, Las Palmas, Spain.	jose.vilar@ulpgc.es	Tvarijonaviciute, Asta/U-4303-2017; del Mar Granados Machuca, Maria/AAD-4705-2022; Vilar, José Manuel/AAA-7925-2019; POVEDA, JOSE MARIA CARRILLO/ABG-2030-2020; Sopena, Joaquín/AAF-7088-2019; Dominguez Perez, Juan Manuel/AGG-5203-2022; Ceron, Jose J/H-9043-2015; Garcia Balletbo, Montserrat/GZL-1919-2022	Tvarijonaviciute, Asta/0000-0002-5323-5001; Vilar, José Manuel/0000-0002-2060-2274; POVEDA, JOSE MARIA CARRILLO/0000-0002-9789-8886; Sopena, Joaquín/0000-0002-3601-9745; Ceron, Jose J/0000-0002-8654-1793; Garcia Balletbo, Montserrat/0000-0002-3933-0168; CUERVO SERRATO, BELEN/0000-0002-8104-4560	Fundacion Garcia Cugat; Ministerio de Sanidad, politica e Igualdad of Spain [EC11-0046]	Fundacion Garcia Cugat; Ministerio de Sanidad, politica e Igualdad of Spain	The Fundacion Garcia Cugat, which supported this research study, received funds from the Ministerio de Sanidad, politica e Igualdad of Spain (grant No EC11-0046). The Fundacion Garcia Cugat is a non-profit institution that supports biomedical research. This institution does not promote or commercialize therapies or techniques of any kind. Artroscopia GC is a company and one of the contributors to the Fundacion. The authors affiliated with the Fundacion and Artroscopia GC collaborated as coauthors in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Anitua E, 2007, BIOMATERIALS, V28, P4551, DOI 10.1016/j.biomaterials.2007.06.037; ARICAN M, 1994, J COMP PATHOL, V111, P185, DOI 10.1016/S0021-9975(05)80050-7; Bedson J, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-116; Budsberg SC, 2006, AM J VET RES, V67, P429, DOI 10.2460/ajvr.67.3.429; Chu Q, 2002, OSTEOARTHR CARTILAGE, V10, P662, DOI 10.1053/joca.2002.0812; Cuervo B, 2014, INT J MOL SCI, V15, P13437, DOI 10.3390/ijms150813437; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Garnero P, 2003, CURR OPIN RHEUMATOL, V15, P641, DOI 10.1097/00002281-200309000-00020; Garnero P, 2007, OSTEOARTHR CARTILAGE, V15, P68; Goranov NV, 2007, VET CLIN PATH, V36, P192, DOI 10.1111/j.1939-165X.2007.tb00208.x; Gordon CD, 2008, CLIN CHIM ACTA, V398, P21, DOI 10.1016/j.cca.2008.07.031; Hayashi K, 2009, VET SURG, V38, P117, DOI 10.1111/j.1532-950X.2008.00446.x; Hegemann N, 2002, OSTEOARTHR CARTILAGE, V10, P714, DOI 10.1053/joca.2002.0820; Hirvasniemi J, 2014, OSTEOARTHR CARTILAGE, V22, P1724, DOI 10.1016/j.joca.2014.06.021; Ishijima M, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3246; Juni P, 2006, BEST PRACT RES CL RH, V20, P721, DOI 10.1016/j.berh.2006.05.002; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kumahashi N, 2015, OSTEOARTHR CARTILAGE, V23, P1506, DOI 10.1016/j.joca.2015.04.022; LEIPOLD HR, 1989, ARTHRITIS RHEUM, V32, P312, DOI 10.1002/anr.1780320313; Lotz M, 2013, ANN RHEUM DIS, V72, P1756, DOI 10.1136/annrheumdis-2013-203726; Malek S, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-185; Matyas JR, 2004, ARTHRITIS RHEUM-US, V50, P543, DOI 10.1002/art.20027; Nganvongpanit K., 2014, ISRN VET SCI, V2014, DOI [10.1155/2014/459809, DOI 10.1155/2014/459809]; Nganvongpanit K, 2008, J VET SCI, V9, P317, DOI 10.4142/jvs.2008.9.3.317; Piermattei D, 2006, BRINKER PIERMATTEI F, P461; Poole AR, 2004, J IMMUNOL METHODS, V294, P145, DOI 10.1016/j.jim.2004.09.005; Prink A, 2010, VET SURG, V39, P65, DOI 10.1111/j.1532-950X.2009.00604.x; Ramonda R, 2013, EUR J INTERN MED, V24, P11, DOI 10.1016/j.ejim.2012.10.002; Sasaki E, 2013, INT ORTHOP, V37, P925, DOI 10.1007/s00264-013-1849-x; Seki M, 2010, J SMALL ANIM PRACT, V51, P260, DOI 10.1111/j.1748-5827.2010.00934.x; THONAR EJMA, 1995, J RHEUMATOL, V22, P68; Vilar JM, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-143; Vilar JM, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-131	33	9	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149472	10.1371/journal.pone.0149472	http://dx.doi.org/10.1371/journal.pone.0149472			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886592	Green Published, gold			2022-12-27	WOS:000371218400088
J	Acosta, AL; Giannini, TC; Imperatriz-Fonseca, VL; Saraiva, AM				Acosta, Andre L.; Giannini, Tereza C.; Imperatriz-Fonseca, Vera L.; Saraiva, Antonio M.			Worldwide Alien Invasion: A Methodological Approach to Forecast the Potential Spread of a Highly Invasive Pollinator	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; BOMBUS-TERRESTRIS L.; BUMBLE BEE HYMENOPTERA; PSEUDO-ABSENCES; BIOLOGICAL INVASIONS; INTRODUCED BEES; DISTRIBUTIONS; NICHE; APIDAE; PERFORMANCE	The ecological impacts of alien species invasion are a major threat to global biodiversity. The increasing number of invasion events by alien species and the high cost and difficulty of eradicating invasive species once established require the development of new methods and tools for predicting the most susceptible areas to invasion. Invasive pollinators pose serious threats to biodiversity and human activity due to their close relationship with many plants (including crop species) and high potential competitiveness for resources with native pollinators. Although at an early stage of expansion, the bumblebee species Bombus terrestris is becoming a representative case of pollinator invasion at a global scale, particularly given its high velocity of invasive spread and the increasing number of reports of its impacts on native bees and crops in many countries. We present here a methodological framework of habitat suitability modeling that integrates new approaches for detecting habitats that are susceptible to Bombus terrestris invasion at a global scale. Our approach did not include reported invaded locations in the modeling procedure; instead, those locations were used exclusively to evaluate the accuracy of the models in predicting suitability over regions already invaded. Moreover, a new and more intuitive approach was developed to select the models and evaluate different algorithms based on their performance and predictive convergence. Finally, we present a comprehensive global map of susceptibility to Bombus terrestris invasion that highlights priority areas for monitoring.	[Acosta, Andre L.; Giannini, Tereza C.; Imperatriz-Fonseca, Vera L.] Univ Sao Paulo, Biosci Inst, Dept Ecol, Rua Matao,Travessa 14,321, BR-05508090 Sao Paulo, SP, Brazil; [Giannini, Tereza C.; Imperatriz-Fonseca, Vera L.] Vale Inst Technol Sustainable Dev, Rua Boaventura da Silva 955, BR-66055090 Belem, Para, Brazil; [Saraiva, Antonio M.] Univ Sao Paulo, Dept Comp & Digital Syst Engn, Polytech Sch, Ave Prof Luciano Gualberto 380, BR-05508970 Sao Paulo, SP, Brazil; [Acosta, Andre L.; Giannini, Tereza C.; Imperatriz-Fonseca, Vera L.; Saraiva, Antonio M.] Res Ctr Biodivers & Comp BioComp, Ave Prof Luciano Gualberto,Travessa 3,158, BR-05508900 Sao Paulo Capital, SP, Brazil	Universidade de Sao Paulo; Instituto Tecnologico Vale Desenvolvimento Sustentavel; Universidade de Sao Paulo	Acosta, AL (corresponding author), Univ Sao Paulo, Biosci Inst, Dept Ecol, Rua Matao,Travessa 14,321, BR-05508090 Sao Paulo, SP, Brazil.; Acosta, AL (corresponding author), Res Ctr Biodivers & Comp BioComp, Ave Prof Luciano Gualberto,Travessa 3,158, BR-05508900 Sao Paulo Capital, SP, Brazil.	andreluisacosta@usp.br	Imperatriz-Fonseca, Vera Lucia/AAU-7633-2021; Acosta, Andre Luis/H-2036-2012; Giannini, Tereza C/F-2676-2012; Saraiva, Antonio M/B-6350-2011; Imperatriz-Fonseca, Vera Lucia/H-5582-2012; Giannini, Tereza Cristina/AAA-2958-2019	Imperatriz-Fonseca, Vera Lucia/0000-0002-1079-2158; Acosta, Andre Luis/0000-0002-4244-9637; Saraiva, Antonio M/0000-0003-2283-1123; Imperatriz-Fonseca, Vera Lucia/0000-0002-1079-2158; Giannini, Tereza Cristina/0000-0001-9830-1204	Sao Paulo State Research Foundation [2011/12779-7]; National Counsel of Technological and Scientific Development [472702/2013-0]; Sao Paulo State Research Foundation (FAPESP) [2011/12779-7]; National Counsel of Technological and Scientific Development (CNPq) [472702/2013-0]	Sao Paulo State Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Counsel of Technological and Scientific Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo State Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Sao Paulo State Research Foundation (2011/12779-7) to ALA (http://www.fapesp.br/) and National Counsel of Technological and Scientific Development (472702/2013-0) to TCG (http://www.cnpq.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Luisa Carvalheiro, Jean Paul Metzger and Jesus Aguirre-Gutierrez for their suggestions on earlier versions of this manuscript. We thank the Sao Paulo State Research Foundation (FAPESP) for the scholarship of Andre L. Acosta (2011/12779-7) and the National Counsel of Technological and Scientific Development (CNPq) for granting Tereza C. Giannini (472702/2013-0). We also thank the Research Center on Biodiversity and Computing (NAP-Biocomp, Universidade de Sao Paulo) for providing computing infrastructure.	Aguirre-Gutierrez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063708; AHGA-Australian Hydroponics and Greenhouse Association, 2005, EX SUMM PROP IMP BOM; Aizen MA, 2014, NEW PHYTOL, V204, P322, DOI 10.1111/nph.12924; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Alpert Peter, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P52, DOI 10.1078/1433-8319-00004; [Anonymous], 2001, CBD TECHNICAL SERI N, V1; [Anonymous], 2010, ESRI ARCGIS DESKT 10, pR10; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Arbetman MP, 2013, BIOL INVASIONS, V15, P489, DOI 10.1007/s10530-012-0311-0; Aslan MM, 2008, J ENVIRON BIOL, V29, P151; Bahn V, 2013, OIKOS, V122, P321, DOI 10.1111/j.1600-0706.2012.00299.x; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Bontemps S, 2009, GLOBCOVER PRODUCT DE; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; CDB-Convention on Biological Diversity, 2009, INVASIVE ALIEN SPECI; Chefaoui RM, 2008, ECOL MODEL, V210, P478, DOI 10.1016/j.ecolmodel.2007.08.010; Dafni A., 1996, CONSERVATION BEES; Dafni A, 2010, APPL ENTOMOL ZOOL, V45, P101, DOI 10.1303/aez.2010.101; Domisch S, 2013, ECOL MODEL, V257, P1, DOI 10.1016/j.ecolmodel.2013.02.019; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Engler R, 2011, GLOBAL CHANGE BIOL, V17, P2330, DOI 10.1111/j.1365-2486.2010.02393.x; Evangelista PH, 2008, DIVERS DISTRIB, V14, P808, DOI 10.1111/j.1472-4642.2008.00486.x; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Franklin J, 2009, MAPPING SPECIES DIST; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; GADM, 2012, GLOB ADM AR YEAR 201, V20; Gallien L, 2012, GLOBAL ECOL BIOGEOGR, V21, P1126, DOI 10.1111/j.1466-8238.2012.00768.x; Giannini TC, 2013, ECOGRAPHY, V36, P649, DOI 10.1111/j.1600-0587.2012.07191.x; Giovanelli JGR, 2008, BIOL INVASIONS, V10, P585, DOI 10.1007/s10530-007-9154-5; Goshtasby AA, 2012, ADV COMPUTER VISION, P7, DOI DOI 10.1007/978-1-4471-2458-02; Goulson D, 2004, NEW ZEAL J ECOL, V28, P225; Goulson D, 2003, ANNU REV ECOL EVOL S, V34, P1, DOI 10.1146/annurev.ecolsys.34.011802.132355; Goulson D, 2001, APIDOLOGIE, V32, P105, DOI 10.1051/apido:2001115; Goulson D, 2010, BUMBLEBEES BEHAV ECO, V2; Griffiths D., 2004, PRACTICAL HYDROPONIC, V77, P42; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ., 2012, RASTER GEOGRAPHIC AN; Hingston AB, 2002, AUSTRAL ECOL, V27, P162, DOI 10.1046/j.1442-9993.2002.01179.x; Hingston AB, 1998, AUSTR J ECOLOGY, V23, P39; Hopkins I., 1914, NZ DEP AGR IND COMME, V46, P1; Howlett BG, 2010, NZ ENTOMOL, V33, P92, DOI 10.1080/00779962.2010.9722196; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Inari N, 2005, POPUL ECOL, V47, P77, DOI 10.1007/s10144-004-0205-9; Inoue MN, 2008, J INSECT CONSERV, V12, P135, DOI 10.1007/s10841-007-9071-z; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Jones CC, 2010, ECOL APPL, V20, P311, DOI 10.1890/08-2261.1; Kadoya T, 2010, BIOL CONSERV, V143, P1228, DOI 10.1016/j.biocon.2010.02.030; Kadoya T, 2009, BIOL CONSERV, V142, P1011, DOI 10.1016/j.biocon.2009.01.012; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kenis M, 2009, BIOL INVASIONS, V11, P21, DOI 10.1007/s10530-008-9318-y; Kondo NI, 2009, NATURWISSENSCHAFTEN, V96, P467, DOI 10.1007/s00114-008-0495-4; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Le Maitre DC, 2008, GLOBAL ECOL BIOGEOGR, V17, P569, DOI 10.1111/j.1466-8238.2008.00407.x; Levine JM, 2003, CONSERV BIOL, V17, P322, DOI 10.1046/j.1523-1739.2003.02038.x; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Loo SE, 2007, ECOL APPL, V17, P181, DOI 10.1890/1051-0761(2007)017[0181:FNZMIR]2.0.CO;2; Mack Richard N., 2011, NeoBiota, V9, P13, DOI 10.3897/neobiota.9.1156; Mateo RG, 2010, DIVERS DISTRIB, V16, P84, DOI 10.1111/j.1472-4642.2009.00617.x; Matsumura Chizuru, 2004, Global Environmental Research, V8, P51; McClay A, 2005, CLIMEX MODELS PREDIC; McGregor S. E., 1976, INSECT POLLINATION C; Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x; Merckx B, 2011, ECOL MODEL, V222, P588, DOI 10.1016/j.ecolmodel.2010.11.016; Milbau A, 2009, BIOL INVASIONS, V11, P941, DOI 10.1007/s10530-008-9306-2; Morales CL, 2013, FRONT ECOL ENVIRON, V11, P529, DOI 10.1890/120321; Morandin LA, 2001, J ECON ENTOMOL, V94, P172, DOI 10.1603/0022-0493-94.1.172; Morandin LA, 2001, J ECON ENTOMOL, V94, P462, DOI 10.1603/0022-0493-94.2.462; Mouton AM, 2010, ECOL MODEL, V221, P1995, DOI 10.1016/j.ecolmodel.2010.04.017; Nenzen HK, 2011, ECOL MODEL, V222, P3346, DOI 10.1016/j.ecolmodel.2011.07.011; NSW-New South Wales Government, 2004, AUSTR INTR LARG EART; Ozbek H., 1993, Melissa, P7; Parolo G, 2008, J APPL ECOL, V45, P1410, DOI 10.1111/j.1365-2664.2008.01516.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Perkins LB, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.47; Peterson AT, 2007, ENTOMOL EXP APPL, V125, P39, DOI 10.1111/j.1570-7458.2007.00603.x; Peterson AT, 2003, WEED SCI, V51, P863, DOI 10.1614/P2002-081; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Potts SG, 2001, OIKOS, V92, P71, DOI 10.1034/j.1600-0706.2001.920109.x; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; R Development Core Team, 2011, R A LANGUAGE AND ENV; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Roques A., 2009, HDB ALIEN SPECIES EU; Ruz L, 2001, ACTA HORTIC, P165, DOI 10.17660/ActaHortic.2001.561.24; Ruz L, 2002, POLLINATING BEES CON, P155; Schmid-Hempel P, 2007, HEREDITY, V99, P414, DOI 10.1038/sj.hdy.6801017; Schmid-Hempel R, 2014, J ANIM ECOL, V83, P823, DOI 10.1111/1365-2656.12185; SEMMENS TD, 1993, J AUST ENTOMOL SOC, V32, P346; Shi JA, 2010, BIODIVERS CONSERV, V19, P2485, DOI 10.1007/s10531-010-9855-4; Sladen FWL, 1912, HUMBLE BEE ITS ITS L; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stout JC, 2000, BEE WORLD, V81, P80, DOI 10.1080/0005772X.2000.11099475; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; Thuiller W, 2013, ENSEMBLE PLATFORM SP; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Torretta JP, 2006, T AM ENTOMOL SOC, V132, P285; Velthuis H.H.W., 2002, POLLINATING BEES CON, P177; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; Walther-Hellwig K, 2000, J APPL ENTOMOL, V124, P299, DOI 10.1046/j.1439-0418.2000.00484.x; Ward DF, 2007, BIOL INVASIONS, V9, P723, DOI 10.1007/s10530-006-9072-y; Williamson M, 1999, ECOGRAPHY, V22, P5, DOI 10.1111/j.1600-0587.1999.tb00449.x; Winter K., 2006, IMPORTATION NONNATIV, P1; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wolf S, 2008, APIDOLOGIE, V39, P419, DOI 10.1051/apido:2008020	106	26	27	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148295	10.1371/journal.pone.0148295	http://dx.doi.org/10.1371/journal.pone.0148295			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882479	gold, Green Submitted, Green Published			2022-12-27	WOS:000371219000014
J	Forbes, S; Latimer, J; Sreenivasan, PK; McBain, AJ				Forbes, Sarah; Latimer, Joe; Sreenivasan, Prem K.; McBain, Andrew J.			Simultaneous Assessment of Acidogenesis-Mitigation and Specific Bacterial Growth-Inhibition by Dentifrices	PLOS ONE			English	Article							DENTAL PLAQUE; STREPTOCOCCUS-MUTANS; CARIES; TRICLOSAN; GLYCOLYSIS; GINGIVITIS; BIOCIDES; SPECTRUM; AGENT; SUGAR	Dentifrices can augment oral hygiene by inactivating bacteria and at sub-lethal concentrations may affect bacterial metabolism, potentially inhibiting acidogenesis, the main cause of caries. Reported herein is the development of a rapid method to simultaneously measure group-specific bactericidal and acidogenesis-mitigation effects of dentifrices on oral bacteria. Saliva was incubated aerobically and anaerobically in Tryptone Soya Broth, Wilkins-Chalgren Broth with mucin, or artificial saliva and was exposed to dentifrices containing triclosan/ copolymer (TD); sodium fluoride (FD); stannous fluoride and zinc lactate (SFD1); or stannous fluoride, zinc lactate and stannous chloride (SFD2). Minimum inhibitory concentrations (MIC) were determined turbidometrically whilst group-specific minimum bactericidal concentrations (MBC) were assessed using growth media and conditions selective for total aerobes, total anaerobes, streptococci and Gram-negative anaerobes. Minimum acid neutralization concentration (MNC) was defined as the lowest concentration of dentifrice at which acidification was inhibited. Differences between MIC and MNC were calculated and normalized with respect to MIC to derive the combined inhibitory and neutralizing capacity (CINC), a cumulative measure of acidogenesis-mitigation and growth inhibition. The overall rank order for growth inhibition potency (MIC) under aerobic and anaerobic conditions was: TD>SFD2>SFD1>FD. Acidogenesis-mitigation (MNC) was ordered; TD>FD>SFD2>SFD1. CINC was ordered TD>FD>SFD2>SFD1 aerobically and TD>FD>SFD1>SFD2 anaerobically. With respect to group-specific bactericidal activity, TD generally exhibited the greatest potency, particularly against total aerobes, total anaerobes and streptococci. This approach enables the rapid simultaneous evaluation of acidity mitigation, growth inhibition and specific antimicrobial activity by dentifrices.	[Forbes, Sarah; Latimer, Joe; McBain, Andrew J.] Univ Manchester, Manchester Pharm Sch, Manchester, Lancs, England; [Sreenivasan, Prem K.] Colgate Palmol Technol Ctr, Piscataway, NJ USA	University of Manchester	McBain, AJ (corresponding author), Univ Manchester, Manchester Pharm Sch, Manchester, Lancs, England.	andrew.mcbain@manchester.ac.uk		McBain, Andrew/0000-0002-5255-5425; Sreenivasan, Prem/0000-0003-3902-1135	Colgate Palmolive Company	Colgate Palmolive Company	This research was supported by an unrestricted grant from Colgate Palmolive Company. The authors SF, JL, AJM discussed study design with PKS. The funders had no role in study design, data collection and analysis or decision to publish. However, PKS provided constructive comments on drafts of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Axelsson P, 2004, J CLIN PERIODONTOL, V31, P749, DOI 10.1111/j.1600-051X.2004.00563.x; BIBBY BG, 1986, J DENT RES, V65, P686, DOI 10.1177/00220345860650051101; Chandrabhan D, 2012, OPEN J MED MICROBIOL, V2; Dong YM, 1999, CARIES RES, V33, P428, DOI 10.1159/000016547; Filoche SK, 2008, FEMS IMMUNOL MED MIC, V54, P27, DOI 10.1111/j.1574-695X.2008.00443.x; Giacaman RA, 2010, ARCH ORAL BIOL, V55, P550, DOI 10.1016/j.archoralbio.2010.05.010; He G, 2002, ARCH ORAL BIOL, V47, P117, DOI 10.1016/S0003-9969(01)00093-0; Heath RJ, 1998, J BIOL CHEM, V273, P30316, DOI 10.1074/jbc.273.46.30316; HELDERMAN WHV, 1983, ARCH ORAL BIOL, V28, P599; KORNMAN KS, 1986, J PERIODONTAL RES, V21, P5, DOI 10.1111/j.1600-0765.1986.tb01511.x; Leonardo MR, 1999, J ENDODONT, V25, P167, DOI 10.1016/S0099-2399(99)80135-6; Mankodi S, 2005, J CLIN PERIODONTOL, V32, P75, DOI 10.1111/j.1600-051X.2004.00639.x; Marczuk-Kolada Grazyna, 2006, Postepy Hig Med Dosw (Online), V60, P416; Marsh P D, 1994, Adv Dent Res, V8, P263; MAZZA JE, 1981, J CLIN PERIODONTOL, V8, P203, DOI 10.1111/j.1600-051X.1981.tb02031.x; McBain AJ, 2003, J APPL MICROBIOL, V94, P655, DOI 10.1046/j.1365-2672.2003.01876.x; McMurry LM, 1998, NATURE, V394, P531, DOI 10.1038/28970; Moore LE, 2008, APPL ENVIRON MICROB, V74, P4825, DOI 10.1128/AEM.00573-08; NEWBRUN E, 1982, SCIENCE, V217, P418, DOI 10.1126/science.7046052; Panagakos Fotinos S, 2005, J Clin Dent, V16 Suppl, pS1; Phan TN, 2006, CAN J MICROBIOL, V52, P977, DOI 10.1139/W06-055; REGOS J, 1979, DERMATOLOGICA, V158, P72, DOI 10.1159/000250746; Touger-Decker R, 2003, AM J CLIN NUTR, V78, p881S, DOI 10.1093/ajcn/78.4.881S; Triratana T, 2002, J AM DENT ASSOC, V133, P219, DOI 10.14219/jada.archive.2002.0147; Van Loveren C, 1990, J Dent Res, V69 Spec No, P676; VANHOUTE J, 1991, J DENT RES, V70, P1503, DOI 10.1177/00220345910700120601; VANHOUTE J, 1991, J DENT RES, V70, P1497, DOI 10.1177/00220345910700120501; Villalain J, 2001, ARCH BIOCHEM BIOPHYS, V390, P128, DOI 10.1006/abbi.2001.2356; Wiegand A, 2007, DENT MATER, V23, P343, DOI 10.1016/j.dental.2006.01.022; WOODWARD M, 1994, BRIT DENT J, V176, P297, DOI 10.1038/sj.bdj.4808437	31	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149390	10.1371/journal.pone.0149390	http://dx.doi.org/10.1371/journal.pone.0149390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882309	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000371219000073
J	Zou, Q; Wu, MJ; Zhong, LW; Fan, ZX; Zhang, B; Chen, Q; Ma, F				Zou, Qing; Wu, Mingjun; Zhong, Liwu; Fan, Zhaoxin; Zhang, Bo; Chen, Qiang; Ma, Feng			Development of a Xeno-Free Feeder-Layer System from Human Umbilical Cord Mesenchymal Stem Cells for Prolonged Expansion of Human Induced Pluripotent Stem Cells in Culture	PLOS ONE			English	Article							AMNIOTIC-FLUID; UNDIFFERENTIATED PROPAGATION; SELF-RENEWAL; SUPPORT; GROWTH; DIFFERENTIATION; DISEASE; MAINTENANCE; FIBROBLASTS; DERIVATION	Various feeder layers have been extensively applied to support the prolonged growth of human pluripotent stem cells (hPSCs) for in vitro cultures. Among them, mouse embryonic fibroblast (MEF) and mouse fibroblast cell line (SNL) are most commonly used feeder cells for hPSCs culture. However, these feeder layers from animal usually cause immunogenic contaminations, which compromises the potential of hPSCs in clinical applications. In the present study, we tested human umbilical cord mesenchymal stem cells (hUC-MSCs) as a potent xeno-free feeder system for maintaining human induced pluripotent stem cells (hiPSCs). The hUC-MSCs showed characteristics of MSCs in xeno-free culture condition. On the mitomycin-treated hUC-MSCs feeder, hiPSCs maintained the features of undifferentiated human embryonic stem cells (hESCs), such as low efficiency of spontaneous differentiation, stable expression of stemness markers, maintenance of normal karyotypes, in vitro pluripotency and in vivo ability to form teratomas, even after a prolonged culture of more than 30 passages. Our study indicates that the xeno-free culture system may be a good candidate for growth and expansion of hiPSCs as the stepping stone for stem cell research to further develop better and safer stem cells.	[Zou, Qing; Wu, Mingjun; Zhong, Liwu; Fan, Zhaoxin; Zhang, Bo; Chen, Qiang; Ma, Feng] Sichuan Neolife Stem Cell Biotech INC, Res Ctr Stem Cell & Regenerat Med, Chengdu, Sichuan, Peoples R China; [Zou, Qing; Chen, Qiang; Ma, Feng] Chinese Acad Med Sci, Inst Blood Transfus, Ctr Stem Cell Res & Applicat, Chengdu, Sichuan, Peoples R China; [Zou, Qing; Chen, Qiang; Ma, Feng] Peking Union Med Coll, Chengdu, Sichuan, Peoples R China; [Ma, Feng] Chinese Acad Med Sci, State Key Lab Expt Hematol, Tianjin, Peoples R China; [Ma, Feng] Peking Union Med Coll, Tianjin, Peoples R China; [Ma, Feng] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Blood Transfusion - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Sichuan University	Chen, Q; Ma, F (corresponding author), Sichuan Neolife Stem Cell Biotech INC, Res Ctr Stem Cell & Regenerat Med, Chengdu, Sichuan, Peoples R China.; Chen, Q; Ma, F (corresponding author), Chinese Acad Med Sci, Inst Blood Transfus, Ctr Stem Cell Res & Applicat, Chengdu, Sichuan, Peoples R China.; Chen, Q; Ma, F (corresponding author), Peking Union Med Coll, Chengdu, Sichuan, Peoples R China.; Ma, F (corresponding author), Chinese Acad Med Sci, State Key Lab Expt Hematol, Tianjin, Peoples R China.; Ma, F (corresponding author), Peking Union Med Coll, Tianjin, Peoples R China.; Ma, F (corresponding author), Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China.	qchen0810@126.com; mafeng@hotmail.co.jp		Chen, Qiang/0000-0003-2759-987X	National Basic Research Program of China (973 Program) [2015CB964902]; Sichuan Provincial Science and Technology Planning [2014SZ0122]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Sichuan Provincial Science and Technology Planning	This study was funded from the National Basic Research Program of China (973 Program); No. 2015CB964902 (website: http://www.most.gov.cn/eng/) and the Sichuan Provincial Science and Technology Planning Project Grants; No. 2014SZ0122 (website: http://www.scst.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Batsali AK, 2013, CURR STEM CELL RES T, V8, P144; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Carvalho MM, 2011, CURR STEM CELL RES T, V6, P221; Cheng HC, 2011, MOL BIOL REP, V38, P5161, DOI 10.1007/s11033-010-0665-2; Cheng LZ, 2003, STEM CELLS, V21, P131, DOI 10.1634/stemcells.21-2-131; Cho M, 2010, FERTIL STERIL, V93, P2525, DOI 10.1016/j.fertnstert.2010.03.027; Cyranoski D, 2014, NATURE; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; Deuse T, 2011, CELL TRANSPLANT, V20, P655, DOI 10.3727/096368910X536473; Ding DC, 2012, CELL TRANSPLANT, V21, P1515, DOI 10.3727/096368912X647199; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Drawnel FM, 2014, CELL REP, V9, P810, DOI 10.1016/j.celrep.2014.09.055; Esposito M, 2013, IN VIVO, V27, P495; Fukusumi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055226; Guo J, 2011, EUR J HAEMATOL, V87, P235, DOI 10.1111/j.1600-0609.2011.01635.x; Harris DT, 2013, CURR STEM CELL RES T, V8, P394; Havasi P, 2013, MOL BIOL REP, V40, P3023, DOI 10.1007/s11033-012-2376-3; Holm F, 2010, HUM REPROD, V25, P1271, DOI 10.1093/humrep/deq040; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kao SY, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/306158; Kim N, 2013, ANN HEMATOL, V92, P1295, DOI 10.1007/s00277-013-1796-z; Klein C, 2013, TISSUE ENG PT A, V19, P2577, DOI 10.1089/ten.tea.2013.0073; Lei T, 2007, CELL RES, V17, P682, DOI 10.1038/cr.2007.61; Leite C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111059; Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013; Lu LL, 2006, HAEMATOLOGICA, V91, P1017; Ma F, 2008, P NATL ACAD SCI USA, V105, P13087, DOI 10.1073/pnas.0802220105; Ma F, 2008, STEM CELLS, V26, P706, DOI 10.1634/stemcells.2007-0348; Ma F, 2007, INT J HEMATOL, V85, P371, DOI 10.1532/IJH97.06203; Ma XR, 2014, INT J CLIN EXP PATHO, V7, P4661; Mallon BS, 2006, INT J BIOCHEM CELL B, V38, P1063, DOI 10.1016/j.biocel.2005.12.014; Mannello F, 2007, STEM CELLS, V25, P1603, DOI 10.1634/stemcells.2007-0127; Mobarra Naser, 2014, Int J Hematol Oncol Stem Cell Res, V8, P20; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Park Y, 2010, STEM CELLS DEV, V19, P1713, DOI 10.1089/scd.2010.0014; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Roubelakis MG, 2007, STEM CELLS DEV, V16, P931, DOI 10.1089/scd.2007.0036; Sampsell-Barron Tori, 2013, Methods Mol Biol, V1001, P81, DOI 10.1007/978-1-62703-363-3_8; Sanchez L, 2012, TISSUE ENG PART C-ME, V18, P387, DOI [10.1089/ten.TEC.2011.0546, 10.1089/ten.tec.2011.0546]; Sharma RR, 2014, TRANSFUSION, V54, P1418, DOI 10.1111/trf.12421; Shinoda G, 2007, BLOOD, V109, P2406, DOI 10.1182/blood-2006-06-031039; Son MY, 2015, PROTEOMICS, V15, P2220, DOI 10.1002/pmic.201400510; Soong YK, 2015, J TISSUE ENG REGEN M, V9, pE302, DOI 10.1002/term.1702; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Suh JH, 2014, BIOCHEM BIOPH RES CO, V444, P311, DOI 10.1016/j.bbrc.2014.01.038; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Umeda K, 2006, STEM CELLS, V24, P2627, DOI 10.1634/stemcells.2006-0199; Unger C, 2009, HUM REPROD, V24, P2567, DOI 10.1093/humrep/dep232; Varlakhanova NV, 2010, DIFFERENTIATION, V80, P9, DOI 10.1016/j.diff.2010.05.001; Watson N, 2015, CYTOTHERAPY, V17, P18, DOI 10.1016/j.jcyt.2014.08.009; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang LF, 2013, CELL REPROGRAM, V15, P216, DOI 10.1089/cell.2012.0064; Zheng G, 2015, BIO-MED MATER ENG, V25, pS145, DOI 10.3233/BME-141249	59	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149023	10.1371/journal.pone.0149023	http://dx.doi.org/10.1371/journal.pone.0149023			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882313	Green Published, Green Submitted, gold			2022-12-27	WOS:000371219000043
J	Akers, JC; Ramakrishnan, V; Nolan, JP; Duggan, E; Fu, CC; Hochberg, FH; Chen, CC; Carter, BS				Akers, Johnny C.; Ramakrishnan, Valya; Nolan, John P.; Duggan, Erika; Fu, Chia-Chun; Hochberg, Fred H.; Chen, Clark C.; Carter, Bob S.			Comparative Analysis of Technologies for Quantifying Extracellular Vesicles (EVs) in Clinical Cerebrospinal Fluids (CSF)	PLOS ONE			English	Article							EXOSOMES; MICROVESICLES; QUANTIFICATION; BIOGENESIS	Extracellular vesicles (EVs) have emerged as a promising biomarker platform for glioblastoma patients. However, the optimal method for quantitative assessment of EVs in clinical bio-fluid remains a point of contention. Multiple high-resolution platforms for quantitative EV analysis have emerged, including methods grounded in diffraction measurement of Brownian motion (NTA), tunable resistive pulse sensing (TRPS), vesicle flow cytometry (VFC), and transmission electron microscopy (TEM). Here we compared quantitative EV assessment using cerebrospinal fluids derived from glioblastoma patients using these methods. For EVs <150 nm in diameter, NTA detected more EVs than TRPS in three of the four samples tested. VFC particle counts are consistently 2-3 fold lower than NTA and TRPS, suggesting contribution of protein aggregates or other non-lipid particles to particle count by these platforms. While TEM yield meaningful data in terms of the morphology, its particle count are consistently two orders of magnitude lower relative to counts generated by NTA and TRPS. For larger particles (>150 nm in diameter), NTA consistently detected lower number of EVs relative to TRPS. These results unveil the strength and pitfalls of each quantitative method alone for assessing EVs derived from clinical cerebrospinal fluids and suggest that thoughtful synthesis of multi-platform quantitation will be required to guide meaningful clinical investigations.	[Akers, Johnny C.; Ramakrishnan, Valya; Chen, Clark C.; Carter, Bob S.] Univ Calif San Diego, Ctr Theoret & Appl Neurooncol, San Diego, CA 92103 USA; [Nolan, John P.; Duggan, Erika] Scintillon Inst Biomed & Bioenergy Res, San Diego, CA USA; [Fu, Chia-Chun] Izon Sci, Christchurch, New Zealand; [Hochberg, Fred H.] Massachusetts Gen Hosp, Neurol Serv, Boston, MA 02114 USA; [Hochberg, Fred H.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA USA	University of California System; University of California San Diego; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Chen, CC (corresponding author), Univ Calif San Diego, Ctr Theoret & Appl Neurooncol, San Diego, CA 92103 USA.	clarkchen@ucsd.edu	RAMAKRISHNAN, VALYA/L-6415-2016; Carter, Bob/AAB-4868-2021	Carter, Bob/0000-0002-3586-1324	NIH [UH2 TR000931-0, PO1 2P30CA023100-28]; Doris Duke Charitable Foundation; Sontag Foundation; Burroughs Wellcome Fund; Kimmel Scholar Award; Accelerated Brain Cancer Cure; William Guy Forbeck Research Foundation; Program of international science & technology cooperation of China [2014DFA31470]; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000931, UH3TR000931] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Sontag Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Kimmel Scholar Award; Accelerated Brain Cancer Cure; William Guy Forbeck Research Foundation; Program of international science & technology cooperation of China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The work is supported by NIH UH2 TR000931-0, NIH PO1 2P30CA023100-28 (BSC and CCC). CCC is supported by the Doris Duke Charitable Foundation Clinical Scientist Development Award, Sontag Foundation Distinguished Scientist Award, Burroughs Wellcome Fund Career Awards for Medical Scientists, the Kimmel Scholar Award, a Grant from Accelerated Brain Cancer Cure, the William Guy Forbeck Research Foundation, and Program of international science & technology cooperation of China (2014DFA31470). Chia-Chun Fu is an employee of Izon Science. The funder provided support in the form of salaries for authors BSC, CCC, JCA, and VR. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon A, 2014, RAMBAM MAIMONIDES ME, V5, DOI 10.5041/RMMJ.10166; Akers JC, 2015, J NEURO-ONCOL, V123, P205, DOI 10.1007/s11060-015-1784-3; Akers JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078115; Akers JC, 2013, J NEURO-ONCOL, V113, P1, DOI 10.1007/s11060-013-1084-8; Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Anderson W, 2013, J COLLOID INTERF SCI, V405, P322, DOI 10.1016/j.jcis.2013.02.030; de Vrij J, 2013, NANOMEDICINE-UK, V8, P1443, DOI [10.2217/NNM.12.173, 10.2217/nnm.12.173]; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Maas SLN, 2015, J CONTROL RELEASE, V200, P87, DOI 10.1016/j.jconrel.2014.12.041; Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005; Nolte-'t Hoen ENM, 2012, NANOMED-NANOTECHNOL, V8, P712, DOI 10.1016/j.nano.2011.09.006; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Shifrin DA, 2013, MOL BIOL CELL, V24, P1253, DOI 10.1091/mbc.E12-08-0572; Stoner SA, 2016, CYTOM PART A, V89A, P196, DOI 10.1002/cyto.a.22787; van der Pol E, 2014, J THROMB HAEMOST, V12, P1182, DOI 10.1111/jth.12602	17	79	81	9	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149866	10.1371/journal.pone.0149866	http://dx.doi.org/10.1371/journal.pone.0149866			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901428	gold, Green Submitted, Green Published			2022-12-27	WOS:000371276100168
J	Kim, MH; Zhou, A; Mazenga, A; Ahmed, S; Markham, C; Zomba, G; Simon, K; Kazembe, PN; Abrams, EJ				Kim, Maria H.; Zhou, Amy; Mazenga, Alick; Ahmed, Saeed; Markham, Christine; Zomba, Gerald; Simon, Katie; Kazembe, Peter N.; Abrams, Elaine J.			Why Did I Stop? Barriers and Facilitators to Uptake and Adherence to ART in Option B plus HIV Care in Lilongwe, Malawi	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; BREAST-FEEDING WOMEN; ANTIRETROVIRAL THERAPY; FOLLOW-UP; PREVENTION; PROGRAM; HEALTH; EFAVIRENZ; SYSTEM; PMTCT	Causes for loss-to-follow-up, including early refusals of and stopping antiretroviral therapy (ART), in Malawi's Option B+ program are poorly understood. This study examines the main barriers and facilitators to uptake and adherence to ART under Option B+. In depth interviews were conducted with HIV-infected women who were pregnant or postpartum in Lilongwe, Malawi (N = 65). Study participants included women who refused ART initiation (N = 10), initiated ART and then stopped (N = 26), and those who initiated ART and remained on treatment (N = 29). The barriers to ART initiation were varied and included concerns about partner support, feeling healthy, and needing time to think. The main reasons for stopping ART included side effects and lack of partner support. A substantial number of women started ART after initially refusing or stopping ART. There were several facilitators for re-starting ART, including encouragement from community health workers, side effects subsiding, decline in health, change in partner, and fear of future sickness. Amongst those who remained on ART, desire to prevent transmission and improve health were the most influential facilitators. Reasons for refusing and stopping ART were varied. ART-related side effects and feeling healthy were common barriers to ART initiation and adherence. Providing consistent pre-ART counseling, early support for patients experiencing side effects, and targeted efforts to bring women who stop treatment back into care may improve long term health outcomes.	[Kim, Maria H.; Ahmed, Saeed] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Sect Global Hlth & Retrovirol, Houston, TX 77030 USA; [Kim, Maria H.; Mazenga, Alick; Ahmed, Saeed; Simon, Katie; Kazembe, Peter N.] Baylor Coll Med, Abbott Fund Childrens Clin Ctr Excellence, Lilongwe, Malawi; [Zhou, Amy] Univ Calif Los Angeles, Dept Sociol, Los Angeles, CA 90024 USA; [Markham, Christine] Univ Texas Sch Publ Hlth, Hlth Promot & Behav Sci, Houston, TX USA; [Zomba, Gerald] Malawi Minist Hlth, HIV Unit, Lilongwe, Malawi; [Abrams, Elaine J.] Columbia Univ, Mailman Sch Publ Hlth, ICAP, New York, NY USA; [Abrams, Elaine J.] Columbia Univ, Coll Phys & Surg, New York, NY USA	Baylor College of Medicine; Baylor College of Medicine; University of California System; University of California Los Angeles; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Columbia University; Columbia University	Kim, MH (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Sect Global Hlth & Retrovirol, Houston, TX 77030 USA.; Kim, MH (corresponding author), Baylor Coll Med, Abbott Fund Childrens Clin Ctr Excellence, Lilongwe, Malawi.	mhkim@bcm.edu		Zhou, Amy/0000-0001-8727-8678	United States Agency for International Development (USAID) [674-A-00-10-00093-00]; Fogarty International Center of the National Institutes of Health (NIH) [K01 TW009644]; FOGARTY INTERNATIONAL CENTER [K01TW009644] Funding Source: NIH RePORTER; Direct For Social, Behav & Economic Scie [1436010] Funding Source: National Science Foundation	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Fogarty International Center of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This study was made possible by the Tingathe program supported by United States Agency for International Development (USAID) cooperative agreement number 674-A-00-10-00093-00. MHK was supported by the Fogarty International Center of the National Institutes of Health (NIH) under award number K01 TW009644.	Ahmed S, 2013, CURR OPIN HIV AIDS, V8, P474, DOI 10.1097/COH.0b013e328363a8f2; [Anonymous], 2012, WHO PMTCT UPD; Bajunirwe Francis, 2005, AIDS Res Ther, V2, P10, DOI 10.1186/1742-6405-2-10; Bwirire LD, 2008, T ROY SOC TROP MED H, V102, P1195, DOI 10.1016/j.trstmh.2008.04.002; Chimbwandira F, 2013, MMWR-MORBID MORTAL W, V62, P148; Chinkonde JR, 2009, REPROD HEALTH MATTER, V17, P143, DOI 10.1016/S0968-8080(09)33440-0; Clouse K, 2014, JAIDS-J ACQ IMM DEF, V67, pE12, DOI 10.1097/QAI.0000000000000263; Creswell JW, 2013, RES DESIGN QUALITATI; Dhoro M, 2015, BMC PHARMACOL TOXICO, V16, DOI 10.1186/s40360-015-0004-2; Dickinson L, 2015, CLIN PHARMACOL THER, V98, P406, DOI 10.1002/cpt.156; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Fox MP, 2010, BARRIERS TO INITIATI, P1; Gourlay A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18588; Guest G., 2011, APPL THEMAT ANAL; Haas DW, 2004, AIDS, V18, P2391; Health MO, 2014, MAL HIV PROGR DAT 20; Higgins JA, 2010, AM J PUBLIC HEALTH, V100, P435, DOI 10.2105/AJPH.2009.159723; Hodgson I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111421; Kebaabetswe PM, 2007, AIDS CARE, V19, P355, DOI 10.1080/09540120600942407; Kieffer MP, 2014, JAIDS-J ACQ IMM DEF, V67, pS188, DOI 10.1097/QAI.0000000000000372; Kim MH, 2015, JAIDS-J ACQ IMM DEF, V68, pE77, DOI 10.1097/QAI.0000000000000517; Kim MH, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.4.17389; Kim M, 2013, ECON MODEL, V31, P31, DOI 10.1016/j.econmod.2012.11.024; Laher F, 2012, AIDS BEHAV, V16, P91, DOI 10.1007/s10461-010-9875-9; MacPherson P, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.18020; Morfaw F, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-5; Mugavero MJ, 2011, CLIN INFECT DIS, V52, pS238, DOI 10.1093/cid/ciq048; Ngarina M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085310; Office LDH, 2014, MID POP PROJ; Patton M. Q., 1990, QUALITATIVE EVALUATI; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; Schouten EJ, 2011, LANCET, V378, P282, DOI 10.1016/S0140-6736(10)62303-3; Sinxadi PZ, 2015, BRIT J CLIN PHARM; Sprague C, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-10; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; Tweya H, 2014, TROP MED INT HEALTH, V19, P1360, DOI 10.1111/tmi.12369	37	45	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149527	10.1371/journal.pone.0149527	http://dx.doi.org/10.1371/journal.pone.0149527			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26901563	gold, Green Published, Green Submitted			2022-12-27	WOS:000371276100092
J	Lam, C; Kang, JH; Lin, HY; Huang, HC; Wu, CC; Chen, PL				Lam, Carlos; Kang, Jiunn-Horng; Lin, Hsiao-Yu; Huang, Hung-Chang; Wu, Chia-Chieh; Chen, Ping-Ling			First Fall-Related Injuries Requiring Hospitalization Increase the Risk of Recurrent Injurious Falls: A Nationwide Cohort Study in Taiwan	PLOS ONE			English	Article							INSURANCE RESEARCH DATABASE; DWELLING OLDER-PEOPLE; HEALTH INSURANCE; FOLLOW-UP; POPULATION; MEN; VALIDATION; DIAGNOSIS; WOMEN; URBANIZATION	Objectives Recurrent falls not only have risk factors different from those of single falls but also have less favorable outcomes. The aim of our study was to determine the association between the injury characteristics of a first fall and the likelihood of recurrent injurious falls in a cohort of hospitalized patients. Methods We designed a nationwide retrospective cohort study and selected hospitalized patients who had injurious falls between 2001 and 2010. Cox proportional hazards models were used to estimate the hazard ratios (HRs) of recurrent injurious falls requiring hospitalization in the following year on the basis of the patients' demographic characteristics, comorbidities, and the characteristics of injuries from the first injurious fall requiring hospitalization. Results Among the 504 512 patients hospitalized for injurious falls, 19 442 experienced recurrent injurious falls requiring hospitalization. The 1-year incidence of recurrent injurious falls requiring hospitalization was 3.85%. The incidence density was the highest within the 3-month period after the first injurious fall. The risk of recurrent injurious falls among patients aged 40 to 64, 65 to 74, and >= 75 years increased progressively (HR: 2.11, 95% confidence interval [CI]: 1.90-2.34; HR: 2.80, 95% CI: 2.51-3.11; and HR: 3.80, 95% CI: 3.42-4.23, respectively). The length of hospitalization (LOH) >= 15 or >= 31 days (HR: 1.39, 95% CI: 1.30-1.48; and HR: 1.59, 95% CI: 1.43-1.77, respectively) and injury to the head (HR: 1.59, 95% CI: 1.53-1.65) or spine (HR: 1.66, 95% CI: 1.59-1.74) were also found to be major risk factors. Conclusions Our findings show that the LOH and head and spine injuries are associated with an increased risk of recurrent injurious falls leading to hospitalization. The risk of recurrent injurious falls requiring hospitalization increased significantly among adults older than 40 years. We suggest further research on the effects of injury characteristics associated with the first injurious fall requiring hospitalization and resultant anatomical damages on the risk of recurrent injurious falls requiring hospitalization. High-risk patients should receive tailored rehabilitation addressing their respective injuries within 3 months after hospital discharge.	[Lam, Carlos; Wu, Chia-Chieh] Taipei Med Univ, Wan Fang Hosp, Emergency Dept, Dept Emergency & Crit Care Med, Taipei, Taiwan; [Lam, Carlos; Chen, Ping-Ling] Taipei Med Univ, Grad Inst Injury Prevent & Control, Coll Publ Hlth & Nutr, Taipei, Taiwan; [Lam, Carlos] Taipei Med Univ, Dept Emergency Med, Coll Med, Taipei, Taiwan; [Kang, Jiunn-Horng] Taipei Med Univ, Taipei Med Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Kang, Jiunn-Horng] Taipei Med Univ, Sch Med, Dept Phys Med & Rehabil, Coll Med, Taipei, Taiwan; [Lin, Hsiao-Yu] Taipei Med Univ Hosp, Dept Urol, Taipei, Taiwan; [Huang, Hung-Chang] Taipei Med Univ Hosp, Div Acute Care Surg & Traumatol, Dept Surg, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital	Chen, PL (corresponding author), Taipei Med Univ, Grad Inst Injury Prevent & Control, Coll Publ Hlth & Nutr, Taipei, Taiwan.	plchen@tmu.edu.tw		Lam, Carlos/0000-0002-8051-7485	Health Promotion Administration, Ministry of Health and Welfare, Executive Yuan, Taiwan [E1020766]; Wan Fang Hospital, Taipei Medical University [103-wf-eva-26]	Health Promotion Administration, Ministry of Health and Welfare, Executive Yuan, Taiwan; Wan Fang Hospital, Taipei Medical University	This research was supported by grants from the Health Promotion Administration, Ministry of Health and Welfare, Executive Yuan, Taiwan (grant number E1020766). PLC received the funding (the funder's website: http://www.hpa.gov.tw/Bhpnet/Web/Index/Index.aspx); and grants from the Wan Fang Hospital, Taipei Medical University (grant number 103-wf-eva-26). CL received the funding (the funder's website: http://www.wanfang.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Geriatrics Society British Geriatrics Society, 2010, AGS BGS CLIN PRACT G; Askari M, 2013, DRUG AGING, V30, P845, DOI 10.1007/s40266-013-0110-z; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Center JR, 2007, JAMA-J AM MED ASSOC, V297, P387, DOI 10.1001/jama.297.4.387; Chen CS, 2008, EUR J OBSTET GYN R B, V141, P104, DOI 10.1016/j.ejogrb.2008.07.016; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chien WC, 2013, INT J INJ CONTROL SA, V20, P50, DOI 10.1080/17457300.2012.674042; de Vries OJ, 2013, OSTEOPOROSIS INT, V24, P2397, DOI 10.1007/s00198-013-2303-z; Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905; Donald IP, 1999, AGE AGEING, V28, P121, DOI 10.1093/ageing/28.2.121; Gassmann KG, 2009, Z GERONTOL GERIATR, V42, P3, DOI 10.1007/s00391-008-0506-2; Hanlon JT, 2009, J GERONTOL A-BIOL, V64, P492, DOI 10.1093/gerona/gln043; Hoang PD, 2014, ARCH PHYS MED REHAB, V95, P480, DOI 10.1016/j.apmr.2013.09.017; Huang YL, 2013, J OCCUP SAF HLTH, V21, P38; Kanjwal K, 2015, J CARDIOVASC MED, V16, P75, DOI 10.2459/01.JCM.0000446386.01100.35; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Ku YC, 2013, INT J GERONTOL, V7, P80, DOI 10.1016/j.ijge.2012.07.004; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Lin MR, 2014, OSTEOPOROSIS INT, V25, P863, DOI 10.1007/s00198-013-2549-5; Lin YJ, 2011, HEALTH POLICY, V103, P236, DOI 10.1016/j.healthpol.2011.08.007; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; LUUKINEN H, 1995, PUBLIC HEALTH, V109, P57, DOI 10.1016/S0033-3506(95)80076-X; Matinolli M, 2011, ACTA NEUROL SCAND, V123, P193, DOI 10.1111/j.1600-0404.2010.01386.x; Muraki S, 2013, BONE, V52, P516, DOI 10.1016/j.bone.2012.10.020; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; Newgard CD, 2010, ACAD EMERG MED, V17, P142, DOI 10.1111/j.1553-2712.2009.00647.x; Okubo Y, 2015, ARCH GERONTOL GERIAT, V60, P45, DOI 10.1016/j.archger.2014.10.008; Pijpers E, 2012, AGE AGEING, V41, P358, DOI 10.1093/ageing/afr145; Pluijm SMF, 2006, OSTEOPOROSIS INT, V17, P417, DOI 10.1007/s00198-005-0002-0; Rossat A, 2010, J NUTR HEALTH AGING, V14, P787, DOI 10.1007/s12603-010-0089-7; Spector WD, 2012, MED CARE, V50, P863, DOI 10.1097/MLR.0b013e31825f2840; Spice CL, 2009, AGE AGEING, V38, P33, DOI 10.1093/ageing/afn192; Stel VS, 2003, J AM GERIATR SOC, V51, P1356, DOI 10.1046/j.1532-5415.2003.51452.x; Talbot LA, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-86; Tamburella F, 2013, EUR J PHYS REHAB MED, V49, P353; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806; van Nieuwenhuizen RC, 2010, AM J EMERG MED, V28, P994, DOI 10.1016/j.ajem.2009.06.003; Wu TY, 2013, PREV MED, V57, P511, DOI 10.1016/j.ypmed.2013.07.012; Yoo IY, 2011, J GERONTOL NURS, V37, P28, DOI 10.3928/00989134-20110503-01	40	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149887	10.1371/journal.pone.0149887	http://dx.doi.org/10.1371/journal.pone.0149887			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26900917	Green Published, gold			2022-12-27	WOS:000371276100175
J	Paigen, B; Currer, JM; Svenson, KL				Paigen, Beverly; Currer, Joanne M.; Svenson, Karen L.			Effects of Varied Housing Density on a Hybrid Mouse Strain Followed for 20 Months	PLOS ONE			English	Article							LABORATORY MICE; CAGE DENSITY; BEHAVIOR; HEALTH; AGGRESSION; PARAMETERS; MANAGEMENT; FREQUENCY; C57BL/6J; STRESS	To evaluate the effect of increased housing density in a hybrid mouse strain, we evaluated a panel of physiological and behavioral traits in animals that were housed in groups of 3, 5, 8, or 12, using cages that provide 78.1 in(2) of floor space. Such groupings resulted in cage densities that ranged from half to almost twice the density recommended by the Guide for the Care and Use of Laboratory Animals. While previous studies have investigated physiological effects of increased housing density using inbred mouse strains, including C57BL/6J and 129S1/SvImJ, this study tested an F1 hybrid population of C57BL/6J x 129S1/SvImJ for changes resulting from either decreased or increased housing density. Mice were followed until they were 20 months old, a substantially longer duration than has been used in previous density studies. We evaluated mortality, growth, home cage behavior, blood pressure, body composition, clinical plasma chemistries, immune function, and organ weights (heart, kidney, adrenal glands, and testes) as endpoints of chronic stress that may arise from sub-optimal housing conditions. Few statistically different parameters were observed in this study, none of which describe chronic stress and all within normal physiological ranges for research mice, suggesting that this hybrid strain was not adversely affected by housing at twice the density currently recommended.	[Paigen, Beverly; Currer, Joanne M.; Svenson, Karen L.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA	Jackson Laboratory	Svenson, KL (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	Karen.Svenson@jax.org			National Institutes of Health (US) [RR012552, R37 HL077796]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR012552] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL077796] Funding Source: NIH RePORTER	National Institutes of Health (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants RR012552 and R37 HL077796, awarded to BP, both from the National Institutes of Health (US) (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Davidson LP, 2007, COMPARATIVE MED, V57, P355; Foltz C, 2007, LAB ANIMAL, V36, P40, DOI 10.1038/laban1107-40; Fullwood Steven, 1998, ILAR J, V39, P29; Gonder JC, 2007, ILAR J, V48, P29, DOI 10.1093/ilar.48.1.29; Grewal IS, 1997, AUTOIMMUNITY, V26, P209, DOI 10.3109/08916939709008026; Horn MJ, 2012, J AM ASSOC LAB ANIM, V51, P781; Kalueff AV, 2006, BEHAV PROCESS, V71, P8, DOI 10.1016/j.beproc.2005.09.004; Kim B, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0051-6; Koh HY, 2008, GENES BRAIN BEHAV, V7, P120, DOI 10.1111/j.1601-183X.2007.00351.x; LEVIN S, 1993, TOXICOL PATHOL, V21, P1; McGlone JJ, 2001, CONTEMP TOP LAB ANIM, V40, P21; Morgan JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090012; National Research Council, 2012, GUIDE CARE USE LAB A; National Research Council, 1996, GUIDE CARE USE LAB A, V7th ed., P140, DOI [10.17226/5140, DOI 10.17226/5140]; Nicholson A, 2009, J AM ASSOC LAB ANIM, V48, P740; Paigen B, 2012, J ANIM SCI, V90, P5182, DOI 10.2527/jas.2012-5417; Perez C, 1997, LAB ANIM, V31, P357, DOI 10.1258/002367797780596158; R Development Core Team, 2012, R LANG ENV STAT COMP; Reeb-Whitaker CK, 2001, LAB ANIM-UK, V35, P58, DOI 10.1258/0023677011911381; Sa-Rocha VM, 2006, PHYSIOL BEHAV, V88, P108, DOI 10.1016/j.physbeh.2006.03.015; Schmidt MV, 2010, HORM BEHAV, V57, P415, DOI 10.1016/j.yhbeh.2010.01.010; Smith AL, 2005, ILAR J, V46, P140, DOI 10.1093/ilar.46.2.140; Sommershof A, 2011, BRAIN BEHAV IMMUN, V25, P340, DOI 10.1016/j.bbi.2010.10.016; Sterlemann V, 2008, HORM BEHAV, V53, P386, DOI 10.1016/j.yhbeh.2007.11.001; Svenson KL, 2007, J APPL PHYSIOL, V102, P2369, DOI 10.1152/japplphysiol.01077.2006; Svenson KL, 2003, J APPL PHYSIOL, V94, P1650, DOI 10.1152/japplphysiol.01029.2003; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; Van Loo PLP, 2003, LAB ANIM-UK, V37, P300, DOI 10.1258/002367703322389870; Van Loo PLP, 2001, PHYSIOL BEHAV, V72, P675, DOI 10.1016/S0031-9384(01)00425-5; Whittaker AL, 2012, LAB ANIM-UK, V46, P3, DOI 10.1258/la.2011.011049; Wohleb ES, 2013, J NEUROSCI, V33, P13820, DOI 10.1523/JNEUROSCI.1671-13.2013; Xing S, 2009, GENETIC INFLUENCE EL	32	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149647	10.1371/journal.pone.0149647	http://dx.doi.org/10.1371/journal.pone.0149647			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900840	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100119
J	Sun, KS; Tsai, CF; Chen, SCC; Chen, YY; Huang, WC				Sun, Kuo-Shao; Tsai, Ching-Fang; Chen, Solomon Chih-Cheng; Chen, Yih-Yuan; Huang, Wan-Chun			Galactomannan Testing and the Incidence of Invasive Pulmonary Aspergillosis: A 10-Year Nationwide Population-Based Study in Taiwan	PLOS ONE			English	Article							CELL TRANSPLANT RECIPIENTS; GENDER-DIFFERENCES; MOLD INFECTIONS; FUNGAL DISEASE; EPIDEMIOLOGY; DIAGNOSIS; REGISTRY; THERAPY; IMPACT; ASSAY	Background The clinical impact of the galactomannan (GM) test for the diagnosis of invasive pulmonary aspergillosis (IPA) is controversial. Our study evaluated the incidence and trends of IPA and GM testing in patients with aspergillus infections. Methods We conducted a nationwide inpatient population study using the Taiwan National Health Insurance Research Database. A total of 346 IPA (62.14% male) patients from the years 2002 to 2011 were identified for inclusion in the study. Results The average incidence of IPA was 1.51 per million person-years. Over the study period, we observed an increasing trend from 0.94 to 2.06 per million person-years (P < 0.0001). We observed male predominance in IPA incidence (M/F: 1.85/1.15). Both males and females showed significantly increasing trends of IPA incidence over time (0.87 to 4.55 and 0.36 to 2.07 per million person-years for the males and females, respectively). GM testing for IPA significantly increased from 2002 to 2011, and the GM test was utilized more frequently for males than females. The increase in the incidence of IPA might be positively associated with the increase in GM testing over the past decade. Conclusion The incidence rates of both IPA and GM testing have increased over time. GM testing is recommended for the early diagnosis of patients with suspected aspergillosis.	[Sun, Kuo-Shao; Huang, Wan-Chun] Chia Yi Christian Hosp, Dept Internal Med, Ditmanson Med Fdn, Div Pulm & Crit Care Med, Chiayi, Taiwan; [Sun, Kuo-Shao] Chung Jen Jr Coll Nursing Hlth Sci & Management, Chiayi, Taiwan; [Tsai, Ching-Fang; Chen, Solomon Chih-Cheng] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Med Res, Chiayi, Taiwan; [Chen, Solomon Chih-Cheng] Taipei Med Univ, Sch Med, Dept Pediat, Taipei, Taiwan; [Chen, Yih-Yuan] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Internal Med, Chiayi, Taiwan	Taipei Medical University	Huang, WC (corresponding author), Chia Yi Christian Hosp, Dept Internal Med, Ditmanson Med Fdn, Div Pulm & Crit Care Med, Chiayi, Taiwan.	erick720730@gmail.com	Huang, Wan-Chun/L-8846-2019	Huang, Wan-Chun/0000-0002-3781-103X				Arvanitis M, 2015, EUR J CLIN INVEST, V45, P646, DOI 10.1111/eci.12448; Bulpa P, 2007, EUR RESPIR J, V30, P782, DOI 10.1183/09031936.00062206; Chamilos G, 2006, HAEMATOL-HEMATOL J, V91, P986; Chen HS, 2007, RHEUMATOLOGY, V46, P539, DOI 10.1093/rheumatology/kel343; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Dorak M. Tevfik, 2012, Frontiers in Genetics, V3, P268, DOI 10.3389/fgene.2012.00268; Guinea J, 2010, CLIN MICROBIOL INFEC, V16, P870, DOI 10.1111/j.1469-0691.2009.03015.x; Hoenigl M, 2012, MED MYCOL, V50, P266, DOI 10.3109/13693786.2011.603102; Hsiue HC, 2012, EUR J CLIN MICROBIOL, V31, P1319, DOI 10.1007/s10096-011-1445-1; Jarrin I, 2008, AM J EPIDEMIOL, V168, P532, DOI 10.1093/aje/kwn179; Kim A, 2011, MYCOSES, V54, pE301, DOI 10.1111/j.1439-0507.2010.01903.x; Lortholary O, 2011, CLIN MICROBIOL INFEC, V17, P1882, DOI 10.1111/j.1469-0691.2011.03548.x; Marr KA, 2005, CLIN INFECT DIS, V40, P1762, DOI 10.1086/429921; Marr KA, 2002, BLOOD, V100, P4358, DOI 10.1182/blood-2002-05-1496; Montagna MT, 2014, INFECTION, V42, P141, DOI 10.1007/s15010-013-0539-3; Perkhofer S, 2010, INT J ANTIMICROB AG, V36, P531, DOI 10.1016/j.ijantimicag.2010.08.010; Pfeiffer CD, 2006, CLIN INFECT DIS, V42, P1417, DOI 10.1086/503427; Prasad P, 2014, TRANSPLANTATION, V98, P773, DOI 10.1097/TP.0000000000000131; Segal BH, 2009, NEW ENGL J MED, V360, P1870, DOI 10.1056/NEJMra0808853; Sinko J, 2008, TRANSPL INFECT DIS, V10, P106, DOI 10.1111/j.1399-3062.2007.00264.x; Steinbach WJ, 2012, J INFECTION, V65, P453, DOI 10.1016/j.jinf.2012.08.003; Taccone FS, 2015, CRIT CARE, V19, DOI 10.1186/s13054-014-0722-7; Vandewoude KH, 2006, CRIT CARE, V10, DOI 10.1186/cc4823; Walsh TJ, 2004, J CLIN MICROBIOL, V42, P4744, DOI 10.1128/JCM.42.10.4744-4748.2004	24	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149964	10.1371/journal.pone.0149964	http://dx.doi.org/10.1371/journal.pone.0149964			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900697	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100195
J	Van Hoeven, N; Joshi, SW; Nana, GI; Bosco-Lauth, A; Fox, C; Bowen, RA; Clements, DE; Martyak, T; Parks, DE; Baldwin, S; Reed, SG; Coler, RN				Van Hoeven, Neal; Joshi, Sharvari Waghmare; Nana, Ghislain Ismael; Bosco-Lauth, Angela; Fox, Christopher; Bowen, Richard A.; Clements, David E.; Martyak, Timothy; Parks, D. Elliot; Baldwin, Susan; Reed, Steven G.; Coler, Rhea N.			A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations	PLOS ONE			English	Article							JAPANESE ENCEPHALITIS VACCINE; NEUTRALIZING ANTIBODY-RESPONSE; RECOMBINANT ENVELOPE PROTEIN; CELLULAR IMMUNE-RESPONSES; AMINO-ACID SUBSTITUTION; VECTOR-BASED VACCINE; DNA VACCINE; DOMAIN-III; CRYSTAL-STRUCTURE; HUMORAL IMMUNITY	West Nile virus (WNV) is a mosquito-transmitted member of the Flaviviridae family that has emerged in recent years to become a serious public health threat. Given the sporadic nature of WNV epidemics both temporally and geographically, there is an urgent need for a vaccine that can rapidly provide effective immunity. Protection from WNV infection is correlated with antibodies to the viral envelope (E) protein, which encodes receptor binding and fusion functions. Despite many promising E-protein vaccine candidates, there are currently none licensed for use in humans. This study investigates the ability to improve the immunogenicity and protective capacity of a promising clinical-stage WNV recombinant E-protein vaccine (WN-80E) by combining it with a novel synthetic TLR-4 agonist adjuvant. Using the murine model of WNV disease, we find that inclusion of a TLR-4 agonist in either a stable oil-in-water emulsion (SE) or aluminum hydroxide (Alum) formulation provides both dose and dosage sparing functions, whereby protection can be induced after a single immunization containing only 100 ng of WN-80E. Additionally, we find that inclusion of adjuvant with a single immunization reduced viral titers in sera to levels undetectable by viral plaque assay. The enhanced protection provided by adjuvanted immunization correlated with induction of a Th1 T-cell response and the resultant shaping of the IgG response. These findings suggest that inclusion of a next generation adjuvant may greatly enhance the protective capacity of WNV recombinant subunit vaccines, and establish a baseline for future development.	[Van Hoeven, Neal; Joshi, Sharvari Waghmare; Nana, Ghislain Ismael; Fox, Christopher; Baldwin, Susan; Reed, Steven G.; Coler, Rhea N.] Infect Dis Res Inst, 1616 Eastlake Ave E, Seattle, WA 98103 USA; [Bosco-Lauth, Angela; Bowen, Richard A.] Colorado State Univ, Dept Biomed Sci, Foothills Campus, Ft Collins, CO 80523 USA; [Clements, David E.; Martyak, Timothy; Parks, D. Elliot] Hawaii Biotech Inc, 99-193 Aiea Hts Dr, Aiea, HI 96701 USA	Colorado State University	Van Hoeven, N (corresponding author), Infect Dis Res Inst, 1616 Eastlake Ave E, Seattle, WA 98103 USA.	neal.vanhoeven@idri.org			Bill and Melinda Gates Foundation [OPP1055855]; IDRI; Hawaii Biotech Inc.	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); IDRI; Hawaii Biotech Inc.	This research was supported with funding from the Bill and Melinda Gates Foundation, under grant OPP1055855, and with unrestricted IDRI funds. The external funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Hawaii Biotech Inc. provided support in the form of salaries for authors DEC, TM, and DEP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alving CR, 2012, CURR OPIN IMMUNOL, V24, P310, DOI 10.1016/j.coi.2012.03.008; Amanna IJ, 2014, EXPERT REV VACCINES, V13, P589, DOI 10.1586/14760584.2014.906309; Anwar A, 2005, VIROLOGY, V332, P66, DOI 10.1016/j.virol.2004.11.022; Bakonyi T, 2006, EMERG INFECT DIS, V12, P618; Bakonyi T, 2013, VET MICROBIOL, V165, P61, DOI 10.1016/j.vetmic.2013.03.005; Barzon L, 2013, EXPERT REV ANTI-INFE, V11, P479, DOI [10.1586/ERI.13.34, 10.1586/eri.13.34]; Biedenbender R, 2011, J INFECT DIS, V203, P75, DOI 10.1093/infdis/jiq003; Brandler S, 2013, VIRUSES-BASEL, V5, P2384, DOI 10.3390/v5102384; Brandler S, 2012, J INFECT DIS, V206, P212, DOI 10.1093/infdis/jis328; Brinton MA, 2014, VIRUSES-BASEL, V6, P13, DOI 10.3390/v6010013; Centers for Disease Control and Prevention, 2015, W NIL VIR DIS CAS DE; Chang DC, 2008, NAT BIOTECHNOL, V26, P571, DOI 10.1038/nbt1400; Chowers MY, 2001, EMERG INFECT DIS, V7, P675; Chu JHJ, 2007, J IMMUNOL, V178, P2699, DOI 10.4049/jimmunol.178.5.2699; Chua AJS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-129; Clegg CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088979; Clegg CH, 2012, P NATL ACAD SCI USA, V109, P17585, DOI 10.1073/pnas.1207308109; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Coler RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013677; Coller BA, 2012, United States patent, Patent No. [US20120141520A1, 20120141520, US 20120141520]; Coutant F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003973; Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001; Dayan GH, 2012, VACCINE, V30, P6656, DOI 10.1016/j.vaccine.2012.08.063; Deardorff E, 2006, EMERG INFECT DIS, V12, P314, DOI 10.3201/eid1202.050871; Demento SL, 2010, J IMMUNOL, V185, P2989, DOI 10.4049/jimmunol.1000768; Despres P, 2005, J INFECT DIS, V191, P207, DOI 10.1086/426824; Durbin AP, 2013, VACCINE, V31, P5772, DOI 10.1016/j.vaccine.2013.07.064; Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098; Hall RA, 2003, P NATL ACAD SCI USA, V100, P10460, DOI 10.1073/pnas.1834270100; Iglesias MC, 2006, J GENE MED, V8, P265, DOI 10.1002/jgm.837; Ireton GC, 2013, EXPERT REV VACCINES, V12, P793, DOI 10.1586/14760584.2013.811204; Ishikawa T, 2007, MICROBES INFECT, V9, P1089, DOI 10.1016/j.micinf.2007.05.013; Iyer AV, 2009, VACCINE, V27, P893, DOI 10.1016/j.vaccine.2008.11.087; Jarmer J, 2014, J VIROL, V88, P13845, DOI 10.1128/JVI.02086-14; Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06; Karaca K, 2005, VACCINE, V23, P3808, DOI 10.1016/j.vaccine.2005.02.020; Kim DY, 2014, P NATL ACAD SCI USA, V111, P10708, DOI 10.1073/pnas.1408677111; Ledizet M, 2005, VACCINE, V23, P3915, DOI 10.1016/j.vaccine.2005.03.006; Lieberman MM, 2007, VACCINE, V25, P414, DOI 10.1016/j.vaccine.2006.08.018; Lieberman MM, 2009, CLIN VACCINE IMMUNOL, V16, P1332, DOI 10.1128/CVI.00119-09; Lim CK, 2008, VIROLOGY, V374, P60, DOI 10.1016/j.virol.2007.12.021; Lindsey Nicole P., 2010, Morbidity and Mortality Weekly Report, V59, P1; Liu WJ, 2006, J VIROL, V80, P2396, DOI 10.1128/JVI.80.5.2396-2404.2006; Long MT, 2007, EQUINE VET J, V39, P491, DOI 10.2746/042516407X217416; Lustig S, 2000, VIRAL IMMUNOL, V13, P401, DOI 10.1089/vim.2000.13.401; Magnusson SE, 2014, VACCINE, V32, P800, DOI 10.1016/j.vaccine.2013.12.030; McDonald WF, 2007, J INFECT DIS, V195, P1607, DOI 10.1086/517613; Merino-Ramos T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108056; Mizel SB, 2010, J IMMUNOL, V185, P5677, DOI 10.4049/jimmunol.1002156; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Monath TP, 2006, P NATL ACAD SCI USA, V103, P6694, DOI 10.1073/pnas.0601932103; Morales MA, 2006, EMERG INFECT DIS, V12, P1559, DOI 10.3201/eid1210.060852; Morrey JD, 2013, ANTIVIR RES, V100, P535, DOI 10.1016/j.antiviral.2013.09.010; Muraki Y, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0282-8; Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06; O'Leary DR, 2004, VECTOR-BORNE ZOONOT, V4, P61, DOI 10.1089/153036604773083004; Orlinger KK, 2010, VACCINE, V28, P3318, DOI 10.1016/j.vaccine.2010.02.092; Pepperell C, 2003, CAN MED ASSOC J, V168, P1399; Petersen LR, 2013, EPIDEMIOL INFECT, V141, P591, DOI 10.1017/S0950268812001070; Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042; Petrovsky N, 2013, J VIROL, V87, P10324, DOI 10.1128/JVI.00480-13; Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004; Pinto AK, 2013, J VIROL, V87, P1926, DOI 10.1128/JVI.02903-12; Pletnev AG, 2003, VIROLOGY, V314, P190, DOI 10.1016/S0042-6822(03)00450-1; Qiao M, 2004, J INFECT DIS, V190, P2104, DOI 10.1086/425933; Ramanathan MP, 2009, VACCINE, V27, P4370, DOI 10.1016/j.vaccine.2009.01.137; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Samina I, 2007, VACCINE, V25, P8338, DOI 10.1016/j.vaccine.2007.09.055; Scheiermann J, 2014, VACCINE, V32, P6377, DOI 10.1016/j.vaccine.2014.06.065; Schepp-Berglind J, 2007, CLIN VACCINE IMMUNOL, V14, P1117, DOI 10.1128/CVI.00070-07; Schneeweiss A, 2011, VACCINE, V29, P6352, DOI 10.1016/j.vaccine.2011.04.116; Sejvar JJ, 2014, VIRUSES-BASEL, V6, P606, DOI 10.3390/v6020606; Seligman SJ, 2014, VACCINE, V32, P5769, DOI 10.1016/j.vaccine.2014.08.051; Seregin A, 2006, VIROLOGY, V356, P115, DOI 10.1016/j.virol.2006.07.038; Shirota H, 2014, EXPERT REV VACCINES, V13, P299, DOI 10.1586/14760584.2014.863715; Siger L, 2004, AM J VET RES, V65, P1459, DOI 10.2460/ajvr.2004.65.1459; Siirin MT, 2008, AM J TROP MED HYG, V79, P955, DOI 10.4269/ajtmh.2008.79.955; Spohn G, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-146; Takasaki T, 2003, VACCINE, V21, P4514, DOI 10.1016/S0264-410X(03)00507-3; Tesh RB, 2002, EMERG INFECT DIS, V8, P1392, DOI 10.3201/eid0812.020229; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; Vasilakos JP, 2013, EXPERT REV VACCINES, V12, P809, DOI 10.1586/14760584.2013.811208; Venter M, 2010, VECTOR-BORNE ZOONOT, V10, P659, DOI 10.1089/vbz.2009.0230; Wang T, 2001, J IMMUNOL, V167, P5273, DOI 10.4049/jimmunol.167.9.5273; Whiteman MC, 2010, VACCINE, V28, P1075, DOI 10.1016/j.vaccine.2009.10.112; Wicker JA, 2006, VIROLOGY, V349, P245, DOI 10.1016/j.virol.2006.03.007; Widman DG, 2010, AM J TROP MED HYG, V82, P1160, DOI 10.4269/ajtmh.2010.09-0310; Wiley SR, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002135; Yamshchikov G, 2004, VIROLOGY, V330, P304, DOI 10.1016/j.virol.2004.09.014; Yu L, 2008, VACCINE, V26, P5981, DOI 10.1016/j.vaccine.2008.08.064	91	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149610	10.1371/journal.pone.0149610	http://dx.doi.org/10.1371/journal.pone.0149610			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901122	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100110
J	Prado, CHBD; de Camargo-Bortolin, LHG; Castro, E; Martinez, CA				Britto de Assis Prado, Carlos Henrique; Guedes de Camargo-Bortolin, Livia Haik; Castro, Erique; Martinez, Carlos Alberto			Leaf Dynamics of Panicum maximum under Future Climatic Changes	PLOS ONE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; CO2 ENRICHMENT FACE; TEMPERATURE-ACCLIMATION; C-4 GRASSES; PHOTOSYNTHESIS; RESPONSES; PLANTS; CLASSIFICATION; GROWTH; STATE	Panicum maximum Jacq. 'Mombaca' (C4) was grown in field conditions with sufficient water and nutrients to examine the effects of warming and elevated CO2 concentrations during the winter. Plants were exposed to either the ambient temperature and regular atmospheric CO2 (Control); elevated CO2 (600 ppm, eC); canopy warming (+2 degrees C above regular canopy temperature, eT); or elevated CO2 and canopy warming (eC+eT). The temperatures and CO2 in the field were controlled by temperature free-air controlled enhancement (T-FACE) and mini free-air CO2 enrichment (miniFACE) facilities. The most green, expanding, and expanded leaves and the highest leaf appearance rate (LAR, leaves day(-1)) and leaf elongation rate (LER, cm day(-1)) were observed under eT. Leaf area and leaf biomass were higher in the eT and eC+ eT treatments. The higher LER and LAR without significant differences in the number of senescent leaves could explain why tillers had higher foliage area and leaf biomass in the eT treatment. The eC treatment had the lowest LER and the fewest expanded and green leaves, similar to Control. The inhibitory effect of eC on foliage development in winter was indicated by the fewer green, expanded, and expanding leaves under eC+ eT than eT. The stimulatory and inhibitory effects of the eT and eC treatments, respectively, on foliage raised and lowered, respectively, the foliar nitrogen concentration. The inhibition of foliage by eC was confirmed by the eC treatment having the lowest leaf/stem biomass ratio and by the change in leaf biomass-area relationships from linear or exponential growth to rectangular hyperbolic growth under eC. Besides, eC+ eT had a synergist effect, speeding up leaf maturation. Therefore, with sufficient water and nutrients in winter, the inhibitory effect of elevated CO2 on foliage could be partially offset by elevated temperatures and relatively high P. maximum foliage production could be achieved under future climatic change.	[Britto de Assis Prado, Carlos Henrique; Guedes de Camargo-Bortolin, Livia Haik; Castro, Erique] Univ Fed Sao Paulo, Dept Bot, BR-13565905 Sao Paulo, Brazil; [Martinez, Carlos Alberto] Univ Sao Paulo, FFCLRP, Dept Biol, BR-14040901 Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	de Camargo-Bortolin, LHG (corresponding author), Univ Fed Sao Paulo, Dept Bot, BR-13565905 Sao Paulo, Brazil.	li.bortolin@gmail.com	Castro, Erique/U-7369-2019; Martinez, Carlos/B-8222-2011; Camargo-Bortolin, Lívia H. G./D-3888-2016; de Assis Prado, Carlos Henrique Britto/ABB-6028-2020	Castro, Erique/0000-0002-0931-2575; Martinez, Carlos/0000-0002-0246-9481; Camargo-Bortolin, Lívia H. G./0000-0002-2764-2009; Prado, Carlos/0000-0002-1652-2642	Sao Paulo Research Foundation, FAPESP [08/58075-8]; LHGCB [2012/20847-5]; CNPq	Sao Paulo Research Foundation, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); LHGCB; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Sao Paulo Research Foundation, FAPESP (http://www.fapesp.br) to CAM (Thematic Project Grant 08/58075-8) and LHGCB (PhD scholarship 2012/20847-5). CAM and CHBAP are fellow researchers from CNPq. CNPq provided a graduate scholarship to EC.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; [Anonymous], 1999, SOIL TAX BAS SYST SO; [Anonymous], 2010, GLOBAL CLIMATE CHANG; Barros VR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1133; Batistoti C, 2012, ANIM FEED SCI TECH, V171, P173, DOI 10.1016/j.anifeedsci.2011.11.008; BAZZAZ FA, 1990, ANNU REV ECOL SYST, V21, P167, DOI 10.1146/annurev.es.21.110190.001123; Bhatt RK, 2007, PHOTOSYNTHETICA, V45, P296, DOI 10.1007/s11099-007-0048-7; Dwyer SA, 2007, PLANT CELL ENVIRON, V30, P53, DOI 10.1111/j.1365-3040.2006.01605.x; Geiger R., 1928, KLIMATE DER ERDE; Kim SH, 2007, ENVIRON EXP BOT, V61, P224, DOI 10.1016/j.envexpbot.2007.06.005; Kimball BA, 2008, GLOBAL CHANGE BIOL, V14, P309, DOI 10.1111/j.1365-2486.2007.01486.x; Leakey ADB, 2012, CURR OPIN PLANT BIOL, V15, P228, DOI 10.1016/j.pbi.2012.01.009; Leakey ADB, 2009, P ROY SOC B-BIOL SCI, V276, P2333, DOI 10.1098/rspb.2008.1517; Li PH, 2007, TRENDS PLANT SCI, V12, P87, DOI 10.1016/j.tplants.2007.01.003; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; Long SP, 2006, SCIENCE, V312, P1918, DOI 10.1126/science.1114722; MacAdam JW, 2003, AGRON J, V95, P414, DOI 10.2134/agronj2003.0414; Malavolta E., 1989, AVALIACAO ESTADO NUT; Miglietta F, 2001, NEW PHYTOL, V150, P465, DOI 10.1046/j.1469-8137.2001.00115.x; Pinto H, 2014, J EXP BOT, V65, P3669, DOI 10.1093/jxb/eru155; Rolim GD, 2016, INT J CLIMATOL, V36, P636, DOI 10.1002/joc.4372; Rolim Glauco de Souza, 2007, Bragantia, V66, P711, DOI 10.1590/S0006-87052007000400022; Rudmann SG, 2001, ANN BOT-LONDON, V88, P571, DOI 10.1006/anbo.2001.1503; Santos P. M., 2011, REV BRASILEIRA GEOGR, V4, P1176; Santos RM, 2014, REV BRAS ZOOTECN, V43, P404, DOI 10.1590/S1516-35982014000800002; Streck Nereu Augusto, 2005, Cienc. Rural, V35, P730, DOI 10.1590/S0103-84782005000300041; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Wand SJE, 1999, GLOB CHANGE BIOL, V5, P723, DOI 10.1046/j.1365-2486.1999.00265.x; Watling JR, 2000, PLANT PHYSIOL, V123, P1143, DOI 10.1104/pp.123.3.1143; Yamori W, 2014, PHOTOSYNTH RES, V119, P101, DOI 10.1007/s11120-013-9874-6; Yamori W, 2012, PLANT J, V71, P871, DOI 10.1111/j.1365-313X.2012.05041.x	31	21	21	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149620	10.1371/journal.pone.0149620	http://dx.doi.org/10.1371/journal.pone.0149620			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894932	Green Published, gold, Green Submitted			2022-12-27	WOS:000371223400069
J	Li, XM; Zhang, SF; Xu, HW; Tang, XF; Zhou, HX; Yuan, JQ; Wang, XH; Qu, ZY; Wang, FG; Zhu, H; Guo, S; Tian, DH; Zhang, WJ				Li, Xuemei; Zhang, Shengfa; Xu, Huiwen; Tang, Xinfeng; Zhou, Huixuan; Yuan, Jiaqi; Wang, Xiaohua; Qu, Zhiyong; Wang, Fugang; Zhu, He; Guo, Shuai; Tian, Donghua; Zhang, Weijun			Type D Personality Predicts Poor Medication Adherence in Chinese Patients with Type 2 Diabetes Mellitus: A Six-Month Follow-Up Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SELF-CARE; DEPRESSIVE SYMPTOMS; HEALTH LITERACY; MORTALITY; FAILURE; NONADHERENCE; OUTCOMES; THERAPY; IMPACT	Background Type D personality and medication nonadherence have been shown to be associated with poor health outcomes. Type D personality is associated with poor medication adherence in patients with coronary artery disease, myocardial infarction, and heart failure. However, the relationship between type D personality and medication adherence in patients with Type 2 Diabetes Mellitus (T2DM) remains unknown. This study aims to examine whether type D personality was associated with medication adherence in patients with T2DM. Design and Settings A follow-up study was conducted in general hospital of the People's Liberation Army in Beijing. Methods 412 T2DM patients (205 females), who were recruited by circular systematic random sampling, provided demographic and baseline data about medical information and completed measures of Type D personality. Then, 330 patients went on to complete a self-report measure of medication adherence at the sixth month after baseline data collection. Chi-square test, t tests, and hierarchical multiple regression analyses were conducted, as needed. Results Patients with type D personality were significantly more likely to have poor medication adherence (p < 0.001). Type D personality predicts poor medication adherence before and after controlling for covariates when it was analyzed as a categorical variable. However, the dimensional construct of type D personality was not associated with medication adherence when analyzed as a continuous variable. Conclusion Although, as a dimensional construct, type D personality may not reflect the components of the personality associated with poor medication adherence in patients with T2DM, screening for type D personality may help to identify those who are at higher risk of poor medication adherence. Interventions, aiming to improve medication adherence, should be launched for these high-risk patients.	[Zhang, Shengfa; Tang, Xinfeng; Zhou, Huixuan; Yuan, Jiaqi; Wang, Xiaohua; Qu, Zhiyong; Wang, Fugang; Guo, Shuai; Tian, Donghua; Zhang, Weijun] Beijing Normal Univ, China Inst Hlth, Sch Social Dev & Publ Policy, Beijing 100875, Peoples R China; [Li, Xuemei] Peoples Liberat Army, Hosp 301, Gen Hosp, Clin Cadre,Dept Outpatient, Beijing, Peoples R China; [Xu, Huiwen] Univ Rochester, Sch Med & Dent, Dept Publ Hlth Sci, Rochester, NY USA; [Zhu, He] Duke Univ, Med Ctr, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27710 USA	Beijing Normal University; Chinese People's Liberation Army General Hospital; University of Rochester; Duke University	Tian, DH; Zhang, WJ (corresponding author), Beijing Normal Univ, China Inst Hlth, Sch Social Dev & Publ Policy, Beijing 100875, Peoples R China.	tian65216@hotmail.com; zwj@bnu.edu.cn	Zhou, Huixuan/GRY-5023-2022; zhang, weijun/AFU-6997-2022; Xu, Huiwen/HHN-2986-2022; Xu, Huiwen/AAP-8744-2020	zhang, weijun/0000-0003-3436-3371; Xu, Huiwen/0000-0002-4033-0659; Guo, Shuai/0000-0001-7279-2412; Tang, Xinfeng/0000-0001-5017-1295	Fundamental Research Funds for the Central Universities [SKZZX2013053]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the Fundamental Research Funds for the Central Universities (No. SKZZX2013053 in Beijing Normal University).	Al-Qazaz HK, 2010, DIABETES RES CLIN PR, V90, P216, DOI 10.1016/j.diabres.2010.08.012; Aquarius AE, 2009, ARCH SURG-CHICAGO, V144, P728, DOI 10.1001/archsurg.2009.75; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bauer AM, 2013, J GEN INTERN MED, V28, P1181, DOI 10.1007/s11606-013-2402-8; Bezie Y, 2006, DIABETES METAB, V32, P611, DOI 10.1016/S1262-3636(07)70316-6; Brostrom A, 2007, J SLEEP RES, V16, P439, DOI 10.1111/j.1365-2869.2007.00620.x; Buse J.B., 2011, WILLIAMS TXB ENDOCRI, P1371; Buysman EK, 2015, ADV THER, V32, P341, DOI 10.1007/s12325-015-0199-z; Cani CG, 2015, CLINICS, V70, P102, DOI 10.6061/clinics/2015(02)06; Clifford S, 2014, CURR MED RES OPIN, V30, P1071, DOI 10.1185/03007995.2014.884491; Cohen HW, 2010, DIABETIC MED, V27, P210, DOI 10.1111/j.1464-5491.2009.02898.x; Conden E, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-11; Corsonello Andrea, 2009, Ther Clin Risk Manag, V5, P209; Coyne JC, 2011, PSYCHOSOM MED, V73, P557, DOI 10.1097/PSY.0b013e318227ac75; Curkendall SM, 2013, CURR MED RES OPIN, V29, P1275, DOI 10.1185/03007995.2013.821056; Dailey G, 2001, CLIN THER, V23, P1311, DOI 10.1016/S0149-2918(01)80110-7; de Oliveira AD, 2014, RES SOC ADMIN PHARM, V10, P554, DOI 10.1016/j.sapharm.2013.10.006; de Voogd JN, 2009, ANN BEHAV MED, V38, P86, DOI 10.1007/s12160-009-9105-8; Denollet J, 2000, CIRCULATION, V102, P630, DOI 10.1161/01.CIR.102.6.630; Denollet J, 2006, AM J CARDIOL, V97, P970, DOI 10.1016/j.amjcard.2005.10.035; Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49; Denollet J, 2003, BRAIN BEHAV IMMUN, V17, P304, DOI 10.1016/S0889-1591(03)00060-6; Denollet J, 1996, LANCET, V347, P417, DOI 10.1016/S0140-6736(96)90007-0; Denollet J, 2008, BRAIN BEHAV IMMUN, V22, P736, DOI 10.1016/j.bbi.2007.10.015; Dieltjens M, 2013, SLEEP BREATH, V17, P985, DOI 10.1007/s11325-012-0788-x; Elliott DJ, 2013, POPUL HEALTH MANAG, V16, P99, DOI 10.1089/pop.2012.0031; Ferguson E, 2009, PSYCHOSOM MED, V71, P981, DOI 10.1097/PSY.0b013e3181bd888b; Geisel-Marbaise S, 2010, J PUBLIC HEALTH-HEID, V18, P219, DOI 10.1007/s10389-009-0305-2; Gilmour J, 2012, J HEALTH PSYCHOL, V17, P471, DOI 10.1177/1359105311423117; Grande G, 2011, PSYCHOSOM MED, V73, P548, DOI 10.1097/PSY.0b013e318227a9bc; Grant RW, 2003, DIABETES CARE, V26, P1408, DOI 10.2337/diacare.26.5.1408; Ho PM, 2006, ARCH INTERN MED, V166, P1836, DOI 10.1001/archinte.166.17.1836; International Diabetes Federation, 2015, IDF DIAB ATL, V7; Jackson IL, 2015, DIABETES TECHNOL THE, V17, P398, DOI 10.1089/dia.2014.0279; Kupper N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058370; Kupper N, 2009, PSYCHOSOM MED, V71, P973, DOI 10.1097/PSY.0b013e3181bee6dc; Lane JD, 2000, DIABETES CARE, V23, P1321, DOI 10.2337/diacare.23.9.1321; Lee GKY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062775; Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154; Mahler C, 2012, J EVAL CLIN PRACT, V18, P409, DOI 10.1111/j.1365-2753.2010.01589.x; Marzec LN, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0418-7; MAXWELL SE, 1993, PSYCHOL BULL, V113, P181, DOI 10.1037/0033-2909.113.1.181; Meece Jerry, 2014, J Pharm Pract, V27, P187, DOI 10.1177/0897190013513803; Molloy GJ, 2008, PSYCHOSOM MED, V70, P863, DOI 10.1097/PSY.0b013e3181842e0c; Molloy GJ, 2012, PSYCHOSOM MED, V74, P100, DOI 10.1097/PSY.0b013e31823a5b2f; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Odegard PS, 2008, DIABETES EDUCATOR, V34, P692, DOI 10.1177/0145721708320558; Odegard PS, 2007, DIABETES EDUCATOR, V33, P1014, DOI 10.1177/0145721707308407; Osborn CY, 2012, GEN HOSP PSYCHIAT, V34, P249, DOI 10.1016/j.genhosppsych.2012.01.015; Osborn CY, 2011, J HEALTH COMMUN, V16, P268, DOI 10.1080/10810730.2011.604388; Paes AHP, 1997, DIABETES CARE, V20, P1512, DOI 10.2337/diacare.20.10.1512; Pedersini R, 2014, VALUE HEALTH, V17, pA183, DOI 10.1016/j.jval.2014.03.1066; Pelle AJ, 2010, INT J CARDIOL, V142, P65, DOI 10.1016/j.ijcard.2008.12.086; Pelle AJ, 2010, CIRC-HEART FAIL, V3, P261, DOI 10.1161/CIRCHEARTFAILURE.109.871483; Rivellese AA, 2010, NUTR METAB CARDIOVAS, V20, P474, DOI 10.1016/j.numecd.2010.01.008; Sakthong P, 2009, ANN PHARMACOTHER, V43, P950, DOI 10.1345/aph.1L453; Saleh F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-431; Schiffer AA, 2007, HEART, V93, P814, DOI 10.1136/hrt.2006.102822; Schiffer AA, 2010, INT J CARDIOL, V142, P230, DOI 10.1016/j.ijcard.2008.12.090; Shamsi A, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/s40200-014-0096-z; Siyu Z, 2010, CHINESE J ANTITUBERC, V32, P55; Smith TW, 2011, PSYCHOSOM MED, V73, P528, DOI 10.1097/PSY.0b013e31822e095e; Tzeng JI, 2008, J PAIN SYMPTOM MANAG, V36, P157, DOI 10.1016/j.jpainsymman.2007.10.015; Volz A, 2011, J BEHAV MED, V34, P13, DOI 10.1007/s10865-010-9282-8; Voorham J, 2011, CLIN THER, V33, P121, DOI 10.1016/j.clinthera.2011.01.024; Walker RJ, 2012, GEN HOSP PSYCHIAT, V34, P598, DOI 10.1016/j.genhosppsych.2012.07.005; Wallach-Kildemoes H, 2013, EUR J CLIN PHARMACOL, V69, P1553, DOI 10.1007/s00228-013-1488-6; [王洁 Wang Jie], 2013, [中国糖尿病杂志, Chinese Journal of Diabetes], V21, P1101; Williams L, 2008, J PSYCHOSOM RES, V64, P63, DOI 10.1016/j.jpsychores.2007.06.008; Williams L, 2012, J PSYCHOSOM RES, V72, P422, DOI 10.1016/j.jpsychores.2012.02.007; Williams L, 2011, PSYCHOL HEALTH, V26, P703, DOI 10.1080/08870446.2010.488265; Williams L, 2009, PSYCHOL HEALTH, V24, P489, DOI 10.1080/08870440701885616; Wong MCS, 2015, J CLIN PHARMACOL, V55, P279, DOI 10.1002/jcph.408; Wu JR, 2014, INT J BEHAV MED, V21, P833, DOI 10.1007/s12529-013-9366-2; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yu XN, 2008, J PSYCHOSOM RES, V65, P595, DOI 10.1016/j.jpsychores.2008.06.009; Zhang WJ, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0053-0; Zhang Yong, 2011, Depress Res Treat, V2011, P143045, DOI 10.1155/2011/143045	78	20	22	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0146892	10.1371/journal.pone.0146892	http://dx.doi.org/10.1371/journal.pone.0146892			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3DG	26894925	Green Published, gold, Green Submitted			2022-12-27	WOS:000371223400003
J	Braschler, B; Baur, B				Braschler, Brigitte; Baur, Bruno			Diverse Effects of a Seven-Year Experimental Grassland Fragmentation on Major Invertebrate Groups	PLOS ONE			English	Article							EXPERIMENTAL HABITAT FRAGMENTATION; CALCAREOUS GRASSLANDS; SPECIES LOSS; PLANTS; EXTINCTION; DYNAMICS; COLONIZATION; CONSERVATION; LANDSCAPES; MOVEMENT	Habitat fragmentation is a major driver of biodiversity loss, but observed effects vary and may depend on the group examined. Time since fragmentation may explain some differences between taxonomical groups, as some species and thus species composition respond with a delay to changes in their environment. Impacts of drivers of global change may thus be underestimated in short-term studies. In our study we experimentally fragmented nutrient-poor dry calcareous grasslands and studied the response of species richness, individual density and species composition of various groups of invertebrates (gastropods, ants, ground beetles, rove beetles, orthoptera, spiders, woodlice) in 12 small (1.5 m * 1.5 m) and 12 large (4.5 m * 4.5 m) fragments and their corresponding control plots after 7 years. We further examined responses to fragmentation in relation to body size and habitat preferences. Responses to fragmentation varied between taxonomical groups. While spider species richness and individual density were lower in fragments, the opposite was true for an orthopteran species and woodlice. Species composition and beta-diversity differed between fragments and control plots for some groups. However, the interaction treatment*plot size was rarely significant. Species with high occupancy rates in undisturbed control plots responded more negatively to the fragmentation, while species with large body size were relatively more abundant in fragments in some groups. No effect of the fragmentation was found for ants, which may have the longest lag times because of long-lived colonies. However, relationships between abundance and the species' preferences for environmental factors affected by edge effects indicate that ant diversity too may be affected in the longer-term. Our results show the importance of considering different groups in conservation management in times of widespread fragmentation of landscapes. While species richness may respond slowly, changes in abundance related to habitat preferences or morphology may allow insights into likely long-term changes.	[Braschler, Brigitte; Baur, Bruno] Univ Basel, Dept Environm Sci, Sect Conservat Biol, Basel, Switzerland	University of Basel	Braschler, B (corresponding author), Univ Basel, Dept Environm Sci, Sect Conservat Biol, Basel, Switzerland.	brigitte.braschler@unibas.ch	Braschler, Brigitte/N-6953-2017	Braschler, Brigitte/0000-0003-0088-3651	Swiss National Science Foundation [5001-44620]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was funded by the Swiss National Science Foundation (www.snf.ch; grant 5001-44620 to BBaur). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; [Anonymous], 1995, GAIA ECOL PERSP SCI, DOI [10.14512/gaia.4.4.5, DOI 10.14512/GAIA.4.4.5]; BAUR A, 1990, CAN J ZOOL, V68, P613, DOI 10.1139/z90-091; Baur B, 1996, REV SUISSE ZOOL, V103, P801, DOI 10.5962/bhl.part.79977; Bhattacharya M, 2003, BIOL CONSERV, V109, P37, DOI 10.1016/S0006-3207(02)00130-1; Bommarco R, 2014, DIVERS DISTRIB, V20, P591, DOI 10.1111/ddi.12187; Braschler B, 2003, ECOL ENTOMOL, V28, P651, DOI 10.1111/j.1365-2311.2003.00549.x; Braschler B, 2005, OECOLOGIA, V143, P291, DOI 10.1007/s00442-004-1778-x; Braschler B, 2003, OIKOS, V100, P581, DOI 10.1034/j.1600-0706.2003.12220.x; Braschler B, 2009, ECOL ENTOMOL, V34, P321, DOI 10.1111/j.1365-2311.2008.01080.x; Braschler Brigitte, 2002, Mitteilungen der Entomologischen Gesellschaft Basel, V52, P139; Collinge SK, 2000, ECOLOGY, V81, P2211, DOI 10.1890/0012-9658(2000)081[2211:EOGFOI]2.0.CO;2; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; Dolt C, 2005, ACTA OECOL, V27, P49, DOI 10.1016/j.actao.2004.09.002; Ellenberg H., 1996, VEGETATION MITTELEUR, V5th ed; Essl F, 2015, TRENDS ECOL EVOL, V30, P375, DOI 10.1016/j.tree.2015.05.002; Falkner G., 2001, SHELLED GASTROPODA W; Gonzalez A, 2002, J ANIM ECOL, V71, P594, DOI 10.1046/j.1365-2656.2002.00625.x; Goverde M, 2002, BIOL CONSERV, V104, P293, DOI 10.1016/S0006-3207(01)00194-X; Groppe K, 2001, J ECOL, V89, P247, DOI 10.1046/j.1365-2745.2001.00538.x; HANSKI I, 1994, TRENDS ECOL EVOL, V9, P131, DOI 10.1016/0169-5347(94)90177-5; HARRISON S, 1991, BIOL J LINN SOC, V42, P73, DOI 10.1111/j.1095-8312.1991.tb00552.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holsinger KE, 2000, CONSERV BIOL SER, V4, P55; Joshi J, 2006, OECOLOGIA, V148, P144, DOI 10.1007/s00442-005-0341-8; KAREIVA P, 1987, NATURE, V326, P388, DOI 10.1038/326388a0; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Krauss J, 2004, MOL ECOL, V13, P311, DOI 10.1046/j.1365-294X.2003.02072.x; KRUESS A, 1994, SCIENCE, V264, P1581, DOI 10.1126/science.264.5165.1581; Kuussaari M, 2009, TRENDS ECOL EVOL, V24, P564, DOI 10.1016/j.tree.2009.04.011; Niemela J, 1998, BIODIVERS CONSERV, V7, P1407, DOI 10.1023/A:1008835529764; Oggier Peter, 1998, Malakologische Abhandlungen (Dresden), V19, P89; Oksanen J., 2020, VEGAN COMMUNITY ECOL; PICKETT S T A, 1989, P110; Pinheiro J, 2020, R PACKAGE VERSION 31; R Core Team, 2012, LANG ENV STAT COMP; Radford JQ, 2005, BIOL CONSERV, V124, P317, DOI 10.1016/j.biocon.2005.01.039; Rossetti MR, 2014, ARTHROPOD-PLANT INTE, V8, P593, DOI 10.1007/s11829-014-9342-z; Rusterholz HP, 2010, OECOLOGIA, V163, P141, DOI 10.1007/s00442-010-1567-7; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Schlapfer M, 1998, BOT HELV, V108, P57; SEIFERT B, 2007, AMEISEN MITTEL NORDE; STAMPS JA, 1987, AM NAT, V129, P533, DOI 10.1086/284656; Stangler ES, 2015, BIODIVERS CONSERV, V24, P563, DOI 10.1007/s10531-014-0836-x; Stoll P, 2009, J ANIM ECOL, V78, P236, DOI 10.1111/j.1365-2656.2008.01478.x; Stoll P, 2006, BASIC APPL ECOL, V7, P307, DOI 10.1016/j.baae.2005.09.001; WallisDeVries MF, 2002, BIOL CONSERV, V104, P265, DOI 10.1016/S0006-3207(01)00191-4; Wiens JA, 1994, IBIS, V137, P97, DOI DOI 10.1111/J.1474-919X.1995.TB08464.X; Wirth Thierry, 1999, Zeitschrift fuer Oekologie und Naturschutz, V8, P23; Zoller H., 1947, BER GEOBOT INST RUBEL ZURICH, V1946, P51; Zschokke S, 2000, OECOLOGIA, V125, P559, DOI 10.1007/s004420000483	52	10	12	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149567	10.1371/journal.pone.0149567	http://dx.doi.org/10.1371/journal.pone.0149567			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891049	gold, Green Published, Green Submitted			2022-12-27	WOS:000371221500060
J	Castano, J; Morera, C; Sese, B; Boue, S; Bonet-Costa, C; Marti, M; Roque, A; Jordan, A; Barrero, MJ				Castano, Julio; Morera, Cristina; Sese, Borja; Boue, Stephanie; Bonet-Costa, Carles; Marti, Merce; Roque, Alicia; Jordan, Albert; Barrero, Maria J.			SETD7 Regulates the Differentiation of Human Embryonic Stem Cells	PLOS ONE			English	Article							LYSINE METHYLATION; SECONDARY STRUCTURE; HISTONE H1; TRANSCRIPTIONAL ACTIVATION; SET9-MEDIATED METHYLATION; INFRARED-SPECTROSCOPY; SELF-RENEWAL; P53 ACTIVITY; HUMAN ESCS; METHYLTRANSFERASE	The successful use of specialized cells in regenerative medicine requires an optimization in the differentiation protocols that are currently used. Understanding the molecular events that take place during the differentiation of human pluripotent cells is essential for the improvement of these protocols and the generation of high quality differentiated cells. In an effort to understand the molecular mechanisms that govern differentiation we identify the methyltransferase SETD7 as highly induced during the differentiation of human embryonic stem cells and differentially expressed between induced pluripotent cells and somatic cells. Knock-down of SETD7 causes differentiation defects in human embryonic stem cell including delay in both the silencing of pluripotency-related genes and the induction of differentiation genes. We show that SETD7 methylates linker histone H1 in vitro causing conformational changes in H1. These effects correlate with a decrease in the recruitment of H1 to the pluripotency genes OCT4 and NANOG during differentiation in the SETD7 knock down that might affect the proper silencing of these genes during differentiation.	[Castano, Julio; Morera, Cristina; Sese, Borja; Boue, Stephanie; Marti, Merce; Barrero, Maria J.] Ctr Regenerat Med Barcelona CMRB, Barcelona 08003, Spain; [Boue, Stephanie] Biomed Res Networking Ctr Bioengn, Biomat & Nanomed CIBER BBN, Madrid 28029, Spain; [Bonet-Costa, Carles; Roque, Alicia; Jordan, Albert] Inst Biol Mol Barcelona IBMB CSIC, Barcelona 08028, Spain; [Roque, Alicia] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Fac Biociencias, Barcelona 08193, Spain; [Barrero, Maria J.] Spanish Natl Canc Res Ctr CNIO, Madrid 28029, Spain; [Castano, Julio] Univ Barcelona, Fac Med, Josep Carreras Leukaemia Res Inst, Barcelona 08036, Spain; [Sese, Borja] BWH Regenerat Med Ctr, Boston, MA 02139 USA	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Autonomous University of Barcelona; Centro Nacional de Investigaciones Oncologicas (CNIO); Institut de Recerca Contra la Leucemia Josep Carreras (IJC); University of Barcelona	Barrero, MJ (corresponding author), Ctr Regenerat Med Barcelona CMRB, Barcelona 08003, Spain.; Barrero, MJ (corresponding author), Spanish Natl Canc Res Ctr CNIO, Madrid 28029, Spain.	mjbarrero@cnio.es	Córdova, Alicia Roque/W-5229-2019; Barrero, Maria J./Q-1785-2017; jordan, albert/K-4678-2014; jordan, albert/ABC-8229-2020; Roque, Alicia/H-7756-2015; Cardoso, Julio Castaño/AAB-5820-2019	Córdova, Alicia Roque/0000-0002-6206-6481; Barrero, Maria J./0000-0002-5990-7040; jordan, albert/0000-0002-3970-8693; jordan, albert/0000-0002-3970-8693; Roque, Alicia/0000-0002-6206-6481; Sese, Borja/0000-0001-8554-897X; Castano Cardoso, Julio/0000-0002-0712-5856; Bonet-Costa, Carles/0000-0003-4720-8928; Boue, Stephanie/0000-0003-0680-4168	Ramon y Cajal program of MEC [RYC-2007-01510]; MEC [BES-2008-009567]; PRB2-ISCIII-SGEFI-FEDER-PE I+D+i [PT13/0001/0041]; Fundacion CELLEX; TERCEL-RETICS-ISCIII-MINECO-FEDER [RD12/0019/0034]; MICINN [SAF2009-08588];  [BFU2014-52237]	Ramon y Cajal program of MEC(German Research Foundation (DFG)); MEC(European Commission); PRB2-ISCIII-SGEFI-FEDER-PE I+D+i; Fundacion CELLEX(Foundation CELLEX); TERCEL-RETICS-ISCIII-MINECO-FEDER; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); 	M.J.B. was partially supported by the Ramon y Cajal program of MEC (RYC-2007-01510). B.S. was a recipient of a predoctoral fellowship from MEC (BES-2008-009567). C.M. was supported by PT13/0001/0041 PRB2-ISCIII-SGEFI-FEDER-PE I+D+i 2013-2016. J.C. was partially supported by Fundacion CELLEX. This work was partially supported by grant RD12/0019/0034 TERCEL-RETICS-ISCIII-MINECO-FEDER, grant SAF2009-08588 from MICINN to M.J.B and grant BFU2014-52237 to A.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Arrondo JLR, 1999, PROG BIOPHYS MOL BIO, V72, P367, DOI 10.1016/S0079-6107(99)00007-3; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Balasubramaniyan N, 2012, AM J PHYSIOL-GASTR L, V302, pG937, DOI 10.1152/ajpgi.00441.2011; Barrero MJ, 2006, MOL CELL, V24, P233, DOI 10.1016/j.molcel.2006.09.020; Barrero MJ, 2013, J BIOL CHEM, V288, P16110, DOI 10.1074/jbc.M113.466144; Barrero MJ, 2013, CELL REP, V3, P1005, DOI 10.1016/j.celrep.2013.02.029; Barrero MJ, 2013, CELL REP; Barsyte-Lovejoy D, 2014, P NATL ACAD SCI USA, V111, P12853, DOI 10.1073/pnas.1407358111; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boue S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012664; Boulard M, 2015, NAT GENET, V47, P479, DOI 10.1038/ng.3272; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eisert RJ, 2015, BIOCHEMISTRY-US, V54, P2314, DOI 10.1021/acs.biochem.5b00024; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Fang L, 2014, MOL CELL, V55, P537, DOI 10.1016/j.molcel.2014.06.018; Gaughan L, 2011, NUCLEIC ACIDS RES, V39, P1266, DOI 10.1093/nar/gkq861; Herberts CA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-29; Hughes RM, 2007, P NATL ACAD SCI USA, V104, P11184, DOI 10.1073/pnas.0610850104; Kamieniarz K, 2012, GENE DEV, V26, P797, DOI 10.1101/gad.182014.111; Kassner I, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120173; Kassner I, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-1; Kim SK, 2014, CELL STEM CELL, V15, P735, DOI 10.1016/j.stem.2014.10.016; Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lee MR, 2013, STEM CELLS, V31, P666, DOI 10.1002/stem.1302; Lehnertz B, 2011, MOL CELL, V43, P673, DOI 10.1016/j.molcel.2011.08.006; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Liu XY, 2011, P NATL ACAD SCI USA, V108, P1925, DOI 10.1073/pnas.1019619108; Lopez R, 2015, NUCLEIC ACIDS RES, V43, P4463, DOI 10.1093/nar/gkv304; Loyola A, 2004, METHOD ENZYMOL, V377, P474; Masatsugu T, 2009, BIOCHEM BIOPH RES CO, V381, P22, DOI 10.1016/j.bbrc.2009.01.185; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Millan-Arino L, 2014, NUCLEIC ACIDS RES, V42, P4474, DOI 10.1093/nar/gku079; Munro S, 2010, ONCOGENE, V29, P2357, DOI 10.1038/onc.2009.511; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Oudhoff MJ, 2013, DEV CELL, V26, P188, DOI 10.1016/j.devcel.2013.05.025; Raya A, 2008, COLD SH Q B, V73, P127, DOI 10.1101/sqb.2008.73.038; Roque A, 2008, NUCLEIC ACIDS RES, V36, P4719, DOI 10.1093/nar/gkn440; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; STEWART C, 1987, CELL, V51, P383, DOI 10.1016/0092-8674(87)90634-9; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Tabar V, 2014, NAT REV GENET, V15, P82, DOI 10.1038/nrg3563; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Terme JM, 2011, J BIOL CHEM; Trievel RC, 2002, CELL, V111, P91, DOI 10.1016/S0092-8674(02)01000-0; Vila R, 2001, J BIOL CHEM, V276, P30898, DOI 10.1074/jbc.M104189200; Virtaneva K, 2001, P NATL ACAD SCI USA, V98, P1124, DOI 10.1073/pnas.98.3.1124; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Wang DL, 2013, P NATL ACAD SCI USA, V110, P5516, DOI 10.1073/pnas.1216596110; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wu XD, 2013, MOL CELL, V49, P1134, DOI 10.1016/j.molcel.2013.01.016; Xie Q, 2012, EMBO REP, V13, P371, DOI 10.1038/embor.2012.25; Xie RY, 2013, CELL STEM CELL, V12, P224, DOI 10.1016/j.stem.2012.11.023; Yang JB, 2010, P NATL ACAD SCI USA, V107, P21499, DOI 10.1073/pnas.1016147107	61	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149502	10.1371/journal.pone.0149502	http://dx.doi.org/10.1371/journal.pone.0149502			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890252	Green Submitted, Green Published, gold			2022-12-27	WOS:000371221500053
J	Shaik, SS; Obata, T; Hebelstrup, KH; Schwahn, K; Fernie, AR; Mateiu, RV; Blennow, A				Shaik, Shahnoor S.; Obata, Toshihiro; Hebelstrup, Kim H.; Schwahn, Kevin; Fernie, Alisdair R.; Mateiu, Ramona V.; Blennow, Andreas			Starch Granule Re-Structuring by Starch Branching Enzyme and Glucan Water Dikinase Modulation Affects Caryopsis Physiology and Metabolism	PLOS ONE			English	Article							ADP-GLUCOSE PYROPHOSPHORYLASE; MUTATOR INSERTIONAL MUTANTS; ARABIDOPSIS LEAVES; SEED DEVELOPMENT; GENE-EXPRESSION; SOLUBLE SUGARS; SPRING WHEAT; BARLEY; PROTEIN; REVEAL	Starch is of fundamental importance for plant development and reproduction and its optimized molecular assembly is potentially necessary for correct starch metabolism. Re-structuring of starch granules in-planta can therefore potentially affect plant metabolism. Modulation of granule micro-structure was achieved by decreasing starch branching and increasing starch-bound phosphate content in the barley caryopsis starch by RNAi suppression of all three Starch Branching Enzyme (SBE) isoforms or overexpression of potato Glucan Water Dikinase (GWD). The resulting lines displayed Amylose-Only (AO) and Hyper-Phosphorylated (HP) starch chemotypes, respectively. We studied the influence of these alterations on primary metabolism, grain composition, starch structural features and starch granule morphology over caryopsis development at 10, 20 and 30 days after pollination (DAP) and at grain maturity. While HP showed relatively little effect, AO showed significant reduction in starch accumulation with re-direction to protein and beta-glucan (BG) accumulation. Metabolite profiling indicated significantly higher sugar accumulation in AO, with re-partitioning of carbon to accumulate amino acids, and interestingly it also had high levels of some important stress-related metabolites and potentially protective metabolites, possibly to elude deleterious effects. Investigations on starch molecular structure revealed significant increase in starch phosphate and amylose content in HP and AO respectively with obvious differences in starch granule morphology at maturity. The results demonstrate that decreasing the storage starch branching resulted in metabolic adjustments and re-directions, tuning to evade deleterious effects on caryopsis physiology and plant performance while only little effect was evident by increasing starch-bound phosphate as a result of over-expressing GWD.	[Shaik, Shahnoor S.; Blennow, Andreas] Univ Copenhagen, Dept Plant & Environm Sci, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark; [Obata, Toshihiro; Schwahn, Kevin; Fernie, Alisdair R.] Max Planck Inst Mol Pflanzenphysiol, Muhlenberg 1, D-14476 Potsdam, Germany; [Hebelstrup, Kim H.] Aarhus Univ, Dept Mol Biol & Genet, Forsogsvej 1, DK-4200 Slagelse, Denmark; [Mateiu, Ramona V.] Tech Univ Denmark, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark	University of Copenhagen; Max Planck Society; Aarhus University; Technical University of Denmark	Blennow, A (corresponding author), Univ Copenhagen, Dept Plant & Environm Sci, Thorvaldsensvej 40, DK-1871 Frederiksberg C, Denmark.	abl@plen.ku.dk	Mateiu, Ramona/K-9106-2015; Obata, Toshihiro/AAX-4353-2020	Mateiu, Ramona/0000-0003-2968-5704; Obata, Toshihiro/0000-0001-8931-7722	Danish Council for Independent Research Technology and Production Sciences [274-08-0220]; Graduate School of Agriculture, Food and Environment (SAFE), Aarhus University	Danish Council for Independent Research Technology and Production Sciences(Det Frie Forskningsrad (DFF)); Graduate School of Agriculture, Food and Environment (SAFE), Aarhus University	This work was supported by The Danish Council for Independent Research Technology and Production Sciences (Andreas Blennow) 274-08-0220, and Graduate School of Agriculture, Food and Environment (SAFE), Aarhus University (Kim Hebelstrup).; We thank Massimiliano Carciofi for his help with plant growth and Lene Hornum Rasmussen, KMC, Denmark, for her technical assistance with starch granule distribution analysis. This work was funded by The Danish Council for Independent Research Technology and Production Sciences and by Graduate School of Agriculture, Food and Environment (SAFE), Aarhus University. We acknowledge Center for Advanced Bioimaging (CAB), Faculty of Science, University of Copenhagen for microscopy facilities.	Alexander RD, 2006, PROTEOMICS, V6, P1886, DOI 10.1002/pmic.200500548; Baud S, 2002, PLANT PHYSIOL BIOCH, V40, P151, DOI 10.1016/S0981-9428(01)01350-X; Baunsgaard L, 2005, PLANT J, V41, P595, DOI 10.1111/j.1365-313X.2004.02322.x; Blauth SL, 2002, PLANT MOL BIOL, V48, P287, DOI 10.1023/A:1013335217744; Blauth SL, 2001, PLANT PHYSIOL, V125, P1396, DOI 10.1104/pp.125.3.1396; Blennow A, 1998, J CHROMATOGR A, V829, P385, DOI 10.1016/S0021-9673(98)00855-3; Blennow A, 1998, CARBOHYD RES, V307, P45, DOI 10.1016/S0008-6215(98)00015-9; Blennow A, 2003, J STRUCT BIOL, V143, P229, DOI 10.1016/j.jsb.2003.08.009; Blennow A, 2000, CARBOHYD POLYM, V41, P163, DOI 10.1016/S0144-8617(99)00082-X; Blennow A, 2013, CEREAL CHEM, V90, P274, DOI 10.1094/CCHEM-01-13-0010-FI; Blennow A, 2010, TRENDS PLANT SCI, V15, P236, DOI 10.1016/j.tplants.2010.01.009; BOYER CD, 1981, PLANT PHYSIOL, V67, P1141, DOI 10.1104/pp.67.6.1141; Brancourt-Hulmel M, 2003, CROP SCI, V43, P37, DOI 10.2135/cropsci2003.0037; Carciofi M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-223; Carciofi M, 2011, J CEREAL SCI, V54, P339, DOI 10.1016/j.jcs.2011.06.013; Casey R, 1998, J PLANT PHYSIOL, V152, P636, DOI 10.1016/S0176-1617(98)80023-0; DELZER BW, 1995, CROP SCI, V35, P730, DOI 10.2135/cropsci1995.0011183X003500030014x; Edner C, 2007, PLANT PHYSIOL, V145, P17, DOI 10.1104/pp.107.104224; ElSayed AI, 2014, PLANT BIOLOGY, V16, P1, DOI 10.1111/plb.12053; ENGLYST H, 1982, ANALYST, V107, P307, DOI 10.1039/an9820700307; Faix B, 2012, PLANT J, V69, P1077, DOI 10.1111/j.1365-313X.2011.04857.x; FANNON JE, 1993, CEREAL CHEM, V70, P611; FANNON JE, 1992, CEREAL CHEM, V69, P284; Fernie AR, 2011, PLANT CELL, V23, P2477, DOI 10.1105/tpc.111.086272; Fincher G., 2011, BARLEY PRODUCTION IM, P449; Furtado A, 2009, PLANT BIOTECHNOL J, V7, P240, DOI 10.1111/j.1467-7652.2008.00394.x; GARWOOD DL, 1976, CEREAL CHEM, V53, P355; Geigenberger P, 2011, PLANT PHYSIOL, V155, P1566, DOI 10.1104/pp.110.170399; Gibon Y, 2002, PLANT J, V30, P221, DOI 10.1046/j.1365-313X.2001.01278.x; Gubatz S., 2011, BARLEY PRODUCTION IM, P391; Han XZ, 2005, CEREAL CHEM, V82, P351, DOI 10.1094/CC-82-0351; Hejazi M, 2009, PLANT PHYSIOL, V150, P962, DOI 10.1104/pp.109.138750; Heyer AG, 1999, CURR OPIN BIOTECH, V10, P169, DOI 10.1016/S0958-1669(99)80030-5; Hofvander P, 2004, PLANT BIOTECHNOL J, V2, P311, DOI 10.1111/j.1467-7652.2004.00073.x; Izumo A, 2011, PLANT SCI, V180, P238, DOI 10.1016/j.plantsci.2010.08.014; Jobling S, 2004, CURR OPIN PLANT BIOL, V7, P210, DOI 10.1016/j.pbi.2003.12.001; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; Kotting O, 2005, PLANT PHYSIOL, V137, P242, DOI 10.1104/pp.104.055954; LI XM, 1993, ANN BOT-LONDON, V71, P303, DOI 10.1006/anbo.1993.1039; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Liu FS, 2009, J EXP BOT, V60, P4423, DOI 10.1093/jxb/erp297; Luedemann Alexander, 2012, Methods Mol Biol, V860, P255, DOI 10.1007/978-1-61779-594-7_16; Mangelsen E, 2010, PLANT PHYSIOL, V153, P14, DOI 10.1104/pp.110.154856; Munck L, 2004, J CEREAL SCI, V40, P213, DOI 10.1016/j.jcs.2004.07.006; Obata T, 2012, CELL MOL LIFE SCI, V69, P3225, DOI 10.1007/s00018-012-1091-5; Patrick JW, 2001, J EXP BOT, V52, P551, DOI 10.1093/jexbot/52.356.551; Patron NJ, 2004, PLANT PHYSIOL, V135, P2088, DOI 10.1104/pp.104.045203; Perez M. D., 1993, Seed Science Research, V3, P187, DOI 10.1017/S096025850000177X; Radchuk VV, 2009, PLANT PHYSIOL, V150, P190, DOI 10.1104/pp.108.133520; Ral JP, 2012, PLANT BIOTECHNOL J, V10, P871, DOI 10.1111/j.1467-7652.2012.00711.x; Regina A, 2006, P NATL ACAD SCI USA, V103, P3546, DOI 10.1073/pnas.0510737103; Ritte G, 2006, FEBS LETT, V580, P4872, DOI 10.1016/j.febslet.2006.07.085; Rolletschek H, 2002, PLANTA, V214, P954, DOI 10.1007/s00425-001-0710-4; SARAVITZ DM, 1987, PLANT PHYSIOL, V83, P185, DOI 10.1104/pp.83.1.185; Schwall GP, 2000, NAT BIOTECHNOL, V18, P551, DOI 10.1038/75427; Schwender J, 2008, CURR OPIN BIOTECH, V19, P131, DOI 10.1016/j.copbio.2008.02.006; Shaik SS, 2014, J EXP BOT, V65, P2257, DOI 10.1093/jxb/eru107; Skeffington AW, 2014, PLANT PHYSIOL, V165, P866, DOI 10.1104/pp.114.237016; SMITH AM, 1988, PLANTA, V175, P270, DOI 10.1007/BF00392437; Sreenivasulu N, 2004, PLANT J, V37, P539, DOI 10.1046/j.1365-313X.2003.01981.x; Sreenivasulu N, 2008, PLANT PHYSIOL, V146, P1738, DOI 10.1104/pp.107.111781; Sreenivasulu N, 2006, PLANT J, V47, P310, DOI 10.1111/j.1365-313X.2006.02789.x; STEWART DW, 1990, CAN J PLANT SCI, V70, P33, DOI 10.4141/cjps90-004; TAKEDA Y, 1987, CARBOHYD RES, V165, P139, DOI 10.1016/0008-6215(87)80089-7; Tetlow IJ, 2011, SEED SCI RES, V21, P5, DOI 10.1017/S0960258510000292; Tetlow IJ, 2004, J EXP BOT, V55, P2131, DOI 10.1093/jxb/erh248; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Wang T. L., 1991, Seed Science Research, V1, P3, DOI 10.1017/S096025850000057X; Weigelt K, 2009, PLANT PHYSIOL, V149, P395, DOI 10.1104/pp.108.129940; Weschke W, 2000, PLANT J, V21, P455, DOI 10.1046/j.1365-313x.2000.00695.x; Wickramasinghe HAM, 2009, CARBOHYD POLYM, V77, P118, DOI 10.1016/j.carbpol.2008.12.013; WISE RR, 1995, PHOTOSYNTH RES, V45, P79, DOI 10.1007/BF00032579; Yu TS, 2001, PLANT CELL, V13, P1907, DOI 10.1105/tpc.13.8.1907; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301	74	22	24	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149613	10.1371/journal.pone.0149613	http://dx.doi.org/10.1371/journal.pone.0149613			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891365	Green Published, gold, Green Submitted			2022-12-27	WOS:000371221500063
J	Smallwood, M; Vijh, R; Nauche, B; Lebouche, B; Joseph, L; Pai, NP				Smallwood, Megan; Vijh, Rohit; Nauche, Benedicte; Lebouche, Bertrand; Joseph, Lawrence; Pai, Nitika Pant			Evaluation of a Rapid Point of Care Test for Detecting Acute and Established HIV Infection, and Examining the Role of Study Quality on Diagnostic Accuracy: A Bayesian Meta-Analysis	PLOS ONE			English	Article							TRANSMISSION; PERFORMANCE; ACCEPTABILITY; ANTIGEN; RATES; STAGE	Introduction Fourth generation (Ag/Ab combination) point of care HIV tests like the FDA-approved Determine HIV1/2 Ag/Ab Combo test offer the promise of timely detection of acute HIV infection, relevant in the context of HIV control. However, a synthesis of their performance has not yet been done. In this meta-analysis we not only assessed device performance but also evaluated the role of study quality on diagnostic accuracy. Methods Two independent reviewers searched seven databases, including conferences and bibliographies, and independently extracted data from 17 studies. Study quality was assessed with QUADAS-2. Data on sensitivity and specificity (overall, antigen, and antibody) were pooled using a Bayesian hierarchical random effects meta-analysis model. Subgroups were analyzed by blood samples (serum/plasma vs. whole blood) and study designs (case-control vs. cross-sectional). Results The overall specificity of the Determine Combo test was 99.1%, 95% credible interval (CrI) [97.3-99.8]. The overall pooled sensitivity for the device was at 88.5%, 95% [80.1-93.4]. When the components of the test were analyzed separately, the pooled specificities were 99.7%, 95% CrI [96.8-100] and 99.6%, 95% CrI [99.0-99.8], for the antigen and antibody components, respectively. Pooled sensitivity of the antibody component was 97.3%, 95% CrI [60.7-99.9], and pooled sensitivity for the antigen component was found to be 12.3%, 95% (CrI) [1.1-44.2]. No significant differences were found between subgroups by blood sample or study design. However, it was noted that many studies restricted their study sample to p24 antigen or RNA positive specimens, which may have led to underestimation of overall test performance. Detection bias, selection (spectrum) bias, incorporation bias, and verification bias impaired study quality. Conclusions Although the specificity of all test components was high, antigenic sensitivity will merit from an improvement. Besides the accuracy of the device itself, study quality, also impacts the performance of the test. These factors must be kept in mind in future evaluations of an improved device, relevant for global scale up and implementation.	[Smallwood, Megan; Joseph, Lawrence] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Vijh, Rohit; Joseph, Lawrence; Pai, Nitika Pant] McGill Univ, Ctr Hlth, Dept Med, Div Clin Epidemiol, Montreal, PQ, Canada; [Nauche, Benedicte] McGill Univ, Ctr Hlth, Royal Victoria Hosp, Med Lib, Montreal, PQ, Canada; [Lebouche, Bertrand] McGill Univ, Ctr Hlth, Chron Viral Illness Serv, Res Inst, Montreal, PQ, Canada; [Lebouche, Bertrand] McGill Univ, Dept Family Med, Montreal, PQ H3A 2T5, Canada; [Pai, Nitika Pant] McGill Univ, Dept Med, Montreal, PQ, Canada	McGill University; McGill University; McGill University; Royal Victoria Hospital; McGill University; McGill University; McGill University	Pai, NP (corresponding author), McGill Univ, Ctr Hlth, Dept Med, Div Clin Epidemiol, Montreal, PQ, Canada.; Pai, NP (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.	nitika.pai@mcgill.ca	LEBOUCHE, Bertrand/GZL-8127-2022; LEBOUCHE, Bertrand/AAC-6047-2022	LEBOUCHE, Bertrand/0000-0002-1273-9393; Vijh, Rohit/0000-0002-9493-9283; Smallwood, Megan/0000-0002-7731-488X	Gates Foundation; Canadian Institute for Health Research [HIB 131558]	Gates Foundation(Bill & Melinda Gates Foundation); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	Funding was provided by the Gates Foundation and the Canadian Institute for Health Research, operating grant no. HIB 131558.	Alere International Limited, 2014, AL DET HIV 1 2 AG AB; Alere International Limited, 2012, THE ALERE DETERMINE; [Anonymous], 2014, MIDWIFERY, V30; Appiah LT, 2009, AIDS PATIENT CARE ST, V23, P365, DOI 10.1089/apc.2008.0224; Beelaert G, 2010, J VIROL METHODS, V168, P218, DOI 10.1016/j.jviromet.2010.06.002; Bell SK, 2010, J INFECT DIS, V202, pS278, DOI 10.1086/655655; Bhowan K, 2012, AFR J LAB MED, V1, DOI 10.4102/ajlm.v1i1.4; Branson B., 2003, LAB MED, V27, P288; Branson Bernard M, 2010, J Acquir Immune Defic Syndr, V55 Suppl 2, pS102, DOI 10.1097/QAI.0b013e3181fbca44; Branson BM, 2012, J INFECT DIS, V205, P521, DOI 10.1093/infdis/jir793; Branson BM., 2014, LAB TESTING DIAGNOSI; Brauer M, 2013, J VIROL METHODS, V189, P180, DOI 10.1016/j.jviromet.2013.01.017; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Burns F, 2013, HIV MED, V14, P10, DOI 10.1111/hiv.12056; Chetty V, 2012, J CLIN VIROL, V54, P180, DOI 10.1016/j.jcv.2012.02.021; Cohen MS, 2010, J INFECT DIS, V202, pS270, DOI 10.1086/655651; Conway DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094062; Delaney KP, 2011, CLIN INFECT DIS, V52, P257, DOI 10.1093/cid/ciq068; Dombrowski JC, 2013, SEX TRANSM DIS, V40, P41, DOI 10.1097/OLQ.0b013e3182753327; Duong YT, 2014, J CLIN MICROBIOL, V52, P3743, DOI 10.1128/JCM.01989-14; Epstein JS., 2013, AUGUST 9 2013 APPROV; Faraoni S, 2013, J CLIN VIROL, V57, P84, DOI 10.1016/j.jcv.2013.01.007; Fox J, 2011, SEX TRANSM INFECT, V87, P178, DOI 10.1136/sti.2010.042564; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Jones CB, 2012, J INFECT DIS, V206, P1947, DOI 10.1093/infdis/jis617; Kilembe W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037154; Laperche S, 2012, J INFECT DIS, V206, P1946, DOI 10.1093/infdis/jis616; Lewis NM, 2013, SEX HEALTH, V10, P124, DOI 10.1071/SH12100; Macaskill P, 2010, COCHRANE HDB SYSTEMA; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Masciotra S, 2013, J CLIN VIROL, V58, pE54, DOI 10.1016/j.jcv.2013.07.002; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; O'Brien M, 2012, CURR HIV-AIDS REP, V9, P101, DOI 10.1007/s11904-012-0113-0; Patel P, 2012, J CLIN VIROL, V54, P42, DOI 10.1016/j.jcv.2012.01.022; Pavie J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011581; Pilcher CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080629; Piwowar-Manning Estelle M, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P170, DOI 10.1177/1545109710368151; Prabhu VS, 2009, AIDS, V23, P1792, DOI 10.1097/QAD.0b013e32832e7d04; Rosenberg NE, 2012, J INFECT DIS, V205, P528, DOI 10.1093/infdis/jir789; Stekler JD, 2013, J CLIN VIROL, V58, pE119, DOI 10.1016/j.jcv.2013.09.018; Stekler JD, 2009, CLIN INFECT DIS, V49, P444, DOI 10.1086/600043; UNAIDS, 2015, AIDS NUMB 2015; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; WHO, 2014, GLOB SUMM AIDS EP 20; Willis BH, 2008, FAM PRACT, V25, P390, DOI 10.1093/fampra/cmn051; Wood E, 2014, JAMA-J AM MED ASSOC, V312, P278, DOI 10.1001/jama.2014.5954; Yang M, 2014, SYMPHONY J XIAN CONS, P1; Yerly S, 2012, EXPERT REV ANTI-INFE, V10, P31, DOI [10.1586/eri.11.154, 10.1586/ERI.11.154]	49	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149592	10.1371/journal.pone.0149592	http://dx.doi.org/10.1371/journal.pone.0149592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891218	Green Published, Green Submitted, gold			2022-12-27	WOS:000371221500062
J	Wang, T; Chen, XY; Long, XH; Liu, ZP; Yan, SH				Wang, Tao; Chen, Xiaoyan; Long, Xiaohua; Liu, Zhaopu; Yan, Shaohua			Copper Nanoparticles and Copper Sulphate Induced Cytotoxicity in Hepatocyte Primary Cultures of Epinephelus coioides	PLOS ONE			English	Article							ORANGE-SPOTTED GROUPER; OXIDATIVE STRESS; INDUCED APOPTOSIS; IMMUNE-RESPONSES; RAINBOW-TROUT; ANTIOXIDANT DEFENSE; CUO NANOPARTICLES; DOWN-REGULATION; DNA-DAMAGE; IN-VITRO	Copper nanoparticles (Cu-NPs) were widely used in various industrial and commercial applications. The aim of this study was to analyze the cytotoxicity of Cu-NPs on primary hepatocytes of E. coioides compared with copper sulphate (CuSO4). Cultured cells were exposed to 0 or 2.4 mg Cu L-1 as CuSO4 or Cu-NPs for 24-h. Results showed either form of Cu caused a dramatic loss in cell viability, more so in the CuSO4 than Cu-NPs treatment. Compared to control, either CuSO4 or Cu-NPs significantly increased reactive oxygen species (ROS) and malondialdehyde(MDA) concentration in hepatocytes by overwhelming total superoxide dismutase (T-SOD) activity, catalase(CAT) activity and glutathione(GSH) concentration. In addition, the antioxidative-related genes [SOD (Cu/Zn), SOD (Mn), CAT, GPx(4)] were also down-regulated. The apoptosis and necrosis percentage was significantly higher after the CuSO4 or Cu-NPs treatment than the control. The apoptosis was induced by the increased cytochrome c concentration in the cytosol and elevated caspase-3, caspase-8 and caspase-9 activities. Additionally, the apoptosis-related genes (p53, p38 beta and TNF-alpha) and protein (p53 protein) were up-regulated after the CuSO4 or Cu-NPs treatment, with CuSO4 exposure having a greater effect than Cu-NPs. In conclusion, Cu-NPs had similar types of toxic effects as CuSO4 on primary hepatocytes of E. coioides, but toxicity of CuSO4 was more severe than that of Cu-NPs.	[Wang, Tao; Chen, Xiaoyan; Long, Xiaohua; Liu, Zhaopu; Yan, Shaohua] Nanjing Agr Univ, Jiangsu Prov Key Lab Marine Biol, Coll Resources & Environm Sci, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Long, XH (corresponding author), Nanjing Agr Univ, Jiangsu Prov Key Lab Marine Biol, Coll Resources & Environm Sci, Nanjing 210095, Jiangsu, Peoples R China.	longxiaohua@njau.edu.cn	chen, xi/GXH-3653-2022; chen, xia/GYR-3948-2022; chen, xia/GXM-5435-2022		National Key Projects of Scientific and Technical Support Programs - Ministry of Science and Technology of China [2011BAD13B09]	National Key Projects of Scientific and Technical Support Programs - Ministry of Science and Technology of China	The authors are grateful for the financial support of the National Key Projects of Scientific and Technical Support Programs funded by the Ministry of Science and Technology of China (No. 2011BAD13B09).	Ahamed M, 2010, BIOCHEM BIOPH RES CO, V396, P578, DOI 10.1016/j.bbrc.2010.04.156; Al-Bairuty GA, 2013, AQUAT TOXICOL, V126, P104, DOI 10.1016/j.aquatox.2012.10.005; Aruoja V, 2009, SCI TOTAL ENVIRON, V407, P1461, DOI 10.1016/j.scitotenv.2008.10.053; Barillet S, 2010, TOXICOL LETT, V198, P324, DOI 10.1016/j.toxlet.2010.07.009; Bondarenko O, 2013, ARCH TOXICOL, V87, P1181, DOI 10.1007/s00204-013-1079-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai J, 2011, FISH SHELLFISH IMMUN, V31, P1129, DOI 10.1016/j.fsi.2011.10.004; Chang CC, 2006, FISH SHELLFISH IMMUN, V20, P574, DOI 10.1016/j.fsi.2005.06.012; Choi YJ, 2004, FASEB J, V18, pA906; Cruz-Lacierda ER, 2001, AQUACULTURE, V201, P211, DOI 10.1016/S0044-8486(01)00668-8; Cui YT, 2014, FISH SHELLFISH IMMUN, V38, P74, DOI 10.1016/j.fsi.2014.02.018; DaMata JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141196; Dan XM, 2013, FISH SHELLFISH IMMUN, V34, P885, DOI 10.1016/j.fsi.2012.12.011; Gomes T, 2011, ENVIRON SCI TECHNOL, V45, P9356, DOI 10.1021/es200955s; Guicciardi ME, 2005, GUT, V54, P1024, DOI 10.1136/gut.2004.053850; Handy RD, 2011, J FISH BIOL, V79, P821, DOI 10.1111/j.1095-8649.2011.03080.x; Ivanov VN, 2000, ONCOGENE, V19, P3003, DOI 10.1038/sj.onc.1203602; Jia R, 2014, AQUAT TOXICOL, V152, P11, DOI 10.1016/j.aquatox.2014.02.014; Ju-Nam Y, 2008, SCI TOTAL ENVIRON, V400, P396, DOI 10.1016/j.scitotenv.2008.06.042; Kong XH, 2013, CHEMOSPHERE, V92, P1458, DOI 10.1016/j.chemosphere.2013.04.004; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Larsen BD, 2010, P NATL ACAD SCI USA, V107, P4230, DOI 10.1073/pnas.0913089107; Li J, 1998, AQUAT TOXICOL, V43, P1, DOI 10.1016/S0166-445X(98)00047-2; Lin YH, 2008, AQUACULTURE, V274, P161, DOI 10.1016/j.aquaculture.2007.11.006; Liu XJ, 2010, ECOTOX ENVIRON SAFE, V73, P1286, DOI 10.1016/j.ecoenv.2010.06.019; McConkey DJ, 1998, TOXICOL LETT, V99, P157, DOI 10.1016/S0378-4274(98)00155-6; Niska K, 2015, TOXICOL IN VITRO, V29, P663, DOI 10.1016/j.tiv.2015.02.004; Nowack B, 2012, ENVIRON TOXICOL CHEM, V31, P50, DOI 10.1002/etc.726; Pan CY, 2012, FISH SHELLFISH IMMUN, V32, P947, DOI 10.1016/j.fsi.2012.01.023; Paz-Elizur T, 2008, CANCER LETT, V266, P60, DOI 10.1016/j.canlet.2008.02.032; Qi ZH, 2013, FISH SHELLFISH IMMUN, V35, P1466, DOI 10.1016/j.fsi.2013.08.011; Rocchetta I, 2006, ENVIRON POLLUT, V141, P353, DOI 10.1016/j.envpol.2005.08.035; Saquib Q, 2012, TOXICOL IN VITRO, V26, P351, DOI 10.1016/j.tiv.2011.12.011; Selvaraj V, 2013, CHEMOSPHERE, V90, P1201, DOI 10.1016/j.chemosphere.2012.09.039; Shaw BJ, 2012, AQUAT TOXICOL, V116, P90, DOI 10.1016/j.aquatox.2012.02.032; Shaw BJ, 2011, ENVIRON INT, V37, P1083, DOI 10.1016/j.envint.2011.03.009; Singh S, 2007, TOXICOL APPL PHARM, V222, P141, DOI 10.1016/j.taap.2007.05.001; Sovova T, 2014, AQUAT TOXICOL, V152, P195, DOI 10.1016/j.aquatox.2014.04.003; Suska F, 2003, BIOMATERIALS, V24, P461, DOI 10.1016/S0142-9612(02)00359-9; TELFORD WG, 1991, CELL PROLIFERAT, V24, P447, DOI 10.1111/j.1365-2184.1991.tb01173.x; Thit A, 2015, TOXICOL IN VITRO, V29, P1053, DOI 10.1016/j.tiv.2015.03.020; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vera LM, 2009, AQUACULTURE, V296, P150, DOI 10.1016/j.aquaculture.2009.08.010; von Moos N, 2015, AQUAT TOXICOL, V161, P267, DOI 10.1016/j.aquatox.2015.02.010; Wang T, 2015, FISH SHELLFISH IMMUN, V44, P674, DOI 10.1016/j.fsi.2015.03.030; Wang T, 2014, AQUAT TOXICOL, V152, P96, DOI 10.1016/j.aquatox.2014.03.023; Xu WN, 2009, CHEMOSPHERE, V77, P895, DOI 10.1016/j.chemosphere.2009.08.043; Zhang YM, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-13; Zhao J, 2011, J HAZARD MATER, V197, P304, DOI 10.1016/j.jhazmat.2011.09.094	49	30	30	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149484	10.1371/journal.pone.0149484	http://dx.doi.org/10.1371/journal.pone.0149484			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890000	Green Submitted, Green Published, gold			2022-12-27	WOS:000371221500051
J	Bartholomew, AJ; Lad, EM; Cao, DC; Bach, M; Cirulli, ET				Bartholomew, Alex J.; Lad, Eleonora M.; Cao, Dingcai; Bach, Michael; Cirulli, Elizabeth T.			Individual Differences in Scotopic Visual Acuity and Contrast Sensitivity: Genetic and Non-Genetic Influences	PLOS ONE			English	Article							STATIONARY NIGHT BLINDNESS; LOSS-OF-FUNCTION; IRIS COLOR; VISION; MUTATIONS; PERFORMANCE; ASSOCIATION; ABERRATIONS; QUALITY; RODS	Despite the large amount of variation found in the night (scotopic) vision capabilities of healthy volunteers, little effort has been made to characterize this variation and factors, genetic and non-genetic, that influence it. In the largest population of healthy observers measured for scotopic visual acuity (VA) and contrast sensitivity (CS) to date, we quantified the effect of a range of variables on visual performance. We found that young volunteers with excellent photopic vision exhibit great variation in their scotopic VA and CS, and this variation is reliable from one testing session to the next. We additionally identified that factors such as Circadian preference, iris color, astigmatism, depression, sex and education have no significant impact on scotopic visual function. We confirmed previous work showing that the amount of time spent on the vision test influences performance and that laser eye surgery results in worse scotopic vision. We also showed a significant effect of intelligence and photopic visual performance on scotopic VA and CS, but all of these variables collectively explain <30% of the variation in scotopic vision. The wide variation seen in young healthy volunteers with excellent photopic vision, the high test-retest agreement, and the vast majority of the variation in scotopic vision remaining unexplained by obvious non-genetic factors suggests a strong genetic component. Our preliminary genome-wide association study (GWAS) of 106 participants ruled out any common genetic variants of very large effect and paves the way for future, larger genetic studies of scotopic vision.	[Bartholomew, Alex J.; Cirulli, Elizabeth T.] Duke Univ, Sch Med, Ctr Appl Genom & Precis Med, Durham, NC 27708 USA; [Lad, Eleonora M.] Duke Univ, Dept Ophthalmol, Durham, NC 27710 USA; [Cao, Dingcai] Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60612 USA; [Bach, Michael] Univ Freiburg, Sect Visual Funct, Ctr Eye, Hugstetter Str 55, D-79106 Freiburg, Germany	Duke University; Duke University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Freiburg	Cirulli, ET (corresponding author), Duke Univ, Sch Med, Ctr Appl Genom & Precis Med, Durham, NC 27708 USA.	etc3@duke.edu	Bach, Michael/A-6637-2010	Bach, Michael/0000-0003-2028-535X; Cirulli Rogers, Liz/0000-0001-7808-2809	National Institute of Mental Health of the National Institutes of Health [K01MH098126]; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH098126] Funding Source: NIH RePORTER	National Institute of Mental Health of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research reported in this publication was supported by the National Institute of Mental Health of the National Institutes of Health under award number K01MH098126. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach M, 1996, OPTOMETRY VISION SCI, V73, P49, DOI 10.1097/00006324-199601000-00008; Bach M, 2007, GRAEF ARCH CLIN EXP, V245, P965, DOI 10.1007/s00417-006-0474-4; Barbur J, 2010, PHOTOPIC MESOPIC SCO; Bartholomew AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091773; BASSI CJ, 1986, PHYSIOL BEHAV, V38, P871, DOI 10.1016/0031-9384(86)90056-9; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bradley JC, 2010, J OCUL PHARMACOL TH, V26, P335, DOI 10.1089/jop.2010.0061; Christian P, 1998, AM J CLIN NUTR, V68, p435S, DOI 10.1093/ajcn/68.2.435S; Cirulli E. T., 2015, SCIENCE; Cirulli ET, 2011, CLIN NEUROPSYCHOL, V25, P778, DOI 10.1080/13854046.2011.578587; Cirulli ET, 2010, EUR J HUM GENET, V18, P815, DOI 10.1038/ejhg.2010.2; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; CURCIO CA, 1993, INVEST OPHTH VIS SCI, V34, P3278; Dirani M, 2006, TWIN RES HUM GENET, V9, P566, DOI 10.1375/twin.9.4.566; Feng S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-12; FERRIS FL, 1982, AM J OPHTHALMOL, V94, P91, DOI 10.1016/0002-9394(82)90197-0; Flanagan SE, 2010, GENET TEST MOL BIOMA, V14, P533, DOI 10.1089/gtmb.2010.0036; Hammond BR, 2000, OPHTHAL PHYSL OPT, V20, P381, DOI 10.1016/S0275-5408(99)00098-8; Hecht S, 1939, J GEN PHYSIOL, V22, P593, DOI 10.1085/jgp.22.5.593; Heinrich SP, 2010, GRAEF ARCH CLIN EXP, V248, P389, DOI 10.1007/s00417-009-1268-2; Hertenstein H, 2015, GRAEFES ARCH CLIN EX, P1; Hohberger B, 2007, GRAEF ARCH CLIN EXP, V245, P1805, DOI 10.1007/s00417-007-0662-x; Jackson GR, 2000, VISION RES, V40, P2467, DOI 10.1016/S0042-6989(00)00108-5; Jagle H, 2006, GRAEF ARCH CLIN EXP, V244, P447, DOI 10.1007/s00417-005-0086-4; Kabanarou SA, 2004, BRIT J OPHTHALMOL, V88, P1018, DOI 10.1136/bjo.2003.033555; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kasper T, 2006, J CATARACT REFR SURG, V32, P2022, DOI 10.1016/j.jcrs.2006.07.029; Kniestedt Christoph, 2003, Ophthalmol Clin North Am, V16, P155, DOI 10.1016/S0896-1549(03)00013-0; Koh S, 2002, AM J OPHTHALMOL, V134, P115, DOI 10.1016/S0002-9394(02)01430-7; Kohnen T, 2005, ESSENT OPHTHALMOL, P303; Lee YC, 2003, J CATARACT REFR SURG, V29, P769, DOI 10.1016/S0886-3350(02)01844-8; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; Muth E R, 2000, Altern Med Rev, V5, P164; Ottoni GL, 2011, CHRONOBIOL INT, V28, P229, DOI 10.3109/07420528.2011.553696; Owsley C, 2010, VISION RES, V50, P2348, DOI 10.1016/j.visres.2010.05.021; Pierce EA, 1999, NAT GENET, V22, P248, DOI 10.1038/10305; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pulvermuller A, 1997, BIOCHEMISTRY-US, V36, P9253, DOI 10.1021/bi970772g; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Puts MJH, 2005, J NEUROSCI METH, V142, P77, DOI 10.1016/j.jneumeth.2004.07.013; Ribelayga C, 2008, NEURON, V59, P790, DOI 10.1016/j.neuron.2008.07.017; Roosing S, 2013, AM J HUM GENET, V93, P110, DOI 10.1016/j.ajhg.2013.05.005; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; Schefrin BE, 1999, VISION RES, V39, P3728, DOI 10.1016/S0042-6989(99)00072-3; Seiler T, 2000, ARCH OPHTHALMOL-CHIC, V118, P17, DOI 10.1001/archopht.118.1.17; Sherwin JC, 2012, T ROY SOC TROP MED H, V106, P205, DOI 10.1016/j.trstmh.2012.01.004; SMITH VC, 1975, VISION RES, V15, P161, DOI 10.1016/0042-6989(75)90203-5; StataCorp, 2013, STAT STAT SOFTW STAT; Sullivan LS, 1999, NAT GENET, V22, P255, DOI 10.1038/10314; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; TEIKARI JM, 1992, SCAND J SOC MED, V20, P73; Terman JS, 1999, BIOL PSYCHIAT, V46, P1642, DOI 10.1016/S0006-3223(99)00221-8; Verhulst S, 1998, VISION RES, V38, P3387, DOI 10.1016/S0042-6989(97)00339-8; Villa C, 2007, BRIT J OPHTHALMOL, V91, P1031, DOI 10.1136/bjo.2006.110874; WIKLER KC, 1990, J COMP NEUROL, V297, P499, DOI 10.1002/cne.902970404; Zele AJ, 2014, FRONT PSYCHOL, P5	60	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148192	10.1371/journal.pone.0148192	http://dx.doi.org/10.1371/journal.pone.0148192			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886100	Green Published, Green Submitted, gold			2022-12-27	WOS:000371218400018
J	Fotschki, B; Juskiewicz, J; Jurgonski, A; Kolodziejczyk, K; Milala, J; Kosmala, M; Zdunczyk, Z				Fotschki, Bartosz; Juskiewicz, Jerzy; Jurgonski, Adam; Kolodziejczyk, Krzysztof; Milala, Joanna; Kosmala, Monika; Zdunczyk, Zenon			Anthocyanins in Strawberry Polyphenolic Extract Enhance the Beneficial Effects of Diets with Fructooligosaccharides in the Rat Cecal Environment	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; ELLAGIC ACID; PHENOLIC-COMPOUNDS; HUMAN HEALTH; ELLAGITANNINS; PROANTHOCYANIDINS; BIOAVAILABILITY; METABOLITES; CONSUMPTION; COMPONENTS	The administration of fructooligosaccharides (FOS) beneficially modulates gastrointestinal functions and may enhance the metabolism of polyphenols. However, different polyphenolic components in the diet may have different influences on the activities of the digestive enzymes and microbiota in the gastrointestinal tract. Therefore, a 4-week study of fortyeight male Wistar rats was conducted to investigate the physiological response of the rat cecal environment to diets without and with FOS that contained two different strawberry polyphenolic extracts, specifically EP (polyphenolic profile 60, 35, 5, and 0% ellagitannins, proanthocyanidins, flavonols, anthocyanins, respectively) and EPA (polyphenolic profile: 50, 35, 6, and 9%, respectively). When combined with FOS, both extracts beneficially enhanced the acidification of the cecal digesta (P <= 0.05 vs the groups without extracts), but the dietary combination of EPA and FOS elicited the greatest reduction in putrefactive short-chain fatty acid production and the lowest fecal beta-glucuronidase activity in the cecum (P <= 0.05 vs group EP). Moreover, the addition of dietary FOS elevated the metabolism of the examined strawberry extracts in the cecum and thereby increased the concentrations of the metabolites in the cecal digesta and urine (P <= 0.05 vs the group with cellulose). Overall, both strawberry extracts modulated the effects of FOS in the gastrointestinal tract; however, the combination with EPA extract that contained anthocyanins exhibited greater beneficial effects in the lower gut environment than the EP extract.	[Fotschki, Bartosz; Juskiewicz, Jerzy; Jurgonski, Adam; Zdunczyk, Zenon] Polish Acad Sci, Inst Anim Reprod & Food Res, Div Food Sci, Olsztyn, Poland; [Kolodziejczyk, Krzysztof; Milala, Joanna; Kosmala, Monika] Lodz Univ Technol, Inst Food Technol & Anal, Lodz, Poland	Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences; Lodz University of Technology	Fotschki, B (corresponding author), Polish Acad Sci, Inst Anim Reprod & Food Res, Div Food Sci, Olsztyn, Poland.	b.fotschki@pan.olsztyn.pl	Kołodziejczyk, Krzysztof/M-2951-2018; Kosmala, Monika/AAB-3395-2019; FOTSCHKI, Bartosz/Q-4275-2019; Zduńczyk, Zenon/H-7272-2017; Milala, Joanna/AAZ-6460-2021; Fotschki, Bartosz/H-7172-2017; Jurgonski, Adam/A-5864-2009; Juśkiewicz, Jerzy/H-7193-2017	Kołodziejczyk, Krzysztof/0000-0003-3817-5140; Kosmala, Monika/0000-0002-9018-3028; Zduńczyk, Zenon/0000-0002-0640-7552; Milala, Joanna/0000-0002-4732-1907; Fotschki, Bartosz/0000-0002-9727-7481; Jurgonski, Adam/0000-0003-3524-3259; Juśkiewicz, Jerzy/0000-0003-0068-5970	National Science Centre of Poland [DEC-2012/05/B/NZ9/03402]	National Science Centre of Poland(National Science Centre, Poland)	This study was financially supported by the National Science Centre of Poland (Grant DEC-2012/05/B/NZ9/03402), https://www.ncn.gov.pl/?language=en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaby K, 2012, FOOD CHEM, V132, P86, DOI 10.1016/j.foodchem.2011.10.037; AOAC, 2005, OFFICIAL METHODS ANA; Asgar MA, 2013, INT J FOOD PROP, V16, P91, DOI 10.1080/10942912.2011.595864; Aviram M, 2004, CLIN NUTR, V23, P423, DOI 10.1016/j.clnu.2003.10.002; Beecher GR, 2004, PHARM BIOL, V42, P2, DOI 10.3109/13880200490893474; Blade C, 2010, MOL NUTR FOOD RES, V54, P37, DOI 10.1002/mnfr.200900476; DANIEL EM, 1991, J NAT PROD, V54, P946, DOI 10.1021/np50076a004; Duda-Chodak A, 2015, EUR J NUTR, V54, P325, DOI 10.1007/s00394-015-0852-y; Duncan SH, 2002, APPL ENVIRON MICROB, V68, P5186, DOI 10.1128/AEM.68.10.5186-5190.2002; Espin J. C., 2013, EVID-BASED COMPL ALT, V2013, P1; Fernandes I, 2014, J FUNCT FOODS, V7, P54, DOI 10.1016/j.jff.2013.05.010; Fotschki B, 2014, POL J FOOD NUTR SCI, V64, P193, DOI 10.2478/pjfns-2013-0001; Fotschki B, 2014, J AGR FOOD CHEM, V62, P5871, DOI 10.1021/jf405612a; Gimenez-Bastida JA, 2012, MOL NUTR FOOD RES, V56, P784, DOI 10.1002/mnfr.201100677; Jakobsdottir G, 2013, J NUTR METAB, V2013, DOI 10.1155/2013/202534; Jurgonski A, 2008, J ANIM FEED SCI, V17, P88, DOI 10.22358/jafs/66473/2008; Jurgonski A, 2013, NUTRITION, V29, P898, DOI 10.1016/j.nut.2012.11.006; Juskiewicz J, 2011, BRIT J NUTR, V105, P710, DOI 10.1017/S0007114510004344; Juskiewicz J, 2011, NUTRITION, V27, P351, DOI 10.1016/j.nut.2010.02.002; Kennedy JA, 2001, J AGR FOOD CHEM, V49, P1740, DOI 10.1021/jf001030o; Klewicka E, 2009, EUR FOOD RES TECHNOL, V229, P153, DOI 10.1007/s00217-009-1036-x; Kosmala M, 2015, J AGR FOOD CHEM, V63, P2989, DOI 10.1021/acs.jafc.5b00648; Kosmala M, 2014, EUR J NUTR, V53, P521, DOI 10.1007/s00394-013-0557-z; Landete JM, 2011, FOOD RES INT, V44, P1150, DOI 10.1016/j.foodres.2011.04.027; Larrosa M, 2006, J NUTR BIOCHEM, V17, P611, DOI 10.1016/j.jnutbio.2005.09.004; Lhoste EF, 2001, J SCI FOOD AGR, V81, P1397, DOI 10.1002/jsfa.957; McDougall GJ, 2005, J AGR FOOD CHEM, V53, P2760, DOI 10.1021/jf0489926; Nile SH, 2014, NUTRITION, V30, P134, DOI 10.1016/j.nut.2013.04.007; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reeves PG, 1997, J NUTR, V127, pS838; Roberfroid MB, 2005, BRIT J NUTR, V93, pS13, DOI 10.1079/BJN20041350; Seeram NP, 2004, CLIN CHIM ACTA, V348, P63, DOI 10.1016/j.cccn.2004.04.029; Sojka M, 2013, EUR FOOD RES TECHNOL, V237, P995, DOI 10.1007/s00217-013-2070-2; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; VISEK WJ, 1978, AM J CLIN NUTR, V31, pS216, DOI 10.1093/ajcn/31.10.S216; Zdunczyk Z, 2006, NUTRITION, V22, P898, DOI 10.1016/j.nut.2006.05.010	37	37	37	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149081	10.1371/journal.pone.0149081	http://dx.doi.org/10.1371/journal.pone.0149081			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882456	Green Submitted, gold, Green Published			2022-12-27	WOS:000371219000044
J	Hornschemeyer, P; Liss, V; Heermann, R; Jung, K; Hunke, S				Hoernschemeyer, Patrick; Liss, Viktoria; Heermann, Ralf; Jung, Kirsten; Hunke, Sabine			Interaction Analysis of a Two-Component System Using Nanodiscs	PLOS ONE			English	Article							ENVELOPE STRESS-RESPONSE; ESCHERICHIA-COLI; SIGNAL-TRANSDUCTION; HISTIDINE KINASE; MICROSCALE THERMOPHORESIS; PROTEIN; REGULATOR; PHOSPHORYLATION; SPECIFICITY; INTEGRATION	Two-component systems are the major means by which bacteria couple adaptation to environmental changes. All utilize a phosphorylation cascade from a histidine kinase to a response regulator, and some also employ an accessory protein. The system-wide signaling fidelity of two-component systems is based on preferential binding between the signaling proteins. However, information on the interaction kinetics between membrane embedded histidine kinase and its partner proteins is lacking. Here, we report the first analysis of the interactions between the full-length membrane-bound histidine kinase CpxA, which was reconstituted in nanodiscs, and its cognate response regulator CpxR and accessory protein CpxP. Using surface plasmon resonance spectroscopy in combination with interaction map analysis, the affinity of membrane-embedded CpxA for CpxR was quantified, and found to increase by tenfold in the presence of ATP, suggesting that a considerable portion of phosphorylated CpxR might be stably associated with CpxA in vivo. Using microscale thermophoresis, the affinity between CpxA in nanodiscs and CpxP was determined to be substantially lower than that between CpxA and CpxR. Taken together, the quantitative interaction data extend our understanding of the signal transduction mechanism used by two-component systems.	[Hoernschemeyer, Patrick; Liss, Viktoria; Hunke, Sabine] Univ Osnabruck, Fachbereich Biol Chem, Mikrobiol, Barbarastr 11, D-49076 Osnabruck, Germany; [Heermann, Ralf; Jung, Kirsten] Univ Munich, Dept Microbiol, Munich Ctr Integrated Prot Sci CiPSM, D-82152 Martinsried, Germany	University Osnabruck; University of Munich	Hunke, S (corresponding author), Univ Osnabruck, Fachbereich Biol Chem, Mikrobiol, Barbarastr 11, D-49076 Osnabruck, Germany.	sabine.hunke@uos.de	Heermann, Ralf/E-1793-2013; Heermann, Ralf/CAF-8609-2022	Heermann, Ralf/0000-0003-0631-6156; Liss, Viktoria/0000-0002-1304-2512	DFG [Hu1011/2-1, SFB944];  [Exc114/2]	DFG(German Research Foundation (DFG)); 	This work was supported by DFG grants Hu1011/2-1 and SFB944 to S.H. as well as Exc114/2 to K.J.; We thank K.-H. Altendorf and Daniel Kummel for continuous support, Michael Hensel, Jacob Piehler and Karl Andersson for fruitful discussions, and E. Limpinsel for technical support. SPR spectroscopy was performed in the Bioanalytics Core Facility at the Ludwig-Maximilians-Universitat Munchen Biocenter. This work was supported by DFG grants Hu1011/2-1 and SFB944 to S.H. as well as Exc114/2 to K.J.	Altschuh D, 2012, BIOCHEM BIOPH RES CO, V428, P74, DOI 10.1016/j.bbrc.2012.10.008; Barbieri CM, 2008, ANAL BIOCHEM, V376, P73, DOI 10.1016/j.ab.2008.02.004; Bauer J, 2013, MOL PLANT, V6, P959, DOI 10.1093/mp/sss126; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Bernal-Cabas M, 2015, J BACTERIOL, V197, P603, DOI 10.1128/JB.02449-14; Bhattacharya M, 2010, BIOCHIMIE, V92, P263, DOI 10.1016/j.biochi.2009.11.009; Buelow DR, 2010, MOL MICROBIOL, V75, P547, DOI 10.1111/j.1365-2958.2009.06982.x; Bury-Mone S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000651; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; Danese PN, 1998, J BACTERIOL, V180, P831, DOI 10.1128/JB.180.4.831-839.1998; DeGrip WJ, 1998, BIOCHEM J, V330, P667; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Dorel C, 2006, RES MICROBIOL, V157, P306, DOI 10.1016/j.resmic.2005.12.003; Fleischer R, 2007, J BIOL CHEM, V282, P8583, DOI 10.1074/jbc.M605785200; Gobin AS, 2006, INT J NANOMED, V1, P81, DOI 10.2147/nano.2006.1.1.81; Heermann R, 2010, FEMS MICROBIOL LETT, V304, P97, DOI 10.1111/j.1574-6968.2010.01906.x; Hung DL, 2001, EMBO J, V20, P1508, DOI 10.1093/emboj/20.7.1508; Hunke S, 2012, FEMS MICROBIOL LETT, V326, P12, DOI 10.1111/j.1574-6968.2011.02436.x; Isaac DD, 2005, P NATL ACAD SCI USA, V102, P17775, DOI 10.1073/pnas.0508936102; IUCHI S, 1993, J BIOL CHEM, V268, P23972; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Jung K, 2012, CURR OPIN MICROBIOL, V15, P118, DOI 10.1016/j.mib.2011.11.009; Kinoshita E, 2011, PROTEOMICS, V11, P319, DOI 10.1002/pmic.201000472; Krell T, 2010, ANNU REV MICROBIOL, V64, P539, DOI 10.1146/annurev.micro.112408.134054; Kwon E, 2012, PROTEIN SCI, V21, P1334, DOI 10.1002/pro.2120; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; MacRitchie DM, 2008, ADV EXP MED BIOL, V631, P80, DOI 10.1007/978-0-387-78885-2_6; Marman HE, 2014, INFECT IMMUN, V82, P3612, DOI 10.1128/IAI.01532-13; Martin J, 1997, P NATL ACAD SCI USA, V94, P1107, DOI 10.1073/pnas.94.4.1107; Mattison K, 2002, J BIOL CHEM, V277, P11143, DOI 10.1074/jbc.M111128200; MCCLEARY WR, 1994, J BIOL CHEM, V269, P31567; Mechaly AE, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001776; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Mullineaux CW, 2006, J BACTERIOL, V188, P3442, DOI 10.1128/JB.188.10.3442-3448.2006; Nakayama SI, 1998, J BACTERIOL, V180, P3522, DOI 10.1128/JB.180.14.3522-3528.1998; Podgornaia AI, 2013, CURR OPIN MICROBIOL, V16, P156, DOI 10.1016/j.mib.2013.01.004; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Raivio TL, 1999, J BACTERIOL, V181, P5263, DOI 10.1128/JB.181.17.5263-5272.1999; Raivio TL, 2014, BBA-MOL CELL RES, V1843, P1529, DOI 10.1016/j.bbamcr.2013.10.018; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Schrecke K, 2013, MOL MICROBIOL, V87, P769, DOI 10.1111/mmi.12130; Shi L, 2012, SCIENCE, V335, P1355, DOI 10.1126/science.1214984; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Sochacki KA, 2011, BIOPHYS J, V100, P22, DOI 10.1016/j.bpj.2010.11.044; Srivastava SK, 2014, J BACTERIOL, V196, P2876, DOI 10.1128/JB.01530-14; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; STOCK JB, 1977, J BIOL CHEM, V252, P7850; Szurmant H, 2010, CURR OPIN MICROBIOL, V13, P190, DOI 10.1016/j.mib.2010.01.007; Tschauner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107383; Vogt SL, 2014, J BACTERIOL, V196, P4229, DOI 10.1128/JB.02138-14; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Willett JW, 2013, MBIO, V4, DOI 10.1128/mBio.00420-13; Wolfe AJ, 2008, J BACTERIOL, V190, P2314, DOI 10.1128/JB.01906-07; Yoshida T, 2002, MOL MICROBIOL, V46, P1283, DOI 10.1046/j.1365-2958.2002.03240.x; Zhou XH, 2011, J BIOL CHEM, V286, P9805, DOI 10.1074/jbc.M110.194092	56	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149187	10.1371/journal.pone.0149187	http://dx.doi.org/10.1371/journal.pone.0149187			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882435	Green Published, gold, Green Submitted			2022-12-27	WOS:000371219000054
J	Bottcher, L; Araujo, NAM; Nagler, J; Mendes, JFF; Helbing, D; Herrmann, HJ				Boettcher, Lucas; Araujo, Nuno A. M.; Nagler, Jan; Mendes, Jose F. F.; Helbing, Dirk; Herrmann, Hans J.			Gender Gap in the ERASMUS Mobility Program	PLOS ONE			English	Article							STUDENT MOBILITY; NETWORK; DETERMINANTS	Studying abroad has become very popular among students. The ERASMUS mobility program is one of the largest international student exchange programs in the world, which has supported already more than three million participants since 1987. We analyzed the mobility pattern within this program in 2011-12 and found a gender gap across countries and subject areas. Namely, for almost all participating countries, female students are over-represented in the ERASMUS program when compared to the entire population of tertiary students. The same tendency is observed across different subject areas. We also found a gender asymmetry in the geographical distribution of hosting institutions, with a bias of male students in Scandinavian countries. However, a detailed analysis reveals that this latter asymmetry is rather driven by subject and consistent with the distribution of gender ratios among subject areas.	[Boettcher, Lucas; Nagler, Jan; Herrmann, Hans J.] ETH, Inst Bldg Mat, Computat Phys Engn Mat, Zurich, Switzerland; [Araujo, Nuno A. M.] Univ Lisbon, Dept Fis, Fac Ciencias, P-1699 Lisbon, Portugal; [Araujo, Nuno A. M.] Univ Lisbon, Ctr Fis Teor & Computac, P-1699 Lisbon, Portugal; [Mendes, Jose F. F.] Univ Aveiro, Dept Fis, P-3800 Aveiro, Portugal; [Mendes, Jose F. F.] Univ Aveiro, I3N, P-3800 Aveiro, Portugal; [Helbing, Dirk] ETH, Professorship Computat Social Sci, Zurich, Switzerland; [Herrmann, Hans J.] Univ Fed Ceara, Dept Fis, Fortaleza, Ceara, Brazil	Swiss Federal Institutes of Technology Domain; ETH Zurich; Universidade de Lisboa; Universidade de Lisboa; Universidade de Aveiro; Universidade de Aveiro; Swiss Federal Institutes of Technology Domain; ETH Zurich; Universidade Federal do Ceara	Bottcher, L (corresponding author), ETH, Inst Bldg Mat, Computat Phys Engn Mat, Zurich, Switzerland.	lucasb@ethz.ch	Araujo, Nuno A M/B-6313-2008; Araujo, Nuno/AAA-2996-2020; Mendes, Jose Fernando Ferreira/A-6996-2010	Araujo, Nuno A M/0000-0002-1677-6060; Mendes, Jose Fernando Ferreira/0000-0002-4707-5945; Bottcher, Lucas/0000-0003-1700-1897	ETH Risk Center; Brazilian Institute INCT-SC (Instituto Nacional de Ciencia e Tecnologia de Sistemas Complexos); ERC of the European Research Council [FP7-319968, FP7-3242247]; Portuguese Foundation for Science and Technology (FCT) [IF/00255/2013, UID/FIS/00618/2013]	ETH Risk Center; Brazilian Institute INCT-SC (Instituto Nacional de Ciencia e Tecnologia de Sistemas Complexos); ERC of the European Research Council(European Research Council (ERC)); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	The authors acknowledge financial support from the ETH Risk Center, the Brazilian Institute INCT-SC (Instituto Nacional de Ciencia e Tecnologia de Sistemas Complexos), ERC Advanced grants numbers FP7-319968 and FP7-3242247 of the European Research Council, and the Portuguese Foundation for Science and Technology (FCT) under contract no. IF/00255/2013 and UID/FIS/00618/2013.	[Anonymous], 2015, TERTIARY STUDENTS IS; BRACHT O., 2006, LEMMENS MEDIEN; Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200; Derzsi A, 2011, PHYSICA A, V390, P2601, DOI 10.1016/j.physa.2011.02.041; European Commission, 2014, ER FACTS FIG TRENDS; European Commission, 2014, ERASMUS IMP STUD; European Commission, 2013, STAT OV ERASMUS PROG; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Parey M, 2011, ECON J, V121, P194, DOI 10.1111/j.1468-0297.2010.02369.x; Gonzalez CR, 2011, HIGH EDUC, V62, P413, DOI 10.1007/s10734-010-9396-5; Souto-Otero M, 2013, EDUC RESEARCHER, V42, P70, DOI 10.3102/0013189X12466696; Theodossiou I, 2009, LABOUR ECON, V16, P566, DOI 10.1016/j.labeco.2009.01.006; Van Mol C, 2014, POPUL SPACE PLACE, V20, P465, DOI 10.1002/psp.1833; Verma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05638; Vincent-Lancrin S, 2008, THE REVERSAL OF GEND, V1	15	38	38	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149514	10.1371/journal.pone.0149514	http://dx.doi.org/10.1371/journal.pone.0149514			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901133	gold, Green Submitted, Green Published			2022-12-27	WOS:000371276100089
J	Bohacsova, M; Mediannikov, O; Kazimirova, M; Raoult, D; Sekeyova, Z				Bohacsova, Monika; Mediannikov, Oleg; Kazimirova, Maria; Raoult, Didier; Sekeyova, Zuzana			Arsenophonus nasoniae and Rickettsiae Infection of Ixodes ricinus Due to Parasitic Wasp Ixodiphagus hookeri	PLOS ONE			English	Article							SON-KILLER BACTERIUM; HUNTERELLUS-HOOKERI; ACARI IXODIDAE; AMBLYOMMA-VARIEGATUM; SCAPULARIS ACARI; HYMENOPTERA ENCYRTIDAE; DERMACENTOR-VARIABILIS; MICROBIAL COMMUNITIES; HOWARD HYMENOPTERA; TICKS ACARI	Arsenophonus nasoniae, a male-killing endosymbiont of chalcid wasps, was recently detected in several hard tick species. Following the hypothesis that its presence in ticks may not be linked to the direct occurrence of bacteria in tick's organs, we identified A. nasoniae in wasps emerging from parasitised nymphs. We confirmed that 28.1% of Ixodiphagus hookeri wasps parasitizing Ixodes ricinus ticks were infected by A. nasoniae. Moreover, in examined I. ricinus nymphs, A. nasoniae was detected only in those, which were parasitized by the wasp. However, in part of the adult wasps as well as in some ticks that contained wasp's DNA, we did not confirm A. nasoniae. We also found, that in spite of reported male-killing, some newly emerged adult wasp males were also infected by A. nasoniae. Additionally, we amplified the DNA of Rickettsia helvetica and Rickettsia monacensis (known to be Ixodes ricinus-associated bacteria) in adult parasitoid wasps. This may be related either with the digested bacterial DNA in wasp body lumen or with a role of wasps in circulation of rickettsiae among tick vectors.	[Bohacsova, Monika; Sekeyova, Zuzana] Slovak Acad Sci, Inst Virol, Biomed Res Ctr, Dept Rickettsiol, Bratislava, Slovakia; [Mediannikov, Oleg; Raoult, Didier] Aix Marseille Univ, Inst Hosp Univ IHU Mediterranee Infect, Unite Rech Malad Infect & Trop Emergentes URMITE, CNRS 7278,INSERM 1095, Marseille, France; [Kazimirova, Maria] Slovak Acad Sci, Inst Zool, Dept Med Zool, Bratislava, Slovakia	Slovak Academy of Sciences; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Slovak Academy of Sciences	Sekeyova, Z (corresponding author), Slovak Acad Sci, Inst Virol, Biomed Res Ctr, Dept Rickettsiol, Bratislava, Slovakia.	viruseke@savba.sk	Mediannikov, Oleg/H-4018-2015; Danchenko, Monika/J-3347-2017; RAOULT, Didier/A-8434-2008; Sekeyova, Zuzana/E-5956-2018; Kazimirova, Maria/U-8222-2017	Mediannikov, Oleg/0000-0001-6039-2008; Danchenko, Monika/0000-0002-8505-2365; RAOULT, Didier/0000-0002-0633-5974; Kazimirova, Maria/0000-0001-6904-8342; Sekeyova, Zuzana/0000-0002-2597-4405	Slovak Research and Development Agency [APVV-028012]; VEGA from the Scientific Grant Agency of Ministry of Education [2/0005/15]; Slovak Academy of Sciences; EU [FP7-261504 EDENext]; Fondation - IHU Mediterranee Infection	Slovak Research and Development Agency(Slovak Research and Development Agency); VEGA from the Scientific Grant Agency of Ministry of Education; Slovak Academy of Sciences(Slovak Academy of Sciences); EU(European Commission); Fondation - IHU Mediterranee Infection	This work was supported by APVV-028012 from Slovak Research and Development Agency, VEGA Nos. 2/0005/15 from the Scientific Grant Agency of Ministry of Education and Slovak Academy of Sciences, by EU grant FP7-261504 EDENext and "Fondation - IHU Mediterranee Infection."	Ahantarig A, 2013, FOLIA MICROBIOL, V58, P419, DOI 10.1007/s12223-013-0222-1; [Anonymous], 2005, BERGEYS MANUAL BERGE; Balas MT, 1996, EVOL ECOL, V10, P593, DOI 10.1007/BF01237709; Boucek Z, 1954, FOLIA ZOOLOGICA ENTO, V3, P109; Chaves Sandra, 2009, Biotechnology Journal, V4, P1753, DOI 10.1002/biot.200800237; Clay K, 2008, MOL ECOL, V17, P4371, DOI 10.1111/j.1365-294X.2008.03914.x; Collatz J, 2011, J APPL ENTOMOL, V135, P351, DOI 10.1111/j.1439-0418.2010.01560.x; Collatz J, 2010, ENTOMOL EXP APPL, V134, P131, DOI 10.1111/j.1570-7458.2009.00943.x; Darby AC, 2010, INSECT MOL BIOL, V19, P75, DOI 10.1111/j.1365-2583.2009.00950.x; DAVIS A J, 1986, Tijdschrift voor Entomologie, V129, P181; DAVIS AJ, 1979, CAN J ZOOL, V57, P1164, DOI 10.1139/z79-147; Demas FA, 2002, J INSECT BEHAV, V15, P477, DOI 10.1023/A:1016377132585; Demas FA, 2000, J CHEM ECOL, V26, P1079, DOI 10.1023/A:1005497201074; Dergousoff SJ, 2010, EXP APPL ACAROL, V52, P85, DOI 10.1007/s10493-010-9340-5; Doube B M, 1975, J Med Entomol, V12, P433; ehuYek, 1998, ENVIROMAGAZIN, V3, P19; Ferree PM, 2008, CURR BIOL, V18, P1409, DOI 10.1016/j.cub.2008.07.093; GHERNA RL, 1991, INT J SYST BACTERIOL, V41, P563, DOI 10.1099/00207713-41-4-563; Grindle N, 2003, J INVERTEBR PATHOL, V83, P264, DOI 10.1016/S0022-2011(03)00080-6; Howard LO, 1908, CAN ENTOMOL, V40, P239; Hu RJ, 1998, J MED ENTOMOL, V35, P1050, DOI 10.1093/jmedent/35.6.1050; HU RJ, 1993, J MED ENTOMOL, V30, P277, DOI 10.1093/jmedent/30.1.277; HUGER AM, 1985, J INVERTEBR PATHOL, V46, P272, DOI 10.1016/0022-2011(85)90069-2; Jongejan F, 2004, PARASITOLOGY, V129, pS3, DOI 10.1017/S0031182004005967; Kagemann J, 2013, J MED ENTOMOL, V50, P155, DOI 10.1603/ME12086; Knipling EF, 2000, J MED ENTOMOL, V37, P645, DOI 10.1603/0022-2585-37.5.645; Liu LM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-310; Liu LM, 2013, APPL ENVIRON MICROB, V79, P2450, DOI 10.1128/AEM.03575-12; Lopes AJO, 2012, J ECON ENTOMOL, V105, P1979, DOI 10.1603/EC12012; MATHER TN, 1987, MED VET ENTOMOL, V1, P3, DOI 10.1111/j.1365-2915.1987.tb00317.x; Mediannikov O, 2012, TICKS TICK-BORNE DIS, V3, P366, DOI 10.1016/j.ttbdis.2012.10.016; Mwangi EN, 1997, EXP APPL ACAROL, V21, P117, DOI 10.1023/B:APPA.0000031790.30821.57; MWANGI EN, 1994, BIOL CONTROL, V4, P101, DOI 10.1006/bcon.1994.1017; Parola P, 2001, CLIN MICROBIOL INFEC, V7, P80, DOI 10.1046/j.1469-0691.2001.00200.x; Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13; Philip CB, 1931, PUBLIC HEALTH REP, V46, P2168, DOI 10.2307/4580173; Plantard O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030692; Ramos RA, 2015, TICKS TICK BORNE DIS; REHACEK J, 1992, ACTA VIROL, V36, P492; Renvoise A, 2012, FEMS IMMUNOL MED MIC, V64, P126, DOI 10.1111/j.1574-695X.2011.00899.x; Rynkiewicz EC, 2015, MOL ECOL, V24, P2566, DOI 10.1111/mec.13187; Sekeyova Z, 2000, J MED ENTOMOL, V37, P707, DOI 10.1603/0022-2585-37.5.707; SKINNER SW, 1985, GENETICS, V109, P745; Slovak M, 2003, BIOLOGIA, V58, P890; Socolovschi C, 2010, EMERG INFECT DIS, V16, P1140, DOI 10.3201/eid1607.100070; Sparagano OAE, 2011, WOODHEAD PUBL FOOD S, P394; Stafford KC, 2003, J MED ENTOMOL, V40, P642, DOI 10.1603/0022-2585-40.5.642; Stafford KC, 1996, J MED ENTOMOL, V33, P183, DOI 10.1093/jmedent/33.1.183; Subramanian G, 2012, TICKS TICK-BORNE DIS, V3, P405, DOI 10.1016/j.ttbdis.2012.10.001; Takasu K, 2008, BIOL CONTROL, V46, P114, DOI 10.1016/j.biocontrol.2008.04.013; Taylor GP, 2011, J INVERTEBR PATHOL, V106, P371, DOI 10.1016/j.jip.2010.12.004; Tijsse-Klasen E, 2011, PARASITES VECTORS, P4; WERREN JH, 1986, SCIENCE, V231, P990, DOI 10.1126/science.3945814; Wilkes TE, 2010, INSECT MOL BIOL, V19, P59, DOI 10.1111/j.1365-2583.2009.00963.x	54	23	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149950	10.1371/journal.pone.0149950	http://dx.doi.org/10.1371/journal.pone.0149950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901622	Green Submitted, gold, Green Published			2022-12-27	WOS:000371276100192
J	de Oliveira, C; Patel, K; Mishra, V; Trivedi, RN; Noel, P; Singh, A; Yaron, JR; Singh, VP				de Oliveira, Cristiane; Patel, Krutika; Mishra, Vivek; Trivedi, Ram N.; Noel, Pawan; Singh, Abhilasha; Yaron, Jordan R.; Singh, Vijay P.			Characterization and Predictive Value of Near Infrared 2-Deoxyglucose Optical Imaging in Severe Acute Pancreatitis	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CANCER; FAT; DIFFERENTIATION; NECROSIS; ATHEROSCLEROSIS; MOUSE; RAT	Background Studying the uptake of 2-deoxy glucose (2-DG) analogs such as 2-Deoxy-2-[18F] fluoroglucose (FDG) is a common approach to identify and monitor malignancies and more recently chronic inflammation. While pancreatitis is a common cause for false positive results in human studies on pancreatic cancer using FDG, the relevance of these findings to acute pancreatitis (AP) is unknown. FDG has a short half-life. Thus, with an aim to accurately characterize the metabolic demand of the pancreas during AP in real-time, we studied the uptake of the non-radioactive, near infrared fluorescence labelled 2-deoxyglucose analog, IRDye (R) 800CW 2-DG probe (NIR 2-DG; Li-Cor) during mild and severe biliary AP. Methods Wistar rats (300 g; 8-12/group) were administered NIR 2-DG (10 nM; I.V.). Mild and severe biliary AP were respectively induced by biliopancreatic duct ligation (DL) alone or along with infusing glyceryl trilinoleate (GTL; 50 mu L/100 g) within 10 minutes of giving NIR 2-DG. Controls (CON) only received NIR 2-DG. Imaging was done every 5-10 minutes over 3 hrs. Average Radiant Efficiency [p/s/cm(2)/sr]/[mu W/cm(2)] was measured over the pancreas using the IVIS 200 in-vivo imaging system (PerkinElmer) using the Living Image (R) software and verified in ex vivo pancreata. Blood amylase, lipase and pancreatic edema, necrosis were measured over the course of AP. Results NIR 2-DG uptake over the first hour was not influenced by AP induction. However, while the signal declined in controls and rats with mild AP, there was significantly higher retention of NIR 2-DG in the pancreas after 1 hour in those with GTL pancreatitis. The increase was > 3 fold over controls in the GTL group and was verified to be in the pancreas ex vivo. In vitro, pancreatic acini exposed to GTL had a similar increase in NIR 2-DG uptake which was followed by progressively worse acinar necrosis. Greater retention of NIR 2-DG in vivo was associated with worse pancreatic necrosis, reduced ATP concentrations and mortality, which were not predicted by the blood parameters. Conclusion In-vivo fluorescent imaging of a non-radioactive near infrared 2-DG optical probe can predict the AP severity early during the disease.	[de Oliveira, Cristiane; Patel, Krutika; Trivedi, Ram N.; Noel, Pawan; Singh, Abhilasha; Yaron, Jordan R.; Singh, Vijay P.] Mayo Clin, Dept Med, Scottsdale, AZ USA; [Mishra, Vivek] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA	Mayo Clinic; Mayo Clinic Phoenix; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Singh, VP (corresponding author), Mayo Clin, Dept Med, Scottsdale, AZ USA.	singh.vijay@mayo.edu	Patel, Krutika/AAA-1302-2022; Yaron, Jordan R/S-1136-2019	Yaron, Jordan R/0000-0002-4133-474X; Singh, Abhilasha/0000-0002-8203-2895; Singh, Vijay/0000-0001-6611-1908	Department of Army (DOA) [PR110417, W81XWH-12-1-0327]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK092460, R01DK100358]; Mayo Clinic; Mayo Clinic Arizona, Department of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100358, R01DK092460] Funding Source: NIH RePORTER	Department of Army (DOA); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Mayo Clinic; Mayo Clinic Arizona, Department of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support was provided by grant number PR110417 Award #W81XWH-12-1-0327 from the Department of Army (DOA) (VPS), and award number R01DK092460, R01DK100358 (VPS) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of the manuscript are solely the responsibility of the authors and do not necessarily represent the official view of DOA, NIDDK. Mayo Clinic provided support in the form of salaries for each of the authors listed, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Supported by Grant number PR110417 Award # W81XWH-12-1-0327 from the Department of Army (DOA) (VPS), award number R01DK092460, R01DK100358 (VPS) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of the manuscript are solely the responsibility of the authors and do not necessarily represent the official view of DOA, NIDDK. Also supported by a startup package from the Mayo Clinic Arizona, Department of Medicine (VPS).	Acharya C, 2014, PANCREATOLOGY, V14, P403, DOI 10.1016/j.pan.2014.06.004; Acharya C, 2013, GASTROENTEROLOGY, V145, P466, DOI 10.1053/j.gastro.2013.05.012; AHO HJ, 1980, SCAND J GASTROENTERO, V15, P1027, DOI 10.3109/00365528009181808; AHO HJ, 1986, ACTA PATH MICRO IM A, V94, P101; AHO HJ, 1980, SCAND J GASTROENTERO, V15, P411, DOI 10.3109/00365528009181493; Albano D, 2015, CLIN NUCL MED; Besselink M, 2013, PANCREATOLOGY, V13, pE1, DOI 10.1016/j.pan.2013.07.063; Dong AS, 2013, CLIN NUCL MED, V38, pE354, DOI 10.1097/RLU.0b013e3182708503; Durgampudi C, 2014, AM J PATHOL, V184, P1773, DOI 10.1016/j.ajpath.2014.02.015; Fitz RH, 1889, ACUTE PANCREATITIS C; Folco EJ, 2011, J AM COLL CARDIOL, V58, P603, DOI 10.1016/j.jacc.2011.03.044; Hotchkiss LW, 1912, ANN SURG, V56, P111, DOI 10.1097/00000658-191207000-00009; Imdahl A, 1999, BRIT J SURG, V86, P194, DOI 10.1046/j.1365-2168.1999.01016.x; Kang WJ, 2015, KOREAN J RADIOL, V16, P1257, DOI 10.3348/kjr.2015.16.6.1257; Kato K, 2013, CLIN NUCL MED, V38, P417, DOI 10.1097/RLU.0b013e3182817d9d; Kloppel G, 1984, PATHOMORPHOLOGY ACUT; Kovar JL, 2007, ANAL BIOCHEM, V367, P1, DOI 10.1016/j.ab.2007.04.011; Kovar JL, 2011, ANAL BIOCHEM, V416, P167, DOI 10.1016/j.ab.2011.05.011; Kovar JL, 2009, ANAL BIOCHEM, V384, P254, DOI 10.1016/j.ab.2008.09.050; Le TM, 2015, PANCREAS, V44, P493, DOI 10.1097/MPA.0000000000000285; Mishra V.N., 2013, J INEQUAL APPL, V2013, DOI DOI 10.1155/2013/814824; Mishra V, 2014, PANCREATOLOGY, V14, P459, DOI 10.1016/j.pan.2014.06.006; Mukheriee R, 2008, CELL CALCIUM, V44, P14, DOI 10.1016/j.ceca.2007.11.013; Navina S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002573; Nioka S, 2005, TECHNOL CANCER RES T, V4, P497, DOI 10.1177/153303460500400504; Noel P., 2014, GUT; NORDBACK I, 1986, J CLIN PATHOL, V39, P68, DOI 10.1136/jcp.39.1.68; Okuyucu K, 2015, Q J NUCL MED MOL IMA; Ozaki Y, 2008, J GASTROENTEROL, V43, P144, DOI 10.1007/s00535-007-2132-y; Panek J, 2001, Med Sci Monit, V7, P894; Patel K, 2015, AM J PATHOL, V185, P808, DOI 10.1016/j.ajpath.2014.11.019; Pery C, 2010, GASTROEN CLIN BIOL, V34, P465, DOI 10.1016/j.gcb.2009.04.014; Petersen OH, 2009, CELL CALCIUM, V45, P634, DOI 10.1016/j.ceca.2009.02.005; Pinnick KE, 2008, OBESITY, V16, P522, DOI 10.1038/oby.2007.110; RENNER IG, 1985, DIGEST DIS SCI, V30, P1005, DOI 10.1007/BF01308298; Saboury B, 2015, NUCL MED COMMUNICATI; Saisho Y, 2007, CLIN ANAT, V20, P933, DOI 10.1002/ca.20543; SCHMITZMOORMANN P, 1981, PATHOL RES PRACT, V171, P325, DOI 10.1016/S0344-0338(81)80105-7; SCHMITZMOORMANN P, 1981, PATHOL RES PRACT, V173, P45, DOI 10.1016/S0344-0338(81)80006-4; Singh VP, 2008, MOL BIOL CELL, V19, P2339, DOI 10.1091/mbc.E07-11-1130; Wu JC, 2011, J AM COLL CARDIOL, V58, P615, DOI 10.1016/j.jacc.2011.04.021; Yokoyama Y, 2005, PANCREAS, V31, P192, DOI 10.1097/01.mpa.0000168226.36085.58; Zhou HL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008051	43	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149073	10.1371/journal.pone.0149073	http://dx.doi.org/10.1371/journal.pone.0149073			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901564	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000371276100037
J	Kryza, D; Debordeaux, F; Azema, L; Hassan, A; Paurelle, O; Schulz, J; Savona-Baron, C; Charignon, E; Bonazza, P; Taleb, J; Fernandez, P; Janier, M; Toulme, JJ				Kryza, David; Debordeaux, Frederic; Azema, Laurent; Hassan, Aref; Paurelle, Olivier; Schulz, Juergen; Savona-Baron, Catherine; Charignon, Elsa; Bonazza, Pauline; Taleb, Jacqueline; Fernandez, Philippe; Janier, Marc; Toulme, Jean Jacques			Ex Vivo and In Vivo Imaging and Biodistribution of Aptamers Targeting the Human Matrix MetalloProtease-9 in Melanomas	PLOS ONE			English	Article							CANCER THERAPEUTICS; NEXT-GENERATION; SELECTION; VITRO; THERAPY; PROBES	The human Matrix MetalloProtease-9 (hMMP-9) is overexpressed in tumors where it promotes the release of cancer cells thus contributing to tumor metastasis. We raised aptamers against hMMP-9, which constitutes a validated marker of malignant tumors, in order to design probes for imaging tumors in human beings. A chemically modified RNA aptamer (F3B), fully resistant to nucleases was previously described. This compound was subsequently used for the preparation of F3B-Cy5, F3B-S-acetylmercaptoacetyltriglycine (MAG) and F3B-DOTA. The binding properties of these derivatives were determined by surface plasmon resonance and electrophoretic mobility shift assay. Optical fluorescence imaging confirmed the binding to hMMP-9 in A375 melanoma bearing mice. Quantitative biodistribution studies were performed at 30 min, 1h and 2 h post injection of Tc-99m-MAG-aptamer and In-111-DOTA-F3B. Tc-99m radiolabeled aptamer specifically detected hMMP-9 in A375 melanoma tumors but accumulation in digestive tract was very high. Following i.v. injection of In-111-DOTA-F3B, high level of radioactivity was observed in kidneys and bladder but digestive tract uptake was very limited. Tumor uptake was significantly (student t test, p<0.05) higher for In-111-DOTA-F3B with 2.0% ID/g than for the In-111-DOTA-control oligonucleotide (0.7% ID/g) with tumor to muscle ratio of 4.0. Such difference in tumor accumulation has been confirmed by ex vivo scintigraphic images performed at 1h post injection and by autoradiography, which revealed the overexpression of hMMP-9 in sections of human melanomas. These results demonstrate that F3B aptamer is of interest for detecting hMMP-9 in melanoma tumor.	[Kryza, David; Taleb, Jacqueline; Janier, Marc] Univ Lyon 1, CNRS, LAGEP, UMR 5007, F-69622 Villeurbanne, France; [Kryza, David; Charignon, Elsa; Bonazza, Pauline; Janier, Marc] Hosp Civils Lyon, Imthernat Plateform, Lyon, France; [Debordeaux, Frederic; Schulz, Juergen; Savona-Baron, Catherine; Fernandez, Philippe] Univ Bordeaux, CNRS, INCIA, UMR 5287, Bordeaux, France; [Debordeaux, Frederic; Schulz, Juergen; Fernandez, Philippe] CHU Bordeaux, Serv Med Nucl, Bordeaux, France; [Azema, Laurent; Hassan, Aref; Paurelle, Olivier; Toulme, Jean Jacques] INSERM, U1212, Bordeaux, France; [Azema, Laurent; Hassan, Aref; Paurelle, Olivier; Toulme, Jean Jacques] CNRS, UMR5320, Pessac, France; [Azema, Laurent; Hassan, Aref; Paurelle, Olivier; Toulme, Jean Jacques] Univ Bordeaux, ARNA Lab, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux	Kryza, D (corresponding author), Univ Lyon 1, CNRS, LAGEP, UMR 5007, F-69622 Villeurbanne, France.; Kryza, D (corresponding author), Hosp Civils Lyon, Imthernat Plateform, Lyon, France.	david.kryza@chu-lyon.fr		Toulme, Jean-jacques/0000-0002-8432-5034; DEBORDEAUX, Frederic/0000-0003-3189-4679; Azema, Laurent/0000-0002-7087-6927; Janier, Marc/0000-0001-5937-9180	French Agence Nationale de la Recherche within the context of the Investments for the Future Program [ANR-10-LABX-57]; TRAIL	French Agence Nationale de la Recherche within the context of the Investments for the Future Program(French National Research Agency (ANR)); TRAIL	This study - Imelapt - was supported by a public grant from the French Agence Nationale de la Recherche within the context of the Investments for the Future Program, referenced ANR-10-LABX-57 and named TRAIL.	Bunka DHJ, 2006, NAT REV MICROBIOL, V4, P588, DOI 10.1038/nrmicro1458; Chen HY, 2015, MOL IMAGING BIOL, V17, P38, DOI 10.1007/s11307-014-0763-y; Chen YH, 2012, J DERMATOL, V39, P339, DOI 10.1111/j.1346-8138.2011.01441.x; Cibiel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087002; Dassie JP, 2013, THER DELIV, V4, P1527, DOI [10.4155/tde.13.118, 10.4155/TDE.13.118]; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Finn L, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-23; Forget MA, 1999, CAN J PHYSIOL PHARM, V77, P465; Gomes SD, 2012, BIOCONJUGATE CHEM, V23, P2192, DOI 10.1021/bc300146c; Haubner R, 2005, PLOS MED, V2, P244, DOI 10.1371/journal.pmed.0020070; Hicke BJ, 2006, J NUCL MED, V47, P668; Hofmann UB, 2000, J INVEST DERMATOL, V115, P337, DOI 10.1046/j.1523-1747.2000.00068.x; Hwang DW, 2009, CHEM-EUR J, V15, P9387, DOI 10.1002/chem.200900344; Jacobson O, 2015, J NUCL MED, V56, P616, DOI 10.2967/jnumed.114.149484; Javier DJ, 2008, BIOCONJUGATE CHEM, V19, P1309, DOI 10.1021/bc8001248; Kruspe S, 2014, CHEMMEDCHEM, V9, P1998, DOI 10.1002/cmdc.201402163; Lao YH, 2015, ACS NANO, V9, P2235, DOI 10.1021/nn507494p; Merdad A, 2014, ANTICANCER RES, V34, P1355; Meyer M, 2013, APPL MICROBIOL BIOT, V97, P7097, DOI 10.1007/s00253-013-5070-z; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; Noaparast Z, 2015, J DRUG TARGET, V12, P1; Okarvi SM, 2006, CANCER BIOTHER RADIO, V21, P49, DOI 10.1089/cbr.2006.21.49; Ozalp VC, 2015, CURR TOP MED CHEM, V15, P1125, DOI 10.2174/1568026615666150413154233; Parat A, 2015, J MATER CHEM B, V3, P2560, DOI 10.1039/c5tb00235d; Pestourie C, 2005, BIOCHIMIE, V87, P921, DOI 10.1016/j.biochi.2005.04.013; Piorek BD, 2012, ANAL CHEM, V84, P9700, DOI [10.1021/ac302497y, 10.1021/ac3026866]; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; Rolland O, 2009, NEW J CHEM, V33, P1809, DOI 10.1039/b901054h; Shi H, 2010, CHEM-ASIAN J, V5, P2209, DOI 10.1002/asia.201000242; Shi JY, 2009, BIOCONJUGATE CHEM, V20, P1559, DOI 10.1021/bc9001739; Shigdar S, 2013, SENSORS-BASEL, V13, P13624, DOI 10.3390/s131013624; Shum Ka-To, 2013, J Cancer Ther, V4, P872; Smith AM, 2009, NAT BIOTECHNOL, V27, P732, DOI 10.1038/nbt0809-732; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; Sun HG, 2015, SMALL, V11, P2352, DOI 10.1002/smll.201403073; Tan WH, 2013, CHEM REV, V113, P2842, DOI 10.1021/cr300468w; Tavitian Bertrand, 2009, V535, P241, DOI 10.1007/978-1-59745-557-2_15; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wang J, 2011, CURR MED CHEM, V18, P4107, DOI 10.2174/092986711797189628; Winnard P, 1997, NUCL MED BIOL, V24, P425, DOI 10.1016/S0969-8051(97)00027-9; Xiang DX, 2015, THERANOSTICS, V5, P23, DOI 10.7150/thno.10202; Yu MK, 2011, SMALL, V7, P2241, DOI 10.1002/smll.201100472; Zhang CL, 2013, ANAL CHEM, V85, P5843, DOI 10.1021/ac400606e; Zhu GZ, 2012, CHEM COMMUN, V48, P10472, DOI 10.1039/c2cc35042d	44	33	33	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149387	10.1371/journal.pone.0149387	http://dx.doi.org/10.1371/journal.pone.0149387			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901393	gold, Green Published, Green Submitted			2022-12-27	WOS:000371276100067
J	Kushwah, N; Jain, V; Deep, S; Prasad, D; Singh, SB; Khan, N				Kushwah, Neetu; Jain, Vishal; Deep, Satayanarayan; Prasad, Dipti; Singh, Shashi Bala; Khan, Nilofar			Neuroprotective Role of Intermittent Hypobaric Hypoxia in Unpredictable Chronic Mild Stress Induced Depression in Rats	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; TRKB MESSENGER-RNA; NEUROTROPHIC FACTOR; LIFE EVENTS; SUCROSE PREFERENCE; OXIDATIVE STRESS; DENTATE GYRUS; HIGH-ALTITUDE; BRAIN; BDNF	Hypoxic exposure results in several pathophysiological conditions associated with nervous system, these include acute and chronic mountain sickness, loss of memory, and high altitude cerebral edema. Previous reports have also suggested the role of hypoxia in pathogenesis of depression and related psychological conditions. On the other hand, sub lethal intermittent hypoxic exposure induces protection against future lethal hypoxia and may have beneficial effect. Therefore, the present study was designed to explore the neuroprotective role of intermittent hypobaric hypoxia (IHH) in Unpredictable Chronic Mild Stress (UCMS) induced depression like behaviour in rats. The IHH refers to the periodic exposures to hypoxic conditions interrupted by the normoxic or lesser hypoxic conditions. The current study examines the effect of IHH against UCMS induced depression, using elevated plus maze (EPM), open field test (OFT), force swim test (FST), as behavioural paradigm and related histological and molecular approaches. The data indicated the UCMS induced depression like behaviour as evident from decreased exploration activity in OFT with increased anxiety levels in EPM, and increased immobility time in the FST; whereas on providing the IHH (5000m altitude, 4hrs/day for two weeks) these behavioural changes were ameliorated. The morphological and molecular studies also validated the neuroprotective effect of IHH against UCMS induced neuronal loss and decreased neurogenesis. Here, we also explored the role of Brain- Derived Neurotrophic Factor (BDNF) in anticipatory action of IHH against detrimental effect of UCMS as upon blocking of BDNF-TrkB signalling the beneficial effect of IHH was nullified. Taken together, the findings of our study demonstrate that the intermittent hypoxia has a therapeutic potential similar to an antidepressant in animal model of depression and could be developed as a preventive therapeutic option against this pathophysiological state.	[Kushwah, Neetu; Jain, Vishal; Deep, Satayanarayan; Prasad, Dipti; Singh, Shashi Bala; Khan, Nilofar] Def Inst Physiol & Allied Sci, Div Neurobiol, DRDO, Lucknow Rd, Delhi 110054, India	Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS)	Khan, N (corresponding author), Def Inst Physiol & Allied Sci, Div Neurobiol, DRDO, Lucknow Rd, Delhi 110054, India.	nilofarkhan2003@yahoo.com	Singh, Shashi Bala/AAS-9889-2021; Khan, Nilofar/J-4489-2019	Khan, Nilofar/0000-0003-0098-0072	Defence Research and Development Organization (DRDO), Ministry of Defence, Government of India [DIP-251]	Defence Research and Development Organization (DRDO), Ministry of Defence, Government of India(Defence Research & Development Organisation (DRDO))	The study was fully supported by Defence Research and Development Organization (DRDO), project no. DIP-251, Ministry of Defence, Government of India.	Adams RD, 1991, PRINCIPLES NEUROLOGY; Anisman H, 2005, NEUROSCI BIOBEHAV R, V29, P525, DOI 10.1016/j.neubiorev.2005.03.007; ANISMAN H, 1990, PHARMACOL THERAPEUT, V46, P119, DOI 10.1016/0163-7258(90)90039-5; Barhwal K, 2007, EUR J PHARMACOL, V570, P97, DOI 10.1016/j.ejphar.2007.05.063; Bath KG, 2008, J NEUROSCI, V28, P2383, DOI 10.1523/JNEUROSCI.4387-07.2008; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; Birbrair A, 2013, EXP CELL RES, V319, P45, DOI 10.1016/j.yexcr.2012.09.008; Bondi CO, 2006, SOC NEUROSCI; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown TA, 1998, J ABNORM PSYCHOL, V107, P179, DOI 10.1037/0021-843X.107.2.179; Chen B, 2001, BIOL PSYCHIAT, V50, P260, DOI 10.1016/S0006-3223(01)01083-6; Chen J, 2013, J CHILD PSYCHOL PSYC, V54, P1066, DOI 10.1111/jcpp.12099; Choi DW, 1996, CURR OPIN NEUROBIOL, V6, P667, DOI 10.1016/S0959-4388(96)80101-2; Costa DC, 2013, J MOL NEUROSCI, V50, P402, DOI 10.1007/s12031-012-9945-8; Coles ME, 2002, CLIN PSYCHOL REV, V22, P587, DOI 10.1016/S0272-7358(01)00113-1; Drew Michael R., 2007, CNS & Neurological Disorders-Drug Targets, V6, P205, DOI 10.2174/187152707780619353; DSM-IV, 2000, DSM 4 DIAGN STAT MAN; Duman RS, 2000, BIOL PSYCHIAT, V48, P732, DOI 10.1016/S0006-3223(00)00935-5; Farooq RK, 2012, BEHAV BRAIN RES, V231, P130, DOI 10.1016/j.bbr.2012.03.020; Gu HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112683; HOCHACHKA PW, 1986, SCIENCE, V231, P234, DOI 10.1126/science.2417316; HOCHACHKA PW, 1994, J CEREBR BLOOD F MET, V14, P671, DOI 10.1038/jcbfm.1994.84; Itoh T, 2004, EUR J PHARMACOL, V498, P135, DOI 10.1016/j.ejphar.2004.07.084; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; KENDLER KS, 1995, AM J PSYCHIAT, V152, P833; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; Lang UE, 2004, NEUROPSYCHOPHARMACOL, V29, P795, DOI 10.1038/sj.npp.1300382; Lin AMY, 2002, EXP NEUROL, V176, P328, DOI 10.1006/exnr.2002.7938; Liu J, 2005, STROKE, V36, P1264, DOI 10.1161/01.STR.0000166180.91042.02; Liu W, 2006, BLOOD, V107, P698, DOI 10.1182/blood-2005-03-1278; Maiti P, 2007, BRAIN RES, V1175, P1, DOI 10.1016/j.brainres.2007.06.106; Malberg JE, 2005, CURR PHARM DESIGN, V11, P145, DOI 10.2174/1381612053382223; Malberg JE, 2004, J PSYCHIATR NEUROSCI, V29, P196; Mathews A, 1998, COGNITIVE THER RES, V22, P539, DOI 10.1023/A:1018738019346; MCGONAGLE KA, 1990, AM J COMMUN PSYCHOL, V18, P681, DOI 10.1007/BF00931237; Mineur YS, 2003, BEHAV GENET, V33, P513, DOI 10.1023/A:1025770616068; Moller P, 2001, FASEB J, V15, P1181, DOI 10.1096/fj.00-0703com; Nahon E, 2005, FEBS LETT, V579, P5105, DOI 10.1016/j.febslet.2005.08.020; Nibuya M, 1999, NEUROSCI LETT, V267, P81, DOI 10.1016/S0304-3940(99)00335-3; NIBUYA M, 1995, J NEUROSCI, V15, P7539; O'Connor JC, 2009, J IMMUNOL, V182, P3202, DOI 10.4049/jimmunol.0802722; Pizarro JM, 2004, BRAIN RES, V1025, P10, DOI 10.1016/j.brainres.2004.06.085; Pothion S, 2004, BEHAV BRAIN RES, V155, P135, DOI 10.1016/j.bbr.2004.04.008; Rasmusson AM, 2002, NEUROPSYCHOPHARMACOL, V27, P133, DOI 10.1016/S0893-133X(02)00286-5; RASOOL CG, 1986, ANN NEUROL, V20, P482, DOI 10.1002/ana.410200407; Russo-Neustadt A, 2001, BEHAV BRAIN RES, V120, P87, DOI 10.1016/S0166-4328(00)00364-8; Rybnikova E, 2005, BEHAV BRAIN RES, V160, P107, DOI 10.1016/j.bbr.2004.11.023; Rybnikova E A, 2008, Neurosci Behav Physiol, V38, P721, DOI 10.1007/s11055-008-9038-x; Rybnikova E, 2006, BRAIN RES, V1089, P195, DOI 10.1016/j.brainres.2006.03.053; Serebrovskaya TV, 2008, EXP BIOL MED, V233, P627, DOI 10.3181/0710-MR-267; Shalaby Amany, 2009, Int J Physiol Pathophysiol Pharmacol, V1, P154; Shi SS, 2010, YONSEI MED J, V51, P661, DOI 10.3349/ymj.2010.51.5.661; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Theus MH, 2008, EXP NEUROL, V210, P656, DOI 10.1016/j.expneurol.2007.12.020; UHL GR, 1985, NEUROLOGY, V35, P1215, DOI 10.1212/WNL.35.8.1215; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Wibrand K, 2006, EUR J NEUROSCI, V23, P1501, DOI 10.1111/j.1460-9568.2006.04687.x; Willner P, 1996, PHYSIOL BEHAV, V60, P129, DOI 10.1016/0031-9384(95)02256-2; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Wong ML, 2001, NAT REV NEUROSCI, V2, P343, DOI 10.1038/35072566; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yalcin I, 2005, EUR J PHARMACOL, V514, P165, DOI 10.1016/j.ejphar.2005.03.029; Yasuda S, 2009, MOL PSYCHIATR, V14, P51, DOI 10.1038/sj.mp.4002099; Zhen JL, 2014, BRAIN RES, V1563, P122, DOI 10.1016/j.brainres.2014.03.032; Zhu WZ, 2006, J MOL CELL CARDIOL, V40, P96, DOI 10.1016/j.yjmcc.2005.09.016; Zhu XH, 2010, J NEUROSCI, V30, P12653, DOI 10.1523/JNEUROSCI.6414-09.2010	67	34	40	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149309	10.1371/journal.pone.0149309	http://dx.doi.org/10.1371/journal.pone.0149309			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901349	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100057
J	Li, LL; Wang, HR; Zhou, ZY; Luo, J; Wang, XL; Xiao, XQ; Zhou, YB; Zeng, Y				Li, Li-Li; Wang, He-Rong; Zhou, Zhi-Yi; Luo, Jing; Wang, Xiao-Li; Xiao, Xiang-Qian; Zhou, Yu-Bai; Zeng, Yi			C3-Luc Cells Are an Excellent Model for Evaluation of Cellular Immunity following HPV16L1 Vaccination	PLOS ONE			English	Article							CERVICAL-CANCER; HPV; RISK; ONCOGENE; PROTEIN; MICE; E6	C3 and TC-1 are the two model cell lines most commonly used in studies of vaccines and drugs against human papillomavirus (HPV) infection. Because C3 cells contain both the HPV16 E and L genes, but TC-1 cells contain only the HPV16 E genes, C3 cells are usually used as the model cell line in studies targeting the HPV16 L protein. However, expression of the L1 protein is difficult to detect in C3 cells using common methods. In our study, Short tandem repeat analysis (STR) was used to demonstrate that C3 cells are indeed derived from mice, PCR results show that HPV16 L1, E6 and E7 genes were detected in C3 genomic DNA, and RT-PCR results demonstrated that L1 transcription had occurred in C3 cells. However, the expression of C3 protein was not found in the results of western blot and immunohistochemistry (IHC). Growth and proliferation of C3 were inhibited by mice spleen lymphocytes that had been immunized with a vaccine against HPV16L1. The luciferase gene was integrated into C3 cells, and it was confirmed that addition of the exogenous gene had no effect on C3 cells by comparing cell growth and tumor formation with untransformed cells. Cells stably expressing luciferase (C3-luc) were screened and subcutaneously injected into the mice. Tumors became established and were observed using a Spectrum Pre-clinical in Vivo Imaging System. Tumor size of mice in the different groups at various time points was calculated by counting photons. The sensitivity of the animals to the vaccine was quantified by statistical comparison. Ten or 30 days following injection of the C3-luc cells, tumor size differed significantly between the PBS and vaccine groups, indicating that C3 cells were susceptible to vaccination even after tumors were formed in vivo.	[Li, Li-Li; Wang, He-Rong; Zhou, Zhi-Yi; Luo, Jing; Wang, Xiao-Li; Xiao, Xiang-Qian; Zhou, Yu-Bai] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing Key Lab Environm & Viral Oncol, Beijing, Peoples R China; [Li, Li-Li; Zeng, Yi] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Zhou, Yu-Bai] 100 Pingleyuan, Beijing 100124, Peoples R China; [Zeng, Yi] 100 YingXin St, Beijing 100032, Peoples R China	Beijing University of Technology; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Zhou, YB (corresponding author), Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing Key Lab Environm & Viral Oncol, Beijing, Peoples R China.; Zeng, Y (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.; Zhou, YB (corresponding author), 100 Pingleyuan, Beijing 100124, Peoples R China.; Zeng, Y (corresponding author), 100 YingXin St, Beijing 100032, Peoples R China.	zhouyobai@bjut.edu.cn; zengy@public.bta.net.cn	周, 玉柏/AAG-3933-2020		independent research fund from the State Key Laboratory for Infectious Disease Prevention and Control [2011SKLID103]; National High Technology Research Program of China (863 program) [2012AA02A404]; Major National Research and Development Projects [2012ZX10001005-007]	independent research fund from the State Key Laboratory for Infectious Disease Prevention and Control; National High Technology Research Program of China (863 program); Major National Research and Development Projects	Funding was provided by an independent research fund from the State Key Laboratory for Infectious Disease Prevention and Control (Grant No. 2011SKLID103); National High Technology Research Program of China (863 program)(Grant No. 2012AA02A404); Major National Research and Development Projects (2012ZX10001005-007).	Blioumi E, 2014, ORAL ONCOL, V50, P840, DOI 10.1016/j.oraloncology.2014.06.011; Cheah P L, 1998, Malays J Pathol, V20, P1; De Bruijn MLH, 1998, VIROLOGY, V250, P371, DOI 10.1006/viro.1998.9372; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; Hsu LC, 2004, BIOCHEM BIOPH RES CO, V320, P249, DOI 10.1016/j.bbrc.2004.05.160; Kaczmar JM, 2016, HEAD NECK-J SCI SPEC, V38, P59, DOI 10.1002/hed.23850; Kenter GG, 2008, CLIN CANCER RES, V14, P169, DOI 10.1158/1078-0432.CCR-07-1881; Khurshid A, 1998, J Pak Med Assoc, V48, P138; Klaes R, 1999, CANCER RES, V59, P6132; Kuroda M, 2005, BRIT J CANCER, V92, P290, DOI 10.1038/sj.bjc.6602329; Lin KY, 1996, CANCER RES, V56, P21; Luker GD, 2011, METHODS MOL BIOL, V680, P29, DOI 10.1007/978-1-60761-901-7_2; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Mydlarz WK, 2015, ORAL ONCOL, V51, P305, DOI 10.1016/j.oraloncology.2014.10.005; Ohlschlager P, 2003, J VIROL, V77, P4635, DOI 10.1128/JVI.77.8.4635-4645.2003; Pinto LA, 2005, VACCINE, V23, P3555, DOI 10.1016/j.vaccine.2005.01.146; Qi Z, 2013, DIS ESOPHAGUS, V26, P61, DOI 10.1111/j.1442-2050.2012.01334.x; Schmitt M, 2011, MOL CELL PROBE, V25, P108, DOI 10.1016/j.mcp.2011.03.003; Wang XQ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-19; Xiao W, 2010, ACTA CYTOL, V54, P661, DOI 10.1159/000325229; Zhi Huijun, 2002, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V16, P124	21	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149748	10.1371/journal.pone.0149748	http://dx.doi.org/10.1371/journal.pone.0149748			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900913	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100142
J	Logan, CA; Thiel, L; Bornemann, R; Koenig, W; Reister, F; Brenner, H; Rothenbacher, D; Genuneit, J				Logan, Chad A.; Thiel, Larissa; Bornemann, Rebecca; Koenig, Wolfgang; Reister, Frank; Brenner, Hermann; Rothenbacher, Dietrich; Genuneit, Jon			Delivery Mode, Duration of Labor, and Cord Blood Adiponectin, Leptin, and C-Reactive Protein: Results of the Population-Based Ulm Birth Cohort Studies	PLOS ONE			English	Article							CESAREAN-SECTION; GUT MICROBIOTA; RISK; DISEASE; OVERWEIGHT; GROWTH	Background Numerous studies have reported associations between delivery mode and health outcomes in infancy and later life. Previous smaller studies indicated a relationship between delivery mode and newborn inflammation potentially constituting a mediating factor. We aimed to determine the influence of delivery mode and duration of labor on cord blood concentrations of adiponectin, leptin, and high-sensitivity C-reactive protein (hs-CRP). Methods In the Ulm SPATZ Health Study, 934 singleton newborns and their mothers were recruited during their hospital stay in the University Medical Center Ulm, Southern Germany, from 04/2012-05/2013. Inflammatory biomarkers were measured by ELISAs (n = 836). Delivery mode was analyzed categorically (elective cesarean (reference), active labor delivery: emergency cesarean, assisted vaginal, and spontaneous vaginal); duration of labor continuously. Following log-transformation, linear regression was used to estimate geometric means ratios (GMR) adjusted for potential confounders for the effects of delivery mode and duration of labor on each biomarker separately. Independent replication was sought in the similarly conducted Ulm Birth Cohort Study recruited from 11/2000-11/2001. Results Individually, active labor delivery modes as well as increasing duration of labor were associated with higher leptin and hs-CRP concentrations. After mutual adjustment, the associations with delivery modes were attenuated but those for duration of labor remained statistically significant (GMR (95% CI) 1.10 (1.00; 1.21) and 1.15 (1.04; 1.27) for leptin and hs-CRP per hour of labor, respectively). No significant adjusted associations were observed between delivery modes and adiponectin concentrations. These findings were replicated in an independent birth cohort study. Conclusions Cord blood leptin and hs-CRP concentrations were associated with duration of labor rather than delivery mode. Further research is warranted to investigate these associations with additional cytokines involved in inflammatory response to delineate the inflammatory profile. Subsequently, research on determinants of these associations and their role in development of chronic disease is needed.	[Logan, Chad A.; Thiel, Larissa; Bornemann, Rebecca; Rothenbacher, Dietrich; Genuneit, Jon] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Koenig, Wolfgang] Univ Med Ctr Ulm, Dept Internal Med Cardiol 2, Ulm, Germany; [Reister, Frank] Univ Med Ctr Ulm, Dept Gynecol & Obstet, Ulm, Germany; [Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Genuneit, Jon] World Univ Network WUN, In FLAME, Ulm, Germany	Ulm University; Ulm University; Ulm University; Helmholtz Association; German Cancer Research Center (DKFZ)	Genuneit, J (corresponding author), Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany.; Genuneit, J (corresponding author), World Univ Network WUN, In FLAME, Ulm, Germany.	jon.genuneit@uni-ulm.de	Genuneit, Jon/I-9323-2012; Brenner, Hermann/ABE-6383-2020; Brenner, Hermann/B-4627-2017	Genuneit, Jon/0000-0001-5764-1528; Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572; Rothenbacher, Dietrich/0000-0002-3563-2791; Koenig, Wolfgang/0000-0002-2064-9603; Logan, Chad/0000-0002-6157-3641	Medical Faculty of Ulm University; German Research Council [BR 1704/3-1, BR1704/3-2, BR1704/3-3]	Medical Faculty of Ulm University; German Research Council(German Research Foundation (DFG))	The Ulm SPATZ Health Study was funded through an unrestricted grant by the Medical Faculty of Ulm University. The Ulm Birth Cohort Study was supported by grants of the German Research Council (BR 1704/3-1, BR1704/3-2, BR1704/3-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bager P, 2008, CLIN EXP ALLERGY, V38, P634, DOI 10.1111/j.1365-2222.2008.02939.x; Bager P, 2012, INFLAMM BOWEL DIS, V18, P857, DOI 10.1002/ibd.21805; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Braig S, 2015, PSYCHONEUROENDOCRINO, V52, P289, DOI 10.1016/j.psyneuen.2014.12.006; Cardwell CR, 2008, DIABETOLOGIA, V51, P726, DOI 10.1007/s00125-008-0941-z; Collado MC, 2015, PEDIATR RES, V77, P182, DOI 10.1038/pr.2014.173; Cho CE, 2013, AM J OBSTET GYNECOL, V208, P249, DOI 10.1016/j.ajog.2012.08.009; Decker E, 2010, PEDIATRICS, V125, pE1433, DOI 10.1542/peds.2009-2260; Gronlund MM, 1999, J PEDIATR GASTR NUTR, V28, P19, DOI 10.1097/00005176-199901000-00007; Hermansson H, 2014, NEONATOLOGY, V105, P172, DOI 10.1159/000357178; Hyde MJ, 2012, EARLY HUM DEV, V88, P943, DOI 10.1016/j.earlhumdev.2012.09.006; Ishibashi M, 2002, CLIN CHEM, V48, P1103; Ismail AQT, 2015, J MATERN-FETAL NEO M, V28, P3, DOI 10.3109/14767058.2014.885499; Kaar JL, 2014, J DEV ORIG HLTH DIS, V5, P214, DOI 10.1017/S204017441400021X; Lappas M, 2015, J PERINATOL, V35, P32, DOI 10.1038/jp.2014.144; Lee SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096603; Leung JYY, 2015, CLIN EXP ALLERGY, V45, P1109, DOI 10.1111/cea.12548; Li HT, 2013, INT J OBESITY, V37, P893, DOI 10.1038/ijo.2012.195; Luo ZC, 2013, OBESITY, V21, P210, DOI 10.1002/oby.20250; Malek A, 2006, PLACENTA, V27, P619, DOI 10.1016/j.placenta.2005.05.009; Mantzoros CS, 2009, PEDIATRICS, V123, P682, DOI 10.1542/peds.2008-0343; Morales E, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.056; Negele K, 2004, PEDIAT ALLERG IMM-UK, V15, P48, DOI 10.1046/j.0905-6157.2003.00101.x; Odegard RA, 2002, AM J OBSTET GYNECOL, V186, P427, DOI 10.1067/mob.2002.120486; Rothenbacher D, 2007, CLIN EXP ALLERGY, V37, P1143, DOI 10.1111/j.1365-2222.2007.02759.x; Sanz Y, 2015, PEDIATR RES, V77, P236, DOI 10.1038/pr.2014.170; Sevelsted A, 2015, PEDIATRICS, V135, pE92, DOI 10.1542/peds.2014-0596; Wang L, 2013, EUR J PEDIATR, V172, P1341, DOI 10.1007/s00431-013-2043-2; West CE, 2015, CLIN EXP ALLERGY, V45, P43, DOI 10.1111/cea.12332; Weyermann M, 2006, CLIN CHEM, V52, P2095, DOI 10.1373/clinchem.2006.071019; Yoon B H, 2003, J Matern Fetal Neonatal Med, V14, P85; Yoshimitsu N, 2000, OBSTET GYNECOL, V96, P342, DOI 10.1016/S0029-7844(00)00927-3; 조현희, 2005, Obstetrics & Gynecology Science, V48, P709	33	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149918	10.1371/journal.pone.0149918	http://dx.doi.org/10.1371/journal.pone.0149918			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900695	gold, Green Published			2022-12-27	WOS:000371276100184
J	Migliaccio, R; Boutet, C; Valabregue, R; Ferrieux, S; Nogues, M; Lehericy, S; Dormont, D; Levy, R; Dubois, B; Teichmann, M				Migliaccio, Raffaella; Boutet, Claire; Valabregue, Romain; Ferrieux, Sophie; Nogues, Marie; Lehericy, Stephane; Dormont, Didier; Levy, Richard; Dubois, Bruno; Teichmann, Marc			The Brain Network of Naming: A Lesson from Primary Progressive Aphasia	PLOS ONE			English	Article							ANTERIOR TEMPORAL INVOLVEMENT; SEMANTIC DEMENTIA; LEXICAL RETRIEVAL; SPEECH PRODUCTION; 3 VARIANTS; WORD; LANGUAGE; ANATOMY; MRI; PERFORMANCE	Objective Word finding depends on the processing of semantic and lexical information, and it involves an intermediate level for mapping semantic-to-lexical information which also subserves lexical-to-semantic mapping during word comprehension. However, the brain regions implementing these components are still controversial and have not been clarified via a comprehensive lesion model encompassing the whole range of language-related cortices. Primary progressive aphasia (PPA), for which anomia is thought to be the most common sign, provides such a model, but the exploration of cortical areas impacting naming in its three main variants and the underlying processing mechanisms is still lacking. Methods We addressed this double issue, related to language structure and PPA, with thirty patients (11 semantic, 12 logopenic, 7 agrammatic variant) using a picture-naming task and voxel-based morphometry for anatomo-functional correlation. First, we analyzed correlations for each of the three variants to identify the regions impacting naming in PPA and to disentangle the core regions of word finding. We then combined the three variants and correlation analyses for naming (semantic-to-lexical mapping) and single-word comprehension (lexical-to-semantic mapping), predicting an overlap zone corresponding to a bidirectional lexical-semantic hub. Results and Conclusions Our results showed that superior portions of the left temporal pole and left posterior temporal cortices impact semantic and lexical naming mechanisms in semantic and logopenic PPA, respectively. In agrammatic PPA naming deficits were rare, and did not correlate with any cortical region. Combined analyses revealed a cortical overlap zone in superior/middle mid-temporal cortices, distinct from the two former regions, impacting bidirectional binding of lexical and semantic information. Altogether, our findings indicate that lexical/semantic word processing depends on an anterior-posterior axis within lateral-temporal cortices, including an anatomically intermediate hub dedicated to lexical-semantic integration. Within this axis our data reveal the underpinnings of anomia in the PPA variants, which is of relevance for both diagnosis and future therapy strategies.	[Migliaccio, Raffaella; Boutet, Claire; Valabregue, Romain; Lehericy, Stephane; Levy, Richard; Dubois, Bruno; Teichmann, Marc] UMR INSERM CNRS UPMC 1127, Inst Cerveau & Moelle Epiniere, Paris, France; [Migliaccio, Raffaella; Ferrieux, Sophie; Nogues, Marie; Dubois, Bruno; Teichmann, Marc] Hop La Pitie Salpetriere, AP HP, Natl Reference Ctr PPA & Rare Dementias, Dept Neurol, Paris, France; [Boutet, Claire; Valabregue, Romain; Lehericy, Stephane] Ctr Neuroimagerie Rech CENIR, Inst Cerveau & Moelle Epiniere, Paris, France; [Dormont, Didier] Univ Paris 06, INSERM, UMR S 678, Paris, France; [Dormont, Didier] Hop La Pitie Salpetriere, AP HP, Serv Neuroradiol Diagnost & Fonct, Paris, France; [Levy, Richard] Hop St Antoine, AP HP, Dept Neurol, F-75571 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Teichmann, M (corresponding author), UMR INSERM CNRS UPMC 1127, Inst Cerveau & Moelle Epiniere, Paris, France.; Teichmann, M (corresponding author), Hop La Pitie Salpetriere, AP HP, Natl Reference Ctr PPA & Rare Dementias, Dept Neurol, Paris, France.	marc.teichmann@psl.aphp.fr	valabregue, romain/GWQ-7484-2022; Levy, Richard/D-8411-2011	valabregue, romain/0000-0002-1814-9570; Migliaccio, Raffaella/0000-0002-6960-8474	"France Alzheimer" Foundation; "Philippe Chatrier" Foundation	"France Alzheimer" Foundation; "Philippe Chatrier" Foundation	We would like to thank Dalila Samri, Tiffany Landure and Richard Gnassounou for assessing patients with general cognitive tests. Raffaella Migliaccio was supported by the "France Alzheimer" and "Philippe Chatrier" Foundations; however no specific funding for this study was received by the author.	Agniel Aau, 1992, PROTOCOLE MONTREAL T; Agosta F, 2010, BRAIN, V133, P286, DOI 10.1093/brain/awp233; Amici S, 2007, COGN BEHAV NEUROL, V20, P203, DOI 10.1097/WNN.0b013e31815e6265; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bozeat S, 2000, NEUROPSYCHOLOGIA, V38, P1207, DOI 10.1016/S0028-3932(00)00034-8; Brambati SM, 2006, J COGNITIVE NEUROSCI, V18, P1644, DOI 10.1162/jocn.2006.18.10.1644; Brambati SM, 2015, NEUROIMAGE-CLIN, V8, P345, DOI 10.1016/j.nicl.2015.01.011; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Caviness VS, 2002, STROKE, V33, P2549, DOI 10.1161/01.STR.0000036083.90045.08; Damasio H, 2004, COGNITION, V92, P179, DOI 10.1016/j.cognition.2002.07.001; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; DeLeon J, 2007, BRAIN, V130, P1408, DOI 10.1093/brain/awm011; Deloche G, 1997, TEST DENOMINATION OR; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galantucci S, 2011, BRAIN, V134, P3011, DOI 10.1093/brain/awr099; Gesierich B, 2012, CEREB CORTEX, V22, P2217, DOI 10.1093/cercor/bhr286; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Gorno-Tempini ML, 2004, ANN NEUROL, V55, P335, DOI 10.1002/ana.10825; Grande M, 2012, NEUROIMAGE, V61, P702, DOI 10.1016/j.neuroimage.2012.03.087; Graves WW, 2008, J COGNITIVE NEUROSCI, V20, P1698, DOI 10.1162/jocn.2008.20113; Graves WW, 2007, J COGNITIVE NEUROSCI, V19, P617, DOI 10.1162/jocn.2007.19.4.617; Grossman M, 2004, BRAIN, V127, P628, DOI 10.1093/brain/awh075; Henry ML, 2010, CURR OPIN NEUROL, V23, P633, DOI 10.1097/WCO.0b013e32833fb93e; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hillis AE, 2004, ANN NEUROL, V55, P268, DOI 10.1002/ana.10812; Hillis AE, 2006, J NEUROSCI, V26, P8069, DOI 10.1523/JNEUROSCI.2088-06.2006; Hurley RS, 2012, J NEUROSCI, V32, P4848, DOI 10.1523/JNEUROSCI.5984-11.2012; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Kotz SA, 2002, NEUROIMAGE, V17, P1761, DOI 10.1006/nimg.2002.1316; Lau EF, 2013, J NEUROSCI, V 33, P17174, DOI 10.1523/JNEUROSCI.1018-13.2013; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Leyton CE, 2013, NEUROLOGY, V80, P897, DOI 10.1212/WNL.0b013e318285c15b; Leyton CE, 2011, BRAIN, V134, P3030, DOI 10.1093/brain/awr216; Mahoney CJ, 2013, NEUROBIOL AGING, V34, P1687, DOI 10.1016/j.neurobiolaging.2012.12.002; Mazaux JM, 1982, BOSTON DIAGNOSTIC AP; Mesulam MM, 2014, NAT REV NEUROL, V10, P554, DOI 10.1038/nrneurol.2014.159; Mesulam MM, 2013, BRAIN, V136, P601, DOI 10.1093/brain/aws336; Mesulam MM, 2003, ANN NEUROL, V54, pS11, DOI 10.1002/ana.10569; Migliaccio R, 2012, ALZHEIMERS DEMENT S, V8, pS78; Miller ZA, 2013, BRAIN, V136, P3461, DOI 10.1093/brain/awt242; Miozzo M, 2015, CEREB CORTEX, V25, P3343, DOI 10.1093/cercor/bhu137; Nestor PJ, 2003, BRAIN, V126, P2406, DOI 10.1093/brain/awg240; New B, 2004, BEHAV RES METH INS C, V36, P516, DOI 10.3758/BF03195598; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Powers JP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00212; Race DS, 2013, BRAIN LANG, V127, P167, DOI 10.1016/j.bandl.2013.09.004; Ralph MAL, 2001, J COGNITIVE NEUROSCI, V13, P341, DOI 10.1162/08989290151137395; Ralph MAL, 2008, ANN NY ACAD SCI, V1124, P61, DOI 10.1196/annals.1440.006; Ralph MAL, 2007, BRAIN, V130, P1127, DOI 10.1093/brain/awm025; Raymer AM, 1997, BRAIN LANG, V58, P137, DOI 10.1006/brln.1997.1786; ROELOFS A, 1992, J EXPT PSYCHOL LEARN, V42, P107, DOI DOI 10.1016/0010-0277(92)90041-F; Rohrer JD, 2010, NEUROIMAGE, V49, P984, DOI 10.1016/j.neuroimage.2009.08.002; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Schwartz MF, 2009, BRAIN, V132, P3411, DOI 10.1093/brain/awp284; Teichmann M, 2013, BRAIN, V136, P3474, DOI 10.1093/brain/awt266; Walker GM, 2011, BRAIN LANG, V117, P110, DOI 10.1016/j.bandl.2010.09.008; Wilson SM, 2010, BRAIN, V133, P2069, DOI 10.1093/brain/awq129; Wilson SM, 2009, HUM BRAIN MAPP, V30, P3596, DOI 10.1002/hbm.20782; Wise RJS, 2003, BRIT MED BULL, V65, P95, DOI 10.1093/bmb/65.1.95	60	35	36	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148707	10.1371/journal.pone.0148707	http://dx.doi.org/10.1371/journal.pone.0148707			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26901052	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100022
J	Otten, M				Otten, Marte			Race Guides Attention in Visual Search	PLOS ONE			English	Article							IMPLICIT ASSOCIATION TEST; PERCEPTION; FACES; PREJUDICE; EMOTION; STEREOTYPES; EXPRESSIONS; THREAT; BRAIN; BLACK	It is known that faces are rapidly and even unconsciously categorized into social groups (black vs. white, male vs. female). Here, I test whether preferences for specific social groups guide attention, using a visual search paradigm. In Experiment 1 participants searched displays of neutral faces for an angry or frightened target face. Black target faces were detected more efficiently than white targets, indicating that black faces attracted more attention. Experiment 2 showed that attention differences between black and white faces were correlated with individual differences in automatic race preference. In Experiment 3, using happy target faces, the attentional preference for black over white faces was eliminated. Taken together, these results suggest that automatic preferences for social groups guide attention to individuals from negatively valenced groups, when people are searching for a negative emotion such as anger or fear.	[Otten, Marte] Univ Amsterdam, Amsterdam, Netherlands; [Otten, Marte] Univ Sussex, Brighton, E Sussex, England	University of Amsterdam; University of Sussex	Otten, M (corresponding author), Univ Amsterdam, Amsterdam, Netherlands.; Otten, M (corresponding author), Univ Sussex, Brighton, E Sussex, England.	m.otten@uva.nl			Netherlands Organization for Scientific Research NWO [446-07-016]	Netherlands Organization for Scientific Research NWO(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organization for Scientific Research NWO (http://www.nwo.nl/en) [Rubicon grant 446-07-016 to MO]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Janabi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046119; Brosch T, 2012, COGNITION, V125, P309, DOI 10.1016/j.cognition.2012.07.007; BRUNER JS, 1947, J ABNORM SOC PSYCH, V42, P33, DOI 10.1037/h0058484; Chiao JY, 2006, PSYCHOL SCI, V17, P387, DOI 10.1111/j.1467-9280.2006.01717.x; Correll J, 2002, J PERS SOC PSYCHOL, V83, P1314, DOI 10.1037//0022-3514.83.6.1314; DEVINE PG, 1989, J PERS SOC PSYCHOL, V56, P5, DOI 10.1037/0022-3514.56.1.5; Dickter C, 2012, SOC NEUROSCI-UK, V7, P240, DOI 10.1080/17470919.2011.609906; Donders NC, 2008, J EXP SOC PSYCHOL, V44, P1328, DOI 10.1016/j.jesp.2008.04.002; Eberhardt JL, 2004, J PERS SOC PSYCHOL, V87, P876, DOI 10.1037/0022-3514.87.6.876; Fox E, 2000, COGNITION EMOTION, V14, P61, DOI 10.1080/026999300378996; Frischen A, 2008, PSYCHOL BULL, V134, P662, DOI 10.1037/0033-2909.134.5.662; Goldstein B., 2001, BLACKWELL HDB PERCEP, P272; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Hugenberg K, 2003, PSYCHOL SCI, V14, P640, DOI 10.1046/j.0956-7976.2003.psci_1478.x; Ito TA, 2013, VIS COGN, V21, P1096, DOI 10.1080/13506285.2013.821430; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Kubota JT, 2007, J EXP SOC PSYCHOL, V43, P738, DOI 10.1016/j.jesp.2006.10.023; Levin DT, 1996, J EXP PSYCHOL LEARN, V22, P1364, DOI 10.1037/0278-7393.22.6.1364; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; NEISSER U, 1963, AM J PSYCHOL, V76, P376, DOI 10.2307/1419778; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Payne BK, 2001, J PERS SOC PSYCHOL, V81, P181, DOI 10.1037/0022-3514.81.2.181; POSNER MI, 1994, P NATL ACAD SCI USA, V91, P7398, DOI 10.1073/pnas.91.16.7398; Purcell DG, 1996, PERCEPTION, V25, P1091, DOI 10.1068/p251091; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Trawalter S, 2008, J EXP SOC PSYCHOL, V44, P1322, DOI 10.1016/j.jesp.2008.03.006; Walker PM, 2008, SOC COGN AFFECT NEUR, V3, P16, DOI 10.1093/scan/nsm035; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411; Yiend J, 2010, COGNITION EMOTION, V24, P3, DOI 10.1080/02699930903205698	31	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149158	10.1371/journal.pone.0149158	http://dx.doi.org/10.1371/journal.pone.0149158			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26900957	Green Submitted, Green Published, gold			2022-12-27	WOS:000371276100043
J	Vilaca, M; Aragao, I; Cardoso, T; Dias, C; Cabral-Campello, G				Vilaca, Marta; Aragao, Irene; Cardoso, Teresa; Dias, Claudia; Cabral-Campello, Gloria			The Role of Noninvasive Ventilation in Patients with "Do Not Intubate" Order in the Emergency Setting	PLOS ONE			English	Article							ACUTE RESPIRATORY-FAILURE; POSITIVE-PRESSURE VENTILATION; MECHANICAL VENTILATION; PALLIATIVE USE; CARE; PREDICTORS	Background Noninvasive ventilation (NIV) is being used increasingly in patients who have a "do not intubate" (DNI) order. However, the impact of NIV on the clinical and health-related quality of life (HRQOL) in the emergency setting is not known, nor is its effectiveness for relieving symptoms in end-of-life care. Objective The aim of this prospective study was to determine the outcome and HRQOL impact of regular use of NIV outcomes on patients with a DNI order who were admitted to the emergency room department (ED). METHODS: Eligible for participation were DNI-status patients who receive NIV for acute or acute-on-chronic respiratory failure when admitted to the ED of a tertiary care, university-affiliated, 600-bed hospital between January 2014 and December 2014. Patients were divided into 2 groups: (1) those whose DNI order related to a decision to withhold therapy and (2) those for whom any treatment, including NIV, was provided for symptom relief only. HRQOL was evaluated only in group 1, using the 12-item Short Form Health Survey (SF-12). Long-term outcome was evaluated 90 days after hospital discharge by means of a telephone interview. Results During the study period 1727 patients were admitted to the ED, 243 were submitted to NIV and 70 (29%) were included in the study. Twenty-nine (41%) of the 70 enrollees received NIV for symptom relief only (group2). Active cancer [7% vs 35%, p = 0,004] and neuromuscular diseases [0% vs. 17%] were more prevalent in this group. NIV was stopped in 59% of the patients in group 2 due to lake of clinical benefit. The in-hospital mortality rate was 37% for group 1 and 86% for group 2 0,001). Among patients who were discharged from hospital, 23% of the group 1 and all patients in group 2 died within 90 days. Relative to baseline, no significant decline in HRQOL occurred in group 1 by 90 days postdischarge. Conclusion The survival rate was 49% among DNI-status patients for whom NIV was used as a treatment in ED, and these patients did not experience a decline in HRQOL throughout the study. NIV did not provide significant relief of symptoms in more than half the patients who receive it for that purpose.	[Vilaca, Marta] Univ Porto, MIM, ICBAS, Oporto, Portugal; [Aragao, Irene; Cardoso, Teresa; Cabral-Campello, Gloria] Oporto Hosp Ctr, Intens Care Unit UCIP, Oporto, Portugal; [Dias, Claudia] Univ Porto, Fac Med, Ctr Hlth Technol & Serv Res CINTESIS, Oporto, Portugal; [Dias, Claudia] Univ Porto, Fac Med, Informat Sci & Decis Hlth Dept CIDES, Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto	Vilaca, M (corresponding author), Univ Porto, MIM, ICBAS, Oporto, Portugal.	martarnvilaca@gmail.com	Dias, Claudia Camila/N-7130-2014	Dias, Claudia Camila/0000-0001-9356-3272; Aragao, Irene/0000-0001-5750-2739	Discipline of Initiation to Clinical Investigation (Disciplina de Iniciacao a Investigacao Clinica) of Instituto de Ciencias Biomedicas Abel Salazar; ASSUCIP (Associacao dos Amigos da Unidade de Cuidados Intensivos Polivalente, Hospital de Santo Antonio, Porto, Portugal)	Discipline of Initiation to Clinical Investigation (Disciplina de Iniciacao a Investigacao Clinica) of Instituto de Ciencias Biomedicas Abel Salazar; ASSUCIP (Associacao dos Amigos da Unidade de Cuidados Intensivos Polivalente, Hospital de Santo Antonio, Porto, Portugal)	Supported, in part, by grants from the Discipline of Initiation to Clinical Investigation (Disciplina de Iniciacao a Investigacao Clinica) of Instituto de Ciencias Biomedicas Abel Salazar and in part by ASSUCIP (Associacao dos Amigos da Unidade de Cuidados Intensivos Polivalente, Hospital de Santo Antonio, Porto, Portugal).	Antonelli M, 2001, INTENS CARE MED, V27, P1718, DOI 10.1007/s00134-001-1114-4; Azoulay E, 2014, INTENS CARE MED, V40, P305, DOI 10.1007/s00134-014-3217-8; Azoulay E, 2013, INTENS CARE MED, V39, P292, DOI 10.1007/s00134-012-2746-2; Azoulay E, 2011, INTENS CARE MED, V37, P1250, DOI 10.1007/s00134-011-2263-8; Baudouin S, 2002, THORAX, V57, P192; Brochard L, 2014, SEMIN RESP CRIT CARE, V35, P492, DOI 10.1055/s-0034-1383863; Cabrini L, 2012, RESP CARE, V57, P704, DOI 10.4187/respcare.01474; Chiumello D, 2009, RESP CARE, V54, P1302; Curtis JR, 2007, CRIT CARE MED, V35, P932, DOI 10.1097/01.CCM.0000256725.73993.74; Fiorino S, 2015, INTERN MED J, V45, P527, DOI 10.1111/imj.12726; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Hill NS, 2009, RESP CARE, V54, P62; L'Her E, 2004, INTENS CARE MED, V30, P882, DOI 10.1007/s00134-004-2183-y; Nava S, 2009, MINERVA ANESTESIOL, V75, P31; Nava S, 2013, LANCET ONCOL, V14, P219, DOI 10.1016/S1470-2045(13)70009-3; Phua J, 2005, INTENS CARE MED, V31, P533, DOI 10.1007/s00134-005-2582-8; Quill CM, 2014, J PALLIAT MED, V17, P657, DOI 10.1089/jpm.2014.0010; Scarpazza P, 2011, INT J CHRONIC OBSTR, V6, P253, DOI 10.2147/COPD.S18501; Scarpazza Paolo, 2008, Int J Chron Obstruct Pulmon Dis, V3, P797; Schnell D, 2014, INTENS CARE MED, V40, P582, DOI 10.1007/s00134-014-3222-y; Schortgen F, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-5; Shreves Ashley, 2013, Emerg Med Pract, V15, P1; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Squadrone E, 2004, INTENS CARE MED, V30, P1303, DOI 10.1007/s00134-004-2320-7; Thille AW, 2013, CRIT CARE, V17, DOI 10.1186/cc13103	25	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149649	10.1371/journal.pone.0149649	http://dx.doi.org/10.1371/journal.pone.0149649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901060	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100121
J	Chang, Y; Li, B; Xu, XL; Shen, L; Bai, HX; Gao, F; Zhang, ZB; Jonas, JB				Chang, Ying; Li, Bin; Xu, Xiaolin; Shen, Ling; Bai, Haixia; Gao, Fei; Zhang, Zhibao; Jonas, Jost B.			Lentivirus-Mediated Knockdown of Astrocyte Elevated Gene-1 Inhibits Growth and Induces Apoptosis through MAPK Pathways in Human Retinoblastoma Cells	PLOS ONE			English	Article							RAPID SUBTRACTION HYBRIDIZATION; PROTEIN-KINASES; CYTOCHROME-C; CANCER-CELLS; EXPRESSION; PROGRESSION; ACTIVATION; SURVIVAL; DEATH; JNK	Purpose To explore expression and function of astrocyte elevated gene-1 (AEG-1) in human retinoblastoma (RB). Methods The expression of AEG-1 in histological sections of human RBs and in RB cell lines was examined using immunohistochemical staining and RT-PCR and Western blotting respectively. We knocked down AEG-1 gene levels by AEG-1-siRNA lentivirus transfection of human RB cell lines SO-RB50 and Y79, and using an MTT assay, we assessed the role of AEG-1 on RB cell proliferation. The biological significance of lentivirus transfection induced AEG-1 down-regulation was examined by assessing the apoptosis rate in the transfected RB cells by Annexin V-APC staining and flow cytometry. We additionally measured the expression of Bcl-2, Bax, cleaved-caspase-3 and caspase-3, and the phosphorylation and non-phosphorylation alternation of MAPKs. Results AEG-1 expression was detected to be strongly positive in the histological slides of 35 out of 54 (65%) patients with RB. AEG-1 expression increased significantly (P<0.05) with tumor stage. In the RB cell lines SO-RB50, Y79 and WERI-RB1 as compared with retinal pigment epithelium cells, expression of AEG-1 mRNA and AEG-1 protein was significantly higher. In AEG-1-siRNA lentivirus transfected cell cultures as compared with negative control lentivirus transfected cell cultures, levels of AEG-1 mRNA and of AEG-1 protein (P<0.05) and cell growth rates (P<0.01) were significantly lower, and apoptosis rate (P<0.001), Bax/Bcl-2 ratio and cleaved-caspase-3 protein level were significantly increased. The P-ERK/ERK ratio was significantly decreased in the AEG-1-siRNA lentivirus transfected cell lines. Conclusions Expression of AEG-1 was associated with RB, in histological slides of patients and in cell culture experiments. Lentivirus transfection induced knockdown of AEG-1 had a tumor suppressive effect, potentially by tumor cell apoptosis induction through inhibition of ERK.	[Chang, Ying; Li, Bin; Xu, Xiaolin; Shen, Ling; Bai, Haixia; Gao, Fei; Zhang, Zhibao] Capital Med Univ, Beijing TongRen Hosp, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Inst Ophthalmol,Beijing TongRen Eye Ctr, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany	Capital Medical University; Ruprecht Karls University Heidelberg	Li, B (corresponding author), Capital Med Univ, Beijing TongRen Hosp, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Inst Ophthalmol,Beijing TongRen Eye Ctr, Beijing, Peoples R China.	libin43_99@163.com	Shen, Ling/AAF-9067-2020; fei, Gao/GQQ-8024-2022; Bai, Haixia/HDO-0641-2022		National Natural Science Foundation of China [81172393]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grant No. 81172393, 2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaman-Pillet N, 2013, OPHTHALMIC GENET, V34, P1, DOI 10.3109/13816810.2011.615077; Cai BB, 2006, J BIOL CHEM, V281, P25215, DOI 10.1074/jbc.M512627200; Chevez-Barrios P, 2000, AM J PATHOL, V157, P1405, DOI 10.1016/S0002-9440(10)64653-6; Corson TW, 2007, GENE CHROMOSOME CANC, V46, P617, DOI 10.1002/gcc.20457; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; de Jong MC, 2014, LANCET ONCOL, V15, P1157, DOI 10.1016/S1470-2045(14)70336-5; Dimaras H, 2012, LANCET, V379, P1436, DOI 10.1016/S0140-6736(11)61137-9; Emdad L, 2007, PHARMACOL THERAPEUT, V114, P155, DOI 10.1016/j.pharmthera.2007.01.010; Emdad L, 2013, ADV CANCER RES, V120, P75, DOI 10.1016/B978-0-12-401676-7.00003-6; Emdad L, 2010, MOL CANCER THER, V9, P79, DOI 10.1158/1535-7163.MCT-09-0752; Fan MY, 2001, DRUG RESIST UPDATE, V4, P253, DOI 10.1054/drup.2001.0214; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kivela T, 2003, OPHTHALMOLOGY, V110, P1983, DOI 10.1016/S0161-6420(03)00484-6; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Kong XL, 2012, CANCER BIOL THER, V13, P43, DOI 10.4161/cbt.13.1.18868; Lee SG, 2009, ONCOGENE, V28, P2476, DOI 10.1038/onc.2009.93; Li J, 2008, CLIN CANCER RES, V14, P3319, DOI 10.1158/1078-0432.CCR-07-4054; Li L, 2011, INVEST OPHTH VIS SCI, V52, P8393, DOI 10.1167/iovs.11-8139; Li SP, 2003, CANCER RES, V63, P3473; Liu LP, 2010, CANCER RES, V70, P3750, DOI 10.1158/0008-5472.CAN-09-3838; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCFALL RC, 1977, CANCER RES, V37, P1003; Min HB, 2012, MOL CARCINOGEN, V51, P576, DOI 10.1002/mc.20825; Muthusamy V, 2010, ARCH DERMATOL RES, V302, P5, DOI 10.1007/s00403-009-0994-y; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Park KJ, 2015, J NEURO-ONCOL, V121, P31, DOI 10.1007/s11060-014-1603-2; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; REID TW, 1974, J NATL CANCER I, V53, P347, DOI 10.1093/jnci/53.2.347; Rodriguez-Galindo C, 2008, PEDIATRICS, V122, pE763, DOI 10.1542/peds.2008-0518; Seregard S, 2004, OPHTHALMOLOGY, V111, P1228, DOI 10.1016/j.ophtha.2003.10.023; Singh L, 2015, CLIN EXP OPHTHALMOL, V43, P259, DOI 10.1111/ceo.12397; Su ZZ, 2003, GENE, V306, P67, DOI 10.1016/S0378-1119(03)00404-9; Su ZZ, 2002, ONCOGENE, V21, P3592, DOI 10.1038/sj.onc.1205445; Temming P, 2012, FUTURE ONCOL, V8, P525, DOI [10.2217/fon.12.41, 10.2217/FON.12.41]; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Wagner N, 2003, EXP EYE RES, V77, P1, DOI 10.1016/s0014-4835(03)00108-8; Wang JW, 2014, FEBS J, V281, P1355, DOI 10.1111/febs.12659; Wang JW, 2022, FEBS LETT, DOI 10.1016/j.febslet.2013.04.029; Xia ZB, 2010, CLIN NEUROL NEUROSUR, V112, P413, DOI 10.1016/j.clineuro.2010.02.007; Xu YF, 2009, CANCER LETT, V284, P229, DOI 10.1016/j.canlet.2009.04.028; Yoo BK, 2011, PHARMACOL THERAPEUT, V130, P1, DOI 10.1016/j.pharmthera.2011.01.008; Yoo BK, 2009, J CLIN INVEST, V119, P465, DOI 10.1172/JCI36460; Yunoki T, 2015, GRAEF ARCH CLIN EXP, V253, P399, DOI 10.1007/s00417-014-2874-1	44	15	16	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148763	10.1371/journal.pone.0148763	http://dx.doi.org/10.1371/journal.pone.0148763			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894431	Green Submitted, Green Published, gold			2022-12-27	WOS:000371223400021
J	Mastrantonio, R; Cervelli, M; Pietropaoli, S; Mariottini, P; Colasanti, M; Persichini, T				Mastrantonio, Roberta; Cervelli, Manuela; Pietropaoli, Stefano; Mariottini, Paolo; Colasanti, Marco; Persichini, Tiziana			HIV-Tat Induces the Nrf2/ARE Pathway through NMDA Receptor-Elicited Spermine Oxidase Activation in Human Neuroblastoma Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; POLYAMINE CATABOLISM; PROTEIN; NEUROTOXICITY; LOCALIZATION; EXPRESSION; DAMAGE; GP120; MODEL; ACID	Previously, we reported that HIV-Tat elicits spermine oxidase (SMO) activity upregulation through NMDA receptor (NMDAR) stimulation in human SH-SY5Y neuroblastoma cells, thus increasing ROS generation, which in turn leads to GSH depletion, oxidative stress, and reduced cell viability. In several cell types, ROS can trigger an antioxidant cell response through the transcriptional induction of oxidative stress-responsive genes regulated by the nuclear factor erythroid 2-related factor 2 (Nrf2). Here, we demonstrate that Tat induces both antioxidant gene expression and Nrf2 activation in SH-SY5Y cells, mediated by SMO activity. Furthermore, NMDAR is involved in Tat-induced Nrf2 activation. These findings suggest that the NMDAR/SMO/Nrf2 pathway is an important target for protection against HIV-associated neurocognitive disorders.	[Mastrantonio, Roberta; Cervelli, Manuela; Pietropaoli, Stefano; Mariottini, Paolo; Colasanti, Marco; Persichini, Tiziana] Univ ROMA TRE, Dept Sci, Rome, Italy	Italfarmaco; Roma Tre University	Persichini, T (corresponding author), Univ ROMA TRE, Dept Sci, Rome, Italy.	tiziana.persichini@uniroma3.it	COLASANTI, MARCO/A-5616-2010; Cervelli, Manuela/ABC-6913-2020	COLASANTI, MARCO/0000-0002-5752-4943; Cervelli, Manuela/0000-0001-8535-8279; PERSICHINI, TIZIANA/0000-0001-8291-6706; mastrantonio, roberta/0000-0002-1764-457X; Pietropaoli, Stefano/0000-0002-8423-9187	University "ROMA TRE"	University "ROMA TRE"	This work was supported by University "ROMA TRE" contribution for the laboratory (CAL) to M. Cervelli, M. Colasanti, PM, TP, and for the PhD school (Department of Science) to RM and SP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akay C, 2014, J NEUROVIROL, V20, P39, DOI 10.1007/s13365-013-0227-1; Banerjee A, 2010, FREE RADICAL BIO MED, V48, P1388, DOI 10.1016/j.freeradbiomed.2010.02.023; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Capone C, 2013, FREE RADICAL BIO MED, V63, P99, DOI 10.1016/j.freeradbiomed.2013.05.007; Casero RA, 2009, BIOCHEM J, V421, P323, DOI 10.1042/BJ20090598; Cervelli M, 2004, EUR J BIOCHEM, V271, P760, DOI 10.1111/j.1432-1033.2004.03979.x; Cervelli M, 2003, J BIOL CHEM, V278, P5271, DOI 10.1074/jbc.M207888200; Cervelli M, 2014, AMINO ACIDS, V46, P521, DOI 10.1007/s00726-013-1572-3; Cervelli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064810; Cervelli M, 2013, J ENZYM INHIB MED CH, V28, P463, DOI 10.3109/14756366.2011.650691; Cervelli M, 2012, AMINO ACIDS, V42, P441, DOI 10.1007/s00726-011-1014-z; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; Davinelli S, 2014, BIOGERONTOLOGY, V15, P449, DOI 10.1007/s10522-014-9511-6; de Vera N, 2008, J NEUROSCI RES, V86, P861, DOI 10.1002/jnr.21538; Facecchia K, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/683728; Ghafouri M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-28; Gill AJ, 2013, CRIT REV IMMUNOL, V33, P307, DOI 10.1615/critrevimmunol.2013007247; Isaguliants M, 2013, HUM VACC IMMUNOTHER, V9, P2111, DOI 10.4161/hv.25813; Jing X, 2015, NEUROSCIENCE, V286, P131, DOI 10.1016/j.neuroscience.2014.11.047; Johnson DA, 2015, FREE RADIC IN PRESS; Kanninen KM, 2015, FREE RADIC IN PRESS; Kolson DL, 2002, CLIN LAB MED, V22, P703, DOI 10.1016/S0272-2712(02)00009-4; Kwak MK, 2003, BIOCHEM BIOPH RES CO, V305, P662, DOI 10.1016/S0006-291X(03)00834-9; LEFF JA, 1992, FREE RADICAL BIO MED, V13, P143, DOI 10.1016/0891-5849(92)90076-S; Mann GE, 2015, FREE RADIC BIOL MED; MATES JM, 1992, AGENTS ACTIONS, V36, P17, DOI 10.1007/BF01991222; Niture SK, 2014, FREE RADICAL BIO MED, V66, P36, DOI 10.1016/j.freeradbiomed.2013.02.008; PACE GW, 1995, FREE RADICAL BIO MED, V19, P523, DOI 10.1016/0891-5849(95)00047-2; Park MH, 2013, BIOMOL THER, V21, P1, DOI 10.4062/biomolther.2012.097; Persichini T, 2014, FREE RADICAL BIO MED, V74, P14, DOI 10.1016/j.freeradbiomed.2014.06.009; Reddy PVB, 2012, NEUROCHEM INT, V61, P807, DOI 10.1016/j.neuint.2011.06.011; Reynolds A, 2007, INT REV NEUROBIOL, V82, P297, DOI 10.1016/S0074-7742(07)82016-2; Suzuki T, 2015, FREE RADIC IN PRESS; Takahashi K, 1996, ANN NEUROL, V39, P705, DOI 10.1002/ana.410390606; Toborek M, 2003, J NEUROCHEM, V84, P169, DOI 10.1046/j.1471-4159.2003.01543.x; Wang Q, 2005, MOL NEUROBIOL, V31, P3, DOI 10.1385/MN:31:1-3:003; Wood PL, 2006, BRAIN RES, V1095, P190, DOI 10.1016/j.brainres.2006.04.038; Zahedi K, 2010, J NEUROTRAUM, V27, P515, DOI 10.1089/neu.2009.1097; Zhang HS, 2009, FREE RADICAL BIO MED, V47, P261, DOI 10.1016/j.freeradbiomed.2009.04.028	39	34	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149802	10.1371/journal.pone.0149802	http://dx.doi.org/10.1371/journal.pone.0149802			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895301	Green Submitted, Green Published, gold			2022-12-27	WOS:000371223400083
J	Odajima, T; Takanashi, M; Sugimori, H; Tanba, T; Yoshinaga, K; Motoji, T; Munakata, M; Nakajima, K; Minami, M				Odajima, Takeshi; Takanashi, Minoko; Sugimori, Hiroki; Tanba, Taiko; Yoshinaga, Kentaro; Motoji, Toshiko; Munakata, Masaya; Nakajima, Kazunori; Minami, Mutsuhiko			Impact of Elevated Hemoglobin and Serum Protein on Vasovagal Reaction from Blood Donation	PLOS ONE			English	Article							ADVERSE-REACTIONS; DONORS; SEX	We conducted a cross-sectional study to elucidate factors contributing to vasovagal reaction (VVR), the most frequent side effect following whole blood and apheresis donations. Complications recorded at the collection sites after voluntary donations by the Japanese Red Cross Tokyo Blood Center (JRC), in the 2006 and 2007 fiscal years, were analyzed by both univariate analysis and the multivariate conditional logistic regression model. Of 1,119,716 blood donations over the full two years, complications were recorded for 13,320 donations (1.18%), among which 67% were VVR. There were 4,303 VVR cases which had sufficient information and could be used for this study. For each VVR case, two sex- and age-matched controls (n = 8,606) were randomly selected from the donors without complications. Age, sex, body mass index (BMI), predonation blood pressure, pulse and blood test results, including total protein, albumin, and hemoglobin, were compared between the VVR group and the control group. In univariate analysis, the VVR group was significantly younger, with a lower BMI, higher blood pressure and higher blood protein and hemoglobin levels than the control group (p<0.001). Furthermore, blood protein and hemoglobin levels showed dose-dependent relationships with VVR incidences by the Cochran-Armitage trend test (p<0.01). For both sexes, after adjusting for confounders with the multivariate conditional logistic regression model, the higher than median groups for total protein (male: OR 1.97; 95% CI 1.76,-2.21; female: OR 2.29; 95% CI 2.05-2.56), albumin (male: 1.75; 1.55-1.96; female: 1.76; 1.57-1.97) and hemoglobin (male: 1.98; 1.76-2.22; female: 1.62; 1.45-1.81) had statistically significant higher risk of VVR compared to the lower than median groups. These elevated serum protein and hemoglobin levels might offer new indicators to help understand VVR occurrence.	[Odajima, Takeshi; Nakajima, Kazunori; Minami, Mutsuhiko] Japanese Red Cross Kanto Koshinetsu Block Blood C, Koto Ku, Tokyo, Japan; [Takanashi, Minoko] Japanese Red Cross Soc, Minato Ku, Tokyo, Japan; [Sugimori, Hiroki; Tanba, Taiko; Munakata, Masaya] Daito Bunka Univ, Dept Sports & Hlth Sci, Saitama, Japan; [Yoshinaga, Kentaro; Motoji, Toshiko] Tokyo Womens Med Univ, Dept Haematol, Shinjuku Ku, Tokyo, Japan	Tokyo Women's Medical University	Sugimori, H (corresponding author), Daito Bunka Univ, Dept Sports & Hlth Sci, Saitama, Japan.	hsugimor@ic.daito.ac.jp		SUGIMORI, HIROKI/0000-0003-1234-417X				Ando S, 2009, TRANSFUSION, V49, P1630, DOI 10.1111/j.1537-2995.2009.02189.x; Bravo M, 2011, VOX SANG, V101, P303, DOI 10.1111/j.1423-0410.2011.01494.x; Eder AF, 2008, TRANSFUSION, V48, P1809, DOI 10.1111/j.1537-2995.2008.01811.x; Eder AF, 2008, JAMA-J AM MED ASSOC, V299, P2279, DOI 10.1001/jama.299.19.2279; Goncalez TT, 2012, TRANSFUSION, V52, P1070, DOI 10.1111/j.1537-2995.2011.03432.x; Hanson SA, 2004, TRANSFUSION, V44, P924, DOI 10.1111/j.1537-2995.2004.03426.x; Kaga Y, 2006, J JPN B, V29, P439; Kamel H, 2010, TRANSFUSION, V50, P556, DOI 10.1111/j.1537-2995.2009.02397.x; Ministry of Health Labour and Welfare, 2009, ANN REP BLOOD PROGR; Ministry of Health Labour and Welfare, 2011, ANN REP BLOOD PROGR; Ministry of Health Labour and Welfare, 2010, ANN REP BLOOD PROGR; Newman BH, 2005, TRANSFUSION, V45, P1715, DOI 10.1111/j.1537-2995.2005.00595.x; Newman BH, 2002, TRANSFUSION, V42, P1557, DOI 10.1046/j.1537-2995.2002.00238.x; Newman B, 2007, TRANSFUSION, V47, P1524, DOI 10.1111/j.1537-2995.2007.01293.x; OGATA H, 1980, TRANSFUSION, V20, P679, DOI 10.1046/j.1537-2995.1980.20681057157.x; OGAWA R, 1970, Respiration and Circulation, V18, P833; Philip Joseph, 2014, Asian J Transfus Sci, V8, P43, DOI 10.4103/0973-6247.126690; Rios JA, 2010, TRANSFUSION, V50, P1265, DOI 10.1111/j.1537-2995.2009.02578.x; Saito F, 2013, TRANSFUSION, V53, P2744, DOI 10.1111/trf.12120; SAS Institute Inc, 1993, SAS US GUID STAT VER; Takanashi M, 2012, TRANSFUS APHER SCI, V47, P319, DOI 10.1016/j.transci.2012.04.002; Tomita T, 2002, TRANSFUSION, V42, P1561, DOI 10.1046/j.1537-2995.2002.00241.x; Trouern-Trend JJ, 1999, TRANSFUSION, V39, P316, DOI 10.1046/j.1537-2995.1999.39399219291.x; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Wiltbank TB, 2008, TRANSFUSION, V48, P1799, DOI 10.1111/j.1537-2995.2008.01745.x	25	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148854	10.1371/journal.pone.0148854	http://dx.doi.org/10.1371/journal.pone.0148854			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894814	Green Published, Green Submitted, gold			2022-12-27	WOS:000371223400024
J	Chatziharalambous, D; Lygirou, V; Latosinska, A; Stravodimos, K; Vlahou, A; Jankowski, V; Zoidakis, J				Chatziharalambous, Despina; Lygirou, Vasiliki; Latosinska, Agnieszka; Stravodimos, Konstantinos; Vlahou, Antonia; Jankowski, Vera; Zoidakis, Jerome			Analytical Performance of ELISA Assays in Urine: One More Bottleneck towards Biomarker Validation and Clinical Implementation	PLOS ONE			English	Article							BLADDER-CANCER; PROTEOMIC BIOMARKERS; MASS-SPECTROMETRY; DIAGNOSIS; ALBUMIN; DEGRADATION; CARCINOMA; SURVIVIN; FLUID	ELISA is the main approach for the sensitive quantification of protein biomarkers in body fluids and is currently employed in clinical laboratories for the measurement of clinical markers. As such, it also constitutes the main methodological approach for biomarker validation and further qualification. For the latter, specific assay performance requirements have to be met, as described in respective guidelines of regulatory agencies. Even though many clinical ELISA assays in serum are regularly used, ELISA clinical applications in urine are significantly less. The scope of our study was to evaluate ELISA assay analytical performance in urine for a series of potential biomarkers for bladder cancer, as a first step towards their large scale clinical validation. Seven biomarkers (Secreted protein acidic and rich in cysteine, Survivin, Slit homolog 2 protein, NRC-Interacting Factor 1, Histone 2B, Proteinase-3 and Profilin-1) previously described in the literature as having differential expression in bladder cancer were included in the study. A total of 11 commercially available ELISA tests for these markers were tested by standard curve analysis, assay reproducibility, linearity and spiking experiments. The results show disappointing performance with coefficients of variation>20% for the vast majority of the tests performed. Only 3 assays (for Secreted protein acidic and rich in cysteine, Survivin and Slit homolog 2 protein) passed the accuracy thresholds and were found suitable for further application in marker quantification. These results collectively reflect the difficulties in developing urine-based ELISA assays of sufficient analytical performance for clinical application, presumably attributed to the urine matrix itself and/or presence of markers in various isoforms.	[Chatziharalambous, Despina; Lygirou, Vasiliki; Latosinska, Agnieszka; Vlahou, Antonia; Zoidakis, Jerome] Acad Athens, Biomed Res Fdn, Ctr Basic Res, Biotechnol Lab, Athens, Greece; [Stravodimos, Konstantinos] Univ Athens, Sch Med, Laikon Hosp, Dept Urol, GR-11527 Athens, Greece; [Latosinska, Agnieszka] Charite, D-13353 Berlin, Germany; [Jankowski, Vera] Rhein Westfal TH Aachen, Inst Mol Cardiovasc Res IMCAR, D-52062 Aachen, Germany	Academy of Athens; Athens Medical School; Laiko General Hospital; National & Kapodistrian University of Athens; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; RWTH Aachen University	Zoidakis, J (corresponding author), Acad Athens, Biomed Res Fdn, Ctr Basic Res, Biotechnol Lab, Athens, Greece.	izoidakis@bioacademy.gr	Zoidakis, Jerome/P-9599-2018; Zoidakis, Jerome/AAO-8236-2021	Zoidakis, Jerome/0000-0002-4557-3430; Zoidakis, Jerome/0000-0002-4557-3430; Latosinska, Agnieszka/0000-0001-8917-2412; Vlahou, Antonia/0000-0003-3284-5713; Lygirou, Vasiliki/0000-0003-1555-1326; STRAVODIMOS, KONSTANTINOS/0000-0003-4030-4546	EU Commission [601933]; FP7 - PEOPLE - ITN program [PITN-GA-2012-317450]	EU Commission(European CommissionEuropean Commission Joint Research Centre); FP7 - PEOPLE - ITN program	TransBioBC is an FP7- Health project funded by the EU Commission under grant agreement no: 601933 (http://www.transbiobc.org/). Agnieska Latosinska is supported by grant PITN-GA-2012-317450 BCMolMed (Molecular Medicine for Bladder Cancer) from the FP7 - PEOPLE - 2012 ITN program (http://www.bcmolmed.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r80; [Anonymous], 2001, GUIDANCE IND BIOANAL, P1; Beasley-Green A, 2014, J PROTEOME RES, V13, P3930, DOI 10.1021/pr500204c; Cheung G, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-13; Fichorova RN, 2008, ANAL CHEM, V80, P4741, DOI 10.1021/ac702628q; Filip S, 2014, BIOANALYSIS, V6, P2549, DOI 10.4155/bio.14.210; Frantzi M, 2015, NAT REV UROL, V12, P317, DOI 10.1038/nrurol.2015.100; Frantzi M, 2013, J PROTEOME RES, V12, P3969, DOI 10.1021/pr400255h; Gao YH, 2015, ADV EXP MED BIOL, V845, P3, DOI 10.1007/978-94-017-9523-4_1; Huttenhain R, 2009, CURR OPIN CHEM BIOL, V13, P518, DOI 10.1016/j.cbpa.2009.09.014; Jeon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076719; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Kift RL, 2013, ANN CLIN BIOCHEM, V50, P236, DOI 10.1258/acb.2012.012117; Kluth LA, 2015, EUR UROL, V68, P238, DOI 10.1016/j.eururo.2015.01.032; Li XF, 2013, CHINESE J CANCER RES, V25, P375, DOI 10.3978/j.issn.1000-9604.2013.08.11; Lopez-Giacoman Salvador, 2015, World J Nephrol, V4, P57, DOI 10.5527/wjn.v4.i1.57; Makridalds M, 2010, J PROTEOME RES, V9, P3243, DOI 10.1021/pr100189d; Martyn-Hemphill C, 2013, INT J SURG, V11, P749, DOI 10.1016/j.ijsu.2013.08.018; Mbeutcha A, 2016, UROL CLIN N AM, V43, P47, DOI 10.1016/j.ucl.2015.08.005; Miller WG, 2009, CLIN CHEM, V55, P24, DOI 10.1373/clinchem.2008.106567; Miremami J, 2014, INT J MOL SCI, V15, P23897, DOI 10.3390/ijms151223897; Mischak H, 2012, EUR J CLIN INVEST, V42, P1027, DOI 10.1111/j.1365-2362.2012.02674.x; Osicka TM, 1997, CLIN SCI, V93, P557, DOI 10.1042/cs0930557; Osicka TM, 2000, DIABETES, V49, P1579, DOI 10.2337/diabetes.49.9.1579; Shariat SF, 2004, J UROLOGY, V171, P626, DOI 10.1097/01.ju.0000107826.78479.90; Speeckaert MM, 2011, CRIT REV CL LAB SCI, V48, P87, DOI 10.3109/10408363.2011.591366; Stoop MP, 2010, MOL CELL PROTEOMICS, V9, P2063, DOI 10.1074/mcp.M900877-MCP200; Talukdar S, 2015, EXPERT REV ANTICANC, V15, P283, DOI 10.1586/14737140.2015.989838; Taylor TP, 2012, BIOMARK INSIGHTS, V7, P1, DOI 10.4137/BMI.S8703; Tetu B, 2009, MODERN PATHOL, V22, pS53, DOI 10.1038/modpathol.2008.193; Whiteaker JR, 2010, MOL CELL PROTEOMICS, V9, P184, DOI 10.1074/mcp.M900254-MCP200; Wu J, 2010, J ZHEJIANG UNIV-SC B, V11, P227, DOI 10.1631/jzus.B0900327; Yafi F. A., 2015, UROL ONCOL, V33, pe25, DOI DOI 10.1016/J.UR0L0NC.2014.06.008; Ye F, 2014, AM J CLIN EXP UROL, V2, P1; Zoidakis J, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.009449	35	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149471	10.1371/journal.pone.0149471	http://dx.doi.org/10.1371/journal.pone.0149471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26889680	Green Published, gold, Green Submitted			2022-12-27	WOS:000371221500049
J	Lee, CS; Taib, NAM; Ashrafzadeh, A; Fadzli, F; Harun, F; Rahmat, K; Hoong, SM; Abdul-Rahman, PS; Hashim, OH				Lee, Cheng-Siang; Taib, Nur Aishah Mohd; Ashrafzadeh, Ali; Fadzli, Farhana; Harun, Faizah; Rahmat, Kartini; Hoong, See Mee; Abdul-Rahman, Puteri Shafinaz; Hashim, Onn Haji			Unmasking Heavily O-Glycosylated Serum Proteins Using Perchloric Acid: Identification of Serum Proteoglycan 4 and Protease C1 Inhibitor as Molecular Indicators for Screening of Breast Cancer	PLOS ONE			English	Article							BOVINE SYNOVIAL-FLUID; LINKED GLYCOSYLATION; BIOMARKER DISCOVERY; ARTOCARPUS-INTEGER; MASS-SPECTROMETRY; BINDING LECTINS; MUCIN; LUBRICIN; GLYCOPROTEOME; DISEASES	Heavily glycosylated mucin glycopeptides such as CA 27.29 and CA 15-3 are currently being used as biomarkers for detection and monitoring of breast cancer. However, they are not well detected at the early stages of the cancer. In the present study, perchloric acid (PCA) was used to enhance detection of mucin-type O-glycosylated proteins in the serum in an attempt to identify new biomarkers for early stage breast cancer. Sensitivity and specificity of an earlier developed sandwich enzyme-linked lectin assay were significantly improved with the use of serum PCA isolates. When a pilot case-control study was performed using the serum PCA isolates of normal participants (n = 105) and patients with stage 0 (n = 31) and stage I (n = 48) breast cancer, higher levels of total O-glycosylated proteins in sera of both groups of early stage breast cancer patients compared to the normal control women were demonstrated. Further analysis by gel-based proteomics detected significant inverse altered abundance of proteoglycan 4 and plasma protease C1 inhibitor in both the early stages of breast cancer patients compared to the controls. Our data suggests that the ratio of serum proteoglycan 4 to protease C1 inhibitor may be used for screening of early breast cancer although this requires further validation in clinically representative populations.	[Lee, Cheng-Siang; Abdul-Rahman, Puteri Shafinaz; Hashim, Onn Haji] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia; [Taib, Nur Aishah Mohd; Fadzli, Farhana; Harun, Faizah; Hoong, See Mee] Univ Malaya, Fac Med, Dept Surg, Kuala Lumpur, Malaysia; [Ashrafzadeh, Ali] Univ Malaya, Med Biotechnol Lab, Fac Med, Kuala Lumpur, Malaysia; [Rahmat, Kartini] Univ Malaya, Fac Med, Dept Biomed Imaging, Kuala Lumpur, Malaysia; [Abdul-Rahman, Puteri Shafinaz; Hashim, Onn Haji] Univ Malaya, Univ Malaya Ctr Prote Res, Fac Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Hashim, OH (corresponding author), Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia.; Hashim, OH (corresponding author), Univ Malaya, Univ Malaya Ctr Prote Res, Fac Med, Kuala Lumpur, Malaysia.	onnhashim@um.edu.my	Taib, Nur Aishah Mohd/B-2370-2010; See, Mee Hoong/AAO-9275-2021; See, Mee-Hoong/P-8440-2014; FADZLI, FARHANA/B-8487-2010; Fadzli, Farhana/AAB-5625-2022; Hashim, Onn H/B-9459-2010; See, Mee-Hoong/GRN-9904-2022; Lee, Cheng-Siang/N-7704-2018; Rahman, Puteri Shafinaz Akmar Binti Abdul/B-9511-2010; Rahmat, Kartini/A-2218-2013	Taib, Nur Aishah Mohd/0000-0001-8419-0478; See, Mee Hoong/0000-0002-3966-3368; See, Mee-Hoong/0000-0002-7197-5759; FADZLI, FARHANA/0000-0001-8276-5813; Hashim, Onn H/0000-0002-0196-6793; See, Mee-Hoong/0000-0002-3966-3368; Rahman, Puteri Shafinaz Akmar Binti Abdul/0000-0002-1818-4552; Rahmat, Kartini/0000-0001-8513-9076	HIR-MOHE research grant from the University of Malaya [H-20001-00-E000009]	HIR-MOHE research grant from the University of Malaya	This work was funded by the HIR-MOHE H-20001-00-E000009 research grant from the University of Malaya. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the HIR-MOHE H-20001-00-E000009 research grant from the University of Malaya. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article. All authors have read the journal's authorship agreement and policy on disclosure of potential conflicts of interest.	Adamczyk B, 2012, BBA-GEN SUBJECTS, V1820, P1347, DOI 10.1016/j.bbagen.2011.12.001; Ali L, 2014, MOL CELL PROTEOMICS, V13, P3396, DOI 10.1074/mcp.M114.040865; ANDERSON AJ, 1965, NATURE, V208, P491, DOI 10.1038/208491a0; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; BOCK SC, 1986, BIOCHEMISTRY-US, V25, P4292, DOI 10.1021/bi00363a018; Bringans S, 2008, PROTEOMICS, V8, P1081, DOI 10.1002/pmic.200700948; Brockhausen I, 2001, BIOL CHEM, V382, P219; Brockhausen I., 2009, ESSENTIALS GLYCOBIOL; Bunkenborg J, 2004, PROTEOMICS, V4, P454, DOI 10.1002/pmic.200300556; BURSTON D, 1963, BRIT J CANCER, V17, P162, DOI 10.1038/bjc.1963.24; Caliezi C, 2000, PHARMACOL REV, V52, P91; Campos D, 2015, EXPERT REV PROTEOMIC, V12, P337, DOI 10.1586/14789450.2015.1059758; Campos D, 2015, MOL CELL PROTEOMICS, V14, P1616, DOI 10.1074/mcp.M114.046862; Cheriyan T, 2012, J BIOMED MATER RES B, V100B, P1961, DOI 10.1002/jbm.b.32763; Cicardi M, 2005, SPRINGER SEMIN IMMUN, V27, P286, DOI 10.1007/s00281-005-0001-4; Clausen H, 1996, GLYCOBIOLOGY, V6, P635, DOI 10.1093/glycob/6.6.635; Duffy MJ, 2010, CLIN CHIM ACTA, V411, P1869, DOI 10.1016/j.cca.2010.08.039; Gomes C, 2013, J PROTEOME RES, V12, P1454, DOI 10.1021/pr301112x; Halim A, 2013, J PROTEOME RES, V12, P573, DOI 10.1021/pr300963h; Halim A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013649; HASHIM OH, 1991, MOL IMMUNOL, V28, P393, DOI 10.1016/0161-5890(91)90152-A; HASHIM OH, 1993, BIOCHEM MOL BIOL INT, V29, P69; Ikegawa S, 2000, CYTOGENET CELL GENET, V90, P291, DOI 10.1159/000056791; JAY GD, 1992, CONNECT TISSUE RES, V28, P71, DOI 10.3109/03008209209014228; Jayapalan JJ, 2012, ELECTROPHORESIS, V33, P1855, DOI 10.1002/elps.201100608; Jin CS, 2012, J BIOL CHEM, V287, P35922, DOI 10.1074/jbc.M112.363119; Lee CS, 2013, ANALYST, V138, P3522, DOI 10.1039/c3an36258b; Liu DX, 2005, INFECT IMMUN, V73, P4478, DOI 10.1128/IAI.73.8.4478-4487.2005; Liu T, 2005, J PROTEOME RES, V4, P2070, DOI 10.1021/pr0502065; Mohamed E, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-19; Mukhopadhyay P, 2011, BBA-REV CANCER, V1815, P224, DOI 10.1016/j.bbcan.2011.01.001; Nakano M, 2004, GLYCOBIOLOGY, V14, P431, DOI 10.1093/glycob/cwh034; Nilsson J, 2009, NAT METHODS, V6, P809, DOI [10.1038/NMETH.1392, 10.1038/nmeth.1392]; Pichon MF, 2009, CLIN CHEM LAB MED, V47, P985, DOI 10.1515/CCLM.2009.213; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Rahman MA, 2002, BIOCHEM BIOPH RES CO, V295, P1007, DOI 10.1016/S0006-291X(02)00795-7; Reis CA, 2010, J CLIN PATHOL, V63, P322, DOI 10.1136/jcp.2009.071035; Schmidt TA, 2013, JAMA OPHTHALMOL, V131, P766, DOI 10.1001/jamaophthalmol.2013.2385; STARCEVIC D, 1991, ANN CLIN BIOCHEM, V28, P595, DOI 10.1177/000456329102800609; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; SWANN DA, 1985, BIOCHEM J, V225, P195, DOI 10.1042/bj2250195; SWANN DA, 1977, BIOCHEM J, V161, P473, DOI 10.1042/bj1610473; TREUHEIT MJ, 1992, BIOCHEM J, V283, P105, DOI 10.1042/bj2830105; Triggianese P, 2015, AUTOIMMUN REV; VARIYAM EP, 1981, GASTROENTEROLOGY, V81, P751; Velaiutham S, 2008, ASIAN PAC J CANCER P, V9, P445; WINZLER RJ, 1948, J CLIN INVEST, V27, P609, DOI 10.1172/JCI102006	47	17	18	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149551	10.1371/journal.pone.0149551	http://dx.doi.org/10.1371/journal.pone.0149551			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890881	Green Published, gold, Green Submitted			2022-12-27	WOS:000371221500058
J	Rhee, SY; Hong, SM; Chon, S; Ahn, KJ; Kim, SH; Baik, SH; Park, YS; Nam, MS; Lee, KW; Woo, JT; Kim, YS				Rhee, Sang Youl; Hong, Soo Min; Chon, Suk; Ahn, Kyu Jeung; Kim, Sung Hoon; Baik, Sei Hyun; Park, Yong Soo; Nam, Moon Suk; Lee, Kwan Woo; Woo, Jeong-Taek; Kim, Young Seol			Hypoglycemia and Medical Expenses in Patients with Type 2 Diabetes Mellitus: An Analysis Based on the Korea National Diabetes Program Cohort	PLOS ONE			English	Article							ECONOMIC-IMPACT; COSTS; COMPLICATIONS; ADHERENCE; RESOURCE; THERAPY; PEN	Background and Aims Hypoglycemia is one of the most important adverse events in individuals with type 2 diabetes mellitus (T2DM). However, hypoglycemia-related events are usually overlooked and have been documented less in clinical practice. Materials and Methods We evaluated the incidence, clinical characteristics, and medical expenses of hypoglycemia related events in T2DM patients based on the Korea National Diabetes Program (KNDP), which is the largest multi-center, prospective cohort in Korea (n = 4,350). For accurate outcomes, the KNDP data were merged with claims data from the Health Insurance Review and Assessment Service (HIRA) of Korea. Results During a median follow-up period of 3.23 years (95% CI: 3.14, 3.19), 88 subjects (2.02%) were newly diagnosed with hypoglycemia, and the incidence of hypoglycemia was 6.44 cases per 1,000 person-years (PY). Individuals with hypoglycemia were significantly older (59.7 +/- 10.7 vs. 53.3 +/- 10.4 years, p < 0.001), had more hospital visits (121.94 +/- 126.88 days/PY, p < 0.001), had a longer hospital stays (16.13 +/- 29.21 days/PY, p < 0.001), and incurred greater medical costs ($ 2,447.56 +/- 4,056.38 vs. $ 1,336.37 +/- 3,403.39 /PY, p < 0.001) than subjects without hypoglycemia. Conclusion Hypoglycemia-related events were infrequently identified among the medical records of T2DM subjects. However, they were associated significantly with poor clinical outcomes, and thus, hypoglycemia could have a substantial burden on the Korean national healthcare system.	[Rhee, Sang Youl; Chon, Suk; Ahn, Kyu Jeung; Woo, Jeong-Taek; Kim, Young Seol] Kyung Hee Univ, Sch Med, Dept Endocrinol & Metab, Seoul, South Korea; [Hong, Soo Min] Kyung Hee Univ, Grad Sch Med, Dept Endocrinol & Metab, Seoul, South Korea; [Kim, Sung Hoon] Dankook Univ, Coll Med, Cheil Gen Hosp & Womens Healthcare Ctr, Div Endocrinol & Metab,Dept Internal Med, Seoul, South Korea; [Baik, Sei Hyun] Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul 136705, South Korea; [Park, Yong Soo] Hanyang Univ, Coll Med, Dept Internal Med, Guri, South Korea; [Nam, Moon Suk] Inha Univ, Sch Med, Dept Internal Med, Incheon, South Korea; [Lee, Kwan Woo] Ajou Univ, Sch Med, Dept Endocrinol & Metab, Suwon 441749, South Korea	Kyung Hee University; Kyung Hee University; Dankook University; Korea University; Korea University Medicine (KU Medicine); Hanyang University; Inha University; Ajou University	Kim, YS (corresponding author), Kyung Hee Univ, Sch Med, Dept Endocrinol & Metab, Seoul, South Korea.	kimys@khmc.or.kr	Rhee, Sang Youl/P-1895-2018	Rhee, Sang Youl/0000-0003-0119-5818; Woo, Jeong-Taek/0000-0001-9201-0713; Ahn, Kyu Jeung/0000-0002-4648-3605	Korea Healthcare Technology RAMP;D Project, Ministry of Health and Welfare Republic of Korea [HI10C2020]	Korea Healthcare Technology RAMP;D Project, Ministry of Health and Welfare Republic of Korea	The study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare Republic of Korea (HI10C2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Childs BP, 2005, DIABETES CARE, V28, P1245; Cobden D, 2007, PHARMACOTHERAPY, V27, P948, DOI 10.1592/phco.27.7.948; Desouza CV, 2010, DIABETES CARE, V33, P1389, DOI 10.2337/dc09-2082; Fabunmi R, 2009, CURR MED RES OPIN, V25, P777, DOI [10.1185/03007990802715199, 10.1185/03007990802715199 ]; Foos V, 2015, J MED ECON, V18, P420, DOI 10.3111/13696998.2015.1006730; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Holstein A, 2002, DIABETES CARE, V25, P2109, DOI 10.2337/diacare.25.11.2109; Jakubczyk M, 2015, EXPERT REV PHARM OUT, V15, P813, DOI 10.1586/14737167.2015.1076338; Jonsson L, 2006, VALUE HEALTH, V9, P193, DOI 10.1111/j.1524-4733.2006.00100.x; Korean Diabetes Research Foundation, 2013, INT C DIAB MET 2013; Lee WC, 2006, CLIN THER, V28, P1712, DOI 10.1016/j.clinthera.2006.10.004; Lesniowska J, 2014, EUR J HEALTH ECON, V15, P653, DOI 10.1007/s10198-013-0513-0; Lundkvist Jonas, 2005, Eur J Health Econ, V6, P197, DOI 10.1007/s10198-005-0276-3; McAulay V, 2001, DIABETIC MED, V18, P690, DOI 10.1046/j.1464-5491.2001.00620.x; Pelletier EM, 2008, APPL HEALTH ECON HEA, V6, P103, DOI 10.2165/00148365-200806020-00003; Rhee SY, 2011, DIABETES METAB J, V35, P504, DOI 10.4093/dmj.2011.35.5.504; Snell-Bergeon JK, 2012, DIABETES TECHNOL THE, V14, pS51, DOI 10.1089/dia.2012.0031; Warren RE, 2005, DIABETES OBES METAB, V7, P493, DOI 10.1111/j.1463-1326.2004.00421.x; Willis WD, 2013, EXPERT REV PHARM OUT, V13, P123, DOI [10.1586/erp.12.80, 10.1586/ERP.12.80]; Zhang Y., 2010, JCOM, V17, P547	20	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0148630	10.1371/journal.pone.0148630	http://dx.doi.org/10.1371/journal.pone.0148630			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890789	gold, Green Published, Green Submitted			2022-12-27	WOS:000371221500012
J	Xu, XY; Chai, JJ; Chen, YP; Rui, HL; Wang, YY; Dong, HR; Man, YL; Cheng, H				Xu, Xiao-yi; Chai, Jing-jing; Chen, Yi-pu; Rui, Hong-liang; Wang, Yan-yan; Dong, Hong-rui; Man, Yu-lin; Cheng, Hong			Hirsutella sinensis Attenuates Aristolochic Acid-Induced Renal Tubular Epithelial-Mesenchymal Transition by Inhibiting TGF-beta 1 and Snail Expression	PLOS ONE			English	Article							INTERSTITIAL FIBROSIS; KIDNEY FIBROSIS; MYOFIBROBLASTS; ORIGIN; EVENTS; CELLS; RDNA	Objective To investigate the inhibitory effect of Hirsutella sinensis (HS) on epithelial-mesenchymal transition (EMT) of renal tubular epithelial cells induced by aristolochic acid (AA) and its possible mechanism. Methods 18 male Sprague-Dawley rats were randomly and equally divided into the following 3 groups: AA group, AA+HS group and control group. Urinary protein excretion and creatinine clearance (CCr) were measured. All rats were sacrificed at the end of 12th week. The pathological examination of renal tissue was performed and the mRNA and protein expression of transforming growth factor-beta 1 (TGF-beta 1), alpha-smooth muscle actin (alpha-SMA), cytokeratin-18 and Snail in renal cortex were determined by real time quantitative PCR and immunohistochemical staining respectively. In addition, human renal proximal tubule epithelial cells line (HKC) was divided into the following 4 groups: AA group, AA+HS group, HS control group and control group. The above mRNA and protein expression in HKC was determined by real time quantitative PCR and Western blot respectively. Results (1) CCr was significantly decreased, and the urinary protein excretion and relative area of renal interstitial fibrosis were significantly increased in the rats of AA and AA+HS group compared to those in control group (P<0.05 or P<0.01); all the above abnormalities significantly lightened in the rats of AA+HS group compared to those in AA group (P<0.05). (2) The mRNA and protein expression of TGF-beta 1, alpha-SMA and Snail was significantly up-regulated and the expression of cytokeratin-18 was significantly down-regulated in the rat renal cortex as well as in the cultured HKC cells in AA and AA+HS groups compared to those in control group (P<0.05 or P<0.01); all the above abnormalities significantly alleviated in AA+HS group compared to those in AA group (P<0.05 or P<0.01). (3) Knockdown endogenous Snail expression by siRNA could ameliorate AA-induced EMT of HKC cells, while overexpression of Snail by plasmid transfection diminished the antagonistic effect of HS on AA-induced EMT. These results suggest Snail might be a potential target of HS effect. Conclusion HS is able to antagonize, to some extent, tubular EMT and renal interstitial fibrosis caused by AA, which might be related to its inhibitory effects on the TGF-beta 1 and Snail expression.	[Xu, Xiao-yi; Chen, Yi-pu; Rui, Hong-liang; Wang, Yan-yan; Dong, Hong-rui; Man, Yu-lin; Cheng, Hong] Capital Med Univ, Beijing Anzhen Hosp, Div Nephrol, Beijing 100029, Peoples R China; [Chai, Jing-jing] Beijing Union Med Coll Hosp, Emergency Dept, Beijing 100730, Peoples R China	Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Chen, YP (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Div Nephrol, Beijing 100029, Peoples R China.	chen_yipu@medmail.com.cn	Rui, Hongliang/GNM-9930-2022; wang, yan/GSE-6489-2022; Wang, Yanbo/HFZ-8018-2022	Rui, Hongliang/0000-0002-7584-9610; Chen, Yi-pu/0000-0002-5079-4334; Cheng, Hong/0000-0002-7908-3333	National Natural Science Foundation of China [81001516, 8144134]; Beijing Municipal Natural Science Foundation [7132090]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	Our work was supported by National Natural Science Foundation of China (81001516 and 8144134) and Beijing Municipal Natural Science Foundation (7132090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nieto MA, 2009, INT J DEV BIOL, V53, P1541, DOI 10.1387/ijdb.072410mn; Ballhause TM, 2014, INT UROL NEPHROL, V46, P659, DOI 10.1007/s11255-013-0626-5; Barnes JL, 2011, CONTRIB NEPHROL, V169, P73, DOI 10.1159/000313946; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Chen YP, 2009, CHIN J INTAGR TRADIT, V10, P847; Chen YQ, 2001, BIOCHEM SYST ECOL, V29, P597, DOI 10.1016/S0305-1978(00)00100-9; Chen YQ, 2002, PLANTA MED, V68, P635, DOI 10.1055/s-2002-32892; Falke LL, 2015, NAT REV NEPHROL, V11, P233, DOI 10.1038/nrneph.2014.246; Fan JM, 1999, KIDNEY INT, V56, P1455, DOI 10.1046/j.1523-1755.1999.00656.x; [方静 Fang Jing], 2004, [中华肾脏病杂志, Chinese Journal of Nephrology], V20, P321; [高艳丽 Gao Yanli], 2005, [中华肾脏病杂志, Chinese Journal of Nephrology], V21, P31; Gao YL, 2003, CHIN J INTEGR TRAD S, V23, P109; [胡征 Hu Zheng], 2003, [氨基酸和生物资源, Amino acids & biotic resources], V25, P20; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jiang Yi, 2003, Mycosystema, V22, P161; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim YS, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.44; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lin RQ, 2009, CHIN J INTAGR TRADIT, V10, P921; Lin RQ, 2009, CHIN J INTAGR TRADIT, V10, P1011; Liu XJ, 1989, MYCOSYSTEMA, V8, P35; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Mack M, 2015, KIDNEY INT, V87, P297, DOI 10.1038/ki.2014.287; Mo MH, 2001, MYCOSYSTEMA, V20, P482; National Committee of Pharmacopoeia, 2012, PHARM PEOPL REP CHIN, P681; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Ohkubo T, 2004, J CELL SCI, V117, P1675, DOI 10.1242/jcs.01004; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; [魏鑫丽 Wei Xinli], 2006, [菌物学报, Mygosystema], V25, P192; Xiong J, 2014, MOL BIOL REP, V41, P241, DOI 10.1007/s11033-013-2857-z; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Yang YL, 2011, J CELL BIOCHEM, V112, P2558, DOI 10.1002/jcb.23180; Yoshino J, 2007, BIOCHEM BIOPH RES CO, V362, P63, DOI 10.1016/j.bbrc.2007.07.146; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; [张聪 ZHANG Cong], 2006, [中华肾脏病杂志, Chinese Journal of Nephrology], V22, P49; [张媺 Zhang Mei], 2006, [中华肾脏病杂志, Chinese Journal of Nephrology], V22, P472; Zhu Yun-feng, 2007, Zhonghua Yi Xue Za Zhi, V87, P2667; 唐功耀, 2002, [中华肾脏病杂志, Chinese Journal of Nephrology], V18, P266	40	5	9	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149242	10.1371/journal.pone.0149242	http://dx.doi.org/10.1371/journal.pone.0149242			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890569	gold, Green Published, Green Submitted			2022-12-27	WOS:000371221500026
J	Chisholm, SA; McHugh, E; Lundie, R; Dixon, MWA; Ghosh, S; O'Keefe, M; Tilley, L; Kalanon, M; de Koning-Ward, TF				Chisholm, Scott A.; McHugh, Emma; Lundie, Rachel; Dixon, Matthew W. A.; Ghosh, Sreejoyee; O'Keefe, Meredith; Tilley, Leann; Kalanon, Ming; de Koning-Ward, Tania F.			Contrasting Inducible Knockdown of the Auxiliary PTEX Component PTEX88 in P-falciparum and P-berghei Unmasks a Role in Parasite Virulence	PLOS ONE			English	Article							RED-BLOOD-CELLS; EXPORTED PROTEINS PTEX; MALARIA PARASITES; INFECTED ERYTHROCYTES; HOST ERYTHROCYTE; MAURERS CLEFTS; IN-VIVO; TRANSLOCON; LOCALIZATION; PATHOGENESIS	Pathogenesis of malaria infections is linked to remodeling of erythrocytes, a process dependent on the trafficking of hundreds of parasite-derived proteins into the host erythrocyte. Recent studies have demonstrated that the Plasmodium translocon of exported proteins (PTEX) serves as the central gateway for trafficking of these proteins, as inducible knockdown of the core PTEX constituents blocked the trafficking of all classes of cargo into the erythrocyte. However, the role of the auxiliary component PTEX88 in protein export remains less clear. Here we have used inducible knockdown technologies in P. falciparum and P. berghei to assess the role of PTEX88 in parasite development and protein export, which reveal that the in vivo growth of PTEX88-deficient parasites is hindered. Interestingly, we were unable to link this observation to a general defect in export of a variety of known parasite proteins, suggesting that PTEX88 functions in a different fashion to the core PTEX components. Strikingly, PTEX88-deficient P. berghei were incapable of causing cerebral malaria despite a robust pro-inflammatory response from the host. These parasites also exhibited a reduced ability to sequester in peripheral tissues and were removed more readily from the circulation by the spleen. In keeping with these findings, PTEX88-deficient P. falciparum-infected erythrocytes displayed reduced binding to the endothelial cell receptor, CD36. This suggests that PTEX88 likely plays a specific direct or indirect role in mediating parasite sequestration rather than making a universal contribution to the trafficking of all exported proteins.	[Chisholm, Scott A.; Ghosh, Sreejoyee; Kalanon, Ming; de Koning-Ward, Tania F.] Deakin Univ, Sch Med, Waurn Ponds, Vic, Australia; [McHugh, Emma; Dixon, Matthew W. A.; Tilley, Leann] Bio21 Inst, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Lundie, Rachel; O'Keefe, Meredith] Burnet Inst, Melbourne, Vic, Australia	Deakin University; Burnet Institute	de Koning-Ward, TF (corresponding author), Deakin Univ, Sch Med, Waurn Ponds, Vic, Australia.	taniad@deakin.edu.au	Ghosh, Sreejoyee/AAQ-8421-2020; Dixon, Matthew/N-4503-2019; Chisholm, Scott/K-2661-2019; de Koning-Ward, Tania F/N-3572-2017; Tilley, Leann/AAU-5281-2020; O'Keeffe, Meredith/U-9347-2017	Dixon, Matthew/0000-0001-9732-9686; Chisholm, Scott/0000-0002-3833-8854; de Koning-Ward, Tania F/0000-0001-5810-8063; O'Keeffe, Meredith/0000-0002-0779-4654; Tilley, Leann/0000-0001-9910-0199; McHugh, Emma/0000-0003-0278-4171	National Health and Medical Research Council [APP1021560, APP1006091]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the National Health and Medical Research Council, APP1021560, APP1006091 (https://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bachmann A, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0784-2; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Beck JR, 2014, NATURE, V511, P592, DOI 10.1038/nature13574; Blisnick T, 2000, MOL BIOCHEM PARASIT, V111, P107, DOI 10.1016/S0166-6851(00)00301-7; Boddey JA, 2013, ANNU REV MICROBIOL, V67, P243, DOI 10.1146/annurev-micro-092412-155730; Bullen HE, 2012, J BIOL CHEM, V287, P7871, DOI 10.1074/jbc.M111.328591; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Decherf G, 2004, BLOOD CELL MOL DIS, V32, P366, DOI 10.1016/j.bcmd.2004.01.008; Deitsch KW, 1996, MOL BIOCHEM PARASIT, V76, P1, DOI 10.1016/0166-6851(95)02575-8; Denks K, 2014, MOL MEMBR BIOL, V31, P58, DOI 10.3109/09687688.2014.907455; Dixon MWA, 2008, TRAFFIC, V9, P1316, DOI 10.1111/j.1600-0854.2008.00768.x; Dondorp AM, 2002, T ROY SOC TROP MED H, V96, P282, DOI 10.1016/S0035-9203(02)90100-8; Elsworth B, 2014, NATURE, V511, P587, DOI 10.1038/nature13555; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Fischer K, 1998, MOL BIOCHEM PARASIT, V92, P47, DOI 10.1016/S0166-6851(97)00224-7; Frenal K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005069; Goel S, 2015, NAT MED, V21, P314, DOI 10.1038/nm.3812; Gold DA, 2015, CELL HOST MICROBE, V17, P642, DOI 10.1016/j.chom.2015.04.003; Haase S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061482; Haase S, 2013, MALARIA PARASITES: COMPARATIVE GENOMICS , EVOLUTION AND MOLECULAR BIOLOGY, P199; Haase S, 2010, CELL MICROBIOL, V12, P580, DOI 10.1111/j.1462-5822.2010.01455.x; Haque A, 2011, EUR J IMMUNOL, V41, P2688, DOI 10.1002/eji.201141539; Heiber A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003546; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Ingmundson A, 2012, MOL MICROBIOL, V83, P1229, DOI 10.1111/j.1365-2958.2012.08004.x; Janse CJ, 2006, NAT PROTOC, V1, P614, DOI 10.1038/nprot.2006.88; Johnson D, 1994, PARASITOLOGY, V109; Kalanon M, 2015, CELL MICROB IN PRESS; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; MAKLER MT, 1993, AM J TROP MED HYG, V48, P205, DOI 10.4269/ajtmh.1993.48.205; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Matthews K, 2013, MOL MICROBIOL, V89, P1167, DOI 10.1111/mmi.12334; Matz JM, 2015, EUKARYOT CELL, V14, P528, DOI 10.1128/EC.00276-14; Matz JM, 2013, MOL BIOCHEM PARASIT, V191, P44, DOI 10.1016/j.molbiopara.2013.09.003; McHugh E, 2015, MOL MICROBIOL; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Niang M, 2014, CELL HOST MICROBE, V16, P81, DOI 10.1016/j.chom.2014.06.004; Paschen SA, 2000, EMBO J, V19, P6392, DOI 10.1093/emboj/19.23.6392; Pasini EM, 2013, MOL CELL PROTEOMICS, V12, P426, DOI 10.1074/mcp.M112.021238; Pick C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-167; Pino P, 2012, CELL HOST MICROBE, V12, P824, DOI 10.1016/j.chom.2012.10.016; Spycher C, 2003, J BIOL CHEM, V278, P35373, DOI 10.1074/jbc.M305851200; Stanley WA, 2007, FEBS LETT, V581, P4795, DOI 10.1016/j.febslet.2007.09.001; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Yanez DM, 1996, J IMMUNOL, V157, P1620; Zhang Y, 2015, P NATL ACAD SCI USA, V112, P6068, DOI 10.1073/pnas.1505584112	50	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149296	10.1371/journal.pone.0149296	http://dx.doi.org/10.1371/journal.pone.0149296			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886275	Green Published, gold			2022-12-27	WOS:000371218400075
J	Hsia, J; Holtz, WJ; Maharbiz, MM; Arcak, M; Keasling, JD				Hsia, Justin; Holtz, William J.; Maharbiz, Michel M.; Arcak, Murat; Keasling, Jay D.			Modular Synthetic Inverters from Zinc Finger Proteins and Small RNAs	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; REGULATORS; ROBUST; SWITCH	Synthetic zinc finger proteins (ZFPs) can be created to target promoter DNA sequences, repressing transcription. The binding of small RNA (sRNA) to ZFP mRNA creates an ultra-sensitive response to generate higher effective Hill coefficients. Here we combined three "off the shelf" ZFPs and three sRNAs to create new modular inverters in E. coli and quantify their behavior using induction fold. We found a general ordering of the effects of the ZFPs and sRNAs on induction fold that mostly held true when combining these parts. We then attempted to construct a ring oscillator using our new inverters. Our chosen parts performed insufficiently to create oscillations, but we include future directions for improvement upon our work presented here.	[Hsia, Justin; Holtz, William J.; Maharbiz, Michel M.; Arcak, Murat] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Holtz, William J.; Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Biol Syst & Engn, Berkeley, CA 94720 USA; [Holtz, William J.] Lygos Inc, Emeryville, CA USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Hsia, J (corresponding author), Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA.	jhsia@eecs.berkeley.edu	Keasling, Jay D/J-9162-2012	Keasling, Jay D/0000-0003-4170-6088; Arcak, Murat/0000-0001-9060-4032; Holtz, William/0000-0001-5281-1794	Joint BioEnergy Institute - US Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; Synthetic Biology Engineering Research Center (SynBERC) through National Science Foundation [NSF EEC 0540879]; National Institute of Health National Institute of General Medical Sciences [1R01GM109460-01]; Air Force Office of Scientific Research [FA9550-14-1-0089]; Berkeley Sensor & Actuator Center; Lawrence Berkeley National Laboratory; US Department of Energy; NIH National Institute of General Medical Sciences [1R01GM109460-01]; AFOSR [FA9550-14-1-0089]; Berkeley Sensor & Actuator Center (BSAC); Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish; NNF Center for Biosustainability [Synthetic Biology Tools for Yeast] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109460] Funding Source: NIH RePORTER	Joint BioEnergy Institute - US Department of Energy, Office of Science, Office of Biological and Environmental Research; Synthetic Biology Engineering Research Center (SynBERC) through National Science Foundation; National Institute of Health National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Berkeley Sensor & Actuator Center; Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); US Department of Energy(United States Department of Energy (DOE)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Berkeley Sensor & Actuator Center (BSAC); Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Joint BioEnergy Institute (http://www.jbei.org), which is supported by the US Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the US Department of Energy and by the Synthetic Biology Engineering Research Center (SynBERC) through National Science Foundation grant NSF EEC 0540879. This work was also funded by the National Institute of Health (http://www.nih.gov) National Institute of General Medical Sciences grant 1R01GM109460-01, Air Force Office of Scientific Research (http://www.afosr.af.mil) grant FA9550-14-1-0089, and the Berkeley Sensor & Actuator Center (http://bsac.eecs.berkeley.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the Joint BioEnergy Institute (http://www.jbei.org), which is supported by the US Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the US Department of Energy and by the Synthetic Biology Engineering Research Center (SynBERC) through National Science Foundation grant NSF EEC 0540879. Authors would like to acknowledge funding from NIH National Institute of General Medical Sciences 1R01GM109460-01, AFOSR FA9550-14-1-0089, and the Berkeley Sensor & Actuator Center (BSAC).	Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; [Anonymous], 2009, REGISTRY STANDARD BI; Boch J, 2011, NAT BIOTECHNOL, V29, P135, DOI 10.1038/nbt.1767; Buchler NE, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.30; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gersbach CA, 2014, ACCOUNTS CHEM RES, V47, P2309, DOI 10.1021/ar500039w; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Hillson NJ, 2012, ACS SYNTH BIOL, V1, P14, DOI 10.1021/sb2000116; Holtz WJ, 2011, ENG SCALABLE COMBINA; Hsia J, 2012, IEEE DECIS CONTR P, P1633, DOI 10.1109/CDC.2012.6426642; Hsia J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002331; Huang D, 2012, J BIOL ENG, V6, DOI 10.1186/1754-1611-6-9; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Khlebnikov A, 2002, J IND MICROBIOL BIOT, V29, P34, DOI 10.1038/sj.jim.7000259; Kizer L, 2008, APPL ENVIRON MICROB, V74, P3229, DOI 10.1128/AEM.02750-07; Lee TS, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-12; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P8617, DOI 10.1073/pnas.1015741108; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mutalik VK, 2013, NAT METHODS, V10, P354, DOI [10.1038/NMETH.2404, 10.1038/nmeth.2404]; Mutalik VK, 2012, NAT CHEM BIOL, V8, P447, DOI [10.1038/NCHEMBIO.919, 10.1038/nchembio.919]; Na D, 2013, NAT BIOTECHNOL, V31, P170, DOI 10.1038/nbt.2461; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Wang BJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1516	28	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149483	10.1371/journal.pone.0149483	http://dx.doi.org/10.1371/journal.pone.0149483			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886888	gold, Green Published, Green Submitted			2022-12-27	WOS:000371218400090
J	Miyamoto, T; Kato, Y; Sekiguchi, Y; Tsuneda, S; Noda, N				Miyamoto, Tatsuki; Kato, Yuka; Sekiguchi, Yuji; Tsuneda, Satoshi; Noda, Naohiro			Characterization of MazF-Mediated Sequence-Specific RNA Cleavage in Pseudomonas putida Using Massive Parallel Sequencing	PLOS ONE			English	Article							TOXIN-ANTITOXIN SYSTEMS; PROGRAMMED CELL-DEATH; MESSENGER-RNA; ESCHERICHIA-COLI; BACTERIAL PERSISTENCE; STOCHASTIC INDUCTION; RIBOSOMAL-RNA; TRANSLATION; INTERFERASES; GROWTH	Under environmental stress, microbes are known to alter their translation patterns using sequence-specific endoribonucleases that we call RNA interferases. However, there has been limited insight regarding which RNAs are specifically cleaved by these RNA interferases, hence their physiological functions remain unknown. In the current study, we developed a novel method to effectively identify cleavage specificities with massive parallel sequencing. This approach uses artificially designed RNAs composed of diverse sequences, which do not form extensive secondary structures, and it correctly identified the cleavage sequence of a well-characterized Escherichia coli RNA interferase, MazF, as ACA. In addition, we also determined that an uncharacterized MazF homologue isolated from Pseudomonas putida specifically recognizes the unique triplet, UAC. Using a real-time fluorescence resonance energy transfer assay, the UAC triplet was further proved to be essential for cleavage in P. putida MazF. These results highlight an effective method to determine cleavage specificity of RNA interferases.	[Miyamoto, Tatsuki; Tsuneda, Satoshi; Noda, Naohiro] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, 2-2 Wakamatsu Cho, Tokyo 1628480, Japan; [Miyamoto, Tatsuki; Kato, Yuka; Sekiguchi, Yuji; Noda, Naohiro] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, 1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan	Waseda University; National Institute of Advanced Industrial Science & Technology (AIST)	Tsuneda, S; Noda, N (corresponding author), Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, 2-2 Wakamatsu Cho, Tokyo 1628480, Japan.; Noda, N (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, 1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	stsuneda@waseda.jp; noda-naohiro@aist.go.jp	NODA, Naohiro/M-2383-2018	NODA, Naohiro/0000-0001-7592-5495				Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Akiyama H, 2015, ANAL BIOCHEM, V472, P75, DOI 10.1016/j.ab.2014.11.012; Amitai S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000390; Buermans HPJ, 2014, BBA-MOL BASIS DIS, V1842, P1932, DOI 10.1016/j.bbadis.2014.06.015; Chopra N, 2013, GENOME BIOL EVOL, V5, P2268, DOI 10.1093/gbe/evt175; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; Christensen-Dalsgaard M, 2010, MOL MICROBIOL, V75, P333, DOI 10.1111/j.1365-2958.2009.06969.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cruz JW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8480; Germain E, 2015, P NATL ACAD SCI USA, V112, P5171, DOI 10.1073/pnas.1423536112; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; KIRPEKAR F, 1994, NUCLEIC ACIDS RES, V22, P3866, DOI 10.1093/nar/22.19.3866; Koga M, 2011, GENETICS, V187, P123, DOI 10.1534/genetics.110.121798; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; McKenzie JL, 2012, RNA, V18, P1267, DOI 10.1261/rna.031229.111; Nariya H, 2008, CELL, V132, P55, DOI 10.1016/j.cell.2007.11.044; Otsuka Y, 2007, GENES GENET SYST, V82, P291, DOI 10.1266/ggs.82.291; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Park JH, 2011, FEBS LETT, V585, P2526, DOI 10.1016/j.febslet.2011.07.008; Poblete-Castro I, 2012, APPL MICROBIOL BIOT, V93, P2279, DOI 10.1007/s00253-012-3928-0; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; Rothenbacher FP, 2012, J BACTERIOL, V194, P3464, DOI 10.1128/JB.00217-12; Sat B, 2001, J BACTERIOL, V183, P2041, DOI 10.1128/JB.183.6.2041-2045.2001; Schifano JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4538; Schifano JM, 2013, P NATL ACAD SCI USA, V110, P8501, DOI 10.1073/pnas.1222031110; Schuster CF, 2013, FEMS MICROBIOL LETT, V340, P73, DOI 10.1111/1574-6968.12074; Schuster CF, 2013, J BACTERIOL, V195, P115, DOI 10.1128/JB.00400-12; Shao YC, 2011, NUCLEIC ACIDS RES, V39, pD606, DOI 10.1093/nar/gkq908; Sharp JD, 2012, J BIOL CHEM, V287, P12835, DOI 10.1074/jbc.M112.340109; Tamman H, 2014, J BACTERIOL, V196, P157, DOI 10.1128/JB.00851-13; Tiwari P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7059; Verma S, 2014, BIOCHEM BIOPH RES CO, V450, P998, DOI 10.1016/j.bbrc.2014.06.092; Vesper O, 2011, CELL, V147, P147, DOI 10.1016/j.cell.2011.07.047; Wang NR, 2007, ANAL BIOCHEM, V371, P173, DOI 10.1016/j.ab.2007.07.017; Yamaguchi Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1621; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Yamaguchi Y, 2009, J BIOL CHEM, V284, P28746, DOI 10.1074/jbc.M109.032904; Zhang JJ, 2004, J BIOL CHEM, V279, P20678, DOI 10.1074/jbc.M314284200; Zhang YL, 2005, J BIOL CHEM, V280, P26080, DOI 10.1074/jbc.M502050200; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhang YL, 2005, J BIOL CHEM, V280, P3143, DOI 10.1074/jbc.M411811200; Zhang YL, 2009, J BIOL CHEM, V284, P25522, DOI 10.1074/jbc.M109.036624; Zhang Y, 2009, J BIOL CHEM, V284, P6627, DOI 10.1074/jbc.M808779200; Zhu L, 2008, MOL MICROBIOL, V69, P559, DOI 10.1111/j.1365-2958.2008.06284.x; Zhu L, 2006, J BIOL CHEM, V281, P18638, DOI 10.1074/jbc.M512693200; Zhu L, 2009, J BACTERIOL, V191, P3248, DOI 10.1128/JB.01815-08	50	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149494	10.1371/journal.pone.0149494	http://dx.doi.org/10.1371/journal.pone.0149494			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885644	Green Published, Green Submitted, gold			2022-12-27	WOS:000371218400092
J	Uranbileg, B; Ikeda, H; Kurano, M; Enooku, K; Sato, M; Saigusa, D; Aoki, J; Ishizawa, T; Hasegawa, K; Kokudo, N; Yatomi, Y				Uranbileg, Baasanjav; Ikeda, Hitoshi; Kurano, Makoto; Enooku, Kenichiro; Sato, Masaya; Saigusa, Daisuke; Aoki, Junken; Ishizawa, Takeaki; Hasegawa, Kiyoshi; Kokudo, Norihiro; Yatomi, Yutaka			Increased mRNA Levels of Sphingosine Kinases and S1P Lyase and Reduced Levels of S1P Were Observed in Hepatocellular Carcinoma in Association with Poorer Differentiation and Earlier Recurrence	PLOS ONE			English	Article							1-PHOSPHATE RECEPTOR 2; IN-VIVO; LYSOPHOSPHOLIPID RECEPTORS; BIOLOGICAL SAMPLES; G-PROTEIN; SPHINGOSINE-1-PHOSPHATE; ACTIVATION; EXPRESSION; CANCER; CELLS	Although sphingosine 1-phosphate (S1P) has been reported to play an important role in cancer pathophysiology, little is known about S1P and hepatocellular carcinoma (HCC). To clarify the relationship between S1P and HCC, 77 patients with HCC who underwent surgical treatment were consecutively enrolled in this study. In addition, S1P and its metabolites were quantitated by LC-MS/MS. The mRNA levels of sphingosine kinases (SKs), which phosphorylate sphingosine to generate S1P, were increased in HCC tissues compared with adjacent non-HCC tissues. Higher mRNA levels of SKs in HCC were associated with poorer differentiation and microvascular invasion, whereas a higher level of SK2 mRNA was a risk factor for intra-and extra-hepatic recurrence. S1P levels, however, were unexpectedly reduced in HCC compared with non-HCC tissues, and increased mRNA levels of S1P lyase (SPL), which degrades S1P, were observed in HCC compared with non-HCC tissues. Higher SPL mRNA levels in HCC were associated with poorer differentiation. Finally, in HCC cell lines, inhibition of the expression of SKs or SPL by siRNA led to reduced proliferation, invasion and migration, whereas overexpression of SKs or SPL enhanced proliferation. In conclusion, increased SK and SPL mRNA expression along with reduced S1P levels were more commonly observed in HCC tissues compared with adjacent non-HCC tissues and were associated with poor differentiation and early recurrence. SPL as well as SKs may be therapeutic targets for HCC treatment.	[Uranbileg, Baasanjav; Ikeda, Hitoshi; Kurano, Makoto; Enooku, Kenichiro; Sato, Masaya; Yatomi, Yutaka] Univ Tokyo, Dept Clin Lab Med, Tokyo, Japan; [Ishizawa, Takeaki; Hasegawa, Kiyoshi; Kokudo, Norihiro] Univ Tokyo, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo, Japan; [Saigusa, Daisuke] Tohoku Med Megabank Org, Dept Integrat Genom, Sendai, Miyagi, Japan; [Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 980, Japan; [Ikeda, Hitoshi; Kurano, Makoto; Saigusa, Daisuke; Aoki, Junken; Yatomi, Yutaka] JST, CREST, Tokyo, Japan	University of Tokyo; University of Tokyo; Tohoku University; Japan Science & Technology Agency (JST)	Ikeda, H (corresponding author), Univ Tokyo, Dept Clin Lab Med, Tokyo, Japan.; Ikeda, H (corresponding author), JST, CREST, Tokyo, Japan.	ikeda-1im@h.u-tokyo.ac.jp		Aoki, Junken/0000-0001-9435-1896; Saigusa, Daisuke/0000-0001-9484-9870; xing zhi, shi zhi/0000-0003-3289-5681; Yatomi, Yutaka/0000-0003-1719-4297	JSPS [25253040, 15H05906]; AMED-CREST; Grants-in-Aid for Scientific Research [16K09343, 15H05897] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); AMED-CREST; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 25253040 and 15H05906 (YY) and by AMED-CREST.	Abuhusain HJ, 2013, J BIOL CHEM, V288, P37355, DOI 10.1074/jbc.M113.494740; Bao MY, 2012, LIVER INT, V32, P331, DOI 10.1111/j.1478-3231.2011.02666.x; Bayerl MG, 2008, LEUKEMIA LYMPHOMA, V49, P948, DOI 10.1080/10428190801911654; Beljanski V, 2011, CANCER BIOL THER, V11, P524, DOI 10.4161/cbt.11.5.14677; Brizuela L, 2012, MOL CANCER THER, V11, P1841, DOI 10.1158/1535-7163.MCT-12-0227; Chae SS, 2004, J CLIN INVEST, V114, P1082, DOI 10.1172/JCI200422716; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Degagne E, 2014, CLIN EXP GASTROENTER, V7, P205, DOI 10.2147/CEG.S43453; Don AS, 2014, BIOMOLECULES, V4, P315, DOI 10.3390/biom4010315; Edsall LC, 1997, J NEUROSCI, V17, P6952; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; French KJ, 2003, CANCER RES, V63, P5962; Gardell SE, 2006, TRENDS MOL MED, V12, P65, DOI 10.1016/j.molmed.2005.12.001; GOODEMOTE KA, 1995, J BIOL CHEM, V270, P10272, DOI 10.1074/jbc.270.17.10272; Herr DR, 2007, J NEUROSCI, V27, P1474, DOI 10.1523/JNEUROSCI.4245-06.2007; Hibbs K, 2004, AM J PATHOL, V165, P397, DOI 10.1016/S0002-9440(10)63306-8; Ikeda H, 2000, AM J PHYSIOL-GASTR L, V279, pG304, DOI 10.1152/ajpgi.2000.279.2.G304; Ikeda H, 2004, BIOCHEM BIOPH RES CO, V320, P754, DOI 10.1016/j.bbrc.2004.04.207; Ikeda H, 2003, GASTROENTEROLOGY, V124, P459, DOI 10.1053/gast.2003.50049; Ikeda H, 2009, J LIPID RES, V50, P556, DOI 10.1194/jlr.M800496-JLR200; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Jiang YX, 2013, BIOMOLECULES, V3, P435, DOI 10.3390/biom3030435; Kageyama Y, 2012, HEPATOLOGY, V56, P1427, DOI 10.1002/hep.25780; Kariya Y, 2005, GENES CELLS, V10, P605, DOI 10.1111/j.1365-2443.2005.00862.x; Kharel Y, 2011, BIOCHEM J, V440, P345, DOI 10.1042/BJ20110817; Kihara A, 2014, BBA-MOL CELL BIOL L, V1841, P766, DOI 10.1016/j.bbalip.2013.08.014; Lafaro KJ, 2015, SURG ONCOL CLIN N AM, V24, P1, DOI 10.1016/j.soc.2014.09.001; Li CY, 2011, J HEPATOL, V54, P1205, DOI 10.1016/j.jhep.2010.08.028; Li CY, 2009, AM J PATHOL, V175, P1464, DOI 10.2353/ajpath.2009.090037; Li CY, 2009, J HEPATOL, V50, P1174, DOI 10.1016/j.jhep.2009.01.028; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Nagahashi M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/651727; Okudaira M, 2014, J LIPID RES, V55, P2178, DOI 10.1194/jlr.D048439; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Oskouian B, 2006, P NATL ACAD SCI USA, V103, P17384, DOI 10.1073/pnas.0600050103; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Rex K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068328; Schnute ME, 2012, BIOCHEM J, V444, P79, DOI 10.1042/BJ20111929; Serriere-Lanneau V, 2007, FASEB J, V21, P2005, DOI 10.1096/fj.06-6889com; Tosaka M, 2001, STROKE, V32, P2913, DOI 10.1161/hs1201.099525; Uranbileg B, 2014, INT J CANCER, V134, P2189, DOI 10.1002/ijc.28547; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Yang AH, 2002, BBA-MOL CELL BIOL L, V1582, P197, DOI 10.1016/S1388-1981(02)00172-5; YATOMI Y, 1995, ANAL BIOCHEM, V230, P315, DOI 10.1006/abio.1995.1480	46	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149462	10.1371/journal.pone.0149462	http://dx.doi.org/10.1371/journal.pone.0149462			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886371	Green Submitted, Green Published, gold			2022-12-27	WOS:000371218400086
J	Willener, AST; Handrich, Y; Halsey, LG; Strike, S				Willener, Astrid S. T.; Handrich, Yves; Halsey, Lewis G.; Strike, Siobhan			Fat King Penguins Are Less Steady on Their Feet	PLOS ONE			English	Article							METABOLIC-RATE; STEP WIDTH; GAIT; WALKING; ACCELERATION; BIOMECHANICS; VARIABILITY; LOCOMOTION; ENERGETICS; ADULTS	Returning to the shore after a feeding sojourn at sea, king penguins often undertake a relatively long terrestrial journey to the breeding colony carrying a heavy, mostly frontal, accumulation of fat along with food in the stomach for chick-provisioning. There they must survive a fasting period of up to a month in duration, during which their complete reliance on endogenous energy stores results in a dramatic loss in body mass. Our aim was to determine if the king penguin's walking gait changes with variations in body mass. We investigated this by walking king penguins on a treadmill while instrumented with an acceleration data logger. The stride frequency, dynamic body acceleration (DBA) and posture of fat (pre-fasting; 13.2 kg) and slim (post fasting; 11 kg) king penguins were assessed while they walked at the same speed (1.4km/h) on a treadmill. Paired statistical tests indicated no evidence for a difference in dynamic body acceleration or stride frequency between the two body masses however there was substantially less variability in both leaning angle and the leaning amplitude of the body when the birds were slimmer. Furthermore, there was some evidence that the slimmer birds exhibited a decrease in waddling amplitude. We suggest the increase in variability of both leaning angle and amplitude, as well as a possibly greater variability in the waddling amplitude, is likely to result from the frontal fat accumulation when the birds are heavier, which may move the centre of mass anteriorly, resulting in a less stable upright posture. This study is the first to use accelerometry to better understand the gait of a species within a specific ecological context: the considerable body mass change exhibited by king penguins.	[Willener, Astrid S. T.; Halsey, Lewis G.; Strike, Siobhan] Univ Roehampton, Dept Life Sci, London, England; [Willener, Astrid S. T.; Handrich, Yves] Univ Strasbourg, Inst Pluridisciplinaire Hubert CURIEN, Strasbourg, France; [Willener, Astrid S. T.; Handrich, Yves] CNRS, Unite Mixte Rech 7178, Strasbourg, France	Roehampton University; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Willener, AST (corresponding author), Univ Roehampton, Dept Life Sci, London, England.; Willener, AST (corresponding author), Univ Strasbourg, Inst Pluridisciplinaire Hubert CURIEN, Strasbourg, France.; Willener, AST (corresponding author), CNRS, Unite Mixte Rech 7178, Strasbourg, France.	astrid.willener@gmail.com	Handrich, Yves/AAD-6472-2022; Halsey, Lewis/B-8498-2011	Halsey, Lewis/0000-0002-0786-7585; Strike, Siobhan/0000-0001-8195-6888	French Polar Institut (Institut Polaire Paul Emile Victor); Experimental Biology	French Polar Institut (Institut Polaire Paul Emile Victor); Experimental Biology	French Polar Institut (Institut Polaire Paul Emile Victor): financial and logistical support for the field part; The Swiss Fund for Women at University (Association Suisse des femmes diplomees des universites): founded part of the material; Company of Biologists and the Society: founded part of the travel cost for the field work; Experimental Biology provided funding for travel costs.	Barrat A, 1976, COM NAT FR RECH ANTA, V40, P9, DOI DOI 10.1016/J.ATHEROSCLEROSIS.2014.12.010; CHEREL Y, 1994, J ZOOL, V234, P1, DOI 10.1111/j.1469-7998.1994.tb06052.x; CHEREL Y, 1993, PHYSIOL ZOOL, V66, P750, DOI 10.1086/physzool.66.5.30163822; DEWASMES G, 1980, J APPL PHYSIOL, V49, P888, DOI 10.1152/jappl.1980.49.5.888; FISHER RA, 1959, STAT METHODS SCI INF; Fourati H, 2011, BIOMED SIGNAL PROCES, V6, P94, DOI 10.1016/j.bspc.2010.06.004; Gilleard WL, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-71; Griffin TM, 2000, NATURE, V408, P929, DOI 10.1038/35050167; Halsey LG, 2007, COMP BIOCHEM PHYS A, V147, P1009, DOI 10.1016/j.cbpa.2007.03.009; Halsey LG, 2015, NAT METHODS, V12, P179, DOI 10.1038/nmeth.3288; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Helbostad JL, 2003, GAIT POSTURE, V18, P27, DOI 10.1016/S0966-6362(02)00197-2; Kirtley C, 2006, CLIN GAIT ANAL THEOR; Kurz MJ, 2008, J THEOR BIOL, V252, P272, DOI 10.1016/j.jtbi.2008.01.012; Lai PPK, 2008, CLIN BIOMECH, V23, pS2, DOI 10.1016/j.clinbiomech.2008.02.004; LaRoche DP, 2011, J ELECTROMYOGR KINES, V21, P754, DOI 10.1016/j.jelekin.2011.07.006; Lew MJ, 2012, BRIT J PHARMACOL, V166, P1559, DOI 10.1111/j.1476-5381.2012.01931.x; Moe-Nilssen R, 2005, GAIT POSTURE, V21, P164, DOI 10.1016/j.gaitpost.2004.01.013; PINSHOW B, 1977, SCIENCE, V195, P592, DOI 10.1126/science.835018; PINSHOW B, 1976, AM J PHYSIOL, V231, P903, DOI 10.1152/ajplegacy.1976.231.3.903; R Core Team, 2012, R LANG ENV STAT COMP; Ranavolo A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/142323; Runhaar J, 2011, OBES REV, V12, P1071, DOI 10.1111/j.1467-789X.2011.00916.x; Willener AST, 2015, J THEOR BIOL, V387, P166, DOI 10.1016/j.jtbi.2015.09.019; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x	25	3	4	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0147784	10.1371/journal.pone.0147784	http://dx.doi.org/10.1371/journal.pone.0147784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886216	Green Submitted, gold, Green Published			2022-12-27	WOS:000371218400008
J	Wu, WH; Tran, W; Taatjes, CA; Alonso-Gutierrez, J; Lee, TS; Gladden, JM				Wu, Weihua; Tran, William; Taatjes, Craig A.; Alonso-Gutierrez, Jorge; Lee, Taek Soon; Gladden, John M.			Rapid Discovery and Functional Characterization of Terpene Synthases from Four Endophytic Xylariaceae	PLOS ONE			English	Article							FIR ABIES-GRANDIS; TRANS-CARYOPHYLLENE; BETA-CARYOPHYLLENE; ESCHERICHIA-COLI; CDNA ISOLATION; (E)-BETA-CARYOPHYLLENE SYNTHASE; (-)-LIMONENE SYNTHASE; DIPHOSPHATE SYNTHASE; PINENE SYNTHASE; ALPHA-PINENE	Endophytic fungi are ubiquitous plant endosymbionts that establish complex and poorly understood relationships with their host organisms. Many endophytic fungi are known to produce a wide spectrum of volatile organic compounds (VOCs) with potential energy applications, which have been described as "mycodiesel". Many of these mycodiesel hydrocarbons are terpenes, a chemically diverse class of compounds produced by many plants, fungi, and bacteria. Due to their high energy densities, terpenes, such as pinene and bisabolene, are actively being investigated as potential "drop-in" biofuels for replacing diesel and aviation fuel. In this study, we rapidly discovered and characterized 26 terpene synthases (TPSs) derived from four endophytic fungi known to produce mycodiesel hydrocarbons. The TPS genes were expressed in an E. coli strain harboring a heterologous mevalonate pathway designed to enhance terpene production, and their product profiles were determined using Solid Phase Micro-Extraction (SPME) and GC-MS. Out of the 26 TPS's profiled, 12 TPS's were functional, with the majority of them exhibiting both monoterpene and sesquiterpene synthase activity.	[Wu, Weihua; Tran, William; Gladden, John M.] Sandia Natl Labs, Biomass Sci & Convers Technol, Livermore, CA USA; [Taatjes, Craig A.] Sandia Natl Labs, Combust Chem Dept, Livermore, CA USA; [Alonso-Gutierrez, Jorge; Lee, Taek Soon] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Alonso-Gutierrez, Jorge; Lee, Taek Soon; Gladden, John M.] Joint BioEnergy Inst, Emeryville, CA USA	United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI	Gladden, JM (corresponding author), Sandia Natl Labs, Biomass Sci & Convers Technol, Livermore, CA USA.; Gladden, JM (corresponding author), Joint BioEnergy Inst, Emeryville, CA USA.	jmgladden@lbl.gov		Taatjes, Craig/0000-0002-9271-0282	Laboratory Directed Research and Development program at Sandia National Laboratories [DE-AC04-94AL85000]; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH1123]	Laboratory Directed Research and Development program at Sandia National Laboratories; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE))	This work was supported by the Laboratory Directed Research and Development program at Sandia National Laboratories, which is a multiprogram laboratory operated by Sandia Corporation, a Lockheed Martin Company, for the United States Department of Energy's National Nuclear Security Agency under contract DE-AC04-94AL85000. The funders provided financial support in the form of all authors' salaries and/or research materials, but had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Also this work was partially performed at Joint BioEnergy Institute (http://www.jbei.org) supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy.	Al Mansouri S, 2014, PHARMACOL BIOCHEM BE, V124, P260, DOI 10.1016/j.pbb.2014.06.025; Alonso-Gutierrez J, 2013, METAB ENG, V19, P33, DOI 10.1016/j.ymben.2013.05.004; Banerjee D, 2014, INDIAN J MICROBIOL, V54, P27, DOI 10.1007/s12088-013-0400-5; Benjamin G, 2010, ENERG FUEL, V24, P264; Bogorad IW, 2014, P NATL ACAD SCI USA, V111, P15928, DOI 10.1073/pnas.1413470111; Bohlmann J, 1997, J BIOL CHEM, V272, P21784, DOI 10.1074/jbc.272.35.21784; Bombarda I, 2001, ANAL CHIM ACTA, V447, P113, DOI 10.1016/S0003-2670(01)01307-1; Burke C, 2002, ARCH BIOCHEM BIOPHYS, V405, P130, DOI 10.1016/S0003-9861(02)00335-1; Carothers JM, 2010, NUCLEIC ACIDS RES, V38, P2736, DOI 10.1093/nar/gkq082; Chang MCY, 2006, NAT CHEM BIOL, V2, P674, DOI 10.1038/nchembio836; Chappell J, 2008, IN VITRO CELL DEV-AN, V44, pS27; Chen WQ, 2015, J PHARMACOL SCI, V127, P332, DOI 10.1016/j.jphs.2015.01.008; Cheng AX, 2007, PHYTOCHEMISTRY, V68, P1632, DOI 10.1016/j.phytochem.2007.04.008; Croteau R Ga H, 1984, J BIOL CHEM, V259, P740; Davis EM, 2000, TOP CURR CHEM, V209, P53; Degenhardt J, 2009, PHYTOCHEMISTRY, V70, P1621, DOI 10.1016/j.phytochem.2009.07.030; Dewick PM, 2002, NAT PROD REP, V19, P181, DOI 10.1039/b002685i; Fischbach RJ, 2000, PHYTOCHEMISTRY, V54, P257, DOI 10.1016/S0031-9422(00)00119-9; FUJISAKI S, 1990, J BIOCHEM-TOKYO, V108, P995, DOI 10.1093/oxfordjournals.jbchem.a123327; Gladden CAT, 2013, 2013201310094 SAND; Gong CMS, 2004, ABSTR PAP AM CHEM S, V227, pU84; Griffin MA, 2010, MICROBIOL-SGM, V156, P3814, DOI 10.1099/mic.0.041327-0; Gunnewich N, 2007, NAT PROD COMMUN, V2, P223; Haehnel-Taguchi M, 2014, J NEUROPHYSIOL, V112, P1329, DOI 10.1152/jn.00274.2014; Han LH, 2014, EUR FOOD RES TECHNOL, V239, P1061, DOI 10.1007/s00217-014-2302-0; Harvey BG, 2015, ENERG FUEL, V29, P2431, DOI 10.1021/ef5027746; He ZL, 2010, APPL ENVIRON MICROB, V76, P1574, DOI 10.1128/AEM.02141-09; Huang XZ, 2013, PLANT PHYSIOL BIOCH, V73, P302, DOI 10.1016/j.plaphy.2013.10.017; Hyatt DC, 2005, ARCH BIOCHEM BIOPHYS, V439, P222, DOI 10.1016/j.abb.2005.05.017; Katoh S, 2004, ARCH BIOCHEM BIOPHYS, V425, P65, DOI 10.1016/j.abb.2004.02.015; Khodayari A, 2014, METAB ENG, V25, P50, DOI 10.1016/j.ymben.2014.05.014; Klauke AL, 2014, EUR NEUROPSYCHOPHARM, V24, P608, DOI 10.1016/j.euroneuro.2013.10.008; Koksal M, 2011, NATURE, V469, P116, DOI 10.1038/nature09628; Kollner TG, 2008, PLANT CELL, V20, P482, DOI 10.1105/tpc.107.051672; Kudalkar P, 2012, MYCOSCIENCE, V53, P319, DOI 10.1007/s10267-011-0165-9; Kumar S, 2012, BIOINFORMATICS, V28, P2685, DOI 10.1093/bioinformatics/bts507; Kumeta Y, 2010, PLANT PHYSIOL, V154, P1998, DOI 10.1104/pp.110.161828; Guzman-Gutierrez SL, 2015, LIFE SCI, V128, P24, DOI 10.1016/j.lfs.2015.02.021; Lee JB, 2014, NAT PROD COMMUN, V9, P1231; Liu H, 2015, NEUROCHEM RES, V40, P118, DOI 10.1007/s11064-014-1474-0; Lu S, 2002, PLANT PHYSIOL, V130, P477, DOI 10.1104/pp.006544; Myburg AA, 2014, NATURE, V510, P356, DOI 10.1038/nature13308; Nagegowda DA, 2008, PLANT J, V55, P224, DOI 10.1111/j.1365-313X.2008.03496.x; Nakano C, 2011, CHEMBIOCHEM, V12, P1988, DOI 10.1002/cbic.201100330; Oldfield E, 2012, ANGEW CHEM INT EDIT, V51, P1124, DOI 10.1002/anie.201103110; Ouyang Z, 2012, REV BRAS FARMACOGN, V22, P957, DOI 10.1590/S0102-695X2012005000051; Pant A, 2014, EXP GERONTOL, V57, P81, DOI 10.1016/j.exger.2014.05.007; Paula-Freire LIG, 2014, PHYTOMEDICINE, V21, P356, DOI 10.1016/j.phymed.2013.08.006; Peralta-Yahya PP, 2011, NAT COMMUN, P2; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Phillips MA, 2003, ARCH BIOCHEM BIOPHYS, V411, P267, DOI 10.1016/S0003-9861(02)00746-4; Rabe P, 2013, CHEMBIOCHEM, V14, P2345, DOI 10.1002/cbic.201300329; Riyaz-Ul-Hassan S, 2013, J MICROBIOL BIOTECHN, V23, P29, DOI 10.4014/jmb.1208.04062; Rufino AT, 2015, EUR J PHARMACOL, V750, P141, DOI 10.1016/j.ejphar.2015.01.018; Saranya J, 2012, J ESSENT OIL BEAR PL, V15, P283, DOI 10.1080/0972060X.2012.10644048; Schmidt CO, 1999, ARCH BIOCHEM BIOPHYS, V364, P167, DOI 10.1006/abbi.1999.1122; Schwab W, 2001, ARCH BIOCHEM BIOPHYS, V392, P123, DOI 10.1006/abbi.2001.2442; Shaw JJ, 2015, J BIOL CHEM, V290, P8511, DOI 10.1074/jbc.M114.636159; Shen Hai-Yan, 2007, Sheng Wu Gong Cheng Xue Bao, V23, P976, DOI 10.1016/S1872-2075(07)60059-4; Singh SK, 2011, MICROB ECOL, V61, P729, DOI 10.1007/s00248-011-9818-7; Sosa ME, 2012, BIOCHEM SYST ECOL, V43, P132, DOI 10.1016/j.bse.2012.03.007; Steele CL, 1998, J BIOL CHEM, V273, P2078, DOI 10.1074/jbc.273.4.2078; Stolle A, 2009, HELV CHIM ACTA, V92, P1673, DOI 10.1002/hlca.200900041; Strobel G, 2004, J NAT PROD, V67, P257, DOI 10.1021/np030397v; Strobel GA, 1996, J IND MICROBIOL BIOT, V17, P417, DOI 10.1007/BF01574772; Strobel GA, 1998, ASM NEWS, V64, P263; Strobel G, 2014, CURR OPIN MICROBIOL, V19, P52, DOI 10.1016/j.mib.2014.06.003; Strobel G, 2011, FEMS MICROBIOL LETT, V320, P87, DOI 10.1111/j.1574-6968.2011.02297.x; Strobel GA, 2008, MICROBIOL-SGM, V154, P3319, DOI 10.1099/mic.0.2008/022186-0; Tang YJJ, 2009, J BACTERIOL, V191, P5224, DOI 10.1128/JB.00085-09; Tholl D, 2005, PLANT J, V42, P757, DOI 10.1111/j.1365-313X.2005.02417.x; Tim Edwards CM, 2010, 46 AIAA ASME SAE ASE; Tomsheck AR, 2010, MICROB ECOL, V60, P903, DOI 10.1007/s00248-010-9759-6; Ul-Hassan SR, 2012, MICROBIOL-SGM, V158, P465, DOI 10.1099/mic.0.054643-0; VanDien SJ, 1997, APPL ENVIRON MICROB, V63, P1689, DOI 10.1128/AEM.63.5.1689-1695.1997; Wang SJ, 2014, BIOCHEM BIOPH RES CO, V444, P451, DOI 10.1016/j.bbrc.2013.11.136; Wu SQ, 2005, PLANT PHYSIOL, V138, P1322, DOI 10.1104/pp.105.059386; Yukie Kumeta MI, 2011, J NATURAL MED, V65, P508, DOI [10.1007/s11418-011-0529-7, DOI 10.1007/S11418-011-0529-7]; Zhang Z, 2015, DRUG RES, V65, P214, DOI 10.1055/s-0034-1377025	79	22	26	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0146983	10.1371/journal.pone.0146983	http://dx.doi.org/10.1371/journal.pone.0146983			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885833	Green Published, gold, Green Submitted			2022-12-27	WOS:000371218400005
J	Hempenius, L; Slaets, JPJ; van Asselt, D; de Bock, TH; Wiggers, T; van Leeuwen, BL				Hempenius, Liesbeth; Slaets, Joris P. J.; van Asselt, Dieneke; de Bock, Truuske H.; Wiggers, Theo; van Leeuwen, Barbara L.			Long Term Outcomes of a Geriatric Liaison Intervention in Frail Elderly Cancer Patients	PLOS ONE			English	Article							HOSPITALIZED OLDER PATIENTS; MULTICOMPONENT INTERVENTION; POSTOPERATIVE DELIRIUM; MEDICAL INPATIENTS; HEALTH SURVEY; SURGERY; RISK; MORTALITY; INDICATOR; QUALITY	Background The aim of this study was to evaluate the long term effects after discharge of a hospital-based geriatric liaison intervention to prevent postoperative delirium in frail elderly cancer patients treated with an elective surgical procedure for a solid tumour. In addition, the effect of a postoperative delirium on long term outcomes was examined. Methods A three month follow-up was performed in participants of the Liaison Intervention in Frail Elderly study, a multicentre, prospective, randomized, controlled trial. Patients were randomized to standard treatment or a geriatric liaison intervention. The intervention consisted of a preoperative geriatric consultation, an individual treatment plan targeted at risk factors for delirium and daily visits by a geriatric nurse during the hospital stay. The long term outcomes included: mortality, rehospitalisation, Activities of Daily Living (ADL) functioning, return to the independent pre-operative living situation, use of supportive care, cognitive functioning and health related quality of life. Results Data of 260 patients (intervention n = 127, Control n = 133) were analysed. There were no differences between the intervention group and usual-care group for any of the outcomes three months after discharge. The presence of postoperative delirium was associated with: an increased risk of decline in ADL functioning (OR: 2.65, 95% CI: 1.02-6.88), an increased use of supportive assistance (OR: 2.45, 95% CI: 1.02-5.87) and a decreased chance to return to the independent preoperative living situation (OR: 0.18, 95% CI: 0.07-0.49). Conclusions A hospital-based geriatric liaison intervention for the prevention of postoperative delirium in frail elderly cancer patients undergoing elective surgery for a solid tumour did not improve outcomes 3 months after discharge from hospital. The negative effect of a postoperative delirium on late outcome was confirmed.	[Hempenius, Liesbeth; Slaets, Joris P. J.] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Geriatr Med, Groningen, Netherlands; [Hempenius, Liesbeth] Med Ctr Leeuwarden, Geriatr Ctr, Leeuwarden, Netherlands; [van Asselt, Dieneke] Radboud Univ Nijmegen, Med Ctr, Dept Geriatr, NL-6525 ED Nijmegen, Netherlands; [de Bock, Truuske H.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Wiggers, Theo; van Leeuwen, Barbara L.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands	University of Groningen; Medical Center Leeuwarden; Radboud University Nijmegen; University of Groningen; University of Groningen	Hempenius, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Geriatr Med, Groningen, Netherlands.; Hempenius, L (corresponding author), Med Ctr Leeuwarden, Geriatr Ctr, Leeuwarden, Netherlands.	l.hempenius@umcg.nl	de Bock, Geertruida Hendrika/F-6529-2014; van Asselt, Dieneke/ABF-4742-2020	de Bock, Geertruida Hendrika/0000-0003-3104-4471; van Leeuwen, Barbara/0000-0002-6745-4424	Netherlands Organisation for Health Research and Development [945-07-516]	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	Funding was obtained from the Netherlands Organisation for Health Research and Development, trial number 945-07-516 (http://www.zonmw.nl). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaldriks AA, 2015, LEUKEMIA LYMPHOMA, V19, P1; Aaldriks AA, 2013, J GERIATR ONCOL, V4, P218, DOI 10.1016/j.jgo.2013.04.001; Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Andela RM, 2010, INT J NURS PRACT, V16, P14, DOI 10.1111/j.1440-172X.2009.01807.x; Biesma B, 2011, ANN ONCOL, V22, P1520, DOI 10.1093/annonc/mdq637; Bogardus ST, 2003, AM J MED, V114, P383, DOI 10.1016/S0002-9343(02)01569-3; Counsell SR, 2000, J AM GERIATR SOC, V48, P1572, DOI 10.1111/j.1532-5415.2000.tb03866.x; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; Dekker JWT, 2012, EJSO-EUR J SURG ONC, V38, P1071, DOI 10.1016/j.ejso.2012.04.017; Dijkstra A, 1996, SCAND J CARING SCI, V10, P137, DOI 10.1111/j.1471-6712.1996.tb00326.x; Hempenius L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064834; Huisman MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086863; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Inouye SK, 1998, J GEN INTERN MED, V13, P234, DOI 10.1046/j.1525-1497.1998.00073.x; Kristjansson SR, 2009, CANCER TREAT REV, V35, P499, DOI 10.1016/j.ctrv.2009.04.004; Lawrence VA, 2004, J AM COLL SURGEONS, V199, P762, DOI 10.1016/j.jamcollsurg.2004.05.280; Mahoney JE, 1999, J GERONTOL A-BIOL, V54, pM83, DOI 10.1093/gerona/54.2.M83; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V271, P134, DOI 10.1001/jama.271.2.134; McCusker J, 2001, CAN MED ASSOC J, V165, P575; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; OKeeffe S, 1997, J AM GERIATR SOC, V45, P174, DOI 10.1111/j.1532-5415.1997.tb04503.x; Peters LL, 2012, J AM MED DIR ASSOC, V13, P546, DOI 10.1016/j.jamda.2012.04.007; Pol RA, 2011, EUR J VASC ENDOVASC, V42, P824, DOI 10.1016/j.ejvs.2011.07.006; Robinson TN, 2013, ANN SURG, V258, P582, DOI 10.1097/SLA.0b013e3182a4e96c; Robinson TN, 2009, ANN SURG, V249, P173, DOI 10.1097/SLA.0b013e31818e4776; Sager MA, 1998, CLIN GERIATR MED, V14, P669; Schuurmans H, 2004, J GERONTOL A-BIOL, V59, P962; Schuurmans Marieke J, 2003, Res Theory Nurs Pract, V17, P31, DOI 10.1891/088971803780956425; Slaets JPJ, 1997, PSYCHOSOM MED, V59, P585, DOI 10.1097/00006842-199711000-00005; Steverink N, 2001, GERONTOLOGIST, V41, P236; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Ware J., 1993, SF 36 HLTH SURVEY MA; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013	34	25	26	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0143364	10.1371/journal.pone.0143364	http://dx.doi.org/10.1371/journal.pone.0143364			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26901417	gold, Green Published, Green Submitted			2022-12-27	WOS:000371276100003
J	Kumar, G; Rattan, UK; Singh, AK				Kumar, Gulshan; Rattan, Usha Kumari; Singh, Anil Kumar			Chilling-Mediated DNA Methylation Changes during Dormancy and Its Release Reveal the Importance of Epigenetic Regulation during Winter Dormancy in Apple (Malus x domestica Borkh.)	PLOS ONE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEINS; AMPLIFICATION POLYMORPHISM MSAP; GENOME-WIDE ANALYSIS; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; FLOWERING TIME; ZEA-MAYS; HISTONE METHYLTRANSFERASE; CYTOSINE METHYLATION; PLANT GENOMES	Winter dormancy is a well known mechanism adopted by temperate plants, to mitigate the chilling temperature of winters. However, acquisition of sufficient chilling during winter dormancy ensures the normal phenological traits in subsequent growing period. Thus, low temperature appears to play crucial roles in growth and development of temperate plants. Apple, being an important temperate fruit crop, also requires sufficient chilling to release winter dormancy and normal phenological traits, which are often associated with yield and quality of fruits. DNA cytosine methylation is one of the important epigenetic modifications which remarkably affect the gene expression during various developmental and adaptive processes. In present study, methylation sensitive amplified polymorphism was employed to assess the changes in cytosine methylation during dormancy, active growth and fruit set in apple, under differential chilling conditions. Under high chill conditions, total methylation was decreased from 27.2% in dormant bud to 21.0% in fruit set stage, while no significant reduction was found under low chill conditions. Moreover, the demethylation was found to be decreased, while methylation increased from dormant bud to fruit set stage under low chill as compared to high chill conditions. In addition, RNA-Seq analysis showed high expression of DNA methyltransferases and histone methyltransferases during dormancy and fruit set, and low expression of DNA glcosylases during active growth under low chill conditions, which was in accordance with changes in methylation patterns. The RNA-Seq data of 47 genes associated with MSAP fragments involved in cellular metabolism, stress response, antioxidant system and transcriptional regulation showed correlation between methylation and their expression. Similarly, bisulfite sequencing and qRT-PCR analysis of selected genes also showed correlation between gene body methylation and gene expression. Moreover, significant association between chilling and methylation changes was observed, which suggested that chilling acquisition during dormancy in apple is likely to affect the epigenetic regulation through DNA methylation.	[Kumar, Gulshan; Rattan, Usha Kumari; Singh, Anil Kumar] CSIR Inst Himalayan Bioresource Technol, Dept Biotechnol, Palampur 176061, Himachal Prades, India; [Kumar, Gulshan; Singh, Anil Kumar] Acad Sci & Innovat Res, New Delhi, India; [Singh, Anil Kumar] IINRG, ICAR Indian Inst Agr Biotechnol, PDU Campus, Ranchi 834010, JH, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT); Academy of Scientific & Innovative Research (AcSIR); Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Agricultural Biotechnology; ICAR - Indian Institute of Natural Resins & Gums	Singh, AK (corresponding author), CSIR Inst Himalayan Bioresource Technol, Dept Biotechnol, Palampur 176061, Himachal Prades, India.; Singh, AK (corresponding author), IINRG, ICAR Indian Inst Agr Biotechnol, PDU Campus, Ranchi 834010, JH, India.	anils13@gmail.com		Singh, Anil/0000-0002-3569-5207	Council of Scientific and Industrial Research, New Delhi [BSC0107]; University Grants Commission, India	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, India(University Grants Commission, India)	This study was supported by the grants from Council of Scientific and Industrial Research, New Delhi, in the form of Network Project PlaGen (BSC0107) to AKS at CSIR-IHBT, Palampur.; We gratefully acknowledge Director, CSIR-Institute of Himalayan Bioresource Technology, Palampur for the constant support. GK acknowledges senior research fellowship received from University Grants Commission, India. We kindly acknowledge Associate Director, Hill Agricultural Research & Extension Centre, Bajaura, Kullu (HP) and Director, SASE (DRDO) station Bahang, Manali (HP) for providing the temperature data. This manuscript represents CSIR-IHBT communication number 3952.	Abedi T, 2016, J BIOSCI BIOENG, V121, P573, DOI 10.1016/j.jbiosc.2015.09.014; Anderson JV, 2005, PLANT CELL ENVIRON, V28, P1567, DOI 10.1111/j.1365-3040.2005.01393.x; Angers B, 2010, MOL ECOL, V19, P1283, DOI 10.1111/j.1365-294X.2010.04580.x; Arya P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107987; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Bassa C, 2012, PLANT CELL PHYSIOL, V53, P1583, DOI 10.1093/pcp/pcs101; Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bond DM, 2007, TRENDS PLANT SCI, V12, P211, DOI 10.1016/j.tplants.2007.03.010; BURN JE, 1993, P NATL ACAD SCI USA, V90, P287, DOI 10.1073/pnas.90.1.287; Caro E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002995; Causevic A, 2005, PLANT PHYSIOL BIOCH, V43, P681, DOI 10.1016/j.plaphy.2005.05.011; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Deng WW, 2007, PLANT PHYSIOL, V143, P1660, DOI [10.1104/pp.107.095521, 10.1104/pp.106.095521]; Du JM, 2012, CELL, V151, P167, DOI 10.1016/j.cell.2012.07.034; DUFF SMG, 1994, PHYSIOL PLANTARUM, V90, P791, DOI 10.1111/j.1399-3054.1994.tb02539.x; Ebbs ML, 2006, PLANT CELL, V18, P1166, DOI 10.1105/tpc.106.041400; Ebbs ML, 2005, MOL CELL BIOL, V25, P10507, DOI 10.1128/MCB.25.23.10507-10515.2005; Santamaria ME, 2011, ANN BOT-LONDON, V108, P485, DOI 10.1093/aob/mcr185; Finnegan EJ, 1998, P NATL ACAD SCI USA, V95, P5824, DOI 10.1073/pnas.95.10.5824; Fulnecek J, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-2; Gehring M, 2007, BBA-GENE STRUCT EXPR, V1769, P276, DOI 10.1016/j.bbaexp.2007.01.009; GEORGIEVA EI, 1991, J BIOL CHEM, V266, P18751; Hashida SN, 2006, PLANT CELL, V18, P104, DOI 10.1105/tpc.105.037655; Hedley PE, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-202; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Hsieh MH, 2002, PLANT PHYSIOL, V130, P1797, DOI 10.1104/pp.007484; Phan HA, 2011, PLANT CELL, V23, P2209, DOI 10.1105/tpc.110.082651; Jangra MS, 2013, INT J FARM SCI, V3; Jeddeloh JA, 1996, PLANT J, V9, P579, DOI 10.1046/j.1365-313X.1996.9050579.x; Johnson LM, 2007, CURR BIOL, V17, P379, DOI 10.1016/j.cub.2007.01.009; Karan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040203; Ko JH, 2011, TREE PHYSIOL, V31, P208, DOI 10.1093/treephys/tpq109; Kovarik A, 1997, GENE, V204, P25, DOI 10.1016/S0378-1119(97)00503-9; Kumar G, 2015, SCI HORTIC-AMSTERDAM, V197, P597, DOI 10.1016/j.scienta.2015.10.025; LANG GA, 1987, HORTSCIENCE, V22, P817; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Law RD, 2003, PLANT MOL BIOL, V51, P437, DOI 10.1023/A:1022002304479; Leida C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035777; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liu ZW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1003948; Lizal P, 2001, PHYSIOL PLANTARUM, V113, P121, DOI 10.1034/j.1399-3054.2001.1130116.x; Luca M, 2007, J EXP BOT, V58, P1035; LUND G, 1995, MOL GEN GENET, V246, P716, DOI 10.1007/BF00290717; Mazzitelli L, 2007, J EXP BOT, V58, P1035, DOI 10.1093/jxb/erl266; MCCLELLAND M, 1994, NUCLEIC ACIDS RES, V22, P3640, DOI 10.1093/nar/22.17.3640; MESSEGUER R, 1991, PLANT MOL BIOL, V16, P753, DOI 10.1007/BF00015069; Muoki RC, 2012, MOL BIOTECHNOL, V52, P82, DOI 10.1007/s12033-011-9476-5; Ning YQ, 2015, NUCLEIC ACIDS RES, V43, P1469, DOI 10.1093/nar/gku1382; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Ortega-Galisteo AP, 2008, PLANT MOL BIOL, V67, P671, DOI 10.1007/s11103-008-9346-0; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Portis E, 2004, PLANT SCI, V166, P169, DOI 10.1016/j.plantsci.2003.09.004; PRADHAN S, 1995, PLANT J, V7, P471, DOI 10.1046/j.1365-313X.1995.7030471.x; Rautengarten C, 2014, P NATL ACAD SCI USA, V111, P11563, DOI 10.1073/pnas.1406073111; REISER L, 1995, CELL, V83, P735, DOI 10.1016/0092-8674(95)90186-8; Rowland LJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-46; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Shan XH, 2013, J PLANT BIOL, V56, P32, DOI 10.1007/s12374-012-0251-3; Sherman JD, 2002, GENOME, V45, P253, DOI 10.1139/g01-147; Shim D, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.59; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Sridhar VV, 2004, P NATL ACAD SCI USA, V101, P11494, DOI 10.1073/pnas.0403055101; Steward N, 2002, J BIOL CHEM, V277, P37741, DOI 10.1074/jbc.M204050200; Sugiura T, 2012, JARQ-JPN AGR RES Q, V46, P7, DOI 10.6090/jarq.46.7; Takuno S, 2012, MOL BIOL EVOL, V29, P219, DOI 10.1093/molbev/msr188; Tang XM, 2014, MOL GENET GENOMICS, V289, P1075, DOI 10.1007/s00438-014-0869-6; Thorstensen T, 2006, NUCLEIC ACIDS RES, V34, P5461, DOI 10.1093/nar/gkl687; Tran RK, 2005, CURR BIOL, V15, P154, DOI 10.1016/j.cub.2005.01.008; Tzafrir I, 2004, PLANT PHYSIOL, V135, P1206, DOI 10.1104/pp.104.045179; Ulian EC, 1996, THEOR APPL GENET, V92, P976, DOI 10.1007/BF00224037; Vaissiere T, 2008, MUTAT RES-REV MUTAT, V659, P40, DOI 10.1016/j.mrrev.2008.02.004; Walton EF, 2009, J EXP BOT, V60, P3835, DOI 10.1093/jxb/erp231; Wang WS, 2011, J EXP BOT, V62, P1951, DOI 10.1093/jxb/erq391; Woo HR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000156; Wrobelska JG, 2013, ACTA PHYSIOL PLANT, V35, P817; Xin ZG, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-26; Yoo SY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000642; Yu QB, 2014, MOL PLANT, V7, P206, DOI 10.1093/mp/sst092; Zhang MS, 2011, PLANT PHYSIOL, V156, P1955, DOI 10.1104/pp.111.176842; Zhang XY, 2008, SCIENCE, V320, P489, DOI 10.1126/science.1153996; Zhang XY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r62; Zhou JL, 2010, PLANT MOL BIOL, V72, P585, DOI 10.1007/s11103-009-9594-7; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	85	58	62	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149934	10.1371/journal.pone.0149934	http://dx.doi.org/10.1371/journal.pone.0149934			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901339	gold, Green Submitted, Green Published			2022-12-27	WOS:000371276100189
J	Romanelli, AM; Raciti, M; Protti, MA; Prediletto, R; Fornai, E; Faustini, A				Romanelli, Anna Maria; Raciti, Mauro; Protti, Maria Angela; Prediletto, Renato; Fornai, Edo; Faustini, Annunziata			How Reliable Are Current Data for Assessing the Actual Prevalence of Chronic Obstructive Pulmonary Disease?	PLOS ONE			English	Article							GLOBAL BURDEN; DIAGNOSED COPD; SPIROMETRY USE; RISK-FACTORS; VALIDITY; POPULATION; VALIDATION; MORTALITY	Background Estimating COPD occurrence is perceived by the scientific community as a matter of increasing interest because of the worldwide diffusion of the disease. We aimed to estimate COPD prevalence by using administrative databases from a city in central Italy for 20022006, improving both the sensitivity and the reliability of the estimate. Methods Multiple sources were used, integrating the hospital discharge register (HDR), clinical charts, spirometry and the cause-specific mortality register (CMR) in a longitudinal algorithm, to reduce underestimation of COPD prevalence. Prevalence was also estimated on the basis of COPD cases confirmed through spirometry, to correct misclassification. Estimating such prevalence relied on using coefficients of validation, derived as the positive predictive value (PPV) for being an actual COPD case from clinical and spirometric data at the Institute of Clinical Physiology of the National Research Council. Results We found that sensitivity of COPD prevalence increased by 37%. The highest estimate (4.43 per 100 residents) was observed in the 5-year period, using a 3-year longitudinal approach and combined data from three sources. We found that 17% of COPD cases were misclassified. The above estimate of COPD prevalence decreased (3.66 per 100 residents) when coefficients of validation were applied. The PPV was 80% for the HDR, 82% for clinical diagnoses and 91% for the CMR. Conclusions Adjusting the COPD prevalence for both underestimation and misclassification of the cases makes administrative data more reliable for epidemiological purposes.	[Romanelli, Anna Maria; Raciti, Mauro; Protti, Maria Angela; Prediletto, Renato; Fornai, Edo] CNR, Inst Clin Physiol, Via Savi 8, I-56100 Pisa, Italy; [Prediletto, Renato] Fdn Gabriele Monasterio, CNR Reg Toscana, Pisa, Italy; [Faustini, Annunziata] Reg Hlth Serv, Dept Epidemiol, Rome, Lazio Region, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Faustini, A (corresponding author), Reg Hlth Serv, Dept Epidemiol, Rome, Lazio Region, Italy.	a.faustini@deplazio.it		Raciti, Mauro/0000-0001-8748-5511				Arne M, 2010, RESP MED, V104, P550, DOI 10.1016/j.rmed.2009.10.023; Atsou K, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-7; Bauleo L, 2014, 38 C IT EP ASS NAPL; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Cooke CR, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-37; Cricelli C, 2003, J PUBLIC HEALTH MED, V25, P254, DOI 10.1093/pubmed/fdg060; Damarla M, 2006, RESP CARE, V51, P1120; Eisner MD, 2010, CHEST, V137, P846, DOI 10.1378/chest.09-1855; Faustini A, 2012, COPD, V9, P184, DOI 10.3109/15412555.2011.654014; Gershon AS, 2009, COPD, V6, P388, DOI 10.1080/15412550903140865; Gupta RP, 2014, INT J TUBERC LUNG D, V18, P998, DOI 10.5588/ijtld.13.0910; Han MK, 2007, CHEST, V132, P403, DOI 10.1378/chest.06-2846; Hansell A, 2003, EUR RESPIR J, V21, P279, DOI 10.1183/09031936.03.00006102; Hardie JA, 2002, EUR RESPIR J, V20, P1117, DOI 10.1183/09031936.02.00023202; Hill K, 2010, CAN MED ASSOC J, V182, P673, DOI 10.1503/cmaj.091784; Hoesein FAAM, 2011, RESP MED, V105, P907, DOI 10.1016/j.rmed.2011.01.008; ISRAEL RA, 1986, AM J EPIDEMIOL, V124, P161, DOI 10.1093/oxfordjournals.aje.a114375; Joo MJ, 2008, CHEST, V134, P38, DOI 10.1378/chest.08-0013; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; Lacasse Yves, 2005, Can Respir J, V12, P251; Lacasse Y, 2012, CAN RESPIR J, V19, pE5, DOI 10.1155/2012/260374; Lee TA, 2006, CHEST, V129, P1509, DOI 10.1378/chest.129.6.1509; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Merry AHH, 2009, EUR J EPIDEMIOL, V24, P237, DOI 10.1007/s10654-009-9335-x; Mohammed MA, 2007, BMJ-BRIT MED J, V334, P1014, DOI 10.1136/bmj.39211.453275.80; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Quint JK, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005540; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rycroft CE, 2012, INT J CHRONIC OBSTR, V7, P457, DOI 10.2147/COPD.S32330; Saydah SH, 2004, ANN EPIDEMIOL, V14, P507, DOI 10.1016/j.annepidem.2003.09.016; Simonato L, 2008, EPIDEMIOL PREV, V32, P5; Soriano JB, 2001, EUR J EPIDEMIOL, V17, P1075, DOI 10.1023/A:1021235123382; STOCKS J, 1995, EUR RESPIR J, V8, P492, DOI 10.1183/09031936.95.08030492; Thomsen RW, 2011, RESP MED, V105, P1063, DOI 10.1016/j.rmed.2011.01.012; Wirehn ABE, 2007, SCAND J PUBLIC HEALT, V35, P424, DOI 10.1080/14034940701195230; Zhao YJ, 2008, AUST NZ J PUBL HEAL, V32, P307, DOI 10.1111/j.1753-6405.2008.00245.x	39	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149302	10.1371/journal.pone.0149302	http://dx.doi.org/10.1371/journal.pone.0149302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901166	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100056
J	Sharma, VK; Kudva, IT; Bearson, BL; Stasko, JA				Sharma, Vijay K.; Kudva, Indira T.; Bearson, Bradley L.; Stasko, Judith A.			Contributions of EspA Filaments and Curli Fimbriae in Cellular Adherence and Biofilm Formation of Enterohemorrhagic Escherichia coli O157:H7	PLOS ONE			English	Article							ENTEROCYTE EFFACEMENT GENES; O157-H7 REQUIRES INTIMIN; III SECRETION SYSTEM; BUNDLE-FORMING PILI; EPITHELIAL-CELLS; TRANSCRIPTIONAL REGULATION; PROTEIN TRANSLOCATION; PATHOGENICITY ISLAND; ABIOTIC SURFACES; TERMINAL RECTUM	In Escherichia coli O157:H7 (O157), the filamentous structure of the type III secretion system is produced from the polymerization of the EspA protein. EspA filaments are essential for O157 adherence to epithelial cells. In previous studies, we demonstrated that O157 hha deletion mutants showed increased adherence to HEp-2 cells and produced abundant biofilms. Transcriptional analysis revealed increased expression of espA as well as the csgA gene, which encodes curli fimbriae that are essential for biofilm formation. In the present study, we constructed hha espA, hha csgA, and hha csgA espA deletion mutants to determine the relative importance of EspA and CsgA in O157 adherence to HEp-2 cells and biofilm formation. In vitro adherence assays, conducted at 37 degrees C in a tissue culture medium containing 0.1% glucose, showed that HEp-2 cell adherence required EspA because hha espA and hha csgA espA mutants adhered to HEp-2 cells at higher levels only when complemented with an espA-expressing plasmid. Biofilm assays performed at 28 degrees C in a medium lacking glucose showed dependency of biofilm formation on CsgA; however EspA was not produced under these conditions. Despite production of detectable levels of EspA at 37 degrees C in media supplemented with 0.1% glucose, the biofilm formation occurred independent of EspA. These results indicate dependency of O157 adherence to epithelial cells on EspA filaments, while CsgA promoted biofilm formation under conditions mimicking those found in the environment (low temperature with nutrient limitations) and in the digestive tract of an host animal (higher temperature and low levels of glucose).	[Sharma, Vijay K.; Kudva, Indira T.] USDA ARS, Food Safety & Enter Pathogens Res Unit, Natl Anim Dis Ctr, Ames, IA USA; [Bearson, Bradley L.] USDA ARS, Agroecosyst Management Res Unit, Natl Lab Agr & Environm, Ames, IA USA; [Stasko, Judith A.] USDA ARS, Microscopy Serv Lab, Natl Anim Dis Ctr, Ames, IA USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Sharma, VK (corresponding author), USDA ARS, Food Safety & Enter Pathogens Res Unit, Natl Anim Dis Ctr, Ames, IA USA.	vijay.sharma@ars.usda.gov						Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bearson BL, 2009, MICROBIOL-SGM, V155, P805, DOI 10.1099/mic.0.022905-0; Beltrametti F, 1999, J BACTERIOL, V181, P3409, DOI 10.1128/JB.181.11.3409-3418.1999; BenNasr A, 1996, MOL MICROBIOL, V20, P927; Bertin Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098367; Bertin Y, 2013, ENVIRON MICROBIOL, V15, P610, DOI 10.1111/1462-2920.12019; Besser TE, 2001, EPIDEMIOL INFECT, V127, P555, DOI 10.1017/S095026880100615X; Brombacher E, 2006, J BACTERIOL, V188, P2027, DOI 10.1128/JB.188.6.2027-2037.2006; Cleary J, 2004, MICROBIOL-SGM, V150, P527, DOI 10.1099/mic.0.26740-0; Cookson AL, 2003, INT J MED MICROBIOL, V292, P547, DOI 10.1078/1438-4221-00235; Cookson AL, 2002, INT J MED MICROBIOL, V292, P195, DOI 10.1078/1438-4221-00203; Daniell SJ, 2003, MOL MICROBIOL, V49, P301, DOI 10.1046/j.1365-2958.2003.03555.x; Daniell SJ, 2001, INFECT IMMUN, V69, P4055, DOI 10.1128/IAI.69.6.4055-4064.2001; Dean-Nystrom EA, 1998, INFECT IMMUN, V66, P4560; Delahay RM, 2002, MOL MICROBIOL, V45, P905, DOI 10.1046/j.1365-2958.2002.03083.x; DeVinney R, 1999, INFECT IMMUN, V67, P2389, DOI 10.1128/IAI.67.5.2389-2398.1999; Ebel F, 1998, MOL MICROBIOL, V30, P147, DOI 10.1046/j.1365-2958.1998.01046.x; Elliott SJ, 1999, INFECT IMMUN, V67, P4260, DOI 10.1128/IAI.67.8.4260-4263.1999; Farfan MJ, 2012, INFECT IMMUN, V80, P903, DOI 10.1128/IAI.05907-11; Fitzhenry RJ, 2002, GUT, V50, P180, DOI 10.1136/gut.50.2.180; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; GRIFFIN PM, 1988, ANN INTERN MED, V109, P705, DOI 10.7326/0003-4819-109-9-705; Gualdi L, 2007, J BACTERIOL, V189, P8034, DOI 10.1128/JB.00900-07; Hammar M, 1995, MOL MICROBIOL, V18, P661, DOI 10.1111/j.1365-2958.1995.mmi_18040661.x; Hancock DD, 1997, EPIDEMIOL INFECT, V118, P193, DOI 10.1017/S0950268896007212; Hansen AM, 2009, MOL MICROBIOL, V73, P446, DOI 10.1111/j.1365-2958.2009.06781.x; Hu J, 2013, VET MICROBIOL, V164, P344, DOI 10.1016/j.vetmic.2013.02.023; Iyoda S, 2004, MICROBIOL-SGM, V150, P2357, DOI 10.1099/mic.0.27100-0; Iyoda S, 2011, INFECT IMMUN, V79, P4628, DOI 10.1128/IAI.05023-11; Jackson DW, 2002, J BACTERIOL, V184, P3406, DOI 10.1128/JB.184.12.3406-3410.2002; Jarvis KG, 1996, INFECT IMMUN, V64, P4826, DOI 10.1128/IAI.64.11.4826-4829.1996; JARVIS KG, 1995, P NATL ACAD SCI USA, V92, P7996, DOI 10.1073/pnas.92.17.7996; JERSE AE, 1991, INFECT IMMUN, V59, P4302, DOI 10.1128/IAI.59.12.4302-4309.1991; Kai-Larsen Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001010; Kaper JB, 1998, CURR OPIN MICROBIOL, V1, P103, DOI 10.1016/S1369-5274(98)80149-5; KARMALI MA, 1988, PEDIATR NEPHROL, V2, P409, DOI 10.1007/BF00853433; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; Kikuchi T, 2005, MICROBIOL IMMUNOL, V49, P875, DOI 10.1111/j.1348-0421.2005.tb03678.x; Larsen P, 2007, ENVIRON MICROBIOL, V9, P3077, DOI 10.1111/j.1462-2920.2007.01418.x; LETOURNEAU J, 2011, JOVE-J VIS EXP   MAY, DOI DOI 10.3791/2783; Li YL, 2000, INFECT IMMUN, V68, P5090, DOI 10.1128/IAI.68.9.5090-5095.2000; Loferer H, 1997, MOL MICROBIOL, V26, P11, DOI 10.1046/j.1365-2958.1997.5231883.x; Macarisin D, 2014, INT J FOOD MICROBIOL, V173, P48, DOI 10.1016/j.ijfoodmicro.2013.12.004; MCKEE ML, 1995, INFECT IMMUN, V63, P3739, DOI 10.1128/IAI.63.9.3739-3744.1995; Melton-Celsa AR, 1998, JPN J MED SCI BIOL, V51, pS108, DOI 10.7883/yoken1952.51.Supplement1_S108; MOON HW, 1983, INFECT IMMUN, V41, P1340, DOI 10.1128/IAI.41.3.1340-1351.1983; Moreira CG, 2006, J BACTERIOL, V188, P3952, DOI 10.1128/JB.00177-06; Naylor SW, 2005, MICROBIOL-SGM, V151, P2773, DOI 10.1099/mic.0.28060-0; Naylor SW, 2003, INFECT IMMUN, V71, P1505, DOI 10.1128/IAI.71.3.1505-1512.2003; OLSEN A, 1989, NATURE, V338, P652, DOI 10.1038/338652a0; Pawar DM, 2005, J APPL MICROBIOL, V99, P418, DOI 10.1111/j.1365-2672.2005.02499.x; Perna NT, 1998, INFECT IMMUN, V66, P3810, DOI 10.1128/IAI.66.8.3810-3817.1998; Pesavento C, 2008, GENE DEV, V22, P2434, DOI 10.1101/gad.475808; Prigent-Combaret C, 2001, J BACTERIOL, V183, P7213, DOI 10.1128/JB.183.24.7213-7223.2001; Roe AJ, 2003, INFECT IMMUN, V71, P5900, DOI 10.1128/IAI.71.10.5900-5909.2003; Romling U, 1998, J BACTERIOL, V180, P722; Rosser T, 2008, INFECT IMMUN, V76, P5598, DOI 10.1128/IAI.01180-08; Russell RM, 2007, J BACTERIOL, V189, P5387, DOI 10.1128/JB.00553-07; Saldana Z, 2009, ENVIRON MICROBIOL, V11, P992, DOI 10.1111/j.1462-2920.2008.01824.x; Sharma VK, 2012, INFECT IMMUN, V80, P1333, DOI 10.1128/IAI.05869-11; Sharma VK, 2013, APPL ENVIRON MICROB, V79, P2384, DOI 10.1128/AEM.02998-12; Sharma VK, 2005, FEMS MICROBIOL LETT, V243, P189, DOI 10.1016/j.femsle.2004.12.003; Sharma VK, 2004, J BACTERIOL, V186, P7290, DOI 10.1128/JB.186.21.7290-7301.2004; Shaw RK, 2001, CELL MICROBIOL, V3, P213, DOI 10.1046/j.1462-5822.2001.00105.x; Sperandio V, 2001, J BACTERIOL, V183, P5187, DOI 10.1128/JB.183.17.5187-5197.2001; Sperandio V, 1999, P NATL ACAD SCI USA, V96, P15196, DOI 10.1073/pnas.96.26.15196; Torres AG, 2005, APPL ENVIRON MICROB, V71, P8008, DOI 10.1128/AEM.71.12.8008-8015.2005; Uhlich GA, 2006, APPL ENVIRON MICROB, V72, P2564, DOI 10.1128/AEM.72.4.2564-2572.2006; Uhlich GA, 2009, INFECT IMMUN, V77, P1543, DOI 10.1128/IAI.00949-08; Vlisidou I, 2006, INFECT IMMUN, V74, P758, DOI 10.1128/IAI.74.1.758-764.2006; White-Ziegler CA, 2008, MICROBIOL-SGM, V154, P148, DOI 10.1099/mic.0.2007/012021-0; Wolff C, 1998, MOL MICROBIOL, V28, P143, DOI 10.1046/j.1365-2958.1998.00782.x; YU J, 1992, MOL MICROBIOL, V6, P411, DOI 10.1111/j.1365-2958.1992.tb01484.x; Zhang LH, 2004, INFECT IMMUN, V72, P7282, DOI 10.1128/IAI.72.12.7282-7293.2004	74	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149745	10.1371/journal.pone.0149745	http://dx.doi.org/10.1371/journal.pone.0149745			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900701	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100140
J	Bachiller, E; Skaret, G; Nottestad, L; Slotte, A				Bachiller, Eneko; Skaret, Georg; Nottestad, Leif; Slotte, Aril			Feeding Ecology of Northeast Atlantic Mackerel, Norwegian Spring-Spawning Herring and Blue Whiting in the Norwegian Sea	PLOS ONE			English	Article							CAPELIN MALLOTUS-VILLOSUS; SMALL PELAGIC FISH; CLUPEA-HARENGUS L; CALANUS-FINMARCHICUS; PLANKTIVOROUS FISH; SCOMBER-SCOMBRUS; BARENTS SEA; OVERLAP; SUMMER; MIGRATION	The Norwegian spring-spawning (NSS) herring (Clupea harengus), blue whiting (Micromesistius poutassou) and Northeast Atlantic (NEA) mackerel (Scomber scombrus) are extremely abundant pelagic planktivores that feed in the Norwegian Sea (NS) during spring and summer. This study investigated the feeding ecology and diet composition of these commercially important fish stocks on the basis of biological data, including an extensive set of stomach samples in combination with hydrographical data, zooplankton samples and acoustic abundance data from 12 stock monitoring surveys carried out in 2005-2010. Mackerel were absent during the spring, but had generally high feeding overlap with herring in the summer, with a diet mainly based on calanoid copepods, especially Calanus finmarchicus, as well as a similar diet width. Stomach fullness in herring diminished from spring to summer and feeding incidence was lower than that of mackerel in summer. However, stomach fullness did not differ between the two species, indicating that herring maintain an equally efficient pattern of feeding as mackerel in summer, but on a diet that is less dominated by copepods and is more reliant on larger prey. Blue whiting tended to have a low dietary overlap with mackerel and herring, with larger prey such as euphausiids and amphipods dominating, and stomach fullness and feeding incidence increasing with length. For all the species, feeding incidence increased with decreasing temperature, and for mackerel so did stomach fullness, indicating that feeding activity is highest in areas associated with colder water masses. Significant annual effects on diet composition and feeding-related variables suggested that the three species are able to adapt to different food and environmental conditions. These annual effects are likely to have an important impact on the predation pressure on different plankton groups and the carrying capacity of individual systems, and emphasise the importance of regular monitoring of pelagic fish diets.	[Bachiller, Eneko; Skaret, Georg; Nottestad, Leif; Slotte, Aril] Inst Marine Res, Pelag Fish Res Grp, POB 1870, NO-5817 Bergen, Norway; [Bachiller, Eneko] AZTI Fdn, Marine Ecosyst Functioning Area, Gipuzkoa 20110, Basque Country, Spain	Institute of Marine Research - Norway; AZTI	Bachiller, E (corresponding author), Inst Marine Res, Pelag Fish Res Grp, POB 1870, NO-5817 Bergen, Norway.; Bachiller, E (corresponding author), AZTI Fdn, Marine Ecosyst Functioning Area, Gipuzkoa 20110, Basque Country, Spain.	eneko.bachiller@imr.no	Bachiller, Eneko/H-3528-2019	Bachiller, Eneko/0000-0002-6189-6176	Department of Education, Language policy and Culture of the Basque Country Government	Department of Education, Language policy and Culture of the Basque Country Government	This work was supported by a postdoctoral fellowship to EB from the Department of Education, Language policy and Culture of the Basque Country Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Bachiller E, 2015, MAR ECOL PROG SER, V534, P179, DOI 10.3354/meps11375; Bachiller E, 2013, ICES J MAR SCI, V70, P232, DOI 10.1093/icesjms/fss171; Berge J, 2015, ARCTIC, V68, P54, DOI 10.14430/arctic4455; Blindheim J., 1989, P366; Broms C, 2012, MAR BIOL RES, V8, P461, DOI 10.1080/17451000.2011.640689; Dalpadado P, 1998, SARSIA, V83, P103; Dalpadado P, 2000, ICES J MAR SCI, V57, P843, DOI 10.1006/jmsc.2000.0573; Dragesund O, 1997, SARSIA, V82, P97, DOI 10.1080/00364827.1997.10413643; Entsminger GL, 2014, ECOSIM PROFESSIONAL; FAO, 2005, REVIEW OF THE STATE; Ferno A, 1998, SARSIA, V83, P149; GIBSON RN, 1992, J FISH BIOL, V40, P577, DOI 10.1111/j.1095-8649.1992.tb02607.x; Gislason A, 2002, FOOD NORWEGIAN SPRIN, P236; Hamre J., 1980, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V177, P212; Harris R., 2000, ICES ZOOPLANKTON MET; HASSEL A, 1991, POLAR RES, V10, P371, DOI 10.1111/j.1751-8369.1991.tb00660.x; Huse G, 1996, SARSIA, V81, P143, DOI 10.1080/00364827.1996.10413618; Huse G, 2012, MAR BIOL RES, V8, P488, DOI 10.1080/17451000.2011.639779; Huse G, 2012, MAR BIOL RES, V8, P415, DOI 10.1080/17451000.2011.653372; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; ICES (International Council for the Exploration of the Sea), 2014, REP WORK GROUP WID D; Iversen S.A., 2002, ICES J MAR SCI, V215, P382, DOI [10.17895/ices.pub.8877, DOI 10.17895/ICES.PUB.8877]; Johannessen O.M., 1986, BRIEF OVERVIEW PHYS, P103; Kaartvedt S, 2000, ICES J MAR SCI, V57, P1819, DOI 10.1006/jmsc.2000.0964; Langoy H, 2012, MAR BIOL RES, V8, P442, DOI 10.1080/17451000.2011.642803; LAWLOR LR, 1980, AM NAT, V116, P394, DOI 10.1086/283634; Melle W, 2004, ZOOPLANKTON LINK HIG, P137; Misund OA, 1998, SARSIA, V83, P117; Mjanger H, 2007, BERGEN I MAR RES, V3, P45; Nottestad L, 1999, CAN J FISH AQUAT SCI, V56, P26, DOI 10.1139/cjfas-56-S1-26; Nottestad L, 1996, SARSIA, V80, P277, DOI 10.1080/00364827.1996.10413601; Nottestad L, ICES J MAR SCI; Olaso T, 2005, J MAR BIOL ASSOC UK, V85, P415, DOI 10.1017/S0025315405011343h; PIANKA ER, 1974, P NATL ACAD SCI USA, V71, P2141, DOI 10.1073/pnas.71.5.2141; Prokopchuk I, 2006, ICES J MAR SCI, V63, P117, DOI 10.1016/j.icesjms.2005.08.005; Skaret G, 2015, ICES J MAR SCI, V72, P2313, DOI 10.1093/icesjms/fsv087; Skjoldal H.R., 2004, NORWEGIAN SEA ECOSYS; Toresen R, 2000, FISH FISH, V1, P231, DOI 10.1111/j.1467-2979.2000.00022.x; Utne KR, 2012, MAR BIOL RES, V8, P548, DOI 10.1080/17451000.2011.639781; Utne KR, 2012, MAR BIOL RES, V8, P527, DOI 10.1080/17451000.2011.642804; Utne KR, 2012, MAR BIOL RES, V8, P420, DOI 10.1080/17451000.2011.640937; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; ZILANOV VK, 1964, MATERIALY RYBOKHOZUS, V4, P45; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	45	59	59	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149238	10.1371/journal.pone.0149238	http://dx.doi.org/10.1371/journal.pone.0149238			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895485	Green Published, Green Submitted, gold			2022-12-27	WOS:000371223400041
J	Bonnyaud, C; Roche, N; Van Hamme, A; Bensmail, D; Pradon, D				Bonnyaud, Celine; Roche, Nicolas; Van Hamme, Angele; Bensmail, Djamel; Pradon, Didier			Locomotor Trajectories of Stroke Patients during Oriented Gait and Turning	PLOS ONE			English	Article							GO TEST; OLDER-ADULTS; KINEMATICS; RELIABILITY; WALKING; ADAPTATIONS; STAND; SIT; INDIVIDUALS; IMPAIRMENTS	Background The Timed Up and Go (TUG) test is widely used to assess locomotion in patients with stroke and is considered to predict the risk of falls. The analysis of locomotor trajectories during the TUG appears pertinent in stroke patients. The aims of this study were i) to analyze locomotor trajectories in patients with stroke during the walking and turning sub-tasks of the TUG, and to compare them with healthy subjects, ii) to determine whether trajectory parameters provide additional information to that provided by the conventional measure (performance time), iii) to compare the trajectory parameters of fallers and non-fallers with stroke and of patients with right and left hemisphere stroke, and iv) to evaluate correlations between trajectory parameters and Berg Balance Scale scores. Methods 29 patients with stroke (mean age 54.2 +/- 12.2 years, 18 men, 8 fallers) and 25 healthy subjects (mean age 51.6 +/- 8.7 years, 11 men) underwent three-dimensional analysis of the TUG. The trajectory of the center of mass was analyzed by calculation of the global trajectory length, Hausdorff distance and Dynamic Time Warping. The parameters were compared with a reference trajectory during the total task and each sub-task (Go, Turn, Return) of the TUG. Results Values of trajectory parameters were significantly higher for the stroke group during the total TUG and the Go and Turn sub-tasks (p<0.05). Moreover, logistic regression indicated that these parameters better discriminated stroke patients and healthy subjects than the conventional timed performance during the Go sub-task. In addition, fallers were distinguished by higher Dynamic Time Warping during the Go (p<0.05). There were no differences between patients with right and left hemisphere stroke. Discussion and Conclusion The trajectories of the stroke patients were longer and more deviated during the turn and the preceding phase. Trajectory parameters provided additional information to timed performance of this locomotor task. Focusing rehabilitation programs on lead-up to turn and turning could be relevant for stroke patients since the Turn was related to the balance and the phase preceding the turn seemed to distinguish fallers.	[Bonnyaud, Celine; Roche, Nicolas; Van Hamme, Angele; Pradon, Didier] UVSQ, Hop Raymond Poincare, APHP,Inserm,U1179,Serv Physiol & Explorat Fonct, Team Technol & Innovat Therapies Appl Neuromuscul, F-92380 Garches, France; [Bensmail, Djamel] UVSQ, Hop Raymond Poincare, APHP,Inserm,U1179,Serv Med Phys & Readaptat, Team Technol & Innovat Therapies Appl Neuromuscul, F-92380 Garches, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Raymond-Poincare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Raymond-Poincare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Bonnyaud, C (corresponding author), UVSQ, Hop Raymond Poincare, APHP,Inserm,U1179,Serv Physiol & Explorat Fonct, Team Technol & Innovat Therapies Appl Neuromuscul, F-92380 Garches, France.	celine.bonnyaud@aphp.fr	roche, nicolas/R-6080-2018; Bonnyaud, Celine/AGK-7246-2022; Bensmail, Djamel/R-6035-2018	Bensmail, Djamel/0000-0001-9360-9330				Arnadottir SA, 2000, PHYS THER, V80, P17, DOI 10.1093/ptj/80.1.17; Barre A, 2014, COMPUT METH PROG BIO, V114, DOI 10.1016/j.cmpb.2014.01.012; Berndt D.J., 1994, AAAI WORK NOT KNOWL; Bonnyaud C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129821; Brunt D, 2002, ARCH PHYS MED REHAB, V83, P924, DOI 10.1053/apmr.2002.3324; Faria CDCD, 2009, TOP STROKE REHABIL, V16, P196, DOI 10.1310/tsr1603-196; Courtine G, 2003, EUR J NEUROSCI, V18, P177, DOI 10.1046/j.1460-9568.2003.02736.x; Cruz TH, 2009, J BIOMECH, V42, P1673, DOI 10.1016/j.jbiomech.2009.04.015; Dempster W.T., 1955, SPACE REQUIREMENTS S; Di Brina C, 2008, HUM MOVEMENT SCI, V27, P242, DOI 10.1016/j.humov.2008.02.012; Ding H, 2008, PROC VLDB ENDOW, V1, P1542; Duval K, 2011, J NEUROPHYSIOL, V106, P280, DOI 10.1152/jn.00657.2010; Etienne L, 2011, MOTIFS SPATIO TEMPOR; Faria CD, 2012, ARCH PHYS MED REHAB, V93, P1034, DOI 10.1016/j.apmr.2011.11.025; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Flansbjer UB, 2005, J REHABIL MED, V37, P75, DOI 10.1080/16501970410017215; Frykberg GE, 2009, ARCH PHYS MED REHAB, V90, P1009, DOI 10.1016/j.apmr.2008.12.023; Fu TC, 2011, ENG APPL ARTIF INTEL, V24, P164, DOI 10.1016/j.engappai.2010.09.007; Gerin-Lajoie M, 2005, MOTOR CONTROL, V9, P242, DOI 10.1123/mcj.9.3.242; Gilleard W, 2008, GAIT POSTURE, V27, P8, DOI 10.1016/j.gaitpost.2006.11.002; Glaister BC, 2007, GAIT POSTURE, V25, P289, DOI 10.1016/j.gaitpost.2006.04.003; Hackney AL, 2013, GAIT POSTURE, V37, P93, DOI 10.1016/j.gaitpost.2012.06.020; Hicheur H, 2007, EUR J NEUROSCI, V26, P2376, DOI 10.1111/j.1460-9568.2007.05836.x; Higuchi T, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00277; Hollands KL, 2010, NEUROREHAB NEURAL RE, V24, P358, DOI 10.1177/1545968309348508; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Lamontagne A, 2010, NEUROREHAB NEURAL RE, V24, P457, DOI 10.1177/1545968309355985; Laxhammar R., 2011, PROC 14 INT C INF FU, V2011, P1; MacLellan MJ, 2006, EXP BRAIN RES, V173, P521, DOI 10.1007/s00221-006-0399-5; McGinley JL, 2009, GAIT POSTURE, V29, P360, DOI 10.1016/j.gaitpost.2008.09.003; Mendis S, 2013, INT J STROKE, V8, P3, DOI 10.1111/j.1747-4949.2012.00969.x; Ng SS, 2005, ARCH PHYS MED REHAB, V86, P1641, DOI 10.1016/j.apmr.2005.01.011; OLNEY SJ, 1994, PHYS THER, V74, P872, DOI 10.1093/ptj/74.9.872; Perennou DA, 2008, BRAIN, V131, P2401, DOI 10.1093/brain/awn170; Perry J., 1992, GAIT ANAL NORMAL PAT; Persson CU, 2011, J REHABIL MED, V43, P348, DOI 10.2340/16501977-0677; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Psarrou A, 2002, IMAGE VISION COMPUT, V20, P349, DOI 10.1016/S0262-8856(02)00007-0; Roy G, 2006, CLIN BIOMECH, V21, P585, DOI 10.1016/j.clinbiomech.2006.01.007; Schoene D, 2013, J AM GERIATR SOC, V61, P202, DOI 10.1111/jgs.12106; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Thigpen MT, 2000, PHYS THER, V80, P1174, DOI 10.1093/ptj/80.12.1174; Vallis LA, 2003, EXP BRAIN RES, V152, P409, DOI 10.1007/s00221-003-1558-6; WINTER DA, 1974, J BIOMECH, V7, P157, DOI 10.1016/0021-9290(74)90056-6; Yavuzer G, 2008, GAIT POSTURE, V27, P31, DOI 10.1016/j.gaitpost.2006.12.016	46	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149757	10.1371/journal.pone.0149757	http://dx.doi.org/10.1371/journal.pone.0149757			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894916	gold, Green Published			2022-12-27	WOS:000371223400080
J	Chen, X; Zou, XB; He, JM; Zheng, J; Chiarella, J; Kozal, MJ				Chen, Xi; Zou, Xiaobai; He, Jianmei; Zheng, Jun; Chiarella, Jennifer; Kozal, Michael J.			HIV Drug Resistance Mutations (DRMs) Detected by Deep Sequencing in Virologic Failure Subjects on Therapy from Hunan Province, China	PLOS ONE			English	Article							TREATMENT-EXPERIENCED PATIENTS; REVERSE-TRANSCRIPTASE; ANTIRETROVIRAL TREATMENT; MINORITY POPULATIONS; IMPACT; VARIANTS; GENOTYPE; RISK	Objective Determine HIV drug resistance mutations (DRMs) prevalence at low and high levels in ART-experienced patients experiencing virologic failure (VF). Methods 29 subjects from 18 counties in Hunan Province that experienced VF were evaluated for the prevalence of DRMs (Stanford DRMs with an algorithm value >= 15, include low-, intermediate and high-level resistance) by both Sanger sequencing (SS) and deep sequencing (DS) to 1% frequency levels. Results DS was performed on samples from 29 ART-experienced subjects; the median viral load 4.95x10(4) c/ml; 82.76% subtype CRF01_AE. 58 DRMs were detected by DS. 18 DRMs were detected by SS. Of the 58 mutations detected by DS, 40 were at levels <20% frequency (26 NNRTI, 12 NRTI and 2 PI) and the majority of these 95.00% (38/40) were not detected by standard genotyping. Of these 40 low-level DRMs, 16 (40%) were detected at frequency levels of 1-4% and 24 (60%) at levels of 5-19%. SS detected 15 of 17 (88.24%) DRMs at levels >= 20% that were detected by DS. The only variable associated with the detection of DRMs by DS was ART adherence (missed doses in the prior 7 days); all patients that reported missing a dose in the last 7 days had DRMs detected by DS. Conclusions DS of VF samples from treatment experienced subjects infected with primarily AE subtype frequently identified Stanford HIVdb NRTI and NNRTI resistance mutations with an algorithm value 15. Low frequency level resistant variants detected by DS were frequently missed by standard genotyping in VF specimens from antiretroviral-experienced subjects.	[Chen, Xi; Zou, Xiaobai; He, Jianmei; Zheng, Jun] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Chiarella, Jennifer; Kozal, Michael J.] Yale Univ, Sch Med, New Haven, CT USA	Yale University	Chen, X (corresponding author), Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China.	Chenxi161@sohu.com		, Michael/0000-0002-7719-7396; Kozal, Michael/0000-0002-3100-8254	National Science and Technology Major Project of China [2012ZX1001001]	National Science and Technology Major Project of China	This work was funded by National Science and Technology Major Project of China (No. 2012ZX1001001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avidor B, 2013, J CLIN MICROBIOL, V51, P880, DOI 10.1128/JCM.02652-12; Barzon L, 2011, INT J MOL SCI, V12, P7861, DOI 10.3390/ijms12117861; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Chabria SB, 2014, ANNU REV GENOM HUM G, V15, P295, DOI 10.1146/annurev-genom-091212-153406; Chen X, 2005, PRACTICAL PREVENTIVE, V12, P483; Chen Xi, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P787; Chinese center for disease control and prevention, 2012, NAT FREE AIDS ARV GU; Codoner FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019461; Cozzi-Lepri A, 2014, J ANTIMICROB CHEMOTH; Dunn DT, 2011, CURR OPIN HIV AIDS, V6, P251, DOI 10.1097/COH.0b013e32834732e8; Fisher R, 2012, J VIROL, V86, P6231, DOI 10.1128/JVI.06541-11; Geretti AM, 2015, CURR OPIN INFECT DIS, V28, P23, DOI 10.1097/QCO.0000000000000136; Gianella S, 2011, J VIROL, V85, P8359, DOI 10.1128/JVI.02582-10; Halvas EK, 2010, J INFECT DIS, V201, P672, DOI 10.1086/650542; He JM, 2007, PRACT PREV MED, V14, P1260; Hedskog C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011345; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Kozal MJ, 2007, HIV CLIN TRIALS, V8, P357, DOI 10.1310/hct0806-357; Lataillade M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030118; Lataillade M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010952; Le T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006079; Lecossier D, 2005, JAIDS-J ACQ IMM DEF, V38, P37, DOI 10.1097/00126334-200501010-00007; Li JZ, 2013, J INFECT DIS, V207, P893, DOI 10.1093/infdis/jis925; Li JZ, 2012, AIDS, V26, P185, DOI 10.1097/QAD.0b013e32834e9d7d; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Metzner KJ, 2011, J CLIN VIROL, V50, P156, DOI 10.1016/j.jcv.2010.10.001; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Mitsuya Y, 2008, J VIROL, V82, P10747, DOI 10.1128/JVI.01827-07; Palmer S, 2006, AIDS, V20, P701, DOI 10.1097/01.aids.0000216370.69066.7f; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Pou C, 2014, CLIN INFECT DIS, V59, P578, DOI 10.1093/cid/ciu287; Roquebert B, 2006, AIDS, V20, P287, DOI 10.1097/01.aids.0000202650.03279.69; Santos AF, 2009, J ANTIMICROB CHEMOTH, V63, P593, DOI 10.1093/jac/dkn526; Shao YM, 2001, AIDS PATIENT CARE ST, V15, P431, DOI 10.1089/108729101316914449; Simen BB, 2014, J VIROL METHODS, V204, P31, DOI 10.1016/j.jviromet.2014.04.007; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Svarovskaia ES, 2007, JAIDS-J ACQ IMM DEF, V46, P174, DOI 10.1097/QAI.0b013e31814258c0; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Vandenbroucke I, 2011, BIOTECHNIQUES, V51, P167, DOI 10.2144/000113733; Vandenhende MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086771; Zou XB, 2010, CHIN J INFECT CONTRO, V9, P305; Zou XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098740	43	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149215	10.1371/journal.pone.0149215	http://dx.doi.org/10.1371/journal.pone.0149215			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895182	Green Published, Green Submitted, gold			2022-12-27	WOS:000371223400038
J	Ho, MH; Huang, L; Goodwin, JS; Dong, XH; Chen, CH; Xie, H				Ho, Meng-Hsuan; Huang, Li; Goodwin, J. Shawn; Dong, Xinhong; Chen, Chin-Ho; Xie, Hua			Two Small Molecules Block Oral Epithelial Cell Invasion by Porphyromons gingivalis	PLOS ONE			English	Article							MEMBRANE VESICLE PRODUCTION; IN-VITRO; BACTERIAL INVASION; IDENTIFICATION; MECHANISMS; MICROBIOTA; INTEGRINS; VIRULENCE; ALOPERINE; DYNASORE	Porphyromonas gingivalis is a keystone pathogen of periodontitis. One of its bacterial characteristics is the ability to invade various host cells, including nonphagocytic epithelial cells and fibroblasts, which is known to facilitate P. gingivalis adaptation and survival in the gingival environment. In this study, we investigated two small compounds, Alop1 and dynasore, for their role in inhibition of P. gingivalis invasion. Using confocal microscopy, we showed that these two compounds significantly reduced invasion of P. gingivalis and its outer membrane vesicles into human oral keratinocytes in a dose-dependent manner. The inhibitory effects of dynasore, a dynamin inhibitor, on the bacterial entry is consistent with the notion that P. gingivalis invasion is mediated by a clathrin-mediated endocytic machinery. We also observed that microtubule arrangement, but not actin, was altered in the host cells treated with Alop1 or dynasore, suggesting an involvement of microtubule in this inhibitory activity. This work provides an opportunity to develop compounds against P. gingivalis infection.	[Ho, Meng-Hsuan; Xie, Hua] Meharry Med Coll, Sch Dent, Nashville, TN 37208 USA; [Huang, Li; Chen, Chin-Ho] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Goodwin, J. Shawn] Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA; [Dong, Xinhong] Meharry Med Coll, Dept Microbiol, Nashville, TN 37208 USA	Meharry Medical College; Duke University; Meharry Medical College; Meharry Medical College	Xie, H (corresponding author), Meharry Med Coll, Sch Dent, Nashville, TN 37208 USA.; Chen, CH (corresponding author), Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.	chc@duke.edu; hxie@mmc.edu			NIDCR [DE022428, 025332]; NIMHD [MD007593, MD007586]; NCRR [UL1 RR024975]; NCATS [UL1 TR000445]; NIH [MD007593, MD007586, CA163069, DA036420, RR0254970]; NATIONAL CANCER INSTITUTE [U54CA163069] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975, S10RR025497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE022428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R24DA036420] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007586, U54MD007593, U54MD007586] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIMHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by NIDCR grants DE022428 and 025332 (HX) and by NIMHD grants MD007593 and MD007586. The project described was also supported by NCRR grant UL1 RR024975 (currently NCATS grant UL1 TR000445). Microscopy was conducted in the MMC Morphology Core, which is supported by NIH grants MD007593, MD007586, CA163069, DA036420, and RR0254970.	Abazeed ME, 2005, J BIOL CHEM, V280, P4442, DOI 10.1074/jbc.M412553200; Amar S, 2009, J IMMUNOL, V182, P1584, DOI 10.4049/jimmunol.182.3.1584; Belton CM, 1999, CELL MICROBIOL, V1, P215, DOI 10.1046/j.1462-5822.1999.00022.x; Boisvert H, 2008, CELL MICROBIOL, V10, P2538, DOI 10.1111/j.1462-5822.2008.01228.x; Chaudhuri S, 2014, INFECT IMMUN, V82, P2728, DOI 10.1128/IAI.00084-14; Chu VC, 2004, P NATL ACAD SCI USA, V101, P18153, DOI 10.1073/pnas.0405172102; Dang Z, 2014, ACS MED CHEM LETT, V5, P942, DOI 10.1021/ml500236n; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Deshpande RG, 1998, INFECT IMMUN, V66, P5337, DOI 10.1128/IAI.66.11.5337-5343.1998; Dorn BR, 2002, INT ENDOD J, V35, P366, DOI 10.1046/j.0143-2885.2001.00489.x; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Furuta N, 2009, INFECT IMMUN, V77, P4187, DOI 10.1128/IAI.00009-09; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Ho MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123448; Hunstad DA, 2010, ANNU REV MICROBIOL, V64, P203, DOI 10.1146/annurev.micro.112408.134258; Killoy WJ, 2002, J CLIN PERIODONTOL, V29, P22; Kolenbrander PE, 2000, ANNU REV MICROBIOL, V54, P413, DOI 10.1146/annurev.micro.54.1.413; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Lamont RJ, 2000, ORAL MICROBIOL IMMUN, V15, P341, DOI 10.1034/j.1399-302x.2000.150601.x; LAMONT RJ, 1995, INFECT IMMUN, V63, P3878, DOI 10.1128/IAI.63.10.3878-3885.1995; Lamont RJ, 2002, PERIODONTOL 2000, V30, P61, DOI 10.1034/j.1600-0757.2002.03006.x; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Li L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-26; Lin WC, 2011, J AGR FOOD CHEM, V59, P184, DOI 10.1021/jf103581r; MacDonald IA, 2013, J BACTERIOL, V195, P2971, DOI 10.1128/JB.02267-12; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Madianos PN, 1996, INFECT IMMUN, V64, P660, DOI 10.1128/IAI.64.2.660-664.1996; Mantri CK, 2015, MICROBIOLOGYOPEN, V4, P53, DOI 10.1002/mbo3.221; Moffatt CE, 2012, CELL MICROBIOL, V14, P577, DOI 10.1111/j.1462-5822.2011.01743.x; Mues MB, 2015, J VIROL, V89, P6673, DOI 10.1128/JVI.00636-15; Nakagawa I, 2005, MICROBES INFECT, V7, P157, DOI 10.1016/j.micinf.2004.10.007; Radhakrishnan Girish K, 2012, Biomol Concepts, V3, P571; Robinson MS, 2015, TRAFFIC, V16, P1210, DOI 10.1111/tra.12335; Takeuchi Hiroki, 2011, Commun Integr Biol, V4, P587, DOI 10.4161/cib.4.5.16549; Takeuchi H, 2011, CELL MICROBIOL, V13, P677, DOI 10.1111/j.1462-5822.2010.01564.x; Thompson HM, 2004, NAT CELL BIOL, V6, P335, DOI 10.1038/ncb1112; Tribble GD, 2006, P NATL ACAD SCI USA, V103, P11027, DOI 10.1073/pnas.0509813103; Tribble GD, 2010, PERIODONTOL 2000, V52, P68, DOI 10.1111/j.1600-0757.2009.00323.x; Wang H, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0120-x; Ximenez-Fyvie LA, 2000, J CLIN PERIODONTOL, V27, P648, DOI 10.1034/j.1600-051x.2000.027009648.x; Yilmaz O, 2003, MICROBIOL-SGM, V149, P2417, DOI 10.1099/mic.0.26483-0; Yilmaz O, 2002, CELL MICROBIOL, V4, P305, DOI 10.1046/j.1462-5822.2002.00192.x; Yoshida S, 2003, TRENDS MICROBIOL, V11, P139, DOI 10.1016/S0966-842X(03)00023-4; Zenobia C, 2015, VIRULENCE, V6, P236, DOI 10.1080/21505594.2014.999567; ZHOU CC, 1989, ACTA PHARM SINIC, V10, P360	46	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149618	10.1371/journal.pone.0149618	http://dx.doi.org/10.1371/journal.pone.0149618			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894834	Green Published, gold			2022-12-27	WOS:000371223400068
J	Hu, Y; Xie, SY; Yao, JH				Hu, Yu; Xie, Shuying; Yao, Jihua			Identification of Novel Reference Genes Suitable for qRT-PCR Normalization with Respect to the Zebrafish Developmental Stage	PLOS ONE			English	Article							RNA-SEQ DATA; EXPRESSION ANALYSIS; HOUSEKEEPING GENES; RT-QPCR; EMBRYONIC-DEVELOPMENT; PROSTATE-CANCER; SELECTION; TISSUE; TOOL; VALIDATION	Reference genes used in normalizing qRT-PCR data are critical for the accuracy of gene expression analysis. However, many traditional reference genes used in zebrafish early development are not appropriate because of their variable expression levels during embryogenesis. In the present study, we used our previous RNA-Seq dataset to identify novel reference genes suitable for gene expression analysis during zebrafish early developmental stages. We first selected 197 most stably expressed genes from an RNA-Seq dataset (29,291 genes in total), according to the ratio of their maximum to minimum RPKM values. Among the 197 genes, 4 genes with moderate expression levels and the least variation throughout 9 developmental stages were identified as candidate reference genes. Using four independent statistical algorithms (delta-CT, geNorm, BestKeeper and NormFinder), the stability of qRT-PCR expression of these candidates was then evaluated and compared to that of actb1 and actb2, two commonly used zebrafish reference genes. Stability rankings showed that two genes, namely mobk13 (mob4) and lsm12b, were more stable than actb1 and actb2 in most cases. To further test the suitability of mobk13 and lsm12b as novel reference genes, they were used to normalize three well-studied target genes. The results showed that mobk13 and lsm12b were more suitable than actb1 and actb2 with respect to zebrafish early development. We recommend mobk13 and lsm12b as new optimal reference genes for zebrafish qRT-PCR analysis during embryogenesis and early larval stages.	[Hu, Yu; Xie, Shuying; Yao, Jihua] Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China	Fudan University	Yao, JH (corresponding author), Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	yaojh@fudan.edu.cn	Hu, Yu/AAI-1837-2020	Hu, Yu/0000-0003-3178-0874	National Basic Research Program of China [2012CB944603, 2011CB943804]; State Key Laboratory of Genetic Engineering, Fudan University [SKLGE-1408]	National Basic Research Program of China(National Basic Research Program of China); State Key Laboratory of Genetic Engineering, Fudan University	This work was funded by the National Basic Research Program of China (2012CB944603 and 2011CB943804) and the Open Research Funds of the State Key Laboratory of Genetic Engineering, Fudan University (SKLGE-1408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2004, FEBS LETT, V569, P18, DOI 10.1016/j.febslet.2004.03.126; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Brudal Espen, 2013, BMC Res Notes, V6, P76, DOI 10.1186/1756-0500-6-76; Carvalho DM, 2014, ANTON LEEUW INT J G, V106, P605, DOI 10.1007/s10482-014-0231-3; Casadei R, 2011, GENE EXPR PATTERNS, V11, P271, DOI 10.1016/j.gep.2011.01.003; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Coulson DTR, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-46; Souza AFD, 2013, MOL BIOL REP, V40, P2955, DOI 10.1007/s11033-012-2366-5; Danielsson F, 2013, J PROTEOME RES, V12, P299, DOI 10.1021/pr3009308; De Santis C, 2011, MAR BIOTECHNOL, V13, P170, DOI 10.1007/s10126-010-9277-z; Elsalini OA, 2003, DEV GENES EVOL, V212, P593, DOI 10.1007/s00427-002-0279-3; Flanagan-Steet HR, 2013, GLYCOCONJUGATE J, V30, P33, DOI 10.1007/s10719-012-9390-5; Galeano Esteban, 2014, BMC Res Notes, V7, P464, DOI 10.1186/1756-0500-7-464; Gonzalez-Aguero M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-878; Guo CM, 2013, CLIN TRANSL ONCOL, V15, P167, DOI 10.1007/s12094-012-0924-x; Haas BJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-734; Huang Y, 2013, J COMPUT BIOL, V20, P167, DOI 10.1089/cmb.2012.0230; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Liu JJ, 2013, J BIOSCI BIOENG, V116, P460, DOI 10.1016/j.jbiosc.2013.04.011; Ma LM, 2013, MAR GENOM, V11, P67, DOI 10.1016/j.margen.2013.08.002; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Martyn U, 2003, DEV BIOL, V260, P58, DOI 10.1016/S0012-1606(03)00221-5; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; McGowan I, 2015, CYTOKINE, V71, P81, DOI 10.1016/j.cyto.2014.08.010; Merrick BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061768; Mori R, 2008, PROSTATE, V68, P1555, DOI 10.1002/pros.20815; Nikaido M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054833; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pollier J, 2014, PLANT PHYSIOL BIOCH, V83, P20, DOI 10.1016/j.plaphy.2014.07.004; Schulte J, 2010, J NEUROSCI, V30, P5189, DOI 10.1523/JNEUROSCI.5823-09.2010; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sinha DK, 2014, SCI REP-UK, V4, DOI 10.1038/srep05059; Sun Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041659; Swisher KD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010006; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Tobia C, 2013, BBA-MOL BASIS DIS, V1832, P1371, DOI 10.1016/j.bbadis.2013.01.016; Trammell MA, 2008, J CELL SCI, V121, P1284, DOI 10.1242/jcs.017210; van Delft J, 2012, TOXICOL SCI, V130, P427, DOI 10.1093/toxsci/kfs250; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vanhauwaert S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109091; Wang M, 2013, GENE, V530, P44, DOI 10.1016/j.gene.2013.07.084; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Westerfield M, 1994, ZEBRAFISH BOOK; Xiong J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030630; Yang CG, 2013, GENE, V527, P183, DOI 10.1016/j.gene.2013.06.013; Yang HL, 2014, GENE, V538, P113, DOI 10.1016/j.gene.2013.12.057; Yang HX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064799, 10.1371/journal.pone.0064058]; Zemp N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092893; Zhan C, 2014, ACTA BIOCH BIOPH SIN, V46, P330, DOI 10.1093/abbs/gmt153; Zhang C, 2005, DEV BIOL, V278, P526, DOI 10.1016/j.ydbio.2004.11.008	51	19	20	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149277	10.1371/journal.pone.0149277	http://dx.doi.org/10.1371/journal.pone.0149277			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891128	Green Published, Green Submitted, gold			2022-12-27	WOS:000371221500031
J	Sanford, EL; Choy, KW; Donahoe, PK; Tracy, AA; Hila, R; Loscertales, M; Longoni, M				Sanford, Ethan L.; Choy, Kwong W.; Donahoe, Patricia K.; Tracy, Adam A.; Hila, Regis; Loscertales, Maria; Longoni, Mauro			MiR-449a Affects Epithelial Proliferation during the Pseudoglandular and Canalicular Phases of Avian and Mammal Lung Development	PLOS ONE			English	Article							CONGENITAL DIAPHRAGMATIC-HERNIA; REPLICATION-COMPETENT RETROVIRUSES; N-MYC ONCOGENE; PROGENITOR CELLS; GENE-EXPRESSION; DIFFERENTIATION; MORPHOGENESIS; MICRORNAS; AIRWAY; PATHOGENESIS	Congenital diaphragmatic hernia is associated with pulmonary hypoplasia and respiratory distress, which result in high mortality and morbidity. Although several transgenic mouse models of lung hypoplasia exist, the role of miRNAs in this phenotype is incompletely characterized. In this study, we assessed microRNA expression levels during the pseudoglandular to canalicular phase transition of normal human fetal lung development. At this critical time, when the distal respiratory portion of the airways begins to form, microarray analysis showed that the most significantly differentially expressed miRNA was miR-449a. Prediction algorithms determined that N-myc is a target of miR-449a and identified the likely miR-449a: N-myc binding sites, confirmed by luciferase assays and targeted mutagenesis. Functional ex vivo knock-down in organ cultures of murine embryonic lungs, as well as in ovo overexpression in avian embryonic lungs, suggested a role for miR-449a in distal epithelial proliferation. Finally, miR-449a expression was found to be abnormal in rare pulmonary specimens of human fetuses with Congenital Diaphragmatic Hernia in the pseudoglandular or canalicular phase. This study confirms the conserved role of miR-449a for proper pulmonary organogenesis, supporting the delicate balance between expansion of progenitor cells and their terminal differentiation, and proposes the potential involvement of this miRNA in human pulmonary hypoplasia.	[Sanford, Ethan L.; Hila, Regis; Loscertales, Maria; Longoni, Mauro] Massachusetts Gen Hosp, Pediat Surg Res Labs, Boston, MA 02114 USA; [Sanford, Ethan L.] Harvard Univ, Sch Med, Hlth Sci & Technol Med Program, Boston, MA USA; [Sanford, Ethan L.] Boston Childrens Hosp, Dept Med, Boston, MA USA; [Choy, Kwong W.] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Donahoe, Patricia K.; Tracy, Adam A.; Loscertales, Maria; Longoni, Mauro] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Donahoe, Patricia K.; Tracy, Adam A.] Broad Inst & Harvard, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Chinese University of Hong Kong; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Loscertales, M; Longoni, M (corresponding author), Massachusetts Gen Hosp, Pediat Surg Res Labs, Boston, MA 02114 USA.; Loscertales, M; Longoni, M (corresponding author), Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA.	mloscertales@mgh.harvard.edu; mlongoni@mgh.harvard.edu	Choy, Richard/AAW-8230-2020	Choy, Richard/0000-0002-3616-6200; Sanford, Ethan/0000-0002-7423-6521	National Institute of Child Health and Human Development [P01 HD068250-03]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD068250] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding was provided by National Institute of Child Health and Human Development P01 HD068250-03 to P.K.D. (www.nichd.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AREECHON W, 1963, BRIT MED J, P230, DOI 10.1136/bmj.1.5325.230; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beltran H, 2014, MOL CANCER RES, V12, P815, DOI 10.1158/1541-7786.MCR-13-0536; Bhaskaran M, 2009, PHYSIOL GENOMICS, V37, P268, DOI 10.1152/physiolgenomics.90268.2008; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Cognet M, 2011, EUR J HUM GENET, V19, P602, DOI 10.1038/ejhg.2010.225; Dong J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010854; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Greer JJ, 2013, RESP PHYSIOL NEUROBI, V189, P232, DOI 10.1016/j.resp.2013.04.015; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Khoshgoo N, 2013, PEDIATR PULM, V48, P317, DOI 10.1002/ppul.22739; Kim YH, 2006, ONCOGENE, V25, P130, DOI 10.1038/sj.onc.1208997; Kimura J, 2007, PEDIATR DEVEL PATHOL, V10, P335, DOI 10.2350/07-06-0290.1; Kinane TB, 2007, AM J MED GENET C, V145C, P117, DOI 10.1002/ajmg.c.30124; KITAGAWA M, 1971, BRIT J SURG, V58, P342, DOI 10.1002/bjs.1800580507; Lize M, 2010, CELL DEATH DIFFER, V17, P452, DOI 10.1038/cdd.2009.188; Lize M, 2010, CELL CYCLE, V9, P4579, DOI 10.4161/cc.9.22.13870; Logan M, 1998, METHODS, V14, P407, DOI 10.1006/meth.1998.0595; Longoni M, 2014, P NATL ACAD SCI USA, V111, P12450, DOI 10.1073/pnas.1412509111; Loscertales M, 2008, DEVELOPMENT, V135, P1365, DOI 10.1242/dev.010504; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Lu Yun, 2008, Proc Am Thorac Soc, V5, P300, DOI 10.1513/pats.200710-162DR; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Marcet B, 2011, NAT CELL BIOL, V13, P693, DOI 10.1038/ncb2241; Matsushita S, 1999, DEV GROWTH DIFFER, V41, P313; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; Okubo T, 2005, DEVELOPMENT, V132, P1363, DOI 10.1242/dev.01678; Pacheco BA, 1997, SURG FORUM, P652; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Pober BR, 1993, SOURCE GENEREVIEWSTM; Rhodes J, 2015, AM J PHYSIOL-LUNG C, V309, pL168, DOI 10.1152/ajplung.00299.2014; Russell MK, 2012, P NATL ACAD SCI USA, V109, P2978, DOI 10.1073/pnas.1121621109; Schmitz R, 2014, COLD SPRING HARB PER, V4; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Sluiter I, 2013, EXP MOL PATHOL, V94, P195, DOI 10.1016/j.yexmp.2012.09.010; STANTON BR, 1992, GENE DEV, V6, P2235, DOI 10.1101/gad.6.12a.2235; Theiler K., 1989, HOUSE MOUSE, P1; Tsao PN, 2008, J BIOL CHEM, V283, P29532, DOI 10.1074/jbc.M801565200; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; Yang XJ, 2009, GENE DEV, V23, P2388, DOI 10.1101/gad.1819009	43	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149425	10.1371/journal.pone.0149425	http://dx.doi.org/10.1371/journal.pone.0149425			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26891231	gold, Green Published, Green Submitted			2022-12-27	WOS:000371221500046
J	Gross, K; Sun, M; Schiestl, FP				Gross, Karin; Sun, Mimi; Schiestl, Florian P.			Why Do Floral Perfumes Become Different? Region-Specific Selection on Floral Scent in a Terrestrial Orchid	PLOS ONE			English	Article							POLLINATOR-MEDIATED SELECTION; FLOWER COLOR; PHENOTYPIC SELECTION; SPUR LENGTH; GEOGRAPHIC STRUCTURE; SPATIAL VARIATION; EVOLUTION; TRAITS; PLANT; ADAPTATION	Geographically structured phenotypic selection can lead to adaptive divergence. However, in flowering plants, such divergent selection has rarely been shown, and selection on floral signals is generally little understood. In this study, we measured phenotypic selection on display size, floral color, and floral scent in four lowland and four mountain populations of the nectar-rewarding terrestrial orchid Gymnadenia odoratissima in two years. We also quantified population differences in these traits and pollinator community composition. Our results show positive selection on display size and positive, negative, or absence of selection on different scent compounds and floral color. Selection on the main scent compounds was consistently stronger in the lowlands than in the mountains, and lowland plants emitted higher amounts of most of these compounds. Pollinator community composition also differed between regions, suggesting different pollinators select for differences in floral volatiles. Overall, our study is the first to document consistent regional differences in selection on floral scent, suggesting this pattern of selection is one of the evolutionary forces contributing to regional divergence in floral chemical signaling.	[Gross, Karin; Sun, Mimi; Schiestl, Florian P.] Univ Zurich, Inst Systemat Bot, Zollikerstr 107, CH-8008 Zurich, Switzerland	University of Zurich	Schiestl, FP (corresponding author), Univ Zurich, Inst Systemat Bot, Zollikerstr 107, CH-8008 Zurich, Switzerland.	florian.schiestl@systbot.uzh.ch		Gross, Karin/0000-0002-2363-452X; Schiestl, Florian/0000-0001-7637-6918	Swiss National Science Foundation [31003A-125340]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by the Swiss National Science Foundation grant 31003A-125340 to FPS.	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bischoff M, 2013, NEW ZEAL J BOT, V51, P181, DOI 10.1080/0028825X.2013.806933; Boberg E, 2014, ANN BOT-LONDON, V113, P267, DOI 10.1093/aob/mct217; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Brown M, 2011, PLANT SYST EVOL, V294, P199, DOI 10.1007/s00606-011-0443-1; Brunet J, 2009, ANN BOT-LONDON, V103, P1567, DOI 10.1093/aob/mcp096; Bustamante E, 2010, AM J BOT, V97, P2020, DOI 10.3732/ajb.1000071; Campbell DR, 2012, J EVOLUTION BIOL, V25, P352, DOI 10.1111/j.1420-9101.2011.02430.x; Campbell DR, 1997, AM NAT, V149, P295, DOI 10.1086/285991; Caruso CM, 2010, INT J PLANT SCI, V171, P1020, DOI 10.1086/656511; Chittka L, 2006, CURR OPIN PLANT BIOL, V9, P428, DOI 10.1016/j.pbi.2006.05.002; Dotterl S, 2005, PHYTOCHEMISTRY, V66, P203, DOI 10.1016/j.phytochem.2004.12.002; Dudash MR, 2011, AM J BOT, V98, P275, DOI 10.3732/ajb.1000350; Ehrlen J, 2012, BASIC APPL ECOL, V13, P509, DOI 10.1016/j.baae.2012.08.001; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; GALEN C, 1985, ECOLOGY, V66, P792, DOI 10.2307/1940540; Gomez JM, 2008, P ROY SOC B-BIOL SCI, V275, P2241, DOI 10.1098/rspb.2008.0512; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; GRANT V, 1949, EVOLUTION, V3, P82, DOI 10.2307/2405454; Gustafsson S, 2002, CONSERV GENET, V3, P225, DOI 10.1023/A:1019969014333; Hall MC, 2006, EVOLUTION, V60, P2466, DOI 10.1554/05-688.1; Harder LD, 2009, NEW PHYTOL, V183, P530, DOI 10.1111/j.1469-8137.2009.02914.x; Herrera C.M., 2006, ECOLOGY EVOLUTION FL, P278; Hess HE, 1976, FLORA DER SCHWEIZ UN; Hirota SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085601; Hopkins R, 2012, EVOLUTION, V66, P469, DOI 10.1111/j.1558-5646.2011.01452.x; Huber FK, 2005, OECOLOGIA, V142, P564, DOI 10.1007/s00442-004-1750-9; Hulten E., 1986, ATLAS N EUROPEAN VAS; Johnson SD, 1997, EVOLUTION, V51, P45, DOI 10.1111/j.1558-5646.1997.tb02387.x; Junker RR, 2010, ANN BOT-LONDON, V105, P777, DOI 10.1093/aob/mcq045; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; Maad J, 2000, EVOLUTION, V54, P112, DOI 10.1111/j.0014-3820.2000.tb00012.x; Majetic CJ, 2008, ANN BOT-LONDON, V102, P911, DOI 10.1093/aob/mcn181; Malo JE, 2002, DIVERS DISTRIB, V8, P365, DOI 10.1046/j.1472-4642.2002.00161.x; Mant J, 2005, EVOLUTION, V59, P1449, DOI 10.1111/j.0014-3820.2005.tb01795.x; Gomez JM, 2010, INT J PLANT SCI, V171, P987, DOI 10.1086/656475; Moeller DA, 2006, ECOLOGY, V87, P1510, DOI 10.1890/0012-9658(2006)87[1510:GSOPCR]2.0.CO;2; Newman E, 2012, P ROY SOC B-BIOL SCI, V279, P2309, DOI 10.1098/rspb.2011.2375; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Parachnowitsch AL, 2012, NEW PHYTOL, V195, P667, DOI 10.1111/j.1469-8137.2012.04188.x; PELLMYR O, 1986, OECOLOGIA, V68, P304, DOI 10.1007/BF00384804; Price MV, 2005, ECOLOGY, V86, P2106, DOI 10.1890/04-1274; Raguso RA, 2008, ENTOMOL EXP APPL, V128, P196, DOI 10.1111/j.1570-7458.2008.00683.x; RCoreTeam, 2013, LANG ENV STAT COMP; Renoult JP, 2013, J EVOLUTION BIOL, V26, P2415, DOI 10.1111/jeb.12234; Reynolds RJ, 2010, EVOLUTION, V64, P358, DOI 10.1111/j.1558-5646.2009.00805.x; Salzmann CC, 2007, PLANT BIOLOGY, V9, P720, DOI 10.1055/s-2007-965614; Sandring S, 2009, EVOLUTION, V63, P1292, DOI 10.1111/j.1558-5646.2009.00624.x; Schemske DW, 1999, P NATL ACAD SCI USA, V96, P11910, DOI 10.1073/pnas.96.21.11910; Schiestl FP, 2015, NEW PHYTOL, V206, P571, DOI 10.1111/nph.13243; Schiestl FP, 2013, TRENDS ECOL EVOL, V28, P307, DOI 10.1016/j.tree.2013.01.019; Schiestl FP, 2011, EVOL ECOL, V25, P237, DOI 10.1007/s10682-010-9409-y; Siepielski AM, 2013, ECOL LETT, V16, P1382, DOI 10.1111/ele.12174; Sletvold N, 2010, INT J PLANT SCI, V171, P999, DOI 10.1086/656597; Sletvold N, 2010, NEW PHYTOL, V188, P385, DOI 10.1111/j.1469-8137.2010.03296.x; Soler C, 2011, PHYTOCHEMISTRY, V72, P74, DOI 10.1016/j.phytochem.2010.10.012; Strauss S.Y., 2006, ECOLOGY EVOLUTION FL, P120; Suinyuy TN, 2012, BIOL J LINN SOC, V106, P514, DOI 10.1111/j.1095-8312.2012.01905.x; Sun M, 2014, ANN BOT-LONDON, V113, P289, DOI 10.1093/aob/mct219; Thompson JN, 2006, ECOLOGY, V87, P103, DOI 10.1890/05-0123; Thompson JN, 2002, NATURE, V417, P735, DOI 10.1038/nature00810; Thompson John N., 2005, pi; van der Niet T, 2012, TRENDS ECOL EVOL, V27, P353, DOI 10.1016/j.tree.2012.02.002; van dersCingel N. A., 1995, ATLAS ORCHID POLLINA; Vereecken NJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-103; Zu PJ, 2016, NEW PHYTOL, V209, P1208, DOI 10.1111/nph.13652	66	68	69	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0147975	10.1371/journal.pone.0147975	http://dx.doi.org/10.1371/journal.pone.0147975			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886766	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000371218400012
J	Schmidt, A; Eriksson, M; Shang, MM; Weyd, H; Tegner, J				Schmidt, Angelika; Eriksson, Matilda; Shang, Ming-Mei; Weyd, Heiko; Tegner, Jesper			Comparative Analysis of Protocols to Induce Human CD4+Foxp3+Regulatory T Cells by Combinations of IL-2, TGF-beta, Retinoic Acid, Rapamycin and Butyrate	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; DE-NOVO GENERATION; GROWTH-FACTOR-BETA; FOXP3 EXPRESSION; RECEPTOR STIMULATION; SUPPRESSIVE FUNCTION; PROMOTES GENERATION; EPIGENETIC CHANGES; IN-VIVO; DIFFERENTIATION	Regulatory T cells (Tregs) suppress other immune cells and are critical mediators of peripheral tolerance. Therapeutic manipulation of Tregs is subject to numerous clinical investigations including trials for adoptive Treg transfer. Since the number of naturally occurring Tregs (nTregs) is minute, it is highly desirable to develop a complementary approach of inducing Tregs (iTregs) from naive T cells. Mouse studies exemplify the importance of peripherally induced Tregs as well as the applicability of iTreg transfer in different disease models. Yet, procedures to generate iTregs are currently controversial, particularly for human cells. Here we therefore comprehensively compare different established and define novel protocols of human iTreg generation using TGF-beta in combination with other compounds. We found that human iTregs expressed several Treg signature molecules, such as Foxp3, CTLA-4 and EOS, while exhibiting low expression of the cytokines Interferon-gamma, IL-10 and IL-17. Importantly, we identified a novel combination of TGF-beta, retinoic acid and rapamycin as a robust protocol to induce human iTregs with superior suppressive activity in vitro compared to currently established induction protocols. However, iTregs generated by these protocols did not stably retain Foxp3 expression and did not suppress in vivo in a humanized graft-versus-host-disease mouse model, highlighting the need for further research to attain stable, suppressive iTregs. These results advance our understanding of the conditions enabling human iTreg generation and may have important implications for the development of adoptive transfer strategies targeting autoimmune and inflammatory diseases.	[Schmidt, Angelika; Eriksson, Matilda; Shang, Ming-Mei; Tegner, Jesper] Karolinska Inst, Dept Med, Ctr Mol Med, Unit Computat Med, Stockholm, Sweden; [Schmidt, Angelika; Eriksson, Matilda; Shang, Ming-Mei; Tegner, Jesper] Karolinska Univ Hosp, Stockholm, Sweden; [Weyd, Heiko] German Canc Res Ctr, Tumor Immunol Program, Div Immunogenet, Heidelberg, Germany	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ)	Schmidt, A (corresponding author), Karolinska Inst, Dept Med, Ctr Mol Med, Unit Computat Med, Stockholm, Sweden.; Schmidt, A (corresponding author), Karolinska Univ Hosp, Stockholm, Sweden.	angelika.schmidt@ki.se	Schmidt, Angelika/E-1909-2016; tegner, jesper N/R-5095-2017; Schmidt, Angelika/J-8773-2019	Schmidt, Angelika/0000-0002-1185-3012; tegner, jesper N/0000-0002-9568-5588; Schmidt, Angelika/0000-0002-1185-3012; Shang, Ming-Mei/0000-0002-4480-6095	Marie Curie Intra European Fellowship within the 7th European Community Framework Programme (FP7-PEOPLE-IEF); Dr. Ake Olssons Foundation; KI Research Foundations; Swedish Research Council; CERIC Linne Center; AFA insurance; Stockholm County Council; Torsten Soderberg Foundation	Marie Curie Intra European Fellowship within the 7th European Community Framework Programme (FP7-PEOPLE-IEF); Dr. Ake Olssons Foundation; KI Research Foundations; Swedish Research Council(Swedish Research CouncilEuropean Commission); CERIC Linne Center; AFA insurance; Stockholm County Council(Stockholm County Council); Torsten Soderberg Foundation	This research was supported by a Marie Curie Intra European Fellowship within the 7th European Community Framework Programme (FP7-PEOPLE-2012-IEF; to AS), Dr. Ake Olssons Foundation (AS), KI Research Foundations (AS; JT), Swedish Research Council (JT), CERIC Linne Center (JT), AFA insurance (JT), Stockholm County Council (JT), and Torsten Soderberg Foundation (JT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2013, NAT IMMUNOL, V14, P307, DOI 10.1038/ni.2554; Ahmadzadeh M, 2006, BLOOD, V107, P2409, DOI 10.1182/blood-2005-06-2399; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Allan SE, 2008, EUR J IMMUNOL, V38, P3282, DOI 10.1002/eji.200838373; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Battaglia M, 2006, J IMMUNOL, V177, P8338, DOI 10.4049/jimmunol.177.12.8338; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Betts BC, 2014, J LEUKOCYTE BIOL, V95, P205, DOI 10.1189/jlb.0313154; Beyer M, 2011, NAT IMMUNOL, V12, P898, DOI 10.1038/ni.2084; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Brunstein CG, 2011, BLOOD, V117, P1061, DOI 10.1182/blood-2010-07-293795; Chen Q, 2011, J IMMUNOL, V186, P6329, DOI 10.4049/jimmunol.1100061; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; de Vries IJM, 2011, CLIN CANCER RES, V17, P841, DOI 10.1158/1078-0432.CCR-10-2227; Delacher M, 2014, CURR TOP MICROBIOL I; Dhamne C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00253; DIIANNI M, 2011, BLOOD, V117, P3921, DOI [DOI 10.1182/blood-2010-10-311894, DOI 10.1182/BLOOD-2010-10-311894]; Duthoit CT, 2004, J IMMUNOL, V172, P2238, DOI 10.4049/jimmunol.172.4.2238; Edinger M, 2011, CURR OPIN IMMUNOL, V23, P679, DOI 10.1016/j.coi.2011.06.006; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fu WX, 2012, NAT IMMUNOL, V13, P972, DOI 10.1038/ni.2420; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gasteiger G, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00179; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Geiger TL, 2012, HUM IMMUNOL, V73, P232, DOI 10.1016/j.humimm.2011.12.012; Golovina TN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015868; Gottschalk RA, 2010, J EXP MED, V207, P1701, DOI 10.1084/jem.20091999; Gu J, 2014, J IMMUNOL, V193, P3388, DOI 10.4049/jimmunol.1400207; Haribhai D, 2011, IMMUNITY, V35, P109, DOI 10.1016/j.immuni.2011.03.029; Haribhai D, 2009, J IMMUNOL, V182, P3461, DOI 10.4049/jimmunol.0802535; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Hippen KL, 2011, AM J TRANSPLANT, V11, P1148, DOI 10.1111/j.1600-6143.2011.03558.x; Hippen KL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001809; Hoffmann P, 2006, BLOOD, V108, P4260, DOI 10.1182/blood-2006-06-027409; Huang YJ, 2014, EUR J IMMUNOL, V44, P460, DOI 10.1002/eji.201343463; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Hulsdunker J, 2015, TISSUE ANTIGENS, V85, P2, DOI 10.1111/tan.12497; Huter EN, 2008, EUR J IMMUNOL, V38, P1814, DOI 10.1002/eji.200838346; Inaba H, 2008, J IMMUNOL, V181, P3323, DOI 10.4049/jimmunol.181.5.3323; Inaba H, 2006, INT IMMUNOL, V18, P1043, DOI 10.1093/intimm/dxl038; Issa F, 2010, TRANSPLANTATION, V90, P1321, DOI 10.1097/TP.0b013e3181ff8772; Ito R, 2009, TRANSPLANTATION, V87, P1654, DOI 10.1097/TP.0b013e3181a5cb07; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Jhunjhunwala S, 2013, J LEUKOCYTE BIOL, V94, P981, DOI 10.1189/jlb.0312167; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Kang SG, 2007, J IMMUNOL, V179, P3724, DOI 10.4049/jimmunol.179.6.3724; Kitagawa Y, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00106; Koenecke C, 2009, EUR J IMMUNOL, V39, P3091, DOI 10.1002/eji.200939432; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Kopf H, 2007, INT IMMUNOPHARMACOL, V7, P1819, DOI 10.1016/j.intimp.2007.08.027; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lan Q, 2012, J MOL CELL BIOL, V4, P22, DOI 10.1093/jmcb/mjr039; Lee JH, 2012, EUR J IMMUNOL, V42, P2683, DOI 10.1002/eji.201142317; Lu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024590; Lu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015150; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Meenu Sharma, 2013, Journal of Current Chemical and Pharmaceutical Sciences, V3, P23; Merkenschlager M, 2010, J EXP MED, V207, P1347, DOI 10.1084/jem.20101156; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Morikawa H, 2014, P NATL ACAD SCI USA, V111, P5289, DOI 10.1073/pnas.1312717110; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Ng THS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00129; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Oliveira VG, 2011, EUR J IMMUNOL, V41, P1249, DOI 10.1002/eji.201040896; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Park J., 2014, MUCOSAL IMMUNOL; Pere H, 2012, ONCOIMMUNOLOGY, V1, P326, DOI 10.4161/onci.18852; Pillai V, 2007, CLIN IMMUNOL, V123, P18, DOI 10.1016/j.clim.2006.10.014; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Qian XF, 2011, INT IMMUNOPHARMACOL, V11, P630, DOI 10.1016/j.intimp.2010.11.036; Sakaguchi S, 2011, METHODS MOL BIOL, V707, P3, DOI 10.1007/978-1-61737-979-6_1; Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Schmidt A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002179; Schmitt EG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00152; Schmitt EG, 2012, J IMMUNOL, V189, P5638, DOI 10.4049/jimmunol.1200936; Schroeder MA, 2011, DIS MODEL MECH, V4, P318, DOI 10.1242/dmm.006668; Scotta C, 2013, HAEMATOLOGICA, V98, P1291, DOI 10.3324/haematol.2012.074088; Sela U, 2011, J EXP MED, V208, P2489, DOI 10.1084/jem.20110466; Semple K, 2011, BLOOD, V117, P3096, DOI 10.1182/blood-2010-08-301275; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shevach EM, 2014, IMMUNOL REV, V259, P88, DOI 10.1111/imr.12160; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Strainic MG, 2013, NAT IMMUNOL, V14, P162, DOI 10.1038/ni.2499; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Toker A, 2013, J IMMUNOL, V190, P3180, DOI 10.4049/jimmunol.1203473; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Trzonkowski P, 2009, CLIN IMMUNOL, V133, P22, DOI 10.1016/j.clim.2009.06.001; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Wang J, 2009, J IMMUNOL, V183, P4119, DOI 10.4049/jimmunol.0901065; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Wu DC, 2013, TRANSPLANTATION, V96, P707, DOI 10.1097/TP.0b013e31829fa271; Yadav M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00232; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Yagi H, 2004, INT IMMUNOL, V16, P1643, DOI 10.1093/intimm/dxh165; Yamaguchi T, 2013, P NATL ACAD SCI USA, V110, pE2116, DOI 10.1073/pnas.1307185110; Zhang H, 2005, NAT MED, V11, P1238, DOI 10.1038/nm1312; Zhang P, 2013, J IMMUNOL, V191, P5291, DOI 10.4049/jimmunol.1301181; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zheng Y, 2008, J IMMUNOL, V181, P1683, DOI 10.4049/jimmunol.181.3.1683; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zorn E, 2006, CLIN CANCER RES, V12, P5265, DOI 10.1158/1078-0432.CCR-06-1417; Zuniga LA, 2013, IMMUNOL REV, V252, P78, DOI 10.1111/imr.12036	116	69	72	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148474	10.1371/journal.pone.0148474	http://dx.doi.org/10.1371/journal.pone.0148474			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886923	Green Published, Green Submitted, gold			2022-12-27	WOS:000371218400036
J	Van Tuyl, S; Whitmire, AL				Van Tuyl, Steven; Whitmire, Amanda L.			Water, Water, Everywhere: Defining and Assessing Data Sharing in Academia	PLOS ONE			English	Article								Sharing of research data has begun to gain traction in many areas of the sciences in the past few years because of changing expectations from the scientific community, funding agencies, and academic journals. National Science Foundation (NSF) requirements for a data management plan (DMP) went into effect in 2011, with the intent of facilitating the dissemination and sharing of research results. Many projects that were funded during 2011 and 2012 should now have implemented the elements of the data management plans required for their grant proposals. In this paper we define 'data sharing' and present a protocol for assessing whether data have been shared and how effective the sharing was. We then evaluate the data sharing practices of researchers funded by the NSF at Oregon State University in two ways: by attempting to discover project-level research data using the associated DMP as a starting point, and by examining data sharing associated with journal articles that acknowledge NSF support. Sharing at both the project level and the journal article level was not carried out in the majority of cases, and when sharing was accomplished, the shared data were often of questionable usability due to access, documentation, and formatting issues. We close the article by offering recommendations for how data producers, journal publishers, data repositories, and funding agencies can facilitate the process of sharing data in a meaningful way.	[Van Tuyl, Steven] Oregon State Univ, Ctr Digital Scholarship & Serv, Univ Lib, Corvallis, OR 97331 USA; [Whitmire, Amanda L.] Stanford Univ, Hopkins Marine Stn, Harold A Miller Lib, Pacific Grove, CA 93950 USA	Oregon State University; Stanford University	Van Tuyl, S (corresponding author), Oregon State Univ, Ctr Digital Scholarship & Serv, Univ Lib, Corvallis, OR 97331 USA.	steve.vantuyl@oregonstate.edu	Whitmire, Amanda/H-7035-2012; Van Tuyl, Steven/E-2814-2014	Whitmire, Amanda/0000-0003-2429-8879; Van Tuyl, Steven/0000-0002-8752-272X	Oregon State University Libraries & Press Open Access Fund	Oregon State University Libraries & Press Open Access Fund	Publication of this article in an open access journal was funded by the Oregon State University Libraries & Press Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, NY TIMES; Ball A., 2012, CITE DATASETS LINK P; Bloom T., 2013, PLOSS DATA POLICY; Collberg C, 2013, MEASURING REPRODUCIB, P37; Ferguson L, 2014, EXCHANGES       1103; Holdren J.F., 2013, MEMORANDUM HEADS EXE; Kervin K, 2013, J ESCIENCE LIBRARIAN, V2; Kim Y, 2016, J ASSOC INF SCI TECH, V67, P776, DOI 10.1002/asi.23424; Lin J, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001975; Martone M, 2014, JOINT DECLARATION DA, DOI 10.25490/a97f-egyk; Martone ME, 2014, BRAIN BEHAV, V4, P1, DOI 10.1002/brb3.192; McNutt M, 2015, SCIENCE, V347, P7, DOI 10.1126/science.aaa5057; National Fire Protection Association, 1995, 9527 NSF, P47; National Science Foundation, 2013, PROP AW POL PROC GUI; National Science Foundation, 2010, DAT MAN SHAR FREQ AS; National Science Foundation, 2011, SIGN CHANG GPG; National Science Foundation, 2015, NSF15052, P31; Schofield PN, 2009, NATURE, V461, P171, DOI 10.1038/461171a; Strasser C, 2014, F1000RESEARCH, V3, DOI 10.1268/f1000research.3979.2; Sturges P, 2015, J ASSOC INF SCI TECH, V66, P2445, DOI 10.1002/asi.23336; Van Tuyl S, 2015, DATA WATER WATER EVE; White EP, 2013, ECOL EVOL, V6, DOI [10.4033/iee.v6i2.4608, DOI 10.4033/IEE.V6I2.4608]; Wicherts JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026828	23	24	24	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0147942	10.1371/journal.pone.0147942	http://dx.doi.org/10.1371/journal.pone.0147942			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886581	gold, Green Published, Green Submitted			2022-12-27	WOS:000371218400011
J	Velankar, AD; Kumara, HN; Pal, A; Mishra, PS; Singh, M				Velankar, Avadhoot D.; Kumara, Honnavalli N.; Pal, Arijit; Mishra, Partha Sarathi; Singh, Mewa			Population Recovery of Nicobar Long-Tailed Macaque Macaca fascicularis umbrosus following a Tsunami in the Nicobar Islands, India	PLOS ONE			English	Article							DECEMBER; DROUGHT; GROWTH; IMPACT	Natural disasters pose a threat to isolated populations of species with restricted distributions, especially those inhabiting islands. The Nicobar long tailed macaque. Macaca fascicularis umbrosus, is one such species found in the three southernmost islands (viz. Great Nicobar, Little Nicobar and Katchal) of the Andaman and Nicobar archipelago, India. These islands were hit by a massive tsunami (Indian Ocean tsunami, 26 December 2004) after a 9.2 magnitude earthquake. Earlier studies [Umapathy et al. 2003; Sivakumar, 2004] reported a sharp decline in the population of M. f. umbrosus after thetsunami. We studied the distribution and population status of M. f. umbrosus on thethree Nicobar Islands and compared our results with those of the previous studies. We carried out trail surveys on existing paths and trails on three islands to get encounter rate as measure of abundance. We also checked the degree of inundation due to tsunami by using Normalized Difference Water Index (NDWI) on landsat imageries of the study area before and after tsunami. Theencounter rate of groups per kilometre of M. f. umbrosus in Great Nicobar, Little Nicobar and Katchal was 0.30, 0.35 and 0.48 respectively with the mean group size of 39 in Great Nicobar and 43 in Katchal following the tsunami. This was higher than that reported in the two earlier studies conducted before and after the tsunami. Post tsunami, there was a significant change in the proportion of adult males, adult females and immatures, but mean group size did not differ as compared to pre tsunami. The results show that population has recovered from a drastic decline caused by tsunami, but it cannot be ascertained whether it has reached stability because of the altered group structure. This study demonstrates the effect of natural disasters on island occurring species.	[Velankar, Avadhoot D.; Kumara, Honnavalli N.; Pal, Arijit; Mishra, Partha Sarathi] Salim Ali Ctr Ornithol & Nat Hist, Coimbatore, Tamil Nadu, India; [Velankar, Avadhoot D.; Pal, Arijit] Manipal Univ, Manipal, Karnataka, India; [Singh, Mewa] Univ Mysore, Biopsychol Lab, Mysore, Karnataka, India; [Singh, Mewa] Univ Mysore, Inst Excellence, Mysore, Karnataka, India; [Singh, Mewa] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Organismal Biol Unit, Bangalore 560012, Karnataka, India; [Singh, Mewa] Natl Inst Adv Studies, Bangalore, Karnataka, India	Salim Ali Center for Ornithology & Natural History (SACON); Manipal Academy of Higher Education (MAHE); University of Mysore; University of Mysore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Kumara, HN (corresponding author), Salim Ali Ctr Ornithol & Nat Hist, Coimbatore, Tamil Nadu, India.	honnavallik@gmail.com		PAL, ARIJIT/0000-0002-1472-2878; Kumara, Honnavalli/0000-0002-7958-6395	Department of Science and Technology, Government of India [SR/SO/AS-49/2011]	Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was conducted with the financial support from the Department of Science and Technology, Government of India to HNK (Grant No. SR/SO/AS-49/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews HV, 2006, INDIAN OCEAN TURTLE, V4, P3; Berec L, 2007, TRENDS ECOL EVOL, V22, P185, DOI 10.1016/j.tree.2006.12.002; BERENSTAIN L, 1986, BIOTROPICA, V18, P257, DOI 10.2307/2388494; BIRCH LC, 1948, J ANIM ECOL, V17, P15, DOI 10.2307/1605; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Crawford RJM, 2006, AFR J MAR SCI, V28, P99, DOI 10.2989/18142320609504137; DITTUS WPJ, 1979, BEHAVIOUR, V69, P265, DOI 10.1163/156853979X00511; Eudey Ardith A., 2008, Primate Conservation, V23, P129, DOI 10.1896/052.023.0115; Ewens W.J., 1987, P59, DOI 10.1017/CBO9780511623400.005; Fedigan LM, 1998, INT J PRIMATOL, V19, P405, DOI 10.1023/A:1020304304558; Fittinghoff N.A. Jr, 1980, P182; FOODEN J, 1982, Primates, V23, P574, DOI 10.1007/BF02373969; Fooden J., 1995, FIELDIANA ZOOLOGY, V81, P1, DOI DOI 10.5962/BHL.TITLE.3456; Gerber LR, 2001, MAMMAL REV, V31, P131, DOI 10.1046/j.1365-2907.2001.00081.x; GOLDSTEIN SJ, 1989, INT J PRIMATOL, V10, P531, DOI 10.1007/BF02739364; Gould L, 1999, INT J PRIMATOL, V20, P69, DOI 10.1023/A:1020584200807; Gumert Michael D., 2011, P3; Hahn I, 2015, POPUL ECOL, V57, P143, DOI 10.1007/s10144-014-0457-y; Hajra PK, 1999, FLORA GREAT NICOBAR; Karr J.R., 1985, P153; LEWIS J, 1990, DISASTERS, V14, P240, DOI 10.1111/j.1467-7717.1990.tb01066.x; MARTIN JL, 1995, OIKOS, V72, P115, DOI 10.2307/3546045; McConkey KR, 2004, ORYX, V38, P439, DOI 10.1017/S0030605304000821; McFeeters SK, 1996, INT J REMOTE SENS, V17, P1425, DOI 10.1080/01431169608948714; Milton K, 1982, DIETARY QUALITY POPU, P273; Ong P., 2008, IUCN RED LIST THREAT; Porwal MC, 2012, BIODIVERS CONSERV, V21, P1267, DOI 10.1007/s10531-011-0214-x; Ramachandran S, 2005, CURR SCI INDIA, V89, P195; SALTER R E, 1985, Primates, V26, P436, DOI 10.1007/BF02382458; Sekhsaria Pankaj, 2009, Journal of the Bombay Natural History Society, V106, P256; Shaffer M., 1987, P69, DOI 10.1017/CBO9780511623400.006; Shilova SA, 2005, RUSS J ECOL+, V36, P27, DOI 10.1007/s11184-005-0005-2; Sivakumar K, 2010, ORYX, V44, P71, DOI 10.1017/S0030605309990810; Sivakumar K, 2010, HYSTRIX, V21, P35; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Thieler RE, 2009, DIGITAL SHORELINE AN; Umapathy G, 2003, INT J PRIMATOL, V24, P281, DOI 10.1023/A:1023045132009; Van Schaik C. P., 1996, P160; Viera VM, 2006, POLAR BIOL, V29, P713, DOI 10.1007/s00300-006-0128-3	39	8	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148205	10.1371/journal.pone.0148205	http://dx.doi.org/10.1371/journal.pone.0148205			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886197	Green Submitted, Green Published, gold			2022-12-27	WOS:000371218400019
J	Werner, A; Sturzl, W; Zanker, J				Werner, Annette; Stuerzl, Wolfgang; Zanker, Johannes			Object Recognition in Flight: How Do Bees Distinguish between 3D Shapes?	PLOS ONE			English	Article							PATTERN-RECOGNITION; COLOR CONSTANCY; MOTION PARALLAX; PERCEPTION; HONEYBEE; DISCRIMINATION; INFORMATION; NAVIGATION	Honeybees (Apis mellifera) discriminate multiple object features such as colour, pattern and 2D shape, but it remains unknown whether and how bees recover three-dimensional shape. Here we show that bees can recognize objects by their three-dimensional form, whereby they employ an active strategy to uncover the depth profiles. We trained individual, free flying honeybees to collect sugar water from small three-dimensional objects made of styrofoam (sphere, cylinder, cuboids) or folded paper (convex, concave, planar) and found that bees can easily discriminate between these stimuli. We also tested possible strategies employed by the bees to uncover the depth profiles. For the card stimuli, we excluded overall shape and pictorial features (shading, texture gradients) as cues for discrimination. Lacking sufficient stereo vision, bees are known to use speed gradients in optic flow to detect edges; could the bees apply this strategy also to recover the fine details of a surface depth profile? Analysing the bees' flight tracks in front of the stimuli revealed specific combinations of flight maneuvers (lateral translations in combination with yaw rotations), which are particularly suitable to extract depth cues from motion parallax. We modelled the generated optic flow and found characteristic patterns of angular displacement corresponding to the depth profiles of our stimuli: optic flow patterns from pure translations successfully recovered depth relations from the magnitude of angular displacements, additional rotation provided robust depth information based on the direction of the displacements; thus, the bees flight maneuvers may reflect an optimized visuo-motor strategy to extract depth structure from motion signals. The robustness and simplicity of this strategy offers an efficient solution for 3D-object-recognition without stereo vision, and could be employed by other flying insects, or mobile robots.	[Werner, Annette] Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Tubingen, Germany; [Stuerzl, Wolfgang] German Aerosp Ctr DLR, Inst Robot & Mechatron, Wessling, Germany; [Zanker, Johannes] Royal Holloway Univ London, Dept Psychol, Egham, Surrey, England	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Aerospace Centre (DLR); University of London; Royal Holloway University London	Werner, A (corresponding author), Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Tubingen, Germany.	annette.werner@uni-tuebingen.de			Bundesministerium fur Bildung und Forschung (BMBF)-Bernsteinzentrum fur Computational Neuroscience Tubingen [BMBF FKZ 01GQ1002]; Werner Reichardt Centre for Integrative Neuroscience Tubingen; DFG; Open Access Publishing Fund of University of Tubingen	Bundesministerium fur Bildung und Forschung (BMBF)-Bernsteinzentrum fur Computational Neuroscience Tubingen(Federal Ministry of Education & Research (BMBF)); Werner Reichardt Centre for Integrative Neuroscience Tubingen; DFG(German Research Foundation (DFG)); Open Access Publishing Fund of University of Tubingen	This work was supported by Bundesministerium fur Bildung und Forschung (BMBF)-Bernsteinzentrum fur Computational Neuroscience Tubingen BMBF FKZ 01GQ1002 and Werner Reichardt Centre for Integrative Neuroscience Tubingen. This work was also supported by DFG and Open Access Publishing Fund of University of Tubingen.	ANDERSON AM, 1977, ANIM BEHAV, V25, P67, DOI 10.1016/0003-3472(77)90068-9; Autrum H, 1957, STUD GEN, V10, P211; Avargues-Weber A, 2011, ANNU REV ENTOMOL, V56, P423, DOI 10.1146/annurev-ento-120709-144855; Baird E, 2013, P NATL ACAD SCI USA, V110, P18686, DOI 10.1073/pnas.1314311110; Campan R, 2002, J EXP BIOL, V205, P559; Chen L, 2003, P NATL ACAD SCI USA, V100, P6884, DOI 10.1073/pnas.0732090100; Chittka L, 2014, J COMP PHYSIOL A, V200, P435, DOI 10.1007/s00359-014-0897-z; Collett TS, 1996, CURR DIR PSYCHOL SCI, V5, P149, DOI 10.1111/1467-8721.ep11512352; Dittmar L, 2010, J EXP BIOL, V213, P2913, DOI 10.1242/jeb.043737; Efler D, 2000, VISION RES, V40, P3391, DOI 10.1016/S0042-6989(00)00189-9; Evangelista C, 2010, J EXP BIOL, V213, P262, DOI 10.1242/jeb.037465; GIBSON EJ, 1959, J EXP PSYCHOL, V58, P40, DOI 10.1037/h0043883; Giurfa M, 1996, NATURE, V382, P458, DOI 10.1038/382458a0; GOULD JL, 1986, ANIM BEHAV, V34, P990, DOI 10.1016/S0003-3472(86)80157-9; HERTZ MATHILDE, 1929, ZEITSCHR VERGL PHYSIOL, V8, P693, DOI 10.1007/BF00340937; Kapustjansky A, 2010, NATURWISSENSCHAFTEN, V97, P229, DOI 10.1007/s00114-009-0627-5; Lehrer M, 2005, J EXP BIOL, V208, P3233, DOI 10.1242/jeb.01790; LEHRER M, 1991, BEHAVIOUR AND PHYSIOLOGY OF BEES, P185; LEHRER M, 1993, J COMP PHYSIOL A, V172, P549, DOI 10.1007/BF00213678; LEHRER M, 1988, NATURE, V332, P356, DOI 10.1038/332356a0; Lehrer M, 1996, J EXP BIOL, V199, P253; Lent DD, 2013, CURR BIOL, V23, P684, DOI 10.1016/j.cub.2013.03.016; MAZOKHIN-PORSHNYAKOV G A, 1969, Zoologicheskii Zhurnal, V48, P1125; Menzel R, 2001, TRENDS COGN SCI, V5, P62, DOI 10.1016/S1364-6613(00)01601-6; Riesenhuber M, 2000, NAT NEUROSCI, V3, P1199, DOI 10.1038/81479; RONACHER B, 1992, ETHOLOGY, V92, P205, DOI 10.1111/j.1439-0310.1992.tb00960.x; SCHNETTER B, 1968, Z VERGL PHYSIOL, V59, P90, DOI 10.1007/BF00298814; Serres JR, 2008, NATURWISSENSCHAFTEN, V95, P1181, DOI 10.1007/s00114-008-0440-6; Srinivasan MV, 2011, PHYSIOL REV, V91, P413, DOI 10.1152/physrev.00005.2010; Srinivasan MV, 2010, ANNU REV ENTOMOL, V55, P267, DOI 10.1146/annurev.ento.010908.164537; Srinivasan MV, 2006, CURR BIOL, V16, pR58, DOI 10.1016/j.cub.2006.01.002; Srinivasan MV, 2004, ANNU REV NEUROSCI, V27, P679, DOI 10.1146/annurev.neuro.27.070203.144343; SRINIVASAN MV, 1990, PROC R SOC SER B-BIO, V238, P331, DOI 10.1098/rspb.1990.0003; Srinivasan MV, 1998, ECOL PSYCHOL, V10, P251, DOI 10.1207/s15326969eco103&4_5; Stach S, 2004, NATURE, V429, P758, DOI 10.1038/nature02594; Tarr MJ, 1998, COGNITION, V67, P1, DOI 10.1016/S0010-0277(98)00026-2; von Frisch, 1915, ZOOL JB ABT ALLG ZOO, V35, P1; Voss R, 1998, J COMP PHYSIOL A, V182, P377, DOI 10.1007/s003590050187; WEHNER R, 1967, NATURE, V215, P1244, DOI 10.1038/2151244a0; WERNER A, 1988, J NEUROSCI, V8, P156; Zanker JM, 2014, PERCEPTION, V43, P162; Zeil J, 1996, J EXP BIOL, V199, P245; ZEIL J, 1993, J COMP PHYSIOL A, V172, P189, DOI 10.1007/BF00189396; ZHANG SW, 1995, P NATL ACAD SCI USA, V92, P3029, DOI 10.1073/pnas.92.7.3029	44	8	8	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0147106	10.1371/journal.pone.0147106	http://dx.doi.org/10.1371/journal.pone.0147106			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886006	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000371218400006
J	Liu, LJ; Tong, Q; Liu, S; Cui, JL; Zhang, QS; Sun, W; Yang, S				Liu, Lingjia; Tong, Qi; Liu, Shuo; Cui, Jianlin; Zhang, Quansheng; Sun, Wei; Yang, Shuang			ZEB1 Upregulates VEGF Expression and Stimulates Angiogenesis in Breast Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TO-MESENCHYMAL TRANSITION; E-CADHERIN EXPRESSION; TRANSCRIPTIONAL REPRESSOR; ZINC-FINGER; CELLS; DELTA-EF1; DIFFERENTIATION; ACTIVATION; MUSCLE	Although zinc finger E-box binding homeobox 1 (ZEB1) has been identified as a key factor in the regulation of breast cancer differentiation and metastasis, its potential role in modulating tumor angiogenesis has not been fully examined. Here, we present the novel finding that conditioned medium derived from ZEB1-expressing MDA-MB-231 cells significantly increased the capillary tube formation of human umbilical vein endothelial cells (HUVECs), whereas ZEB1 knockdown by RNA interference had the opposite effect. ZEB1 caused marked upregulation of the expression of vascular endothelial growth factor A (VEGFA) at both mRNA and protein levels. Pre-incubation of HUVECs with anti-VEGFA neutralized antibody attenuated ZEB1-mediated tube formation of HUVECs. In breast cancer tissues, expression of ZEB1 was positively correlated with those of VEGFA and CD31. At the molecular level, ZEB1 activated VEGFA transcription by increasing SP1 recruitment to its promoter, which was mediated via the activation of PI3K and p38 pathways. Using a nude mouse xenograft model, we demonstrated that elevated expression of ZEB1 promotes in vivo tumorigenesis and angiogenesis in breast cancer. Collectively, we found that ZEB1-expressing breast cancer cells increase VEGFA production and thus stimulate tumor growth and angiogenesis via a paracrine mechanism.	[Liu, Lingjia; Tong, Qi; Liu, Shuo; Cui, Jianlin; Sun, Wei; Yang, Shuang] Nankai Univ, Coll Med, Tianjin Key Lab Tumor Microenvironm & Neurovasc R, Tianjin 300071, Peoples R China; [Zhang, Quansheng] Tianjin First Ctr Hosp, Tianjin Key Lab Organ Transplantat, Tianjin 300192, Peoples R China	Nankai University	Sun, W; Yang, S (corresponding author), Nankai Univ, Coll Med, Tianjin Key Lab Tumor Microenvironm & Neurovasc R, Tianjin 300071, Peoples R China.	sunweibio@nankai.edu.cn; yangshuang@nankai.edu.cn			International S&T Cooperation Program of China [2015DFA30420]; National Natural Science Foundation of China [81272184, 81472545, 81170443, 81372386]; Natural Science Foundation of Tianjin [13JCZDJC30200]	International S&T Cooperation Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin)	This work is supported by grants from the International S&T Cooperation Program of China (No. 2015DFA30420), the National Natural Science Foundation of China (No. 81272184; No. 81472545; No. 81170443), the Natural Science Foundation of Tianjin (No. 13JCZDJC30200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by grants from the International S&T Cooperation Program of China (No. 2015DFA30420), the National Natural Science Foundation of China (No. 81272184; No. 81372386; No. 81472545), the Natural Science Foundation of Tianjin (No. 13JCZDJC30200).	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Ahn YH, 2012, J CLIN INVEST, V122, P3170, DOI 10.1172/JCI63608; Blancher C, 2000, CANCER RES, V60, P7106; Brabletz T, 1999, INT IMMUNOL, V11, P1701, DOI 10.1093/intimm/11.10.1701; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Bruick RK, 2001, GENE DEV, V15, P2497, DOI 10.1101/gad.931601; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Chuang CW, 2013, J CELL PHYSIOL, V228, P341, DOI 10.1002/jcp.24136; Clarhaut J, 2009, NEOPLASIA, V11, P157, DOI 10.1593/neo.81074; Dai JL, 2005, CANCER RES, V65, P8274, DOI 10.1158/0008-5472.CAN-05-1891; Ebrahem Q, 2010, AM J PATHOL, V176, P496, DOI 10.2353/ajpath.2010.080642; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Finkenzeller Gunter, 2004, Angiogenesis, V7, P59, DOI 10.1023/B:AGEN.0000037332.66411.f0; Fitzpatrick TE, 2003, EXP CELL RES, V283, P247, DOI 10.1016/S0014-4827(02)00044-7; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Fox SB, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1796; FUNAHASHI J, 1993, DEVELOPMENT, V119, P433; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guo SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052380; Hu F, 2011, BBA-GENE REGUL MECH, V1809, P200, DOI 10.1016/j.bbagrm.2011.01.003; Hurt EM, 2008, MOL CELL BIOCHEM, V318, P89, DOI 10.1007/s11010-008-9860-z; Jia D, 2013, BLOOD, V121, P707, DOI 10.1182/blood-2012-05-433045; Joseph JV, 2015, CANCER LETT, V359, P107, DOI 10.1016/j.canlet.2015.01.010; Karihtala P, 2013, BREAST CANCER RES TR, V138, P81, DOI 10.1007/s10549-013-2442-0; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Kumar S. R. S., 2012, International Journal of Advanced Life Sciences (IJALS), V1, P1; Loureiro RMB, 2005, CYTOKINE GROWTH F R, V16, P77, DOI 10.1016/j.cytogfr.2005.01.005; Luo ZL, 2013, STEM CELLS, V31, P1749, DOI 10.1002/stem.1448; Maae E, 2012, BREAST CANCER RES TR, V133, P257, DOI 10.1007/s10549-012-1957-0; Mironchik Y, 2005, CANCER RES, V65, P10801, DOI 10.1158/0008-5472.CAN-05-0712; Morel AP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002723; Ponticos M, 2004, MOL CELL BIOL, V24, P6151, DOI 10.1128/MCB.24.14.6151-6161.2004; Pore N, 2004, MOL BIOL CELL, V15, P4841, DOI 10.1091/mbc.E04-05-0374; Postigo AA, 1999, MOL CELL BIOL, V19, P7961; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Roy R, 2006, EXP CELL RES, V312, P608, DOI 10.1016/j.yexcr.2005.11.022; Roy R, 2009, J CLIN ONCOL, V27, P5287, DOI 10.1200/JCO.2009.23.5556; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Shenoy SK, 2012, ONCOGENE, V31, P282, DOI 10.1038/onc.2011.238; Siles L, 2013, MOL CELL BIOL, V33, P1368, DOI 10.1128/MCB.01259-12; Song YD, 2009, CLIN CANCER RES, V15, P492, DOI 10.1158/1078-0432.CCR-08-1945; Takagi T, 1998, DEVELOPMENT, V125, P21; Wang J, 2009, INT IMMUNOL, V21, P227, DOI 10.1093/intimm/dxn143; Wang YS, 2014, CANCER RES, V74, P520, DOI 10.1158/0008-5472.CAN-13-2182; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wong LL, 2010, EXP CELL RES, V316, P3387, DOI 10.1016/j.yexcr.2010.06.007; Xu KM, 2007, CANCER RES, V67, P6121, DOI 10.1158/0008-5472.CAN-07-0141; Yang S, 2007, J BIOMED SCI, V14, P663, DOI 10.1007/s11373-007-9155-5; Yang S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-211; Yang YA, 2014, J CLIN INVEST, V124, P2696, DOI 10.1172/JCI72171; Yao YS, 2015, J CELL MOL MED, V19, P760, DOI 10.1111/jcmm.12432; Yen G, 2001, MOL BRAIN RES, V96, P59, DOI 10.1016/S0169-328X(01)00267-4; Yen L, 2000, ONCOGENE, V19, P3460, DOI 10.1038/sj.onc.1203685	57	29	31	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148774	10.1371/journal.pone.0148774	http://dx.doi.org/10.1371/journal.pone.0148774			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882471	Green Published, Green Submitted, gold			2022-12-27	WOS:000371219000024
J	Abdellatif', AM; Oishi, H; Itagaki, T; Jung, YS; Shawki, HH; Okita, Y; Hasegawa, Y; Suzuki, H; El-Morsy, SE; El-Sayed, MA; Shoaib, MB; Sugiyama, F; Takahashi, S				Abdellatif', Ahmed M.; Oishi, Hisashi; Itagaki, Takahiro; Jung, Yunshin; Shawki, Hossam H.; Okita, Yukari; Hasegawa, Yoshikazu; Suzuki, Hiroyuki; El-Morsy, Salah E.; El-Sayed, Mesbah A.; Shoaib, Mahmoud B.; Sugiyama, Fumihiro; Takahashi, Satoru			beta-Cell-Specific Mafk Overexpression Impairs Pancreatic Endocrine Cell Development	PLOS ONE			English	Article							GENE-EXPRESSION; ALPHA-CELL; INSULIN; TRANSCRIPTION; CONTRIBUTES; NEUROGENIN3; REPRESSION; C57BL/6N; IDENTITY; BINDING	The MAF family transcription factors are homologs of v-Maf, the oncogenic component of the avian retrovirus AS42. They are subdivided into 2 groups, small and large MAF proteins, according to their structure, function, and molecular size. MAFK is a member of the small MAF family and acts as a dominant negative form of large MAFs. In previous research we generated transgenic mice that overexpress MAFK in order to suppress the function of large MAF proteins in pancreatic beta-cells. These mice developed hyperglycemia in adulthood due to impairment of glucose-stimulated insulin secretion. The aim of the current study is to examine the effects of beta-cell-specific Mafk overexpression in endocrine cell development. The developing islets of Mafk-transgenic embryos appeared to be disorganized with an inversion of total numbers of insulin+ and glucagon+ cells due to reduced beta-cell proliferation. Gene expression analysis by quantitative RT-PCR revealed decreased levels of beta-cell-related genes whose expressions are known to be controlled by large MAF proteins. Additionally, these changes were accompanied with a significant increase in key beta-cell transcription factors likely due to compensatory mechanisms that might have been activated in response to the beta-cell loss. Finally, microarray comparison of gene expression profiles between wild-type and transgenic pancreata revealed alteration of some uncharacterized genes including Pcbd1, Fam132a, Cryba2, and Npy, which might play important roles during pancreatic endocrine development. Taken together, these results suggest that Mafk overexpression impairs endocrine development through a regulation of numerous beta-cell-related genes. The microarray analysis provided a unique data set of differentially expressed genes that might contribute to a better understanding of the molecular basis that governs the development and function of endocrine pancreas.	[Abdellatif', Ahmed M.; Oishi, Hisashi; Itagaki, Takahiro; Jung, Yunshin; Shawki, Hossam H.; Takahashi, Satoru] Univ Tsukuba, Dept Anat & Embryol, Fac Med, Tsukuba, Ibaraki, Japan; [Abdellatif', Ahmed M.; El-Morsy, Salah E.; El-Sayed, Mesbah A.; Shoaib, Mahmoud B.] Mansoura Univ, Dept Anat & Embryol, Fac Vet Med, Mansoura, Egypt; [Oishi, Hisashi; Itagaki, Takahiro; Jung, Yunshin; Shawki, Hossam H.; Hasegawa, Yoshikazu; Sugiyama, Fumihiro; Takahashi, Satoru] Univ Tsukuba, Lab Anim Resource Ctr, Fac Med, Tsukuba, Ibaraki, Japan; [Oishi, Hisashi; Takahashi, Satoru] Univ Tsukuba, Life Sci Ctr, TARA, Tsukuba, Ibaraki, Japan; [Okita, Yukari; Suzuki, Hiroyuki] Univ Tsukuba, Dept Expt Pathol, Fac Med, Tsukuba, Ibaraki, Japan; [Takahashi, Satoru] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki, Japan	University of Tsukuba; Egyptian Knowledge Bank (EKB); Mansoura University; University of Tsukuba; University of Tsukuba; University of Tsukuba; University of Tsukuba	Oishi, H; Takahashi, S (corresponding author), Univ Tsukuba, Dept Anat & Embryol, Fac Med, Tsukuba, Ibaraki, Japan.; Oishi, H; Takahashi, S (corresponding author), Univ Tsukuba, Lab Anim Resource Ctr, Fac Med, Tsukuba, Ibaraki, Japan.; Oishi, H; Takahashi, S (corresponding author), Univ Tsukuba, Life Sci Ctr, TARA, Tsukuba, Ibaraki, Japan.; Takahashi, S (corresponding author), Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki, Japan.	hoishi@md.tsukuba.ac.jp; satoruta@md.tsukuba.ac.jp	Abdellatif, Ahmed M./Y-2793-2018	Abdellatif, Ahmed M./0000-0001-9235-2449; Jung, Yunshin/0000-0001-8093-5620; Shawki, Hossam/0000-0002-1962-9701; Shoeib, Mahmoud/0000-0003-4897-4755; El-Sayed, Mesbah/0000-0001-9642-1931	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [26221004]	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research (26221004) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) (to S.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo-Mazzucato C, 2011, DIABETOLOGIA, V54, P583, DOI 10.1007/s00125-010-2026-z; Akpinar P, 2005, CELL METAB, V2, P385, DOI 10.1016/j.cmet.2005.11.001; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; Artner I, 2007, P NATL ACAD SCI USA, V104, P3853, DOI 10.1073/pnas.0700013104; Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190; Benitez C.M., 2012, COLD SPRING HARB PER, V4, DOI DOI 10.1101/CSHPERSPECT.A012401; Cho YR, 2004, BIOCHEM BIOPH RES CO, V314, P773, DOI 10.1016/j.bbrc.2003.12.170; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; Crawford LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001611; DEKRIJGER RR, 1992, DEV BIOL, V153, P368, DOI 10.1016/0012-1606(92)90121-V; Desgraz R, 2009, DEVELOPMENT, V136, P3567, DOI 10.1242/dev.039214; Dhawan S, 2011, DEV CELL, V20, P419, DOI 10.1016/j.devcel.2011.03.012; Enomoto T, 2011, J BIOL CHEM, V286, P34552, DOI 10.1074/jbc.M111.277319; Eto K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104184; Eychene A, 2008, NAT REV CANCER, V8, P683, DOI 10.1038/nrc2460; Fukui K, 2005, CELL METAB, V2, P373, DOI 10.1016/j.cmet.2005.11.003; Gannon M, 2008, DEV BIOL, V314, P406, DOI 10.1016/j.ydbio.2007.10.038; Gao T, 2014, CELL METAB, V19, P259, DOI 10.1016/j.cmet.2013.12.002; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hang Y, 2011, TRENDS ENDOCRIN MET, V22, P364, DOI 10.1016/j.tem.2011.05.003; Hasegawa Y, 2014, EXP ANIM TOKYO, V63, P183, DOI 10.1538/expanim.63.183; Hasegawa Y, 2013, EXP ANIM TOKYO, V62, P295; HASHIMOTO T, 1988, ANAT EMBRYOL, V178, P489, DOI 10.1007/BF00305036; Hoffman BG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r99; Jensen J, 2000, DIABETES, V49, P163, DOI 10.2337/diabetes.49.2.163; Kajihara M, 2003, BIOCHEM BIOPH RES CO, V312, P831, DOI 10.1016/j.bbrc.2003.10.196; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; Katsuoka F, 2005, MOL CELL BIOL, V25, P8044, DOI 10.1128/MCB.25.18.8044-8051.2005; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Kotkow KJ, 1996, P NATL ACAD SCI USA, V93, P3514, DOI 10.1073/pnas.93.8.3514; Lecoin L, 2004, GENE EXPR PATTERNS, V4, P35, DOI 10.1016/S1567-133X(03)00152-2; Liu ZT, 2011, EURASIP J ADV SIG PR, DOI 10.1155/2011/490289; Matsuoka T, 2004, P NATL ACAD SCI USA, V101, P2930, DOI 10.1073/pnas.0306233101; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; MyrsenAxcrona U, 1997, REGUL PEPTIDES, V68, P165, DOI 10.1016/S0167-0115(96)02113-1; Nishimura W, 2015, DIABETOLOGIA, V58, P566, DOI 10.1007/s00125-014-3464-9; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; NISHIZAWA M, 1989, P NATL ACAD SCI USA, V86, P7711, DOI 10.1073/pnas.86.20.7711; Nomoto H, 2015, ENDOCRINOLOGY, V156, P3570, DOI 10.1210/en.2014-1906; Obermuller S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008936; Okita Y, 2013, J BIOL CHEM, V288, P20658, DOI 10.1074/jbc.M113.450478; Onodera K, 1999, J BIOL CHEM, V274, P21162, DOI 10.1074/jbc.274.30.21162; Petri A, 2006, J MOL ENDOCRINOL, V37, P301, DOI 10.1677/jme.1.02096; Puk O, 2011, INVEST OPHTH VIS SCI, V52, P2571, DOI 10.1167/iovs.10-6443; Rubel CA, 2012, MOL ENDOCRINOL, V26, P1428, DOI 10.1210/me.2011-1355; Shavit JA, 1998, GENE DEV, V12, P2164, DOI 10.1101/gad.12.14.2164; Shields BM, 2010, DIABETOLOGIA, V53, P2504, DOI 10.1007/s00125-010-1799-4; Shimohata H, 2006, BIOCHEM BIOPH RES CO, V346, P671, DOI 10.1016/j.bbrc.2006.05.184; Shimohata H, 2009, BIOCHEM BIOPH RES CO, V389, P235, DOI 10.1016/j.bbrc.2009.08.124; Simaite D, 2014, DIABETES, V63, P3557, DOI 10.2337/db13-1784; SLACK JMW, 1995, DEVELOPMENT, V121, P1569; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Vetere A, 2014, NAT REV DRUG DISCOV, V13, P278, DOI 10.1038/nrd4231; Whim MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019478; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yoh K, 2001, GENES CELLS, V6, P1055, DOI 10.1046/j.1365-2443.2001.00489.x; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005	59	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0150010	10.1371/journal.pone.0150010	http://dx.doi.org/10.1371/journal.pone.0150010			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901059	gold, Green Published			2022-12-27	WOS:000371276100198
J	Delaney, A; Tamas, PA; Crane, TA; Chesterman, S				Delaney, Aogan; Tamas, Peter A.; Crane, Todd A.; Chesterman, Sabrina			Systematic Review of Methods in Low-Consensus Fields: Supporting Commensuration through 'Construct-Centered Methods Aggregation' in the Case of Climate Change Vulnerability Research	PLOS ONE			English	Review							QUALITATIVE RESEARCH; STANDARDS; FRAMEWORK; FOREST; BASE	There is increasing interest in using systematic review to synthesize evidence on the social and environmental effects of and adaptations to climate change. Use of systematic review for evidence in this field is complicated by the heterogeneity of methods used and by uneven reporting. In order to facilitate synthesis of results and design of subsequent research a method, construct-centered methods aggregation, was designed to 1) provide a transparent, valid and reliable description of research methods, 2) support comparability of primary studies and 3) contribute to a shared empirical basis for improving research practice. Rather than taking research reports at face value, research designs are reviewed through inductive analysis. This involves bottom-up identification of constructs, definitions and operationalizations; assessment of concepts' commensurability through comparison of definitions; identification of theoretical frameworks through patterns of construct use; and integration of transparently reported and valid operationalizations into ideal-type research frameworks. Through the integration of reliable bottom-up inductive coding from operationalizations and top-down coding driven from stated theory with expert interpretation, construct-centered methods aggregation enabled both resolution of heterogeneity within identically named constructs and merging of differently labeled but identical constructs. These two processes allowed transparent, rigorous and contextually sensitive synthesis of the research presented in an uneven set of reports undertaken in a heterogenous field. If adopted more broadly, construct-centered methods aggregation may contribute to the emergence of a valid, empirically-grounded description of methods used in primary research. These descriptions may function as a set of expectations that improves the transparency of reporting and as an evolving comprehensive framework that supports both interpretation of existing and design of future research.	[Delaney, Aogan; Tamas, Peter A.] Wageningen Univ, Res Methodol Grp, NL-6700 AP Wageningen, Netherlands; [Crane, Todd A.] Int Livestock Res Inst, Nairobi, Kenya; [Chesterman, Sabrina] Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England	Wageningen University & Research; CGIAR; International Livestock Research Institute (ILRI); University of London; London School of Hygiene & Tropical Medicine	Tamas, PA (corresponding author), Wageningen Univ, Res Methodol Grp, NL-6700 AP Wageningen, Netherlands.	peter.tamas@vvur.nl		Tamas, Peter/0000-0002-5409-1273; Delaney, Aogan/0000-0003-1692-5174	International Livestock Research Institute; International Livestock Research Center	International Livestock Research Institute(CGIAR); International Livestock Research Center	This work was support by International Livestock Research Institute (Grant Number: none, https://www.ilri.org/, Recipient: Peter Tamas, Wageningen University). The role of the funders in this research is as follows. Study design: The funders had no role in designing the study other than approval. In fact, the study design did not promise nor did it meet the Funder's initial expectations (a review of evidence). Data collection: The funder provided the initial set of articles examined. This initial set was supplemented by a sampling procedure that the funder did not influence. Data analysis: The funder served as the "expert" at two points during data analysis. Their role in this process is fully documented. Decision to publish: This article was not initiated by the funder. The funder was asked to support and agreed to participate in publication of this article. Their desired outputs were the technical report and the GEC article. The article submitted to PLONE was driven entirely by academic interest. Preparation of the manuscript: The funder prepared the first draft of the conclusion and commented on other sections. The authors asked the funder to prepare the first draft of the conclusion as neither of the WUR authors are experts in the subject matter and the authors were concerned that their findings be framed in a manner that was engaging to scholars in climate studies.; We would like to thank Polly Ericksen of the International Livestock Research Center for her willingness to fund an experimental review method that promised to cost more and deliver less. We hope that we have met her expectations. Dr. Henk van den Belt of the Philosophy group of Wageningen University was instrumental in identifying the link between systematic review and commensuration made in this paper. Of course, the authors retain responsibility for all errors and misunderstandings.	Alastalo M, 2014, SOC POLICY ADMIN, V48, P721, DOI 10.1111/spol.12073; Ascui F, 2011, ACCOUNT AUDIT ACCOUN, V24, P978, DOI 10.1108/09513571111184724; Baca M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088463; Beauchamp A, 2014, OBES REV, V15, P541, DOI 10.1111/obr.12161; Bing-Jonsson PC, 2013, HOME HLTH CARE MAN P, V25, P282, DOI 10.1177/1084822313494784; Borgatti S., 1994, J QUANT ANTHR, V4, P261; Brunsson N, 2012, ORGAN STUD, V33, P613, DOI 10.1177/0170840612450120; Campbell R, 2003, SOC SCI MED, V56, P671, DOI 10.1016/S0277-9536(02)00064-3; Carroll C, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-37; Carroll C, 2012, QUAL HEALTH RES, V22, P1425, DOI 10.1177/1049732312452937; Castleden M, 2011, J PUBLIC HEALTH-UK, V33, P369, DOI 10.1093/pubmed/fdr027; da Silva S, LAT AM RES IN PRESS; Delaney A, 2014, SYSTEMATIC REV LOCAL, P97; Delaney A, J DEV EFF IN PRESS; Dixon-Woods M., 2006, QUAL RES, V6, P27, DOI [10.1177/1468794106058867, DOI 10.1177/1468794106058867]; Dixon-Woods Mary, 2006, BMC Med Res Methodol, V6, P35, DOI 10.1186/1471-2288-6-35; Driscoll DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095053; Dubois CA, 2013, BMC NURS, V12, DOI 10.1186/1472-6955-12-7; Edwards AG, 1998, FAM PRACT, V15, P319, DOI 10.1093/fampra/15.4.319; Edwards PN, 2004, SCIENCE, V304, P827, DOI 10.1126/science.1099290; Espeland WN, 1998, ANNU REV SOCIOL, V24, P313, DOI 10.1146/annurev.soc.24.1.313; Ford JD, 2004, ARCTIC, V57, P389, DOI 10.14430/arctic516; GLASER BG, 1965, SOC PROBL, V12, P436, DOI 10.1525/sp.1965.12.4.03a00070; Hahn MB, 2009, GLOBAL ENVIRON CHANG, V19, P74, DOI 10.1016/j.gloenvcha.2008.11.002; Hallfors MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102979; Jensen MD, 2013, J EUR PUBLIC POLICY, V20, P1, DOI 10.1080/13501763.2012.699656; Kampen JK, 2014, QUAL QUANT, V48, P1213, DOI 10.1007/s11135-013-9830-8; Lakerveld RP, 2015, ECOSYST SERV, V14, P56, DOI 10.1016/j.ecoser.2015.04.001; Le Reste JY, 2013, J AM MED DIR ASSOC, V14, P319, DOI 10.1016/j.jamda.2013.01.001; Lemmer B, 1999, QUAL HEALTH RES, V9, P315, DOI 10.1177/104973299129121884; Lepori B, 2013, MINERVA, V51, P271, DOI 10.1007/s11024-013-9235-9; Liquete C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067737; Lovell H, 2014, ECON SOC, V43, P260, DOI 10.1080/03085147.2013.812830; Magarey J M, 2001, Int J Nurs Pract, V7, P376; Merry SE, 2014, AM ETHNOL, V41, P1, DOI 10.1111/amet.12055; Morse JM, 2004, QUAL HEALTH RES, V14, P1387, DOI 10.1177/1049732304269676; Noblit G. W., 1988, METAETHNOGRAPHY SYNT; Plummer R, 2012, WATER RESOUR MANAG, V26, P4327, DOI 10.1007/s11269-012-0147-5; Pronk M, DISASTERS UNPUB; Schultz CA, 2012, ENVIRON IMPACT ASSES, V32, P74, DOI 10.1016/j.eiar.2011.03.003; Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45; Timmermans S, 2010, ANNU REV SOCIOL, V36, P69, DOI 10.1146/annurev.soc.012809.102629; van der Lee JH, 2007, JAMA-J AM MED ASSOC, V297, P2741, DOI 10.1001/jama.297.24.2741; Weiler V, 2014, CURR OPIN ENV SUST, V8, P29, DOI 10.1016/j.cosust.2014.07.009; Wells K, 2009, RES SOCIAL WORK PRAC, V19, P52, DOI 10.1177/1049731508317278	45	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149071	10.1371/journal.pone.0149071	http://dx.doi.org/10.1371/journal.pone.0149071			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901409	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100036
J	Langan, LM; Dodd, NJF; Owen, SF; Purcell, WM; Jackson, SK; Jha, AN				Langan, Laura M.; Dodd, Nicholas J. F.; Owen, Stewart F.; Purcell, Wendy M.; Jackson, Simon K.; Jha, Awadhesh N.			Direct Measurements of Oxygen Gradients in Spheroid Culture System Using Electron Parametric Resonance Oximetry	PLOS ONE			English	Article							MULTICELLULAR TUMOR SPHEROIDS; PARAMAGNETIC-RESONANCE; LITHIUM PHTHALOCYANINE; CELL-CULTURE; FISH CELLS; IN-VITRO; BIOCHEMICAL REACTIONS; CANCER-CELLS; CONSUMPTION; EPR	Advanced in vitro culture from tissues of different origin includes three-dimensional (3D) organoid micro structures that may mimic conditions in vivo. One example of simple 3D culture is spheroids; ball shaped structures typically used as liver and tumour models. Oxygen is critically important in physiological processes, but is difficult to quantify in 3D culture: and the question arises, how small does a spheroid have to be to have minimal micro-environment formation? This question is of particular importance in the growing field of 3D based models for toxicological assessment. Here, we describe a simple non-invasive approach modified for the quantitative measurement and subsequent evaluation of oxygen gradients in spheroids developed from a non-malignant fish cell line (i.e. RTG-2 cells) using Electron Paramagnetic Resonance (EPR) oximetry. Sonication of the paramagnetic probe Lithium phthalocyanine (LiPc) allows for incorporation of probe particulates into spheroid during its formation. Spectra signal strength after incorporation of probe into spheroid indicated that a volume of 20 mu l of probe (stock solution: 0.10 mg/mL) is sufficient to provide a strong spectra across a range of spheroid sizes. The addition of non-toxic probes (that do not produce or consume oxygen) report on oxygen diffusion throughout the spheroid as a function of size. We provide evidence supporting the use of this model over a range of initial cell seeding densities and spheroid sizes with the production of oxygen distribution as a function of these parameters. In our spheroid model, lower cell seeding densities (similar to 2,500 cells/spheroid) and absolute size (118 +/- 32 mu m) allow control of factors such as pre-existing stresses (e.g. similar to 2% normoxic/hypoxic interface) for more accurate measurement of treatment response. The applied methodology provides an elegant, widely applicable approach to directly characterize spheroid (and other organoid) cultures in biomedical and toxicological research.	[Langan, Laura M.; Dodd, Nicholas J. F.; Purcell, Wendy M.; Jha, Awadhesh N.] Univ Plymouth, Sch Biol Sci, Plymouth PL4 8AA, Devon, England; [Jackson, Simon K.] Univ Plymouth, Sch Biomed & Healthcare Sci, Plymouth PL4 8AA, Devon, England; [Owen, Stewart F.] AstraZeneca, Alderley Pk, Macclesfield SK10 4TF, Cheshire, England	University of Plymouth; University of Plymouth; AstraZeneca	Jha, AN (corresponding author), Univ Plymouth, Sch Biol Sci, Plymouth PL4 8AA, Devon, England.	A.Jha@plymouth.ac.uk	PURCELL, WENDY M/O-4082-2018; Owen, Stewart/ABF-1216-2021	PURCELL, WENDY M/0000-0002-9820-1526; Owen, Stewart/0000-0003-1398-7142; Jha, Awadhesh/0000-0001-9660-4308	Plymouth University, UK; AstraZeneca Global Environment Research programme; AstraZeneca; EU-INTERREG IVA [4059]; Biotechnology and Biological Sciences Research Council [BB/L01016X/1] Funding Source: researchfish; BBSRC [BB/L01016X/1] Funding Source: UKRI	Plymouth University, UK; AstraZeneca Global Environment Research programme; AstraZeneca(AstraZeneca); EU-INTERREG IVA; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by Plymouth University, UK as a PhD Studentship to LML. Part of the funding to support salary and consumable costs of this PhD studentship came from AstraZeneca Global Environment Research programme. AstraZeneca supported LML's studentship but did not play any additional role in the study design, data collection and analysis, decision to publish, or preparation of manuscript. NJFD's contribution to this work was supported by EU-INTERREG IVA (Grant No. 4059) awarded to ANJ. The specific roles of these authors are articulated in the "Authors Contributions" section.	Abu-Absi SF, 2004, CYTOTECHNOLOGY, V45, P125, DOI 10.1007/s10616-004-7996-6; Ahmad R, 2010, CHEM REV, V110, P3212, DOI 10.1021/cr900396q; BACKER JM, 1977, BIOCHIM BIOPHYS ACTA, V460, P152, DOI 10.1016/0005-2728(77)90161-X; Baron MG, 2012, ECOTOXICOLOGY, V21, P2419, DOI 10.1007/s10646-012-0965-5; Bobko AA, 2009, FREE RADICAL BIO MED, V47, P654, DOI 10.1016/j.freeradbiomed.2009.06.007; Breslin S, 2013, DRUG DISCOV TODAY, V18, P240, DOI 10.1016/j.drudis.2012.10.003; Carmel Mothersill, 2003, IN VITRO METHODS AQU; Cheng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004632; Diepart C, 2010, ANAL BIOCHEM, V396, P250, DOI 10.1016/j.ab.2009.09.029; DOBRUCKI JW, 1991, MAGNET RESON MED, V19, P42, DOI 10.1002/mrm.1910190105; Fennema E, 2013, TRENDS BIOTECHNOL, V31, P108, DOI 10.1016/j.tibtech.2012.12.003; Friedrich J, 2007, J BIOMOL SCREEN, V12, P925, DOI 10.1177/1087057107306839; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Glicklis R, 2004, BIOTECHNOL BIOENG, V86, P672, DOI 10.1002/bit.20086; Grimes DR, 2014, OXYGEN CONSUMPTION D; Hashem M, 2015, J MAGN RESON, V256, P77, DOI 10.1016/j.jmr.2015.04.012; Haycock JW, 2011, METHODS MOL BIOL, V695, P1, DOI 10.1007/978-1-60761-984-0_1; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Ho WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044640; Hyodo F, 2010, METHODS MOL BIOL, V610, P29, DOI 10.1007/978-1-60327-029-8_2; IKEYA M, 1989, ANAL SCI, V5, P5, DOI 10.2116/analsci.5.5; Ilangovan G, 2001, J PHYS CHEM B, V105, P5323, DOI 10.1021/jp010130+; JAMES PE, 1995, FREE RADICAL BIO MED, V18, P641, DOI 10.1016/0891-5849(94)00179-N; Khramtsov VV, 2012, IN VIVO SPECTROSCOPY; KOCAN RM, 1982, ENVIRON MUTAGEN, V4, P181, DOI 10.1002/em.2860040208; Krohn KA, 2008, J NUCL MED S2, V49, p129S, DOI DOI 10.2967/JNUMED.107.045914; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Liu J, 2007, J CELL BIOCHEM, V102, P1180, DOI 10.1002/jcb.21345; LIU KJ, 1993, P NATL ACAD SCI USA, V90, P5438, DOI 10.1073/pnas.90.12.5438; Ma HL, 2012, MOL IMAGING, V11, P487, DOI 10.2310/7290.2012.00012; Ma MW, 2003, J CELL BIOCHEM, V90, P1166, DOI 10.1002/jcb.10730; Matsumoto A, 2005, MAGN RESON MED, V54, P1530, DOI 10.1002/mrm.20714; Mehta G, 2012, J CONTROL RELEASE, V164, P192, DOI 10.1016/j.jconrel.2012.04.045; Miniaev MV, 2013, J ANAL METHODS CHEM, V2013, DOI 10.1155/2013/249752; MUELLERKLIESER W, 1984, BIOPHYS J, V46, P343, DOI 10.1016/S0006-3495(84)84030-8; MUELLERKLIESER WF, 1982, BRIT J CANCER, V45, P256, DOI 10.1038/bjc.1982.41; Naciri M, 2008, CYTOTECHNOLOGY, V57, P245, DOI 10.1007/s10616-008-9160-1; Nagelkerke A, 2013, ANAL BIOCHEM, V437, P17, DOI 10.1016/j.ab.2013.02.004; NICHOLS MG, 1994, PHYS MED BIOL, V39, P2161, DOI 10.1088/0031-9155/39/12/003; Pandian RP, 2003, FREE RADICAL BIO MED, V35, P1138, DOI 10.1016/S0891-5849(03)00496-9; Papis E, 2011, ECOTOXICOLOGY, V20, P208, DOI 10.1007/s10646-010-0572-2; Perkel JM, 2007, SCIENCE; Presley T, 2006, BIOPHYS J, V91, P4623, DOI 10.1529/biophysj.106.090175; Raisuddin S, 2004, ENVIRON MOL MUTAGEN, V44, P83, DOI 10.1002/em.20027; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Sceats E, 2010, INNOVAT PHARM TECHNO, P28; Schulz M, 1995, ALTEX, V12, P95; SMITH RW, 1995, J COMP PHYSIOL B, V165, P93, DOI 10.1007/BF00301473; Subczynski WK, 2005, MET MED PHYSL, P229, DOI [10.1007/0-387-26741-7_10, DOI 10.1007/0-387-26741-7_10]; SUTHERLAND R, 1981, CANCER RES, V41, P2980; Tung YC, 2011, ANALYST, V136, P473, DOI 10.1039/c0an00609b; VAUPEL P, 1989, CANCER RES, V49, P6449; Wallace DI, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00051; Wartenberg M, 2001, FASEB J, V15, P995, DOI 10.1096/fj.00-0350com; WOLF K, 1962, SCIENCE, V135, P1065, DOI 10.1126/science.135.3508.1065	55	48	48	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149492	10.1371/journal.pone.0149492	http://dx.doi.org/10.1371/journal.pone.0149492			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900704	Green Submitted, Green Published, gold			2022-12-27	WOS:000371276100085
J	McMahon, CM; Ibrahim, RK; Mathur, A				McMahon, Catherine M.; Ibrahim, Ronny K.; Mathur, Ankit			Cortical Reorganisation during a 30-Week Tinnitus Treatment Program	PLOS ONE			English	Article							ENRICHED ACOUSTIC ENVIRONMENT; AUDITORY-CORTEX; HEARING-LOSS; PSYCHOMETRIC PROPERTIES; FREQUENCY ORGANIZATION; NEURAL ACTIVITY; PLASTICITY; SYSTEM; GAIN; HYPERACTIVITY	Subjective tinnitus is characterised by the conscious perception of a phantom sound. Previous studies have shown that individuals with chronic tinnitus have disrupted sound-evoked cortical tonotopic maps, time-shifted evoked auditory responses, and altered oscillatory cortical activity. The main objectives of this study were to: (i) compare sound-evoked brain responses and cortical tonotopic maps in individuals with bilateral tinnitus and those without tinnitus; and (ii) investigate whether changes in these sound-evoked responses occur with amelioration of the tinnitus percept during a 30-week tinnitus treatment program. Magneto-encephalography (MEG) recordings of 12 bilateral tinnitus participants and 10 control normal-hearing subjects reporting no tinnitus were recorded at baseline, using 500 Hz, 1000 Hz, 2000 Hz, and 4000 Hz tones presented monaurally at 70 dBSPL through insert tube phones. For the tinnitus participants, MEG recordings were obtained at 5-, 10-, 20- and 30-week time points during tinnitus treatment. Results for the 500 Hz and 1000 Hz sources (where hearing thresholds were within normal limits for all participants) showed that the tinnitus participants had a significantly larger and more anteriorly located source strengths when compared to the non-tinnitus participants. During the 30-week tinnitus treatment, the participants' 500 Hz and 1000 Hz source strengths remained higher than the non-tinnitus participants; however, the source locations shifted towards the direction recorded from the non-tinnitus control group. Further, in the left hemisphere, there was a time-shifted association between the trajectory of change of the individual's objective (source strength and anterior-posterior source location) and subjective measures (using tinnitus reaction questionnaire, TRQ). The differences in source strength between the two groups suggest that individuals with tinnitus have enhanced central gain which is not significantly influenced by the tinnitus treatment, and may result from the hearing loss per se. On the other hand, the shifts in the tonotopic map towards the non-tinnitus participants' source location suggests that the tinnitus treatment might reduce the disruptions in the map, presumably produced by the tinnitus percept directly or indirectly. Further, the similarity in the trajectory of change across the objective and subjective parameters after time-shifting the perceptual changes by 5 weeks suggests that during or following treatment, perceptual changes in the tinnitus percept may precede neurophysiological changes. Subgroup analyses conducted by magnitude of hearing loss suggest that there were no differences in the 500 Hz and 1000 Hz source strength amplitudes for the mild-moderate compared with the mild-severe hearing loss subgroup, although the mean source strength was consistently higher for the mild-severe subgroup. Further, the mild-severe subgroup had 500 Hz and 1000 Hz source locations located more anteriorly (i.e., more disrupted compared to the control group) compared to the mild-moderate group, although this was trending towards significance only for the 500Hz left hemisphere source. While the small numbers of participants within the subgroup analyses reduce the statistical power, this study suggests that those with greater magnitudes of hearing loss show greater cortical disruptions with tinnitus and that tinnitus treatment appears to reduce the tonotopic map disruptions but not the source strength (or central gain).	[McMahon, Catherine M.; Ibrahim, Ronny K.; Mathur, Ankit] Macquarie Univ, Fac Human Sci, Dept Linguist, Sydney, NSW 2109, Australia; [McMahon, Catherine M.; Ibrahim, Ronny K.; Mathur, Ankit] HEARing Cooperat Res Ctr, Carlton, Vic, Australia	Macquarie University	McMahon, CM (corresponding author), Macquarie Univ, Fac Human Sci, Dept Linguist, Sydney, NSW 2109, Australia.; McMahon, CM (corresponding author), HEARing Cooperat Res Ctr, Carlton, Vic, Australia.	cath.mcmahon@mq.edu.au		McMahon, Catherine/0000-0001-7312-6593; Ibrahim, Ronny Kurniawan/0000-0003-1023-6351	HEARing CRC; Cooperative Research Centres Programme-Business Australia	HEARing CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Cooperative Research Centres Programme-Business Australia(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was funded by the HEARing CRC, established and supported under the Cooperative Research Centres Programme - Business Australia (http://www.hearingcrc.org) (CM RI AM), as well as the clinical and technical support from Neuromonics Pty Ltd, specifically from Professor Paul Davis and Kris Robinson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the tinnitus participants for their commitment to this longitudinal study, Christopher Sewell and John Newall in assisting with the study design, the recruitment of participants and collection of data, and Associate Professor Blake Johnson, ARC Centre of Excellence in Cognition and its Disorders for guidance in the data analysis. The authors acknowledge the funding from the Cooperative Research Centres Programme-Business Australia, as well as the clinical and technical support from Neuromonics Pty Ltd, specifically from Professor Paul Davis and Kris Robinson.	Ali R, 2002, ADDICTION, V97, P1183; Auerbach BD, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00206; Baguley DM, 2002, BRIT MED BULL, V63, P195, DOI 10.1093/bmb/63.1.195; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Chen GD, 2013, HEARING RES, V295, P100, DOI 10.1016/j.heares.2012.11.016; Davis A., 2000, TINNITUS HDB, P1; Davis PB, 2008, ENT-EAR NOSE THROAT, V87, P330, DOI 10.1177/014556130808700611; Davis PB, 2007, EAR HEARING, V28, P242, DOI 10.1097/AUD.0b013e3180312619; Dietrich V, 2001, HEARING RES, V158, P95, DOI 10.1016/S0378-5955(01)00282-9; Eggermont JJ, 2006, ACTA OTO-LARYNGOL, V126, P9, DOI 10.1080/03655230600895259; Eggermont JJ, 2007, HEARING RES, V229, P69, DOI 10.1016/j.heares.2007.01.008; Flor H, 1997, NEUROSCI LETT, V224, P5, DOI 10.1016/S0304-3940(97)13441-3; Hays RD, 2005, SLEEP MED, V6, P41, DOI 10.1016/j.sleep.2004.07.006; HELLER MF, 1953, ANN OTO RHINOL LARYN, V62, P73, DOI 10.1177/000348945306200107; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Ille N, 2002, J CLIN NEUROPHYSIOL, V19, P113, DOI 10.1097/00004691-200203000-00002; JASTREBOFF PJ, 1994, HEARING RES, V80, P216, DOI 10.1016/0378-5955(94)90113-9; Kaltenbach JA, 2004, NEUROSCI LETT, V355, P121, DOI 10.1016/j.neulet.2003.10.038; Kaltenbach JA, 2002, J NEUROPHYSIOL, V88, P699, DOI 10.1152/jn.2002.88.2.699; Kaltenbach JA, 2011, HEARING RES, V276, P52, DOI 10.1016/j.heares.2010.12.003; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Kopp B, 1999, NEUROREPORT, V10, P807, DOI 10.1097/00001756-199903170-00026; KRAUS N, 1995, J COGNITIVE NEUROSCI, V7, P25, DOI 10.1162/jocn.1995.7.1.25; Kuner R, 2010, NAT MED, V16, P1258, DOI 10.1038/nm.2231; Langguth B, 2006, ACTA OTO-LARYNGOL, V126, P84, DOI 10.1080/03655230600895317; Leaver AM, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00021; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; Liepert J, 2000, MUSCLE NERVE, V23, P1761, DOI 10.1002/1097-4598(200011)23:11<1761::AID-MUS14>3.0.CO;2-M; Lockwood AH, 1998, NEUROLOGY, V50, P114, DOI 10.1212/WNL.50.1.114; Meikle MB, 2012, EAR HEARING, V33, P153, DOI 10.1097/AUD.0b013e31822f67c0; Menning H, 2000, NEUROREPORT, V11, P817, DOI 10.1097/00001756-200003200-00032; Moller AR, 2007, PROG BRAIN RES, V166, P3, DOI 10.1016/S0079-6123(07)66001-4; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; Nenonen J, 2010, 17 INT C BIOM ADV BI; Nondahl DM, 2007, J AM ACAD AUDIOL, V18, P257, DOI 10.3766/jaaa.18.3.7; Norena AJ, 2005, J NEUROSCI, V25, P699, DOI 10.1523/JNEUROSCI.2226-04.2005; Norena AJ, 2007, NEUROREPORT, V18, P1251, DOI 10.1097/WNR.0b013e3282202c35; Norena AJ, 2011, NEUROSCI BIOBEHAV R, V35, P1089, DOI 10.1016/j.neubiorev.2010.11.003; Pienkowski M, 2012, EAR HEARING, V33, P305, DOI 10.1097/AUD.0b013e318241e880; Platz T, 2005, J NEUROL, V252, P1363, DOI 10.1007/s00415-005-0868-y; ROBERTSON D, 1989, J COMP NEUROL, V282, P456, DOI 10.1002/cne.902820311; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; RODIECK RW, 1962, BIOPHYS J, V2, P351, DOI 10.1016/S0006-3495(62)86860-X; Rossini PM, 2003, LANCET NEUROL, V2, P493, DOI 10.1016/S1474-4422(03)00485-X; Rossini PM, 1998, NEUROREPORT, V9, P2141, DOI 10.1097/00001756-199806220-00043; Rossiter S, 2006, J SPEECH LANG HEAR R, V49, P150, DOI 10.1044/1092-4388(2006/012); Salinas E, 2001, NEUROSCIENTIST, V7, P430, DOI 10.1177/107385840100700512; Salvi RJ, 2000, HEARING RES, V147, P261, DOI 10.1016/S0378-5955(00)00136-2; Sarkar S, 2001, AM J PHYSIOL-GASTR L, V281, pG1196, DOI 10.1152/ajpgi.2001.281.5.G1196; Schaette R, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00034; Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; Shiomi Y, 1997, HEARING RES, V108, P83, DOI 10.1016/S0378-5955(97)00043-9; Sindhusake D, 2003, EAR HEARING, V24, P501, DOI 10.1097/01.AUD.0000100204.08771.3D; Spielberger C. D., 1983, MIND GARDEN; Sun W, 2009, NEUROSCIENCE, V159, P325, DOI 10.1016/j.neuroscience.2008.12.024; Tavora-Vieira D, 2011, INT J AUDIOL, V50, P881, DOI 10.3109/14992027.2011.606286; Traversa R, 1997, STROKE, V28, P110, DOI 10.1161/01.STR.28.1.110; Tremblay K, 2001, EAR HEARING, V22, P79, DOI 10.1097/00003446-200104000-00001; Tremblay K, 1998, NEUROREPORT, V9, P3557, DOI 10.1097/00001756-199811160-00003; Tremblay K, 1997, J ACOUST SOC AM, V102, P3762, DOI 10.1121/1.420139; Wang HT, 2001, CHINESE MED J-PEKING, V114, P848; Wang JA, 2002, HEARING RES, V168, P238, DOI 10.1016/S0378-5955(02)00360-X; Ware J.E., 2000, SF 36 HLTH SURVEY MA; Weisz N, 2005, BRAIN, V128, P2722, DOI 10.1093/brain/awh588; Wienbruch C, 2006, NEUROIMAGE, V33, P180, DOI 10.1016/j.neuroimage.2006.06.023; WILSON PH, 1991, J SPEECH HEAR RES, V34, P197, DOI 10.1044/jshr.3401.197; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Yang G, 2007, HEARING RES, V226, P244, DOI 10.1016/j.heares.2006.06.013; Zeng FG, 2013, HEARING RES, V295, P172, DOI 10.1016/j.heares.2012.05.009	69	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148828	10.1371/journal.pone.0148828	http://dx.doi.org/10.1371/journal.pone.0148828			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26901425	Green Published, gold			2022-12-27	WOS:000371276100025
J	Mou, X; Zhou, DY; Zhou, DY; Ma, JR; Liu, YH; Chen, HP; Hu, YB; Shou, CM; Chen, JW; Liu, WH; Ma, GL				Mou, Xin; Zhou, Di-Yi; Zhou, Dan-Yang; Ma, Jing-Ru; Liu, Ying-Hui; Chen, Hui-Ping; Hu, Yong-Bin; Shou, Cheng-Min; Chen, Jia-Wei; Liu, Wen-Hong; Ma, Guo-Ling			Serum TGF-beta 1 as a Biomarker for Type 2 Diabetic Nephropathy: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							MATRIX GENE-EXPRESSION; TRANSFORMING GROWTH-FACTOR-BETA-1; TGF-BETA; ASSOCIATION; PATHWAY; INFLAMMATION; POLYMORPHISM; FIBROSIS; ANTIBODY; RISK	Background Abnormal expression of serum TGF-beta 1 was found in patients with diabetic nephropathy. However, the association of TGF-beta 1 with the risk of diabetic nephropathy remains unknown. The present study was undertaken to investigate whether such an association exists. Methods We searched the Chinese VIP, Wangfang, China National Knowledge Infrastructure, PubMed, Embase, and Google Scholar databases for relevant studies and extracted all eligible data. Stata12 software was used for statistical analysis. Results Nine reports met our criteria and were used for data extraction. There were 264 patients and 227 healthy controls from qualified reports in this meta-analysis. The results suggested that serum TGF-beta 1 levels were significantly up-regulated in patients with diabetic nephropathy; the instrumental variable was 3.94 (95% confidence interval 3.20-4.68, p<0.01). Conclusions Meta-analysis suggested that elevated serum TGF-beta level in patients with diabetes is associated with a high risk of nephropathy. Further studies are required to validate these observations.	[Mou, Xin; Zhou, Di-Yi; Zhou, Dan-Yang; Liu, Ying-Hui; Chen, Hui-Ping; Hu, Yong-Bin; Shou, Cheng-Min; Chen, Jia-Wei; Ma, Guo-Ling] Hangzhou Red Cross Hosp, Dept Endocrinol, Hangzhou 310003, Zhejiang, Peoples R China; [Ma, Jing-Ru; Liu, Wen-Hong] Zhejiang Chinese Med Univ, City Rd 548, Hangzhou 310053, Zhejiang, Peoples R China	Zhejiang Chinese Medical University	Ma, GL (corresponding author), Hangzhou Red Cross Hosp, Dept Endocrinol, Hangzhou 310003, Zhejiang, Peoples R China.	MAGuoling8888@163.com			National Natural Science Foundation [30801467, 81273623]; Department of Science and Technology of Zhejiang Province [2013C33212]; China Postdoctoral Science Foundation [2014M551775]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Zhejiang Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by grants awarded to X. Mou from National Natural Science Foundation (grant nos. 30801467 and 81273623), a grant awarded to D-Y. Zhou from the Department of Science and Technology of Zhejiang Province (grant no. 2013C33212), and a grant awarded to X. Mou from the China Postdoctoral Science Foundation (grant no. 2014M551775). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, NATURE REV NEPHROLOG, V11, P254, DOI [10.1038/nrneph.2015.45, DOI 10.1038/NRNEPH.2015.45]; Caramori ML, 2000, DIABETES, V49, P1399, DOI 10.2337/diabetes.49.9.1399; Changxin F, 2007, J RADIOIMMUNOLOGY, V20; Gilg J, 2015, NEPHRON, V129, P1, DOI 10.1159/000370271; Ju Haibing Gp, 2001, CHINESE J PATHOPHYSI, V17; Kondo S, 2004, BBA-MOL CELL RES, V1693, P91, DOI 10.1016/j.bbamcr.2004.05.005; Lee SJ, 2009, METABOLISM, V58, P616, DOI 10.1016/j.metabol.2008.12.006; Lee YM, 2003, J KOREAN MED SCI, V18, P97; Lehmann R, 2000, CLIN CHIM ACTA, V297, P135, DOI 10.1016/S0009-8981(00)00240-0; Li LY, 2010, EXP BIOL MED, V235, P383, DOI 10.1258/ebm.2009.009218; Liu Ruiji LL, 2011, HEBEI MED J, V33; McKnight AJ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-5; Miner JH, 2005, J AM SOC NEPHROL, V16, P857, DOI 10.1681/ASN.2004121139; Ni BB, 2014, CYTOKINE, V70, P87, DOI 10.1016/j.cyto.2014.07.249; Ning L, 2014, AM J PATHOL, V184, P1683, DOI 10.1016/j.ajpath.2014.02.006; Perkins BA, 2007, J AM SOC NEPHROL, V18, P1353, DOI 10.1681/ASN.2006080872; Russo LM, 2007, DIABETES, V56, P380, DOI 10.2337/db06-1018; Saran R, 2015, AM J KIDNEY DIS, V66, pS1, DOI 10.1053/j.ajkd.2015.05.001; Schilter H, 2015, IMMUNOL LETT, V165, P90, DOI 10.1016/j.imlet.2015.04.003; Sharma K, 1996, DIABETES, V45, P522, DOI 10.2337/diabetes.45.4.522; Tas F, 2015, TUMOR BIOL, V36, P2097, DOI 10.1007/s13277-014-2817-9; Weikang Z, 2008, J CLIN RES, V25; Wu Xingfu CL, 2011, J RADIOIMMUNOLOGY, V24; Xie Hongfang PL, 2006, J RADIOIMMUNOLOGY, V19; Yang Qin, 2007, Chinese Medical Sciences Journal, V22, P243; Yaping W, 2008, J RADIOIMMUNOLOGY, V21; Zhang J, 2014, RENAL FAILURE, V36, P321, DOI 10.3109/0886022X.2013.832320; Zhang Xuejun LP, 2004, LIAONING J PRACTICAL, V12; Zhen L, 2011, LAB MED CLIN, V8; Zhou TB, 2014, NEPHROLOGY, V19, P107, DOI 10.1111/nep.12176; Ziyadeh FN, 2000, P NATL ACAD SCI USA, V97, P8015, DOI 10.1073/pnas.120055097	31	21	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149513	10.1371/journal.pone.0149513	http://dx.doi.org/10.1371/journal.pone.0149513			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901047	gold, Green Published			2022-12-27	WOS:000371276100088
J	Ngabo, F; Mvundura, M; Gazley, L; Gatera, M; Rugambwa, C; Kayonga, E; Tuyishime, Y; Niyibaho, J; Mwenda, JM; Donnen, P; Lepage, P; Binagwaho, A; Atherly, D				Ngabo, Fidele; Mvundura, Mercy; Gazley, Lauren; Gatera, Maurice; Rugambwa, Celse; Kayonga, Eugene; Tuyishime, Yvette; Niyibaho, Jeanne; Mwenda, Jason M.; Donnen, Philippe; Lepage, Philippe; Binagwaho, Agnes; Atherly, Deborah			The Economic Burden Attributable to a Child's Inpatient Admission for Diarrheal Disease in Rwanda	PLOS ONE			English	Article							ROTAVIRUS VACCINATION; COST-EFFECTIVENESS; HEALTH; IMPACT; COUNTRIES; CARE; GASTROENTERITIS	Background Diarrhea is one of the leading causes of childhood morbidity and mortality. Hospitalization for diarrhea can pose a significant burden to health systems and households. The objective of this study was to estimate the economic burden attributable to hospitalization for diarrhea among children less than five years old in Rwanda. These data can be used by decisionmakers to assess the impact of interventions that reduce diarrhea morbidity, including rotavirus vaccine introduction. Methods This was a prospective costing study where medical records and hospital bills for children admitted with diarrhea at three hospitals were collected to estimate resource use and costs. Hospital length of stay was calculated from medical records. Costs incurred during the hospitalization were abstracted from the hospital bills. Interviews with the child's caregivers provided data to estimate household costs which included transport costs and lost income. The portion of medical costs borne by insurance and household were reported separately. Annual economic burden before and after rotavirus vaccine introduction was estimated by multiplying the reported number of diarrhea hospitalizations in public health centers and district hospitals by the estimated economic burden per hospitalization. All costs are presented in 2014 US$. Results Costs for 203 children were analyzed. Approximately 93% of the children had health insurance coverage. Average hospital length of stay was 5.3 +/- 3.9 days. Average medical costs for each child for the illness resulting in a hospitalization were $44.22 +/- $23.74 and the total economic burden was $101, of which 65% was borne by the household. For households in the lowest income quintile, the household costs were 110% of their monthly income. The annual economic burden to Rwanda attributable to diarrhea hospitalizations ranged from $1.3 million to $1.7 million before rotavirus vaccine introduction. Conclusion Households often bear the largest share of the economic burden attributable to diarrhea hospitalization and the burden can be substantial, especially for households in the lowest income quintile.	[Ngabo, Fidele; Donnen, Philippe] Univ Libre Bruxelles, Ecole Sante Publ, Brussels, Belgium; [Ngabo, Fidele; Gatera, Maurice; Kayonga, Eugene; Tuyishime, Yvette; Niyibaho, Jeanne] Minist Hlth, Rwanda Biomed Ctr, Kigali, Rwanda; [Mvundura, Mercy] PATH, Devices & Tools Global Program, Seattle, WA 98121 USA; [Gazley, Lauren; Atherly, Deborah] PATH, Vaccine Access & Delivery Global Program, Seattle, WA 98121 USA; [Rugambwa, Celse] WHO, Rwanda Country Off, Kigali, Rwanda; [Mwenda, Jason M.] WHO, Reg Off Africa, Brazzaville, Rep Congo; [Lepage, Philippe] Univ Libre Bruxelles, Hop Univ Enfants Reine Fabiola, Brussels, Belgium; [Binagwaho, Agnes] Minist Hlth, Kigali, Rwanda; [Binagwaho, Agnes] Harvard Univ, Sch Med, Boston, MA USA; [Binagwaho, Agnes] Dartmouth, Geisel Sch Med, Hanover, NH USA	Universite Libre de Bruxelles; Rwanda Biomedical Center; World Health Organization; World Health Organization; Universite Libre de Bruxelles; Harvard University; Harvard Medical School; Dartmouth College	Mvundura, M (corresponding author), PATH, Devices & Tools Global Program, Seattle, WA 98121 USA.	mmvundura@path.org		Mvundura, Mercy/0000-0002-7711-9558	Bill and Melinda Gates Foundation [OPP1017334]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	MM, LG, EK, YT, JN, and DA were supported by a grant received from the Bill and Melinda Gates Foundation, grant number OPP1017334. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikins M, 2010, J INFECT DIS, V202, pS126, DOI 10.1086/653573; Alkoshi S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1400-7; Atherly DE, 2012, VACCINE, V30, pA7, DOI 10.1016/j.vaccine.2011.12.096; Burke RM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-708; Fischer TK, 2005, J INFECT DIS, V192, P1720, DOI 10.1086/497339; Giaquinto C, 2007, J INFECT DIS, V195, pS36, DOI 10.1086/516716; Jin H, 2011, VACCINE, V29, P7801, DOI 10.1016/j.vaccine.2011.07.104; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; MacIntyre UE, 2010, J INFECT DIS, V202, pS116, DOI 10.1086/653560; Ngabo F, 2014, PEDIATR INFECT DIS J, V33, pS89, DOI 10.1097/INF.0000000000000054; Oanda, 1996, CURR CONV; Osano BO, 2011, VACCINE, V29, P4019, DOI 10.1016/j.vaccine.2011.03.053; Rheingans R, 2012, CLIN INFECT DIS, V55, pS317, DOI 10.1093/cid/cis763; Rheingans R, 2012, CLIN INFECT DIS, V55, pS327, DOI 10.1093/cid/cis764; Rheingans R, 2012, VACCINE, V30, pA15, DOI 10.1016/j.vaccine.2012.01.018; Rheingans RD, 2009, J INFECT DIS, V200, pS16, DOI 10.1086/605026; Rwanda Ministry of Health, 2010, RWAND NAT HLTH INS P; Tate JE, 2009, J INFECT DIS, V200, pS76, DOI 10.1086/605058; United Nations Department of Economic and Social Affairs, 2015, WORLD POP PROSP 2012; Walker CLF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029151; WHO, 2005, WHOIVB0510; World Health Organization, 2016, WHO VACC PREV DIS MO	22	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149805	10.1371/journal.pone.0149805	http://dx.doi.org/10.1371/journal.pone.0149805			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901113	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100154
J	Turner, KB; Naciri, J; Liu, JL; Anderson, GP; Goldman, ER; Zabetakis, D				Turner, Kendrick B.; Naciri, Jennifer; Liu, Jinny L.; Anderson, George P.; Goldman, Ellen R.; Zabetakis, Dan			Next-Generation Sequencing of a Single Domain Antibody Repertoire Reveals Quality of Phage Display Selected Candidates	PLOS ONE			English	Article							FRAGMENTS; TOXIN; LIBRARY; SEQ	Next-Generation Sequencing and bioinformatics are powerful tools for analyzing the large number of DNA sequences present in an immune library. In this work, we constructed a cDNA library of single domain antibodies from a llama immunized with staphylococcal enterotoxin B. The resulting library was sequenced, resulting in approximately 8.5 million sequences with 5.4 million representing intact, useful sequences. The sequenced library was interrogated using sequences of known SEB-binding single domain antibodies from the library obtained through phage display panning methods in a previous study. New antibodies were identified, produced, and characterized, and were shown to have affinities and melting temperatures comparable to those obtained by traditional panning methods. This demonstrates the utility of using NGS as a complementary tool to phage-displayed biopanning as a means for rapidly obtaining additional antibodies from an immune library. It also shows that phage display, using a library of high diversity, is able to select high quality antibodies even when they are low in frequency.	[Turner, Kendrick B.; Naciri, Jennifer] US Naval Res Lab, Washington, DC USA; [Liu, Jinny L.; Anderson, George P.; Goldman, Ellen R.; Zabetakis, Dan] US Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC USA	United States Department of Defense; United States Navy; Naval Research Laboratory; United States Department of Defense; United States Navy; Naval Research Laboratory	Zabetakis, D (corresponding author), US Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC USA.	daniel.zabetakis@nrl.navy.mil	Turner, Kendrick/A-5063-2018; Anderson, George P/D-2461-2011	Turner, Kendrick/0000-0002-4966-3396; Anderson, George P/0000-0001-7545-9893	 [DTRA: CBCALL12-LS6-2-0036]		This study was supported by DTRA: CBCALL12-LS6-2-0036 (www.dtra.mil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GP, 2012, ANAL CHEM, V84, P5198, DOI 10.1021/ac300864j; Anderson GP, 2008, ANAL CHEM, V80, P9604, DOI 10.1021/ac8019398; Baum PD, 2012, EUR J IMMUNOL, V42, P2834, DOI 10.1002/eji.201242999; Benichou J, 2012, IMMUNOLOGY, V135, P183, DOI 10.1111/j.1365-2567.2011.03527.x; Bolotin D, 2012, TISSUE ANTIGENS, V79, P545; de Marco A, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-44; Eyer L, 2012, VET MED-CZECH, V57, P439, DOI 10.17221/6336-VETMED; Fischer N, 2011, MABS-AUSTIN, V3, P17, DOI 10.4161/mabs.3.1.14169; Fridy PC, 2014, NAT METHODS, V11, P1253, DOI [10.1038/NMETH.3170, 10.1038/nmeth.3170]; Gasper WC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05152; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; He LL, 2014, SCI REP-UK, V4, DOI 10.1038/srep06778; Heyduk E, 2014, ANAL BIOCHEM, V464, P73, DOI 10.1016/j.ab.2014.07.014; Jirimutu, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2192; Liu JL, 2007, MOL IMMUNOL, V44, P1775, DOI 10.1016/j.molimm.2006.07.299; MacRae T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072884; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Murigneux V, 2013, METHODS, V63, P32, DOI 10.1016/j.ymeth.2013.03.022; Turner Kendrick B, 2015, Biotechnol Rep (Amst), V6, P27, DOI 10.1016/j.btre.2015.01.001; Turner KB, 2014, SENSORS-BASEL, V14, P10846, DOI 10.3390/s140610846; Turner KB, 2014, PROTEIN ENG DES SEL, V27, P89, DOI 10.1093/protein/gzu001; Wang CL, 2010, P NATL ACAD SCI USA, V107, P1518, DOI 10.1073/pnas.0913939107; Warren RL, 2011, GENOME RES, V21, P790, DOI 10.1101/gr.115428.110; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020	26	22	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149393	10.1371/journal.pone.0149393	http://dx.doi.org/10.1371/journal.pone.0149393			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895405	Green Published, gold, Green Submitted			2022-12-27	WOS:000371223400051
J	Han, YC; Huang, HM; Sun, L; Tan, CM; Gao, M; Liu, H; Tang, RN; Wang, YL; Wang, B; Ma, KL; Liu, BC				Han, Yu-Chen; Huang, Han-Ming; Sun, Ling; Tan, Chao-Ming; Gao, Min; Liu, Hong; Tang, Ri-Ning; Wang, Yan-Li; Wang, Bei; Ma, Kun-Ling; Liu, Bi-Cheng			Epidemiological Study of RRT-Treated ESRD in Nanjing - A Ten-Year Experience in Nearly Three Million Insurance Covered Population	PLOS ONE			English	Article							KIDNEY-DISEASE; CHINA; HEMODIALYSIS; SURVIVAL; ACCESS; CARE	Background The growing burden of end-stage renal disease (ESRD) has been a great challenge to the health care system of China. However, the exact epidemiological data for ESRD in China remain unclear. We aimed to investigate the epidemiology of ESRD treated by renal replacement therapy (RRT) in Nanjing based on analysing ten-year data of Nanjing three million insurance covered population. Methods Using the electronic registry system of Urban Employee Basic Medical Insurance (UEBMI), we included all subjects insured by UEBMI in Nanjing from 2005 to 2014 and identified subjects who developed ESRD and started RRT in this cohort. Results The UEBMI population in Nanjing increased from 1,301,882 in 2005 to 2,921,065 in 2014, among which a total of 5,840 subjects developed ESRD and received RRT. Over the 10-year period, the adjusted incidence rates of RRT in the UEBMI cohort gradually decreased from 289.3pmp in 2005 to 218.8pmp in 2014. However, the adjusted prevalence rate increased steadily from 891.7pmp in 2005 to 1,228.6pmp in 2014. The adjusted annual mortality rate decreased from 138.4 per 1000 patient-years in 2005 to 97.8 per 1000 patient-years in 2014. The long-term survival rate fluctuated over the past decade, with the 1-year survival rate ranging from 85.1% to 91.7%, the 3-year survival rate from 69.9% to 78.3% and the 5-year survival rate from 58% to 65.4%. Conclusion Nanjing is facing an increasing burden of ESRD with its improvement of medical reform. The ten-year complete registry data on RRT in urban employees in Nanjing provided a unique opportunity to understand the real threat of ESRD confronting China during its process of health care transition.	[Han, Yu-Chen; Sun, Ling; Gao, Min; Liu, Hong; Tang, Ri-Ning; Wang, Yan-Li; Ma, Kun-Ling; Liu, Bi-Cheng] Southeast Univ, Sch Med, Zhongda Hosp, Inst Nephrol, Nanjing, Jiangsu, Peoples R China; [Huang, Han-Ming; Tan, Chao-Ming] Nanjing Municipal Human Resources & Social Secur, Social Insurance Management Ctr, Nanjing, Jiangsu, Peoples R China; [Wang, Bei] Southeast Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Liu, BC (corresponding author), Southeast Univ, Sch Med, Zhongda Hosp, Inst Nephrol, Nanjing, Jiangsu, Peoples R China.	liubc64@163.com			National Natural Science Foundation of China [81130010, 81470997]; National Key Basic Research Project ("973"); Clinic Research Center program of Jiangsu Province [BL2014080]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Project ("973")(National Basic Research Program of China); Clinic Research Center program of Jiangsu Province	This study was supported by grants to Bi-Cheng Liu from the National Natural Science Foundation of China (81130010, 81470997), National Key Basic Research Project ("973") and Clinic Research Center program of Jiangsu Province (BL2014080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, LANCET, V378, P457, DOI DOI 10.1016/S0140-6736(11)61232-4; Gan L, 2015, CLIN NEPHROL, V83; Kimmel PL, 2013, J AM SOC NEPHROL, V24, P293, DOI 10.1681/ASN.2012070659; Kurella-Tamura M, 2014, J AM SOC NEPHROL, V25, P1321, DOI 10.1681/ASN.2013060658; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9; Nakai S, 2014, THER APHER DIAL, V18, P535, DOI 10.1111/1744-9987.12281; Nanjing Municipal Human Resources and Social Security Bureau, 2010, COMP DOC URB EMPL BA; Steenkamp R, 2015, NEPHRON, V129, P99, DOI 10.1159/000370275; U.S. Renal Data System USRDS, 2013, USDRS 2013 ANN DAT R; Wu M-S, 2012, ACTA NEPHROLOGICA, V26, P104; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Yao Q, 2009, ETHN DIS S1, V19; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; ZHANG W, 2012, CHIN J BLOOD PURIF, V11, P233; Zuo L, 2010, CLIN NEPHROL, V74, pS20; Zuo L, 2006, ETHN DIS S2, V16; Zuo L, 2013, KIDNEY INT SUPPL, V3, P167, DOI 10.1038/kisup.2013.6; 2001, CHIN J NEPHROL, V17, P77	20	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149038	10.1371/journal.pone.0149038	http://dx.doi.org/10.1371/journal.pone.0149038			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26889828	Green Submitted, Green Published, gold			2022-12-27	WOS:000371221500020
J	Piccirillo, A; Lavezzo, E; Niero, G; Moreno, A; Massi, P; Franchin, E; Toppo, S; Salata, C; Palu, G				Piccirillo, Alessandra; Lavezzo, Enrico; Niero, Giulia; Moreno, Ana; Massi, Paola; Franchin, Elisa; Toppo, Stefano; Salata, Cristiano; Palu, Giorgio			Full Genome Sequence-Based Comparative Study of Wild-Type and Vaccine Strains of Infectious Laryngotracheitis Virus from Italy	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; POLYMERASE-CHAIN-REACTION; LIVE ATTENUATED VACCINES; UNITED-STATES; FIELD; PROTEIN; DNA; DIFFERENTIATION; HERPESVIRUS-1; EPIDEMIOLOGY	Infectious laryngotracheitis (ILT) is an acute and highly contagious respiratory disease of chickens caused by an alphaherpesvirus, infectious laryngotracheitis virus (ILTV). Recently, full genome sequences of wild-type and vaccine strains have been determined worldwide, but none was from Europe. The aim of this study was to determine and analyse the complete genome sequences of five ILTV strains. Sequences were also compared to reveal the similarity of strains across time and to discriminate between wild-type and vaccine strains. Genomes of three ILTV field isolates from outbreaks occurred in Italy in 1980, 2007 and 2011, and two commercial chicken embryo origin (CEO) vaccines were sequenced using the 454 Life Sciences technology. The comparison with the Serva genome showed that 35 open reading frames (ORFs) differed across the five genomes. Overall, 54 single nucleotide polymorphisms (SNPs) and 27 amino acid differences in 19 ORFs and two insertions in the UL52 and ORFC genes were identified. Similarity among the field strains and between the field and the vaccine strains ranged from 99.96% to 99.99%. Phylogenetic analysis revealed a close relationship among them, as well. This study generated data on genomic variation among Italian ILTV strains revealing that, even though the genetic variability of the genome is well conserved across time and between wild-type and vaccine strains, some mutations may help in differentiating among them and may be involved in ILTV virulence/attenuation. The results of this study can contribute to the understanding of the molecular bases of ILTV pathogenicity and provide genetic markers to differentiate between wild-type and vaccine strains.	[Piccirillo, Alessandra; Niero, Giulia] Univ Padua, Dept Comparat Biomed & Food Sci BCA, Legnaro, Padua, Italy; [Lavezzo, Enrico; Franchin, Elisa; Toppo, Stefano; Salata, Cristiano; Palu, Giorgio] Univ Padua DMM, Dept Mol Med, Padua, Italy; [Moreno, Ana] IZSLER, Dept Virol, Brescia, Italy; [Massi, Paola] IZSLER, Dept Diagnost, Forli, Italy	University of Padua; University of Padua; IZS Lombardia e Emilia	Piccirillo, A (corresponding author), Univ Padua, Dept Comparat Biomed & Food Sci BCA, Legnaro, Padua, Italy.	alessandra.piccirillo@unipd.it	Piccirillo, Alessandra/AAI-8464-2020; Salata, Cristiano/T-6601-2019; Moreno, Ana/Q-2173-2019; Toppo, Stefano/Z-5479-2019; Lavezzo, Enrico/K-7962-2016	Salata, Cristiano/0000-0002-5136-7406; Moreno, Ana/0000-0002-8497-9708; Toppo, Stefano/0000-0002-0246-3119; Lavezzo, Enrico/0000-0002-3902-8356	University of Padua [PRAT CPDA138081/13, GRIC13AAI9]; Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (Ricerca Corrente IZSLER) [PRC2011005]; Regione Veneto	University of Padua; Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (Ricerca Corrente IZSLER); Regione Veneto(Regione Veneto)	This work was funded by University of Padua (ex 60% 2009 and 2012, AP; "Progetto di Ateneo" PRAT CPDA138081/13, ST; "Assegno senior" and "Bando giovani studiosi", GRIC13AAI9, EL) (http://www.unipd.it/), Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (Ricerca Corrente 2011 IZSLER, PRC2011005, AP, AM and PM) (http://www.izsler.it/), Regione Veneto (GP) (http://www.regione.veneto.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blacker HP, 2011, AUST VET J, V89, P89, DOI 10.1111/j.1751-0813.2010.00665.x; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Chacon JL, 2015, TROP ANIM HEALTH PRO, V47, P1101, DOI 10.1007/s11250-015-0834-3; Chacon JL, 2010, AVIAN PATHOL, V39, P425, DOI 10.1080/03079457.2010.516386; Chacon JL, 2009, VACCINE, V27, P6731, DOI 10.1016/j.vaccine.2009.08.083; Chandra YG, 2012, VIRUS GENES, V44, P470, DOI 10.1007/s11262-012-0728-7; Connolly SA, 2011, NAT REV MICROBIOL, V9, P369, DOI 10.1038/nrmicro2548; Coppo MJC, 2013, AVIAN PATHOL, V42, P195, DOI 10.1080/03079457.2013.800634; Creelan JL, 2006, AVIAN PATHOL, V35, P173, DOI 10.1080/03079450600598244; Davison AJ, 2010, VET MICROBIOL, V143, P52, DOI 10.1016/j.vetmic.2010.02.014; Dufour-Zavala L, 2008, AVIAN DIS, V52, P1, DOI 10.1637/8018-051007-Review; Eisenberg RJ, 2012, VIRUSES-BASEL, V4, P800, DOI 10.3390/v4050800; Fan WH, 2015, J VIROL, V89, P1502, DOI 10.1128/JVI.02887-14; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Garcia M., 2013, DIS POULTRY, V13, P161, DOI 10.1002/9781119421481.ch5; Garcia M, 2013, VIROLOGY, V440, P64, DOI 10.1016/j.virol.2013.02.007; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kim HR, 2013, POULTRY SCI, V92, P2053, DOI 10.3382/ps.2013-03134; Kirkpatrick NC, 2006, AVIAN DIS, V50, P28, DOI 10.1637/7414-072205R.1; Kong CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070154; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le Sage V, 2013, J VIROL, V87, P5904, DOI 10.1128/JVI.03489-12; Lee SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055121; Lee SW, 2012, SCIENCE, V337, P188, DOI 10.1126/science.1217134; Lee SW, 2011, VACCINE, V29, P9583, DOI 10.1016/j.vaccine.2011.10.055; Lee SW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-197; Mandelli G, 1981, RIV ZOOT VET, V8, P328; Menendez KR, 2014, AVIAN PATHOL, V43, P108, DOI 10.1080/03079457.2014.886004; Moreno A, 2010, AVIAN DIS, V54, P1172, DOI 10.1637/9398-051910-Reg.1; Muylaert I, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.R111.233981; Neff C, 2008, AVIAN DIS, V52, P278, DOI 10.1637/8168-110107-Reg.1; Ojkic D, 2006, AVIAN PATHOL, V35, P286, DOI 10.1080/03079450600815481; Oldoni I, 2008, AVIAN DIS, V52, P59, DOI 10.1637/8054-070607-Reg; Oldoni I, 2007, AVIAN PATHOL, V36, P167, DOI 10.1080/03079450701216654; Pavlova S, 2013, AVIAN DIS, V57, P416, DOI 10.1637/10332-082612-Reg.1; Sadeghi M, 2011, AFR J MICROBIOL RES, V5, P4112; Sandri-Goldin RM, 2011, FUTURE MICROBIOL, V6, P1261, DOI [10.2217/FMB.11.119, 10.2217/fmb.11.119]; Shehata AA, 2013, VIRUS GENES, V46, P423, DOI 10.1007/s11262-012-0870-2; Spatz SJ, 2012, VIRUS GENES, V44, P273, DOI 10.1007/s11262-011-0696-3; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thiry E, 2005, REV MED VIROL, V15, P89, DOI 10.1002/rmv.451; Thureen DR, 2006, J VIROL, V80, P7863, DOI 10.1128/JVI.00134-06; Veits J, 2003, J GEN VIROL, V84, P1415, DOI 10.1099/vir.0.18926-0; Weller SK, 2013, EXPERT OPIN THER TAR, V17, P1119, DOI 10.1517/14728222.2013.827663; Zhao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067598; Zhou GY, 2000, J VIROL, V74, P11782, DOI 10.1128/JVI.74.24.11782-11791.2000	48	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149529	10.1371/journal.pone.0149529	http://dx.doi.org/10.1371/journal.pone.0149529			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890525	Green Published, Green Submitted, gold			2022-12-27	WOS:000371221500055
J	Thompson, B; Varticovski, L; Baek, S; Hager, GL				Thompson, Bethtrice; Varticovski, Lyuba; Baek, Songjoon; Hager, Gordon L.			Genome-Wide Chromatin Landscape Transitions Identify Novel Pathways in Early Commitment to Osteoblast Differentiation	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR; TRANSCRIPTION FACTORS; STEM-CELLS; EXPRESSION; RUNX2; INTERLEUKIN-11; ANTAGONISTS; MUTATIONS; MECHANISM; LINEAGE	Bone continuously undergoes remodeling by a tightly regulated process that involves osteoblast differentiation from Mesenchymal Stem Cells ( MSC). However, commitment of MSC to osteoblastic lineage is a poorly understood process. Chromatin organization functions as a molecular gatekeeper of DNA functions. Detection of sites that are hypersensitive to Dnase I has been used for detailed examination of changes in response to hormones and differentiation cues. To investigate the early steps in commitment of MSC to osteoblasts, we used a model human temperature-sensitive cell line, hFOB. When shifted to non-permissive temperature, these cells undergo "spontaneous" differentiation that takes several weeks, a process that is greatly accelerated by osteogenic induction media. We performed Dnase I hypersensitivity assays combined with deep sequencing to identify genome-wide potential regulatory events in cells undergoing early steps of commitment to osteoblasts. Massive reorganization of chromatin occurred within hours of differentiation. Whereas similar to 30% of unique DHS sites were located in the promoters, the majority was outside of the promoters, designated as enhancers. Many of them were at novel genomic sites and need to be confirmed experimentally. We developed a novel method for identification of cellular networks based solely on DHS enhancers signature correlated to gene expression. The analysis of enhancers that were unique to differentiating cells led to identification of bone developmental program encompassing 147 genes that directly or indirectly participate in osteogenesis. Identification of these pathways provided an unprecedented view of genomic regulation during early steps of differentiation and changes related to WNT, AP-1 and other pathways may have therapeutic implications.	[Thompson, Bethtrice; Varticovski, Lyuba; Baek, Songjoon; Hager, Gordon L.] NCI, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 20892 USA; [Thompson, Bethtrice] Clark Atlanta Univ, Ctr Canc Res & Therapeut Dev, Atlanta, GA 30314 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Clark Atlanta University	Varticovski, L (corresponding author), NCI, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 20892 USA.	varticol@mail.nih.gov		Varticovski, Lyuba/0000-0002-5105-9008	Intramural NIH program; NATIONAL CANCER INSTITUTE [ZIABC005450] Funding Source: NIH RePORTER	Intramural NIH program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Government funding was provided: Intramural NIH program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2015, BONE, V70, P28, DOI 10.1016/j.bone.2014.07.028; Astuti D, 2012, NAT GENET, V44, P277, DOI 10.1038/ng.1071; Aubin J E, 2001, Rev Endocr Metab Disord, V2, P81, DOI 10.1023/A:1010011209064; Baek S, 2012, METHODS MOL BIOL, V833, P433, DOI 10.1007/978-1-61779-477-3_26; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Benisch P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045142; Biddie SC, 2010, TRENDS ENDOCRIN MET, V21, P3, DOI 10.1016/j.tem.2009.08.006; Chen Y, 2012, STEM CELLS DEV, V21, P143, DOI 10.1089/scd.2010.0585; Cohnheim J, 2015, PATH ANAT PHYSL KLIN, V40, P1; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Gifre L, 2013, BONE, V57, P272, DOI 10.1016/j.bone.2013.08.016; Hakelien AM, 2014, STEM CELLS, V32, P2780, DOI 10.1002/stem.1759; HARRIS SA, 1995, J BONE MINER RES, V10, P178; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Inoue K, 2014, J BONE MINER RES, V29, P1823, DOI 10.1002/jbmr.2229; John S, 2013, CURR PROTOC MOL BIOL, P1; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Keogh MB, 2011, BIOTECHNOL BIOENG, V108, P1203, DOI 10.1002/bit.23032; Kim DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083363; Kim EK, 2012, J CELL PHYSIOL, V227, P1680, DOI 10.1002/jcp.22892; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Kuriwaka-Kido R, 2013, ENDOCRINOLOGY, V154, P1156, DOI 10.1210/en.2013-1915; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Maes C, 2013, CALCIFIED TISSUE INT, V92, P307, DOI 10.1007/s00223-012-9689-z; Matsumoto T, 2012, ENDOCR J, V59, P91, DOI 10.1507/endocrj.EJ11-0219; Meyer MB, 2014, J BIOL CHEM, V289, P16016, DOI 10.1074/jbc.M114.552216; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Ohnaka K, 2004, BIOCHEM BIOPH RES CO, V318, P259, DOI 10.1016/j.bbrc.2004.04.025; Pregizer S, 2008, J CELL BIOCHEM, V105, P965, DOI 10.1002/jcb.21900; Przekora A, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/1/015009; Puc J, 2015, CELL, V160, P367, DOI 10.1016/j.cell.2014.12.023; Rawadi G, 2005, EXPERT OPIN THER TAR, V9, P1063, DOI 10.1517/14728222.9.5.1063; Siersbaek R, 2011, COLD SPRING HARB PER, V3, P1; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Tassabehji M, 2008, HUM MUTAT, V29, P1017, DOI 10.1002/humu.20741; van der Deen M, 2012, J BIOL CHEM, V287, P4503, DOI 10.1074/jbc.M111.287771; Wu H, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r52; Yen ML, 2007, STEM CELLS, V25, P125, DOI 10.1634/stemcells.2006-0295; Yu SH, 2013, BIOCHEM BIOPH RES CO, V430, P173, DOI 10.1016/j.bbrc.2012.11.033	43	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0148619	10.1371/journal.pone.0148619	http://dx.doi.org/10.1371/journal.pone.0148619			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890492	gold, Green Published, Green Submitted			2022-12-27	WOS:000371221500010
J	Guo, YC; Sun, NY; Duan, XB; Xu, X; Zheng, LW; Seriwatanachai, D; Wang, YY; Yuan, Q				Guo, Yuchen; Sun, Ningyuan; Duan, Xiaobo; Xu, Xin; Zheng, Liwei; Seriwatanachai, Dutmanee; Wang, Yongyue; Yuan, Quan			Estrogen Deficiency Leads to Further Bone Loss in the Mandible of CKD Mice	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; OF-THE-LITERATURE; HEMODIALYSIS-PATIENTS; TITANIUM IMPLANTS; JAW ENLARGEMENT; MOUSE MODEL; OSTEOPOROSIS; RATS; HISTOMORPHOMETRY	Background Chronic kidney disease (CKD) has been regarded as a grave public health problem. Estrogen is a critical factor for both renal protection and bone remodeling. Our previous study demonstrated that CKD impairs the healing of titanium implants. The aim of this study was to investigate the effects of estrogen deficiency on the mandibular bone in CKD mice. Methods Forty eleven-week-old female C57BL mice were used in this study. Uremia and estrogen deficiency were induced by 5/6 nephrectomy and ovariectomy (OVX), respectively. After 8 weeks, the mice were sacrificed, and their mandibles were collected for micro-CT analysis and histological examination. Results All the mice survived the experimental period. Serum measurements confirmed a significant increase in BUN in the CKD group that was further increased by OVX. OVX led to significant decreases in both the BV/TV and cortical thickness of the mandibular bone in CKD mice. Conclusion In summary, our findings indicate that estrogen deficiency leads to further mandibular bone loss in CKD mice.	[Guo, Yuchen; Sun, Ningyuan; Duan, Xiaobo; Xu, Xin; Zheng, Liwei; Wang, Yongyue; Yuan, Quan] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China; [Seriwatanachai, Dutmanee] Mahidol Univ, Fac Dent, Dept Oral Biol, Bangkok 10700, Thailand	Sichuan University; Mahidol University	Wang, YY; Yuan, Q (corresponding author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China.	westchinawangyy@163.com; yuanquan@scu.edu.cn	yuan, quan/GZM-5597-2022; Seriwatanachai, Dutmanee/K-3423-2019	Seriwatanachai, Dutmanee/0000-0001-8955-1324; Xu, Xin/0000-0003-4608-4556; Yuan, Quan/0000-0002-2836-1081	National Natural Science Foundation of China (NSFC) [81371173, 81321002]; 111 project of Ministry of Education of China; Sichuan Province Youth Fund [2013JQ0017]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); 111 project of Ministry of Education of China(Ministry of Education, China - 111 Project); Sichuan Province Youth Fund	This work was supported by grants from the National Natural Science Foundation of China (NSFC 81371173, 81321002) (http://www.nsfc.gov.cn/), 111 project of Ministry of Education of China, and Sichuan Province Youth Fund (2013JQ0017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MR, 2013, AM J NEPHROL, V38, P458, DOI 10.1159/000356335; Barreto FC, 2006, KIDNEY INT, V69, P1852, DOI 10.1038/sj.ki.5000311; Bayraktar G, 2007, ORAL DIS, V13, P393, DOI 10.1111/j.1601-0825.2006.01297.x; Carrillo-Lopez N, 2009, J AM SOC NEPHROL, V20, P2009, DOI 10.1681/ASN.2008121258; Cauley JA, 2015, STEROIDS A, V99, P11, DOI [10.1016/j.steroids.2014.12.010, DOI 10.1016/J.STEROIDS.2014.12.010]; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Diaz MN, 2007, BONE, V41, P614, DOI 10.1016/j.bone.2007.06.026; GAGNON RF, 1988, UROL RES, V16, P119, DOI 10.1007/BF00261969; Gal-Moscovici A, 2007, ADV CHRONIC KIDNEY D, V14, P27, DOI 10.1053/j.ackd.2006.10.010; Giro G, 2008, ORAL SURG ORAL MED O, V105, P162, DOI 10.1016/j.tripleo.2007.06.010; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Gross ML, 2004, J AM SOC NEPHROL, V15, P348, DOI 10.1097/01.ASN.0000105993.63023.D8; Holley JL, 2001, SEMIN DIALYSIS, V14, P146, DOI 10.1046/j.1525-139X.2001.00040.x; Hutchens MP, 2012, AM J PHYSIOL-RENAL, V303, pF377, DOI 10.1152/ajprenal.00354.2011; Imai Yuuki, 2014, Clin Calcium, V24, P815, DOI CliCa1406815819; Cervero AJ, 2008, MED ORAL PATOL ORAL, V13, pE419; Kalyvas D, 2004, ORAL SURG ORAL MED O, V97, P68, DOI 10.1016/S1079-2104(03)00381-0; Kimura Genjiro, 2007, Clin Exp Nephrol, V11, P188, DOI 10.1007/s10157-007-0474-7; Kummer S, 2012, PEDIATR NEPHROL, V27, P1213, DOI 10.1007/s00467-011-1963-1; Lasota A, 2004, Rocz Akad Med Bialymst, V49 Suppl 1, P129; Lee MM, 2010, J PERIODONTOL, V81, P300, DOI 10.1902/jop.2009.090379; Lerman MA, 2012, OR SURG OR MED OR PA, V113, P384, DOI 10.1016/j.tripleo.2011.04.039; Maeda SS, 2014, ARQ BRAS ENDOCRINOL, V58, P162, DOI 10.1590/0004-2730000003039; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Neugarten J, 2002, J AM SOC NEPHROL, V13, P2807, DOI 10.1097/01.ASN.0000035846.89753.D4; Nociti FH, 2002, J DENT RES, V81, P817, DOI 10.1177/154405910208101204; RICHELSON LS, 1984, NEW ENGL J MED, V311, P1273, DOI 10.1056/NEJM198411153112002; Riggs BL, 2002, NOVART FDN SYMP, V242, P247; Schober HC, 1998, J AM SOC NEPHROL, V9, P1225; Tarrass F, 2008, HEMODIAL INT, V12, P316, DOI 10.1111/j.1542-4758.2008.00273.x; Tateishi H, 2013, INT J ORAL MAX IMPL, V28, pE252, DOI 10.11607/jomi.te05; Thorman R, 2009, SCAND J UROL NEPHROL, V43, P154, DOI 10.1080/00365590802464817; Weisinger JR, 2000, KIDNEY INT, V58, P331, DOI 10.1046/j.1523-1755.2000.00170.x; Yang J, 2005, J DENT, V33, P123, DOI 10.1016/j.jdent.2004.09.001; Yang J, 2003, DENTOMAXILLOFAC RAD, V32, P247, DOI 10.1259/dmfr/12560890; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhang S, 2015, OSTEOPOROSIS INT, V26, P1073, DOI 10.1007/s00198-014-2952-6; Zhao D, 2014, J PERIODONTOL, V85, P1515, DOI 10.1902/jop.2014.140119; Zou HW, 2013, BONE, V56, P410, DOI 10.1016/j.bone.2013.07.014	41	9	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148804	10.1371/journal.pone.0148804	http://dx.doi.org/10.1371/journal.pone.0148804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886008	Green Submitted, Green Published, gold			2022-12-27	WOS:000371218400050
J	Kornfeld, SF; Lynch-Godrei, A; Bonin, SR; Gibeault, S; De Repentigny, Y; Kothary, R				Kornfeld, Samantha F.; Lynch-Godrei, Anisha; Bonin, Sawyer R.; Gibeault, Sabrina; De Repentigny, Yves; Kothary, Rashmi			Cytoskeletal Linker Protein Dystonin Is Not Critical to Terminal Oligodendrocyte Differentiation or CNS Myelination	PLOS ONE			English	Article							SCHWANN-CELLS; PROCESS OUTGROWTH; NERVOUS-SYSTEM; BPAG1 LOCUS; ACTIN; NEURONS; KINASE; MACF; REGENERATION; EXPRESSION	Oligodendrocyte differentiation and central nervous system myelination require massive reorganization of the oligodendrocyte cytoskeleton. Loss of specific actin-and tubulin-organizing factors can lead to impaired morphological and/or molecular differentiation of oligodendrocytes, resulting in a subsequent loss of myelination. Dystonin is a cytoskeletal linker protein with both actin-and tubulin-binding domains. Loss of function of this protein results in a sensory neuropathy called Hereditary Sensory Autonomic Neuropathy VI in humans and dystonia musculorum in mice. This disease presents with severe ataxia, dystonic muscle and is ultimately fatal early in life. While loss of the neuronal isoforms of dystonin primarily leads to sensory neuron degeneration, it has also been shown that peripheral myelination is compromised due to intrinsic Schwann cell differentiation abnormalities. The role of this cytoskeletal linker in oligodendrocytes, however, remains unclear. We sought to determine the effects of the loss of neuronal dystonin on oligodendrocyte differentiation and central myelination. To address this, primary oligodendrocytes were isolated from a severe model of dystonia musculorum, Dst(dt-27J), and assessed for morphological and molecular differentiation capacity. No defects could be discerned in the differentiation of Dst(dt-27J) oligodendrocytes relative to oligodendrocytes from wild-type littermates. Survival was also compared between Dst(dt-27J) and wild-type oligodendrocytes, revealing no significant difference. Using a recently developed migration assay, we further analysed the ability of primary oligodendrocyte progenitor cell motility, and found that Dst(dt-27J) oligodendrocyte progenitor cells were able to migrate normally. Finally, in vivo analysis of oligodendrocyte myelination was done in phenotype-stage optic nerve, cerebral cortex and spinal cord. The density of myelinated axons and g-ratios of Dst(dt-27J) optic nerves was normal, as was myelin basic protein expression in both cerebral cortex and spinal cord. Together these data suggest that, unlike Schwann cells, oligodendrocytes do not have an intrinsic requirement for neuronal dystonin for differentiation and myelination.	[Kornfeld, Samantha F.; Lynch-Godrei, Anisha; Bonin, Sawyer R.; Gibeault, Sabrina; De Repentigny, Yves; Kothary, Rashmi] Ottawa Hosp, Res Inst, Regenerat Med Program, Ottawa, ON K1H 8L6, Canada; [Kornfeld, Samantha F.; Lynch-Godrei, Anisha; Kothary, Rashmi] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Kothary, Rashmi] Univ Ottawa, Dept Med, Ottawa, ON K1H 8M5, Canada; [Kothary, Rashmi] Univ Ottawa, Ctr Neuromuscular Dis, Ottawa, ON K1H 8M5, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa	Kothary, R (corresponding author), Ottawa Hosp, Res Inst, Regenerat Med Program, Ottawa, ON K1H 8L6, Canada.; Kothary, R (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada.; Kothary, R (corresponding author), Univ Ottawa, Dept Med, Ottawa, ON K1H 8M5, Canada.; Kothary, R (corresponding author), Univ Ottawa, Ctr Neuromuscular Dis, Ottawa, ON K1H 8M5, Canada.	rkothary@ohri.ca		Kothary, Rashmi/0000-0002-9239-7310; Kornfeld, Samantha F./0000-0002-2372-2626; Lynch-Godrei, Anisha/0000-0001-5195-3264	Canadian Institutes of Health Research [MOP-126085]; Frederick Banting and Charles Best Canadian Institutes of Health Research Doctoral Studentship [CGSD-291473, CGSM-136195]; Natural Sciences and Engineering Research Council [USRA-472230]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Frederick Banting and Charles Best Canadian Institutes of Health Research Doctoral Studentship(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This project was funded by a grant from the Canadian Institutes of Health Research (MOP-126085) to RK. SFK was supported by a Frederick Banting and Charles Best Canadian Institutes of Health Research Doctoral Studentship (CGSD-291473), ALG was supported by a Frederick Banting and Charles Best Canadian Institutes of Health Research Master's Studentship (CGSM-136195), and SRB was a recipient of a Natural Sciences and Engineering Research Council Undergraduate Student Research Award (USRA-472230).	Bacon C, 2007, GLIA, V55, P844, DOI 10.1002/glia.20505; Bauer NG, 2009, GLIA, V57, P1691, DOI 10.1002/glia.20885; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Bernier G, 1995, MOL CELL NEUROSCI, V6, P509, DOI 10.1006/mcne.1995.0003; Bernier G, 1998, DEVELOPMENT, V125, P2135; Bernier G, 1996, GENOMICS, V38, P19, DOI 10.1006/geno.1996.0587; Bernier G, 2000, DEV DYNAM, V219, P216, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1041>3.0.CO;2-O; BROWN A, 1995, GENOMICS, V29, P777, DOI 10.1006/geno.1995.9936; BROWN A, 1995, NAT GENET, V10, P301, DOI 10.1038/ng0795-301; BUNGE RP, 1989, J CELL BIOL, V109, P273, DOI 10.1083/jcb.109.1.273; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Dalpe G, 1998, MOL CELL NEUROSCI, V10, P243, DOI 10.1006/mcne.1997.0660; De Repentigny Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021093; Edvardson S, 2012, ANN NEUROL, V71, P569, DOI 10.1002/ana.23524; Fancy SPJ, 2011, ANNU REV NEUROSCI, V34, P21, DOI 10.1146/annurev-neuro-061010-113629; Ferrier A, 2013, INT REV CEL MOL BIO, V300, P85, DOI 10.1016/B978-0-12-405210-9.00003-5; Forrest AD, 2009, J NEUROSCI RES, V87, P3456, DOI 10.1002/jnr.22022; Franklin RJM, 1999, J NEUROSCI RES, V58, P207, DOI 10.1002/(SICI)1097-4547(19991015)58:2<207::AID-JNR1>3.0.CO;2-1; Karakesisoglou I, 2000, J CELL BIOL, V149, P195, DOI 10.1083/jcb.149.1.195; Kim HJ, 2006, J NEUROSCI, V26, P5849, DOI 10.1523/JNEUROSCI.4921-05.2006; Klein C, 2002, J NEUROSCI, V22, P698, DOI 10.1523/JNEUROSCI.22-03-00698.2002; Lee J, 2005, J CELL BIOL, V170, P661, DOI 10.1083/jcb.200411047; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Lehotzky A, 2010, GLIA, V58, P157, DOI 10.1002/glia.20909; Leung CL, 1999, J CELL BIOL, V147, P1275, DOI 10.1083/jcb.147.6.1275; Leung CL, 1999, J CELL BIOL, V144, P435, DOI 10.1083/jcb.144.3.435; Leung CL, 2001, J CELL BIOL, V154, P691, DOI 10.1083/jcb.200012098; Monteiro de Castro G, 2015, AM J PATHOL AM SOC I, V185, P1; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; O'Meara RW, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0242-2; O'Meara RW, 2013, J NEUROSCI, V33, P9781, DOI 10.1523/JNEUROSCI.5582-12.2013; O'Meara RW, 2011, JOVE-J VIS EXP, DOI 10.3791/3324; O'Meara Ryan W, 2011, J Signal Transduct, V2011, P354091, DOI 10.1155/2011/354091; Okumura M, 2002, J BIOL CHEM, V277, P6682, DOI 10.1074/jbc.M109209200; Pellegatta M, 2013, J NEUROSCI, V33, P17995, DOI 10.1523/JNEUROSCI.3179-13.2013; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Poliakova K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107535; Pool M, 2005, MAMM GENOME, V16, P909, DOI 10.1007/s00335-005-0073-4; Ryan SD, 2012, J CELL BIOL, V196, P727, DOI 10.1083/jcb.201107096; Saulnier R, 2002, J NEUROSCI RES, V69, P233, DOI 10.1002/jnr.10289; SAWAMURA D, 1991, J BIOL CHEM, V266, P17784; Simons M, 2014, J CELL BIOL, V206, P335, DOI 10.1083/jcb.201404154; Triolo D, 2012, DEVELOPMENT, V139, P1359, DOI 10.1242/dev.072371; Tsiper MV, 2002, J CELL SCI, V115, P1005; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002	46	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149201	10.1371/journal.pone.0149201	http://dx.doi.org/10.1371/journal.pone.0149201			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886550	gold, Green Published, Green Submitted			2022-12-27	WOS:000371218400066
J	Pinar, G; Dalnodar, D; Voitl, C; Reschreiter, H; Sterflinger, K				Pinar, Guadalupe; Dalnodar, Dennis; Voitl, Christian; Reschreiter, Hans; Sterflinger, Katja			Biodeterioration Risk Threatens the 3100 Year Old Staircase of Hallstatt (Austria): Possible Involvement of Halophilic Microorganisms	PLOS ONE			English	Article							SP-NOV.; MOLECULAR CHARACTERIZATION; CAPUCHIN CATACOMBS; WALL PAINTINGS; IDENTIFICATION; COMMUNITIES; DIVERSITY; BACTERIA; ART; STRAINS	Background The prosperity of Hallstatt (Salzkammergut region, Austria) is based on the richness of salt in the surrounding mountains and salt mining, which is documented as far back as 1500 years B.C. Substantial archaeological evidence of Bronze and Iron Age salt mining has been discovered, with a wooden staircase (1108 B.C.) being one of the most impressive and well preserved finds. However, after its discovery, fungal mycelia have been observed on the surface of the staircase, most probably due to airborne contamination after its find. Objective As a basis for the further preservation of this valuable object, the active micro-flora was examined to investigate the presence of potentially biodegradative microorganisms. Results Most of the strains isolated from the staircase showed to be halotolerant and halophilic microorganisms, due to the saline environment of the mine. Results derived from culture-dependent assays revealed a high fungal diversity, including both halotolerant and halophilic fungi, the most dominant strains being members of the genus Phialosimplex (synonym: Aspergillus). Additionally, some typical cellulose degraders, namely Stachybotrys sp. and Cladosporium sp. were detected. Numerous bacterial strains were isolated and identified as members of 12 different genera, most of them being moderately halophilic species. The most dominant isolates affiliated with species of the genera Halovibrio and Marinococcus. Halophilic archaea were also isolated and identified as species of the genera Halococcus and Halorubrum. Molecular analyses complemented the cultivation assays, enabling the identification of some uncultivable archaea of the genera Halolamina, Haloplanus and Halobacterium. Results derived from fungi and bacteria supported those obtained by cultivation methods, exhibiting the same dominant members in the communities. Conclusion The results clearly showed the presence of some cellulose degraders that may become active if the requirements for growth and the environmental conditions turn suitable; therefore, these microorganisms must be regarded as a threat to the wood.	[Pinar, Guadalupe; Dalnodar, Dennis; Voitl, Christian; Sterflinger, Katja] Univ Nat Resources & Life Sci, VIBT, Dept Biotechnol, Vienna, Austria; [Reschreiter, Hans] Museum Nat Hist, Prehist Dept, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna	Pinar, G (corresponding author), Univ Nat Resources & Life Sci, VIBT, Dept Biotechnol, Vienna, Austria.	guadalupe.pinar@boku.ac.at	Pinar, Guadalupe/I-8959-2016	Pinar, Guadalupe/0000-0001-7881-8572; Reschreiter, Hans/0000-0003-0337-5660; Sterflinger, Katja/0000-0002-0296-6728				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ausubel FM, 1991, CURRENT PROTOCOLS MO; Bauer MW, 1999, J BACTERIOL, V181, P284, DOI 10.1128/JB.181.1.284-290.1999; Berrada I, 2012, AFR J MICROBIOL RES, V6, P2419, DOI 10.5897/AJMR-11-1490; Birbir M, 2004, WORLD J MICROB BIOT, V20, P613, DOI 10.1023/B:WIBI.0000043185.06176.b8; Birbir M, 2007, WORLD J MICROB BIOT, V23, P309, DOI 10.1007/s11274-006-9223-4; Du HL, 2006, FEMS MICROBIOL ECOL, V57, P92, DOI 10.1111/j.1574-6941.2006.00090.x; Echigo A, 2012, INT J SYST EVOL MICR, V62, P289, DOI 10.1099/ijs.0.028506-0; Greiner K, 2014, IMA FUNGUS, V5, P161, DOI 10.5598/imafungus.2014.05.02.01; Gromer K., 2013, TEXTILES HALLSTATT, P13; Gunde-Cimerman N, 2000, FEMS MICROBIOL ECOL, V32, P235; Gunde-Cimerman N, 2009, MYCOL RES, V113, P1231, DOI 10.1016/j.mycres.2009.09.002; Hamada M, 2013, INT J SYST EVOL MICR, V63, P3687, DOI 10.1099/ijs.0.051532-0; Heuer H, 1999, APPL ENVIRON MICROB, V65, P1045; Kern A, 2008, 7000 JAHRE HALLSTATT; Krakova L, 2012, LETT APPL MICROBIOL, V54, P433, DOI 10.1111/j.1472-765X.2012.03227.x; Laiz L, 2009, NATURWISSENSCHAFTEN, V96, P71, DOI 10.1007/s00114-008-0452-2; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Limauro D, 2001, EXTREMOPHILES, V5, P213, DOI 10.1007/s007920100200; Michaelsen A, 2006, INT BIODETER BIODEGR, V58, P133, DOI 10.1016/j.ibiod.2006.06.019; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; NEEFS JM, 1990, NUCLEIC ACIDS RES, V18, P2237, DOI 10.1093/nar/18.suppl.2237; Nguyen HDT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120894; ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225; Pangallo D, 2007, LETT APPL MICROBIOL, V45, P87, DOI 10.1111/j.1472-765X.2007.02138.x; Pinar G, 2014, EXTREMOPHILES, V18, P677, DOI 10.1007/s00792-014-0649-6; Pinar G, 2001, FEMS MICROBIOL ECOL, V37, P45, DOI 10.1016/S0168-6496(01)00144-1; Pinar G, 2015, ENVIRON MICROBIOL, V17, P427, DOI 10.1111/1462-2920.12471; Pinar G, 2013, FEMS MICROBIOL ECOL, V86, P341, DOI 10.1111/1574-6941.12165; RASKIN L, 1994, APPL ENVIRON MICROB, V60, P1232, DOI 10.1128/AEM.60.4.1232-1240.1994; Ravindran C, 2012, MICROB PATHOGENESIS, V53, P168, DOI 10.1016/j.micpath.2012.07.004; Ripka K, 2006, INT BIODETER BIODEGR, V58, P124, DOI 10.1016/j.ibiod.2006.05.004; Saiz-Jimenez C, 2011, SCIENCE, V334, P42, DOI 10.1126/science.1206788; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Samson RA, 2014, STUD MYCOL, P141, DOI 10.1016/j.simyco.2014.07.004; Samson R. A., 2010, CBS LAB MANUAL SERIE, V2; Sanchez-Porro C, 2003, J APPL MICROBIOL, V94, P295, DOI 10.1046/j.1365-2672.2003.01834.x; Schabereiter-Gurtner C, 2001, J MICROBIOL METH, V45, P77, DOI 10.1016/S0167-7012(01)00227-5; Sert HB, 2010, MYCOL PROG, V9, P353, DOI 10.1007/s11557-009-0643-z; Sigler L, 2010, MED MYCOL, V48, P335, DOI 10.3109/13693780903225805; Spring S, 1996, INT J SYST BACTERIOL, V46, P492, DOI 10.1099/00207713-46-2-492; Stan-Lotter H, 1999, MICROBIOL-SGM, V145, P3565, DOI 10.1099/00221287-145-12-3565; Sterflinger K, 2013, APPL MICROBIOL BIOT, V97, P9637, DOI 10.1007/s00253-013-5283-1; TOMLINSON GA, 1976, CAN J MICROBIOL, V22, P587, DOI 10.1139/m76-087; Ventosa A, 1998, EXTREMOPHILES, V2, P297, DOI 10.1007/s007920050072; von Reschreiter H., 2014, OSTERREICHISCHE Z KU, V3, P354; WELSH J, 1990, NUCLEIC ACIDS RES, V18, P7213, DOI 10.1093/nar/18.24.7213; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531; Yoon JH, 2005, INT J SYST EVOL MICR, V55, P1007, DOI 10.1099/ijs.0.63464-0; Yoon JH, 2010, INT J SYST EVOL MICR, V60, P291, DOI 10.1099/ijs.0.009837-0; Yun JH, 2011, INT J SYST EVOL MICR, V61, P286, DOI 10.1099/ijs.0.021469-0; Zalar P, 2005, ANTON LEEUW INT J G, V87, P311, DOI 10.1007/s10482-004-6783-x; Zotti M, 2008, INT BIODETER BIODEGR, V62, P186, DOI 10.1016/j.ibiod.2008.01.005; Zyska B, 1997, INT BIODETER BIODEGR, V40, P43, DOI 10.1016/S0964-8305(97)00061-9	55	26	26	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148279	10.1371/journal.pone.0148279	http://dx.doi.org/10.1371/journal.pone.0148279			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885815	Green Published, gold, Green Submitted			2022-12-27	WOS:000371218400027
J	Teixidor, P; Arraez, MA; Villalba, G; Garcia, R; Tardaguila, M; Gonzalez, JJ; Rimbau, J; Vidal, X; Montane, E				Teixidor, Pilar; Angel Arraez, Miguel; Villalba, Gloria; Garcia, Roser; Tardaguila, Manel; Jose Gonzalez, Juan; Rimbau, Jordi; Vidal, Xavier; Montane, Eva			Safety and Efficacy of 5-Aminolevulinic Acid for High Grade Glioma in Usual Clinical Practice: A Prospective Cohort Study	PLOS ONE			English	Article							ADJUVANT TEMOZOLOMIDE; PHASE-III; RESECTION; GLIOBLASTOMA; SURVIVAL; FLUORESCENCE; EPIDEMIOLOGY; RADIOTHERAPY; CONCOMITANT; EXTENT	Background During the last decade, the use of 5-aminolevulinic acid (5-ALA) has been steadily increasing in neurosurgery. The study's main objectives were to prospectively evaluate the effectiveness and safety of 5-ALA when used in clinical practice setting on high-grade gliomas' patients. Methods National, multicenter and prospective observational study. Inclusion criteria: authorized conditions of use of 5-ALA. Exclusion criteria: contraindication to 5-ALA, inoperable or partial resected tumors, pregnancy and children. Epidemiological, clinical, laboratory, radiological, and safety data were collected. Effectiveness was assessed using complete resection of the tumor, and progression-free and overall survival probabilities. Results Between May 2010 and September 2014, 85 patients treated with 5-ALA were included, and 77 were suitable for the effectiveness analysis. Complete resection was achieved in 41 patients (54%). Surgeons considered suboptimal the fluorescence of 5-ALA in 40% of the patients assessed. The median duration of follow-up was 12.3 months. The progression-free survival probability at 6 months was 58%. The median duration overall survival was 14.2 months. Progression tumor risk factors were grade of glioma, age and resection degree; and death risk factors were grade of glioma and gender. No severe adverse effects were reported. At one month after surgery, new or increased neurological morbidity was 6.5%. Hepatic enzymes were frequently increased within the first month after surgery; however, they subsequently normalized, and this was found to have no clinical significance. Conclusion In clinical practice, the 5-ALA showed a good safety profile, but the benefits related to 5-ALA have not been yet clearly shown. The improved differentiation expected by fluorescence between normal and tumor cerebral tissue was suboptimal in a relevant number of patients; in addition, the expected higher degree of resection was lower than in clinical trials as well as incomplete resection was not identified as a prognostic factor risk for death. Because optimal fluorescence was correlated to higher complete resection rate, further research is needed to identify patients (or tumors) with more surgery benefits when using the 5-ALA.	[Teixidor, Pilar; Garcia, Roser; Tardaguila, Manel; Rimbau, Jordi] Hosp Badalona Germans Trias & Pujol, Dept Neurosurg, Barcelona, Spain; [Angel Arraez, Miguel] Hosp Carlos Haya, Dept Neurosurg, Malaga, Spain; [Villalba, Gloria] Hosp del Mar, Dept Neurosurg, Barcelona, Spain; [Jose Gonzalez, Juan] Hosp Clin I Prov Barcelona, Dept Neurosurg, Barcelona, Spain; [Vidal, Xavier] Hosp Univ Vall dHebron, Fundacio Inst Catala Farmacol, Barcelona, Spain; [Vidal, Xavier; Montane, Eva] Univ Autonoma Barcelona, Dept Pharmacol Therapeut & Toxicol, E-08193 Barcelona, Spain; [Montane, Eva] Hosp Badalona Germans Trias & Pujol, Dept Clin Pharmacol, Barcelona, Spain	Hospital Germans Trias i Pujol; Hospital Carlos Haya; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Germans Trias i Pujol	Montane, E (corresponding author), Univ Autonoma Barcelona, Dept Pharmacol Therapeut & Toxicol, E-08193 Barcelona, Spain.; Montane, E (corresponding author), Hosp Badalona Germans Trias & Pujol, Dept Clin Pharmacol, Barcelona, Spain.	emontane.germanstrias@gencat.cat	Vidal, Xavier/I-5958-2019; Eva, Montané/O-5164-2019	Vidal, Xavier/0000-0001-6705-4298; Eva, Montané/0000-0002-1691-7652; Garcia-Armengol, Roser/0000-0002-9315-0985	Spanish Ministry of Health [TRA-085, SAS 2481/2009, EC11-040, SPI 2885/2011]	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government)	Funding for this work was provided by the Spanish Ministry of Health (through two research projects which codes were: TRA-085 [convocatoria de ayudas para el fomento de la traslacion de la aplicacion de terapeutica de medicamentos de uso humano, huerfanos y terapias avanzadas de la Orden Ministerial SAS 2481/2009] and EC11-040 [convocatoria de ayudas para la investigacion clinica independiente de la Orden Ministerial SPI 2885/2011]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chaichana KL, 2014, NEURO-ONCOLOGY, V16, P113, DOI 10.1093/neuonc/not137; Chung IWH, 2013, PHOTODIAGN PHOTODYN, V10, P362, DOI 10.1016/j.pdpdt.2013.03.007; Crocetti E, 2012, EUR J CANCER, V48, P1532, DOI 10.1016/j.ejca.2011.12.013; Della Puppa A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/232561; Valle RD, 2014, NEUROLOGIA, V29, P131, DOI 10.1016/j.nrl.2013.05.004; Valle RD, 2011, J NEURO-ONCOL, V102, P105, DOI 10.1007/s11060-010-0296-4; Eljamel S, 2015, INT J MOL SCI, V16, P10443, DOI 10.3390/ijms160510443; Henegar MM, 1996, J NEUROSURG, V84, P174, DOI 10.3171/jns.1996.84.2.0174; Honorato-Cia C, 2015, J NEUROSURG ANESTH, V27, P304, DOI 10.1097/ANA.0000000000000172; MacLehose R R, 2000, Health Technol Assess, V4, P1; Orringer D, 2012, J NEUROSURG, V117, P851, DOI 10.3171/2012.8.JNS12234; Sanai N, 2011, REV NEUROL-FRANCE, V167, P648, DOI 10.1016/j.neurol.2011.07.004; Schucht P, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14082; Song JW, 2010, PLAST RECONSTR SURG, V126, P2234, DOI 10.1097/PRS.0b013e3181f44abc; Stark AM, 2012, CLIN NEUROL NEUROSUR, V114, P840, DOI 10.1016/j.clineuro.2012.01.026; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stummer W, 1998, J PHOTOCH PHOTOBIO B, V45, P160, DOI 10.1016/S1011-1344(98)00176-6; Stummer W, 2011, J NEUROSURG, V114, P613, DOI 10.3171/2010.3.JNS097; Stummer W, 2009, CURR OPIN NEUROL, V22, P645, DOI 10.1097/WCO.0b013e3283320165; Stupp R, 2014, ANN ONCOL, V25, P93, DOI 10.1093/annonc/mdu050; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Valdes PA, 2011, J NEUROSURG, V115, P11, DOI 10.3171/2011.2.JNS101451; Vandenbroucke JP, 2007, PLOS MED, V4, P1628, DOI 10.1371/journal.pmed.0040297; Zhao SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063682	25	53	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149244	10.1371/journal.pone.0149244	http://dx.doi.org/10.1371/journal.pone.0149244			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885645	Green Published, gold, Green Submitted			2022-12-27	WOS:000371218400070
J	Vega, JF; Vicente-Alique, E; Nunez-Ramirez, R; Wang, Y; Martinez-Salazar, J				Vega, Juan F.; Vicente-Alique, Ernesto; Nunez-Ramirez, Rafael; Wang, Yang; Martinez-Salazar, Javier			Evidences of Changes in Surface Electrostatic Charge Distribution during Stabilization of HPV16 Virus-Like Particles	PLOS ONE			English	Article							PAPILLOMAVIRUS TYPE-16 L1; DYNAMIC LIGHT-SCATTERING; BOVINE SERUM-ALBUMIN; ELECTROPHORETIC MOBILITY; MONOCLONAL-ANTIBODIES; IONIC-STRENGTH; PROTEIN; CAPSIDS; BACTERIOPHAGE-MS2; RECONSTRUCTION	The stabilization of human papillomavirus type 16 virus-like particles has been examined by means of different techniques including dynamic and static light scattering, transmission electron microscopy and electrophoretic mobility. All these techniques provide different and often complementary perspectives about the aggregation process and generation of stabilized virus-like particles after a period of time of 48 hours at a temperature of 298 K. Interestingly, static light scattering results point towards a clear colloidal instability in the initial systems, as suggested by a negative value of the second virial coefficient. This is likely related to small repulsive electrostatic interactions among the particles, and in agreement with relatively small absolute values of the electrophoretic mobility and, hence, of the net surface charges. At this initial stage the small repulsive interactions are not able to compensate binding interactions, which tend to aggregate the particles. As time proceeds, an increase of the size of the particles is accompanied by strong increases, in absolute values, of the electrophoretic mobility and net surface charge, suggesting enhanced repulsive electrostatic interactions and, consequently, a stabilized colloidal system. These results show that electrophoretic mobility is a useful methodology that can be applied to screen the stabilization factors for virus-like particles during vaccine development.	[Vega, Juan F.; Vicente-Alique, Ernesto; Nunez-Ramirez, Rafael; Martinez-Salazar, Javier] CSIC, IEM, Biophym, Dept Fis Macromol, Madrid, Spain; [Wang, Yang] Sino Biol Inc, Beijing, Peoples R China	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Estructura de la Materia (IEM)	Vega, JF (corresponding author), CSIC, IEM, Biophym, Dept Fis Macromol, Madrid, Spain.	jf.vega@csic.es	martinez-salazar, javier/H-9763-2015; Vega, Juan F/C-2087-2011	martinez-salazar, javier/0000-0003-0755-0155; Vega, Juan F/0000-0002-0377-4410; Nunez, Rafael/0000-0002-2949-8709	Spanish Ministry of Economy and Competitiveness (MINECO) [MAT2012-36341]; CSIC [PIE201360E097]; Sino Biological, Inc.	Spanish Ministry of Economy and Competitiveness (MINECO); CSIC; Sino Biological, Inc.	This research work was supported by Spanish Ministry of Economy and Competitiveness (MINECO), Project MAT2012-36341, and by the CSIC, Project PIE201360E097. Sino Biological, Inc., provided support in the form of salaries for author YW, but did not have any additional role, such as in the study design or data collection.	BAKER TS, 1991, BIOPHYS J, V60, P1445, DOI 10.1016/S0006-3495(91)82181-6; Belnap DM, 1996, J MOL BIOL, V259, P249, DOI 10.1006/jmbi.1996.0317; Berne B. J., 2000, DYNAMIC LIGHT SCATTE; Bozic AL, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4790576; Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Buck CB, 2008, J VIROL, V82, P5190, DOI 10.1128/JVI.02726-07; CANN PL, 1994, FEMS MICROBIOL LETT, V117, P269, DOI DOI 10.1111/J.1574-6968.1994.TB06778.X; Cardone G, 2014, MBIO, V5, DOI 10.1128/mBio.01104-14; Carpentier GS, 2005, J MED VIROL, V77, P558, DOI 10.1002/jmv.20492; Casini GL, 2004, VIROLOGY, V325, P320, DOI 10.1016/j.virol.2004.04.034; Chen XJS, 2000, MOL CELL, V5, P557, DOI 10.1016/S1097-2765(00)80449-9; Christensen ND, 1996, VIROLOGY, V223, P174, DOI 10.1006/viro.1996.0466; Cook JC, 1999, PROTEIN EXPRES PURIF, V17, P477, DOI 10.1006/prep.1999.1155; Dika C, 2011, APPL ENVIRON MICROB, V77, P4939, DOI 10.1128/AEM.00407-11; Duval JFL, 2006, LANGMUIR, V22, P3533, DOI 10.1021/la0528293; Finnen RL, 2003, J VIROL, V77, P4818, DOI 10.1128/JVI.77.8.4818-4826.2003; Frisken BJ, 2001, APPL OPTICS, V40, P4087, DOI 10.1364/AO.40.004087; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hanslip SJ, 2008, BIOCHEM BIOPH RES CO, V375, P351, DOI 10.1016/j.bbrc.2008.08.019; Hassan PA, 2006, J COLLOID INTERF SCI, V300, P744, DOI 10.1016/j.jcis.2006.04.013; Itakura M, 2006, J APPL POLYM SCI, V99, P1953, DOI 10.1002/app.22695; JOHNSON MW, 1973, J GEN VIROL, V19, P263, DOI 10.1099/0022-1317-19-2-263; KIRNBAUER R, 1993, J VIROL, V67, P6929, DOI 10.1128/JVI.67.12.6929-6936.1993; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Kulski JK, 1998, VIROLOGY, V243, P275, DOI 10.1006/viro.1997.9011; Kuznetsov YG, 2011, MICROBIOL MOL BIOL R, V75, P268, DOI 10.1128/MMBR.00041-10; Langlet J, 2008, BIOPHYS J, V94, P3293, DOI 10.1529/biophysj.107.115477; Leckband D, 2000, ANNU REV BIOPH BIOM, V29, P1, DOI 10.1146/annurev.biophys.29.1.1; Lua LHL, 2014, BIOTECHNOL BIOENG, V111, P425, DOI 10.1002/bit.25159; Ma YF, 2015, J BIOL PHYS, V41, P85, DOI 10.1007/s10867-014-9367-7; Mach H, 2006, J PHARM SCI-US, V95, P2195, DOI 10.1002/jps.20696; MCMILLAN WG, 1945, J CHEM PHYS, V13, P276, DOI 10.1063/1.1724036; Mertens BS, 2015, SOFT MATTER, V11, P8621, DOI 10.1039/c5sm01778e; Michen B, 2010, J APPL MICROBIOL, V109, P388, DOI 10.1111/j.1365-2672.2010.04663.x; Modis Y, 2002, EMBO J, V21, P4754, DOI 10.1093/emboj/cdf494; Neal BL, 1998, BIOPHYS J, V75, P2469, DOI 10.1016/S0006-3495(98)77691-X; Nguyen TH, 2011, SOFT MATTER, V7, P10449, DOI 10.1039/c1sm06092a; PENROD SL, 1995, J COLLOID INTERF SCI, V173, P521, DOI 10.1006/jcis.1995.1354; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4; Siber A, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.061906; STIGTER D, 1959, J PHYS CHEM-US, V63, P551, DOI 10.1021/j150574a025; TAYLOR DH, 1981, J COLLOID INTERF SCI, V83, P153, DOI 10.1016/0021-9797(81)90020-5; THOMAS JC, 1987, J COLLOID INTERF SCI, V117, P187, DOI 10.1016/0021-9797(87)90182-2; Trus BL, 1997, NAT STRUCT BIOL, V4, P413, DOI 10.1038/nsb0597-413; van der Schoot P, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061928; VANREGEN.MH, 1967, VIROLOGY, V31, P391, DOI 10.1016/0042-6822(67)90217-6; Vega-Acosta JR, 2014, J PHYS CHEM B, V118, P1984, DOI 10.1021/jp407379t; von Smoluchowski, 1903, B INT ACAD SCI CRACO, V8, P182; White WI, 1999, J VIROL, V73, P4882, DOI 10.1128/JVI.73.6.4882-4889.1999; Wolf M, 2010, P NATL ACAD SCI USA, V107, P6298, DOI 10.1073/pnas.0914604107; Wu JZ, 1999, FLUID PHASE EQUILIBR, V155, P139, DOI 10.1016/S0378-3812(98)00435-X; Zandi R, 2006, BIOPHYS J, V90, P1939, DOI 10.1529/biophysj.105.072975; Zhao QJ, 2012, NANOMED-NANOTECHNOL, V8, P1182, DOI 10.1016/j.nano.2012.01.007; Zhao QJ, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-52; ZIMM BH, 1948, J CHEM PHYS, V16, P1093, DOI 10.1063/1.1746738	55	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149009	10.1371/journal.pone.0149009	http://dx.doi.org/10.1371/journal.pone.0149009			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885635	gold, Green Published			2022-12-27	WOS:000371218400059
J	Ash, C; Drabek, O; Tejnecky, V; Jehlicka, J; Michon, N; Boruvka, L				Ash, Christopher; Drabek, Ondrej; Tejnecky, Vaclav; Jehlicka, Jan; Michon, Ninon; Boruvka, Lubos			Sustainable Soil Washing: Shredded Card Filtration of Potentially Toxic Elements after Leaching from Soil Using Organic Acid Solutions	PLOS ONE			English	Article							LEAD; ADSORPTION; CHROMIUM; SLUDGE; NICKEL; IMMOBILIZATION; REMEDIATION; ENVIRONMENT; COPPER; IONS	Shredded card (SC) was assessed for use as a sorbent of potentially toxic elements (PTE) carried from contaminated soil in various leachates (oxalic acid, formic acid, CaCl2, water). We further assessed SC for retention of PTE, using acidified water (pH 3.4). Vertical columns and a peristaltic pump were used to leach PTE from soils (O and A/B horizons) before passing through SC. Sorption onto SC was studied by comparing leachates, and by monitoring total PTE contents on SC before and after leaching. SC buffers against acidic soil conditions that promote metals solubility; considerable increases in solution pH (+4.49) were observed. Greatest differences in solution PTE content after leaching with/without SC occurred for Pb. In oxalic acid, As, Cd, Pb showed a high level of sorption (25, 15, and 58x more of the respective PTE in leachates without SC). In formic acid, Pb sorption was highly efficient (219x more Pb in leachate without SC). In water, only Pb showed high sorption (191x more Pb in leachate without SC). In desorption experiments, release of PTE from SC varied according to the source of PTE (organic/mineral soil), and type of solvent used. Arsenic was the PTE most readily leached in desorption experiments. Low As sorption from water was followed by fast release (70% As released from SC). A high rate of Cd sorption from organic acid solutions was followed by strong retention (similar to 12% Cd desorption). SC also retained Pb after sorption from water, with subsequent losses of <= 8.5% of total bound Pb. The proposed use of this material is for the filtration of PTE from extract solution following soil washing. Low-molecular-mass organic acids offer a less destructive, biodegradable alternative to strong inorganic acids for soil washing.	[Ash, Christopher; Drabek, Ondrej; Tejnecky, Vaclav; Michon, Ninon; Boruvka, Lubos] Czech Univ Life Sci, Fac Agrobiol Food & Nat Resources, Dept Soil Sci & Soil Protect, Prague, Czech Republic; [Jehlicka, Jan] Czech Univ Life Sci, Fac Environm Sci, Dept Environm Geosci, Prague, Czech Republic	Czech University of Life Sciences Prague; Czech University of Life Sciences Prague	Ash, C (corresponding author), Czech Univ Life Sci, Fac Agrobiol Food & Nat Resources, Dept Soil Sci & Soil Protect, Prague, Czech Republic.	ash@af.czu.cz	Tejnecký, Václav/K-9043-2013; Drábek, Ondřej/AAU-3496-2021; Boruvka, Lubos/U-8869-2019	Tejnecký, Václav/0000-0003-0296-4981; Boruvka, Lubos/0000-0001-5317-0933	Internal Grant Agency of Czech University of Life Sciences (CIGA) [20132005]; Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences in Prague	Internal Grant Agency of Czech University of Life Sciences (CIGA); Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences in Prague	The research was supported by a grant from the Internal Grant Agency of Czech University of Life Sciences (CIGA) (no. 20132005) and was also financed by a grant issued by the Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences in Prague.	Andrabi SMA, 2010, J INDIAN CHEM SOC, V87, P963; Battaglia A, 2007, BIORESOURCE TECHNOL, V98, P2993, DOI 10.1016/j.biortech.2006.10.007; Battaglia A, 2003, MICROCHEM J, V75, P97, DOI 10.1016/S0026-265X(03)00074-2; Bulut Y, 2007, J ENVIRON SCI, V19, P160, DOI 10.1016/S1001-0742(07)60026-6; Calace N, 2005, ENVIRON POLLUT, V136, P485, DOI 10.1016/j.envpol.2004.12.014; Ettler V, 2010, GEODERMA, V155, P409, DOI 10.1016/j.geoderma.2009.12.027; He XJ, 2010, J ENVIRON SCI-CHINA, V22, P413, DOI 10.1016/S1001-0742(09)60123-6; Hesse PR, 1998, TXB SOIL CHEM ANAL, P101; Houben D, 2012, J GEOCHEM EXPLOR, V123, P87, DOI 10.1016/j.gexplo.2011.10.004; Jean-Soro L, 2012, ENVIRON POLLUT, V164, P175, DOI 10.1016/j.envpol.2012.01.022; Kabata-Pendias A, 2010, TRACE ELEMENTS SOILS, Vfourth, DOI [DOI 10.1201/B10158, 10.1201/9781420039900]; Kim KH, 2013, COLLOID SURFACE A, V425, P6, DOI 10.1016/j.colsurfa.2013.02.044; Lestan D, 2008, ENVIRON POLLUT, V153, P3, DOI 10.1016/j.envpol.2007.11.015; Lodenius M., 1989, Ecological impact of acidification., P131; Meuser H, 2013, SOIL REMEDIATION REH; Nathanail C.P., 2004, RECLAMATION CONTAMIN; Novozamski I, 1993, HARMONIZATION LEACHI, V51, P47; Perelomov LV, 2011, EURASIAN SOIL SCI+, V44, P22, DOI 10.1134/S1064229311010091; Podlesakova E, 1992, 2783 RES I SOIL IMPR; Prica M, 2012, ARCH ENVIRON PROT, V38, P109, DOI 10.2478/v10265-012-0039-z; Rafatullah M, 2009, J HAZARD MATER, V170, P969, DOI 10.1016/j.jhazmat.2009.05.066; Sillerova H, 2013, J COLLOID INTERF SCI, V396, P227, DOI 10.1016/j.jcis.2013.01.029; Smith E, 1998, ADV AGRON, V64, P149, DOI 10.1016/S0065-2113(08)60504-0; Tejnecky V, 2013, SCI TOTAL ENVIRON, V442, P165, DOI 10.1016/j.scitotenv.2012.10.053; Wang F, 2002, J PULP PAP SCI, V28, P347; Wang SL, 2006, ENVIRON GEOCHEM HLTH, V28, P197, DOI 10.1007/s10653-005-9032-y	26	11	11	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149882	10.1371/journal.pone.0149882	http://dx.doi.org/10.1371/journal.pone.0149882			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900684	gold, Green Published			2022-12-27	WOS:000371276100173
J	Fernandez-Garcia, A; Delgado, E; Cuevas, MT; Vega, Y; Montero, V; Sanchez, M; Carrera, C; Lopez-Alvarez, MJ; Miralles, C; Perez-Castro, S; Cilla, G; Hinojosa, C; Perez-Alvarez, L; Thomson, MM				Fernandez-Garcia, Aurora; Delgado, Elena; Teresa Cuevas, Maria; Vega, Yolanda; Montero, Vanessa; Sanchez, Monica; Carrera, Cristina; Jose Lopez-Alvarez, Maria; Miralles, Celia; Perez-Castro, Sonia; Cilla, Gustavo; Hinojosa, Carmen; Perez-Alvarez, Lucia; Thomson, Michael M.			Identification of an HIV-1 BG Intersubtype Recombinant Form (CRF73_BG), Partially Related to CRF14_BG, Which Is Circulating in Portugal and Spain	PLOS ONE			English	Article							INJECTING DRUG-USERS; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; SUBTYPE-G; TYPE-1; SEQUENCES; GALICIA; INFECTION; INFERENCE; STRAINS	HIV-1 exhibits a characteristically high genetic diversity, with the M group, responsible for the pandemic, being classified into nine subtypes, 72 circulating recombinant forms (CRFs) and numerous unique recombinant forms (URFs). Here we characterize the near full-length genome sequence of an HIV-1 BG intersubtype recombinant virus (X3208) collected in Galicia (Northwest Spain) which exhibits a mosaic structure coincident with that of a previously characterized BG recombinant virus (9601_01), collected in Germany and epidemiologically linked to Portugal, and different from currently defined CRFs. Similar recombination patterns were found in partial genome sequences from three other BG recombinant viruses, one newly derived, from a virus collected in Spain, and two retrieved from databases, collected in France and Portugal, respectively. Breakpoint coincidence and clustering in phylogenetic trees of these epidemiologically-unlinked viruses allow to define a new HIV-1 CRF (CRF73_BG). CRF73_BG shares one breakpoint in the envelope with CRF14_BG, which circulates in Portugal and Spain, and groups with it in a subtype B envelope fragment, but the greatest part of its genome does not appear to derive from CRF14_BG, although both CRFs share as parental strain the subtype G variant circulating in the Iberian Peninsula. Phylogenetic clustering of partial pol and env segments from viruses collected in Portugal and Spain with X3208 and 9691_01 indicates that CRF73_BG is circulating in both countries, with proportions of around 2-3% Portuguese database HIV-1 isolates clustering with CRF73_BG. The fact that an HIV-1 recombinant virus characterized ten years ago as a URF has been shown to represent a CRF suggests that the number of HIV-1 CRFs may be much greater than currently known.	[Fernandez-Garcia, Aurora; Delgado, Elena; Teresa Cuevas, Maria; Vega, Yolanda; Montero, Vanessa; Sanchez, Monica; Carrera, Cristina; Perez-Alvarez, Lucia; Thomson, Michael M.] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain; [Fernandez-Garcia, Aurora] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Jose Lopez-Alvarez, Maria] Hosp Univ Lucus Augusti, Lugo, Spain; [Miralles, Celia; Perez-Castro, Sonia] Complejo Hosp Univ Vigo, Vigo, Pontevedra, Spain; [Cilla, Gustavo] Hosp Univ Donostia, San Sebastian, Spain; [Hinojosa, Carmen] Hosp Clin Univ Valladolid, Valladolid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Universitario Lucus Augusti-Lugo; Complexo Hospitalario Universitario de Vigo; Universidad de Valladolid	Thomson, MM (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain.	mthomson@iscii.es	gonzalez-nico, maria teresa cuevas/E-2001-2014; Thomson, Michael M/P-8949-2017; CARRERA, CRISTINA/N-1887-2019; Delgado, Elena/E-2785-2019	gonzalez-nico, maria teresa cuevas/0000-0002-4195-1975; Thomson, Michael M/0000-0002-0622-7527; CARRERA, CRISTINA/0000-0003-1608-8820; Delgado, Elena/0000-0002-0754-8533; PEREZ CASTRO, SONIA/0000-0003-1734-1904	Direccion General de Farmacia, Ministerio de Sanidad, Servicios Sociales e Igualdad, Government of Spain [EC11-272]; Instituto de Salud Carlos III; Subdireccion General de Evaluacion; Fondo Europeo de Desarrollo Regional (FEDER), Plan Nacional I + D + I [RD12/0017/0026]; Conselleria de Sanidade, Government of Galicia, Spain [MVI 1291/08]; Osakidetza-Servicio Vasco de Salud, Basque Country, Spain [MVI-1255-08]	Direccion General de Farmacia, Ministerio de Sanidad, Servicios Sociales e Igualdad, Government of Spain; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Subdireccion General de Evaluacion; Fondo Europeo de Desarrollo Regional (FEDER), Plan Nacional I + D + I; Conselleria de Sanidade, Government of Galicia, Spain; Osakidetza-Servicio Vasco de Salud, Basque Country, Spain	Funded by Direccion General de Farmacia, Ministerio de Sanidad, Servicios Sociales e Igualdad, Government of Spain (Grant EC11-272 URL: http://www.msssi.gob.es/); Instituto de Salud Carlos III, Subdireccion General de Evaluacion, and Fondo Europeo de Desarrollo Regional (FEDER), Plan Nacional I + D + I (Grant RD12/0017/0026 URL: http://www.isciii.es/); Conselleria de Sanidade, Government of Galicia, Spain (Grant MVI 1291/08 URL: http://www.sergas.es/); Osakidetza-Servicio Vasco de Salud, Basque Country, Spain Grant: MVI-1255-08 URL: http://www.osakidetza.euskadi.eus/r85-ghhome00/es/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis AB, 2011, AIDS RES HUM RETROV, V27, P803, DOI [10.1089/aid.2010.0312, 10.1089/AID.2010.0312]; Bartolo I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024130; Cuevas M, 2009, EUROSURVEILLANCE, V14; Delgado E, 2002, J ACQ IMMUN DEF SYND, V29, P536, DOI 10.1097/00126334-200204150-00016; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Esteves A, 2003, AIDS RES HUM RETROV, V19, P511, DOI 10.1089/088922203766774568; Esteves A, 2002, AIDS RES HUM RETROV, V18, P313, DOI 10.1089/088922202753519089; Fernandez-Garcia A, 2010, AIDS RES HUM RETROV, V26, P827, DOI 10.1089/aid.2009.0311; Harris B, 2005, AIDS RES HUM RETROV, V21, P654, DOI 10.1089/aid.2005.21.654; HIV Sequence Database, HIV SEQ DAT; Holguin A, 2008, CURR HIV RES, V6, P327, DOI 10.2174/157016208785132455; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Munoz-Nieto M, 2008, AIDS RES HUM RETROV, V24, P337, DOI 10.1089/aid.2007.0230; Perez-Alvarez L, 2014, J ANTIMICROB CHEMOTH, V69, P246, DOI 10.1093/jac/dkt305; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schultz AK, 2009, NUCLEIC ACIDS RES, V37, pW647, DOI 10.1093/nar/gkp371; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Shcherbakova NS, 2014, AIDS RES HUM RETROV, V30, P912, DOI [10.1089/aid.2014.0075, 10.1089/AID.2014.0075]; Sierra Maria, 2005, Infection Genetics and Evolution, V5, P209, DOI 10.1016/j.meegid.2004.07.010; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Thomson MM, 2007, J INFECT DIS, V196, P1120, DOI 10.1086/521683; Thomson MM, 2012, JAIDS-J ACQ IMM DEF, V59, pE49, DOI 10.1097/QAI.0b013e3182400fc4; Thomson MM, 2002, LANCET INFECT DIS, V2, P461, DOI 10.1016/S1473-3099(02)00343-2; Thomson MM, 2001, CLIN INFECT DIS, V32, P1732, DOI 10.1086/320764; Thomson MM, 2001, AIDS, V15, P509, DOI 10.1097/00002030-200103090-00010	28	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148549	10.1371/journal.pone.0148549	http://dx.doi.org/10.1371/journal.pone.0148549			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900693	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100019
J	Koga, H; Iida, K; Maeda, T; Takahashi, M; Fukushima, N; Goshi, T				Koga, Hiroshi; Iida, Koichi; Maeda, Tomoki; Takahashi, Mizuho; Fukushima, Naoki; Goshi, Terufumi			Epidemiologic Research on Malformations Associated with Cleft Lip and Cleft Palate in Japan	PLOS ONE			English	Article							PRENATAL-DIAGNOSIS; EXPERIENCE; CHILDREN; POPULATION; EUROPE	To investigate malformations associated with cleft lip and cleft palate, we conducted surveys at neonatal intensive care units (NICUs) and other non-NICU facilities and to determine whether there are differences among facilities. The regional survey investigated NICU facilities located in Oita Prefecture, including 92 patients with cleft lip and palate (CLP) or cleft palate (CP) that occurred between 2004 and 2013, and the national survey investigated oral surgery, plastic surgery, and obstetrics and gynecology facilities located in Japan, including 16,452 patients with cleft lip (CL), CLP, or CP that occurred since 2000. The incidence per 10,000 births was 4.2, 6.2, and 2.8 for CL, CLP, and CP, respectively, according to the national survey, and 6.3 and 2.9 for CLP and CP, respectively according to the regional survey. These results indicated comparable incidences between the two surveys. In contrast, when the survey results on malformations associated with CLP and CP according to the ICD-10 classification were compared between the national survey conducted at oral surgery or plastic surgery facilities and the regional survey conducted at NICU facilities, the occurrence of associated malformations was 19.8% vs. 41.3% for any types of associated malformation, 6.8% vs. 21.7% for congenital heart disease, and 0.5% vs. 16.3% for chromosomal abnormalities. These results indicated that the incidences of all of these associated malformations were significantly greater in the survey conducted at NICU facilities and similar to the findings from international epidemiological surveys. When comparing the survey conducted at obstetrics facilities vs. NICU facilities, the occurrence of associated malformations was similar results as above. The incidence of CLP and CP was not different between surveys conducted at NICU facilities vs. non-NICU facilities; however, when conducting surveys on associated malformations, it is possible to obtain accurate epidemiological data by investigating NICU facilities where detailed examinations are thoroughly performed.	[Koga, Hiroshi] Natl Hosp Org Beppu Med Ctr, Dept Pediat, Oita, Japan; [Iida, Koichi] Oita Prefectural Hosp, Dept Neonatol, Oita, Japan; [Maeda, Tomoki; Takahashi, Mizuho] Oita Univ, Fac Med, Dept Pediat, Oita 87011, Japan; [Fukushima, Naoki] Almeida Hosp, Dept Pediat, Oita, Japan; [Goshi, Terufumi] Nakatsu Municipal Hosp, Dept Pediat, Oita, Japan	Oita University	Koga, H (corresponding author), Natl Hosp Org Beppu Med Ctr, Dept Pediat, Oita, Japan.	sakuraliberty@beppu2.hosp.go.jp	Koga, Hiroshi/AAR-3755-2020	Koga, Hiroshi/0000-0001-9583-9842				[Anonymous], 2016, ICD 10 VERS 2016; Boyd PA, 1998, LANCET, V352, P1577, DOI 10.1016/S0140-6736(98)03202-4; Calzolari E, 2004, CLEFT PALATE-CRAN J, V41, P244, DOI 10.1597/02-074.1; Calzolari E, 2007, AM J MED GENET A, V143A, P528, DOI 10.1002/ajmg.a.31447; Chen YW, 2012, LARYNGOSCOPE, V122, P220, DOI 10.1002/lary.22425; de Vries IAC, 2014, CLIN ORAL INVEST, V18, P1507, DOI [10.1007/s00784-014-1190-9, 10.1007/s00784-013-1117-x]; Funayama E, 2014, INT J PEDIATR OTORHI, V78, P2127, DOI 10.1016/j.ijporl.2014.09.021; Gundlach KKH, 2006, J CRANIO MAXILL SURG, V34, P1; Hardin-Jones MA, 2005, CLEFT PALATE-CRAN J, V42, P7, DOI 10.1597/03-134.1; Jordan VA, 2014, LARYNGOSCOPE, V124, pE384, DOI 10.1002/lary.24727; Kogo M, 1997, CLEFT PALATE-CRAN J, V34, P351, DOI 10.1597/1545-1569(1997)034<0350:BFFCLA>2.3.CO;2; Mossey P., 2003, GLOBAL REGISTRY DATA; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Natsume N, 2000, BRIT J ORAL MAX SURG, V38, P605, DOI 10.1054/bjom.2000.0539; Paterson P, 2011, CLEFT PALATE-CRAN J, V48, P608, DOI 10.1597/09-238; Prahl C, 2005, CLEFT PALATE-CRAN J, V42, P171, DOI 10.1597/03-111.1; Richmond S, 2005, BJOG-INT J OBSTET GY, V112, P1349, DOI 10.1111/j.1471-0528.2005.00660.x; Sago H, 2015, PRENATAL DIAG, V35, P331, DOI 10.1002/pd.4539; Uzel A, 2011, CLEFT PALATE-CRAN J, V48, P587, DOI 10.1597/10-008; Vettore MV, 2011, EUR J ORTHODONT, V33, P311, DOI 10.1093/ejo/cjq078	20	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149773	10.1371/journal.pone.0149773	http://dx.doi.org/10.1371/journal.pone.0149773			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901758	Green Published, gold			2022-12-27	WOS:000371276100149
J	Lefebvre, A; Rochefort, GY; Santos, F; Le Denmat, D; Salmon, B; Petillon, JM				Lefebvre, Alexandre; Rochefort, Gael Y.; Santos, Frederic; Le Denmat, Dominique; Salmon, Benjamin; Petillon, Jean-Marc			A Non-Destructive Method for Distinguishing Reindeer Antler (Rangifer tarandus) from Red Deer Antler (Cervus elaphus) Using X-Ray Micro-Tomography Coupled with SVM Classifiers	PLOS ONE			English	Article							SPECIES IDENTIFICATION; MECHANICAL-PROPERTIES; BONE MICROSTRUCTURE; COMPUTED-TOMOGRAPHY; IVORY; HUMANS; MICROTOMOGRAPHY; QUANTIFICATION; EMPHASIS; NORTHERN	Over the last decade, biomedical 3D-imaging tools have gained widespread use in the analysis of prehistoric bone artefacts. While initial attempts to characterise the major categories used in osseous industry (i.e. bone, antler, and dentine/ivory) have been successful, the taxonomic determination of prehistoric artefacts remains to be investigated. The distinction between reindeer and red deer antler can be challenging, particularly in cases of anthropic and/or taphonomic modifications. In addition to the range of destructive physicochemical identification methods available (mass spectrometry, isotopic ratio, and DNA analysis), Xray micro-tomography (micro-CT) provides convincing non-destructive 3D images and analyses. This paper presents the experimental protocol (sample scans, image processing, and statistical analysis) we have developed in order to identify modern and archaeological antler collections (from Isturitz, France). This original method is based on bone microstructure analysis combined with advanced statistical support vector machine (SVM) classifiers. A combination of six microarchitecture biomarkers (bone volume fraction, trabecular number, trabecular separation, trabecular thickness, trabecular bone pattern factor, and structure model index) were screened using micro-CT in order to characterise internal alveolar structure. Overall, reindeer alveoli presented a tighter mesh than red deer alveoli, and statistical analysis allowed us to distinguish archaeological antler by species with an accuracy of 96%, regardless of anatomical location on the antler. In conclusion, micro-CT combined with SVM classifiers proves to be a promising additional non-destructive method for antler identification, suitable for archaeological artefacts whose degree of human modification and cultural heritage or scientific value has previously made it impossible (tools, ornaments, etc.).	[Lefebvre, Alexandre; Santos, Frederic] Univ Bordeaux, Prehist Actuel, Culture, Environm,Anthropol,UMR 5199, Bordeaux, France; [Rochefort, Gael Y.; Le Denmat, Dominique; Salmon, Benjamin] Univ Paris 05, Sorbonne Paris Cite, EA Pathol Imagerie & Biotherapies Orofaciales 249, Plateforme Imagerie Vivant,Dent Sch, Montrouge, France; [Salmon, Benjamin] Hop Univ PNVS, AP HP, Serv Odontol Bretonneau, Paris, France; [Petillon, Jean-Marc] Univ Toulouse Jean Jaures, Travaux & Rech Archeol Cultures, Espaces & Soc UMR 5608, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bretonneau - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite de Toulouse - Jean Jaures	Lefebvre, A (corresponding author), Univ Bordeaux, Prehist Actuel, Culture, Environm,Anthropol,UMR 5199, Bordeaux, France.	alexandre.lefebvre@u-bordeaux.fr	Lefebvre, Alexandre/ABG-2400-2020; Rochefort, Gaël Y./H-3359-2019; SALMON, Benjamin/X-4286-2019; Santos, Frédéric/I-3565-2019	Lefebvre, Alexandre/0000-0003-1980-4546; Rochefort, Gaël Y./0000-0001-6428-3570; SALMON, Benjamin/0000-0001-8739-2753; Santos, Frédéric/0000-0003-1445-3871; Petillon, Jean-Marc/0000-0003-4123-2361	Research National Agency [ANR 2011 BSH3 0005]; "Pathologie, Imagerie et Biotherapies orofaciales" laboratories [EA2496]; Ministere de l'Enseignement Superieur et de la Recherche; laboratory PACEA in Bordeaux (UMR 5199, CNRS); MAGDATIS Project [ANR 2011 BSH3 0005]; Pacea (UMR 5199, CNRS)	Research National Agency; "Pathologie, Imagerie et Biotherapies orofaciales" laboratories; Ministere de l'Enseignement Superieur et de la Recherche; laboratory PACEA in Bordeaux (UMR 5199, CNRS); MAGDATIS Project; Pacea (UMR 5199, CNRS)	This research is funded by a ministerial grant from the Research National Agency as a program of prospects investments (the MAGDATIS Project [ANR 2011 BSH3 0005]) (project 'Des chasseurs-cueilleurs face aux changements environnementaux 18-14 kyr cal BP'; dir: JMP), "Pathologie, Imagerie et Biotherapies orofaciales" laboratories (EA2496), and has also been performed thanks to the PhD research grant from the Ministere de l'Enseignement Superieur et de la Recherche for AL. The acquisition of the experimental material is supported by the laboratory PACEA in Bordeaux (UMR 5199, CNRS). All the experiments presented were performed at the IDV platform in the Universite Paris Descartes Sorbonne Cite. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Catherine Schwab, curator at the Palaeolithic Department of MAN, for her support. Many thanks also to the micro-CT IDV Platform (EA2496, Montrouge, France) and particularly to Jeremy Sadoine. We would also like to thank Brad Gravina, Marie-Claire Dawson and Sarita Jannin for helping with the translation. We are indebted to the anonymous reviewers whose comments helped to improve the manuscript significantly. Finally we would like to thank the MAGDATIS Project (ANR 2011 BSH3 0005), Pacea (UMR 5199, CNRS) and the "Pathologie, Imagerie et Biotherapies orofaciales" (EA2496) laboratories for supporting this study.	Akhtar R, 2008, ACTA BIOMATER, V4, P1677, DOI 10.1016/j.actbio.2008.05.008; Albrecht G., 1977, METHODOLOGIE APPLIQU, P119; Altuna J, 1995, FINAL PALEOLITICO CA, P77; [Anonymous], 2000, NATURE STAT LEARNING, DOI DOI 10.1007/978-1-4757-3264-1; Averbouh A, 2000, THESIS U PARIS 1 PAN, P500; Averbouh A., 2005, COMPORTEMENTS HOMMES, P59; Bartos L., 1990, P442; Bello SM, 2013, J ARCHAEOL SCI, V40, P2464, DOI 10.1016/j.jas.2012.12.016; Bello SM, 2013, J ARCHAEOL SCI, V40, P4528, DOI 10.1016/j.jas.2013.07.016; Benazzi S, 2011, NATURE, V479, P525, DOI 10.1038/nature10617; Bernardini F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044904; Bjorck S., 1998, J QUATERNARY SCI, V13, P238, DOI [10.1002/(SICI)1099-1417(199807/08)13:4&LT;283::AID-JQS386&GT;3.0.CO;2-A, DOI 10.1002/(SICI)1099-1417(199807/08)13:4<283::AID-JQS386>3.0.CO;2-A]; Blosseville R, 2014, MEMOIRE DE MASTER, V2; Bocherens H, 2006, J HUM EVOL, V50, P370, DOI 10.1016/j.jhevol.2005.12.002; Boschin F, 2015, ARCHAEOMETRY, V57, P194, DOI 10.1111/arcm.12122; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Bradfield J, 2013, J ARCHAEOL SCI, V40, P2606, DOI 10.1016/j.jas.2013.02.007; Buckley M, 2014, J ARCHAEOL SCI, V41, P631, DOI 10.1016/j.jas.2013.08.021; Buckley M., 2011, ANTIQUA, V1, pe1, DOI [10.4081/antiqua.2011.e1.-e1, DOI 10.4081/ANTIQUA.2011.E1.-E1, DOI 10.4081/ANTIQUA.2011.E1]; Buckley M, 2009, RAPID COMMUN MASS SP, V23, P3843, DOI 10.1002/rcm.4316; Buckley M, 2011, ARCHAEOL ANTHROP SCI, V3, P271, DOI 10.1007/s12520-011-0066-z; CHAPMAN D I, 1975, Mammal Review, V5, P121, DOI 10.1111/j.1365-2907.1975.tb00194.x; Colombo A., 2013, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V25, P127, DOI 10.1007/s13219-012-0076-4; Colombo A, 2014, THESIS U BORDEAUX, P283; Criegel MH, 2001, ANN MED VET, V145, P25; CURREY JD, 1989, J BIOMECH, V22, P469, DOI 10.1016/0021-9290(89)90207-8; CURREY JD, 1987, J BIOMECH, V20, P1035, DOI 10.1016/0021-9290(87)90021-2; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; DeSilva JM, 2012, J HUM EVOL, V63, P536, DOI 10.1016/j.jhevol.2012.06.006; Enzmann F, 2008, SKRIPTEN, V228, P81; Fennessy P.F., 1985, Royal Society of New Zealand Bulletin, P239; Franklin D, 2005, HOMO, V56, P17, DOI 10.1016/j.jchb.2004.07.004; Gilbert C, 2006, MOL PHYLOGENET EVOL, V40, P101, DOI 10.1016/j.ympev.2006.02.017; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; HAHN M, 1992, BONE, V13, P327, DOI 10.1016/8756-3282(92)90078-B; Heinz C, 2001, HIST HOMMES HIST PLA, P57; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Izenman AJ, 2008, MODERN MULTIVARIATE, V25, P733; JALUT G, 1992, QUATERNARY SCI REV, V11, P449, DOI 10.1016/0277-3791(92)90027-6; Jalut G, 2000, PALEOECOLOGICAL EVEN, P612; Krauss S, 2011, J STRUCT BIOL, V175, P457, DOI 10.1016/j.jsb.2011.06.005; Kulin RM, 2011, MAT SCI ENG C-MATER, V31, P1030, DOI 10.1016/j.msec.2011.03.002; Leonard A, 2007, J MICROSC-OXFORD, V225, P258, DOI 10.1111/j.1365-2818.2007.01740.x; Li C, 2003, GEN COMP ENDOCR, V131, P21, DOI 10.1016/S0016-6480(02)00625-1; Macchiarelli R., 2013, ANTHR PERSPECTIVES T, P250, DOI DOI 10.1017/CBO9780511984464.011; Macho GA, 2005, INT J OSTEOARCHAEOL, V15, P421, DOI 10.1002/oa.797; Martiniakova M, 2006, J FORENSIC SCI, V51, P1235, DOI 10.1111/j.1556-4029.2006.00260.x; Mazurier A, 2006, APPL PHYS A-MATER, V83, P229, DOI 10.1007/s00339-006-3511-6; Meyer D., 2015, E1071 MISC FUNCTIONS; Muller BR, 2009, ADV ENG MATER, V11, P435, DOI 10.1002/adem.200800346; Muller K, 2011, J ARCHAEOL SCI, V38, P3234, DOI 10.1016/j.jas.2011.06.029; ODGAARD A, 1993, BONE, V14, P173, DOI 10.1016/8756-3282(93)90245-6; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Paral V, 2007, INT J OSTEOARCHAEOL, V17, P627, DOI 10.1002/oa.912; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Patou-Mathis M, 2005, ERAUL, V111, P27; Penniman TK, 1952, PICTURES IVORY OTHER, V5, P60; Petillon JM, 2013, J HUM EVOL, V65, P525, DOI 10.1016/j.jhevol.2013.06.006; Pokines JT, 1998, J ARCHAEOL SCI, V25, P875, DOI 10.1006/jasc.1997.0269; R Core Team, 2013, R LANG ENV STAT COMP; RAJARAM A, 1982, CALCIFIED TISSUE INT, V34, P301, DOI 10.1007/BF02411255; Reiche I, 2011, J ANAL ATOM SPECTROM, V26, P1802, DOI 10.1039/c0ja00246a; Rolf HJ, 1996, COMP BIOCHEM PHYS A, V115, P207, DOI 10.1016/0300-9629(96)00051-5; Rolf HJ, 1999, ANAT REC, V255, P69, DOI 10.1002/(SICI)1097-0185(19990501)255:1<69::AID-AR8>3.0.CO;2-R; Sanchez-Goni M.F., 1996, ZEPHYRUS, V49, P3; Smith TM, 2012, J HUM EVOL, V62, P395, DOI 10.1016/j.jhevol.2011.12.004; Stewart D, 2002, ANTLEROGENESIS ANTLE, P28; SUTTIE JM, 1984, J REPROD FERTIL, V71, P7, DOI 10.1530/jrf.0.0710007; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; Tafforeau P, 2008, J HUM EVOL, V54, P272, DOI 10.1016/j.jhevol.2007.09.018; Tolksdorf JF, 2015, ARCHAEOL ANTHROP SCI, V7, P351, DOI 10.1007/s12520-014-0197-0; Villa P, 2001, J HUM EVOL, V41, P69, DOI 10.1006/jhev.2001.0479; von Holstein ICC, 2014, J ARCHAEOL SCI, V41, P1, DOI 10.1016/j.jas.2013.07.026; Zanolli C, 2013, CR PALEVOL, V12, P293, DOI 10.1016/j.crpv.2013.06.004; Zioupos P, 1996, J BIOMECH, V29, P969, DOI [10.1016/0021-9290(96)00001-2, DOI 10.1016/0021-9290(96)00001-2]	75	3	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149658	10.1371/journal.pone.0149658	http://dx.doi.org/10.1371/journal.pone.0149658			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901355	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100123
J	Raab, RW; Moore, JE; Vargo, EL; Rose, L; Raab, J; Culbreth, M; Burzumato, G; Koyee, A; McCarthy, B; Raffaele, J; Schal, C; Vaidyanathan, R				Raab, Ronald W.; Moore, Julia E.; Vargo, Edward L.; Rose, Lucy; Raab, Julie; Culbreth, Madeline; Burzumato, Gracie; Koyee, Aurvan; McCarthy, Brittany; Raffaele, Jennifer; Schal, Coby; Vaidyanathan, Rajeev			New Introductions, Spread of Existing Matrilines, and High Rates of Pyrethroid Resistance Result in Chronic Infestations of Bed Bugs (Cimex lectularius L.) in Lower-Income Housing	PLOS ONE			English	Article							HEMIPTERA-CIMICIDAE; UNITED-STATES; INSECTICIDE RESISTANCE; MOLECULAR MARKERS; POPULATIONS; BEDBUGS	Infestations of the common bed bug (Cimex lectularius L.) have increased substantially in the United States in the past 10-15 years. The housing authority in Harrisonburg, Virginia, conducts heat-treatments after bed bugs are detected in a lower-income housing complex, by treating each infested unit at 60 degrees C for 4-6 hours. However, a high frequency of recurrent infestations called into question the efficacy of this strategy. Genetic analysis using Bayesian clustering of polymorphic microsatellite loci from 123 bed bugs collected from 23 units from May 2012 to April 2013 in one building indicated that (a) 16/21 (73%) infestations were genetically similar, suggesting ineffective heat-treatments or reintroductions from within the building or from a common external source, followed by local spread of existing populations; and (b) up to 5 of the infestations represented new genotypes, indicating that 5 new populations were introduced into this building in one year, assuming they were not missed in earlier screens. There was little to no gene flow among the 8 genetic clusters identified in the building. Bed bugs in the U.S. often possess one or both point mutations in the voltage-gated sodium channel, termed knockdown resistance (kdr), from valine to leucine (V419L) and leucine to isoleucine (L925I) that confer target-site resistance against pyrethroid insecticides. We found that 48/121 (40%) bed bugs were homozygous for both kdr mutations (L419/I925), and a further 59% possessed at least one of the kdr mutations. We conclude that ineffective heat treatments, new introductions, reintroductions and local spread, and an exceptionally high frequency of pyrethroid resistance are responsible for chronic infestations in lower-income housing. Because heat treatments fail to protect from reintroductions, and pesticide use has not decreased the frequency of infestations, preventing new introductions and early detection are the most effective strategies to avoid bed bug infestations in multistory apartment buildings.	[Raab, Ronald W.; McCarthy, Brittany; Raffaele, Jennifer] James Madison Univ, Coll Integrated Sci & Technol, Harrisonburg, VA 22807 USA; [Moore, Julia E.; Vaidyanathan, Rajeev] SRI Int, Ctr Immun & Infect Dis, Harrisonburg, VA USA; [Vargo, Edward L.; Schal, Coby] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Rose, Lucy; Raab, Julie; Culbreth, Madeline; Burzumato, Gracie; Koyee, Aurvan] Harrisonburg High Sch, Harrisonburg, VA USA; [Vargo, Edward L.] Texas A&M Univ, Bldg 1804 F&B Rd 2556, College Stn, TX 77843 USA; [Moore, Julia E.] Clarke Mosquito, 675 Sidwell Court, St Charles, IL 60175 USA	James Madison University; SRI International; University of North Carolina; North Carolina State University; Texas A&M University System; Texas A&M University College Station	Vaidyanathan, R (corresponding author), SRI Int, Ctr Immun & Infect Dis, Harrisonburg, VA USA.	rvadyanathan@clarke.com	Schal, Coby/A-8717-2010	Schal, Coby/0000-0001-7195-6358	U.S. Department of Housing and Urban Development [NCHHU0001-11]; Blanton J. Whitmire Endowment at North Carolina State University; SRI International	U.S. Department of Housing and Urban Development; Blanton J. Whitmire Endowment at North Carolina State University; SRI International	CS was supported by a grant from U.S. Department of Housing and Urban Development (NCHHU0001-11) and by the Blanton J. Whitmire Endowment at North Carolina State University. JEM and RV were supported by internal R&D funding from SRI International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was possible because of the cooperation of residents who allowed us to collect samples in their homes. We thank Michael Wong, Duane Bontrager, Lisa Benasher, and Paul Harlow of the Harrisonburg Redevelopment and Housing Authority (HRHA) for their kind help. The HRHA reviewed our protocol and granted us access to the field site. We thank Deb Berger, Jim Boggs, Vitaliy Makayev, and John Hall of Pure Environmental Services who allowed us to collect bed bugs before and after heat-treatment. We thank Paul Labadie for technical assistance with the microsatellite genotyping and analysis. CS was supported by a grant from U.S. Department of Housing and Urban Development (NCHHU0001-11) and by the Blanton J. Whitmire Endowment at North Carolina State University. JEM and RV were supported by internal R&D funding from SRI International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adelman ZN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026228; Anderson AL, 2008, J ENVIRON HEALTH, V70, P24; Booth W, 2012, J MED ENTOMOL, V49, P535, DOI 10.1603/ME11256; Brown AW, 1973, OMS SERIE MONOGR, V38; Busvine J R, 1958, Bull World Health Organ, V19, P1041; Corander J, 2003, GENETICS, V163, P367; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Davies TGE, 2012, MED VET ENTOMOL, DOI [10.1111/j.1365-2915.2011.1006.x, DOI 10.1111/J.1365-2915.2011.1006.X]; Doggett S, 2004, ENVIRON HEALTH-GLOB, V4, P30; FEROZ M, 1971, B WORLD HEALTH ORGAN, V45, P795; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GRATZ N G, 1959, Bull World Health Organ, V20, P835; Harlan HJ, 2006, BED BUGS IMPROTANCE; Herborg LM, 2007, MOL ECOL, V16, P231, DOI 10.1111/j.1365-294X.2006.03133.x; Johnson M. S., 1948, MED NEWS LETT, V12, P26; Krueger L, 2000, PEST CONTROL, V68, P58; Madden AH, 1944, J ECON ENTOMOL, V37, P127, DOI 10.1093/jee/37.1.127; Mamidala P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-6; Pereira RM, 2009, J ECON ENTOMOL, V102, P1182, DOI 10.1603/029.102.0342; Potter Michael F., 2011, American Entomologist, V57, P14; Puckett RT, 2012, PEST MANAG SCI; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Romero A, 2007, J MED ENTOMOL, V44, P175, DOI 10.1603/0022-2585(2007)44[175:IRITBB]2.0.CO;2; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Saenz VL, 2012, J MED ENTOMOL, V49, P865, DOI 10.1603/ME11202; Steelman CD, 2008, J AGR URBAN ENTOMOL, V25, P41, DOI 10.3954/1523-5475-25.1.41; Tawatsin A, 2011, J MED ENTOMOL, V48, P1023, DOI 10.1603/ME11003; Usinger R. L., 1966, MONOGRAPH CIMICIDAE; Wong M., 2013, J HOUSING COMMUN MAY, V70, P20; Yoon KS, 2008, J MED ENTOMOL, V45, P1092, DOI 10.1603/0022-2585(2008)45[1092:BAMAOD]2.0.CO;2; Zhu F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01456; Zhu F, 2010, ARCH INSECT BIOCHEM, V73, P245, DOI 10.1002/arch.20355	32	10	11	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0117805	10.1371/journal.pone.0117805	http://dx.doi.org/10.1371/journal.pone.0117805			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901153	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100001
J	Tan, L; Chen, JJ; Zheng, B; Ouyang, FY				Tan, Lei; Chen, Jun-Jie; Zheng, Bo; Ouyang, Fang-Yan			Exploring Market State and Stock Interactions on the Minute Timescale	PLOS ONE			English	Article							CROSS-CORRELATIONS; FINANCIAL-MARKETS; CORPORATE GOVERNANCE; INTRADAY PATTERNS; VOLATILITY; BEHAVIOR; MODEL	A stock market is a non-stationary complex system. The stock interactions are important for understanding the state of the market. However, our knowledge on the stock interactions on the minute timescale is limited. Here we apply the random matrix theory and methods in complex networks to study the stock interactions and sector interactions. Further, we construct a new kind of cross-correlation matrix to investigate the correlation between the stock interactions at different minutes within one trading day. Based on 50 million minute-to-minute price data in the Shanghai stock market, we discover that the market states in the morning and afternoon are significantly different. The differences mainly exist in three aspects, i.e. the co-movement of stock prices, interactions of sectors and correlation between the stock interactions at different minutes. In the afternoon, the component stocks of sectors are more robust and the structure of sectors is firmer. Therefore, the market state in the afternoon is more stable. Furthermore, we reveal that the information of the sector interactions can indicate the financial crisis in the market, and the indicator based on the empirical data in the afternoon is more effective.	[Tan, Lei; Chen, Jun-Jie; Zheng, Bo; Ouyang, Fang-Yan] Zhejiang Univ, Dept Phys, Hangzhou 310027, Zhejiang, Peoples R China; [Tan, Lei; Chen, Jun-Jie; Zheng, Bo; Ouyang, Fang-Yan] Collaborat Innovat Ctr Adv Microstruct, Nanjing 210093, Jiangsu, Peoples R China	Zhejiang University	Zheng, B (corresponding author), Zhejiang Univ, Dept Phys, Hangzhou 310027, Zhejiang, Peoples R China.; Zheng, B (corresponding author), Collaborat Innovat Ctr Adv Microstruct, Nanjing 210093, Jiangsu, Peoples R China.	zhengbo@zju.edu.cn	zheng, bo/E-8351-2011		National Natural Science Foundation of China [11375149, 11075137]; Zhejiang Provincial Natural Science Foundation of China [Z6090130]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported in part by the National Natural Science Foundation of China under Grant Nos. 11375149 and 11075137, and Zhejiang Provincial Natural Science Foundation of China under Grant No. Z6090130. The funding is received by BZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admati AR, 1988, REV FINANC STUD, V1, P3, DOI 10.1093/rfs/1.1.3; Andersen TG, 1998, J FINANC, V53, P219, DOI 10.1111/0022-1082.85732; Aste T, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/085009; BERNANKE BS, 1983, AM ECON REV, V73, P257; Bonanno G, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046130; Bouchaud JP, 2001, PHYS REV LETT, V87, part. no., DOI 10.1103/PhysRevLett.87.228701; Campello M, 2010, J FINANC ECON, V97, P470, DOI 10.1016/j.jfineco.2010.02.009; CHAN KC, 1995, J BUS, V68, P35, DOI 10.1086/296652; Chen JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08399; Chen JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079531; EKMAN PD, 1992, J FUTURES MARKETS, V12, P365, DOI 10.1002/fut.3990120402; EPPS TW, 1979, J AM STAT ASSOC, V74, P291, DOI 10.2307/2286325; Erb C. B., 1994, FINANC ANAL J, V50, P32, DOI DOI 10.2469/FAJ.V50.N6.32; Gabaix X, 2003, NATURE, V423, P267, DOI 10.1038/nature01624; Gopikrishnan P, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.035106; Gopikrishnan P, 1999, PHYS REV E, V60, P5305, DOI 10.1103/PhysRevE.60.5305; HARRIS L, 1986, J FINANC ECON, V16, P99, DOI 10.1016/0304-405X(86)90044-9; Ivashina Victoria, 2010, J FINANC ECON, V97, P319, DOI DOI 10.1016/J.JFINEC0.2009.12.001; Jiang XF, 2014, SCI REP-UK, V4, DOI 10.1038/srep05321; Jiang XF, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/48006; Johnson N. F., 2003, FINANCIAL MARKET COM; Johnson S, 2000, J FINANC ECON, V58, P141, DOI 10.1016/S0304-405X(00)00069-6; Kenett DY, 2013, SCI REP-UK, V3, DOI 10.1038/srep02110; Kenett DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015032; Krawiecki A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.158701; Kumar S, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.026101; Laloux L, 1999, PHYS REV LETT, V83, P1467, DOI 10.1103/PhysRevLett.83.1467; Lemmon ML, 2003, J FINANC, V58, P1445, DOI 10.1111/1540-6261.00573; Liu YH, 1999, PHYS REV E, V60, P1390, DOI 10.1103/PhysRevE.60.1390; MANTEGNA RN, 1995, NATURE, V376, P46, DOI 10.1038/376046a0; Meng H, 2014, SCI REP-UK, V4, DOI 10.1038/srep03655; Munnix MC, 2012, SCI REP-UK, V2, DOI 10.1038/srep00644; Pan RK, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046116; Plerou V, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066126; Podobnik B, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/68001; Pozzi F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01665; Preis T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00752; Qiu T, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.065103; Reinhart CM, 2008, AM ECON REV, V98, P339, DOI 10.1257/aer.98.2.339; Reno R, 2003, INT J THEOR APPL FIN, V6, P87, DOI [DOI 10.1142/S0219024903001839, 10.2139/ssrn.314723, DOI 10.2139/SSRN.314723, 10.1142/S0219024903001839]; Shen J, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/48005; Solnik B., 1996, FINANCIAL ANAL J, V52, P17, DOI [10.2469/faj.v52.n5.2021, DOI 10.2469/FAJ.V52.N5.2021]; Sornette D, 2003, PHYS REP, V378, P1, DOI 10.1016/S0370-1573(02)00634-8; Tan L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118399; Tumminello M, 2005, P NATL ACAD SCI USA, V102, P10421, DOI 10.1073/pnas.0500298102; Utsugi A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.026110; WOOD RA, 1985, J FINANC, V40, P723, DOI 10.1111/j.1540-6261.1985.tb04996.x; Zhang L, 2011, J ECONOMETRICS, V160, P33, DOI 10.1016/j.jeconom.2010.03.012; Zhao L, 2011, P NATL ACAD SCI USA, V108, P15058, DOI 10.1073/pnas.1105239108; Zheng ZY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00888	50	0	0	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149648	10.1371/journal.pone.0149648	http://dx.doi.org/10.1371/journal.pone.0149648			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26900948	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100120
J	Ward, DG; Baxter, L; Gordon, NS; Ott, S; Savage, RS; Beggs, AD; James, JD; Lickiss, J; Green, S; Wallis, Y; Wei, WB; James, ND; Zeegers, MP; Cheng, KK; Mathews, GM; Patel, P; Griffiths, M; Bryan, RT				Ward, Douglas G.; Baxter, Laura; Gordon, Naheema S.; Ott, Sascha; Savage, Richard S.; Beggs, Andrew D.; James, Jonathan D.; Lickiss, Jennifer; Green, Shaun; Wallis, Yvonne; Wei, Wenbin; James, Nicholas D.; Zeegers, Maurice P.; Cheng, K. K.; Mathews, Glenn M.; Patel, Prashant; Griffiths, Michael; Bryan, Richard T.			Multiplex PCR and Next Generation Sequencing for the Non-Invasive Detection of Bladder Cancer	PLOS ONE			English	Article							TERT PROMOTER MUTATIONS; VOIDED URINE; DISEASE RECURRENCE; CARCINOMA; FGFR3	Background Highly sensitive and specific urine-based tests to detect either primary or recurrent bladder cancer have proved elusive to date. Our ever increasing knowledge of the genomic aberrations in bladder cancer should enable the development of such tests based on urinary DNA. Methods DNA was extracted from urine cell pellets and PCR used to amplify the regions of the TERT promoter and coding regions of FGFR3, PIK3CA, TP53, HRAS, KDM6A and RXRA which are frequently mutated in bladder cancer. The PCR products were barcoded, pooled and paired-end 2 x 250 bp sequencing performed on an Illumina MiSeq. Urinary DNA was analysed from 20 non-cancer controls, 120 primary bladder cancer patients (41 pTa, 40 pT1, 39 pT2+) and 91 bladder cancer patients post-TURBT (89 cancer-free). Results Despite the small quantities of DNA extracted from some urine cell pellets, 96% of the samples yielded mean read depths >500. Analysing only previously reported point mutations, TERT mutations were found in 55% of patients with bladder cancer (independent of stage), FGFR3 mutations in 30% of patients with bladder cancer, PIK3CA in 14% and TP53 mutations in 12% of patients with bladder cancer. Overall, these previously reported bladder cancer mutations were detected in 86 out of 122 bladder cancer patients (70% sensitivity) and in only 3 out of 109 patients with no detectable bladder cancer (97% specificity). Conclusion This simple, cost-effective approach could be used for the non-invasive surveillance of patients with non-muscle-invasive bladder cancers harbouring these mutations. The method has a low DNA input requirement and can detect low levels of mutant DNA in a large excess of normal DNA. These genes represent a minimal biomarker panel to which extra markers could be added to develop a highly sensitive diagnostic test for bladder cancer.	[Ward, Douglas G.; Gordon, Naheema S.; Beggs, Andrew D.; James, Jonathan D.; Wei, Wenbin; Zeegers, Maurice P.; Mathews, Glenn M.; Patel, Prashant; Griffiths, Michael; Bryan, Richard T.] Univ Birmingham, Inst Canc & Genom Sci, Birmingham B15 2TT, W Midlands, England; [Baxter, Laura; Ott, Sascha; Savage, Richard S.] Univ Warwick, Warwick Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England; [Lickiss, Jennifer; Green, Shaun; Wallis, Yvonne; Griffiths, Michael] Birmingham Womens Hosp NHS Fdn Trust, West Midlands Reg Genet Lab, Birmingham B15 2TG, W Midlands, England; [James, Nicholas D.] Univ Warwick, Clin Trials Unit, Coventry CV4 7AL, W Midlands, England; [Zeegers, Maurice P.] Maastricht Univ, Med Ctr, NUTRIM Sch Nutr & Translat Res Metab, Dept Complex Genet, NL-6200 MD Maastricht, Netherlands; [Cheng, K. K.] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England; [Savage, Richard S.] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England	University of Birmingham; University of Warwick; Birmingham Women's Hospital; University of Warwick; Maastricht University; Maastricht University Medical Centre (MUMC); University of Birmingham; University of Warwick	Bryan, RT (corresponding author), Univ Birmingham, Inst Canc & Genom Sci, Birmingham B15 2TT, W Midlands, England.	r.t.bryan@bham.ac.uk	Baxter, laura/GWD-1304-2022; Cheng, Kar/AAL-8899-2021; Beggs, Andrew D/A-6912-2013; Ott, Sascha/A-1180-2011; Bryan, Richard T/AAJ-9325-2021	Cheng, Kar/0000-0002-1516-1857; Beggs, Andrew D/0000-0003-0784-2967; Bryan, Richard T/0000-0003-2853-4293; Zeegers, Maurice/0000-0002-2387-083X; Patel, Prashant/0000-0002-2882-5990; Wei, Wenbin/0000-0003-1288-6999	Wellcome Trust follow-on-fund grant; Cancer Research UK; University of Birmingham; Birmingham Comprehensive Local Research Network; Black Country Comprehensive Local Research Network; West Midlands North and South Comprehensive Local Research Network; Birmingham ECMC; MRC [MR/M009157/1] Funding Source: UKRI; Medical Research Council [MR/M009157/1] Funding Source: researchfish	Wellcome Trust follow-on-fund grant; Cancer Research UK(Cancer Research UK); University of Birmingham; Birmingham Comprehensive Local Research Network; Black Country Comprehensive Local Research Network; West Midlands North and South Comprehensive Local Research Network; Birmingham ECMC; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was funded by a Wellcome Trust follow-on-fund grant administered by the University of Birmingham. BCPP is funded by Cancer Research UK, the University of Birmingham and the Birmingham and The Black Country and West Midlands North and South Comprehensive Local Research Networks, and sponsored by the University of Birmingham. The BCPP biospecimen collection is supported by funding from the Birmingham ECMC. DGW is funded by a philanthropic donation to the University of Birmingham in support of bladder cancer research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allory Y, 2013, EUR UROL; [Anonymous], 2014, NATURE, V507, P315, DOI DOI 10.1038/NATURE12965; Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; de Martino M, 2015, EUR UROL, V68, P552, DOI 10.1016/j.eururo.2015.06.015; Hurst CD, 2014, EUR UROL, V65, P367, DOI 10.1016/j.eururo.2013.08.057; Kandimalla R, 2013, CLIN CANCER RES, V19, P4760, DOI 10.1158/1078-0432.CCR-12-3276; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Kinde I, 2013, CANCER RES, V73, P7162, DOI 10.1158/0008-5472.CAN-13-2498; Knowles MA, 2015, NAT REV CANCER, V15, P25, DOI 10.1038/nrc3817; Liu XL, 2013, CELL CYCLE, V12, P1637, DOI 10.4161/cc.24662; MILLHOLLAND J, 2012, RES REPORTS UROLOGY, V2012, P33; Rachakonda PS, 2013, P NATL ACAD SCI USA, V110, P17426, DOI 10.1073/pnas.1310522110; Reinert T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046297; Rieger-Christ KM, 2003, CANCER-AM CANCER SOC, V98, P737, DOI 10.1002/cncr.11536; Schmitz-Drager BJ, 2015, UROL INT, V94, P1, DOI 10.1159/000369357; Tognieri F, 2016, EUROPEAN J IN PRESS; van Kessel K, 2015, J UROL; van Rhijn BWG, 2003, CLIN CANCER RES, V9, P257; Williamson SR, 2010, CRIT REV ONCOL HEMAT, V76, P112, DOI 10.1016/j.critrevonc.2010.01.005; Zeegers MP, 2010, BJU INT, V105, P784, DOI 10.1111/j.1464-410X.2009.08849.x; Zheng CJ, 2012, BJU INT, V110, pE680, DOI 10.1111/j.1464-410X.2012.11500.x	22	56	59	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149756	10.1371/journal.pone.0149756	http://dx.doi.org/10.1371/journal.pone.0149756			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901314	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000371276100145
J	Wolinski, K; Stangierski, A; Szczepanek-Parulska, E; Gurgul, E; Budny, B; Wrotkowska, E; Biczysko, M; Ruchala, M				Wolinski, Kosma; Stangierski, Adam; Szczepanek-Parulska, Ewelina; Gurgul, Edyta; Budny, Bardomiej; Wrotkowska, Elzbieta; Biczysko, Maciej; Ruchala, Marek			VEGF-C Is a Thyroid Marker of Malignancy Superior to VEGF-A in the Differential Diagnostics of Thyroid Lesions	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; MESSENGER-RNA; EXPRESSION; CANCER; FEATURES; NODULES; ULTRASOUND; BENIGN; BIOPSY	Introduction Thyroid nodular goiter is one of the most common medical conditions affecting even over a half of adult population. The risk of malignancy is rather small but noticeable-estimated by numerous studies to be about 3-10%. The definite differentiation between benign and malignant ones is a vital issue in endocrine practice. The aim of the current study was to assess the expression of vascular endothelial growth factor A (VEGF-A) and VEGF-C on the mRNA level in FNAB washouts in case of benign and malignant thyroid nodules and to evaluate the diagnostic value of these markers of malignancy. Materials and Methods Patients undergoing fine-needle aspiration biopsy (FNAB) in our department between January 2013 and May 2014 were included. In case of all patients who gave the written consent, after ultrasonography (US) and fine-needle aspiration biopsy (FNAB) performed as routine medical procedure the needle was flushed with RNA Later solution, the washouts were frozen in -80 Celsius degrees. Expression of VEGF-A and VEGF-C and GADPH (reference gene) was assessed in washouts on the mRNA level using the real-time PCR technique. Probes of patients who underwent subsequent thyroidectomy and were diagnosed with differentiated thyroid cancer (DTC; proved by post-surgical histopathology) were analyzed. Similar number of patients with benign cytology were randomly selected to be a control group. Results Thirty one DTCs and 28 benign thyroid lesions were analyzed. Expression of VEGF-A was insignificantly higher in patients with DTCs (p = 0.13). Expression of VEGF-C was significantly higher in patients with DTC. The relative expression of VEGF-C (in comparison with GAPDH) was 0.0049 for DTCs and 0.00070 for benign lesions, medians -0.0036 and 0.000024 respectively (p<0.0001). Conclusions Measurement of expression VEGF-C on the mRNA level in washouts from FNAB is more useful than more commonly investigated VEGF-A. Measurement of VEGF-C in FNAB washouts do not allow for fully reliable differentiation of benign and malignant thyroid nodules and should be interpreted carefully. Further studies on larger groups are indicated. However, measurement of VEGF-C on mRNA level can bring important information without exposing patient for additional risk and invasive procedures.	[Wolinski, Kosma; Stangierski, Adam; Szczepanek-Parulska, Ewelina; Gurgul, Edyta; Budny, Bardomiej; Wrotkowska, Elzbieta; Ruchala, Marek] Poznan Univ Med Sci, Dept Endocrinol Metab & Internal Med, Poznan, Poland; [Biczysko, Maciej] Poznan Univ Med Sci, Dept Gen Gastroenterol & Endocrine Surg, Poznan, Poland	Poznan University of Medical Sciences; Poznan University of Medical Sciences	Wolinski, K (corresponding author), Poznan Univ Med Sci, Dept Endocrinol Metab & Internal Med, Poznan, Poland.	kosma1644@poczta.onet.pl	Budny, Bartlomiej/AIC-4615-2022; Budny, Bartlomiej/ABF-5760-2021	Budny, Bartlomiej/0000-0002-2860-395X; Wrotkowska, Elzbieta/0000-0003-0965-7300; Wolinski, Kosma/0000-0001-9800-7881	State Committee for Scientific Research (Polish-Komitet Badan Naukowych) [N N402 545540]; Poznan University of Medical Sciences, Faculty of Medicine II [502-14-02221354-41127]	State Committee for Scientific Research (Polish-Komitet Badan Naukowych); Poznan University of Medical Sciences, Faculty of Medicine II	This study was supported by the State Committee for Scientific Research (Polish-Komitet Badan Naukowych), grant no. N N402 545540 and Poznan University of Medical Sciences, Faculty of Medicine II, grant no. 502-14-02221354-41127. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Maqbali T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049078; Brito JP, 2014, J CLIN ENDOCR METAB, V99, P1253, DOI 10.1210/jc.2013-2928; Carpi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047758; Choi YJ, 2008, YONSEI MED J, V49, P748, DOI 10.3349/ymj.2008.49.5.748; Durante C, 2011, EUR J ENDOCRINOL, V165, P455, DOI 10.1530/EJE-11-0283; Garcia EA, 2010, ENDOCR PATHOL, V21, P101, DOI 10.1007/s12022-010-9116-9; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; Hung CJ, 2003, J CLIN ENDOCR METAB, V88, P3694, DOI 10.1210/jc.2003-030080; Kajdaniuk D, 2011, ENDOKRYNOL POL, V62, P456; Kansakar E, 2009, AM SURGEON, V75, P785; Klubo-Gwiezdzinska J, 2007, EUR J ENDOCRINOL, V157, P521, DOI 10.1530/EJE-07-0252; Konturek A, 2005, LANGENBECK ARCH SURG, V390, P216, DOI 10.1007/s00423-004-0529-0; Kushner EJ, 2013, CURR OPIN HEMATOL, V20, P231, DOI 10.1097/MOH.0b013e328360614b; Liang HS, 2011, ANTICANCER RES, V31, P3433; Lin SY, 2003, CLIN ENDOCRINOL, V58, P513, DOI 10.1046/j.1365-2265.2003.01749.x; Salajegheh A, 2011, EJSO-EUR J SURG ONC, V37, P93, DOI 10.1016/j.ejso.2010.10.010; Salajegheh A, 2013, HUM PATHOL, V44, P2204, DOI 10.1016/j.humpath.2013.04.014; Stangierski A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109612; Stangierski A, 2013, NEUROENDOCRINOL LETT, V34, P798; Stanicic J, 2009, ACTA CLIN CROAT, V48, P413; Szczepanek-Parulska E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081532; Takahashi M, 2004, INT J HEMATOL, V80, P29, DOI 10.1532/IJH97.04042; Tan GH, 1997, ANN INTERN MED, V126, P226, DOI 10.7326/0003-4819-126-3-199702010-00009; Tanaka K, 2002, SURG TODAY, V32, P761, DOI 10.1007/s005950200146; Tian X, 2008, J INT MED RES, V36, P699, DOI 10.1177/147323000803600411; Waligorska-Stachura J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100534; Wolinski K, 2014, ENDOKRYNOL POL, V65, P314, DOI 10.5603/EP.2014.0043; Wolinski K, 2014, ENDOKRYNOL POL, V65, P114, DOI 10.5603/EP.2014.0016; Wolinski K, 2014, POL ARCH MED WEWN, V124, P97, DOI 10.20452/pamw.2132; Yoon JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058592; Yu XM, 2008, ANN SURG, V247, P483, DOI 10.1097/SLA.0b013e31815fa447	31	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0150124	10.1371/journal.pone.0150124	http://dx.doi.org/10.1371/journal.pone.0150124			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900960	Green Submitted, Green Published, gold			2022-12-27	WOS:000371276100208
J	Zhang, XY; Ding, LL; Yang, L; Qin, W; Yuan, JL; Li, SJ; Hu, WL				Zhang, Xiaoyu; Ding, Lingling; Yang, Lei; Qin, Wei; Yuan, Junliang; Li, Shujuan; Hu, Wenli			Brain Atrophy Correlates with Severe Enlarged Perivascular Spaces in Basal Ganglia among Lacunar Stroke Patients	PLOS ONE			English	Article							VIRCHOW-ROBIN SPACES; SMALL VESSEL DISEASE; WHITE-MATTER; BLOOD-PRESSURE; MRI MARKER; PARKINSONISM; DILATATION; STRIATUM	Background Enlarged perivascular spaces (EPVS) correlate with cognitive impairment and incident dementia. However, etiologies for severe basal ganglia EPVS (BG-EPVS) are still unclear. Our aim was to investigate the independent risk factors for severe BG-EPVS in patients with acute lacunar stroke. Methods We prospectively identified patients with lacunar stroke (diameter on DWI <= 20mm) from Jan 2011 to May 2015. Patients with severe BG-EPVS were identified on T2 weighted MRI. Age (+/- 1 year) and sex matched controls were also recruited in the same population (two controls for one case). Vascular risk factors, clinical data, EPVS in centrum semiovale (rated 0 to 4), white matter hyperintensities (WMH) (by Fazekas scale), brain atrophy (rated 0 to 6) were compared between two groups. Logistic regression was performed to determine independent risk factors for severe BG-EPVS. Results During study period, 89 patients with severe BG-EPVS and 178-matched controls were included. Vascular risk factors did not differ between two groups. Patients with severe BG-EPVS had lower level of HbA1c and diastolic BP at admission, but presented with larger infarct size, more severe WMH (including total WMH, periventricular WMH and deep WMH) and brain atrophy. In logistic regression, brain atrophy (OR = 1.40; 95% CI 1.13, 1.73) and deep WMH (OR = 1.88; 95% CI 1.24, 2.83) were independent risk factors for severe BG-EPVS. Conclusions Brain atrophy and deep WMH are independent risk factors for severe BG-EPVS, supporting the hypothesis that brain atrophy may be associated with the development of EPVS in basal ganglia.	[Zhang, Xiaoyu; Ding, Lingling; Yang, Lei; Qin, Wei; Yuan, Junliang; Li, Shujuan; Hu, Wenli] Capital Med Univ, Beijing Chaoyang Hosp, Dept Neurol, Beijing, Peoples R China	Capital Medical University	Hu, WL (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Neurol, Beijing, Peoples R China.	huwenli@sina.com	Zhang, xiaoyu/GXA-3206-2022		National Natural Science Foundation of China [81271309]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (Grant No 81271309) supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aribisala BS, 2014, STROKE, V45, P605, DOI 10.1161/STROKEAHA.113.004059; Berezuk C, 2015, SLEEP, V38, P853, DOI 10.5665/sleep.4726; Burnett MS, 2014, JAMA NEUROL, V71, P735, DOI 10.1001/jamaneurol.2014.286; Charidimou A, 2015, STROKE, V46, P1707, DOI 10.1161/STROKEAHA.115.009090; Charidimou A, 2014, NEUROLOGY, V82, P57, DOI 10.1212/01.wnl.0000438225.02729.04; Charidimou A, 2013, J NEUROL NEUROSUR PS, V84, P624, DOI 10.1136/jnnp-2012-304434; Doubal FN, 2010, STROKE, V41, P450, DOI 10.1161/STROKEAHA.109.564914; Duker AP, 2007, NEUROLOGY, V68, P1540, DOI 10.1212/01.wnl.0000261483.49248.b8; Farrell C, 2009, EUR RADIOL, V19, P177, DOI 10.1007/s00330-008-1119-2; Fenelon G, 1995, MOVEMENT DISORD, V10, P754, DOI 10.1002/mds.870100609; Gutierrez J, 2013, AM J NEURORADIOL, V34, P1711, DOI 10.3174/ajnr.A3498; Klarenbeek P, 2013, J NEUROL, V260, P115, DOI 10.1007/s00415-012-6598-z; Kolominsky-Rabas PL, 2001, STROKE, V32, P2735, DOI 10.1161/hs1201.100209; Kwee RM, 2007, RADIOGRAPHICS, V27, P1071, DOI 10.1148/rg.274065722; MacLullich AMJ, 2004, J NEUROL NEUROSUR PS, V75, P1519, DOI 10.1136/jnnp.2003.030858; MANCARDI GL, 1989, EUR NEUROL, V29, P16, DOI 10.1159/000116459; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Potter GM, 2015, INT J STROKE, V10, P376, DOI 10.1111/ijs.12054; Sahin N, 2015, ACTA RADIOL, V56, P852, DOI 10.1177/0284185114544243; Satizabal CL, 2013, J ALZHEIMERS DIS, V33, P323, DOI 10.3233/JAD-2012-120874; van Straaten ECW, 2006, STROKE, V37, P836, DOI 10.1161/01.STR.0000202585.26325.74; VANSWIETEN JC, 1991, BRAIN, V114, P761; Wuerfel J, 2008, BRAIN, V131, P2332, DOI 10.1093/brain/awn171; Xiao LL, 2015, STROKE, V46, P2081, DOI 10.1161/STROKEAHA.114.008155; Yakushiji Y, 2014, NEUROLOGY, V83, P2116, DOI 10.1212/WNL.0000000000001054; Zhang CQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105505; Zhu YC, 2011, AM J NEURORADIOL, V32, P709, DOI 10.3174/ajnr.A2366; Zhu YC, 2010, J ALZHEIMERS DIS, V22, P663, DOI 10.3233/JAD-2010-100378; Zhu YC, 2010, STROKE, V41, P2483, DOI 10.1161/STROKEAHA.110.591586	29	14	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149593	10.1371/journal.pone.0149593	http://dx.doi.org/10.1371/journal.pone.0149593			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900696	Green Submitted, Green Published, gold			2022-12-27	WOS:000371276100107
J	Zhao, X; Han, YM; Liang, Y; Nie, C; Wang, J				Zhao, Xin; Han, Yingmin; Liang, Yu; Nie, Chao; Wang, Jian			RNA-Seq Reveals the Angiogenesis Diversity between the Fetal and Adults Bone Mesenchyme Stem Cell	PLOS ONE			English	Article							TUMOR ANGIOGENESIS; GENE; TRANSCRIPTOME; HETEROGENEITY; EXPRESSION; MARROW	In this research, we used RNA sequencing (RNA-seq) to analyze 23 single cell samples and 2 bulk cells sample from human adult bone mesenchyme stem cell line and human fetal bone mesenchyme stem cell line. The results from the research demonstrated that there were big differences between two cell lines. Adult bone mesenchyme stem cell lines showed a strong trend on the blood vessel differentiation and cell motion, 48/49 vascular related differential expressed genes showed higher expression in adult bone mesenchyme stem cell lines (Abmsc) than fetal bone mesenchyme stem cell lines (Fbmsc). 96/106 cell motion related genes showed the same tendency. Further analysis showed that genes like ANGPT1, VEGFA, FGF2, PDGFB and PDGFRA showed higher expression in Abmsc. This work showed cell heterogeneity between human adult bone mesenchyme stem cell line and human fetal bone mesenchyme stem cell line. Also the work may give an indication that Abmsc had a better potency than Fbmsc in the future vascular related application.	[Zhao, Xin; Wang, Jian] Univ Chinese Acad Sci, BGI Educ Ctr, Shenzhen 518083, Guangdong, Peoples R China; [Zhao, Xin; Nie, Chao; Wang, Jian] BGI Shenzhen, Shenzhen 518083, Guangdong, Peoples R China; [Han, Yingmin; Liang, Yu] BGI Tianjin, Binhai Genom Inst, Tianjin 300308, Peoples R China; [Han, Yingmin; Liang, Yu] Geneis, Beijing 100094, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI)	Wang, J (corresponding author), Univ Chinese Acad Sci, BGI Educ Ctr, Shenzhen 518083, Guangdong, Peoples R China.; Nie, C; Wang, J (corresponding author), BGI Shenzhen, Shenzhen 518083, Guangdong, Peoples R China.; Liang, Y (corresponding author), BGI Tianjin, Binhai Genom Inst, Tianjin 300308, Peoples R China.; Liang, Y (corresponding author), Geneis, Beijing 100094, Peoples R China.	liangyu@genomics.cn; niechao@genomics.cn; wangjian@genomics.cn		Zhao, Xin/0000-0001-8502-0139	BGI Education Center, University of Chinese Academy of Sciences; Shenzhen Municipal of Government of China [CXB201108250094A]	BGI Education Center, University of Chinese Academy of Sciences; Shenzhen Municipal of Government of China	XZ was supported by a PhD studentship from the BGI Education Center, University of Chinese Academy of Sciences, and the authors thank the support of the Shenzhen Municipal of Government of China (CXB201108250094A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2003, CIRCULATION, V107, P2134, DOI 10.1161/01.CIR.0000062649.63838.C9; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Brown KC, 2012, ANGIOGENESIS, V15, P99, DOI 10.1007/s10456-011-9246-9; Chai ZT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077957; Claesson-Welsh L, 2013, J INTERN MED, V273, P114, DOI 10.1111/joim.12019; Copland Ian B, 2011, J Cardiovasc Dis Res, V2, P3, DOI 10.4103/0975-3583.78581; De Kock J, 2012, STEM CELLS DEV, V21, P3309, DOI 10.1089/scd.2011.0723; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Han Hui, 2014, ScientificWorldJournal, V2014, P878209, DOI 10.1155/2014/878209; Hua J, 2014, INT J CLIN EXP PATHO, V7, P3580; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang W, 2010, J MOL CELL CARDIOL, V48, P702, DOI 10.1016/j.yjmcc.2009.10.032; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lee MCW, 2014, P NATL ACAD SCI USA, V111, pE4726, DOI 10.1073/pnas.1404656111; Li A, 2007, BIOINFORMATICS, V23, P222, DOI 10.1093/bioinformatics/btl581; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Samper E, 2013, STEM CELL REV REP, V9, P266, DOI 10.1007/s12015-012-9353-z; Scotti L, 2014, REPROD FERTIL DEV; Shen KK, 2014, CHEM-BIOL INTERACT, V218, P99, DOI 10.1016/j.cbi.2014.04.020; Streets AM, 2014, NAT BIOTECHNOL, V32, P1005, DOI 10.1038/nbt.3039; Strioga M, 2012, STEM CELLS DEV, V21, P2724, DOI 10.1089/scd.2011.0722; Tang FC, 2011, NAT METHODS, V8, pS6, DOI [10.1038/NMETH.1557, 10.1038/nmeth.1557]; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; van den Oord EJCG, 2008, AM J MED GENET B, V147B, P637, DOI 10.1002/ajmg.b.30650; Xue G, 2015, ONCOGENE, V34, P1393, DOI 10.1038/onc.2014.82; Zhang DS, 2008, J MOL CELL CARDIOL, V44, P281, DOI 10.1016/j.yjmcc.2007.11.010; Zhu K, 2013, CARCINOGENESIS, V34, P2071, DOI 10.1093/carcin/bgt160	31	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149171	10.1371/journal.pone.0149171	http://dx.doi.org/10.1371/journal.pone.0149171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901069	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100044
J	Han, WGH; Hodemaekers, HM; Nagarajah, B; Poelen, MMC; Helm, K; Janssen, R; van Els, CACM				Han, Wanda G. H.; Hodemaekers, Hennie M.; Nagarajah, Bhawani; Poelen, Martien M. C.; Helm, Kina; Janssen, Riny; van Els, Cecile A. C. M.			Association of Vitamin D Receptor Polymorphism with Susceptibility to Symptomatic Pertussis	PLOS ONE			English	Article							SYNCYTIAL VIRUS BRONCHIOLITIS; BINDING LECTIN DEFICIENCY; BORDETELLA-PERTUSSIS; GENETIC SUSCEPTIBILITY; INFECTIOUS-DISEASES; RSV BRONCHIOLITIS; IMMUNE-SYSTEM; T-CELLS; PATHOGENESIS; EPIDEMIOLOGY	Pertussis, caused by infection with the gram negative B. pertussis bacterium, is a serious respiratory illness that can last for months. While B. pertussis infection rates are estimated between 1-10% in the general population, notifications of symptomatic pertussis only comprise 0.01-0.1% indicating that most individuals clear B. pertussis infections without developing (severe) clinical symptoms. In this study we investigated whether genetic risk factors are involved in the development of symptomatic pertussis upon B. pertussis infection. Single-nucleotide polymorphisms (SNPs) in candidate genes, MBL2, IL17A, TNF alpha, VDR, and IL10 were genotyped in a unique Dutch cohort of symptomatic clinically confirmed (ex-)pertussis patients and in a Dutch population cohort. Of the seven investigated SNPs in five genes, a polymorphism in the Vitamin D receptor (VDR) gene (rs10735810) was associated with pertussis. The VDR major allele and its homozygous genotype were more present in the symptomatic pertussis patient cohort compared to the control population cohort. Interestingly, the VDR major allele correlated also with the duration of reported pertussis symptoms. Vitamin D-3 (VD3) and VDR are important regulators of immune activation. Altogether, these findings suggest that polymorphisms in the VDR gene may affect immune activation and the clinical outcome of B. pertussis infection.	[Han, Wanda G. H.; Poelen, Martien M. C.; Helm, Kina; van Els, Cecile A. C. M.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Hodemaekers, Hennie M.; Nagarajah, Bhawani; Janssen, Riny] Natl Inst Publ Hlth & Environm, Ctr Hlth Protect, NL-3720 BA Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment	Han, WGH (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	wanda.han@rivm.nl			Dutch government	Dutch government	This study was financially supported by the Dutch government.	Asner SA, 2014, CLIN MICROBIOL INFEC, V20, P1246, DOI 10.1111/1469-0691.12806; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Brock KE, 2013, J STEROID BIOCHEM, V136, P214, DOI 10.1016/j.jsbmb.2012.12.005; Caballero MT, 2015, J CLIN INVEST, V125, P571, DOI 10.1172/JCI75183; Chen JH, 2010, J CLIN IMMUNOL, V30, P539, DOI 10.1007/s10875-010-9391-8; Cherry JD, 2012, NEW ENGL J MED, V367, P785, DOI 10.1056/NEJMp1209051; Chun RF, 2014, J STEROID BIOCHEM, V144, P132, DOI 10.1016/j.jsbmb.2013.09.012; Clark TA, 2014, J INFECT DIS, V209, P978, DOI 10.1093/infdis/jiu001; Dickie LJ, 2010, RHEUMATOLOGY, V49, P1466, DOI 10.1093/rheumatology/keq124; Eisen DP, 2003, CLIN INFECT DIS, V37, P1496, DOI 10.1086/379324; Gao L, 2010, INT J TUBERC LUNG D, V14, P15; Geurtsen J, 2007, CLIN VACCINE IMMUNOL, V14, P821, DOI 10.1128/CVI.00074-07; Grondahl-Yli-Hannuksela K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088919; Grondahl-Yli-Hannuksela K, 2013, APMIS, V121, P311, DOI 10.1111/apm.12000; Heitzeneder S, 2012, CLIN IMMUNOL, V143, P22, DOI 10.1016/j.clim.2011.11.002; Hewlett EL, 2014, J INFECT DIS, V209, P982, DOI 10.1093/infdis/jit639; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Hoebee B, 2004, J INFECT DIS, V189, P239, DOI 10.1086/380908; Hoebee B, 2003, J INFECT DIS, V187, P2, DOI 10.1086/345859; Janssen R, 2007, J INFECT DIS, V196, P826, DOI 10.1086/520886; Jeffery LE, 2012, J IMMUNOL, V189, P5155, DOI 10.4049/jimmunol.1200786; Jurutka PW, 2000, MOL ENDOCRINOL, V14, P401, DOI 10.1210/me.14.3.401; Khoo AL, 2012, CRIT REV MICROBIOL, V38, P122, DOI 10.3109/1040841X.2011.622716; Kresfelder TL, 2011, J MED VIROL, V83, P1834, DOI 10.1002/jmv.22179; Louis E, 1998, CLIN EXP IMMUNOL, V113, P401; Lucas RM, 2013, J STEROID BIOCHEM, V136, P300, DOI 10.1016/j.jsbmb.2013.01.011; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Melvin JA, 2014, NAT REV MICROBIOL, V12, P274, DOI 10.1038/nrmicro3235; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Paddock CD, 2008, CLIN INFECT DIS, V47, P328, DOI 10.1086/589753; Randolph AG, 2014, CLIN EXP ALLERGY, V44, P231, DOI 10.1111/cea.12247; Ross PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003264; Roth DE, 2008, J INFECT DIS, V197, P676, DOI 10.1086/527488; Sadeghi K, 2006, EUR J IMMUNOL, V36, P361, DOI 10.1002/eji.200425995; Temple SEL, 2003, IMMUNOGENETICS, V55, P629, DOI 10.1007/s00251-003-0621-6; Unger WWJ, 2009, EUR J IMMUNOL, V39, P3147, DOI 10.1002/eji.200839103; van der Ark AAJ, 2012, EXPERT REV VACCINES, V11, P1121, DOI [10.1586/ERV.12.83, 10.1586/erv.12.83]; van der Maas NAT, 2013, VACCINE, V31, P4541, DOI 10.1016/j.vaccine.2013.07.060; van Etten E, 2007, EUR J IMMUNOL, V37, P395, DOI 10.1002/eji.200636043; van Lier EA, 2014, 150202003 RIVM; Viet AL vGH, 1998, RISK FACTORS HLTH NE; Wang T, 2004, J NEURAL ENG, V1, DOI 10.1088/1741-2560/1/1/001; Warfel JM, 2014, P NATL ACAD SCI USA, V111, P787, DOI 10.1073/pnas.1314688110; Whitfield GK, 2001, MOL CELL ENDOCRINOL, V177, P145; Wilkinson RJ, 2000, LANCET, V355, P618, DOI 10.1016/S0140-6736(99)02301-6; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124; YU XP, 1995, P NATL ACAD SCI USA, V92, P10990, DOI 10.1073/pnas.92.24.10990; Yucesoy B, 2009, VACCINE, V27, P6991, DOI 10.1016/j.vaccine.2009.09.076	48	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149576	10.1371/journal.pone.0149576	http://dx.doi.org/10.1371/journal.pone.0149576			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894582	gold, Green Published			2022-12-27	WOS:000371223400066
J	Munang'andu, HM; Santi, N; Fredriksen, BN; Lokling, KE; Evensen, O				Munang'andu, Hetron Mweemba; Santi, Nina; Fredriksen, Borge Nilsen; Lokling, Knut-Egil; Evensen, Oystein			A Systematic Approach towards Optimizing a Cohabitation Challenge Model for Infectious Pancreatic Necrosis Virus in Atlantic Salmon (Salmo salar L.)	PLOS ONE			English	Article							PARAFFIN-EMBEDDED SPECIMENS; TROUT ONCORHYNCHUS-MYKISS; SAMPLE-SIZE; VACCINATION; VIRULENCE; EFFICACY; IPNV	A cohabitation challenge model was developed for use in evaluating the efficacy of vaccines developed against infectious pancreatic necrosis virus (IPNV) in Atlantic salmon (Salmo salar L) using a stepwise approach. The study involved identifying a set of input variables that were optimized before inclusion in the model. Input variables identified included the highly virulent Norwegian Sp strain NVI015-TA encoding the T(217)A(221) motif having the ability to cause >90% mortality and a hazard risk ratio of 490.18 (p<0.000) for use as challenge virus. The challenge dose was estimated at 1x10(7) TCID50/mL per fish while the proportion of virus shedders was estimated at 12.5% of the total number of fish per tank. The model was designed based on a three parallel tank system in which the Cox hazard proportional regression model was used to estimate the minimum number of fish required to show significant differences between the vaccinated and control fish in each tank. All input variables were optimized to generate mortality >75% in the unvaccinated fish in order to attain a high discriminatory capacity (DC) between the vaccinated and control fish as a measure of vaccine efficacy. The model shows the importance of using highly susceptible fish to IPNV in the optimization of challenge models by showing that highly susceptible fish had a better DC of differentiating vaccine protected fish from the unvaccinated control fish than the less susceptible fish. Once all input variables were optimized, the model was tested for its reproducibility by generating similar results from three independent cohabitation challenge trials using the same input variables. Overall, data presented here show that the cohabitation challenge model developed in this study is reproducible and that it can reliably be used to evaluate the efficacy of vaccines developed against IPNV in Atlantic salmon. We envision that the approach used here will open new avenues for developing optimal challenge models for use in evaluating the efficacy of different vaccines used in aquaculture.	[Munang'andu, Hetron Mweemba; Evensen, Oystein] Norwegian Univ Life Sci, Fac Vet Med & Biosci, Dept Basic Sci & Aquat Med, Sect Aquat Med & Nutr, Ullevalsveien 72, Oslo, Norway; [Santi, Nina] AquaGen, Trondheim, Norway; [Fredriksen, Borge Nilsen; Lokling, Knut-Egil] PHARMAQ AS, Harbitzalleen 2A, N-0275 Oslo, Norway	Norwegian University of Life Sciences	Evensen, O (corresponding author), Norwegian Univ Life Sci, Fac Vet Med & Biosci, Dept Basic Sci & Aquat Med, Sect Aquat Med & Nutr, Ullevalsveien 72, Oslo, Norway.	oystein.evensen@nmbu.no	Munang'andu, Hetron Mweemba/C-5926-2014	Munang'andu, Hetron Mweemba/0000-0002-1021-6396				Amend D.F., 1981, FISH BIOL SERODIAGNO, V49, P447; BLACKWELDER WC, 1993, STAT MED, V12, P691, DOI 10.1002/sim.4780120708; Bowden TJ, 2003, J FISH DIS, V26, P309, DOI 10.1046/j.1365-2761.2003.00456.x; Bowden TJ, 2002, J FISH DIS, V25, P555, DOI 10.1046/j.1365-2761.2002.00402.x; Carpenter TE, 2001, AM J VET RES, V62, P1582, DOI 10.2460/ajvr.2001.62.1582; COX DR, 1972, J R STAT SOC B, V34, P187; DOBOS P, 1976, NUCLEIC ACIDS RES, V3, P1903, DOI 10.1093/nar/3.8.1903; EMEA, 1998, EUR AG EV MED PROD C; Evensen O, 1997, VET PATHOL, V34, P253, DOI 10.1177/030098589703400316; Evensen O, 1997, DIS AQUAT ORGAN, V29, P227, DOI 10.3354/dao029227; Gomez-Casado E, 2011, VACCINE, V29, P2657, DOI 10.1016/j.vaccine.2011.01.097; JARP J, 1995, J FISH DIS, V18, P67, DOI 10.1111/j.1365-2761.1995.tb01267.x; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Munang'andu HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054263; Munang'andu HM, 2012, VACCINE, V30, P4007, DOI 10.1016/j.vaccine.2012.04.039; Munang'andu HM, 2014, DEV COMP IMMUNOL, V43, P184, DOI 10.1016/j.dci.2013.08.008; Munang'andu HM, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-7; Munang'andu HM, 2013, VACCINE, V31, P1956, DOI 10.1016/j.vaccine.2013.02.008; Munang'andu HM, 2013, THESIS NORWEGIAN SCH; Mutoloki S, 2013, FISH SHELLFISH IMMUN, V34, P1667, DOI 10.1016/j.fsi.2013.03.103; Ramstad A, 2008, J FISH DIS, V31, P567, DOI 10.1111/j.1365-2761.2008.00929.x; Ramstad A, 2007, J FISH DIS, V30, P723, DOI 10.1111/j.1365-2761.2007.00858.x; Rao MR, 2002, VACCINE, V20, P3364, DOI 10.1016/S0264-410X(02)00317-1; Rusche B, 2003, ALTEX-ALTERN TIEREXP, V20, P63; Santi N, 2004, VIROLOGY, V322, P31, DOI 10.1016/j.virol.2003.12.016	25	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0148467	10.1371/journal.pone.0148467	http://dx.doi.org/10.1371/journal.pone.0148467			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895162	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000371223400016
J	Singh, UB; Pandey, P; Mehta, G; Bhatnagar, AK; Mohan, A; Goyal, V; Ahuja, V; Ramachandran, R; Sachdeva, KS; Samantaray, JC				Singh, Urvashi B.; Pandey, Pooja; Mehta, Girija; Bhatnagar, Anuj K.; Mohan, Anant; Goyal, Vinay; Ahuja, Vineet; Ramachandran, Ranjani; Sachdeva, Kuldeep S.; Samantaray, Jyotish C.			Genotypic, Phenotypic and Clinical Validation of GeneXpert in Extra-Pulmonary and Pulmonary Tuberculosis in India	PLOS ONE			English	Article							XPERT MTB/RIF ASSAY; MYCOBACTERIUM-TUBERCULOSIS; RIFAMPIN RESISTANCE; DRUG-RESISTANCE; RAPID DIAGNOSIS; RPOB GENE; PERFORMANCE; COMPLEX; HETERORESISTANCE; EPIDEMIOLOGY	Background Newer molecular diagnostics have brought paradigm shift in early diagnosis of tuberculosis [TB]. WHO recommended use of GeneXpert MTB/RIF [Xpert] for Extra-pulmonary [EP] TB; critics have since questioned its efficiency. Methods The present study was designed to assess the performance of GeneXpert in 761 extra-pulmonary and 384 pulmonary specimens from patients clinically suspected of TB and compare with Phenotypic, Genotypic and Composite reference standards [CRS]. Results Comparison of GeneXpert results to CRS, demonstrated sensitivity of 100% and 90.68%, specificity of 100% and 99.62% for pulmonary and extra-pulmonary samples. On comparison with culture, sensitivity for Rifampicin [Rif] resistance detection was 87.5% and 81.82% respectively, while specificity was 100% for both pulmonary and extra-pulmonary TB. On comparison to sequencing of rpoB gene [Rif resistance determining region, RRDR], sensitivity was respectively 93.33% and 90% while specificity was 100% in both pulmonary and extra-pulmonary TB. GeneXpert assay missed 533CCG mutation in one sputum and dual mutation [517 & 519] in one pus sample, detected by sequencing. Sequencing picked dual mutation [529, 530] in a sputum sample sensitive to Rif, demonstrating, not all RRDR mutations lead to resistance. Conclusions Current study reports observations in a patient care setting in a high burden region, from a large collection of pulmonary and extra-pulmonary samples and puts to rest questions regarding sensitivity, specificity, detection of infrequent mutations and mutations responsible for low-level Rif resistance by GeneXpert. Improvements in the assay could offer further improvement in sensitivity of detection in different patient samples; nevertheless it may be difficult to improve sensitivity of Rif resistance detection if only one gene is targeted. Assay specificity was high both for TB detection and Rif resistance detection. Despite a few misses, the assay offers major boost to early diagnosis of TB and MDR-TB, in difficult to diagnose pauci-bacillary TB.	[Singh, Urvashi B.; Pandey, Pooja; Mehta, Girija; Samantaray, Jyotish C.] All India Inst Med Sci, Dept Microbiol, New Delhi 110029, India; [Bhatnagar, Anuj K.] Rajan Babu Inst Pulm Med & TB, Delhi, India; [Mohan, Anant] All India Inst Med Sci, Dept Pulm Med & Sleep Disorders, New Delhi, India; [Goyal, Vinay] All India Inst Med Sci, Dept Neurol, New Delhi, India; [Ahuja, Vineet] All India Inst Med Sci, Dept Gastroenterol & Human Nutr, New Delhi, India; [Ramachandran, Ranjani] WHO, Country Off India, New Delhi, India; [Sachdeva, Kuldeep S.] Govt India, Cent TB Div, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; World Health Organization	Singh, UB (corresponding author), All India Inst Med Sci, Dept Microbiol, New Delhi 110029, India.	drurvashi@gmail.com	Ahuja, Vineet/N-1705-2019; Kedia, Saurabh/AAD-7227-2020	Ahuja, Vineet/0000-0002-5474-9709; 	Indian Council of Medical Research [5/8/5/27/2011-ECD-1]; Indian Council of Medical Research [ICMR]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Indian Council of Medical Research [ICMR](Indian Council of Medical Research (ICMR))	This work was supported by Indian Council of Medical Research 5/8/5/27/2011-ECD-1, http://www.icmr.nic.in/ (UBS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all our patients that made this study possible. We also thank the technical staff of TB division, Department of Microbiology, AIIMS, New Delhi, India for their support. The authors acknowledge the funding received from Indian Council of Medical Research [ICMR].	Al-Mutairi NM, 2011, INT J TUBERC LUNG D, V15, P110; Blakemore R, 2010, J CLIN MICROBIOL, V48, P2495, DOI 10.1128/JCM.00128-10; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Central TB Division Ministry of Health and Family Welfare, 2010, TRAIN MOD MED PRACT; Central TB Division Ministry of Health and Family Welfare, 2009, TRAIN MAN MYC TUB CU; Central TB Division Ministry of Health and Family Welfare New Delhi India Revised National TB Control Programme, 2012, GUIDELINES PROGRAMMA; Chakravorty S, 2012, J CLIN MICROBIOL, V50, P2194, DOI 10.1128/JCM.00143-12; Denkinger CM, 2014, EUR RESPIR J, V44, P435, DOI 10.1183/09031936.00007814; El-Hajj HH, 2001, J CLIN MICROBIOL, V39, P4131, DOI 10.1128/JCM.39.11.4131-4137.2001; Friedrich SO, 2011, J CLIN MICROBIOL, V49, P4341, DOI 10.1128/JCM.05454-11; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Huang WL, 2009, J CLIN MICROBIOL, V47, P2520, DOI 10.1128/JCM.02499-08; Jamieson FB, 2014, J CLIN MICROBIOL, V52, P2157, DOI 10.1128/JCM.00691-14; Jou R, 2005, J CLIN MICROBIOL, V43, P1390, DOI 10.1128/JCM.43.3.1390-1394.2005; Kim S., 2012, J NANOMATER, V2012, P1, DOI DOI 10.1080/19443994.2012.664382; KUBICA GP, 1963, AM REV RESPIR DIS, V87, P775; Ligthelm LJ, 2011, J CLIN MICROBIOL, V49, P3967, DOI 10.1128/JCM.01310-11; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; Rigouts L, 2013, J CLIN MICROBIOL, V51, P2641, DOI 10.1128/JCM.02741-12; Sharma SK, 2004, INDIAN J MED RES, V120, P354; Siddiqi SH, 2006, MGIT PROCEDURE MANUA; Somoskovi A, 2014, J CLIN MICROBIOL, V52, P705, DOI 10.1128/JCM.02682-13; Somoskovi A, 2006, J CLIN MICROBIOL, V44, P4459, DOI 10.1128/JCM.01506-06; SUO J, 1988, AM REV RESPIR DIS, V138, P999, DOI 10.1164/ajrccm/138.4.999; Suresh N, 2006, INFECT GENET EVOL, V6, P474, DOI 10.1016/j.meegid.2006.03.001; Taniguchi H, 1996, FEMS MICROBIOL LETT, V144, P103, DOI 10.1016/0378-1097(96)00346-1; Thomsen Todd W, 2006, N Engl J Med, V355, pe16, DOI 10.1056/NEJMvcm053812; Tortoli E, 2012, EUR RESPIR J, V40, P442, DOI 10.1183/09031936.00176311; Vadwai V, 2011, J CLIN MICROBIOL, V49, P2540, DOI 10.1128/JCM.02319-10; Van Deun A, 2011, INT J TUBERC LUNG D, V15, P116; Van Deun A, 2009, J CLIN MICROBIOL, V47, P3501, DOI 10.1128/JCM.01209-09; Van Deun A, 2013, J CLIN MICROBIOL, V51, P2633, DOI 10.1128/JCM.00553-13; van Rie A, 2005, AM J RESP CRIT CARE, V172, P636, DOI 10.1164/rccm.200503-449OC; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; Varma-Basil M, 2004, J CLIN MICROBIOL, V42, P5512, DOI 10.1128/JCM.42.12.5512-5516.2004; Victor TC, 2002, IUBMB LIFE, V53, P231, DOI 10.1080/15216540212642; WHO, STANDARD OPERATING P; World Health Organization, 2008, MOL LIN PROB ASS RAP; World Health Organization, 2011, RAP IMPL XPERT MTB R; World Health Organization, 2013, DEFINITIONS REPORTIN; World Health Organization, 2007, US LIQ TB CULT DRUG; Zeka AN, 2011, J CLIN MICROBIOL, V49, P4138, DOI 10.1128/JCM.05434-11; Zetola NM, 2014, J CLIN MICROBIOL, V52, P2422, DOI 10.1128/JCM.02489-13; Zhang ZJ, 2014, ANTIMICROB AGENTS CH, V58, P5632, DOI 10.1128/AAC.02778-14	46	35	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149258	10.1371/journal.pone.0149258	http://dx.doi.org/10.1371/journal.pone.0149258			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894283	Green Submitted, Green Published, gold			2022-12-27	WOS:000371223400042
J	Soldanova, M; Selbach, C; Sures, B				Soldanova, Miroslava; Selbach, Christian; Sures, Bernd			The Early Worm Catches the Bird? Productivity and Patterns of Trichobilharzia szidati Cercarial Emission from Lymnaea stagnalis	PLOS ONE			English	Article							DIPLOSTOMUM-SPATHACEUM; BIOMPHALARIA-GLABRATA; SCHISTOSOMA-MANSONI; TREMATODE COMMUNITIES; LARVAL POPULATIONS; PARASITES; HOST; TRANSMISSION; DIVERSITY; EMERGENCE	Digenean trematodes are common and abundant in aquatic habitats and their free-living larvae, the cercariae, have recently been recognized as important components of ecosystems in terms of comprising a significant proportion of biomass and in having a potentially strong influence on food web dynamics. One strategy to enhance their transmission success is to produce high numbers of cercariae which are available during the activity peak of the next host. In laboratory experiments with 13 Lymnaea stagnalis snails infected with Trichobilharzia szidati the average daily emergence rate per snail was determined as 2,621 cercariae, with a maximum of 29,560. During a snail's lifetime this summed up to a mass equivalent of or even exceeding the snail's own body mass. Extrapolated for the eutrophic pond where the snails were collected, annual T. szidati biomass may reach 4.65 tons, a value equivalent to a large Asian elephant. Emission peaks were observed after the onset of illumination, indicating emission synchronizing with the high morning activities of the definitive hosts, ducks. However, high cercarial emission is possible throughout the day under favorable lightning conditions. Therefore, although bird schistosomes, such as T. szidati constitute only a fraction of the diverse trematode communities in the studied aquatic ecosystem, their cercariae can still pose a considerable risk for humans of getting cercarial dermatitis (swimmer's itch) due to the high number of cercariae emitted from infected snails.	[Soldanova, Miroslava] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic; [Selbach, Christian; Sures, Bernd] Univ Duisburg Essen, Dept Aquat Ecol, Essen, Germany; [Selbach, Christian; Sures, Bernd] Univ Duisburg Essen, Ctr Water & Environm Res ZWU, Essen, Germany; [Sures, Bernd] Univ Johannesburg, Dept Zool, Johannesburg, South Africa	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of Duisburg Essen; University of Duisburg Essen; University of Johannesburg	Soldanova, M (corresponding author), Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.	soldanova@paru.cas.cz	Sures, Bernd/B-6652-2013; Soldanova, Miroslava/G-7215-2014	Soldanova, Miroslava/0000-0002-5277-3799; Selbach, Christian/0000-0002-7777-6515; Sures, Bernd/0000-0001-6865-6186	Czech Science Foundation [15-14198S]; Institute of Parasitology, Biology Centre of the Czech Academy of Sciences [RVO:60077344]; Bundesministerium fur Bildung und Forschung (BMBF) [02WRS1283]; Deutsche Bundesstiftung Umwelt (DBU); Faculty of Biology of the University of Duisburg-Essen	Czech Science Foundation(Grant Agency of the Czech Republic); Institute of Parasitology, Biology Centre of the Czech Academy of Sciences; Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Bundesstiftung Umwelt (DBU); Faculty of Biology of the University of Duisburg-Essen	This study was partially funded by the Czech Science Foundation (Proj. No. 15-14198S to MS), Institute of Parasitology, Biology Centre of the Czech Academy of Sciences (RVO:60077344) and the 'Sichere Ruhr' project as part of the Bundesministerium fur Bildung und Forschung (BMBF) program 'Sustainable Water Management' (grant 02WRS1283 to MS and BS). CS benefited from a Deutsche Bundesstiftung Umwelt (DBU) PhD fellowship and a research grant by the Faculty of Biology of the University of Duisburg-Essen.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Amundsen PA, 2009, J ANIM ECOL, V78, P563, DOI 10.1111/j.1365-2656.2008.01518.x; ANDERSON PA, 1976, CAN J ZOOL, V54, P1481, DOI 10.1139/z76-171; Brant SV, 2013, TRENDS PARASITOL, V29, P449, DOI 10.1016/j.pt.2013.06.004; BRASSARD P, 1982, CAN J ZOOL, V60, P2258, DOI 10.1139/z82-291; Brown R, 2011, PARASITOL RES, V108, P137, DOI 10.1007/s00436-010-2047-z; COMBES C, 1994, PARASITOLOGY, V109, pS3, DOI 10.1017/S0031182000085048; ESCH GW, 1994, AM MIDL NAT, V131, P209, DOI 10.2307/2426248; Finch Caleb E., 1999, P613; Galaktionov K.V., 2003, BIOL EVOLUTION TREMA; Gloer P., 2002, DIE SU BETA WASSERGA; Haas W, 2003, ZOOLOGY, V106, P349, DOI 10.1078/0944-2006-00125; Hechinger RF, 2005, P ROY SOC B-BIOL SCI, V272, P1059, DOI 10.1098/rspb.2005.3070; Hechinger RF, 2009, EVOL ECOL, V23, P651, DOI 10.1007/s10682-008-9262-4; Hechinger RF, 2007, OECOLOGIA, V151, P82, DOI 10.1007/s00442-006-0568-z; Hechinger RF, 2013, AM NAT, V182, P234, DOI 10.1086/670820; Horak P, 2005, PARASITE IMMUNOL, V27, P247, DOI 10.1111/j.1365-3024.2005.00776.x; Horak P, 2002, ADV PARASIT, V52, P155, DOI 10.1016/S0065-308X(02)52012-1; Horak P, 2001, TRENDS PARASITOL, V17, P66, DOI 10.1016/S1471-4922(00)01770-0; Horak P, 2015, CLIN MICROBIOL REV, V28, P165, DOI 10.1128/CMR.00043-14; Horak P, 2014, ADV EXP MED BIOL, V766, P331, DOI 10.1007/978-1-4939-0915-5_10; Horak P, 2011, FRESHWATER BIOL, V56, P779, DOI 10.1111/j.1365-2427.2010.02545.x; Horsak M, 2013, MEKKYSI CESKE SLOVEN; Hudson P, 2005, PARASITISM AND ECOSYSTEMS, P1; Johnson PTJ, 2010, TRENDS ECOL EVOL, V25, P362, DOI 10.1016/j.tree.2010.01.005; Jurkiewicz-Karnkowska E, 2008, POL J ECOL, V56, P99; Karvonen A, 2004, PARASITOLOGY, V129, P87, DOI 10.1017/S0031182004005281; Koehler AV, 2012, EVOL ECOL, V26, P1497, DOI 10.1007/s10682-012-9558-2; KURIS A, 1990, PARASITE COMMUNITIES : PATTERNS AND PROCESSES, P69, DOI 10.1007/978-94-009-0837-6_4; Kuris AM, 2008, NATURE, V454, P515, DOI 10.1038/nature06970; Lafferty KD, 2008, ECOL LETT, V11, P533, DOI 10.1111/j.1461-0248.2008.01174.x; Lafferty KD, 2006, P NATL ACAD SCI USA, V103, P11211, DOI 10.1073/pnas.0604755103; Lindblade KA, 1998, J PARASITOL, V84, P19, DOI 10.2307/3284521; Loy C, 2001, PARASITOL RES, V87, P878, DOI 10.1007/s004360100462; Lyholt HCK, 1996, DIS AQUAT ORGAN, V25, P169, DOI 10.3354/dao025169; Morley NJ, 2013, PARASITOLOGY, V140, P1211, DOI 10.1017/S0031182012001783; Morley NJ, 2012, HYDROBIOLOGIA, V691, P7, DOI 10.1007/s10750-012-1029-9; Neuhaus W., 1952, Zeitschrift fuer Parasitenkunde, V15, P203; NGoran E, 1997, ACTA TROP, V66, P35, DOI 10.1016/S0001-706X(97)00676-1; PAGES JR, 1990, INT J PARASITOL, V20, P193, DOI 10.1016/0020-7519(90)90100-2; Pietrock M, 2003, TRENDS PARASITOL, V19, P293, DOI 10.1016/S1471-4922(03)00117-X; Poulin R, 2006, PARASITOLOGY, V132, P143, DOI 10.1017/S0031182005008693; Poulin R, 2007, INT J PARASITOL, V37, P359, DOI 10.1016/j.ijpara.2006.11.009; Preston DL, 2013, J ANIM ECOL, V82, P509, DOI 10.1111/1365-2656.12030; Preston Daniel L., 2012, Ecology (Washington D C), V93, P1760; Rudolfova J, 2005, PARASITOL RES, V95, P79, DOI 10.1007/s00436-004-1262-x; Sauter A, 2012, J ORNITHOL, V153, P713, DOI 10.1007/s10336-011-0788-9; Selbach C, 2015, INT J HYG E IN PRESS; SLUITERS JF, 1980, Z PARASITENKD, V63, P13, DOI 10.1007/BF00927722; Soldanova M, 2011, PARASITOLOGY, V138, P789, DOI 10.1017/S0031182011000291; Soldanova M, 2013, TRENDS PARASITOL, V29, P65, DOI 10.1016/j.pt.2012.12.002; Soldanova M, 2012, J PARASITOL, V98, P460, DOI 10.1645/GE-2964.1; Soldanova M, 2011, INT J PARASITOL, V41, P981, DOI 10.1016/j.ijpara.2011.05.005; Soldanova M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-56; Studer A, 2013, MAR BIOL, V160, P2763, DOI 10.1007/s00227-013-2269-6; Taskinen J, 1998, J PARASITOL, V84, P345, DOI 10.2307/3284493; Theron A, 1997, PARASITOL RES, V83, P356, DOI 10.1007/s004360050261; THERON A, 1981, ANN TROP MED PARASIT, V75, P547, DOI 10.1080/00034983.1981.11687479; THERON A, 1981, ANN TROP MED PARASIT, V75, P71, DOI 10.1080/00034983.1981.11720796; Thieltges DW, 2008, PARASITOLOGY, V135, P407, DOI 10.1017/S0031182007000248; Thieltges DW, 2013, OIKOS, V122, P1473, DOI 10.1111/j.1600-0706.2013.00243.x; Thieltges DW, 2008, MAR ECOL PROG SER, V372, P147, DOI 10.3354/meps07703; Toledo R, 1999, J PARASITOL, V85, P263, DOI 10.2307/3285630; Verbrugge LM, 2004, J PARASITOL, V90, P697, DOI 10.1645/GE-237R; Welsh JE, 2014, J MAR BIOL ASSOC UK, V94, P697, DOI 10.1017/S0025315414000034; Zbikowska E, 2001, Wiad Parazytol, V47, P427; Zbikowska E, 2006, PARASITOL RES, V99, P434, DOI 10.1007/s00436-006-0178-z; Zikmundova J, 2014, SYST PARASITOL, V88, P37, DOI 10.1007/s11230-014-9481-8	68	46	46	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149678	10.1371/journal.pone.0149678	http://dx.doi.org/10.1371/journal.pone.0149678			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26895541	Green Published, gold, Green Submitted			2022-12-27	WOS:000371223400074
J	Vea, IM; Tanaka, S; Shiotsuki, T; Jouraku, A; Tanaka, T; Minakuchi, C				Vea, Isabelle Mifom; Tanaka, Sayumi; Shiotsuki, Takahiro; Jouraku, Akiya; Tanaka, Toshiharu; Minakuchi, Chieka			Differential Juvenile Hormone Variations in Scale Insect Extreme Sexual Dimorphism	PLOS ONE			English	Article							BEETLE TRIBOLIUM-CASTANEUM; RED FLOUR BEETLE; KRUPPEL HOMOLOG 1; METHOPRENE-TOLERANT; BROAD-COMPLEX; DROSOPHILA-MELANOGASTER; METAMORPHOSIS; GENE; EVOLUTION; EXPRESSION	Scale insects have evolved extreme sexual dimorphism, as demonstrated by sedentary juvenile-like females and ephemeral winged males. This dimorphism is established during the post-embryonic development; however, the underlying regulatory mechanisms have not yet been examined. We herein assessed the role of juvenile hormone (JH) on the diverging developmental pathways occurring in the male and female Japanese mealybug Planococcus kraunhiae (Kuwana). We provide, for the first time, detailed gene expression profiles related to JH signaling in scale insects. Prior to adult emergence, the transcript levels of JH acid O-methyltransferase, encoding a rate-limiting enzyme in JH biosynthesis, were higher in males than in females, suggesting that JH levels are higher in males. Furthermore, male quiescent pupal-like stages were associated with higher transcript levels of the JH receptor gene, Methoprene-tolerant and its co-activator taiman, as well as the JH early-response genes, Kruppel homolog 1 and broad. The exposure of male juveniles to an ectopic JH mimic prolonged the expression of Kruppel homolog 1 and broad, and delayed adult emergence by producing a supernumeral pupal stage. We propose that male wing development is first induced by up-regulated JH signaling compared to female expression pattern, but a decrease at the end of the prepupal stage is necessary for adult emergence, as evidenced by the JH mimic treatments. Furthermore, wing development seems linked to JH titers as JHM treatments on the pupal stage led to wing deformation. The female pedomorphic appearance was not reflected by the maintenance of high levels of JH. The results in this study suggest that differential variations in JH signaling may be responsible for sex-specific and radically different modes of metamorphosis.	[Vea, Isabelle Mifom; Tanaka, Sayumi; Tanaka, Toshiharu; Minakuchi, Chieka] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Shiotsuki, Takahiro; Jouraku, Akiya] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Vea, Isabelle Mifom; Minakuchi, Chieka] Nagoya Univ, Grad Sch Bioagr Sci, Appl Entomol Lab, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan	Nagoya University; National Institute of Agrobiological Sciences - Japan; Nagoya University	Vea, IM (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.; Vea, IM (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Appl Entomol Lab, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	isabelle.vea@gmail.com	; Vea, Isabelle/K-1618-2015	Shiotsuki, Takahiro/0000-0001-5077-7270; Vea, Isabelle/0000-0001-9351-7970; Jouraku, Akiya/0000-0003-3264-8293	Japanese Society for the Promotion of Science; Japan Society for the Promotion of Science [15K07791]; Grants-in-Aid for Scientific Research [14F04402, 15K07791] Funding Source: KAKEN	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	IMV was funded by a Japanese Society for the Promotion of Science Postdoctoral Fellowship for North American and European and a Postdoctoral Fellowship for Overseas Researchers and this work was supported by a Grant-in-aid for Scientific Research (15K07791) to CM from the Japan Society for the Promotion of Science.	Bachtrog D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001899; Beck Y, 2004, DEV BIOL, V268, P64, DOI 10.1016/j.ydbio.2003.12.017; Belles X., 2011, ORIGIN AND EVOLUTION; Belles X, 2014, INSECT BIOCHEM MOLEC, V52, P60, DOI 10.1016/j.ibmb.2014.06.009; Bongiorni S, 2001, DEVELOPMENT, V128, P3809; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; Erezyilmaz DF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093614; Erezyilmaz DF, 2006, P NATL ACAD SCI USA, V103, P6925, DOI 10.1073/pnas.0509983103; Grimaldi D, 2005, EVOLUTION OF THE INS; Gullan PJ, 1997, ANNU REV ENTOMOL, V42, P23, DOI 10.1146/annurev.ento.42.1.23; Hodin J, 2000, DEV GENES EVOL, V210, P358, DOI 10.1007/s004270000079; Huang JH, 2013, BBA-GEN SUBJECTS, V1830, P2178, DOI 10.1016/j.bbagen.2012.09.025; Jindra M, 2015, CURR OPIN INSECT SCI, V11, P39, DOI 10.1016/j.cois.2015.08.004; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Karlson P, 1996, INT J DEV BIOL, V40, P93; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; KISS I, 1988, GENETICS, V118, P247; KISS I, 1976, NATURE, V262, P136, DOI 10.1038/262136a0; Konopova B, 2008, DEVELOPMENT, V135, P559, DOI 10.1242/dev.016097; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; Konopova B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028728; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Li WF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068544; Lozano J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004769; Lozano J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103614; Lozano J, 2011, SCI REP-UK, V1, DOI 10.1038/srep00163; Marchal E, 2011, INSECT BIOCHEM MOLEC, V41, P219, DOI 10.1016/j.ibmb.2010.12.007; Matsuda R, 1976, MORPHOLOGY AND EVOLU; Matsuda R., 1987, ANIMAL EVOLUTION IN; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Minakuchi C, 2008, FEBS J, V275, P2919, DOI 10.1111/j.1742-4658.2008.06428.x; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; Minakuchi C, 2011, INSECT BIOCHEM MOLEC, V41, P125, DOI 10.1016/j.ibmb.2010.11.004; Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Nijhout H.F., 1998, INSECT HORMONES, P280; NUR U, 1980, INSECT CYTOGENETICS, P97; Parthasarathy R, 2008, MECH DEVELOP, V125, P299, DOI 10.1016/j.mod.2007.11.001; Pecasse F, 2000, DEV BIOL, V221, P53, DOI 10.1006/dbio.2000.9687; Pflugfelder O., 1936, Zoologischer Anzeiger Leipzig, V114, P49; Piulachs MD, 2010, INSECT BIOCHEM MOLEC, V40, P468, DOI 10.1016/j.ibmb.2010.04.006; RIDDIFORD LM, 1994, ADV INSECT PHYSIOL, V24, P213, DOI 10.1016/S0065-2806(08)60084-3; Ross L, 2010, EVOL ECOL RES, V12, P89; Schrader F, 1921, BIOL BULL-US, V40, P259, DOI 10.2307/1536736; SCHUH R, 1986, CELL, V47, P1025, DOI 10.1016/0092-8674(86)90817-2; Sehnal Frantisek, 1996, P3, DOI 10.1016/B978-012283245-1/50003-8; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; Suzuki Y, 2008, DEVELOPMENT, V135, P569, DOI 10.1242/dev.015263; Truman JW, 1999, NATURE, V401, P447, DOI 10.1038/46737; Truman JW, 2002, ANNU REV ENTOMOL, V47, P467, DOI 10.1146/annurev.ento.47.091201.145230; Vea IM, 2015, AM MUS NOVIT, P1, DOI 10.1206/3823.1; Wigglesworth VB, 1934, Q J MICROSC SCI, V77, P191; Yang P, 2015, SCI REP-UK, V5, DOI 10.1038/srep08141; Zhang ZL, 2011, J BIOL CHEM, V286, P8437, DOI 10.1074/jbc.M110.191684; Zhou BH, 2001, DEV BIOL, V231, P125, DOI 10.1006/dbio.2000.0143; Zhou XF, 2002, DEVELOPMENT, V129, P2259	56	21	21	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2016	11	2							e0149459	10.1371/journal.pone.0149459	http://dx.doi.org/10.1371/journal.pone.0149459			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3DG	26894583	Green Published, gold, Green Submitted			2022-12-27	WOS:000371223400055
J	Mi, F; Zhang, Y; Yang, D; Tang, XZ; Wang, PF; He, XX; Zhang, YR; Dong, JY; Cao, Y; Liu, CL; Zhang, KQ; Xu, JP				Mi, Fei; Zhang, Ying; Yang, Dan; Tang, Xiaozhao; Wang, Pengfei; He, Xiaoxia; Zhang, Yunrun; Dong, Jianyong; Cao, Yang; Liu, Chunli; Zhang, Ke-Qin; Xu, Jianping			Evidence for Inbreeding and Genetic Differentiation among Geographic Populations of the Saprophytic Mushroom Trogia venenata from Southwestern China	PLOS ONE			English	Article							NATURAL-POPULATIONS; EVOLUTION; RECOMBINATION; HYBRIDIZATION; DIVERGENCE; DIVERSITY; SOFTWARE; YUNNAN	During the past 40 years, more than 400 Sudden Unexplained Deaths (SUDs) have occurred in Yunnan, southwestern China. Epidemiological and toxicological analyses suggested that a newly discovered mushroom called Trogia venenata was the leading culprit for SUDs. At present, relatively little is known about the genetics and natural history of this mushroom. In this study, we analyzed the sequence variation at four DNA fragments among 232 fruiting bodies of T. venenata collected from seven locations. Our ITS sequence analyses confirmed that all the isolates belonged to the same species. The widespread presence of sequence heterozygosity within many strains at each of three protein-coding genes suggested that the fruiting bodies were diploid, dikaryotic or heterokaryotic. Within individual geographic populations, we found significant deviations of genotype frequencies from Hardy-Weinberg expectations, with the overall observed heterozygosity lower than that expected under random mating, consistent with prevalent inbreeding within local populations. The geographic populations were overall genetically differentiated. Interestingly, while a positive correlation was found between population genetic distance and geographic distance, there was little correlation between genetic distance and barium concentration difference for the geographic populations. Our results suggest frequent inbreeding, geographic structuring, and limited gene flow among geographic populations of T. venenata from southwestern China.	[Mi, Fei; Zhang, Ying; Yang, Dan; Tang, Xiaozhao; Wang, Pengfei; He, Xiaoxia; Zhang, Yunrun; Dong, Jianyong; Zhang, Ke-Qin; Xu, Jianping] Yunnan Univ, Minist Educ, Lab Conservat & Utilizat Bio Resources, Kunming, Yunnan, Peoples R China; [Mi, Fei; Zhang, Ying; Yang, Dan; Tang, Xiaozhao; Wang, Pengfei; He, Xiaoxia; Zhang, Yunrun; Dong, Jianyong; Zhang, Ke-Qin; Xu, Jianping] Yunnan Univ, Minist Educ, Key Lab Microbial Resources, Kunming, Yunnan, Peoples R China; [Mi, Fei] Guizhou Prov Ctr Dis Control & Prevent, Inst Communicable Dis Control & Prevent, Guiyang, Guizhou, Peoples R China; [Cao, Yang] Yunnan Inst Trop Crop Res, Jinghong, Yunnan, Peoples R China; [Liu, Chunli] All China Federat Supply & Mkt Cooperat, Kunming Edible Fungi Inst, Kunming, Yunnan, Peoples R China; [Xu, Jianping] McMaster Univ, Dept Biol, Hamilton, ON, Canada	Yunnan University; Yunnan University; McMaster University	Xu, JP (corresponding author), Yunnan Univ, Minist Educ, Lab Conservat & Utilizat Bio Resources, Kunming, Yunnan, Peoples R China.; Xu, JP (corresponding author), Yunnan Univ, Minist Educ, Key Lab Microbial Resources, Kunming, Yunnan, Peoples R China.; Xu, JP (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	jpxu@mcmaster.ca	zhang, ke/AAH-8217-2019		Yunnan Provincial Department of Science and Technology [2010CI106]; National Natural Science Foundation Program of the People's Republic of China [31100018, 31470147]; Education Department of Yunnan Province [2014Z005]	Yunnan Provincial Department of Science and Technology; National Natural Science Foundation Program of the People's Republic of China(National Natural Science Foundation of China (NSFC)); Education Department of Yunnan Province	This study was jointly supported by grants from the Yunnan Provincial Department of Science and Technology (2010CI106), National Natural Science Foundation Program of the People's Republic of China (31100018 and 31470147), and Education Department of Yunnan Province (2014Z005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arabatzis M, 2012, MYCOLOGIA, P11; Arora D, 1986, MUSHROOMS DEMYSTIFIE; Cao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073174; Chen W, 2011, J ZOOL, V284, P215, DOI 10.1111/j.1469-7998.2011.00797.x; Chen ZH, 2014, FUNGAL DIVERS, V64, P123, DOI 10.1007/s13225-013-0260-7; Chowdhary A, 2011, ENVIRON MICROBIOL, V13, P1875, DOI 10.1111/j.1462-2920.2011.02510.x; Daniel F, 2003, GENETICS, V164, P574; DIETZ EJ, 1983, SYST ZOOL, V32, P21, DOI 10.2307/2413216; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Iii EJB, 2010, PLOS PATHOG, V6, P1257; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kidd SE, 2005, EUKARYOT CELL, V4, P1629, DOI 10.1128/EC.4.10.1629-1638.2005; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Lecis R, 2006, MOL ECOL, V15, P119, DOI 10.1111/j.1365-294X.2005.02812.x; Levy D, 2008, MOL BIOL EVOL, V23; Li MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010684; Liang J, 2009, FUNGAL DIVERS, V38, pe124; Liang Y, 2004, MYCORRHIZA, V14, P235, DOI 10.1007/s00572-003-0260-7; Liao DQ, 2000, J MOL EVOL, V51, P305, DOI 10.1007/s002390010093; Lu BL, 2010, CHIN J DIS CONTROL P, V14, P305; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; [卯晓岚 MAO XiaoLan], 2006, [菌物学报, Mygosystema], V25, P345; Matheny PB, 2007, MOL PHYLOGENET EVOL, V43, P430, DOI 10.1016/j.ympev.2006.08.024; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; Nagy LG, 2011, SYST BIOL, V60, P303, DOI 10.1093/sysbio/syr005; Ostrowski MF, 2006, MOL ECOL, V15, P1507, DOI 10.1111/j.1365-294X.2006.02865.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; Sha T, 2008, MICROBIOL-SGM, V154, P3460, DOI 10.1099/mic.0.2008/020495-0; Shi GQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038712; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stone R, 2010, SCIENCE, V329, P132, DOI 10.1126/science.329.5988.132; Swindell S R, 1997, Methods Mol Biol, V70, P75, DOI 10.1385/0-89603-358-9:75; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Urbanelli S, 2003, HEREDITY, V90, P253, DOI 10.1038/sj.hdy.6800239; Wang HM, 2007, FUNGAL GENET BIOL, V44, P991, DOI 10.1016/j.fgb.2007.03.005; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wright S, 1931, GENETICS, V16, P0097; Xu J, 1997, J HERED, V88, P482, DOI 10.1093/oxfordjournals.jhered.a023141; Xu J, 2010, INT J FOOD MICROBIOL, V143, P254; Xu JP, 2008, MOL ECOL, V17, P1238, DOI 10.1111/j.1365-294X.2007.03665.x; Xu J, 2006, CURR ISSUES MOL BIOL, V8, P75; Xu JP, 2009, MOL ECOL, V18, P2628, DOI 10.1111/j.1365-294X.2009.04227.x; Xu JP, 2000, MOL ECOL, V9, P1471, DOI 10.1046/j.1365-294x.2000.01021.x; XU JP, 1994, TRENDS GENET, V10, P226, DOI 10.1016/0168-9525(94)90158-9; XU JP, 1995, GENETICS, V141, P137; Yang L, 2008, J PREVENTIVE MED INF, V21, P110; Yang ZL, 2012, MYCOL PROG, V11, P937, DOI 10.1007/s11557-012-0809-y; Zeisset I, 2001, P ROY SOC B-BIOL SCI, V268, P933, DOI 10.1098/rspb.2001.1600; Zhang Y, 2012, APPL ENVIRON MICROB, V78, P8834, DOI 10.1128/AEM.01798-12; Zhao MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083253; Zhou ZY, 2012, ANGEW CHEM INT EDIT, V51, P2368, DOI 10.1002/anie.201106502	57	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2016	11	2							e0149507	10.1371/journal.pone.0149507	http://dx.doi.org/10.1371/journal.pone.0149507			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3CO	26890380	Green Published, gold			2022-12-27	WOS:000371221500054
J	Dale, R; Ohmuro-Matsuyama, Y; Ueda, H; Kato, N				Dale, Renee; Ohmuro-Matsuyama, Yuki; Ueda, Hiroshi; Kato, Naohiro			Mathematical Model of the Firefly Luciferase Complementation Assay Reveals a Non-Linear Relationship between the Detected Luminescence and the Affinity of the Protein Pair Being Analyzed	PLOS ONE			English	Article								The firefly luciferase complementation assay is widely used as a bioluminescent reporter technology to detect protein-protein interactions in vitro, in cellulo, and in vivo. Upon the interaction of a protein pair, complemented firefly luciferase emits light through the adenylation and oxidation of its substrate, luciferin. Although it has been suggested that kinetics of light production in the firefly luciferase complementation assay is different from that in full length luciferase, the mechanism behind this is still not understood. To quantitatively understand the different kinetics and how changes in affinity of a protein pair affect the light emission in the assay, a mathematical model of the in vitro firefly luciferase complementation assay was constructed. Analysis of the model finds that the change in kinetics is caused by rapid dissociation of the protein pair, low adenylation rate of luciferin, and increased affinity of adenylated luciferin to the enzyme. The model suggests that the affinity of the protein pair has an exponential relationship with the light detected in the assay. This relationship causes the change of affinity in a protein pair to be underestimated. This study underlines the importance of understanding the molecular mechanism of the firefly luciferase complementation assay in order to analyze protein pair affinities quantitatively.	[Dale, Renee; Kato, Naohiro] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Ohmuro-Matsuyama, Yuki; Ueda, Hiroshi] Tokyo Inst Technol, Chem Resources Lab, Nagatsuta Cho, Yokohama, Kanagawa 227, Japan	Louisiana State University System; Louisiana State University; Tokyo Institute of Technology	Kato, N (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	kato@lsu.edu	Dale, Renee/AAG-8754-2021; Ueda, Hiroshi/A-3515-2011; Kato, Naohiro/B-2353-2008	Dale, Renee/0000-0002-1674-1247; Ueda, Hiroshi/0000-0001-8849-4217; Kato, Naohiro/0000-0002-4571-3456	Grants-in-Aid for Scientific Research [15H04191] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Aelvoet SA, NONINVASIVE BIOLUMIN, V34, P16518; Aouida M, SACCHAROMYCES CEREVI, V8; Arkin MR, SMALL MOL INHIBITORS, V3, P301; Ayabe K, ROLE FIREFLY LUCIFER, V579, P4389; Azad T, OSCILLATION APOPTOSO, V760, P64; Banaszynski LA, CHARACTERIZATION FKB, V127, P4715; Beyleveld G, NEW GENERATION SCREE, V100, P120; Branchini BR, 2000, BIOCHEMISTRY-US, V39, P5433, DOI 10.1021/bi9928804; Branchini BR, MUTAGENESIS STUDY PU, V42, P10429; Branchini BR, MUTAGENESIS EVIDENCE, V44, P1385; Cer RZ, 2000, IC50 TO KI WEB BASED, V37, pW441; Chen H, FIREFLY LUCIFERASE C, V146, P368; Choi Jida, IDENTIFICATION SUMO, V56, P176; Close DM, IN VIVO BIOLUMINESCE, V11, P180; Conti E, CRYSTAL STRUCTURE FI, V4, P287; Coppola JM, NONINVASIVE IMAGING, V14, P2492; Dai M, 2000, PP6 TYPE PHOSPHATASE, V24, P2497; Deng K, LECTIN RECEPTOR KINA, V8; Endo M, TISSUE SPECIFIC CLOC, V515, P419; Endoh T, CONSTRUCTION INTRAMO, V18, P956; Esteves da Silva JCG, KINETICS INHIBITION, V10, P1039; Fujikawa Y, TECHNICAL ADV SPLIT, V52, P185; Gaud G, EVER2 PROTEIN BINDS, V4, pe499; Hashimoto T, CHARACTERIZATION OLI, V286, P27081; Hsu WC, IDENTIFYING KINASE N, V10; Huang D, GIBBERELLIN MEDIATED; Hubbard BP, CARBOXAMIDE SIRT1 IN, V12, P2233; Huwaldt JA, PLOT DIGITIZER; Ignowski JM, KINETIC ANAL MODELIN, V86, P827; Jiang J, 2001, ARABIDOPSIS RNA BIND, V9; Kato N., LUCIFERASE BIOLUMINE, V02; Kim HK, 2008, FUNCTIONAL ROLES FGL, V8; Kim HK, SPLIT LUCIFERASE COM, V58, P179; Kimura M, FUNCTIONAL MOL IMAGI, V123, P747; Krycer JR, CROSS TALK ANDROGEN, V286, P20637; Lake MC, LUCIFERASE FRAGMENT, V1, P310; Lang Z, METHYL CPG BINDING P, V57, P971; Li JF, LARGE SCALE PROTEIN, V6; Li L, FLS2 ASS KINASE BIK1, V15, P329; Li W, PSEUDOMONAS SYRINGAE, V161, P2062; Luker KE, 2007, CONSTITUTIVE CHEMOKI, V29, P4599; Luker KE, CONSTITUTIVE CHEMOKI, V29, P4599; Luker KE, KINETICS REGULATED P, V101, P12288; Marques SM, FIREFLY BIOLUMINESCE, V61, P6; Moisy D, 2001, HMGB1 PROTEIN BINDS, V86, P9122; Morsy M, CHARTING PLANT INTER, V13, P183; Nyati S, NOVEL MOL IMAGING PL, V10, P23; Ohmuro-Matsuyama Y, DEMONSTRATION PROTEI, V13, P31; Paulmurugan R, NONINVASIVE IMAGING, V99, P15608; Pollard TD, GUIDE SIMPLE INFORM, V21, P4061; Ramiere C, 2000, ACTIVITY HEXOKINASE, V88, P3246; Ramkumar KM, REPORTER PROTEIN COM, V85, P7542; Ray P, 2007, CARBOXY TERMINUS CXC, V44, P669; Ray P, SECRETED CXCL 12 SDF, V442, P433; Schon O, MOL MECH INTERACTION, V323, P491; Sebaugh JL., 2000, GUIDELINES ACCURATE, V10, P128; Shavkunov AS, FIBROBLAST GROWTH FA, V288, P19370; Shrestha B, INVOLVEMENT COREPRES, V14, P54; Thorne N, ILLUMINATING INSIGHT, V17, P646; Velten J, LUCIFERASE REPORTER, V2, P1; Wang M, BOLOST1 ORTHOLOG OPE, V442, P214; Willmann JK, 2007, MOL IMAGING DRUG DEV, V7, P591; Xie CG, ROLES SCABP8 SALT ST, V4, P956; Xiong Y, RAPAMYCIN GLUCOSE TA, V287, P2836; Zako T, LUMINESCENT SUBSTRAT, V1649, P183; Zhang L, MOL IMAGING C MET TY, V412, P1; Zhu Y, 2002, ANAL INTERACTIONS CL, V61, P223; Zhu Y, ANAL INTERACTIONS CL, V61, P223	68	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148256	10.1371/journal.pone.0148256	http://dx.doi.org/10.1371/journal.pone.0148256			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886551	Green Submitted, Green Published, gold			2022-12-27	WOS:000371218400022
J	Hampel, D; Shahab-Ferdows, S; Adair, LS; Bentley, ME; Flax, VL; Jamieson, DJ; Ellington, SR; Tegha, G; Chasela, CS; Kamwendo, D; Allen, LH				Hampel, Daniela; Shahab-Ferdows, Setareh; Adair, Linda S.; Bentley, Margaret E.; Flax, Valerie L.; Jamieson, Denise J.; Ellington, Sascha R.; Tegha, Gerald; Chasela, Charles S.; Kamwendo, Debbie; Allen, Lindsay H.			Thiamin and Riboflavin in Human Milk: Effects of Lipid-Based Nutrient Supplementation and Stage of Lactation on Vitamer Secretion and Contributions to Total Vitamin Content	PLOS ONE			English	Article							CANCER RESISTANCE PROTEIN; BREAST-MILK; RANDOMIZED-TRIAL; MATERNAL STATUS; B VITAMINS; WOMEN; TRANSPORTER; DEFICIENCY; TRANSMISSION; POSTPARTUM	While thiamin and riboflavin in breast milk have been analyzed for over 50 years, less attention has been given to the different forms of each vitamin. Thiamin-monophosphate (TMP) and free thiamin contribute to total thiamin content; flavin adenine-dinucleotide (FAD) and free riboflavin are the main contributors to total riboflavin. We analyzed milk collected at 2 (n = 258) or 6 (n = 104), and 24 weeks (n = 362) from HIV-infected Malawian mothers within the Breastfeeding, Antiretrovirals and Nutrition (BAN) study, randomly assigned at delivery to lipid-based nutrient supplements (LNS) or a control group, to investigate each vitamer's contribution to total milk vitamin content and the effects of supplementation on the different thiamin and riboflavin vitamers at early and later stages of lactation, and obtain insight into the transport and distribution of these vitamers in human milk. Thiamin vitamers were derivatized into thiochrome-esters and analyzed by high-performance liquid-chromatography-fluorescence-detection (HPLC-FLD). Riboflavin and FAD were analyzed by ultra-performance liquid-chromatography-tandem-mass-spectrometry (ULPC-MS/MS). Thiamin-pyrophosphate (TPP), identified here for the first time in breast milk, contributed 1.9-4.5% to total thiamin. Free thiamin increased significantly from 2/6 to 24 weeks regardless of treatment indicating an active transport of this vitamer in milk. LNS significantly increased TMP and free thiamin only at 2 weeks compared to the control: median 170 versus 151 mu g/L (TMP), 13.3 versus 10.5 mu g/L (free thiamin, p<0.05 for both, suggesting an up-regulated active mechanism for TMP and free thiamin accumulation at early stages of lactation. Free riboflavin was consistently and significantly increased with LNS (range: 14.8-19.6 mu g/L (LNS) versus 5.0-7.4 mu g/L (control), p<0.001), shifting FAD: riboflavin relative amounts from 92-94:6-8% to 85:15%, indicating a preferred secretion of the free form into breast milk. The continuous presence of FAD in breast milk suggests an active transport and secretion system for this vitamer or possibly formation of this co-enymatic form in the mammary gland.	[Hampel, Daniela; Shahab-Ferdows, Setareh; Allen, Lindsay H.] ARS, USDA, Western Human Nutr Res Ctr, Davis, CA USA; [Hampel, Daniela; Allen, Lindsay H.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Adair, Linda S.; Bentley, Margaret E.; Flax, Valerie L.] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Jamieson, Denise J.; Ellington, Sascha R.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Tegha, Gerald; Chasela, Charles S.; Kamwendo, Debbie] UNC Project, Lilongwe, Malawi; [Chasela, Charles S.] Univ Witwatersrand, Sch Publ Hlth, Div Epidemiol & Biostat, Johannesburg, South Africa	United States Department of Agriculture (USDA); University of California System; University of California Davis; University of North Carolina; University of North Carolina Chapel Hill; Centers for Disease Control & Prevention - USA; University of Witwatersrand	Hampel, D (corresponding author), ARS, USDA, Western Human Nutr Res Ctr, Davis, CA USA.; Hampel, D (corresponding author), Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.	dhampel@ucdavis.edu		Jamieson, Denise/0000-0003-2597-1201; Flax, Valerie/0000-0003-0200-3355	Prevention Research Centers Special Interest Project of the Centers for Disease Control and Prevention [SIP 13-01 U48-CCU409660-09, SIP 26-04 U48-DP000059-01, SIP 22-09 U48-DP001944-01]; Bill & Melinda Gates Foundation [OPP53107, OPP1061055]; National Institute of Allergy and Infectious Diseases; University of North Carolina Center for AIDS Research [P30-AI50410]; Carolina Population Center [R24 HD050924]; NIH Fogarty AIDS International Training and Research Program [DHHS/NIH/FIC 2-D43 Tw01039-06, R24 Tw00798]; NIH Fogarty AIDS International Training and Research Program (American Recovery and Reinvestment Act); intramural USDA-ARS Project [5306-51000-003-00D]; Elizabeth Glaser Pediatric AIDS Foundation; United Nations Children's Fund; World Food Program; Malawi Ministry of Health and Population; Johnson Johnson; U.S. Agency for International Development; ARS [ARS-0426640] Funding Source: Federal RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924, P2CHD050924] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW001039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	Prevention Research Centers Special Interest Project of the Centers for Disease Control and Prevention; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of North Carolina Center for AIDS Research; Carolina Population Center; NIH Fogarty AIDS International Training and Research Program; NIH Fogarty AIDS International Training and Research Program (American Recovery and Reinvestment Act); intramural USDA-ARS Project; Elizabeth Glaser Pediatric AIDS Foundation; United Nations Children's Fund; World Food Program; Malawi Ministry of Health and Population; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); U.S. Agency for International Development(United States Agency for International Development (USAID)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The Breastfeeding, Antiretrovirals, and Nutrition Study was supported by grants from the Prevention Research Centers Special Interest Project of the Centers for Disease Control and Prevention (SIP 13-01 U48-CCU409660-09, SIP 26-04 U48-DP000059-01, and SIP 22-09 U48-DP001944-01), Bill & Melinda Gates Foundation (OPP53107 and OPP1061055), the National Institute of Allergy and Infectious Diseases, the University of North Carolina Center for AIDS Research (P30-AI50410), the Carolina Population Center (R24 HD050924), the NIH Fogarty AIDS International Training and Research Program (DHHS/NIH/FIC 2-D43 Tw01039-06 and R24 Tw00798; the American Recovery and Reinvestment Act), and intramural USDA-ARS Project (5306-51000-003-00D). The antiretrovirals used in the BAN study were donated by Abbott Laboratories, GlaxoSmithKline, Boehringer Ingelheim, Roche Pharmaceuticals, and Bristol-Myers Squibb. The Call to Action PMTCT program was supported by the Elizabeth Glaser Pediatric AIDS Foundation, the United Nations Children's Fund, the World Food Program, the Malawi Ministry of Health and Population, Johnson & Johnson, and the U.S. Agency for International Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen L H, 1994, SCN News, P21; Allen LH, 2015, AM J CLIN NUTR, V102, P1468, DOI 10.3945/ajcn.114.105106; Allen LH, 2012, ADV NUTR, V3, P362, DOI 10.3945/an.111.001172; BATES CJ, 1982, AM J CLIN NUTR, V35, P701, DOI 10.1093/ajcn/35.4.701; Bernshaw N J, 1991, J Hum Lact, V7, P73, DOI 10.1177/089033449100700227; BETTENDORFF L, 2013, OA BIOCH, V1, P1; Bohm V, 1997, Z ERNAHRUNGSWISS, V36, P214, DOI 10.1007/BF01623366; Buehler BA, 2011, J EVID-BASED INTEGR, V16, P88, DOI 10.1177/1533210110392943; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Coats D, 2013, AM J CLIN NUTR, V98, P839, DOI 10.3945/ajcn.113.062737; Dedina L., 2012, THESIS U TORONTO; Dutta B, 1999, J BIOL CHEM, V274, P31925, DOI 10.1074/jbc.274.45.31925; EITENMILLER RR, 1999, VITAMIN ANAL HLTH FO; Eudy JD, 2000, MOL GENET METAB, V71, P581, DOI 10.1006/mgme.2000.3112; Ferguson YO, 2009, AIDS EDUC PREV, V21, P141, DOI 10.1521/aeap.2009.21.2.141; Gibson RS, 1990, Q REV BIOL; Hampel D, 2012, J CHROMATOGR B, V903, P7, DOI 10.1016/j.jchromb.2012.06.024; Institute of Medicine, 1998, DIET REF INT THIAM R; Kauffman G, 2011, AM J CLIN NUTR, V94, P616, DOI 10.3945/ajcn.111.018457; Kayira D, 2012, AM J CLIN NUTR, V95, P759, DOI 10.3945/ajcn.111.018812; Khounnorath S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000969; Liu SQ, 2003, MOL CANCER RES, V1, P665; LONNERDAL B, 1986, J NUTR, V116, P499; Luxemburger C, 2003, T ROY SOC TROP MED H, V97, P251, DOI 10.1016/S0035-9203(03)90134-9; McGready R, 2001, AM J CLIN NUTR, V74, P808; Montalbetti N, 2014, J MAMMARY GLAND BIOL, V19, P73, DOI 10.1007/s10911-014-9317-9; NAIL PA, 1980, AM J CLIN NUTR, V33, P198, DOI 10.1093/ajcn/33.2.198; Ortega RM, 2004, BRIT J NUTR, V92, P129, DOI 10.1079/BJN20041153; Ortega RM, 1999, J AM COLL NUTR, V18, P324, DOI 10.1080/07315724.1999.10718871; Picciano MF, 2003, J NUTR, V133, p1997S, DOI 10.1093/jn/133.6.1997S; Powers HJ, 2003, AM J CLIN NUTR, V77, P1352; RINDI G, 1982, Acta Vitaminologica et Enzymologica, V4, P59; Rindi G, 2000, P SOC EXP BIOL MED, V224, P246, DOI 10.1046/j.1525-1373.2000.22428.x; ROUGHEAD ZK, 1990, AM J CLIN NUTR, V52, P854, DOI 10.1093/ajcn/52.5.854; Said HM, 2004, AM J PHYSIOL-GASTR L, V286, pG491, DOI 10.1152/ajpgi.00361.2003; Sakurai T, 2005, J NUTR SCI VITAMINOL, V51, P239, DOI 10.3177/jnsv.51.239; Stuetz W., 2011, EUROPEAN J CLIN NUTR, V51, P425, DOI DOI 10.1007/S00394-011-0226-Z; Stuetz W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036280; THOMAS MR, 1980, AM J CLIN NUTR, V33, P2151, DOI 10.1093/ajcn/33.10.2151; van der Horst C, 2009, CONTEMP CLIN TRIALS, V30, P24, DOI 10.1016/j.cct.2008.09.001; van Herwaarden AE, 2006, TRENDS PHARMACOL SCI, V27, P10, DOI 10.1016/j.tips.2005.11.007; van Herwaarden AE, 2007, MOL CELL BIOL, V27, P1247, DOI 10.1128/MCB.01621-06; World Health Organization, 2001, OPT DUR EXCL BREASTF; World Health Organization, 2010, GUID HIV INF FEED 20; Zastre JA, 2013, J NUTR BIOCHEM, V24, P1616, DOI 10.1016/j.jnutbio.2013.02.002	45	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149479	10.1371/journal.pone.0149479	http://dx.doi.org/10.1371/journal.pone.0149479			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886782	Green Published, gold			2022-12-27	WOS:000371218400089
J	Kazior, Z; Willis, SJ; Moberg, M; Apro, W; Calbet, JAL; Holmberg, HC; Blomstrand, E				Kazior, Zuzanna; Willis, Sarah J.; Moberg, Marcus; Apro, William; Calbet, Jose A. L.; Holmberg, Hans-Christer; Blomstrand, Eva			Endurance Exercise Enhances the Effect of Strength Training on Muscle Fiber Size and Protein Expression of Akt and mTOR	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; RESISTANCE EXERCISE; MESSENGER-RNA; ADENOSINE TRIPHOSPHATASE; CONTRACTILE ACTIVITY; CONCURRENT EXERCISE; MOLECULAR-BASES; KINASE-ACTIVITY; TIME-COURSE; HYPERTROPHY	Reports concerning the effect of endurance exercise on the anabolic response to strength training have been contradictory. This study re-investigated this issue, focusing on training effects on indicators of protein synthesis and degradation. Two groups of male subjects performed 7 weeks of resistance exercise alone (R; n = 7) or in combination with preceding endurance exercise, including both continuous and interval cycling (ER; n = 9). Muscle biopsies were taken before and after the training period. Similar increases in leg-press 1 repetition maximum (30%; P< 0.05) were observed in both groups, whereas maximal oxygen uptake was elevated (8%; P< 0.05) only in the ER group. The ER training enlarged the areas of both type I and type II fibers, whereas the R protocol increased only the type II fibers. The mean fiber area increased by 28% (P< 0.05) in the ER group, whereas no significant increase was observed in the R group. Moreover, expression of Akt and mTOR protein was enhanced in the ER group, whereas only the level of mTOR was elevated following R training. Training-induced alterations in the levels of both Akt and mTOR protein were correlated to changes in type I fiber area (r = 0.55-0.61, P< 0.05), as well as mean fiber area (r = 0.55-0.61, P< 0.05), reflecting the important role played by these proteins in connection with muscle hypertrophy. Both training regimes reduced the level of MAFbx protein (P< 0.05) and tended to elevate that of MuRF-1. The present findings indicate that the larger hypertrophy observed in the ER group is due more to pronounced stimulation of anabolic rather than inhibition of catabolic processes.	[Kazior, Zuzanna; Willis, Sarah J.; Holmberg, Hans-Christer] Mid Sweden Univ, Dept Hlth Sci, Swedish Winter Sports Res Ctr, Ostersund, Sweden; [Moberg, Marcus; Apro, William; Blomstrand, Eva] Swedish Sch Sport & Hlth Sci, Stockholm, Sweden; [Calbet, Jose A. L.] Univ Las Palmas Gran Canaria, Dept Phys Educ, Las Palmas Gran Canaria, Spain; [Calbet, Jose A. L.] Univ Las Palmas Gran Canaria, Res Inst Biomed & Hlth Sci IUIBS, Campus Univ Tafira S-N, Las Palmas Gran Canaria, Canary Island, Spain	Mid-Sweden University; Swedish School of Sport & Health Sciences; Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria	Blomstrand, E (corresponding author), Swedish Sch Sport & Hlth Sci, Stockholm, Sweden.	eva.blomstrand@gih.se	Apro, William/AAZ-4717-2020; Calbet, Jose A L/H-6693-2015; Moberg, Marcus/AAU-5487-2021	Calbet, Jose A L/0000-0002-9215-6234; Moberg, Marcus/0000-0003-3747-0148; Holmberg, Hans-Christer/0000-0002-3814-6246; antunez, Ariel/0000-0002-2548-7885; Apro, William/0000-0003-1942-2919; Willis, Sarah/0000-0002-0150-3182	Swedish National Centre for Research in Sports [55-351/10]	Swedish National Centre for Research in Sports	This study was supported by funding from the Swedish National Centre for Research in Sports to HCH (55-351/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALP PR, 1976, BIOCHEM J, V154, P689, DOI 10.1042/bj1540689; ANDERSEN P, 1975, ACTA PHYSIOL SCAND, V95, P203, DOI 10.1111/j.1748-1716.1975.tb10043.x; ANDERSEN P, 1977, J PHYSIOL-LONDON, V270, P677, DOI 10.1113/jphysiol.1977.sp011975; Apro W, 2015, AM J PHYSIOL-ENDOC M, V308, pE470, DOI 10.1152/ajpendo.00486.2014; Apro W, 2013, AM J PHYSIOL-ENDOC M, V305, pE22, DOI 10.1152/ajpendo.00091.2013; Baechle TR, 2008, ESSENTIALS STRENGTH; Benziane B, 2008, AM J PHYSIOL-ENDOC M, V295, pE1427, DOI 10.1152/ajpendo.90428.2008; Bergstrom J, 1962, SCAND J CLIN LAB INV; BLOMSTRAND E, 1982, ACTA PHYSIOL SCAND, V116, P437, DOI 10.1111/j.1748-1716.1982.tb07163.x; BLOMSTRAND E, 1984, ACTA PHYSIOL SCAND, V122, P545, DOI 10.1111/j.1748-1716.1984.tb07543.x; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bodine SC, 2014, AM J PHYSIOL-ENDOC M, V307, pE469, DOI 10.1152/ajpendo.00204.2014; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Borgenvik M, 2012, AM J PHYSIOL-ENDOC M, V302, pE510, DOI 10.1152/ajpendo.00353.2011; Borsheim E, 2004, J APPL PHYSIOL, V96, P674, DOI 10.1152/japplphysiol.00333.2003; BROOKE MH, 1970, J HISTOCHEM CYTOCHEM, V18, P670, DOI 10.1177/18.9.670; BROOKE MH, 1969, J HISTOCHEM CYTOCHEM, V17, P431, DOI 10.1177/17.6.431; Camera DM, 2015, MED SCI SPORT EXER, V47, P82, DOI 10.1249/MSS.0000000000000390; Camera DM, 2010, MED SCI SPORT EXER, V42, P1843, DOI 10.1249/MSS.0b013e3181d964e4; Carrithers JA, 2007, AVIAT SPACE ENVIR MD, V78, P457; Chen ZP, 2003, DIABETES, V52, P2205, DOI 10.2337/diabetes.52.9.2205; Churchley EG, 2007, J APPL PHYSIOL, V102, P1604, DOI 10.1152/japplphysiol.01260.2006; Coffey VG, 2007, SPORTS MED, V37, P737, DOI 10.2165/00007256-200737090-00001; Coffey VG, 2009, AM J PHYSIOL-REG I, V297, pR1441, DOI 10.1152/ajpregu.00351.2009; Coffey VG, 2009, J APPL PHYSIOL, V106, P1187, DOI 10.1152/japplphysiol.91221.2008; Coffey VG, 2006, AM J PHYSIOL-ENDOC M, V290, pE849, DOI 10.1152/ajpendo.00299.2005; COSTILL DL, 1979, J APPL PHYSIOL, V46, P96, DOI 10.1152/jappl.1979.46.1.96; Deldicque L, 2008, EUR J APPL PHYSIOL, V104, P57, DOI 10.1007/s00421-008-0786-7; Drummond MJ, 2009, J APPL PHYSIOL, V106, P1403, DOI 10.1152/japplphysiol.90842.2008; Egerman MA, 2014, CRIT REV BIOCHEM MOL, V49, P59, DOI 10.3109/10409238.2013.857291; ESSEN B, 1975, ACTA PHYSIOL SCAND, V95, P153, DOI 10.1111/j.1748-1716.1975.tb10038.x; Fry AC, 2004, SPORTS MED, V34, P663, DOI 10.2165/00007256-200434100-00004; Fyfe JJ, 2014, SPORTS MED, V44, P743, DOI 10.1007/s40279-014-0162-1; Green H, 1999, AM J PHYSIOL-REG I, V276, pR591, DOI 10.1152/ajpregu.1999.276.2.R591; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hennessey JV, 1997, J APPL PHYSIOL, V82, P1739, DOI 10.1152/jappl.1997.82.6.1739; HICKSON RC, 1980, EUR J APPL PHYSIOL O, V45, P255, DOI 10.1007/BF00421333; JANSSON E, 1990, ACTA PHYSIOL SCAND, V140, P359, DOI 10.1111/j.1748-1716.1990.tb09010.x; Krook A, 1998, DIABETES, V47, P1281, DOI 10.2337/diabetes.47.8.1281; Lamas L, 2010, SCAND J MED SCI SPOR, V20, P216, DOI 10.1111/j.1600-0838.2009.00905.x; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Leveritt M, 1999, SPORTS MED, V28, P413, DOI 10.2165/00007256-199928060-00004; Louis E, 2007, J APPL PHYSIOL, V103, P1744, DOI 10.1152/japplphysiol.00679.2007; Lundberg TR, 2014, J APPL PHYSIOL, V116, P611, DOI 10.1152/japplphysiol.01082.2013; Lundberg TR, 2013, J APPL PHYSIOL, V114, P81, DOI 10.1152/japplphysiol.01013.2012; MacNeil LG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109189; Mascher H, 2008, AM J PHYSIOL-ENDOC M, V294, pE43, DOI 10.1152/ajpendo.00504.2007; Perez-Gomez J, 2008, APPL PHYSIOL NUTR ME, V33, P501, DOI 10.1139/H08-026; Phillips SM, 2002, CAN J PHYSIOL PHARM, V80, P1045, DOI [10.1139/y02-134, 10.1139/Y02-134]; Phillips SM, 2014, SPORTS MED, V44, P71, DOI 10.1007/s40279-014-0152-3; Rahbek SK, 2014, AMINO ACIDS, V46, P2377, DOI 10.1007/s00726-014-1792-1; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Saltin B, 2010, COMPR PHYSIOL, P555; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; SCHANTZ P, 1983, CLIN PHYSIOL, V3, P141, DOI 10.1111/j.1475-097X.1983.tb00685.x; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Tang JE, 2006, APPL PHYSIOL NUTR ME, V31, P495, DOI 10.1139/H06-026; Thorell A, 1999, AM J PHYSIOL-ENDOC M, V277, pE733, DOI 10.1152/ajpendo.1999.277.4.E733; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang L, 2011, J APPL PHYSIOL, V111, P1335, DOI 10.1152/japplphysiol.00086.2011; Wojtaszewski JFP, 2000, J PHYSIOL-LONDON, V528, P221, DOI 10.1111/j.1469-7793.2000.t01-1-00221.x; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yu M, 2001, J APPL PHYSIOL, V90, P29, DOI 10.1152/jappl.2001.90.1.29	63	41	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149082	10.1371/journal.pone.0149082	http://dx.doi.org/10.1371/journal.pone.0149082			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26885978	Green Submitted, Green Published, gold			2022-12-27	WOS:000371218400061
J	Nakajima, M; Yoshida, R; Miyanaga, A; Abe, K; Takahashi, Y; Sugimoto, N; Toyoizumi, H; Nakai, H; Kitaoka, M; Taguchi, H				Nakajima, Masahiro; Yoshida, Ryuta; Miyanaga, Akimasa; Abe, Koichi; Takahashi, Yuta; Sugimoto, Naohisa; Toyoizumi, Hiroyuki; Nakai, Hiroyuki; Kitaoka, Motomitsu; Taguchi, Hayao			Functional and Structural Analysis of a beta-Glucosidase Involved in beta-1,2-Glucan Metabolism in Listeria innocua	PLOS ONE			English	Article							FLAVOBACTERIUM-MENINGOSEPTICUM; 3-DIMENSIONAL STRUCTURE; CYCLIC BETA-1,2-GLUCAN; SUBSTRATE-SPECIFICITY; PERIPLASMIC GLUCANS; CRYSTAL-STRUCTURES; IDENTIFICATION; PURIFICATION; ADAPTATION; VIRULENCE	Despite the presence of beta-1,2-glucan in nature, few beta-1,2-glucan degrading enzymes have been reported to date. Recently, the Lin1839 protein from Listeria innocua was identified as a 1,2-beta-oligoglucan phosphorylase. Since the adjacent lin1840 gene in the gene cluster encodes a putative glycoside hydrolase family 3 beta-glucosidase, we hypothesized that Lin1840 is also involved in beta-1,2-glucan dissimilation. Here we report the functional and structural analysis of Lin1840. A recombinant Lin1840 protein (Lin1840r) showed the highest hydrolytic activity toward sophorose (Glc-beta-1,2-Glc) among beta-1,2-glucooligosaccharides, suggesting that Lin1840 is a beta-glucosidase involved in sophorose degradation. The enzyme also rapidly hydrolyzed laminaribiose (beta-1,3), but not cellobiose (beta-1,4) or gentiobiose (beta-1,6) among beta-linked gluco-disaccharides. We determined the crystal structures of Lin1840r in complexes with sophorose and laminaribiose as productive binding forms. In these structures, Arg572 forms many hydrogen bonds with sophorose and laminaribiose at subsite + 1, which seems to be a key factor for substrate selectivity. The opposite side of subsite + 1 from Arg572 is connected to a large empty space appearing to be subsite + 2 for the binding of sophorotriose (Glc-beta-1,2-Glc-beta-1,2-Glc) in spite of the higher Km value for sophorotriose than that for sophorose. The conformations of sophorose and laminaribiose are almost the same on the Arg572 side but differ on the subsite + 2 side that provides no interaction with a substrate. Therefore, Lin1840r is unable to distinguish between sophorose and laminaribiose as substrates. These results provide the first mechanistic insights into beta-1,2-glucooligosaccharide recognition by beta-glucosidase.	[Nakajima, Masahiro; Yoshida, Ryuta; Abe, Koichi; Toyoizumi, Hiroyuki; Taguchi, Hayao] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 278, Japan; [Miyanaga, Akimasa] Tokyo Inst Technol, Dept Chem, Meguro Ku, Tokyo 152, Japan; [Takahashi, Yuta; Sugimoto, Naohisa; Nakai, Hiroyuki] Niigata Univ, Grad Sch Sci & Technol, Nishi Ku, Niigata 9518510, Japan; [Kitaoka, Motomitsu] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki, Japan	Tokyo University of Science; Tokyo Institute of Technology; Niigata University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan	Nakajima, M (corresponding author), Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 278, Japan.	m-nakajima@rs.tus.ac.jp	Nakajima, Masahiro/J-3566-2019; Kitaoka, Motomitsu/R-1536-2019; Miyanaga, Akimasa/C-1472-2015	Nakajima, Masahiro/0000-0002-3182-0859; Kitaoka, Motomitsu/0000-0002-0083-1838; Miyanaga, Akimasa/0000-0003-2219-6051; Taguchi, Hayao/0000-0001-5270-581X				Abe K., 2015, J APPL GLYCOSCI, V62, P47, DOI [DOI 10.5458/JAG.JAG, 10.5458/jag.jag.JAG-2014_011, DOI 10.5458/JAG.JAG.JAG-2014_011]; Arellano-Reynoso B, 2005, NAT IMMUNOL, V6, P618, DOI 10.1038/ni1202; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baba Y, 2015, AMB EXPRESS, V5, DOI 10.1186/s13568-014-0090-3; Bacik JP, 2012, CHEM BIOL, V19, P1471, DOI 10.1016/j.chembiol.2012.09.016; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bohin JP, 2000, FEMS MICROBIOL LETT, V186, P11, DOI 10.1016/S0378-1097(00)00110-5; BREEDVELD MW, 1994, MICROBIOL REV, V58, P145, DOI 10.1128/MMBR.58.2.145-161.1994; Briones G, 2001, INFECT IMMUN, V69, P4528, DOI 10.1128/IAI.69.7.4528-4535.2001; Buchrieser C, 2003, FEMS IMMUNOL MED MIC, V35, P207, DOI 10.1016/S0928-8244(02)00448-0; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chir J, 2002, BIOCHEM J, V365, P857, DOI 10.1042/BJ20020186; CREMER D, 1975, J AM CHEM SOC, V97, P1354, DOI 10.1021/ja00839a011; Davies GJ, 1998, BIOCHEMISTRY-US, V37, P11707, DOI 10.1021/bi981315i; Di Tommaso P, 2007, NUCLEIC ACIDS RES, V39, pW13; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gay-Fraret J, 2012, FEMS MICROBIOL LETT, V333, P28, DOI 10.1111/j.1574-6968.2012.02595.x; HISAMATSU M, 1982, J GEN MICROBIOL, V128, P1873; HISAMATSU M, 1992, CARBOHYD RES, V231, P137, DOI 10.1016/0008-6215(92)84014-J; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hovel K, 2003, EMBO J, V22, P4922, DOI 10.1093/emboj/cdg494; Hrmova M, 2004, J BIOL CHEM, V279, P4970, DOI 10.1074/jbc.M307188200; Hrmova M, 2002, PLANT CELL, V14, P1033, DOI 10.1105/tpc.010442; Hrmova M, 2001, STRUCTURE, V9, P1005, DOI 10.1016/S0969-2126(01)00673-6; Karkehabadi S, 2014, J BIOL CHEM, V289, P31624, DOI 10.1074/jbc.M114.587766; KITAHATA S, 1987, AGR BIOL CHEM TOKYO, V51, P2701; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li YK, 2002, BIOCHEMISTRY-US, V41, P2751, DOI 10.1021/bi016049e; Li YK, 1998, J CHIN CHEM SOC-TAIP, V45, P603, DOI 10.1002/jccs.199800091; McAndrew RP, 2013, J BIOL CHEM, V288, P14985, DOI 10.1074/jbc.M113.458356; MENDOZA NS, 1983, J FERMENT TECHNOL, V61, P473; MILLER KJ, 1986, SCIENCE, V231, P48, DOI 10.1126/science.3941890; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakajima M, 2014, ACTA CRYSTALLOGR F, V70, P1398, DOI 10.1107/S2053230X14018597; Nakajima M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092353; Nakajima M, 2012, APPL MICROBIOL BIOT, V93, P1989, DOI 10.1007/s00253-011-3538-2; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pozzo T, 2010, J MOL BIOL, V397, P724, DOI 10.1016/j.jmb.2010.01.072; Rigano LA, 2007, PLANT CELL, V19, P2077, DOI 10.1105/tpc.106.047944; Schmidt S, 2010, RAPID COMMUN MASS SP, V24, P2009, DOI 10.1002/rcm.4605; Stortz CA, 2003, CARBOHYD RES, V338, P1679, DOI 10.1016/S0008-6215(03)00265-9; Suzuki K, 2013, BIOCHEM J, V452, P211, DOI 10.1042/BJ20130054; TALAGA P, 1994, J BACTERIOL, V176, P6538, DOI 10.1128/JB.176.21.6538-6544.1994; Varghese JN, 1999, STRUCTURE, V7, P179, DOI 10.1016/S0969-2126(99)80024-0; Vasella A, 2002, CURR OPIN CHEM BIOL, V6, P619, DOI 10.1016/S1367-5931(02)00380-0; Yoshida E, 2010, BIOCHEM J, V431, P39, DOI 10.1042/BJ20100351; Zheng HP, 2014, NAT PROTOC, V9, P156, DOI 10.1038/nprot.2013.172	51	27	28	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148870	10.1371/journal.pone.0148870	http://dx.doi.org/10.1371/journal.pone.0148870			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886583	Green Published, gold, Green Submitted			2022-12-27	WOS:000371218400055
J	Reijne, AC; Ciapaite, J; van Dijk, TH; Havinga, R; van der Zee, EA; Groen, AK; Reijngoud, DJ; Bakker, BM; van Dijk, G				Reijne, Aaffien C.; Ciapaite, Jolita; van Dijk, Theo H.; Havinga, Rick; van der Zee, Eddy A.; Groen, Albert K.; Reijngoud, Dirk-Jan; Bakker, Barbara M.; van Dijk, Gertjan			Whole-Body Vibration Partially Reverses Aging-Induced Increases in Visceral Adiposity and Hepatic Lipid Storage in Mice	PLOS ONE			English	Article							RAT SKELETAL-MUSCLE; BONE-MINERAL DENSITY; UNCOUPLING PROTEIN-2; POSTMENOPAUSAL WOMEN; METABOLIC-RATE; OBESE WOMEN; EXERCISE; STRENGTH; MITOCHONDRIA; STIMULATION	At old age, humans generally have declining muscle mass and increased fat deposition, which can increase the risk of developing cardiometabolic diseases. While regular physical activity postpones these age-related derangements, this is not always possible in the elderly because of disabilities or risk of injury. Whole-body vibration (WBV) training may be considered as an alternative to physical activity particularly in the frail population. To explore this possibility, we characterized whole-body and organ-specific metabolic processes in 6-month and 25-month old mice, over a period of 14 weeks of WBV versus sham training. WBV training tended to increase blood glucose turnover rates and stimulated hepatic glycogen utilization during fasting irrespective of age. WBV was effective in reducing white fat mass and hepatic triglyceride content only in old but not in young mice and these reductions were related to upregulation of hepatic mitochondrial uncoupling of metabolism (assessed by high-resolution respirometry) and increased expression of uncoupling protein 2. Because these changes occurred independent of changes in food intake and whole-body metabolic rate (assessed by indirect calorimetry), the liver-specific effects of WBV may be a primary mechanism to improve metabolic health during aging, rather than that it is a consequence of alterations in energy balance.	[Reijne, Aaffien C.; van Dijk, Gertjan] Univ Groningen, Unit Behav Neurosci, Neurobiol, Groningen Inst Evolutionary Life Sci, Nijenborgh 7, NL-9747 AG Groningen, Netherlands; [Reijne, Aaffien C.; Ciapaite, Jolita; Havinga, Rick; Groen, Albert K.; Reijngoud, Dirk-Jan; Bakker, Barbara M.] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Pediat, Hanzepl 1, NL-9713 GZ Groningen, Netherlands; [Reijne, Aaffien C.; Ciapaite, Jolita; Groen, Albert K.; Reijngoud, Dirk-Jan; Bakker, Barbara M.] Univ Groningen, Univ Med Ctr Groningen, Syst Biol Ctr Energy Metab & Ageing, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands; [van Dijk, Theo H.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Hanzepl 1, NL-9700 RB Groningen, Netherlands; [van der Zee, Eddy A.] Univ Groningen, Mol Neurobiol Unit, Groningen Inst Evolutionary Life Sci, Neurobiol, Nijenborgh 7, NL-9747 AG Groningen, Netherlands; [van Dijk, Gertjan] Univ Groningen, ESRIG Ctr Isotope Res, Nijenborgh 4, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	van Dijk, G (corresponding author), Univ Groningen, Unit Behav Neurosci, Neurobiol, Groningen Inst Evolutionary Life Sci, Nijenborgh 7, NL-9747 AG Groningen, Netherlands.; van Dijk, G (corresponding author), Univ Groningen, ESRIG Ctr Isotope Res, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	Gertjan.van.dijk@rug.nl	van Dijk, Theo/H-6436-2013; van der Zee, Eddy/AAZ-2120-2020	Bakker, Barbara/0000-0001-6274-3633; Ciapaite, Jolita/0000-0001-8761-9233; Reijngoud, Dirk-Jan/0000-0003-1157-4491	Netherlands Organization for Scientific Research (NWO) [853.00.110]; Rosalind Franklin Fellowship for the University of Groningen	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Rosalind Franklin Fellowship for the University of Groningen	This work was supported by a grant from the Netherlands Organization for Scientific Research (NWO, grant no. 853.00.110); http://www.nwo.nl/onderzoek-en-resultaten/onderzoeksprojecten/94/2300159494.html. Barbara M. Bakker was supported by a Rosalind Franklin Fellowship for the University of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando H, 2003, SCAND J WORK ENV HEA, V29, P216, DOI 10.5271/sjweh.724; Andrews ZB, 2009, AM J PHYSIOL-ENDOC M, V296, pE621, DOI 10.1152/ajpendo.90903.2008; Badin PM, 2013, TRENDS ENDOCRIN MET, V24, P607, DOI 10.1016/j.tem.2013.08.001; Bann D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116058; Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343; Barazzoni R, 2001, AM J PHYSIOL-ENDOC M, V280, pE413, DOI 10.1152/ajpendo.2001.280.3.E413; Baum Klaus, 2007, Int J Med Sci, V4, P159; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bosco C, 2000, EUR J APPL PHYSIOL, V81, P449, DOI 10.1007/s004210050067; Bosco C, 1999, CLIN PHYSIOL, V19, P183; BURKE D, 1976, J NEUROL NEUROSUR PS, V39, P729, DOI 10.1136/jnnp.39.8.729; Cochrane DJ, 2012, SCAND J MED SCI SPOR, V22, P705, DOI 10.1111/j.1600-0838.2011.01411.x; Conn VS, 2014, J PRIM CARE COMMUNIT, V5, P211, DOI 10.1177/2150131913520328; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; Hazell TJ, 2012, EUR J APPL PHYSIOL, V112, P413, DOI 10.1007/s00421-011-1984-2; Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134; Huang CC, 2014, INT J MED SCI, V11, P1218, DOI 10.7150/ijms.9975; Issurin VB, 1999, J SPORT SCI, V17, P177, DOI 10.1080/026404199366073; Kang CH, 2013, EXP GERONTOL, V48, P1343, DOI 10.1016/j.exger.2013.08.004; Kim TN, 2015, J CELL BIOCHEM, V116, P1171, DOI 10.1002/jcb.25077; Kvorning T, 2006, EUR J APPL PHYSIOL, V96, P615, DOI 10.1007/s00421-006-0139-3; Lameloise N, 2001, DIABETES, V50, P803, DOI 10.2337/diabetes.50.4.803; Lau RWK, 2011, CLIN REHABIL, V25, P975, DOI 10.1177/0269215511405078; LAVOINNE A, 1987, BIOCHEM J, V248, P429, DOI 10.1042/bj2480429; Lin CI, 2015, METABOLISM, V64, P1146, DOI 10.1016/j.metabol.2015.05.007; Liu CJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002759.pub2; LUSK G, 1976, ELEMENTS SCI NUTR; Maddalozzo GF, 2008, INT J OBESITY, V32, P1348, DOI 10.1038/ijo.2008.111; Mildaziene V, 2002, TOXICOL SCI, V65, P220, DOI 10.1093/toxsci/65.2.220; Nagase I, 2001, FEBS LETT, V494, P175, DOI 10.1016/S0014-5793(01)02341-9; Naghii MR, 2011, ACTA PHYSIOL HUNG, V98, P442, DOI 10.1556/APhysiol.98.2011.4.7; Oklejewicz M, 1997, J BIOL RHYTHM, V12, P413, DOI 10.1177/074873049701200503; Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427; Prisby RD, 2008, AGEING RES REV, V7, P319, DOI 10.1016/j.arr.2008.07.004; Rees SS, 2008, PHYS THER, V88, P462, DOI 10.2522/ptj.20070027; Regterschot GRH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100506; Riedel G, 2010, FEMS FOR, P5; Rittweger J, 2002, INT J SPORTS MED, V23, P428, DOI 10.1055/s-2002-33739; Rizzo MR, 2005, J CLIN ENDOCR METAB, V90, P409, DOI 10.1210/jc.2004-0390; Roelants M, 2004, INT J SPORTS MED, V25, P1, DOI 10.1055/s-2003-45238; Samec S, 1999, POSTSTARVATION GENE, V17, P1339; Srere PA, 1963, ACTA CHEM SCAND; Stuermer EK, 2010, CALCIFIED TISSUE INT, V87, P168, DOI 10.1007/s00223-010-9381-0; Tapp LR, 2014, CLIN INTERV AGING, V9, P63, DOI 10.2147/CIA.S30048; Timmer M, 2006, FENS FOR, P3; van den Broek NMA, 2010, FASEB J, V24, P1354, DOI 10.1096/fj.09-143842; van Dijk TH, 2003, ANAL BIOCHEM, V322, P1, DOI 10.1016/j.ab.2003.07.008; van Dijk TH, 2001, J BIOL CHEM, V276, P25727, DOI 10.1074/jbc.M101223200; Verschueren SMP, 2004, J BONE MINER RES, V19, P352, DOI 10.1359/JBMR.0301245; VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740; Vissers D, 2009, PHYSICIAN SPORTSMED, V37, P88, DOI 10.3810/psm.2009.10.1733; Vissers D, 2010, OBESITY FACTS, V3, P93, DOI 10.1159/000301785; von Stengel S, 2011, OSTEOPOROSIS INT, V22, P317, DOI 10.1007/s00198-010-1215-4; Vozza A, 2014, P NATL ACAD SCI USA, V111, P960, DOI 10.1073/pnas.1317400111; Wilms B, 2012, INT J SPORTS MED, V33, P740, DOI 10.1055/s-0032-1306284; WINKLER E, 1994, J BIOL CHEM, V269, P2508; Zhao L, 2014, EXP GERONTOL, V56, P3, DOI 10.1016/j.exger.2014.02.001	60	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0149419	10.1371/journal.pone.0149419	http://dx.doi.org/10.1371/journal.pone.0149419			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886917	gold, Green Published, Green Submitted			2022-12-27	WOS:000371218400080
J	Talamas, SN; Mavor, KI; Perrett, DI				Talamas, Sean N.; Mavor, Kenneth I.; Perrett, David I.			Blinded by Beauty: Attractiveness Bias and Accurate Perceptions of Academic Performance	PLOS ONE			English	Article							HUMAN FACIAL ATTRACTIVENESS; MOTHERS FACE RECOGNITION; PHYSICAL ATTRACTIVENESS; COGNITIVE PERFORMANCE; SEXUAL-DIMORPHISM; IMPLICIT THEORIES; NEWBORN-INFANTS; TEACHER EXPECTATIONS; SUPPRESSOR VARIABLES; OLDER-ADULTS	Despite the old adage not to 'judge a book by its cover', facial cues often guide first impressions and these first impressions guide our decisions. Literature suggests there are valid facial cues that assist us in assessing someone's health or intelligence, but such cues are overshadowed by an 'attractiveness halo' whereby desirable attributions are preferentially ascribed to attractive people. The impact of the attractiveness halo effect on perceptions of academic performance in the classroom is concerning as this has shown to influence students' future performance. We investigated the limiting effects of the attractiveness halo on perceptions of actual academic performance in faces of 100 university students. Given the ambiguity and various perspectives on the definition of intelligence and the growing consensus on the importance of conscientiousness over intelligence in predicting actual academic performance, we also investigated whether perceived conscientiousness was a more accurate predictor of academic performance than perceived intelligence. Perceived conscientiousness was found to be a better predictor of actual academic performance when compared to perceived intelligence and perceived academic performance, and accuracy was improved when controlling for the influence of attractiveness on judgments. These findings emphasize the misleading effect of attractiveness on the accuracy of first impressions of competence, which can have serious consequences in areas such as education and hiring. The findings also have implications for future research investigating impression accuracy based on facial stimuli.	[Talamas, Sean N.; Mavor, Kenneth I.; Perrett, David I.] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland	University of St Andrews	Talamas, SN (corresponding author), Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland.	st87@st-andrews.ac.uk	Perrett, David/AAA-6264-2020; Mavor, Ken/E-6475-2011	Mavor, Ken/0000-0002-3160-3889; Perrett, David/0000-0002-6025-0939				Alaimo K, 2001, PEDIATRICS, V108, P44; AMBADY N, 1993, J PERS SOC PSYCHOL, V64, P431, DOI 10.1037/0022-3514.64.3.431; Axelsson J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6614; Barber I, 2001, P ROY SOC B-BIOL SCI, V268, P71, DOI 10.1098/rspb.2000.1331; BENSON P, 1992, NEW SCI, V133, P32; BENSON PJ, 1993, PERCEPTION, V22, P257, DOI 10.1068/p220257; Bishop SJ, 2009, NAT NEUROSCI, V12, P92, DOI 10.1038/nn.2242; Blackwell LS, 2007, CHILD DEV, V78, P246, DOI 10.1111/j.1467-8624.2007.00995.x; Borkenau P, 2009, J RES PERS, V43, P703, DOI 10.1016/j.jrp.2009.03.007; Bushnell IWR, 2001, INFANT CHILD DEV, V10, P67, DOI 10.1002/icd.248; CERELLA J, 1994, ACTA PSYCHOL, V86, P109, DOI 10.1016/0001-6918(94)90002-7; Chamorro-Premuzic, 2007, PERS INDIV DIFFER; Chamorro-Premuzic T, 2004, BRIT J PSYCHOL, V95, P249, DOI 10.1348/000712604773952458; Clayton V.P., 1980, LIFE SPAN DEV BEHAV, P103; CLIFFORD MM, 1973, SOCIOL EDUC, V46, P248, DOI 10.2307/2112099; CLIFFORD MM, 1975, CHILD STUDY J, V5, P201; Coetzee V, 2009, PERCEPTION, V38, P1700, DOI 10.1068/p6423; CONGER AJ, 1974, EDUC PSYCHOL MEAS, V34, P35, DOI 10.1177/001316447403400105; de Boer H, 2010, J EDUC PSYCHOL, V102, P168, DOI 10.1037/a0017289; de Haan M, 2001, COGNITIVE DEV, V16, P659, DOI 10.1016/S0885-2014(01)00051-X; Denny K, 2008, INTELLIGENCE, V36, P616, DOI 10.1016/j.intell.2008.01.003; DION K, 1972, J PERS SOC PSYCHOL, V24, P285, DOI 10.1037/h0033731; DUSEK JB, 1983, J EDUC PSYCHOL, V75, P327, DOI 10.1037/0022-0663.75.3.327; DWECK CS, 1995, PSYCHOL INQ, V6, P267, DOI 10.1207/s15327965pli0604_1; Dweck CS, 1989, THEORIES INTELLIGENC; Englert P., 2009, AUSTR NZ J ORG PSYCH, V2, P19, DOI [10.1375/ajop.2.1.19, DOI 10.1375/AJOP.2.1.19]; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; FELSON RB, 1980, REPRESENT R SOC PSYC, V11, P64; Fink B, 2005, P ROY SOC B-BIOL SCI, V272, P1995, DOI 10.1098/rspb.2005.3179; Fry AF, 2000, BIOL PSYCHOL, V54, P1, DOI 10.1016/S0301-0511(00)00051-X; Gehrman PR, 2011, SLEEP, P4; Gregg EW, 2000, ARCH INTERN MED, V160, P174, DOI 10.1001/archinte.160.2.174; Gurian M, 2004, EDUC LEADERSHIP, V62, P21; Haines MM, 2001, PSYCHOL MED, V31, P265, DOI 10.1017/S0033291701003282; Holtzman NS, 2011, J RES PERS, V45, P648, DOI 10.1016/j.jrp.2011.09.002; Hong YY, 1999, J PERS SOC PSYCHOL, V77, P588, DOI 10.1037/0022-3514.77.3.588; Horn JL, 1967, ACTA PSYCHOL AMST; JACKSON LA, 1995, SOC PSYCHOL QUART, V58, P108, DOI 10.2307/2787149; Jardim-Botelho A, 2008, TROP MED INT HEALTH, V13, P994, DOI 10.1111/j.1365-3156.2008.02103.x; Kalick SM, 1998, PSYCHOL SCI, V9, P8, DOI 10.1111/1467-9280.00002; Kanazawa S, 2011, INTELLIGENCE, V39, P7, DOI 10.1016/j.intell.2010.11.003; KENEALY P, 1988, J SOC PSYCHOL, V128, P373, DOI 10.1080/00224545.1988.9713754; Kleisner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081237; Kramer RSS, 2011, PERCEPTION, V40, P549, DOI 10.1068/p6856; Kramer RSS, 2010, Q J EXP PSYCHOL, V63, P2273, DOI 10.1080/17470211003770912; LANGLOIS JH, 1990, DEV PSYCHOL, V26, P153, DOI 10.1037/0012-1649.26.1.153; LANGLOIS JH, 1990, PSYCHOL SCI, V1, P115, DOI 10.1111/j.1467-9280.1990.tb00079.x; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Lefevre CE, 2013, EVOL HUM BEHAV, V34, P273, DOI 10.1016/j.evolhumbehav.2013.03.005; Little AC, 2001, P ROY SOC B-BIOL SCI, V268, P39, DOI 10.1098/rspb.2000.1327; Little AC, 2007, BRIT J PSYCHOL, V98, P111, DOI 10.1348/000712606X109648; Little AC, 2007, EVOL HUM BEHAV, V28, P18, DOI 10.1016/j.evolhumbehav.2006.09.002; Maassen GH, 2001, SOCIOL METHOD RES, V30, P241, DOI 10.1177/0049124101030002004; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; Mavor KI, 2009, PERS INDIV DIFFER, V46, P592, DOI 10.1016/j.paid.2008.12.016; Mitchem DG, 2015, EVOL HUM BEHAV, V36, P240, DOI 10.1016/j.evolhumbehav.2014.11.009; Moutafi J, 2004, PERS INDIV DIFFER, V37, P1013, DOI 10.1016/j.paid.2003.11.010; Moutafi J, 2003, EUR J PERSONALITY, V17, P79, DOI 10.1002/per.471; Mueller U, 1996, SOC FORCES, V74, P823, DOI 10.2307/2580383; Munshi M, 2006, DIABETES CARE, V29, P1794, DOI 10.2337/dc06-0506; MURPHY MJ, 1981, PSYCHOL REP, V48, P103, DOI 10.2466/pr0.1981.48.1.103; Neisser U, 1996, AM PSYCHOL, V51, P77, DOI 10.1037/0003-066X.51.2.77; Nunnally J, 1978, PSYCHOMETRIC METHODS; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Ohayon MM, 2005, SLEEP, V28, P981; Okereke OI, 2013, AM J GERIAT PSYCHIAT, V21, P1125, DOI 10.1016/j.jagp.2013.01.050; Olivola CY, 2010, J EXP SOC PSYCHOL, V46, P315, DOI 10.1016/j.jesp.2009.12.002; Osborne J, 2003, RES EVAL, V8; PASCALIS O, 1995, INFANT BEHAV DEV, V18, P79, DOI 10.1016/0163-6383(95)90009-8; Penton-Voak IS, 2006, SOC COGNITION, V24, P607, DOI 10.1521/soco.2006.24.5.607; Penton-Voak IS, 2004, EVOL HUM BEHAV, V25, P229, DOI 10.1016/j.evolhumbehav.2004.04.003; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Perrett DI, 1999, EVOL HUM BEHAV, V20, P295, DOI 10.1016/S1090-5138(99)00014-8; Pound N, 2009, P ROY SOC B-BIOL SCI, V276, P153, DOI 10.1098/rspb.2008.0990; Rantala MJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2495; Re DE, 2012, PERS INDIV DIFFER, V53, P901, DOI 10.1016/j.paid.2012.07.001; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; RITTS V, 1992, REV EDUC RES, V62, P413, DOI 10.2307/1170486; Rosenthal R, 1968, SCI AM; Rule NO, 2008, PSYCHOL SCI, V19, P109, DOI 10.1111/j.1467-9280.2008.02054.x; SALVIA J, 1977, J SCHOOL PSYCHOL, V15, P60, DOI 10.1016/0022-4405(77)90062-0; Sell A, 2009, P R SOC B, V276, P575, DOI 10.1098/rspb.2008.1177; Sim T, 2001, SUBST ABUS, V21, P61; SINGER JE, 1964, SOCIOMETRY, V27, P128, DOI 10.2307/2785711; Slater A, 1998, INFANT BEHAV DEV, V21, P345, DOI 10.1016/S0163-6383(98)90011-X; Slater A, 2000, INFANCY, V1, P265, DOI 10.1207/S15327078IN0102_8; Sorhagen NS, 2013, J EDUC PSYCHOL, V105, P465, DOI 10.1037/a0031754; SPARACINO J, 1979, J PERS, V47, P449, DOI 10.1111/j.1467-6494.1979.tb00626.x; Stephen ID, 2009, INT J PRIMATOL, V30, P845, DOI 10.1007/s10764-009-9380-z; Sundelin T, 2013, SLEEP, V36, P1355, DOI 10.5665/sleep.2964; Thornhill R, 2006, EVOL HUM BEHAV, V27, P131, DOI 10.1016/j.evolhumbehav.2005.06.001; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; Todorov A, 2015, ANNU REV PSYCHOL, V66, P519, DOI 10.1146/annurev-psych-113011-143831; Todorov A, 2014, PSYCHOL SCI, V25, P1404, DOI 10.1177/0956797614532474; Todorov A, 2008, TRENDS COGN SCI, V12, P455, DOI 10.1016/j.tics.2008.10.001; Tovee MJ, 2006, EVOL HUM BEHAV, V27, P443, DOI 10.1016/j.evolhumbehav.2006.05.004; TZELGOV J, 1991, PSYCHOL BULL, V109, P524, DOI 10.1037/0033-2909.109.3.524; Yassuda MS, 2012, J NUTR HEALTH AGING, V16, P55, DOI 10.1007/s12603-012-0003-6; Zebrowitz LA, 2004, J NONVERBAL BEHAV, V28, P167, DOI 10.1023/B:JONB.0000039648.30935.1b; ZEBROWITZ LA, 1991, LAW HUMAN BEHAV, V15, P603, DOI 10.1007/BF01065855; Zebrowitz LA, 2002, PERS SOC PSYCHOL B, V28, P238, DOI 10.1177/0146167202282009; ZEBROWITZ LA, 1991, J EXP CHILD PSYCHOL, V52, P221, DOI 10.1016/0022-0965(91)90060-6; Zebrowitz LA, 2007, SOC COGNITION, V25, P306, DOI 10.1521/soco.2007.25.2.306	103	47	48	4	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148284	10.1371/journal.pone.0148284	http://dx.doi.org/10.1371/journal.pone.0148284			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3BJ	26885976	Green Submitted, Green Published, gold			2022-12-27	WOS:000371218400028
J	Wu, W; Sun, X; Gao, Y; Jiang, J; Cui, ZL; Ge, BX; Wu, H; Zhang, L; Li, Y				Wu, Wei; Sun, Xian; Gao, Yun; Jiang, Jun; Cui, Zhenling; Ge, Baoxue; Wu, Hai; Zhang, Lu; Li, Yao			Genome-Wide De Novo Prediction of Cis-Regulatory Binding Sites in Mycobacterium tuberculosis H37Rv	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; REPRESSOR; DATABASE; REGULON; NUCLEOTIDE; COMPLEXITY	The transcription regulatory system of Mycobacterium tuberculosis (M. tb) remains incompletely understood. In this study, we have applied the eGLECLUBS algorithm to a group of related prokaryotic genomes for de novo genome-wide prediction of cis-regulatory binding sites (CRBSs) inM. tb H37Rv. The top 250 clusters from our prediction recovered 83.3% (50/60) of all known CRBSs in extracted inter-operonic sequences of this strain. We further demonstrated that the integration of our prediction results with the ChIP-Seq datasets is very effective in identifying true binding sites of TFs. Using electrophoretic mobility shift assays and real-time RT-PCR, we experimentally verified our prediction of CRBSs for Rv0081, an important transcription factor thought to be involved in regulation ofM. tb under hypoxia.	[Wu, Wei; Sun, Xian; Gao, Yun; Jiang, Jun; Wu, Hai; Zhang, Lu; Li, Yao] Fudan Univ, Coll Life Sci, Shanghai Engn Res Ctr Ind Microorganisms, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Cui, Zhenling; Ge, Baoxue] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Shanghai Key Lab TB, Shanghai 200092, Peoples R China	Fudan University; Tongji University	Zhang, L; Li, Y (corresponding author), Fudan Univ, Coll Life Sci, Shanghai Engn Res Ctr Ind Microorganisms, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	zhanglu407@fudan.edu.cn; yaoli@fudan.edu.cn	Li, Yao/AAE-3550-2019	Zhang, Lu/0000-0002-4858-0361	National Key Technologies R & D Program of China [2013ZX10003007-003]; National Natural Science Foundation of China [31171246]; Shanghai Science and Technology Commission [13DZ2252000]	National Key Technologies R & D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by a grant from the National Key Technologies R & D Program of China during the Twelfth Five-Year Plan Period (No. 2013ZX10003007-003, http://www.most.gov.cn/), a grant from the National Natural Science Foundation of China (No. 31171246, http://www.nsfc.gov.cn/), and a grant from Shanghai Science and Technology Commission (No. 13DZ2252000, http://www.stcsm.gov.cn/). YL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2012, FEBS J, V279, P3214, DOI 10.1111/j.1742-4658.2012.08707.x; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bolla JR, 2012, NUCLEIC ACIDS RES, V40, P9340, DOI 10.1093/nar/gks677; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Cavet JS, 2003, J BIOL CHEM, V278, P44560, DOI 10.1074/jbc.M307877200; Engohang-Ndong J, 2004, MOL MICROBIOL, V51, P175, DOI 10.1046/j.1365-2958.2003.03809.x; Galagan J, 2013, CURR TOP MICROBIOL, V363, P43, DOI 10.1007/82_2012_257; Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337; Haydel SE, 2006, J BACTERIOL, V188, P150, DOI 10.1128/JB.188.1.150-159.2006; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Kummerfeld SK, 2006, NUCLEIC ACIDS RES, V34, pD74, DOI 10.1093/nar/gkj131; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Maciag A, 2007, J BACTERIOL, V189, P730, DOI 10.1128/JB.01190-06; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Micklinghoff JC, 2009, J BACTERIOL, V191, P7260, DOI 10.1128/JB.01009-09; Midha M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036094; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Reddy TBK, 2009, NUCLEIC ACIDS RES, V37, pD499, DOI 10.1093/nar/gkn652; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Sala C, 2009, MOL MICROBIOL, V71, P1102, DOI 10.1111/j.1365-2958.2008.06583.x; TAGLE DA, 1988, J MOL BIOL, V203, P439, DOI 10.1016/0022-2836(88)90011-3; Zhang SQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-397; Zhang SQ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp248	23	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2016	11	2							e0148965	10.1371/journal.pone.0148965	http://dx.doi.org/10.1371/journal.pone.0148965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BJ	26886880	Green Published, gold, Green Submitted			2022-12-27	WOS:000371218400057
J	Li, F; Zhou, CL; Xu, L; Tao, SQ; Zhao, JY; Gu, Q				Li, Feng; Zhou, Changlin; Xu, Liang; Tao, Shuqing; Zhao, Jingyi; Gu, Qun			Effect of Stem Cell Therapy on Bone Mineral Density: A Meta-Analysis of Preclinical Studies in Animal Models of Osteoporosis	PLOS ONE			English	Article							SYSTEMATIC REVIEWS; PUBLICATION BIAS; PREVENTION; FRACTURE; MANAGEMENT; BISPHOSPHONATES; TRANSPLANTATION; EPIDEMIOLOGY; EFFICACY; QUALITY	Background Preclinical studies of the therapeutic role of stem cell based therapy in animal models of osteoporosis have largely yielded inconsistent results. We performed a meta-analysis to provide an overview of the currently available evidence. Methods Pubmed, Embase and Cochrane Library databases were systematically searched for relevant controlled studies. A random-effect model was used for pooled analysis of the effect of stem cell based therapy on bone mineral density (BMD). Stratified analyses were performed to explore the effect of study characteristics on the outcomes. Results Pooled results from 12 preclinical studies (110 animals in stem cell treatment groups, and 106 animals in control groups) indicated that stem cell based treatment was associated with significantly improved BMD (standardized mean difference [SMD] = 1.29, 95% Confidence Interval [CI]: 0.84-1.74, P < 0.001) with moderate heterogeneity (Cochrane's Q test: P = 0.02, I-2 = 45%) among the constituent studies. Implantation of bone marrow cells, bone marrow mesenchymal stem cells, adipose-derived stem cells, and human umbilical cord blood-derived CD34+ cells, were all associated with improved BMD as compared to that in the controls (P < 0.05 for all); the only exception being the use of embryonic stem cell transplantation (P > 0.05). Egger's test detected potential publication bias (P = 0.055); however, 'trim and fill' analysis yielded similar results after statistically incorporating the hypothetical studies in the analysis (SMD = 1.24, 95% CI: 0.32-2.16, P < 0.001). Conclusions Stem cell transplantation may improve BMD in animal models of osteoporosis. Our meta-analysis indicates a potential therapeutic role of stem cell based therapy for osteoporosis, and serves to augment the rationale for clinical studies.	[Li, Feng; Xu, Liang; Tao, Shuqing; Gu, Qun] Harbin Med Univ, Affiliated Hosp 2, Dept Bone Joint Surg, Harbin 150086, Heilongjiang Pr, Peoples R China; [Zhou, Changlin] Harbin Med Univ, Affiliated Hosp 2, Dept Emergency Surg, Harbin 150086, Heilongjiang Pr, Peoples R China; [Zhao, Jingyi] Heilongjiang Acad Tradit Chinese Med, Harbin 150086, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University	Zhou, CL (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Emergency Surg, Harbin 150086, Heilongjiang Pr, Peoples R China.	osteo2015@163.com			Research project of science and technology of Heilongjiang Province [12521315]	Research project of science and technology of Heilongjiang Province	This work was supported by Research project of science and technology of Heilongjiang Province, number: 12521315 to CZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039365; Antebi B, 2014, CURR OSTEOPOROS REP, V12, P41, DOI 10.1007/s11914-013-0184-x; Bebarta V, 2003, ACAD EMERG MED, V10, P684, DOI 10.1197/aemj.10.6.684; Bonyadi M, 2003, P NATL ACAD SCI USA, V100, P5840, DOI 10.1073/pnas.1036475100; Briel M, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-23; Cefalu CA, 2004, CURR MED RES OPIN, V20, P341, DOI 10.1185/030079903125003062; Cho SW, 2009, MOL THER, V17, P1979, DOI 10.1038/mt.2009.153; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eriksen EF, 2014, BONE, V58, P126, DOI 10.1016/j.bone.2013.09.023; Faggion CM, 2015, EUR J ORAL SCI, V123, P61, DOI 10.1111/eos.12175; Feng W, 2010, TRANSPLANTATION, V89, P395, DOI 10.1097/TP.0b013e3181ca86bb; Garnero P., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P50; Gedmintas L, 2013, J BONE MINER RES, V28, P1729, DOI 10.1002/jbmr.1893; Green S, 2008, COCHRANE BOOK SERIES; Herrmann M, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00079; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ichioka N, 2002, STEM CELLS, V20, P542, DOI 10.1634/stemcells.20-6-542; Katsara O, 2011, STEM CELLS DEV, V20, P1550, DOI 10.1089/scd.2010.0280; Khan SN, 2013, CLIN OBSTET GYNECOL, V56, P694, DOI 10.1097/01.grf.0000437016.19989.61; Kim JE, 2014, TISSUE ENG REGEN MED, V11, P24, DOI [10.1007/s13770-013-1123-8, 10.1007/s13770-014-0001-3]; Korevaar DA, 2011, LAB ANIM-UK, V45, P225, DOI 10.1258/la.2011.010121; Lin X, 2015, CLIN INTERV AGING, V10, P1017, DOI 10.2147/CIA.S54613; Liu HY, 2012, BIOMATERIALS, V33, P6105, DOI 10.1016/j.biomaterials.2012.05.024; Liu Y, 2014, CLIN EXP MED, V14, P13, DOI 10.1007/s10238-012-0218-1; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Reid IR, 2014, LANCET, V383, P146, DOI 10.1016/S0140-6736(13)61647-5; Sale JEM, 2014, CLIN GERIATR MED, V30, P317, DOI 10.1016/j.cger.2014.01.009; Sandhu SK, 2011, J CLIN PATHOL, V64, P1042, DOI 10.1136/jcp.2010.077842; Taiani JT, 2014, BONE, V64, P263, DOI 10.1016/j.bone.2014.04.019; Tao Hui, 2011, Jiepou Xuebao, V42, P220, DOI 10.3969/j.issn.0529-1356.2011.02.016; Uejima S, 2008, CYTOTHERAPY, V10, P479, DOI 10.1080/14653240802071616; Willson T, 2015, CLIN EPIDEMIOL, V7, P65, DOI 10.2147/CLEP.S40966; Ye XH, 2014, CYTOTHERAPY, V16, P1643, DOI 10.1016/j.jcyt.2014.07.009; Yu Yang, 2013, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V29, P1267; Yu ZR, 2012, INT ORTHOP, V36, P2163, DOI 10.1007/s00264-012-1543-4; Zhang J, 2012, ASIAN PAC J TROP MED, V5, P743, DOI 10.1016/S1995-7645(12)60118-7; Zigdon-Giladi H, 2015, WORLD J STEM CELLS, V7, P630, DOI 10.4252/wjsc.v7.i3.630	38	24	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149400	10.1371/journal.pone.0149400	http://dx.doi.org/10.1371/journal.pone.0149400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	26882451	Green Submitted, Green Published, gold			2022-12-27	WOS:000371219000074
J	Saloojee, S; Burns, JK; Motala, AA				Saloojee, Shamima; Burns, Jonathan K.; Motala, Ayesha A.			Metabolic Syndrome in South African Patients with Severe Mental Illness: Prevalence and Associated Risk Factors	PLOS ONE			English	Article							CARDIOVASCULAR RISK; BODY-MASS; SCHIZOPHRENIA; ANTIPSYCHOTICS; DISORDERS; PATTERNS; DISEASE; OBESITY; POLYPHARMACY; MORTALITY	Background There is a surge of cardiovascular disease (CVD) in Africa. CVD is the leading cause of mortality among patients with severe mental illness (SMI) in developed countries, with little evidence from the African context. Objective To determine the prevalence and risk factors for MetS among South African patients with SMI. Method In a cross sectional study, individuals with SMI treated with antipsychotics and a control group without a mental illness, matched for age, gender and ethnicity were evaluated for MetS using the 2009 Joint Interim statement (JIS) criteria. Results Of the 276 study group subjects, 65.9% were male, 84.1% black African, 9.1% white, 5.4% of Indian descent and 1.5% coloured (mixed race) with a mean age of 34.7 years (+/- 12.5). Schizophrenia was the most common diagnosis (73.2%) and 40% were taking first generation antipsychotics. The prevalence of MetS was 23.2% (M: 15.4%, F: 38.3%) in the study group and 19.9%(M: 11.9%, F: 36.3%) in the control group (p = 0.4). MetS prevalence was significantly higher in study subjects over 55 years compared to controls (p = 0.03). Increased waist circumference (p<0.001) and low high density lipoprotein (HDL) cholesterol (p = 0.003) were significantly more prevalent in study subjects compared to controls. In study subjects, risk factors associated with MetS included age (OR: 1.09, 95% CI 1.06-1.12, p < 0.001), female gender (OR: 2.19, 95% CI 1.06-4.55, p = 0.035) and Indian descent (OR: 5.84, 95% CI 1.66-20.52, p = 0.006) but not class of antipsychotic (p = 0.26). Conclusion The overall MetS prevalence was not increased in patients with SMI compared to controls; however, the higher prevalence of the individual components (HDL cholesterol and waist circumference) suggests an increased risk for CVD, especially in patients over 55 years.	[Saloojee, Shamima; Burns, Jonathan K.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Psychiat, Durban, South Africa; [Motala, Ayesha A.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Endocrinol & Diabet, Durban, South Africa	University of Kwazulu Natal; University of Kwazulu Natal	Saloojee, S (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Psychiat, Durban, South Africa.	saloojees1@ukzn.ac.za		Motala, Ayesha/0000-0003-0517-1784	Office of the U.S. Global AIDS Coordinator [R24TW008863]; FOGARTY INTERNATIONAL CENTER [R24TW008863] Funding Source: NIH RePORTER	Office of the U.S. Global AIDS Coordinator; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This publication was made possible by grant number: R24TW008863 from the Office of the U.S. Global AIDS Coordinator and the U. S. Department of Health and Human Services, National Institutes of Health (NIH OAR and NIH ORWH). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the government."	Ader M, 2008, J PSYCHIATR RES, V42, P1076, DOI 10.1016/j.jpsychires.2008.01.004; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Diaz-Dominguez DA, 2013, INT J MENT HEALTH, V42, P95, DOI 10.2753/IMH0020-7411420405; Aly HAA, 2015, WHO TECH REP SER, V994, P1; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], FAT CHANCE SLIM NONE; Arango C, 2008, SCHIZOPHR RES, V104, P1, DOI 10.1016/j.schres.2008.05.009; Baptista T, 2011, SCHIZOPHR RES, V126, P93, DOI 10.1016/j.schres.2010.10.014; Bressington DT, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-87; Carliner H, 2014, COMPR PSYCHIAT, V55, P233, DOI 10.1016/j.comppsych.2013.09.009; Chang HH, 2010, J AFFECT DISORDERS, V124, P319, DOI 10.1016/j.jad.2009.12.011; Chiliza B, 2015, EUR PSYCHIAT, V30, DOI 10.1016/j.eurpsy.2014.11.013; Coccurello R, 2010, PHARMACOL THERAPEUT, V127, P210, DOI 10.1016/j.pharmthera.2010.04.008; Correll CU, 2007, SCHIZOPHR RES, V89, P91, DOI 10.1016/j.schres.2006.08.017; De Hert M, 2009, EUR PSYCHIAT, V24, P412, DOI 10.1016/j.eurpsy.2009.01.005; Hert M, 2012, NAT REV ENDOCRINOL, V8, P114, DOI 10.1038/nrendo.2011.156; Dold M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009831.pub2; Draper CE, 2016, PUBLIC HEALTH NUTR, V19, P548, DOI 10.1017/S1368980015001688; Faasen N, 2014, SAJP-S AFR J PSYCHI, V20, P54, DOI 10.7196/SAJP.528; Falissard B, 2011, INT CLIN PSYCHOPHARM, V26, P291, DOI 10.1097/YIC.0b013e32834a5bf6; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Fisher MD, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0341-5; Foley DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082606; Gale EAM, 2005, DIABETOLOGIA, V48, P1679, DOI 10.1007/s00125-005-1873-5; Gallego JA, 2012, SCHIZOPHR RES, V138, P18, DOI 10.1016/j.schres.2012.03.018; Gardner-Sood P, 2015, PSYCHOL MED, V45, P2619, DOI 10.1017/S0033291715000562; Hagg S, 2006, INT CLIN PSYCHOPHARM, V21, P93; Hennekens CH, 2005, AM HEART J, V150, P1115, DOI 10.1016/j.ahj.2005.02.007; Holt RIG, 2015, NAT REV ENDOCRINOL, V11, P79, DOI 10.1038/nrendo.2014.203; Horowitz E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092573; Kahn R, 2008, LANCET, V371, P1892, DOI 10.1016/S0140-6736(08)60731-X; Keenan TE, 2013, SCHIZOPHR RES, V150, P211, DOI 10.1016/j.schres.2013.07.022; Lasich A J, 2007, Afr J Psychiatry (Johannesbg), V10, P143; Laursen TM, 2012, CURR OPIN PSYCHIATR, V25, P83, DOI 10.1097/YCO.0b013e32835035ca; Lee NY, 2011, PROG NEURO-PSYCHOPH, V35, P1273, DOI 10.1016/j.pnpbp.2011.03.022; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Maaroganye K, 2013, AFR J PSYCHIATRY, V16, P414, DOI [http://dx.doi.org/10.4314/ajpsy.v16i6.53, 10.4314/ajpsy.v16i6.53]; Marthoenis M, 2015, ASIAN J PSYCHIATR, V15, P10, DOI 10.1016/j.ajp.2015.04.004; McEvoy JP, 2005, SCHIZOPHR RES, V80, P19, DOI 10.1016/j.schres.2005.07.014; Mensah GA, 2015, CARDIOVASC J AFR, V26, pS6, DOI 10.5830/CVJA-2015-036; Mitchell AJ, 2013, SCHIZOPHRENIA BULL, V39, P306, DOI 10.1093/schbul/sbr148; Motala AA, 2011, DIABETES CARE, V34, P1032, DOI 10.2337/dc10-1921; Palaniappan LP, 2011, INT J OBESITY, V35, P393, DOI 10.1038/ijo.2010.152; Papanastasiou E, 2013, THER ADV PSYCHOPHARM, V3, P33, DOI 10.1177/2045125312464385; Peer N, 2014, SAMJ S AFR MED J, V104, P691, DOI [10.7196/SAMJ.8125, 10.7196/samj.8125]; Peer N, 2015, EUR J PREV CARDIOL, V22, P1036, DOI 10.1177/2047487314549744; Purgato M, 2012, INT J MENT HEALTH SY, V6, DOI 10.1186/1752-4458-6-9; Ritchie SA, 2007, NUTR METAB CARDIOVAS, V17, P319, DOI 10.1016/j.numecd.2006.07.005; Rukat A, 2014, J CLIN PSYCHOPHARM, V34, P571, DOI 10.1097/JCP.0000000000000166; Rummel-Kluge C, 2010, SCHIZOPHR RES, V123, P225, DOI 10.1016/j.schres.2010.07.012; Seeman MV, 2009, SCHIZOPHRENIA BULL, V35, P937, DOI 10.1093/schbul/sbn023; Srisurapanont M, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-14; Sugawara N, 2010, SCHIZOPHR RES, V123, P244, DOI 10.1016/j.schres.2010.08.030; Tirupati S, 2007, AUST NZ J PSYCHIAT, V41, P606, DOI 10.1080/00048670701392841	55	23	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0149209	10.1371/journal.pone.0149209	http://dx.doi.org/10.1371/journal.pone.0149209			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3BP	26882230	Green Published, Green Submitted, gold			2022-12-27	WOS:000371219000061
J	Snow, NJ; Mang, CS; Roig, M; McDonnell, MN; Campbell, KL; Boyd, LA				Snow, Nicholas J.; Mang, Cameron S.; Roig, Marc; McDonnell, Michelle N.; Campbell, Kristin L.; Boyd, Lara A.			The Effect of an Acute Bout of Moderate-Intensity Aerobic Exercise on Motor Learning of a Continuous Tracking Task	PLOS ONE			English	Article							PAIRED ASSOCIATIVE STIMULATION; SINGLE BOUT; CARDIOVASCULAR EXERCISE; MEMORY CONSOLIDATION; PERFORMANCE; ACCURACY; RELIABILITY; PLASTICITY; INCREASES; AROUSAL	Introduction There is evidence for beneficial effects of acute and long-term exercise interventions on several forms of memory, including procedural motor learning. In the present study we examined how performing a single bout of continuous moderate intensity aerobic exercise would impact motor skill acquisition and retention in young healthy adults, compared to a period of rest. We hypothesized that exercise would improve motor skill acquisition and retention, compared to motor practice alone. Materials and Methods Sixteen healthy adults completed sessions of aerobic exercise or seated rest that were immediately followed by practice of a novel motor task (practice). Exercise consisted of 30 minutes of continuous cycling at 60% peak O-2 uptake. Twenty-four hours after practice, we assessed motor learning with a no-exercise retention test (retention). We also quantified changes in offline motor memory consolidation, which occurred between practice and retention (offline). Tracking error was separated into indices of temporal precision and spatial accuracy. Results There were no differences between conditions in the timing of movements during practice (p = 0.066), at retention (p = 0.761), or offline (p = 0.966). However, the exercise condition enabled participants to maintain spatial accuracy during practice (p = 0.477); whereas, following rest performance diminished (p = 0.050). There were no significant differences between conditions at retention (p = 0.532) or offline (p = 0.246). Discussion An acute bout of moderate-intensity aerobic exercise facilitated the maintenance of motor performance during skill acquisition, but did not influence motor learning. Given past work showing that pairing high intensity exercise with skilled motor practice benefits learning, it seems plausible that intensity is a key modulator of the effects of acute aerobic exercise on changes in complex motor behavior. Further work is necessary to establish a dose-response relationship between aerobic exercise and motor learning.	[Snow, Nicholas J.; Mang, Cameron S.; Campbell, Kristin L.; Boyd, Lara A.] Univ British Columbia, Fac Med, Grad Program Rehabil Sci, Vancouver, BC, Canada; [Roig, Marc] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Roig, Marc] Montreal Ctr Interdisciplinary Res Rehabil CRIR, Memory & Motor Rehabil Lab MEMORY LAB, Feil & Oberfeld Res Ctr, Jewish Rehabil Hosp, Laval, PQ, Canada; [McDonnell, Michelle N.] Univ S Australia, Int Ctr Allied Hlth Evidence & Alliance Res Exerc, Sansom Inst Hlth Res, Sch Hlth Sci, Adelaide, SA 5001, Australia; [Boyd, Lara A.] Univ British Columbia, Fac Med, Grad Program Neurosci, Vancouver, BC, Canada	University of British Columbia; McGill University; McGill University; University of South Australia; University of British Columbia	Boyd, LA (corresponding author), Univ British Columbia, Fac Med, Grad Program Rehabil Sci, Vancouver, BC, Canada.; Boyd, LA (corresponding author), Univ British Columbia, Fac Med, Grad Program Neurosci, Vancouver, BC, Canada.	lara.boyd@ubc.ca	Campbell, Kristin L/A-5947-2009; Boyd, Lara/CAF-0372-2022; McDonnell, Michelle Nadine/B-9712-2009	McDonnell, Michelle Nadine/0000-0003-4445-0647; Snow, Nathan/0000-0002-5171-6493; Snow, Nicholas/0000-0003-0942-0688; Roig, Marc/0000-0002-1016-467X; Mang, Cameron/0000-0002-3376-5355	Natural Sciences and Engineering Research Council of Canada [RGPIN 401890-11]; Peter Wall Institute for Interdisciplinary Studies at the University of British Columbia; Natural Sciences and Engineering Research Council of Canada; University of British Columbia; Canada Research Chairs; Michael Smith Foundation for Health Research; Canada Foundation for Innovation; Reseau Provincial de Recherche en Adaptation-Readaptation (Recherche Clinique); Montreal Centre for Interdisciplinary Research in Rehabilitation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Peter Wall Institute for Interdisciplinary Studies at the University of British Columbia; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of British Columbia; Canada Research Chairs(Canada Research ChairsCGIAR); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Reseau Provincial de Recherche en Adaptation-Readaptation (Recherche Clinique); Montreal Centre for Interdisciplinary Research in Rehabilitation	This work was funded by awards from the Natural Sciences and Engineering Research Council of Canada (RGPIN 401890-11 to LAB; http://www.nserc-crsng.gc.ca/) and the Peter Wall Institute for Interdisciplinary Studies at the University of British Columbia (award to LAB; http://pwias.ubc.ca/). NJS and CSM are supported by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) and the University of British Columbia (https://www.ubc.ca/). LAB receives salary support from the Canada Research Chairs (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx) and the Michael Smith Foundation for Health Research (http://www.msfhr.org/). MR was supported with funds from the Natural Sciences and Engineering Research Council of Canada (Discovery Grant; http://www.nserc-crsng.gc.ca/), Canada Foundation for Innovation (John R. Evans Leaders Fund; http://www.innovation.ca/), Reseau Provincial de Recherche en Adaptation-Readaptation (Recherche Clinique; http://www.repar.ca/FR/000/default.asp), and the Montreal Centre for Interdisciplinary Research in Rehabilitation (http:// www.crir.ca/?lang=EN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Sports Medicine [ACSM], 2013, ACSMS GUIDELINES EXE; Audiffren M, 2008, ACTA PSYCHOL, V129, P410, DOI 10.1016/j.actpsy.2008.09.006; Bakken RC, 2001, PHYS THER, V81, P1870, DOI 10.1093/ptj/81.12.1870; Borg G, 1978, PSYCHOL RES PRACTICE, P333; Boyd LA, 2004, NEUROREHAB NEURAL RE, V18, P134, DOI 10.1177/0888439004269072; Boyd LA, 2004, LEARN MEMORY, V11, P388, DOI 10.1101/lm.80104; Boyd LA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-72; Cahill L, 2003, NEUROBIOL LEARN MEM, V79, P194, DOI 10.1016/S1074-7427(02)00036-9; Canadian Society for Exercise Physiology (CSEP), 2002, PHYS ACT READ QUEST; Cirillo J, 2009, J PHYSIOL-LONDON, V587, P5831, DOI 10.1113/jphysiol.2009.181834; Coco M, 2010, SOMATOSENS MOT RES, V27, P1, DOI 10.3109/08990220903471765; Cohen J.E., 1988, STAT POWER ANAL BEHA; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Crouter SE, 2006, EUR J APPL PHYSIOL, V98, P139, DOI 10.1007/s00421-006-0255-0; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Gold SM, 2003, J NEUROIMMUNOL, V138, P99, DOI 10.1016/S0165-5728(03)00121-8; Heyman E, 2012, PSYCHONEUROENDOCRINO, V37, P844, DOI 10.1016/j.psyneuen.2011.09.017; Hillman CH, 2003, INT J PSYCHOPHYSIOL, V48, P307, DOI 10.1016/S0167-8760(03)00080-1; Huang T, 2014, SCAND J MED SCI SPOR, V24, P1, DOI 10.1111/sms.12069; ISSEKUTZ B, 1962, J APPL PHYSIOL, V17, P47, DOI 10.1152/jappl.1962.17.1.47; Kamijo K, 2004, EUR J APPL PHYSIOL, V92, P305, DOI 10.1007/s00421-004-1097-2; Kantak SS, 2012, BEHAV BRAIN RES, V228, P219, DOI 10.1016/j.bbr.2011.11.028; Krakauer JW, 2006, CURR OPIN NEUROL, V19, P84, DOI 10.1097/01.wco.0000200544.29915.cc; Labban JD, 2011, RES Q EXERCISE SPORT, V82, P712, DOI 10.1080/02701367.2011.10599808; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Mang CS, 2014, J APPL PHYSIOL, V117, P1325, DOI 10.1152/japplphysiol.00498.2014; McClernon FJ, 2016, ADDICT BIOL, V21, P954, DOI 10.1111/adb.12253; McDonnell MN, 2013, J APPL PHYSIOL, V114, P1174, DOI 10.1152/japplphysiol.01378.2012; McDonnell MN, 2011, ARCH PHYS MED REHAB, V92, P1044, DOI 10.1016/j.apmr.2011.01.021; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McMorris T, 2012, BRAIN COGNITION, V80, P338, DOI 10.1016/j.bandc.2012.09.001; McMorris T, 2011, PHYSIOL BEHAV, V102, P421, DOI 10.1016/j.physbeh.2010.12.007; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Potter D, 2005, J SPORT EXERCISE PSY, V27, P117, DOI 10.1123/jsep.27.1.117; Powers ME, 2015, J ATHL TRAINING, V50, P453, DOI 10.4085/1062-6050-50.1.07; Quaney BM, 2009, NEUROREHAB NEURAL RE, V23, P879, DOI 10.1177/1545968309338193; Redondo RL, 2011, NAT REV NEUROSCI, V12, P17, DOI 10.1038/nrn2963; Rhee J, 2016, PSYCHOL RES-PSYCH FO, V80, P518, DOI 10.1007/s00426-015-0682-9; Robertson EM, 2009, PLOS BIOL, V7, P11, DOI 10.1371/journal.pbio.1000019; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Roig M, 2014, NEUROBIOL AGING, V35, P1892, DOI 10.1016/j.neurobiolaging.2014.02.022; Roig M, 2013, NEUROSCI BIOBEHAV R, V37, P1645, DOI 10.1016/j.neubiorev.2013.06.012; Roig M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044594; Saunders AC, 2005, J INHERIT METAB DIS, V28, P695, DOI 10.1007/s10545-005-0090-1; Segal SK, 2012, J ALZHEIMERS DIS, V32, P1011, DOI 10.3233/JAD-2012-121078; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; Singh AM, 2016, BEHAV BRAIN RES, V301, P19, DOI 10.1016/j.bbr.2015.12.020; Singh AM, 2015, J MOTOR BEHAV, V47, P328, DOI 10.1080/00222895.2014.983450; Singh AM, 2014, EXP BRAIN RES, V232, P3675, DOI 10.1007/s00221-014-4049-z; Singh AM, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-23; Skriver K, 2014, NEUROBIOL LEARN MEM, V116, P46, DOI 10.1016/j.nlm.2014.08.004; Smith AE, 2014, EXP BRAIN RES, V232, P1875, DOI 10.1007/s00221-014-3879-z; SQUIRE LR, 1992, J COGNITIVE NEUROSCI, V4, P232, DOI 10.1162/jocn.1992.4.3.232; Statton MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141393; Taubert M, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00692; Wadden K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00169; Willingham DB, 1998, PSYCHOL REV, V105, P558, DOI 10.1037/0033-295X.105.3.558; Winter B, 2007, NEUROBIOL LEARN MEM, V87, P597, DOI 10.1016/j.nlm.2006.11.003; Wulf G, 1997, J EXP PSYCHOL LEARN, V23, P987, DOI 10.1037/0278-7393.23.4.987	59	81	84	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0150039	10.1371/journal.pone.0150039	http://dx.doi.org/10.1371/journal.pone.0150039			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26812148	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000371276100203
J	Snow, NP; Halseth, JM; Lavelle, MJ; Hanson, TE; Blass, CR; Foster, JA; Humphrys, ST; Staples, LD; Hewitt, DG; VerCauteren, KC				Snow, Nathan P.; Halseth, Joseph M.; Lavelle, Michael J.; Hanson, Thomas E.; Blass, Chad R.; Foster, Justin A.; Humphrys, Simon T.; Staples, Linton D.; Hewitt, David G.; VerCauteren, Kurt C.			Bait Preference of Free-Ranging Feral Swine for Delivery of a Novel Toxicant	PLOS ONE			English	Article							BOAR SUS-SCROFA; BIRDS; PIGS; PHARMACEUTICALS; CONSUMPTION; BEHAVIOR; COLOR; HOGS	Invasive feral swine (Sus scrofa) cause extensive damage to agricultural and wildlife resources throughout the United States. Development of sodium nitrite as a new, orally delivered toxicant is underway to provide an additional tool to curtail growth and expansion of feral swine populations. A micro-encapsulation coating around sodium nitrite is used to minimize detection by feral swine and maximize stability for the reactive molecule. To maximize uptake of this toxicant by feral swine, development a bait matrix is needed to 1) protect the micro-encapsulation coating so that sodium nitrite remains undetectable to feral swine, 2) achieve a high degree of acceptance by feral swine, and 3) be minimally appealing to non-target species. With these purposes, a field evaluation at 88 sites in south-central Texas was conducted using remote cameras to evaluate preferences by feral swine for several oil-based bait matrices including uncolored peanut paste, black-colored peanut paste, and peanut-based slurry mixed onto whole-kernel corn. These placebo baits were compared to a reference food, whole-kernel corn, known to be readily taken by feral swine (i.e., control). The amount of bait consumed by feral swine was also estimated using remote cameras and grid boards at 5 additional sites. On initial exposure, feral swine showed reduced visitations to the uncolored peanut paste and peanut slurry treatments. This reduced visitation subsided by the end of the treatment period, suggesting that feral swine needed time to accept these bait types. The black-colored peanut paste was visited equally to the control throughout the study, and enough of this matrix was consumed to deliver lethal doses of micro-encapsulated sodium nitrite to most feral swine during 1-2 feeding events. None of the treatment matrices reduced visitations by nontarget species, but feral swine dominated visitations for all matrices. It was concluded that black-colored peanut paste achieved satisfactory preference and consumption by feral swine, and no discernable preference by non-target species, compared to the other treatments.	[Snow, Nathan P.; Hewitt, David G.] Texas A&M Univ, Caesar Kleberg Wildlife Res Inst, 700 Univ Blvd,MSC 218, Kingsville, TX 78363 USA; [Snow, Nathan P.; Halseth, Joseph M.; Lavelle, Michael J.; Hanson, Thomas E.; Blass, Chad R.; VerCauteren, Kurt C.] US Fish & Wildlife Serv, USDA, APHIS, Natl Wildlife Res Ctr, 4101 LaPorte Ave, Ft Collins, CO 80521 USA; [Foster, Justin A.] Texas Parks & Wildlife Dept, Kerr Wildlife Management Area, 2625 FM 1340, Hunt, TX 78024 USA; [Humphrys, Simon T.; Staples, Linton D.] Invas Anim CRC, 33 Flemington St, Glenside, SA 5062, Australia; [Staples, Linton D.] Anim Control Technol Australia Pty Ltd, 46-50 Freight Dr, Somerton, Vic 3062, Australia	Texas A&M University System; Texas A&M University Kingsville; United States Department of Agriculture (USDA); United States Department of the Interior; US Fish & Wildlife Service	Snow, NP (corresponding author), Texas A&M Univ, Caesar Kleberg Wildlife Res Inst, 700 Univ Blvd,MSC 218, Kingsville, TX 78363 USA.; Snow, NP (corresponding author), US Fish & Wildlife Serv, USDA, APHIS, Natl Wildlife Res Ctr, 4101 LaPorte Ave, Ft Collins, CO 80521 USA.	Nathan.P.Snow@aphis.usda.gov	Campbell, Kristin L/A-5947-2009; Boyd, Lara/CAF-0372-2022; McDonnell, Michelle Nadine/B-9712-2009	McDonnell, Michelle Nadine/0000-0003-4445-0647; Snow, Nathan/0000-0002-5171-6493; Snow, Nicholas/0000-0003-0942-0688; Roig, Marc/0000-0002-1016-467X; Mang, Cameron/0000-0002-3376-5355	USDA National Feral Swine Damage Management Program; Invasive Animals Cooperative Research Center	USDA National Feral Swine Damage Management Program; Invasive Animals Cooperative Research Center	Funding was provided by the USDA National Feral Swine Damage Management Program and the Invasive Animals Cooperative Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One author (LS) of this manuscript was commercially affiliated with Animal Control Technologies Australia Pty Ltd. This author played a role in the study by providing the test materials and preparation of the manuscript.	Adams CE., 2006, URBAN WILDLIFE MANAG; Bailey RG., 1980, DESCRIPTION ECOREGIO; Bailey RG, 1998, ECOREGIONS; Barrios-Garcia MN, 2012, BIOL INVASIONS, V14, P2283, DOI 10.1007/s10530-012-0229-6; Baubet E, 2003, WILDLIFE RES, V30, P179, DOI 10.1071/WR00113; Bevins SN, 2014, BIOSCIENCE, V64, P291, DOI 10.1093/biosci/biu015; BRYANT H, 1984, AUST WILDLIFE RES, V11, P509; CAITHNES.TA, 1971, NEW ZEAL J AGR, V122, P38; Campbell TA, 2012, P 25 VERT PEST C; Campbell TA, 2007, J WILDLIFE DIS, V43, P485, DOI 10.7589/0090-3558-43.3.485; Campbell TA, 2006, WILDLIFE SOC B, V34, P1184, DOI 10.2193/0091-7648(2006)34[1184:UBTDPT]2.0.CO;2; Campbell TA, 2013, INT J PEST MANAGE, V59, P197, DOI 10.1080/09670874.2013.815830; Campbell TA, 2011, PREV VET MED, V98, P243, DOI 10.1016/j.prevetmed.2010.11.018; Campbell TA, 2010, J WILDLIFE MANAGE, V74, P337, DOI 10.2193/2009-131; Campbell TA, 2009, J WILDLIFE MANAGE, V73, P615, DOI 10.2193/2008-326; Chapman J., 2003, WILD MAMMALS N AM, P1164; CHOQUENOT D, 1993, WILDLIFE RES, V20, P15, DOI 10.1071/WR9930015; COBLENTZ BE, 1987, J APPL ECOL, V24, P403, DOI 10.2307/2403883; Cowled BD, 2008, WILDLIFE RES, V35, P651, DOI 10.1071/WR07072; Cushman JH, 2004, ECOL APPL, V14, P1746, DOI 10.1890/03-5142; Day TD, 1999, NEW ZEAL J ECOL, V23, P261; Deligeorgis SG, 2006, APPL ANIM BEHAV SCI, V96, P233, DOI 10.1016/j.applanim.2005.06.006; DICKSON JG, 2001, WILDLIFE SO FORESTS, P191; Figueroa J, 2013, APPL ANIM BEHAV SCI, V148, P120, DOI 10.1016/j.applanim.2013.06.002; Fry J, 2011, PHOTOGRAMM ENG REMOT, V77, P858; Homer C, 2007, PHOTOGRAMM ENG REM S, V73, P337; Hone J, 2002, BIOL CONSERV, V105, P231, DOI 10.1016/S0006-3207(01)00185-9; ILSE LM, 1995, J MAMMAL, V76, P784, DOI 10.2307/1382747; Jolley DB, 2010, J MAMMAL, V91, P519, DOI 10.1644/09-MAMM-A-129.1; Kittawornrat Apisit, 2011, Animal Health Research Reviews, V12, P25, DOI 10.1017/S1466252310000174; Kruschke JK, 2013, J EXP PSYCHOL GEN, V142, P573, DOI 10.1037/a0029146; Lapidge S, 2012, USDA NATL WILDLIFE C, P1158; Massei G, 2010, J WILDLIFE MANAGE, V74, P333, DOI 10.2193/2008-489; MAYER J, 2009, WILD PIGS BIOL DAMAG; Mayer J. J., 2014, SRNLSTI201400292; Newkirk ES, 2014, CPW PHOTO DATABASE; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Pimentel David, 2007, P2; SMITH JE, 1966, AM J PHYSIOL, V210, P347, DOI 10.1152/ajplegacy.1966.210.2.347; Snow N, 2015, BAIT PREFERENCE FREE; Tanida H, 1996, APPL ANIM BEHAV SCI, V49, P173, DOI 10.1016/0168-1591(96)01039-8; Taylor RB, 1997, SOUTHWEST NAT, V42, P33; Theobald DM, 2007, ENVIRON MANAGE, V40, P134, DOI 10.1007/s00267-005-0199-x; van Riper C, 2001, STUD AVIAN BIOL-SER, P221; Weser C, 2013, NEW ZEAL J ZOOL, V40, P137, DOI 10.1080/03014223.2012.710639; West B.C., 2009, MANAGING WILD PIGS T; Williams BL, 2011, J WILDLIFE MANAGE, V75, P655, DOI 10.1002/jwmg.75; Zhang YW, 2013, STAT COMPUT, V23, P743, DOI 10.1007/s11222-012-9343-7	48	81	84	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2016	11	1							e0146712	10.1371/journal.pone.0146712	http://dx.doi.org/10.1371/journal.pone.0146712			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC9GB	26812148	gold, Green Published			2022-12-27	WOS:000369528000012
